data_6y6m_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6y6m _Structure_validation_residue.Date_analyzed 2020-07-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.542 0.687 . . . . 12.72 109.409 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.5 ' HB3' ' HG2' ' A' ' 27' ' ' ARG . 42.7 mt-10 -120.26 143.52 48.27 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.771 -0.649 . . . . 11.63 110.356 -174.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -110.87 144.36 40.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.439 . . . . 9.47 111.05 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.78 172.63 31.84 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.363 -0.922 . . . . 7.73 112.15 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.0 mt -120.8 133.99 65.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 110.083 -0.34 . . . . 10.57 110.083 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.04 112.79 11.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.536 -0.542 . . . . 8.73 109.536 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.452 ' HB2' ' CG ' ' A' ' 23' ' ' GLN . 11.8 tp10 -91.54 -29.95 16.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.799 -0.637 . . . . 10.86 110.988 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -159.77 128.33 5.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.039 -0.528 . . . . 14.48 109.62 -175.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 mt -99.45 126.8 45.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.178 0.513 . . . . 11.73 111.17 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.06 179.26 4.32 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.232 -1.025 . . . . 11.9 108.232 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -91.09 112.53 24.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.503 -0.554 . . . . 16.67 109.503 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 t 70.28 23.85 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.332 -0.849 . . . . 13.28 110.564 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -164.67 151.57 11.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.98 -0.555 . . . . 12.68 109.656 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -162.19 165.37 35.94 Favored Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.349 -0.929 . . . . 7.92 112.669 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -117.18 134.13 55.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.686 0.279 . . . . 9.69 111.486 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.6 mt -106.37 122.84 60.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 7.75 110.058 174.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.452 ' CG ' ' HB2' ' A' ' 13' ' ' GLU . 6.5 mm100 -83.8 147.98 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.533 0.938 . . . . 12.4 113.533 -175.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.2 p -77.94 6.59 7.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.811 -1.54 . . . . 12.96 113.302 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -49.87 -48.66 51.19 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.584 0.587 . . . . 13.58 112.584 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.4 -3.51 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.735 -0.386 . . . . 12.19 112.005 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 28.4 tpt180 -152.48 139.38 19.03 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.991 -0.374 . . . . 12.99 109.991 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -73.03 49.81 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.984 0.364 . . . . 17.26 111.984 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.22 127.86 12.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.933 0.397 . . . . 12.1 111.201 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -108.66 102.31 11.38 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.312 -0.625 . . . . 13.0 109.312 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.442 HD12 ' CE1' ' A' ' 53' ' ' PHE . 71.1 mt -109.91 135.7 50.37 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.876 0.369 . . . . 9.21 111.332 -176.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -91.57 125.36 36.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.139 -0.689 . . . . 9.75 109.139 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -118.13 147.89 42.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.885 0.374 . . . . 6.85 110.518 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -99.08 158.88 15.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.208 -0.451 . . . . 10.15 109.939 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -70.83 -12.42 61.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.058 0.392 . . . . 10.56 112.058 -174.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -81.09 -13.3 58.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.31 0.576 . . . . 12.44 109.895 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -103.94 29.33 5.95 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.652 -0.704 . . . . 11.14 110.771 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -126.31 128.45 47.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.016 0.436 . . . . 8.78 110.949 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 t -101.36 115.65 31.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.716 -0.675 . . . . 9.11 110.818 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.65 -156.19 21.53 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.787 -0.72 . . . . 9.98 112.278 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -89.73 113.62 25.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.854 0.359 . . . . 12.91 110.621 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -68.11 -24.28 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.29 0.567 . . . . 11.97 109.921 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -81.51 -2.61 50.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.768 -0.651 . . . . 14.73 110.369 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -112.94 15.7 19.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.454 0.645 . . . . 13.3 109.716 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.8 tp -103.49 134.0 47.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.51 -0.922 . . . . 10.07 108.51 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -133.75 170.13 16.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.9 0.381 . . . . 13.53 111.116 -171.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.437 ' N ' HD13 ' A' ' 47' ' ' ILE . 3.0 mp -81.15 119.24 30.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.971 -0.559 . . . . 12.26 109.565 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.48 36.65 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.322 -0.711 . . . . 11.04 111.322 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.568 ' CG ' ' HZ1' ' A' ' 71' ' ' LYS . 14.7 t70 -92.93 127.26 48.27 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.442 -0.379 . . . . 8.39 110.143 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -89.31 128.91 1.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.062 2.508 . . . . 8.18 112.929 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.49 161.05 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.166 -0.47 . . . . 4.78 111.207 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.42 128.69 56.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.848 -0.614 . . . . 7.09 109.516 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.442 ' CE1' HD12 ' A' ' 31' ' ' LEU . 44.5 p90 -132.14 155.58 47.9 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.097 0.475 . . . . 7.82 111.204 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.467 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 38.1 tt0 -103.24 120.76 41.34 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.611 -0.722 . . . . 11.59 109.592 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.17 116.33 28.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.116 -0.493 . . . . 12.41 109.853 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 p -139.96 153.29 46.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.103 0.477 . . . . 13.93 111.73 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -92.86 108.95 20.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.964 -0.562 . . . . 16.22 109.944 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.496 ' OD2' HG23 ' A' ' 61' ' ' THR . 14.3 t70 -73.97 110.82 8.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.027 0.441 . . . . 16.64 109.835 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 59' ' ' ARG . 3.3 mmp_? -79.97 -7.2 58.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.059 -0.519 . . . . 23.23 111.2 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.448 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 54.3 ttt180 -70.86 -59.13 2.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 21.87 110.471 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.496 HG23 ' OD2' ' A' ' 58' ' ' ASP . 15.1 t -92.97 -19.26 21.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.25 -0.432 . . . . 17.49 110.44 178.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.57 31.54 15.71 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.856 -0.688 . . . . 17.22 112.492 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -132.63 149.28 72.58 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.036 -0.357 . . . . 14.83 110.036 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.52 126.79 8.51 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.079 1.853 . . . . 13.33 111.468 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.8 pt -130.65 168.75 22.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.321 0.581 . . . . 12.33 111.295 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.19 156.53 17.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.2 -0.909 . . . . 8.91 108.88 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.467 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 8.4 t -79.45 -150.9 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.399 -0.364 . . . . 10.33 110.101 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -8.87 51.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.649 0.611 . . . . 12.02 112.649 -172.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.2 t 55.88 99.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.471 0.653 . . . . 6.52 111.165 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 m -99.46 125.11 45.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.092 0.472 . . . . 6.18 111.12 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.568 ' HZ1' ' CG ' ' A' ' 49' ' ' ASP . 14.1 mmmt -60.16 135.77 57.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.788 -0.642 . . . . 6.59 109.744 172.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.1 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 120.775 0.321 . . . . 6.16 110.791 -176.773 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.443 HG13 ' HB1' ' A' ' 144' ' ' ALA . 6.2 t . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.726 0.298 . . . . 6.19 110.41 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' A' ' 79' ' ' SER . 43.4 t -97.5 134.12 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.306 -0.406 . . . . 6.54 110.548 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -75.15 16.41 0.32 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.685 0.279 . . . . 6.46 111.504 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 77' ' ' VAL . 8.3 t 66.53 -2.3 1.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.812 0.845 . . . . 7.24 111.842 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 62.58 13.76 6.53 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.274 0.63 . . . . 7.07 111.621 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -129.62 118.03 21.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.268 -0.424 . . . . 6.68 109.858 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -95.67 124.32 39.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.063 -0.517 . . . . 6.93 109.862 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.82 164.97 15.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.284 0.564 . . . . 4.0 111.452 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.8 p -125.88 148.28 49.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.292 -0.867 . . . . 3.84 109.774 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.09 161.09 25.54 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.224 -0.989 . . . . 2.58 112.37 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.7 m -102.24 125.61 49.0 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.408 -0.59 . . . . 3.7 109.408 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 51.0 t -68.11 126.23 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 110.189 -0.3 . . . . 3.14 110.189 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.3 p -113.7 -17.02 12.21 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.799 0.333 . . . . 3.77 111.844 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.2 m -150.95 135.03 16.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.282 -0.261 . . . . 3.29 110.597 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -100.0 171.22 7.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 4.39 110.508 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.47 ' N ' HD23 ' A' ' 91' ' ' LEU . 1.8 pt? . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 109.256 -0.646 . . . . 3.62 109.256 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.615 -0.513 . . . . 3.7 109.615 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 t -146.87 143.31 28.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.402 -0.363 . . . . 2.84 110.748 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -97.61 -162.38 31.36 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.723 -0.751 . . . . 1.91 111.918 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 82.9 mmt-85 -140.15 135.15 32.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.99 0.424 . . . . 3.31 111.15 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.26 130.7 68.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.657 -0.701 . . . . 2.17 109.444 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.7 t -109.35 116.3 31.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.86 -0.422 . . . . 3.61 109.86 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -122.57 132.76 54.45 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.411 -0.589 . . . . 3.58 109.411 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -107.05 109.73 21.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.788 -0.642 . . . . 5.1 109.49 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -163.99 147.74 9.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.86 -0.609 . . . . 5.11 110.438 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 62.53 21.01 12.36 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.441 0.463 . . . . 7.42 111.714 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.52 -0.97 87.21 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.732 -0.746 . . . . 5.36 111.99 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -101.89 139.09 37.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.074 0.464 . . . . 5.38 110.589 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 13.8 p -139.47 106.18 5.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.501 -0.772 . . . . 4.96 109.997 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -155.69 162.16 40.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.376 -0.375 . . . . 5.13 110.537 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -95.22 133.75 38.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.646 -0.706 . . . . 4.32 110.584 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.6 mp -106.25 130.77 22.44 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.448 -0.342 . . . . 3.17 110.636 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.74 131.79 22.01 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.632 2.222 . . . . 2.61 111.246 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -138.78 145.39 40.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.978 0.418 . . . . 2.49 110.3 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 p -112.94 164.22 13.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.616 -0.72 . . . . 3.18 109.335 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -77.16 -20.06 56.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.885 0.328 . . . . 5.22 111.885 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.82 -13.83 61.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.897 0.332 . . . . 4.81 111.897 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.498 ' OD2' ' HA ' ' A' ' 154' ' ' CYS . 7.2 t70 -101.11 -0.44 36.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.511 0.672 . . . . 4.0 110.161 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.5 t -82.38 107.32 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.223 0.535 . . . . 4.39 110.374 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.4 145.84 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.992 -0.549 . . . . 6.43 110.774 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.5 -15.98 59.4 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.672 -0.775 . . . . 6.14 112.074 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 62.28 34.8 15.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.102 0.477 . . . . 6.26 110.911 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.3 m -79.98 174.71 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.038 -0.528 . . . . 5.62 110.663 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -127.84 81.35 2.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.295 0.569 . . . . 6.25 110.238 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.411 ' H ' HD22 ' A' ' 133' ' ' LEU . 2.3 pt? -68.44 148.91 49.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.207 -0.906 . . . . 3.62 111.09 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -133.21 139.81 47.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.287 -0.415 . . . . 7.5 109.961 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.595 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -55.62 121.32 8.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.164 0.506 . . . . 4.12 111.675 -173.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.65 -13.2 11.9 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.301 -0.863 . . . . 4.2 112.572 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -91.19 177.41 6.26 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.292 0.546 . . . . 4.06 109.864 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -116.97 116.58 27.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.089 0.471 . . . . 4.48 110.711 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.11 159.98 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.076 -0.511 . . . . 2.98 110.714 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.1 t -114.83 139.51 49.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.974 -0.75 . . . . 3.68 108.974 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -144.73 143.62 30.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.016 0.436 . . . . 3.35 110.149 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -98.95 119.2 37.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.579 -0.737 . . . . 5.34 109.937 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.8 mt -78.67 96.86 2.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.085 -0.507 . . . . 4.66 109.709 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.443 ' HB1' HG13 ' A' ' 76' ' ' VAL . . . -90.16 111.2 22.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.796 -0.638 . . . . 5.08 110.758 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 28.4 m -84.25 112.9 20.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.509 -0.769 . . . . 5.68 110.335 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.42 158.52 31.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.936 -0.574 . . . . 6.25 109.549 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -60.92 -20.27 61.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.99 0.424 . . . . 9.03 111.379 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 148' ' ' ARG . 2.7 mmt180 -78.26 -8.2 58.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 8.29 111.717 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.71 -1.96 84.48 Favored Glycine 0 C--O 1.227 -0.292 0 C-N-CA 120.824 -0.703 . . . . 5.65 112.328 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -100.4 132.4 45.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.902 -0.406 . . . . 5.26 109.902 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.47 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -150.76 178.78 8.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.534 -0.303 . . . . 4.63 110.847 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -150.36 -125.17 1.28 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.805 -0.918 . . . . 3.57 110.805 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -121.28 126.1 48.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.841 -0.429 . . . . 2.84 109.841 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.498 ' HA ' ' OD2' ' A' ' 126' ' ' ASP . 17.7 t -136.59 159.22 42.46 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.114 -0.328 . . . . 4.34 110.114 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 63.08 36.26 12.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.319 0.581 . . . . 6.23 110.558 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.8 mt -75.77 115.99 18.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.637 -0.711 . . . . 3.55 110.816 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -135.94 160.04 39.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.806 0.336 . . . . 6.3 110.165 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.9 tp -92.35 110.93 22.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 4.63 110.353 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -98.84 -57.55 2.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.782 -0.645 . . . . 4.97 110.686 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -111.17 96.63 31.39 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.244 -0.434 . . . . 5.57 110.022 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.14 158.25 23.45 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.233 1.956 . . . . 5.69 113.114 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.578 -0.737 . . . . 6.1 109.775 175.555 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 120.998 0.428 . . . . 12.72 109.969 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.428 ' CD ' ' HE ' ' A' ' 27' ' ' ARG . 6.3 mm-40 -98.13 136.77 37.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.106 -0.497 . . . . 11.63 109.886 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 67.2 p -109.33 138.69 45.3 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 121.102 -0.239 . . . . 9.47 110.593 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 26' ' ' GLU . . . -150.86 -176.03 23.38 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.147 -1.025 . . . . 7.73 112.45 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.0 mt -132.43 155.41 41.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.336 -0.987 . . . . 10.57 108.336 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.76 118.86 34.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.508 -0.477 . . . . 8.73 110.387 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.574 ' OE1' ' HD2' ' A' ' 30' ' ' ARG . 5.8 pt-20 -82.58 -32.59 28.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.376 -0.374 . . . . 10.86 111.089 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -159.19 158.15 32.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.28 -0.418 . . . . 14.48 109.899 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -125.44 118.16 25.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.107 -0.497 . . . . 11.73 110.984 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -105.57 178.95 4.41 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.488 -1.301 . . . . 11.9 107.488 172.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -92.1 138.46 31.52 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 119.917 -0.713 . . . . 16.67 109.986 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.3 p 74.62 -23.07 0.24 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.185 1.394 . . . . 13.28 112.032 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 49.5 p90 -151.8 158.59 43.5 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.872 0.368 . . . . 12.68 111.303 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.44 178.24 21.73 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.198 -0.761 . . . . 7.92 111.198 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -119.54 141.68 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.137 0.468 . . . . 9.69 111.542 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.418 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 67.4 mt -103.28 125.35 57.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.449 -0.796 . . . . 7.75 110.006 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 25.0 tt0 -80.59 134.77 35.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.439 -0.8 . . . . 12.4 111.833 -172.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 p -78.96 2.33 20.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.718 -1.128 . . . . 12.96 112.231 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.461 ' H ' ' HG2' ' A' ' 23' ' ' GLN . 49.2 t -60.17 -29.96 69.02 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.059 -0.4 . . . . 13.58 110.949 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 19.8 tp10 -103.99 -43.41 5.29 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.446 -0.343 . . . . 12.19 110.914 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.494 ' HG2' ' N ' ' A' ' 28' ' ' GLN . 28.5 ttt180 -95.09 155.48 16.71 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 110.16 -0.311 . . . . 12.99 110.16 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.494 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 87.2 mt-30 -77.62 20.06 0.34 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.282 0.475 . . . . 17.26 112.282 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.471 ' HB1' ' NH1' ' A' ' 27' ' ' ARG . . . -169.82 144.85 2.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.33 -0.395 . . . . 12.1 110.335 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.574 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 11.2 ttp180 -90.34 148.45 22.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 13.0 109.927 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -144.57 163.86 32.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.362 0.265 . . . . 9.21 110.676 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -121.1 149.3 42.96 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.953 -0.758 . . . . 9.75 108.953 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -138.98 153.38 48.16 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.852 -0.339 . . . . 6.85 110.237 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.503 ' HB2' ' OE1' ' A' ' 37' ' ' GLN . 67.1 m80 -98.6 159.51 14.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.98 -0.748 . . . . 10.15 108.98 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -70.27 -9.65 56.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.134 0.492 . . . . 10.56 110.979 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.1 m -75.13 -15.37 60.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.02 0.438 . . . . 12.44 110.162 174.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.503 ' OE1' ' HB2' ' A' ' 34' ' ' HIS . 25.3 mp0 -113.28 36.95 3.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.002 -0.545 . . . . 11.14 110.938 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -125.32 116.31 21.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.852 0.358 . . . . 8.78 110.13 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 68' ' ' GLN . 22.3 t -87.04 95.36 9.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.017 -0.538 . . . . 9.11 110.856 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.1 175.57 14.48 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.73 -0.668 . . . . 9.98 111.613 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.04 122.25 16.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.679 0.276 . . . . 12.91 110.353 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.6 tp -66.08 -18.81 24.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.227 0.537 . . . . 11.97 110.335 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.7 -25.71 65.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.686 . . . . 14.73 110.637 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -83.88 0.25 48.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 13.3 110.459 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.9 tp -104.04 123.01 46.45 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.051 0.453 . . . . 10.07 110.472 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 12.9 mmmm -120.17 162.29 19.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.612 -0.722 . . . . 13.53 110.225 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.5 mt -71.8 114.81 11.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.993 -0.548 . . . . 12.26 109.793 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.07 -4.12 28.63 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.905 -0.664 . . . . 11.04 111.679 -173.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -80.01 133.75 57.46 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-O 120.621 0.248 . . . . 8.39 110.41 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.6 142.03 7.93 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.168 2.578 . . . . 8.18 113.102 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.81 161.14 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.65 -0.705 . . . . 4.78 110.588 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.72 135.06 53.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.065 0.46 . . . . 7.09 109.801 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -144.78 158.3 43.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 7.82 110.985 -170.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 2.5 mp0 -97.98 122.6 41.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.385 -0.37 . . . . 11.59 110.546 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.446 ' HG2' ' NH2' ' A' ' 27' ' ' ARG . 14.6 tpt -88.41 107.89 19.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.481 -0.563 . . . . 12.41 109.481 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.6 p -132.75 165.67 24.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.903 0.382 . . . . 13.93 111.149 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -118.64 122.28 42.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.1 -0.704 . . . . 16.22 109.1 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -90.65 134.58 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.133 0.492 . . . . 16.64 111.654 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -79.94 -13.8 59.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.474 -0.785 . . . . 23.23 112.757 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -92.24 -43.29 9.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 21.87 111.107 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -86.7 -32.9 20.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.356 -0.384 . . . . 17.49 111.483 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.49 19.34 68.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.024 -0.608 . . . . 17.22 112.122 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -122.38 158.26 56.49 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.263 -0.273 . . . . 14.83 110.263 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.28 126.53 8.53 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.33 2.02 . . . . 13.33 110.616 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.09 154.34 35.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.925 0.393 . . . . 12.33 111.338 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -99.83 158.81 15.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.865 -0.607 . . . . 8.91 109.997 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 56.2 p -73.75 -150.04 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.16 0.505 . . . . 10.33 111.592 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 39' ' ' SER . 30.1 pt20 -70.95 -5.35 30.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.817 -0.628 . . . . 12.02 112.277 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.9 t 50.95 89.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.714 0.769 . . . . 6.52 111.219 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.6 m -90.61 135.94 33.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.762 -0.654 . . . . 6.18 111.16 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -72.6 123.15 22.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.054 -0.721 . . . . 6.59 109.054 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.5 mt . . . . . 0 C--O 1.233 0.237 0 O-C-N 123.805 0.69 . . . . 6.16 111.845 -173.363 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.413 ' CG2' ' HB3' ' A' ' 144' ' ' ALA . 9.9 p . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 109.691 -0.485 . . . . 6.19 109.691 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 39.6 t -76.93 108.07 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.035 0.445 . . . . 6.54 111.369 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.1 mt -104.24 -48.72 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 6.46 111.289 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.515 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 66.2 m -99.72 86.94 3.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.312 0.486 . . . . 7.24 112.312 -175.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 79' ' ' SER . 0.9 OUTLIER -177.55 116.04 0.09 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.095 0.958 . . . . 7.07 108.809 174.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 66.34 64.36 0.51 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.813 0.816 . . . . 6.68 109.885 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 6.4 ptm180 -78.32 107.39 10.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.351 -0.841 . . . . 6.93 110.322 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.4 m -93.7 160.49 2.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.986 -0.552 . . . . 4.0 111.76 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 p -119.51 139.39 52.18 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.285 -0.871 . . . . 3.84 109.426 171.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.92 163.69 25.27 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.277 -0.963 . . . . 2.58 112.081 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.8 m -107.76 125.16 51.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.493 -0.558 . . . . 3.7 109.493 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 1.6 t -66.47 131.2 32.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.05 -0.722 . . . . 3.14 109.05 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.8 p -109.45 -16.54 13.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.052 0.453 . . . . 3.77 110.756 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.8 m -154.44 122.7 6.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.291 -0.413 . . . . 3.29 110.859 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 134' ' ' ARG . 4.7 mp0 -95.45 135.25 37.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.463 -0.335 . . . . 4.39 110.84 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.544 ' H ' HD23 ' A' ' 91' ' ' LEU . 1.7 pt? . . . . . 0 C--N 1.324 -0.539 0 CA-C-O 122.706 1.241 . . . . 3.62 109.414 170.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.519 HG21 ' HB2' ' A' ' 91' ' ' LEU . 4.8 t . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 109.641 -0.503 . . . . 3.7 109.641 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.4 m -134.28 134.51 41.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.542 -0.299 . . . . 2.84 110.373 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.86 168.9 54.91 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.896 -0.668 . . . . 1.91 112.257 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -128.81 122.6 30.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.808 0.337 . . . . 3.31 110.915 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 99.5 mt -112.17 127.67 69.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.773 -0.825 . . . . 2.17 108.773 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.7 t -111.53 125.8 54.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.8 0.333 . . . . 3.61 110.288 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 1.0 OUTLIER -129.41 145.81 51.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.171 -0.677 . . . . 3.58 109.171 178.177 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -118.2 112.37 20.05 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.255 -0.646 . . . . 5.1 109.255 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -126.78 108.65 11.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 5.11 110.476 -175.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 62.4 30.44 17.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.028 -0.533 . . . . 7.42 111.994 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.03 -0.47 60.49 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.962 -0.637 . . . . 5.36 113.95 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -108.71 137.64 46.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.667 0.733 . . . . 5.38 109.718 172.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 3.8 p -141.03 92.54 2.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.053 -0.521 . . . . 4.96 110.776 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -98.02 163.52 12.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.964 -0.562 . . . . 5.13 110.345 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -98.44 121.17 40.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.29 -0.633 . . . . 4.32 109.29 176.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.0 mt -103.86 130.34 23.61 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.157 -0.474 . . . . 3.17 110.934 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.54 141.61 17.76 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.709 2.273 . . . . 2.61 111.997 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -146.78 144.26 29.24 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.417 -0.586 . . . . 2.49 109.417 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 37.9 p -105.89 173.25 6.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.677 -0.49 . . . . 3.18 109.677 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -71.04 -19.48 62.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.394 0.616 . . . . 5.22 109.95 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -81.03 -10.8 59.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.02 -0.991 . . . . 4.81 111.43 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -87.88 -10.25 51.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.93 0.395 . . . . 4.0 110.711 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.6 t -87.09 120.3 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.826 -0.624 . . . . 4.39 110.825 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -106.45 153.86 21.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.677 -0.692 . . . . 6.43 110.222 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.75 -1.57 85.46 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.96 -0.638 . . . . 6.14 112.31 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 63.61 17.11 10.17 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.103 0.561 . . . . 6.26 111.066 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.15 147.94 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.117 0.484 . . . . 5.62 110.892 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.83 108.6 20.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.2 -0.454 . . . . 6.25 110.564 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.469 ' H ' HD22 ' A' ' 133' ' ' LEU . 2.5 pt? -106.36 150.36 26.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.862 -0.608 . . . . 3.62 110.169 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.5 ' HA ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -149.96 175.31 11.79 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.786 -0.365 . . . . 7.5 110.511 171.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.54 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -69.81 119.5 14.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.677 0.275 . . . . 4.12 111.087 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.89 -7.54 11.94 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.859 -0.686 . . . . 4.2 113.567 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -111.6 173.57 6.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.898 0.849 . . . . 4.06 110.584 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -110.93 116.41 31.18 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.173 0.511 . . . . 4.48 111.519 -173.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.35 157.49 18.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.634 -0.712 . . . . 2.98 110.906 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.427 ' HB2' ' CG ' ' A' ' 159' ' ' GLU . 8.0 t -119.2 134.44 55.2 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.02 -0.733 . . . . 3.68 109.02 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -132.73 144.91 50.61 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.892 0.377 . . . . 3.35 110.237 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -95.42 112.26 24.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.779 -0.646 . . . . 5.34 109.699 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 57.8 mt -79.25 96.1 2.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.83 -0.623 . . . . 4.66 110.222 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.692 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -81.54 108.23 14.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.189 -0.46 . . . . 5.08 110.516 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 m -85.16 110.36 18.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.037 0.446 . . . . 5.68 110.862 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -75.14 155.37 37.08 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.108 -0.701 . . . . 6.25 109.108 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -61.22 -23.42 65.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.939 0.348 . . . . 9.03 111.939 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -72.21 -23.88 61.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.997 0.427 . . . . 8.29 110.414 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 96.3 10.76 55.57 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.048 -0.596 . . . . 5.65 112.701 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.01 132.95 46.18 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.827 -0.435 . . . . 5.26 109.827 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.481 HD11 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -155.44 -178.45 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.857 -0.611 . . . . 4.63 110.887 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.96 -139.79 2.78 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.854 -0.898 . . . . 3.57 110.854 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.42 110.05 21.92 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.861 -0.422 . . . . 2.84 109.861 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 59.0 m -117.87 151.14 37.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.417 -0.356 . . . . 4.34 110.704 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 56.74 51.58 10.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.856 -0.611 . . . . 6.23 110.958 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.6 mp -66.54 115.72 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 3.55 110.364 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -114.21 157.91 22.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.165 -0.47 . . . . 6.3 109.98 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.2 tp -97.56 123.25 41.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.401 -0.363 . . . . 4.63 110.354 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.427 ' CG ' ' HB2' ' A' ' 140' ' ' SER . 21.3 mm-40 -102.33 -53.37 2.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.986 0.422 . . . . 4.97 111.192 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -136.34 102.62 9.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.187 -0.461 . . . . 5.57 110.75 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.89 160.9 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.418 2.079 . . . . 5.69 111.778 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 116.222 -0.444 . . . . 6.1 110.031 176.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 121.375 0.607 . . . . 12.72 111.013 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -100.74 144.81 29.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.635 -0.711 . . . . 11.63 110.003 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p -113.68 136.11 53.19 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.711 0.291 . . . . 9.47 110.962 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.38 177.01 28.73 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.546 -0.835 . . . . 7.73 112.622 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -128.82 140.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.255 -0.646 . . . . 10.57 109.255 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.57 118.09 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.837 -0.345 . . . . 8.73 110.64 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 22.3 tt0 -83.04 -44.93 14.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 10.86 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -157.82 137.01 11.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.44 -0.8 . . . . 14.48 109.83 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.0 mt -99.55 121.14 40.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.445 0.64 . . . . 11.73 111.306 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.29 -178.45 3.65 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.834 -1.075 . . . . 11.9 108.421 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -88.78 111.11 21.62 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.562 -0.455 . . . . 16.67 110.33 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.0 t 79.03 3.43 2.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.595 -1.184 . . . . 13.28 111.429 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -158.92 153.19 23.89 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 110.276 -0.268 . . . . 12.68 110.276 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.95 162.79 27.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.423 -0.894 . . . . 7.92 112.407 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -104.44 136.45 43.97 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.058 0.456 . . . . 9.69 110.968 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -103.64 127.71 57.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.651 -0.704 . . . . 7.75 110.384 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.438 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -71.77 141.81 49.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.215 -0.902 . . . . 12.4 111.644 -178.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.8 p -78.14 2.78 16.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.626 -1.17 . . . . 12.96 111.408 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.4 t -50.3 -39.33 45.36 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.659 0.614 . . . . 13.58 112.659 -170.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -105.55 7.53 32.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.045 0.387 . . . . 12.19 112.045 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.2 -159.37 1.02 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.806 0.336 . . . . 12.99 111.143 -176.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -120.66 22.41 11.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.689 0.28 . . . . 17.26 111.291 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.13 135.64 34.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.021 0.439 . . . . 12.1 111.458 -173.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -106.92 102.58 11.93 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.479 -0.934 . . . . 13.0 108.479 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -110.88 162.18 15.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.208 0.528 . . . . 9.21 111.379 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -126.25 139.41 53.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.381 -0.827 . . . . 9.75 109.333 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -132.59 152.37 51.65 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.053 -0.351 . . . . 6.85 110.053 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -91.98 161.4 14.82 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.204 -0.665 . . . . 10.15 109.204 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -71.71 -8.23 52.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 10.56 111.677 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -79.34 -12.21 59.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.368 0.604 . . . . 12.44 109.517 172.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -103.38 36.49 2.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.547 -0.751 . . . . 11.14 110.133 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -138.09 139.54 39.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.063 -0.347 . . . . 8.78 110.063 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t -121.69 119.48 31.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.25 -0.432 . . . . 9.11 110.552 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.57 -161.94 20.8 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.893 -0.67 . . . . 9.98 112.337 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -77.45 113.53 15.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.754 0.312 . . . . 12.91 110.836 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -72.35 -25.71 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.048 0.451 . . . . 11.97 110.911 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.71 -12.29 59.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.234 0.54 . . . . 14.73 110.332 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -89.17 -7.48 55.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 13.3 109.889 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.2 tp -93.17 124.79 37.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.593 -0.731 . . . . 10.07 109.944 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -132.12 178.26 6.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.028 0.442 . . . . 13.53 110.671 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.2 mp -73.8 129.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.946 -0.57 . . . . 12.26 109.745 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.65 -1.53 66.22 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.674 -0.774 . . . . 11.04 111.946 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.447 ' CG ' ' HZ1' ' A' ' 71' ' ' LYS . 22.3 t0 -91.34 123.32 64.41 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.823 -0.436 . . . . 8.39 109.823 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.97 142.98 32.12 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.985 2.457 . . . . 8.18 113.808 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.85 156.79 40.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.63 -0.714 . . . . 4.78 110.91 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -116.6 138.6 51.3 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.483 -0.562 . . . . 7.09 109.483 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -150.16 176.6 10.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.52 -0.309 . . . . 7.82 110.688 -177.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 26.7 mt-10 -118.88 132.86 56.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.22 -0.659 . . . . 11.59 109.22 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.5 tpt -93.59 113.85 26.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.001 -0.545 . . . . 12.41 109.64 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 p -135.8 138.45 42.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.587 0.588 . . . . 13.93 112.587 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -95.35 110.7 22.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.078 -0.51 . . . . 16.22 109.709 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.98 121.71 32.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.8 0.333 . . . . 16.64 111.076 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -79.23 -20.95 46.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 23.23 110.964 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.419 ' HE ' ' C ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -67.09 -53.86 26.91 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.392 -0.596 . . . . 21.87 109.392 -177.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.8 p -86.36 -29.69 22.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.149 -0.478 . . . . 17.49 111.172 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.86 31.74 28.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.729 -0.748 . . . . 17.22 111.81 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -135.12 141.34 37.73 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.133 -0.321 . . . . 14.83 110.133 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.22 125.31 10.71 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.809 1.673 . . . . 13.33 110.642 172.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.13 162.6 27.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.245 0.545 . . . . 12.33 111.816 -174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.42 173.41 6.77 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.453 -0.794 . . . . 8.91 110.779 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 22.7 t -87.26 -160.97 0.64 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.983 -0.553 . . . . 10.33 110.114 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -83.49 25.35 0.76 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.693 -0.23 . . . . 12.02 111.491 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t 30.02 96.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.693 1.197 . . . . 6.52 113.713 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -91.83 141.93 28.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.231 0.539 . . . . 6.18 110.761 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.447 ' HZ1' ' CG ' ' A' ' 49' ' ' ASP . 0.6 OUTLIER -76.16 110.03 10.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.802 -0.635 . . . . 6.59 111.44 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 115.498 -0.774 . . . . 6.16 110.372 178.032 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.479 ' CG1' ' HB3' ' A' ' 144' ' ' ALA . 45.0 t . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 122.688 1.232 . . . . 6.19 109.246 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 t -88.34 114.73 27.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 113.831 -1.532 . . . . 6.54 110.649 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.67 -18.14 58.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.005 0.431 . . . . 6.46 110.317 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 t -95.5 52.49 1.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 7.24 110.694 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.47 -68.2 0.92 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.953 -0.567 . . . . 7.07 110.343 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -152.52 106.13 3.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.899 -0.591 . . . . 6.68 109.627 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -95.04 133.38 38.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.606 -0.516 . . . . 6.93 109.606 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.98 169.07 20.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.204 0.526 . . . . 4.0 111.202 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.4 p -118.7 144.57 46.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.496 -0.775 . . . . 3.84 109.502 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.45 170.2 23.99 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.076 -1.059 . . . . 2.58 112.268 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.9 m -121.74 132.06 54.42 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.833 -0.432 . . . . 3.7 109.833 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.6 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 48.8 t -65.25 126.34 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.322 -0.399 . . . . 3.14 110.501 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.0 p -111.19 -16.63 13.39 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.857 0.361 . . . . 3.77 111.199 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.8 m -153.65 130.33 10.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.237 -0.438 . . . . 3.29 109.916 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -176.86 3.2 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.274 0.359 . . . . 4.39 111.093 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.0 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.97 0.414 . . . . 3.62 111.072 -176.705 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 109.074 -0.713 . . . . 3.7 109.074 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.11 125.51 44.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.429 -0.35 . . . . 2.84 110.721 -175.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -81.65 176.74 54.16 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.667 -0.778 . . . . 1.91 111.617 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -134.4 130.49 36.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 3.31 111.386 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.7 mt -112.57 129.11 68.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.458 -0.792 . . . . 2.17 108.961 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -107.28 132.74 52.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.616 0.246 . . . . 3.61 110.479 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.66 156.04 47.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.731 -0.84 . . . . 3.58 108.731 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.05 125.74 54.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.754 -0.462 . . . . 5.1 109.754 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.565 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 47.9 t30 -138.68 135.94 35.35 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.545 -0.909 . . . . 5.11 108.545 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 63.79 18.54 11.21 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.519 0.512 . . . . 7.42 111.8 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.33 3.73 78.2 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.668 -0.777 . . . . 5.36 112.171 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -123.11 141.29 52.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.111 0.482 . . . . 5.38 110.598 178.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 13.9 p -105.11 136.67 44.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.944 -0.571 . . . . 4.96 110.865 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -128.69 172.58 11.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.924 -0.58 . . . . 5.13 110.121 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.85 124.39 40.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.964 -0.562 . . . . 4.32 110.228 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 5.6 mp -104.36 131.45 21.88 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 110.18 -0.304 . . . . 3.17 110.18 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 3.6 Cg_exo -75.96 132.12 13.87 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.945 2.43 . . . . 2.61 111.55 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -138.5 153.42 48.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.067 0.46 . . . . 2.49 110.642 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.5 p -118.11 -175.16 2.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.878 -0.601 . . . . 3.18 110.121 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.425 ' HZ1' ' HB2' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -72.79 -17.65 61.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 5.22 110.651 177.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -82.82 -23.84 33.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.687 -0.688 . . . . 4.81 111.066 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -77.39 -26.09 51.46 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.281 -0.418 . . . . 4.0 111.364 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.83 116.22 47.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.646 0.736 . . . . 4.39 111.119 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.87 163.61 12.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.435 -0.802 . . . . 6.43 109.413 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.31 -9.52 30.99 Favored Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.69 -0.767 . . . . 6.14 112.521 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.1 t30 66.14 16.98 10.65 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.533 0.682 . . . . 6.26 110.655 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 t -78.12 120.35 28.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.808 -0.441 . . . . 5.62 109.808 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -81.57 119.56 23.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.934 0.397 . . . . 6.25 110.933 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 133' ' ' LEU . 1.8 pt? -115.56 149.24 38.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.424 -0.807 . . . . 3.62 110.679 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.588 ' HD2' ' OD1' ' A' ' 137' ' ' ASP . 0.0 OUTLIER -137.18 155.9 48.98 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.962 -0.755 . . . . 7.5 108.962 174.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.6 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -57.32 121.82 11.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.044 0.449 . . . . 4.12 110.835 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.26 -13.23 11.18 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.86 -0.686 . . . . 4.2 113.302 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.588 ' OD1' ' HD2' ' A' ' 134' ' ' ARG . 6.4 p30 -95.32 174.94 6.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.142 0.971 . . . . 4.06 110.216 172.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -110.17 122.27 47.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 4.48 111.381 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.28 150.68 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.018 -0.537 . . . . 2.98 110.929 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.6 t -120.92 133.83 55.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.113 -0.699 . . . . 3.68 109.113 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -137.37 143.26 41.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.021 0.438 . . . . 3.35 110.825 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -94.86 124.58 38.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.518 -0.764 . . . . 5.34 109.628 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.33 99.16 3.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.364 0.602 . . . . 4.66 110.582 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.479 ' HB3' ' CG1' ' A' ' 76' ' ' VAL . . . -89.79 109.32 20.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.196 -0.911 . . . . 5.08 110.867 -176.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.2 m -80.29 113.97 18.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.103 -0.498 . . . . 5.68 111.908 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.52 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 1.6 m120 -66.24 159.05 27.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.402 -0.363 . . . . 6.25 110.068 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -31.06 67.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.955 0.407 . . . . 9.03 111.263 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -77.04 -13.33 59.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.084 -0.507 . . . . 8.29 111.17 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.59 5.65 78.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.571 -0.823 . . . . 5.65 111.434 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 5.1 m-20 -107.92 120.99 43.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.325 . . . . 5.26 110.279 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.46 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.1 178.35 9.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.299 -0.41 . . . . 4.63 110.623 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -131.36 -112.96 1.5 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.455 -0.658 . . . . 3.57 111.455 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -123.11 137.3 54.95 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.526 -0.546 . . . . 2.84 109.526 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 84.1 m -139.81 156.57 46.67 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.2 -0.2 . . . . 4.34 110.896 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 57.46 44.42 21.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.881 0.738 . . . . 6.23 111.045 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.73 114.89 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.68 -0.691 . . . . 3.55 110.729 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -119.48 131.12 55.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.208 -0.451 . . . . 6.3 110.554 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.19 116.13 22.78 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.96 -0.756 . . . . 4.63 108.96 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -95.42 -43.99 7.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.76 0.281 . . . . 4.97 111.76 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -126.29 96.26 36.9 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 5.57 110.001 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.35 155.12 14.29 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.759 2.306 . . . . 5.69 113.4 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.632 -0.713 . . . . 6.1 109.822 175.909 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.374 -0.602 . . . . 12.72 109.374 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.511 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 3.5 pt-20 -121.73 166.73 13.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 11.63 110.729 -173.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 80.6 p -108.44 156.84 18.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.479 0.548 . . . . 9.47 112.479 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.82 -173.38 30.41 Favored Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 110.839 -0.904 . . . . 7.73 110.839 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.424 HG13 ' HB2' ' A' ' 23' ' ' GLN . 12.6 pt -128.52 152.63 36.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 117.158 0.479 . . . . 10.57 110.327 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.07 127.33 28.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.76 0.314 . . . . 8.73 110.888 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.491 ' HG2' ' HG2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -68.95 -56.24 8.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.677 -0.692 . . . . 10.86 109.284 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -169.1 166.54 10.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.791 -1.095 . . . . 14.48 108.432 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -112.0 126.29 54.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.215 0.531 . . . . 11.73 111.521 -175.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 3.0 mm? -122.16 -179.02 4.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.946 -1.024 . . . . 11.9 108.598 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -88.71 124.57 34.24 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.007 -0.433 . . . . 16.67 110.114 -177.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m 78.39 -35.86 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.959 0.903 . . . . 13.28 112.169 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 17.5 p90 -131.79 151.57 51.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.45 . . . . 12.68 111.248 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.08 172.95 23.21 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.844 -0.903 . . . . 7.92 110.844 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -119.49 155.22 32.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.049 0.425 . . . . 9.69 110.742 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.7 mt -111.69 128.77 68.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.97 -0.559 . . . . 7.75 110.141 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.491 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 2.5 mm-40 -74.79 132.03 41.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.309 0.576 . . . . 12.4 111.525 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.2 p -80.6 1.61 29.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.161 -0.927 . . . . 12.96 111.861 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 70.9 m -52.77 -42.21 64.77 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.604 0.24 . . . . 13.58 111.621 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.88 -42.84 14.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.234 0.54 . . . . 12.19 111.148 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 8' ' ' GLU . 31.5 tpt180 -132.34 142.29 49.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.077 -0.51 . . . . 12.99 109.779 -174.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.92 52.69 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.285 0.476 . . . . 17.26 112.285 -175.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.78 101.74 2.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.906 0.384 . . . . 12.1 110.428 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -85.91 100.91 12.42 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.293 -1.003 . . . . 13.0 108.293 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.8 mt -110.8 163.42 13.8 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.497 -0.774 . . . . 9.21 111.457 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -115.12 135.31 54.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.02 -0.733 . . . . 9.75 109.02 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -132.89 136.05 45.95 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.767 -0.457 . . . . 6.85 109.767 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 73.2 m80 -84.92 164.4 18.37 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.467 -0.568 . . . . 10.15 109.467 178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -70.07 -10.23 58.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.951 0.405 . . . . 10.56 110.71 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.6 p -84.12 -9.04 58.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.007 -0.542 . . . . 12.44 110.077 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -108.73 26.63 10.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.515 -0.766 . . . . 11.14 110.339 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -130.68 130.02 43.35 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.688 -0.405 . . . . 8.78 110.087 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -93.35 107.79 19.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.725 -0.671 . . . . 9.11 110.493 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.74 -156.34 22.06 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.429 -0.891 . . . . 9.98 113.15 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 44' ' ' HIS . 1.0 OUTLIER -93.55 117.85 30.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.17 0.509 . . . . 12.91 111.803 -176.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.04 -22.63 10.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.492 -0.776 . . . . 11.97 110.319 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.95 -40.11 92.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.097 -0.501 . . . . 14.73 111.42 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.478 ' HB2' ' ND2' ' A' ' 41' ' ' ASN . 18.8 m80 -97.05 12.15 33.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.182 -0.463 . . . . 13.3 110.198 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.64 136.28 33.08 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.399 -0.593 . . . . 10.07 109.399 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.493 ' HE2' ' HB2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -130.41 157.49 42.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.241 0.544 . . . . 13.53 111.29 -174.167 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.6 mt -69.25 141.72 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.241 -0.89 . . . . 12.26 110.969 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.35 11.47 66.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.438 -0.886 . . . . 11.04 112.248 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.493 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 6.5 t70 -84.97 131.65 48.24 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.956 -0.143 . . . . 8.39 111.016 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.17 120.09 5.56 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.766 2.31 . . . . 8.18 112.864 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.458 HG11 ' HE3' ' A' ' 71' ' ' LYS . 27.8 m -128.45 162.45 35.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.893 -0.594 . . . . 4.78 110.451 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 1.2 pt-20 -113.22 139.57 48.68 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.369 -0.604 . . . . 7.09 109.369 173.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.511 ' CE1' ' HG3' ' A' ' 8' ' ' GLU . 31.2 p90 -132.08 139.58 48.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.714 0.768 . . . . 7.82 111.784 -177.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 39.1 tt0 -88.9 104.87 17.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.847 -1.069 . . . . 11.59 108.7 174.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 13.7 tpt -88.45 114.85 25.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.197 -0.456 . . . . 12.41 110.473 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.6 p -142.85 167.12 22.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.057 0.456 . . . . 13.93 111.283 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.462 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 73.6 m-85 -112.47 109.41 18.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.901 -0.59 . . . . 16.22 109.508 175.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.22 125.53 31.05 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.839 -0.345 . . . . 16.64 110.212 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -78.35 -17.92 55.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.413 -0.358 . . . . 23.23 111.664 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -77.8 -42.55 33.46 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.6 -0.44 . . . . 21.87 110.007 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.4 p -84.35 -33.59 23.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.023 -0.535 . . . . 17.49 110.597 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.53 24.72 62.3 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.763 -0.653 . . . . 17.22 112.11 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -126.63 148.1 63.33 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.974 -0.38 . . . . 14.83 109.974 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HB3' ' CE1' ' A' ' 57' ' ' TYR . 43.1 Cg_endo -70.27 124.73 11.15 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 121.728 1.619 . . . . 13.33 109.807 169.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -139.77 151.17 22.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.88 0.848 . . . . 12.33 112.696 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.66 136.23 33.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.591 -1.186 . . . . 8.91 108.16 169.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.486 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 7.4 t -69.69 -150.16 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.984 0.421 . . . . 10.33 111.035 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -56.45 -18.89 12.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.322 0.86 . . . . 12.02 113.322 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.1 t 55.13 96.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.635 0.731 . . . . 6.52 111.136 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m -79.5 152.0 30.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.703 -0.681 . . . . 6.18 110.197 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.516 ' HE2' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -93.57 108.28 20.01 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.901 0.381 . . . . 6.59 110.52 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.516 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 65.5 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 6.16 109.877 175.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.589 ' CG1' ' HB2' ' A' ' 144' ' ' ALA . 23.3 t . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.051 0.453 . . . . 6.19 110.08 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 67.5 t -72.77 97.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.557 -0.747 . . . . 6.54 111.34 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.01 -63.92 0.99 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.462 -0.57 . . . . 6.46 109.462 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.3 t -139.36 117.43 11.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.036 0.446 . . . . 7.24 110.615 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -159.39 -49.39 0.06 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.687 -0.688 . . . . 7.07 109.415 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -81.5 -172.98 4.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.641 -0.709 . . . . 6.68 109.947 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -166.83 71.41 0.12 Allowed 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.5 -0.555 . . . . 6.93 109.5 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.5 m -82.29 151.58 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.628 0.728 . . . . 4.0 111.027 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.5 p -117.65 139.74 50.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.313 -0.858 . . . . 3.84 109.976 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.51 154.02 25.24 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.209 -0.996 . . . . 2.58 112.642 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.9 m -109.6 136.1 49.51 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.68 -0.489 . . . . 3.7 109.68 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 46.9 t -68.58 118.43 12.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.83 0.348 . . . . 3.14 110.086 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.5 p -95.35 -27.89 15.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.027 0.441 . . . . 3.77 110.84 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 m -153.16 127.88 9.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.864 -0.607 . . . . 3.29 110.112 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.08 -171.37 2.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.409 -0.36 . . . . 4.39 110.402 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.331 -0.395 . . . . 3.62 110.668 -179.758 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 110.345 -0.243 . . . . 3.7 110.345 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.6 t -112.92 153.92 27.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.849 -0.426 . . . . 2.84 109.849 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.66 -173.63 36.61 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.624 -0.59 . . . . 1.91 111.624 177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -133.82 126.13 29.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.992 0.425 . . . . 3.31 111.381 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.491 HG13 ' CE1' ' A' ' 122' ' ' TYR . 83.7 mt -112.12 129.02 68.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.004 -0.739 . . . . 2.17 109.004 171.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 t -105.23 117.8 34.92 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.831 -0.433 . . . . 3.61 109.831 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 11.2 p90 -119.47 150.81 39.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.207 -0.452 . . . . 3.58 109.945 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -111.95 123.45 50.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.113 -0.494 . . . . 5.1 110.592 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.513 ' OD1' ' HG3' ' A' ' 114' ' ' ARG . 49.9 t-20 -131.59 119.07 20.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.148 -0.686 . . . . 5.11 109.148 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.513 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 71.2 mtp180 63.2 21.41 12.83 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.199 -0.455 . . . . 7.42 111.223 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.36 -9.67 71.75 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.04 -0.6 . . . . 5.36 112.163 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -92.16 122.74 34.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.764 0.316 . . . . 5.38 110.247 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.04 123.05 38.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.318 -0.401 . . . . 4.96 110.272 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.595 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . 64.4 m-85 -120.92 151.15 40.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.531 -0.304 . . . . 5.13 110.634 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.28 126.43 52.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 4.32 110.709 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 mt -112.94 135.25 21.66 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.053 -0.521 . . . . 3.17 110.848 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.74 137.64 11.4 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.713 2.275 . . . . 2.61 111.799 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.491 ' CE1' HG13 ' A' ' 109' ' ' ILE . 26.8 p90 -146.04 155.23 42.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.37 . . . . 2.49 110.14 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.0 p -115.42 -178.96 3.5 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.693 -0.484 . . . . 3.18 109.693 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -71.71 -21.1 61.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.44 0.638 . . . . 5.22 110.31 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.35 -23.56 50.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.398 -0.819 . . . . 4.81 111.289 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -86.99 3.95 43.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.992 0.425 . . . . 4.0 111.316 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 131' ' ' VAL . 52.7 t -87.52 137.65 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.234 -0.439 . . . . 4.39 110.921 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -87.17 135.55 33.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.986 -0.552 . . . . 6.43 110.105 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.76 2.03 68.85 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.177 -0.535 . . . . 6.14 112.671 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 56.42 38.08 29.39 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.159 0.504 . . . . 6.26 111.574 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 127' ' ' VAL . 43.7 t -78.63 145.82 9.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.884 -0.598 . . . . 5.62 109.749 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -91.39 137.82 32.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.332 -0.248 . . . . 6.25 110.332 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.7 mp -114.31 149.57 35.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.663 0.602 . . . . 3.62 111.018 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -141.7 123.67 15.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.636 -0.505 . . . . 7.5 109.636 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.542 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -50.14 129.14 20.57 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.515 0.674 . . . . 4.12 112.101 -170.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.83 -15.79 11.21 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 114.981 -1.009 . . . . 4.2 111.797 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.508 ' OD1' HG13 ' A' ' 139' ' ' VAL . 2.4 p30 -85.4 169.25 13.86 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.397 -0.594 . . . . 4.06 109.397 173.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.469 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -123.1 116.8 24.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.071 0.462 . . . . 4.48 109.971 -177.273 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.508 HG13 ' OD1' ' A' ' 137' ' ' ASP . 30.2 m -116.0 179.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.516 0.674 . . . . 2.98 111.294 -173.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.9 m -143.12 145.76 33.14 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.367 -0.833 . . . . 3.68 109.086 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.38 172.53 12.65 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.127 -0.694 . . . . 3.35 109.127 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -112.76 136.89 51.85 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.399 0.437 . . . . 5.34 109.866 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.4 mt -106.72 101.66 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.98 0.419 . . . . 4.66 110.95 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -80.04 107.57 12.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.523 -0.547 . . . . 5.08 109.523 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.1 m -97.46 102.76 14.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.121 0.486 . . . . 5.68 110.747 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 148' ' ' ARG . 47.6 t30 -75.05 157.0 35.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.716 -0.846 . . . . 6.25 108.716 172.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.19 13.91 0.1 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.05 0.452 . . . . 9.03 112.049 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.471 ' NE ' ' HA ' ' A' ' 148' ' ' ARG . 5.0 mmp_? -110.05 -8.55 14.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.751 0.31 . . . . 8.29 110.207 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.73 20.98 77.82 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 116.009 -0.542 . . . . 5.65 112.374 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -112.29 111.49 22.4 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.905 -0.406 . . . . 5.26 109.905 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.3 179.94 8.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.128 0.49 . . . . 4.63 111.575 -177.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.85 -156.94 7.7 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.498 -1.041 . . . . 3.57 110.498 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.17 112.09 24.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.495 0.648 . . . . 2.84 109.491 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 24.2 m -103.87 140.03 38.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.123 -0.489 . . . . 4.34 111.242 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 52.43 61.39 3.22 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 123.848 0.718 . . . . 6.23 111.225 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.2 mt -78.78 125.65 38.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.643 -0.708 . . . . 3.55 110.225 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -126.93 145.54 50.64 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.748 -0.381 . . . . 6.3 110.588 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.484 ' HA ' HG11 ' A' ' 139' ' ' VAL . 55.4 tp -80.71 101.52 9.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 4.63 109.87 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.65 -53.96 5.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.566 . . . . 4.97 110.834 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -118.21 97.82 51.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 5.57 110.329 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.31 158.94 33.2 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.458 2.106 . . . . 5.69 112.164 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 116.198 -0.455 . . . . 6.1 110.206 177.387 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 121.246 0.546 . . . . 12.72 110.422 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -93.34 136.88 33.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.515 -0.92 . . . . 11.63 108.515 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -118.39 140.6 49.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.48 -0.488 . . . . 9.47 111.463 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.72 -177.12 30.52 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.784 -0.722 . . . . 7.73 112.051 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.473 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 2.3 mt -124.97 143.36 38.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.809 -0.441 . . . . 10.57 109.809 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.53 116.15 11.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.414 -0.514 . . . . 8.73 109.675 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -88.47 -38.68 14.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 10.86 110.478 -176.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -153.79 140.62 19.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.619 -0.719 . . . . 14.48 109.591 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.4 mt -105.16 102.55 12.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.137 0.494 . . . . 11.73 110.591 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 mp -84.36 -178.34 6.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.053 -0.976 . . . . 11.9 109.307 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -89.69 108.73 19.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.864 0.364 . . . . 16.67 110.298 -173.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.5 m 67.57 22.31 9.2 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.251 -0.886 . . . . 13.28 110.983 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -160.52 141.21 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.628 -0.715 . . . . 12.68 109.429 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.14 157.33 21.62 Favored Glycine 0 C--N 1.322 -0.209 0 C-N-CA 120.471 -0.871 . . . . 7.92 113.094 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.0 129.19 55.01 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.108 0.163 . . . . 9.69 110.737 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.7 mt -112.59 126.92 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.846 0.355 . . . . 7.75 110.838 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 10.3 pt20 -85.38 145.73 27.34 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.145 0.498 . . . . 12.4 110.781 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 p -79.71 1.58 25.93 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.129 -0.942 . . . . 12.96 113.076 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.1 m -52.79 -24.87 9.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.932 1.086 . . . . 13.58 113.932 -170.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -99.37 10.59 41.11 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.123 0.416 . . . . 12.19 112.123 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -164.59 -158.97 0.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.438 -0.579 . . . . 12.99 109.438 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -123.37 24.37 8.71 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.162 0.506 . . . . 17.26 110.517 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.3 127.97 25.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.559 . . . . 12.1 111.125 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -96.2 119.42 34.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 13.0 110.147 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.66 162.46 18.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.407 0.622 . . . . 9.21 111.792 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -131.86 147.5 52.48 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.346 -0.983 . . . . 9.75 108.346 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -134.15 159.24 41.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.124 0.488 . . . . 6.85 111.204 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -98.84 154.77 17.77 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.994 -0.743 . . . . 10.15 108.994 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -68.86 -16.22 63.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.854 0.359 . . . . 10.56 110.786 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 t -78.36 -10.24 59.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.091 -0.504 . . . . 12.44 110.177 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -108.22 27.03 9.72 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.141 -0.482 . . . . 11.14 110.688 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -122.96 111.81 17.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.463 . . . . 8.78 110.376 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -89.15 111.66 22.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.089 0.471 . . . . 9.11 109.996 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.02 -151.01 23.04 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.988 -0.845 . . . . 9.98 110.988 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -107.22 120.71 42.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.808 0.304 . . . . 12.91 110.685 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -67.48 -19.63 25.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.601 0.715 . . . . 11.97 109.13 173.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.45 -32.44 70.23 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.803 -1.09 . . . . 14.73 110.688 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -109.65 21.24 17.21 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.584 -0.735 . . . . 13.3 111.092 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.8 tp -111.65 114.99 28.39 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.462 -0.57 . . . . 10.07 109.462 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -121.13 -179.27 3.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.008 0.433 . . . . 13.53 110.342 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 47' ' ' ILE . 3.5 mp -76.24 120.51 26.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.648 -0.501 . . . . 12.26 109.648 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.59 0.1 30.76 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.74 -0.743 . . . . 11.04 112.471 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.54 122.99 88.31 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.559 0.219 . . . . 8.39 110.895 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -83.58 126.25 4.04 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.609 2.206 . . . . 8.18 111.979 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.05 156.08 39.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.068 0.461 . . . . 4.78 111.065 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -119.48 126.77 52.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.698 -0.683 . . . . 7.09 109.26 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -132.21 166.81 21.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.349 0.595 . . . . 7.82 111.036 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 31.8 tt0 -101.32 109.66 21.54 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.645 -0.707 . . . . 11.59 109.272 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.68 109.13 19.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.281 -0.637 . . . . 12.41 109.281 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.7 p -131.6 175.28 9.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.052 0.453 . . . . 13.93 111.352 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.23 121.48 42.18 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.492 -0.558 . . . . 16.22 109.492 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -75.22 124.9 27.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.409 0.623 . . . . 16.64 110.659 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -79.33 -7.33 58.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.002 -0.999 . . . . 23.23 111.506 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -92.43 -55.12 3.52 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.957 -0.297 . . . . 21.87 111.17 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.9 p -86.46 -22.69 26.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 111.772 0.286 . . . . 17.49 111.772 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.68 32.34 54.37 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.559 -0.829 . . . . 17.22 111.66 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -121.15 147.55 47.04 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.303 -0.258 . . . . 14.83 110.303 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.69 126.16 11.18 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 121.949 1.766 . . . . 13.33 110.753 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.54 162.1 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.222 0.534 . . . . 12.33 111.304 -174.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.27 139.06 40.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.551 -0.749 . . . . 8.91 109.146 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 54' ' ' GLU . 17.6 m -70.0 -157.13 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.084 -0.507 . . . . 10.33 110.762 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -75.68 27.86 0.11 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.326 1.232 . . . . 12.02 114.326 -168.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.2 t 21.31 101.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 125.079 1.352 . . . . 6.52 114.582 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.4 m -107.67 143.3 36.35 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.106 -0.497 . . . . 6.18 110.096 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.56 142.33 51.77 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.165 -0.68 . . . . 6.59 109.165 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.6 mt . . . . . 0 C--O 1.235 0.321 0 CA-C-O 121.112 0.482 . . . . 6.16 111.137 -177.466 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 30.9 t . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 121.018 0.437 . . . . 6.19 111.434 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.59 111.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 6.54 111.244 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.437 ' N ' HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -118.91 16.38 13.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 6.46 110.921 176.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 m -114.06 60.53 0.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.856 0.36 . . . . 7.24 111.516 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -117.11 -34.63 4.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.716 0.293 . . . . 7.07 110.834 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -168.1 147.85 4.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 6.68 110.191 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -105.23 115.49 30.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 6.93 110.413 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.04 159.44 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.2 -0.454 . . . . 4.0 110.452 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 p -110.46 139.66 45.46 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.127 -0.488 . . . . 3.84 110.13 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.48 163.43 23.19 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.231 -0.985 . . . . 2.58 112.443 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.2 m -122.44 129.04 51.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.771 -0.455 . . . . 3.7 109.771 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 90.4 t -69.27 126.16 28.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.416 -0.356 . . . . 3.14 110.665 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 p -105.82 -19.92 13.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.237 0.541 . . . . 3.77 110.63 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.5 m -149.9 129.42 13.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 3.29 110.198 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.13 -178.27 3.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.737 0.303 . . . . 4.39 110.71 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 115.777 -0.647 . . . . 3.62 109.649 177.384 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.153 -0.684 . . . . 3.7 109.153 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.5 m -145.28 130.2 18.27 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.993 -0.373 . . . . 2.84 109.993 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.64 169.71 49.3 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.656 -0.783 . . . . 1.91 112.183 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -129.61 133.64 47.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.918 0.39 . . . . 3.31 110.892 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 64.9 mt -111.8 126.48 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.6 -0.727 . . . . 2.17 109.89 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.8 p -98.07 119.18 36.26 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.9 -0.407 . . . . 3.61 109.9 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -127.4 153.69 45.93 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.639 -0.504 . . . . 3.58 109.639 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.95 120.61 38.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.246 -0.433 . . . . 5.1 110.35 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -146.72 137.81 24.14 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.058 -0.719 . . . . 5.11 109.058 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 64.08 20.89 12.39 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.867 0.365 . . . . 7.42 110.364 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.83 -8.15 63.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.202 -0.523 . . . . 5.36 112.366 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -100.68 138.84 37.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.893 -0.41 . . . . 5.38 109.893 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 1.3 p -108.2 121.58 45.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.046 0.451 . . . . 4.96 110.837 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -115.73 164.83 13.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.927 -0.579 . . . . 5.13 110.652 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 96.0 m-85 -119.39 119.3 33.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.01 -0.541 . . . . 4.32 110.397 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 153' ' ' ALA . 4.1 mm? -105.42 143.37 26.64 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.336 -0.393 . . . . 3.17 110.626 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.98 146.93 9.14 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.126 2.551 . . . . 2.61 112.066 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -153.75 151.78 29.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.102 0.477 . . . . 2.49 111.366 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.73 162.17 23.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.453 -0.794 . . . . 3.18 109.38 172.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.94 -30.57 71.66 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.005 0.431 . . . . 5.22 111.204 -175.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.43 -20.42 66.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.076 -0.511 . . . . 4.81 111.871 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -104.22 13.81 31.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.147 0.499 . . . . 4.0 110.638 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.06 128.45 41.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 4.39 110.792 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.411 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 1.4 tm-20 -94.93 145.62 24.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.939 -0.763 . . . . 6.43 108.939 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.01 -17.18 58.77 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.754 -0.736 . . . . 6.14 112.039 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 61.25 24.2 14.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.514 0.673 . . . . 6.26 110.671 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.6 t -90.81 137.71 21.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.065 -0.516 . . . . 5.62 110.284 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -79.08 102.53 8.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 6.25 110.314 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.501 ' H ' HD22 ' A' ' 133' ' ' LEU . 2.6 pt? -88.6 148.85 23.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 3.62 110.605 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -133.13 171.5 13.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.11 -0.495 . . . . 7.5 109.809 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.572 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.96 118.9 17.47 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.095 -0.502 . . . . 4.12 110.581 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.93 -20.42 9.91 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.666 -0.697 . . . . 4.2 113.195 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.93 166.18 12.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.898 0.849 . . . . 4.06 110.634 175.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -98.58 122.96 42.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.732 0.777 . . . . 4.48 111.976 -170.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.33 157.94 24.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.678 -1.146 . . . . 2.98 110.125 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.4 m -126.23 141.07 52.07 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.913 -0.773 . . . . 3.68 108.913 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -135.37 149.59 49.72 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.953 0.406 . . . . 3.35 110.26 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -100.59 115.05 29.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.739 -0.664 . . . . 5.34 110.497 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 64.7 mt -78.05 110.31 13.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.603 -0.726 . . . . 4.66 110.375 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -90.26 110.45 21.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.854 -0.612 . . . . 5.08 110.427 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 40.2 m -80.6 103.15 10.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.682 -0.69 . . . . 5.68 110.352 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -67.69 163.38 21.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.1 -0.5 . . . . 6.25 111.043 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.39 -18.32 65.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 9.03 111.663 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -100.03 6.85 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.118 0.485 . . . . 8.29 110.235 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.61 18.2 75.45 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.868 -0.605 . . . . 5.65 113.98 172.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -122.33 129.9 52.6 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.404 -0.591 . . . . 5.26 109.404 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.446 ' N ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.31 179.37 8.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.906 0.384 . . . . 4.63 111.685 -175.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -131.38 -112.43 1.45 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.839 -0.904 . . . . 3.57 110.839 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 120' ' ' LEU . . . -135.41 129.68 33.68 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.109 -0.33 . . . . 2.84 110.109 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 82.6 m -128.14 150.16 50.11 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.87 -0.419 . . . . 4.34 109.87 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 57.65 58.08 3.92 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.438 0.461 . . . . 6.23 111.333 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.8 mp -74.57 113.61 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.346 -0.983 . . . . 3.55 108.346 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.411 ' HD2' ' OE2' ' A' ' 128' ' ' GLU . 26.4 ttt180 -129.2 131.14 47.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.977 0.418 . . . . 6.3 110.864 -173.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 133' ' ' LEU . 6.4 tt -83.42 115.82 22.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.338 -0.616 . . . . 4.63 109.338 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -105.89 -26.92 11.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.086 -0.506 . . . . 4.97 111.485 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.12 107.03 5.26 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.792 0.33 . . . . 5.57 110.7 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.42 161.66 17.22 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.843 2.362 . . . . 5.69 113.522 -175.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.411 -0.813 . . . . 6.1 109.314 174.653 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.508 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 19.2 ptt180 . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.255 0.55 . . . . 12.72 111.563 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 27' ' ' ARG . 4.9 mm-40 -109.63 137.04 48.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.298 -0.865 . . . . 11.63 110.249 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 p -105.48 141.7 36.5 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.458 -0.337 . . . . 9.47 111.383 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.29 178.85 39.44 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.583 -0.607 . . . . 7.73 111.583 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.3 pt -121.19 149.95 24.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.824 0.312 . . . . 10.57 110.617 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.7 mm -67.69 122.24 18.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.377 -0.374 . . . . 8.73 110.514 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 47' ' ' ILE . 33.5 tt0 -78.13 -51.16 10.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.749 0.309 . . . . 10.86 110.392 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -152.72 171.7 17.82 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.023 -0.535 . . . . 14.48 110.444 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.7 mt -127.59 99.53 5.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.6 -0.727 . . . . 11.73 110.628 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.2 mp -97.05 -179.9 4.7 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.286 -1.005 . . . . 11.9 108.286 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -91.19 131.9 36.43 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.506 -0.478 . . . . 16.67 110.293 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.3 t 76.24 -22.68 0.26 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.991 0.916 . . . . 13.28 112.196 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -152.27 162.89 40.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 12.68 111.26 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.99 -172.87 19.18 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.796 -0.521 . . . . 7.92 111.796 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.23 149.49 52.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.781 0.324 . . . . 9.69 110.931 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.1 mt -113.89 126.85 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.826 -0.625 . . . . 7.75 109.553 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.14 136.95 35.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.4 0.619 . . . . 12.4 111.561 -172.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 p -81.94 -0.59 44.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.999 -1.0 . . . . 12.96 112.887 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.4 m -53.6 -37.22 62.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.194 0.452 . . . . 13.58 112.035 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.53 20.32 13.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 12.19 111.476 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.438 HH21 ' HB3' ' A' ' 29' ' ' ALA . 7.1 ptm85 -163.16 -160.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.422 -0.174 . . . . 12.99 111.096 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -124.8 20.08 8.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.826 0.346 . . . . 17.26 111.223 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB3' HH21 ' A' ' 27' ' ' ARG . . . -146.13 122.46 10.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.392 -0.367 . . . . 12.1 111.692 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 30' ' ' ARG . 11.8 ptt180 -85.97 130.74 34.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.428 -0.953 . . . . 13.0 108.428 171.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.1 tp -141.64 158.6 43.62 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.689 -0.404 . . . . 9.21 110.777 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -113.99 149.92 34.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.141 -0.481 . . . . 9.75 109.831 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -136.49 155.39 50.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.006 -0.368 . . . . 6.85 110.006 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -110.73 150.25 29.33 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.691 -0.485 . . . . 10.15 109.691 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -63.93 -19.25 64.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.379 -0.373 . . . . 10.56 111.6 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -70.34 -24.07 62.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 12.44 111.129 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.88 40.1 1.72 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.026 -0.533 . . . . 11.14 110.525 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -120.5 129.8 53.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.336 -0.393 . . . . 8.78 110.393 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.3 m -97.7 104.78 16.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.263 -0.426 . . . . 9.11 110.349 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.89 -172.42 23.67 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.754 -0.736 . . . . 9.98 111.525 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -95.4 115.94 28.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.482 0.658 . . . . 12.91 110.3 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.63 -23.95 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.391 -0.822 . . . . 11.97 112.537 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -67.7 -21.19 65.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 14.73 111.329 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -99.62 9.07 43.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.766 0.317 . . . . 13.3 110.928 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.3 tp -94.17 130.75 40.27 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.242 -0.651 . . . . 10.07 109.242 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -122.92 172.98 8.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.96 0.409 . . . . 13.53 110.546 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.41 ' N ' HD13 ' A' ' 47' ' ' ILE . 3.5 mp -81.79 128.44 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.756 -0.656 . . . . 12.26 109.397 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.47 0.58 67.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.687 -0.768 . . . . 11.04 112.119 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.502 ' CG ' ' HZ1' ' A' ' 71' ' ' LYS . 31.9 t70 -80.4 129.97 67.1 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.192 . . . . 8.39 110.743 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.22 127.43 12.7 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.938 2.426 . . . . 8.18 113.032 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.79 154.47 34.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 4.78 110.88 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.508 ' OE1' ' HD2' ' A' ' 7' ' ' ARG . 37.3 tt0 -112.77 124.19 52.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.185 -0.461 . . . . 7.09 109.899 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -142.3 151.27 41.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.394 -0.366 . . . . 7.82 110.679 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.4 130.49 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.313 -0.625 . . . . 11.59 109.313 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 14.7 tpt -83.19 114.68 21.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.25 -0.432 . . . . 12.41 109.853 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.5 p -133.2 170.96 14.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.371 0.605 . . . . 13.93 111.927 -173.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -132.37 115.06 15.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.018 -0.734 . . . . 16.22 109.018 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -80.5 116.5 20.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.767 -0.457 . . . . 16.64 109.767 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.71 -7.05 57.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.57 . . . . 23.23 111.947 -173.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.07 -37.92 9.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.203 -0.453 . . . . 21.87 110.913 -175.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 p -87.69 -34.09 18.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.89 0.376 . . . . 17.49 110.924 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.54 8.58 63.88 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.503 -0.856 . . . . 17.22 112.178 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -106.45 145.51 31.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 122.893 -0.181 . . . . 14.83 110.804 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.48 125.02 5.48 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.8 1.667 . . . . 13.33 110.433 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.31 157.49 24.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.272 0.558 . . . . 12.33 111.21 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.0 157.79 16.6 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.742 -0.663 . . . . 8.91 109.556 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 69' ' ' VAL . 23.0 t -65.3 -166.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.177 -0.465 . . . . 10.33 110.148 176.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -73.94 19.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.535 0.568 . . . . 12.02 112.535 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 67' ' ' SER . 42.0 t 32.87 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.421 1.089 . . . . 6.52 113.193 176.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.8 m -88.4 136.45 32.98 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.113 0.482 . . . . 6.18 110.114 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.502 ' HZ1' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -73.97 119.7 18.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.149 -0.478 . . . . 6.59 110.344 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.41 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 65.4 mt . . . . . 0 N--CA 1.452 -0.341 0 CA-C-N 115.951 -0.568 . . . . 6.16 109.77 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 108.763 -0.828 . . . . 6.19 108.763 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.73 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 39.0 t -68.13 89.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.419 . . . . 6.54 110.394 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 144' ' ' ALA . 1.5 tt -91.43 -8.7 47.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.153 -0.931 . . . . 6.46 110.782 -173.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.3 t -140.89 103.59 4.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.049 -0.523 . . . . 7.24 110.479 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.65 -59.77 1.96 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.553 -0.906 . . . . 7.07 108.553 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -135.97 119.73 17.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.912 -1.04 . . . . 6.68 108.51 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -79.77 107.85 12.87 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.695 -0.483 . . . . 6.93 109.695 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.49 179.3 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 4.0 111.571 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 138' ' ' LYS . 37.4 p -121.55 165.16 16.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.445 -0.798 . . . . 3.84 108.853 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.18 145.1 15.47 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.136 -1.03 . . . . 2.58 113.002 -177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 m -108.05 127.91 54.21 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.606 -0.516 . . . . 3.7 109.606 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -74.83 124.89 33.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.096 -0.335 . . . . 3.14 110.096 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 p -104.29 -22.41 13.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.119 0.485 . . . . 3.77 110.65 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.4 m -136.66 126.46 25.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.959 -0.564 . . . . 3.29 110.634 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -84.09 -176.73 6.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 4.39 110.709 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 108.876 -0.787 . . . . 3.62 108.876 171.434 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.444 -0.768 0 N-CA-C 109.414 -0.587 . . . . 3.7 109.414 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.3 m -137.39 135.44 36.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.051 0.453 . . . . 2.84 110.532 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.48 176.98 48.5 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.777 -0.725 . . . . 1.91 111.92 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -129.89 127.37 40.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.884 0.373 . . . . 3.31 111.256 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.3 127.06 69.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.872 -0.604 . . . . 2.17 109.441 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.9 p -102.54 132.87 48.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.618 -0.264 . . . . 3.61 110.868 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.425 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -145.14 160.69 41.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.661 -0.496 . . . . 3.58 109.661 175.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -117.04 124.33 49.04 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.501 -0.555 . . . . 5.1 109.501 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -137.65 112.43 8.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 5.11 110.456 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 66.08 21.82 11.18 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.495 -0.32 . . . . 7.42 111.756 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.56 -1.22 68.77 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.675 -0.774 . . . . 5.36 111.7 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.476 ' HB3' ' CE2' ' A' ' 118' ' ' PHE . 69.8 mm-40 -96.85 128.75 44.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.9 -0.407 . . . . 5.38 109.9 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 84.9 m -118.16 101.44 8.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.124 -0.489 . . . . 4.96 110.293 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 116' ' ' GLU . 62.5 m-85 -116.79 155.0 29.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.168 0.508 . . . . 5.13 111.099 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -107.75 118.58 37.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.786 -0.82 . . . . 4.32 108.786 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.425 HD11 ' CE2' ' A' ' 111' ' ' TYR . 5.5 mp -102.42 137.89 19.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 120.875 -0.33 . . . . 3.17 110.66 -173.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.88 134.45 18.05 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.743 2.295 . . . . 2.61 112.115 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -137.09 151.22 48.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.175 -0.466 . . . . 2.49 109.797 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.3 p -116.72 178.77 4.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.419 -0.355 . . . . 3.18 110.137 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -69.91 -19.71 63.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.388 0.613 . . . . 5.22 110.167 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -78.98 -9.87 59.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.456 -0.793 . . . . 4.81 111.42 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -93.34 -14.55 26.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.411 -0.359 . . . . 4.0 111.873 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.426 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 7.6 p -103.98 137.68 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.183 0.516 . . . . 4.39 111.052 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -106.17 169.7 8.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.55 . . . . 6.43 111.196 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.73 -4.01 83.6 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.907 -0.588 . . . . 6.14 113.174 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 62.6 24.96 14.86 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.797 0.439 . . . . 6.26 110.65 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 t -84.34 122.18 37.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.958 -0.565 . . . . 5.62 110.41 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -83.86 95.31 8.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.308 0.575 . . . . 6.25 110.438 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.459 HD21 ' H ' ' A' ' 133' ' ' LEU . 2.4 pt? -75.37 150.35 38.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.863 -1.062 . . . . 3.62 111.008 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.524 ' HG3' ' OD1' ' A' ' 137' ' ' ASP . 3.9 ppt_? -120.38 162.33 19.67 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.77 -0.456 . . . . 7.5 109.77 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.585 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -72.41 125.62 27.85 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.605 -0.438 . . . . 4.12 110.87 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.48 -25.73 7.59 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.934 -0.651 . . . . 4.2 113.613 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.524 ' OD1' ' HG3' ' A' ' 134' ' ' ARG . 2.8 p30 -86.53 178.66 7.02 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.258 1.029 . . . . 4.06 110.141 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.559 ' HD2' ' HB ' ' A' ' 84' ' ' THR . 2.3 tppp? -118.9 124.7 47.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.414 0.626 . . . . 4.48 111.795 -172.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.526 HG13 ' HG ' ' A' ' 158' ' ' LEU . 24.5 m -117.22 170.59 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 2.98 110.039 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -119.97 135.4 54.92 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.034 -0.728 . . . . 3.68 109.034 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -134.44 153.58 51.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.774 0.321 . . . . 3.35 110.536 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -113.83 131.23 56.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.864 -0.607 . . . . 5.34 109.801 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.4 mt -95.96 108.71 21.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.778 -0.647 . . . . 4.66 110.951 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.73 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -101.86 110.98 23.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.718 0.294 . . . . 5.08 111.285 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.41 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 66.8 m -99.0 122.7 42.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 5.68 111.814 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.52 174.92 8.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 6.25 110.533 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -59.58 -28.54 67.23 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.001 -0.545 . . . . 9.03 112.214 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 148' ' ' ARG . 21.8 mmt180 -88.48 8.66 26.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.877 0.325 . . . . 8.29 111.877 -174.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.07 14.51 73.67 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.909 -0.662 . . . . 5.65 113.22 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.9 130.51 53.84 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.254 -0.647 . . . . 5.26 109.254 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -152.94 -178.52 6.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.356 -0.384 . . . . 4.63 110.938 -177.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.14 -166.11 13.81 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.031 -0.828 . . . . 3.57 111.031 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.39 109.96 21.89 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.046 -0.353 . . . . 2.84 110.046 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 71.9 m -121.01 166.76 13.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.434 -0.348 . . . . 4.34 110.871 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 59.22 36.51 23.79 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.632 0.583 . . . . 6.23 110.144 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 127' ' ' VAL . 77.1 mt -64.9 114.55 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.807 -0.633 . . . . 3.55 110.021 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -122.12 123.89 42.62 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.816 -0.809 . . . . 6.3 108.816 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.526 ' HG ' HG13 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -81.78 103.05 11.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.178 -0.464 . . . . 4.63 109.876 -176.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -97.08 -32.44 11.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.993 -0.549 . . . . 4.97 111.305 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -126.39 84.38 62.26 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 5.57 110.742 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.28 179.87 4.31 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.918 2.412 . . . . 5.69 112.975 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.73 -0.668 . . . . 6.1 110.49 178.73 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 121.108 0.48 . . . . 12.72 111.142 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.72 162.7 21.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.691 -0.686 . . . . 11.63 110.038 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 26' ' ' GLU . 36.8 p -100.79 162.12 13.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.399 -0.364 . . . . 9.47 110.233 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' A' ' 26' ' ' GLU . . . -162.38 177.56 38.49 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.967 -0.635 . . . . 7.73 112.055 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.6 mt -129.45 141.9 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.557 -0.534 . . . . 10.57 109.557 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.6 mm -65.81 111.5 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.836 0.351 . . . . 8.73 110.086 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.15 -54.24 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.724 -0.671 . . . . 10.86 110.495 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -146.47 163.9 34.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.434 -0.803 . . . . 14.48 110.253 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.5 mt -131.45 101.33 5.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.803 -0.635 . . . . 11.73 110.543 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.5 mt -92.41 -179.87 5.33 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.558 -1.275 . . . . 11.9 107.558 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -90.37 125.1 35.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.097 -0.641 . . . . 16.67 109.977 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.3 m 79.63 -16.6 0.65 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.136 0.974 . . . . 13.28 112.212 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -150.19 147.77 28.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.561 0.22 . . . . 12.68 110.949 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.48 -176.21 15.62 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.021 -0.609 . . . . 7.92 112.871 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -127.87 149.78 50.15 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.843 0.354 . . . . 9.69 111.312 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.8 mt -115.53 130.43 70.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 7.75 110.897 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.79 145.83 34.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.92 -0.582 . . . . 12.4 111.252 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 p -80.28 2.49 24.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.088 -0.96 . . . . 12.96 112.862 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -52.62 -35.44 54.6 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.006 0.372 . . . . 13.58 112.006 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 22.6 mm-40 -108.89 -25.39 10.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 12.19 111.409 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.445 ' HD3' ' N ' ' A' ' 28' ' ' GLN . 1.6 tmt_? -113.38 135.3 54.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.475 -0.565 . . . . 12.99 109.475 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.445 ' N ' ' HD3' ' A' ' 27' ' ' ARG . 19.6 mp0 -74.62 43.7 0.19 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.797 0.332 . . . . 17.26 111.255 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' A' ' 27' ' ' ARG . . . -177.33 146.4 0.48 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.717 0.807 . . . . 12.1 109.541 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.574 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -100.96 111.81 24.1 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.57 -0.53 . . . . 13.0 109.57 177.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.1 mt -113.88 163.03 15.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.234 0.54 . . . . 9.21 111.923 -170.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -112.07 149.12 32.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.237 -0.892 . . . . 9.75 109.506 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -140.53 158.72 43.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.874 0.369 . . . . 6.85 110.195 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -103.76 158.19 16.56 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.703 -0.48 . . . . 10.15 109.703 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -67.91 -18.79 64.89 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.957 0.355 . . . . 10.56 111.957 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 t -82.56 -8.08 59.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.403 0.62 . . . . 12.44 109.773 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -107.48 37.89 2.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.618 -0.719 . . . . 11.14 110.03 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -129.67 125.39 35.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.964 0.412 . . . . 8.78 111.16 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 t -100.75 104.6 15.88 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.961 -0.563 . . . . 9.11 109.977 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.54 -148.85 20.67 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.114 -0.795 . . . . 9.98 111.114 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -107.13 104.03 13.58 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 110.022 -0.362 . . . . 12.91 110.022 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.0 tp -63.25 -25.48 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.155 0.502 . . . . 11.97 110.726 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.04 -25.42 61.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 14.73 110.383 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -97.17 -10.43 25.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.756 -0.656 . . . . 13.3 110.568 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.0 tp -68.37 147.2 52.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 10.07 110.169 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 169.95 17.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.191 -0.458 . . . . 13.53 110.431 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.8 mm -77.69 135.27 26.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.562 -0.533 . . . . 12.26 109.562 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.59 11.29 62.43 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.477 -0.868 . . . . 11.04 111.837 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -86.38 125.93 66.15 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.253 -0.277 . . . . 8.39 110.253 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.91 129.74 6.35 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.906 2.404 . . . . 8.18 112.985 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.98 165.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 4.78 110.584 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.429 ' HB3' HG23 ' A' ' 9' ' ' THR . 10.2 pt-20 -126.52 146.63 50.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.969 0.414 . . . . 7.09 110.218 172.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -152.24 178.52 9.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.026 -0.534 . . . . 7.82 110.879 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.7 mp0 -124.08 114.17 19.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.882 -0.599 . . . . 11.59 110.575 177.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.9 ttt -78.28 109.65 12.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.599 -0.519 . . . . 12.41 109.599 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.5 p -131.67 167.74 18.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.937 0.399 . . . . 13.93 111.043 -176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -118.36 110.4 17.43 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 16.22 109.58 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.38 111.2 5.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.838 0.352 . . . . 16.64 110.143 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -73.12 -6.63 46.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.0 -0.545 . . . . 23.23 111.608 -176.012 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.8 mmt-85 -78.25 -59.7 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 21.87 110.259 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.4 p -86.68 -30.36 21.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 17.49 111.896 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.17 31.55 16.73 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.937 -0.649 . . . . 17.22 111.893 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.28 141.5 33.26 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 122.935 -0.156 . . . . 14.83 110.827 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.91 125.53 7.4 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.298 1.999 . . . . 13.33 110.886 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.63 165.61 22.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.186 -0.461 . . . . 12.33 110.591 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -102.16 161.15 13.91 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.661 -0.496 . . . . 8.91 109.661 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 11.9 t -66.89 -166.91 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.721 -0.474 . . . . 10.33 109.721 172.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -78.46 26.27 0.23 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.355 0.502 . . . . 12.02 112.355 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.7 t 35.25 94.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.2 1.0 . . . . 6.52 113.447 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -93.21 132.26 37.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.285 -0.416 . . . . 6.18 110.435 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -67.46 140.36 57.09 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.444 -0.576 . . . . 6.59 109.444 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.2 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 6.16 110.895 -176.303 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.507 ' CG2' ' HB3' ' A' ' 144' ' ' ALA . 1.7 p . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.773 -0.455 . . . . 6.19 109.773 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 4.8 p -79.97 107.21 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.575 0.703 . . . . 6.54 111.225 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.5 tp -89.87 -52.34 5.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.815 -1.084 . . . . 6.46 110.354 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.7 m -89.52 67.15 7.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.896 0.379 . . . . 7.24 111.718 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -88.64 -65.93 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.006 -0.738 . . . . 7.07 109.006 170.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -152.49 133.57 14.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.555 -0.906 . . . . 6.68 108.555 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -77.8 118.27 19.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.758 0.313 . . . . 6.93 110.278 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.13 166.9 7.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.215 0.531 . . . . 4.0 111.172 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 p -133.22 150.4 51.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.502 -0.772 . . . . 3.84 110.496 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -150.52 173.66 30.07 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.508 -0.853 . . . . 2.58 112.143 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.1 m -122.86 135.48 54.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.819 0.343 . . . . 3.7 110.256 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.529 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 39.8 t -64.9 132.02 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.269 -0.423 . . . . 3.14 110.728 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.5 p -115.15 -10.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.048 0.388 . . . . 3.77 112.048 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.5 m -145.05 131.99 20.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.711 0.291 . . . . 3.29 110.657 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.12 179.59 6.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 4.39 111.427 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.57 -0.741 . . . . 3.62 109.339 175.757 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.7 m . . . . . 0 N--CA 1.436 -1.138 0 CA-C-O 121.027 0.441 . . . . 3.7 110.511 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 t -136.25 141.27 43.9 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.073 -0.512 . . . . 2.84 109.981 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -81.2 177.58 54.23 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.468 -0.872 . . . . 1.91 111.541 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 8.0 mmt85 -132.82 127.65 34.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.989 0.423 . . . . 3.31 111.104 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.3 130.15 66.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 2.17 109.223 172.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.5 t -106.56 116.45 31.95 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.552 -0.536 . . . . 3.61 109.552 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -118.87 144.63 46.27 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.34 -0.615 . . . . 3.58 109.34 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -104.78 109.29 21.17 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.573 -0.74 . . . . 5.1 109.713 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.569 ' OD1' ' HD3' ' A' ' 114' ' ' ARG . 59.2 t30 -129.33 114.84 16.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.372 -0.376 . . . . 5.11 111.147 -174.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.569 ' HD3' ' OD1' ' A' ' 113' ' ' ASN . 6.0 mpt_? 61.55 26.13 15.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.978 0.418 . . . . 7.42 111.57 173.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.94 -2.77 69.67 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.872 -0.68 . . . . 5.36 112.617 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -110.19 135.23 51.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.828 0.347 . . . . 5.38 110.268 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 2.3 p -117.16 103.61 10.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.399 -0.364 . . . . 4.96 110.313 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -98.03 153.89 18.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.97 -0.559 . . . . 5.13 110.617 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -101.89 124.3 47.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.186 -0.461 . . . . 4.32 110.37 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 22.4 mt -105.66 130.01 23.73 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.839 -0.619 . . . . 3.17 110.685 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 76.2 Cg_endo -81.4 134.04 8.75 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.733 2.289 . . . . 2.61 111.544 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -140.24 157.76 45.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 2.49 111.363 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.5 p -120.73 177.2 5.17 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.612 -0.722 . . . . 3.18 109.582 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -76.65 -25.34 53.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.569 0.581 . . . . 5.22 112.569 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.01 -10.12 59.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.385 0.513 . . . . 4.81 112.385 -170.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -97.14 -12.63 22.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.037 0.446 . . . . 4.0 111.092 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.5 t -67.91 110.26 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.09 0.471 . . . . 4.39 111.041 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -68.25 127.51 33.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.571 -0.74 . . . . 6.43 110.719 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.89 -0.29 55.13 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.743 -0.741 . . . . 6.14 112.695 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 65.33 18.42 11.35 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.856 0.36 . . . . 6.26 110.771 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.63 135.08 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.803 -0.635 . . . . 5.62 112.238 -172.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -90.65 79.16 6.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.893 0.854 . . . . 6.25 109.135 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -77.34 149.95 35.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.86 -1.064 . . . . 3.62 112.129 -172.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -108.66 167.49 10.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.594 -0.73 . . . . 7.5 109.525 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.529 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.21 127.9 34.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.071 -0.652 . . . . 4.12 110.008 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.19 -24.24 9.4 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.847 -0.692 . . . . 4.2 111.605 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -64.99 137.94 58.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.855 0.36 . . . . 4.06 110.295 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -84.46 117.12 23.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.587 -0.523 . . . . 4.48 109.587 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -118.71 157.41 20.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.29 0.567 . . . . 2.98 111.998 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 m -118.8 129.94 55.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.534 -0.757 . . . . 3.68 109.336 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -138.24 152.52 48.67 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.77 -0.456 . . . . 3.35 109.77 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -107.94 132.4 53.53 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.837 -0.431 . . . . 5.34 109.837 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 75.6 mt -84.7 131.21 34.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.271 -0.422 . . . . 4.66 110.868 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -131.13 110.0 10.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.966 -0.561 . . . . 5.08 110.525 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 45.3 m -85.98 112.04 20.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 5.68 110.844 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -81.61 174.01 11.81 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.388 -0.597 . . . . 6.25 109.388 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -65.9 -7.29 15.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.168 0.803 . . . . 9.03 113.168 -172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -90.54 -9.48 47.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.763 -0.375 . . . . 8.29 111.117 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.11 13.35 83.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.73 -0.748 . . . . 5.65 112.004 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -111.27 121.26 44.81 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.858 -0.423 . . . . 5.26 109.858 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -136.34 -178.25 5.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.275 -0.42 . . . . 4.63 110.308 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.78 -78.08 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.594 -1.003 . . . . 3.57 110.594 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -160.23 163.1 33.78 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.085 -0.709 . . . . 2.84 109.085 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -150.52 147.06 27.02 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.98 -0.378 . . . . 4.34 109.98 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.4 p80 40.74 51.2 3.06 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 124.638 1.211 . . . . 6.23 111.361 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.9 mt -59.52 114.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.827 -1.079 . . . . 3.55 110.063 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.27 148.0 31.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.454 -0.339 . . . . 6.3 110.363 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.5 tp -72.68 125.23 27.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.237 -0.653 . . . . 4.63 109.237 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.2 -62.17 1.3 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.334 -0.617 . . . . 4.97 109.334 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -135.6 109.18 10.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.812 -0.631 . . . . 5.57 109.484 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.08 154.95 65.97 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.789 2.326 . . . . 5.69 113.017 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 115.563 -0.744 . . . . 6.1 111.467 -177.409 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 7' ' ' ARG . 43.6 mtt85 . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 120.834 0.349 . . . . 12.72 110.176 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.511 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 17.5 mm-40 -103.24 137.8 40.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.911 -0.586 . . . . 11.63 110.3 -173.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -97.94 136.91 37.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.659 -0.701 . . . . 9.47 110.656 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.5 174.6 32.1 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.978 -1.106 . . . . 7.73 112.918 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.512 HG13 ' HB3' ' A' ' 23' ' ' GLN . 7.9 pt -124.88 146.13 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.92 -0.4 . . . . 10.57 109.92 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.7 mm -67.47 122.88 19.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.414 0.149 . . . . 8.73 110.664 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 23.6 tt0 -88.09 -45.61 10.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.023 0.44 . . . . 10.86 110.428 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -147.6 140.93 25.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.9 -0.591 . . . . 14.48 109.954 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.3 mt -113.01 110.19 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.324 0.583 . . . . 11.73 111.282 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.12 178.41 4.52 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.32 -1.363 . . . . 11.9 107.32 171.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -90.79 130.76 36.73 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.575 -0.85 . . . . 16.67 110.172 -174.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.9 m 76.63 -25.51 0.2 Allowed 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.203 0.939 . . . . 13.28 112.17 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -141.79 142.28 33.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.647 0.26 . . . . 12.68 110.844 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.15 179.82 18.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.814 -0.708 . . . . 7.92 112.448 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.09 134.7 55.18 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.747 0.308 . . . . 9.69 111.383 -177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.406 HG21 ' CE1' ' A' ' 53' ' ' PHE . 74.8 mt -99.75 129.09 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.617 -0.512 . . . . 7.75 109.617 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.513 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . 37.6 tt0 -85.79 133.7 33.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.465 0.65 . . . . 12.4 111.357 -173.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.6 p -79.21 1.41 24.76 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.231 -0.895 . . . . 12.96 112.444 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 t -57.11 -29.46 63.55 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.197 0.443 . . . . 13.58 112.197 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -97.3 -1.28 44.99 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.83 0.348 . . . . 12.19 111.512 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.494 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 12.8 tpt180 -148.59 -158.85 0.96 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.342 -0.614 . . . . 12.99 109.342 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.494 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 26.5 mm-40 -119.21 19.01 12.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.248 0.546 . . . . 17.26 109.703 170.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.3 131.5 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.669 -0.696 . . . . 12.1 111.352 -175.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -121.18 125.71 47.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.734 -0.839 . . . . 13.0 108.734 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.75 160.67 26.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.42 0.628 . . . . 9.21 112.624 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -95.49 110.89 22.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.871 -1.059 . . . . 9.75 108.307 172.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -103.06 138.02 40.47 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.726 -0.79 . . . . 6.85 110.417 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -95.85 151.41 19.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.629 -0.714 . . . . 10.15 109.571 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.417 ' CD1' HG23 ' A' ' 42' ' ' ILE . 6.7 m-30 -72.4 -16.77 61.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.949 0.404 . . . . 10.56 110.981 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -70.18 -23.99 63.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 12.44 109.942 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -108.71 40.31 1.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.588 -0.733 . . . . 11.14 110.711 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -129.44 119.56 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.557 -0.534 . . . . 8.78 109.557 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 t -88.02 106.53 18.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.146 0.498 . . . . 9.11 110.409 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.66 -167.89 22.5 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.684 -0.769 . . . . 9.98 111.972 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -79.12 96.34 5.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.077 -0.342 . . . . 12.91 110.077 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.417 HG23 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -70.1 -27.28 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.504 0.669 . . . . 11.97 109.3 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.09 -21.77 65.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.465 -0.789 . . . . 14.73 110.952 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -99.72 13.95 31.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 13.3 110.646 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.1 tp -88.42 147.77 24.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 10.07 110.914 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -125.28 168.7 13.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.307 -0.406 . . . . 13.53 110.837 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 47' ' ' ILE . 3.7 mp -80.55 122.8 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.915 -0.584 . . . . 12.26 109.889 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.36 -3.45 32.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.872 -0.68 . . . . 11.04 111.826 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.83 122.71 84.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.806 -0.197 . . . . 8.39 110.478 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.44 123.66 10.43 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.676 2.251 . . . . 8.18 112.052 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.62 153.0 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.048 0.452 . . . . 4.78 111.624 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.25 124.44 52.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.104 -0.702 . . . . 7.09 109.104 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 8' ' ' GLU . 53.5 p90 -132.69 144.56 50.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.375 0.607 . . . . 7.82 111.039 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 26.9 tt0 -97.28 102.72 14.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.441 -0.8 . . . . 11.59 109.199 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.9 ttt -82.05 132.86 35.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.933 -0.576 . . . . 12.41 110.784 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.52 164.45 8.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.162 -0.472 . . . . 13.93 110.505 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -99.69 133.27 44.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.458 -0.337 . . . . 16.22 110.713 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.563 ' OD2' HG23 ' A' ' 61' ' ' THR . 8.4 t70 -95.39 134.34 38.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.955 -0.566 . . . . 16.64 110.295 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -81.26 -13.39 58.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.24 0.459 . . . . 23.23 112.24 -177.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.536 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 8.4 mmm-85 -74.38 -60.8 2.1 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.943 -0.391 . . . . 21.87 109.943 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.563 HG23 ' OD2' ' A' ' 58' ' ' ASP . 5.7 t -91.81 -26.2 18.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.976 -0.556 . . . . 17.49 111.075 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.46 -4.58 85.47 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.798 -0.715 . . . . 17.22 112.634 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.449 ' H ' HG22 ' A' ' 61' ' ' THR . 38.5 mtpt -93.89 142.52 25.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.517 -0.549 . . . . 14.83 109.517 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.08 128.56 23.22 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.58 2.186 . . . . 13.33 112.119 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.31 179.5 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.205 -0.452 . . . . 12.33 111.001 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -133.57 173.14 11.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.642 -0.708 . . . . 8.91 109.69 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 69' ' ' VAL . 52.6 p -74.98 -160.53 0.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.231 0.332 . . . . 10.33 110.405 175.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.5 pm0 -76.61 24.29 0.15 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.406 0.521 . . . . 12.02 112.406 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 67' ' ' SER . 30.6 t 32.75 87.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.3 1.04 . . . . 6.52 112.724 174.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.4 m -90.16 135.73 33.48 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.246 -0.434 . . . . 6.18 110.876 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HZ3' ' HB3' ' A' ' 71' ' ' LYS . 6.5 mtpm? -62.73 134.86 56.92 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.082 -0.71 . . . . 6.59 109.082 173.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt . . . . . 0 C--N 1.327 -0.407 0 CA-C-O 121.247 0.546 . . . . 6.16 111.145 -174.978 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.006 -0.738 . . . . 6.19 109.006 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.2 100.16 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.88 0.371 . . . . 6.54 111.351 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 68.9 mt -105.19 9.32 34.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.502 0.668 . . . . 6.46 109.791 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.9 m -83.73 26.53 0.69 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.982 -1.008 . . . . 7.24 112.137 -172.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -92.66 -93.74 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.113 0.483 . . . . 7.07 111.07 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -164.49 124.31 1.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.424 -0.584 . . . . 6.68 109.424 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -63.6 118.48 8.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 6.93 110.499 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.08 160.14 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.16 0.505 . . . . 4.0 111.629 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.7 p -119.22 140.19 50.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.607 -0.724 . . . . 3.84 109.884 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.76 -179.11 16.94 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.346 -0.93 . . . . 2.58 112.464 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.1 m -129.39 130.62 46.24 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.765 -0.457 . . . . 3.7 109.765 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 33.7 t -71.62 129.41 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.402 -0.363 . . . . 3.14 110.031 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.5 p -106.2 -32.57 8.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.06 0.457 . . . . 3.77 110.562 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.8 m -146.38 122.98 11.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.938 -0.573 . . . . 3.29 110.218 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -85.24 -171.2 3.5 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.911 -0.403 . . . . 4.39 109.911 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 108.911 -0.774 . . . . 3.62 108.911 172.49 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 120.877 0.37 . . . . 3.7 110.572 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.4 p -100.55 151.79 21.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.123 -0.49 . . . . 2.84 110.444 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -90.77 175.7 40.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.724 -0.75 . . . . 1.91 111.536 175.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 119' ' ' PHE . 24.2 mmt180 -130.51 122.18 27.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.024 0.44 . . . . 3.31 111.751 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.87 134.14 63.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.474 -0.785 . . . . 2.17 109.388 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.2 t -112.39 148.67 33.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.353 -0.24 . . . . 3.61 110.353 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -159.49 167.22 29.18 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 110.084 -0.339 . . . . 3.58 110.084 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -140.06 112.67 7.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.833 -0.432 . . . . 5.1 109.833 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -168.03 154.24 7.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.827 -0.434 . . . . 5.11 109.827 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 64.35 20.99 12.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.117 0.567 . . . . 7.42 110.474 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.77 89.84 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.165 -0.54 . . . . 5.36 112.47 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -111.71 140.84 46.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.227 0.537 . . . . 5.38 111.655 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 52.5 t -140.94 101.51 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.126 -0.943 . . . . 4.96 109.797 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -151.78 169.57 21.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.617 -0.265 . . . . 5.13 110.499 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.45 ' HB3' ' HD2' ' A' ' 108' ' ' ARG . 74.9 m-85 -98.34 130.85 45.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.067 -0.515 . . . . 4.32 110.742 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.6 mp -105.64 134.5 19.68 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.29 -0.413 . . . . 3.17 110.244 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 93.3 Cg_endo -84.01 134.33 6.08 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.745 2.297 . . . . 2.61 112.029 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -135.77 159.44 41.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.41 -0.359 . . . . 2.49 110.224 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.31 175.09 5.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.24 -0.436 . . . . 3.18 110.689 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.82 -38.46 85.51 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.08 0.467 . . . . 5.22 111.694 -174.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -85.2 -3.1 58.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.793 -0.639 . . . . 4.81 112.363 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.83 -15.23 61.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.086 0.47 . . . . 4.0 110.94 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.5 t -81.99 114.57 23.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.199 -0.455 . . . . 4.39 110.171 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.61 110.05 3.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 6.43 110.606 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.5 -3.18 56.29 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.722 -0.672 . . . . 6.14 112.092 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.9 t30 59.12 71.01 0.61 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.071 0.462 . . . . 6.26 110.386 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.7 t -103.46 148.47 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.958 -0.565 . . . . 5.62 110.615 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -81.54 109.1 15.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.011 -0.54 . . . . 6.25 110.496 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.3 pt? -110.9 148.86 31.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.963 -0.562 . . . . 3.62 109.603 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -136.18 124.78 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.855 -0.424 . . . . 7.5 109.855 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.565 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -51.46 123.1 9.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.105 0.479 . . . . 4.12 112.207 -173.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.65 3.66 16.07 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.409 -0.814 . . . . 4.2 111.828 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -105.64 -174.21 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.115 0.484 . . . . 4.06 110.652 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.503 ' HB2' ' HB2' ' A' ' 160' ' ' ASN . 2.7 mmmm -113.53 123.19 49.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.139 -0.482 . . . . 4.48 110.858 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.12 152.02 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.994 0.426 . . . . 2.98 110.665 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 m -113.57 128.8 56.57 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.386 -0.598 . . . . 3.68 109.386 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -130.87 159.5 37.2 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.094 -0.336 . . . . 3.35 110.094 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -111.01 125.14 53.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.326 -0.397 . . . . 5.34 110.218 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.0 mt -78.6 98.54 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.286 -0.635 . . . . 4.66 109.286 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -111.88 144.11 41.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.271 -0.877 . . . . 5.08 111.236 -171.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.2 m -117.96 116.99 28.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.364 -0.38 . . . . 5.68 110.784 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.559 ' H ' HD23 ' A' ' 151' ' ' LEU . 60.9 t30 -99.25 172.62 7.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.263 -0.643 . . . . 6.25 109.263 176.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -51.44 -43.91 62.18 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.187 0.81 . . . . 9.03 113.187 -171.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -23.05 62.55 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.416 0.524 . . . . 8.29 112.416 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.59 16.44 80.74 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.539 -0.838 . . . . 5.65 112.814 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.501 ' O ' HD12 ' A' ' 151' ' ' LEU . 18.7 m120 -105.66 77.46 1.27 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 110.051 -0.352 . . . . 5.26 110.051 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 146' ' ' ASN . 1.6 mm? -127.11 169.64 13.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.306 -0.406 . . . . 4.63 110.546 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.36 -102.91 0.4 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.631 -0.988 . . . . 3.57 110.631 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -125.49 110.26 13.68 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.307 -0.627 . . . . 2.84 109.307 175.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 3.7 t -125.48 168.67 13.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.499 -0.319 . . . . 4.34 110.509 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 57.79 41.44 25.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.23 0.538 . . . . 6.23 110.074 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 56.6 mt -68.63 118.58 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.339 -0.846 . . . . 3.55 111.277 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -102.89 133.64 47.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.554 -0.748 . . . . 6.3 109.363 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.4 tp -76.86 107.68 9.35 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.722 -0.844 . . . . 4.63 108.722 175.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -83.05 -62.7 1.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.89 -0.595 . . . . 4.97 110.626 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.503 ' HB2' ' HB2' ' A' ' 138' ' ' LYS . 16.1 m120 -129.08 103.19 18.55 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.995 -0.743 . . . . 5.57 108.995 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.46 158.66 53.51 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.252 1.968 . . . . 5.69 112.264 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.68 0 CA-C-O 121.334 0.587 . . . . 6.1 109.993 175.163 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.813 0.339 . . . . 12.72 110.219 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -141.18 170.28 16.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.282 -0.417 . . . . 11.63 110.684 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 27.2 p -97.26 173.52 7.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.113 0.482 . . . . 9.47 111.996 -174.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA2' ' HG3' ' A' ' 26' ' ' GLU . . . -169.06 152.07 19.21 Favored Glycine 0 C--O 1.225 -0.414 0 CA-C-N 115.405 -0.816 . . . . 7.73 111.176 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.432 HD11 ' SG ' ' A' ' 25' ' ' CYS . 18.1 pt -100.83 147.89 7.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 117.646 0.723 . . . . 10.57 110.407 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.79 121.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.486 -0.325 . . . . 8.73 111.043 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -72.03 -56.33 5.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.552 -0.749 . . . . 10.86 110.284 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -166.09 157.23 13.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.397 -0.819 . . . . 14.48 109.013 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -115.62 116.1 27.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.326 0.584 . . . . 11.73 111.33 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 2.8 mm? -98.3 -178.93 4.19 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.965 -1.124 . . . . 11.9 107.965 173.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 18' ' ' SER . 2.9 t60 -90.02 124.84 35.11 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.001 -0.74 . . . . 16.67 109.001 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 17' ' ' HIS . 68.7 m 81.35 -21.52 0.31 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.255 0.972 . . . . 13.28 112.399 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 50.4 p90 -150.01 156.68 42.13 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.104 -0.373 . . . . 12.68 111.062 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.36 178.27 21.66 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.667 -0.573 . . . . 7.92 111.667 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -119.34 146.36 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.03 0.415 . . . . 9.69 111.443 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.4 mt -108.33 134.71 49.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.631 -0.713 . . . . 7.75 109.798 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.1 144.77 28.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.651 0.739 . . . . 12.4 111.667 -175.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -80.68 2.83 24.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.573 -1.194 . . . . 12.96 113.065 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.432 ' SG ' HD11 ' A' ' 11' ' ' ILE . 69.1 m -52.85 -31.59 40.07 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.612 0.244 . . . . 13.58 111.3 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 17.0 mm-40 -84.37 -39.36 19.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.409 -0.36 . . . . 12.19 111.106 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.22 148.46 28.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.994 -0.373 . . . . 12.99 109.994 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -70.8 68.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.936 0.717 . . . . 17.26 112.936 -174.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -169.75 139.24 1.94 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.9 -0.591 . . . . 12.1 110.132 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 5.5 ptp180 -107.33 118.37 36.54 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.488 -0.56 . . . . 13.0 109.488 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.46 150.08 29.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.842 0.353 . . . . 9.21 111.052 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -110.65 133.71 53.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.032 -0.729 . . . . 9.75 109.032 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -125.21 143.64 50.84 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.145 -0.317 . . . . 6.85 110.145 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -94.14 155.09 17.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.477 -0.564 . . . . 10.15 109.477 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -69.23 -9.22 52.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.899 0.38 . . . . 10.56 111.583 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -80.57 -13.33 59.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.055 0.455 . . . . 12.44 109.777 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -116.44 35.81 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.922 -0.581 . . . . 11.14 111.486 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -119.01 124.94 48.21 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.062 -0.347 . . . . 8.78 110.062 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 t -94.76 94.96 8.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.066 0.46 . . . . 9.11 110.25 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.86 -169.71 26.03 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.054 -0.593 . . . . 9.98 111.738 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -87.8 120.34 29.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.286 -0.264 . . . . 12.91 110.286 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -66.56 -20.77 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.236 0.541 . . . . 11.97 110.954 -176.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.04 -24.56 66.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.914 -0.584 . . . . 14.73 110.583 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -92.91 2.95 56.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.835 -0.621 . . . . 13.3 110.453 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -102.54 129.93 49.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.636 -0.711 . . . . 10.07 109.417 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.38 177.22 8.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.529 -0.305 . . . . 13.53 110.768 -175.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.05 141.03 15.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.537 -0.302 . . . . 12.26 110.187 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.53 10.57 85.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.091 -0.576 . . . . 11.04 111.767 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.9 134.47 21.48 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.583 -0.309 . . . . 8.39 110.194 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HB2' HD12 ' A' ' 72' ' ' ILE . 90.4 Cg_endo -81.99 128.82 5.93 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.594 2.196 . . . . 8.18 113.653 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.0 m -120.65 167.99 13.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.448 -0.796 . . . . 4.78 109.779 175.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 4.7 pt-20 -120.17 124.48 45.85 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.258 -0.645 . . . . 7.09 109.258 174.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -131.27 147.8 52.62 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 122.165 0.983 . . . . 7.82 112.278 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 30.6 tt0 -100.29 122.13 42.59 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.003 -1.453 . . . . 11.59 108.448 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.93 118.08 36.26 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.243 -0.183 . . . . 12.41 110.726 -173.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.5 p -141.94 153.49 44.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.161 0.505 . . . . 13.93 111.459 -176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -96.8 108.52 21.2 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.13 -0.693 . . . . 16.22 109.13 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.57 111.13 18.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.062 0.458 . . . . 16.64 110.928 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -81.18 -7.08 59.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.966 -0.561 . . . . 23.23 111.706 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -67.99 -46.56 70.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.033 -0.729 . . . . 21.87 109.033 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.4 p -93.78 -31.33 14.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.179 -0.918 . . . . 17.49 110.9 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.33 28.46 17.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.679 -0.772 . . . . 17.22 111.905 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -133.41 152.91 80.1 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 110.132 -0.321 . . . . 14.83 110.132 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.06 125.88 6.77 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.322 2.015 . . . . 13.33 110.763 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -137.43 172.51 14.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.748 0.785 . . . . 12.33 112.749 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.69 149.76 24.12 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.753 -1.112 . . . . 8.91 108.028 170.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.491 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 8.6 t -69.39 -151.07 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.329 0.585 . . . . 10.33 110.547 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -75.79 26.7 0.11 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.524 0.564 . . . . 12.02 112.524 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.434 ' H ' ' C ' ' A' ' 67' ' ' SER . 38.5 t 21.58 96.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.959 1.304 . . . . 6.52 113.632 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.3 t -88.55 154.32 20.44 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.777 -0.647 . . . . 6.18 110.22 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -96.64 123.58 40.37 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.001 -0.545 . . . . 6.59 109.877 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 50' ' ' PRO . 63.8 mt . . . . . 0 C--O 1.236 0.371 0 O-C-N 124.0 0.812 . . . . 6.16 111.386 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 120.547 0.213 . . . . 6.19 110.624 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 38.9 t -77.64 103.56 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 6.54 109.749 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.19 41.57 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.624 -0.716 . . . . 6.46 110.493 -174.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 71.1 m -156.18 33.15 0.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.951 -0.568 . . . . 7.24 110.853 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 145' ' ' THR . 6.1 mm-40 -83.22 62.99 6.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.228 -0.442 . . . . 7.07 110.466 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 68.81 112.72 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.192 -1.367 . . . . 6.68 111.463 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 3.3 ptm180 -77.71 81.95 4.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.616 0.722 . . . . 6.93 109.927 177.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.3 m -77.42 168.95 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.715 -0.675 . . . . 4.0 110.974 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.441 ' HB ' ' HE3' ' A' ' 138' ' ' LYS . 46.8 p -116.45 150.26 38.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.819 -0.628 . . . . 3.84 109.83 175.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.29 153.88 20.78 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.425 -0.893 . . . . 2.58 111.713 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -107.03 126.4 52.28 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.289 -0.634 . . . . 3.7 109.289 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 21.4 t -70.56 110.87 3.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.4 -0.363 . . . . 3.14 110.784 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.3 p -98.24 -13.26 20.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.698 0.761 . . . . 3.77 110.172 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 26.7 m -155.34 115.93 3.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.118 -0.946 . . . . 3.29 109.381 -175.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' HG3' ' HB3' ' A' ' 135' ' ' ALA . 0.3 OUTLIER -104.62 148.8 26.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 4.39 111.102 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 108.335 -0.987 . . . . 3.62 108.335 174.636 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 121.366 0.603 . . . . 3.7 109.708 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t -97.34 135.98 38.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.27 -0.423 . . . . 2.84 110.193 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 122' ' ' TYR . . . -75.41 -177.54 41.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.632 -0.794 . . . . 1.91 112.048 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.597 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -146.27 120.85 9.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.102 0.477 . . . . 3.31 110.164 -177.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -111.56 130.38 65.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.853 -0.612 . . . . 2.17 110.209 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.7 t -105.31 124.46 49.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.032 -0.531 . . . . 3.61 109.625 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -140.84 146.83 38.07 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.388 -0.597 . . . . 3.58 109.388 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.38 112.0 18.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.152 0.501 . . . . 5.1 110.802 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.71 121.89 46.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.568 -0.742 . . . . 5.11 109.936 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 60.57 23.82 13.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.502 -0.772 . . . . 7.42 111.06 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.25 -2.01 65.18 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.911 -0.661 . . . . 5.36 113.171 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.84 121.71 41.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.241 0.521 . . . . 5.38 110.559 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.4 p -102.47 113.15 26.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.117 -0.492 . . . . 4.96 110.754 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -118.51 147.03 44.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.291 -0.413 . . . . 5.13 110.377 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -101.63 126.84 48.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 4.32 109.648 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.9 118.54 55.95 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.586 -0.279 . . . . 3.17 110.93 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.82 132.68 14.6 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.691 2.261 . . . . 2.61 110.712 168.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.447 ' HH ' HD12 ' A' ' 133' ' ' LEU . 35.0 p90 -140.95 159.78 41.48 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.932 -0.307 . . . . 2.49 110.54 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 64.7 p -121.02 -175.62 3.09 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.012 -0.54 . . . . 3.18 110.009 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -62.89 -30.13 71.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.351 . . . . 5.22 111.655 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.01 -9.38 59.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.07 -0.514 . . . . 4.81 111.202 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -91.17 -12.44 35.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.28 0.562 . . . . 4.0 110.309 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.2 t -85.81 126.82 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.002 -0.545 . . . . 4.39 110.152 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -80.92 127.93 33.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.229 -0.441 . . . . 6.43 109.973 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.24 -0.23 87.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.808 -0.711 . . . . 6.14 112.838 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.0 m120 59.6 35.98 22.62 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.139 0.495 . . . . 6.26 111.087 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.87 137.19 23.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.145 -0.479 . . . . 5.62 111.249 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -80.74 112.62 18.29 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.694 -0.484 . . . . 6.25 109.694 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.512 HD21 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -102.9 150.9 23.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.055 -0.52 . . . . 3.62 111.536 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -115.46 135.57 53.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.689 -0.687 . . . . 7.5 110.044 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.566 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -60.91 114.39 3.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.258 0.551 . . . . 4.12 110.815 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.06 -3.92 14.11 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.517 -0.765 . . . . 4.2 112.874 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . 16.5 p30 -90.78 -177.35 4.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.442 0.621 . . . . 4.06 110.18 173.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.441 ' HE3' ' HB ' ' A' ' 84' ' ' THR . 50.9 tptt -112.95 113.55 25.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.061 0.458 . . . . 4.48 110.874 -174.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.9 m -117.82 154.28 19.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.84 -0.618 . . . . 2.98 110.515 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.5 t -124.18 135.88 53.78 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.395 -0.594 . . . . 3.68 109.395 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.44 146.33 52.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.164 -0.471 . . . . 3.35 110.129 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -93.8 118.92 32.09 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.792 -0.64 . . . . 5.34 109.704 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 93.8 mt -78.4 133.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.646 -0.501 . . . . 4.66 109.646 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -125.81 110.7 14.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.992 -0.549 . . . . 5.08 110.322 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.404 ' H ' ' HG3' ' A' ' 80' ' ' GLU . 20.0 m -99.01 132.09 44.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.962 0.411 . . . . 5.68 110.895 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -107.27 -163.8 0.93 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.845 -0.616 . . . . 6.25 110.935 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -75.71 -37.94 59.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.969 -0.559 . . . . 9.03 110.651 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -74.94 -18.42 60.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.384 -0.371 . . . . 8.29 110.794 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.98 22.78 54.4 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.839 -0.696 . . . . 5.65 111.801 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -113.96 121.53 44.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.462 0.173 . . . . 5.26 110.585 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -148.9 -179.32 6.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.006 0.432 . . . . 4.63 111.659 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.23 -124.81 1.64 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.635 -0.986 . . . . 3.57 110.635 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -138.72 117.11 11.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.832 0.316 . . . . 2.84 110.378 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 4.7 t -128.59 158.48 38.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.446 -0.343 . . . . 4.34 110.08 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 57.43 42.95 23.85 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.741 0.65 . . . . 6.23 110.953 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 22.3 mt -74.6 116.29 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.329 -0.85 . . . . 3.55 110.666 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -114.2 142.02 46.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 6.3 110.901 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.1 tp -83.41 119.21 24.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.927 -0.578 . . . . 4.63 110.125 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -87.64 -53.74 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.744 0.307 . . . . 4.97 110.581 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -142.92 122.94 7.89 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.918 0.389 . . . . 5.57 110.9 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.424 ' HA ' ' HB2' ' A' ' 137' ' ' ASP . 82.3 Cg_endo -79.78 157.36 24.42 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.787 2.325 . . . . 5.69 112.59 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 115.804 -0.634 . . . . 6.1 110.696 178.931 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.426 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 15.0 ptt180 . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 120.935 0.398 . . . . 12.72 110.604 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.514 ' HB2' ' NH1' ' A' ' 27' ' ' ARG . 38.3 mt-10 -130.91 155.67 46.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.031 -0.531 . . . . 11.63 109.633 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -87.48 169.57 12.1 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.178 -0.465 . . . . 9.47 110.291 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.23 162.97 34.68 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.55 -0.833 . . . . 7.73 111.999 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -117.64 137.0 53.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.407 -0.59 . . . . 10.57 109.407 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.75 110.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.149 0.5 . . . . 8.73 110.471 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -72.09 -50.53 27.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.77 -0.65 . . . . 10.86 110.37 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HA ' HD13 ' A' ' 47' ' ' ILE . 38.1 ttpt -161.04 155.17 22.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.899 -1.046 . . . . 14.48 109.098 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 mt -116.15 126.76 54.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.156 0.503 . . . . 11.73 111.183 -175.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.4 mp -114.57 -179.89 3.76 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.649 -1.241 . . . . 11.9 107.649 173.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -90.62 126.64 36.02 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.182 -0.607 . . . . 16.67 110.27 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 m 80.56 -14.58 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.605 1.191 . . . . 13.28 111.995 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 12.5 p90 -159.59 162.31 35.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.764 0.316 . . . . 12.68 111.389 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.24 -176.78 27.82 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.085 -0.579 . . . . 7.92 112.054 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -115.94 143.92 44.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.823 0.344 . . . . 9.69 111.475 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.9 mt -113.79 120.19 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.856 -0.611 . . . . 7.75 110.075 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -69.48 147.04 51.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.476 0.655 . . . . 12.4 111.809 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.2 p -79.89 0.57 30.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.842 -1.072 . . . . 12.96 112.299 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 m -53.24 -31.32 42.83 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.662 0.616 . . . . 13.58 112.662 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -105.53 11.27 32.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.712 0.291 . . . . 12.19 111.431 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.514 ' NH1' ' HB2' ' A' ' 8' ' ' GLU . 7.5 ptm85 -153.95 -170.24 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.524 0.202 . . . . 12.99 111.326 -173.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -112.14 17.81 19.22 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.15 0.426 . . . . 17.26 112.15 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.81 149.17 17.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.524 -0.307 . . . . 12.1 110.885 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -92.86 135.69 33.91 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.177 -0.675 . . . . 13.0 109.177 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.1 mt -135.82 163.23 30.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.355 0.597 . . . . 9.21 111.904 -174.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -124.08 149.2 46.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.447 -0.946 . . . . 9.75 108.447 172.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -135.36 152.15 51.17 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.941 -0.304 . . . . 6.85 110.248 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 32.4 p-80 -109.71 152.4 25.67 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.689 -0.485 . . . . 10.15 109.689 175.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -70.2 4.52 2.15 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.252 0.834 . . . . 10.56 113.252 -168.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 t -77.78 -17.78 57.14 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.725 -0.472 . . . . 12.44 109.725 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -116.66 40.46 2.92 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.863 -0.608 . . . . 11.14 112.114 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -126.59 124.91 41.04 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.203 -0.599 . . . . 8.78 111.331 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 m -101.92 106.68 17.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.662 -0.699 . . . . 9.11 110.707 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.57 176.08 19.2 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.722 -0.751 . . . . 9.98 112.023 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -68.67 109.65 3.9 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.703 -0.481 . . . . 12.91 109.703 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -63.68 -25.05 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.166 0.508 . . . . 11.97 110.8 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.39 -23.19 62.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.126 -0.488 . . . . 14.73 110.745 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -93.42 2.96 56.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 13.3 110.949 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.431 HD12 ' OD1' ' A' ' 49' ' ' ASP . 26.3 tp -94.43 117.03 29.5 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.698 -0.853 . . . . 10.07 108.698 176.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -119.19 -173.9 2.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.523 -0.308 . . . . 13.53 110.849 -173.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 14' ' ' LYS . 24.6 mm -87.55 133.03 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.76 -0.459 . . . . 12.26 109.76 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.73 10.85 82.62 Favored Glycine 0 CA--C 1.51 -0.235 0 N-CA-C 110.922 -0.871 . . . . 11.04 110.922 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.431 ' OD1' HD12 ' A' ' 45' ' ' LEU . 43.4 t0 -92.97 121.73 65.16 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.838 -0.681 . . . . 8.39 109.906 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.62 143.21 18.79 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.102 2.535 . . . . 8.18 114.058 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.0 m -138.75 160.71 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.667 -0.697 . . . . 4.78 110.413 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -117.74 130.53 56.37 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.807 -0.442 . . . . 7.09 109.807 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -142.35 155.57 45.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.443 0.639 . . . . 7.82 111.245 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 21.1 mt-10 -104.53 131.53 51.82 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.46 -0.791 . . . . 11.59 109.075 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.7 ttt -103.87 123.11 46.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.557 -0.292 . . . . 12.41 110.944 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.0 p -141.97 169.76 16.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.923 0.392 . . . . 13.93 111.124 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 53.1 m-85 -116.9 120.7 39.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.564 -0.532 . . . . 16.22 109.564 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD2' HG21 ' A' ' 61' ' ' THR . 21.4 t70 -81.99 121.43 26.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.724 0.297 . . . . 16.64 110.38 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -79.86 -6.97 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 23.23 112.267 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -84.04 -57.66 3.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.601 0.238 . . . . 21.87 110.702 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.473 HG23 ' HG2' ' A' ' 63' ' ' LYS . 8.8 t -91.62 -19.26 22.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.116 0.484 . . . . 17.49 110.774 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.86 34.16 22.39 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.457 -0.878 . . . . 17.22 113.365 172.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HG2' HG23 ' A' ' 61' ' ' THR . 19.2 ptpt -124.74 150.05 64.36 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 117.485 0.643 . . . . 14.83 110.963 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.494 ' HB3' ' CE1' ' A' ' 57' ' ' TYR . 58.4 Cg_endo -73.43 126.66 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.398 2.065 . . . . 13.33 110.913 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.29 -179.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.286 0.565 . . . . 12.33 111.252 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.0 162.96 19.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.445 -0.798 . . . . 8.91 109.842 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 30.4 t -72.87 -164.03 0.15 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.706 -0.679 . . . . 10.33 109.576 175.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -74.11 17.34 0.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.833 0.679 . . . . 12.02 112.833 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 67' ' ' SER . 61.2 t 37.88 93.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.149 0.98 . . . . 6.52 112.602 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.2 t -82.13 123.06 28.63 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.354 -0.609 . . . . 6.18 109.354 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -73.76 121.65 21.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.329 -0.619 . . . . 6.59 109.329 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.4 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.481 -0.781 . . . . 6.16 111.639 -174.525 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.448 -0.575 . . . . 6.19 109.448 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 26.6 t -78.65 83.87 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.062 0.458 . . . . 6.54 110.541 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.522 HD13 ' HB3' ' A' ' 144' ' ' ALA . 3.6 tp -82.74 17.26 1.9 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.694 -0.684 . . . . 6.46 110.61 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 m -133.69 36.93 3.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.506 0.558 . . . . 7.24 112.506 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.14 -51.17 11.45 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.373 -0.531 . . . . 7.07 110.334 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -167.43 139.5 3.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 6.68 110.032 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.485 ' HD3' ' C ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -96.1 114.46 26.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.545 -0.539 . . . . 6.93 109.545 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.88 171.0 12.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.694 -0.684 . . . . 4.0 110.112 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.9 p -108.4 148.44 30.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.333 -0.618 . . . . 3.84 109.333 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -114.04 137.41 14.07 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.429 -0.891 . . . . 2.58 112.311 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -120.0 112.1 18.74 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.115 -0.698 . . . . 3.7 109.115 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.635 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 59.1 t -66.83 127.63 28.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.161 -0.472 . . . . 3.14 110.483 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.1 p -109.07 -20.0 13.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.135 0.493 . . . . 3.77 111.092 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.7 m -148.98 124.99 10.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.462 -0.57 . . . . 3.29 109.462 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.86 -179.1 7.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.033 0.444 . . . . 4.39 110.869 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.0 mt . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.824 -0.626 . . . . 3.62 109.506 175.237 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 121.395 0.617 . . . . 3.7 110.055 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 56.9 p -98.56 137.2 37.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.435 -0.802 . . . . 2.84 111.537 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -86.39 -169.06 45.54 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.059 -0.816 . . . . 1.91 111.059 173.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -128.3 120.81 27.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.982 0.42 . . . . 3.31 111.226 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.432 HG13 ' CD1' ' A' ' 122' ' ' TYR . 80.0 mt -110.95 125.09 68.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.599 -0.728 . . . . 2.17 109.341 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.7 t -104.25 142.1 35.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.984 0.421 . . . . 3.61 110.681 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -147.44 165.58 29.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.456 -0.942 . . . . 3.58 108.456 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.96 125.21 27.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.386 -0.598 . . . . 5.1 109.386 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -135.27 107.75 7.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 5.11 110.938 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 62.64 28.66 16.71 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.749 -0.66 . . . . 7.42 111.906 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.34 -1.57 62.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.162 -0.542 . . . . 5.36 112.996 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -104.65 110.81 23.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.1 0.476 . . . . 5.38 110.365 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 45.5 t -112.39 127.44 56.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.883 -0.599 . . . . 4.96 109.872 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -135.37 166.95 21.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 5.13 111.013 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -110.26 123.96 50.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.562 -0.744 . . . . 4.32 109.593 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 8.4 mp -104.48 132.88 20.54 Favored Pre-proline 0 C--N 1.322 -0.607 0 C-N-CA 121.069 -0.252 . . . . 3.17 110.492 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 2.8 Cg_exo -75.37 133.16 15.73 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.741 2.294 . . . . 2.61 111.664 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.432 ' CD1' HG13 ' A' ' 109' ' ' ILE . 17.6 p90 -135.16 144.81 47.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.679 -0.237 . . . . 2.49 110.483 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.4 p -109.18 -177.62 3.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.109 -0.33 . . . . 3.18 110.109 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -70.6 -22.4 62.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.236 0.541 . . . . 5.22 110.725 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.25 -25.93 52.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.488 -0.778 . . . . 4.81 110.975 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 153' ' ' ALA . 21.7 m-20 -74.26 -30.55 62.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.027 -0.533 . . . . 4.0 111.795 -175.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 156' ' ' ILE . 2.5 p -84.59 118.63 32.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.651 0.739 . . . . 4.39 111.052 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -89.92 136.22 33.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.347 -0.842 . . . . 6.43 109.769 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.34 -19.85 38.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.772 -0.728 . . . . 6.14 111.848 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 60.09 71.01 0.59 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.383 0.611 . . . . 6.26 110.904 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 t -108.12 149.43 11.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.117 -0.492 . . . . 5.62 110.122 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -91.7 102.03 14.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.002 0.43 . . . . 6.25 110.155 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.532 HD23 ' H ' ' A' ' 133' ' ' LEU . 1.8 pt? -114.97 143.44 45.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.593 -0.731 . . . . 3.62 110.267 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -117.62 -179.99 3.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 7.5 109.913 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.635 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.81 132.46 42.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.314 -0.403 . . . . 4.12 110.47 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 104.95 -14.44 48.95 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.068 -0.587 . . . . 4.2 112.444 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.488 ' OD2' ' HB1' ' A' ' 162' ' ' ALA . 54.3 m-20 -84.77 146.45 27.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.466 -0.568 . . . . 4.06 109.466 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -93.5 116.47 29.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.588 0.709 . . . . 4.48 111.778 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.1 m -120.22 166.31 14.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.974 -1.012 . . . . 2.98 110.311 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.604 ' HB3' ' OE1' ' A' ' 159' ' ' GLU . 21.0 p -118.96 133.27 55.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.755 -0.461 . . . . 3.68 109.755 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -135.12 142.52 46.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.774 -0.454 . . . . 3.35 109.774 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -98.26 129.33 44.98 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.838 -0.619 . . . . 5.34 110.057 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.41 98.62 2.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.067 -0.716 . . . . 4.66 109.067 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -102.72 110.07 21.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.148 -0.933 . . . . 5.08 111.599 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.45 122.35 26.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.93 -0.577 . . . . 5.68 110.459 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.1 p30 -86.38 -172.42 4.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.057 0.456 . . . . 6.25 110.803 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -83.54 6.54 20.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.957 -0.565 . . . . 9.03 111.574 -172.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -115.28 1.66 13.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.353 -0.385 . . . . 8.29 110.935 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.79 20.75 70.2 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.768 -0.73 . . . . 5.65 113.294 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -123.99 154.97 39.05 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 5.26 109.127 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.474 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -156.07 176.43 12.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.225 0.536 . . . . 4.63 111.822 -178.135 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.59 -138.9 3.0 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.351 -1.1 . . . . 3.57 110.351 174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 126' ' ' ASP . . . -121.97 109.0 14.06 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.582 -0.525 . . . . 2.84 109.582 175.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.17 162.7 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.505 -0.316 . . . . 4.34 110.535 -175.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 60.53 33.81 20.45 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.552 0.691 . . . . 6.23 110.043 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 127' ' ' VAL . 70.8 mt -59.84 123.33 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.7 -1.136 . . . . 3.55 110.95 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -124.13 127.55 47.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.9 0.381 . . . . 6.3 110.606 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.46 96.72 2.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 4.63 109.692 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.604 ' OE1' ' HB3' ' A' ' 140' ' ' SER . 6.6 pt-20 -76.86 -35.68 57.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 4.97 110.916 -176.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -137.56 102.26 8.76 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.499 -0.319 . . . . 5.57 110.699 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.23 151.71 49.31 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.523 2.149 . . . . 5.69 112.223 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.488 ' HB1' ' OD2' ' A' ' 137' ' ' ASP . . . . . . . . 0 C--N 1.317 -0.814 0 CA-C-O 121.462 0.649 . . . . 6.1 110.549 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 10.6 ptp180 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.344 0.592 . . . . 12.72 109.798 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.37 156.23 21.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.551 -0.75 . . . . 11.63 110.652 -173.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.1 p -110.52 136.75 49.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.414 -0.357 . . . . 9.47 111.007 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.96 178.21 25.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 7.73 111.909 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.9 mt -124.56 143.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.842 0.321 . . . . 10.57 110.249 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.3 mm -73.58 106.59 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.438 -0.579 . . . . 8.73 109.438 174.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -73.41 -43.92 59.44 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.966 0.412 . . . . 10.86 110.504 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -155.75 162.59 40.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.005 -0.543 . . . . 14.48 109.563 -176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 mt -119.82 118.63 31.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.171 0.51 . . . . 11.73 111.071 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -111.82 179.99 3.86 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.328 -0.99 . . . . 11.9 108.328 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -90.2 117.31 28.86 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.749 -0.781 . . . . 16.67 110.151 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.6 m 78.71 -7.55 1.77 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.06 -0.973 . . . . 13.28 112.442 178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.69 168.57 26.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.718 0.294 . . . . 12.68 110.886 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.68 -166.61 22.82 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.187 -0.53 . . . . 7.92 112.068 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -125.99 139.51 53.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 9.69 110.945 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.0 mt -101.77 120.36 51.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 7.75 109.574 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -75.92 143.02 41.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.559 -0.746 . . . . 12.4 110.993 -175.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -79.14 3.1 18.64 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.353 -0.839 . . . . 12.96 112.631 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.0 t -51.43 -51.26 56.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.506 0.558 . . . . 13.58 112.506 -173.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -90.46 16.94 7.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.289 0.566 . . . . 12.19 111.01 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.571 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 38.6 ttt180 -144.83 -158.63 0.91 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.041 -1.096 . . . . 12.99 108.041 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.571 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 13.4 mm-40 -136.22 23.58 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.189 0.518 . . . . 17.26 110.413 167.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.421 ' O ' ' HD3' ' A' ' 27' ' ' ARG . . . -151.8 119.53 6.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.664 -0.698 . . . . 12.1 110.633 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -86.63 151.71 23.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.147 -0.479 . . . . 13.0 110.112 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.509 HD12 ' SD ' ' A' ' 55' ' ' MET . 59.6 mt -141.77 162.17 36.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 9.21 111.423 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -103.6 143.41 32.79 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.664 -0.865 . . . . 9.75 108.664 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -137.93 147.62 44.51 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.269 -0.572 . . . . 6.85 110.179 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -103.41 155.11 18.73 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.368 -0.604 . . . . 10.15 109.368 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -67.25 -13.27 61.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.697 0.284 . . . . 10.56 111.37 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 p -70.78 -24.17 62.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.537 . . . . 12.44 110.148 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -94.1 20.53 7.83 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.642 -0.708 . . . . 11.14 110.995 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -125.03 123.17 39.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.932 0.396 . . . . 8.78 110.705 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 t -111.51 100.8 9.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.72 -0.673 . . . . 9.11 110.218 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.77 -169.78 36.53 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.968 -0.634 . . . . 9.98 111.915 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -83.89 103.68 13.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 12.91 110.323 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.9 tp -67.62 -24.18 30.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.943 -0.571 . . . . 11.97 110.918 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.79 -12.78 61.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 14.73 111.023 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -104.25 4.5 33.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 13.3 110.202 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.9 tp -103.79 110.14 22.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.485 . . . . 10.07 110.701 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -114.11 -178.87 3.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.221 0.534 . . . . 13.53 110.935 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.3 mp -73.08 140.19 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.601 -0.727 . . . . 12.26 110.208 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.84 -2.19 66.37 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 121.013 -0.613 . . . . 11.04 112.378 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.501 ' CG ' ' HZ2' ' A' ' 71' ' ' LYS . 32.2 t70 -91.71 127.98 48.03 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 120.58 0.229 . . . . 8.39 110.608 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.76 141.7 13.73 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.194 2.596 . . . . 8.18 113.632 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.7 m -128.57 157.93 40.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.799 -0.637 . . . . 4.78 111.186 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -113.17 124.06 51.67 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.997 -0.742 . . . . 7.09 108.997 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -136.87 142.13 42.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.286 0.565 . . . . 7.82 111.614 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' CD ' ' HB2' ' A' ' 67' ' ' SER . 0.2 OUTLIER -88.88 141.29 28.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.009 -0.737 . . . . 11.59 109.009 173.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.509 ' SD ' HD12 ' A' ' 31' ' ' LEU . 24.5 ttt -124.0 114.01 19.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.35 -0.241 . . . . 12.41 110.35 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.5 p -134.99 164.67 27.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.153 0.501 . . . . 13.93 111.425 -177.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -95.31 113.4 25.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.025 -0.534 . . . . 16.22 110.083 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.97 124.08 26.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.032 0.444 . . . . 16.64 110.469 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -79.72 -8.87 59.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.684 -0.689 . . . . 23.23 111.266 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -81.0 -56.87 3.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 21.87 110.357 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.5 p -86.65 -45.84 10.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.169 -0.469 . . . . 17.49 111.645 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.0 0.22 35.85 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.626 -0.797 . . . . 17.22 112.322 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -95.87 150.78 37.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.152 -0.314 . . . . 14.83 110.152 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.15 125.29 8.45 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.953 1.769 . . . . 13.33 109.502 171.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -126.94 162.4 31.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.04 0.447 . . . . 12.33 111.362 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.54 151.62 20.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.405 -0.816 . . . . 8.91 109.284 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.533 ' HB2' ' CD ' ' A' ' 54' ' ' GLU . 11.8 t -75.88 -157.22 0.07 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.041 -0.527 . . . . 10.33 109.79 177.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -75.12 19.23 0.16 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.838 0.681 . . . . 12.02 112.838 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.416 ' H ' ' C ' ' A' ' 67' ' ' SER . 87.0 t 33.83 94.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.537 1.135 . . . . 6.52 113.108 178.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.8 m -80.36 120.73 24.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.461 0.648 . . . . 6.18 110.358 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.673 ' HE2' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -68.1 113.48 5.8 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.664 -0.698 . . . . 6.59 110.537 -179.038 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.673 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 79.5 mt . . . . . 0 C--O 1.236 0.376 0 CA-C-N 116.175 -0.466 . . . . 6.16 110.328 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.666 0.27 . . . . 6.19 110.93 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 38.4 t -67.7 89.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 6.54 110.962 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 144' ' ' ALA . 4.1 tt -91.18 -27.95 18.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 6.46 110.781 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 t -116.37 99.86 7.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.071 -0.513 . . . . 7.24 110.68 -175.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -125.21 -68.15 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.514 -0.767 . . . . 7.07 109.017 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -130.69 127.88 39.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.181 -0.674 . . . . 6.68 109.181 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.98 126.39 32.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.964 0.411 . . . . 6.93 110.151 -177.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.39 167.4 13.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.093 -0.503 . . . . 4.0 111.117 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 p -120.75 146.23 46.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.809 -0.632 . . . . 3.84 110.327 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.39 162.61 26.5 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.6 -0.81 . . . . 2.58 112.382 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.5 m -106.61 135.24 48.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.826 -0.435 . . . . 3.7 109.826 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 1.1 t -68.98 121.56 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.863 -0.421 . . . . 3.14 109.863 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -27.82 16.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.146 0.498 . . . . 3.77 110.227 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.5 m -155.29 138.01 15.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.003 -0.544 . . . . 3.29 110.407 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -99.85 -171.8 2.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.339 0.59 . . . . 4.39 111.568 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 91' ' ' LEU . 2.5 mm? . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 114.95 -1.023 . . . . 3.62 109.22 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.968 -0.382 . . . . 3.7 109.968 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 t -130.52 143.67 50.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.914 0.388 . . . . 2.84 110.3 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.74 -168.34 39.58 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.727 -0.749 . . . . 1.91 111.881 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.515 ' NH2' ' HB3' ' A' ' 121' ' ' PRO . 1.1 mmp_? -136.29 130.33 32.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.844 0.354 . . . . 3.31 110.746 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.6 mt -112.53 126.99 69.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.228 -0.656 . . . . 2.17 109.228 171.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 p -108.18 123.19 48.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.439 -0.346 . . . . 3.61 110.608 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.36 156.9 47.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.763 -0.458 . . . . 3.58 109.763 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 116' ' ' GLU . 3.5 tm-20 -132.35 120.86 22.64 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.339 -0.615 . . . . 5.1 109.339 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.762 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 8.6 t30 -130.74 106.48 8.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.199 -0.455 . . . . 5.11 110.724 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 57.94 38.19 26.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.024 -0.535 . . . . 7.42 111.64 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.59 -5.67 64.72 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.983 -0.627 . . . . 5.36 114.091 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.762 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 11.7 pt-20 -95.01 124.6 39.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 118.071 0.935 . . . . 5.38 109.733 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 44.1 t -124.24 104.46 8.83 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.518 -0.549 . . . . 4.96 109.518 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.23 152.71 32.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 5.13 110.979 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -102.65 117.55 34.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.776 -0.824 . . . . 4.32 108.776 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.19 127.64 29.31 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.817 0.341 . . . . 3.17 110.622 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.515 ' HB3' ' NH2' ' A' ' 108' ' ' ARG . 58.7 Cg_endo -76.18 135.88 17.46 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.547 2.165 . . . . 2.61 111.906 175.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -148.73 159.95 43.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.996 -0.742 . . . . 2.49 108.996 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.7 p -116.45 171.9 7.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.921 0.391 . . . . 3.18 110.294 175.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -63.93 -21.98 66.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.443 0.64 . . . . 5.22 110.484 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.4 -4.11 58.16 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.606 -0.724 . . . . 4.81 111.88 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -90.76 -9.54 46.24 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.712 0.291 . . . . 4.0 111.417 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 p -102.73 133.02 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.218 0.532 . . . . 4.39 111.335 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -94.45 144.86 25.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.948 -0.569 . . . . 6.43 110.24 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.33 -14.12 23.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.908 -0.663 . . . . 6.14 112.998 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 62.3 t30 53.89 50.86 15.92 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.653 0.74 . . . . 6.26 110.139 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.83 156.48 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.515 -0.766 . . . . 5.62 110.424 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -84.84 120.72 26.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.814 0.34 . . . . 6.25 111.632 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.42 136.72 44.45 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.69 -0.855 . . . . 3.62 108.69 173.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -142.62 157.5 44.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.741 -0.384 . . . . 7.5 110.561 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.523 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -58.66 120.28 8.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.869 0.366 . . . . 4.12 111.121 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.27 -17.4 10.51 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.668 -0.777 . . . . 4.2 113.487 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -92.45 175.47 6.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.017 0.908 . . . . 4.06 109.967 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -119.15 118.81 32.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.353 0.597 . . . . 4.48 111.17 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.2 m -117.18 160.79 16.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.586 -0.734 . . . . 2.98 111.339 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.3 t -117.14 131.74 56.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.051 -0.722 . . . . 3.68 109.051 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -134.31 155.42 50.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.823 0.344 . . . . 3.35 110.46 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -109.15 140.86 42.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.032 0.444 . . . . 5.34 110.292 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.6 mt -110.72 110.1 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.896 -0.593 . . . . 4.66 110.589 -174.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -87.39 107.17 18.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.033 0.444 . . . . 5.08 111.083 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 28.3 m -96.26 117.02 29.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.699 -0.682 . . . . 5.68 111.777 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -85.97 164.21 17.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.423 -0.584 . . . . 6.25 109.423 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.47 -27.95 62.93 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.698 0.399 . . . . 9.03 111.191 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -71.14 -13.53 61.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.08 -0.509 . . . . 8.29 111.704 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.65 22.3 62.27 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.689 -0.767 . . . . 5.65 111.967 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -105.47 124.06 48.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.832 -0.433 . . . . 5.26 109.832 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.457 ' N ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.43 168.87 23.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.963 0.411 . . . . 4.63 112.065 -177.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.78 -168.27 16.57 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.763 -0.935 . . . . 3.57 110.763 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.31 116.73 33.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.122 0.461 . . . . 2.84 110.852 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.3 t -140.46 158.5 43.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.519 -0.549 . . . . 4.34 109.519 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 58.2 65.72 1.23 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.294 0.569 . . . . 6.23 110.554 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 mp -89.16 138.5 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.432 -0.804 . . . . 3.55 110.53 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -126.09 129.36 48.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.872 -0.604 . . . . 6.3 110.278 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.6 tp -82.69 110.98 18.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.982 -0.377 . . . . 4.63 109.982 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.07 -48.25 6.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 4.97 111.261 -176.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -128.19 100.13 23.83 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.806 0.336 . . . . 5.57 110.945 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -87.2 151.28 8.08 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.013 2.475 . . . . 5.69 111.913 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.787 0 CA-C-O 120.964 0.411 . . . . 6.1 110.474 178.657 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 . . . . . 0 C--O 1.234 0.276 0 N-CA-C 109.278 -0.638 . . . . 12.72 109.278 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.641 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.9 pt-20 -156.82 148.93 22.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.667 0.746 . . . . 11.63 112.293 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 11.8 p -116.67 162.15 18.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.226 -0.897 . . . . 9.47 110.968 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.56 -176.21 36.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.155 -0.545 . . . . 7.73 111.992 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.2 mt -121.35 142.53 37.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.156 -0.683 . . . . 10.57 109.156 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.3 mm -65.87 117.99 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 117.843 0.292 . . . . 8.73 110.223 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -84.21 -49.73 8.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.76 -0.655 . . . . 10.86 110.427 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -151.47 145.9 25.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.376 -0.829 . . . . 14.48 110.324 -177.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.6 mt -117.58 110.51 18.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.218 0.532 . . . . 11.73 110.842 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.2 mt -108.35 -177.82 3.43 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.085 -0.961 . . . . 11.9 108.727 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 18' ' ' SER . 44.2 m80 -87.28 122.3 30.87 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.246 -0.582 . . . . 16.67 109.874 -174.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 17' ' ' HIS . 38.2 m 83.1 -20.31 0.34 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.671 1.232 . . . . 13.28 112.102 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 32.3 p90 -147.19 143.51 28.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.028 0.442 . . . . 12.68 111.678 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.2 164.63 22.15 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.69 -0.686 . . . . 7.92 111.632 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -117.5 145.34 44.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.012 0.434 . . . . 9.69 111.369 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.3 mt -111.49 132.86 58.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.496 -0.775 . . . . 7.75 110.287 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.96 145.88 37.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.505 0.669 . . . . 12.4 111.401 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.0 p -79.51 3.97 17.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.894 -1.048 . . . . 12.96 112.639 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.4 m -51.14 -30.41 16.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.59 0.589 . . . . 13.58 112.59 -174.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 9' ' ' THR . 32.7 mm-40 -109.91 6.68 23.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.6 0.238 . . . . 12.19 111.523 -176.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 10.5 tpt180 -143.71 -176.75 5.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.8 0.333 . . . . 12.99 111.062 -171.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.473 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 14.6 mm100 -104.09 12.97 33.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.435 0.636 . . . . 17.26 109.963 176.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.97 140.42 16.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.219 -0.901 . . . . 12.1 110.499 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.453 ' O ' ' HD3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -96.43 120.27 36.43 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.338 -0.616 . . . . 13.0 109.338 171.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.4 mt -102.5 162.96 12.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.379 0.609 . . . . 9.21 111.883 -173.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -125.22 145.31 50.04 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.064 -0.971 . . . . 9.75 109.346 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -142.7 149.48 38.88 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.555 -0.535 . . . . 6.85 109.555 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 8.8 p-80 -99.78 165.51 11.55 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.267 -0.573 . . . . 10.15 109.919 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -66.3 -2.41 4.39 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.845 0.683 . . . . 10.56 112.845 -169.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 m -79.28 -17.87 53.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.945 0.402 . . . . 12.44 110.531 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 67' ' ' SER . 26.0 mp0 -111.61 39.68 2.29 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.306 -0.407 . . . . 11.14 111.419 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -125.97 130.19 50.72 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.503 -0.479 . . . . 8.78 110.123 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 m -84.44 109.91 18.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 9.11 111.025 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.88 -157.63 15.07 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.636 -0.793 . . . . 9.98 112.607 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -90.07 133.2 34.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.788 0.328 . . . . 12.91 110.988 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -72.42 -11.25 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.416 0.627 . . . . 11.97 109.911 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.34 -29.42 68.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.164 -0.925 . . . . 14.73 111.79 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -106.11 14.08 28.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 13.3 111.817 -175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 tp -97.81 128.38 44.4 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.42 -0.512 . . . . 10.07 109.92 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -118.27 163.5 16.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.206 0.527 . . . . 13.53 110.455 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.28 122.9 24.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.269 -1.011 . . . . 12.26 108.269 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.82 -8.44 29.74 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.691 -0.766 . . . . 11.04 112.377 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.54 130.24 90.79 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.818 0.309 . . . . 8.39 110.167 176.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.39 122.62 5.68 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.697 2.264 . . . . 8.18 111.688 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.15 151.85 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.44 0.638 . . . . 4.78 111.746 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -111.17 125.73 54.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.921 -1.036 . . . . 7.09 109.045 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.641 ' CE2' ' HG3' ' A' ' 8' ' ' GLU . 33.2 p90 -131.75 179.35 6.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.405 0.621 . . . . 7.82 111.246 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.514 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 25.9 tt0 -148.51 104.29 3.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.432 -0.804 . . . . 11.59 109.074 -170.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.0 ttt -84.16 128.79 34.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.38 -0.373 . . . . 12.41 111.154 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -145.44 164.72 30.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.243 -0.435 . . . . 13.93 110.672 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -107.6 110.75 22.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.57 -0.286 . . . . 16.22 110.755 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD2' HG23 ' A' ' 61' ' ' THR . 16.6 t70 -79.15 109.81 13.81 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.825 -0.435 . . . . 16.64 109.825 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -69.61 -15.41 63.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.473 -0.785 . . . . 23.23 111.819 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.457 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 40.1 ttm105 -76.97 -54.01 7.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.713 0.292 . . . . 21.87 110.839 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.511 HG23 ' OD2' ' A' ' 58' ' ' ASP . 9.1 t -85.64 -35.03 21.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.18 -0.463 . . . . 17.49 111.059 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.07 30.77 9.78 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.878 -0.677 . . . . 17.22 113.762 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.463 ' HE3' ' OG1' ' A' ' 61' ' ' THR . 16.8 ptpt -135.6 148.45 65.72 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 117.357 0.578 . . . . 14.83 110.022 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.82 126.89 11.06 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.088 1.859 . . . . 13.33 110.944 176.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.31 167.53 25.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.085 0.469 . . . . 12.33 111.303 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.23 159.91 15.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.058 -0.719 . . . . 8.91 109.058 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.514 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 9.1 t -70.91 -166.05 0.14 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.914 -0.402 . . . . 10.33 109.914 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -75.64 22.69 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.495 0.924 . . . . 12.02 113.495 -170.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t 34.24 98.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.141 1.164 . . . . 6.52 114.141 171.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.2 t -105.52 138.07 42.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.262 -0.644 . . . . 6.18 109.262 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -73.84 144.28 45.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.372 -0.603 . . . . 6.59 109.372 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 120.887 0.375 . . . . 6.16 111.037 -175.304 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 110.318 -0.253 . . . . 6.19 110.318 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 43.8 t -70.35 105.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.923 0.392 . . . . 6.54 111.369 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.5 mt -97.08 5.59 50.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.49 . . . . 6.46 111.705 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.7 t -149.16 100.73 3.07 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.528 -0.469 . . . . 7.24 111.434 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -132.69 -66.95 0.66 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.811 -0.811 . . . . 7.07 108.811 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -165.5 148.32 7.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.126 -0.943 . . . . 6.68 108.831 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -82.59 102.02 11.15 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.711 -0.478 . . . . 6.93 109.711 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 m -77.34 156.94 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.114 -0.493 . . . . 4.0 110.335 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.8 p -123.16 141.77 51.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.065 -0.516 . . . . 3.84 110.493 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.99 169.36 25.34 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.018 -0.611 . . . . 2.58 111.644 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.2 m -103.94 130.32 51.55 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.583 -0.525 . . . . 3.7 109.583 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 2.1 t -68.87 121.37 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 109.236 -0.653 . . . . 3.14 109.236 176.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.1 p -91.63 -24.71 19.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.34 0.59 . . . . 3.77 110.553 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.6 m -151.77 125.58 9.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.391 -0.822 . . . . 3.29 109.123 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.59 172.66 6.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.307 0.575 . . . . 4.39 112.079 -172.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.0 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.054 -0.975 . . . . 3.62 110.354 177.889 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.219 0.533 . . . . 3.7 110.128 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.7 p -106.2 134.63 49.03 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.773 -0.649 . . . . 2.84 111.007 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -78.61 174.25 55.17 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.465 -0.874 . . . . 1.91 110.988 175.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -125.56 123.72 39.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.244 0.522 . . . . 3.31 111.502 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -111.3 129.1 67.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.971 -0.752 . . . . 2.17 108.971 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.4 t -116.07 132.95 56.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.178 0.513 . . . . 3.61 110.931 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -143.81 155.95 44.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.946 -0.761 . . . . 3.58 108.946 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -109.02 137.12 47.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.793 0.33 . . . . 5.1 110.144 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -158.64 130.21 6.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.267 -0.424 . . . . 5.11 111.475 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 57.09 29.98 17.46 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.231 0.539 . . . . 7.42 112.121 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.33 -14.12 65.95 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.618 -0.719 . . . . 5.36 112.598 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -102.95 135.86 43.84 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.824 0.345 . . . . 5.38 110.811 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 12.1 p -107.6 111.73 24.11 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.114 -0.494 . . . . 4.96 109.69 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -101.11 153.76 19.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.217 0.532 . . . . 5.13 111.961 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -119.5 113.49 20.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.686 -0.857 . . . . 4.32 108.686 172.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.49 136.13 19.27 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.298 -0.41 . . . . 3.17 111.007 -172.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -77.32 132.9 12.81 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.733 2.289 . . . . 2.61 111.953 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -135.63 143.79 45.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.055 0.455 . . . . 2.49 110.035 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.8 p -114.25 -179.01 3.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.574 -0.528 . . . . 3.18 109.574 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -16.98 59.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.039 0.447 . . . . 5.22 110.769 178.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -84.03 -10.89 57.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.797 -0.638 . . . . 4.81 111.053 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -88.28 -21.05 24.67 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.758 0.313 . . . . 4.0 111.385 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -96.8 111.61 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.467 0.651 . . . . 4.39 110.918 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -89.87 129.37 36.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.561 -0.745 . . . . 6.43 110.115 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 128.22 -15.68 6.1 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.58 -0.737 . . . . 6.14 111.359 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.2 m120 57.95 46.6 16.33 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 122.978 0.511 . . . . 6.26 110.755 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.4 p -112.01 152.99 13.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.042 -0.527 . . . . 5.62 110.808 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -87.95 115.4 25.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 6.25 110.667 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.507 ' H ' HD22 ' A' ' 133' ' ' LEU . 2.3 pt? -114.82 142.83 46.02 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.738 -0.467 . . . . 3.62 109.738 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.07 175.2 11.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.335 -0.546 . . . . 7.5 111.474 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.548 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -65.66 122.81 18.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.317 -0.401 . . . . 4.12 111.77 -177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 120.09 -29.69 5.9 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.836 -0.697 . . . . 4.2 113.265 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.61 166.96 11.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.576 0.688 . . . . 4.06 110.281 173.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -113.23 128.14 56.38 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.789 0.804 . . . . 4.48 111.245 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.32 152.6 19.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.593 -1.185 . . . . 2.98 110.796 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.3 m -106.35 137.48 44.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.813 -0.631 . . . . 3.68 109.675 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -142.6 149.57 39.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.809 0.338 . . . . 3.35 110.365 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.58 112.44 24.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.994 -0.373 . . . . 5.34 109.994 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 66.4 mt -79.06 111.69 16.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.974 -0.557 . . . . 4.66 110.141 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -89.71 107.31 19.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.143 -0.688 . . . . 5.08 109.143 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.64 117.61 24.64 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.203 0.525 . . . . 5.68 111.352 -174.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -82.63 154.4 24.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.451 -0.795 . . . . 6.25 108.9 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -62.36 -29.04 70.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.439 0.638 . . . . 9.03 109.63 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -69.92 -19.7 63.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.122 -0.945 . . . . 8.29 110.511 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.21 12.5 83.14 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.796 -0.638 . . . . 5.65 112.43 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -106.62 119.49 39.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.197 -0.668 . . . . 5.26 109.197 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.439 ' N ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -148.88 -177.81 6.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.645 -0.252 . . . . 4.63 111.537 -177.332 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.57 -173.73 16.18 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.393 -0.683 . . . . 3.57 111.393 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.44 111.43 23.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.864 0.332 . . . . 2.84 110.423 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 6.2 t -127.09 165.15 20.06 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 110.042 -0.355 . . . . 4.34 110.042 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 59.05 36.08 24.16 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.0 -0.545 . . . . 6.23 110.424 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.78 142.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.363 -0.835 . . . . 3.55 110.758 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -149.22 142.24 24.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.7 0.286 . . . . 6.3 110.904 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.2 tp -76.75 106.48 8.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 4.63 110.054 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -103.31 -35.19 8.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.122 -0.49 . . . . 4.97 111.805 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -132.13 90.4 35.03 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.965 -0.294 . . . . 5.57 110.852 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.55 156.55 28.4 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.559 2.173 . . . . 5.69 111.742 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.245 0.545 . . . . 6.1 111.037 -179.811 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 109.831 -0.433 . . . . 12.72 109.831 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -119.45 148.78 42.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.648 -0.705 . . . . 11.63 111.164 -166.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.403 ' HG1' ' CG ' ' A' ' 26' ' ' GLU . 21.3 p -102.89 144.22 31.48 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.918 -0.583 . . . . 9.47 111.707 -174.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.19 176.57 29.62 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.371 -0.692 . . . . 7.73 111.371 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.0 mt -127.06 140.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.659 -0.497 . . . . 10.57 109.659 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.7 mm -66.15 126.04 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 121.206 -0.198 . . . . 8.73 110.491 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -87.0 -51.45 6.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.37 0.605 . . . . 10.86 111.258 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -157.92 131.77 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.086 -0.709 . . . . 14.48 109.086 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.11 105.56 17.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.546 0.689 . . . . 11.73 111.362 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.66 179.4 4.43 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.302 -0.999 . . . . 11.9 108.302 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -91.4 136.3 33.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.756 -0.378 . . . . 16.67 110.71 -177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t 76.75 -33.32 0.2 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.263 -0.881 . . . . 13.28 111.742 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -139.7 152.37 46.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.64 0.257 . . . . 12.68 111.24 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.8 168.76 23.49 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.636 -0.793 . . . . 7.92 112.418 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -116.89 140.8 49.03 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.914 0.388 . . . . 9.69 111.203 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.3 mt -111.59 130.51 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.905 -0.589 . . . . 7.75 110.462 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -72.98 138.46 46.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.445 0.64 . . . . 12.4 111.985 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.1 p -79.53 1.55 25.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.062 -0.972 . . . . 12.96 111.412 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -55.77 -30.06 60.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.298 -0.41 . . . . 13.58 111.776 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.403 ' CG ' ' HG1' ' A' ' 9' ' ' THR . 6.9 tp10 -113.89 -11.94 12.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.106 0.479 . . . . 12.19 111.259 -176.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.606 HH11 ' HB3' ' A' ' 29' ' ' ALA . 3.9 tmt_? -137.52 137.56 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.692 -0.855 . . . . 12.99 108.692 -175.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -68.32 42.79 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.427 0.899 . . . . 17.26 113.427 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.606 ' HB3' HH11 ' A' ' 27' ' ' ARG . . . 177.2 133.98 0.06 Allowed 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 123.406 0.682 . . . . 12.1 110.12 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.508 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 6.6 ppt_? -86.27 141.31 29.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.147 -0.686 . . . . 13.0 109.147 171.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 47.1 mt -133.25 162.43 31.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.953 0.406 . . . . 9.21 111.486 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -114.9 141.87 47.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.128 -0.942 . . . . 9.75 108.506 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -136.21 145.3 45.53 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.455 -0.498 . . . . 6.85 110.733 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -84.53 141.44 30.73 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.919 -0.771 . . . . 10.15 108.919 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -63.87 -17.48 63.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.637 0.256 . . . . 10.56 111.481 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -70.6 -13.51 62.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.51 -0.314 . . . . 12.44 110.697 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -103.47 1.11 31.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.564 -0.289 . . . . 11.14 111.235 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -85.04 114.86 22.51 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.698 -0.401 . . . . 8.78 110.121 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.8 t -81.91 91.3 6.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.241 -0.436 . . . . 9.11 110.474 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.39 -175.02 26.06 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.637 -0.585 . . . . 9.98 111.637 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -79.14 123.85 27.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.698 -0.482 . . . . 12.91 109.698 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tp -65.24 -24.96 36.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.176 0.513 . . . . 11.97 111.094 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.22 -0.91 26.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.166 0.508 . . . . 14.73 111.168 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -103.39 10.1 37.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 13.3 109.672 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 tp -112.82 129.24 56.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.714 -0.676 . . . . 10.07 110.008 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -119.64 168.95 10.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.336 0.589 . . . . 13.53 111.099 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.41 HD13 ' N ' ' A' ' 47' ' ' ILE . 3.6 mp -73.37 114.78 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.089 -0.505 . . . . 12.26 109.742 174.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.14 9.43 22.19 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.474 -0.87 . . . . 11.04 112.012 -175.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.29 133.08 71.99 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.245 -0.279 . . . . 8.39 110.245 175.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -85.58 109.88 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.941 2.428 . . . . 8.18 111.644 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.93 151.6 16.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.888 -0.596 . . . . 4.78 111.255 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -110.32 130.03 55.63 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.19 -0.67 . . . . 7.09 109.19 173.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.09 178.04 7.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.349 0.595 . . . . 7.82 111.014 -174.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 32.9 tt0 -142.65 105.08 4.47 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.468 -0.938 . . . . 11.59 108.468 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.3 ttt -83.15 124.29 30.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.767 0.318 . . . . 12.41 111.077 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.2 p -141.19 161.25 38.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.313 -0.403 . . . . 13.93 110.697 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -97.6 121.5 39.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.39 -0.368 . . . . 16.22 110.078 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -74.76 120.08 19.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.182 0.515 . . . . 16.64 110.312 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -79.85 -5.79 56.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.648 -0.705 . . . . 23.23 112.197 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -79.77 -70.41 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.212 0.529 . . . . 21.87 110.641 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 t -101.71 -4.38 26.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 17.49 111.203 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.58 33.0 35.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.079 -0.582 . . . . 17.22 113.451 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -110.02 131.3 22.05 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.725 -0.279 . . . . 14.83 110.335 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.6 125.59 10.74 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.734 1.623 . . . . 13.33 110.028 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.69 179.54 2.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.455 0.645 . . . . 12.33 111.989 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.19 148.41 29.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.442 -0.799 . . . . 8.91 109.886 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.458 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 10.3 t -74.62 -150.38 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 10.33 111.48 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 2.1 mp0 -68.97 30.12 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.853 1.057 . . . . 12.02 113.853 -175.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 67' ' ' SER . 39.8 t 0.0 101.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.228 1.411 . . . . 6.52 113.514 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -109.53 134.38 51.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.855 -0.338 . . . . 6.18 110.747 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -68.68 139.71 55.43 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.743 -0.465 . . . . 6.59 109.743 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.6 mt . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 121.228 0.537 . . . . 6.16 111.84 -172.914 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.537 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.906 0.384 . . . . 6.19 110.154 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 4.5 m -94.46 121.84 45.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.873 -0.603 . . . . 6.54 111.08 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.08 -27.54 67.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.586 -0.733 . . . . 6.46 109.859 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -131.29 103.56 6.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.188 -0.46 . . . . 7.24 111.238 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.96 -87.69 0.15 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.215 -0.661 . . . . 7.07 109.215 173.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -90.73 71.68 6.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.761 0.791 . . . . 6.68 110.353 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -68.53 137.64 54.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.442 -0.799 . . . . 6.93 109.935 177.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 m -140.39 170.42 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.037 0.446 . . . . 4.0 111.119 -174.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 p -115.7 139.88 49.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.768 -0.651 . . . . 3.84 109.689 175.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.7 155.18 20.0 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.032 -1.08 . . . . 2.58 112.878 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 m -111.04 127.0 55.4 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.388 -0.597 . . . . 3.7 109.388 175.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.545 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 57.3 t -69.21 120.63 17.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.217 -0.29 . . . . 3.14 110.217 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.5 p -107.47 -17.82 14.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.134 0.492 . . . . 3.77 111.113 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.7 m -150.78 131.29 13.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.38 -0.6 . . . . 3.29 109.38 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.77 -175.11 2.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.249 0.547 . . . . 4.39 111.296 -176.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.729 . . . . 3.62 109.675 179.915 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 120.988 0.423 . . . . 3.7 109.87 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.75 118.91 25.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.943 0.402 . . . . 2.84 110.793 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.74 175.23 47.48 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.832 -0.699 . . . . 1.91 112.689 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 48.5 mmt-85 -132.47 126.72 33.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.862 0.363 . . . . 3.31 110.442 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.3 mt -111.64 126.49 69.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.052 -0.522 . . . . 2.17 109.82 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 118' ' ' PHE . 12.0 t -103.62 125.46 50.15 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.603 -0.517 . . . . 3.61 109.603 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.651 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 4.1 p90 -134.06 155.58 49.78 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.323 -0.621 . . . . 3.58 109.323 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.16 119.56 37.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.983 0.42 . . . . 5.1 110.137 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -142.99 133.08 24.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.496 -0.775 . . . . 5.11 108.988 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 63.48 21.27 12.68 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.647 0.592 . . . . 7.42 111.042 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.05 21.15 59.57 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.96 -0.564 . . . . 5.36 112.446 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -132.83 135.47 45.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.675 0.274 . . . . 5.38 110.68 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 4.0 p -111.82 116.41 30.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.316 -0.402 . . . . 4.96 110.662 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 110' ' ' SER . 81.5 m-85 -114.59 172.77 6.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 5.13 110.898 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -114.75 120.01 38.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.831 -0.622 . . . . 4.32 110.058 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.8 mt -106.28 135.16 19.51 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.818 -0.628 . . . . 3.17 111.737 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.02 138.75 18.62 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.952 2.435 . . . . 2.61 111.872 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -150.35 160.29 43.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.997 0.427 . . . . 2.49 110.888 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.0 p -123.31 175.01 6.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.302 -0.863 . . . . 3.18 109.66 175.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -66.02 -23.39 66.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.548 0.69 . . . . 5.22 109.99 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.5 -20.47 62.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.443 -0.799 . . . . 4.81 111.42 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -87.95 -2.63 58.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.09 -0.504 . . . . 4.0 110.671 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.16 137.61 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.258 -0.428 . . . . 4.39 111.516 -174.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -82.29 124.32 29.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.933 -0.576 . . . . 6.43 109.978 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.37 9.28 85.9 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.901 -0.666 . . . . 6.14 112.472 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.7 p30 47.08 29.27 1.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.14 0.976 . . . . 6.26 112.699 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.77 150.11 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.203 -0.453 . . . . 5.62 110.631 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -80.42 130.92 35.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.991 -0.55 . . . . 6.25 110.95 -175.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 mp -99.27 149.04 23.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.897 -0.592 . . . . 3.62 110.338 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -134.82 129.99 35.36 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.594 -0.521 . . . . 7.5 109.594 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.545 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -63.77 130.76 45.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.807 -0.633 . . . . 4.12 110.966 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.04 -23.09 10.13 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.519 -0.764 . . . . 4.2 112.307 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.09 177.42 5.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.101 0.477 . . . . 4.06 111.401 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -106.77 131.3 54.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.878 -0.601 . . . . 4.48 111.583 -170.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.25 165.95 18.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.213 -0.449 . . . . 2.98 110.326 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.1 m -129.71 127.93 41.46 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.816 -0.439 . . . . 3.68 109.816 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -128.99 150.21 50.5 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.963 -0.384 . . . . 3.35 109.963 -177.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -96.95 120.26 36.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.996 0.427 . . . . 5.34 110.113 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 59.2 mt -79.3 107.62 11.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.784 -0.644 . . . . 4.66 109.857 176.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -81.04 107.7 14.08 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.076 -0.713 . . . . 5.08 109.076 174.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 19.8 m -92.49 103.08 15.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.71 -0.677 . . . . 5.68 111.288 -173.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.511 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 15.5 m120 -67.91 153.63 43.31 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.566 -0.902 . . . . 6.25 108.566 170.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.65 -20.03 66.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.891 0.377 . . . . 9.03 111.339 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -72.08 -23.34 61.33 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.079 0.466 . . . . 8.29 110.531 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.22 22.91 59.9 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.533 -0.841 . . . . 5.65 112.406 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -122.58 114.29 20.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.204 -0.295 . . . . 5.26 110.204 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -146.55 -178.15 6.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.286 -0.415 . . . . 4.63 111.168 -175.155 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -122.77 -132.07 3.96 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.993 -0.843 . . . . 3.57 110.993 174.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -132.0 126.82 34.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.814 0.34 . . . . 2.84 110.277 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 80.4 m -140.35 162.44 35.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.29 -0.413 . . . . 4.34 110.664 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 57.32 53.18 7.88 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.813 0.696 . . . . 6.23 110.676 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.3 mt -82.12 115.0 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.523 -0.762 . . . . 3.55 110.097 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -114.52 129.94 56.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.785 -0.643 . . . . 6.3 110.602 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 161' ' ' PRO . 50.9 tp -82.59 98.33 8.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.67 -0.696 . . . . 4.63 110.057 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -82.68 -23.66 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.076 -0.511 . . . . 4.97 111.084 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -133.59 102.43 12.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 5.57 110.065 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.47 ' HA ' HD23 ' A' ' 158' ' ' LEU . 71.8 Cg_endo -79.03 154.32 25.56 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.562 2.175 . . . . 5.69 112.738 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.854 -0.612 . . . . 6.1 111.744 -175.771 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.759 0.314 . . . . 12.72 111.021 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.65 172.68 12.44 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.79 -0.641 . . . . 11.63 109.88 -176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.0 p -112.9 167.36 10.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.988 0.423 . . . . 9.47 111.534 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.6 172.65 37.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 116.19 -0.459 . . . . 7.73 112.189 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.0 mt -117.04 133.67 63.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.015 -0.365 . . . . 10.57 110.015 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.3 118.09 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.949 0.404 . . . . 8.73 110.585 176.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.52 -56.24 9.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.39 -0.823 . . . . 10.86 110.46 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -156.03 141.08 17.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.205 -0.907 . . . . 14.48 108.765 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.3 mt -98.2 103.16 15.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.268 0.556 . . . . 11.73 110.712 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.37 -179.77 4.89 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.034 -0.985 . . . . 11.9 108.412 173.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -90.68 123.11 34.03 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.518 -0.473 . . . . 16.67 110.022 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t 82.6 -27.86 0.11 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.453 1.095 . . . . 13.28 111.773 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -135.64 147.8 48.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.806 0.336 . . . . 12.68 111.304 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -139.89 162.85 26.3 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-N 116.055 -0.52 . . . . 7.92 111.87 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -118.38 146.89 44.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.821 0.31 . . . . 9.69 111.313 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.5 mt -121.34 128.16 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.301 -0.409 . . . . 7.75 110.535 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -76.85 146.0 38.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.202 0.525 . . . . 12.4 111.575 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.5 p -79.82 -0.02 32.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.246 -0.888 . . . . 12.96 112.888 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.7 t -53.52 -31.32 45.73 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.85 0.685 . . . . 13.58 112.85 -173.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.97 -5.92 43.58 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.871 0.367 . . . . 12.19 111.889 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 12.0 ttt180 -131.66 -160.66 1.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.532 -0.303 . . . . 12.99 110.203 -173.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.52 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 78.0 mt-30 -118.66 14.93 13.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.379 0.609 . . . . 17.26 110.218 176.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' NH1' ' A' ' 27' ' ' ARG . . . -164.41 138.45 5.34 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.312 -0.858 . . . . 12.1 110.213 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -85.62 151.02 24.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.424 -0.584 . . . . 13.0 109.424 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -138.86 162.52 34.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.026 0.441 . . . . 9.21 110.887 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.38 142.24 51.48 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.951 -0.759 . . . . 9.75 108.951 173.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -128.35 147.38 50.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.001 -0.37 . . . . 6.85 110.001 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.461 ' HB2' ' OE1' ' A' ' 37' ' ' GLN . 76.3 m-70 -95.64 160.81 14.32 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.525 -0.546 . . . . 10.15 109.525 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -70.71 -4.24 22.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.816 0.341 . . . . 10.56 111.675 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -85.75 -7.39 58.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.944 -0.391 . . . . 12.44 109.944 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.461 ' OE1' ' HB2' ' A' ' 34' ' ' HIS . 23.4 mp0 -117.44 40.48 3.05 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.936 -0.575 . . . . 11.14 111.199 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -122.63 139.48 53.88 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.42 -0.512 . . . . 8.78 111.142 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.3 t -116.27 114.49 24.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.549 . . . . 9.11 110.036 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.05 -161.35 23.51 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.736 . . . . 9.98 111.823 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -83.06 108.11 16.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.215 -0.291 . . . . 12.91 110.215 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.402 HD13 HD12 ' A' ' 45' ' ' LEU . 10.6 tp -68.52 -25.16 30.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.344 0.592 . . . . 11.97 110.081 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -66.68 -22.7 66.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.489 -0.778 . . . . 14.73 110.908 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -105.45 20.25 19.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.854 -0.612 . . . . 13.3 111.303 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.402 HD12 HD13 ' A' ' 42' ' ' ILE . 1.5 mt -87.2 133.97 33.59 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.021 -0.363 . . . . 10.07 110.021 175.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -127.6 167.0 16.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.462 -0.57 . . . . 13.53 109.462 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 47' ' ' ILE . 3.5 mp -81.99 132.82 30.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.563 -0.532 . . . . 12.26 109.563 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.65 11.24 58.27 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.647 -0.787 . . . . 11.04 111.987 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 32.3 t70 -86.15 133.35 41.03 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.655 -0.273 . . . . 8.39 110.75 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 49' ' ' ASP . 6.6 Cg_endo -86.18 127.42 2.95 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.241 2.627 . . . . 8.18 112.638 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.9 m -125.33 160.33 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.43 . . . . 4.78 111.092 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -112.54 128.03 56.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.913 -0.585 . . . . 7.09 110.029 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -131.94 150.19 52.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.345 0.593 . . . . 7.82 111.048 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 16.4 tt0 -101.58 119.65 39.1 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.735 -0.839 . . . . 11.59 108.735 177.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 14.3 tpt -90.93 133.42 35.28 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.909 -0.404 . . . . 12.41 109.909 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.91 169.81 23.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.966 0.412 . . . . 13.93 110.531 -172.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -126.4 109.44 12.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.742 0.305 . . . . 16.22 110.426 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -83.12 113.42 20.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.223 -0.444 . . . . 16.64 110.108 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -79.21 -10.31 59.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.36 -0.382 . . . . 23.23 111.783 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -74.34 -41.54 60.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.405 -0.591 . . . . 21.87 109.405 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.8 p -88.55 -40.81 13.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.255 -0.43 . . . . 17.49 110.817 174.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.78 31.92 11.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.906 -0.664 . . . . 17.22 112.207 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -132.59 152.92 80.83 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.056 -0.35 . . . . 14.83 110.056 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.75 125.85 10.88 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.293 1.996 . . . . 13.33 110.641 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.85 153.81 25.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.537 0.684 . . . . 12.33 112.251 -175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.42 157.29 16.52 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.576 -0.898 . . . . 8.91 108.576 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 69' ' ' VAL . 12.8 t -70.66 -162.95 0.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.006 -0.368 . . . . 10.33 110.006 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -72.77 27.13 0.06 Allowed 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 113.368 0.877 . . . . 12.02 113.368 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 67' ' ' SER . 53.3 t 32.23 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.438 1.095 . . . . 6.52 113.664 172.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.5 t -88.61 151.29 22.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.429 -0.805 . . . . 6.18 111.378 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.418 ' HZ1' ' CG ' ' A' ' 49' ' ' ASP . 20.0 mmmt -87.55 137.96 31.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.376 -0.829 . . . . 6.59 110.993 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.8 mt . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.064 -0.516 . . . . 6.16 109.873 177.864 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.2 t . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 109.497 -0.557 . . . . 6.19 109.497 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 29.0 t -80.25 97.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.067 0.395 . . . . 6.54 112.067 -171.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.436 ' CD2' ' HB2' ' A' ' 144' ' ' ALA . 22.2 mt -88.96 -30.36 18.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.525 . . . . 6.46 110.948 175.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 p -98.95 96.95 8.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.334 0.588 . . . . 7.24 111.616 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.52 -69.14 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.434 -0.803 . . . . 7.07 109.31 174.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -131.57 147.67 52.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.899 -0.591 . . . . 6.68 109.987 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.4 ptt85 -107.77 125.88 51.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.845 0.355 . . . . 6.93 110.158 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.12 158.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.066 0.46 . . . . 4.0 111.9 -173.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.8 p -118.65 140.65 49.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.39 -0.823 . . . . 3.84 109.622 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.45 170.16 24.27 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.075 -1.06 . . . . 2.58 112.615 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.5 m -115.69 135.36 54.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.528 -0.545 . . . . 3.7 109.528 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 21.9 t -67.36 115.36 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.589 -0.522 . . . . 3.14 109.589 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.05 -34.1 15.24 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.326 0.584 . . . . 3.77 110.042 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.7 m -151.26 120.75 6.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.619 -0.719 . . . . 3.29 109.613 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.74 -176.82 5.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.799 0.333 . . . . 4.39 110.465 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.515 -0.311 . . . . 3.62 110.186 178.675 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.578 0 CA-C-O 121.003 0.43 . . . . 3.7 111.845 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 m -142.55 127.84 18.76 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.198 -0.667 . . . . 2.84 109.198 173.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -94.7 176.02 34.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.582 -0.818 . . . . 1.91 112.581 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 20.3 mmt180 -133.43 132.31 40.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.643 0.259 . . . . 3.31 110.599 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 79.0 mt -113.94 130.66 67.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.028 -0.533 . . . . 2.17 109.584 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.5 p -105.86 123.0 47.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.316 -0.402 . . . . 3.61 110.389 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.675 ' CE2' HD13 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -140.47 152.36 45.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.817 0.341 . . . . 3.58 110.608 178.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' HB3' ' A' ' 117' ' ' CYS . 4.8 mp0 -107.31 122.48 46.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.053 0.454 . . . . 5.1 110.165 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -131.96 120.85 23.05 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.698 -0.683 . . . . 5.11 109.823 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 61.09 31.96 19.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.326 0.584 . . . . 7.42 110.861 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -20.15 50.82 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.413 -0.812 . . . . 5.36 113.395 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -99.47 136.32 39.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.672 0.273 . . . . 5.38 110.833 -175.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . 0.404 ' HB3' ' HG3' ' A' ' 112' ' ' GLU . 7.8 p -102.51 128.3 49.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.178 -0.465 . . . . 4.96 110.572 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -128.59 164.2 23.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.323 -0.398 . . . . 5.13 110.875 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -122.85 114.37 20.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.696 -0.683 . . . . 4.32 109.595 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.675 HD13 ' CE2' ' A' ' 111' ' ' TYR . 2.5 mp -105.49 140.94 21.65 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.682 0.277 . . . . 3.17 110.878 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 94.1 Cg_endo -79.3 155.82 25.43 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.104 2.536 . . . . 2.61 112.068 175.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -163.99 163.68 23.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.9 -0.408 . . . . 2.49 109.9 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -118.76 -179.15 3.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.996 0.427 . . . . 3.18 111.154 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -71.57 -21.26 61.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.08 -0.509 . . . . 5.22 110.54 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.49 -9.73 57.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 4.81 111.238 -173.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -85.41 -25.42 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 4.0 111.7 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 p -92.49 123.05 44.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.518 0.675 . . . . 4.39 110.69 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.61 159.63 16.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.6 -0.727 . . . . 6.43 110.844 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.92 -16.44 60.95 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.852 -0.689 . . . . 6.14 112.274 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 68.94 16.26 8.8 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.917 0.487 . . . . 6.26 110.783 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 t -72.45 116.29 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 5.62 110.088 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -85.98 84.86 7.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.749 0.785 . . . . 6.25 110.706 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.441 HD21 ' H ' ' A' ' 133' ' ' LEU . 2.2 pt? -81.44 150.71 28.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.1 -1.409 . . . . 3.62 110.761 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.465 ' HD2' ' H ' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -110.49 -179.74 3.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.219 -0.659 . . . . 7.5 109.219 177.247 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.565 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.45 131.81 41.38 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.423 -0.511 . . . . 4.12 111.05 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.53 -14.55 13.14 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.135 -0.555 . . . . 4.2 112.072 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -81.11 154.38 26.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.633 0.254 . . . . 4.06 110.544 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 160' ' ' ASN . 13.4 mmmm -104.6 127.83 52.45 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.162 0.506 . . . . 4.48 110.372 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.7 m -130.35 160.58 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.386 -0.825 . . . . 2.98 112.382 -171.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.6 p -122.53 140.96 52.19 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.993 -1.003 . . . . 3.68 109.534 172.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -151.24 167.9 26.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.568 -0.287 . . . . 3.35 110.654 -174.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -104.24 133.42 49.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.15 0.5 . . . . 5.34 110.779 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 34.6 mm -95.49 102.27 13.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.428 -0.805 . . . . 4.66 110.368 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.66 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -87.59 108.78 19.23 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.622 -0.431 . . . . 5.08 110.406 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 15.6 m -90.04 125.7 35.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.046 -0.524 . . . . 5.68 111.345 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -98.72 164.98 12.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.204 -1.036 . . . . 6.25 108.204 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -59.98 -24.8 64.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.943 0.497 . . . . 9.03 111.883 -174.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -70.6 -17.75 62.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 8.29 110.868 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.93 5.39 86.24 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.856 -0.688 . . . . 5.65 111.891 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -99.39 119.64 38.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.164 -0.68 . . . . 5.26 109.164 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -132.87 163.33 29.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.171 0.51 . . . . 4.63 112.23 -177.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -136.14 -173.26 12.9 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.782 -0.927 . . . . 3.57 110.782 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.7 120.88 40.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.103 0.452 . . . . 2.84 110.91 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.6 t -128.12 154.37 45.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.749 -0.463 . . . . 4.34 109.749 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 55.75 65.29 1.5 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.794 0.807 . . . . 6.23 110.266 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.5 mt -92.44 135.29 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.566 -1.197 . . . . 3.55 109.794 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -132.14 152.84 51.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.909 -0.404 . . . . 6.3 109.909 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.9 tp -101.47 123.71 45.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.176 -0.465 . . . . 4.63 110.24 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -111.59 -40.56 4.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.515 -0.311 . . . . 4.97 111.067 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 7.7 t30 -118.95 101.11 50.47 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 110.226 -0.287 . . . . 5.57 110.226 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -83.15 155.56 14.75 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.127 2.551 . . . . 5.69 113.43 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.78 -0.646 . . . . 6.1 110.86 177.409 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.193 0.52 . . . . 12.72 110.033 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.471 ' CG ' ' HG3' ' A' ' 27' ' ' ARG . 35.5 tt0 -100.02 136.61 39.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.463 -0.789 . . . . 11.63 109.014 -177.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.0 p -96.95 151.84 19.3 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.947 -0.301 . . . . 9.47 110.674 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.29 -177.5 37.75 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.913 -0.661 . . . . 7.73 111.893 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.501 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 1.2 mt -130.06 146.41 34.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.343 -0.614 . . . . 10.57 109.343 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.72 118.56 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.437 -0.579 . . . . 8.73 109.437 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -87.65 -44.72 10.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.536 -0.756 . . . . 10.86 109.37 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -149.16 154.59 39.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.217 -0.901 . . . . 14.48 110.806 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.8 mt -119.14 109.68 16.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.656 . . . . 11.73 110.169 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.47 179.04 4.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.238 -1.023 . . . . 11.9 108.238 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -90.44 114.14 26.23 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.148 -0.621 . . . . 16.67 110.354 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 m 72.16 16.38 5.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.942 -1.026 . . . . 13.28 111.095 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -156.58 139.87 15.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.717 -0.674 . . . . 12.68 109.764 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 33' ' ' PHE . . . -127.44 156.45 20.46 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.697 -0.763 . . . . 7.92 112.667 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.74 129.83 55.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.463 -0.199 . . . . 9.69 110.463 -176.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -114.22 127.55 71.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.153 -0.314 . . . . 7.75 110.153 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 9.8 pt20 -83.14 144.14 30.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.62 0.724 . . . . 12.4 111.877 -175.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 p -79.54 2.23 22.96 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 114.461 -1.245 . . . . 12.96 112.764 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.4 m -53.2 -24.46 11.03 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.803 0.668 . . . . 13.58 112.803 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -91.4 -6.95 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.977 0.362 . . . . 12.19 111.977 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HG3' ' CG ' ' A' ' 8' ' ' GLU . 9.7 mmt85 -151.33 -158.53 0.92 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.999 0.428 . . . . 12.99 110.529 -170.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.409 ' H ' ' HB3' ' A' ' 27' ' ' ARG . 10.4 pt20 -123.74 28.57 6.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.045 0.45 . . . . 17.26 109.996 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.48 135.22 19.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.844 -0.617 . . . . 12.1 110.699 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.404 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 16.7 ptp180 -89.39 121.76 31.95 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.658 -0.497 . . . . 13.0 109.658 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.37 155.13 23.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.172 0.51 . . . . 9.21 110.77 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -132.06 142.88 49.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.701 -0.681 . . . . 9.75 109.555 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.432 ' CE1' ' HA3' ' A' ' 20' ' ' GLY . 17.6 p90 -126.63 163.79 22.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.027 0.441 . . . . 6.85 110.416 -176.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -112.65 152.44 28.97 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.691 -0.485 . . . . 10.15 109.691 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -62.98 -21.55 66.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.316 -0.402 . . . . 10.56 111.772 -175.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.6 t -72.93 -19.82 61.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.526 -0.306 . . . . 12.44 111.09 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 1.9 mp0 -95.56 -26.24 15.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.603 -0.272 . . . . 11.14 111.41 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -68.48 112.81 5.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 8.78 110.553 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.2 t -91.56 97.22 10.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.977 -0.556 . . . . 9.11 110.195 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.6 -176.04 34.8 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.84 -0.904 . . . . 9.98 110.84 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -77.67 95.75 4.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.816 0.341 . . . . 12.91 110.176 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -60.75 -25.86 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.383 0.611 . . . . 11.97 110.514 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.38 -25.79 68.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.369 -0.832 . . . . 14.73 111.22 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -108.18 17.52 22.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.39 -0.368 . . . . 13.3 111.069 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.7 tp -97.71 125.95 42.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.009 -0.737 . . . . 10.07 109.009 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -123.4 173.88 7.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.998 -0.371 . . . . 13.53 109.998 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mp -70.97 131.78 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.968 -0.382 . . . . 12.26 109.968 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.79 2.24 58.51 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.504 -0.855 . . . . 11.04 112.276 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.0 124.61 89.58 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 110.559 -0.163 . . . . 8.39 110.559 175.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.55 132.05 7.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.788 2.326 . . . . 8.18 112.662 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.436 HG11 ' HG2' ' A' ' 71' ' ' LYS . 27.3 m -136.96 161.18 36.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.115 0.483 . . . . 4.78 111.311 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -120.41 136.67 54.65 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.175 -0.676 . . . . 7.09 109.175 170.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -131.8 148.91 52.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.451 0.643 . . . . 7.82 111.214 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 35.8 tt0 -88.98 110.49 21.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.408 -0.815 . . . . 11.59 109.309 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.61 105.32 13.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.271 -0.64 . . . . 12.41 109.271 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.9 p -134.87 171.25 14.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.373 0.606 . . . . 13.93 111.987 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -113.45 111.02 21.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.739 -0.664 . . . . 16.22 110.394 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -72.59 122.84 22.05 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.777 -0.453 . . . . 16.64 109.777 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -79.36 -6.74 57.46 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.666 0.617 . . . . 23.23 112.666 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -82.91 -44.54 15.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.49 . . . . 21.87 109.807 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.9 p -90.69 -28.23 18.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.832 -0.622 . . . . 17.49 111.391 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.9 29.13 61.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.113 -0.565 . . . . 17.22 111.871 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -127.37 153.73 77.17 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 110.224 -0.287 . . . . 14.83 110.224 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.77 125.47 9.47 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.051 1.834 . . . . 13.33 111.061 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -138.44 179.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.193 0.52 . . . . 12.33 111.078 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.7 139.32 50.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.724 -0.671 . . . . 8.91 109.302 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 14.7 m -70.16 -148.03 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.096 -0.502 . . . . 10.33 110.949 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 14.0 mm100 -66.74 29.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.841 1.423 . . . . 12.02 114.841 -170.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' A' ' 67' ' ' SER . 39.0 t 4.97 99.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 125.201 1.4 . . . . 6.52 113.677 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.8 m -112.15 138.02 49.41 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.981 0.419 . . . . 6.18 110.522 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HG2' HG11 ' A' ' 51' ' ' VAL . 50.0 mtpt -70.51 142.2 51.87 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.494 -0.558 . . . . 6.59 109.494 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.3 mt . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 121.282 0.563 . . . . 6.16 110.739 -178.064 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.3 t . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.536 0.208 . . . . 6.19 111.09 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.07 111.6 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.493 -0.321 . . . . 6.54 110.908 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.483 ' N ' HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -112.16 -7.57 14.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.919 0.39 . . . . 6.46 111.507 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.8 m -85.45 28.6 0.74 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.34 0.496 . . . . 7.24 112.34 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.92 -36.78 13.26 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.585 -0.446 . . . . 7.07 111.372 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -169.13 144.65 3.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.291 0.567 . . . . 6.68 111.3 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -112.49 97.44 6.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.383 -0.826 . . . . 6.93 109.136 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.88 168.15 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.328 0.585 . . . . 4.0 111.137 -175.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -108.85 139.09 44.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.512 -0.767 . . . . 3.84 110.729 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -135.27 166.49 24.43 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.593 -0.813 . . . . 2.58 112.379 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 m -118.4 134.62 54.91 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.634 -0.506 . . . . 3.7 109.634 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 47.9 t -67.46 123.89 21.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.792 -0.447 . . . . 3.14 109.792 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.7 -24.13 12.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.196 -0.456 . . . . 3.77 111.131 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.6 m -153.09 132.44 12.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.084 -0.507 . . . . 3.29 110.11 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -92.52 -172.37 3.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.946 0.403 . . . . 4.39 110.169 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 108.711 -0.848 . . . . 3.62 108.711 172.074 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 122.153 0.978 . . . . 3.7 109.311 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.6 m -94.27 132.96 38.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.036 -0.984 . . . . 2.84 110.612 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.75 169.35 48.28 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.795 -0.717 . . . . 1.91 112.323 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -130.81 134.79 47.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.261 0.553 . . . . 3.31 111.551 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.488 HG13 ' CD1' ' A' ' 122' ' ' TYR . 97.7 mt -112.9 125.41 70.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.967 -1.015 . . . . 2.17 109.435 172.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 p -97.66 126.16 42.83 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.691 -0.485 . . . . 3.61 109.691 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -134.23 154.42 51.27 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.844 -0.428 . . . . 3.58 109.844 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -115.54 121.31 42.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.175 -0.466 . . . . 5.1 110.38 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.507 ' OD1' ' HG3' ' A' ' 114' ' ' ARG . 23.5 t-20 -160.69 143.27 12.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.464 . . . . 5.11 109.959 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.507 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 79.7 mtp180 64.48 20.77 12.27 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.464 0.478 . . . . 7.42 110.893 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.75 1.12 90.1 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.855 -0.611 . . . . 5.36 112.555 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -114.29 151.05 33.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.658 -0.497 . . . . 5.38 109.658 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.47 104.64 10.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.136 0.493 . . . . 4.96 110.435 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -104.2 169.24 8.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.757 -0.656 . . . . 5.13 111.054 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -120.27 123.15 42.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.708 -0.678 . . . . 4.32 110.173 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.51 138.19 19.44 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.536 -0.302 . . . . 3.17 110.372 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.83 142.62 22.7 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.773 2.315 . . . . 2.61 111.827 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.488 ' CD1' HG13 ' A' ' 109' ' ' ILE . 34.5 p90 -146.35 152.27 38.85 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.086 0.469 . . . . 2.49 110.776 176.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.83 156.81 23.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.714 -0.676 . . . . 3.18 110.304 174.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -66.97 -28.15 68.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.084 0.469 . . . . 5.22 111.252 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.62 -16.18 63.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.811 -0.631 . . . . 4.81 111.38 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.05 23.93 12.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.078 -0.51 . . . . 4.0 111.242 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.08 114.71 39.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.352 0.596 . . . . 4.39 111.338 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 157' ' ' ARG . 0.6 OUTLIER -79.71 151.78 30.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.428 -0.805 . . . . 6.43 108.856 178.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.14 -16.55 42.58 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.714 -0.755 . . . . 6.14 111.47 -174.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m120 63.47 24.76 14.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.257 0.623 . . . . 6.26 111.445 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.61 138.17 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.362 -0.381 . . . . 5.62 109.985 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -83.01 91.84 7.25 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.737 -0.468 . . . . 6.25 109.737 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -71.69 144.2 49.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.633 -0.712 . . . . 3.62 110.943 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -140.69 148.96 41.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.833 -0.622 . . . . 7.5 110.33 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.605 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -49.98 124.34 9.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.124 -0.489 . . . . 4.12 112.181 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.0 -24.43 8.3 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.477 -0.783 . . . . 4.2 113.569 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -87.65 178.07 6.86 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 117.782 0.791 . . . . 4.06 110.625 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -117.18 122.77 44.96 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.461 0.648 . . . . 4.48 111.58 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.02 157.66 20.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.979 -1.01 . . . . 2.98 110.788 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.0 m -113.89 129.9 56.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.445 -0.576 . . . . 3.68 109.445 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -126.4 139.19 53.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.127 0.489 . . . . 3.35 109.734 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -94.97 116.84 29.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.588 -0.733 . . . . 5.34 109.417 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 76.4 mt -77.7 111.52 14.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.854 -0.612 . . . . 4.66 110.304 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -97.43 109.04 21.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.585 -0.734 . . . . 5.08 110.658 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 88.6 m -85.43 120.86 27.36 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.455 0.472 . . . . 5.68 111.076 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -72.74 171.33 12.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.557 . . . . 6.25 110.698 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -57.92 -22.39 48.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.167 0.803 . . . . 9.03 113.167 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -111.08 -2.7 15.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.109 -0.636 . . . . 8.29 111.617 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 98.07 11.03 50.66 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.281 -0.961 . . . . 5.65 114.469 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -98.19 132.27 43.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.812 -0.81 . . . . 5.26 108.812 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.491 ' N ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -146.6 -178.24 6.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.212 0.53 . . . . 4.63 112.333 -174.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.16 -122.77 1.47 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.862 -1.063 . . . . 3.57 111.026 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.87 131.47 33.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.917 0.358 . . . . 2.84 110.389 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 74.5 m -142.65 159.53 42.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.128 -0.487 . . . . 4.34 109.738 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 57.72 54.96 5.84 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.762 0.664 . . . . 6.23 110.68 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.2 mp -82.84 114.22 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.803 -0.443 . . . . 3.55 109.803 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 34.3 ttt180 -120.14 128.76 53.72 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.99 -0.374 . . . . 6.3 109.99 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.2 tt -77.04 117.01 18.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.998 -0.546 . . . . 4.63 110.012 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -92.2 -54.82 3.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 4.97 111.015 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -122.1 106.46 36.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.068 -0.515 . . . . 5.57 110.653 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.58 -176.62 3.32 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.262 1.974 . . . . 5.69 112.069 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.994 -0.548 . . . . 6.1 110.186 178.868 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 109.814 -0.439 . . . . 12.72 109.814 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.418 ' CD ' ' HB2' ' A' ' 55' ' ' MET . 7.5 pt-20 -121.41 138.04 54.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.191 0.519 . . . . 11.63 111.056 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.0 p -109.11 160.89 15.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.031 -0.531 . . . . 9.47 111.562 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.73 174.28 42.11 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.001 -0.839 . . . . 7.73 111.001 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.9 mt -109.87 144.94 17.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.767 0.283 . . . . 10.57 110.393 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.33 114.35 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.284 -0.265 . . . . 8.73 110.284 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.21 -55.17 5.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 10.86 111.49 -176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.584 ' HD3' ' N ' ' A' ' 15' ' ' LEU . 8.2 tmtt? -159.39 136.47 9.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.729 -0.471 . . . . 14.48 109.729 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 72.7 mt -93.62 117.17 29.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.311 0.577 . . . . 11.73 111.492 178.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.17 -178.57 3.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.876 -1.157 . . . . 11.9 107.876 172.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -88.26 130.61 35.05 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.082 -0.647 . . . . 16.67 109.696 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m 75.28 -44.24 0.53 Allowed 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.303 1.002 . . . . 13.28 112.016 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -121.87 148.85 44.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.131 0.491 . . . . 12.68 111.417 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -139.89 169.86 24.5 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.478 -0.649 . . . . 7.92 111.478 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -121.86 144.53 48.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.057 0.456 . . . . 9.69 111.608 -177.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -105.83 129.92 58.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.655 -0.702 . . . . 7.75 109.695 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.427 ' HG3' ' H ' ' A' ' 25' ' ' CYS . 13.8 tp60 -77.07 132.77 39.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.928 -0.578 . . . . 12.4 111.27 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.58 ' HB3' ' N ' ' A' ' 30' ' ' ARG . 6.5 p -84.94 0.62 50.6 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.348 0.87 . . . . 12.96 113.348 175.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.427 ' H ' ' HG3' ' A' ' 23' ' ' GLN . 68.4 m -60.74 -22.93 64.54 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.675 0.991 . . . . 13.58 113.675 -168.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -102.59 -29.47 11.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.347 0.594 . . . . 12.19 110.435 -178.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 12.6 ttp85 -105.61 -157.69 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.447 -0.797 . . . . 12.99 110.088 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.521 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 44.4 mt-30 -123.37 21.34 9.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 17.26 110.744 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.13 115.38 5.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.787 0.327 . . . . 12.1 111.847 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.58 ' N ' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -87.03 141.59 28.56 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.873 -0.788 . . . . 13.0 108.873 172.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.9 mt -138.37 162.39 34.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.662 0.267 . . . . 9.21 110.95 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -113.19 148.56 35.2 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.515 -0.55 . . . . 9.75 109.515 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -145.39 159.4 43.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.511 -0.551 . . . . 6.85 109.511 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -106.75 162.78 13.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.439 -0.578 . . . . 10.15 109.439 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.52 -19.12 65.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.938 0.399 . . . . 10.56 110.508 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.7 p -76.91 -15.32 59.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.031 -0.531 . . . . 12.44 110.729 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -102.06 20.69 16.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.389 -0.369 . . . . 11.14 110.789 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -123.02 108.11 12.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.222 0.534 . . . . 8.78 109.717 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.435 ' OG ' ' HB2' ' A' ' 68' ' ' GLN . 51.1 m -94.44 104.33 16.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.711 -0.677 . . . . 9.11 111.052 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.37 -165.84 35.07 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.48 -1.048 . . . . 9.98 110.48 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -94.21 119.34 32.87 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 117.347 0.573 . . . . 12.91 109.904 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.81 -20.66 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 11.97 111.067 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.65 -3.99 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 14.73 111.355 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -118.41 21.87 12.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.073 0.464 . . . . 13.3 109.89 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -125.88 112.34 15.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.205 -0.665 . . . . 10.07 109.205 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -120.05 178.58 4.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.255 0.55 . . . . 13.53 111.298 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.51 130.73 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.383 -0.826 . . . . 12.26 109.363 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.12 10.9 61.97 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.41 -0.9 . . . . 11.04 110.991 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -89.06 123.52 67.15 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.137 -0.531 . . . . 8.39 110.05 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.51 126.6 11.69 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.661 2.241 . . . . 8.18 112.539 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.405 HG12 ' CD ' ' A' ' 71' ' ' LYS . 28.0 m -125.51 151.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 4.78 111.389 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.33 129.8 56.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.222 -0.658 . . . . 7.09 109.222 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -144.61 175.56 10.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.249 0.547 . . . . 7.82 111.357 -175.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -123.48 138.44 54.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.604 -0.726 . . . . 11.59 109.969 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.418 ' HB2' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -92.1 111.38 22.91 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.56 -0.533 . . . . 12.41 109.56 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 p -134.43 133.77 40.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 13.93 112.037 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 64' ' ' PRO . 16.8 m-85 -89.13 109.6 20.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.158 -0.474 . . . . 16.22 110.103 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -77.28 97.38 4.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.723 -0.473 . . . . 16.64 109.723 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -72.38 -5.43 36.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.318 -0.401 . . . . 23.23 111.471 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -69.63 -30.6 68.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.356 -0.609 . . . . 21.87 109.356 174.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.9 p -113.11 -36.93 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.799 -0.637 . . . . 17.49 111.208 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.34 17.29 15.94 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.955 -0.566 . . . . 17.22 112.128 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -121.02 148.66 49.39 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.641 0.258 . . . . 14.83 111.277 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 78.7 Cg_endo -80.17 126.34 6.26 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.42 2.08 . . . . 13.33 112.144 175.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.0 pt -132.28 165.0 33.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.075 0.464 . . . . 12.33 110.555 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.52 157.24 16.3 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.979 -0.749 . . . . 8.91 108.979 171.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.9 t -70.68 -162.55 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.873 0.368 . . . . 10.33 110.038 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HB2' ' OG ' ' A' ' 39' ' ' SER . 22.3 pt20 -74.05 8.16 2.25 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.66 0.615 . . . . 12.02 112.66 -172.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.2 t 53.33 99.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.705 0.764 . . . . 6.52 112.572 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -96.26 129.98 43.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.039 -0.528 . . . . 6.18 110.105 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.405 ' CD ' HG12 ' A' ' 51' ' ' VAL . 13.9 mmmm -76.72 132.34 39.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.242 -0.435 . . . . 6.59 110.411 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.6 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 115.759 -0.655 . . . . 6.16 110.573 -176.123 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.4 t . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.788 0.328 . . . . 6.19 111.242 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 64.0 t -77.27 102.86 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 6.54 111.402 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.32 16.23 22.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.822 0.82 . . . . 6.46 108.829 177.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -102.63 77.06 1.57 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.511 0.672 . . . . 7.24 110.137 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -149.17 106.8 3.65 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.974 -1.121 . . . . 7.07 107.974 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.462 ' OE1' ' HG2' ' A' ' 82' ' ' ARG . 7.8 tp10 -44.67 140.87 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.09 -0.959 . . . . 6.68 111.955 -175.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.462 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 8.5 ptp85 -60.14 106.73 0.55 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.99 -1.004 . . . . 6.93 110.973 -176.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.04 156.18 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.638 -0.71 . . . . 4.0 110.133 178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.7 p -115.77 140.0 49.63 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.827 -0.624 . . . . 3.84 110.695 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.6 166.9 26.04 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.649 -0.786 . . . . 2.58 112.052 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -97.02 127.97 43.52 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.173 -0.306 . . . . 3.7 110.173 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 91.2 t -64.0 124.51 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.479 -0.328 . . . . 3.14 110.242 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.7 p -112.02 -8.26 14.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.748 0.309 . . . . 3.77 111.159 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.466 ' HB ' ' N ' ' A' ' 108' ' ' ARG . 11.4 m -152.29 138.58 18.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.46 -0.336 . . . . 3.29 110.275 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.577 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 18.5 mt-10 -119.16 161.71 19.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 4.39 110.851 -174.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 108.85 -0.796 . . . . 3.62 108.85 173.009 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 108.759 -0.83 . . . . 3.7 108.759 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 p -125.3 122.19 36.16 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.19 0.441 . . . . 2.84 112.19 -172.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -72.53 156.43 52.02 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 108.891 -1.683 . . . . 1.91 108.891 166.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.466 ' N ' ' HB ' ' A' ' 89' ' ' THR . 19.5 mtt180 -135.08 141.68 46.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.511 1.156 . . . . 3.31 111.723 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 72.4 mt -113.21 128.5 69.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.01 -0.995 . . . . 2.17 109.516 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 t -104.69 122.55 45.91 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.282 -0.636 . . . . 3.61 109.282 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -131.75 167.56 19.3 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.146 -0.316 . . . . 3.58 110.146 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -137.26 118.29 14.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.009 -0.738 . . . . 5.1 109.009 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -132.81 113.64 13.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.362 -0.381 . . . . 5.11 110.712 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 65.34 23.23 12.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.118 -0.492 . . . . 7.42 111.191 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.31 5.63 61.91 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.021 -0.609 . . . . 5.36 112.672 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -110.68 118.12 35.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.056 0.455 . . . . 5.38 110.157 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.5 p -119.97 125.09 47.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.954 -0.566 . . . . 4.96 110.584 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -134.81 172.36 13.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.706 0.289 . . . . 5.13 110.576 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -112.21 119.36 38.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.738 -0.665 . . . . 4.32 109.416 174.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 3.1 mm? -104.54 118.17 57.23 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.711 0.291 . . . . 3.17 110.344 -177.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 32.9 Cg_endo -80.2 131.67 8.87 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.19 1.927 . . . . 2.61 111.569 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -133.39 156.69 47.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.787 0.327 . . . . 2.49 110.273 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.64 169.01 9.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.99 -0.55 . . . . 3.18 110.156 175.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -70.76 -18.95 62.76 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.08 0.4 . . . . 5.22 112.08 -174.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.59 -5.39 57.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.344 -0.389 . . . . 4.81 111.149 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -86.77 -13.84 44.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.652 -0.249 . . . . 4.0 111.031 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 156' ' ' ILE . 4.7 p -119.27 112.69 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.224 0.535 . . . . 4.39 110.688 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.05 175.17 6.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.167 -0.47 . . . . 6.43 110.415 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.76 -12.71 68.68 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.653 -0.784 . . . . 6.14 111.869 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.6 m120 59.31 41.41 19.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.062 0.458 . . . . 6.26 111.251 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.71 150.42 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.869 -0.605 . . . . 5.62 110.331 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -101.44 85.38 2.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.131 0.491 . . . . 6.25 110.037 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.525 HD21 ' H ' ' A' ' 133' ' ' LEU . 2.1 pt? -75.37 128.6 35.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.694 -0.684 . . . . 3.62 110.325 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.577 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 18.0 tpt180 -105.65 143.71 33.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.673 . . . . 7.5 110.448 -173.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.58 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -63.82 113.64 3.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.997 0.427 . . . . 4.12 110.051 174.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 116.31 -11.52 16.79 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.268 -0.733 . . . . 4.2 111.268 -173.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.511 ' OD2' ' HA ' ' A' ' 161' ' ' PRO . 4.9 t70 -87.83 -179.13 6.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.211 -0.663 . . . . 4.06 109.211 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -122.87 114.62 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.123 0.487 . . . . 4.48 110.71 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.2 m -119.93 149.8 22.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.068 0.461 . . . . 2.98 111.316 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -100.88 135.07 42.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.602 -0.726 . . . . 3.68 109.554 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -144.95 149.71 35.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.41 -0.359 . . . . 3.35 110.536 -178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . 0.675 HE21 ' N ' ' A' ' 142' ' ' GLN . 0.0 OUTLIER -102.7 139.36 38.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.191 -0.459 . . . . 5.34 109.893 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.2 mt -101.88 100.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.033 0.444 . . . . 4.66 110.627 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -97.3 110.92 23.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.3 -0.409 . . . . 5.08 110.964 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.7 m -79.89 110.79 15.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 5.68 111.311 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -83.53 165.68 18.89 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.059 -0.519 . . . . 6.25 110.466 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -48.98 -44.8 41.32 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.667 0.988 . . . . 9.03 113.667 -172.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -81.31 3.18 25.05 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.158 -0.617 . . . . 8.29 111.519 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.64 23.1 40.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.525 -0.845 . . . . 5.65 111.76 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -96.33 127.35 42.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.186 -0.302 . . . . 5.26 110.186 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.448 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.54 163.64 39.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.807 0.336 . . . . 4.63 110.401 175.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.86 -110.82 0.32 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.892 -0.883 . . . . 3.57 110.892 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.89 110.44 4.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.678 -0.49 . . . . 2.84 109.678 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -115.91 158.81 22.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.699 -0.482 . . . . 4.34 109.699 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.4 p80 38.46 65.35 0.63 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.352 1.033 . . . . 6.23 111.608 -174.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.414 ' HB ' ' HB ' ' A' ' 127' ' ' VAL . 77.7 mt -77.43 133.77 29.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.192 -1.367 . . . . 3.55 110.707 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -126.84 124.31 39.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.068 0.461 . . . . 6.3 110.825 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.5 tt -85.99 106.8 17.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.717 -0.846 . . . . 4.63 108.717 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.69 -42.37 5.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.078 -0.51 . . . . 4.97 111.934 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -121.22 93.84 48.8 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.789 -0.449 . . . . 5.57 109.789 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.511 ' HA ' ' OD2' ' A' ' 137' ' ' ASP . 74.2 Cg_endo -75.43 156.41 41.1 Favored 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 122.649 2.233 . . . . 5.69 112.603 -176.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.909 -0.587 . . . . 6.1 111.018 -177.548 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.977 0.418 . . . . 12.72 111.078 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.529 ' OE1' ' HD3' ' A' ' 27' ' ' ARG . 15.0 mm-40 -110.21 138.22 46.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.699 -0.682 . . . . 11.63 110.351 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -93.38 145.12 24.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.259 -0.428 . . . . 9.47 111.128 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.3 -175.48 23.18 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.553 -0.619 . . . . 7.73 111.553 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.1 mt -127.75 141.9 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.808 -0.442 . . . . 10.57 109.808 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.01 122.77 19.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.969 -0.292 . . . . 8.73 110.441 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -81.73 -53.78 5.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 10.86 111.197 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -158.98 147.94 18.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.01 -0.541 . . . . 14.48 110.51 -177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.78 95.67 8.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 11.73 110.905 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 4.3 mm? -92.07 179.25 5.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.578 -0.737 . . . . 11.9 109.549 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -91.14 120.78 32.37 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.262 -0.273 . . . . 16.67 110.262 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.6 t 79.15 -40.97 0.25 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.961 0.905 . . . . 13.28 111.379 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 7.1 p90 -119.34 146.22 45.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.919 0.39 . . . . 12.68 111.051 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.77 163.02 22.89 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.599 -0.6 . . . . 7.92 111.599 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.97 143.59 47.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.892 0.377 . . . . 9.69 111.364 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.4 mt -110.44 129.28 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.65 -0.704 . . . . 7.75 110.232 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.79 140.53 42.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.81 0.814 . . . . 12.4 111.678 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.4 p -80.09 0.95 29.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.335 -1.302 . . . . 12.96 112.131 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.6 m -51.91 -39.6 59.36 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.471 0.545 . . . . 13.58 112.471 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -89.59 -13.31 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.251 0.548 . . . . 12.19 111.174 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.529 ' HD3' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -128.99 -158.46 0.89 Allowed 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.103 -0.373 . . . . 12.99 110.346 -175.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -124.03 19.22 9.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.076 0.465 . . . . 17.26 110.369 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.47 130.32 26.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.705 -0.679 . . . . 12.1 110.954 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -94.39 124.83 38.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.963 -0.754 . . . . 13.0 108.963 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.7 mt -123.72 162.4 23.22 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.069 0.462 . . . . 9.21 111.525 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -126.05 148.51 49.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.669 -0.696 . . . . 9.75 109.356 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -142.39 153.35 43.7 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.894 -0.41 . . . . 6.85 109.894 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -95.71 161.65 13.94 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.603 -0.517 . . . . 10.15 109.603 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -64.05 -13.61 48.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.059 0.457 . . . . 10.56 111.118 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.4 t -74.88 -20.64 59.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.13 -0.487 . . . . 12.44 110.155 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -100.25 23.37 10.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.415 -0.357 . . . . 11.14 111.332 -178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -124.02 111.69 16.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.027 0.442 . . . . 8.78 110.341 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.8 t -89.17 91.85 8.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.013 -0.54 . . . . 9.11 110.335 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.05 173.84 31.21 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.929 -0.653 . . . . 9.98 112.18 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -75.4 117.92 17.72 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.975 -0.38 . . . . 12.91 109.975 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.44 -18.86 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 11.97 111.93 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -54.97 -36.58 65.52 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.375 -0.375 . . . . 14.73 111.868 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -102.15 21.76 14.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.241 0.46 . . . . 13.3 112.241 -173.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -103.21 107.27 18.02 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.798 -0.361 . . . . 10.07 110.138 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -116.09 173.88 6.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.043 0.449 . . . . 13.53 110.904 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 47' ' ' ILE . 3.7 mp -80.56 125.84 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.911 -0.774 . . . . 12.26 108.911 177.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.19 -13.75 28.52 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.953 -0.641 . . . . 11.04 111.893 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.7 125.05 91.76 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-O 120.697 0.285 . . . . 8.39 110.553 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.98 132.07 15.04 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.469 2.113 . . . . 8.18 111.006 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 m -126.44 154.83 36.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.01 0.433 . . . . 4.78 111.296 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -109.51 126.57 53.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.414 -0.812 . . . . 7.09 109.468 176.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.3 161.08 38.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.901 0.381 . . . . 7.82 110.711 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -122.82 109.5 14.27 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.53 -0.544 . . . . 11.59 109.53 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.3 ttt -79.32 120.04 23.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.59 -0.732 . . . . 12.41 110.482 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.3 p -138.71 152.1 47.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.324 -0.398 . . . . 13.93 110.617 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -96.34 117.13 30.2 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.967 -0.383 . . . . 16.22 109.967 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -92.37 128.51 38.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.912 -0.585 . . . . 16.64 111.454 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -79.87 -13.28 59.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.535 -0.757 . . . . 23.23 111.473 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -79.53 -52.53 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 21.87 110.073 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.6 p -85.43 -37.8 19.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.024 -0.535 . . . . 17.49 110.75 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.03 14.06 50.42 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.491 -0.644 . . . . 17.22 111.491 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -116.6 151.42 47.09 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.542 0.211 . . . . 14.83 110.489 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.31 124.42 8.41 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.725 1.617 . . . . 13.33 110.044 168.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.47 169.69 17.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.15 0.5 . . . . 12.33 111.346 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.84 157.63 17.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.673 -0.862 . . . . 8.91 108.673 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.7 t -70.88 -162.23 0.06 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.481 -0.327 . . . . 10.33 110.56 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -74.57 7.85 2.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.301 0.482 . . . . 12.02 112.301 -172.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.9 t 49.84 91.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 124.026 0.829 . . . . 6.52 112.429 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.92 111.49 16.3 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.791 -0.64 . . . . 6.18 110.545 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 112.27 6.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.709 -0.678 . . . . 6.59 109.462 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.1 mt . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.696 -0.684 . . . . 6.16 111.093 -173.784 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 109.78 -0.452 . . . . 6.19 109.78 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 94.6 t -72.72 96.2 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 6.54 111.627 -176.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 144' ' ' ALA . 54.3 mt -85.38 -27.81 25.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.811 -0.632 . . . . 6.46 111.152 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.0 m -110.86 81.2 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.197 0.523 . . . . 7.24 112.407 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -96.22 -66.72 0.89 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.682 -1.229 . . . . 7.07 107.682 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -147.02 142.76 27.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.936 -0.574 . . . . 6.68 109.786 173.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 82' ' ' ARG . 45.7 ttm180 -82.86 100.64 10.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.815 -0.629 . . . . 6.93 110.072 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.53 153.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.323 0.582 . . . . 4.0 111.554 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.471 HG21 ' OG ' ' A' ' 140' ' ' SER . 60.7 p -116.11 140.49 49.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.599 -0.728 . . . . 3.84 109.582 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.0 174.06 23.37 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.003 -1.094 . . . . 2.58 112.421 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.0 m -125.52 128.67 48.36 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.607 0.242 . . . . 3.7 110.467 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.582 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 51.9 t -71.97 132.79 32.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.053 -0.522 . . . . 3.14 110.326 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.4 p -116.16 -9.17 11.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.178 0.513 . . . . 3.77 111.31 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.2 m -152.57 125.38 8.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 3.29 109.847 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.1 174.73 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.361 . . . . 4.39 110.904 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 CA--C 1.516 -0.349 0 CA-C-O 120.945 0.403 . . . . 3.62 110.735 179.267 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 110.187 -0.301 . . . . 3.7 110.187 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.7 p -101.57 125.64 48.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.494 -0.321 . . . . 2.84 111.398 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -71.2 167.66 51.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.895 -0.882 . . . . 1.91 110.895 174.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -131.75 132.44 43.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.305 0.552 . . . . 3.31 111.289 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.1 mt -113.05 133.62 58.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.391 -0.822 . . . . 2.17 109.309 173.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.9 t -84.17 134.47 34.57 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.222 -0.659 . . . . 3.61 109.222 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.507 ' CD2' HD13 ' A' ' 120' ' ' LEU . 36.5 t80 -157.01 142.73 17.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.16 0.505 . . . . 3.58 111.27 -168.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -129.82 131.49 46.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 5.1 109.311 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -152.29 131.89 13.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.871 0.367 . . . . 5.11 110.639 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 63.48 21.87 12.96 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.017 -0.538 . . . . 7.42 111.616 171.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.26 70.22 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.966 -0.635 . . . . 5.36 112.344 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.97 132.87 43.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.049 0.452 . . . . 5.38 110.24 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 15.1 m -121.8 115.55 22.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.108 -0.496 . . . . 4.96 109.896 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -156.64 173.89 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.77 0.319 . . . . 5.13 111.168 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -107.38 141.85 38.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.971 -0.559 . . . . 4.32 110.167 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.507 HD13 ' CD2' ' A' ' 111' ' ' TYR . 1.7 mp -105.78 139.95 20.72 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.085 -0.709 . . . . 3.17 109.085 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 83.7 Cg_endo -86.93 132.17 3.3 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.951 2.434 . . . . 2.61 112.423 177.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -137.42 149.99 47.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.786 0.327 . . . . 2.49 110.559 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 31.8 p -113.56 177.99 4.44 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.781 -0.452 . . . . 3.18 109.781 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -70.85 -18.17 62.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.001 0.429 . . . . 5.22 110.635 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.98 -27.9 54.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.874 -0.603 . . . . 4.81 110.977 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -75.67 -25.79 57.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.069 0.461 . . . . 4.0 110.916 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 156' ' ' ILE . 2.0 p -90.73 107.78 18.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.619 0.724 . . . . 4.39 111.263 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.84 139.72 34.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.321 -0.854 . . . . 6.43 108.696 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 136.55 -12.81 4.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.517 -0.849 . . . . 6.14 112.252 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 68.09 19.17 9.31 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.913 0.485 . . . . 6.26 112.093 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.62 144.16 9.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.044 0.449 . . . . 5.62 110.855 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -105.28 97.38 7.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.029 -0.532 . . . . 6.25 110.392 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -89.71 149.86 22.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.075 -0.966 . . . . 3.62 110.741 -177.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -122.6 162.35 22.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.063 -0.517 . . . . 7.5 109.678 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.582 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.28 123.47 23.8 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.888 -0.508 . . . . 4.12 110.453 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.78 -14.07 11.57 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.606 -0.807 . . . . 4.2 113.405 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.61 176.42 6.02 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 117.763 0.782 . . . . 4.06 110.323 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -107.19 115.11 29.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.0 0.428 . . . . 4.48 110.951 -173.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.3 m -118.58 172.85 5.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.789 -0.641 . . . . 2.98 111.257 -178.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.471 ' OG ' HG21 ' A' ' 84' ' ' THR . 43.4 m -138.1 129.86 28.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.954 -0.758 . . . . 3.68 108.954 175.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -127.9 140.29 52.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.033 0.444 . . . . 3.35 110.982 -172.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -93.81 111.28 22.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.73 -0.668 . . . . 5.34 109.708 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.1 mt -79.07 100.36 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.086 -0.506 . . . . 4.66 110.128 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -80.7 110.08 15.86 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.226 -0.443 . . . . 5.08 110.195 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 m -103.09 126.05 50.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.792 -0.64 . . . . 5.68 109.885 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -93.97 -171.09 2.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.302 -0.408 . . . . 6.25 110.401 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -84.44 -8.79 58.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.999 0.428 . . . . 9.03 111.166 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -89.25 -23.04 22.44 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.956 -0.566 . . . . 8.29 109.846 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.84 22.63 59.32 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.67 -0.695 . . . . 5.65 112.094 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -116.89 109.68 17.37 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.637 -0.505 . . . . 5.26 109.637 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.497 ' N ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.88 179.76 8.8 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.102 0.477 . . . . 4.63 111.491 -175.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -141.51 -94.46 0.23 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.505 -0.77 . . . . 3.57 111.267 174.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -143.58 156.09 44.49 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.386 -0.598 . . . . 2.84 109.386 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 155' ' ' HIS . 13.9 t -162.55 161.84 27.04 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.842 -0.429 . . . . 4.34 109.842 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.46 ' HD2' ' SG ' ' A' ' 154' ' ' CYS . 35.2 m-70 48.13 66.3 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.643 0.589 . . . . 6.23 111.69 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.531 ' O ' HG21 ' A' ' 127' ' ' VAL . 68.4 mt -93.94 117.72 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.335 -0.848 . . . . 3.55 110.365 -177.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.12 158.51 17.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 6.3 110.47 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.84 113.38 26.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.51 -0.552 . . . . 4.63 109.51 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -83.0 -58.59 2.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.013 0.435 . . . . 4.97 111.383 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -136.42 100.6 10.28 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.284 -0.416 . . . . 5.57 110.129 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.88 159.68 51.79 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.391 2.061 . . . . 5.69 111.478 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 121.029 0.442 . . . . 6.1 111.138 -177.073 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 83.3 mtt180 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.399 0.618 . . . . 12.72 111.478 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 6.8 mm-40 -102.76 143.74 32.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.839 -1.073 . . . . 11.63 110.441 -174.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.6 p -104.3 160.95 14.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.282 -0.636 . . . . 9.47 109.282 174.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.25 174.68 46.93 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.102 -1.047 . . . . 7.73 113.562 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.46 HG13 ' HB3' ' A' ' 23' ' ' GLN . 19.8 pt -120.57 148.81 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.924 -0.769 . . . . 10.57 108.924 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 mp -80.07 131.45 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.307 -0.557 . . . . 8.73 110.774 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.456 ' OE2' ' HB2' ' A' ' 14' ' ' LYS . 4.3 tm-20 -74.66 -46.74 36.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.687 -0.688 . . . . 10.86 111.026 -176.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.499 ' HD3' ' N ' ' A' ' 15' ' ' LEU . 6.8 tmtt? -157.09 133.17 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.002 -0.37 . . . . 14.48 110.002 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.499 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 3.6 mm? -78.06 110.88 13.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.943 -0.571 . . . . 11.73 110.901 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 72.2 mt -109.79 177.52 4.7 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.922 -1.14 . . . . 11.9 107.922 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -98.91 139.87 33.93 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.486 -0.485 . . . . 16.67 110.511 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t 76.89 -46.05 0.5 Allowed 'General case' 0 N--CA 1.468 0.425 0 O-C-N 124.366 1.041 . . . . 13.28 111.04 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.488 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 39.6 p90 -129.92 154.29 47.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.264 -0.425 . . . . 12.68 109.925 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -144.51 163.57 27.86 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.897 -0.668 . . . . 7.92 111.72 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -109.33 134.39 51.87 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.231 0.538 . . . . 9.69 111.262 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 22' ' ' ILE . 74.6 mt -99.86 126.4 53.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 7.75 109.569 176.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.551 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 18.9 tp60 -79.31 130.65 35.66 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.089 0.471 . . . . 12.4 110.319 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 p -67.86 3.63 1.43 Allowed 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 113.894 1.072 . . . . 12.96 113.894 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.551 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 74.4 m -51.75 -26.33 9.28 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.537 0.939 . . . . 13.58 113.537 -172.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -99.53 -6.35 27.62 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.131 0.419 . . . . 12.19 112.131 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HG3' ' HB3' ' A' ' 8' ' ' GLU . 17.2 mmt180 -152.28 -159.89 1.07 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.801 0.334 . . . . 12.99 110.841 -173.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -116.3 17.23 15.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.092 0.472 . . . . 17.26 110.601 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.37 113.24 14.71 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.197 -0.456 . . . . 12.1 111.768 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -87.9 104.65 16.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.661 -0.866 . . . . 13.0 108.661 170.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.99 161.22 14.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.928 0.394 . . . . 9.21 111.232 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -110.95 129.36 55.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.308 -0.997 . . . . 9.75 108.308 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -110.64 141.56 43.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.084 0.469 . . . . 6.85 110.158 -175.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -87.16 137.61 32.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.031 -0.729 . . . . 10.15 109.031 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.46 -11.31 32.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.924 0.342 . . . . 10.56 111.924 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.6 t -72.21 -27.41 62.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.28 -0.418 . . . . 12.44 110.494 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.48 40.31 1.57 Allowed 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.154 -0.475 . . . . 11.14 111.321 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.428 ' CE1' ' HG ' ' A' ' 45' ' ' LEU . 22.8 t80 -113.7 129.16 56.61 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.057 -0.72 . . . . 8.78 109.057 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.0 t -108.79 115.25 29.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.907 -0.405 . . . . 9.11 109.907 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.3 -157.3 20.74 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.873 -0.679 . . . . 9.98 111.724 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -93.45 103.47 15.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.89 0.376 . . . . 12.91 110.626 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.3 tp -67.05 -21.82 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.917 -0.583 . . . . 11.97 110.757 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.64 -21.44 65.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 14.73 110.283 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -99.31 11.74 38.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.769 -0.651 . . . . 13.3 110.222 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.428 ' HG ' ' CE1' ' A' ' 38' ' ' PHE . 2.8 tm? -101.28 115.41 30.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.148 -0.686 . . . . 10.07 109.148 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -123.43 -177.6 3.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.382 -0.372 . . . . 13.53 111.153 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.421 HD11 ' N ' ' A' ' 47' ' ' ILE . 3.9 mp -77.48 117.84 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.0 -0.371 . . . . 12.26 110.0 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.35 -1.3 64.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.86 -0.686 . . . . 11.04 111.776 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.98 125.28 90.34 Favored Pre-proline 0 C--O 1.234 0.276 0 N-CA-C 109.882 -0.414 . . . . 8.39 109.882 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.89 128.1 7.35 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.637 2.224 . . . . 8.18 113.66 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.48 161.66 38.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 4.78 110.358 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -122.41 127.35 49.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.399 0.618 . . . . 7.09 109.655 174.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 8' ' ' GLU . 45.3 p90 -131.71 -179.32 5.31 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.921 -0.582 . . . . 7.82 110.872 -174.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 37.6 tt0 -127.91 126.95 42.49 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.959 -0.756 . . . . 11.59 108.959 -176.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.5 ttt -100.53 112.45 24.83 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.289 -0.263 . . . . 12.41 110.289 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.2 p -131.9 170.67 14.55 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.339 -0.391 . . . . 13.93 111.351 -175.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -115.77 109.41 17.63 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.81 -0.441 . . . . 16.22 109.81 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.532 ' OD2' HG23 ' A' ' 61' ' ' THR . 31.2 t70 -76.59 122.88 25.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.139 -0.482 . . . . 16.64 111.063 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -79.51 -13.34 59.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 23.23 111.367 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 60' ' ' ARG . 14.3 ttm180 -78.42 -62.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.377 . . . . 21.87 110.935 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.532 HG23 ' OD2' ' A' ' 58' ' ' ASP . 15.3 t -88.45 -22.49 23.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.308 -0.405 . . . . 17.49 110.594 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.02 17.63 57.43 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.747 -0.739 . . . . 17.22 113.288 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -104.5 141.72 23.12 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.589 0.195 . . . . 14.83 110.569 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.92 124.13 7.84 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.451 1.434 . . . . 13.33 109.317 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -141.27 171.56 11.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.133 -0.627 . . . . 12.33 112.397 -169.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.3 143.48 28.02 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.928 -1.033 . . . . 8.91 109.038 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.429 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 14.1 t -69.71 -155.68 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.357 -0.383 . . . . 10.33 110.46 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -75.27 29.1 0.1 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.397 0.888 . . . . 12.02 113.397 -172.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.0 t 19.92 103.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 125.14 1.376 . . . . 6.52 114.403 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -101.94 143.11 32.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.089 0.471 . . . . 6.18 111.572 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -69.72 138.85 53.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.569 -0.741 . . . . 6.59 110.791 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.0 mt . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 109.265 -0.642 . . . . 6.16 109.265 174.375 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.892 0.377 . . . . 6.19 110.728 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 47.3 t -80.75 95.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.312 0.577 . . . . 6.54 109.792 175.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tt -98.92 -24.68 14.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.112 -0.949 . . . . 6.46 110.741 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t -101.34 103.08 14.02 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.358 0.599 . . . . 7.24 112.088 -170.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -129.49 -63.59 0.93 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.166 -1.05 . . . . 7.07 108.166 169.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -168.64 147.09 4.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.723 -1.126 . . . . 6.68 108.392 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -77.11 98.56 5.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.61 -0.515 . . . . 6.93 109.61 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.6 m -81.8 157.24 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.44 0.638 . . . . 4.0 111.546 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.6 p -124.69 146.87 48.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.609 -0.723 . . . . 3.84 109.257 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.43 -173.33 13.71 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.272 -0.966 . . . . 2.58 112.063 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.7 m -130.92 131.15 44.29 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.015 -0.365 . . . . 3.7 110.015 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 88.0 t -64.18 129.95 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.519 -0.309 . . . . 3.14 110.33 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.3 p -113.98 -9.98 12.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.983 0.421 . . . . 3.77 110.722 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.7 m -152.26 128.76 10.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.429 . . . . 3.29 110.209 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -99.07 169.63 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 4.39 110.726 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.999 -0.546 . . . . 3.62 110.122 172.636 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.448 -0.556 0 CA-C-O 121.008 0.432 . . . . 3.7 109.872 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.19 116.2 32.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.109 0.481 . . . . 2.84 111.141 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -69.09 160.77 52.42 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.729 -0.748 . . . . 1.91 111.554 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -129.9 127.61 40.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.342 0.592 . . . . 3.31 110.868 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.5 mt -112.0 127.45 69.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.204 -0.907 . . . . 2.17 109.241 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.4 t -112.4 137.46 50.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.764 0.316 . . . . 3.61 110.441 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 2.7 p90 -143.37 155.42 44.42 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.115 -0.698 . . . . 3.58 109.115 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -111.56 125.24 53.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.864 0.364 . . . . 5.1 110.463 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.732 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 9.4 t30 -130.03 115.66 17.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.945 -0.571 . . . . 5.11 109.584 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 60.94 21.63 11.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.663 0.268 . . . . 7.42 111.581 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.87 -4.18 68.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.825 -0.702 . . . . 5.36 113.011 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.732 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 7.9 pt-20 -99.68 132.96 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.145 -0.687 . . . . 5.38 109.145 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 7.8 p -116.77 118.36 32.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.94 0.4 . . . . 4.96 110.427 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.431 ' CE1' ' HG3' ' A' ' 116' ' ' GLU . 78.9 m-85 -108.4 155.01 21.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.142 -0.481 . . . . 5.13 110.494 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -110.26 123.34 49.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.952 -0.567 . . . . 4.32 109.715 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.77 120.2 52.14 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.384 -0.371 . . . . 3.17 110.408 -175.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -76.7 132.91 13.62 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.906 2.404 . . . . 2.61 111.722 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -145.3 155.0 42.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.804 0.335 . . . . 2.49 110.25 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 62.8 p -107.4 -174.71 2.6 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.124 -0.489 . . . . 3.18 110.084 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -71.39 -19.61 62.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.222 0.534 . . . . 5.22 110.514 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.85 -28.28 33.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.754 -0.657 . . . . 4.81 111.437 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.22 -19.61 60.46 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.387 -0.369 . . . . 4.0 111.364 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.9 p -107.43 107.91 23.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.588 0.709 . . . . 4.39 111.009 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -90.46 138.43 31.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 6.43 110.183 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.23 -20.65 4.98 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.777 -0.647 . . . . 6.14 111.51 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.8 t30 61.58 31.57 18.77 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.74 0.781 . . . . 6.26 110.001 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -89.92 138.51 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.692 -0.685 . . . . 5.62 110.151 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 132' ' ' ASN . 0.9 OUTLIER -82.5 103.38 12.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.735 0.302 . . . . 6.25 110.379 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.52 HD11 ' H ' ' A' ' 133' ' ' LEU . 2.2 mp -75.56 134.87 40.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.751 -0.659 . . . . 3.62 109.51 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -121.34 126.74 50.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.889 0.376 . . . . 7.5 110.159 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.567 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -57.46 112.91 1.56 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.359 0.599 . . . . 4.12 111.317 -175.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.36 -2.8 14.04 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.296 -0.865 . . . . 4.2 112.851 -174.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.6 p30 -95.01 178.27 5.61 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.442 0.621 . . . . 4.06 110.459 172.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -100.22 122.88 43.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.978 0.418 . . . . 4.48 111.036 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.09 151.82 24.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.668 -0.696 . . . . 2.98 110.584 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.3 t -124.93 129.33 50.16 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.704 -0.48 . . . . 3.68 109.704 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -136.67 154.6 50.58 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.557 -0.534 . . . . 3.35 109.557 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -113.0 114.76 27.36 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.37 -0.604 . . . . 5.34 109.37 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -78.43 108.16 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.594 . . . . 4.66 111.304 -174.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -100.62 110.5 22.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.128 -0.487 . . . . 5.08 109.81 172.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.2 m -85.85 108.95 18.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.198 -0.455 . . . . 5.68 111.126 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -64.53 146.1 55.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.937 -0.574 . . . . 6.25 109.661 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.17 -17.97 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.571 0.582 . . . . 9.03 112.571 -173.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -85.75 2.07 47.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 8.29 110.31 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.48 16.77 80.43 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.68 -0.691 . . . . 5.65 113.143 174.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -119.69 113.09 20.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.332 -0.618 . . . . 5.26 109.332 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -144.72 -179.17 6.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.214 -0.448 . . . . 4.63 111.067 -175.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.58 -153.3 5.84 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.057 -0.817 . . . . 3.57 111.057 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.26 118.01 34.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.213 0.507 . . . . 2.84 110.086 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 33.9 t -116.44 159.59 21.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.59 -0.277 . . . . 4.34 110.646 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 60.47 33.58 20.57 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.95 -0.568 . . . . 6.23 111.174 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 55.0 mt -64.69 125.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.764 -0.653 . . . . 3.55 110.921 -176.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -140.44 159.92 41.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.724 -0.671 . . . . 6.3 110.056 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.1 tp -77.6 119.24 20.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.281 -0.637 . . . . 4.63 109.281 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -84.41 -47.67 10.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.031 -0.531 . . . . 4.97 109.628 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -162.5 113.94 1.12 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.864 -0.607 . . . . 5.57 109.492 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.12 152.08 80.46 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.126 1.884 . . . . 5.69 112.481 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.886 0 CA-C-N 115.897 -0.592 . . . . 6.1 110.774 -178.041 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 . . . . . 0 C--O 1.236 0.362 0 N-CA-C 110.128 -0.323 . . . . 12.72 110.128 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.479 ' CD ' ' HE ' ' A' ' 27' ' ' ARG . 14.1 pt-20 -142.38 162.12 36.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.924 -0.399 . . . . 11.63 109.924 174.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 52' ' ' GLU . 68.9 p -109.14 157.38 18.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.536 0.684 . . . . 9.47 112.133 -171.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.69 157.0 28.42 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.224 -1.15 . . . . 7.73 110.224 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.0 pt -105.01 141.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 117.097 0.448 . . . . 10.57 110.646 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.406 HG13 HD11 ' A' ' 45' ' ' LEU . 41.6 mm -74.37 123.45 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 110.067 -0.346 . . . . 8.73 110.067 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.68 -34.5 17.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.333 0.494 . . . . 10.86 112.333 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.42 ' HA ' HD13 ' A' ' 47' ' ' ILE . 1.9 tmtp? -160.74 130.4 4.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.947 0.404 . . . . 14.48 111.059 -175.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.482 ' H ' HD11 ' A' ' 47' ' ' ILE . 3.0 mm? -91.55 106.55 18.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.854 -0.612 . . . . 11.73 110.796 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 5.3 mp -96.93 179.77 4.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.763 -0.829 . . . . 11.9 108.763 174.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -89.81 116.11 27.66 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.268 -0.573 . . . . 16.67 110.434 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.4 t 78.54 -14.0 0.91 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.298 0.999 . . . . 13.28 111.635 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 10.1 p90 -145.45 162.97 36.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.187 -0.301 . . . . 12.68 110.187 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.67 177.22 33.72 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.67 -0.776 . . . . 7.92 112.125 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -126.68 148.49 49.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 9.69 110.914 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.7 mt -108.87 126.21 65.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.571 -0.741 . . . . 7.75 109.666 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.22 143.2 47.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.426 0.631 . . . . 12.4 110.766 -175.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.7 p -77.04 6.04 7.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.068 -0.969 . . . . 12.96 111.942 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -49.57 -39.97 36.85 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.077 0.399 . . . . 13.58 112.077 -173.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -116.91 6.38 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.835 -0.346 . . . . 12.19 111.4 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.615 ' HD3' ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -120.41 141.31 50.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.533 -0.543 . . . . 12.99 109.533 -173.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.615 ' N ' ' HD3' ' A' ' 27' ' ' ARG . 27.7 mm-40 -77.04 26.01 0.15 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.064 -0.397 . . . . 17.26 111.484 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 27' ' ' ARG . . . 178.99 145.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.575 0.75 . . . . 12.1 109.333 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.523 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.9 OUTLIER -86.9 132.37 33.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.557 -0.534 . . . . 13.0 109.557 174.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.52 162.39 19.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.209 0.528 . . . . 9.21 111.636 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -116.16 147.98 40.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.486 -0.779 . . . . 9.75 109.882 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -150.22 172.92 14.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.77 -0.456 . . . . 6.85 109.77 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 7.1 p-80 -135.06 165.79 24.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 10.15 111.172 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -66.29 -18.95 65.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.835 -0.621 . . . . 10.56 111.896 -173.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t -86.27 2.36 47.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.546 -0.297 . . . . 12.44 110.837 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 36.6 tp60 -110.74 -30.16 7.69 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.774 -0.454 . . . . 11.14 109.774 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -77.35 121.55 23.91 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.875 -0.602 . . . . 8.78 109.956 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.416 ' HB2' ' CG ' ' A' ' 68' ' ' GLN . 34.1 t -97.07 139.99 32.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.196 0.522 . . . . 9.11 110.528 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.41 -169.15 14.51 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.635 -0.793 . . . . 9.98 112.573 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -72.9 110.73 7.43 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.363 0.601 . . . . 12.91 111.068 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -77.75 -20.65 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.372 -0.831 . . . . 11.97 109.998 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.75 -31.63 72.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 14.73 110.401 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -97.02 24.53 6.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.815 -0.63 . . . . 13.3 110.768 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.406 HD11 HG13 ' A' ' 12' ' ' ILE . 3.2 tm? -113.19 120.79 42.44 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.007 -1.108 . . . . 10.07 108.007 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.29 176.49 8.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.628 0.252 . . . . 13.53 110.816 -170.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.482 HD11 ' H ' ' A' ' 15' ' ' LEU . 31.4 mm -70.63 128.25 33.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.562 -0.29 . . . . 12.26 110.26 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.13 11.09 67.82 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.322 -0.942 . . . . 11.04 112.611 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.45 121.35 71.21 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.972 -0.381 . . . . 8.39 109.972 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.48 125.3 9.51 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.564 2.176 . . . . 8.18 112.712 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 71' ' ' LYS . 34.0 m -124.61 152.96 31.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.78 -0.645 . . . . 4.78 109.65 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.517 ' HB3' HG22 ' A' ' 9' ' ' THR . 13.8 pt-20 -114.46 131.05 56.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.323 0.582 . . . . 7.09 109.752 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -137.67 172.73 12.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.371 0.605 . . . . 7.82 111.701 -172.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -118.4 133.69 55.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.189 -1.041 . . . . 11.59 108.189 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.9 ttt -100.7 122.53 43.49 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.283 -0.266 . . . . 12.41 110.283 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.3 p -135.09 144.25 47.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.413 0.625 . . . . 13.93 111.253 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -90.6 109.66 20.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.691 . . . . 16.22 109.16 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.02 117.93 8.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.825 -0.625 . . . . 16.64 111.618 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 -80.12 -12.25 59.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.175 -0.92 . . . . 23.23 111.712 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.82 -57.81 3.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.886 0.374 . . . . 21.87 110.397 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.3 p -104.68 -39.43 6.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.074 -0.512 . . . . 17.49 111.117 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.87 16.85 7.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.511 -0.852 . . . . 17.22 112.825 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -101.34 148.31 35.0 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.156 -0.313 . . . . 14.83 110.156 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -79.63 125.22 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.675 1.583 . . . . 13.33 110.358 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.3 pt -128.87 162.91 35.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.483 0.659 . . . . 12.33 111.553 -175.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.46 161.97 13.25 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.977 -1.01 . . . . 8.91 108.635 170.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.428 ' O ' HG23 ' A' ' 69' ' ' VAL . 26.3 t -75.39 -153.29 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.222 -0.288 . . . . 10.33 110.222 177.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.583 HE21 ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -67.82 -4.02 11.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.798 0.666 . . . . 12.02 112.798 -173.133 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 67' ' ' SER . 42.3 t 50.93 86.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.538 0.685 . . . . 6.52 111.56 176.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -97.23 129.86 44.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.836 -0.62 . . . . 6.18 110.649 -174.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.427 ' HA ' HG13 ' A' ' 51' ' ' VAL . 35.9 mtmm -67.61 141.21 56.84 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.157 -0.682 . . . . 6.59 109.157 175.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.9 mt . . . . . 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 6.16 111.318 -176.534 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.45 ' CG2' ' HB3' ' A' ' 144' ' ' ALA . 3.2 p . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 121.206 0.526 . . . . 6.19 111.016 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.482 HG11 ' H ' ' A' ' 79' ' ' SER . 46.7 t -85.37 118.97 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.915 -0.584 . . . . 6.54 111.856 -175.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.487 ' HG ' ' CE1' ' A' ' 155' ' ' HIS . 10.7 mp -97.19 13.57 28.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.106 -0.497 . . . . 6.46 110.548 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.482 ' H ' HG11 ' A' ' 77' ' ' VAL . 21.1 m -116.48 -112.2 0.34 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.168 -0.469 . . . . 7.24 110.532 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 81' ' ' GLU . 6.3 tt0 57.82 33.05 22.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.098 0.559 . . . . 7.07 111.143 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 80' ' ' GLU . 10.3 tp10 76.0 117.51 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.222 -0.899 . . . . 6.68 111.126 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -77.71 90.88 4.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.662 0.744 . . . . 6.93 110.159 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.65 160.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.496 -0.775 . . . . 4.0 111.226 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 p -107.86 139.52 42.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.542 -0.754 . . . . 3.84 109.924 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.36 161.26 24.41 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.515 -0.85 . . . . 2.58 112.479 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -116.96 125.01 50.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.483 -0.562 . . . . 3.7 109.483 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 58.1 t -68.5 123.68 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 108.973 -0.751 . . . . 3.14 108.973 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.0 p -105.08 -20.3 13.56 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.623 -0.431 . . . . 3.77 111.066 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -151.83 126.18 9.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.273 -0.421 . . . . 3.29 110.258 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.27 -172.68 4.12 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.951 -0.388 . . . . 4.39 109.951 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.412 HD21 ' HG3' ' A' ' 124' ' ' LYS . 5.3 mp . . . . . 0 C--N 1.325 -0.457 0 N-CA-C 109.284 -0.636 . . . . 3.62 109.284 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.447 -0.585 0 CA-C-O 121.408 0.623 . . . . 3.7 109.341 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 t -122.09 148.76 44.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.71 -0.677 . . . . 2.84 110.631 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.03 163.41 39.74 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.671 -0.971 . . . . 1.91 110.671 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -125.27 128.42 48.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.965 0.412 . . . . 3.31 110.886 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 71.6 mt -112.88 125.46 70.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.909 -0.587 . . . . 2.17 109.506 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.8 t -100.17 137.89 37.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.838 -0.43 . . . . 3.61 109.838 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.52 ' CE2' HD12 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -148.8 167.48 25.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.527 0.203 . . . . 3.58 110.549 -178.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.38 127.93 56.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.366 -0.379 . . . . 5.1 110.446 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -152.85 130.12 11.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.604 -0.517 . . . . 5.11 109.604 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 64.74 20.85 12.25 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.427 0.455 . . . . 7.42 111.168 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.57 18.73 79.68 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.778 -0.725 . . . . 5.36 111.868 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -121.21 144.92 48.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.628 -0.508 . . . . 5.38 109.628 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 11.4 p -122.98 115.49 21.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.277 -0.42 . . . . 4.96 110.265 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -132.19 157.4 44.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.251 -0.431 . . . . 5.13 110.528 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -99.77 129.25 45.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 4.32 109.819 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.52 HD12 ' CE2' ' A' ' 111' ' ' TYR . 4.2 mp -105.03 143.39 26.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 110.133 -0.321 . . . . 3.17 110.133 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.11 148.56 19.34 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.511 2.141 . . . . 2.61 112.036 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -155.19 144.57 21.13 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.029 -0.73 . . . . 2.49 109.029 173.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.8 p -113.11 -175.59 2.7 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.67 0.272 . . . . 3.18 110.489 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.412 ' HG3' HD21 ' A' ' 91' ' ' LEU . 55.2 mttp -65.76 -27.97 68.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.24 0.543 . . . . 5.22 110.183 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -75.16 -22.92 57.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.211 -0.904 . . . . 4.81 111.598 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -83.13 -11.25 58.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 4.0 111.86 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 p -119.98 106.55 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.441 0.639 . . . . 4.39 111.37 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -108.26 150.25 27.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.779 -0.646 . . . . 6.43 110.102 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 125.39 16.93 2.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.913 -0.66 . . . . 6.14 112.943 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.9 t30 64.25 22.62 12.88 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.447 0.642 . . . . 6.26 110.454 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.2 130.54 35.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.946 -0.57 . . . . 5.62 110.929 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -111.61 111.56 22.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 6.25 110.148 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 133' ' ' LEU . 5.5 mp -98.97 149.83 22.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 3.62 110.939 -176.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -146.52 121.14 9.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.475 -0.565 . . . . 7.5 109.475 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.492 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -46.68 131.57 11.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.83 -0.623 . . . . 4.12 112.532 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.22 -12.69 14.15 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.126 -0.943 . . . . 4.2 111.192 -172.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -89.64 174.9 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 4.06 110.482 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -121.86 118.69 29.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.346 0.594 . . . . 4.48 110.147 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.7 m -121.19 159.07 23.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.314 -0.857 . . . . 2.98 111.264 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.9 m -109.73 137.82 46.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.622 -0.717 . . . . 3.68 109.22 173.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -139.79 139.21 36.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.024 0.44 . . . . 3.35 110.114 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -97.2 121.08 38.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.949 -0.569 . . . . 5.34 109.532 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.05 107.91 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 4.66 110.122 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.45 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . . . -94.87 107.98 20.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.07 -0.514 . . . . 5.08 110.995 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 50.9 m -85.38 109.41 18.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.691 . . . . 5.68 111.075 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -74.76 159.29 32.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.316 -0.624 . . . . 6.25 109.316 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -57.77 -24.91 59.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 122.451 0.3 . . . . 9.03 111.693 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.611 ' HD2' ' OD1' ' A' ' 150' ' ' ASN . 1.3 tmt_? -69.81 -21.03 63.43 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.184 0.516 . . . . 8.29 110.116 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.41 2.76 61.69 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.882 -0.675 . . . . 5.65 112.107 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.611 ' OD1' ' HD2' ' A' ' 148' ' ' ARG . 15.1 m120 -99.73 135.92 40.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.632 -0.507 . . . . 5.26 109.632 177.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.517 ' HB3' ' HA ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -145.34 174.44 11.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.062 0.458 . . . . 4.63 111.332 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.32 -160.83 10.7 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.995 -0.842 . . . . 3.57 110.995 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.6 109.79 22.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.123 0.487 . . . . 2.84 110.54 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 38.1 m -131.56 176.62 8.16 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.141 -0.688 . . . . 4.34 109.141 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.487 ' CE1' ' HG ' ' A' ' 78' ' ' LEU . 13.9 m80 58.47 38.6 25.54 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.317 -0.623 . . . . 6.23 109.317 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.3 mt -79.48 128.76 38.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.173 -0.921 . . . . 3.55 111.137 -169.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -134.73 140.86 46.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.281 0.562 . . . . 6.3 110.349 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.6 tp -103.97 105.76 16.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.828 -0.624 . . . . 4.63 109.906 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -109.74 -24.64 10.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.063 -0.517 . . . . 4.97 111.297 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -117.79 86.12 23.78 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.209 -0.45 . . . . 5.57 110.821 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.34 156.21 14.51 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.54 2.16 . . . . 5.69 111.772 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 116.288 -0.415 . . . . 6.1 110.685 -179.12 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.484 ' HG2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 120.892 0.377 . . . . 12.72 111.061 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.76 153.56 21.6 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.098 -0.704 . . . . 11.63 109.098 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.503 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 20.3 p -86.52 161.36 18.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.066 0.46 . . . . 9.47 111.736 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.22 162.73 32.02 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.433 -0.667 . . . . 7.73 111.433 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 pt -113.9 148.57 16.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.724 0.262 . . . . 10.57 110.43 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.0 mm -75.28 123.4 31.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.513 -0.312 . . . . 8.73 110.687 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.512 ' OE2' ' HB3' ' A' ' 21' ' ' PHE . 29.1 mt-10 -72.53 -46.05 56.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.054 -0.521 . . . . 10.86 111.219 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.12 146.94 17.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.023 -0.535 . . . . 14.48 110.084 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.51 105.25 17.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.927 -0.579 . . . . 11.73 110.695 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 2.6 mm? -106.71 179.09 4.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.752 -0.833 . . . . 11.9 108.752 174.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -91.64 129.37 37.62 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.714 -0.394 . . . . 16.67 110.223 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.3 m 76.25 -37.79 0.31 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 124.152 0.907 . . . . 13.28 112.083 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 46.8 p90 -126.98 153.37 45.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.898 0.38 . . . . 12.68 111.081 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.4 165.95 26.24 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.03 -0.828 . . . . 7.92 111.03 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.512 ' HB3' ' OE2' ' A' ' 13' ' ' GLU . 91.5 m-85 -115.21 146.16 41.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.225 0.513 . . . . 9.69 111.459 -177.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.508 HG22 ' CE2' ' A' ' 53' ' ' PHE . 61.6 mt -117.71 127.15 75.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 7.75 110.338 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.418 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -78.22 133.14 37.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.588 0.708 . . . . 12.4 111.962 -172.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.5 p -81.22 -1.09 43.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.855 -1.066 . . . . 12.96 113.229 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -60.94 -43.18 99.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.085 0.469 . . . . 13.58 111.342 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.432 ' OE1' ' HB3' ' A' ' 128' ' ' GLU . 7.2 tp10 -90.28 -9.14 49.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.043 0.925 . . . . 12.19 109.747 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 9' ' ' THR . 1.1 mmt180 -112.29 -167.58 1.2 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.83 -1.077 . . . . 12.99 110.462 -174.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.61 21.62 6.0 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.147 -0.686 . . . . 17.26 109.147 171.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.05 128.21 1.93 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.922 -1.035 . . . . 12.1 110.169 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -85.91 140.24 30.53 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.831 -0.803 . . . . 13.0 108.831 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.1 mt -145.59 161.32 40.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.106 0.479 . . . . 9.21 111.89 -175.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -120.96 130.15 53.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.363 -0.835 . . . . 9.75 108.767 172.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -119.21 157.37 28.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.922 -0.399 . . . . 6.85 109.922 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -108.19 151.99 25.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.324 -0.398 . . . . 10.15 110.051 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -57.76 -26.41 61.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.275 0.842 . . . . 10.56 113.275 -172.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.2 t -68.7 -13.54 62.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.181 0.515 . . . . 12.44 110.898 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.66 38.96 2.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.056 -0.52 . . . . 11.14 110.145 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -127.17 117.36 22.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.165 -0.47 . . . . 8.78 109.904 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.5 t -79.71 91.85 5.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.544 -0.753 . . . . 9.11 110.225 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.91 -163.3 27.7 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.797 -0.716 . . . . 9.98 112.465 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -86.3 112.51 21.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.818 -0.438 . . . . 12.91 109.818 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -28.91 40.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.678 0.275 . . . . 11.97 111.556 -174.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -75.33 -13.36 60.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.426 0.631 . . . . 14.73 109.671 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -95.61 6.8 48.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.588 -0.733 . . . . 13.3 110.334 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.8 tp -94.43 125.81 39.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.738 -0.665 . . . . 10.07 110.026 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 2.6 mppt? -103.2 167.74 9.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.205 0.526 . . . . 13.53 110.841 -174.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.5 mt -84.5 114.68 25.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.814 -0.63 . . . . 12.26 109.688 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.74 9.4 43.36 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.259 -0.736 . . . . 11.04 111.259 -170.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -79.55 124.52 83.78 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 109.532 -0.544 . . . . 8.39 109.532 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HB2' HD13 ' A' ' 72' ' ' ILE . 86.1 Cg_endo -82.39 129.22 5.77 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.847 2.364 . . . . 8.18 113.621 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.4 166.27 29.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 4.78 111.097 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.432 ' HB3' HG21 ' A' ' 9' ' ' THR . 7.7 pt-20 -122.58 124.89 44.54 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.578 -0.527 . . . . 7.09 109.578 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.508 ' CE2' HG22 ' A' ' 22' ' ' ILE . 54.3 p90 -133.0 149.75 52.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.109 0.48 . . . . 7.82 111.349 -172.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 7' ' ' ARG . 2.6 mp0 -88.72 149.46 23.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.019 -0.992 . . . . 11.59 110.361 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.05 121.69 42.97 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.328 -0.619 . . . . 12.41 109.328 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.5 p -138.9 172.08 13.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.398 . . . . 13.93 111.265 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -125.75 125.33 42.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.333 -0.394 . . . . 16.22 110.573 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.59 124.96 34.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.066 0.46 . . . . 16.64 110.542 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -79.97 -25.26 40.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.791 -0.64 . . . . 23.23 111.404 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -70.85 -57.54 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.559 -0.292 . . . . 21.87 111.233 -172.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.0 p -91.46 -28.54 17.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.962 0.41 . . . . 17.49 110.559 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.98 11.01 57.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 17.22 112.741 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 131.32 31.35 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 122.815 -0.226 . . . . 14.83 110.442 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.02 126.43 15.82 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.257 1.971 . . . . 13.33 109.93 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 30.2 pt -126.52 147.67 31.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.411 0.624 . . . . 12.33 111.63 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.24 155.04 18.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.022 -0.99 . . . . 8.91 108.433 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.467 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 39.1 t -75.26 -151.29 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.338 0.399 . . . . 10.33 110.496 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -67.9 -10.28 51.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.248 0.462 . . . . 12.02 112.248 -175.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.3 t 56.56 96.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.489 0.661 . . . . 6.52 111.198 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 t -93.77 147.7 22.8 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.603 -0.518 . . . . 6.18 109.603 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.492 ' HZ1' ' HB3' ' A' ' 71' ' ' LYS . 7.7 mtpm? -81.51 157.5 24.81 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.434 -0.58 . . . . 6.59 109.434 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 50' ' ' PRO . 24.6 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-O 121.375 0.607 . . . . 6.16 109.905 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 108.831 -0.804 . . . . 6.19 108.831 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 47.5 t -68.49 103.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 6.54 111.531 -174.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -78.71 83.21 4.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.764 -0.653 . . . . 6.46 109.743 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 p 23.44 96.37 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.96 1.467 . . . . 7.24 114.96 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.73 -30.55 71.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.525 0.679 . . . . 7.07 109.533 171.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -108.68 117.71 34.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.081 -0.963 . . . . 6.68 109.947 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -81.4 144.71 31.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.354 -0.385 . . . . 6.93 109.968 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.91 152.95 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.342 0.591 . . . . 4.0 111.111 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.1 p -114.94 145.7 41.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.607 -0.724 . . . . 3.84 110.086 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.99 165.77 24.54 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.347 -0.93 . . . . 2.58 112.648 -177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 m -118.82 130.18 55.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.457 -0.571 . . . . 3.7 109.457 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.635 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 3.1 t -73.64 123.4 28.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.015 -0.365 . . . . 3.14 110.015 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.6 p -101.34 -22.48 14.58 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.143 0.497 . . . . 3.77 109.979 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.8 m -140.29 118.42 11.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.497 -0.774 . . . . 3.29 109.898 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -97.83 163.77 12.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.093 0.473 . . . . 4.39 110.895 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.751 -0.658 . . . . 3.62 110.498 179.709 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 109.366 -0.605 . . . . 3.7 109.366 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.4 t -146.89 149.11 32.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.679 -0.489 . . . . 2.84 109.679 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 122' ' ' TYR . . . -85.71 168.35 41.55 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.445 -0.883 . . . . 1.91 111.928 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -125.66 120.66 31.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.629 0.252 . . . . 3.31 110.657 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 82.8 mt -110.98 127.17 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.337 -0.616 . . . . 2.17 109.337 174.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.9 p -106.42 129.52 54.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.231 -0.441 . . . . 3.61 110.813 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.514 ' CE2' HD13 ' A' ' 120' ' ' LEU . 1.2 p90 -146.68 166.52 26.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.265 -0.643 . . . . 3.58 109.265 175.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.414 ' HG2' ' SG ' ' A' ' 117' ' ' CYS . 43.8 mt-10 -107.28 121.66 45.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.17 0.509 . . . . 5.1 111.18 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -116.36 114.1 23.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.454 -0.794 . . . . 5.11 109.069 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 64.84 21.01 12.28 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.978 0.511 . . . . 7.42 110.65 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.3 66.15 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.014 -0.539 . . . . 5.36 112.045 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -102.63 129.05 49.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.888 0.375 . . . . 5.38 110.887 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . 0.414 ' SG ' ' HG2' ' A' ' 112' ' ' GLU . 62.9 m -81.78 124.95 30.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.202 -0.454 . . . . 4.96 110.332 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -121.38 147.13 46.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.225 -0.443 . . . . 5.13 110.491 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.85 123.22 49.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 4.32 109.845 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.514 HD13 ' CE2' ' A' ' 111' ' ' TYR . 4.9 mp -105.38 134.88 19.46 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.262 -0.273 . . . . 3.17 110.262 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.57 133.15 11.48 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.966 2.444 . . . . 2.61 111.381 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.404 ' CE1' ' HA3' ' A' ' 107' ' ' GLY . 12.7 p90 -144.81 147.76 33.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.789 -0.448 . . . . 2.49 109.789 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.2 p -112.95 -179.94 3.79 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.845 -0.428 . . . . 3.18 109.845 173.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -72.76 -20.22 61.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.24 0.543 . . . . 5.22 110.867 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.77 -4.8 58.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.79 -0.641 . . . . 4.81 111.23 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -89.45 -13.5 37.45 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.138 0.494 . . . . 4.0 110.58 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 156' ' ' ILE . 2.8 p -110.48 116.19 51.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.716 0.769 . . . . 4.39 111.124 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.432 ' HB3' ' OE1' ' A' ' 26' ' ' GLU . 1.1 mp0 -99.72 179.02 4.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.786 -1.097 . . . . 6.43 109.997 177.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.55 -10.78 64.93 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.569 -0.824 . . . . 6.14 112.315 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 66.46 25.46 10.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.88 0.472 . . . . 6.26 111.388 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -103.55 140.93 20.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.635 -0.257 . . . . 5.62 110.866 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -97.51 129.14 44.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.064 0.459 . . . . 6.25 110.239 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.502 ' H ' HD22 ' A' ' 133' ' ' LEU . 2.6 pt? -115.33 149.56 37.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.859 -0.61 . . . . 3.62 110.075 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -124.23 174.44 7.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.16 0.505 . . . . 7.5 109.992 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.635 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.97 122.06 22.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.269 0.557 . . . . 4.12 111.442 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.04 -14.88 13.68 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.595 -0.812 . . . . 4.2 113.622 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -86.58 -177.55 6.18 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 117.901 0.85 . . . . 4.06 110.687 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -116.85 115.46 25.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.195 0.521 . . . . 4.48 111.815 -174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.86 162.36 15.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.633 -0.712 . . . . 2.98 110.985 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 45.8 t -126.37 129.47 48.87 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.612 -0.885 . . . . 3.68 108.612 177.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.0 146.99 50.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.071 0.462 . . . . 3.35 110.488 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -106.18 112.81 26.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.736 -0.665 . . . . 5.34 109.919 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.72 100.63 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.496 -0.775 . . . . 4.66 111.539 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -83.01 111.05 18.5 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.731 -0.47 . . . . 5.08 109.731 173.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 21.1 m -86.72 116.12 24.61 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.802 -0.635 . . . . 5.68 111.309 -174.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -74.44 166.14 24.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 6.25 110.398 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.1 -32.58 73.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 9.03 111.856 -173.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.566 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 3.3 tmt_? -76.23 -22.9 54.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 8.29 110.382 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.68 11.78 42.92 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.575 -0.821 . . . . 5.65 112.766 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -114.49 127.34 55.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.794 -0.239 . . . . 5.26 110.384 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -147.63 -176.92 5.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.094 0.474 . . . . 4.63 111.672 -173.684 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -139.27 -143.56 4.43 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.92 -0.872 . . . . 3.57 110.92 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.76 110.52 14.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.143 0.472 . . . . 2.84 109.963 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 45.6 t -122.78 162.14 22.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.563 -0.532 . . . . 4.34 109.563 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 56.56 37.87 29.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.162 0.506 . . . . 6.23 110.748 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.424 ' O ' HG21 ' A' ' 127' ' ' VAL . 69.5 mt -61.53 115.69 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.32 -0.855 . . . . 3.55 110.382 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 140' ' ' SER . 0.7 OUTLIER -111.56 143.84 41.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.979 0.418 . . . . 6.3 110.58 -176.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.4 tp -103.48 93.36 4.9 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.194 -0.669 . . . . 4.63 109.194 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.1 -28.4 15.1 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.739 -0.385 . . . . 4.97 110.958 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -114.86 84.02 10.0 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.451 -0.574 . . . . 5.57 109.451 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.93 158.75 18.37 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.943 2.429 . . . . 5.69 113.185 -174.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.74 -0.664 . . . . 6.1 110.174 176.336 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 N-CA-C 112.038 -0.425 . . . . 22.01 112.038 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.452 ' HA ' ' HG2' ' A' ' 5' ' ' GLU . . . 65.24 31.57 10.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.945 0.498 . . . . 20.23 111.948 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -76.94 -34.47 57.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.989 0.424 . . . . 18.59 110.18 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -152.8 91.78 1.59 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.764 -0.653 . . . . 17.11 109.953 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 5' ' ' GLU . 5.1 pt-20 -165.38 130.09 2.45 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.485 -0.78 . . . . 18.35 109.767 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -128.34 96.13 4.35 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.485 -0.78 . . . . 16.2 109.715 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -86.95 106.06 17.54 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.542 0.687 . . . . 12.72 109.409 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.5 ' HB3' ' HG2' ' A' ' 27' ' ' ARG . 42.7 mt-10 -120.26 143.52 48.27 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.771 -0.649 . . . . 11.63 110.356 -174.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -110.87 144.36 40.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.439 . . . . 9.47 111.05 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.78 172.63 31.84 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.363 -0.922 . . . . 7.73 112.15 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.0 mt -120.8 133.99 65.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 110.083 -0.34 . . . . 10.57 110.083 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.04 112.79 11.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.536 -0.542 . . . . 8.73 109.536 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.452 ' HB2' ' CG ' ' A' ' 23' ' ' GLN . 11.8 tp10 -91.54 -29.95 16.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.799 -0.637 . . . . 10.86 110.988 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -159.77 128.33 5.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.039 -0.528 . . . . 14.48 109.62 -175.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 mt -99.45 126.8 45.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.178 0.513 . . . . 11.73 111.17 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.06 179.26 4.32 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.232 -1.025 . . . . 11.9 108.232 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -91.09 112.53 24.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.503 -0.554 . . . . 16.67 109.503 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 t 70.28 23.85 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.332 -0.849 . . . . 13.28 110.564 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -164.67 151.57 11.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.98 -0.555 . . . . 12.68 109.656 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -162.19 165.37 35.94 Favored Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.349 -0.929 . . . . 7.92 112.669 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -117.18 134.13 55.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.686 0.279 . . . . 9.69 111.486 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 75.6 mt -106.37 122.84 60.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 7.75 110.058 174.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.452 ' CG ' ' HB2' ' A' ' 13' ' ' GLU . 6.5 mm100 -83.8 147.98 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.533 0.938 . . . . 12.4 113.533 -175.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.2 p -77.94 6.59 7.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.811 -1.54 . . . . 12.96 113.302 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -49.87 -48.66 51.19 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.584 0.587 . . . . 13.58 112.584 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.4 -3.51 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.735 -0.386 . . . . 12.19 112.005 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 28.4 tpt180 -152.48 139.38 19.03 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.991 -0.374 . . . . 12.99 109.991 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -73.03 49.81 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.984 0.364 . . . . 17.26 111.984 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.22 127.86 12.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.933 0.397 . . . . 12.1 111.201 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -108.66 102.31 11.38 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.312 -0.625 . . . . 13.0 109.312 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.442 HD12 ' CE1' ' A' ' 53' ' ' PHE . 71.1 mt -109.91 135.7 50.37 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.876 0.369 . . . . 9.21 111.332 -176.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -91.57 125.36 36.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.139 -0.689 . . . . 9.75 109.139 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -118.13 147.89 42.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.885 0.374 . . . . 6.85 110.518 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -99.08 158.88 15.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.208 -0.451 . . . . 10.15 109.939 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -70.83 -12.42 61.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.058 0.392 . . . . 10.56 112.058 -174.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -81.09 -13.3 58.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.31 0.576 . . . . 12.44 109.895 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -103.94 29.33 5.95 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.652 -0.704 . . . . 11.14 110.771 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -126.31 128.45 47.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.016 0.436 . . . . 8.78 110.949 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 t -101.36 115.65 31.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.716 -0.675 . . . . 9.11 110.818 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.65 -156.19 21.53 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.787 -0.72 . . . . 9.98 112.278 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -89.73 113.62 25.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.854 0.359 . . . . 12.91 110.621 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -68.11 -24.28 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.29 0.567 . . . . 11.97 109.921 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -81.51 -2.61 50.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.768 -0.651 . . . . 14.73 110.369 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -112.94 15.7 19.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.454 0.645 . . . . 13.3 109.716 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.8 tp -103.49 134.0 47.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.51 -0.922 . . . . 10.07 108.51 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -133.75 170.13 16.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.9 0.381 . . . . 13.53 111.116 -171.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.437 ' N ' HD13 ' A' ' 47' ' ' ILE . 3.0 mp -81.15 119.24 30.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.971 -0.559 . . . . 12.26 109.565 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.48 36.65 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.322 -0.711 . . . . 11.04 111.322 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.568 ' CG ' ' HZ1' ' A' ' 71' ' ' LYS . 14.7 t70 -92.93 127.26 48.27 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.442 -0.379 . . . . 8.39 110.143 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -89.31 128.91 1.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.062 2.508 . . . . 8.18 112.929 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.49 161.05 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.166 -0.47 . . . . 4.78 111.207 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.42 128.69 56.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.848 -0.614 . . . . 7.09 109.516 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.442 ' CE1' HD12 ' A' ' 31' ' ' LEU . 44.5 p90 -132.14 155.58 47.9 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.097 0.475 . . . . 7.82 111.204 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 38.1 tt0 -103.24 120.76 41.34 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.611 -0.722 . . . . 11.59 109.592 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.17 116.33 28.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.116 -0.493 . . . . 12.41 109.853 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 p -139.96 153.29 46.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.103 0.477 . . . . 13.93 111.73 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -92.86 108.95 20.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.964 -0.562 . . . . 16.22 109.944 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.496 ' OD2' HG23 ' A' ' 61' ' ' THR . 14.3 t70 -73.97 110.82 8.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.027 0.441 . . . . 16.64 109.835 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 59' ' ' ARG . 3.3 mmp_? -79.97 -7.2 58.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.059 -0.519 . . . . 23.23 111.2 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.448 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 54.3 ttt180 -70.86 -59.13 2.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 21.87 110.471 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.496 HG23 ' OD2' ' A' ' 58' ' ' ASP . 15.1 t -92.97 -19.26 21.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.25 -0.432 . . . . 17.49 110.44 178.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.57 31.54 15.71 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.856 -0.688 . . . . 17.22 112.492 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -132.63 149.28 72.58 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.036 -0.357 . . . . 14.83 110.036 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.52 126.79 8.51 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.079 1.853 . . . . 13.33 111.468 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.8 pt -130.65 168.75 22.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.321 0.581 . . . . 12.33 111.295 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.19 156.53 17.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.2 -0.909 . . . . 8.91 108.88 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.467 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 8.4 t -79.45 -150.9 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.399 -0.364 . . . . 10.33 110.101 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -8.87 51.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.649 0.611 . . . . 12.02 112.649 -172.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.2 t 55.88 99.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.471 0.653 . . . . 6.52 111.165 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 m -99.46 125.11 45.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.092 0.472 . . . . 6.18 111.12 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.568 ' HZ1' ' CG ' ' A' ' 49' ' ' ASP . 14.1 mmmt -60.16 135.77 57.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.788 -0.642 . . . . 6.59 109.744 172.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.72 113.3 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.775 0.321 . . . . 6.16 110.791 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 60.12 72.26 0.78 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 115.279 -0.873 . . . . 6.03 111.496 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -88.3 -61.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.802 2.335 . . . . 7.28 112.43 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -99.78 -7.39 25.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.312 0.577 . . . . 8.49 110.13 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.443 HG13 ' HB1' ' A' ' 144' ' ' ALA . 6.2 t -79.6 113.26 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.533 . . . . 6.19 110.41 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' A' ' 79' ' ' SER . 43.4 t -97.5 134.12 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.306 -0.406 . . . . 6.54 110.548 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -75.15 16.41 0.32 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.685 0.279 . . . . 6.46 111.504 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.449 ' H ' ' C ' ' A' ' 77' ' ' VAL . 8.3 t 66.53 -2.3 1.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.812 0.845 . . . . 7.24 111.842 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 62.58 13.76 6.53 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.274 0.63 . . . . 7.07 111.621 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -129.62 118.03 21.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.268 -0.424 . . . . 6.68 109.858 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -95.67 124.32 39.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.063 -0.517 . . . . 6.93 109.862 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.82 164.97 15.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.284 0.564 . . . . 4.0 111.452 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.8 p -125.88 148.28 49.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.292 -0.867 . . . . 3.84 109.774 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.09 161.09 25.54 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.224 -0.989 . . . . 2.58 112.37 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.7 m -102.24 125.61 49.0 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.408 -0.59 . . . . 3.7 109.408 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 51.0 t -68.11 126.23 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 110.189 -0.3 . . . . 3.14 110.189 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.3 p -113.7 -17.02 12.21 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.799 0.333 . . . . 3.77 111.844 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.2 m -150.95 135.03 16.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.282 -0.261 . . . . 3.29 110.597 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -100.0 171.22 7.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 4.39 110.508 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.47 ' N ' HD23 ' A' ' 91' ' ' LEU . 1.8 pt? -124.67 144.25 50.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.256 -0.646 . . . . 3.62 109.256 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 34.0 ptt85 -88.32 108.83 19.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.102 0.953 . . . . 7.76 112.006 -172.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.1 p -140.75 -154.07 0.5 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.466 -1.243 . . . . 5.1 107.739 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.24 43.25 14.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.183 0.516 . . . . 7.53 110.573 169.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.0 p -73.26 -163.91 0.17 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.818 -0.628 . . . . 7.77 110.486 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.35 6.29 34.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.944 -0.571 . . . . 8.0 111.125 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -155.15 -45.29 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.886 0.328 . . . . 8.83 111.886 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -109.43 156.38 20.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.023 0.439 . . . . 7.69 111.509 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.75 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 7.9 p -154.01 141.17 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.783 -0.644 . . . . 5.85 109.373 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.75 ' HG ' ' O ' ' A' ' 99' ' ' VAL . 3.9 pp 59.65 2.16 0.33 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.483 1.113 . . . . 7.65 112.909 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 99' ' ' VAL . 28.5 t-20 -66.77 -39.46 87.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.349 0.595 . . . . 8.21 110.0 178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.9 m -82.38 90.22 6.67 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.568 -0.742 . . . . 5.58 109.842 175.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.9 p -87.8 8.34 26.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.178 0.513 . . . . 4.8 110.795 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -96.68 14.62 24.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.896 -0.593 . . . . 5.09 110.463 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -122.94 139.88 53.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.615 -0.513 . . . . 3.7 109.615 176.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 t -146.87 143.31 28.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.402 -0.363 . . . . 2.84 110.748 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -97.61 -162.38 31.36 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.723 -0.751 . . . . 1.91 111.918 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 82.9 mmt-85 -140.15 135.15 32.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.99 0.424 . . . . 3.31 111.15 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.26 130.7 68.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.657 -0.701 . . . . 2.17 109.444 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.7 t -109.35 116.3 31.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.86 -0.422 . . . . 3.61 109.86 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -122.57 132.76 54.45 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.411 -0.589 . . . . 3.58 109.411 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -107.05 109.73 21.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.788 -0.642 . . . . 5.1 109.49 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -163.99 147.74 9.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.86 -0.609 . . . . 5.11 110.438 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 62.53 21.01 12.36 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.441 0.463 . . . . 7.42 111.714 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.52 -0.97 87.21 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.732 -0.746 . . . . 5.36 111.99 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -101.89 139.09 37.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.074 0.464 . . . . 5.38 110.589 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 13.8 p -139.47 106.18 5.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.501 -0.772 . . . . 4.96 109.997 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -155.69 162.16 40.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.376 -0.375 . . . . 5.13 110.537 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -95.22 133.75 38.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.646 -0.706 . . . . 4.32 110.584 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.6 mp -106.25 130.77 22.44 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.448 -0.342 . . . . 3.17 110.636 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.74 131.79 22.01 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.632 2.222 . . . . 2.61 111.246 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -138.78 145.39 40.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.978 0.418 . . . . 2.49 110.3 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 p -112.94 164.22 13.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.616 -0.72 . . . . 3.18 109.335 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -77.16 -20.06 56.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.885 0.328 . . . . 5.22 111.885 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.82 -13.83 61.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.897 0.332 . . . . 4.81 111.897 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.498 ' OD2' ' HA ' ' A' ' 154' ' ' CYS . 7.2 t70 -101.11 -0.44 36.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.511 0.672 . . . . 4.0 110.161 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.5 t -82.38 107.32 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.223 0.535 . . . . 4.39 110.374 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.4 145.84 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.992 -0.549 . . . . 6.43 110.774 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.5 -15.98 59.4 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.672 -0.775 . . . . 6.14 112.074 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 62.28 34.8 15.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.102 0.477 . . . . 6.26 110.911 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.3 m -79.98 174.71 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.038 -0.528 . . . . 5.62 110.663 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -127.84 81.35 2.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.295 0.569 . . . . 6.25 110.238 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.411 ' H ' HD22 ' A' ' 133' ' ' LEU . 2.3 pt? -68.44 148.91 49.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.207 -0.906 . . . . 3.62 111.09 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -133.21 139.81 47.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.287 -0.415 . . . . 7.5 109.961 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.595 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -55.62 121.32 8.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.164 0.506 . . . . 4.12 111.675 -173.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.65 -13.2 11.9 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.301 -0.863 . . . . 4.2 112.572 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -91.19 177.41 6.26 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.292 0.546 . . . . 4.06 109.864 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -116.97 116.58 27.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.089 0.471 . . . . 4.48 110.711 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.11 159.98 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.076 -0.511 . . . . 2.98 110.714 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.1 t -114.83 139.51 49.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.974 -0.75 . . . . 3.68 108.974 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -144.73 143.62 30.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.016 0.436 . . . . 3.35 110.149 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -98.95 119.2 37.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.579 -0.737 . . . . 5.34 109.937 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.8 mt -78.67 96.86 2.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.085 -0.507 . . . . 4.66 109.709 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.443 ' HB1' HG13 ' A' ' 76' ' ' VAL . . . -90.16 111.2 22.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.796 -0.638 . . . . 5.08 110.758 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 28.4 m -84.25 112.9 20.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.509 -0.769 . . . . 5.68 110.335 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.42 158.52 31.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.936 -0.574 . . . . 6.25 109.549 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -60.92 -20.27 61.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.99 0.424 . . . . 9.03 111.379 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 148' ' ' ARG . 2.7 mmt180 -78.26 -8.2 58.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 8.29 111.717 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.71 -1.96 84.48 Favored Glycine 0 C--O 1.227 -0.292 0 C-N-CA 120.824 -0.703 . . . . 5.65 112.328 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -100.4 132.4 45.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.902 -0.406 . . . . 5.26 109.902 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.47 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -150.76 178.78 8.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.534 -0.303 . . . . 4.63 110.847 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -150.36 -125.17 1.28 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.805 -0.918 . . . . 3.57 110.805 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -121.28 126.1 48.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.841 -0.429 . . . . 2.84 109.841 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.498 ' HA ' ' OD2' ' A' ' 126' ' ' ASP . 17.7 t -136.59 159.22 42.46 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.114 -0.328 . . . . 4.34 110.114 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 63.08 36.26 12.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.319 0.581 . . . . 6.23 110.558 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.8 mt -75.77 115.99 18.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.637 -0.711 . . . . 3.55 110.816 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -135.94 160.04 39.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.806 0.336 . . . . 6.3 110.165 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.9 tp -92.35 110.93 22.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 4.63 110.353 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -98.84 -57.55 2.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.782 -0.645 . . . . 4.97 110.686 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -111.17 96.63 31.39 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.244 -0.434 . . . . 5.57 110.022 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.14 158.25 23.45 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.233 1.956 . . . . 5.69 113.114 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -120.4 91.6 3.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.578 -0.737 . . . . 6.1 109.775 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -100.02 125.16 40.97 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.902 -0.59 . . . . 10.1 110.771 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.06 99.33 0.98 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.474 2.116 . . . . 8.39 112.001 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 115.853 -0.612 . . . . 10.65 110.637 178.673 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 111.783 -0.527 . . . . 22.01 111.783 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.1 -75.33 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.555 0.216 . . . . 20.23 110.454 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.21 -38.23 27.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.408 0.623 . . . . 18.59 109.667 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.4 65.94 8.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.619 -0.719 . . . . 17.11 109.886 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -85.39 -19.28 31.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.497 0.665 . . . . 18.35 110.329 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -83.01 84.98 7.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.297 -0.865 . . . . 16.2 110.738 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -85.73 129.2 34.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.998 0.428 . . . . 12.72 109.969 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.428 ' CD ' ' HE ' ' A' ' 27' ' ' ARG . 6.3 mm-40 -98.13 136.77 37.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.106 -0.497 . . . . 11.63 109.886 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.406 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 67.2 p -109.33 138.69 45.3 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 121.102 -0.239 . . . . 9.47 110.593 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA2' ' HB3' ' A' ' 26' ' ' GLU . . . -150.86 -176.03 23.38 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.147 -1.025 . . . . 7.73 112.45 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.0 mt -132.43 155.41 41.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.336 -0.987 . . . . 10.57 108.336 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.76 118.86 34.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.508 -0.477 . . . . 8.73 110.387 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.574 ' OE1' ' HD2' ' A' ' 30' ' ' ARG . 5.8 pt-20 -82.58 -32.59 28.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.376 -0.374 . . . . 10.86 111.089 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -159.19 158.15 32.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.28 -0.418 . . . . 14.48 109.899 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -125.44 118.16 25.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.107 -0.497 . . . . 11.73 110.984 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -105.57 178.95 4.41 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.488 -1.301 . . . . 11.9 107.488 172.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -92.1 138.46 31.52 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 119.917 -0.713 . . . . 16.67 109.986 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.3 p 74.62 -23.07 0.24 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.185 1.394 . . . . 13.28 112.032 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 49.5 p90 -151.8 158.59 43.5 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.872 0.368 . . . . 12.68 111.303 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.44 178.24 21.73 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.198 -0.761 . . . . 7.92 111.198 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -119.54 141.68 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.137 0.468 . . . . 9.69 111.542 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.418 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 67.4 mt -103.28 125.35 57.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.449 -0.796 . . . . 7.75 110.006 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 25.0 tt0 -80.59 134.77 35.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.439 -0.8 . . . . 12.4 111.833 -172.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 p -78.96 2.33 20.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.718 -1.128 . . . . 12.96 112.231 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.461 ' H ' ' HG2' ' A' ' 23' ' ' GLN . 49.2 t -60.17 -29.96 69.02 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.059 -0.4 . . . . 13.58 110.949 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 19.8 tp10 -103.99 -43.41 5.29 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.446 -0.343 . . . . 12.19 110.914 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.494 ' HG2' ' N ' ' A' ' 28' ' ' GLN . 28.5 ttt180 -95.09 155.48 16.71 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 110.16 -0.311 . . . . 12.99 110.16 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.494 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 87.2 mt-30 -77.62 20.06 0.34 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.282 0.475 . . . . 17.26 112.282 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.471 ' HB1' ' NH1' ' A' ' 27' ' ' ARG . . . -169.82 144.85 2.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.33 -0.395 . . . . 12.1 110.335 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.574 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 11.2 ttp180 -90.34 148.45 22.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 13.0 109.927 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -144.57 163.86 32.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.362 0.265 . . . . 9.21 110.676 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -121.1 149.3 42.96 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.953 -0.758 . . . . 9.75 108.953 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -138.98 153.38 48.16 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.852 -0.339 . . . . 6.85 110.237 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.503 ' HB2' ' OE1' ' A' ' 37' ' ' GLN . 67.1 m80 -98.6 159.51 14.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.98 -0.748 . . . . 10.15 108.98 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -70.27 -9.65 56.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.134 0.492 . . . . 10.56 110.979 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.1 m -75.13 -15.37 60.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.02 0.438 . . . . 12.44 110.162 174.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.503 ' OE1' ' HB2' ' A' ' 34' ' ' HIS . 25.3 mp0 -113.28 36.95 3.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.002 -0.545 . . . . 11.14 110.938 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -125.32 116.31 21.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.852 0.358 . . . . 8.78 110.13 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 68' ' ' GLN . 22.3 t -87.04 95.36 9.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.017 -0.538 . . . . 9.11 110.856 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.1 175.57 14.48 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.73 -0.668 . . . . 9.98 111.613 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.04 122.25 16.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.679 0.276 . . . . 12.91 110.353 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.6 tp -66.08 -18.81 24.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.227 0.537 . . . . 11.97 110.335 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.7 -25.71 65.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.686 . . . . 14.73 110.637 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -83.88 0.25 48.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 13.3 110.459 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.9 tp -104.04 123.01 46.45 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.051 0.453 . . . . 10.07 110.472 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 12.9 mmmm -120.17 162.29 19.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.612 -0.722 . . . . 13.53 110.225 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.5 mt -71.8 114.81 11.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.993 -0.548 . . . . 12.26 109.793 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.07 -4.12 28.63 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.905 -0.664 . . . . 11.04 111.679 -173.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -80.01 133.75 57.46 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-O 120.621 0.248 . . . . 8.39 110.41 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.6 142.03 7.93 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.168 2.578 . . . . 8.18 113.102 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.81 161.14 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.65 -0.705 . . . . 4.78 110.588 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.72 135.06 53.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.065 0.46 . . . . 7.09 109.801 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -144.78 158.3 43.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 7.82 110.985 -170.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 2.5 mp0 -97.98 122.6 41.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.385 -0.37 . . . . 11.59 110.546 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.446 ' HG2' ' NH2' ' A' ' 27' ' ' ARG . 14.6 tpt -88.41 107.89 19.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.481 -0.563 . . . . 12.41 109.481 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.6 p -132.75 165.67 24.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.903 0.382 . . . . 13.93 111.149 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -118.64 122.28 42.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.1 -0.704 . . . . 16.22 109.1 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -90.65 134.58 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.133 0.492 . . . . 16.64 111.654 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -79.94 -13.8 59.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.474 -0.785 . . . . 23.23 112.757 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -92.24 -43.29 9.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 21.87 111.107 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -86.7 -32.9 20.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.356 -0.384 . . . . 17.49 111.483 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.49 19.34 68.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.024 -0.608 . . . . 17.22 112.122 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -122.38 158.26 56.49 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.263 -0.273 . . . . 14.83 110.263 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.28 126.53 8.53 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.33 2.02 . . . . 13.33 110.616 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.09 154.34 35.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.925 0.393 . . . . 12.33 111.338 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -99.83 158.81 15.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.865 -0.607 . . . . 8.91 109.997 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 56.2 p -73.75 -150.04 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.16 0.505 . . . . 10.33 111.592 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 39' ' ' SER . 30.1 pt20 -70.95 -5.35 30.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.817 -0.628 . . . . 12.02 112.277 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.9 t 50.95 89.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.714 0.769 . . . . 6.52 111.219 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.6 m -90.61 135.94 33.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.762 -0.654 . . . . 6.18 111.16 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -72.6 123.15 22.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.054 -0.721 . . . . 6.59 109.054 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.5 mt -52.94 113.01 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.237 0 O-C-N 123.805 0.69 . . . . 6.16 111.845 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.63 141.66 42.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 6.03 109.893 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.62 139.36 33.93 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.656 2.237 . . . . 7.28 113.304 -176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -91.64 179.56 5.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.464 -0.789 . . . . 8.49 109.867 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.413 ' CG2' ' HB3' ' A' ' 144' ' ' ALA . 9.9 p -80.96 156.38 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.691 -0.485 . . . . 6.19 109.691 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 39.6 t -76.93 108.07 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.035 0.445 . . . . 6.54 111.369 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.1 mt -104.24 -48.72 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 6.46 111.289 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.515 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 66.2 m -99.72 86.94 3.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.312 0.486 . . . . 7.24 112.312 -175.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 79' ' ' SER . 0.9 OUTLIER -177.55 116.04 0.09 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.095 0.958 . . . . 7.07 108.809 174.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 66.34 64.36 0.51 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.813 0.816 . . . . 6.68 109.885 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 6.4 ptm180 -78.32 107.39 10.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.351 -0.841 . . . . 6.93 110.322 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.4 m -93.7 160.49 2.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.986 -0.552 . . . . 4.0 111.76 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 p -119.51 139.39 52.18 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.285 -0.871 . . . . 3.84 109.426 171.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.92 163.69 25.27 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.277 -0.963 . . . . 2.58 112.081 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.8 m -107.76 125.16 51.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.493 -0.558 . . . . 3.7 109.493 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 1.6 t -66.47 131.2 32.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.05 -0.722 . . . . 3.14 109.05 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.8 p -109.45 -16.54 13.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.052 0.453 . . . . 3.77 110.756 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.8 m -154.44 122.7 6.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.291 -0.413 . . . . 3.29 110.859 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 134' ' ' ARG . 4.7 mp0 -95.45 135.25 37.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.463 -0.335 . . . . 4.39 110.84 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.544 ' H ' HD23 ' A' ' 91' ' ' LEU . 1.7 pt? -82.99 76.4 9.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.706 1.241 . . . . 3.62 109.414 170.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -71.71 176.56 4.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.033 -1.439 . . . . 7.76 110.306 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.9 p -81.19 97.12 7.46 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.018 -0.734 . . . . 5.1 109.018 170.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -92.44 69.61 5.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.793 0.806 . . . . 7.53 110.458 -172.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 61.2 m -149.65 178.39 8.89 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.699 -1.137 . . . . 7.77 108.542 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 98' ' ' ASN . . . -75.75 76.98 2.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.502 0.191 . . . . 8.0 110.547 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 t30 74.44 -20.45 0.32 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.596 0.758 . . . . 8.83 111.903 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 95' ' ' SER . 18.9 m120 -83.8 168.81 15.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.149 0.5 . . . . 7.69 111.146 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 p -114.24 132.14 64.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.83 -0.623 . . . . 5.85 109.495 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.0 tp -158.11 -75.47 0.08 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.418 0.628 . . . . 7.65 112.097 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -77.85 19.68 0.39 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.186 -0.916 . . . . 8.21 112.405 -171.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.18 -0.18 53.77 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 111.961 0.356 . . . . 5.58 111.961 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.9 p -106.67 -32.91 7.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.881 0.372 . . . . 4.8 111.235 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.11 -25.61 55.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 5.09 110.905 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.519 HG21 ' HB2' ' A' ' 91' ' ' LEU . 4.8 t -95.85 160.47 14.46 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.977 -0.556 . . . . 3.7 109.641 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.4 m -134.28 134.51 41.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.542 -0.299 . . . . 2.84 110.373 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.86 168.9 54.91 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.896 -0.668 . . . . 1.91 112.257 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -128.81 122.6 30.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.808 0.337 . . . . 3.31 110.915 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 99.5 mt -112.17 127.67 69.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.773 -0.825 . . . . 2.17 108.773 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.7 t -111.53 125.8 54.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.8 0.333 . . . . 3.61 110.288 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.482 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 1.0 OUTLIER -129.41 145.81 51.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.171 -0.677 . . . . 3.58 109.171 178.177 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -118.2 112.37 20.05 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.255 -0.646 . . . . 5.1 109.255 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -126.78 108.65 11.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 5.11 110.476 -175.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 62.4 30.44 17.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.028 -0.533 . . . . 7.42 111.994 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.03 -0.47 60.49 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.962 -0.637 . . . . 5.36 113.95 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -108.71 137.64 46.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.667 0.733 . . . . 5.38 109.718 172.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 3.8 p -141.03 92.54 2.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.053 -0.521 . . . . 4.96 110.776 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -98.02 163.52 12.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.964 -0.562 . . . . 5.13 110.345 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -98.44 121.17 40.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.29 -0.633 . . . . 4.32 109.29 176.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.0 mt -103.86 130.34 23.61 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.157 -0.474 . . . . 3.17 110.934 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.54 141.61 17.76 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.709 2.273 . . . . 2.61 111.997 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -146.78 144.26 29.24 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.417 -0.586 . . . . 2.49 109.417 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 37.9 p -105.89 173.25 6.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.677 -0.49 . . . . 3.18 109.677 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -71.04 -19.48 62.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.394 0.616 . . . . 5.22 109.95 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -81.03 -10.8 59.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.02 -0.991 . . . . 4.81 111.43 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -87.88 -10.25 51.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.93 0.395 . . . . 4.0 110.711 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.6 t -87.09 120.3 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.826 -0.624 . . . . 4.39 110.825 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -106.45 153.86 21.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.677 -0.692 . . . . 6.43 110.222 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.75 -1.57 85.46 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.96 -0.638 . . . . 6.14 112.31 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 63.61 17.11 10.17 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.103 0.561 . . . . 6.26 111.066 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.15 147.94 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.117 0.484 . . . . 5.62 110.892 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.83 108.6 20.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.2 -0.454 . . . . 6.25 110.564 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.469 ' H ' HD22 ' A' ' 133' ' ' LEU . 2.5 pt? -106.36 150.36 26.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.862 -0.608 . . . . 3.62 110.169 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.5 ' HA ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -149.96 175.31 11.79 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.786 -0.365 . . . . 7.5 110.511 171.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.54 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -69.81 119.5 14.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.677 0.275 . . . . 4.12 111.087 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.89 -7.54 11.94 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.859 -0.686 . . . . 4.2 113.567 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -111.6 173.57 6.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.898 0.849 . . . . 4.06 110.584 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -110.93 116.41 31.18 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.173 0.511 . . . . 4.48 111.519 -173.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.35 157.49 18.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.634 -0.712 . . . . 2.98 110.906 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.427 ' HB2' ' CG ' ' A' ' 159' ' ' GLU . 8.0 t -119.2 134.44 55.2 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.02 -0.733 . . . . 3.68 109.02 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -132.73 144.91 50.61 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.892 0.377 . . . . 3.35 110.237 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -95.42 112.26 24.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.779 -0.646 . . . . 5.34 109.699 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 57.8 mt -79.25 96.1 2.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.83 -0.623 . . . . 4.66 110.222 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.692 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -81.54 108.23 14.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.189 -0.46 . . . . 5.08 110.516 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 m -85.16 110.36 18.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.037 0.446 . . . . 5.68 110.862 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -75.14 155.37 37.08 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.108 -0.701 . . . . 6.25 109.108 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -61.22 -23.42 65.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.939 0.348 . . . . 9.03 111.939 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -72.21 -23.88 61.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.997 0.427 . . . . 8.29 110.414 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 96.3 10.76 55.57 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.048 -0.596 . . . . 5.65 112.701 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.01 132.95 46.18 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.827 -0.435 . . . . 5.26 109.827 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.481 HD11 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -155.44 -178.45 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.857 -0.611 . . . . 4.63 110.887 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.96 -139.79 2.78 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.854 -0.898 . . . . 3.57 110.854 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.42 110.05 21.92 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.861 -0.422 . . . . 2.84 109.861 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 59.0 m -117.87 151.14 37.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.417 -0.356 . . . . 4.34 110.704 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 56.74 51.58 10.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.856 -0.611 . . . . 6.23 110.958 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.6 mp -66.54 115.72 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 3.55 110.364 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -114.21 157.91 22.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.165 -0.47 . . . . 6.3 109.98 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.2 tp -97.56 123.25 41.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.401 -0.363 . . . . 4.63 110.354 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.427 ' CG ' ' HB2' ' A' ' 140' ' ' SER . 21.3 mm-40 -102.33 -53.37 2.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.986 0.422 . . . . 4.97 111.192 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -136.34 102.62 9.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.187 -0.461 . . . . 5.57 110.75 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.89 160.9 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.418 2.079 . . . . 5.69 111.778 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.99 92.96 2.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.222 -0.444 . . . . 6.1 110.031 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -99.05 124.71 44.39 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.96 -0.564 . . . . 10.1 109.947 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.04 129.48 19.59 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.42 2.08 . . . . 8.39 111.549 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 116.411 -0.359 . . . . 10.65 111.04 178.587 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.42 0 N-CA-C 111.886 -0.486 . . . . 22.01 111.886 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.68 -12.55 60.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.913 0.387 . . . . 20.23 111.124 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -81.83 -14.78 55.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.217 0.532 . . . . 18.59 109.901 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.48 19.88 4.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 17.11 111.545 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -152.81 128.77 10.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.727 0.775 . . . . 18.35 110.411 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -133.51 137.02 45.41 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.611 -1.177 . . . . 16.2 109.043 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -91.22 117.4 29.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.375 0.607 . . . . 12.72 111.013 -177.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -100.74 144.81 29.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.635 -0.711 . . . . 11.63 110.003 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p -113.68 136.11 53.19 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.711 0.291 . . . . 9.47 110.962 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.38 177.01 28.73 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.546 -0.835 . . . . 7.73 112.622 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -128.82 140.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.255 -0.646 . . . . 10.57 109.255 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.57 118.09 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.837 -0.345 . . . . 8.73 110.64 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 22.3 tt0 -83.04 -44.93 14.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 10.86 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -157.82 137.01 11.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.44 -0.8 . . . . 14.48 109.83 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.0 mt -99.55 121.14 40.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.445 0.64 . . . . 11.73 111.306 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.29 -178.45 3.65 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.834 -1.075 . . . . 11.9 108.421 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -88.78 111.11 21.62 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.562 -0.455 . . . . 16.67 110.33 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.0 t 79.03 3.43 2.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.595 -1.184 . . . . 13.28 111.429 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -158.92 153.19 23.89 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 110.276 -0.268 . . . . 12.68 110.276 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.95 162.79 27.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.423 -0.894 . . . . 7.92 112.407 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -104.44 136.45 43.97 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.058 0.456 . . . . 9.69 110.968 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -103.64 127.71 57.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.651 -0.704 . . . . 7.75 110.384 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.438 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -71.77 141.81 49.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.215 -0.902 . . . . 12.4 111.644 -178.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.8 p -78.14 2.78 16.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.626 -1.17 . . . . 12.96 111.408 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.4 t -50.3 -39.33 45.36 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.659 0.614 . . . . 13.58 112.659 -170.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -105.55 7.53 32.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.045 0.387 . . . . 12.19 112.045 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.2 -159.37 1.02 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.806 0.336 . . . . 12.99 111.143 -176.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -120.66 22.41 11.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.689 0.28 . . . . 17.26 111.291 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.13 135.64 34.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.021 0.439 . . . . 12.1 111.458 -173.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -106.92 102.58 11.93 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.479 -0.934 . . . . 13.0 108.479 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -110.88 162.18 15.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.208 0.528 . . . . 9.21 111.379 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -126.25 139.41 53.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.381 -0.827 . . . . 9.75 109.333 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -132.59 152.37 51.65 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.053 -0.351 . . . . 6.85 110.053 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -91.98 161.4 14.82 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.204 -0.665 . . . . 10.15 109.204 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -71.71 -8.23 52.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 10.56 111.677 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -79.34 -12.21 59.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.368 0.604 . . . . 12.44 109.517 172.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -103.38 36.49 2.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.547 -0.751 . . . . 11.14 110.133 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -138.09 139.54 39.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.063 -0.347 . . . . 8.78 110.063 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t -121.69 119.48 31.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.25 -0.432 . . . . 9.11 110.552 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.57 -161.94 20.8 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.893 -0.67 . . . . 9.98 112.337 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -77.45 113.53 15.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.754 0.312 . . . . 12.91 110.836 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -72.35 -25.71 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.048 0.451 . . . . 11.97 110.911 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.71 -12.29 59.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.234 0.54 . . . . 14.73 110.332 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -89.17 -7.48 55.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 13.3 109.889 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.2 tp -93.17 124.79 37.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.593 -0.731 . . . . 10.07 109.944 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -132.12 178.26 6.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.028 0.442 . . . . 13.53 110.671 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.2 mp -73.8 129.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.946 -0.57 . . . . 12.26 109.745 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.65 -1.53 66.22 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.674 -0.774 . . . . 11.04 111.946 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.447 ' CG ' ' HZ1' ' A' ' 71' ' ' LYS . 22.3 t0 -91.34 123.32 64.41 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.823 -0.436 . . . . 8.39 109.823 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.97 142.98 32.12 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.985 2.457 . . . . 8.18 113.808 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.85 156.79 40.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.63 -0.714 . . . . 4.78 110.91 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -116.6 138.6 51.3 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.483 -0.562 . . . . 7.09 109.483 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -150.16 176.6 10.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.52 -0.309 . . . . 7.82 110.688 -177.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 26.7 mt-10 -118.88 132.86 56.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.22 -0.659 . . . . 11.59 109.22 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.5 tpt -93.59 113.85 26.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.001 -0.545 . . . . 12.41 109.64 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 p -135.8 138.45 42.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.587 0.588 . . . . 13.93 112.587 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -95.35 110.7 22.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.078 -0.51 . . . . 16.22 109.709 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.98 121.71 32.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.8 0.333 . . . . 16.64 111.076 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -79.23 -20.95 46.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 23.23 110.964 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' HE ' ' C ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -67.09 -53.86 26.91 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.392 -0.596 . . . . 21.87 109.392 -177.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.8 p -86.36 -29.69 22.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.149 -0.478 . . . . 17.49 111.172 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.86 31.74 28.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.729 -0.748 . . . . 17.22 111.81 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -135.12 141.34 37.73 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.133 -0.321 . . . . 14.83 110.133 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.22 125.31 10.71 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.809 1.673 . . . . 13.33 110.642 172.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.13 162.6 27.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.245 0.545 . . . . 12.33 111.816 -174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.42 173.41 6.77 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.453 -0.794 . . . . 8.91 110.779 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 22.7 t -87.26 -160.97 0.64 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.983 -0.553 . . . . 10.33 110.114 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -83.49 25.35 0.76 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.693 -0.23 . . . . 12.02 111.491 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 43.1 t 30.02 96.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.693 1.197 . . . . 6.52 113.713 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -91.83 141.93 28.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.231 0.539 . . . . 6.18 110.761 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.447 ' HZ1' ' CG ' ' A' ' 49' ' ' ASP . 0.6 OUTLIER -76.16 110.03 10.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.802 -0.635 . . . . 6.59 111.44 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.92 -70.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.498 -0.774 . . . . 6.16 110.372 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -165.06 99.41 0.81 Allowed Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-N 116.245 -0.434 . . . . 6.03 111.164 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.16 153.98 18.99 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.585 1.523 . . . . 7.28 109.838 167.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 146' ' ' ASN . 19.0 pt-20 -104.72 175.82 5.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.134 -0.627 . . . . 8.49 111.306 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.479 ' CG1' ' HB3' ' A' ' 144' ' ' ALA . 45.0 t 53.26 59.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 122.688 1.232 . . . . 6.19 109.246 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 t -88.34 114.73 27.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 113.831 -1.532 . . . . 6.54 110.649 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.67 -18.14 58.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.005 0.431 . . . . 6.46 110.317 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 t -95.5 52.49 1.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 7.24 110.694 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.47 -68.2 0.92 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.953 -0.567 . . . . 7.07 110.343 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -152.52 106.13 3.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.899 -0.591 . . . . 6.68 109.627 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -95.04 133.38 38.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.606 -0.516 . . . . 6.93 109.606 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.98 169.07 20.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.204 0.526 . . . . 4.0 111.202 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.4 p -118.7 144.57 46.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.496 -0.775 . . . . 3.84 109.502 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.45 170.2 23.99 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.076 -1.059 . . . . 2.58 112.268 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.9 m -121.74 132.06 54.42 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.833 -0.432 . . . . 3.7 109.833 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.6 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 48.8 t -65.25 126.34 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.322 -0.399 . . . . 3.14 110.501 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.0 p -111.19 -16.63 13.39 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.857 0.361 . . . . 3.77 111.199 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.8 m -153.65 130.33 10.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.237 -0.438 . . . . 3.29 109.916 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -176.86 3.2 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.274 0.359 . . . . 4.39 111.093 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.0 mt -87.24 162.69 17.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.97 0.414 . . . . 3.62 111.072 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -109.02 4.53 23.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.315 0.579 . . . . 7.76 110.729 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 38.8 p -94.21 175.43 6.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.419 -0.355 . . . . 5.1 111.183 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.404 ' CG ' ' HZ3' ' A' ' 124' ' ' LYS . 7.4 m-20 71.16 3.31 4.6 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.507 -0.769 . . . . 7.53 111.811 171.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.8 m -87.65 106.67 18.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.472 -0.331 . . . . 7.77 110.285 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 98' ' ' ASN . . . 55.89 64.67 1.66 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.233 -0.439 . . . . 8.0 111.329 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.45 0.9 0.07 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.97 1.308 . . . . 8.83 113.492 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 96' ' ' ALA . 12.8 m120 -82.76 83.1 7.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.438 0.637 . . . . 7.69 110.711 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.4 m -107.3 163.18 5.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.49 -0.777 . . . . 5.85 110.544 176.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.6 tp -146.64 111.71 5.4 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.503 -0.555 . . . . 7.65 109.503 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -53.65 -39.82 65.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.212 -0.904 . . . . 8.21 110.944 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.5 m -65.8 97.08 0.32 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.036 -0.529 . . . . 5.58 109.947 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.0 m -77.33 61.15 2.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.067 -0.515 . . . . 4.8 111.294 -176.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -91.16 -7.91 50.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.131 0.491 . . . . 5.09 110.731 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.1 t -90.58 118.34 29.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.074 -0.713 . . . . 3.7 109.074 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.11 125.51 44.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.429 -0.35 . . . . 2.84 110.721 -175.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -81.65 176.74 54.16 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.667 -0.778 . . . . 1.91 111.617 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -134.4 130.49 36.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 3.31 111.386 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.7 mt -112.57 129.11 68.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.458 -0.792 . . . . 2.17 108.961 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -107.28 132.74 52.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.616 0.246 . . . . 3.61 110.479 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.66 156.04 47.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.731 -0.84 . . . . 3.58 108.731 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.05 125.74 54.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.754 -0.462 . . . . 5.1 109.754 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.565 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 47.9 t30 -138.68 135.94 35.35 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.545 -0.909 . . . . 5.11 108.545 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 63.79 18.54 11.21 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.519 0.512 . . . . 7.42 111.8 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.33 3.73 78.2 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.668 -0.777 . . . . 5.36 112.171 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -123.11 141.29 52.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.111 0.482 . . . . 5.38 110.598 178.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 13.9 p -105.11 136.67 44.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.944 -0.571 . . . . 4.96 110.865 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -128.69 172.58 11.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.924 -0.58 . . . . 5.13 110.121 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.85 124.39 40.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.964 -0.562 . . . . 4.32 110.228 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 5.6 mp -104.36 131.45 21.88 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 110.18 -0.304 . . . . 3.17 110.18 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 3.6 Cg_exo -75.96 132.12 13.87 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.945 2.43 . . . . 2.61 111.55 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -138.5 153.42 48.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.067 0.46 . . . . 2.49 110.642 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.5 p -118.11 -175.16 2.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.878 -0.601 . . . . 3.18 110.121 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.425 ' HZ1' ' HB2' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -72.79 -17.65 61.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 5.22 110.651 177.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -82.82 -23.84 33.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.687 -0.688 . . . . 4.81 111.066 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -77.39 -26.09 51.46 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.281 -0.418 . . . . 4.0 111.364 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.83 116.22 47.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.646 0.736 . . . . 4.39 111.119 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.87 163.61 12.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.435 -0.802 . . . . 6.43 109.413 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.31 -9.52 30.99 Favored Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.69 -0.767 . . . . 6.14 112.521 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.1 t30 66.14 16.98 10.65 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.533 0.682 . . . . 6.26 110.655 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 t -78.12 120.35 28.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.808 -0.441 . . . . 5.62 109.808 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -81.57 119.56 23.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.934 0.397 . . . . 6.25 110.933 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 133' ' ' LEU . 1.8 pt? -115.56 149.24 38.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.424 -0.807 . . . . 3.62 110.679 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.588 ' HD2' ' OD1' ' A' ' 137' ' ' ASP . 0.0 OUTLIER -137.18 155.9 48.98 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.962 -0.755 . . . . 7.5 108.962 174.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.6 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -57.32 121.82 11.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.044 0.449 . . . . 4.12 110.835 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.26 -13.23 11.18 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.86 -0.686 . . . . 4.2 113.302 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.588 ' OD1' ' HD2' ' A' ' 134' ' ' ARG . 6.4 p30 -95.32 174.94 6.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.142 0.971 . . . . 4.06 110.216 172.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -110.17 122.27 47.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 4.48 111.381 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.28 150.68 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.018 -0.537 . . . . 2.98 110.929 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.6 t -120.92 133.83 55.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.113 -0.699 . . . . 3.68 109.113 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -137.37 143.26 41.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.021 0.438 . . . . 3.35 110.825 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -94.86 124.58 38.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.518 -0.764 . . . . 5.34 109.628 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.33 99.16 3.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.364 0.602 . . . . 4.66 110.582 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.479 ' HB3' ' CG1' ' A' ' 76' ' ' VAL . . . -89.79 109.32 20.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.196 -0.911 . . . . 5.08 110.867 -176.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.2 m -80.29 113.97 18.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.103 -0.498 . . . . 5.68 111.908 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.52 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 1.6 m120 -66.24 159.05 27.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.402 -0.363 . . . . 6.25 110.068 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -31.06 67.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.955 0.407 . . . . 9.03 111.263 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -77.04 -13.33 59.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.084 -0.507 . . . . 8.29 111.17 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.59 5.65 78.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.571 -0.823 . . . . 5.65 111.434 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.52 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 5.1 m-20 -107.92 120.99 43.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.325 . . . . 5.26 110.279 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.46 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.1 178.35 9.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.299 -0.41 . . . . 4.63 110.623 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -131.36 -112.96 1.5 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.455 -0.658 . . . . 3.57 111.455 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -123.11 137.3 54.95 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.526 -0.546 . . . . 2.84 109.526 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 84.1 m -139.81 156.57 46.67 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.2 -0.2 . . . . 4.34 110.896 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 57.46 44.42 21.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.881 0.738 . . . . 6.23 111.045 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.73 114.89 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.68 -0.691 . . . . 3.55 110.729 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -119.48 131.12 55.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.208 -0.451 . . . . 6.3 110.554 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.19 116.13 22.78 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.96 -0.756 . . . . 4.63 108.96 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -95.42 -43.99 7.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.76 0.281 . . . . 4.97 111.76 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -126.29 96.26 36.9 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 5.57 110.001 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.35 155.12 14.29 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.759 2.306 . . . . 5.69 113.4 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.54 104.76 14.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.632 -0.713 . . . . 6.1 109.822 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -151.97 161.04 30.57 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.241 -0.436 . . . . 10.1 110.813 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.52 124.15 12.05 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.368 2.045 . . . . 8.39 111.626 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 116.366 -0.379 . . . . 10.65 110.304 178.855 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 111.993 -0.443 . . . . 22.01 111.993 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.56 97.86 4.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.022 0.439 . . . . 20.23 110.794 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -103.53 -38.15 7.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.675 -0.693 . . . . 18.59 109.608 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 46.86 35.68 3.39 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.866 1.432 . . . . 17.11 114.866 166.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -77.97 -22.01 50.07 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.798 -0.564 . . . . 18.35 110.367 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -80.69 89.12 5.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.567 -0.742 . . . . 16.2 111.454 -176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -119.87 105.81 11.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.478 -0.783 . . . . 12.72 109.374 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.511 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 3.5 pt-20 -121.73 166.73 13.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 11.63 110.729 -173.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 80.6 p -108.44 156.84 18.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.479 0.548 . . . . 9.47 112.479 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.82 -173.38 30.41 Favored Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 110.839 -0.904 . . . . 7.73 110.839 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.424 HG13 ' HB2' ' A' ' 23' ' ' GLN . 12.6 pt -128.52 152.63 36.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 117.158 0.479 . . . . 10.57 110.327 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.07 127.33 28.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.76 0.314 . . . . 8.73 110.888 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.491 ' HG2' ' HG2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -68.95 -56.24 8.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.677 -0.692 . . . . 10.86 109.284 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -169.1 166.54 10.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.791 -1.095 . . . . 14.48 108.432 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -112.0 126.29 54.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.215 0.531 . . . . 11.73 111.521 -175.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 3.0 mm? -122.16 -179.02 4.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.946 -1.024 . . . . 11.9 108.598 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -88.71 124.57 34.24 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.007 -0.433 . . . . 16.67 110.114 -177.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m 78.39 -35.86 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.959 0.903 . . . . 13.28 112.169 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.467 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 17.5 p90 -131.79 151.57 51.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.45 . . . . 12.68 111.248 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.08 172.95 23.21 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.844 -0.903 . . . . 7.92 110.844 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -119.49 155.22 32.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.049 0.425 . . . . 9.69 110.742 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.7 mt -111.69 128.77 68.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.97 -0.559 . . . . 7.75 110.141 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.491 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 2.5 mm-40 -74.79 132.03 41.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.309 0.576 . . . . 12.4 111.525 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.2 p -80.6 1.61 29.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.161 -0.927 . . . . 12.96 111.861 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 70.9 m -52.77 -42.21 64.77 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.604 0.24 . . . . 13.58 111.621 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.88 -42.84 14.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.234 0.54 . . . . 12.19 111.148 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 8' ' ' GLU . 31.5 tpt180 -132.34 142.29 49.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.077 -0.51 . . . . 12.99 109.779 -174.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.92 52.69 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.285 0.476 . . . . 17.26 112.285 -175.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.78 101.74 2.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.906 0.384 . . . . 12.1 110.428 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -85.91 100.91 12.42 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.293 -1.003 . . . . 13.0 108.293 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.8 mt -110.8 163.42 13.8 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.497 -0.774 . . . . 9.21 111.457 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -115.12 135.31 54.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.02 -0.733 . . . . 9.75 109.02 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -132.89 136.05 45.95 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.767 -0.457 . . . . 6.85 109.767 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 73.2 m80 -84.92 164.4 18.37 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.467 -0.568 . . . . 10.15 109.467 178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -70.07 -10.23 58.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.951 0.405 . . . . 10.56 110.71 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.6 p -84.12 -9.04 58.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.007 -0.542 . . . . 12.44 110.077 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -108.73 26.63 10.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.515 -0.766 . . . . 11.14 110.339 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -130.68 130.02 43.35 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.688 -0.405 . . . . 8.78 110.087 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 m -93.35 107.79 19.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.725 -0.671 . . . . 9.11 110.493 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.74 -156.34 22.06 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.429 -0.891 . . . . 9.98 113.15 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 44' ' ' HIS . 1.0 OUTLIER -93.55 117.85 30.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.17 0.509 . . . . 12.91 111.803 -176.255 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.04 -22.63 10.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.492 -0.776 . . . . 11.97 110.319 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.95 -40.11 92.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.097 -0.501 . . . . 14.73 111.42 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.478 ' HB2' ' ND2' ' A' ' 41' ' ' ASN . 18.8 m80 -97.05 12.15 33.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.182 -0.463 . . . . 13.3 110.198 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.64 136.28 33.08 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.399 -0.593 . . . . 10.07 109.399 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.493 ' HE2' ' HB2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -130.41 157.49 42.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.241 0.544 . . . . 13.53 111.29 -174.167 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.6 mt -69.25 141.72 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.241 -0.89 . . . . 12.26 110.969 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.35 11.47 66.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.438 -0.886 . . . . 11.04 112.248 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.493 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 6.5 t70 -84.97 131.65 48.24 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.956 -0.143 . . . . 8.39 111.016 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.17 120.09 5.56 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.766 2.31 . . . . 8.18 112.864 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.458 HG11 ' HE3' ' A' ' 71' ' ' LYS . 27.8 m -128.45 162.45 35.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.893 -0.594 . . . . 4.78 110.451 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 1.2 pt-20 -113.22 139.57 48.68 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.369 -0.604 . . . . 7.09 109.369 173.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.511 ' CE1' ' HG3' ' A' ' 8' ' ' GLU . 31.2 p90 -132.08 139.58 48.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.714 0.768 . . . . 7.82 111.784 -177.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 39.1 tt0 -88.9 104.87 17.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.847 -1.069 . . . . 11.59 108.7 174.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 13.7 tpt -88.45 114.85 25.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.197 -0.456 . . . . 12.41 110.473 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.6 p -142.85 167.12 22.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.057 0.456 . . . . 13.93 111.283 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.462 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 73.6 m-85 -112.47 109.41 18.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.901 -0.59 . . . . 16.22 109.508 175.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.22 125.53 31.05 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.839 -0.345 . . . . 16.64 110.212 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -78.35 -17.92 55.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.413 -0.358 . . . . 23.23 111.664 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.7 tpt180 -77.8 -42.55 33.46 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.6 -0.44 . . . . 21.87 110.007 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.4 p -84.35 -33.59 23.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.023 -0.535 . . . . 17.49 110.597 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.53 24.72 62.3 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.763 -0.653 . . . . 17.22 112.11 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -126.63 148.1 63.33 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.974 -0.38 . . . . 14.83 109.974 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.462 ' HB3' ' CE1' ' A' ' 57' ' ' TYR . 43.1 Cg_endo -70.27 124.73 11.15 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 121.728 1.619 . . . . 13.33 109.807 169.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -139.77 151.17 22.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.88 0.848 . . . . 12.33 112.696 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.66 136.23 33.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.591 -1.186 . . . . 8.91 108.16 169.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.486 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 7.4 t -69.69 -150.16 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.984 0.421 . . . . 10.33 111.035 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -56.45 -18.89 12.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.322 0.86 . . . . 12.02 113.322 -175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.1 t 55.13 96.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.635 0.731 . . . . 6.52 111.136 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m -79.5 152.0 30.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.703 -0.681 . . . . 6.18 110.197 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.516 ' HE2' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -93.57 108.28 20.01 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.901 0.381 . . . . 6.59 110.52 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.516 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 65.5 mt -54.96 122.68 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 6.16 109.877 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -66.16 120.6 71.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 123.437 0.461 . . . . 6.03 110.051 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 25.4 Cg_exo -62.04 112.99 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.658 2.238 . . . . 7.28 112.605 -178.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -72.05 175.88 5.57 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.473 -0.936 . . . . 8.49 108.473 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.589 ' CG1' ' HB2' ' A' ' 144' ' ' ALA . 23.3 t -58.33 103.41 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.051 0.453 . . . . 6.19 110.08 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 67.5 t -72.77 97.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.557 -0.747 . . . . 6.54 111.34 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.01 -63.92 0.99 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.462 -0.57 . . . . 6.46 109.462 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.3 t -139.36 117.43 11.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.036 0.446 . . . . 7.24 110.615 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -159.39 -49.39 0.06 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.687 -0.688 . . . . 7.07 109.415 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -81.5 -172.98 4.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.641 -0.709 . . . . 6.68 109.947 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -166.83 71.41 0.12 Allowed 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.5 -0.555 . . . . 6.93 109.5 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.5 m -82.29 151.58 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.628 0.728 . . . . 4.0 111.027 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.5 p -117.65 139.74 50.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.313 -0.858 . . . . 3.84 109.976 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.51 154.02 25.24 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.209 -0.996 . . . . 2.58 112.642 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 39.9 m -109.6 136.1 49.51 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.68 -0.489 . . . . 3.7 109.68 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 46.9 t -68.58 118.43 12.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.83 0.348 . . . . 3.14 110.086 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.5 p -95.35 -27.89 15.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.027 0.441 . . . . 3.77 110.84 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 m -153.16 127.88 9.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.864 -0.607 . . . . 3.29 110.112 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.08 -171.37 2.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.409 -0.36 . . . . 4.39 110.402 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.62 126.91 29.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.331 -0.395 . . . . 3.62 110.668 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -65.74 133.0 50.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.148 -0.478 . . . . 7.76 110.897 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 t -118.17 143.09 46.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.456 0.646 . . . . 5.1 110.307 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -116.73 15.72 15.39 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.135 -0.939 . . . . 7.53 109.536 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.3 t -113.57 -179.85 3.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.341 -0.845 . . . . 7.77 109.884 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' A' ' 98' ' ' ASN . . . -86.2 88.28 7.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.662 0.267 . . . . 8.0 111.047 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 75.23 -34.01 0.25 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.488 -0.778 . . . . 8.83 111.718 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.414 ' H ' ' C ' ' A' ' 96' ' ' ALA . 84.0 m-20 -72.98 112.37 8.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.072 0.463 . . . . 7.69 110.425 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.4 m -79.96 95.48 2.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.216 0.531 . . . . 5.85 110.664 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.4 tp -137.33 90.09 2.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.883 0.849 . . . . 7.65 110.73 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -141.6 82.2 1.8 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.104 -1.407 . . . . 8.21 107.683 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.7 m -52.83 91.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.677 0.992 . . . . 5.58 113.677 -167.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.5 m 53.55 28.84 8.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.18 -0.918 . . . . 4.8 113.049 170.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -87.01 -20.28 27.46 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.596 -0.441 . . . . 5.09 110.488 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -135.45 156.4 48.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.06 -0.518 . . . . 3.7 110.345 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.6 t -112.92 153.92 27.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.849 -0.426 . . . . 2.84 109.849 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.66 -173.63 36.61 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.624 -0.59 . . . . 1.91 111.624 177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -133.82 126.13 29.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.992 0.425 . . . . 3.31 111.381 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.491 HG13 ' CE1' ' A' ' 122' ' ' TYR . 83.7 mt -112.12 129.02 68.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.004 -0.739 . . . . 2.17 109.004 171.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 t -105.23 117.8 34.92 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.831 -0.433 . . . . 3.61 109.831 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.595 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 11.2 p90 -119.47 150.81 39.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.207 -0.452 . . . . 3.58 109.945 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -111.95 123.45 50.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.113 -0.494 . . . . 5.1 110.592 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.513 ' OD1' ' HG3' ' A' ' 114' ' ' ARG . 49.9 t-20 -131.59 119.07 20.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.148 -0.686 . . . . 5.11 109.148 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.513 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 71.2 mtp180 63.2 21.41 12.83 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.199 -0.455 . . . . 7.42 111.223 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.36 -9.67 71.75 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.04 -0.6 . . . . 5.36 112.163 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -92.16 122.74 34.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.764 0.316 . . . . 5.38 110.247 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.04 123.05 38.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.318 -0.401 . . . . 4.96 110.272 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.595 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . 64.4 m-85 -120.92 151.15 40.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.531 -0.304 . . . . 5.13 110.634 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.28 126.43 52.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 4.32 110.709 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 mt -112.94 135.25 21.66 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.053 -0.521 . . . . 3.17 110.848 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.74 137.64 11.4 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.713 2.275 . . . . 2.61 111.799 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.491 ' CE1' HG13 ' A' ' 109' ' ' ILE . 26.8 p90 -146.04 155.23 42.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.37 . . . . 2.49 110.14 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.0 p -115.42 -178.96 3.5 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.693 -0.484 . . . . 3.18 109.693 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -71.71 -21.1 61.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.44 0.638 . . . . 5.22 110.31 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.35 -23.56 50.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.398 -0.819 . . . . 4.81 111.289 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -86.99 3.95 43.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.992 0.425 . . . . 4.0 111.316 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 131' ' ' VAL . 52.7 t -87.52 137.65 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.234 -0.439 . . . . 4.39 110.921 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -87.17 135.55 33.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.986 -0.552 . . . . 6.43 110.105 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.76 2.03 68.85 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.177 -0.535 . . . . 6.14 112.671 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 56.42 38.08 29.39 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.159 0.504 . . . . 6.26 111.574 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 127' ' ' VAL . 43.7 t -78.63 145.82 9.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.884 -0.598 . . . . 5.62 109.749 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -91.39 137.82 32.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.332 -0.248 . . . . 6.25 110.332 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.7 mp -114.31 149.57 35.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.663 0.602 . . . . 3.62 111.018 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -141.7 123.67 15.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.636 -0.505 . . . . 7.5 109.636 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.542 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -50.14 129.14 20.57 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.515 0.674 . . . . 4.12 112.101 -170.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.83 -15.79 11.21 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 114.981 -1.009 . . . . 4.2 111.797 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.508 ' OD1' HG13 ' A' ' 139' ' ' VAL . 2.4 p30 -85.4 169.25 13.86 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.397 -0.594 . . . . 4.06 109.397 173.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.469 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -123.1 116.8 24.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.071 0.462 . . . . 4.48 109.971 -177.273 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.508 HG13 ' OD1' ' A' ' 137' ' ' ASP . 30.2 m -116.0 179.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.516 0.674 . . . . 2.98 111.294 -173.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.9 m -143.12 145.76 33.14 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.367 -0.833 . . . . 3.68 109.086 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.38 172.53 12.65 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.127 -0.694 . . . . 3.35 109.127 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -112.76 136.89 51.85 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.399 0.437 . . . . 5.34 109.866 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.4 mt -106.72 101.66 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.98 0.419 . . . . 4.66 110.95 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.706 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -80.04 107.57 12.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.523 -0.547 . . . . 5.08 109.523 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.1 m -97.46 102.76 14.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.121 0.486 . . . . 5.68 110.747 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 148' ' ' ARG . 47.6 t30 -75.05 157.0 35.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.716 -0.846 . . . . 6.25 108.716 172.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.19 13.91 0.1 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.05 0.452 . . . . 9.03 112.049 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.471 ' NE ' ' HA ' ' A' ' 148' ' ' ARG . 5.0 mmp_? -110.05 -8.55 14.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.751 0.31 . . . . 8.29 110.207 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.73 20.98 77.82 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 116.009 -0.542 . . . . 5.65 112.374 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -112.29 111.49 22.4 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.905 -0.406 . . . . 5.26 109.905 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.3 179.94 8.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.128 0.49 . . . . 4.63 111.575 -177.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.85 -156.94 7.7 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.498 -1.041 . . . . 3.57 110.498 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.17 112.09 24.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.495 0.648 . . . . 2.84 109.491 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 24.2 m -103.87 140.03 38.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.123 -0.489 . . . . 4.34 111.242 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 52.43 61.39 3.22 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 123.848 0.718 . . . . 6.23 111.225 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.2 mt -78.78 125.65 38.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.643 -0.708 . . . . 3.55 110.225 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -126.93 145.54 50.64 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.748 -0.381 . . . . 6.3 110.588 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.484 ' HA ' HG11 ' A' ' 139' ' ' VAL . 55.4 tp -80.71 101.52 9.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 4.63 109.87 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.65 -53.96 5.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.566 . . . . 4.97 110.834 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -118.21 97.82 51.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 5.57 110.329 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.31 158.94 33.2 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.458 2.106 . . . . 5.69 112.164 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -110.23 126.18 53.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.198 -0.455 . . . . 6.1 110.206 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -132.8 104.47 12.94 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.801 -0.444 . . . . 10.1 109.801 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -86.21 161.56 9.95 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.949 2.433 . . . . 8.39 112.651 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.281 -0.418 . . . . 10.65 110.493 178.055 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 112.398 -0.281 . . . . 22.01 112.398 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.51 15.92 10.25 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.981 0.512 . . . . 20.23 111.64 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.07 -23.78 51.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.447 0.641 . . . . 18.59 109.622 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -87.77 29.08 0.94 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.265 -0.879 . . . . 17.11 110.859 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.18 -19.55 22.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.391 0.615 . . . . 18.35 110.632 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -79.28 106.76 11.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.612 -0.722 . . . . 16.2 110.648 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -100.84 121.62 42.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.609 -0.723 . . . . 12.72 110.422 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -93.34 136.88 33.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.515 -0.92 . . . . 11.63 108.515 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -118.39 140.6 49.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.48 -0.488 . . . . 9.47 111.463 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.72 -177.12 30.52 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.784 -0.722 . . . . 7.73 112.051 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.473 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 2.3 mt -124.97 143.36 38.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.809 -0.441 . . . . 10.57 109.809 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.53 116.15 11.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.414 -0.514 . . . . 8.73 109.675 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -88.47 -38.68 14.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 10.86 110.478 -176.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -153.79 140.62 19.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.619 -0.719 . . . . 14.48 109.591 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.4 mt -105.16 102.55 12.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.137 0.494 . . . . 11.73 110.591 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 mp -84.36 -178.34 6.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.053 -0.976 . . . . 11.9 109.307 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -89.69 108.73 19.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.864 0.364 . . . . 16.67 110.298 -173.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.5 m 67.57 22.31 9.2 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.251 -0.886 . . . . 13.28 110.983 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -160.52 141.21 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.628 -0.715 . . . . 12.68 109.429 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.14 157.33 21.62 Favored Glycine 0 C--N 1.322 -0.209 0 C-N-CA 120.471 -0.871 . . . . 7.92 113.094 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.0 129.19 55.01 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.108 0.163 . . . . 9.69 110.737 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.7 mt -112.59 126.92 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.846 0.355 . . . . 7.75 110.838 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 10.3 pt20 -85.38 145.73 27.34 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.145 0.498 . . . . 12.4 110.781 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 p -79.71 1.58 25.93 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.129 -0.942 . . . . 12.96 113.076 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.1 m -52.79 -24.87 9.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.932 1.086 . . . . 13.58 113.932 -170.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -99.37 10.59 41.11 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.123 0.416 . . . . 12.19 112.123 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -164.59 -158.97 0.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.438 -0.579 . . . . 12.99 109.438 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -123.37 24.37 8.71 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.162 0.506 . . . . 17.26 110.517 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.3 127.97 25.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.559 . . . . 12.1 111.125 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -96.2 119.42 34.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 13.0 110.147 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.66 162.46 18.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.407 0.622 . . . . 9.21 111.792 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -131.86 147.5 52.48 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.346 -0.983 . . . . 9.75 108.346 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -134.15 159.24 41.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.124 0.488 . . . . 6.85 111.204 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -98.84 154.77 17.77 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.994 -0.743 . . . . 10.15 108.994 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -68.86 -16.22 63.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.854 0.359 . . . . 10.56 110.786 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 t -78.36 -10.24 59.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.091 -0.504 . . . . 12.44 110.177 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -108.22 27.03 9.72 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.141 -0.482 . . . . 11.14 110.688 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -122.96 111.81 17.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.463 . . . . 8.78 110.376 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -89.15 111.66 22.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.089 0.471 . . . . 9.11 109.996 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.02 -151.01 23.04 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.988 -0.845 . . . . 9.98 110.988 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -107.22 120.71 42.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.808 0.304 . . . . 12.91 110.685 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -67.48 -19.63 25.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.601 0.715 . . . . 11.97 109.13 173.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.45 -32.44 70.23 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.803 -1.09 . . . . 14.73 110.688 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -109.65 21.24 17.21 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.584 -0.735 . . . . 13.3 111.092 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.8 tp -111.65 114.99 28.39 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.462 -0.57 . . . . 10.07 109.462 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -121.13 -179.27 3.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.008 0.433 . . . . 13.53 110.342 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 47' ' ' ILE . 3.5 mp -76.24 120.51 26.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.648 -0.501 . . . . 12.26 109.648 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.59 0.1 30.76 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.74 -0.743 . . . . 11.04 112.471 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.54 122.99 88.31 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.559 0.219 . . . . 8.39 110.895 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -83.58 126.25 4.04 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.609 2.206 . . . . 8.18 111.979 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.05 156.08 39.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.068 0.461 . . . . 4.78 111.065 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -119.48 126.77 52.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.698 -0.683 . . . . 7.09 109.26 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -132.21 166.81 21.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.349 0.595 . . . . 7.82 111.036 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.501 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 31.8 tt0 -101.32 109.66 21.54 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.645 -0.707 . . . . 11.59 109.272 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.68 109.13 19.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.281 -0.637 . . . . 12.41 109.281 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.7 p -131.6 175.28 9.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.052 0.453 . . . . 13.93 111.352 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.23 121.48 42.18 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.492 -0.558 . . . . 16.22 109.492 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -75.22 124.9 27.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.409 0.623 . . . . 16.64 110.659 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -79.33 -7.33 58.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.002 -0.999 . . . . 23.23 111.506 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -92.43 -55.12 3.52 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.957 -0.297 . . . . 21.87 111.17 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.9 p -86.46 -22.69 26.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 111.772 0.286 . . . . 17.49 111.772 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.68 32.34 54.37 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.559 -0.829 . . . . 17.22 111.66 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -121.15 147.55 47.04 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.303 -0.258 . . . . 14.83 110.303 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.69 126.16 11.18 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 121.949 1.766 . . . . 13.33 110.753 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.54 162.1 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.222 0.534 . . . . 12.33 111.304 -174.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.27 139.06 40.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.551 -0.749 . . . . 8.91 109.146 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 54' ' ' GLU . 17.6 m -70.0 -157.13 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.084 -0.507 . . . . 10.33 110.762 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -75.68 27.86 0.11 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.326 1.232 . . . . 12.02 114.326 -168.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.2 t 21.31 101.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 125.079 1.352 . . . . 6.52 114.582 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.4 m -107.67 143.3 36.35 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.106 -0.497 . . . . 6.18 110.096 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.56 142.33 51.77 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.165 -0.68 . . . . 6.59 109.165 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.6 mt -54.87 118.28 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.112 0.482 . . . . 6.16 111.137 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.75 162.42 21.21 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.451 -0.795 . . . . 6.03 110.749 -175.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -62.66 156.14 54.68 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.546 2.164 . . . . 7.28 112.599 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.501 ' HG2' ' H ' ' A' ' 76' ' ' VAL . 28.5 tt0 -85.42 -178.44 6.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.707 -0.679 . . . . 8.49 110.034 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.501 ' H ' ' HG2' ' A' ' 75' ' ' GLU . 30.9 t -59.12 149.21 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.018 0.437 . . . . 6.19 111.434 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.59 111.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 6.54 111.244 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.437 ' N ' HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -118.91 16.38 13.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 6.46 110.921 176.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 m -114.06 60.53 0.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.856 0.36 . . . . 7.24 111.516 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -117.11 -34.63 4.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.716 0.293 . . . . 7.07 110.834 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -168.1 147.85 4.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 6.68 110.191 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -105.23 115.49 30.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 6.93 110.413 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.04 159.44 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.2 -0.454 . . . . 4.0 110.452 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 p -110.46 139.66 45.46 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.127 -0.488 . . . . 3.84 110.13 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.48 163.43 23.19 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.231 -0.985 . . . . 2.58 112.443 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.2 m -122.44 129.04 51.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.771 -0.455 . . . . 3.7 109.771 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 90.4 t -69.27 126.16 28.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.416 -0.356 . . . . 3.14 110.665 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 p -105.82 -19.92 13.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.237 0.541 . . . . 3.77 110.63 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.5 m -149.9 129.42 13.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 3.29 110.198 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.13 -178.27 3.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.737 0.303 . . . . 4.39 110.71 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -64.17 138.91 58.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.777 -0.647 . . . . 3.62 109.649 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -65.67 116.43 6.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.436 0.636 . . . . 7.76 111.465 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 p -135.92 104.81 5.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.246 -0.888 . . . . 5.1 110.042 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.49 -82.97 0.11 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.274 -0.421 . . . . 7.53 111.204 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.426 ' C ' ' H ' ' A' ' 97' ' ' ASN . 13.9 m -91.46 158.85 16.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.59 -0.277 . . . . 7.77 110.266 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.85 40.58 0.25 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.387 0.613 . . . . 8.0 110.869 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 95' ' ' SER . 25.2 t-20 -145.39 -25.1 0.47 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.316 -0.857 . . . . 8.83 109.82 -175.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -114.06 107.36 15.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 7.69 110.289 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.98 99.71 4.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.852 -0.613 . . . . 5.85 109.471 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.7 tp -110.29 92.94 4.25 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.706 0.765 . . . . 7.65 109.988 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.16 70.08 10.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.593 -1.185 . . . . 8.21 109.403 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.543 ' OG ' ' HG2' ' A' ' 104' ' ' GLU . 42.5 p -104.62 168.36 9.13 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.589 -1.187 . . . . 5.58 109.949 174.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.7 p -80.32 9.14 6.16 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.132 0.419 . . . . 4.8 112.132 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.543 ' HG2' ' OG ' ' A' ' 102' ' ' SER . 9.2 pt-20 -84.98 -22.21 29.23 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.047 0.451 . . . . 5.09 110.305 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.7 t -105.38 136.65 44.53 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.153 -0.684 . . . . 3.7 109.153 177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.5 m -145.28 130.2 18.27 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.993 -0.373 . . . . 2.84 109.993 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.64 169.71 49.3 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.656 -0.783 . . . . 1.91 112.183 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -129.61 133.64 47.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.918 0.39 . . . . 3.31 110.892 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 64.9 mt -111.8 126.48 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.6 -0.727 . . . . 2.17 109.89 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.8 p -98.07 119.18 36.26 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.9 -0.407 . . . . 3.61 109.9 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -127.4 153.69 45.93 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.639 -0.504 . . . . 3.58 109.639 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.95 120.61 38.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.246 -0.433 . . . . 5.1 110.35 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -146.72 137.81 24.14 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.058 -0.719 . . . . 5.11 109.058 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 64.08 20.89 12.39 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.867 0.365 . . . . 7.42 110.364 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.83 -8.15 63.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.202 -0.523 . . . . 5.36 112.366 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -100.68 138.84 37.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.893 -0.41 . . . . 5.38 109.893 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 1.3 p -108.2 121.58 45.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.046 0.451 . . . . 4.96 110.837 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -115.73 164.83 13.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.927 -0.579 . . . . 5.13 110.652 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 96.0 m-85 -119.39 119.3 33.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.01 -0.541 . . . . 4.32 110.397 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 153' ' ' ALA . 4.1 mm? -105.42 143.37 26.64 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.336 -0.393 . . . . 3.17 110.626 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.98 146.93 9.14 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.126 2.551 . . . . 2.61 112.066 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -153.75 151.78 29.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.102 0.477 . . . . 2.49 111.366 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.73 162.17 23.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.453 -0.794 . . . . 3.18 109.38 172.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.94 -30.57 71.66 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.005 0.431 . . . . 5.22 111.204 -175.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.43 -20.42 66.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.076 -0.511 . . . . 4.81 111.871 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -104.22 13.81 31.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.147 0.499 . . . . 4.0 110.638 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.06 128.45 41.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 4.39 110.792 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.411 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 1.4 tm-20 -94.93 145.62 24.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.939 -0.763 . . . . 6.43 108.939 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.01 -17.18 58.77 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.754 -0.736 . . . . 6.14 112.039 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 61.25 24.2 14.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.514 0.673 . . . . 6.26 110.671 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.6 t -90.81 137.71 21.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.065 -0.516 . . . . 5.62 110.284 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -79.08 102.53 8.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 6.25 110.314 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.501 ' H ' HD22 ' A' ' 133' ' ' LEU . 2.6 pt? -88.6 148.85 23.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 3.62 110.605 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -133.13 171.5 13.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.11 -0.495 . . . . 7.5 109.809 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.572 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.96 118.9 17.47 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.095 -0.502 . . . . 4.12 110.581 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.93 -20.42 9.91 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.666 -0.697 . . . . 4.2 113.195 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.93 166.18 12.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.898 0.849 . . . . 4.06 110.634 175.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -98.58 122.96 42.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.732 0.777 . . . . 4.48 111.976 -170.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.33 157.94 24.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.678 -1.146 . . . . 2.98 110.125 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.4 m -126.23 141.07 52.07 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.913 -0.773 . . . . 3.68 108.913 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -135.37 149.59 49.72 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.953 0.406 . . . . 3.35 110.26 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -100.59 115.05 29.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.739 -0.664 . . . . 5.34 110.497 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 64.7 mt -78.05 110.31 13.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.603 -0.726 . . . . 4.66 110.375 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -90.26 110.45 21.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.854 -0.612 . . . . 5.08 110.427 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 40.2 m -80.6 103.15 10.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.682 -0.69 . . . . 5.68 110.352 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -67.69 163.38 21.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.1 -0.5 . . . . 6.25 111.043 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.39 -18.32 65.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 9.03 111.663 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -100.03 6.85 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.118 0.485 . . . . 8.29 110.235 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.61 18.2 75.45 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.868 -0.605 . . . . 5.65 113.98 172.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -122.33 129.9 52.6 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.404 -0.591 . . . . 5.26 109.404 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.446 ' N ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.31 179.37 8.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.906 0.384 . . . . 4.63 111.685 -175.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -131.38 -112.43 1.45 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.839 -0.904 . . . . 3.57 110.839 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' A' ' 120' ' ' LEU . . . -135.41 129.68 33.68 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.109 -0.33 . . . . 2.84 110.109 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 82.6 m -128.14 150.16 50.11 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.87 -0.419 . . . . 4.34 109.87 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 57.65 58.08 3.92 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.438 0.461 . . . . 6.23 111.333 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.8 mp -74.57 113.61 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.346 -0.983 . . . . 3.55 108.346 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.411 ' HD2' ' OE2' ' A' ' 128' ' ' GLU . 26.4 ttt180 -129.2 131.14 47.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.977 0.418 . . . . 6.3 110.864 -173.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 133' ' ' LEU . 6.4 tt -83.42 115.82 22.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.338 -0.616 . . . . 4.63 109.338 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -105.89 -26.92 11.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.086 -0.506 . . . . 4.97 111.485 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.12 107.03 5.26 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.792 0.33 . . . . 5.57 110.7 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.42 161.66 17.22 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.843 2.362 . . . . 5.69 113.522 -175.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -126.55 138.58 53.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.411 -0.813 . . . . 6.1 109.314 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 61.35 81.27 0.24 Allowed Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 123.634 0.584 . . . . 10.1 111.389 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.58 95.79 1.08 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.572 2.181 . . . . 8.39 112.085 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 116.296 -0.411 . . . . 10.65 110.999 -177.191 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 111.864 -0.495 . . . . 22.01 111.864 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.46 112.21 23.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.746 0.308 . . . . 20.23 110.457 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.92 -51.78 2.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.246 0.546 . . . . 18.59 110.021 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.85 79.19 5.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.985 -1.007 . . . . 17.11 108.985 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -90.96 -71.57 0.62 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.063 -0.972 . . . . 18.35 113.185 -171.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 41.4 mt-10 -92.5 95.47 9.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.352 -0.84 . . . . 16.2 111.603 -169.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.508 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 19.2 ptt180 -85.76 138.74 31.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.231 -0.895 . . . . 12.72 111.563 -177.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.403 ' CD ' HH22 ' A' ' 27' ' ' ARG . 4.9 mm-40 -109.63 137.04 48.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.298 -0.865 . . . . 11.63 110.249 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 p -105.48 141.7 36.5 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.458 -0.337 . . . . 9.47 111.383 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.29 178.85 39.44 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.583 -0.607 . . . . 7.73 111.583 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.3 pt -121.19 149.95 24.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.824 0.312 . . . . 10.57 110.617 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.7 mm -67.69 122.24 18.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.377 -0.374 . . . . 8.73 110.514 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 47' ' ' ILE . 33.5 tt0 -78.13 -51.16 10.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.749 0.309 . . . . 10.86 110.392 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -152.72 171.7 17.82 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.023 -0.535 . . . . 14.48 110.444 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.7 mt -127.59 99.53 5.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.6 -0.727 . . . . 11.73 110.628 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.2 mp -97.05 -179.9 4.7 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.286 -1.005 . . . . 11.9 108.286 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -91.19 131.9 36.43 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.506 -0.478 . . . . 16.67 110.293 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.3 t 76.24 -22.68 0.26 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.991 0.916 . . . . 13.28 112.196 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -152.27 162.89 40.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 12.68 111.26 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.99 -172.87 19.18 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.796 -0.521 . . . . 7.92 111.796 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.23 149.49 52.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.781 0.324 . . . . 9.69 110.931 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.1 mt -113.89 126.85 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.826 -0.625 . . . . 7.75 109.553 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.14 136.95 35.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.4 0.619 . . . . 12.4 111.561 -172.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 p -81.94 -0.59 44.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.999 -1.0 . . . . 12.96 112.887 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.4 m -53.6 -37.22 62.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.194 0.452 . . . . 13.58 112.035 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.53 20.32 13.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 12.19 111.476 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.438 HH21 ' HB3' ' A' ' 29' ' ' ALA . 7.1 ptm85 -163.16 -160.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.422 -0.174 . . . . 12.99 111.096 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -124.8 20.08 8.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.826 0.346 . . . . 17.26 111.223 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB3' HH21 ' A' ' 27' ' ' ARG . . . -146.13 122.46 10.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.392 -0.367 . . . . 12.1 111.692 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 30' ' ' ARG . 11.8 ptt180 -85.97 130.74 34.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.428 -0.953 . . . . 13.0 108.428 171.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.1 tp -141.64 158.6 43.62 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.689 -0.404 . . . . 9.21 110.777 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -113.99 149.92 34.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.141 -0.481 . . . . 9.75 109.831 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -136.49 155.39 50.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.006 -0.368 . . . . 6.85 110.006 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -110.73 150.25 29.33 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.691 -0.485 . . . . 10.15 109.691 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -63.93 -19.25 64.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.379 -0.373 . . . . 10.56 111.6 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -70.34 -24.07 62.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 12.44 111.129 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.88 40.1 1.72 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.026 -0.533 . . . . 11.14 110.525 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -120.5 129.8 53.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.336 -0.393 . . . . 8.78 110.393 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.3 m -97.7 104.78 16.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.263 -0.426 . . . . 9.11 110.349 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.89 -172.42 23.67 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.754 -0.736 . . . . 9.98 111.525 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -95.4 115.94 28.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.482 0.658 . . . . 12.91 110.3 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.63 -23.95 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.391 -0.822 . . . . 11.97 112.537 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -67.7 -21.19 65.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 14.73 111.329 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -99.62 9.07 43.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.766 0.317 . . . . 13.3 110.928 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.3 tp -94.17 130.75 40.27 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.242 -0.651 . . . . 10.07 109.242 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -122.92 172.98 8.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.96 0.409 . . . . 13.53 110.546 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.41 ' N ' HD13 ' A' ' 47' ' ' ILE . 3.5 mp -81.79 128.44 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.756 -0.656 . . . . 12.26 109.397 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.47 0.58 67.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.687 -0.768 . . . . 11.04 112.119 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.502 ' CG ' ' HZ1' ' A' ' 71' ' ' LYS . 31.9 t70 -80.4 129.97 67.1 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.192 . . . . 8.39 110.743 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.22 127.43 12.7 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.938 2.426 . . . . 8.18 113.032 -178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.79 154.47 34.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 4.78 110.88 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.508 ' OE1' ' HD2' ' A' ' 7' ' ' ARG . 37.3 tt0 -112.77 124.19 52.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.185 -0.461 . . . . 7.09 109.899 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -142.3 151.27 41.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.394 -0.366 . . . . 7.82 110.679 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 33.0 tt0 -104.4 130.49 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.313 -0.625 . . . . 11.59 109.313 174.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 14.7 tpt -83.19 114.68 21.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.25 -0.432 . . . . 12.41 109.853 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.5 p -133.2 170.96 14.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.371 0.605 . . . . 13.93 111.927 -173.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -132.37 115.06 15.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.018 -0.734 . . . . 16.22 109.018 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -80.5 116.5 20.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.767 -0.457 . . . . 16.64 109.767 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.71 -7.05 57.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.57 . . . . 23.23 111.947 -173.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.07 -37.92 9.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.203 -0.453 . . . . 21.87 110.913 -175.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 p -87.69 -34.09 18.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.89 0.376 . . . . 17.49 110.924 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.54 8.58 63.88 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.503 -0.856 . . . . 17.22 112.178 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -106.45 145.51 31.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 122.893 -0.181 . . . . 14.83 110.804 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.48 125.02 5.48 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.8 1.667 . . . . 13.33 110.433 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.31 157.49 24.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.272 0.558 . . . . 12.33 111.21 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.0 157.79 16.6 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.742 -0.663 . . . . 8.91 109.556 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 69' ' ' VAL . 23.0 t -65.3 -166.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.177 -0.465 . . . . 10.33 110.148 176.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -73.94 19.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.535 0.568 . . . . 12.02 112.535 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 67' ' ' SER . 42.0 t 32.87 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.421 1.089 . . . . 6.52 113.193 176.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.8 m -88.4 136.45 32.98 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.113 0.482 . . . . 6.18 110.114 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.502 ' HZ1' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -73.97 119.7 18.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.149 -0.478 . . . . 6.59 110.344 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.41 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 65.4 mt -57.17 108.56 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.951 -0.568 . . . . 6.16 109.77 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.15 165.11 55.62 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.357 -0.838 . . . . 6.03 110.21 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.74 107.66 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.373 2.049 . . . . 7.28 112.147 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -85.73 -163.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.375 -0.83 . . . . 8.49 110.584 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.09 139.09 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.763 -0.828 . . . . 6.19 108.763 172.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.73 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 39.0 t -68.13 89.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.419 . . . . 6.54 110.394 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 144' ' ' ALA . 1.5 tt -91.43 -8.7 47.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.153 -0.931 . . . . 6.46 110.782 -173.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.3 t -140.89 103.59 4.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.049 -0.523 . . . . 7.24 110.479 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.65 -59.77 1.96 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.553 -0.906 . . . . 7.07 108.553 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -135.97 119.73 17.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.912 -1.04 . . . . 6.68 108.51 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -79.77 107.85 12.87 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.695 -0.483 . . . . 6.93 109.695 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.49 179.3 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 4.0 111.571 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 138' ' ' LYS . 37.4 p -121.55 165.16 16.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.445 -0.798 . . . . 3.84 108.853 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.18 145.1 15.47 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.136 -1.03 . . . . 2.58 113.002 -177.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 m -108.05 127.91 54.21 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.606 -0.516 . . . . 3.7 109.606 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.585 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -74.83 124.89 33.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.096 -0.335 . . . . 3.14 110.096 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 p -104.29 -22.41 13.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.119 0.485 . . . . 3.77 110.65 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.4 m -136.66 126.46 25.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.959 -0.564 . . . . 3.29 110.634 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -84.09 -176.73 6.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 4.39 110.709 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.8 mt -102.31 -178.6 3.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.876 -0.787 . . . . 3.62 108.876 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.5 ptt180 -129.39 175.27 8.89 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.247 -0.649 . . . . 7.76 109.247 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 6.8 p -125.42 -13.41 6.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.054 0.454 . . . . 5.1 111.118 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 93' ' ' THR . 1.9 m-20 73.65 -56.66 0.65 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.307 -1.315 . . . . 7.53 110.209 -175.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 98' ' ' ASN . 47.6 t -100.56 155.64 17.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.421 -0.585 . . . . 7.77 109.421 174.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.55 -36.02 38.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.642 0.258 . . . . 8.0 111.392 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -110.59 -1.64 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.562 0.696 . . . . 8.83 110.94 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 95' ' ' SER . 9.1 m120 -130.87 142.02 50.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.619 -0.511 . . . . 7.69 109.619 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.93 127.42 72.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.082 0.468 . . . . 5.85 110.525 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.5 tp -150.94 98.38 2.58 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.381 -0.6 . . . . 7.65 109.381 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.501 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 19.2 m120 -131.43 -62.8 0.86 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.794 -0.639 . . . . 8.21 112.141 -173.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 101' ' ' ASN . 71.6 m 66.05 24.38 11.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.255 0.55 . . . . 5.58 109.784 -171.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.0 m 59.49 52.82 5.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.084 -0.962 . . . . 4.8 111.051 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.501 ' OE1' ' HA ' ' A' ' 101' ' ' ASN . 0.2 OUTLIER -79.63 -35.77 38.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.393 0.616 . . . . 5.09 109.586 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -98.96 167.42 10.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.296 -0.866 . . . . 3.7 109.414 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.3 m -137.39 135.44 36.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.051 0.453 . . . . 2.84 110.532 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.48 176.98 48.5 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.777 -0.725 . . . . 1.91 111.92 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -129.89 127.37 40.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.884 0.373 . . . . 3.31 111.256 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.4 mt -112.3 127.06 69.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.872 -0.604 . . . . 2.17 109.441 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.9 p -102.54 132.87 48.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.618 -0.264 . . . . 3.61 110.868 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.425 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -145.14 160.69 41.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.661 -0.496 . . . . 3.58 109.661 175.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -117.04 124.33 49.04 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.501 -0.555 . . . . 5.1 109.501 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -137.65 112.43 8.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 5.11 110.456 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 66.08 21.82 11.18 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.495 -0.32 . . . . 7.42 111.756 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.56 -1.22 68.77 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.675 -0.774 . . . . 5.36 111.7 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.476 ' HB3' ' CE2' ' A' ' 118' ' ' PHE . 69.8 mm-40 -96.85 128.75 44.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.9 -0.407 . . . . 5.38 109.9 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 84.9 m -118.16 101.44 8.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.124 -0.489 . . . . 4.96 110.293 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.476 ' CE2' ' HB3' ' A' ' 116' ' ' GLU . 62.5 m-85 -116.79 155.0 29.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.168 0.508 . . . . 5.13 111.099 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -107.75 118.58 37.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.786 -0.82 . . . . 4.32 108.786 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.425 HD11 ' CE2' ' A' ' 111' ' ' TYR . 5.5 mp -102.42 137.89 19.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 120.875 -0.33 . . . . 3.17 110.66 -173.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.88 134.45 18.05 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.743 2.295 . . . . 2.61 112.115 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -137.09 151.22 48.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.175 -0.466 . . . . 2.49 109.797 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.3 p -116.72 178.77 4.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.419 -0.355 . . . . 3.18 110.137 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -69.91 -19.71 63.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.388 0.613 . . . . 5.22 110.167 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -78.98 -9.87 59.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.456 -0.793 . . . . 4.81 111.42 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -93.34 -14.55 26.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.411 -0.359 . . . . 4.0 111.873 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.426 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 7.6 p -103.98 137.68 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.183 0.516 . . . . 4.39 111.052 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -106.17 169.7 8.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.55 . . . . 6.43 111.196 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.73 -4.01 83.6 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.907 -0.588 . . . . 6.14 113.174 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 62.6 24.96 14.86 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.797 0.439 . . . . 6.26 110.65 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 t -84.34 122.18 37.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.958 -0.565 . . . . 5.62 110.41 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -83.86 95.31 8.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.308 0.575 . . . . 6.25 110.438 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.459 HD21 ' H ' ' A' ' 133' ' ' LEU . 2.4 pt? -75.37 150.35 38.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.863 -1.062 . . . . 3.62 111.008 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.524 ' HG3' ' OD1' ' A' ' 137' ' ' ASP . 3.9 ppt_? -120.38 162.33 19.67 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.77 -0.456 . . . . 7.5 109.77 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.585 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -72.41 125.62 27.85 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.605 -0.438 . . . . 4.12 110.87 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.48 -25.73 7.59 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.934 -0.651 . . . . 4.2 113.613 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.524 ' OD1' ' HG3' ' A' ' 134' ' ' ARG . 2.8 p30 -86.53 178.66 7.02 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.258 1.029 . . . . 4.06 110.141 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.559 ' HD2' ' HB ' ' A' ' 84' ' ' THR . 2.3 tppp? -118.9 124.7 47.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.414 0.626 . . . . 4.48 111.795 -172.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.526 HG13 ' HG ' ' A' ' 158' ' ' LEU . 24.5 m -117.22 170.59 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 2.98 110.039 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -119.97 135.4 54.92 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.034 -0.728 . . . . 3.68 109.034 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -134.44 153.58 51.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.774 0.321 . . . . 3.35 110.536 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -113.83 131.23 56.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.864 -0.607 . . . . 5.34 109.801 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.4 mt -95.96 108.71 21.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.778 -0.647 . . . . 4.66 110.951 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.73 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -101.86 110.98 23.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.718 0.294 . . . . 5.08 111.285 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.41 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 66.8 m -99.0 122.7 42.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 5.68 111.814 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.52 174.92 8.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 6.25 110.533 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -59.58 -28.54 67.23 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.001 -0.545 . . . . 9.03 112.214 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 148' ' ' ARG . 21.8 mmt180 -88.48 8.66 26.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.877 0.325 . . . . 8.29 111.877 -174.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.07 14.51 73.67 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.909 -0.662 . . . . 5.65 113.22 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.9 130.51 53.84 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.254 -0.647 . . . . 5.26 109.254 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -152.94 -178.52 6.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.356 -0.384 . . . . 4.63 110.938 -177.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.14 -166.11 13.81 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.031 -0.828 . . . . 3.57 111.031 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.39 109.96 21.89 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.046 -0.353 . . . . 2.84 110.046 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 71.9 m -121.01 166.76 13.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.434 -0.348 . . . . 4.34 110.871 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 59.22 36.51 23.79 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.632 0.583 . . . . 6.23 110.144 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.426 ' HB ' ' HA ' ' A' ' 127' ' ' VAL . 77.1 mt -64.9 114.55 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.807 -0.633 . . . . 3.55 110.021 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -122.12 123.89 42.62 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.816 -0.809 . . . . 6.3 108.816 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.526 ' HG ' HG13 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -81.78 103.05 11.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.178 -0.464 . . . . 4.63 109.876 -176.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -97.08 -32.44 11.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.993 -0.549 . . . . 4.97 111.305 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -126.39 84.38 62.26 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 5.57 110.742 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.28 179.87 4.31 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.918 2.412 . . . . 5.69 112.975 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -97.77 141.91 30.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.73 -0.668 . . . . 6.1 110.49 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -105.79 120.26 49.76 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.35 -0.611 . . . . 10.1 109.35 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.06 135.26 67.44 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.696 2.264 . . . . 8.39 111.745 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.084 -0.507 . . . . 10.65 111.197 -176.123 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.157 -0.377 . . . . 22.01 112.157 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.39 103.04 13.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.881 0.372 . . . . 20.23 110.992 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -116.98 -19.78 9.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.047 0.451 . . . . 18.59 110.931 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -105.35 10.28 33.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.902 -0.59 . . . . 17.11 111.464 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -135.68 128.63 31.38 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 122.183 0.992 . . . . 18.35 110.433 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -146.13 88.44 1.8 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 113.668 -1.606 . . . . 16.2 108.157 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -82.73 136.03 34.83 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.108 0.48 . . . . 12.72 111.142 -175.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.72 162.7 21.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.691 -0.686 . . . . 11.63 110.038 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 26' ' ' GLU . 36.8 p -100.79 162.12 13.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.399 -0.364 . . . . 9.47 110.233 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' A' ' 26' ' ' GLU . . . -162.38 177.56 38.49 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.967 -0.635 . . . . 7.73 112.055 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.6 mt -129.45 141.9 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.557 -0.534 . . . . 10.57 109.557 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.6 mm -65.81 111.5 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.836 0.351 . . . . 8.73 110.086 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.15 -54.24 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.724 -0.671 . . . . 10.86 110.495 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -146.47 163.9 34.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.434 -0.803 . . . . 14.48 110.253 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.5 mt -131.45 101.33 5.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.803 -0.635 . . . . 11.73 110.543 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.5 mt -92.41 -179.87 5.33 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.558 -1.275 . . . . 11.9 107.558 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -90.37 125.1 35.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.097 -0.641 . . . . 16.67 109.977 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.3 m 79.63 -16.6 0.65 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.136 0.974 . . . . 13.28 112.212 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -150.19 147.77 28.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.561 0.22 . . . . 12.68 110.949 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.48 -176.21 15.62 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.021 -0.609 . . . . 7.92 112.871 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -127.87 149.78 50.15 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.843 0.354 . . . . 9.69 111.312 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.8 mt -115.53 130.43 70.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 7.75 110.897 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.79 145.83 34.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.92 -0.582 . . . . 12.4 111.252 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 p -80.28 2.49 24.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.088 -0.96 . . . . 12.96 112.862 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -52.62 -35.44 54.6 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.006 0.372 . . . . 13.58 112.006 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.492 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 22.6 mm-40 -108.89 -25.39 10.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 12.19 111.409 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.445 ' HD3' ' N ' ' A' ' 28' ' ' GLN . 1.6 tmt_? -113.38 135.3 54.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.475 -0.565 . . . . 12.99 109.475 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.445 ' N ' ' HD3' ' A' ' 27' ' ' ARG . 19.6 mp0 -74.62 43.7 0.19 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.797 0.332 . . . . 17.26 111.255 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' A' ' 27' ' ' ARG . . . -177.33 146.4 0.48 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.717 0.807 . . . . 12.1 109.541 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.574 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -100.96 111.81 24.1 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.57 -0.53 . . . . 13.0 109.57 177.767 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.1 mt -113.88 163.03 15.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.234 0.54 . . . . 9.21 111.923 -170.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -112.07 149.12 32.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.237 -0.892 . . . . 9.75 109.506 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -140.53 158.72 43.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.874 0.369 . . . . 6.85 110.195 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -103.76 158.19 16.56 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.703 -0.48 . . . . 10.15 109.703 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -67.91 -18.79 64.89 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.957 0.355 . . . . 10.56 111.957 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 t -82.56 -8.08 59.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.403 0.62 . . . . 12.44 109.773 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -107.48 37.89 2.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.618 -0.719 . . . . 11.14 110.03 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -129.67 125.39 35.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.964 0.412 . . . . 8.78 111.16 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 t -100.75 104.6 15.88 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.961 -0.563 . . . . 9.11 109.977 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.54 -148.85 20.67 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.114 -0.795 . . . . 9.98 111.114 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -107.13 104.03 13.58 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 110.022 -0.362 . . . . 12.91 110.022 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.0 tp -63.25 -25.48 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.155 0.502 . . . . 11.97 110.726 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.04 -25.42 61.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 14.73 110.383 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -97.17 -10.43 25.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.756 -0.656 . . . . 13.3 110.568 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.0 tp -68.37 147.2 52.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 10.07 110.169 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 169.95 17.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.191 -0.458 . . . . 13.53 110.431 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.8 mm -77.69 135.27 26.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.562 -0.533 . . . . 12.26 109.562 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.59 11.29 62.43 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.477 -0.868 . . . . 11.04 111.837 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -86.38 125.93 66.15 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.253 -0.277 . . . . 8.39 110.253 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.91 129.74 6.35 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.906 2.404 . . . . 8.18 112.985 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.98 165.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 4.78 110.584 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.429 ' HB3' HG23 ' A' ' 9' ' ' THR . 10.2 pt-20 -126.52 146.63 50.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.969 0.414 . . . . 7.09 110.218 172.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -152.24 178.52 9.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.026 -0.534 . . . . 7.82 110.879 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.7 mp0 -124.08 114.17 19.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.882 -0.599 . . . . 11.59 110.575 177.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.9 ttt -78.28 109.65 12.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.599 -0.519 . . . . 12.41 109.599 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.5 p -131.67 167.74 18.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.937 0.399 . . . . 13.93 111.043 -176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -118.36 110.4 17.43 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 16.22 109.58 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.38 111.2 5.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.838 0.352 . . . . 16.64 110.143 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -73.12 -6.63 46.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.0 -0.545 . . . . 23.23 111.608 -176.012 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.8 mmt-85 -78.25 -59.7 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 21.87 110.259 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.4 p -86.68 -30.36 21.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 17.49 111.896 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.17 31.55 16.73 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.937 -0.649 . . . . 17.22 111.893 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.28 141.5 33.26 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 122.935 -0.156 . . . . 14.83 110.827 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.91 125.53 7.4 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.298 1.999 . . . . 13.33 110.886 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.63 165.61 22.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.186 -0.461 . . . . 12.33 110.591 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -102.16 161.15 13.91 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.661 -0.496 . . . . 8.91 109.661 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 11.9 t -66.89 -166.91 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.721 -0.474 . . . . 10.33 109.721 172.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -78.46 26.27 0.23 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.355 0.502 . . . . 12.02 112.355 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.7 t 35.25 94.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.2 1.0 . . . . 6.52 113.447 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -93.21 132.26 37.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.285 -0.416 . . . . 6.18 110.435 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -67.46 140.36 57.09 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.444 -0.576 . . . . 6.59 109.444 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.2 mt -72.31 100.19 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 6.16 110.895 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -125.52 95.1 41.38 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.905 -0.589 . . . . 6.03 110.378 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -90.24 14.33 2.09 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.073 2.516 . . . . 7.28 112.722 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -110.64 131.78 54.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.601 -0.272 . . . . 8.49 110.762 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.507 ' CG2' ' HB3' ' A' ' 144' ' ' ALA . 1.7 p -63.29 117.01 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.773 -0.455 . . . . 6.19 109.773 172.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 4.8 p -79.97 107.21 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.575 0.703 . . . . 6.54 111.225 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.5 tp -89.87 -52.34 5.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.815 -1.084 . . . . 6.46 110.354 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.7 m -89.52 67.15 7.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.896 0.379 . . . . 7.24 111.718 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -88.64 -65.93 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.006 -0.738 . . . . 7.07 109.006 170.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -152.49 133.57 14.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.555 -0.906 . . . . 6.68 108.555 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -77.8 118.27 19.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.758 0.313 . . . . 6.93 110.278 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.13 166.9 7.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.215 0.531 . . . . 4.0 111.172 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 p -133.22 150.4 51.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.502 -0.772 . . . . 3.84 110.496 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -150.52 173.66 30.07 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.508 -0.853 . . . . 2.58 112.143 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.1 m -122.86 135.48 54.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.819 0.343 . . . . 3.7 110.256 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.529 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 39.8 t -64.9 132.02 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.269 -0.423 . . . . 3.14 110.728 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.5 p -115.15 -10.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.048 0.388 . . . . 3.77 112.048 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.5 m -145.05 131.99 20.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.711 0.291 . . . . 3.29 110.657 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.12 179.59 6.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 4.39 111.427 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.9 mt -107.95 167.8 9.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.57 -0.741 . . . . 3.62 109.339 175.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.459 ' HG2' HG23 ' A' ' 105' ' ' THR . 7.8 ptm180 -106.85 113.89 27.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.362 0.601 . . . . 7.76 111.529 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.6 p -135.58 139.14 43.63 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.522 -0.763 . . . . 5.1 109.604 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -107.69 -23.76 11.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.384 0.611 . . . . 7.53 110.288 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.8 t -157.78 166.7 32.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.785 -0.643 . . . . 7.77 109.441 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.67 -26.84 66.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.251 0.548 . . . . 8.0 109.927 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -93.66 -14.14 26.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.653 -0.703 . . . . 8.83 110.514 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -110.99 85.99 2.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.427 0.632 . . . . 7.69 110.19 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 m -113.69 143.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.027 -0.988 . . . . 5.85 110.103 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.7 mp -111.19 98.56 7.6 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.382 1.087 . . . . 7.65 110.821 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -93.64 13.34 22.41 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 113.165 -1.834 . . . . 8.21 109.992 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.1 m -59.07 123.9 18.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.369 -0.832 . . . . 5.58 109.825 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 27.5 t -70.63 -5.71 31.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.446 . . . . 4.8 111.966 -172.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.49 ' HG3' ' HG1' ' A' ' 105' ' ' THR . 12.8 pt-20 -69.88 -26.41 64.18 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.652 -0.87 . . . . 5.09 108.652 172.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.49 ' HG1' ' HG3' ' A' ' 104' ' ' GLU . 94.7 m -103.02 113.03 26.17 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.828 -1.078 . . . . 3.7 110.511 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 t -136.25 141.27 43.9 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.073 -0.512 . . . . 2.84 109.981 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -81.2 177.58 54.23 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.468 -0.872 . . . . 1.91 111.541 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 8.0 mmt85 -132.82 127.65 34.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.989 0.423 . . . . 3.31 111.104 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.3 130.15 66.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 2.17 109.223 172.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.5 t -106.56 116.45 31.95 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.552 -0.536 . . . . 3.61 109.552 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -118.87 144.63 46.27 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.34 -0.615 . . . . 3.58 109.34 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -104.78 109.29 21.17 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.573 -0.74 . . . . 5.1 109.713 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.569 ' OD1' ' HD3' ' A' ' 114' ' ' ARG . 59.2 t30 -129.33 114.84 16.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.372 -0.376 . . . . 5.11 111.147 -174.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.569 ' HD3' ' OD1' ' A' ' 113' ' ' ASN . 6.0 mpt_? 61.55 26.13 15.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.978 0.418 . . . . 7.42 111.57 173.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.94 -2.77 69.67 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.872 -0.68 . . . . 5.36 112.617 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -110.19 135.23 51.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.828 0.347 . . . . 5.38 110.268 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 2.3 p -117.16 103.61 10.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.399 -0.364 . . . . 4.96 110.313 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -98.03 153.89 18.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.97 -0.559 . . . . 5.13 110.617 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -101.89 124.3 47.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.186 -0.461 . . . . 4.32 110.37 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 22.4 mt -105.66 130.01 23.73 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.839 -0.619 . . . . 3.17 110.685 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 76.2 Cg_endo -81.4 134.04 8.75 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.733 2.289 . . . . 2.61 111.544 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -140.24 157.76 45.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 2.49 111.363 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.5 p -120.73 177.2 5.17 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.612 -0.722 . . . . 3.18 109.582 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -76.65 -25.34 53.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.569 0.581 . . . . 5.22 112.569 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.01 -10.12 59.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.385 0.513 . . . . 4.81 112.385 -170.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -97.14 -12.63 22.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.037 0.446 . . . . 4.0 111.092 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.5 t -67.91 110.26 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.09 0.471 . . . . 4.39 111.041 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -68.25 127.51 33.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.571 -0.74 . . . . 6.43 110.719 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.89 -0.29 55.13 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.743 -0.741 . . . . 6.14 112.695 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 65.33 18.42 11.35 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.856 0.36 . . . . 6.26 110.771 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.63 135.08 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.803 -0.635 . . . . 5.62 112.238 -172.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -90.65 79.16 6.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.893 0.854 . . . . 6.25 109.135 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -77.34 149.95 35.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.86 -1.064 . . . . 3.62 112.129 -172.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -108.66 167.49 10.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.594 -0.73 . . . . 7.5 109.525 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.529 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.21 127.9 34.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.071 -0.652 . . . . 4.12 110.008 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.19 -24.24 9.4 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.847 -0.692 . . . . 4.2 111.605 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -64.99 137.94 58.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.855 0.36 . . . . 4.06 110.295 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -84.46 117.12 23.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.587 -0.523 . . . . 4.48 109.587 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -118.71 157.41 20.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.29 0.567 . . . . 2.98 111.998 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 m -118.8 129.94 55.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.534 -0.757 . . . . 3.68 109.336 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -138.24 152.52 48.67 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.77 -0.456 . . . . 3.35 109.77 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -107.94 132.4 53.53 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.837 -0.431 . . . . 5.34 109.837 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 75.6 mt -84.7 131.21 34.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.271 -0.422 . . . . 4.66 110.868 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -131.13 110.0 10.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.966 -0.561 . . . . 5.08 110.525 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 45.3 m -85.98 112.04 20.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 5.68 110.844 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -81.61 174.01 11.81 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.388 -0.597 . . . . 6.25 109.388 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -65.9 -7.29 15.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.168 0.803 . . . . 9.03 113.168 -172.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -90.54 -9.48 47.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.763 -0.375 . . . . 8.29 111.117 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.11 13.35 83.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.73 -0.748 . . . . 5.65 112.004 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -111.27 121.26 44.81 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.858 -0.423 . . . . 5.26 109.858 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -136.34 -178.25 5.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.275 -0.42 . . . . 4.63 110.308 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -160.78 -78.08 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.594 -1.003 . . . . 3.57 110.594 176.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -160.23 163.1 33.78 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.085 -0.709 . . . . 2.84 109.085 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -150.52 147.06 27.02 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.98 -0.378 . . . . 4.34 109.98 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.4 p80 40.74 51.2 3.06 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 124.638 1.211 . . . . 6.23 111.361 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.9 mt -59.52 114.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.827 -1.079 . . . . 3.55 110.063 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.27 148.0 31.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.454 -0.339 . . . . 6.3 110.363 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.5 tp -72.68 125.23 27.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.237 -0.653 . . . . 4.63 109.237 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.2 -62.17 1.3 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.334 -0.617 . . . . 4.97 109.334 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -135.6 109.18 10.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.812 -0.631 . . . . 5.57 109.484 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.08 154.95 65.97 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.789 2.326 . . . . 5.69 113.017 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -121.17 107.23 12.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.563 -0.744 . . . . 6.1 111.467 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 70.18 107.73 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 115.322 -0.854 . . . . 10.1 112.785 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.98 107.92 2.43 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.342 2.028 . . . . 8.39 111.4 172.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 97.5 t . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.027 -0.533 . . . . 10.65 110.851 -178.705 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.453 0 N-CA-C 111.854 -0.498 . . . . 22.01 111.854 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.64 138.55 32.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.94 0.4 . . . . 20.23 111.294 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -117.36 -50.51 2.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.578 0.704 . . . . 18.59 109.996 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.33 73.38 2.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.77 -1.104 . . . . 17.11 110.951 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -65.65 -76.97 0.07 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.741 -1.118 . . . . 18.35 110.068 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 38.87 72.8 0.12 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.397 1.06 . . . . 16.2 113.129 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 7' ' ' ARG . 43.6 mtt85 -121.7 150.3 41.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.217 -0.447 . . . . 12.72 110.176 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.511 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 17.5 mm-40 -103.24 137.8 40.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.911 -0.586 . . . . 11.63 110.3 -173.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -97.94 136.91 37.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.659 -0.701 . . . . 9.47 110.656 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.5 174.6 32.1 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.978 -1.106 . . . . 7.73 112.918 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.512 HG13 ' HB3' ' A' ' 23' ' ' GLN . 7.9 pt -124.88 146.13 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.92 -0.4 . . . . 10.57 109.92 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.7 mm -67.47 122.88 19.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.414 0.149 . . . . 8.73 110.664 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 23.6 tt0 -88.09 -45.61 10.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.023 0.44 . . . . 10.86 110.428 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -147.6 140.93 25.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.9 -0.591 . . . . 14.48 109.954 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.3 mt -113.01 110.19 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.324 0.583 . . . . 11.73 111.282 176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.12 178.41 4.52 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.32 -1.363 . . . . 11.9 107.32 171.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -90.79 130.76 36.73 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.575 -0.85 . . . . 16.67 110.172 -174.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.9 m 76.63 -25.51 0.2 Allowed 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.203 0.939 . . . . 13.28 112.17 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -141.79 142.28 33.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.647 0.26 . . . . 12.68 110.844 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.15 179.82 18.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.814 -0.708 . . . . 7.92 112.448 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.09 134.7 55.18 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.747 0.308 . . . . 9.69 111.383 -177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.406 HG21 ' CE1' ' A' ' 53' ' ' PHE . 74.8 mt -99.75 129.09 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.617 -0.512 . . . . 7.75 109.617 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.513 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . 37.6 tt0 -85.79 133.7 33.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.465 0.65 . . . . 12.4 111.357 -173.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.6 p -79.21 1.41 24.76 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.231 -0.895 . . . . 12.96 112.444 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 t -57.11 -29.46 63.55 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.197 0.443 . . . . 13.58 112.197 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -97.3 -1.28 44.99 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.83 0.348 . . . . 12.19 111.512 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.494 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 12.8 tpt180 -148.59 -158.85 0.96 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.342 -0.614 . . . . 12.99 109.342 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.494 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 26.5 mm-40 -119.21 19.01 12.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.248 0.546 . . . . 17.26 109.703 170.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.3 131.5 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.669 -0.696 . . . . 12.1 111.352 -175.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -121.18 125.71 47.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.734 -0.839 . . . . 13.0 108.734 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.75 160.67 26.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.42 0.628 . . . . 9.21 112.624 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -95.49 110.89 22.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.871 -1.059 . . . . 9.75 108.307 172.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -103.06 138.02 40.47 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.726 -0.79 . . . . 6.85 110.417 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -95.85 151.41 19.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.629 -0.714 . . . . 10.15 109.571 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.417 ' CD1' HG23 ' A' ' 42' ' ' ILE . 6.7 m-30 -72.4 -16.77 61.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.949 0.404 . . . . 10.56 110.981 -177.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -70.18 -23.99 63.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 12.44 109.942 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -108.71 40.31 1.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.588 -0.733 . . . . 11.14 110.711 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -129.44 119.56 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.557 -0.534 . . . . 8.78 109.557 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 t -88.02 106.53 18.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.146 0.498 . . . . 9.11 110.409 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.66 -167.89 22.5 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.684 -0.769 . . . . 9.98 111.972 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -79.12 96.34 5.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.077 -0.342 . . . . 12.91 110.077 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.417 HG23 ' CD1' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -70.1 -27.28 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.504 0.669 . . . . 11.97 109.3 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.09 -21.77 65.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.465 -0.789 . . . . 14.73 110.952 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -99.72 13.95 31.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 13.3 110.646 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.1 tp -88.42 147.77 24.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 10.07 110.914 -178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -125.28 168.7 13.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.307 -0.406 . . . . 13.53 110.837 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 47' ' ' ILE . 3.7 mp -80.55 122.8 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.915 -0.584 . . . . 12.26 109.889 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.36 -3.45 32.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.872 -0.68 . . . . 11.04 111.826 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.83 122.71 84.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.806 -0.197 . . . . 8.39 110.478 178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.44 123.66 10.43 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.676 2.251 . . . . 8.18 112.052 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.62 153.0 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.048 0.452 . . . . 4.78 111.624 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.25 124.44 52.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.104 -0.702 . . . . 7.09 109.104 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 8' ' ' GLU . 53.5 p90 -132.69 144.56 50.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.375 0.607 . . . . 7.82 111.039 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 26.9 tt0 -97.28 102.72 14.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.441 -0.8 . . . . 11.59 109.199 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.9 ttt -82.05 132.86 35.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.933 -0.576 . . . . 12.41 110.784 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.52 164.45 8.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.162 -0.472 . . . . 13.93 110.505 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -99.69 133.27 44.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.458 -0.337 . . . . 16.22 110.713 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.563 ' OD2' HG23 ' A' ' 61' ' ' THR . 8.4 t70 -95.39 134.34 38.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.955 -0.566 . . . . 16.64 110.295 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -81.26 -13.39 58.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.24 0.459 . . . . 23.23 112.24 -177.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.536 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 8.4 mmm-85 -74.38 -60.8 2.1 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.943 -0.391 . . . . 21.87 109.943 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.563 HG23 ' OD2' ' A' ' 58' ' ' ASP . 5.7 t -91.81 -26.2 18.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.976 -0.556 . . . . 17.49 111.075 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.46 -4.58 85.47 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.798 -0.715 . . . . 17.22 112.634 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' H ' HG22 ' A' ' 61' ' ' THR . 38.5 mtpt -93.89 142.52 25.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.517 -0.549 . . . . 14.83 109.517 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.08 128.56 23.22 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.58 2.186 . . . . 13.33 112.119 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.31 179.5 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.205 -0.452 . . . . 12.33 111.001 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -133.57 173.14 11.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.642 -0.708 . . . . 8.91 109.69 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 69' ' ' VAL . 52.6 p -74.98 -160.53 0.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.231 0.332 . . . . 10.33 110.405 175.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.5 pm0 -76.61 24.29 0.15 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.406 0.521 . . . . 12.02 112.406 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 67' ' ' SER . 30.6 t 32.75 87.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.3 1.04 . . . . 6.52 112.724 174.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.4 m -90.16 135.73 33.48 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.246 -0.434 . . . . 6.18 110.876 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.488 ' HZ3' ' HB3' ' A' ' 71' ' ' LYS . 6.5 mtpm? -62.73 134.86 56.92 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.082 -0.71 . . . . 6.59 109.082 173.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -69.73 100.61 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.247 0.546 . . . . 6.16 111.145 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -96.16 146.31 31.08 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.247 -0.888 . . . . 6.03 109.841 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.26 139.04 28.6 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.751 2.3 . . . . 7.28 112.644 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -79.42 88.1 5.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.002 -0.545 . . . . 8.49 110.389 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.9 t -95.95 155.07 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.006 -0.738 . . . . 6.19 109.006 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.2 100.16 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.88 0.371 . . . . 6.54 111.351 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 68.9 mt -105.19 9.32 34.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.502 0.668 . . . . 6.46 109.791 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.9 m -83.73 26.53 0.69 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.982 -1.008 . . . . 7.24 112.137 -172.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -92.66 -93.74 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.113 0.483 . . . . 7.07 111.07 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -164.49 124.31 1.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.424 -0.584 . . . . 6.68 109.424 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -63.6 118.48 8.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 6.93 110.499 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.08 160.14 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.16 0.505 . . . . 4.0 111.629 -177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.7 p -119.22 140.19 50.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.607 -0.724 . . . . 3.84 109.884 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.76 -179.11 16.94 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.346 -0.93 . . . . 2.58 112.464 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.1 m -129.39 130.62 46.24 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.765 -0.457 . . . . 3.7 109.765 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 33.7 t -71.62 129.41 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.402 -0.363 . . . . 3.14 110.031 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.5 p -106.2 -32.57 8.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.06 0.457 . . . . 3.77 110.562 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.8 m -146.38 122.98 11.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.938 -0.573 . . . . 3.29 110.218 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -85.24 -171.2 3.5 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.911 -0.403 . . . . 4.39 109.911 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.29 113.15 3.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.911 -0.774 . . . . 3.62 108.911 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -61.71 145.67 51.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.43 . . . . 7.76 111.388 -174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.6 p -115.95 147.17 41.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.927 -0.579 . . . . 5.1 110.33 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.77 -66.16 0.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.785 0.291 . . . . 7.53 111.785 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.6 m -75.94 -67.27 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.63 0.253 . . . . 7.77 111.11 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.6 -97.17 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.335 -0.393 . . . . 8.0 110.342 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -97.39 73.45 2.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.792 0.806 . . . . 8.83 109.773 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.544 ' O ' HG12 ' A' ' 99' ' ' VAL . 2.6 m-20 -106.41 -68.48 0.88 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.258 -0.883 . . . . 7.69 111.079 -175.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.544 HG12 ' O ' ' A' ' 98' ' ' ASN . 2.6 p 53.91 14.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 124.617 1.198 . . . . 5.85 111.503 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.8 tp -105.47 82.86 1.87 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.83 -1.174 . . . . 7.65 107.83 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.573 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 18.0 m120 -131.16 36.17 3.85 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.559 -1.2 . . . . 8.21 111.63 -171.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.4 m 53.65 25.08 4.67 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.234 0.457 . . . . 5.58 112.234 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.2 p 49.06 33.15 4.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.317 0.647 . . . . 4.8 112.106 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.573 ' HG2' ' O ' ' A' ' 101' ' ' ASN . 12.6 pt-20 -88.22 11.03 17.52 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.885 0.374 . . . . 5.09 111.117 -177.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.7 t -136.66 135.81 38.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.877 0.37 . . . . 3.7 110.572 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.4 p -100.55 151.79 21.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.123 -0.49 . . . . 2.84 110.444 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -90.77 175.7 40.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.724 -0.75 . . . . 1.91 111.536 175.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 119' ' ' PHE . 24.2 mmt180 -130.51 122.18 27.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.024 0.44 . . . . 3.31 111.751 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.87 134.14 63.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.474 -0.785 . . . . 2.17 109.388 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.2 t -112.39 148.67 33.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.353 -0.24 . . . . 3.61 110.353 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -159.49 167.22 29.18 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 110.084 -0.339 . . . . 3.58 110.084 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -140.06 112.67 7.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.833 -0.432 . . . . 5.1 109.833 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -168.03 154.24 7.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.827 -0.434 . . . . 5.11 109.827 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 64.35 20.99 12.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.117 0.567 . . . . 7.42 110.474 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.77 89.84 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.165 -0.54 . . . . 5.36 112.47 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -111.71 140.84 46.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.227 0.537 . . . . 5.38 111.655 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 52.5 t -140.94 101.51 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.126 -0.943 . . . . 4.96 109.797 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -151.78 169.57 21.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.617 -0.265 . . . . 5.13 110.499 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.45 ' HB3' ' HD2' ' A' ' 108' ' ' ARG . 74.9 m-85 -98.34 130.85 45.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.067 -0.515 . . . . 4.32 110.742 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.6 mp -105.64 134.5 19.68 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.29 -0.413 . . . . 3.17 110.244 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 93.3 Cg_endo -84.01 134.33 6.08 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.745 2.297 . . . . 2.61 112.029 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -135.77 159.44 41.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.41 -0.359 . . . . 2.49 110.224 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.31 175.09 5.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.24 -0.436 . . . . 3.18 110.689 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.82 -38.46 85.51 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.08 0.467 . . . . 5.22 111.694 -174.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -85.2 -3.1 58.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.793 -0.639 . . . . 4.81 112.363 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.83 -15.23 61.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.086 0.47 . . . . 4.0 110.94 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 38.5 t -81.99 114.57 23.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.199 -0.455 . . . . 4.39 110.171 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.61 110.05 3.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 6.43 110.606 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.5 -3.18 56.29 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.722 -0.672 . . . . 6.14 112.092 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.9 t30 59.12 71.01 0.61 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.071 0.462 . . . . 6.26 110.386 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.7 t -103.46 148.47 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.958 -0.565 . . . . 5.62 110.615 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -81.54 109.1 15.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.011 -0.54 . . . . 6.25 110.496 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.3 pt? -110.9 148.86 31.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.963 -0.562 . . . . 3.62 109.603 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -136.18 124.78 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.855 -0.424 . . . . 7.5 109.855 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.565 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -51.46 123.1 9.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.105 0.479 . . . . 4.12 112.207 -173.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.65 3.66 16.07 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.409 -0.814 . . . . 4.2 111.828 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -105.64 -174.21 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.115 0.484 . . . . 4.06 110.652 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.503 ' HB2' ' HB2' ' A' ' 160' ' ' ASN . 2.7 mmmm -113.53 123.19 49.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.139 -0.482 . . . . 4.48 110.858 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.12 152.02 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.994 0.426 . . . . 2.98 110.665 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 m -113.57 128.8 56.57 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.386 -0.598 . . . . 3.68 109.386 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -130.87 159.5 37.2 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.094 -0.336 . . . . 3.35 110.094 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -111.01 125.14 53.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.326 -0.397 . . . . 5.34 110.218 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.0 mt -78.6 98.54 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.286 -0.635 . . . . 4.66 109.286 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -111.88 144.11 41.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.271 -0.877 . . . . 5.08 111.236 -171.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.2 m -117.96 116.99 28.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.364 -0.38 . . . . 5.68 110.784 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.559 ' H ' HD23 ' A' ' 151' ' ' LEU . 60.9 t30 -99.25 172.62 7.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.263 -0.643 . . . . 6.25 109.263 176.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -51.44 -43.91 62.18 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.187 0.81 . . . . 9.03 113.187 -171.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -23.05 62.55 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.416 0.524 . . . . 8.29 112.416 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.59 16.44 80.74 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.539 -0.838 . . . . 5.65 112.814 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.501 ' O ' HD12 ' A' ' 151' ' ' LEU . 18.7 m120 -105.66 77.46 1.27 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 110.051 -0.352 . . . . 5.26 110.051 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 146' ' ' ASN . 1.6 mm? -127.11 169.64 13.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.306 -0.406 . . . . 4.63 110.546 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.36 -102.91 0.4 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.631 -0.988 . . . . 3.57 110.631 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -125.49 110.26 13.68 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.307 -0.627 . . . . 2.84 109.307 175.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 3.7 t -125.48 168.67 13.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.499 -0.319 . . . . 4.34 110.509 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 57.79 41.44 25.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.23 0.538 . . . . 6.23 110.074 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 56.6 mt -68.63 118.58 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.339 -0.846 . . . . 3.55 111.277 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -102.89 133.64 47.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.554 -0.748 . . . . 6.3 109.363 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.4 tp -76.86 107.68 9.35 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.722 -0.844 . . . . 4.63 108.722 175.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -83.05 -62.7 1.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.89 -0.595 . . . . 4.97 110.626 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.503 ' HB2' ' HB2' ' A' ' 138' ' ' LYS . 16.1 m120 -129.08 103.19 18.55 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.995 -0.743 . . . . 5.57 108.995 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -71.46 158.66 53.51 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.252 1.968 . . . . 5.69 112.264 -176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.89 19.48 3.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.334 0.587 . . . . 6.1 109.993 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -94.17 139.35 22.49 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.421 -0.808 . . . . 10.1 109.968 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.41 104.31 1.07 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.533 2.155 . . . . 8.39 112.202 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.256 -0.429 . . . . 10.65 110.556 178.7 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.403 0 N-CA-C 112.096 -0.402 . . . . 22.01 112.096 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.42 143.85 20.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.67 0.271 . . . . 20.23 110.701 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.46 -31.38 18.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.886 0.85 . . . . 18.59 109.527 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.87 69.1 10.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.825 -1.079 . . . . 17.11 111.67 -169.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.51 ' HG3' ' H ' ' A' ' 6' ' ' GLU . 8.4 pt-20 -151.63 -64.62 0.18 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.01 0.374 . . . . 18.35 112.01 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' H ' ' HG3' ' A' ' 5' ' ' GLU . 6.4 mm-40 -88.58 93.74 9.65 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.413 0.625 . . . . 16.2 110.877 -177.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -137.43 116.35 12.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.682 -0.69 . . . . 12.72 110.219 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -141.18 170.28 16.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.282 -0.417 . . . . 11.63 110.684 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 27.2 p -97.26 173.52 7.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.113 0.482 . . . . 9.47 111.996 -174.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.42 ' HA2' ' HG3' ' A' ' 26' ' ' GLU . . . -169.06 152.07 19.21 Favored Glycine 0 C--O 1.225 -0.414 0 CA-C-N 115.405 -0.816 . . . . 7.73 111.176 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.432 HD11 ' SG ' ' A' ' 25' ' ' CYS . 18.1 pt -100.83 147.89 7.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 117.646 0.723 . . . . 10.57 110.407 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.79 121.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.486 -0.325 . . . . 8.73 111.043 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -72.03 -56.33 5.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.552 -0.749 . . . . 10.86 110.284 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -166.09 157.23 13.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.397 -0.819 . . . . 14.48 109.013 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -115.62 116.1 27.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.326 0.584 . . . . 11.73 111.33 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 2.8 mm? -98.3 -178.93 4.19 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.965 -1.124 . . . . 11.9 107.965 173.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 18' ' ' SER . 2.9 t60 -90.02 124.84 35.11 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.001 -0.74 . . . . 16.67 109.001 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 17' ' ' HIS . 68.7 m 81.35 -21.52 0.31 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.255 0.972 . . . . 13.28 112.399 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 50.4 p90 -150.01 156.68 42.13 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.104 -0.373 . . . . 12.68 111.062 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.36 178.27 21.66 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.667 -0.573 . . . . 7.92 111.667 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -119.34 146.36 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.03 0.415 . . . . 9.69 111.443 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.4 mt -108.33 134.71 49.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.631 -0.713 . . . . 7.75 109.798 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.1 144.77 28.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.651 0.739 . . . . 12.4 111.667 -175.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -80.68 2.83 24.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.573 -1.194 . . . . 12.96 113.065 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.432 ' SG ' HD11 ' A' ' 11' ' ' ILE . 69.1 m -52.85 -31.59 40.07 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.612 0.244 . . . . 13.58 111.3 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 17.0 mm-40 -84.37 -39.36 19.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.409 -0.36 . . . . 12.19 111.106 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.22 148.46 28.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.994 -0.373 . . . . 12.99 109.994 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -70.8 68.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.936 0.717 . . . . 17.26 112.936 -174.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -169.75 139.24 1.94 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.9 -0.591 . . . . 12.1 110.132 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 5.5 ptp180 -107.33 118.37 36.54 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.488 -0.56 . . . . 13.0 109.488 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.46 150.08 29.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.842 0.353 . . . . 9.21 111.052 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -110.65 133.71 53.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.032 -0.729 . . . . 9.75 109.032 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -125.21 143.64 50.84 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.145 -0.317 . . . . 6.85 110.145 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -94.14 155.09 17.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.477 -0.564 . . . . 10.15 109.477 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -69.23 -9.22 52.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.899 0.38 . . . . 10.56 111.583 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -80.57 -13.33 59.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.055 0.455 . . . . 12.44 109.777 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -116.44 35.81 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.922 -0.581 . . . . 11.14 111.486 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -119.01 124.94 48.21 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.062 -0.347 . . . . 8.78 110.062 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 t -94.76 94.96 8.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.066 0.46 . . . . 9.11 110.25 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.86 -169.71 26.03 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.054 -0.593 . . . . 9.98 111.738 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -87.8 120.34 29.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.286 -0.264 . . . . 12.91 110.286 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -66.56 -20.77 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.236 0.541 . . . . 11.97 110.954 -176.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.04 -24.56 66.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.914 -0.584 . . . . 14.73 110.583 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -92.91 2.95 56.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.835 -0.621 . . . . 13.3 110.453 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -102.54 129.93 49.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.636 -0.711 . . . . 10.07 109.417 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.38 177.22 8.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.529 -0.305 . . . . 13.53 110.768 -175.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.0 mp -80.05 141.03 15.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.537 -0.302 . . . . 12.26 110.187 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.53 10.57 85.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.091 -0.576 . . . . 11.04 111.767 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.9 134.47 21.48 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.583 -0.309 . . . . 8.39 110.194 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HB2' HD12 ' A' ' 72' ' ' ILE . 90.4 Cg_endo -81.99 128.82 5.93 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.594 2.196 . . . . 8.18 113.653 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.0 m -120.65 167.99 13.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.448 -0.796 . . . . 4.78 109.779 175.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 4.7 pt-20 -120.17 124.48 45.85 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.258 -0.645 . . . . 7.09 109.258 174.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -131.27 147.8 52.62 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 122.165 0.983 . . . . 7.82 112.278 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 30.6 tt0 -100.29 122.13 42.59 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.003 -1.453 . . . . 11.59 108.448 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.93 118.08 36.26 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.243 -0.183 . . . . 12.41 110.726 -173.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.5 p -141.94 153.49 44.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.161 0.505 . . . . 13.93 111.459 -176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -96.8 108.52 21.2 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.13 -0.693 . . . . 16.22 109.13 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.57 111.13 18.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.062 0.458 . . . . 16.64 110.928 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -81.18 -7.08 59.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.966 -0.561 . . . . 23.23 111.706 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -67.99 -46.56 70.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.033 -0.729 . . . . 21.87 109.033 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.4 p -93.78 -31.33 14.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.179 -0.918 . . . . 17.49 110.9 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.33 28.46 17.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.679 -0.772 . . . . 17.22 111.905 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -133.41 152.91 80.1 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 110.132 -0.321 . . . . 14.83 110.132 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.06 125.88 6.77 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.322 2.015 . . . . 13.33 110.763 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -137.43 172.51 14.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.748 0.785 . . . . 12.33 112.749 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.69 149.76 24.12 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.753 -1.112 . . . . 8.91 108.028 170.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.491 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 8.6 t -69.39 -151.07 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.329 0.585 . . . . 10.33 110.547 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -75.79 26.7 0.11 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.524 0.564 . . . . 12.02 112.524 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.434 ' H ' ' C ' ' A' ' 67' ' ' SER . 38.5 t 21.58 96.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.959 1.304 . . . . 6.52 113.632 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.3 t -88.55 154.32 20.44 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.777 -0.647 . . . . 6.18 110.22 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -96.64 123.58 40.37 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.001 -0.545 . . . . 6.59 109.877 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.409 HD12 ' HB2' ' A' ' 50' ' ' PRO . 63.8 mt -47.25 111.09 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 124.0 0.812 . . . . 6.16 111.386 -175.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.95 146.78 49.69 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.26 -0.882 . . . . 6.03 110.113 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.19 109.41 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.45 2.1 . . . . 7.28 111.674 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB3' ' H ' ' A' ' 76' ' ' VAL . 40.5 mt-10 -81.66 -154.21 0.11 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 8.49 110.819 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.44 ' H ' ' HB3' ' A' ' 75' ' ' GLU . 3.9 t -59.56 135.04 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.642 -0.708 . . . . 6.19 110.624 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 38.9 t -77.64 103.56 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 6.54 109.749 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.19 41.57 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.624 -0.716 . . . . 6.46 110.493 -174.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 71.1 m -156.18 33.15 0.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.951 -0.568 . . . . 7.24 110.853 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 145' ' ' THR . 6.1 mm-40 -83.22 62.99 6.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.228 -0.442 . . . . 7.07 110.466 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 68.81 112.72 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.192 -1.367 . . . . 6.68 111.463 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 3.3 ptm180 -77.71 81.95 4.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.616 0.722 . . . . 6.93 109.927 177.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.3 m -77.42 168.95 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.715 -0.675 . . . . 4.0 110.974 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.441 ' HB ' ' HE3' ' A' ' 138' ' ' LYS . 46.8 p -116.45 150.26 38.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.819 -0.628 . . . . 3.84 109.83 175.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.29 153.88 20.78 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.425 -0.893 . . . . 2.58 111.713 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -107.03 126.4 52.28 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.289 -0.634 . . . . 3.7 109.289 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 21.4 t -70.56 110.87 3.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.4 -0.363 . . . . 3.14 110.784 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.3 p -98.24 -13.26 20.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.698 0.761 . . . . 3.77 110.172 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 26.7 m -155.34 115.93 3.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.118 -0.946 . . . . 3.29 109.381 -175.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' HG3' ' HB3' ' A' ' 135' ' ' ALA . 0.3 OUTLIER -104.62 148.8 26.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 4.39 111.102 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -93.58 131.24 39.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.335 -0.987 . . . . 3.62 108.335 174.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.401 ' HG2' ' H ' ' A' ' 93' ' ' THR . 17.9 ttm180 -127.72 178.84 5.87 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.408 -0.59 . . . . 7.76 109.408 -173.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.401 ' H ' ' HG2' ' A' ' 92' ' ' ARG . 12.0 p -66.97 98.08 0.54 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.293 0.568 . . . . 5.1 110.327 174.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -88.52 -17.81 29.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.426 -0.806 . . . . 7.53 109.364 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.89 -164.65 0.24 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.06 -0.973 . . . . 7.77 110.014 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.14 86.22 6.21 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.025 -0.422 . . . . 8.0 110.483 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 m120 73.94 -54.28 0.68 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.005 -0.998 . . . . 8.83 112.589 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -97.26 -178.9 4.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.644 -0.502 . . . . 7.69 109.644 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.91 141.46 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.522 -0.308 . . . . 5.85 110.746 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.2 tp -104.22 -80.59 0.53 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.193 0.521 . . . . 7.65 109.666 171.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.446 ' O ' ' HB3' ' A' ' 102' ' ' SER . 94.8 m-20 -110.96 -32.18 6.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.093 -0.958 . . . . 8.21 110.562 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 47.7 t 76.92 -34.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.538 -0.756 . . . . 5.58 111.125 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 p -70.09 -8.78 52.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.227 0.537 . . . . 4.8 110.611 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -61.82 -24.37 66.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.128 -0.942 . . . . 5.09 110.403 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 t -139.29 117.14 11.6 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.609 -0.723 . . . . 3.7 109.708 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t -97.34 135.98 38.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.27 -0.423 . . . . 2.84 110.193 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 122' ' ' TYR . . . -75.41 -177.54 41.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.632 -0.794 . . . . 1.91 112.048 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.597 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -146.27 120.85 9.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.102 0.477 . . . . 3.31 110.164 -177.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -111.56 130.38 65.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.853 -0.612 . . . . 2.17 110.209 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.7 t -105.31 124.46 49.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.032 -0.531 . . . . 3.61 109.625 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -140.84 146.83 38.07 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.388 -0.597 . . . . 3.58 109.388 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.38 112.0 18.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.152 0.501 . . . . 5.1 110.802 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.71 121.89 46.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.568 -0.742 . . . . 5.11 109.936 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 60.57 23.82 13.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.502 -0.772 . . . . 7.42 111.06 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.25 -2.01 65.18 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.911 -0.661 . . . . 5.36 113.171 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.84 121.71 41.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.241 0.521 . . . . 5.38 110.559 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.4 p -102.47 113.15 26.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.117 -0.492 . . . . 4.96 110.754 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -118.51 147.03 44.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.291 -0.413 . . . . 5.13 110.377 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -101.63 126.84 48.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 4.32 109.648 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.9 118.54 55.95 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.586 -0.279 . . . . 3.17 110.93 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.82 132.68 14.6 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.691 2.261 . . . . 2.61 110.712 168.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.447 ' HH ' HD12 ' A' ' 133' ' ' LEU . 35.0 p90 -140.95 159.78 41.48 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.932 -0.307 . . . . 2.49 110.54 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 64.7 p -121.02 -175.62 3.09 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.012 -0.54 . . . . 3.18 110.009 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -62.89 -30.13 71.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.351 . . . . 5.22 111.655 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.01 -9.38 59.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.07 -0.514 . . . . 4.81 111.202 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -91.17 -12.44 35.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.28 0.562 . . . . 4.0 110.309 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.2 t -85.81 126.82 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.002 -0.545 . . . . 4.39 110.152 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -80.92 127.93 33.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.229 -0.441 . . . . 6.43 109.973 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.24 -0.23 87.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.808 -0.711 . . . . 6.14 112.838 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.0 m120 59.6 35.98 22.62 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.139 0.495 . . . . 6.26 111.087 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.87 137.19 23.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.145 -0.479 . . . . 5.62 111.249 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -80.74 112.62 18.29 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.694 -0.484 . . . . 6.25 109.694 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.512 HD21 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -102.9 150.9 23.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.055 -0.52 . . . . 3.62 111.536 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -115.46 135.57 53.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.689 -0.687 . . . . 7.5 110.044 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.566 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -60.91 114.39 3.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.258 0.551 . . . . 4.12 110.815 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.06 -3.92 14.11 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.517 -0.765 . . . . 4.2 112.874 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . 16.5 p30 -90.78 -177.35 4.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.442 0.621 . . . . 4.06 110.18 173.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.441 ' HE3' ' HB ' ' A' ' 84' ' ' THR . 50.9 tptt -112.95 113.55 25.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.061 0.458 . . . . 4.48 110.874 -174.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.9 m -117.82 154.28 19.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.84 -0.618 . . . . 2.98 110.515 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.5 t -124.18 135.88 53.78 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.395 -0.594 . . . . 3.68 109.395 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.44 146.33 52.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.164 -0.471 . . . . 3.35 110.129 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -93.8 118.92 32.09 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.792 -0.64 . . . . 5.34 109.704 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 93.8 mt -78.4 133.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.646 -0.501 . . . . 4.66 109.646 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -125.81 110.7 14.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.992 -0.549 . . . . 5.08 110.322 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.404 ' H ' ' HG3' ' A' ' 80' ' ' GLU . 20.0 m -99.01 132.09 44.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.962 0.411 . . . . 5.68 110.895 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -107.27 -163.8 0.93 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.845 -0.616 . . . . 6.25 110.935 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -75.71 -37.94 59.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.969 -0.559 . . . . 9.03 110.651 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -74.94 -18.42 60.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.384 -0.371 . . . . 8.29 110.794 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.98 22.78 54.4 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.839 -0.696 . . . . 5.65 111.801 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -113.96 121.53 44.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.462 0.173 . . . . 5.26 110.585 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -148.9 -179.32 6.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.006 0.432 . . . . 4.63 111.659 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.23 -124.81 1.64 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.635 -0.986 . . . . 3.57 110.635 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -138.72 117.11 11.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.832 0.316 . . . . 2.84 110.378 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 4.7 t -128.59 158.48 38.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.446 -0.343 . . . . 4.34 110.08 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 57.43 42.95 23.85 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.741 0.65 . . . . 6.23 110.953 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 22.3 mt -74.6 116.29 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.329 -0.85 . . . . 3.55 110.666 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -114.2 142.02 46.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 6.3 110.901 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.1 tp -83.41 119.21 24.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.927 -0.578 . . . . 4.63 110.125 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -87.64 -53.74 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.744 0.307 . . . . 4.97 110.581 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -142.92 122.94 7.89 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.918 0.389 . . . . 5.57 110.9 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.424 ' HA ' ' HB2' ' A' ' 137' ' ' ASP . 82.3 Cg_endo -79.78 157.36 24.42 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.787 2.325 . . . . 5.69 112.59 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -111.32 152.97 26.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.804 -0.634 . . . . 6.1 110.696 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -104.52 161.48 22.7 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.69 -0.485 . . . . 10.1 109.69 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.06 108.65 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.638 2.226 . . . . 8.39 112.652 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.236 0.349 0 CA-C-N 115.832 -0.622 . . . . 10.65 111.353 -179.23 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 112.087 -0.405 . . . . 22.01 112.087 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.28 149.47 33.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.853 0.359 . . . . 20.23 110.54 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.31 -52.61 4.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.139 -0.482 . . . . 18.59 112.007 -172.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -94.3 25.47 3.83 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.938 0.718 . . . . 17.11 112.938 -167.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -63.37 -77.4 0.05 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.208 0.528 . . . . 18.35 111.331 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -125.76 119.58 28.31 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.519 -0.764 . . . . 16.2 109.645 -176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.426 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 15.0 ptt180 -126.62 153.09 45.78 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.251 -0.431 . . . . 12.72 110.604 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.514 ' HB2' ' NH1' ' A' ' 27' ' ' ARG . 38.3 mt-10 -130.91 155.67 46.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.031 -0.531 . . . . 11.63 109.633 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -87.48 169.57 12.1 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.178 -0.465 . . . . 9.47 110.291 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.23 162.97 34.68 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.55 -0.833 . . . . 7.73 111.999 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -117.64 137.0 53.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.407 -0.59 . . . . 10.57 109.407 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.75 110.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.149 0.5 . . . . 8.73 110.471 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -72.09 -50.53 27.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.77 -0.65 . . . . 10.86 110.37 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HA ' HD13 ' A' ' 47' ' ' ILE . 38.1 ttpt -161.04 155.17 22.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.899 -1.046 . . . . 14.48 109.098 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 mt -116.15 126.76 54.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.156 0.503 . . . . 11.73 111.183 -175.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.4 mp -114.57 -179.89 3.76 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.649 -1.241 . . . . 11.9 107.649 173.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -90.62 126.64 36.02 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.182 -0.607 . . . . 16.67 110.27 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 m 80.56 -14.58 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.605 1.191 . . . . 13.28 111.995 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 12.5 p90 -159.59 162.31 35.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.764 0.316 . . . . 12.68 111.389 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.24 -176.78 27.82 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.085 -0.579 . . . . 7.92 112.054 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -115.94 143.92 44.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.823 0.344 . . . . 9.69 111.475 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.9 mt -113.79 120.19 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.856 -0.611 . . . . 7.75 110.075 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -69.48 147.04 51.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.476 0.655 . . . . 12.4 111.809 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.2 p -79.89 0.57 30.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.842 -1.072 . . . . 12.96 112.299 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 m -53.24 -31.32 42.83 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.662 0.616 . . . . 13.58 112.662 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -105.53 11.27 32.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.712 0.291 . . . . 12.19 111.431 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.514 ' NH1' ' HB2' ' A' ' 8' ' ' GLU . 7.5 ptm85 -153.95 -170.24 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.524 0.202 . . . . 12.99 111.326 -173.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -112.14 17.81 19.22 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.15 0.426 . . . . 17.26 112.15 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.81 149.17 17.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.524 -0.307 . . . . 12.1 110.885 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -92.86 135.69 33.91 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.177 -0.675 . . . . 13.0 109.177 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.1 mt -135.82 163.23 30.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.355 0.597 . . . . 9.21 111.904 -174.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -124.08 149.2 46.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.447 -0.946 . . . . 9.75 108.447 172.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -135.36 152.15 51.17 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.941 -0.304 . . . . 6.85 110.248 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 32.4 p-80 -109.71 152.4 25.67 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.689 -0.485 . . . . 10.15 109.689 175.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -70.2 4.52 2.15 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.252 0.834 . . . . 10.56 113.252 -168.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 t -77.78 -17.78 57.14 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.725 -0.472 . . . . 12.44 109.725 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -116.66 40.46 2.92 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.863 -0.608 . . . . 11.14 112.114 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -126.59 124.91 41.04 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.203 -0.599 . . . . 8.78 111.331 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 m -101.92 106.68 17.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.662 -0.699 . . . . 9.11 110.707 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.57 176.08 19.2 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.722 -0.751 . . . . 9.98 112.023 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -68.67 109.65 3.9 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.703 -0.481 . . . . 12.91 109.703 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -63.68 -25.05 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.166 0.508 . . . . 11.97 110.8 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.39 -23.19 62.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.126 -0.488 . . . . 14.73 110.745 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -93.42 2.96 56.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 13.3 110.949 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.431 HD12 ' OD1' ' A' ' 49' ' ' ASP . 26.3 tp -94.43 117.03 29.5 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.698 -0.853 . . . . 10.07 108.698 176.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -119.19 -173.9 2.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.523 -0.308 . . . . 13.53 110.849 -173.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.454 HD13 ' HA ' ' A' ' 14' ' ' LYS . 24.6 mm -87.55 133.03 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.76 -0.459 . . . . 12.26 109.76 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.73 10.85 82.62 Favored Glycine 0 CA--C 1.51 -0.235 0 N-CA-C 110.922 -0.871 . . . . 11.04 110.922 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.431 ' OD1' HD12 ' A' ' 45' ' ' LEU . 43.4 t0 -92.97 121.73 65.16 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.838 -0.681 . . . . 8.39 109.906 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.62 143.21 18.79 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.102 2.535 . . . . 8.18 114.058 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.0 m -138.75 160.71 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.667 -0.697 . . . . 4.78 110.413 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -117.74 130.53 56.37 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.807 -0.442 . . . . 7.09 109.807 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -142.35 155.57 45.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.443 0.639 . . . . 7.82 111.245 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 21.1 mt-10 -104.53 131.53 51.82 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.46 -0.791 . . . . 11.59 109.075 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.7 ttt -103.87 123.11 46.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.557 -0.292 . . . . 12.41 110.944 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.0 p -141.97 169.76 16.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.923 0.392 . . . . 13.93 111.124 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 53.1 m-85 -116.9 120.7 39.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.564 -0.532 . . . . 16.22 109.564 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' OD2' HG21 ' A' ' 61' ' ' THR . 21.4 t70 -81.99 121.43 26.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.724 0.297 . . . . 16.64 110.38 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -79.86 -6.97 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 23.23 112.267 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -84.04 -57.66 3.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.601 0.238 . . . . 21.87 110.702 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.473 HG23 ' HG2' ' A' ' 63' ' ' LYS . 8.8 t -91.62 -19.26 22.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.116 0.484 . . . . 17.49 110.774 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.86 34.16 22.39 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.457 -0.878 . . . . 17.22 113.365 172.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.473 ' HG2' HG23 ' A' ' 61' ' ' THR . 19.2 ptpt -124.74 150.05 64.36 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 117.485 0.643 . . . . 14.83 110.963 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.494 ' HB3' ' CE1' ' A' ' 57' ' ' TYR . 58.4 Cg_endo -73.43 126.66 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.398 2.065 . . . . 13.33 110.913 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.29 -179.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.286 0.565 . . . . 12.33 111.252 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.0 162.96 19.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.445 -0.798 . . . . 8.91 109.842 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 30.4 t -72.87 -164.03 0.15 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.706 -0.679 . . . . 10.33 109.576 175.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -74.11 17.34 0.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.833 0.679 . . . . 12.02 112.833 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.407 ' H ' ' C ' ' A' ' 67' ' ' SER . 61.2 t 37.88 93.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.149 0.98 . . . . 6.52 112.602 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.2 t -82.13 123.06 28.63 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.354 -0.609 . . . . 6.18 109.354 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -73.76 121.65 21.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.329 -0.619 . . . . 6.59 109.329 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.12 117.89 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.481 -0.781 . . . . 6.16 111.639 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.93 147.69 66.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.79 -0.641 . . . . 6.03 110.464 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.99 123.27 7.76 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.429 2.086 . . . . 7.28 112.297 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -86.6 110.95 20.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.48 0.657 . . . . 8.49 111.051 178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.5 t -90.05 144.38 9.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.438 -0.801 . . . . 6.19 109.448 177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 26.6 t -78.65 83.87 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.062 0.458 . . . . 6.54 110.541 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.522 HD13 ' HB3' ' A' ' 144' ' ' ALA . 3.6 tp -82.74 17.26 1.9 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.694 -0.684 . . . . 6.46 110.61 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 m -133.69 36.93 3.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.506 0.558 . . . . 7.24 112.506 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.14 -51.17 11.45 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.373 -0.531 . . . . 7.07 110.334 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -167.43 139.5 3.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 6.68 110.032 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.485 ' HD3' ' C ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -96.1 114.46 26.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.545 -0.539 . . . . 6.93 109.545 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.88 171.0 12.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.694 -0.684 . . . . 4.0 110.112 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.9 p -108.4 148.44 30.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.333 -0.618 . . . . 3.84 109.333 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -114.04 137.41 14.07 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.429 -0.891 . . . . 2.58 112.311 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -120.0 112.1 18.74 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.115 -0.698 . . . . 3.7 109.115 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.635 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 59.1 t -66.83 127.63 28.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.161 -0.472 . . . . 3.14 110.483 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.1 p -109.07 -20.0 13.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.135 0.493 . . . . 3.77 111.092 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.7 m -148.98 124.99 10.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.462 -0.57 . . . . 3.29 109.462 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.86 -179.1 7.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.033 0.444 . . . . 4.39 110.869 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.56 124.9 23.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.824 -0.626 . . . . 3.62 109.506 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -68.05 121.45 16.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.995 0.426 . . . . 7.76 111.078 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.448 HG22 ' CG2' ' A' ' 99' ' ' VAL . 40.5 p -76.72 97.25 4.42 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.068 0.461 . . . . 5.1 110.067 172.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -92.14 8.75 36.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.502 1.144 . . . . 7.53 108.317 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.5 t -124.85 142.56 51.36 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 113.476 -1.693 . . . . 7.77 107.788 172.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.49 85.57 0.43 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.68 0.276 . . . . 8.0 111.565 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.6 t30 74.94 -29.13 0.19 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.691 0.796 . . . . 8.83 112.33 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.602 ' O ' HG11 ' A' ' 99' ' ' VAL . 63.7 t30 -66.64 -42.85 86.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.402 -0.222 . . . . 7.69 110.402 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.602 HG11 ' O ' ' A' ' 98' ' ' ASN . 5.0 p 50.5 26.56 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.025 0.93 . . . . 5.85 113.12 169.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.438 HD22 ' ND2' ' A' ' 98' ' ' ASN . 2.2 pt? -75.05 -2.81 29.09 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.16 0.8 . . . . 7.65 113.16 -172.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -125.35 32.38 5.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.098 0.475 . . . . 8.21 111.063 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 p -90.42 27.93 1.58 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.131 -0.486 . . . . 5.58 110.876 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.6 m -73.36 -34.99 65.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.145 -0.48 . . . . 4.8 111.36 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.32 -31.87 12.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 5.09 111.933 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -68.38 127.2 32.12 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.395 0.617 . . . . 3.7 110.055 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 56.9 p -98.56 137.2 37.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.435 -0.802 . . . . 2.84 111.537 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -86.39 -169.06 45.54 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.059 -0.816 . . . . 1.91 111.059 173.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -128.3 120.81 27.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.982 0.42 . . . . 3.31 111.226 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.432 HG13 ' CD1' ' A' ' 122' ' ' TYR . 80.0 mt -110.95 125.09 68.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.599 -0.728 . . . . 2.17 109.341 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.7 t -104.25 142.1 35.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.984 0.421 . . . . 3.61 110.681 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -147.44 165.58 29.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.456 -0.942 . . . . 3.58 108.456 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.96 125.21 27.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.386 -0.598 . . . . 5.1 109.386 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -135.27 107.75 7.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 5.11 110.938 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 62.64 28.66 16.71 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.749 -0.66 . . . . 7.42 111.906 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.34 -1.57 62.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.162 -0.542 . . . . 5.36 112.996 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -104.65 110.81 23.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.1 0.476 . . . . 5.38 110.365 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 45.5 t -112.39 127.44 56.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.883 -0.599 . . . . 4.96 109.872 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -135.37 166.95 21.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 5.13 111.013 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -110.26 123.96 50.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.562 -0.744 . . . . 4.32 109.593 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 8.4 mp -104.48 132.88 20.54 Favored Pre-proline 0 C--N 1.322 -0.607 0 C-N-CA 121.069 -0.252 . . . . 3.17 110.492 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 2.8 Cg_exo -75.37 133.16 15.73 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.741 2.294 . . . . 2.61 111.664 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.432 ' CD1' HG13 ' A' ' 109' ' ' ILE . 17.6 p90 -135.16 144.81 47.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.679 -0.237 . . . . 2.49 110.483 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.4 p -109.18 -177.62 3.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.109 -0.33 . . . . 3.18 110.109 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -70.6 -22.4 62.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.236 0.541 . . . . 5.22 110.725 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.25 -25.93 52.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.488 -0.778 . . . . 4.81 110.975 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.483 ' HB3' ' O ' ' A' ' 153' ' ' ALA . 21.7 m-20 -74.26 -30.55 62.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.027 -0.533 . . . . 4.0 111.795 -175.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 156' ' ' ILE . 2.5 p -84.59 118.63 32.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.651 0.739 . . . . 4.39 111.052 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -89.92 136.22 33.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.347 -0.842 . . . . 6.43 109.769 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.34 -19.85 38.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.772 -0.728 . . . . 6.14 111.848 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 60.09 71.01 0.59 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.383 0.611 . . . . 6.26 110.904 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 t -108.12 149.43 11.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.117 -0.492 . . . . 5.62 110.122 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -91.7 102.03 14.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.002 0.43 . . . . 6.25 110.155 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.532 HD23 ' H ' ' A' ' 133' ' ' LEU . 1.8 pt? -114.97 143.44 45.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.593 -0.731 . . . . 3.62 110.267 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -117.62 -179.99 3.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 7.5 109.913 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.635 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.81 132.46 42.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.314 -0.403 . . . . 4.12 110.47 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 104.95 -14.44 48.95 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.068 -0.587 . . . . 4.2 112.444 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.488 ' OD2' ' HB1' ' A' ' 162' ' ' ALA . 54.3 m-20 -84.77 146.45 27.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.466 -0.568 . . . . 4.06 109.466 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -93.5 116.47 29.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.588 0.709 . . . . 4.48 111.778 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.1 m -120.22 166.31 14.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.974 -1.012 . . . . 2.98 110.311 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.604 ' HB3' ' OE1' ' A' ' 159' ' ' GLU . 21.0 p -118.96 133.27 55.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.755 -0.461 . . . . 3.68 109.755 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -135.12 142.52 46.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.774 -0.454 . . . . 3.35 109.774 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -98.26 129.33 44.98 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.838 -0.619 . . . . 5.34 110.057 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.41 98.62 2.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.067 -0.716 . . . . 4.66 109.067 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -102.72 110.07 21.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.148 -0.933 . . . . 5.08 111.599 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.45 122.35 26.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.93 -0.577 . . . . 5.68 110.459 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.1 p30 -86.38 -172.42 4.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.057 0.456 . . . . 6.25 110.803 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -83.54 6.54 20.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.957 -0.565 . . . . 9.03 111.574 -172.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -115.28 1.66 13.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.353 -0.385 . . . . 8.29 110.935 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.79 20.75 70.2 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.768 -0.73 . . . . 5.65 113.294 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -123.99 154.97 39.05 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 5.26 109.127 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.474 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -156.07 176.43 12.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.225 0.536 . . . . 4.63 111.822 -178.135 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.59 -138.9 3.0 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.351 -1.1 . . . . 3.57 110.351 174.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 126' ' ' ASP . . . -121.97 109.0 14.06 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.582 -0.525 . . . . 2.84 109.582 175.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.17 162.7 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.505 -0.316 . . . . 4.34 110.535 -175.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 60.53 33.81 20.45 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.552 0.691 . . . . 6.23 110.043 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 127' ' ' VAL . 70.8 mt -59.84 123.33 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.7 -1.136 . . . . 3.55 110.95 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -124.13 127.55 47.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.9 0.381 . . . . 6.3 110.606 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.46 96.72 2.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 4.63 109.692 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.604 ' OE1' ' HB3' ' A' ' 140' ' ' SER . 6.6 pt-20 -76.86 -35.68 57.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 4.97 110.916 -176.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -137.56 102.26 8.76 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.499 -0.319 . . . . 5.57 110.699 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.23 151.71 49.31 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.523 2.149 . . . . 5.69 112.223 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.488 ' HB1' ' OD2' ' A' ' 137' ' ' ASP . . . -107.97 90.12 3.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.462 0.649 . . . . 6.1 110.549 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -102.12 146.52 32.45 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.42 -0.809 . . . . 10.1 109.903 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.84 107.57 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.472 2.115 . . . . 8.39 112.328 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.3 t . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.969 -0.56 . . . . 10.65 110.333 179.622 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.42 0 N-CA-C 112.21 -0.356 . . . . 22.01 112.21 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.57 11.74 12.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.169 0.509 . . . . 20.23 110.726 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.39 -39.18 85.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.766 . . . . 18.59 111.125 -178.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.39 63.53 3.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.519 . . . . 17.11 110.532 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -117.36 -59.58 1.92 Allowed 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 121.02 0.438 . . . . 18.35 110.705 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 3.8 mp0 -73.46 79.0 1.41 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.544 -0.753 . . . . 16.2 112.13 -178.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 10.6 ptp180 -106.99 115.86 30.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.344 0.592 . . . . 12.72 109.798 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.37 156.23 21.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.551 -0.75 . . . . 11.63 110.652 -173.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.1 p -110.52 136.75 49.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.414 -0.357 . . . . 9.47 111.007 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.96 178.21 25.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 7.73 111.909 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.9 mt -124.56 143.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.842 0.321 . . . . 10.57 110.249 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.3 mm -73.58 106.59 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.438 -0.579 . . . . 8.73 109.438 174.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -73.41 -43.92 59.44 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.966 0.412 . . . . 10.86 110.504 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -155.75 162.59 40.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.005 -0.543 . . . . 14.48 109.563 -176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 mt -119.82 118.63 31.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.171 0.51 . . . . 11.73 111.071 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -111.82 179.99 3.86 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.328 -0.99 . . . . 11.9 108.328 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -90.2 117.31 28.86 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.749 -0.781 . . . . 16.67 110.151 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.6 m 78.71 -7.55 1.77 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.06 -0.973 . . . . 13.28 112.442 178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.69 168.57 26.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.718 0.294 . . . . 12.68 110.886 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.68 -166.61 22.82 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.187 -0.53 . . . . 7.92 112.068 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -125.99 139.51 53.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 9.69 110.945 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.0 mt -101.77 120.36 51.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 7.75 109.574 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -75.92 143.02 41.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.559 -0.746 . . . . 12.4 110.993 -175.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -79.14 3.1 18.64 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.353 -0.839 . . . . 12.96 112.631 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.0 t -51.43 -51.26 56.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.506 0.558 . . . . 13.58 112.506 -173.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -90.46 16.94 7.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.289 0.566 . . . . 12.19 111.01 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.571 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 38.6 ttt180 -144.83 -158.63 0.91 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.041 -1.096 . . . . 12.99 108.041 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.571 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 13.4 mm-40 -136.22 23.58 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.189 0.518 . . . . 17.26 110.413 167.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.421 ' O ' ' HD3' ' A' ' 27' ' ' ARG . . . -151.8 119.53 6.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.664 -0.698 . . . . 12.1 110.633 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -86.63 151.71 23.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.147 -0.479 . . . . 13.0 110.112 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.509 HD12 ' SD ' ' A' ' 55' ' ' MET . 59.6 mt -141.77 162.17 36.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 9.21 111.423 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -103.6 143.41 32.79 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.664 -0.865 . . . . 9.75 108.664 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -137.93 147.62 44.51 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.269 -0.572 . . . . 6.85 110.179 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -103.41 155.11 18.73 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.368 -0.604 . . . . 10.15 109.368 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -67.25 -13.27 61.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.697 0.284 . . . . 10.56 111.37 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 p -70.78 -24.17 62.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.537 . . . . 12.44 110.148 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -94.1 20.53 7.83 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.642 -0.708 . . . . 11.14 110.995 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -125.03 123.17 39.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.932 0.396 . . . . 8.78 110.705 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.3 t -111.51 100.8 9.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.72 -0.673 . . . . 9.11 110.218 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.77 -169.78 36.53 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.968 -0.634 . . . . 9.98 111.915 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -83.89 103.68 13.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 12.91 110.323 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.9 tp -67.62 -24.18 30.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.943 -0.571 . . . . 11.97 110.918 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.79 -12.78 61.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 14.73 111.023 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -104.25 4.5 33.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 13.3 110.202 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.9 tp -103.79 110.14 22.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.485 . . . . 10.07 110.701 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -114.11 -178.87 3.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.221 0.534 . . . . 13.53 110.935 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.3 mp -73.08 140.19 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.601 -0.727 . . . . 12.26 110.208 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.84 -2.19 66.37 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 121.013 -0.613 . . . . 11.04 112.378 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.501 ' CG ' ' HZ2' ' A' ' 71' ' ' LYS . 32.2 t70 -91.71 127.98 48.03 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 120.58 0.229 . . . . 8.39 110.608 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.76 141.7 13.73 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.194 2.596 . . . . 8.18 113.632 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.7 m -128.57 157.93 40.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.799 -0.637 . . . . 4.78 111.186 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -113.17 124.06 51.67 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.997 -0.742 . . . . 7.09 108.997 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -136.87 142.13 42.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.286 0.565 . . . . 7.82 111.614 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' CD ' ' HB2' ' A' ' 67' ' ' SER . 0.2 OUTLIER -88.88 141.29 28.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.009 -0.737 . . . . 11.59 109.009 173.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.509 ' SD ' HD12 ' A' ' 31' ' ' LEU . 24.5 ttt -124.0 114.01 19.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.35 -0.241 . . . . 12.41 110.35 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.5 p -134.99 164.67 27.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.153 0.501 . . . . 13.93 111.425 -177.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -95.31 113.4 25.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.025 -0.534 . . . . 16.22 110.083 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.97 124.08 26.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.032 0.444 . . . . 16.64 110.469 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -79.72 -8.87 59.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.684 -0.689 . . . . 23.23 111.266 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -81.0 -56.87 3.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 21.87 110.357 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.5 p -86.65 -45.84 10.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.169 -0.469 . . . . 17.49 111.645 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.0 0.22 35.85 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.626 -0.797 . . . . 17.22 112.322 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -95.87 150.78 37.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.152 -0.314 . . . . 14.83 110.152 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.15 125.29 8.45 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.953 1.769 . . . . 13.33 109.502 171.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -126.94 162.4 31.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.04 0.447 . . . . 12.33 111.362 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.54 151.62 20.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.405 -0.816 . . . . 8.91 109.284 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.533 ' HB2' ' CD ' ' A' ' 54' ' ' GLU . 11.8 t -75.88 -157.22 0.07 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.041 -0.527 . . . . 10.33 109.79 177.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -75.12 19.23 0.16 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.838 0.681 . . . . 12.02 112.838 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.416 ' H ' ' C ' ' A' ' 67' ' ' SER . 87.0 t 33.83 94.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.537 1.135 . . . . 6.52 113.108 178.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.8 m -80.36 120.73 24.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.461 0.648 . . . . 6.18 110.358 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.673 ' HE2' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -68.1 113.48 5.8 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.664 -0.698 . . . . 6.59 110.537 -179.038 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.673 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 79.5 mt -56.63 106.22 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.175 -0.466 . . . . 6.16 110.328 173.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.91 163.79 4.44 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.067 -0.716 . . . . 6.03 109.067 -177.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -53.67 135.78 63.08 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.143 1.895 . . . . 7.28 111.866 173.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -75.29 -167.35 0.63 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.058 -0.519 . . . . 8.49 111.017 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.12 141.01 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.885 -0.598 . . . . 6.19 110.93 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 38.4 t -67.7 89.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 6.54 110.962 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 144' ' ' ALA . 4.1 tt -91.18 -27.95 18.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 6.46 110.781 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 t -116.37 99.86 7.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.071 -0.513 . . . . 7.24 110.68 -175.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -125.21 -68.15 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.514 -0.767 . . . . 7.07 109.017 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -130.69 127.88 39.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.181 -0.674 . . . . 6.68 109.181 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.98 126.39 32.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.964 0.411 . . . . 6.93 110.151 -177.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.39 167.4 13.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.093 -0.503 . . . . 4.0 111.117 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 p -120.75 146.23 46.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.809 -0.632 . . . . 3.84 110.327 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.39 162.61 26.5 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.6 -0.81 . . . . 2.58 112.382 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.5 m -106.61 135.24 48.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.826 -0.435 . . . . 3.7 109.826 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 1.1 t -68.98 121.56 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.863 -0.421 . . . . 3.14 109.863 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -27.82 16.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.146 0.498 . . . . 3.77 110.227 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.5 m -155.29 138.01 15.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.003 -0.544 . . . . 3.29 110.407 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -99.85 -171.8 2.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.339 0.59 . . . . 4.39 111.568 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 91' ' ' LEU . 2.5 mm? -83.79 136.89 33.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.95 -1.023 . . . . 3.62 109.22 174.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -73.69 141.44 46.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.155 0.502 . . . . 7.76 111.213 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.07 30.97 0.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.387 -0.824 . . . . 5.1 111.057 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.22 83.92 0.09 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.599 -0.728 . . . . 7.53 111.699 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.5 m -163.08 -173.08 3.27 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.053 -0.976 . . . . 7.77 109.173 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.33 -89.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.857 0.317 . . . . 8.0 111.857 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -99.12 -6.98 27.35 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.81 0.338 . . . . 8.83 111.474 -175.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -131.52 -167.68 1.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.28 -1.007 . . . . 7.69 108.28 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.85 166.94 3.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 110.022 -0.362 . . . . 5.85 110.022 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.6 tp -92.3 88.66 6.53 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.999 0.904 . . . . 7.65 108.633 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -63.42 -25.54 68.33 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.901 -1.5 . . . . 8.21 111.409 -175.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.8 t -76.81 102.74 6.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.713 -0.847 . . . . 5.58 108.713 172.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m -75.77 86.27 2.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.158 -0.474 . . . . 4.8 111.819 -172.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 -20.59 28.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.339 0.59 . . . . 5.09 109.634 172.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.3 t -99.0 158.66 15.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.38 -0.827 . . . . 3.7 109.968 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 t -130.52 143.67 50.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.914 0.388 . . . . 2.84 110.3 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.74 -168.34 39.58 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.727 -0.749 . . . . 1.91 111.881 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.515 ' NH2' ' HB3' ' A' ' 121' ' ' PRO . 1.1 mmp_? -136.29 130.33 32.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.844 0.354 . . . . 3.31 110.746 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.6 mt -112.53 126.99 69.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.228 -0.656 . . . . 2.17 109.228 171.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 p -108.18 123.19 48.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.439 -0.346 . . . . 3.61 110.608 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.36 156.9 47.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.763 -0.458 . . . . 3.58 109.763 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 116' ' ' GLU . 3.5 tm-20 -132.35 120.86 22.64 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.339 -0.615 . . . . 5.1 109.339 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.762 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 8.6 t30 -130.74 106.48 8.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.199 -0.455 . . . . 5.11 110.724 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 57.94 38.19 26.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.024 -0.535 . . . . 7.42 111.64 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.59 -5.67 64.72 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.983 -0.627 . . . . 5.36 114.091 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.762 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 11.7 pt-20 -95.01 124.6 39.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 118.071 0.935 . . . . 5.38 109.733 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 44.1 t -124.24 104.46 8.83 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.518 -0.549 . . . . 4.96 109.518 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.23 152.71 32.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 5.13 110.979 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -102.65 117.55 34.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.776 -0.824 . . . . 4.32 108.776 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.19 127.64 29.31 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.817 0.341 . . . . 3.17 110.622 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.515 ' HB3' ' NH2' ' A' ' 108' ' ' ARG . 58.7 Cg_endo -76.18 135.88 17.46 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.547 2.165 . . . . 2.61 111.906 175.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -148.73 159.95 43.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.996 -0.742 . . . . 2.49 108.996 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.7 p -116.45 171.9 7.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.921 0.391 . . . . 3.18 110.294 175.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -63.93 -21.98 66.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.443 0.64 . . . . 5.22 110.484 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.4 -4.11 58.16 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.606 -0.724 . . . . 4.81 111.88 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -90.76 -9.54 46.24 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.712 0.291 . . . . 4.0 111.417 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 p -102.73 133.02 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.218 0.532 . . . . 4.39 111.335 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -94.45 144.86 25.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.948 -0.569 . . . . 6.43 110.24 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.33 -14.12 23.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.908 -0.663 . . . . 6.14 112.998 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 62.3 t30 53.89 50.86 15.92 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.653 0.74 . . . . 6.26 110.139 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.83 156.48 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.515 -0.766 . . . . 5.62 110.424 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -84.84 120.72 26.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.814 0.34 . . . . 6.25 111.632 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.42 136.72 44.45 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.69 -0.855 . . . . 3.62 108.69 173.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -142.62 157.5 44.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.741 -0.384 . . . . 7.5 110.561 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.523 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -58.66 120.28 8.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.869 0.366 . . . . 4.12 111.121 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.27 -17.4 10.51 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.668 -0.777 . . . . 4.2 113.487 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -92.45 175.47 6.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.017 0.908 . . . . 4.06 109.967 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -119.15 118.81 32.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.353 0.597 . . . . 4.48 111.17 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.2 m -117.18 160.79 16.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.586 -0.734 . . . . 2.98 111.339 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.3 t -117.14 131.74 56.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.051 -0.722 . . . . 3.68 109.051 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -134.31 155.42 50.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.823 0.344 . . . . 3.35 110.46 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -109.15 140.86 42.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.032 0.444 . . . . 5.34 110.292 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.6 mt -110.72 110.1 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.896 -0.593 . . . . 4.66 110.589 -174.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -87.39 107.17 18.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.033 0.444 . . . . 5.08 111.083 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.424 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 28.3 m -96.26 117.02 29.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.699 -0.682 . . . . 5.68 111.777 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -85.97 164.21 17.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.423 -0.584 . . . . 6.25 109.423 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.47 -27.95 62.93 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.698 0.399 . . . . 9.03 111.191 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -71.14 -13.53 61.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.08 -0.509 . . . . 8.29 111.704 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.65 22.3 62.27 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.689 -0.767 . . . . 5.65 111.967 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -105.47 124.06 48.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.832 -0.433 . . . . 5.26 109.832 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.457 ' N ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.43 168.87 23.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.963 0.411 . . . . 4.63 112.065 -177.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.78 -168.27 16.57 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.763 -0.935 . . . . 3.57 110.763 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.31 116.73 33.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.122 0.461 . . . . 2.84 110.852 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.3 t -140.46 158.5 43.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.519 -0.549 . . . . 4.34 109.519 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 58.2 65.72 1.23 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.294 0.569 . . . . 6.23 110.554 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 mp -89.16 138.5 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.432 -0.804 . . . . 3.55 110.53 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -126.09 129.36 48.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.872 -0.604 . . . . 6.3 110.278 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 55.6 tp -82.69 110.98 18.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.982 -0.377 . . . . 4.63 109.982 178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.07 -48.25 6.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 4.97 111.261 -176.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -128.19 100.13 23.83 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.806 0.336 . . . . 5.57 110.945 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -87.2 151.28 8.08 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.013 2.475 . . . . 5.69 111.913 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -88.21 97.94 11.29 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.964 0.411 . . . . 6.1 110.474 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -129.52 143.56 49.42 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.883 -0.599 . . . . 10.1 111.221 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -87.94 155.18 7.22 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.791 2.327 . . . . 8.39 112.445 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 52.1 t . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.058 -0.519 . . . . 10.65 110.664 -178.687 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 112.27 -0.332 . . . . 22.01 112.27 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.96 83.35 1.27 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.823 -0.436 . . . . 20.23 109.823 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -113.0 -52.15 2.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.679 -0.691 . . . . 18.59 111.218 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -98.16 80.83 2.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.991 0.901 . . . . 17.11 110.938 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -121.2 -18.24 7.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.641 -1.163 . . . . 18.35 109.835 175.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -106.68 109.68 21.65 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.88 -1.054 . . . . 16.2 110.322 -174.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -103.73 148.75 25.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.278 -0.638 . . . . 12.72 109.278 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.641 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.9 pt-20 -156.82 148.93 22.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.667 0.746 . . . . 11.63 112.293 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.416 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 11.8 p -116.67 162.15 18.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.226 -0.897 . . . . 9.47 110.968 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.56 -176.21 36.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.155 -0.545 . . . . 7.73 111.992 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.2 mt -121.35 142.53 37.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.156 -0.683 . . . . 10.57 109.156 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.3 mm -65.87 117.99 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 117.843 0.292 . . . . 8.73 110.223 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -84.21 -49.73 8.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.76 -0.655 . . . . 10.86 110.427 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -151.47 145.9 25.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.376 -0.829 . . . . 14.48 110.324 -177.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.6 mt -117.58 110.51 18.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.218 0.532 . . . . 11.73 110.842 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.2 mt -108.35 -177.82 3.43 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.085 -0.961 . . . . 11.9 108.727 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 18' ' ' SER . 44.2 m80 -87.28 122.3 30.87 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.246 -0.582 . . . . 16.67 109.874 -174.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 17' ' ' HIS . 38.2 m 83.1 -20.31 0.34 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.671 1.232 . . . . 13.28 112.102 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 32.3 p90 -147.19 143.51 28.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.028 0.442 . . . . 12.68 111.678 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.2 164.63 22.15 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.69 -0.686 . . . . 7.92 111.632 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -117.5 145.34 44.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.012 0.434 . . . . 9.69 111.369 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.3 mt -111.49 132.86 58.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.496 -0.775 . . . . 7.75 110.287 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.96 145.88 37.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.505 0.669 . . . . 12.4 111.401 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.0 p -79.51 3.97 17.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.894 -1.048 . . . . 12.96 112.639 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.4 m -51.14 -30.41 16.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.59 0.589 . . . . 13.58 112.59 -174.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 9' ' ' THR . 32.7 mm-40 -109.91 6.68 23.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.6 0.238 . . . . 12.19 111.523 -176.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 10.5 tpt180 -143.71 -176.75 5.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.8 0.333 . . . . 12.99 111.062 -171.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.473 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 14.6 mm100 -104.09 12.97 33.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.435 0.636 . . . . 17.26 109.963 176.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.97 140.42 16.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.219 -0.901 . . . . 12.1 110.499 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.453 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -96.43 120.27 36.43 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.338 -0.616 . . . . 13.0 109.338 171.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.4 mt -102.5 162.96 12.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.379 0.609 . . . . 9.21 111.883 -173.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -125.22 145.31 50.04 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.064 -0.971 . . . . 9.75 109.346 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -142.7 149.48 38.88 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.555 -0.535 . . . . 6.85 109.555 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 8.8 p-80 -99.78 165.51 11.55 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.267 -0.573 . . . . 10.15 109.919 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -66.3 -2.41 4.39 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.845 0.683 . . . . 10.56 112.845 -169.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 m -79.28 -17.87 53.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.945 0.402 . . . . 12.44 110.531 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 67' ' ' SER . 26.0 mp0 -111.61 39.68 2.29 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.306 -0.407 . . . . 11.14 111.419 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -125.97 130.19 50.72 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.503 -0.479 . . . . 8.78 110.123 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 m -84.44 109.91 18.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 9.11 111.025 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.88 -157.63 15.07 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.636 -0.793 . . . . 9.98 112.607 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -90.07 133.2 34.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.788 0.328 . . . . 12.91 110.988 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -72.42 -11.25 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.416 0.627 . . . . 11.97 109.911 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.34 -29.42 68.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.164 -0.925 . . . . 14.73 111.79 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -106.11 14.08 28.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 13.3 111.817 -175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 tp -97.81 128.38 44.4 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.42 -0.512 . . . . 10.07 109.92 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -118.27 163.5 16.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.206 0.527 . . . . 13.53 110.455 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.28 122.9 24.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.269 -1.011 . . . . 12.26 108.269 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.82 -8.44 29.74 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.691 -0.766 . . . . 11.04 112.377 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.54 130.24 90.79 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.818 0.309 . . . . 8.39 110.167 176.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.39 122.62 5.68 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.697 2.264 . . . . 8.18 111.688 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.15 151.85 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.44 0.638 . . . . 4.78 111.746 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -111.17 125.73 54.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.921 -1.036 . . . . 7.09 109.045 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.641 ' CE2' ' HG3' ' A' ' 8' ' ' GLU . 33.2 p90 -131.75 179.35 6.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.405 0.621 . . . . 7.82 111.246 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.514 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 25.9 tt0 -148.51 104.29 3.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.432 -0.804 . . . . 11.59 109.074 -170.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.0 ttt -84.16 128.79 34.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.38 -0.373 . . . . 12.41 111.154 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -145.44 164.72 30.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.243 -0.435 . . . . 13.93 110.672 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -107.6 110.75 22.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.57 -0.286 . . . . 16.22 110.755 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD2' HG23 ' A' ' 61' ' ' THR . 16.6 t70 -79.15 109.81 13.81 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.825 -0.435 . . . . 16.64 109.825 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -69.61 -15.41 63.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.473 -0.785 . . . . 23.23 111.819 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.457 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 40.1 ttm105 -76.97 -54.01 7.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.713 0.292 . . . . 21.87 110.839 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.511 HG23 ' OD2' ' A' ' 58' ' ' ASP . 9.1 t -85.64 -35.03 21.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.18 -0.463 . . . . 17.49 111.059 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.07 30.77 9.78 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.878 -0.677 . . . . 17.22 113.762 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.463 ' HE3' ' OG1' ' A' ' 61' ' ' THR . 16.8 ptpt -135.6 148.45 65.72 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 117.357 0.578 . . . . 14.83 110.022 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.82 126.89 11.06 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.088 1.859 . . . . 13.33 110.944 176.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.31 167.53 25.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.085 0.469 . . . . 12.33 111.303 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.23 159.91 15.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.058 -0.719 . . . . 8.91 109.058 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.514 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 9.1 t -70.91 -166.05 0.14 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.914 -0.402 . . . . 10.33 109.914 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -75.64 22.69 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.495 0.924 . . . . 12.02 113.495 -170.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t 34.24 98.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.141 1.164 . . . . 6.52 114.141 171.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.2 t -105.52 138.07 42.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.262 -0.644 . . . . 6.18 109.262 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -73.84 144.28 45.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.372 -0.603 . . . . 6.59 109.372 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.7 mt -76.41 116.71 19.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.887 0.375 . . . . 6.16 111.037 -175.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.47 148.88 56.49 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.71 -0.677 . . . . 6.03 110.767 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.24 -50.21 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.414 2.076 . . . . 7.28 113.16 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 57.81 96.2 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.463 0.649 . . . . 8.49 111.967 -173.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.53 113.58 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.671 -0.695 . . . . 6.19 110.318 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 43.8 t -70.35 105.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.923 0.392 . . . . 6.54 111.369 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.5 mt -97.08 5.59 50.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.49 . . . . 6.46 111.705 -178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.7 t -149.16 100.73 3.07 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.528 -0.469 . . . . 7.24 111.434 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -132.69 -66.95 0.66 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.811 -0.811 . . . . 7.07 108.811 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -165.5 148.32 7.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.126 -0.943 . . . . 6.68 108.831 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -82.59 102.02 11.15 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.711 -0.478 . . . . 6.93 109.711 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 m -77.34 156.94 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.114 -0.493 . . . . 4.0 110.335 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.8 p -123.16 141.77 51.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.065 -0.516 . . . . 3.84 110.493 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.99 169.36 25.34 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.018 -0.611 . . . . 2.58 111.644 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.2 m -103.94 130.32 51.55 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.583 -0.525 . . . . 3.7 109.583 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 2.1 t -68.87 121.37 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 109.236 -0.653 . . . . 3.14 109.236 176.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.1 p -91.63 -24.71 19.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.34 0.59 . . . . 3.77 110.553 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.6 m -151.77 125.58 9.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.391 -0.822 . . . . 3.29 109.123 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.59 172.66 6.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.307 0.575 . . . . 4.39 112.079 -172.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.0 mt -75.78 141.17 42.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.054 -0.975 . . . . 3.62 110.354 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -111.0 112.07 23.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.106 0.479 . . . . 7.76 110.828 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 77.4 p -115.87 147.04 41.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.311 -0.858 . . . . 5.1 109.71 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.48 -37.02 57.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.724 0.297 . . . . 7.53 111.32 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 98' ' ' ASN . 34.5 t -151.36 -178.58 6.74 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.886 -0.413 . . . . 7.77 109.886 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.88 -36.11 56.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.272 -0.422 . . . . 8.0 110.257 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -99.04 -6.8 27.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 8.83 110.353 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 20.7 t-20 -109.42 93.9 4.75 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.515 0.674 . . . . 7.69 109.575 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 p -151.37 89.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 114.619 -1.173 . . . . 5.85 109.059 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.2 tp -138.99 96.84 3.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.406 -0.816 . . . . 7.65 110.632 -176.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.453 ' HB2' ' HG2' ' A' ' 104' ' ' GLU . 8.7 p30 -133.47 -30.76 1.26 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.646 -1.161 . . . . 8.21 109.415 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t 58.86 71.29 0.59 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.265 -0.879 . . . . 5.58 111.481 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 p 53.65 23.05 3.38 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.053 1.131 . . . . 4.8 114.053 173.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 101' ' ' ASN . 8.3 pt-20 -79.24 -43.98 22.68 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.227 -0.589 . . . . 5.09 110.272 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.433 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 8.3 t -106.96 123.87 48.8 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.219 0.533 . . . . 3.7 110.128 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.7 p -106.2 134.63 49.03 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.773 -0.649 . . . . 2.84 111.007 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -78.61 174.25 55.17 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.465 -0.874 . . . . 1.91 110.988 175.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -125.56 123.72 39.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.244 0.522 . . . . 3.31 111.502 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -111.3 129.1 67.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.971 -0.752 . . . . 2.17 108.971 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.4 t -116.07 132.95 56.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.178 0.513 . . . . 3.61 110.931 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -143.81 155.95 44.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.946 -0.761 . . . . 3.58 108.946 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -109.02 137.12 47.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.793 0.33 . . . . 5.1 110.144 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -158.64 130.21 6.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.267 -0.424 . . . . 5.11 111.475 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 57.09 29.98 17.46 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.231 0.539 . . . . 7.42 112.121 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.33 -14.12 65.95 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.618 -0.719 . . . . 5.36 112.598 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -102.95 135.86 43.84 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.824 0.345 . . . . 5.38 110.811 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 12.1 p -107.6 111.73 24.11 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.114 -0.494 . . . . 4.96 109.69 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -101.11 153.76 19.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.217 0.532 . . . . 5.13 111.961 -173.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -119.5 113.49 20.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.686 -0.857 . . . . 4.32 108.686 172.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.49 136.13 19.27 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.298 -0.41 . . . . 3.17 111.007 -172.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -77.32 132.9 12.81 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.733 2.289 . . . . 2.61 111.953 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -135.63 143.79 45.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.055 0.455 . . . . 2.49 110.035 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.8 p -114.25 -179.01 3.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.574 -0.528 . . . . 3.18 109.574 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -16.98 59.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.039 0.447 . . . . 5.22 110.769 178.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -84.03 -10.89 57.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.797 -0.638 . . . . 4.81 111.053 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -88.28 -21.05 24.67 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.758 0.313 . . . . 4.0 111.385 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -96.8 111.61 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.467 0.651 . . . . 4.39 110.918 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -89.87 129.37 36.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.561 -0.745 . . . . 6.43 110.115 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 128.22 -15.68 6.1 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.58 -0.737 . . . . 6.14 111.359 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.2 m120 57.95 46.6 16.33 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 122.978 0.511 . . . . 6.26 110.755 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.4 p -112.01 152.99 13.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.042 -0.527 . . . . 5.62 110.808 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -87.95 115.4 25.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 6.25 110.667 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.507 ' H ' HD22 ' A' ' 133' ' ' LEU . 2.3 pt? -114.82 142.83 46.02 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.738 -0.467 . . . . 3.62 109.738 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.07 175.2 11.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.335 -0.546 . . . . 7.5 111.474 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.548 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -65.66 122.81 18.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.317 -0.401 . . . . 4.12 111.77 -177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 120.09 -29.69 5.9 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.836 -0.697 . . . . 4.2 113.265 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.61 166.96 11.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.576 0.688 . . . . 4.06 110.281 173.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -113.23 128.14 56.38 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.789 0.804 . . . . 4.48 111.245 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.32 152.6 19.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.593 -1.185 . . . . 2.98 110.796 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.3 m -106.35 137.48 44.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.813 -0.631 . . . . 3.68 109.675 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -142.6 149.57 39.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.809 0.338 . . . . 3.35 110.365 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.58 112.44 24.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.994 -0.373 . . . . 5.34 109.994 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 66.4 mt -79.06 111.69 16.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.974 -0.557 . . . . 4.66 110.141 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -89.71 107.31 19.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.143 -0.688 . . . . 5.08 109.143 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.64 117.61 24.64 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.203 0.525 . . . . 5.68 111.352 -174.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -82.63 154.4 24.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.451 -0.795 . . . . 6.25 108.9 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -62.36 -29.04 70.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.439 0.638 . . . . 9.03 109.63 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -69.92 -19.7 63.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.122 -0.945 . . . . 8.29 110.511 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.21 12.5 83.14 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.796 -0.638 . . . . 5.65 112.43 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -106.62 119.49 39.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.197 -0.668 . . . . 5.26 109.197 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.439 HD11 ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -148.88 -177.81 6.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.645 -0.252 . . . . 4.63 111.537 -177.332 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.57 -173.73 16.18 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.393 -0.683 . . . . 3.57 111.393 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.44 111.43 23.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.864 0.332 . . . . 2.84 110.423 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 6.2 t -127.09 165.15 20.06 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 110.042 -0.355 . . . . 4.34 110.042 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 59.05 36.08 24.16 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.0 -0.545 . . . . 6.23 110.424 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.78 142.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.363 -0.835 . . . . 3.55 110.758 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -149.22 142.24 24.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.7 0.286 . . . . 6.3 110.904 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.2 tp -76.75 106.48 8.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 4.63 110.054 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -103.31 -35.19 8.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.122 -0.49 . . . . 4.97 111.805 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -132.13 90.4 35.03 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.965 -0.294 . . . . 5.57 110.852 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.55 156.55 28.4 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.559 2.173 . . . . 5.69 111.742 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -83.34 -5.81 59.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.245 0.545 . . . . 6.1 111.037 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -174.32 109.11 0.29 Allowed Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 114.457 -1.247 . . . . 10.1 109.78 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.26 123.19 11.16 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.332 2.021 . . . . 8.39 111.967 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.132 -0.485 . . . . 10.65 110.801 179.437 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 112.105 -0.398 . . . . 22.01 112.105 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.5 107.9 6.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.783 0.325 . . . . 20.23 110.623 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.12 -31.64 17.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.295 0.569 . . . . 18.59 110.591 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -87.13 69.23 10.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.809 -0.632 . . . . 17.11 111.751 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.563 ' HG3' ' H ' ' A' ' 6' ' ' GLU . 3.1 pt-20 -114.91 -92.02 0.51 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.756 0.312 . . . . 18.35 111.494 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' A' ' 5' ' ' GLU . 1.6 tp10 -95.5 95.69 8.58 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.895 0.379 . . . . 16.2 111.075 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -125.63 138.5 53.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.831 -0.433 . . . . 12.72 109.831 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -119.45 148.78 42.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.648 -0.705 . . . . 11.63 111.164 -166.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.403 ' HG1' ' CG ' ' A' ' 26' ' ' GLU . 21.3 p -102.89 144.22 31.48 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.918 -0.583 . . . . 9.47 111.707 -174.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.19 176.57 29.62 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.371 -0.692 . . . . 7.73 111.371 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.0 mt -127.06 140.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.659 -0.497 . . . . 10.57 109.659 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.7 mm -66.15 126.04 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 121.206 -0.198 . . . . 8.73 110.491 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -87.0 -51.45 6.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.37 0.605 . . . . 10.86 111.258 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -157.92 131.77 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.086 -0.709 . . . . 14.48 109.086 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.11 105.56 17.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.546 0.689 . . . . 11.73 111.362 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.66 179.4 4.43 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.302 -0.999 . . . . 11.9 108.302 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -91.4 136.3 33.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.756 -0.378 . . . . 16.67 110.71 -177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t 76.75 -33.32 0.2 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.263 -0.881 . . . . 13.28 111.742 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -139.7 152.37 46.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.64 0.257 . . . . 12.68 111.24 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.8 168.76 23.49 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.636 -0.793 . . . . 7.92 112.418 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -116.89 140.8 49.03 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.914 0.388 . . . . 9.69 111.203 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.3 mt -111.59 130.51 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.905 -0.589 . . . . 7.75 110.462 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -72.98 138.46 46.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.445 0.64 . . . . 12.4 111.985 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.1 p -79.53 1.55 25.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.062 -0.972 . . . . 12.96 111.412 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -55.77 -30.06 60.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.298 -0.41 . . . . 13.58 111.776 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' CG ' ' HG1' ' A' ' 9' ' ' THR . 6.9 tp10 -113.89 -11.94 12.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.106 0.479 . . . . 12.19 111.259 -176.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.606 HH11 ' HB3' ' A' ' 29' ' ' ALA . 3.9 tmt_? -137.52 137.56 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.692 -0.855 . . . . 12.99 108.692 -175.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -68.32 42.79 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.427 0.899 . . . . 17.26 113.427 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.606 ' HB3' HH11 ' A' ' 27' ' ' ARG . . . 177.2 133.98 0.06 Allowed 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 123.406 0.682 . . . . 12.1 110.12 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.508 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 6.6 ppt_? -86.27 141.31 29.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.147 -0.686 . . . . 13.0 109.147 171.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 47.1 mt -133.25 162.43 31.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.953 0.406 . . . . 9.21 111.486 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -114.9 141.87 47.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.128 -0.942 . . . . 9.75 108.506 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -136.21 145.3 45.53 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.455 -0.498 . . . . 6.85 110.733 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -84.53 141.44 30.73 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.919 -0.771 . . . . 10.15 108.919 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -63.87 -17.48 63.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.637 0.256 . . . . 10.56 111.481 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -70.6 -13.51 62.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.51 -0.314 . . . . 12.44 110.697 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -103.47 1.11 31.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.564 -0.289 . . . . 11.14 111.235 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -85.04 114.86 22.51 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.698 -0.401 . . . . 8.78 110.121 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.8 t -81.91 91.3 6.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.241 -0.436 . . . . 9.11 110.474 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.39 -175.02 26.06 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.637 -0.585 . . . . 9.98 111.637 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -79.14 123.85 27.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.698 -0.482 . . . . 12.91 109.698 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tp -65.24 -24.96 36.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.176 0.513 . . . . 11.97 111.094 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.22 -0.91 26.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.166 0.508 . . . . 14.73 111.168 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -103.39 10.1 37.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 13.3 109.672 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 tp -112.82 129.24 56.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.714 -0.676 . . . . 10.07 110.008 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -119.64 168.95 10.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.336 0.589 . . . . 13.53 111.099 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.41 HD13 ' N ' ' A' ' 47' ' ' ILE . 3.6 mp -73.37 114.78 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.089 -0.505 . . . . 12.26 109.742 174.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.14 9.43 22.19 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.474 -0.87 . . . . 11.04 112.012 -175.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.29 133.08 71.99 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.245 -0.279 . . . . 8.39 110.245 175.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -85.58 109.88 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.941 2.428 . . . . 8.18 111.644 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.93 151.6 16.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.888 -0.596 . . . . 4.78 111.255 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -110.32 130.03 55.63 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.19 -0.67 . . . . 7.09 109.19 173.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.09 178.04 7.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.349 0.595 . . . . 7.82 111.014 -174.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 32.9 tt0 -142.65 105.08 4.47 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.468 -0.938 . . . . 11.59 108.468 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.3 ttt -83.15 124.29 30.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.767 0.318 . . . . 12.41 111.077 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.2 p -141.19 161.25 38.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.313 -0.403 . . . . 13.93 110.697 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -97.6 121.5 39.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.39 -0.368 . . . . 16.22 110.078 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -74.76 120.08 19.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.182 0.515 . . . . 16.64 110.312 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -79.85 -5.79 56.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.648 -0.705 . . . . 23.23 112.197 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -79.77 -70.41 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.212 0.529 . . . . 21.87 110.641 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 t -101.71 -4.38 26.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 17.49 111.203 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.58 33.0 35.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.079 -0.582 . . . . 17.22 113.451 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -110.02 131.3 22.05 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.725 -0.279 . . . . 14.83 110.335 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.6 125.59 10.74 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.734 1.623 . . . . 13.33 110.028 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.69 179.54 2.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.455 0.645 . . . . 12.33 111.989 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.19 148.41 29.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.442 -0.799 . . . . 8.91 109.886 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.458 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 10.3 t -74.62 -150.38 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 10.33 111.48 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 2.1 mp0 -68.97 30.12 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.853 1.057 . . . . 12.02 113.853 -175.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 67' ' ' SER . 39.8 t 0.0 101.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.228 1.411 . . . . 6.52 113.514 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -109.53 134.38 51.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.855 -0.338 . . . . 6.18 110.747 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -68.68 139.71 55.43 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.743 -0.465 . . . . 6.59 109.743 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.4 124.48 25.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.228 0.537 . . . . 6.16 111.84 -172.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -112.39 122.42 36.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.383 -0.826 . . . . 6.03 110.628 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 2.9 Cg_exo -73.49 144.4 36.08 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.801 2.334 . . . . 7.28 113.104 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HG2' HE21 ' A' ' 147' ' ' GLN . 0.4 OUTLIER -138.71 -80.3 0.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.419 -0.81 . . . . 8.49 108.937 176.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.537 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 0.7 OUTLIER -104.78 125.64 59.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.452 -0.795 . . . . 6.19 110.154 174.651 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 4.5 m -94.46 121.84 45.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.873 -0.603 . . . . 6.54 111.08 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.2 tt -67.08 -27.54 67.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.586 -0.733 . . . . 6.46 109.859 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -131.29 103.56 6.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.188 -0.46 . . . . 7.24 111.238 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.96 -87.69 0.15 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.215 -0.661 . . . . 7.07 109.215 173.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -90.73 71.68 6.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.761 0.791 . . . . 6.68 110.353 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -68.53 137.64 54.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.442 -0.799 . . . . 6.93 109.935 177.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 m -140.39 170.42 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.037 0.446 . . . . 4.0 111.119 -174.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 p -115.7 139.88 49.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.768 -0.651 . . . . 3.84 109.689 175.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.7 155.18 20.0 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.032 -1.08 . . . . 2.58 112.878 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 m -111.04 127.0 55.4 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.388 -0.597 . . . . 3.7 109.388 175.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.545 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 57.3 t -69.21 120.63 17.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.217 -0.29 . . . . 3.14 110.217 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.5 p -107.47 -17.82 14.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.134 0.492 . . . . 3.77 111.113 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.7 m -150.78 131.29 13.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.38 -0.6 . . . . 3.29 109.38 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.77 -175.11 2.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.249 0.547 . . . . 4.39 111.296 -176.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.0 mt -87.86 135.63 33.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.729 . . . . 3.62 109.675 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -74.01 -11.09 60.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.474 0.654 . . . . 7.76 111.028 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -96.45 -51.9 4.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.95 0.881 . . . . 5.1 111.066 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.515 ' OD1' ' HD3' ' A' ' 124' ' ' LYS . 3.0 m-20 -84.09 25.18 0.85 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.094 -1.412 . . . . 7.53 111.459 -172.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 m -68.49 -31.97 71.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 7.77 110.429 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -167.72 -82.49 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.997 -0.547 . . . . 8.0 111.552 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -127.27 -1.11 6.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.01 0.374 . . . . 8.83 112.01 -174.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -86.65 36.71 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.043 0.449 . . . . 7.69 111.093 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.435 HG21 ' HA ' ' A' ' 94' ' ' ASP . 22.8 t -86.72 105.9 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.097 -0.501 . . . . 5.85 110.53 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.432 ' HB3' ' H ' ' A' ' 101' ' ' ASN . 7.6 mp -119.72 -142.83 0.35 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.388 -0.967 . . . . 7.65 108.388 175.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.432 ' H ' ' HB3' ' A' ' 100' ' ' LEU . 5.0 t30 -109.53 62.64 0.6 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.346 0.593 . . . . 8.21 109.512 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.2 t -129.92 67.35 1.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.624 -0.716 . . . . 5.58 109.157 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.7 p -82.49 24.65 0.68 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.508 -0.769 . . . . 4.8 111.572 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.17 -9.4 59.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 5.09 109.961 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.2 t -82.1 127.78 33.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.247 -0.888 . . . . 3.7 109.87 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.75 118.91 25.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.943 0.402 . . . . 2.84 110.793 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.74 175.23 47.48 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.832 -0.699 . . . . 1.91 112.689 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 48.5 mmt-85 -132.47 126.72 33.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.862 0.363 . . . . 3.31 110.442 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.3 mt -111.64 126.49 69.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.052 -0.522 . . . . 2.17 109.82 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 118' ' ' PHE . 12.0 t -103.62 125.46 50.15 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.603 -0.517 . . . . 3.61 109.603 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.651 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 4.1 p90 -134.06 155.58 49.78 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.323 -0.621 . . . . 3.58 109.323 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.16 119.56 37.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.983 0.42 . . . . 5.1 110.137 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -142.99 133.08 24.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.496 -0.775 . . . . 5.11 108.988 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 63.48 21.27 12.68 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.647 0.592 . . . . 7.42 111.042 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.05 21.15 59.57 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.96 -0.564 . . . . 5.36 112.446 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -132.83 135.47 45.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.675 0.274 . . . . 5.38 110.68 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 4.0 p -111.82 116.41 30.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.316 -0.402 . . . . 4.96 110.662 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 110' ' ' SER . 81.5 m-85 -114.59 172.77 6.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 5.13 110.898 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -114.75 120.01 38.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.831 -0.622 . . . . 4.32 110.058 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.8 mt -106.28 135.16 19.51 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.818 -0.628 . . . . 3.17 111.737 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.02 138.75 18.62 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.952 2.435 . . . . 2.61 111.872 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -150.35 160.29 43.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.997 0.427 . . . . 2.49 110.888 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.0 p -123.31 175.01 6.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.302 -0.863 . . . . 3.18 109.66 175.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.515 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 21.2 ttpp -66.02 -23.39 66.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.548 0.69 . . . . 5.22 109.99 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.5 -20.47 62.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.443 -0.799 . . . . 4.81 111.42 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -87.95 -2.63 58.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.09 -0.504 . . . . 4.0 110.671 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.16 137.61 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.258 -0.428 . . . . 4.39 111.516 -174.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -82.29 124.32 29.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.933 -0.576 . . . . 6.43 109.978 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.37 9.28 85.9 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.901 -0.666 . . . . 6.14 112.472 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.7 p30 47.08 29.27 1.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.14 0.976 . . . . 6.26 112.699 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.77 150.11 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.203 -0.453 . . . . 5.62 110.631 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -80.42 130.92 35.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.991 -0.55 . . . . 6.25 110.95 -175.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 mp -99.27 149.04 23.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.897 -0.592 . . . . 3.62 110.338 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -134.82 129.99 35.36 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.594 -0.521 . . . . 7.5 109.594 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.545 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -63.77 130.76 45.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.807 -0.633 . . . . 4.12 110.966 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.04 -23.09 10.13 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.519 -0.764 . . . . 4.2 112.307 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.09 177.42 5.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.101 0.477 . . . . 4.06 111.401 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -106.77 131.3 54.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.878 -0.601 . . . . 4.48 111.583 -170.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.25 165.95 18.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.213 -0.449 . . . . 2.98 110.326 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.1 m -129.71 127.93 41.46 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.816 -0.439 . . . . 3.68 109.816 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -128.99 150.21 50.5 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.963 -0.384 . . . . 3.35 109.963 -177.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -96.95 120.26 36.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.996 0.427 . . . . 5.34 110.113 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 59.2 mt -79.3 107.62 11.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.784 -0.644 . . . . 4.66 109.857 176.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -81.04 107.7 14.08 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.076 -0.713 . . . . 5.08 109.076 174.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 19.8 m -92.49 103.08 15.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.71 -0.677 . . . . 5.68 111.288 -173.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.511 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 15.5 m120 -67.91 153.63 43.31 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.566 -0.902 . . . . 6.25 108.566 170.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.418 HE21 ' HG2' ' A' ' 75' ' ' GLU . 10.0 pt20 -64.65 -20.03 66.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.891 0.377 . . . . 9.03 111.339 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -72.08 -23.34 61.33 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.079 0.466 . . . . 8.29 110.531 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.22 22.91 59.9 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.533 -0.841 . . . . 5.65 112.406 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -122.58 114.29 20.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.204 -0.295 . . . . 5.26 110.204 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -146.55 -178.15 6.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.286 -0.415 . . . . 4.63 111.168 -175.155 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -122.77 -132.07 3.96 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.993 -0.843 . . . . 3.57 110.993 174.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -132.0 126.82 34.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.814 0.34 . . . . 2.84 110.277 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 80.4 m -140.35 162.44 35.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.29 -0.413 . . . . 4.34 110.664 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 57.32 53.18 7.88 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.813 0.696 . . . . 6.23 110.676 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.3 mt -82.12 115.0 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.523 -0.762 . . . . 3.55 110.097 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -114.52 129.94 56.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.785 -0.643 . . . . 6.3 110.602 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 161' ' ' PRO . 50.9 tp -82.59 98.33 8.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.67 -0.696 . . . . 4.63 110.057 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -82.68 -23.66 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.076 -0.511 . . . . 4.97 111.084 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -133.59 102.43 12.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 5.57 110.065 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.47 ' HA ' HD23 ' A' ' 158' ' ' LEU . 71.8 Cg_endo -79.03 154.32 25.56 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.562 2.175 . . . . 5.69 112.738 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -103.25 113.27 26.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.854 -0.612 . . . . 6.1 111.744 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 62.15 91.6 0.08 OUTLIER Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 123.985 0.803 . . . . 10.1 112.334 173.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.92 -171.37 1.18 Allowed 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 122.896 2.398 . . . . 8.39 111.769 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 32.2 m . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.297 -0.41 . . . . 10.65 111.036 -179.2 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 111.586 -0.606 . . . . 22.01 111.586 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.63 124.11 41.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.858 0.361 . . . . 20.23 110.688 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.25 -53.66 8.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.948 -0.569 . . . . 18.59 111.05 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.02 47.51 1.41 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.813 -0.63 . . . . 17.11 111.496 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -101.09 -38.68 8.05 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 112.024 0.379 . . . . 18.35 112.024 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -139.86 132.98 29.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.981 0.42 . . . . 16.2 111.444 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -134.86 140.24 45.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.079 -0.509 . . . . 12.72 111.021 177.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.65 172.68 12.44 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.79 -0.641 . . . . 11.63 109.88 -176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.0 p -112.9 167.36 10.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.988 0.423 . . . . 9.47 111.534 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.6 172.65 37.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 116.19 -0.459 . . . . 7.73 112.189 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.0 mt -117.04 133.67 63.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.015 -0.365 . . . . 10.57 110.015 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.3 118.09 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.949 0.404 . . . . 8.73 110.585 176.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.52 -56.24 9.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.39 -0.823 . . . . 10.86 110.46 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -156.03 141.08 17.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.205 -0.907 . . . . 14.48 108.765 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.3 mt -98.2 103.16 15.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.268 0.556 . . . . 11.73 110.712 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.37 -179.77 4.89 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.034 -0.985 . . . . 11.9 108.412 173.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -90.68 123.11 34.03 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.518 -0.473 . . . . 16.67 110.022 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t 82.6 -27.86 0.11 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.453 1.095 . . . . 13.28 111.773 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -135.64 147.8 48.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.806 0.336 . . . . 12.68 111.304 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -139.89 162.85 26.3 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-N 116.055 -0.52 . . . . 7.92 111.87 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -118.38 146.89 44.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.821 0.31 . . . . 9.69 111.313 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.5 mt -121.34 128.16 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.301 -0.409 . . . . 7.75 110.535 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -76.85 146.0 38.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.202 0.525 . . . . 12.4 111.575 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.5 p -79.82 -0.02 32.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.246 -0.888 . . . . 12.96 112.888 -175.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.7 t -53.52 -31.32 45.73 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.85 0.685 . . . . 13.58 112.85 -173.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.97 -5.92 43.58 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.871 0.367 . . . . 12.19 111.889 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 12.0 ttt180 -131.66 -160.66 1.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.532 -0.303 . . . . 12.99 110.203 -173.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.52 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 78.0 mt-30 -118.66 14.93 13.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.379 0.609 . . . . 17.26 110.218 176.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' NH1' ' A' ' 27' ' ' ARG . . . -164.41 138.45 5.34 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.312 -0.858 . . . . 12.1 110.213 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -85.62 151.02 24.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.424 -0.584 . . . . 13.0 109.424 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -138.86 162.52 34.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.026 0.441 . . . . 9.21 110.887 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.38 142.24 51.48 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.951 -0.759 . . . . 9.75 108.951 173.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -128.35 147.38 50.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.001 -0.37 . . . . 6.85 110.001 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.461 ' HB2' ' OE1' ' A' ' 37' ' ' GLN . 76.3 m-70 -95.64 160.81 14.32 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.525 -0.546 . . . . 10.15 109.525 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -70.71 -4.24 22.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.816 0.341 . . . . 10.56 111.675 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -85.75 -7.39 58.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.944 -0.391 . . . . 12.44 109.944 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.461 ' OE1' ' HB2' ' A' ' 34' ' ' HIS . 23.4 mp0 -117.44 40.48 3.05 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.936 -0.575 . . . . 11.14 111.199 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -122.63 139.48 53.88 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.42 -0.512 . . . . 8.78 111.142 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.3 t -116.27 114.49 24.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.549 . . . . 9.11 110.036 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.05 -161.35 23.51 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.736 . . . . 9.98 111.823 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -83.06 108.11 16.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.215 -0.291 . . . . 12.91 110.215 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.402 HD13 HD12 ' A' ' 45' ' ' LEU . 10.6 tp -68.52 -25.16 30.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.344 0.592 . . . . 11.97 110.081 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -66.68 -22.7 66.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.489 -0.778 . . . . 14.73 110.908 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -105.45 20.25 19.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.854 -0.612 . . . . 13.3 111.303 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.402 HD12 HD13 ' A' ' 42' ' ' ILE . 1.5 mt -87.2 133.97 33.59 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.021 -0.363 . . . . 10.07 110.021 175.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -127.6 167.0 16.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.462 -0.57 . . . . 13.53 109.462 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 47' ' ' ILE . 3.5 mp -81.99 132.82 30.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.563 -0.532 . . . . 12.26 109.563 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.65 11.24 58.27 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.647 -0.787 . . . . 11.04 111.987 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 32.3 t70 -86.15 133.35 41.03 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.655 -0.273 . . . . 8.39 110.75 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 49' ' ' ASP . 6.6 Cg_endo -86.18 127.42 2.95 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.241 2.627 . . . . 8.18 112.638 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.9 m -125.33 160.33 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.43 . . . . 4.78 111.092 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -112.54 128.03 56.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.913 -0.585 . . . . 7.09 110.029 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -131.94 150.19 52.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.345 0.593 . . . . 7.82 111.048 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 16.4 tt0 -101.58 119.65 39.1 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.735 -0.839 . . . . 11.59 108.735 177.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 14.3 tpt -90.93 133.42 35.28 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.909 -0.404 . . . . 12.41 109.909 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.91 169.81 23.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.966 0.412 . . . . 13.93 110.531 -172.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -126.4 109.44 12.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.742 0.305 . . . . 16.22 110.426 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -83.12 113.42 20.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.223 -0.444 . . . . 16.64 110.108 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -79.21 -10.31 59.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.36 -0.382 . . . . 23.23 111.783 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -74.34 -41.54 60.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.405 -0.591 . . . . 21.87 109.405 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.8 p -88.55 -40.81 13.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.255 -0.43 . . . . 17.49 110.817 174.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.78 31.92 11.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.906 -0.664 . . . . 17.22 112.207 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -132.59 152.92 80.83 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.056 -0.35 . . . . 14.83 110.056 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.75 125.85 10.88 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.293 1.996 . . . . 13.33 110.641 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.0 pp -138.85 153.81 25.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.537 0.684 . . . . 12.33 112.251 -175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.42 157.29 16.52 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.576 -0.898 . . . . 8.91 108.576 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.422 ' C ' ' H ' ' A' ' 69' ' ' VAL . 12.8 t -70.66 -162.95 0.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.006 -0.368 . . . . 10.33 110.006 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -72.77 27.13 0.06 Allowed 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 113.368 0.877 . . . . 12.02 113.368 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 67' ' ' SER . 53.3 t 32.23 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.438 1.095 . . . . 6.52 113.664 172.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.5 t -88.61 151.29 22.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.429 -0.805 . . . . 6.18 111.378 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.418 ' HZ1' ' CG ' ' A' ' 49' ' ' ASP . 20.0 mmmt -87.55 137.96 31.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.376 -0.829 . . . . 6.59 110.993 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.8 mt -86.85 132.79 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.064 -0.516 . . . . 6.16 109.873 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.64 151.14 86.96 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 6.03 111.014 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.13 161.63 25.81 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.955 2.437 . . . . 7.28 112.842 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -96.28 169.28 10.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.668 -0.696 . . . . 8.49 110.663 -177.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.2 t -76.29 141.28 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.497 -0.557 . . . . 6.19 109.497 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 29.0 t -80.25 97.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.067 0.395 . . . . 6.54 112.067 -171.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.436 ' CD2' ' HB2' ' A' ' 144' ' ' ALA . 22.2 mt -88.96 -30.36 18.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.525 . . . . 6.46 110.948 175.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 p -98.95 96.95 8.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.334 0.588 . . . . 7.24 111.616 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.52 -69.14 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.434 -0.803 . . . . 7.07 109.31 174.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -131.57 147.67 52.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.899 -0.591 . . . . 6.68 109.987 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.4 ptt85 -107.77 125.88 51.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.845 0.355 . . . . 6.93 110.158 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.12 158.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.066 0.46 . . . . 4.0 111.9 -173.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.8 p -118.65 140.65 49.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.39 -0.823 . . . . 3.84 109.622 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.45 170.16 24.27 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.075 -1.06 . . . . 2.58 112.615 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.5 m -115.69 135.36 54.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.528 -0.545 . . . . 3.7 109.528 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.565 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 21.9 t -67.36 115.36 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.589 -0.522 . . . . 3.14 109.589 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.05 -34.1 15.24 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.326 0.584 . . . . 3.77 110.042 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.7 m -151.26 120.75 6.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.619 -0.719 . . . . 3.29 109.613 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.74 -176.82 5.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.799 0.333 . . . . 4.39 110.465 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.21 162.96 13.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.515 -0.311 . . . . 3.62 110.186 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -52.73 125.74 17.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.125 -0.489 . . . . 7.76 109.977 174.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.3 m -141.91 6.4 1.79 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.891 0.853 . . . . 5.1 110.426 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.55 132.71 33.84 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.389 -0.823 . . . . 7.53 110.616 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.5 t -161.83 159.68 27.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 7.77 109.874 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.67 -6.73 51.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.025 -0.534 . . . . 8.0 110.124 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -112.93 -65.62 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 8.83 110.608 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -163.54 170.1 17.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.473 -0.33 . . . . 7.69 110.249 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.7 m -75.61 51.08 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.349 0.595 . . . . 5.85 112.372 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.9 tp -99.57 88.08 3.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.688 0.756 . . . . 7.65 109.996 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.436 ' C ' ' HG ' ' A' ' 102' ' ' SER . 3.4 p-10 -111.01 1.32 17.34 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.549 -1.205 . . . . 8.21 110.03 176.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.436 ' HG ' ' C ' ' A' ' 101' ' ' ASN . 57.4 p 49.96 -108.92 0.35 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.401 -0.818 . . . . 5.58 111.555 -174.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -146.6 35.46 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.213 0.53 . . . . 4.8 109.952 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 105' ' ' THR . 0.5 OUTLIER -62.71 -44.73 95.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 5.09 111.024 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.484 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -93.12 175.76 6.66 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.367 -0.833 . . . . 3.7 111.845 -171.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 m -142.55 127.84 18.76 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.198 -0.667 . . . . 2.84 109.198 173.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -94.7 176.02 34.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.582 -0.818 . . . . 1.91 112.581 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 20.3 mmt180 -133.43 132.31 40.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.643 0.259 . . . . 3.31 110.599 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 79.0 mt -113.94 130.66 67.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.028 -0.533 . . . . 2.17 109.584 174.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.5 p -105.86 123.0 47.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.316 -0.402 . . . . 3.61 110.389 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.675 ' CE2' HD13 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -140.47 152.36 45.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.817 0.341 . . . . 3.58 110.608 178.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' HB3' ' A' ' 117' ' ' CYS . 4.8 mp0 -107.31 122.48 46.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.053 0.454 . . . . 5.1 110.165 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -131.96 120.85 23.05 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.698 -0.683 . . . . 5.11 109.823 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 61.09 31.96 19.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.326 0.584 . . . . 7.42 110.861 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -20.15 50.82 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.413 -0.812 . . . . 5.36 113.395 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -99.47 136.32 39.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.672 0.273 . . . . 5.38 110.833 -175.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . 0.404 ' HB3' ' HG3' ' A' ' 112' ' ' GLU . 7.8 p -102.51 128.3 49.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.178 -0.465 . . . . 4.96 110.572 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -128.59 164.2 23.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.323 -0.398 . . . . 5.13 110.875 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -122.85 114.37 20.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.696 -0.683 . . . . 4.32 109.595 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.675 HD13 ' CE2' ' A' ' 111' ' ' TYR . 2.5 mp -105.49 140.94 21.65 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.682 0.277 . . . . 3.17 110.878 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 94.1 Cg_endo -79.3 155.82 25.43 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.104 2.536 . . . . 2.61 112.068 175.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -163.99 163.68 23.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.9 -0.408 . . . . 2.49 109.9 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -118.76 -179.15 3.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.996 0.427 . . . . 3.18 111.154 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -71.57 -21.26 61.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.08 -0.509 . . . . 5.22 110.54 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.49 -9.73 57.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 4.81 111.238 -173.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -85.41 -25.42 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 4.0 111.7 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 p -92.49 123.05 44.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.518 0.675 . . . . 4.39 110.69 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.61 159.63 16.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.6 -0.727 . . . . 6.43 110.844 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.92 -16.44 60.95 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.852 -0.689 . . . . 6.14 112.274 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 68.94 16.26 8.8 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.917 0.487 . . . . 6.26 110.783 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 t -72.45 116.29 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 5.62 110.088 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -85.98 84.86 7.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.749 0.785 . . . . 6.25 110.706 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.441 HD21 ' H ' ' A' ' 133' ' ' LEU . 2.2 pt? -81.44 150.71 28.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.1 -1.409 . . . . 3.62 110.761 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.465 ' HD2' ' H ' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -110.49 -179.74 3.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.219 -0.659 . . . . 7.5 109.219 177.247 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.565 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.45 131.81 41.38 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.423 -0.511 . . . . 4.12 111.05 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.53 -14.55 13.14 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.135 -0.555 . . . . 4.2 112.072 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -81.11 154.38 26.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.633 0.254 . . . . 4.06 110.544 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 160' ' ' ASN . 13.4 mmmm -104.6 127.83 52.45 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.162 0.506 . . . . 4.48 110.372 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.7 m -130.35 160.58 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.386 -0.825 . . . . 2.98 112.382 -171.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.6 p -122.53 140.96 52.19 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.993 -1.003 . . . . 3.68 109.534 172.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -151.24 167.9 26.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.568 -0.287 . . . . 3.35 110.654 -174.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -104.24 133.42 49.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.15 0.5 . . . . 5.34 110.779 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 34.6 mm -95.49 102.27 13.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.428 -0.805 . . . . 4.66 110.368 178.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.66 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -87.59 108.78 19.23 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.622 -0.431 . . . . 5.08 110.406 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.438 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 15.6 m -90.04 125.7 35.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.046 -0.524 . . . . 5.68 111.345 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -98.72 164.98 12.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.204 -1.036 . . . . 6.25 108.204 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -59.98 -24.8 64.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.943 0.497 . . . . 9.03 111.883 -174.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -70.6 -17.75 62.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 8.29 110.868 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.93 5.39 86.24 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.856 -0.688 . . . . 5.65 111.891 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -99.39 119.64 38.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.164 -0.68 . . . . 5.26 109.164 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -132.87 163.33 29.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.171 0.51 . . . . 4.63 112.23 -177.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -136.14 -173.26 12.9 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.782 -0.927 . . . . 3.57 110.782 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.7 120.88 40.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.103 0.452 . . . . 2.84 110.91 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.6 t -128.12 154.37 45.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.749 -0.463 . . . . 4.34 109.749 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 55.75 65.29 1.5 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.794 0.807 . . . . 6.23 110.266 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.5 mt -92.44 135.29 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.566 -1.197 . . . . 3.55 109.794 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -132.14 152.84 51.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.909 -0.404 . . . . 6.3 109.909 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.9 tp -101.47 123.71 45.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.176 -0.465 . . . . 4.63 110.24 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -111.59 -40.56 4.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.515 -0.311 . . . . 4.97 111.067 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 7.7 t30 -118.95 101.11 50.47 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 110.226 -0.287 . . . . 5.57 110.226 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -83.15 155.56 14.75 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.127 2.551 . . . . 5.69 113.43 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -83.68 154.48 23.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.78 -0.646 . . . . 6.1 110.86 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.72 124.97 89.99 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.463 -0.335 . . . . 10.1 110.658 -175.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.36 113.88 2.11 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.71 2.273 . . . . 8.39 112.93 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.952 -0.567 . . . . 10.65 110.28 -178.641 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.454 0 N-CA-C 111.764 -0.535 . . . . 22.01 111.764 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 74.54 -13.07 0.84 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.589 0.756 . . . . 20.23 111.652 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.3 -17.96 47.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.882 0.849 . . . . 18.59 109.118 176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.32 5.35 3.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.375 -1.284 . . . . 17.11 111.317 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -84.51 -21.86 30.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.109 0.48 . . . . 18.35 111.537 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -82.97 89.22 6.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.231 0.539 . . . . 16.2 111.345 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -105.6 121.14 43.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.193 0.52 . . . . 12.72 110.033 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.471 ' CG ' ' HG3' ' A' ' 27' ' ' ARG . 35.5 tt0 -100.02 136.61 39.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.463 -0.789 . . . . 11.63 109.014 -177.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.0 p -96.95 151.84 19.3 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.947 -0.301 . . . . 9.47 110.674 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.29 -177.5 37.75 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.913 -0.661 . . . . 7.73 111.893 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.501 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 1.2 mt -130.06 146.41 34.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.343 -0.614 . . . . 10.57 109.343 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.72 118.56 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.437 -0.579 . . . . 8.73 109.437 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -87.65 -44.72 10.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.536 -0.756 . . . . 10.86 109.37 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -149.16 154.59 39.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.217 -0.901 . . . . 14.48 110.806 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.8 mt -119.14 109.68 16.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.656 . . . . 11.73 110.169 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.6 mp -99.47 179.04 4.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.238 -1.023 . . . . 11.9 108.238 176.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -90.44 114.14 26.23 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.148 -0.621 . . . . 16.67 110.354 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 m 72.16 16.38 5.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.942 -1.026 . . . . 13.28 111.095 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -156.58 139.87 15.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.717 -0.674 . . . . 12.68 109.764 -177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.432 ' HA3' ' CE1' ' A' ' 33' ' ' PHE . . . -127.44 156.45 20.46 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.697 -0.763 . . . . 7.92 112.667 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.74 129.83 55.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.463 -0.199 . . . . 9.69 110.463 -176.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -114.22 127.55 71.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.153 -0.314 . . . . 7.75 110.153 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 9.8 pt20 -83.14 144.14 30.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.62 0.724 . . . . 12.4 111.877 -175.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 p -79.54 2.23 22.96 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 114.461 -1.245 . . . . 12.96 112.764 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.4 m -53.2 -24.46 11.03 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.803 0.668 . . . . 13.58 112.803 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -91.4 -6.95 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.977 0.362 . . . . 12.19 111.977 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.471 ' HG3' ' CG ' ' A' ' 8' ' ' GLU . 9.7 mmt85 -151.33 -158.53 0.92 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.999 0.428 . . . . 12.99 110.529 -170.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.409 ' H ' ' HB3' ' A' ' 27' ' ' ARG . 10.4 pt20 -123.74 28.57 6.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.045 0.45 . . . . 17.26 109.996 177.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.48 135.22 19.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.844 -0.617 . . . . 12.1 110.699 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.404 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 16.7 ptp180 -89.39 121.76 31.95 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.658 -0.497 . . . . 13.0 109.658 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.37 155.13 23.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.172 0.51 . . . . 9.21 110.77 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -132.06 142.88 49.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.701 -0.681 . . . . 9.75 109.555 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.432 ' CE1' ' HA3' ' A' ' 20' ' ' GLY . 17.6 p90 -126.63 163.79 22.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.027 0.441 . . . . 6.85 110.416 -176.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -112.65 152.44 28.97 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.691 -0.485 . . . . 10.15 109.691 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -62.98 -21.55 66.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.316 -0.402 . . . . 10.56 111.772 -175.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.6 t -72.93 -19.82 61.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.526 -0.306 . . . . 12.44 111.09 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.406 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 1.9 mp0 -95.56 -26.24 15.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.603 -0.272 . . . . 11.14 111.41 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -68.48 112.81 5.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 8.78 110.553 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.2 t -91.56 97.22 10.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.977 -0.556 . . . . 9.11 110.195 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.6 -176.04 34.8 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.84 -0.904 . . . . 9.98 110.84 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -77.67 95.75 4.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.816 0.341 . . . . 12.91 110.176 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -60.75 -25.86 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.383 0.611 . . . . 11.97 110.514 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.38 -25.79 68.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.369 -0.832 . . . . 14.73 111.22 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -108.18 17.52 22.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.39 -0.368 . . . . 13.3 111.069 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.7 tp -97.71 125.95 42.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.009 -0.737 . . . . 10.07 109.009 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -123.4 173.88 7.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.998 -0.371 . . . . 13.53 109.998 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.8 mp -70.97 131.78 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.968 -0.382 . . . . 12.26 109.968 179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.79 2.24 58.51 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.504 -0.855 . . . . 11.04 112.276 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.0 124.61 89.58 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 110.559 -0.163 . . . . 8.39 110.559 175.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.55 132.05 7.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.788 2.326 . . . . 8.18 112.662 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.436 HG11 ' HG2' ' A' ' 71' ' ' LYS . 27.3 m -136.96 161.18 36.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.115 0.483 . . . . 4.78 111.311 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -120.41 136.67 54.65 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.175 -0.676 . . . . 7.09 109.175 170.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -131.8 148.91 52.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.451 0.643 . . . . 7.82 111.214 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 35.8 tt0 -88.98 110.49 21.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.408 -0.815 . . . . 11.59 109.309 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.61 105.32 13.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.271 -0.64 . . . . 12.41 109.271 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 23.9 p -134.87 171.25 14.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.373 0.606 . . . . 13.93 111.987 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -113.45 111.02 21.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.739 -0.664 . . . . 16.22 110.394 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -72.59 122.84 22.05 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.777 -0.453 . . . . 16.64 109.777 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -79.36 -6.74 57.46 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.666 0.617 . . . . 23.23 112.666 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -82.91 -44.54 15.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.49 . . . . 21.87 109.807 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.9 p -90.69 -28.23 18.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.832 -0.622 . . . . 17.49 111.391 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.9 29.13 61.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.113 -0.565 . . . . 17.22 111.871 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -127.37 153.73 77.17 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 110.224 -0.287 . . . . 14.83 110.224 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.77 125.47 9.47 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.051 1.834 . . . . 13.33 111.061 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -138.44 179.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.193 0.52 . . . . 12.33 111.078 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.7 139.32 50.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.724 -0.671 . . . . 8.91 109.302 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 14.7 m -70.16 -148.03 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.096 -0.502 . . . . 10.33 110.949 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 14.0 mm100 -66.74 29.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.841 1.423 . . . . 12.02 114.841 -170.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' A' ' 67' ' ' SER . 39.0 t 4.97 99.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 125.201 1.4 . . . . 6.52 113.677 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.8 m -112.15 138.02 49.41 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.981 0.419 . . . . 6.18 110.522 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.436 ' HG2' HG11 ' A' ' 51' ' ' VAL . 50.0 mtpt -70.51 142.2 51.87 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.494 -0.558 . . . . 6.59 109.494 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.3 mt -62.75 110.18 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.282 0.563 . . . . 6.16 110.739 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.48 163.6 21.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 6.03 111.236 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -58.08 146.98 85.52 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.439 2.093 . . . . 7.28 112.091 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.489 ' HG2' ' H ' ' A' ' 76' ' ' VAL . 14.1 tt0 -97.1 -147.11 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.072 -0.513 . . . . 8.49 110.304 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.489 ' H ' ' HG2' ' A' ' 75' ' ' GLU . 18.3 t -62.58 145.8 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 122.766 0.426 . . . . 6.19 111.09 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.07 111.6 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.493 -0.321 . . . . 6.54 110.908 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.483 ' N ' HD11 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -112.16 -7.57 14.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.919 0.39 . . . . 6.46 111.507 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.8 m -85.45 28.6 0.74 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.34 0.496 . . . . 7.24 112.34 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.92 -36.78 13.26 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.585 -0.446 . . . . 7.07 111.372 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -169.13 144.65 3.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.291 0.567 . . . . 6.68 111.3 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -112.49 97.44 6.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.383 -0.826 . . . . 6.93 109.136 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.88 168.15 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.328 0.585 . . . . 4.0 111.137 -175.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -108.85 139.09 44.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.512 -0.767 . . . . 3.84 110.729 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -135.27 166.49 24.43 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.593 -0.813 . . . . 2.58 112.379 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 m -118.4 134.62 54.91 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.634 -0.506 . . . . 3.7 109.634 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.605 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 47.9 t -67.46 123.89 21.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.792 -0.447 . . . . 3.14 109.792 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.7 -24.13 12.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.196 -0.456 . . . . 3.77 111.131 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.6 m -153.09 132.44 12.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.084 -0.507 . . . . 3.29 110.11 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -92.52 -172.37 3.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.946 0.403 . . . . 4.39 110.169 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.62 126.85 30.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.711 -0.848 . . . . 3.62 108.711 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -65.14 111.91 3.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.308 0.575 . . . . 7.76 111.529 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 p -116.67 112.94 21.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.291 -0.868 . . . . 5.1 109.507 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -68.94 -60.03 2.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 7.53 110.983 -175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.0 m -105.78 154.09 20.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.021 -0.536 . . . . 7.77 110.107 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.46 -25.89 67.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 8.0 111.547 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -90.34 -20.59 22.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.882 -0.599 . . . . 8.83 110.437 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -102.87 102.59 12.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.17 0.509 . . . . 7.69 110.698 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.47 127.87 63.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.753 -0.658 . . . . 5.85 109.799 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -127.89 97.64 4.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.555 0.693 . . . . 7.65 110.503 -176.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -90.23 63.01 5.63 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.665 -1.152 . . . . 8.21 109.715 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.3 p -96.46 144.29 26.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.666 -0.697 . . . . 5.58 109.573 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.3 m -76.55 5.24 7.7 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.188 0.44 . . . . 4.8 112.188 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -86.39 -32.73 20.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.984 0.421 . . . . 5.09 110.287 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.3 t -98.8 87.15 3.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.153 0.978 . . . . 3.7 109.311 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 15.6 m -94.27 132.96 38.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.036 -0.984 . . . . 2.84 110.612 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.75 169.35 48.28 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.795 -0.717 . . . . 1.91 112.323 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -130.81 134.79 47.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.261 0.553 . . . . 3.31 111.551 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.488 HG13 ' CD1' ' A' ' 122' ' ' TYR . 97.7 mt -112.9 125.41 70.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.967 -1.015 . . . . 2.17 109.435 172.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 p -97.66 126.16 42.83 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.691 -0.485 . . . . 3.61 109.691 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -134.23 154.42 51.27 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.844 -0.428 . . . . 3.58 109.844 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -115.54 121.31 42.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.175 -0.466 . . . . 5.1 110.38 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.507 ' OD1' ' HG3' ' A' ' 114' ' ' ARG . 23.5 t-20 -160.69 143.27 12.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.464 . . . . 5.11 109.959 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.507 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 79.7 mtp180 64.48 20.77 12.27 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.464 0.478 . . . . 7.42 110.893 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.75 1.12 90.1 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.855 -0.611 . . . . 5.36 112.555 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -114.29 151.05 33.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.658 -0.497 . . . . 5.38 109.658 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.47 104.64 10.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.136 0.493 . . . . 4.96 110.435 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -104.2 169.24 8.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.757 -0.656 . . . . 5.13 111.054 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -120.27 123.15 42.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.708 -0.678 . . . . 4.32 110.173 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.51 138.19 19.44 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.536 -0.302 . . . . 3.17 110.372 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.83 142.62 22.7 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.773 2.315 . . . . 2.61 111.827 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.488 ' CD1' HG13 ' A' ' 109' ' ' ILE . 34.5 p90 -146.35 152.27 38.85 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.086 0.469 . . . . 2.49 110.776 176.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.83 156.81 23.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.714 -0.676 . . . . 3.18 110.304 174.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -66.97 -28.15 68.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.084 0.469 . . . . 5.22 111.252 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.62 -16.18 63.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.811 -0.631 . . . . 4.81 111.38 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.05 23.93 12.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.078 -0.51 . . . . 4.0 111.242 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.08 114.71 39.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.352 0.596 . . . . 4.39 111.338 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 157' ' ' ARG . 0.6 OUTLIER -79.71 151.78 30.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.428 -0.805 . . . . 6.43 108.856 178.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.14 -16.55 42.58 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.714 -0.755 . . . . 6.14 111.47 -174.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m120 63.47 24.76 14.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.257 0.623 . . . . 6.26 111.445 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.61 138.17 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.362 -0.381 . . . . 5.62 109.985 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -83.01 91.84 7.25 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.737 -0.468 . . . . 6.25 109.737 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -71.69 144.2 49.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.633 -0.712 . . . . 3.62 110.943 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -140.69 148.96 41.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.833 -0.622 . . . . 7.5 110.33 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.605 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -49.98 124.34 9.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.124 -0.489 . . . . 4.12 112.181 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.0 -24.43 8.3 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.477 -0.783 . . . . 4.2 113.569 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -87.65 178.07 6.86 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 117.782 0.791 . . . . 4.06 110.625 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -117.18 122.77 44.96 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.461 0.648 . . . . 4.48 111.58 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.02 157.66 20.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.979 -1.01 . . . . 2.98 110.788 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.0 m -113.89 129.9 56.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.445 -0.576 . . . . 3.68 109.445 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -126.4 139.19 53.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.127 0.489 . . . . 3.35 109.734 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -94.97 116.84 29.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.588 -0.733 . . . . 5.34 109.417 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 76.4 mt -77.7 111.52 14.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.854 -0.612 . . . . 4.66 110.304 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -97.43 109.04 21.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.585 -0.734 . . . . 5.08 110.658 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 88.6 m -85.43 120.86 27.36 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.455 0.472 . . . . 5.68 111.076 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -72.74 171.33 12.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.557 . . . . 6.25 110.698 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -57.92 -22.39 48.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.167 0.803 . . . . 9.03 113.167 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -111.08 -2.7 15.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.109 -0.636 . . . . 8.29 111.617 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 98.07 11.03 50.66 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.281 -0.961 . . . . 5.65 114.469 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -98.19 132.27 43.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.812 -0.81 . . . . 5.26 108.812 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.491 ' N ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -146.6 -178.24 6.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.212 0.53 . . . . 4.63 112.333 -174.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.16 -122.77 1.47 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.862 -1.063 . . . . 3.57 111.026 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.87 131.47 33.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.917 0.358 . . . . 2.84 110.389 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 74.5 m -142.65 159.53 42.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.128 -0.487 . . . . 4.34 109.738 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 57.72 54.96 5.84 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.762 0.664 . . . . 6.23 110.68 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.2 mp -82.84 114.22 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.803 -0.443 . . . . 3.55 109.803 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 34.3 ttt180 -120.14 128.76 53.72 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.99 -0.374 . . . . 6.3 109.99 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.2 tt -77.04 117.01 18.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.998 -0.546 . . . . 4.63 110.012 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -92.2 -54.82 3.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 4.97 111.015 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -122.1 106.46 36.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.068 -0.515 . . . . 5.57 110.653 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.58 -176.62 3.32 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.262 1.974 . . . . 5.69 112.069 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -139.75 121.04 14.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.994 -0.548 . . . . 6.1 110.186 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 66.79 90.47 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.257 0 O-C-N 123.829 0.706 . . . . 10.1 111.275 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.72 130.94 20.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.378 2.052 . . . . 8.39 112.659 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.549 . . . . 10.65 110.607 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.162 -0.375 . . . . 22.01 112.162 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.91 110.8 20.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.791 0.329 . . . . 20.23 110.232 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -116.01 -52.43 2.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.576 0.703 . . . . 18.59 110.252 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -85.25 43.27 1.0 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.095 -0.957 . . . . 17.11 111.378 -174.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -75.48 -75.78 0.17 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.831 -0.622 . . . . 18.35 110.816 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.93 133.41 28.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.285 -0.87 . . . . 16.2 110.144 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -104.12 121.97 44.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.959 -0.564 . . . . 12.72 109.814 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.418 ' CD ' ' HB2' ' A' ' 55' ' ' MET . 7.5 pt-20 -121.41 138.04 54.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.191 0.519 . . . . 11.63 111.056 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.0 p -109.11 160.89 15.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.031 -0.531 . . . . 9.47 111.562 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.73 174.28 42.11 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.001 -0.839 . . . . 7.73 111.001 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.9 mt -109.87 144.94 17.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.767 0.283 . . . . 10.57 110.393 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.33 114.35 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.284 -0.265 . . . . 8.73 110.284 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.21 -55.17 5.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 10.86 111.49 -176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.584 ' HD3' ' N ' ' A' ' 15' ' ' LEU . 8.2 tmtt? -159.39 136.47 9.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.729 -0.471 . . . . 14.48 109.729 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.584 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 72.7 mt -93.62 117.17 29.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.311 0.577 . . . . 11.73 111.492 178.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.17 -178.57 3.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.876 -1.157 . . . . 11.9 107.876 172.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -88.26 130.61 35.05 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.082 -0.647 . . . . 16.67 109.696 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m 75.28 -44.24 0.53 Allowed 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.303 1.002 . . . . 13.28 112.016 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -121.87 148.85 44.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.131 0.491 . . . . 12.68 111.417 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -139.89 169.86 24.5 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.478 -0.649 . . . . 7.92 111.478 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -121.86 144.53 48.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.057 0.456 . . . . 9.69 111.608 -177.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -105.83 129.92 58.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.655 -0.702 . . . . 7.75 109.695 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.427 ' HG3' ' H ' ' A' ' 25' ' ' CYS . 13.8 tp60 -77.07 132.77 39.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.928 -0.578 . . . . 12.4 111.27 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.58 ' HB3' ' N ' ' A' ' 30' ' ' ARG . 6.5 p -84.94 0.62 50.6 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.348 0.87 . . . . 12.96 113.348 175.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.427 ' H ' ' HG3' ' A' ' 23' ' ' GLN . 68.4 m -60.74 -22.93 64.54 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.675 0.991 . . . . 13.58 113.675 -168.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -102.59 -29.47 11.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.347 0.594 . . . . 12.19 110.435 -178.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.521 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 12.6 ttp85 -105.61 -157.69 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.447 -0.797 . . . . 12.99 110.088 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.521 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 44.4 mt-30 -123.37 21.34 9.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 17.26 110.744 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.13 115.38 5.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.787 0.327 . . . . 12.1 111.847 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.58 ' N ' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -87.03 141.59 28.56 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.873 -0.788 . . . . 13.0 108.873 172.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.9 mt -138.37 162.39 34.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.662 0.267 . . . . 9.21 110.95 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -113.19 148.56 35.2 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.515 -0.55 . . . . 9.75 109.515 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -145.39 159.4 43.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.511 -0.551 . . . . 6.85 109.511 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -106.75 162.78 13.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.439 -0.578 . . . . 10.15 109.439 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.52 -19.12 65.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.938 0.399 . . . . 10.56 110.508 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.7 p -76.91 -15.32 59.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.031 -0.531 . . . . 12.44 110.729 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -102.06 20.69 16.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.389 -0.369 . . . . 11.14 110.789 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -123.02 108.11 12.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.222 0.534 . . . . 8.78 109.717 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.435 ' OG ' ' HB2' ' A' ' 68' ' ' GLN . 51.1 m -94.44 104.33 16.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.711 -0.677 . . . . 9.11 111.052 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.37 -165.84 35.07 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.48 -1.048 . . . . 9.98 110.48 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -94.21 119.34 32.87 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 117.347 0.573 . . . . 12.91 109.904 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.81 -20.66 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 11.97 111.067 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.65 -3.99 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 14.73 111.355 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -118.41 21.87 12.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.073 0.464 . . . . 13.3 109.89 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -125.88 112.34 15.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.205 -0.665 . . . . 10.07 109.205 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -120.05 178.58 4.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.255 0.55 . . . . 13.53 111.298 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.51 130.73 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.383 -0.826 . . . . 12.26 109.363 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.12 10.9 61.97 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.41 -0.9 . . . . 11.04 110.991 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -89.06 123.52 67.15 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.137 -0.531 . . . . 8.39 110.05 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.51 126.6 11.69 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.661 2.241 . . . . 8.18 112.539 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.405 HG12 ' CD ' ' A' ' 71' ' ' LYS . 28.0 m -125.51 151.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 4.78 111.389 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.33 129.8 56.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.222 -0.658 . . . . 7.09 109.222 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -144.61 175.56 10.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.249 0.547 . . . . 7.82 111.357 -175.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -123.48 138.44 54.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.604 -0.726 . . . . 11.59 109.969 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.418 ' HB2' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -92.1 111.38 22.91 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.56 -0.533 . . . . 12.41 109.56 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 p -134.43 133.77 40.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 13.93 112.037 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 64' ' ' PRO . 16.8 m-85 -89.13 109.6 20.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.158 -0.474 . . . . 16.22 110.103 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -77.28 97.38 4.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.723 -0.473 . . . . 16.64 109.723 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -72.38 -5.43 36.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.318 -0.401 . . . . 23.23 111.471 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -69.63 -30.6 68.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.356 -0.609 . . . . 21.87 109.356 174.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.9 p -113.11 -36.93 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.799 -0.637 . . . . 17.49 111.208 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.34 17.29 15.94 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.955 -0.566 . . . . 17.22 112.128 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -121.02 148.66 49.39 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.641 0.258 . . . . 14.83 111.277 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 78.7 Cg_endo -80.17 126.34 6.26 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.42 2.08 . . . . 13.33 112.144 175.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.0 pt -132.28 165.0 33.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.075 0.464 . . . . 12.33 110.555 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.52 157.24 16.3 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.979 -0.749 . . . . 8.91 108.979 171.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.9 t -70.68 -162.55 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.873 0.368 . . . . 10.33 110.038 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.435 ' HB2' ' OG ' ' A' ' 39' ' ' SER . 22.3 pt20 -74.05 8.16 2.25 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.66 0.615 . . . . 12.02 112.66 -172.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.2 t 53.33 99.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.705 0.764 . . . . 6.52 112.572 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -96.26 129.98 43.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.039 -0.528 . . . . 6.18 110.105 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.405 ' CD ' HG12 ' A' ' 51' ' ' VAL . 13.9 mmmm -76.72 132.34 39.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.242 -0.435 . . . . 6.59 110.411 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.6 mt -68.81 113.32 4.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.759 -0.655 . . . . 6.16 110.573 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.87 166.0 38.3 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.299 -0.864 . . . . 6.03 110.745 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.31 158.35 31.45 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.646 2.231 . . . . 7.28 112.042 174.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.17 167.83 19.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.883 -0.598 . . . . 8.49 110.589 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.4 t -54.4 142.06 8.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.169 -0.469 . . . . 6.19 111.242 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 64.0 t -77.27 102.86 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 6.54 111.402 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.32 16.23 22.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.822 0.82 . . . . 6.46 108.829 177.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -102.63 77.06 1.57 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.511 0.672 . . . . 7.24 110.137 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -149.17 106.8 3.65 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.974 -1.121 . . . . 7.07 107.974 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.462 ' OE1' ' HG2' ' A' ' 82' ' ' ARG . 7.8 tp10 -44.67 140.87 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.09 -0.959 . . . . 6.68 111.955 -175.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.462 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 8.5 ptp85 -60.14 106.73 0.55 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.99 -1.004 . . . . 6.93 110.973 -176.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.04 156.18 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.638 -0.71 . . . . 4.0 110.133 178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.7 p -115.77 140.0 49.63 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.827 -0.624 . . . . 3.84 110.695 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.6 166.9 26.04 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.649 -0.786 . . . . 2.58 112.052 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -97.02 127.97 43.52 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.173 -0.306 . . . . 3.7 110.173 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 91.2 t -64.0 124.51 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.479 -0.328 . . . . 3.14 110.242 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.7 p -112.02 -8.26 14.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.748 0.309 . . . . 3.77 111.159 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.466 ' HB ' ' N ' ' A' ' 108' ' ' ARG . 11.4 m -152.29 138.58 18.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.46 -0.336 . . . . 3.29 110.275 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.577 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 18.5 mt-10 -119.16 161.71 19.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 4.39 110.851 -174.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.2 mp -110.5 146.73 35.47 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.85 -0.796 . . . . 3.62 108.85 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -117.68 173.31 6.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.882 0.373 . . . . 7.76 111.202 -171.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 p -91.62 123.11 34.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.982 -0.554 . . . . 5.1 109.737 172.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.46 -171.2 1.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.888 -0.325 . . . . 7.53 110.7 -174.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.0 t 65.22 -82.31 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.649 0.78 . . . . 7.77 110.863 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -160.04 70.66 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.654 0.264 . . . . 8.0 110.952 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.7 m120 63.9 13.54 7.67 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.815 -0.63 . . . . 8.83 112.421 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -97.86 151.47 20.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.047 -0.353 . . . . 7.69 110.047 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.7 m -79.28 130.82 35.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.514 0.673 . . . . 5.85 110.859 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.5 tp -150.29 121.55 7.82 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.02 -1.474 . . . . 7.65 107.02 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -47.07 -50.81 19.09 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.008 0.818 . . . . 8.21 111.667 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 t 60.48 55.52 3.42 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.024 -0.732 . . . . 5.58 109.024 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.5 m -68.5 6.65 0.77 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.262 -0.881 . . . . 4.8 112.592 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -93.73 -10.77 33.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.946 0.403 . . . . 5.09 110.259 176.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t -119.66 145.25 46.65 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.759 -0.83 . . . . 3.7 108.759 174.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 p -125.3 122.19 36.16 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.19 0.441 . . . . 2.84 112.19 -172.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -72.53 156.43 52.02 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 108.891 -1.683 . . . . 1.91 108.891 166.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.466 ' N ' ' HB ' ' A' ' 89' ' ' THR . 19.5 mtt180 -135.08 141.68 46.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.511 1.156 . . . . 3.31 111.723 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 72.4 mt -113.21 128.5 69.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.01 -0.995 . . . . 2.17 109.516 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 t -104.69 122.55 45.91 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.282 -0.636 . . . . 3.61 109.282 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -131.75 167.56 19.3 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.146 -0.316 . . . . 3.58 110.146 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -137.26 118.29 14.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.009 -0.738 . . . . 5.1 109.009 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -132.81 113.64 13.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.362 -0.381 . . . . 5.11 110.712 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 65.34 23.23 12.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.118 -0.492 . . . . 7.42 111.191 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.31 5.63 61.91 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.021 -0.609 . . . . 5.36 112.672 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -110.68 118.12 35.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.056 0.455 . . . . 5.38 110.157 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.5 p -119.97 125.09 47.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.954 -0.566 . . . . 4.96 110.584 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -134.81 172.36 13.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.706 0.289 . . . . 5.13 110.576 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -112.21 119.36 38.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.738 -0.665 . . . . 4.32 109.416 174.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 3.1 mm? -104.54 118.17 57.23 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.711 0.291 . . . . 3.17 110.344 -177.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 32.9 Cg_endo -80.2 131.67 8.87 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.19 1.927 . . . . 2.61 111.569 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -133.39 156.69 47.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.787 0.327 . . . . 2.49 110.273 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.64 169.01 9.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.99 -0.55 . . . . 3.18 110.156 175.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -70.76 -18.95 62.76 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.08 0.4 . . . . 5.22 112.08 -174.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.59 -5.39 57.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.344 -0.389 . . . . 4.81 111.149 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -86.77 -13.84 44.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.652 -0.249 . . . . 4.0 111.031 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.414 ' HB ' ' HB ' ' A' ' 156' ' ' ILE . 4.7 p -119.27 112.69 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.224 0.535 . . . . 4.39 110.688 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.05 175.17 6.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.167 -0.47 . . . . 6.43 110.415 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.76 -12.71 68.68 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.653 -0.784 . . . . 6.14 111.869 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.6 m120 59.31 41.41 19.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.062 0.458 . . . . 6.26 111.251 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.71 150.42 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.869 -0.605 . . . . 5.62 110.331 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -101.44 85.38 2.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.131 0.491 . . . . 6.25 110.037 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.525 HD21 ' H ' ' A' ' 133' ' ' LEU . 2.1 pt? -75.37 128.6 35.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.694 -0.684 . . . . 3.62 110.325 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.577 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 18.0 tpt180 -105.65 143.71 33.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.673 . . . . 7.5 110.448 -173.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.58 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -63.82 113.64 3.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.997 0.427 . . . . 4.12 110.051 174.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 116.31 -11.52 16.79 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.268 -0.733 . . . . 4.2 111.268 -173.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.511 ' OD2' ' HA ' ' A' ' 161' ' ' PRO . 4.9 t70 -87.83 -179.13 6.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.211 -0.663 . . . . 4.06 109.211 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -122.87 114.62 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.123 0.487 . . . . 4.48 110.71 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.2 m -119.93 149.8 22.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.068 0.461 . . . . 2.98 111.316 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -100.88 135.07 42.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.602 -0.726 . . . . 3.68 109.554 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -144.95 149.71 35.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.41 -0.359 . . . . 3.35 110.536 -178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.675 HE21 ' N ' ' A' ' 142' ' ' GLN . 0.0 OUTLIER -102.7 139.36 38.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.191 -0.459 . . . . 5.34 109.893 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.2 mt -101.88 100.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.033 0.444 . . . . 4.66 110.627 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -97.3 110.92 23.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.3 -0.409 . . . . 5.08 110.964 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.7 m -79.89 110.79 15.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 5.68 111.311 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -83.53 165.68 18.89 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.059 -0.519 . . . . 6.25 110.466 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -48.98 -44.8 41.32 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.667 0.988 . . . . 9.03 113.667 -172.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -81.31 3.18 25.05 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.158 -0.617 . . . . 8.29 111.519 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.64 23.1 40.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.525 -0.845 . . . . 5.65 111.76 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -96.33 127.35 42.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.186 -0.302 . . . . 5.26 110.186 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.448 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.54 163.64 39.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.807 0.336 . . . . 4.63 110.401 175.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.86 -110.82 0.32 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.892 -0.883 . . . . 3.57 110.892 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.89 110.44 4.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.678 -0.49 . . . . 2.84 109.678 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -115.91 158.81 22.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.699 -0.482 . . . . 4.34 109.699 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 10.4 p80 38.46 65.35 0.63 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.352 1.033 . . . . 6.23 111.608 -174.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.414 ' HB ' ' HB ' ' A' ' 127' ' ' VAL . 77.7 mt -77.43 133.77 29.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.192 -1.367 . . . . 3.55 110.707 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -126.84 124.31 39.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.068 0.461 . . . . 6.3 110.825 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.5 tt -85.99 106.8 17.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.717 -0.846 . . . . 4.63 108.717 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.69 -42.37 5.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.078 -0.51 . . . . 4.97 111.934 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -121.22 93.84 48.8 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.789 -0.449 . . . . 5.57 109.789 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.511 ' HA ' ' OD2' ' A' ' 137' ' ' ASP . 74.2 Cg_endo -75.43 156.41 41.1 Favored 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 122.649 2.233 . . . . 5.69 112.603 -176.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.56 157.83 44.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.909 -0.587 . . . . 6.1 111.018 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -111.77 114.07 52.32 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.931 -0.396 . . . . 10.1 109.931 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.79 139.9 13.47 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.733 2.956 . . . . 8.39 113.701 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--O 1.237 0.41 0 CA-C-N 115.57 -0.741 . . . . 10.65 112.064 -178.62 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 111.991 -0.443 . . . . 22.01 111.991 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.91 26.59 16.49 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.748 0.419 . . . . 20.23 111.346 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -99.48 6.14 46.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.483 0.659 . . . . 18.59 109.724 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -136.13 95.14 3.14 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.693 -0.854 . . . . 17.11 108.693 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -113.61 -84.62 0.6 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.228 -0.589 . . . . 18.35 112.558 -176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -132.68 123.58 26.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.518 0.675 . . . . 16.2 111.43 -172.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -99.65 139.96 34.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.113 -0.949 . . . . 12.72 111.078 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.529 ' OE1' ' HD3' ' A' ' 27' ' ' ARG . 15.0 mm-40 -110.21 138.22 46.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.699 -0.682 . . . . 11.63 110.351 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -93.38 145.12 24.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.259 -0.428 . . . . 9.47 111.128 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.3 -175.48 23.18 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.553 -0.619 . . . . 7.73 111.553 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.1 mt -127.75 141.9 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.808 -0.442 . . . . 10.57 109.808 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.01 122.77 19.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.969 -0.292 . . . . 8.73 110.441 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -81.73 -53.78 5.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 10.86 111.197 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -158.98 147.94 18.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.01 -0.541 . . . . 14.48 110.51 -177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.78 95.67 8.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 11.73 110.905 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 4.3 mm? -92.07 179.25 5.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.578 -0.737 . . . . 11.9 109.549 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -91.14 120.78 32.37 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.262 -0.273 . . . . 16.67 110.262 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.6 t 79.15 -40.97 0.25 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.961 0.905 . . . . 13.28 111.379 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 7.1 p90 -119.34 146.22 45.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.919 0.39 . . . . 12.68 111.051 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.77 163.02 22.89 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.599 -0.6 . . . . 7.92 111.599 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.97 143.59 47.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.892 0.377 . . . . 9.69 111.364 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.4 mt -110.44 129.28 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.65 -0.704 . . . . 7.75 110.232 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.79 140.53 42.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.81 0.814 . . . . 12.4 111.678 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.4 p -80.09 0.95 29.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.335 -1.302 . . . . 12.96 112.131 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.6 m -51.91 -39.6 59.36 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.471 0.545 . . . . 13.58 112.471 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -89.59 -13.31 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.251 0.548 . . . . 12.19 111.174 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.529 ' HD3' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -128.99 -158.46 0.89 Allowed 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.103 -0.373 . . . . 12.99 110.346 -175.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -124.03 19.22 9.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.076 0.465 . . . . 17.26 110.369 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.47 130.32 26.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.705 -0.679 . . . . 12.1 110.954 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -94.39 124.83 38.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.963 -0.754 . . . . 13.0 108.963 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.7 mt -123.72 162.4 23.22 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.069 0.462 . . . . 9.21 111.525 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -126.05 148.51 49.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.669 -0.696 . . . . 9.75 109.356 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -142.39 153.35 43.7 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.894 -0.41 . . . . 6.85 109.894 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -95.71 161.65 13.94 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.603 -0.517 . . . . 10.15 109.603 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -64.05 -13.61 48.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.059 0.457 . . . . 10.56 111.118 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.4 t -74.88 -20.64 59.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.13 -0.487 . . . . 12.44 110.155 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -100.25 23.37 10.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.415 -0.357 . . . . 11.14 111.332 -178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -124.02 111.69 16.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.027 0.442 . . . . 8.78 110.341 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.8 t -89.17 91.85 8.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.013 -0.54 . . . . 9.11 110.335 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.05 173.84 31.21 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.929 -0.653 . . . . 9.98 112.18 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -75.4 117.92 17.72 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.975 -0.38 . . . . 12.91 109.975 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.44 -18.86 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 11.97 111.93 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -54.97 -36.58 65.52 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.375 -0.375 . . . . 14.73 111.868 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -102.15 21.76 14.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.241 0.46 . . . . 13.3 112.241 -173.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -103.21 107.27 18.02 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.798 -0.361 . . . . 10.07 110.138 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -116.09 173.88 6.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.043 0.449 . . . . 13.53 110.904 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 47' ' ' ILE . 3.7 mp -80.56 125.84 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.911 -0.774 . . . . 12.26 108.911 177.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.19 -13.75 28.52 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.953 -0.641 . . . . 11.04 111.893 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.7 125.05 91.76 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-O 120.697 0.285 . . . . 8.39 110.553 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.98 132.07 15.04 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.469 2.113 . . . . 8.18 111.006 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 m -126.44 154.83 36.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.01 0.433 . . . . 4.78 111.296 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -109.51 126.57 53.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.414 -0.812 . . . . 7.09 109.468 176.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.3 161.08 38.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.901 0.381 . . . . 7.82 110.711 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -122.82 109.5 14.27 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.53 -0.544 . . . . 11.59 109.53 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.3 ttt -79.32 120.04 23.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.59 -0.732 . . . . 12.41 110.482 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.3 p -138.71 152.1 47.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.324 -0.398 . . . . 13.93 110.617 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -96.34 117.13 30.2 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.967 -0.383 . . . . 16.22 109.967 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -92.37 128.51 38.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.912 -0.585 . . . . 16.64 111.454 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -79.87 -13.28 59.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.535 -0.757 . . . . 23.23 111.473 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -79.53 -52.53 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 21.87 110.073 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.6 p -85.43 -37.8 19.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.024 -0.535 . . . . 17.49 110.75 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.03 14.06 50.42 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.491 -0.644 . . . . 17.22 111.491 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -116.6 151.42 47.09 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.542 0.211 . . . . 14.83 110.489 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.31 124.42 8.41 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.725 1.617 . . . . 13.33 110.044 168.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.47 169.69 17.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.15 0.5 . . . . 12.33 111.346 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.84 157.63 17.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.673 -0.862 . . . . 8.91 108.673 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.7 t -70.88 -162.23 0.06 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.481 -0.327 . . . . 10.33 110.56 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -74.57 7.85 2.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.301 0.482 . . . . 12.02 112.301 -172.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.9 t 49.84 91.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 124.026 0.829 . . . . 6.52 112.429 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.92 111.49 16.3 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.791 -0.64 . . . . 6.18 110.545 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 112.27 6.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.709 -0.678 . . . . 6.59 109.462 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.1 mt -63.55 125.11 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.696 -0.684 . . . . 6.16 111.093 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.3 139.03 20.11 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 6.03 110.707 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -87.13 18.61 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.028 2.485 . . . . 7.28 113.653 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -86.63 174.79 8.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.025 0.44 . . . . 8.49 110.876 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.3 t -106.44 152.2 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.091 -0.504 . . . . 6.19 109.78 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.716 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 94.6 t -72.72 96.2 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 6.54 111.627 -176.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 144' ' ' ALA . 54.3 mt -85.38 -27.81 25.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.811 -0.632 . . . . 6.46 111.152 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.0 m -110.86 81.2 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.197 0.523 . . . . 7.24 112.407 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -96.22 -66.72 0.89 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.682 -1.229 . . . . 7.07 107.682 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -147.02 142.76 27.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.936 -0.574 . . . . 6.68 109.786 173.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 82' ' ' ARG . 45.7 ttm180 -82.86 100.64 10.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.815 -0.629 . . . . 6.93 110.072 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.53 153.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.323 0.582 . . . . 4.0 111.554 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.471 HG21 ' OG ' ' A' ' 140' ' ' SER . 60.7 p -116.11 140.49 49.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.599 -0.728 . . . . 3.84 109.582 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.0 174.06 23.37 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.003 -1.094 . . . . 2.58 112.421 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.0 m -125.52 128.67 48.36 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.607 0.242 . . . . 3.7 110.467 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.582 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 51.9 t -71.97 132.79 32.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.053 -0.522 . . . . 3.14 110.326 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.4 p -116.16 -9.17 11.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.178 0.513 . . . . 3.77 111.31 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.2 m -152.57 125.38 8.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 3.29 109.847 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.1 174.73 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.361 . . . . 4.39 110.904 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.49 150.2 23.62 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.945 0.403 . . . . 3.62 110.735 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -82.53 115.59 21.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.608 -0.724 . . . . 7.76 111.38 -177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.4 p -156.08 143.84 19.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.237 -0.892 . . . . 5.1 109.496 177.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.9 -41.46 82.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.888 0.375 . . . . 7.53 111.231 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 t -163.94 -162.46 0.7 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.296 -0.411 . . . . 7.77 110.04 -175.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.6 -63.32 1.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 8.0 110.565 177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -91.78 65.07 4.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.089 0.471 . . . . 8.83 110.485 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -172.46 92.43 0.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.208 -1.034 . . . . 7.69 108.208 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 30.5 m -126.83 19.46 3.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.744 0.646 . . . . 5.85 112.744 -171.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.508 ' H ' HD22 ' A' ' 100' ' ' LEU . 1.8 pt? -86.13 15.23 5.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.388 0.613 . . . . 7.65 110.769 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -82.56 6.5 17.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.434 -0.803 . . . . 8.21 110.312 176.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m 66.49 84.85 0.15 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.196 -0.911 . . . . 5.58 111.277 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.6 m -82.09 53.03 2.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.959 -0.564 . . . . 4.8 110.429 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -82.44 -22.11 35.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.445 -0.798 . . . . 5.09 111.329 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.9 t -86.73 154.91 20.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.068 -0.515 . . . . 3.7 110.187 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.7 p -101.57 125.64 48.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.494 -0.321 . . . . 2.84 111.398 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.573 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -71.2 167.66 51.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.895 -0.882 . . . . 1.91 110.895 174.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -131.75 132.44 43.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.305 0.552 . . . . 3.31 111.289 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.1 mt -113.05 133.62 58.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.391 -0.822 . . . . 2.17 109.309 173.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.9 t -84.17 134.47 34.57 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.222 -0.659 . . . . 3.61 109.222 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.507 ' CD2' HD13 ' A' ' 120' ' ' LEU . 36.5 t80 -157.01 142.73 17.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.16 0.505 . . . . 3.58 111.27 -168.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -129.82 131.49 46.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 5.1 109.311 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -152.29 131.89 13.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.871 0.367 . . . . 5.11 110.639 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 63.48 21.87 12.96 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.017 -0.538 . . . . 7.42 111.616 171.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.26 70.22 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.966 -0.635 . . . . 5.36 112.344 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.97 132.87 43.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.049 0.452 . . . . 5.38 110.24 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 15.1 m -121.8 115.55 22.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.108 -0.496 . . . . 4.96 109.896 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -156.64 173.89 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.77 0.319 . . . . 5.13 111.168 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -107.38 141.85 38.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.971 -0.559 . . . . 4.32 110.167 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.507 HD13 ' CD2' ' A' ' 111' ' ' TYR . 1.7 mp -105.78 139.95 20.72 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.085 -0.709 . . . . 3.17 109.085 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 83.7 Cg_endo -86.93 132.17 3.3 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.951 2.434 . . . . 2.61 112.423 177.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -137.42 149.99 47.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.786 0.327 . . . . 2.49 110.559 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 31.8 p -113.56 177.99 4.44 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.781 -0.452 . . . . 3.18 109.781 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -70.85 -18.17 62.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.001 0.429 . . . . 5.22 110.635 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.98 -27.9 54.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.874 -0.603 . . . . 4.81 110.977 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -75.67 -25.79 57.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.069 0.461 . . . . 4.0 110.916 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 156' ' ' ILE . 2.0 p -90.73 107.78 18.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.619 0.724 . . . . 4.39 111.263 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.84 139.72 34.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.321 -0.854 . . . . 6.43 108.696 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 136.55 -12.81 4.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.517 -0.849 . . . . 6.14 112.252 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 68.09 19.17 9.31 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.913 0.485 . . . . 6.26 112.093 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.62 144.16 9.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.044 0.449 . . . . 5.62 110.855 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -105.28 97.38 7.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.029 -0.532 . . . . 6.25 110.392 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.484 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -89.71 149.86 22.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.075 -0.966 . . . . 3.62 110.741 -177.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -122.6 162.35 22.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.063 -0.517 . . . . 7.5 109.678 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.582 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.28 123.47 23.8 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.888 -0.508 . . . . 4.12 110.453 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.78 -14.07 11.57 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.606 -0.807 . . . . 4.2 113.405 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.61 176.42 6.02 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 117.763 0.782 . . . . 4.06 110.323 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -107.19 115.11 29.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.0 0.428 . . . . 4.48 110.951 -173.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.3 m -118.58 172.85 5.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.789 -0.641 . . . . 2.98 111.257 -178.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.471 ' OG ' HG21 ' A' ' 84' ' ' THR . 43.4 m -138.1 129.86 28.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.954 -0.758 . . . . 3.68 108.954 175.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -127.9 140.29 52.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.033 0.444 . . . . 3.35 110.982 -172.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -93.81 111.28 22.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.73 -0.668 . . . . 5.34 109.708 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.1 mt -79.07 100.36 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.086 -0.506 . . . . 4.66 110.128 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -80.7 110.08 15.86 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.226 -0.443 . . . . 5.08 110.195 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 m -103.09 126.05 50.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.792 -0.64 . . . . 5.68 109.885 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -93.97 -171.09 2.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.302 -0.408 . . . . 6.25 110.401 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -84.44 -8.79 58.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.999 0.428 . . . . 9.03 111.166 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 -89.25 -23.04 22.44 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.956 -0.566 . . . . 8.29 109.846 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.84 22.63 59.32 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.67 -0.695 . . . . 5.65 112.094 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -116.89 109.68 17.37 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.637 -0.505 . . . . 5.26 109.637 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.497 ' N ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.88 179.76 8.8 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.102 0.477 . . . . 4.63 111.491 -175.551 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -141.51 -94.46 0.23 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.505 -0.77 . . . . 3.57 111.267 174.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -143.58 156.09 44.49 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.386 -0.598 . . . . 2.84 109.386 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 155' ' ' HIS . 13.9 t -162.55 161.84 27.04 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.842 -0.429 . . . . 4.34 109.842 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.46 ' HD2' ' SG ' ' A' ' 154' ' ' CYS . 35.2 m-70 48.13 66.3 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.643 0.589 . . . . 6.23 111.69 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.531 ' O ' HG21 ' A' ' 127' ' ' VAL . 68.4 mt -93.94 117.72 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.335 -0.848 . . . . 3.55 110.365 -177.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.12 158.51 17.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 6.3 110.47 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.84 113.38 26.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.51 -0.552 . . . . 4.63 109.51 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -83.0 -58.59 2.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.013 0.435 . . . . 4.97 111.383 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -136.42 100.6 10.28 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.284 -0.416 . . . . 5.57 110.129 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.88 159.68 51.79 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.391 2.061 . . . . 5.69 111.478 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -131.22 143.34 50.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.029 0.442 . . . . 6.1 111.138 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.01 161.17 50.59 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.698 -0.853 . . . . 10.1 108.698 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -43.07 110.25 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.847 2.365 . . . . 8.39 113.548 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.693 -0.685 . . . . 10.65 111.463 -178.472 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 111.8 -0.52 . . . . 22.01 111.8 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.28 66.75 1.79 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.209 0.528 . . . . 20.23 109.867 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.478 ' OD1' ' HB ' ' A' ' 56' ' ' THR . 9.2 t70 -78.54 -51.76 9.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.698 -0.683 . . . . 18.59 109.674 -177.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.05 63.79 5.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 17.11 110.684 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -141.62 -38.22 0.4 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.222 0.534 . . . . 18.35 110.879 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.67 104.93 8.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.632 -0.713 . . . . 16.2 109.709 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 83.3 mtt180 -114.23 116.76 29.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.698 -0.683 . . . . 12.72 111.478 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.508 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 6.8 mm-40 -102.76 143.74 32.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.839 -1.073 . . . . 11.63 110.441 -174.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.6 p -104.3 160.95 14.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.282 -0.636 . . . . 9.47 109.282 174.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.25 174.68 46.93 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.102 -1.047 . . . . 7.73 113.562 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.46 HG13 ' HB3' ' A' ' 23' ' ' GLN . 19.8 pt -120.57 148.81 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.924 -0.769 . . . . 10.57 108.924 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.9 mp -80.07 131.45 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.307 -0.557 . . . . 8.73 110.774 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.456 ' OE2' ' HB2' ' A' ' 14' ' ' LYS . 4.3 tm-20 -74.66 -46.74 36.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.687 -0.688 . . . . 10.86 111.026 -176.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.499 ' HD3' ' N ' ' A' ' 15' ' ' LEU . 6.8 tmtt? -157.09 133.17 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.002 -0.37 . . . . 14.48 110.002 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.499 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 3.6 mm? -78.06 110.88 13.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.943 -0.571 . . . . 11.73 110.901 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 72.2 mt -109.79 177.52 4.7 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.922 -1.14 . . . . 11.9 107.922 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -98.91 139.87 33.93 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.486 -0.485 . . . . 16.67 110.511 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t 76.89 -46.05 0.5 Allowed 'General case' 0 N--CA 1.468 0.425 0 O-C-N 124.366 1.041 . . . . 13.28 111.04 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.488 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 39.6 p90 -129.92 154.29 47.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.264 -0.425 . . . . 12.68 109.925 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -144.51 163.57 27.86 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.897 -0.668 . . . . 7.92 111.72 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -109.33 134.39 51.87 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.231 0.538 . . . . 9.69 111.262 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 22' ' ' ILE . 74.6 mt -99.86 126.4 53.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 7.75 109.569 176.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.551 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 18.9 tp60 -79.31 130.65 35.66 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.089 0.471 . . . . 12.4 110.319 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 p -67.86 3.63 1.43 Allowed 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 113.894 1.072 . . . . 12.96 113.894 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.551 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 74.4 m -51.75 -26.33 9.28 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.537 0.939 . . . . 13.58 113.537 -172.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -99.53 -6.35 27.62 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.131 0.419 . . . . 12.19 112.131 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.465 ' HG3' ' HB3' ' A' ' 8' ' ' GLU . 17.2 mmt180 -152.28 -159.89 1.07 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.801 0.334 . . . . 12.99 110.841 -173.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -116.3 17.23 15.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.092 0.472 . . . . 17.26 110.601 177.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.37 113.24 14.71 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.197 -0.456 . . . . 12.1 111.768 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -87.9 104.65 16.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.661 -0.866 . . . . 13.0 108.661 170.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.99 161.22 14.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.928 0.394 . . . . 9.21 111.232 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -110.95 129.36 55.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.308 -0.997 . . . . 9.75 108.308 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -110.64 141.56 43.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.084 0.469 . . . . 6.85 110.158 -175.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -87.16 137.61 32.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.031 -0.729 . . . . 10.15 109.031 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.46 -11.31 32.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.924 0.342 . . . . 10.56 111.924 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.6 t -72.21 -27.41 62.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.28 -0.418 . . . . 12.44 110.494 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.48 40.31 1.57 Allowed 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.154 -0.475 . . . . 11.14 111.321 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.428 ' CE1' ' HG ' ' A' ' 45' ' ' LEU . 22.8 t80 -113.7 129.16 56.61 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.057 -0.72 . . . . 8.78 109.057 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.0 t -108.79 115.25 29.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.907 -0.405 . . . . 9.11 109.907 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.3 -157.3 20.74 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.873 -0.679 . . . . 9.98 111.724 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -93.45 103.47 15.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.89 0.376 . . . . 12.91 110.626 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.3 tp -67.05 -21.82 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.917 -0.583 . . . . 11.97 110.757 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.64 -21.44 65.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 14.73 110.283 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -99.31 11.74 38.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.769 -0.651 . . . . 13.3 110.222 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.428 ' HG ' ' CE1' ' A' ' 38' ' ' PHE . 2.8 tm? -101.28 115.41 30.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.148 -0.686 . . . . 10.07 109.148 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -123.43 -177.6 3.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.382 -0.372 . . . . 13.53 111.153 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.421 HD11 ' N ' ' A' ' 47' ' ' ILE . 3.9 mp -77.48 117.84 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.0 -0.371 . . . . 12.26 110.0 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.35 -1.3 64.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.86 -0.686 . . . . 11.04 111.776 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.98 125.28 90.34 Favored Pre-proline 0 C--O 1.234 0.276 0 N-CA-C 109.882 -0.414 . . . . 8.39 109.882 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.89 128.1 7.35 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.637 2.224 . . . . 8.18 113.66 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.48 161.66 38.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 4.78 110.358 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -122.41 127.35 49.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.399 0.618 . . . . 7.09 109.655 174.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.508 ' CE1' ' HB2' ' A' ' 8' ' ' GLU . 45.3 p90 -131.71 -179.32 5.31 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.921 -0.582 . . . . 7.82 110.872 -174.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 37.6 tt0 -127.91 126.95 42.49 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.959 -0.756 . . . . 11.59 108.959 -176.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.5 ttt -100.53 112.45 24.83 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.289 -0.263 . . . . 12.41 110.289 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.478 ' HB ' ' OD1' ' A' ' 3' ' ' ASP . 46.2 p -131.9 170.67 14.55 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.339 -0.391 . . . . 13.93 111.351 -175.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -115.77 109.41 17.63 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.81 -0.441 . . . . 16.22 109.81 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.532 ' OD2' HG23 ' A' ' 61' ' ' THR . 31.2 t70 -76.59 122.88 25.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.139 -0.482 . . . . 16.64 111.063 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -79.51 -13.34 59.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 23.23 111.367 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 60' ' ' ARG . 14.3 ttm180 -78.42 -62.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.377 . . . . 21.87 110.935 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.532 HG23 ' OD2' ' A' ' 58' ' ' ASP . 15.3 t -88.45 -22.49 23.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.308 -0.405 . . . . 17.49 110.594 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.02 17.63 57.43 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.747 -0.739 . . . . 17.22 113.288 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -104.5 141.72 23.12 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.589 0.195 . . . . 14.83 110.569 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.92 124.13 7.84 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.451 1.434 . . . . 13.33 109.317 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -141.27 171.56 11.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.133 -0.627 . . . . 12.33 112.397 -169.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.3 143.48 28.02 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.928 -1.033 . . . . 8.91 109.038 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.429 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 14.1 t -69.71 -155.68 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.357 -0.383 . . . . 10.33 110.46 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -75.27 29.1 0.1 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.397 0.888 . . . . 12.02 113.397 -172.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.0 t 19.92 103.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 125.14 1.376 . . . . 6.52 114.403 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -101.94 143.11 32.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.089 0.471 . . . . 6.18 111.572 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -69.72 138.85 53.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.569 -0.741 . . . . 6.59 110.791 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.0 mt -81.42 100.6 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.265 -0.642 . . . . 6.16 109.265 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.0 153.45 95.39 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.346 -0.843 . . . . 6.03 111.344 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -49.45 139.95 28.51 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.462 2.775 . . . . 7.28 113.288 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 76' ' ' VAL . 3.2 pt-20 -93.02 -91.24 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.809 -0.632 . . . . 8.49 112.147 -175.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.478 ' H ' ' HG3' ' A' ' 75' ' ' GLU . 10.6 p -92.03 151.88 3.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.217 -0.447 . . . . 6.19 110.728 -176.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 47.3 t -80.75 95.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.312 0.577 . . . . 6.54 109.792 175.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tt -98.92 -24.68 14.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.112 -0.949 . . . . 6.46 110.741 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t -101.34 103.08 14.02 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.358 0.599 . . . . 7.24 112.088 -170.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -129.49 -63.59 0.93 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.166 -1.05 . . . . 7.07 108.166 169.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -168.64 147.09 4.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.723 -1.126 . . . . 6.68 108.392 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -77.11 98.56 5.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.61 -0.515 . . . . 6.93 109.61 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.6 m -81.8 157.24 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.44 0.638 . . . . 4.0 111.546 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.6 p -124.69 146.87 48.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.609 -0.723 . . . . 3.84 109.257 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.43 -173.33 13.71 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.272 -0.966 . . . . 2.58 112.063 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.7 m -130.92 131.15 44.29 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.015 -0.365 . . . . 3.7 110.015 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 88.0 t -64.18 129.95 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.519 -0.309 . . . . 3.14 110.33 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.3 p -113.98 -9.98 12.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.983 0.421 . . . . 3.77 110.722 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.7 m -152.26 128.76 10.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.429 . . . . 3.29 110.209 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -99.07 169.63 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 4.39 110.726 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.19 132.8 33.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.999 -0.546 . . . . 3.62 110.122 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -88.76 110.24 20.84 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.055 -0.521 . . . . 7.76 110.554 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m -146.97 155.29 42.15 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.696 -0.483 . . . . 5.1 109.696 173.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -88.7 -43.97 10.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.213 0.53 . . . . 7.53 110.673 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.5 t -140.3 -173.31 3.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.64 -0.709 . . . . 7.77 109.231 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.31 -55.94 23.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.735 0.303 . . . . 8.0 110.636 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -100.05 -12.8 19.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 8.83 112.06 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -81.69 84.77 6.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.343 0.592 . . . . 7.69 109.821 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.1 t -112.81 158.29 13.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.75 -1.114 . . . . 5.85 109.478 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.44 ' HB3' ' H ' ' A' ' 101' ' ' ASN . 0.4 OUTLIER -60.57 -77.47 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.415 0.626 . . . . 7.65 110.114 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.44 ' H ' ' HB3' ' A' ' 100' ' ' LEU . 0.6 OUTLIER -123.59 -46.05 2.03 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.379 -0.828 . . . . 8.21 111.177 173.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.0 p -167.75 -158.13 0.25 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.542 -0.299 . . . . 5.58 110.263 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 m -76.5 57.01 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.177 0.513 . . . . 4.8 110.203 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -78.9 -14.65 59.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.556 -0.747 . . . . 5.09 110.793 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -103.1 118.26 36.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.367 -0.833 . . . . 3.7 109.872 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.19 116.2 32.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.109 0.481 . . . . 2.84 111.141 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -69.09 160.77 52.42 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.729 -0.748 . . . . 1.91 111.554 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -129.9 127.61 40.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.342 0.592 . . . . 3.31 110.868 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.5 mt -112.0 127.45 69.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.204 -0.907 . . . . 2.17 109.241 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.4 t -112.4 137.46 50.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.764 0.316 . . . . 3.61 110.441 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 2.7 p90 -143.37 155.42 44.42 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.115 -0.698 . . . . 3.58 109.115 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -111.56 125.24 53.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.864 0.364 . . . . 5.1 110.463 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.732 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 9.4 t30 -130.03 115.66 17.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.945 -0.571 . . . . 5.11 109.584 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 60.94 21.63 11.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.663 0.268 . . . . 7.42 111.581 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.87 -4.18 68.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.825 -0.702 . . . . 5.36 113.011 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.732 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 7.9 pt-20 -99.68 132.96 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.145 -0.687 . . . . 5.38 109.145 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 7.8 p -116.77 118.36 32.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.94 0.4 . . . . 4.96 110.427 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.431 ' CE1' ' HG3' ' A' ' 116' ' ' GLU . 78.9 m-85 -108.4 155.01 21.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.142 -0.481 . . . . 5.13 110.494 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -110.26 123.34 49.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.952 -0.567 . . . . 4.32 109.715 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.77 120.2 52.14 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.384 -0.371 . . . . 3.17 110.408 -175.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -76.7 132.91 13.62 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.906 2.404 . . . . 2.61 111.722 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -145.3 155.0 42.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.804 0.335 . . . . 2.49 110.25 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 62.8 p -107.4 -174.71 2.6 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.124 -0.489 . . . . 3.18 110.084 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -71.39 -19.61 62.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.222 0.534 . . . . 5.22 110.514 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.85 -28.28 33.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.754 -0.657 . . . . 4.81 111.437 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.22 -19.61 60.46 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.387 -0.369 . . . . 4.0 111.364 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.9 p -107.43 107.91 23.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.588 0.709 . . . . 4.39 111.009 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -90.46 138.43 31.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 6.43 110.183 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.23 -20.65 4.98 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.777 -0.647 . . . . 6.14 111.51 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.8 t30 61.58 31.57 18.77 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.74 0.781 . . . . 6.26 110.001 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -89.92 138.51 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.692 -0.685 . . . . 5.62 110.151 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.432 ' N ' HD21 ' A' ' 132' ' ' ASN . 0.9 OUTLIER -82.5 103.38 12.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.735 0.302 . . . . 6.25 110.379 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.52 HD11 ' H ' ' A' ' 133' ' ' LEU . 2.2 mp -75.56 134.87 40.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.751 -0.659 . . . . 3.62 109.51 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -121.34 126.74 50.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.889 0.376 . . . . 7.5 110.159 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.567 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -57.46 112.91 1.56 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.359 0.599 . . . . 4.12 111.317 -175.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.36 -2.8 14.04 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.296 -0.865 . . . . 4.2 112.851 -174.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.6 p30 -95.01 178.27 5.61 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.442 0.621 . . . . 4.06 110.459 172.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -100.22 122.88 43.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.978 0.418 . . . . 4.48 111.036 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.09 151.82 24.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.668 -0.696 . . . . 2.98 110.584 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.3 t -124.93 129.33 50.16 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.704 -0.48 . . . . 3.68 109.704 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -136.67 154.6 50.58 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.557 -0.534 . . . . 3.35 109.557 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -113.0 114.76 27.36 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.37 -0.604 . . . . 5.34 109.37 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -78.43 108.16 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.594 . . . . 4.66 111.304 -174.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -100.62 110.5 22.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.128 -0.487 . . . . 5.08 109.81 172.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.2 m -85.85 108.95 18.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.198 -0.455 . . . . 5.68 111.126 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -64.53 146.1 55.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.937 -0.574 . . . . 6.25 109.661 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.17 -17.97 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.571 0.582 . . . . 9.03 112.571 -173.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -85.75 2.07 47.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 8.29 110.31 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.48 16.77 80.43 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.68 -0.691 . . . . 5.65 113.143 174.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -119.69 113.09 20.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.332 -0.618 . . . . 5.26 109.332 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.496 ' N ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -144.72 -179.17 6.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.214 -0.448 . . . . 4.63 111.067 -175.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.58 -153.3 5.84 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.057 -0.817 . . . . 3.57 111.057 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.26 118.01 34.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.213 0.507 . . . . 2.84 110.086 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 33.9 t -116.44 159.59 21.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.59 -0.277 . . . . 4.34 110.646 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 60.47 33.58 20.57 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.95 -0.568 . . . . 6.23 111.174 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 55.0 mt -64.69 125.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.764 -0.653 . . . . 3.55 110.921 -176.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -140.44 159.92 41.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.724 -0.671 . . . . 6.3 110.056 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.1 tp -77.6 119.24 20.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.281 -0.637 . . . . 4.63 109.281 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -84.41 -47.67 10.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.031 -0.531 . . . . 4.97 109.628 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -162.5 113.94 1.12 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.864 -0.607 . . . . 5.57 109.492 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.12 152.08 80.46 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.126 1.884 . . . . 5.69 112.481 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -121.64 143.52 49.28 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.897 -0.592 . . . . 6.1 110.774 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -99.03 139.57 21.11 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.0 -0.546 . . . . 10.1 109.662 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.33 107.18 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.152 1.901 . . . . 8.39 111.577 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 55.2 t . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.418 0.627 . . . . 10.65 111.503 -177.694 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 111.926 -0.47 . . . . 22.01 111.926 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.25 66.13 5.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.08 0.467 . . . . 20.23 111.226 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -117.11 6.54 12.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.878 0.847 . . . . 18.59 108.86 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -150.92 99.6 2.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.497 -1.229 . . . . 17.11 109.056 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -135.92 -82.65 0.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.514 0.561 . . . . 18.35 112.514 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -124.67 92.8 3.73 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.028 -0.533 . . . . 16.2 111.869 -169.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -69.64 138.43 53.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.928 -0.578 . . . . 12.72 110.128 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.479 ' CD ' ' HE ' ' A' ' 27' ' ' ARG . 14.1 pt-20 -142.38 162.12 36.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.924 -0.399 . . . . 11.63 109.924 174.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.517 HG22 ' HB3' ' A' ' 52' ' ' GLU . 68.9 p -109.14 157.38 18.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.536 0.684 . . . . 9.47 112.133 -171.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.69 157.0 28.42 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.224 -1.15 . . . . 7.73 110.224 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.0 pt -105.01 141.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 117.097 0.448 . . . . 10.57 110.646 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.406 HG13 HD11 ' A' ' 45' ' ' LEU . 41.6 mm -74.37 123.45 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 110.067 -0.346 . . . . 8.73 110.067 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.68 -34.5 17.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.333 0.494 . . . . 10.86 112.333 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.42 ' HA ' HD13 ' A' ' 47' ' ' ILE . 1.9 tmtp? -160.74 130.4 4.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.947 0.404 . . . . 14.48 111.059 -175.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.482 ' H ' HD11 ' A' ' 47' ' ' ILE . 3.0 mm? -91.55 106.55 18.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.854 -0.612 . . . . 11.73 110.796 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 5.3 mp -96.93 179.77 4.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.763 -0.829 . . . . 11.9 108.763 174.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -89.81 116.11 27.66 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.268 -0.573 . . . . 16.67 110.434 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.4 t 78.54 -14.0 0.91 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.298 0.999 . . . . 13.28 111.635 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 10.1 p90 -145.45 162.97 36.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.187 -0.301 . . . . 12.68 110.187 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.67 177.22 33.72 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.67 -0.776 . . . . 7.92 112.125 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -126.68 148.49 49.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 9.69 110.914 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.7 mt -108.87 126.21 65.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.571 -0.741 . . . . 7.75 109.666 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.22 143.2 47.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.426 0.631 . . . . 12.4 110.766 -175.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.7 p -77.04 6.04 7.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.068 -0.969 . . . . 12.96 111.942 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -49.57 -39.97 36.85 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.077 0.399 . . . . 13.58 112.077 -173.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -116.91 6.38 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.835 -0.346 . . . . 12.19 111.4 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.615 ' HD3' ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -120.41 141.31 50.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.533 -0.543 . . . . 12.99 109.533 -173.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.615 ' N ' ' HD3' ' A' ' 27' ' ' ARG . 27.7 mm-40 -77.04 26.01 0.15 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.064 -0.397 . . . . 17.26 111.484 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' A' ' 27' ' ' ARG . . . 178.99 145.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.575 0.75 . . . . 12.1 109.333 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.523 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.9 OUTLIER -86.9 132.37 33.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.557 -0.534 . . . . 13.0 109.557 174.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.52 162.39 19.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.209 0.528 . . . . 9.21 111.636 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -116.16 147.98 40.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.486 -0.779 . . . . 9.75 109.882 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -150.22 172.92 14.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.77 -0.456 . . . . 6.85 109.77 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 7.1 p-80 -135.06 165.79 24.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 10.15 111.172 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -66.29 -18.95 65.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.835 -0.621 . . . . 10.56 111.896 -173.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t -86.27 2.36 47.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.546 -0.297 . . . . 12.44 110.837 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 36.6 tp60 -110.74 -30.16 7.69 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.774 -0.454 . . . . 11.14 109.774 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -77.35 121.55 23.91 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.875 -0.602 . . . . 8.78 109.956 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.416 ' HB2' ' CG ' ' A' ' 68' ' ' GLN . 34.1 t -97.07 139.99 32.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.196 0.522 . . . . 9.11 110.528 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.41 -169.15 14.51 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.635 -0.793 . . . . 9.98 112.573 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -72.9 110.73 7.43 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.363 0.601 . . . . 12.91 111.068 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -77.75 -20.65 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.372 -0.831 . . . . 11.97 109.998 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.75 -31.63 72.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 14.73 110.401 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -97.02 24.53 6.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.815 -0.63 . . . . 13.3 110.768 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.406 HD11 HG13 ' A' ' 12' ' ' ILE . 3.2 tm? -113.19 120.79 42.44 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.007 -1.108 . . . . 10.07 108.007 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.29 176.49 8.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.628 0.252 . . . . 13.53 110.816 -170.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.482 HD11 ' H ' ' A' ' 15' ' ' LEU . 31.4 mm -70.63 128.25 33.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.562 -0.29 . . . . 12.26 110.26 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.13 11.09 67.82 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.322 -0.942 . . . . 11.04 112.611 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.45 121.35 71.21 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.972 -0.381 . . . . 8.39 109.972 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.48 125.3 9.51 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.564 2.176 . . . . 8.18 112.712 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 71' ' ' LYS . 34.0 m -124.61 152.96 31.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.78 -0.645 . . . . 4.78 109.65 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.517 ' HB3' HG22 ' A' ' 9' ' ' THR . 13.8 pt-20 -114.46 131.05 56.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.323 0.582 . . . . 7.09 109.752 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -137.67 172.73 12.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.371 0.605 . . . . 7.82 111.701 -172.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -118.4 133.69 55.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.189 -1.041 . . . . 11.59 108.189 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.9 ttt -100.7 122.53 43.49 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.283 -0.266 . . . . 12.41 110.283 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.3 p -135.09 144.25 47.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.413 0.625 . . . . 13.93 111.253 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -90.6 109.66 20.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.691 . . . . 16.22 109.16 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -65.02 117.93 8.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.825 -0.625 . . . . 16.64 111.618 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 -80.12 -12.25 59.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.175 -0.92 . . . . 23.23 111.712 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.82 -57.81 3.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.886 0.374 . . . . 21.87 110.397 -176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.3 p -104.68 -39.43 6.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.074 -0.512 . . . . 17.49 111.117 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.87 16.85 7.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.511 -0.852 . . . . 17.22 112.825 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -101.34 148.31 35.0 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.156 -0.313 . . . . 14.83 110.156 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -79.63 125.22 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.675 1.583 . . . . 13.33 110.358 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.3 pt -128.87 162.91 35.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.483 0.659 . . . . 12.33 111.553 -175.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.46 161.97 13.25 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.977 -1.01 . . . . 8.91 108.635 170.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.428 ' O ' HG23 ' A' ' 69' ' ' VAL . 26.3 t -75.39 -153.29 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.222 -0.288 . . . . 10.33 110.222 177.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.583 HE21 ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -67.82 -4.02 11.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.798 0.666 . . . . 12.02 112.798 -173.133 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 67' ' ' SER . 42.3 t 50.93 86.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.538 0.685 . . . . 6.52 111.56 176.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -97.23 129.86 44.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.836 -0.62 . . . . 6.18 110.649 -174.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.427 ' HA ' HG13 ' A' ' 51' ' ' VAL . 35.9 mtmm -67.61 141.21 56.84 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.157 -0.682 . . . . 6.59 109.157 175.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.12 95.62 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 6.16 111.318 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -163.56 136.59 4.21 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.309 -0.859 . . . . 6.03 109.395 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.39 135.32 22.17 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.524 2.149 . . . . 7.28 112.685 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.64 -141.39 0.36 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.34 -0.391 . . . . 8.49 110.239 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.45 ' CG2' ' HB3' ' A' ' 144' ' ' ALA . 3.2 p -64.92 164.16 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.206 0.526 . . . . 6.19 111.016 -177.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.482 HG11 ' H ' ' A' ' 79' ' ' SER . 46.7 t -85.37 118.97 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.915 -0.584 . . . . 6.54 111.856 -175.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.487 ' HG ' ' CE1' ' A' ' 155' ' ' HIS . 10.7 mp -97.19 13.57 28.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.106 -0.497 . . . . 6.46 110.548 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.482 ' H ' HG11 ' A' ' 77' ' ' VAL . 21.1 m -116.48 -112.2 0.34 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.168 -0.469 . . . . 7.24 110.532 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 81' ' ' GLU . 6.3 tt0 57.82 33.05 22.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.098 0.559 . . . . 7.07 111.143 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 80' ' ' GLU . 10.3 tp10 76.0 117.51 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.222 -0.899 . . . . 6.68 111.126 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -77.71 90.88 4.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.662 0.744 . . . . 6.93 110.159 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.65 160.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.496 -0.775 . . . . 4.0 111.226 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 p -107.86 139.52 42.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.542 -0.754 . . . . 3.84 109.924 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.36 161.26 24.41 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.515 -0.85 . . . . 2.58 112.479 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -116.96 125.01 50.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.483 -0.562 . . . . 3.7 109.483 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 58.1 t -68.5 123.68 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 108.973 -0.751 . . . . 3.14 108.973 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.0 p -105.08 -20.3 13.56 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.623 -0.431 . . . . 3.77 111.066 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -151.83 126.18 9.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.273 -0.421 . . . . 3.29 110.258 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.27 -172.68 4.12 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.951 -0.388 . . . . 4.39 109.951 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.412 HD21 ' HG3' ' A' ' 124' ' ' LYS . 5.3 mp -88.89 146.24 25.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.284 -0.636 . . . . 3.62 109.284 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -109.59 152.58 25.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.322 0.582 . . . . 7.76 111.438 -172.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 99' ' ' VAL . 1.3 p -84.16 138.43 33.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.194 -0.912 . . . . 5.1 111.309 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.47 -63.75 1.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.917 -0.583 . . . . 7.53 109.726 173.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.8 m -101.96 -177.5 3.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.598 -0.728 . . . . 7.77 109.993 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -94.74 -23.49 17.52 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.87 0.322 . . . . 8.0 111.87 -176.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -91.74 4.33 53.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.954 0.353 . . . . 8.83 111.954 -173.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -154.91 155.18 33.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.468 0.651 . . . . 7.69 111.719 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.445 ' HA ' HG23 ' A' ' 93' ' ' THR . 7.9 p -110.45 9.76 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 122.418 1.104 . . . . 5.85 109.534 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -148.41 105.3 3.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.595 -1.184 . . . . 7.65 110.065 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -133.81 -50.0 0.83 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.293 -0.867 . . . . 8.21 109.521 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.2 t -123.1 149.07 44.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 5.58 109.746 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.2 m -96.06 1.56 52.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.421 -0.354 . . . . 4.8 110.997 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.31 -14.04 61.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 5.09 111.083 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -82.27 112.08 18.94 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.408 0.623 . . . . 3.7 109.341 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 t -122.09 148.76 44.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.71 -0.677 . . . . 2.84 110.631 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.03 163.41 39.74 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.671 -0.971 . . . . 1.91 110.671 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -125.27 128.42 48.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.965 0.412 . . . . 3.31 110.886 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 71.6 mt -112.88 125.46 70.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.909 -0.587 . . . . 2.17 109.506 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.8 t -100.17 137.89 37.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.838 -0.43 . . . . 3.61 109.838 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.52 ' CE2' HD12 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -148.8 167.48 25.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.527 0.203 . . . . 3.58 110.549 -178.703 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.38 127.93 56.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.366 -0.379 . . . . 5.1 110.446 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -152.85 130.12 11.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.604 -0.517 . . . . 5.11 109.604 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 64.74 20.85 12.25 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.427 0.455 . . . . 7.42 111.168 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.57 18.73 79.68 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.778 -0.725 . . . . 5.36 111.868 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -121.21 144.92 48.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.628 -0.508 . . . . 5.38 109.628 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 11.4 p -122.98 115.49 21.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.277 -0.42 . . . . 4.96 110.265 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -132.19 157.4 44.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.251 -0.431 . . . . 5.13 110.528 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -99.77 129.25 45.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 4.32 109.819 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.52 HD12 ' CE2' ' A' ' 111' ' ' TYR . 4.2 mp -105.03 143.39 26.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 110.133 -0.321 . . . . 3.17 110.133 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.11 148.56 19.34 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.511 2.141 . . . . 2.61 112.036 175.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -155.19 144.57 21.13 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.029 -0.73 . . . . 2.49 109.029 173.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.8 p -113.11 -175.59 2.7 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.67 0.272 . . . . 3.18 110.489 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.412 ' HG3' HD21 ' A' ' 91' ' ' LEU . 55.2 mttp -65.76 -27.97 68.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.24 0.543 . . . . 5.22 110.183 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -75.16 -22.92 57.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.211 -0.904 . . . . 4.81 111.598 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -83.13 -11.25 58.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 4.0 111.86 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 p -119.98 106.55 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.441 0.639 . . . . 4.39 111.37 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -108.26 150.25 27.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.779 -0.646 . . . . 6.43 110.102 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 125.39 16.93 2.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.913 -0.66 . . . . 6.14 112.943 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.9 t30 64.25 22.62 12.88 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.447 0.642 . . . . 6.26 110.454 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.2 130.54 35.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.946 -0.57 . . . . 5.62 110.929 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -111.61 111.56 22.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 6.25 110.148 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.446 ' N ' HD12 ' A' ' 133' ' ' LEU . 5.5 mp -98.97 149.83 22.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 3.62 110.939 -176.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -146.52 121.14 9.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.475 -0.565 . . . . 7.5 109.475 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.492 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -46.68 131.57 11.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.83 -0.623 . . . . 4.12 112.532 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.22 -12.69 14.15 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.126 -0.943 . . . . 4.2 111.192 -172.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -89.64 174.9 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 4.06 110.482 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -121.86 118.69 29.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.346 0.594 . . . . 4.48 110.147 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.7 m -121.19 159.07 23.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.314 -0.857 . . . . 2.98 111.264 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.9 m -109.73 137.82 46.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.622 -0.717 . . . . 3.68 109.22 173.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -139.79 139.21 36.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.024 0.44 . . . . 3.35 110.114 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -97.2 121.08 38.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.949 -0.569 . . . . 5.34 109.532 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.05 107.91 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 4.66 110.122 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.45 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . . . -94.87 107.98 20.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.07 -0.514 . . . . 5.08 110.995 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.517 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 50.9 m -85.38 109.41 18.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.691 . . . . 5.68 111.075 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -74.76 159.29 32.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.316 -0.624 . . . . 6.25 109.316 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -57.77 -24.91 59.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 122.451 0.3 . . . . 9.03 111.693 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.611 ' HD2' ' OD1' ' A' ' 150' ' ' ASN . 1.3 tmt_? -69.81 -21.03 63.43 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.184 0.516 . . . . 8.29 110.116 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.41 2.76 61.69 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.882 -0.675 . . . . 5.65 112.107 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.611 ' OD1' ' HD2' ' A' ' 148' ' ' ARG . 15.1 m120 -99.73 135.92 40.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.632 -0.507 . . . . 5.26 109.632 177.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.517 ' HB3' ' HA ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -145.34 174.44 11.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.062 0.458 . . . . 4.63 111.332 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.32 -160.83 10.7 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.995 -0.842 . . . . 3.57 110.995 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.6 109.79 22.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.123 0.487 . . . . 2.84 110.54 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 38.1 m -131.56 176.62 8.16 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.141 -0.688 . . . . 4.34 109.141 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.487 ' CE1' ' HG ' ' A' ' 78' ' ' LEU . 13.9 m80 58.47 38.6 25.54 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.317 -0.623 . . . . 6.23 109.317 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.3 mt -79.48 128.76 38.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.173 -0.921 . . . . 3.55 111.137 -169.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -134.73 140.86 46.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.281 0.562 . . . . 6.3 110.349 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.6 tp -103.97 105.76 16.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.828 -0.624 . . . . 4.63 109.906 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -109.74 -24.64 10.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.063 -0.517 . . . . 4.97 111.297 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -117.79 86.12 23.78 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.209 -0.45 . . . . 5.57 110.821 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.34 156.21 14.51 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.54 2.16 . . . . 5.69 111.772 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.8 108.56 20.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.288 -0.415 . . . . 6.1 110.685 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.66 151.95 79.63 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.584 -0.28 . . . . 10.1 110.696 176.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.71 126.63 12.88 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.436 2.091 . . . . 8.39 111.959 177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 10.65 111.028 -179.109 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 112.107 -0.397 . . . . 22.01 112.107 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 170.64 -49.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.493 0.717 . . . . 20.23 110.208 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -116.16 5.84 13.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.337 -0.847 . . . . 18.59 111.066 -172.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -133.53 35.5 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.501 -0.318 . . . . 17.11 110.748 -173.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -67.12 -90.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.738 0.644 . . . . 18.35 112.738 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.02 141.08 36.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.835 0.35 . . . . 16.2 110.301 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.484 ' HG2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.36 99.89 5.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.731 -0.668 . . . . 12.72 111.061 178.21 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.76 153.56 21.6 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.098 -0.704 . . . . 11.63 109.098 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.503 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 20.3 p -86.52 161.36 18.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.066 0.46 . . . . 9.47 111.736 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.22 162.73 32.02 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.433 -0.667 . . . . 7.73 111.433 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 pt -113.9 148.57 16.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.724 0.262 . . . . 10.57 110.43 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.0 mm -75.28 123.4 31.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.513 -0.312 . . . . 8.73 110.687 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.512 ' OE2' ' HB3' ' A' ' 21' ' ' PHE . 29.1 mt-10 -72.53 -46.05 56.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.054 -0.521 . . . . 10.86 111.219 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.12 146.94 17.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.023 -0.535 . . . . 14.48 110.084 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.51 105.25 17.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.927 -0.579 . . . . 11.73 110.695 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 2.6 mm? -106.71 179.09 4.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.752 -0.833 . . . . 11.9 108.752 174.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -91.64 129.37 37.62 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.714 -0.394 . . . . 16.67 110.223 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.3 m 76.25 -37.79 0.31 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 124.152 0.907 . . . . 13.28 112.083 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 46.8 p90 -126.98 153.37 45.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.898 0.38 . . . . 12.68 111.081 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.4 165.95 26.24 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.03 -0.828 . . . . 7.92 111.03 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.512 ' HB3' ' OE2' ' A' ' 13' ' ' GLU . 91.5 m-85 -115.21 146.16 41.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.225 0.513 . . . . 9.69 111.459 -177.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.508 HG22 ' CE2' ' A' ' 53' ' ' PHE . 61.6 mt -117.71 127.15 75.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 7.75 110.338 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.418 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -78.22 133.14 37.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.588 0.708 . . . . 12.4 111.962 -172.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.5 p -81.22 -1.09 43.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.855 -1.066 . . . . 12.96 113.229 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -60.94 -43.18 99.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.085 0.469 . . . . 13.58 111.342 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.432 ' OE1' ' HB3' ' A' ' 128' ' ' GLU . 7.2 tp10 -90.28 -9.14 49.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.043 0.925 . . . . 12.19 109.747 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 9' ' ' THR . 1.1 mmt180 -112.29 -167.58 1.2 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.83 -1.077 . . . . 12.99 110.462 -174.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.61 21.62 6.0 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.147 -0.686 . . . . 17.26 109.147 171.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -166.05 128.21 1.93 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.922 -1.035 . . . . 12.1 110.169 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -85.91 140.24 30.53 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.831 -0.803 . . . . 13.0 108.831 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.1 mt -145.59 161.32 40.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.106 0.479 . . . . 9.21 111.89 -175.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -120.96 130.15 53.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.363 -0.835 . . . . 9.75 108.767 172.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -119.21 157.37 28.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.922 -0.399 . . . . 6.85 109.922 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -108.19 151.99 25.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.324 -0.398 . . . . 10.15 110.051 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -57.76 -26.41 61.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.275 0.842 . . . . 10.56 113.275 -172.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.2 t -68.7 -13.54 62.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.181 0.515 . . . . 12.44 110.898 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.66 38.96 2.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.056 -0.52 . . . . 11.14 110.145 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -127.17 117.36 22.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.165 -0.47 . . . . 8.78 109.904 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.5 t -79.71 91.85 5.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.544 -0.753 . . . . 9.11 110.225 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.91 -163.3 27.7 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.797 -0.716 . . . . 9.98 112.465 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -86.3 112.51 21.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.818 -0.438 . . . . 12.91 109.818 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -28.91 40.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.678 0.275 . . . . 11.97 111.556 -174.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -75.33 -13.36 60.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.426 0.631 . . . . 14.73 109.671 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -95.61 6.8 48.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.588 -0.733 . . . . 13.3 110.334 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.8 tp -94.43 125.81 39.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.738 -0.665 . . . . 10.07 110.026 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 2.6 mppt? -103.2 167.74 9.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.205 0.526 . . . . 13.53 110.841 -174.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.5 mt -84.5 114.68 25.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.814 -0.63 . . . . 12.26 109.688 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.74 9.4 43.36 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.259 -0.736 . . . . 11.04 111.259 -170.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -79.55 124.52 83.78 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 109.532 -0.544 . . . . 8.39 109.532 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.429 ' HB2' HD13 ' A' ' 72' ' ' ILE . 86.1 Cg_endo -82.39 129.22 5.77 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.847 2.364 . . . . 8.18 113.621 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.4 166.27 29.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 4.78 111.097 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.432 ' HB3' HG21 ' A' ' 9' ' ' THR . 7.7 pt-20 -122.58 124.89 44.54 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.578 -0.527 . . . . 7.09 109.578 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.508 ' CE2' HG22 ' A' ' 22' ' ' ILE . 54.3 p90 -133.0 149.75 52.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.109 0.48 . . . . 7.82 111.349 -172.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.484 ' HG3' ' HG2' ' A' ' 7' ' ' ARG . 2.6 mp0 -88.72 149.46 23.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.019 -0.992 . . . . 11.59 110.361 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.05 121.69 42.97 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.328 -0.619 . . . . 12.41 109.328 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.5 p -138.9 172.08 13.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.398 . . . . 13.93 111.265 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -125.75 125.33 42.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.333 -0.394 . . . . 16.22 110.573 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.59 124.96 34.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.066 0.46 . . . . 16.64 110.542 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -79.97 -25.26 40.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.791 -0.64 . . . . 23.23 111.404 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -70.85 -57.54 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.559 -0.292 . . . . 21.87 111.233 -172.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.0 p -91.46 -28.54 17.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.962 0.41 . . . . 17.49 110.559 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.98 11.01 57.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 17.22 112.741 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 131.32 31.35 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 122.815 -0.226 . . . . 14.83 110.442 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.02 126.43 15.82 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.257 1.971 . . . . 13.33 109.93 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 30.2 pt -126.52 147.67 31.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.411 0.624 . . . . 12.33 111.63 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.24 155.04 18.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.022 -0.99 . . . . 8.91 108.433 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.467 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 39.1 t -75.26 -151.29 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.338 0.399 . . . . 10.33 110.496 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -67.9 -10.28 51.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.248 0.462 . . . . 12.02 112.248 -175.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.3 t 56.56 96.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.489 0.661 . . . . 6.52 111.198 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 t -93.77 147.7 22.8 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.603 -0.518 . . . . 6.18 109.603 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.492 ' HZ1' ' HB3' ' A' ' 71' ' ' LYS . 7.7 mtpm? -81.51 157.5 24.81 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.434 -0.58 . . . . 6.59 109.434 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 50' ' ' PRO . 24.6 mt -73.97 85.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.375 0.607 . . . . 6.16 109.905 177.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.98 87.43 33.88 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.416 -0.811 . . . . 6.03 110.204 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.7 164.57 20.66 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.813 2.342 . . . . 7.28 111.781 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.42 -20.83 60.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.739 0.78 . . . . 8.49 109.588 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.2 t -83.5 135.59 24.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.945 -1.025 . . . . 6.19 108.831 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.646 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 47.5 t -68.49 103.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 6.54 111.531 -174.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -78.71 83.21 4.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.764 -0.653 . . . . 6.46 109.743 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 p 23.44 96.37 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.96 1.467 . . . . 7.24 114.96 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.73 -30.55 71.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.525 0.679 . . . . 7.07 109.533 171.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -108.68 117.71 34.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.081 -0.963 . . . . 6.68 109.947 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -81.4 144.71 31.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.354 -0.385 . . . . 6.93 109.968 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.91 152.95 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.342 0.591 . . . . 4.0 111.111 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.1 p -114.94 145.7 41.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.607 -0.724 . . . . 3.84 110.086 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.99 165.77 24.54 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.347 -0.93 . . . . 2.58 112.648 -177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 m -118.82 130.18 55.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.457 -0.571 . . . . 3.7 109.457 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.635 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 3.1 t -73.64 123.4 28.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.015 -0.365 . . . . 3.14 110.015 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.6 p -101.34 -22.48 14.58 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.143 0.497 . . . . 3.77 109.979 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.8 m -140.29 118.42 11.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.497 -0.774 . . . . 3.29 109.898 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 92' ' ' ARG . 7.2 pt-20 -97.83 163.77 12.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.093 0.473 . . . . 4.39 110.895 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.9 mt -83.84 108.23 16.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.751 -0.658 . . . . 3.62 110.498 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.58 ' HG2' ' H ' ' A' ' 93' ' ' THR . 21.0 ttm180 -134.65 -175.93 4.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.658 -0.497 . . . . 7.76 109.658 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.58 ' H ' ' HG2' ' A' ' 92' ' ' ARG . 17.8 p -90.2 156.76 18.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.864 0.364 . . . . 5.1 111.841 -175.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.09 -33.2 18.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 7.53 109.625 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.0 t -138.94 -70.06 0.42 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.329 -0.85 . . . . 7.77 109.599 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.08 -44.5 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.421 -0.354 . . . . 8.0 110.579 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 99' ' ' VAL . 83.1 m-20 -119.34 -136.38 0.34 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.584 -0.895 . . . . 8.83 108.584 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.9 t30 69.59 -23.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.787 0.835 . . . . 7.69 112.259 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.726 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 7.6 p -55.09 126.58 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.817 -0.174 . . . . 5.85 110.783 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.726 ' HG ' ' O ' ' A' ' 99' ' ' VAL . 4.4 pp 57.79 7.4 0.57 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.465 1.106 . . . . 7.65 113.066 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -74.97 -27.57 60.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.574 0.702 . . . . 8.21 109.627 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.1 t -150.53 159.37 44.53 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.371 -0.832 . . . . 5.58 109.008 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.2 t -82.96 44.77 0.95 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.488 0.661 . . . . 4.8 110.327 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -99.75 2.44 44.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.593 -0.731 . . . . 5.09 109.854 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -139.89 141.42 36.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.687 -0.688 . . . . 3.7 109.366 175.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.4 t -146.89 149.11 32.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.679 -0.489 . . . . 2.84 109.679 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 122' ' ' TYR . . . -85.71 168.35 41.55 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.445 -0.883 . . . . 1.91 111.928 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -125.66 120.66 31.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.629 0.252 . . . . 3.31 110.657 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 82.8 mt -110.98 127.17 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.337 -0.616 . . . . 2.17 109.337 174.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.9 p -106.42 129.52 54.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.231 -0.441 . . . . 3.61 110.813 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.514 ' CE2' HD13 ' A' ' 120' ' ' LEU . 1.2 p90 -146.68 166.52 26.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.265 -0.643 . . . . 3.58 109.265 175.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.414 ' HG2' ' SG ' ' A' ' 117' ' ' CYS . 43.8 mt-10 -107.28 121.66 45.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.17 0.509 . . . . 5.1 111.18 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -116.36 114.1 23.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.454 -0.794 . . . . 5.11 109.069 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 64.84 21.01 12.28 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.978 0.511 . . . . 7.42 110.65 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.3 66.15 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.014 -0.539 . . . . 5.36 112.045 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -102.63 129.05 49.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.888 0.375 . . . . 5.38 110.887 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . 0.414 ' SG ' ' HG2' ' A' ' 112' ' ' GLU . 62.9 m -81.78 124.95 30.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.202 -0.454 . . . . 4.96 110.332 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -121.38 147.13 46.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.225 -0.443 . . . . 5.13 110.491 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.85 123.22 49.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 4.32 109.845 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.514 HD13 ' CE2' ' A' ' 111' ' ' TYR . 4.9 mp -105.38 134.88 19.46 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.262 -0.273 . . . . 3.17 110.262 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.57 133.15 11.48 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.966 2.444 . . . . 2.61 111.381 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.404 ' CE1' ' HA3' ' A' ' 107' ' ' GLY . 12.7 p90 -144.81 147.76 33.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.789 -0.448 . . . . 2.49 109.789 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.2 p -112.95 -179.94 3.79 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.845 -0.428 . . . . 3.18 109.845 173.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -72.76 -20.22 61.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.24 0.543 . . . . 5.22 110.867 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.77 -4.8 58.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.79 -0.641 . . . . 4.81 111.23 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -89.45 -13.5 37.45 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.138 0.494 . . . . 4.0 110.58 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 156' ' ' ILE . 2.8 p -110.48 116.19 51.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.716 0.769 . . . . 4.39 111.124 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.432 ' HB3' ' OE1' ' A' ' 26' ' ' GLU . 1.1 mp0 -99.72 179.02 4.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.786 -1.097 . . . . 6.43 109.997 177.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.55 -10.78 64.93 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.569 -0.824 . . . . 6.14 112.315 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 66.46 25.46 10.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.88 0.472 . . . . 6.26 111.388 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -103.55 140.93 20.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.635 -0.257 . . . . 5.62 110.866 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -97.51 129.14 44.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.064 0.459 . . . . 6.25 110.239 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.502 ' H ' HD22 ' A' ' 133' ' ' LEU . 2.6 pt? -115.33 149.56 37.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.859 -0.61 . . . . 3.62 110.075 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -124.23 174.44 7.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.16 0.505 . . . . 7.5 109.992 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.635 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.97 122.06 22.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.269 0.557 . . . . 4.12 111.442 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.04 -14.88 13.68 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.595 -0.812 . . . . 4.2 113.622 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -86.58 -177.55 6.18 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 117.901 0.85 . . . . 4.06 110.687 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -116.85 115.46 25.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.195 0.521 . . . . 4.48 111.815 -174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.86 162.36 15.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.633 -0.712 . . . . 2.98 110.985 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 45.8 t -126.37 129.47 48.87 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.612 -0.885 . . . . 3.68 108.612 177.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.0 146.99 50.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.071 0.462 . . . . 3.35 110.488 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -106.18 112.81 26.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.736 -0.665 . . . . 5.34 109.919 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.72 100.63 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.496 -0.775 . . . . 4.66 111.539 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.646 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -83.01 111.05 18.5 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.731 -0.47 . . . . 5.08 109.731 173.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 21.1 m -86.72 116.12 24.61 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.802 -0.635 . . . . 5.68 111.309 -174.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -74.44 166.14 24.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 6.25 110.398 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.1 -32.58 73.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 9.03 111.856 -173.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.566 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 3.3 tmt_? -76.23 -22.9 54.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 8.29 110.382 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.68 11.78 42.92 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.575 -0.821 . . . . 5.65 112.766 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -114.49 127.34 55.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.794 -0.239 . . . . 5.26 110.384 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -147.63 -176.92 5.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.094 0.474 . . . . 4.63 111.672 -173.684 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -139.27 -143.56 4.43 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.92 -0.872 . . . . 3.57 110.92 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.76 110.52 14.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.143 0.472 . . . . 2.84 109.963 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 45.6 t -122.78 162.14 22.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.563 -0.532 . . . . 4.34 109.563 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 56.56 37.87 29.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.162 0.506 . . . . 6.23 110.748 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.424 ' O ' HG21 ' A' ' 127' ' ' VAL . 69.5 mt -61.53 115.69 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.32 -0.855 . . . . 3.55 110.382 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 140' ' ' SER . 0.7 OUTLIER -111.56 143.84 41.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.979 0.418 . . . . 6.3 110.58 -176.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.4 tp -103.48 93.36 4.9 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.194 -0.669 . . . . 4.63 109.194 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.1 -28.4 15.1 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.739 -0.385 . . . . 4.97 110.958 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -114.86 84.02 10.0 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.451 -0.574 . . . . 5.57 109.451 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.93 158.75 18.37 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.943 2.429 . . . . 5.69 113.185 -174.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -91.26 103.64 16.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.74 -0.664 . . . . 6.1 110.174 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -69.3 155.06 94.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.125 -0.489 . . . . 10.1 110.411 177.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.57 114.1 1.32 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.056 2.504 . . . . 8.39 113.055 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.572 -0.74 . . . . 10.65 110.687 179.208 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.542 0.687 . . . . 12.4 109.409 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.52 ' HB3' ' HG2' ' A' ' 27' ' ' ARG . 42.7 mt-10 -120.26 143.52 48.27 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.771 -0.649 . . . . 11.63 110.356 -174.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -110.87 144.36 40.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.439 . . . . 9.15 111.05 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.78 172.63 31.84 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.363 -0.922 . . . . 6.81 112.15 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.0 mt -120.8 133.99 65.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 110.083 -0.34 . . . . 10.17 110.083 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.04 112.79 11.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.536 -0.542 . . . . 8.73 109.536 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 11.8 tp10 -91.54 -29.95 16.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.799 -0.637 . . . . 10.86 110.988 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -159.77 128.33 5.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.039 -0.528 . . . . 14.06 109.62 -175.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 mt -99.45 126.8 45.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.178 0.513 . . . . 11.73 111.17 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.06 179.26 4.32 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.232 -1.025 . . . . 11.36 108.232 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -91.09 112.53 24.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.503 -0.554 . . . . 15.94 109.503 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 t 70.28 23.85 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.332 -0.849 . . . . 13.01 110.564 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -164.67 151.57 11.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.98 -0.555 . . . . 12.34 109.656 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -162.19 165.37 35.94 Favored Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.349 -0.929 . . . . 7.52 112.669 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -117.18 134.13 55.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.686 0.279 . . . . 9.24 111.486 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.407 HG21 ' CE2' ' A' ' 53' ' ' PHE . 75.6 mt -106.37 122.84 60.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 7.75 110.058 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.493 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 6.5 mm100 -83.8 147.98 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.533 0.938 . . . . 11.8 113.533 -175.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.2 p -77.94 6.59 7.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.811 -1.54 . . . . 12.34 113.302 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -49.87 -48.66 51.19 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.584 0.587 . . . . 13.33 112.584 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.4 -3.51 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.735 -0.386 . . . . 11.9 112.005 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 28.4 tpt180 -152.48 139.38 19.03 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.991 -0.374 . . . . 12.99 109.991 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -73.03 49.81 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.984 0.364 . . . . 16.66 111.984 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.22 127.86 12.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.933 0.397 . . . . 12.09 111.201 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -108.66 102.31 11.38 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.312 -0.625 . . . . 12.51 109.312 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.47 HD12 ' CE1' ' A' ' 53' ' ' PHE . 71.1 mt -109.91 135.7 50.37 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.876 0.369 . . . . 8.76 111.332 -176.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -91.57 125.36 36.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.139 -0.689 . . . . 9.15 109.139 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -118.13 147.89 42.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.885 0.374 . . . . 6.85 110.518 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -99.08 158.88 15.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.208 -0.451 . . . . 9.99 109.939 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -70.83 -12.42 61.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.058 0.392 . . . . 9.93 112.058 -174.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -81.09 -13.3 58.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.31 0.576 . . . . 12.28 109.895 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -103.94 29.33 5.95 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.652 -0.704 . . . . 10.62 110.771 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -126.31 128.45 47.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.016 0.436 . . . . 8.78 110.949 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 t -101.36 115.65 31.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.716 -0.675 . . . . 8.97 110.818 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.65 -156.19 21.53 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.787 -0.72 . . . . 9.98 112.278 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -89.73 113.62 25.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.854 0.359 . . . . 12.43 110.621 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -68.11 -24.28 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.29 0.567 . . . . 11.58 109.921 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -81.51 -2.61 50.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.768 -0.651 . . . . 14.73 110.369 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -112.94 15.7 19.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.454 0.645 . . . . 13.3 109.716 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.8 tp -103.49 134.0 47.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.51 -0.922 . . . . 10.07 108.51 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HG3' ' HB2' ' A' ' 49' ' ' ASP . 21.2 ptmt -133.75 170.13 16.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.9 0.381 . . . . 13.13 111.116 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.0 mp -81.15 119.24 30.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.971 -0.559 . . . . 11.74 109.565 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.48 36.65 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.322 -0.711 . . . . 10.13 111.322 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.422 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 14.7 t70 -92.93 127.26 48.27 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.442 -0.379 . . . . 8.39 110.143 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -89.31 128.91 1.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.062 2.508 . . . . 7.28 112.929 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.49 161.05 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.166 -0.47 . . . . 4.74 111.207 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.42 128.69 56.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.848 -0.614 . . . . 7.09 109.516 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.47 ' CE1' HD12 ' A' ' 31' ' ' LEU . 44.5 p90 -132.14 155.58 47.9 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.097 0.475 . . . . 7.82 111.204 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 38.1 tt0 -103.24 120.76 41.34 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.611 -0.722 . . . . 11.59 109.592 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.17 116.33 28.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.116 -0.493 . . . . 12.41 109.853 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 p -139.96 153.29 46.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.103 0.477 . . . . 13.17 111.73 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -92.86 108.95 20.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.964 -0.562 . . . . 16.21 109.944 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.508 ' OD2' HG22 ' A' ' 61' ' ' THR . 14.3 t70 -73.97 110.82 8.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.027 0.441 . . . . 16.64 109.835 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 59' ' ' ARG . 3.3 mmp_? -79.97 -7.2 58.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.059 -0.519 . . . . 22.64 111.2 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.455 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 54.3 ttt180 -70.86 -59.13 2.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 21.43 110.471 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.508 HG22 ' OD2' ' A' ' 58' ' ' ASP . 15.1 t -92.97 -19.26 21.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.25 -0.432 . . . . 17.4 110.44 178.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.57 31.54 15.71 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.856 -0.688 . . . . 16.7 112.492 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -132.63 149.28 72.58 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.036 -0.357 . . . . 14.73 110.036 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.52 126.79 8.51 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.079 1.853 . . . . 12.6 111.468 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.8 pt -130.65 168.75 22.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.321 0.581 . . . . 11.73 111.295 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.19 156.53 17.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.2 -0.909 . . . . 8.91 108.88 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 8.4 t -79.45 -150.9 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.399 -0.364 . . . . 9.83 110.101 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -8.87 51.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.649 0.611 . . . . 11.32 112.649 -172.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.2 t 55.88 99.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.471 0.653 . . . . 6.11 111.165 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 m -99.46 125.11 45.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.092 0.472 . . . . 6.12 111.12 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 71' ' ' LYS . 14.1 mmmt -60.16 135.77 57.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.788 -0.642 . . . . 6.3 109.744 172.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.1 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 120.775 0.321 . . . . 5.77 110.791 -176.773 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.632 HG12 ' HB1' ' A' ' 144' ' ' ALA . 6.2 t . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.726 0.298 . . . . 6.19 110.41 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 79' ' ' SER . 43.4 t -97.5 134.12 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.306 -0.406 . . . . 6.26 110.548 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -75.15 16.41 0.32 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.685 0.279 . . . . 6.05 111.504 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.51 ' H ' HG12 ' A' ' 77' ' ' VAL . 8.3 t 66.53 -2.3 1.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.812 0.845 . . . . 7.02 111.842 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 62.58 13.76 6.53 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.274 0.63 . . . . 7.07 111.621 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -129.62 118.03 21.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.268 -0.424 . . . . 6.68 109.858 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -95.67 124.32 39.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.063 -0.517 . . . . 6.43 109.862 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.82 164.97 15.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.284 0.564 . . . . 3.7 111.452 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.8 p -125.88 148.28 49.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.292 -0.867 . . . . 3.49 109.774 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.09 161.09 25.54 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.224 -0.989 . . . . 2.58 112.37 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.7 m -102.24 125.61 49.0 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.408 -0.59 . . . . 3.34 109.408 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 51.0 t -68.11 126.23 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 110.189 -0.3 . . . . 3.14 110.189 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.3 p -113.7 -17.02 12.21 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.799 0.333 . . . . 3.61 111.844 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.2 m -150.95 135.03 16.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.282 -0.261 . . . . 3.12 110.597 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -100.0 171.22 7.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 4.39 110.508 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 91' ' ' LEU . 1.8 pt? . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 109.256 -0.646 . . . . 3.62 109.256 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.615 -0.513 . . . . 3.33 109.615 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 t -146.87 143.31 28.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.402 -0.363 . . . . 2.57 110.748 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -97.61 -162.38 31.36 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.723 -0.751 . . . . 1.66 111.918 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 82.9 mmt-85 -140.15 135.15 32.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.99 0.424 . . . . 3.03 111.15 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.26 130.7 68.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.657 -0.701 . . . . 1.88 109.444 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.7 t -109.35 116.3 31.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.86 -0.422 . . . . 3.49 109.86 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -122.57 132.76 54.45 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.411 -0.589 . . . . 3.51 109.411 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -107.05 109.73 21.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.788 -0.642 . . . . 5.1 109.49 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -163.99 147.74 9.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.86 -0.609 . . . . 4.78 110.438 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 62.53 21.01 12.36 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.441 0.463 . . . . 6.97 111.714 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.52 -0.97 87.21 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.732 -0.746 . . . . 5.1 111.99 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -101.89 139.09 37.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.074 0.464 . . . . 5.38 110.589 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 13.8 p -139.47 106.18 5.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.501 -0.772 . . . . 4.72 109.997 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -155.69 162.16 40.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.376 -0.375 . . . . 4.61 110.537 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -95.22 133.75 38.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.646 -0.706 . . . . 3.96 110.584 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 5.6 mp -106.25 130.77 22.44 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.448 -0.342 . . . . 2.75 110.636 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 13.1 Cg_exo -69.74 131.79 22.01 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.632 2.222 . . . . 2.3 111.246 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -138.78 145.39 40.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.978 0.418 . . . . 2.13 110.3 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 p -112.94 164.22 13.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.616 -0.72 . . . . 3.07 109.335 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -77.16 -20.06 56.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.885 0.328 . . . . 4.8 111.885 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.82 -13.83 61.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.897 0.332 . . . . 4.81 111.897 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 154' ' ' CYS . 7.2 t70 -101.11 -0.44 36.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.511 0.672 . . . . 3.84 110.161 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.5 t -82.38 107.32 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.223 0.535 . . . . 4.39 110.374 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.4 145.84 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.992 -0.549 . . . . 6.43 110.774 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.5 -15.98 59.4 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.672 -0.775 . . . . 5.91 112.074 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 62.28 34.8 15.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.102 0.477 . . . . 6.07 110.911 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.3 m -79.98 174.71 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.038 -0.528 . . . . 5.27 110.663 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -127.84 81.35 2.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.295 0.569 . . . . 5.78 110.238 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.3 pt? -68.44 148.91 49.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.207 -0.906 . . . . 3.62 111.09 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -133.21 139.81 47.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.287 -0.415 . . . . 6.93 109.961 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.626 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -55.62 121.32 8.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.164 0.506 . . . . 4.12 111.675 -173.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.65 -13.2 11.9 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.301 -0.863 . . . . 4.07 112.572 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -91.19 177.41 6.26 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.292 0.546 . . . . 4.06 109.864 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -116.97 116.58 27.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.089 0.471 . . . . 4.17 110.711 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.11 159.98 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.076 -0.511 . . . . 2.77 110.714 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.1 t -114.83 139.51 49.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.974 -0.75 . . . . 3.47 108.974 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -144.73 143.62 30.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.016 0.436 . . . . 3.35 110.149 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -98.95 119.2 37.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.579 -0.737 . . . . 5.34 109.937 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.8 mt -78.67 96.86 2.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.085 -0.507 . . . . 4.66 109.709 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.632 ' HB1' HG12 ' A' ' 76' ' ' VAL . . . -90.16 111.2 22.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.796 -0.638 . . . . 4.85 110.758 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 28.4 m -84.25 112.9 20.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.509 -0.769 . . . . 5.68 110.335 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.42 158.52 31.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.936 -0.574 . . . . 6.25 109.549 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -60.92 -20.27 61.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.99 0.424 . . . . 8.58 111.379 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 148' ' ' ARG . 2.7 mmt180 -78.26 -8.2 58.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 7.86 111.717 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.71 -1.96 84.48 Favored Glycine 0 C--O 1.227 -0.292 0 C-N-CA 120.824 -0.703 . . . . 5.59 112.328 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -100.4 132.4 45.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.902 -0.406 . . . . 5.18 109.902 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.481 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -150.76 178.78 8.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.534 -0.303 . . . . 4.28 110.847 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -150.36 -125.17 1.28 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.805 -0.918 . . . . 3.36 110.805 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -121.28 126.1 48.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.841 -0.429 . . . . 2.84 109.841 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.514 ' HA ' ' OD2' ' A' ' 126' ' ' ASP . 17.7 t -136.59 159.22 42.46 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.114 -0.328 . . . . 4.34 110.114 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 63.08 36.26 12.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.319 0.581 . . . . 5.75 110.558 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.8 mt -75.77 115.99 18.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.637 -0.711 . . . . 3.55 110.816 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -135.94 160.04 39.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.806 0.336 . . . . 5.96 110.165 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.9 tp -92.35 110.93 22.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 4.34 110.353 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -98.84 -57.55 2.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.782 -0.645 . . . . 4.97 110.686 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -111.17 96.63 31.39 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.244 -0.434 . . . . 5.37 110.022 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.14 158.25 23.45 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.233 1.956 . . . . 5.44 113.114 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.578 -0.737 . . . . 6.1 109.775 175.555 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 120.998 0.428 . . . . 12.4 109.969 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.464 ' CD ' ' HE ' ' A' ' 27' ' ' ARG . 6.3 mm-40 -98.13 136.77 37.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.106 -0.497 . . . . 11.63 109.886 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 67.2 p -109.33 138.69 45.3 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 121.102 -0.239 . . . . 9.15 110.593 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 26' ' ' GLU . . . -150.86 -176.03 23.38 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.147 -1.025 . . . . 6.81 112.45 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.0 mt -132.43 155.41 41.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.336 -0.987 . . . . 10.17 108.336 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.76 118.86 34.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.508 -0.477 . . . . 8.73 110.387 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.586 ' OE1' ' HD2' ' A' ' 30' ' ' ARG . 5.8 pt-20 -82.58 -32.59 28.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.376 -0.374 . . . . 10.86 111.089 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -159.19 158.15 32.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.28 -0.418 . . . . 14.06 109.899 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -125.44 118.16 25.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.107 -0.497 . . . . 11.73 110.984 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -105.57 178.95 4.41 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.488 -1.301 . . . . 11.36 107.488 172.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -92.1 138.46 31.52 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 119.917 -0.713 . . . . 15.94 109.986 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.3 p 74.62 -23.07 0.24 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.185 1.394 . . . . 13.01 112.032 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 49.5 p90 -151.8 158.59 43.5 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.872 0.368 . . . . 12.34 111.303 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.44 178.24 21.73 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.198 -0.761 . . . . 7.52 111.198 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -119.54 141.68 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.137 0.468 . . . . 9.24 111.542 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.443 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 67.4 mt -103.28 125.35 57.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.449 -0.796 . . . . 7.75 110.006 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.558 ' HG2' ' H ' ' A' ' 25' ' ' CYS . 34.8 tt0 -80.59 134.77 35.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.439 -0.8 . . . . 11.8 111.833 -172.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 p -78.96 2.33 20.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.718 -1.128 . . . . 12.34 112.231 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.558 ' H ' ' HG2' ' A' ' 23' ' ' GLN . 49.2 t -60.17 -29.96 69.02 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.059 -0.4 . . . . 13.33 110.949 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.428 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 19.8 tp10 -103.99 -43.41 5.29 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.446 -0.343 . . . . 11.9 110.914 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HG2' ' N ' ' A' ' 28' ' ' GLN . 28.5 ttt180 -95.09 155.48 16.71 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 110.16 -0.311 . . . . 12.99 110.16 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.5 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 87.2 mt-30 -77.62 20.06 0.34 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.282 0.475 . . . . 16.66 112.282 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.443 ' HB3' ' NH1' ' A' ' 27' ' ' ARG . . . -169.82 144.85 2.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.33 -0.395 . . . . 12.09 110.335 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.586 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 11.2 ttp180 -90.34 148.45 22.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 12.51 109.927 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -144.57 163.86 32.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.362 0.265 . . . . 8.76 110.676 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -121.1 149.3 42.96 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.953 -0.758 . . . . 9.15 108.953 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -138.98 153.38 48.16 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.852 -0.339 . . . . 6.85 110.237 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.512 ' HB2' ' OE1' ' A' ' 37' ' ' GLN . 96.8 m-70 -98.6 159.51 14.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.98 -0.748 . . . . 9.99 108.98 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -70.27 -9.65 56.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.134 0.492 . . . . 9.93 110.979 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.1 m -75.13 -15.37 60.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.02 0.438 . . . . 12.28 110.162 174.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.512 ' OE1' ' HB2' ' A' ' 34' ' ' HIS . 25.3 mp0 -113.28 36.95 3.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.002 -0.545 . . . . 10.62 110.938 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -125.32 116.31 21.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.852 0.358 . . . . 8.78 110.13 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 68' ' ' GLN . 22.3 t -87.04 95.36 9.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.017 -0.538 . . . . 8.97 110.856 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.1 175.57 14.48 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.73 -0.668 . . . . 9.98 111.613 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.04 122.25 16.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.679 0.276 . . . . 12.43 110.353 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.6 tp -66.08 -18.81 24.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.227 0.537 . . . . 11.58 110.335 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.7 -25.71 65.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.686 . . . . 14.73 110.637 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -83.88 0.25 48.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 13.3 110.459 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.9 tp -104.04 123.01 46.45 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.051 0.453 . . . . 10.07 110.472 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 12.9 mmmm -120.17 162.29 19.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.612 -0.722 . . . . 13.13 110.225 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.5 mt -71.8 114.81 11.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.993 -0.548 . . . . 11.74 109.793 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.07 -4.12 28.63 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.905 -0.664 . . . . 10.13 111.679 -173.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -80.01 133.75 57.46 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-O 120.621 0.248 . . . . 8.39 110.41 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.6 142.03 7.93 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.168 2.578 . . . . 7.28 113.102 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.81 161.14 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.65 -0.705 . . . . 4.74 110.588 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.72 135.06 53.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.065 0.46 . . . . 7.09 109.801 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -144.78 158.3 43.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 7.82 110.985 -170.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 2.5 mp0 -97.98 122.6 41.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.385 -0.37 . . . . 11.59 110.546 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.445 ' HG2' ' NH2' ' A' ' 27' ' ' ARG . 14.6 tpt -88.41 107.89 19.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.481 -0.563 . . . . 12.41 109.481 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.6 p -132.75 165.67 24.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.903 0.382 . . . . 13.17 111.149 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -118.64 122.28 42.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.1 -0.704 . . . . 16.21 109.1 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -90.65 134.58 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.133 0.492 . . . . 16.64 111.654 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -79.94 -13.8 59.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.474 -0.785 . . . . 22.64 112.757 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -92.24 -43.29 9.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 21.43 111.107 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -86.7 -32.9 20.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.356 -0.384 . . . . 17.4 111.483 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.49 19.34 68.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.024 -0.608 . . . . 16.7 112.122 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -122.38 158.26 56.49 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.263 -0.273 . . . . 14.73 110.263 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.28 126.53 8.53 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.33 2.02 . . . . 12.6 110.616 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.09 154.34 35.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.925 0.393 . . . . 11.73 111.338 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -99.83 158.81 15.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.865 -0.607 . . . . 8.91 109.997 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 p -73.75 -150.04 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.16 0.505 . . . . 9.83 111.592 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 39' ' ' SER . 30.1 pt20 -70.95 -5.35 30.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.817 -0.628 . . . . 11.32 112.277 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.9 t 50.95 89.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.714 0.769 . . . . 6.11 111.219 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.6 m -90.61 135.94 33.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.762 -0.654 . . . . 6.12 111.16 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -72.6 123.15 22.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.054 -0.721 . . . . 6.3 109.054 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.5 mt . . . . . 0 C--O 1.233 0.237 0 O-C-N 123.805 0.69 . . . . 5.77 111.845 -173.363 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.531 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 9.9 p . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 109.691 -0.485 . . . . 6.19 109.691 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 39.6 t -76.93 108.07 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.035 0.445 . . . . 6.26 111.369 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.1 mt -104.24 -48.72 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 6.05 111.289 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.515 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 66.2 m -99.72 86.94 3.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.312 0.486 . . . . 7.02 112.312 -175.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 79' ' ' SER . 0.9 OUTLIER -177.55 116.04 0.09 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.095 0.958 . . . . 7.07 108.809 174.079 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 66.34 64.36 0.51 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.813 0.816 . . . . 6.68 109.885 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 6.4 ptm180 -78.32 107.39 10.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.351 -0.841 . . . . 6.43 110.322 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.4 m -93.7 160.49 2.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.986 -0.552 . . . . 3.7 111.76 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 p -119.51 139.39 52.18 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.285 -0.871 . . . . 3.49 109.426 171.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.92 163.69 25.27 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.277 -0.963 . . . . 2.58 112.081 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.8 m -107.76 125.16 51.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.493 -0.558 . . . . 3.34 109.493 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.551 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 1.6 t -66.47 131.2 32.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.05 -0.722 . . . . 3.14 109.05 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.8 p -109.45 -16.54 13.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.052 0.453 . . . . 3.61 110.756 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.8 m -154.44 122.7 6.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.291 -0.413 . . . . 3.12 110.859 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' A' ' 134' ' ' ARG . 4.7 mp0 -95.45 135.25 37.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.463 -0.335 . . . . 4.39 110.84 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 91' ' ' LEU . 1.7 pt? . . . . . 0 C--N 1.324 -0.539 0 CA-C-O 122.706 1.241 . . . . 3.62 109.414 170.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 91' ' ' LEU . 4.8 t . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 109.641 -0.503 . . . . 3.33 109.641 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.4 m -134.28 134.51 41.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.542 -0.299 . . . . 2.57 110.373 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.86 168.9 54.91 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.896 -0.668 . . . . 1.66 112.257 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -128.81 122.6 30.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.808 0.337 . . . . 3.03 110.915 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 99.5 mt -112.17 127.67 69.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.773 -0.825 . . . . 1.88 108.773 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.7 t -111.53 125.8 54.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.8 0.333 . . . . 3.49 110.288 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 1.0 OUTLIER -129.41 145.81 51.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.171 -0.677 . . . . 3.51 109.171 178.177 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -118.2 112.37 20.05 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.255 -0.646 . . . . 5.1 109.255 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 23.0 t-20 -126.78 108.65 11.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 4.78 110.476 -175.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 62.4 30.44 17.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.028 -0.533 . . . . 6.97 111.994 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.03 -0.47 60.49 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.962 -0.637 . . . . 5.1 113.95 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 5.7 pt-20 -108.71 137.64 46.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.667 0.733 . . . . 5.38 109.718 172.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 3.8 p -141.03 92.54 2.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.053 -0.521 . . . . 4.72 110.776 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -98.02 163.52 12.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.964 -0.562 . . . . 4.61 110.345 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -98.44 121.17 40.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.29 -0.633 . . . . 3.96 109.29 176.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.0 mt -103.86 130.34 23.61 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.157 -0.474 . . . . 2.75 110.934 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.54 141.61 17.76 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.709 2.273 . . . . 2.3 111.997 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -146.78 144.26 29.24 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.417 -0.586 . . . . 2.13 109.417 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.426 ' HA ' HD11 ' A' ' 91' ' ' LEU . 37.9 p -105.89 173.25 6.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.677 -0.49 . . . . 3.07 109.677 175.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -71.04 -19.48 62.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.394 0.616 . . . . 4.8 109.95 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -81.03 -10.8 59.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.02 -0.991 . . . . 4.81 111.43 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -87.88 -10.25 51.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.93 0.395 . . . . 3.84 110.711 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.6 t -87.09 120.3 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.826 -0.624 . . . . 4.39 110.825 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -106.45 153.86 21.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.677 -0.692 . . . . 6.43 110.222 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.75 -1.57 85.46 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.96 -0.638 . . . . 5.91 112.31 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 63.61 17.11 10.17 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.103 0.561 . . . . 6.07 111.066 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.15 147.94 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.117 0.484 . . . . 5.27 110.892 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -106.83 108.6 20.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.2 -0.454 . . . . 5.78 110.564 -177.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.597 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -106.36 150.36 26.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.862 -0.608 . . . . 3.62 110.169 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.569 ' HA ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -149.96 175.31 11.79 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.786 -0.365 . . . . 6.93 110.511 171.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.551 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -69.81 119.5 14.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.677 0.275 . . . . 4.12 111.087 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.89 -7.54 11.94 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.859 -0.686 . . . . 4.07 113.567 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -111.6 173.57 6.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.898 0.849 . . . . 4.06 110.584 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -110.93 116.41 31.18 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.173 0.511 . . . . 4.17 111.519 -173.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.35 157.49 18.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.634 -0.712 . . . . 2.77 110.906 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.449 ' HB2' ' CG ' ' A' ' 159' ' ' GLU . 8.0 t -119.2 134.44 55.2 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.02 -0.733 . . . . 3.47 109.02 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -132.73 144.91 50.61 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.892 0.377 . . . . 3.35 110.237 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -95.42 112.26 24.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.779 -0.646 . . . . 5.34 109.699 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 57.8 mt -79.25 96.1 2.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.83 -0.623 . . . . 4.66 110.222 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.693 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -81.54 108.23 14.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.189 -0.46 . . . . 4.85 110.516 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 m -85.16 110.36 18.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.037 0.446 . . . . 5.68 110.862 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -75.14 155.37 37.08 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.108 -0.701 . . . . 6.25 109.108 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -61.22 -23.42 65.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.939 0.348 . . . . 8.58 111.939 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -72.21 -23.88 61.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.997 0.427 . . . . 7.86 110.414 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 96.3 10.76 55.57 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.048 -0.596 . . . . 5.59 112.701 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.01 132.95 46.18 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.827 -0.435 . . . . 5.18 109.827 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.48 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -155.44 -178.45 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.857 -0.611 . . . . 4.28 110.887 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.96 -139.79 2.78 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.854 -0.898 . . . . 3.36 110.854 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.42 110.05 21.92 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.861 -0.422 . . . . 2.84 109.861 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 59.0 m -117.87 151.14 37.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.417 -0.356 . . . . 4.34 110.704 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 56.74 51.58 10.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.856 -0.611 . . . . 5.75 110.958 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 133' ' ' LEU . 4.6 mp -66.54 115.72 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 3.55 110.364 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -114.21 157.91 22.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.165 -0.47 . . . . 5.96 109.98 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.2 tp -97.56 123.25 41.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.401 -0.363 . . . . 4.34 110.354 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 140' ' ' SER . 21.3 mm-40 -102.33 -53.37 2.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.986 0.422 . . . . 4.97 111.192 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -136.34 102.62 9.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.187 -0.461 . . . . 5.37 110.75 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.89 160.9 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.418 2.079 . . . . 5.44 111.778 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 116.222 -0.444 . . . . 6.1 110.031 176.98 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 121.375 0.607 . . . . 12.4 111.013 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -100.74 144.81 29.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.635 -0.711 . . . . 11.63 110.003 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p -113.68 136.11 53.19 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.711 0.291 . . . . 9.15 110.962 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.38 177.01 28.73 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.546 -0.835 . . . . 6.81 112.622 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -128.82 140.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.255 -0.646 . . . . 10.17 109.255 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.57 118.09 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.837 -0.345 . . . . 8.73 110.64 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 22.3 tt0 -83.04 -44.93 14.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 10.86 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -157.82 137.01 11.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.44 -0.8 . . . . 14.06 109.83 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.0 mt -99.55 121.14 40.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.445 0.64 . . . . 11.73 111.306 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.29 -178.45 3.65 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.834 -1.075 . . . . 11.36 108.421 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -88.78 111.11 21.62 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.562 -0.455 . . . . 15.94 110.33 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.0 t 79.03 3.43 2.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.595 -1.184 . . . . 13.01 111.429 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -158.92 153.19 23.89 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 110.276 -0.268 . . . . 12.34 110.276 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.95 162.79 27.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.423 -0.894 . . . . 7.52 112.407 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -104.44 136.45 43.97 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.058 0.456 . . . . 9.24 110.968 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -103.64 127.71 57.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.651 -0.704 . . . . 7.75 110.384 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -71.77 141.81 49.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.215 -0.902 . . . . 11.8 111.644 -178.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.8 p -78.14 2.78 16.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.626 -1.17 . . . . 12.34 111.408 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.4 t -50.3 -39.33 45.36 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.659 0.614 . . . . 13.33 112.659 -170.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -105.55 7.53 32.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.045 0.387 . . . . 11.9 112.045 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.404 ' HB3' ' H ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -151.2 -159.37 1.02 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.806 0.336 . . . . 12.99 111.143 -176.468 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.404 ' H ' ' HB3' ' A' ' 27' ' ' ARG . 41.5 mt-30 -120.66 22.41 11.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.689 0.28 . . . . 16.66 111.291 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.13 135.64 34.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.021 0.439 . . . . 12.09 111.458 -173.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -106.92 102.58 11.93 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.479 -0.934 . . . . 12.51 108.479 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -110.88 162.18 15.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.208 0.528 . . . . 8.76 111.379 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -126.25 139.41 53.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.381 -0.827 . . . . 9.15 109.333 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -132.59 152.37 51.65 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.053 -0.351 . . . . 6.85 110.053 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -91.98 161.4 14.82 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.204 -0.665 . . . . 9.99 109.204 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -71.71 -8.23 52.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 9.93 111.677 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -79.34 -12.21 59.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.368 0.604 . . . . 12.28 109.517 172.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -103.38 36.49 2.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.547 -0.751 . . . . 10.62 110.133 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -138.09 139.54 39.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.063 -0.347 . . . . 8.78 110.063 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t -121.69 119.48 31.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.25 -0.432 . . . . 8.97 110.552 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.57 -161.94 20.8 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.893 -0.67 . . . . 9.98 112.337 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -77.45 113.53 15.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.754 0.312 . . . . 12.43 110.836 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -72.35 -25.71 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.048 0.451 . . . . 11.58 110.911 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.71 -12.29 59.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.234 0.54 . . . . 14.73 110.332 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.17 -7.48 55.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 13.3 109.889 177.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.2 tp -93.17 124.79 37.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.593 -0.731 . . . . 10.07 109.944 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -132.12 178.26 6.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.028 0.442 . . . . 13.13 110.671 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.2 mp -73.8 129.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.946 -0.57 . . . . 11.74 109.745 177.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.65 -1.53 66.22 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.674 -0.774 . . . . 10.13 111.946 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -91.34 123.32 64.41 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.823 -0.436 . . . . 8.39 109.823 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.97 142.98 32.12 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.985 2.457 . . . . 7.28 113.808 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.408 HG12 ' HE3' ' A' ' 71' ' ' LYS . 18.7 m -134.85 156.79 40.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.63 -0.714 . . . . 4.74 110.91 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -116.6 138.6 51.3 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.483 -0.562 . . . . 7.09 109.483 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' HB3' HG22 ' A' ' 69' ' ' VAL . 33.3 p90 -150.16 176.6 10.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.52 -0.309 . . . . 7.82 110.688 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 26.7 mt-10 -118.88 132.86 56.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.22 -0.659 . . . . 11.59 109.22 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.5 tpt -93.59 113.85 26.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.001 -0.545 . . . . 12.41 109.64 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 p -135.8 138.45 42.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.587 0.588 . . . . 13.17 112.587 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -95.35 110.7 22.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.078 -0.51 . . . . 16.21 109.709 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.98 121.71 32.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.8 0.333 . . . . 16.64 111.076 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -79.23 -20.95 46.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 22.64 110.964 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HE ' ' C ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -67.09 -53.86 26.91 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.392 -0.596 . . . . 21.43 109.392 -177.061 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.8 p -86.36 -29.69 22.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.149 -0.478 . . . . 17.4 111.172 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.86 31.74 28.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.729 -0.748 . . . . 16.7 111.81 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -135.12 141.34 37.73 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.133 -0.321 . . . . 14.73 110.133 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.22 125.31 10.71 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.809 1.673 . . . . 12.6 110.642 172.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.13 162.6 27.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.245 0.545 . . . . 11.73 111.816 -174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.42 173.41 6.77 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.453 -0.794 . . . . 8.91 110.779 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 22.7 t -87.26 -160.97 0.64 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.983 -0.553 . . . . 9.83 110.114 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -83.49 25.35 0.76 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.693 -0.23 . . . . 11.32 111.491 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 53' ' ' PHE . 43.1 t 30.02 96.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.693 1.197 . . . . 6.11 113.713 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -91.83 141.93 28.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.231 0.539 . . . . 6.12 110.761 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HE3' HG12 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -76.16 110.03 10.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.802 -0.635 . . . . 6.3 111.44 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 115.498 -0.774 . . . . 5.77 110.372 178.032 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.606 HG13 ' HB1' ' A' ' 144' ' ' ALA . 45.0 t . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 122.688 1.232 . . . . 6.19 109.246 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 t -88.34 114.73 27.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 113.831 -1.532 . . . . 6.26 110.649 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.67 -18.14 58.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.005 0.431 . . . . 6.05 110.317 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 t -95.5 52.49 1.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 7.02 110.694 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.47 -68.2 0.92 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.953 -0.567 . . . . 7.07 110.343 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -152.52 106.13 3.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.899 -0.591 . . . . 6.68 109.627 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -95.04 133.38 38.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.606 -0.516 . . . . 6.43 109.606 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.98 169.07 20.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.204 0.526 . . . . 3.7 111.202 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.4 p -118.7 144.57 46.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.496 -0.775 . . . . 3.49 109.502 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.45 170.2 23.99 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.076 -1.059 . . . . 2.58 112.268 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.9 m -121.74 132.06 54.42 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.833 -0.432 . . . . 3.34 109.833 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.632 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 48.8 t -65.25 126.34 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.322 -0.399 . . . . 3.14 110.501 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.0 p -111.19 -16.63 13.39 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.857 0.361 . . . . 3.61 111.199 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.8 m -153.65 130.33 10.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.237 -0.438 . . . . 3.12 109.916 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -176.86 3.2 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.274 0.359 . . . . 4.39 111.093 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.0 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.97 0.414 . . . . 3.62 111.072 -176.705 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 109.074 -0.713 . . . . 3.33 109.074 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.11 125.51 44.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.429 -0.35 . . . . 2.57 110.721 -175.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -81.65 176.74 54.16 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.667 -0.778 . . . . 1.66 111.617 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -134.4 130.49 36.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 3.03 111.386 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.7 mt -112.57 129.11 68.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.458 -0.792 . . . . 1.88 108.961 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -107.28 132.74 52.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.616 0.246 . . . . 3.49 110.479 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.66 156.04 47.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.731 -0.84 . . . . 3.51 108.731 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.05 125.74 54.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.754 -0.462 . . . . 5.1 109.754 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 47.9 t30 -138.68 135.94 35.35 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.545 -0.909 . . . . 4.78 108.545 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 114' ' ' ARG . 9.2 mtp180 63.79 18.54 11.21 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.519 0.512 . . . . 6.97 111.8 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.33 3.73 78.2 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.668 -0.777 . . . . 5.1 112.171 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -123.11 141.29 52.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.111 0.482 . . . . 5.38 110.598 178.574 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 13.9 p -105.11 136.67 44.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.944 -0.571 . . . . 4.72 110.865 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -128.69 172.58 11.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.924 -0.58 . . . . 4.61 110.121 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.85 124.39 40.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.964 -0.562 . . . . 3.96 110.228 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 5.6 mp -104.36 131.45 21.88 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 110.18 -0.304 . . . . 2.75 110.18 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 3.6 Cg_exo -75.96 132.12 13.87 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.945 2.43 . . . . 2.3 111.55 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -138.5 153.42 48.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.067 0.46 . . . . 2.13 110.642 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.5 p -118.11 -175.16 2.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.878 -0.601 . . . . 3.07 110.121 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -17.65 61.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 4.8 110.651 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -82.82 -23.84 33.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.687 -0.688 . . . . 4.81 111.066 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -77.39 -26.09 51.46 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.281 -0.418 . . . . 3.84 111.364 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.83 116.22 47.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.646 0.736 . . . . 4.39 111.119 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.87 163.61 12.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.435 -0.802 . . . . 6.43 109.413 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.31 -9.52 30.99 Favored Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.69 -0.767 . . . . 5.91 112.521 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.1 t30 66.14 16.98 10.65 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.533 0.682 . . . . 6.07 110.655 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 t -78.12 120.35 28.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.808 -0.441 . . . . 5.27 109.808 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -81.57 119.56 23.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.934 0.397 . . . . 5.78 110.933 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 133' ' ' LEU . 1.8 pt? -115.56 149.24 38.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.424 -0.807 . . . . 3.62 110.679 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.606 ' HD2' ' OD1' ' A' ' 137' ' ' ASP . 0.0 OUTLIER -137.18 155.9 48.98 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.962 -0.755 . . . . 6.93 108.962 174.26 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.632 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -57.32 121.82 11.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.044 0.449 . . . . 4.12 110.835 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.26 -13.23 11.18 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.86 -0.686 . . . . 4.07 113.302 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.606 ' OD1' ' HD2' ' A' ' 134' ' ' ARG . 6.4 p30 -95.32 174.94 6.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.142 0.971 . . . . 4.06 110.216 172.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -110.17 122.27 47.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 4.17 111.381 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.28 150.68 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.018 -0.537 . . . . 2.77 110.929 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.6 t -120.92 133.83 55.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.113 -0.699 . . . . 3.47 109.113 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -137.37 143.26 41.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.021 0.438 . . . . 3.35 110.825 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -94.86 124.58 38.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.518 -0.764 . . . . 5.34 109.628 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.33 99.16 3.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.364 0.602 . . . . 4.66 110.582 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.606 ' HB1' HG13 ' A' ' 76' ' ' VAL . . . -89.79 109.32 20.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.196 -0.911 . . . . 4.85 110.867 -176.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.2 m -80.29 113.97 18.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.103 -0.498 . . . . 5.68 111.908 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 20.5 m-20 -66.24 159.05 27.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.402 -0.363 . . . . 6.25 110.068 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -31.06 67.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.955 0.407 . . . . 8.58 111.263 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -77.04 -13.33 59.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.084 -0.507 . . . . 7.86 111.17 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.59 5.65 78.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.571 -0.823 . . . . 5.59 111.434 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 5.1 m-20 -107.92 120.99 43.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.325 . . . . 5.18 110.279 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.506 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.1 178.35 9.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.299 -0.41 . . . . 4.28 110.623 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -131.36 -112.96 1.5 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.455 -0.658 . . . . 3.36 111.455 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -123.11 137.3 54.95 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.526 -0.546 . . . . 2.84 109.526 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 84.1 m -139.81 156.57 46.67 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.2 -0.2 . . . . 4.34 110.896 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 57.46 44.42 21.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.881 0.738 . . . . 5.75 111.045 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.73 114.89 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.68 -0.691 . . . . 3.55 110.729 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -119.48 131.12 55.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.208 -0.451 . . . . 5.96 110.554 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.19 116.13 22.78 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.96 -0.756 . . . . 4.34 108.96 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -95.42 -43.99 7.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.76 0.281 . . . . 4.97 111.76 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -126.29 96.26 36.9 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 5.37 110.001 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.35 155.12 14.29 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.759 2.306 . . . . 5.44 113.4 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.632 -0.713 . . . . 6.1 109.822 175.909 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.374 -0.602 . . . . 12.4 109.374 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.524 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 3.5 pt-20 -121.73 166.73 13.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 11.63 110.729 -173.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 80.6 p -108.44 156.84 18.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.479 0.548 . . . . 9.15 112.479 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.82 -173.38 30.41 Favored Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 110.839 -0.904 . . . . 6.81 110.839 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 23' ' ' GLN . 12.6 pt -128.52 152.63 36.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 117.158 0.479 . . . . 10.17 110.327 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.07 127.33 28.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.76 0.314 . . . . 8.73 110.888 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.504 ' HA ' ' HG2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -68.95 -56.24 8.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.677 -0.692 . . . . 10.86 109.284 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -169.1 166.54 10.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.791 -1.095 . . . . 14.06 108.432 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -112.0 126.29 54.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.215 0.531 . . . . 11.73 111.521 -175.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 3.0 mm? -122.16 -179.02 4.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.946 -1.024 . . . . 11.36 108.598 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -88.71 124.57 34.24 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.007 -0.433 . . . . 15.94 110.114 -177.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m 78.39 -35.86 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.959 0.903 . . . . 13.01 112.169 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 17.5 p90 -131.79 151.57 51.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.45 . . . . 12.34 111.248 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.08 172.95 23.21 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.844 -0.903 . . . . 7.52 110.844 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 68.2 m-85 -119.49 155.22 32.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.049 0.425 . . . . 9.24 110.742 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.7 mt -111.69 128.77 68.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.97 -0.559 . . . . 7.75 110.141 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.504 ' HG2' ' HA ' ' A' ' 13' ' ' GLU . 2.5 mm-40 -74.79 132.03 41.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.309 0.576 . . . . 11.8 111.525 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.2 p -80.6 1.61 29.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.161 -0.927 . . . . 12.34 111.861 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 70.9 m -52.77 -42.21 64.77 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.604 0.24 . . . . 13.33 111.621 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.88 -42.84 14.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.234 0.54 . . . . 11.9 111.148 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HE ' ' CD ' ' A' ' 8' ' ' GLU . 31.5 tpt180 -132.34 142.29 49.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.077 -0.51 . . . . 12.99 109.779 -174.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.92 52.69 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.285 0.476 . . . . 16.66 112.285 -175.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.78 101.74 2.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.906 0.384 . . . . 12.09 110.428 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -85.91 100.91 12.42 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.293 -1.003 . . . . 12.51 108.293 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.8 mt -110.8 163.42 13.8 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.497 -0.774 . . . . 8.76 111.457 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -115.12 135.31 54.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.02 -0.733 . . . . 9.15 109.02 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -132.89 136.05 45.95 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.767 -0.457 . . . . 6.85 109.767 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 73.2 m80 -84.92 164.4 18.37 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.467 -0.568 . . . . 9.99 109.467 178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -70.07 -10.23 58.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.951 0.405 . . . . 9.93 110.71 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.6 p -84.12 -9.04 58.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.007 -0.542 . . . . 12.28 110.077 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -108.73 26.63 10.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.515 -0.766 . . . . 10.62 110.339 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -130.68 130.02 43.35 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.688 -0.405 . . . . 8.78 110.087 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 15.6 m -93.35 107.79 19.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.725 -0.671 . . . . 8.97 110.493 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.74 -156.34 22.06 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.429 -0.891 . . . . 9.98 113.15 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -93.55 117.85 30.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.17 0.509 . . . . 12.43 111.803 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.04 -22.63 10.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.492 -0.776 . . . . 11.58 110.319 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.95 -40.11 92.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.097 -0.501 . . . . 14.73 111.42 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -97.05 12.15 33.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.182 -0.463 . . . . 13.3 110.198 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.64 136.28 33.08 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.399 -0.593 . . . . 10.07 109.399 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.512 ' HE2' ' HB2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -130.41 157.49 42.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.241 0.544 . . . . 13.13 111.29 -174.167 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.6 mt -69.25 141.72 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.241 -0.89 . . . . 11.74 110.969 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.35 11.47 66.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.438 -0.886 . . . . 10.13 112.248 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.512 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 6.5 t70 -84.97 131.65 48.24 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.956 -0.143 . . . . 8.39 111.016 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.17 120.09 5.56 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.766 2.31 . . . . 7.28 112.864 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.564 HG12 ' HE3' ' A' ' 71' ' ' LYS . 27.8 m -128.45 162.45 35.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.893 -0.594 . . . . 4.74 110.451 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 1.2 pt-20 -113.22 139.57 48.68 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.369 -0.604 . . . . 7.09 109.369 173.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CE1' ' HG3' ' A' ' 8' ' ' GLU . 31.2 p90 -132.08 139.58 48.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.714 0.768 . . . . 7.82 111.784 -177.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 39.1 tt0 -88.9 104.87 17.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.847 -1.069 . . . . 11.59 108.7 174.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 13.7 tpt -88.45 114.85 25.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.197 -0.456 . . . . 12.41 110.473 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.6 p -142.85 167.12 22.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.057 0.456 . . . . 13.17 111.283 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 73.6 m-85 -112.47 109.41 18.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.901 -0.59 . . . . 16.21 109.508 175.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.22 125.53 31.05 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.839 -0.345 . . . . 16.64 110.212 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -78.35 -17.92 55.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.413 -0.358 . . . . 22.64 111.664 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 23.7 tpt180 -77.8 -42.55 33.46 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.6 -0.44 . . . . 21.43 110.007 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.4 p -84.35 -33.59 23.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.023 -0.535 . . . . 17.4 110.597 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.53 24.72 62.3 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.763 -0.653 . . . . 16.7 112.11 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -126.63 148.1 63.33 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.974 -0.38 . . . . 14.73 109.974 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HB3' ' CE1' ' A' ' 57' ' ' TYR . 43.1 Cg_endo -70.27 124.73 11.15 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 121.728 1.619 . . . . 12.6 109.807 169.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -139.77 151.17 22.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.88 0.848 . . . . 11.73 112.696 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.66 136.23 33.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.591 -1.186 . . . . 8.91 108.16 169.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 7.4 t -69.69 -150.16 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.984 0.421 . . . . 9.83 111.035 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.402 ' HB3' ' OG ' ' A' ' 39' ' ' SER . 15.1 mm100 -56.45 -18.89 12.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.322 0.86 . . . . 11.32 113.322 -175.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.1 t 55.13 96.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.635 0.731 . . . . 6.11 111.136 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m -79.5 152.0 30.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.703 -0.681 . . . . 6.12 110.197 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HE3' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -93.57 108.28 20.01 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.901 0.381 . . . . 6.3 110.52 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.532 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 65.5 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 5.77 109.877 175.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.592 ' CG1' ' HB1' ' A' ' 144' ' ' ALA . 23.3 t . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.051 0.453 . . . . 6.19 110.08 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 67.5 t -72.77 97.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.557 -0.747 . . . . 6.26 111.34 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.01 -63.92 0.99 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.462 -0.57 . . . . 6.05 109.462 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.3 t -139.36 117.43 11.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.036 0.446 . . . . 7.02 110.615 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -159.39 -49.39 0.06 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.687 -0.688 . . . . 7.07 109.415 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -81.5 -172.98 4.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.641 -0.709 . . . . 6.68 109.947 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -166.83 71.41 0.12 Allowed 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.5 -0.555 . . . . 6.43 109.5 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.5 m -82.29 151.58 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.628 0.728 . . . . 3.7 111.027 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.5 p -117.65 139.74 50.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.313 -0.858 . . . . 3.49 109.976 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.51 154.02 25.24 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.209 -0.996 . . . . 2.58 112.642 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 137' ' ' ASP . 39.9 m -109.6 136.1 49.51 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.68 -0.489 . . . . 3.34 109.68 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.571 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 46.9 t -68.58 118.43 12.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.83 0.348 . . . . 3.14 110.086 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.5 p -95.35 -27.89 15.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.027 0.441 . . . . 3.61 110.84 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 m -153.16 127.88 9.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.864 -0.607 . . . . 3.12 110.112 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.08 -171.37 2.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.409 -0.36 . . . . 4.39 110.402 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.331 -0.395 . . . . 3.62 110.668 -179.758 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 110.345 -0.243 . . . . 3.33 110.345 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.6 t -112.92 153.92 27.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.849 -0.426 . . . . 2.57 109.849 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.66 -173.63 36.61 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.624 -0.59 . . . . 1.66 111.624 177.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -133.82 126.13 29.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.992 0.425 . . . . 3.03 111.381 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.501 HG13 ' CE1' ' A' ' 122' ' ' TYR . 83.7 mt -112.12 129.02 68.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.004 -0.739 . . . . 1.88 109.004 171.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 t -105.23 117.8 34.92 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.831 -0.433 . . . . 3.49 109.831 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 11.2 p90 -119.47 150.81 39.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.207 -0.452 . . . . 3.51 109.945 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -111.95 123.45 50.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.113 -0.494 . . . . 5.1 110.592 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.512 ' OD1' ' HG3' ' A' ' 114' ' ' ARG . 49.9 t-20 -131.59 119.07 20.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.148 -0.686 . . . . 4.78 109.148 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 71.2 mtp180 63.2 21.41 12.83 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.199 -0.455 . . . . 6.97 111.223 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.36 -9.67 71.75 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.04 -0.6 . . . . 5.1 112.163 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -92.16 122.74 34.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.764 0.316 . . . . 5.38 110.247 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.04 123.05 38.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.318 -0.401 . . . . 4.72 110.272 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.616 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . 64.4 m-85 -120.92 151.15 40.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.531 -0.304 . . . . 4.61 110.634 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.28 126.43 52.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 3.96 110.709 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 mt -112.94 135.25 21.66 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.053 -0.521 . . . . 2.75 110.848 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.74 137.64 11.4 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.713 2.275 . . . . 2.3 111.799 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.501 ' CE1' HG13 ' A' ' 109' ' ' ILE . 26.8 p90 -146.04 155.23 42.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.37 . . . . 2.13 110.14 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.0 p -115.42 -178.96 3.5 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.693 -0.484 . . . . 3.07 109.693 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -71.71 -21.1 61.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.44 0.638 . . . . 4.8 110.31 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.35 -23.56 50.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.398 -0.819 . . . . 4.81 111.289 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -86.99 3.95 43.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.992 0.425 . . . . 3.84 111.316 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 131' ' ' VAL . 52.7 t -87.52 137.65 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.234 -0.439 . . . . 4.39 110.921 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -87.17 135.55 33.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.986 -0.552 . . . . 6.43 110.105 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.76 2.03 68.85 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.177 -0.535 . . . . 5.91 112.671 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 56.42 38.08 29.39 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.159 0.504 . . . . 6.07 111.574 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.433 ' O ' HG11 ' A' ' 127' ' ' VAL . 43.7 t -78.63 145.82 9.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.884 -0.598 . . . . 5.27 109.749 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -91.39 137.82 32.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.332 -0.248 . . . . 5.78 110.332 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.7 mp -114.31 149.57 35.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.663 0.602 . . . . 3.62 111.018 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -141.7 123.67 15.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.636 -0.505 . . . . 6.93 109.636 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.571 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -50.14 129.14 20.57 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.515 0.674 . . . . 4.12 112.101 -170.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.83 -15.79 11.21 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 114.981 -1.009 . . . . 4.07 111.797 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 139' ' ' VAL . 2.4 p30 -85.4 169.25 13.86 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.397 -0.594 . . . . 4.06 109.397 173.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.463 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -123.1 116.8 24.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.071 0.462 . . . . 4.17 109.971 -177.273 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.513 HG13 ' OD1' ' A' ' 137' ' ' ASP . 30.2 m -116.0 179.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.516 0.674 . . . . 2.77 111.294 -173.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.9 m -143.12 145.76 33.14 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.367 -0.833 . . . . 3.47 109.086 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.38 172.53 12.65 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.127 -0.694 . . . . 3.35 109.127 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -112.76 136.89 51.85 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.399 0.437 . . . . 5.34 109.866 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.4 mt -106.72 101.66 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.98 0.419 . . . . 4.66 110.95 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -80.04 107.57 12.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.523 -0.547 . . . . 4.85 109.523 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.1 m -97.46 102.76 14.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.121 0.486 . . . . 5.68 110.747 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 148' ' ' ARG . 47.6 t30 -75.05 157.0 35.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.716 -0.846 . . . . 6.25 108.716 172.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.19 13.91 0.1 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.05 0.452 . . . . 8.58 112.049 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.479 ' NE ' ' HA ' ' A' ' 148' ' ' ARG . 5.0 mmp_? -110.05 -8.55 14.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.751 0.31 . . . . 7.86 110.207 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.73 20.98 77.82 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 116.009 -0.542 . . . . 5.59 112.374 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -112.29 111.49 22.4 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.905 -0.406 . . . . 5.18 109.905 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.481 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.3 179.94 8.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.128 0.49 . . . . 4.28 111.575 -177.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.85 -156.94 7.7 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.498 -1.041 . . . . 3.36 110.498 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.17 112.09 24.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.495 0.648 . . . . 2.84 109.491 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 24.2 m -103.87 140.03 38.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.123 -0.489 . . . . 4.34 111.242 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 52.43 61.39 3.22 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 123.848 0.718 . . . . 5.75 111.225 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.2 mt -78.78 125.65 38.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.643 -0.708 . . . . 3.55 110.225 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -126.93 145.54 50.64 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.748 -0.381 . . . . 5.96 110.588 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.512 ' HA ' HG12 ' A' ' 139' ' ' VAL . 55.4 tp -80.71 101.52 9.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 4.34 109.87 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.65 -53.96 5.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.566 . . . . 4.97 110.834 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -118.21 97.82 51.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 5.37 110.329 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.31 158.94 33.2 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.458 2.106 . . . . 5.44 112.164 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 116.198 -0.455 . . . . 6.1 110.206 177.387 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 121.246 0.546 . . . . 12.4 110.422 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -93.34 136.88 33.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.515 -0.92 . . . . 11.63 108.515 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -118.39 140.6 49.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.48 -0.488 . . . . 9.15 111.463 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.72 -177.12 30.52 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.784 -0.722 . . . . 6.81 112.051 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 2.3 mt -124.97 143.36 38.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.809 -0.441 . . . . 10.17 109.809 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.53 116.15 11.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.414 -0.514 . . . . 8.73 109.675 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -88.47 -38.68 14.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 10.86 110.478 -176.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -153.79 140.62 19.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.619 -0.719 . . . . 14.06 109.591 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.4 mt -105.16 102.55 12.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.137 0.494 . . . . 11.73 110.591 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 mp -84.36 -178.34 6.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.053 -0.976 . . . . 11.36 109.307 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -89.69 108.73 19.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.864 0.364 . . . . 15.94 110.298 -173.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.5 m 67.57 22.31 9.2 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.251 -0.886 . . . . 13.01 110.983 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -160.52 141.21 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.628 -0.715 . . . . 12.34 109.429 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.14 157.33 21.62 Favored Glycine 0 C--N 1.322 -0.209 0 C-N-CA 120.471 -0.871 . . . . 7.52 113.094 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.0 129.19 55.01 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.108 0.163 . . . . 9.24 110.737 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.7 mt -112.59 126.92 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.846 0.355 . . . . 7.75 110.838 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 10.3 pt20 -85.38 145.73 27.34 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.145 0.498 . . . . 11.8 110.781 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 p -79.71 1.58 25.93 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.129 -0.942 . . . . 12.34 113.076 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.1 m -52.79 -24.87 9.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.932 1.086 . . . . 13.33 113.932 -170.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -99.37 10.59 41.11 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.123 0.416 . . . . 11.9 112.123 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -164.59 -158.97 0.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.438 -0.579 . . . . 12.99 109.438 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -123.37 24.37 8.71 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.162 0.506 . . . . 16.66 110.517 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.3 127.97 25.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.559 . . . . 12.09 111.125 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -96.2 119.42 34.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 12.51 110.147 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.66 162.46 18.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.407 0.622 . . . . 8.76 111.792 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -131.86 147.5 52.48 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.346 -0.983 . . . . 9.15 108.346 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -134.15 159.24 41.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.124 0.488 . . . . 6.85 111.204 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -98.84 154.77 17.77 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.994 -0.743 . . . . 9.99 108.994 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -68.86 -16.22 63.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.854 0.359 . . . . 9.93 110.786 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 t -78.36 -10.24 59.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.091 -0.504 . . . . 12.28 110.177 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -108.22 27.03 9.72 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.141 -0.482 . . . . 10.62 110.688 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -122.96 111.81 17.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.463 . . . . 8.78 110.376 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -89.15 111.66 22.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.089 0.471 . . . . 8.97 109.996 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.02 -151.01 23.04 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.988 -0.845 . . . . 9.98 110.988 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -107.22 120.71 42.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.808 0.304 . . . . 12.43 110.685 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -67.48 -19.63 25.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.601 0.715 . . . . 11.58 109.13 173.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.45 -32.44 70.23 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.803 -1.09 . . . . 14.73 110.688 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -109.65 21.24 17.21 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.584 -0.735 . . . . 13.3 111.092 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.8 tp -111.65 114.99 28.39 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.462 -0.57 . . . . 10.07 109.462 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -121.13 -179.27 3.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.008 0.433 . . . . 13.13 110.342 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 47' ' ' ILE . 3.5 mp -76.24 120.51 26.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.648 -0.501 . . . . 11.74 109.648 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.59 0.1 30.76 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.74 -0.743 . . . . 10.13 112.471 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.54 122.99 88.31 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.559 0.219 . . . . 8.39 110.895 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -83.58 126.25 4.04 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.609 2.206 . . . . 7.28 111.979 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.05 156.08 39.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.068 0.461 . . . . 4.74 111.065 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -119.48 126.77 52.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.698 -0.683 . . . . 7.09 109.26 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -132.21 166.81 21.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.349 0.595 . . . . 7.82 111.036 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.503 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 31.8 tt0 -101.32 109.66 21.54 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.645 -0.707 . . . . 11.59 109.272 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.68 109.13 19.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.281 -0.637 . . . . 12.41 109.281 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.7 p -131.6 175.28 9.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.052 0.453 . . . . 13.17 111.352 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.23 121.48 42.18 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.492 -0.558 . . . . 16.21 109.492 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -75.22 124.9 27.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.409 0.623 . . . . 16.64 110.659 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -79.33 -7.33 58.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.002 -0.999 . . . . 22.64 111.506 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -92.43 -55.12 3.52 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.957 -0.297 . . . . 21.43 111.17 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.9 p -86.46 -22.69 26.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 111.772 0.286 . . . . 17.4 111.772 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.68 32.34 54.37 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.559 -0.829 . . . . 16.7 111.66 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -121.15 147.55 47.04 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.303 -0.258 . . . . 14.73 110.303 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.69 126.16 11.18 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 121.949 1.766 . . . . 12.6 110.753 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.54 162.1 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.222 0.534 . . . . 11.73 111.304 -174.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.27 139.06 40.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.551 -0.749 . . . . 8.91 109.146 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.503 ' OG ' ' HB3' ' A' ' 54' ' ' GLU . 17.6 m -70.0 -157.13 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.084 -0.507 . . . . 9.83 110.762 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -75.68 27.86 0.11 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.326 1.232 . . . . 11.32 114.326 -168.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.2 t 21.31 101.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 125.079 1.352 . . . . 6.11 114.582 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.4 m -107.67 143.3 36.35 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.106 -0.497 . . . . 6.12 110.096 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.56 142.33 51.77 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.165 -0.68 . . . . 6.3 109.165 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.6 mt . . . . . 0 C--O 1.235 0.321 0 CA-C-O 121.112 0.482 . . . . 5.77 111.137 -177.466 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.41 ' CG1' ' HB1' ' A' ' 144' ' ' ALA . 30.9 t . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 121.018 0.437 . . . . 6.19 111.434 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.59 111.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 6.26 111.244 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -118.91 16.38 13.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 6.05 110.921 176.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 m -114.06 60.53 0.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.856 0.36 . . . . 7.02 111.516 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -117.11 -34.63 4.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.716 0.293 . . . . 7.07 110.834 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -168.1 147.85 4.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 6.68 110.191 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -105.23 115.49 30.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 6.43 110.413 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.04 159.44 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.2 -0.454 . . . . 3.7 110.452 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 p -110.46 139.66 45.46 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.127 -0.488 . . . . 3.49 110.13 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.48 163.43 23.19 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.231 -0.985 . . . . 2.58 112.443 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.2 m -122.44 129.04 51.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.771 -0.455 . . . . 3.34 109.771 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.589 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 90.4 t -69.27 126.16 28.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.416 -0.356 . . . . 3.14 110.665 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 p -105.82 -19.92 13.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.237 0.541 . . . . 3.61 110.63 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.5 m -149.9 129.42 13.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 3.12 110.198 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.13 -178.27 3.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.737 0.303 . . . . 4.39 110.71 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.435 HD12 HG23 ' A' ' 105' ' ' THR . 3.2 mm? . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 115.777 -0.647 . . . . 3.62 109.649 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.435 HG23 HD12 ' A' ' 91' ' ' LEU . 6.7 t . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.153 -0.684 . . . . 3.33 109.153 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.5 m -145.28 130.2 18.27 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.993 -0.373 . . . . 2.57 109.993 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.64 169.71 49.3 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.656 -0.783 . . . . 1.66 112.183 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -129.61 133.64 47.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.918 0.39 . . . . 3.03 110.892 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 64.9 mt -111.8 126.48 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.6 -0.727 . . . . 1.88 109.89 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.8 p -98.07 119.18 36.26 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.9 -0.407 . . . . 3.49 109.9 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 2.5 p90 -127.4 153.69 45.93 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.639 -0.504 . . . . 3.51 109.639 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.95 120.61 38.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.246 -0.433 . . . . 5.1 110.35 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -146.72 137.81 24.14 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.058 -0.719 . . . . 4.78 109.058 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 64.08 20.89 12.39 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.867 0.365 . . . . 6.97 110.364 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.83 -8.15 63.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.202 -0.523 . . . . 5.1 112.366 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -100.68 138.84 37.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.893 -0.41 . . . . 5.38 109.893 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 1.3 p -108.2 121.58 45.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.046 0.451 . . . . 4.72 110.837 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -115.73 164.83 13.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.927 -0.579 . . . . 4.61 110.652 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 96.0 m-85 -119.39 119.3 33.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.01 -0.541 . . . . 3.96 110.397 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 153' ' ' ALA . 4.1 mm? -105.42 143.37 26.64 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.336 -0.393 . . . . 2.75 110.626 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.98 146.93 9.14 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.126 2.551 . . . . 2.3 112.066 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -153.75 151.78 29.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.102 0.477 . . . . 2.13 111.366 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.73 162.17 23.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.453 -0.794 . . . . 3.07 109.38 172.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.94 -30.57 71.66 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.005 0.431 . . . . 4.8 111.204 -175.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.43 -20.42 66.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.076 -0.511 . . . . 4.81 111.871 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -104.22 13.81 31.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.147 0.499 . . . . 3.84 110.638 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.06 128.45 41.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 4.39 110.792 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.426 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 1.4 tm-20 -94.93 145.62 24.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.939 -0.763 . . . . 6.43 108.939 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.01 -17.18 58.77 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.754 -0.736 . . . . 5.91 112.039 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 61.25 24.2 14.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.514 0.673 . . . . 6.07 110.671 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.6 t -90.81 137.71 21.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.065 -0.516 . . . . 5.27 110.284 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -79.08 102.53 8.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 5.78 110.314 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.709 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -88.6 148.85 23.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 3.62 110.605 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -133.13 171.5 13.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.11 -0.495 . . . . 6.93 109.809 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.589 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.96 118.9 17.47 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.095 -0.502 . . . . 4.12 110.581 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.93 -20.42 9.91 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.666 -0.697 . . . . 4.07 113.195 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.93 166.18 12.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.898 0.849 . . . . 4.06 110.634 175.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -98.58 122.96 42.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.732 0.777 . . . . 4.17 111.976 -170.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.33 157.94 24.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.678 -1.146 . . . . 2.77 110.125 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.4 m -126.23 141.07 52.07 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.913 -0.773 . . . . 3.47 108.913 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -135.37 149.59 49.72 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.953 0.406 . . . . 3.35 110.26 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -100.59 115.05 29.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.739 -0.664 . . . . 5.34 110.497 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 64.7 mt -78.05 110.31 13.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.603 -0.726 . . . . 4.66 110.375 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.537 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . . . -90.26 110.45 21.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.854 -0.612 . . . . 4.85 110.427 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 40.2 m -80.6 103.15 10.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.682 -0.69 . . . . 5.68 110.352 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -67.69 163.38 21.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.1 -0.5 . . . . 6.25 111.043 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.39 -18.32 65.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 8.58 111.663 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -100.03 6.85 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.118 0.485 . . . . 7.86 110.235 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.61 18.2 75.45 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.868 -0.605 . . . . 5.59 113.98 172.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -122.33 129.9 52.6 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.404 -0.591 . . . . 5.18 109.404 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.31 179.37 8.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.906 0.384 . . . . 4.28 111.685 -175.364 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -131.38 -112.43 1.45 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.839 -0.904 . . . . 3.36 110.839 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 120' ' ' LEU . . . -135.41 129.68 33.68 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.109 -0.33 . . . . 2.84 110.109 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 82.6 m -128.14 150.16 50.11 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.87 -0.419 . . . . 4.34 109.87 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 57.65 58.08 3.92 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.438 0.461 . . . . 5.75 111.333 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 156' ' ' ILE . 4.8 mp -74.57 113.61 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.346 -0.983 . . . . 3.55 108.346 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.426 ' HD2' ' OE2' ' A' ' 128' ' ' GLU . 26.4 ttt180 -129.2 131.14 47.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.977 0.418 . . . . 5.96 110.864 -173.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 133' ' ' LEU . 6.4 tt -83.42 115.82 22.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.338 -0.616 . . . . 4.34 109.338 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -105.89 -26.92 11.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.086 -0.506 . . . . 4.97 111.485 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.12 107.03 5.26 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.792 0.33 . . . . 5.37 110.7 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.42 161.66 17.22 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.843 2.362 . . . . 5.44 113.522 -175.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.411 -0.813 . . . . 6.1 109.314 174.653 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.521 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 19.2 ptt180 . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.255 0.55 . . . . 12.4 111.563 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.412 ' CD ' HH22 ' A' ' 27' ' ' ARG . 4.9 mm-40 -109.63 137.04 48.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.298 -0.865 . . . . 11.63 110.249 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 p -105.48 141.7 36.5 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.458 -0.337 . . . . 9.15 111.383 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.29 178.85 39.44 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.583 -0.607 . . . . 6.81 111.583 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.3 pt -121.19 149.95 24.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.824 0.312 . . . . 10.17 110.617 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.7 mm -67.69 122.24 18.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.377 -0.374 . . . . 8.73 110.514 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.13 -51.16 10.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.749 0.309 . . . . 10.86 110.392 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -152.72 171.7 17.82 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.023 -0.535 . . . . 14.06 110.444 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.7 mt -127.59 99.53 5.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.6 -0.727 . . . . 11.73 110.628 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.2 mp -97.05 -179.9 4.7 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.286 -1.005 . . . . 11.36 108.286 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -91.19 131.9 36.43 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.506 -0.478 . . . . 15.94 110.293 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.3 t 76.24 -22.68 0.26 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.991 0.916 . . . . 13.01 112.196 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -152.27 162.89 40.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 12.34 111.26 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.99 -172.87 19.18 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.796 -0.521 . . . . 7.52 111.796 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.23 149.49 52.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.781 0.324 . . . . 9.24 110.931 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.1 mt -113.89 126.85 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.826 -0.625 . . . . 7.75 109.553 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.14 136.95 35.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.4 0.619 . . . . 11.8 111.561 -172.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 p -81.94 -0.59 44.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.999 -1.0 . . . . 12.34 112.887 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.4 m -53.6 -37.22 62.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.194 0.452 . . . . 13.33 112.035 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.53 20.32 13.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 11.9 111.476 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.476 HH21 ' HB3' ' A' ' 29' ' ' ALA . 7.1 ptm85 -163.16 -160.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.422 -0.174 . . . . 12.99 111.096 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -124.8 20.08 8.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.826 0.346 . . . . 16.66 111.223 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.476 ' HB3' HH21 ' A' ' 27' ' ' ARG . . . -146.13 122.46 10.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.392 -0.367 . . . . 12.09 111.692 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 30' ' ' ARG . 11.8 ptt180 -85.97 130.74 34.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.428 -0.953 . . . . 12.51 108.428 171.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.1 tp -141.64 158.6 43.62 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.689 -0.404 . . . . 8.76 110.777 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -113.99 149.92 34.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.141 -0.481 . . . . 9.15 109.831 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -136.49 155.39 50.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.006 -0.368 . . . . 6.85 110.006 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -110.73 150.25 29.33 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.691 -0.485 . . . . 9.99 109.691 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -63.93 -19.25 64.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.379 -0.373 . . . . 9.93 111.6 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -70.34 -24.07 62.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 12.28 111.129 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.88 40.1 1.72 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.026 -0.533 . . . . 10.62 110.525 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -120.5 129.8 53.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.336 -0.393 . . . . 8.78 110.393 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.3 m -97.7 104.78 16.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.263 -0.426 . . . . 8.97 110.349 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.89 -172.42 23.67 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.754 -0.736 . . . . 9.98 111.525 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -95.4 115.94 28.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.482 0.658 . . . . 12.43 110.3 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.63 -23.95 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.391 -0.822 . . . . 11.58 112.537 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -67.7 -21.19 65.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 14.73 111.329 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -99.62 9.07 43.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.766 0.317 . . . . 13.3 110.928 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.3 tp -94.17 130.75 40.27 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.242 -0.651 . . . . 10.07 109.242 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -122.92 172.98 8.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.96 0.409 . . . . 13.13 110.546 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.5 mp -81.79 128.44 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.756 -0.656 . . . . 11.74 109.397 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.47 0.58 67.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.687 -0.768 . . . . 10.13 112.119 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 31.9 t70 -80.4 129.97 67.1 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.192 . . . . 8.39 110.743 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 49' ' ' ASP . 8.2 Cg_exo -72.22 127.43 12.7 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.938 2.426 . . . . 7.28 113.032 -178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.79 154.47 34.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 4.74 110.88 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.521 ' OE1' ' HD2' ' A' ' 7' ' ' ARG . 37.3 tt0 -112.77 124.19 52.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.185 -0.461 . . . . 7.09 109.899 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -142.3 151.27 41.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.394 -0.366 . . . . 7.82 110.679 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.4 130.49 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.313 -0.625 . . . . 11.59 109.313 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 14.7 tpt -83.19 114.68 21.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.25 -0.432 . . . . 12.41 109.853 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.5 p -133.2 170.96 14.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.371 0.605 . . . . 13.17 111.927 -173.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.411 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 84.4 m-85 -132.37 115.06 15.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.018 -0.734 . . . . 16.21 109.018 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -80.5 116.5 20.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.767 -0.457 . . . . 16.64 109.767 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -78.71 -7.05 57.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.57 . . . . 22.64 111.947 -173.339 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.07 -37.92 9.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.203 -0.453 . . . . 21.43 110.913 -175.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 p -87.69 -34.09 18.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.89 0.376 . . . . 17.4 110.924 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.54 8.58 63.88 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.503 -0.856 . . . . 16.7 112.178 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -106.45 145.51 31.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 122.893 -0.181 . . . . 14.73 110.804 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.48 125.02 5.48 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.8 1.667 . . . . 12.6 110.433 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.31 157.49 24.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.272 0.558 . . . . 11.73 111.21 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.0 157.79 16.6 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.742 -0.663 . . . . 8.91 109.556 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -65.3 -166.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.177 -0.465 . . . . 9.83 110.148 176.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -73.94 19.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.535 0.568 . . . . 11.32 112.535 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t 32.87 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.421 1.089 . . . . 6.11 113.193 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.8 m -88.4 136.45 32.98 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.113 0.482 . . . . 6.12 110.114 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.428 ' HE2' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -73.97 119.7 18.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.149 -0.478 . . . . 6.3 110.344 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.428 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 65.4 mt . . . . . 0 N--CA 1.452 -0.341 0 CA-C-N 115.951 -0.568 . . . . 5.77 109.77 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 108.763 -0.828 . . . . 6.19 108.763 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.74 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 39.0 t -68.13 89.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.419 . . . . 6.26 110.394 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 144' ' ' ALA . 1.5 tt -91.43 -8.7 47.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.153 -0.931 . . . . 6.05 110.782 -173.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.3 t -140.89 103.59 4.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.049 -0.523 . . . . 7.02 110.479 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.65 -59.77 1.96 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.553 -0.906 . . . . 7.07 108.553 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -135.97 119.73 17.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.912 -1.04 . . . . 6.68 108.51 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -79.77 107.85 12.87 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.695 -0.483 . . . . 6.43 109.695 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.49 179.3 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 3.7 111.571 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.573 ' HB ' ' HD2' ' A' ' 138' ' ' LYS . 37.4 p -121.55 165.16 16.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.445 -0.798 . . . . 3.49 108.853 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.18 145.1 15.47 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.136 -1.03 . . . . 2.58 113.002 -177.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 m -108.05 127.91 54.21 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.606 -0.516 . . . . 3.34 109.606 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.613 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -74.83 124.89 33.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.096 -0.335 . . . . 3.14 110.096 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 p -104.29 -22.41 13.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.119 0.485 . . . . 3.61 110.65 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.4 m -136.66 126.46 25.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.959 -0.564 . . . . 3.12 110.634 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -84.09 -176.73 6.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 4.39 110.709 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 108.876 -0.787 . . . . 3.62 108.876 171.434 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.444 -0.768 0 N-CA-C 109.414 -0.587 . . . . 3.33 109.414 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.3 m -137.39 135.44 36.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.051 0.453 . . . . 2.57 110.532 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.48 176.98 48.5 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.777 -0.725 . . . . 1.66 111.92 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -129.89 127.37 40.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.884 0.373 . . . . 3.03 111.256 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.4 HG13 ' CD1' ' A' ' 122' ' ' TYR . 78.4 mt -112.3 127.06 69.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.872 -0.604 . . . . 1.88 109.441 173.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.9 p -102.54 132.87 48.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.618 -0.264 . . . . 3.49 110.868 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.446 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -145.14 160.69 41.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.661 -0.496 . . . . 3.51 109.661 175.007 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -117.04 124.33 49.04 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.501 -0.555 . . . . 5.1 109.501 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -137.65 112.43 8.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 4.78 110.456 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 66.08 21.82 11.18 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.495 -0.32 . . . . 6.97 111.756 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.56 -1.22 68.77 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.675 -0.774 . . . . 5.1 111.7 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.489 ' HB3' ' CE2' ' A' ' 118' ' ' PHE . 69.8 mm-40 -96.85 128.75 44.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.9 -0.407 . . . . 5.38 109.9 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 84.9 m -118.16 101.44 8.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.124 -0.489 . . . . 4.72 110.293 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 116' ' ' GLU . 62.5 m-85 -116.79 155.0 29.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.168 0.508 . . . . 4.61 111.099 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -107.75 118.58 37.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.786 -0.82 . . . . 3.96 108.786 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.446 HD11 ' CE2' ' A' ' 111' ' ' TYR . 5.5 mp -102.42 137.89 19.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 120.875 -0.33 . . . . 2.75 110.66 -173.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.88 134.45 18.05 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.743 2.295 . . . . 2.3 112.115 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.4 ' CD1' HG13 ' A' ' 109' ' ' ILE . 23.0 p90 -137.09 151.22 48.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.175 -0.466 . . . . 2.13 109.797 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.3 p -116.72 178.77 4.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.419 -0.355 . . . . 3.07 110.137 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -69.91 -19.71 63.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.388 0.613 . . . . 4.8 110.167 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -78.98 -9.87 59.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.456 -0.793 . . . . 4.81 111.42 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -93.34 -14.55 26.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.411 -0.359 . . . . 3.84 111.873 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.449 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 7.6 p -103.98 137.68 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.183 0.516 . . . . 4.39 111.052 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -106.17 169.7 8.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.55 . . . . 6.43 111.196 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.73 -4.01 83.6 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.907 -0.588 . . . . 5.91 113.174 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 62.6 24.96 14.86 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.797 0.439 . . . . 6.07 110.65 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 t -84.34 122.18 37.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.958 -0.565 . . . . 5.27 110.41 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -83.86 95.31 8.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.308 0.575 . . . . 5.78 110.438 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.4 pt? -75.37 150.35 38.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.863 -1.062 . . . . 3.62 111.008 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.521 ' HG3' ' OD1' ' A' ' 137' ' ' ASP . 3.9 ppt_? -120.38 162.33 19.67 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.77 -0.456 . . . . 6.93 109.77 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.613 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -72.41 125.62 27.85 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.605 -0.438 . . . . 4.12 110.87 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.48 -25.73 7.59 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.934 -0.651 . . . . 4.07 113.613 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.521 ' OD1' ' HG3' ' A' ' 134' ' ' ARG . 2.8 p30 -86.53 178.66 7.02 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.258 1.029 . . . . 4.06 110.141 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.573 ' HD2' ' HB ' ' A' ' 84' ' ' THR . 2.3 tppp? -118.9 124.7 47.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.414 0.626 . . . . 4.17 111.795 -172.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.617 HG12 ' HG ' ' A' ' 158' ' ' LEU . 24.5 m -117.22 170.59 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 2.77 110.039 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -119.97 135.4 54.92 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.034 -0.728 . . . . 3.47 109.034 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -134.44 153.58 51.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.774 0.321 . . . . 3.35 110.536 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -113.83 131.23 56.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.864 -0.607 . . . . 5.34 109.801 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.4 mt -95.96 108.71 21.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.778 -0.647 . . . . 4.66 110.951 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.74 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -101.86 110.98 23.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.718 0.294 . . . . 4.85 111.285 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 66.8 m -99.0 122.7 42.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 5.68 111.814 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.52 174.92 8.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 6.25 110.533 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -59.58 -28.54 67.23 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.001 -0.545 . . . . 8.58 112.214 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 148' ' ' ARG . 21.8 mmt180 -88.48 8.66 26.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.877 0.325 . . . . 7.86 111.877 -174.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.07 14.51 73.67 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.909 -0.662 . . . . 5.59 113.22 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.9 130.51 53.84 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.254 -0.647 . . . . 5.18 109.254 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.491 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -152.94 -178.52 6.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.356 -0.384 . . . . 4.28 110.938 -177.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.14 -166.11 13.81 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.031 -0.828 . . . . 3.36 111.031 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.39 109.96 21.89 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.046 -0.353 . . . . 2.84 110.046 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 71.9 m -121.01 166.76 13.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.434 -0.348 . . . . 4.34 110.871 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 59.22 36.51 23.79 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.632 0.583 . . . . 5.75 110.144 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.449 ' HB ' ' HA ' ' A' ' 127' ' ' VAL . 77.1 mt -64.9 114.55 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.807 -0.633 . . . . 3.55 110.021 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -122.12 123.89 42.62 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.816 -0.809 . . . . 5.96 108.816 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.617 ' HG ' HG12 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -81.78 103.05 11.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.178 -0.464 . . . . 4.34 109.876 -176.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -97.08 -32.44 11.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.993 -0.549 . . . . 4.97 111.305 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -126.39 84.38 62.26 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 5.37 110.742 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.28 179.87 4.31 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.918 2.412 . . . . 5.44 112.975 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.408 ' HB2' ' HE ' ' A' ' 134' ' ' ARG . . . . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.73 -0.668 . . . . 6.1 110.49 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.429 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 17.3 ptt180 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 121.108 0.48 . . . . 12.4 111.142 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.72 162.7 21.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.691 -0.686 . . . . 11.63 110.038 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 26' ' ' GLU . 36.8 p -100.79 162.12 13.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.399 -0.364 . . . . 9.15 110.233 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 26' ' ' GLU . . . -162.38 177.56 38.49 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.967 -0.635 . . . . 6.81 112.055 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.6 mt -129.45 141.9 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.557 -0.534 . . . . 10.17 109.557 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.6 mm -65.81 111.5 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.836 0.351 . . . . 8.73 110.086 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.15 -54.24 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.724 -0.671 . . . . 10.86 110.495 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HA ' HD12 ' A' ' 47' ' ' ILE . 41.0 mttm -146.47 163.9 34.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.434 -0.803 . . . . 14.06 110.253 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.5 mt -131.45 101.33 5.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.803 -0.635 . . . . 11.73 110.543 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.5 mt -92.41 -179.87 5.33 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.558 -1.275 . . . . 11.36 107.558 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -90.37 125.1 35.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.097 -0.641 . . . . 15.94 109.977 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.3 m 79.63 -16.6 0.65 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.136 0.974 . . . . 13.01 112.212 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -150.19 147.77 28.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.561 0.22 . . . . 12.34 110.949 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.48 -176.21 15.62 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.021 -0.609 . . . . 7.52 112.871 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -127.87 149.78 50.15 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.843 0.354 . . . . 9.24 111.312 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.8 mt -115.53 130.43 70.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 7.75 110.897 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.79 145.83 34.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.92 -0.582 . . . . 11.8 111.252 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 p -80.28 2.49 24.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.088 -0.96 . . . . 12.34 112.862 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -52.62 -35.44 54.6 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.006 0.372 . . . . 13.33 112.006 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.505 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 22.6 mm-40 -108.89 -25.39 10.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 11.9 111.409 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HD3' ' N ' ' A' ' 28' ' ' GLN . 1.6 tmt_? -113.38 135.3 54.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.475 -0.565 . . . . 12.99 109.475 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' N ' ' HD3' ' A' ' 27' ' ' ARG . 19.6 mp0 -74.62 43.7 0.19 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.797 0.332 . . . . 16.66 111.255 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.33 146.4 0.48 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.717 0.807 . . . . 12.09 109.541 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.585 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -100.96 111.81 24.1 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.57 -0.53 . . . . 12.51 109.57 177.767 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.1 mt -113.88 163.03 15.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.234 0.54 . . . . 8.76 111.923 -170.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -112.07 149.12 32.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.237 -0.892 . . . . 9.15 109.506 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -140.53 158.72 43.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.874 0.369 . . . . 6.85 110.195 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -103.76 158.19 16.56 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.703 -0.48 . . . . 9.99 109.703 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -67.91 -18.79 64.89 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.957 0.355 . . . . 9.93 111.957 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 t -82.56 -8.08 59.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.403 0.62 . . . . 12.28 109.773 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -107.48 37.89 2.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.618 -0.719 . . . . 10.62 110.03 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -129.67 125.39 35.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.964 0.412 . . . . 8.78 111.16 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 t -100.75 104.6 15.88 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.961 -0.563 . . . . 8.97 109.977 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.54 -148.85 20.67 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.114 -0.795 . . . . 9.98 111.114 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -107.13 104.03 13.58 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 110.022 -0.362 . . . . 12.43 110.022 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.0 tp -63.25 -25.48 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.155 0.502 . . . . 11.58 110.726 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.04 -25.42 61.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 14.73 110.383 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.17 -10.43 25.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.756 -0.656 . . . . 13.3 110.568 -176.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.0 tp -68.37 147.2 52.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 10.07 110.169 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 169.95 17.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.191 -0.458 . . . . 13.13 110.431 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 14' ' ' LYS . 31.8 mm -77.69 135.27 26.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.562 -0.533 . . . . 11.74 109.562 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.59 11.29 62.43 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.477 -0.868 . . . . 10.13 111.837 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -86.38 125.93 66.15 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.253 -0.277 . . . . 8.39 110.253 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.91 129.74 6.35 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.906 2.404 . . . . 7.28 112.985 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.98 165.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 4.74 110.584 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 9' ' ' THR . 10.2 pt-20 -126.52 146.63 50.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.969 0.414 . . . . 7.09 110.218 172.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -152.24 178.52 9.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.026 -0.534 . . . . 7.82 110.879 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.7 mp0 -124.08 114.17 19.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.882 -0.599 . . . . 11.59 110.575 177.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.9 ttt -78.28 109.65 12.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.599 -0.519 . . . . 12.41 109.599 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.5 p -131.67 167.74 18.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.937 0.399 . . . . 13.17 111.043 -176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -118.36 110.4 17.43 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 16.21 109.58 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.38 111.2 5.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.838 0.352 . . . . 16.64 110.143 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -6.63 46.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.0 -0.545 . . . . 22.64 111.608 -176.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.8 mmt-85 -78.25 -59.7 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 21.43 110.259 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.4 p -86.68 -30.36 21.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 17.4 111.896 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.17 31.55 16.73 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.937 -0.649 . . . . 16.7 111.893 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.28 141.5 33.26 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 122.935 -0.156 . . . . 14.73 110.827 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.91 125.53 7.4 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.298 1.999 . . . . 12.6 110.886 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.63 165.61 22.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.186 -0.461 . . . . 11.73 110.591 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -102.16 161.15 13.91 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.661 -0.496 . . . . 8.91 109.661 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 11.9 t -66.89 -166.91 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.721 -0.474 . . . . 9.83 109.721 172.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -78.46 26.27 0.23 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.355 0.502 . . . . 11.32 112.355 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.7 t 35.25 94.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.2 1.0 . . . . 6.11 113.447 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -93.21 132.26 37.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.285 -0.416 . . . . 6.12 110.435 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -67.46 140.36 57.09 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.444 -0.576 . . . . 6.3 109.444 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.2 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 5.77 110.895 -176.303 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.622 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 1.7 p . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.773 -0.455 . . . . 6.19 109.773 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 4.8 p -79.97 107.21 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.575 0.703 . . . . 6.26 111.225 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.5 tp -89.87 -52.34 5.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.815 -1.084 . . . . 6.05 110.354 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.7 m -89.52 67.15 7.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.896 0.379 . . . . 7.02 111.718 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -88.64 -65.93 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.006 -0.738 . . . . 7.07 109.006 170.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -152.49 133.57 14.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.555 -0.906 . . . . 6.68 108.555 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -77.8 118.27 19.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.758 0.313 . . . . 6.43 110.278 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.13 166.9 7.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.215 0.531 . . . . 3.7 111.172 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 p -133.22 150.4 51.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.502 -0.772 . . . . 3.49 110.496 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -150.52 173.66 30.07 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.508 -0.853 . . . . 2.58 112.143 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.1 m -122.86 135.48 54.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.819 0.343 . . . . 3.34 110.256 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.549 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 39.8 t -64.9 132.02 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.269 -0.423 . . . . 3.14 110.728 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.5 p -115.15 -10.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.048 0.388 . . . . 3.61 112.048 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.5 m -145.05 131.99 20.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.711 0.291 . . . . 3.12 110.657 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.12 179.59 6.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 4.39 111.427 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.57 -0.741 . . . . 3.62 109.339 175.757 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.7 m . . . . . 0 N--CA 1.436 -1.138 0 CA-C-O 121.027 0.441 . . . . 3.33 110.511 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 t -136.25 141.27 43.9 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.073 -0.512 . . . . 2.57 109.981 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -81.2 177.58 54.23 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.468 -0.872 . . . . 1.66 111.541 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 8.0 mmt85 -132.82 127.65 34.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.989 0.423 . . . . 3.03 111.104 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.3 130.15 66.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 1.88 109.223 172.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.5 t -106.56 116.45 31.95 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.552 -0.536 . . . . 3.49 109.552 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -118.87 144.63 46.27 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.34 -0.615 . . . . 3.51 109.34 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -104.78 109.29 21.17 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.573 -0.74 . . . . 5.1 109.713 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.589 ' OD1' ' HD3' ' A' ' 114' ' ' ARG . 59.2 t30 -129.33 114.84 16.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.372 -0.376 . . . . 4.78 111.147 -174.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.589 ' HD3' ' OD1' ' A' ' 113' ' ' ASN . 6.0 mpt_? 61.55 26.13 15.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.978 0.418 . . . . 6.97 111.57 173.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.94 -2.77 69.67 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.872 -0.68 . . . . 5.1 112.617 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -110.19 135.23 51.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.828 0.347 . . . . 5.38 110.268 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 2.3 p -117.16 103.61 10.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.399 -0.364 . . . . 4.72 110.313 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -98.03 153.89 18.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.97 -0.559 . . . . 4.61 110.617 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -101.89 124.3 47.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.186 -0.461 . . . . 3.96 110.37 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 22.4 mt -105.66 130.01 23.73 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.839 -0.619 . . . . 2.75 110.685 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 76.2 Cg_endo -81.4 134.04 8.75 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.733 2.289 . . . . 2.3 111.544 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -140.24 157.76 45.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 2.13 111.363 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.5 p -120.73 177.2 5.17 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.612 -0.722 . . . . 3.07 109.582 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -76.65 -25.34 53.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.569 0.581 . . . . 4.8 112.569 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.01 -10.12 59.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.385 0.513 . . . . 4.81 112.385 -170.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -97.14 -12.63 22.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.037 0.446 . . . . 3.84 111.092 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.5 t -67.91 110.26 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.09 0.471 . . . . 4.39 111.041 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -68.25 127.51 33.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.571 -0.74 . . . . 6.43 110.719 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.89 -0.29 55.13 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.743 -0.741 . . . . 5.91 112.695 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 65.33 18.42 11.35 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.856 0.36 . . . . 6.07 110.771 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.63 135.08 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.803 -0.635 . . . . 5.27 112.238 -172.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -90.65 79.16 6.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.893 0.854 . . . . 5.78 109.135 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.566 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -77.34 149.95 35.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.86 -1.064 . . . . 3.62 112.129 -172.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -108.66 167.49 10.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.594 -0.73 . . . . 6.93 109.525 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.549 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.21 127.9 34.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.071 -0.652 . . . . 4.12 110.008 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.19 -24.24 9.4 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.847 -0.692 . . . . 4.07 111.605 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -64.99 137.94 58.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.855 0.36 . . . . 4.06 110.295 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -84.46 117.12 23.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.587 -0.523 . . . . 4.17 109.587 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -118.71 157.41 20.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.29 0.567 . . . . 2.77 111.998 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 m -118.8 129.94 55.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.534 -0.757 . . . . 3.47 109.336 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -138.24 152.52 48.67 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.77 -0.456 . . . . 3.35 109.77 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -107.94 132.4 53.53 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.837 -0.431 . . . . 5.34 109.837 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 75.6 mt -84.7 131.21 34.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.271 -0.422 . . . . 4.66 110.868 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -131.13 110.0 10.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.966 -0.561 . . . . 4.85 110.525 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 45.3 m -85.98 112.04 20.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 5.68 110.844 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -81.61 174.01 11.81 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.388 -0.597 . . . . 6.25 109.388 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -65.9 -7.29 15.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.168 0.803 . . . . 8.58 113.168 -172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -90.54 -9.48 47.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.763 -0.375 . . . . 7.86 111.117 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.11 13.35 83.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.73 -0.748 . . . . 5.59 112.004 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -111.27 121.26 44.81 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.858 -0.423 . . . . 5.18 109.858 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.519 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -136.34 -178.25 5.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.275 -0.42 . . . . 4.28 110.308 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.422 ' HA2' HD22 ' A' ' 120' ' ' LEU . . . -160.78 -78.08 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.594 -1.003 . . . . 3.36 110.594 176.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -160.23 163.1 33.78 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.085 -0.709 . . . . 2.84 109.085 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -150.52 147.06 27.02 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.98 -0.378 . . . . 4.34 109.98 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.4 p80 40.74 51.2 3.06 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 124.638 1.211 . . . . 5.75 111.361 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.9 mt -59.52 114.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.827 -1.079 . . . . 3.55 110.063 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.27 148.0 31.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.454 -0.339 . . . . 5.96 110.363 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.5 tp -72.68 125.23 27.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.237 -0.653 . . . . 4.34 109.237 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.2 -62.17 1.3 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.334 -0.617 . . . . 4.97 109.334 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -135.6 109.18 10.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.812 -0.631 . . . . 5.37 109.484 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.08 154.95 65.97 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.789 2.326 . . . . 5.44 113.017 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 115.563 -0.744 . . . . 6.1 111.467 -177.409 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 7' ' ' ARG . 43.6 mtt85 . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 120.834 0.349 . . . . 12.4 110.176 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.523 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 17.5 mm-40 -103.24 137.8 40.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.911 -0.586 . . . . 11.63 110.3 -173.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -97.94 136.91 37.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.659 -0.701 . . . . 9.15 110.656 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.5 174.6 32.1 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.978 -1.106 . . . . 6.81 112.918 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.559 HG13 ' HB3' ' A' ' 23' ' ' GLN . 7.9 pt -124.88 146.13 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.92 -0.4 . . . . 10.17 109.92 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.7 mm -67.47 122.88 19.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.414 0.149 . . . . 8.73 110.664 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 23.6 tt0 -88.09 -45.61 10.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.023 0.44 . . . . 10.86 110.428 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -147.6 140.93 25.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.9 -0.591 . . . . 14.06 109.954 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 45' ' ' LEU . 37.3 mt -113.01 110.19 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.324 0.583 . . . . 11.73 111.282 176.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.12 178.41 4.52 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.32 -1.363 . . . . 11.36 107.32 171.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -90.79 130.76 36.73 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.575 -0.85 . . . . 15.94 110.172 -174.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.9 m 76.63 -25.51 0.2 Allowed 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.203 0.939 . . . . 13.01 112.17 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -141.79 142.28 33.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.647 0.26 . . . . 12.34 110.844 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.15 179.82 18.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.814 -0.708 . . . . 7.52 112.448 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.09 134.7 55.18 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.747 0.308 . . . . 9.24 111.383 -177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.416 HG21 ' CE1' ' A' ' 53' ' ' PHE . 74.8 mt -99.75 129.09 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.617 -0.512 . . . . 7.75 109.617 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.559 ' HB3' HG13 ' A' ' 11' ' ' ILE . 37.6 tt0 -85.79 133.7 33.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.465 0.65 . . . . 11.8 111.357 -173.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.6 p -79.21 1.41 24.76 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.231 -0.895 . . . . 12.34 112.444 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 t -57.11 -29.46 63.55 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.197 0.443 . . . . 13.33 112.197 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -97.3 -1.28 44.99 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.83 0.348 . . . . 11.9 111.512 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 12.8 tpt180 -148.59 -158.85 0.96 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.342 -0.614 . . . . 12.99 109.342 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.485 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 26.5 mm-40 -119.21 19.01 12.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.248 0.546 . . . . 16.66 109.703 170.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.3 131.5 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.669 -0.696 . . . . 12.09 111.352 -175.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -121.18 125.71 47.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.734 -0.839 . . . . 12.51 108.734 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.75 160.67 26.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.42 0.628 . . . . 8.76 112.624 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -95.49 110.89 22.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.871 -1.059 . . . . 9.15 108.307 172.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -103.06 138.02 40.47 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.726 -0.79 . . . . 6.85 110.417 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -95.85 151.41 19.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.629 -0.714 . . . . 9.99 109.571 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.4 -16.77 61.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.949 0.404 . . . . 9.93 110.981 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -70.18 -23.99 63.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 12.28 109.942 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -108.71 40.31 1.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.588 -0.733 . . . . 10.62 110.711 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -129.44 119.56 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.557 -0.534 . . . . 8.78 109.557 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 t -88.02 106.53 18.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.146 0.498 . . . . 8.97 110.409 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.66 -167.89 22.5 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.684 -0.769 . . . . 9.98 111.972 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -79.12 96.34 5.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.077 -0.342 . . . . 12.43 110.077 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.1 -27.28 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.504 0.669 . . . . 11.58 109.3 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.09 -21.77 65.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.465 -0.789 . . . . 14.73 110.952 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -99.72 13.95 31.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 13.3 110.646 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.466 HD23 HD21 ' A' ' 15' ' ' LEU . 39.1 tp -88.42 147.77 24.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 10.07 110.914 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -125.28 168.7 13.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.307 -0.406 . . . . 13.13 110.837 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.7 mp -80.55 122.8 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.915 -0.584 . . . . 11.74 109.889 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.36 -3.45 32.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.872 -0.68 . . . . 10.13 111.826 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -67.83 122.71 84.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.806 -0.197 . . . . 8.39 110.478 178.156 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 49' ' ' ASP . 13.4 Cg_exo -69.44 123.66 10.43 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.676 2.251 . . . . 7.28 112.052 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.62 153.0 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.048 0.452 . . . . 4.74 111.624 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.25 124.44 52.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.104 -0.702 . . . . 7.09 109.104 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 8' ' ' GLU . 53.5 p90 -132.69 144.56 50.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.375 0.607 . . . . 7.82 111.039 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 26.9 tt0 -97.28 102.72 14.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.441 -0.8 . . . . 11.59 109.199 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.9 ttt -82.05 132.86 35.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.933 -0.576 . . . . 12.41 110.784 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.52 164.45 8.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.162 -0.472 . . . . 13.17 110.505 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -99.69 133.27 44.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.458 -0.337 . . . . 16.21 110.713 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.554 ' OD1' ' HG2' ' A' ' 60' ' ' ARG . 8.4 t70 -95.39 134.34 38.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.955 -0.566 . . . . 16.64 110.295 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -81.26 -13.39 58.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.24 0.459 . . . . 22.64 112.24 -177.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.554 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 8.4 mmm-85 -74.38 -60.8 2.1 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.943 -0.391 . . . . 21.43 109.943 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.551 HG22 ' OD2' ' A' ' 58' ' ' ASP . 5.7 t -91.81 -26.2 18.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.976 -0.556 . . . . 17.4 111.075 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.46 -4.58 85.47 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.798 -0.715 . . . . 16.7 112.634 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.504 ' H ' HG23 ' A' ' 61' ' ' THR . 38.5 mtpt -93.89 142.52 25.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.517 -0.549 . . . . 14.73 109.517 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.08 128.56 23.22 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.58 2.186 . . . . 12.6 112.119 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.31 179.5 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.205 -0.452 . . . . 11.73 111.001 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -133.57 173.14 11.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.642 -0.708 . . . . 8.91 109.69 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.6 p -74.98 -160.53 0.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.231 0.332 . . . . 9.83 110.405 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.5 pm0 -76.61 24.29 0.15 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.406 0.521 . . . . 11.32 112.406 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.6 t 32.75 87.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.3 1.04 . . . . 6.11 112.724 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.4 m -90.16 135.73 33.48 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.246 -0.434 . . . . 6.12 110.876 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -62.73 134.86 56.92 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.082 -0.71 . . . . 6.3 109.082 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt . . . . . 0 C--N 1.327 -0.407 0 CA-C-O 121.247 0.546 . . . . 5.77 111.145 -174.978 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.417 ' CG1' ' HB1' ' A' ' 144' ' ' ALA . 2.9 t . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.006 -0.738 . . . . 6.19 109.006 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.2 100.16 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.88 0.371 . . . . 6.26 111.351 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 144' ' ' ALA . 68.9 mt -105.19 9.32 34.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.502 0.668 . . . . 6.05 109.791 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.9 m -83.73 26.53 0.69 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.982 -1.008 . . . . 7.02 112.137 -172.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -92.66 -93.74 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.113 0.483 . . . . 7.07 111.07 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -164.49 124.31 1.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.424 -0.584 . . . . 6.68 109.424 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -63.6 118.48 8.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 6.43 110.499 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.418 HG12 HD22 ' A' ' 113' ' ' ASN . 29.6 m -116.08 160.14 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.16 0.505 . . . . 3.7 111.629 -177.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.7 p -119.22 140.19 50.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.607 -0.724 . . . . 3.49 109.884 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.76 -179.11 16.94 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.346 -0.93 . . . . 2.58 112.464 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.1 m -129.39 130.62 46.24 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.765 -0.457 . . . . 3.34 109.765 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.602 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 33.7 t -71.62 129.41 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.402 -0.363 . . . . 3.14 110.031 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.5 p -106.2 -32.57 8.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.06 0.457 . . . . 3.61 110.562 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.8 m -146.38 122.98 11.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.938 -0.573 . . . . 3.12 110.218 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -85.24 -171.2 3.5 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.911 -0.403 . . . . 4.39 109.911 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 108.911 -0.774 . . . . 3.62 108.911 172.49 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 120.877 0.37 . . . . 3.33 110.572 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.4 p -100.55 151.79 21.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.123 -0.49 . . . . 2.57 110.444 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -90.77 175.7 40.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.724 -0.75 . . . . 1.66 111.536 175.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.482 ' HD2' ' HB3' ' A' ' 119' ' ' PHE . 24.2 mmt180 -130.51 122.18 27.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.024 0.44 . . . . 3.03 111.751 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.87 134.14 63.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.474 -0.785 . . . . 1.88 109.388 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.2 t -112.39 148.67 33.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.353 -0.24 . . . . 3.49 110.353 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -159.49 167.22 29.18 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 110.084 -0.339 . . . . 3.51 110.084 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -140.06 112.67 7.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.833 -0.432 . . . . 5.1 109.833 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.418 HD22 HG12 ' A' ' 83' ' ' VAL . 60.6 t30 -168.03 154.24 7.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.827 -0.434 . . . . 4.78 109.827 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 64.35 20.99 12.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.117 0.567 . . . . 6.97 110.474 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.77 89.84 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.165 -0.54 . . . . 5.1 112.47 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -111.71 140.84 46.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.227 0.537 . . . . 5.38 111.655 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 52.5 t -140.94 101.51 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.126 -0.943 . . . . 4.72 109.797 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -151.78 169.57 21.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.617 -0.265 . . . . 4.61 110.499 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.482 ' HB3' ' HD2' ' A' ' 108' ' ' ARG . 74.9 m-85 -98.34 130.85 45.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.067 -0.515 . . . . 3.96 110.742 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 120' ' ' LEU . 5.6 mp -105.64 134.5 19.68 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.29 -0.413 . . . . 2.75 110.244 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 93.3 Cg_endo -84.01 134.33 6.08 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.745 2.297 . . . . 2.3 112.029 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -135.77 159.44 41.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.41 -0.359 . . . . 2.13 110.224 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.31 175.09 5.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.24 -0.436 . . . . 3.07 110.689 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.82 -38.46 85.51 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.08 0.467 . . . . 4.8 111.694 -174.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -85.2 -3.1 58.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.793 -0.639 . . . . 4.81 112.363 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.83 -15.23 61.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.086 0.47 . . . . 3.84 110.94 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.422 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 38.5 t -81.99 114.57 23.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.199 -0.455 . . . . 4.39 110.171 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.61 110.05 3.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 6.43 110.606 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.5 -3.18 56.29 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.722 -0.672 . . . . 5.91 112.092 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.9 t30 59.12 71.01 0.61 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.071 0.462 . . . . 6.07 110.386 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.7 t -103.46 148.47 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.958 -0.565 . . . . 5.27 110.615 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -81.54 109.1 15.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.011 -0.54 . . . . 5.78 110.496 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.3 pt? -110.9 148.86 31.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.963 -0.562 . . . . 3.62 109.603 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -136.18 124.78 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.855 -0.424 . . . . 6.93 109.855 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.602 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -51.46 123.1 9.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.105 0.479 . . . . 4.12 112.207 -173.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.65 3.66 16.07 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.409 -0.814 . . . . 4.07 111.828 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -105.64 -174.21 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.115 0.484 . . . . 4.06 110.652 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 160' ' ' ASN . 2.7 mmmm -113.53 123.19 49.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.139 -0.482 . . . . 4.17 110.858 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.12 152.02 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.994 0.426 . . . . 2.77 110.665 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 m -113.57 128.8 56.57 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.386 -0.598 . . . . 3.47 109.386 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -130.87 159.5 37.2 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.094 -0.336 . . . . 3.35 110.094 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -111.01 125.14 53.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.326 -0.397 . . . . 5.34 110.218 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.0 mt -78.6 98.54 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.286 -0.635 . . . . 4.66 109.286 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.445 ' HB2' HD23 ' A' ' 78' ' ' LEU . . . -111.88 144.11 41.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.271 -0.877 . . . . 4.85 111.236 -171.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.2 m -117.96 116.99 28.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.364 -0.38 . . . . 5.68 110.784 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.716 ' H ' HD21 ' A' ' 151' ' ' LEU . 60.9 t30 -99.25 172.62 7.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.263 -0.643 . . . . 6.25 109.263 176.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -51.44 -43.91 62.18 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.187 0.81 . . . . 8.58 113.187 -171.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -23.05 62.55 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.416 0.524 . . . . 7.86 112.416 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.59 16.44 80.74 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.539 -0.838 . . . . 5.59 112.814 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.522 ' O ' HD13 ' A' ' 151' ' ' LEU . 18.7 m120 -105.66 77.46 1.27 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 110.051 -0.352 . . . . 5.18 110.051 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.716 HD21 ' H ' ' A' ' 146' ' ' ASN . 1.6 mm? -127.11 169.64 13.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.306 -0.406 . . . . 4.28 110.546 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.36 -102.91 0.4 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.631 -0.988 . . . . 3.36 110.631 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -125.49 110.26 13.68 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.307 -0.627 . . . . 2.84 109.307 175.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 3.7 t -125.48 168.67 13.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.499 -0.319 . . . . 4.34 110.509 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 57.79 41.44 25.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.23 0.538 . . . . 5.75 110.074 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 127' ' ' VAL . 56.6 mt -68.63 118.58 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.339 -0.846 . . . . 3.55 111.277 -176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -102.89 133.64 47.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.554 -0.748 . . . . 5.96 109.363 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 161' ' ' PRO . 36.4 tp -76.86 107.68 9.35 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.722 -0.844 . . . . 4.34 108.722 175.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -83.05 -62.7 1.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.89 -0.595 . . . . 4.97 110.626 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.533 ' HB2' ' HB2' ' A' ' 138' ' ' LYS . 16.1 m120 -129.08 103.19 18.55 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.995 -0.743 . . . . 5.37 108.995 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.486 ' HB3' HD21 ' A' ' 158' ' ' LEU . 65.1 Cg_endo -71.46 158.66 53.51 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.252 1.968 . . . . 5.44 112.264 -176.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.68 0 CA-C-O 121.334 0.587 . . . . 6.1 109.993 175.163 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.813 0.339 . . . . 12.4 110.219 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -141.18 170.28 16.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.282 -0.417 . . . . 11.63 110.684 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 27.2 p -97.26 173.52 7.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.113 0.482 . . . . 9.15 111.996 -174.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' HA2' ' HG3' ' A' ' 26' ' ' GLU . . . -169.06 152.07 19.21 Favored Glycine 0 C--O 1.225 -0.414 0 CA-C-N 115.405 -0.816 . . . . 6.81 111.176 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.451 HD11 ' SG ' ' A' ' 25' ' ' CYS . 18.1 pt -100.83 147.89 7.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 117.646 0.723 . . . . 10.17 110.407 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.79 121.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.486 -0.325 . . . . 8.73 111.043 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -72.03 -56.33 5.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.552 -0.749 . . . . 10.86 110.284 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -166.09 157.23 13.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.397 -0.819 . . . . 14.06 109.013 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -115.62 116.1 27.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.326 0.584 . . . . 11.73 111.33 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 2.8 mm? -98.3 -178.93 4.19 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.965 -1.124 . . . . 11.36 107.965 173.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 18' ' ' SER . 2.9 t60 -90.02 124.84 35.11 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.001 -0.74 . . . . 15.94 109.001 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 17' ' ' HIS . 68.7 m 81.35 -21.52 0.31 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.255 0.972 . . . . 13.01 112.399 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.442 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 50.4 p90 -150.01 156.68 42.13 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.104 -0.373 . . . . 12.34 111.062 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.36 178.27 21.66 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.667 -0.573 . . . . 7.52 111.667 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -119.34 146.36 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.03 0.415 . . . . 9.24 111.443 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.4 mt -108.33 134.71 49.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.631 -0.713 . . . . 7.75 109.798 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.411 ' HB2' HG13 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -85.1 144.77 28.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.651 0.739 . . . . 11.8 111.667 -175.64 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -80.68 2.83 24.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.573 -1.194 . . . . 12.34 113.065 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.451 ' SG ' HD11 ' A' ' 11' ' ' ILE . 69.1 m -52.85 -31.59 40.07 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.612 0.244 . . . . 13.33 111.3 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.424 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 17.0 mm-40 -84.37 -39.36 19.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.409 -0.36 . . . . 11.9 111.106 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.22 148.46 28.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.994 -0.373 . . . . 12.99 109.994 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.416 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 6.7 pt20 -70.8 68.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.936 0.717 . . . . 16.66 112.936 -174.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -169.75 139.24 1.94 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.9 -0.591 . . . . 12.09 110.132 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 5.5 ptp180 -107.33 118.37 36.54 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.488 -0.56 . . . . 12.51 109.488 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.46 150.08 29.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.842 0.353 . . . . 8.76 111.052 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -110.65 133.71 53.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.032 -0.729 . . . . 9.15 109.032 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -125.21 143.64 50.84 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.145 -0.317 . . . . 6.85 110.145 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -94.14 155.09 17.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.477 -0.564 . . . . 9.99 109.477 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -69.23 -9.22 52.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.899 0.38 . . . . 9.93 111.583 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -80.57 -13.33 59.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.055 0.455 . . . . 12.28 109.777 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -116.44 35.81 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.922 -0.581 . . . . 10.62 111.486 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -119.01 124.94 48.21 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.062 -0.347 . . . . 8.78 110.062 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 t -94.76 94.96 8.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.066 0.46 . . . . 8.97 110.25 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.86 -169.71 26.03 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.054 -0.593 . . . . 9.98 111.738 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -87.8 120.34 29.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.286 -0.264 . . . . 12.43 110.286 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -66.56 -20.77 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.236 0.541 . . . . 11.58 110.954 -176.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.04 -24.56 66.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.914 -0.584 . . . . 14.73 110.583 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -92.91 2.95 56.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.835 -0.621 . . . . 13.3 110.453 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -102.54 129.93 49.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.636 -0.711 . . . . 10.07 109.417 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.38 177.22 8.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.529 -0.305 . . . . 13.13 110.768 -175.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 47' ' ' ILE . 4.0 mp -80.05 141.03 15.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.537 -0.302 . . . . 11.74 110.187 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.53 10.57 85.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.091 -0.576 . . . . 10.13 111.767 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.9 134.47 21.48 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.583 -0.309 . . . . 8.39 110.194 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.507 ' HB2' HD12 ' A' ' 72' ' ' ILE . 90.4 Cg_endo -81.99 128.82 5.93 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.594 2.196 . . . . 7.28 113.653 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.0 m -120.65 167.99 13.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.448 -0.796 . . . . 4.74 109.779 175.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 4.7 pt-20 -120.17 124.48 45.85 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.258 -0.645 . . . . 7.09 109.258 174.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -131.27 147.8 52.62 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 122.165 0.983 . . . . 7.82 112.278 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 30.6 tt0 -100.29 122.13 42.59 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.003 -1.453 . . . . 11.59 108.448 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.93 118.08 36.26 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.243 -0.183 . . . . 12.41 110.726 -173.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.5 p -141.94 153.49 44.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.161 0.505 . . . . 13.17 111.459 -176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -96.8 108.52 21.2 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.13 -0.693 . . . . 16.21 109.13 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.57 111.13 18.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.062 0.458 . . . . 16.64 110.928 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -81.18 -7.08 59.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.966 -0.561 . . . . 22.64 111.706 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -67.99 -46.56 70.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.033 -0.729 . . . . 21.43 109.033 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.4 p -93.78 -31.33 14.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.179 -0.918 . . . . 17.4 110.9 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.33 28.46 17.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.679 -0.772 . . . . 16.7 111.905 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -133.41 152.91 80.1 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 110.132 -0.321 . . . . 14.73 110.132 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.06 125.88 6.77 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.322 2.015 . . . . 12.6 110.763 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -137.43 172.51 14.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.748 0.785 . . . . 11.73 112.749 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.69 149.76 24.12 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.753 -1.112 . . . . 8.91 108.028 170.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.499 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 8.6 t -69.39 -151.07 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.329 0.585 . . . . 9.83 110.547 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -75.79 26.7 0.11 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.524 0.564 . . . . 11.32 112.524 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.405 ' H ' ' C ' ' A' ' 67' ' ' SER . 38.5 t 21.58 96.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.959 1.304 . . . . 6.11 113.632 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.3 t -88.55 154.32 20.44 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.777 -0.647 . . . . 6.12 110.22 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -96.64 123.58 40.37 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.001 -0.545 . . . . 6.3 109.877 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.507 HD12 ' HB2' ' A' ' 50' ' ' PRO . 63.8 mt . . . . . 0 C--O 1.236 0.371 0 O-C-N 124.0 0.812 . . . . 5.77 111.386 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.436 HG12 ' HB1' ' A' ' 144' ' ' ALA . 3.9 t . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 120.547 0.213 . . . . 6.19 110.624 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 38.9 t -77.64 103.56 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 6.26 109.749 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.19 41.57 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.624 -0.716 . . . . 6.05 110.493 -174.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 71.1 m -156.18 33.15 0.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.951 -0.568 . . . . 7.02 110.853 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 145' ' ' THR . 6.1 mm-40 -83.22 62.99 6.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.228 -0.442 . . . . 7.07 110.466 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 68.81 112.72 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.192 -1.367 . . . . 6.68 111.463 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -77.71 81.95 4.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.616 0.722 . . . . 6.43 109.927 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.3 m -77.42 168.95 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.715 -0.675 . . . . 3.7 110.974 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.44 ' HB ' ' HE3' ' A' ' 138' ' ' LYS . 46.8 p -116.45 150.26 38.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.819 -0.628 . . . . 3.49 109.83 175.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.29 153.88 20.78 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.425 -0.893 . . . . 2.58 111.713 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -107.03 126.4 52.28 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.289 -0.634 . . . . 3.34 109.289 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 21.4 t -70.56 110.87 3.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.4 -0.363 . . . . 3.14 110.784 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.3 p -98.24 -13.26 20.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.698 0.761 . . . . 3.61 110.172 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 26.7 m -155.34 115.93 3.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.118 -0.946 . . . . 3.12 109.381 -175.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 135' ' ' ALA . 0.3 OUTLIER -104.62 148.8 26.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 4.39 111.102 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 108.335 -0.987 . . . . 3.62 108.335 174.636 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 121.366 0.603 . . . . 3.33 109.708 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t -97.34 135.98 38.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.27 -0.423 . . . . 2.57 110.193 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.445 ' HA3' ' CE1' ' A' ' 122' ' ' TYR . . . -75.41 -177.54 41.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.632 -0.794 . . . . 1.66 112.048 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.617 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -146.27 120.85 9.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.102 0.477 . . . . 3.03 110.164 -177.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -111.56 130.38 65.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.853 -0.612 . . . . 1.88 110.209 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.7 t -105.31 124.46 49.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.032 -0.531 . . . . 3.49 109.625 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -140.84 146.83 38.07 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.388 -0.597 . . . . 3.51 109.388 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.38 112.0 18.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.152 0.501 . . . . 5.1 110.802 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.71 121.89 46.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.568 -0.742 . . . . 4.78 109.936 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 60.57 23.82 13.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.502 -0.772 . . . . 6.97 111.06 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.25 -2.01 65.18 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.911 -0.661 . . . . 5.1 113.171 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.84 121.71 41.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.241 0.521 . . . . 5.38 110.559 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.4 p -102.47 113.15 26.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.117 -0.492 . . . . 4.72 110.754 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -118.51 147.03 44.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.291 -0.413 . . . . 4.61 110.377 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -101.63 126.84 48.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 3.96 109.648 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.9 118.54 55.95 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.586 -0.279 . . . . 2.75 110.93 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.82 132.68 14.6 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.691 2.261 . . . . 2.3 110.712 168.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CE1' ' HA3' ' A' ' 107' ' ' GLY . 35.0 p90 -140.95 159.78 41.48 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.932 -0.307 . . . . 2.13 110.54 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 64.7 p -121.02 -175.62 3.09 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.012 -0.54 . . . . 3.07 110.009 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -62.89 -30.13 71.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.351 . . . . 4.8 111.655 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.01 -9.38 59.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.07 -0.514 . . . . 4.81 111.202 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -91.17 -12.44 35.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.28 0.562 . . . . 3.84 110.309 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.2 t -85.81 126.82 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.002 -0.545 . . . . 4.39 110.152 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -80.92 127.93 33.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.229 -0.441 . . . . 6.43 109.973 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.24 -0.23 87.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.808 -0.711 . . . . 5.91 112.838 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 59.6 35.98 22.62 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.139 0.495 . . . . 6.07 111.087 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.87 137.19 23.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.145 -0.479 . . . . 5.27 111.249 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -80.74 112.62 18.29 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.694 -0.484 . . . . 5.78 109.694 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.68 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -102.9 150.9 23.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.055 -0.52 . . . . 3.62 111.536 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -115.46 135.57 53.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.689 -0.687 . . . . 6.93 110.044 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.597 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -60.91 114.39 3.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.258 0.551 . . . . 4.12 110.815 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.06 -3.92 14.11 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.517 -0.765 . . . . 4.07 112.874 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.497 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . 16.5 p30 -90.78 -177.35 4.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.442 0.621 . . . . 4.06 110.18 173.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HE3' ' HB ' ' A' ' 84' ' ' THR . 50.9 tptt -112.95 113.55 25.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.061 0.458 . . . . 4.17 110.874 -174.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.9 m -117.82 154.28 19.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.84 -0.618 . . . . 2.77 110.515 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.5 t -124.18 135.88 53.78 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.395 -0.594 . . . . 3.47 109.395 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.44 146.33 52.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.164 -0.471 . . . . 3.35 110.129 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -93.8 118.92 32.09 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.792 -0.64 . . . . 5.34 109.704 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 93.8 mt -78.4 133.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.646 -0.501 . . . . 4.66 109.646 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -125.81 110.7 14.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.992 -0.549 . . . . 4.85 110.322 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.468 ' H ' ' HG3' ' A' ' 80' ' ' GLU . 20.0 m -99.01 132.09 44.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.962 0.411 . . . . 5.68 110.895 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -107.27 -163.8 0.93 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.845 -0.616 . . . . 6.25 110.935 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -75.71 -37.94 59.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.969 -0.559 . . . . 8.58 110.651 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -74.94 -18.42 60.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.384 -0.371 . . . . 7.86 110.794 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.98 22.78 54.4 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.839 -0.696 . . . . 5.59 111.801 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -113.96 121.53 44.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.462 0.173 . . . . 5.18 110.585 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.504 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -148.9 -179.32 6.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.006 0.432 . . . . 4.28 111.659 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.23 -124.81 1.64 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.635 -0.986 . . . . 3.36 110.635 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -138.72 117.11 11.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.832 0.316 . . . . 2.84 110.378 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 4.7 t -128.59 158.48 38.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.446 -0.343 . . . . 4.34 110.08 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 57.43 42.95 23.85 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.741 0.65 . . . . 5.75 110.953 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 22.3 mt -74.6 116.29 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.329 -0.85 . . . . 3.55 110.666 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -114.2 142.02 46.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 5.96 110.901 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.1 tp -83.41 119.21 24.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.927 -0.578 . . . . 4.34 110.125 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -87.64 -53.74 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.744 0.307 . . . . 4.97 110.581 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -142.92 122.94 7.89 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.918 0.389 . . . . 5.37 110.9 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 137' ' ' ASP . 82.3 Cg_endo -79.78 157.36 24.42 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.787 2.325 . . . . 5.44 112.59 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 115.804 -0.634 . . . . 6.1 110.696 178.931 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.445 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 15.0 ptt180 . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 120.935 0.398 . . . . 12.4 110.604 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.527 ' HB2' ' NH1' ' A' ' 27' ' ' ARG . 38.3 mt-10 -130.91 155.67 46.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.031 -0.531 . . . . 11.63 109.633 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -87.48 169.57 12.1 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.178 -0.465 . . . . 9.15 110.291 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.23 162.97 34.68 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.55 -0.833 . . . . 6.81 111.999 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -117.64 137.0 53.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.407 -0.59 . . . . 10.17 109.407 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.75 110.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.149 0.5 . . . . 8.73 110.471 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -72.09 -50.53 27.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.77 -0.65 . . . . 10.86 110.37 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.547 ' HA ' HD12 ' A' ' 47' ' ' ILE . 38.1 ttpt -161.04 155.17 22.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.899 -1.046 . . . . 14.06 109.098 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 mt -116.15 126.76 54.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.156 0.503 . . . . 11.73 111.183 -175.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.4 mp -114.57 -179.89 3.76 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.649 -1.241 . . . . 11.36 107.649 173.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -90.62 126.64 36.02 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.182 -0.607 . . . . 15.94 110.27 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 m 80.56 -14.58 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.605 1.191 . . . . 13.01 111.995 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 12.5 p90 -159.59 162.31 35.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.764 0.316 . . . . 12.34 111.389 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.24 -176.78 27.82 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.085 -0.579 . . . . 7.52 112.054 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -115.94 143.92 44.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.823 0.344 . . . . 9.24 111.475 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.9 mt -113.79 120.19 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.856 -0.611 . . . . 7.75 110.075 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -69.48 147.04 51.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.476 0.655 . . . . 11.8 111.809 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.404 ' HA ' ' HG3' ' A' ' 27' ' ' ARG . 3.2 p -79.89 0.57 30.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.842 -1.072 . . . . 12.34 112.299 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 m -53.24 -31.32 42.83 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.662 0.616 . . . . 13.33 112.662 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -105.53 11.27 32.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.712 0.291 . . . . 11.9 111.431 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.527 ' NH1' ' HB2' ' A' ' 8' ' ' GLU . 7.5 ptm85 -153.95 -170.24 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.524 0.202 . . . . 12.99 111.326 -173.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -112.14 17.81 19.22 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.15 0.426 . . . . 16.66 112.15 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.81 149.17 17.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.524 -0.307 . . . . 12.09 110.885 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -92.86 135.69 33.91 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.177 -0.675 . . . . 12.51 109.177 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.1 mt -135.82 163.23 30.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.355 0.597 . . . . 8.76 111.904 -174.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -124.08 149.2 46.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.447 -0.946 . . . . 9.15 108.447 172.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -135.36 152.15 51.17 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.941 -0.304 . . . . 6.85 110.248 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 10.9 p80 -109.71 152.4 25.67 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.689 -0.485 . . . . 9.99 109.689 175.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -70.2 4.52 2.15 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.252 0.834 . . . . 9.93 113.252 -168.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 t -77.78 -17.78 57.14 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.725 -0.472 . . . . 12.28 109.725 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -116.66 40.46 2.92 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.863 -0.608 . . . . 10.62 112.114 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -126.59 124.91 41.04 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.203 -0.599 . . . . 8.78 111.331 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 m -101.92 106.68 17.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.662 -0.699 . . . . 8.97 110.707 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.57 176.08 19.2 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.722 -0.751 . . . . 9.98 112.023 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -68.67 109.65 3.9 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.703 -0.481 . . . . 12.43 109.703 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -63.68 -25.05 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.166 0.508 . . . . 11.58 110.8 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.39 -23.19 62.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.126 -0.488 . . . . 14.73 110.745 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -93.42 2.96 56.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 13.3 110.949 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.441 HD12 ' OD1' ' A' ' 49' ' ' ASP . 26.3 tp -94.43 117.03 29.5 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.698 -0.853 . . . . 10.07 108.698 176.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -119.19 -173.9 2.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.523 -0.308 . . . . 13.13 110.849 -173.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 14' ' ' LYS . 24.6 mm -87.55 133.03 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.76 -0.459 . . . . 11.74 109.76 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.73 10.85 82.62 Favored Glycine 0 CA--C 1.51 -0.235 0 N-CA-C 110.922 -0.871 . . . . 10.13 110.922 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.441 ' OD1' HD12 ' A' ' 45' ' ' LEU . 43.4 t0 -92.97 121.73 65.16 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.838 -0.681 . . . . 8.39 109.906 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.62 143.21 18.79 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.102 2.535 . . . . 7.28 114.058 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.0 m -138.75 160.71 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.667 -0.697 . . . . 4.74 110.413 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -117.74 130.53 56.37 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.807 -0.442 . . . . 7.09 109.807 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -142.35 155.57 45.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.443 0.639 . . . . 7.82 111.245 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 21.1 mt-10 -104.53 131.53 51.82 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.46 -0.791 . . . . 11.59 109.075 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.7 ttt -103.87 123.11 46.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.557 -0.292 . . . . 12.41 110.944 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.0 p -141.97 169.76 16.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.923 0.392 . . . . 13.17 111.124 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 53.1 m-85 -116.9 120.7 39.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.564 -0.532 . . . . 16.21 109.564 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.53 ' OD2' HG22 ' A' ' 61' ' ' THR . 21.4 t70 -81.99 121.43 26.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.724 0.297 . . . . 16.64 110.38 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -79.86 -6.97 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 22.64 112.267 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -84.04 -57.66 3.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.601 0.238 . . . . 21.43 110.702 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.599 HG23 ' HG2' ' A' ' 63' ' ' LYS . 8.8 t -91.62 -19.26 22.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.116 0.484 . . . . 17.4 110.774 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.86 34.16 22.39 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.457 -0.878 . . . . 16.7 113.365 172.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.599 ' HG2' HG23 ' A' ' 61' ' ' THR . 19.2 ptpt -124.74 150.05 64.36 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 117.485 0.643 . . . . 14.73 110.963 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.495 ' HB3' ' CE1' ' A' ' 57' ' ' TYR . 58.4 Cg_endo -73.43 126.66 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.398 2.065 . . . . 12.6 110.913 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.29 -179.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.286 0.565 . . . . 11.73 111.252 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.0 162.96 19.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.445 -0.798 . . . . 8.91 109.842 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 30.4 t -72.87 -164.03 0.15 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.706 -0.679 . . . . 9.83 109.576 175.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -74.11 17.34 0.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.833 0.679 . . . . 11.32 112.833 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.2 t 37.88 93.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.149 0.98 . . . . 6.11 112.602 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.2 t -82.13 123.06 28.63 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.354 -0.609 . . . . 6.12 109.354 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -73.76 121.65 21.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.329 -0.619 . . . . 6.3 109.329 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.4 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.481 -0.781 . . . . 5.77 111.639 -174.525 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.435 HG12 ' HB1' ' A' ' 144' ' ' ALA . 19.5 t . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.448 -0.575 . . . . 6.19 109.448 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 26.6 t -78.65 83.87 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.062 0.458 . . . . 6.26 110.541 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.584 HD12 ' HB2' ' A' ' 144' ' ' ALA . 3.6 tp -82.74 17.26 1.9 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.694 -0.684 . . . . 6.05 110.61 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 m -133.69 36.93 3.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.506 0.558 . . . . 7.02 112.506 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.14 -51.17 11.45 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.373 -0.531 . . . . 7.07 110.334 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -167.43 139.5 3.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 6.68 110.032 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.483 ' HD3' ' C ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -96.1 114.46 26.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.545 -0.539 . . . . 6.43 109.545 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.88 171.0 12.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.694 -0.684 . . . . 3.7 110.112 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.9 p -108.4 148.44 30.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.333 -0.618 . . . . 3.49 109.333 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -114.04 137.41 14.07 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.429 -0.891 . . . . 2.58 112.311 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -120.0 112.1 18.74 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.115 -0.698 . . . . 3.34 109.115 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.672 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 59.1 t -66.83 127.63 28.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.161 -0.472 . . . . 3.14 110.483 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.1 p -109.07 -20.0 13.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.135 0.493 . . . . 3.61 111.092 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.7 m -148.98 124.99 10.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.462 -0.57 . . . . 3.12 109.462 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.86 -179.1 7.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.033 0.444 . . . . 4.39 110.869 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.0 mt . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.824 -0.626 . . . . 3.62 109.506 175.237 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 121.395 0.617 . . . . 3.33 110.055 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 56.9 p -98.56 137.2 37.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.435 -0.802 . . . . 2.57 111.537 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -86.39 -169.06 45.54 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.059 -0.816 . . . . 1.66 111.059 173.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -128.3 120.81 27.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.982 0.42 . . . . 3.03 111.226 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.437 HG12 HG22 ' A' ' 87' ' ' VAL . 80.0 mt -110.95 125.09 68.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.599 -0.728 . . . . 1.88 109.341 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.7 t -104.25 142.1 35.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.984 0.421 . . . . 3.49 110.681 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -147.44 165.58 29.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.456 -0.942 . . . . 3.51 108.456 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.96 125.21 27.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.386 -0.598 . . . . 5.1 109.386 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -135.27 107.75 7.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 4.78 110.938 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 62.64 28.66 16.71 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.749 -0.66 . . . . 6.97 111.906 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.34 -1.57 62.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.162 -0.542 . . . . 5.1 112.996 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 118' ' ' PHE . 42.3 mt-10 -104.65 110.81 23.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.1 0.476 . . . . 5.38 110.365 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 45.5 t -112.39 127.44 56.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.883 -0.599 . . . . 4.72 109.872 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 116' ' ' GLU . 73.3 m-85 -135.37 166.95 21.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 4.61 111.013 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -110.26 123.96 50.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.562 -0.744 . . . . 3.96 109.593 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 8.4 mp -104.48 132.88 20.54 Favored Pre-proline 0 C--N 1.322 -0.607 0 C-N-CA 121.069 -0.252 . . . . 2.75 110.492 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 2.8 Cg_exo -75.37 133.16 15.73 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.741 2.294 . . . . 2.3 111.664 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.436 ' CD1' HG13 ' A' ' 109' ' ' ILE . 17.6 p90 -135.16 144.81 47.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.679 -0.237 . . . . 2.13 110.483 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.4 p -109.18 -177.62 3.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.109 -0.33 . . . . 3.07 110.109 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -70.6 -22.4 62.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.236 0.541 . . . . 4.8 110.725 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.25 -25.93 52.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.488 -0.778 . . . . 4.81 110.975 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 153' ' ' ALA . 21.7 m-20 -74.26 -30.55 62.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.027 -0.533 . . . . 3.84 111.795 -175.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 156' ' ' ILE . 2.5 p -84.59 118.63 32.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.651 0.739 . . . . 4.39 111.052 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -89.92 136.22 33.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.347 -0.842 . . . . 6.43 109.769 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.34 -19.85 38.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.772 -0.728 . . . . 5.91 111.848 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.4 t30 60.09 71.01 0.59 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.383 0.611 . . . . 6.07 110.904 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 t -108.12 149.43 11.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.117 -0.492 . . . . 5.27 110.122 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -91.7 102.03 14.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.002 0.43 . . . . 5.78 110.155 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.609 HD23 ' H ' ' A' ' 133' ' ' LEU . 1.8 pt? -114.97 143.44 45.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.593 -0.731 . . . . 3.62 110.267 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -117.62 -179.99 3.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 6.93 109.913 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.672 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.81 132.46 42.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.314 -0.403 . . . . 4.12 110.47 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 104.95 -14.44 48.95 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.068 -0.587 . . . . 4.07 112.444 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.517 ' OD2' ' HB3' ' A' ' 162' ' ' ALA . 54.3 m-20 -84.77 146.45 27.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.466 -0.568 . . . . 4.06 109.466 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -93.5 116.47 29.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.588 0.709 . . . . 4.17 111.778 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.412 HG11 HD13 ' A' ' 133' ' ' LEU . 33.1 m -120.22 166.31 14.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.974 -1.012 . . . . 2.77 110.311 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.604 ' HB3' ' OE1' ' A' ' 159' ' ' GLU . 21.0 p -118.96 133.27 55.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.755 -0.461 . . . . 3.47 109.755 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -135.12 142.52 46.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.774 -0.454 . . . . 3.35 109.774 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' A' ' 142' ' ' GLN . 12.3 mm-40 -98.26 129.33 44.98 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.838 -0.619 . . . . 5.34 110.057 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.41 98.62 2.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.067 -0.716 . . . . 4.66 109.067 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.667 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -102.72 110.07 21.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.148 -0.933 . . . . 4.85 111.599 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.45 122.35 26.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.93 -0.577 . . . . 5.68 110.459 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.1 p30 -86.38 -172.42 4.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.057 0.456 . . . . 6.25 110.803 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -83.54 6.54 20.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.957 -0.565 . . . . 8.58 111.574 -172.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -115.28 1.66 13.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.353 -0.385 . . . . 7.86 110.935 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.79 20.75 70.2 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.768 -0.73 . . . . 5.59 113.294 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -123.99 154.97 39.05 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 5.18 109.127 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.484 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -156.07 176.43 12.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.225 0.536 . . . . 4.28 111.822 -178.135 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.59 -138.9 3.0 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.351 -1.1 . . . . 3.36 110.351 174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 126' ' ' ASP . . . -121.97 109.0 14.06 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.582 -0.525 . . . . 2.84 109.582 175.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.17 162.7 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.505 -0.316 . . . . 4.34 110.535 -175.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 60.53 33.81 20.45 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.552 0.691 . . . . 5.75 110.043 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 127' ' ' VAL . 70.8 mt -59.84 123.33 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.7 -1.136 . . . . 3.55 110.95 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -124.13 127.55 47.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.9 0.381 . . . . 5.96 110.606 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.46 96.72 2.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 4.34 109.692 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.604 ' OE1' ' HB3' ' A' ' 140' ' ' SER . 6.6 pt-20 -76.86 -35.68 57.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 4.97 110.916 -176.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -137.56 102.26 8.76 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.499 -0.319 . . . . 5.37 110.699 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.23 151.71 49.31 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.523 2.149 . . . . 5.44 112.223 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.517 ' HB3' ' OD2' ' A' ' 137' ' ' ASP . . . . . . . . 0 C--N 1.317 -0.814 0 CA-C-O 121.462 0.649 . . . . 6.1 110.549 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.404 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 10.6 ptp180 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.344 0.592 . . . . 12.4 109.798 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.37 156.23 21.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.551 -0.75 . . . . 11.63 110.652 -173.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.1 p -110.52 136.75 49.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.414 -0.357 . . . . 9.15 111.007 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.96 178.21 25.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 6.81 111.909 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 25' ' ' CYS . 52.9 mt -124.56 143.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.842 0.321 . . . . 10.17 110.249 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.3 mm -73.58 106.59 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.438 -0.579 . . . . 8.73 109.438 174.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -73.41 -43.92 59.44 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.966 0.412 . . . . 10.86 110.504 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -155.75 162.59 40.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.005 -0.543 . . . . 14.06 109.563 -176.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 mt -119.82 118.63 31.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.171 0.51 . . . . 11.73 111.071 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -111.82 179.99 3.86 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.328 -0.99 . . . . 11.36 108.328 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -90.2 117.31 28.86 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.749 -0.781 . . . . 15.94 110.151 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.6 m 78.71 -7.55 1.77 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.06 -0.973 . . . . 13.01 112.442 178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.69 168.57 26.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.718 0.294 . . . . 12.34 110.886 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.68 -166.61 22.82 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.187 -0.53 . . . . 7.52 112.068 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -125.99 139.51 53.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 9.24 110.945 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.0 mt -101.77 120.36 51.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 7.75 109.574 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -75.92 143.02 41.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.559 -0.746 . . . . 11.8 110.993 -175.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -79.14 3.1 18.64 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.353 -0.839 . . . . 12.34 112.631 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.413 ' HB3' HD12 ' A' ' 11' ' ' ILE . 44.0 t -51.43 -51.26 56.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.506 0.558 . . . . 13.33 112.506 -173.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -90.46 16.94 7.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.289 0.566 . . . . 11.9 111.01 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.567 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 38.6 ttt180 -144.83 -158.63 0.91 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.041 -1.096 . . . . 12.99 108.041 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.567 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 13.4 mm-40 -136.22 23.58 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.189 0.518 . . . . 16.66 110.413 167.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' O ' ' HD3' ' A' ' 27' ' ' ARG . . . -151.8 119.53 6.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.664 -0.698 . . . . 12.09 110.633 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -86.63 151.71 23.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.147 -0.479 . . . . 12.51 110.112 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.507 HD11 ' SD ' ' A' ' 55' ' ' MET . 59.6 mt -141.77 162.17 36.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 8.76 111.423 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -103.6 143.41 32.79 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.664 -0.865 . . . . 9.15 108.664 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -137.93 147.62 44.51 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.269 -0.572 . . . . 6.85 110.179 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -103.41 155.11 18.73 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.368 -0.604 . . . . 9.99 109.368 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -67.25 -13.27 61.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.697 0.284 . . . . 9.93 111.37 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 p -70.78 -24.17 62.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.537 . . . . 12.28 110.148 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -94.1 20.53 7.83 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.642 -0.708 . . . . 10.62 110.995 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -125.03 123.17 39.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.932 0.396 . . . . 8.78 110.705 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 68' ' ' GLN . 13.3 t -111.51 100.8 9.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.72 -0.673 . . . . 8.97 110.218 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.77 -169.78 36.53 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.968 -0.634 . . . . 9.98 111.915 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -83.89 103.68 13.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 12.43 110.323 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.9 tp -67.62 -24.18 30.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.943 -0.571 . . . . 11.58 110.918 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.79 -12.78 61.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 14.73 111.023 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -104.25 4.5 33.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 13.3 110.202 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.9 tp -103.79 110.14 22.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.485 . . . . 10.07 110.701 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -114.11 -178.87 3.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.221 0.534 . . . . 13.13 110.935 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.3 mp -73.08 140.19 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.601 -0.727 . . . . 11.74 110.208 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.84 -2.19 66.37 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 121.013 -0.613 . . . . 10.13 112.378 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.71 127.98 48.03 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 120.58 0.229 . . . . 8.39 110.608 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.76 141.7 13.73 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.194 2.596 . . . . 7.28 113.632 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.412 HG12 ' HE3' ' A' ' 71' ' ' LYS . 23.7 m -128.57 157.93 40.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.799 -0.637 . . . . 4.74 111.186 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -113.17 124.06 51.67 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.997 -0.742 . . . . 7.09 108.997 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -136.87 142.13 42.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.286 0.565 . . . . 7.82 111.614 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.538 ' CD ' ' HB2' ' A' ' 67' ' ' SER . 0.2 OUTLIER -88.88 141.29 28.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.009 -0.737 . . . . 11.59 109.009 173.282 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' ' 31' ' ' LEU . 24.5 ttt -124.0 114.01 19.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.35 -0.241 . . . . 12.41 110.35 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.5 p -134.99 164.67 27.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.153 0.501 . . . . 13.17 111.425 -177.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -95.31 113.4 25.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.025 -0.534 . . . . 16.21 110.083 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.97 124.08 26.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.032 0.444 . . . . 16.64 110.469 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -79.72 -8.87 59.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.684 -0.689 . . . . 22.64 111.266 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -81.0 -56.87 3.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 21.43 110.357 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.5 p -86.65 -45.84 10.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.169 -0.469 . . . . 17.4 111.645 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.0 0.22 35.85 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.626 -0.797 . . . . 16.7 112.322 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -95.87 150.78 37.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.152 -0.314 . . . . 14.73 110.152 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.15 125.29 8.45 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.953 1.769 . . . . 12.6 109.502 171.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -126.94 162.4 31.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.04 0.447 . . . . 11.73 111.362 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.54 151.62 20.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.405 -0.816 . . . . 8.91 109.284 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.538 ' HB2' ' CD ' ' A' ' 54' ' ' GLU . 11.8 t -75.88 -157.22 0.07 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.041 -0.527 . . . . 9.83 109.79 177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 39' ' ' SER . 23.6 mp0 -75.12 19.23 0.16 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.838 0.681 . . . . 11.32 112.838 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.0 t 33.83 94.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.537 1.135 . . . . 6.11 113.108 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.8 m -80.36 120.73 24.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.461 0.648 . . . . 6.12 110.358 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.686 ' HE2' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -68.1 113.48 5.8 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.664 -0.698 . . . . 6.3 110.537 -179.038 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.686 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 79.5 mt . . . . . 0 C--O 1.236 0.376 0 CA-C-N 116.175 -0.466 . . . . 5.77 110.328 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.666 0.27 . . . . 6.19 110.93 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 38.4 t -67.7 89.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 6.26 110.962 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 144' ' ' ALA . 4.1 tt -91.18 -27.95 18.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 6.05 110.781 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 t -116.37 99.86 7.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.071 -0.513 . . . . 7.02 110.68 -175.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -125.21 -68.15 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.514 -0.767 . . . . 7.07 109.017 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -130.69 127.88 39.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.181 -0.674 . . . . 6.68 109.181 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.457 ' H ' ' CD ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -82.98 126.39 32.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.964 0.411 . . . . 6.43 110.151 -177.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.39 167.4 13.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.093 -0.503 . . . . 3.7 111.117 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 p -120.75 146.23 46.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.809 -0.632 . . . . 3.49 110.327 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.39 162.61 26.5 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.6 -0.81 . . . . 2.58 112.382 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.5 m -106.61 135.24 48.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.826 -0.435 . . . . 3.34 109.826 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 1.1 t -68.98 121.56 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.863 -0.421 . . . . 3.14 109.863 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -27.82 16.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.146 0.498 . . . . 3.61 110.227 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.5 m -155.29 138.01 15.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.003 -0.544 . . . . 3.12 110.407 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -99.85 -171.8 2.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.339 0.59 . . . . 4.39 111.568 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 91' ' ' LEU . 2.5 mm? . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 114.95 -1.023 . . . . 3.62 109.22 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.968 -0.382 . . . . 3.33 109.968 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 t -130.52 143.67 50.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.914 0.388 . . . . 2.57 110.3 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.74 -168.34 39.58 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.727 -0.749 . . . . 1.66 111.881 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.52 ' NH2' ' HB3' ' A' ' 121' ' ' PRO . 1.1 mmp_? -136.29 130.33 32.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.844 0.354 . . . . 3.03 110.746 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.6 mt -112.53 126.99 69.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.228 -0.656 . . . . 1.88 109.228 171.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 p -108.18 123.19 48.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.439 -0.346 . . . . 3.49 110.608 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.36 156.9 47.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.763 -0.458 . . . . 3.51 109.763 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 116' ' ' GLU . 3.5 tm-20 -132.35 120.86 22.64 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.339 -0.615 . . . . 5.1 109.339 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.773 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 8.6 t30 -130.74 106.48 8.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.199 -0.455 . . . . 4.78 110.724 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 57.94 38.19 26.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.024 -0.535 . . . . 6.97 111.64 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.59 -5.67 64.72 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.983 -0.627 . . . . 5.1 114.091 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.773 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 11.7 pt-20 -95.01 124.6 39.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 118.071 0.935 . . . . 5.38 109.733 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 44.1 t -124.24 104.46 8.83 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.518 -0.549 . . . . 4.72 109.518 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.23 152.71 32.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 4.61 110.979 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -102.65 117.55 34.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.776 -0.824 . . . . 3.96 108.776 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.19 127.64 29.31 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.817 0.341 . . . . 2.75 110.622 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.52 ' HB3' ' NH2' ' A' ' 108' ' ' ARG . 58.7 Cg_endo -76.18 135.88 17.46 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.547 2.165 . . . . 2.3 111.906 175.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -148.73 159.95 43.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.996 -0.742 . . . . 2.13 108.996 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.7 p -116.45 171.9 7.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.921 0.391 . . . . 3.07 110.294 175.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -63.93 -21.98 66.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.443 0.64 . . . . 4.8 110.484 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.4 -4.11 58.16 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.606 -0.724 . . . . 4.81 111.88 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -90.76 -9.54 46.24 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.712 0.291 . . . . 3.84 111.417 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 p -102.73 133.02 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.218 0.532 . . . . 4.39 111.335 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -94.45 144.86 25.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.948 -0.569 . . . . 6.43 110.24 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.33 -14.12 23.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.908 -0.663 . . . . 5.91 112.998 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 62.3 t30 53.89 50.86 15.92 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.653 0.74 . . . . 6.07 110.139 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.83 156.48 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.515 -0.766 . . . . 5.27 110.424 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -84.84 120.72 26.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.814 0.34 . . . . 5.78 111.632 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.42 136.72 44.45 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.69 -0.855 . . . . 3.62 108.69 173.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -142.62 157.5 44.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.741 -0.384 . . . . 6.93 110.561 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.543 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -58.66 120.28 8.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.869 0.366 . . . . 4.12 111.121 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.27 -17.4 10.51 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.668 -0.777 . . . . 4.07 113.487 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -92.45 175.47 6.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.017 0.908 . . . . 4.06 109.967 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -119.15 118.81 32.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.353 0.597 . . . . 4.17 111.17 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.2 m -117.18 160.79 16.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.586 -0.734 . . . . 2.77 111.339 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.3 t -117.14 131.74 56.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.051 -0.722 . . . . 3.47 109.051 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -134.31 155.42 50.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.823 0.344 . . . . 3.35 110.46 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -109.15 140.86 42.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.032 0.444 . . . . 5.34 110.292 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.6 mt -110.72 110.1 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.896 -0.593 . . . . 4.66 110.589 -174.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -87.39 107.17 18.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.033 0.444 . . . . 4.85 111.083 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 28.3 m -96.26 117.02 29.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.699 -0.682 . . . . 5.68 111.777 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -85.97 164.21 17.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.423 -0.584 . . . . 6.25 109.423 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.47 -27.95 62.93 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.698 0.399 . . . . 8.58 111.191 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -71.14 -13.53 61.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.08 -0.509 . . . . 7.86 111.704 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.65 22.3 62.27 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.689 -0.767 . . . . 5.59 111.967 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -105.47 124.06 48.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.832 -0.433 . . . . 5.18 109.832 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.477 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.43 168.87 23.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.963 0.411 . . . . 4.28 112.065 -177.652 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.78 -168.27 16.57 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.763 -0.935 . . . . 3.36 110.763 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.31 116.73 33.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.122 0.461 . . . . 2.84 110.852 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.3 t -140.46 158.5 43.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.519 -0.549 . . . . 4.34 109.519 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 58.2 65.72 1.23 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.294 0.569 . . . . 5.75 110.554 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 mp -89.16 138.5 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.432 -0.804 . . . . 3.55 110.53 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -126.09 129.36 48.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.872 -0.604 . . . . 5.96 110.278 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 161' ' ' PRO . 55.6 tp -82.69 110.98 18.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.982 -0.377 . . . . 4.34 109.982 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.07 -48.25 6.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 4.97 111.261 -176.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -128.19 100.13 23.83 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.806 0.336 . . . . 5.37 110.945 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.468 ' HB3' HD21 ' A' ' 158' ' ' LEU . 69.0 Cg_endo -87.2 151.28 8.08 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.013 2.475 . . . . 5.44 111.913 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.787 0 CA-C-O 120.964 0.411 . . . . 6.1 110.474 178.657 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 . . . . . 0 C--O 1.234 0.276 0 N-CA-C 109.278 -0.638 . . . . 12.4 109.278 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.644 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.9 pt-20 -156.82 148.93 22.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.667 0.746 . . . . 11.63 112.293 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 11.8 p -116.67 162.15 18.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.226 -0.897 . . . . 9.15 110.968 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.56 -176.21 36.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.155 -0.545 . . . . 6.81 111.992 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.2 mt -121.35 142.53 37.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.156 -0.683 . . . . 10.17 109.156 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.3 mm -65.87 117.99 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 117.843 0.292 . . . . 8.73 110.223 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -84.21 -49.73 8.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.76 -0.655 . . . . 10.86 110.427 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -151.47 145.9 25.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.376 -0.829 . . . . 14.06 110.324 -177.504 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.6 mt -117.58 110.51 18.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.218 0.532 . . . . 11.73 110.842 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.2 mt -108.35 -177.82 3.43 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.085 -0.961 . . . . 11.36 108.727 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -87.28 122.3 30.87 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.246 -0.582 . . . . 15.94 109.874 -174.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.2 m 83.1 -20.31 0.34 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.671 1.232 . . . . 13.01 112.102 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 32.3 p90 -147.19 143.51 28.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.028 0.442 . . . . 12.34 111.678 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.2 164.63 22.15 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.69 -0.686 . . . . 7.52 111.632 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -117.5 145.34 44.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.012 0.434 . . . . 9.24 111.369 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.3 mt -111.49 132.86 58.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.496 -0.775 . . . . 7.75 110.287 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.96 145.88 37.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.505 0.669 . . . . 11.8 111.401 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.0 p -79.51 3.97 17.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.894 -1.048 . . . . 12.34 112.639 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.4 m -51.14 -30.41 16.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.59 0.589 . . . . 13.33 112.59 -174.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 9' ' ' THR . 32.7 mm-40 -109.91 6.68 23.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.6 0.238 . . . . 11.9 111.523 -176.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 10.5 tpt180 -143.71 -176.75 5.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.8 0.333 . . . . 12.99 111.062 -171.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 81.9 mm-40 -104.09 12.97 33.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.435 0.636 . . . . 16.66 109.963 176.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.97 140.42 16.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.219 -0.901 . . . . 12.09 110.499 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -96.43 120.27 36.43 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.338 -0.616 . . . . 12.51 109.338 171.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.4 mt -102.5 162.96 12.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.379 0.609 . . . . 8.76 111.883 -173.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -125.22 145.31 50.04 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.064 -0.971 . . . . 9.15 109.346 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -142.7 149.48 38.88 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.555 -0.535 . . . . 6.85 109.555 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 8.8 p-80 -99.78 165.51 11.55 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.267 -0.573 . . . . 9.99 109.919 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -66.3 -2.41 4.39 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.845 0.683 . . . . 9.93 112.845 -169.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 m -79.28 -17.87 53.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.945 0.402 . . . . 12.28 110.531 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.449 ' HB3' ' O ' ' A' ' 67' ' ' SER . 26.0 mp0 -111.61 39.68 2.29 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.306 -0.407 . . . . 10.62 111.419 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -125.97 130.19 50.72 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.503 -0.479 . . . . 8.78 110.123 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 m -84.44 109.91 18.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 8.97 111.025 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.88 -157.63 15.07 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.636 -0.793 . . . . 9.98 112.607 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -90.07 133.2 34.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.788 0.328 . . . . 12.43 110.988 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -72.42 -11.25 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.416 0.627 . . . . 11.58 109.911 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.34 -29.42 68.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.164 -0.925 . . . . 14.73 111.79 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -106.11 14.08 28.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 13.3 111.817 -175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 tp -97.81 128.38 44.4 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.42 -0.512 . . . . 10.07 109.92 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -118.27 163.5 16.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.206 0.527 . . . . 13.13 110.455 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.28 122.9 24.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.269 -1.011 . . . . 11.74 108.269 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.82 -8.44 29.74 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.691 -0.766 . . . . 10.13 112.377 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.54 130.24 90.79 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.818 0.309 . . . . 8.39 110.167 176.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.39 122.62 5.68 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.697 2.264 . . . . 7.28 111.688 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.15 151.85 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.44 0.638 . . . . 4.74 111.746 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -111.17 125.73 54.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.921 -1.036 . . . . 7.09 109.045 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.644 ' CE2' ' HG3' ' A' ' 8' ' ' GLU . 33.2 p90 -131.75 179.35 6.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.405 0.621 . . . . 7.82 111.246 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 25.9 tt0 -148.51 104.29 3.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.432 -0.804 . . . . 11.59 109.074 -170.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.0 ttt -84.16 128.79 34.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.38 -0.373 . . . . 12.41 111.154 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -145.44 164.72 30.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.243 -0.435 . . . . 13.17 110.672 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -107.6 110.75 22.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.57 -0.286 . . . . 16.21 110.755 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.515 ' OD2' HG22 ' A' ' 61' ' ' THR . 16.6 t70 -79.15 109.81 13.81 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.825 -0.435 . . . . 16.64 109.825 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -69.61 -15.41 63.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.473 -0.785 . . . . 22.64 111.819 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.464 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 40.1 ttm105 -76.97 -54.01 7.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.713 0.292 . . . . 21.43 110.839 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.515 HG22 ' OD2' ' A' ' 58' ' ' ASP . 9.1 t -85.64 -35.03 21.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.18 -0.463 . . . . 17.4 111.059 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.07 30.77 9.78 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.878 -0.677 . . . . 16.7 113.762 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HG2' HG23 ' A' ' 61' ' ' THR . 16.8 ptpt -135.6 148.45 65.72 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 117.357 0.578 . . . . 14.73 110.022 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.82 126.89 11.06 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.088 1.859 . . . . 12.6 110.944 176.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.31 167.53 25.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.085 0.469 . . . . 11.73 111.303 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.23 159.91 15.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.058 -0.719 . . . . 8.91 109.058 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 9.1 t -70.91 -166.05 0.14 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.914 -0.402 . . . . 9.83 109.914 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -75.64 22.69 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.495 0.924 . . . . 11.32 113.495 -170.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t 34.24 98.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.141 1.164 . . . . 6.11 114.141 171.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.2 t -105.52 138.07 42.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.262 -0.644 . . . . 6.12 109.262 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -73.84 144.28 45.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.372 -0.603 . . . . 6.3 109.372 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 120.887 0.375 . . . . 5.77 111.037 -175.304 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.447 HG12 ' HB1' ' A' ' 144' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 110.318 -0.253 . . . . 6.19 110.318 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 43.8 t -70.35 105.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.923 0.392 . . . . 6.26 111.369 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 144' ' ' ALA . 36.5 mt -97.08 5.59 50.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.49 . . . . 6.05 111.705 -178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.7 t -149.16 100.73 3.07 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.528 -0.469 . . . . 7.02 111.434 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -132.69 -66.95 0.66 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.811 -0.811 . . . . 7.07 108.811 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -165.5 148.32 7.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.126 -0.943 . . . . 6.68 108.831 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -82.59 102.02 11.15 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.711 -0.478 . . . . 6.43 109.711 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 m -77.34 156.94 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.114 -0.493 . . . . 3.7 110.335 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.8 p -123.16 141.77 51.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.065 -0.516 . . . . 3.49 110.493 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.99 169.36 25.34 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.018 -0.611 . . . . 2.58 111.644 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.2 m -103.94 130.32 51.55 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.583 -0.525 . . . . 3.34 109.583 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 2.1 t -68.87 121.37 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 109.236 -0.653 . . . . 3.14 109.236 176.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.1 p -91.63 -24.71 19.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.34 0.59 . . . . 3.61 110.553 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.6 m -151.77 125.58 9.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.391 -0.822 . . . . 3.12 109.123 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.59 172.66 6.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.307 0.575 . . . . 4.39 112.079 -172.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.0 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.054 -0.975 . . . . 3.62 110.354 177.889 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.219 0.533 . . . . 3.33 110.128 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.7 p -106.2 134.63 49.03 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.773 -0.649 . . . . 2.57 111.007 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -78.61 174.25 55.17 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.465 -0.874 . . . . 1.66 110.988 175.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -125.56 123.72 39.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.244 0.522 . . . . 3.03 111.502 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -111.3 129.1 67.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.971 -0.752 . . . . 1.88 108.971 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 118' ' ' PHE . 9.4 t -116.07 132.95 56.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.178 0.513 . . . . 3.49 110.931 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -143.81 155.95 44.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.946 -0.761 . . . . 3.51 108.946 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -109.02 137.12 47.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.793 0.33 . . . . 5.1 110.144 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -158.64 130.21 6.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.267 -0.424 . . . . 4.78 111.475 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 57.09 29.98 17.46 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.231 0.539 . . . . 6.97 112.121 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.33 -14.12 65.95 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.618 -0.719 . . . . 5.1 112.598 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -102.95 135.86 43.84 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.824 0.345 . . . . 5.38 110.811 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 12.1 p -107.6 111.73 24.11 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.114 -0.494 . . . . 4.72 109.69 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 110' ' ' SER . 88.5 m-85 -101.11 153.76 19.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.217 0.532 . . . . 4.61 111.961 -173.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -119.5 113.49 20.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.686 -0.857 . . . . 3.96 108.686 172.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.49 136.13 19.27 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.298 -0.41 . . . . 2.75 111.007 -172.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -77.32 132.9 12.81 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.733 2.289 . . . . 2.3 111.953 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -135.63 143.79 45.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.055 0.455 . . . . 2.13 110.035 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.8 p -114.25 -179.01 3.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.574 -0.528 . . . . 3.07 109.574 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -16.98 59.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.039 0.447 . . . . 4.8 110.769 178.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -84.03 -10.89 57.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.797 -0.638 . . . . 4.81 111.053 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -88.28 -21.05 24.67 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.758 0.313 . . . . 3.84 111.385 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -96.8 111.61 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.467 0.651 . . . . 4.39 110.918 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -89.87 129.37 36.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.561 -0.745 . . . . 6.43 110.115 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 128.22 -15.68 6.1 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.58 -0.737 . . . . 5.91 111.359 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.2 m120 57.95 46.6 16.33 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 122.978 0.511 . . . . 6.07 110.755 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.4 p -112.01 152.99 13.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.042 -0.527 . . . . 5.27 110.808 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -87.95 115.4 25.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 5.78 110.667 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.3 pt? -114.82 142.83 46.02 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.738 -0.467 . . . . 3.62 109.738 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.07 175.2 11.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.335 -0.546 . . . . 6.93 111.474 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.552 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -65.66 122.81 18.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.317 -0.401 . . . . 4.12 111.77 -177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 120.09 -29.69 5.9 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.836 -0.697 . . . . 4.07 113.265 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.61 166.96 11.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.576 0.688 . . . . 4.06 110.281 173.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -113.23 128.14 56.38 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.789 0.804 . . . . 4.17 111.245 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.32 152.6 19.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.593 -1.185 . . . . 2.77 110.796 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.3 m -106.35 137.48 44.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.813 -0.631 . . . . 3.47 109.675 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -142.6 149.57 39.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.809 0.338 . . . . 3.35 110.365 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.58 112.44 24.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.994 -0.373 . . . . 5.34 109.994 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 66.4 mt -79.06 111.69 16.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.974 -0.557 . . . . 4.66 110.141 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.674 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -89.71 107.31 19.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.143 -0.688 . . . . 4.85 109.143 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.64 117.61 24.64 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.203 0.525 . . . . 5.68 111.352 -174.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -82.63 154.4 24.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.451 -0.795 . . . . 6.25 108.9 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -62.36 -29.04 70.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.439 0.638 . . . . 8.58 109.63 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -69.92 -19.7 63.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.122 -0.945 . . . . 7.86 110.511 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.21 12.5 83.14 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.796 -0.638 . . . . 5.59 112.43 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -106.62 119.49 39.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.197 -0.668 . . . . 5.18 109.197 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.438 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -148.88 -177.81 6.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.645 -0.252 . . . . 4.28 111.537 -177.332 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.57 -173.73 16.18 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.393 -0.683 . . . . 3.36 111.393 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.44 111.43 23.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.864 0.332 . . . . 2.84 110.423 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 6.2 t -127.09 165.15 20.06 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 110.042 -0.355 . . . . 4.34 110.042 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 59.05 36.08 24.16 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.0 -0.545 . . . . 5.75 110.424 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.78 142.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.363 -0.835 . . . . 3.55 110.758 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -149.22 142.24 24.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.7 0.286 . . . . 5.96 110.904 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.2 tp -76.75 106.48 8.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 4.34 110.054 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -103.31 -35.19 8.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.122 -0.49 . . . . 4.97 111.805 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -132.13 90.4 35.03 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.965 -0.294 . . . . 5.37 110.852 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.55 156.55 28.4 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.559 2.173 . . . . 5.44 111.742 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.245 0.545 . . . . 6.1 111.037 -179.811 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 109.831 -0.433 . . . . 12.4 109.831 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -119.45 148.78 42.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.648 -0.705 . . . . 11.63 111.164 -166.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.3 p -102.89 144.22 31.48 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.918 -0.583 . . . . 9.15 111.707 -174.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.19 176.57 29.62 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.371 -0.692 . . . . 6.81 111.371 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.0 mt -127.06 140.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.659 -0.497 . . . . 10.17 109.659 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.7 mm -66.15 126.04 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 121.206 -0.198 . . . . 8.73 110.491 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -87.0 -51.45 6.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.37 0.605 . . . . 10.86 111.258 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -157.92 131.77 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.086 -0.709 . . . . 14.06 109.086 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.11 105.56 17.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.546 0.689 . . . . 11.73 111.362 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.66 179.4 4.43 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.302 -0.999 . . . . 11.36 108.302 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -91.4 136.3 33.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.756 -0.378 . . . . 15.94 110.71 -177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t 76.75 -33.32 0.2 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.263 -0.881 . . . . 13.01 111.742 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -139.7 152.37 46.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.64 0.257 . . . . 12.34 111.24 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.8 168.76 23.49 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.636 -0.793 . . . . 7.52 112.418 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -116.89 140.8 49.03 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.914 0.388 . . . . 9.24 111.203 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.3 mt -111.59 130.51 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.905 -0.589 . . . . 7.75 110.462 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -72.98 138.46 46.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.445 0.64 . . . . 11.8 111.985 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.1 p -79.53 1.55 25.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.062 -0.972 . . . . 12.34 111.412 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -55.77 -30.06 60.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.298 -0.41 . . . . 13.33 111.776 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -113.89 -11.94 12.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.106 0.479 . . . . 11.9 111.259 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.745 HH11 ' HB3' ' A' ' 29' ' ' ALA . 3.9 tmt_? -137.52 137.56 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.692 -0.855 . . . . 12.99 108.692 -175.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -68.32 42.79 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.427 0.899 . . . . 16.66 113.427 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.745 ' HB3' HH11 ' A' ' 27' ' ' ARG . . . 177.2 133.98 0.06 Allowed 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 123.406 0.682 . . . . 12.09 110.12 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.511 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 6.6 ppt_? -86.27 141.31 29.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.147 -0.686 . . . . 12.51 109.147 171.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 47.1 mt -133.25 162.43 31.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.953 0.406 . . . . 8.76 111.486 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -114.9 141.87 47.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.128 -0.942 . . . . 9.15 108.506 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -136.21 145.3 45.53 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.455 -0.498 . . . . 6.85 110.733 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -84.53 141.44 30.73 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.919 -0.771 . . . . 9.99 108.919 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -63.87 -17.48 63.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.637 0.256 . . . . 9.93 111.481 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -70.6 -13.51 62.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.51 -0.314 . . . . 12.28 110.697 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -103.47 1.11 31.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.564 -0.289 . . . . 10.62 111.235 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -85.04 114.86 22.51 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.698 -0.401 . . . . 8.78 110.121 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.8 t -81.91 91.3 6.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.241 -0.436 . . . . 8.97 110.474 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.39 -175.02 26.06 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.637 -0.585 . . . . 9.98 111.637 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -79.14 123.85 27.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.698 -0.482 . . . . 12.43 109.698 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tp -65.24 -24.96 36.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.176 0.513 . . . . 11.58 111.094 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.22 -0.91 26.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.166 0.508 . . . . 14.73 111.168 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -103.39 10.1 37.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 13.3 109.672 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 tp -112.82 129.24 56.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.714 -0.676 . . . . 10.07 110.008 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -119.64 168.95 10.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.336 0.589 . . . . 13.13 111.099 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.6 mp -73.37 114.78 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.089 -0.505 . . . . 11.74 109.742 174.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.14 9.43 22.19 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.474 -0.87 . . . . 10.13 112.012 -175.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.29 133.08 71.99 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.245 -0.279 . . . . 8.39 110.245 175.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -85.58 109.88 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.941 2.428 . . . . 7.28 111.644 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.93 151.6 16.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.888 -0.596 . . . . 4.74 111.255 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -110.32 130.03 55.63 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.19 -0.67 . . . . 7.09 109.19 173.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.09 178.04 7.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.349 0.595 . . . . 7.82 111.014 -174.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 32.9 tt0 -142.65 105.08 4.47 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.468 -0.938 . . . . 11.59 108.468 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.3 ttt -83.15 124.29 30.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.767 0.318 . . . . 12.41 111.077 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.2 p -141.19 161.25 38.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.313 -0.403 . . . . 13.17 110.697 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -97.6 121.5 39.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.39 -0.368 . . . . 16.21 110.078 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' A' ' 60' ' ' ARG . 16.6 t70 -74.76 120.08 19.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.182 0.515 . . . . 16.64 110.312 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -79.85 -5.79 56.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.648 -0.705 . . . . 22.64 112.197 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.404 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . 2.4 mpt_? -79.77 -70.41 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.212 0.529 . . . . 21.43 110.641 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 t -101.71 -4.38 26.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 17.4 111.203 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.58 33.0 35.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.079 -0.582 . . . . 16.7 113.451 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -110.02 131.3 22.05 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.725 -0.279 . . . . 14.73 110.335 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.6 125.59 10.74 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.734 1.623 . . . . 12.6 110.028 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.69 179.54 2.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.455 0.645 . . . . 11.73 111.989 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.19 148.41 29.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.442 -0.799 . . . . 8.91 109.886 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 10.3 t -74.62 -150.38 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 9.83 111.48 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 2.1 mp0 -68.97 30.12 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.853 1.057 . . . . 11.32 113.853 -175.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.412 ' H ' ' C ' ' A' ' 67' ' ' SER . 39.8 t 0.0 101.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.228 1.411 . . . . 6.11 113.514 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -109.53 134.38 51.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.855 -0.338 . . . . 6.12 110.747 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -68.68 139.71 55.43 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.743 -0.465 . . . . 6.3 109.743 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.6 mt . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 121.228 0.537 . . . . 5.77 111.84 -172.914 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.614 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.906 0.384 . . . . 6.19 110.154 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 4.5 m -94.46 121.84 45.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.873 -0.603 . . . . 6.26 111.08 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.429 ' O ' HD23 ' A' ' 78' ' ' LEU . 2.2 tt -67.08 -27.54 67.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.586 -0.733 . . . . 6.05 109.859 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -131.29 103.56 6.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.188 -0.46 . . . . 7.02 111.238 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.96 -87.69 0.15 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.215 -0.661 . . . . 7.07 109.215 173.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.433 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 6.2 pt-20 -90.73 71.68 6.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.761 0.791 . . . . 6.68 110.353 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.468 ' HD3' ' H ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -68.53 137.64 54.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.442 -0.799 . . . . 6.43 109.935 177.773 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 m -140.39 170.42 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.037 0.446 . . . . 3.7 111.119 -174.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 p -115.7 139.88 49.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.768 -0.651 . . . . 3.49 109.689 175.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.7 155.18 20.0 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.032 -1.08 . . . . 2.58 112.878 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 m -111.04 127.0 55.4 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.388 -0.597 . . . . 3.34 109.388 175.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.573 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 57.3 t -69.21 120.63 17.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.217 -0.29 . . . . 3.14 110.217 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.5 p -107.47 -17.82 14.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.134 0.492 . . . . 3.61 111.113 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.7 m -150.78 131.29 13.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.38 -0.6 . . . . 3.12 109.38 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.77 -175.11 2.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.249 0.547 . . . . 4.39 111.296 -176.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.729 . . . . 3.62 109.675 179.915 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 120.988 0.423 . . . . 3.33 109.87 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.75 118.91 25.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.943 0.402 . . . . 2.57 110.793 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.74 175.23 47.48 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.832 -0.699 . . . . 1.66 112.689 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 108' ' ' ARG . 48.5 mmt-85 -132.47 126.72 33.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.862 0.363 . . . . 3.03 110.442 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.3 mt -111.64 126.49 69.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.052 -0.522 . . . . 1.88 109.82 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 118' ' ' PHE . 12.0 t -103.62 125.46 50.15 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.603 -0.517 . . . . 3.49 109.603 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 4.1 p90 -134.06 155.58 49.78 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.323 -0.621 . . . . 3.51 109.323 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.16 119.56 37.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.983 0.42 . . . . 5.1 110.137 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -142.99 133.08 24.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.496 -0.775 . . . . 4.78 108.988 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 63.48 21.27 12.68 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.647 0.592 . . . . 6.97 111.042 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.05 21.15 59.57 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.96 -0.564 . . . . 5.1 112.446 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -132.83 135.47 45.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.675 0.274 . . . . 5.38 110.68 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 4.0 p -111.82 116.41 30.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.316 -0.402 . . . . 4.72 110.662 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 110' ' ' SER . 81.5 m-85 -114.59 172.77 6.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 4.61 110.898 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -114.75 120.01 38.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.831 -0.622 . . . . 3.96 110.058 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.8 mt -106.28 135.16 19.51 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.818 -0.628 . . . . 2.75 111.737 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.02 138.75 18.62 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.952 2.435 . . . . 2.3 111.872 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -150.35 160.29 43.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.997 0.427 . . . . 2.13 110.888 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.0 p -123.31 175.01 6.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.302 -0.863 . . . . 3.07 109.66 175.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -66.02 -23.39 66.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.548 0.69 . . . . 4.8 109.99 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.5 -20.47 62.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.443 -0.799 . . . . 4.81 111.42 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -87.95 -2.63 58.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.09 -0.504 . . . . 3.84 110.671 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.16 137.61 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.258 -0.428 . . . . 4.39 111.516 -174.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -82.29 124.32 29.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.933 -0.576 . . . . 6.43 109.978 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.37 9.28 85.9 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.901 -0.666 . . . . 5.91 112.472 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.7 p30 47.08 29.27 1.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.14 0.976 . . . . 6.07 112.699 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.77 150.11 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.203 -0.453 . . . . 5.27 110.631 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -80.42 130.92 35.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.991 -0.55 . . . . 5.78 110.95 -175.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 mp -99.27 149.04 23.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.897 -0.592 . . . . 3.62 110.338 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -134.82 129.99 35.36 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.594 -0.521 . . . . 6.93 109.594 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.573 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -63.77 130.76 45.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.807 -0.633 . . . . 4.12 110.966 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.04 -23.09 10.13 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.519 -0.764 . . . . 4.07 112.307 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.09 177.42 5.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.101 0.477 . . . . 4.06 111.401 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -106.77 131.3 54.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.878 -0.601 . . . . 4.17 111.583 -170.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.25 165.95 18.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.213 -0.449 . . . . 2.77 110.326 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.1 m -129.71 127.93 41.46 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.816 -0.439 . . . . 3.47 109.816 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -128.99 150.21 50.5 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.963 -0.384 . . . . 3.35 109.963 -177.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -96.95 120.26 36.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.996 0.427 . . . . 5.34 110.113 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 59.2 mt -79.3 107.62 11.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.784 -0.644 . . . . 4.66 109.857 176.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -81.04 107.7 14.08 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.076 -0.713 . . . . 4.85 109.076 174.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 19.8 m -92.49 103.08 15.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.71 -0.677 . . . . 5.68 111.288 -173.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -67.91 153.63 43.31 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.566 -0.902 . . . . 6.25 108.566 170.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.65 -20.03 66.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.891 0.377 . . . . 8.58 111.339 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -72.08 -23.34 61.33 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.079 0.466 . . . . 7.86 110.531 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.22 22.91 59.9 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.533 -0.841 . . . . 5.59 112.406 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -122.58 114.29 20.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.204 -0.295 . . . . 5.18 110.204 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.485 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -146.55 -178.15 6.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.286 -0.415 . . . . 4.28 111.168 -175.155 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -122.77 -132.07 3.96 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.993 -0.843 . . . . 3.36 110.993 174.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -132.0 126.82 34.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.814 0.34 . . . . 2.84 110.277 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 80.4 m -140.35 162.44 35.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.29 -0.413 . . . . 4.34 110.664 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 57.32 53.18 7.88 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.813 0.696 . . . . 5.75 110.676 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.3 mt -82.12 115.0 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.523 -0.762 . . . . 3.55 110.097 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.414 ' HD2' HH11 ' A' ' 157' ' ' ARG . 20.9 ttt180 -114.52 129.94 56.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.785 -0.643 . . . . 5.96 110.602 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.468 HD21 ' HA ' ' A' ' 161' ' ' PRO . 50.9 tp -82.59 98.33 8.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.67 -0.696 . . . . 4.34 110.057 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -82.68 -23.66 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.076 -0.511 . . . . 4.97 111.084 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -133.59 102.43 12.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 5.37 110.065 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.468 ' HA ' HD21 ' A' ' 158' ' ' LEU . 71.8 Cg_endo -79.03 154.32 25.56 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.562 2.175 . . . . 5.44 112.738 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.854 -0.612 . . . . 6.1 111.744 -175.771 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.759 0.314 . . . . 12.4 111.021 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.65 172.68 12.44 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.79 -0.641 . . . . 11.63 109.88 -176.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.0 p -112.9 167.36 10.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.988 0.423 . . . . 9.15 111.534 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.6 172.65 37.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 116.19 -0.459 . . . . 6.81 112.189 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.0 mt -117.04 133.67 63.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.015 -0.365 . . . . 10.17 110.015 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.3 118.09 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.949 0.404 . . . . 8.73 110.585 176.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.52 -56.24 9.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.39 -0.823 . . . . 10.86 110.46 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -156.03 141.08 17.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.205 -0.907 . . . . 14.06 108.765 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.3 mt -98.2 103.16 15.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.268 0.556 . . . . 11.73 110.712 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 3.0 mm? -95.37 -179.77 4.89 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.034 -0.985 . . . . 11.36 108.412 173.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -90.68 123.11 34.03 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.518 -0.473 . . . . 15.94 110.022 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t 82.6 -27.86 0.11 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.453 1.095 . . . . 13.01 111.773 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 19.4 p90 -135.64 147.8 48.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.806 0.336 . . . . 12.34 111.304 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -139.89 162.85 26.3 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-N 116.055 -0.52 . . . . 7.52 111.87 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -118.38 146.89 44.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.821 0.31 . . . . 9.24 111.313 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.5 mt -121.34 128.16 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.301 -0.409 . . . . 7.75 110.535 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -76.85 146.0 38.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.202 0.525 . . . . 11.8 111.575 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.402 ' HB3' ' N ' ' A' ' 30' ' ' ARG . 6.5 p -79.82 -0.02 32.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.246 -0.888 . . . . 12.34 112.888 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.7 t -53.52 -31.32 45.73 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.85 0.685 . . . . 13.33 112.85 -173.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.97 -5.92 43.58 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.871 0.367 . . . . 11.9 111.889 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.517 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 12.0 ttt180 -131.66 -160.66 1.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.532 -0.303 . . . . 12.99 110.203 -173.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.517 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 78.0 mt-30 -118.66 14.93 13.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.379 0.609 . . . . 16.66 110.218 176.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.41 138.45 5.34 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.312 -0.858 . . . . 12.09 110.213 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.402 ' N ' ' HB3' ' A' ' 24' ' ' CYS . 6.6 ptp180 -85.62 151.02 24.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.424 -0.584 . . . . 12.51 109.424 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -138.86 162.52 34.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.026 0.441 . . . . 8.76 110.887 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.38 142.24 51.48 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.951 -0.759 . . . . 9.15 108.951 173.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -128.35 147.38 50.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.001 -0.37 . . . . 6.85 110.001 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.48 ' HB2' ' OE1' ' A' ' 37' ' ' GLN . 76.3 m-70 -95.64 160.81 14.32 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.525 -0.546 . . . . 9.99 109.525 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -70.71 -4.24 22.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.816 0.341 . . . . 9.93 111.675 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -85.75 -7.39 58.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.944 -0.391 . . . . 12.28 109.944 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.48 ' OE1' ' HB2' ' A' ' 34' ' ' HIS . 23.4 mp0 -117.44 40.48 3.05 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.936 -0.575 . . . . 10.62 111.199 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -122.63 139.48 53.88 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.42 -0.512 . . . . 8.78 111.142 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.3 t -116.27 114.49 24.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.549 . . . . 8.97 110.036 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.05 -161.35 23.51 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.736 . . . . 9.98 111.823 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -83.06 108.11 16.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.215 -0.291 . . . . 12.43 110.215 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 45' ' ' LEU . 10.6 tp -68.52 -25.16 30.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.344 0.592 . . . . 11.58 110.081 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -66.68 -22.7 66.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.489 -0.778 . . . . 14.73 110.908 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.45 20.25 19.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.854 -0.612 . . . . 13.3 111.303 -173.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 45' ' ' LEU . 1.5 mt -87.2 133.97 33.59 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.021 -0.363 . . . . 10.07 110.021 175.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -127.6 167.0 16.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.462 -0.57 . . . . 13.13 109.462 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.5 mp -81.99 132.82 30.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.563 -0.532 . . . . 11.74 109.563 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.65 11.24 58.27 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.647 -0.787 . . . . 10.13 111.987 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 32.3 t70 -86.15 133.35 41.03 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.655 -0.273 . . . . 8.39 110.75 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 49' ' ' ASP . 6.6 Cg_endo -86.18 127.42 2.95 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.241 2.627 . . . . 7.28 112.638 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.9 m -125.33 160.33 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.43 . . . . 4.74 111.092 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -112.54 128.03 56.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.913 -0.585 . . . . 7.09 110.029 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -131.94 150.19 52.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.345 0.593 . . . . 7.82 111.048 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 16.4 tt0 -101.58 119.65 39.1 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.735 -0.839 . . . . 11.59 108.735 177.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 14.3 tpt -90.93 133.42 35.28 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.909 -0.404 . . . . 12.41 109.909 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.402 HG23 HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -155.91 169.81 23.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.966 0.412 . . . . 13.17 110.531 -172.795 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -126.4 109.44 12.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.742 0.305 . . . . 16.21 110.426 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -83.12 113.42 20.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.223 -0.444 . . . . 16.64 110.108 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -79.21 -10.31 59.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.36 -0.382 . . . . 22.64 111.783 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -74.34 -41.54 60.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.405 -0.591 . . . . 21.43 109.405 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.8 p -88.55 -40.81 13.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.255 -0.43 . . . . 17.4 110.817 174.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.78 31.92 11.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.906 -0.664 . . . . 16.7 112.207 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -132.59 152.92 80.83 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.056 -0.35 . . . . 14.73 110.056 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.75 125.85 10.88 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.293 1.996 . . . . 12.6 110.641 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 56' ' ' THR . 2.0 pp -138.85 153.81 25.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.537 0.684 . . . . 11.73 112.251 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.42 157.29 16.52 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.576 -0.898 . . . . 8.91 108.576 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.8 t -70.66 -162.95 0.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.006 -0.368 . . . . 9.83 110.006 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -72.77 27.13 0.06 Allowed 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 113.368 0.877 . . . . 11.32 113.368 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.3 t 32.23 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.438 1.095 . . . . 6.11 113.664 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.5 t -88.61 151.29 22.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.429 -0.805 . . . . 6.12 111.378 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -87.55 137.96 31.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.376 -0.829 . . . . 6.3 110.993 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.8 mt . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.064 -0.516 . . . . 5.77 109.873 177.864 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.428 HG12 ' HB1' ' A' ' 144' ' ' ALA . 9.2 t . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 109.497 -0.557 . . . . 6.19 109.497 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 29.0 t -80.25 97.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.067 0.395 . . . . 6.26 112.067 -171.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.474 ' CD2' ' HB2' ' A' ' 144' ' ' ALA . 22.2 mt -88.96 -30.36 18.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.525 . . . . 6.05 110.948 175.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 p -98.95 96.95 8.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.334 0.588 . . . . 7.02 111.616 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.52 -69.14 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.434 -0.803 . . . . 7.07 109.31 174.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -131.57 147.67 52.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.899 -0.591 . . . . 6.68 109.987 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.4 ptt85 -107.77 125.88 51.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.845 0.355 . . . . 6.43 110.158 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.12 158.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.066 0.46 . . . . 3.7 111.9 -173.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.8 p -118.65 140.65 49.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.39 -0.823 . . . . 3.49 109.622 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.45 170.16 24.27 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.075 -1.06 . . . . 2.58 112.615 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.5 m -115.69 135.36 54.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.528 -0.545 . . . . 3.34 109.528 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 21.9 t -67.36 115.36 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.589 -0.522 . . . . 3.14 109.589 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.05 -34.1 15.24 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.326 0.584 . . . . 3.61 110.042 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.7 m -151.26 120.75 6.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.619 -0.719 . . . . 3.12 109.613 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.74 -176.82 5.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.799 0.333 . . . . 4.39 110.465 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.515 -0.311 . . . . 3.62 110.186 178.675 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.578 0 CA-C-O 121.003 0.43 . . . . 3.33 111.845 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 m -142.55 127.84 18.76 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.198 -0.667 . . . . 2.57 109.198 173.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -94.7 176.02 34.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.582 -0.818 . . . . 1.66 112.581 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 20.3 mmt180 -133.43 132.31 40.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.643 0.259 . . . . 3.03 110.599 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.4 HG21 ' CE2' ' A' ' 141' ' ' PHE . 79.0 mt -113.94 130.66 67.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.028 -0.533 . . . . 1.88 109.584 174.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.5 p -105.86 123.0 47.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.316 -0.402 . . . . 3.49 110.389 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.686 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -140.47 152.36 45.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.817 0.341 . . . . 3.51 110.608 178.646 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.455 ' HG3' ' HB3' ' A' ' 117' ' ' CYS . 4.8 mp0 -107.31 122.48 46.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.053 0.454 . . . . 5.1 110.165 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -131.96 120.85 23.05 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.698 -0.683 . . . . 4.78 109.823 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 61.09 31.96 19.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.326 0.584 . . . . 6.97 110.861 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -20.15 50.82 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.413 -0.812 . . . . 5.1 113.395 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -99.47 136.32 39.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.672 0.273 . . . . 5.38 110.833 -175.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.455 ' HB3' ' HG3' ' A' ' 112' ' ' GLU . 7.8 p -102.51 128.3 49.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.178 -0.465 . . . . 4.72 110.572 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -128.59 164.2 23.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.323 -0.398 . . . . 4.61 110.875 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -122.85 114.37 20.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.696 -0.683 . . . . 3.96 109.595 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.686 HD11 ' CE2' ' A' ' 111' ' ' TYR . 2.5 mp -105.49 140.94 21.65 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.682 0.277 . . . . 2.75 110.878 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 94.1 Cg_endo -79.3 155.82 25.43 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.104 2.536 . . . . 2.3 112.068 175.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -163.99 163.68 23.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.9 -0.408 . . . . 2.13 109.9 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -118.76 -179.15 3.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.996 0.427 . . . . 3.07 111.154 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -71.57 -21.26 61.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.08 -0.509 . . . . 4.8 110.54 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.49 -9.73 57.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 4.81 111.238 -173.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -85.41 -25.42 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 3.84 111.7 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 p -92.49 123.05 44.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.518 0.675 . . . . 4.39 110.69 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.61 159.63 16.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.6 -0.727 . . . . 6.43 110.844 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.92 -16.44 60.95 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.852 -0.689 . . . . 5.91 112.274 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 68.94 16.26 8.8 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.917 0.487 . . . . 6.07 110.783 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 t -72.45 116.29 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 5.27 110.088 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -85.98 84.86 7.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.749 0.785 . . . . 5.78 110.706 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.608 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.2 pt? -81.44 150.71 28.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.1 -1.409 . . . . 3.62 110.761 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.559 ' HD2' ' H ' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -110.49 -179.74 3.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.219 -0.659 . . . . 6.93 109.219 177.247 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.595 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.45 131.81 41.38 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.423 -0.511 . . . . 4.12 111.05 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.53 -14.55 13.14 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.135 -0.555 . . . . 4.07 112.072 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' A' ' 161' ' ' PRO . 4.9 m-20 -81.11 154.38 26.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.633 0.254 . . . . 4.06 110.544 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 160' ' ' ASN . 13.4 mmmm -104.6 127.83 52.45 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.162 0.506 . . . . 4.17 110.372 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.7 m -130.35 160.58 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.386 -0.825 . . . . 2.77 112.382 -171.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.6 p -122.53 140.96 52.19 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.993 -1.003 . . . . 3.47 109.534 172.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.503 ' HE1' HD11 ' A' ' 143' ' ' ILE . 19.9 p90 -151.24 167.9 26.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.568 -0.287 . . . . 3.35 110.654 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -104.24 133.42 49.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.15 0.5 . . . . 5.34 110.779 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.503 HD11 ' HE1' ' A' ' 141' ' ' PHE . 34.6 mm -95.49 102.27 13.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.428 -0.805 . . . . 4.66 110.368 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -87.59 108.78 19.23 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.622 -0.431 . . . . 4.85 110.406 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 15.6 m -90.04 125.7 35.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.046 -0.524 . . . . 5.68 111.345 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -98.72 164.98 12.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.204 -1.036 . . . . 6.25 108.204 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -59.98 -24.8 64.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.943 0.497 . . . . 8.58 111.883 -174.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -70.6 -17.75 62.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 7.86 110.868 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.93 5.39 86.24 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.856 -0.688 . . . . 5.59 111.891 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -99.39 119.64 38.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.164 -0.68 . . . . 5.18 109.164 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.504 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -132.87 163.33 29.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.171 0.51 . . . . 4.28 112.23 -177.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -136.14 -173.26 12.9 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.782 -0.927 . . . . 3.36 110.782 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.7 120.88 40.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.103 0.452 . . . . 2.84 110.91 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.6 t -128.12 154.37 45.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.749 -0.463 . . . . 4.34 109.749 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 55.75 65.29 1.5 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.794 0.807 . . . . 5.75 110.266 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.5 mt -92.44 135.29 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.566 -1.197 . . . . 3.55 109.794 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -132.14 152.84 51.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.909 -0.404 . . . . 5.96 109.909 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.9 tp -101.47 123.71 45.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.176 -0.465 . . . . 4.34 110.24 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -111.59 -40.56 4.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.515 -0.311 . . . . 4.97 111.067 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASN . . . . . 0.486 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 7.7 t30 -118.95 101.11 50.47 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 110.226 -0.287 . . . . 5.37 110.226 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.412 ' HA ' ' OD1' ' A' ' 137' ' ' ASP . 82.3 Cg_endo -83.15 155.56 14.75 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.127 2.551 . . . . 5.44 113.43 -176.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.78 -0.646 . . . . 6.1 110.86 177.409 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.193 0.52 . . . . 12.4 110.033 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' CG ' ' HG3' ' A' ' 27' ' ' ARG . 35.5 tt0 -100.02 136.61 39.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.463 -0.789 . . . . 11.63 109.014 -177.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 52' ' ' GLU . 38.0 p -96.95 151.84 19.3 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.947 -0.301 . . . . 9.15 110.674 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.29 -177.5 37.75 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.913 -0.661 . . . . 6.81 111.893 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.509 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 1.2 mt -130.06 146.41 34.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.343 -0.614 . . . . 10.17 109.343 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.72 118.56 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.437 -0.579 . . . . 8.73 109.437 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -87.65 -44.72 10.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.536 -0.756 . . . . 10.86 109.37 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -149.16 154.59 39.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.217 -0.901 . . . . 14.06 110.806 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.8 mt -119.14 109.68 16.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.656 . . . . 11.73 110.169 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.401 HD13 ' CD2' ' A' ' 19' ' ' TYR . 4.6 mp -99.47 179.04 4.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.238 -1.023 . . . . 11.36 108.238 176.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -90.44 114.14 26.23 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.148 -0.621 . . . . 15.94 110.354 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 m 72.16 16.38 5.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.942 -1.026 . . . . 13.01 111.095 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.401 ' CD2' HD13 ' A' ' 16' ' ' LEU . 47.2 t80 -156.58 139.87 15.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.717 -0.674 . . . . 12.34 109.764 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' HA3' ' CE1' ' A' ' 33' ' ' PHE . . . -127.44 156.45 20.46 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.697 -0.763 . . . . 7.52 112.667 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.74 129.83 55.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.463 -0.199 . . . . 9.24 110.463 -176.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -114.22 127.55 71.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.153 -0.314 . . . . 7.75 110.153 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 9.8 pt20 -83.14 144.14 30.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.62 0.724 . . . . 11.8 111.877 -175.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 p -79.54 2.23 22.96 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 114.461 -1.245 . . . . 12.34 112.764 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.4 m -53.2 -24.46 11.03 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.803 0.668 . . . . 13.33 112.803 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -91.4 -6.95 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.977 0.362 . . . . 11.9 111.977 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HG3' ' CG ' ' A' ' 8' ' ' GLU . 9.7 mmt85 -151.33 -158.53 0.92 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.999 0.428 . . . . 12.99 110.529 -170.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.74 28.57 6.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.045 0.45 . . . . 16.66 109.996 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.48 135.22 19.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.844 -0.617 . . . . 12.09 110.699 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 16.7 ptp180 -89.39 121.76 31.95 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.658 -0.497 . . . . 12.51 109.658 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.37 155.13 23.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.172 0.51 . . . . 8.76 110.77 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -132.06 142.88 49.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.701 -0.681 . . . . 9.15 109.555 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.433 ' CE1' ' HA3' ' A' ' 20' ' ' GLY . 17.6 p90 -126.63 163.79 22.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.027 0.441 . . . . 6.85 110.416 -176.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -112.65 152.44 28.97 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.691 -0.485 . . . . 9.99 109.691 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -62.98 -21.55 66.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.316 -0.402 . . . . 9.93 111.772 -175.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.6 t -72.93 -19.82 61.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.526 -0.306 . . . . 12.28 111.09 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 1.9 mp0 -95.56 -26.24 15.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.603 -0.272 . . . . 10.62 111.41 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -68.48 112.81 5.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 8.78 110.553 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.2 t -91.56 97.22 10.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.977 -0.556 . . . . 8.97 110.195 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.6 -176.04 34.8 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.84 -0.904 . . . . 9.98 110.84 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -77.67 95.75 4.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.816 0.341 . . . . 12.43 110.176 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -60.75 -25.86 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.383 0.611 . . . . 11.58 110.514 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.38 -25.79 68.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.369 -0.832 . . . . 14.73 111.22 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -108.18 17.52 22.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.39 -0.368 . . . . 13.3 111.069 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.7 tp -97.71 125.95 42.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.009 -0.737 . . . . 10.07 109.009 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -123.4 173.88 7.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.998 -0.371 . . . . 13.13 109.998 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 47' ' ' ILE . 3.8 mp -70.97 131.78 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.968 -0.382 . . . . 11.74 109.968 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.79 2.24 58.51 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.504 -0.855 . . . . 10.13 112.276 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.0 124.61 89.58 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 110.559 -0.163 . . . . 8.39 110.559 175.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.55 132.05 7.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.788 2.326 . . . . 7.28 112.662 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.451 HG12 ' HG2' ' A' ' 71' ' ' LYS . 27.3 m -136.96 161.18 36.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.115 0.483 . . . . 4.74 111.311 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.424 ' HB3' HG22 ' A' ' 9' ' ' THR . 6.6 pt-20 -120.41 136.67 54.65 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.175 -0.676 . . . . 7.09 109.175 170.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -131.8 148.91 52.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.451 0.643 . . . . 7.82 111.214 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 35.8 tt0 -88.98 110.49 21.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.408 -0.815 . . . . 11.59 109.309 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.61 105.32 13.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.271 -0.64 . . . . 12.41 109.271 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.419 HG23 ' HG2' ' A' ' 54' ' ' GLU . 23.9 p -134.87 171.25 14.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.373 0.606 . . . . 13.17 111.987 -174.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -113.45 111.02 21.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.739 -0.664 . . . . 16.21 110.394 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -72.59 122.84 22.05 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.777 -0.453 . . . . 16.64 109.777 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -79.36 -6.74 57.46 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.666 0.617 . . . . 22.64 112.666 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -82.91 -44.54 15.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.49 . . . . 21.43 109.807 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.9 p -90.69 -28.23 18.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.832 -0.622 . . . . 17.4 111.391 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.9 29.13 61.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.113 -0.565 . . . . 16.7 111.871 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -127.37 153.73 77.17 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 110.224 -0.287 . . . . 14.73 110.224 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.77 125.47 9.47 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.051 1.834 . . . . 12.6 111.061 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -138.44 179.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.193 0.52 . . . . 11.73 111.078 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.7 139.32 50.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.724 -0.671 . . . . 8.91 109.302 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 14.7 m -70.16 -148.03 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.096 -0.502 . . . . 9.83 110.949 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 14.0 mm100 -66.74 29.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.841 1.423 . . . . 11.32 114.841 -170.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 68' ' ' GLN . 39.0 t 4.97 99.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 125.201 1.4 . . . . 6.11 113.677 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.8 m -112.15 138.02 49.41 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.981 0.419 . . . . 6.12 110.522 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.451 ' HG2' HG12 ' A' ' 51' ' ' VAL . 50.0 mtpt -70.51 142.2 51.87 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.494 -0.558 . . . . 6.3 109.494 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.3 mt . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 121.282 0.563 . . . . 5.77 110.739 -178.064 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.415 ' CG1' ' HB1' ' A' ' 144' ' ' ALA . 18.3 t . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.536 0.208 . . . . 6.19 111.09 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.07 111.6 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.493 -0.321 . . . . 6.26 110.908 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -112.16 -7.57 14.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.919 0.39 . . . . 6.05 111.507 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.8 m -85.45 28.6 0.74 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.34 0.496 . . . . 7.02 112.34 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.92 -36.78 13.26 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.585 -0.446 . . . . 7.07 111.372 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -169.13 144.65 3.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.291 0.567 . . . . 6.68 111.3 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -112.49 97.44 6.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.383 -0.826 . . . . 6.43 109.136 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.88 168.15 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.328 0.585 . . . . 3.7 111.137 -175.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -108.85 139.09 44.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.512 -0.767 . . . . 3.49 110.729 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -135.27 166.49 24.43 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.593 -0.813 . . . . 2.58 112.379 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 m -118.4 134.62 54.91 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.634 -0.506 . . . . 3.34 109.634 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 47.9 t -67.46 123.89 21.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.792 -0.447 . . . . 3.14 109.792 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.7 -24.13 12.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.196 -0.456 . . . . 3.61 111.131 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.6 m -153.09 132.44 12.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.084 -0.507 . . . . 3.12 110.11 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -92.52 -172.37 3.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.946 0.403 . . . . 4.39 110.169 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 108.711 -0.848 . . . . 3.62 108.711 172.074 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 122.153 0.978 . . . . 3.33 109.311 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.401 HG21 ' HB2' ' A' ' 121' ' ' PRO . 15.6 m -94.27 132.96 38.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.036 -0.984 . . . . 2.57 110.612 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.75 169.35 48.28 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.795 -0.717 . . . . 1.66 112.323 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -130.81 134.79 47.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.261 0.553 . . . . 3.03 111.551 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.495 HG13 ' CD1' ' A' ' 122' ' ' TYR . 97.7 mt -112.9 125.41 70.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.967 -1.015 . . . . 1.88 109.435 172.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 p -97.66 126.16 42.83 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.691 -0.485 . . . . 3.49 109.691 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -134.23 154.42 51.27 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.844 -0.428 . . . . 3.51 109.844 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -115.54 121.31 42.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.175 -0.466 . . . . 5.1 110.38 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.517 ' OD1' ' HG3' ' A' ' 114' ' ' ARG . 23.5 t-20 -160.69 143.27 12.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.464 . . . . 4.78 109.959 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.517 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 79.7 mtp180 64.48 20.77 12.27 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.464 0.478 . . . . 6.97 110.893 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.75 1.12 90.1 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.855 -0.611 . . . . 5.1 112.555 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -114.29 151.05 33.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.658 -0.497 . . . . 5.38 109.658 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.47 104.64 10.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.136 0.493 . . . . 4.72 110.435 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -104.2 169.24 8.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.757 -0.656 . . . . 4.61 111.054 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -120.27 123.15 42.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.708 -0.678 . . . . 3.96 110.173 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.51 138.19 19.44 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.536 -0.302 . . . . 2.75 110.372 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HB2' HG21 ' A' ' 106' ' ' THR . 73.3 Cg_endo -76.83 142.62 22.7 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.773 2.315 . . . . 2.3 111.827 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.495 ' CD1' HG13 ' A' ' 109' ' ' ILE . 34.5 p90 -146.35 152.27 38.85 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.086 0.469 . . . . 2.13 110.776 176.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.83 156.81 23.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.714 -0.676 . . . . 3.07 110.304 174.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -66.97 -28.15 68.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.084 0.469 . . . . 4.8 111.252 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.62 -16.18 63.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.811 -0.631 . . . . 4.81 111.38 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.05 23.93 12.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.078 -0.51 . . . . 3.84 111.242 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.08 114.71 39.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.352 0.596 . . . . 4.39 111.338 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 157' ' ' ARG . 0.6 OUTLIER -79.71 151.78 30.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.428 -0.805 . . . . 6.43 108.856 178.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.14 -16.55 42.58 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.714 -0.755 . . . . 5.91 111.47 -174.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 63.47 24.76 14.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.257 0.623 . . . . 6.07 111.445 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.61 138.17 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.362 -0.381 . . . . 5.27 109.985 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -83.01 91.84 7.25 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.737 -0.468 . . . . 5.78 109.737 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.1 pt? -71.69 144.2 49.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.633 -0.712 . . . . 3.62 110.943 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -140.69 148.96 41.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.833 -0.622 . . . . 6.93 110.33 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.645 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -49.98 124.34 9.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.124 -0.489 . . . . 4.12 112.181 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.0 -24.43 8.3 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.477 -0.783 . . . . 4.07 113.569 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -87.65 178.07 6.86 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 117.782 0.791 . . . . 4.06 110.625 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -117.18 122.77 44.96 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.461 0.648 . . . . 4.17 111.58 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.02 157.66 20.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.979 -1.01 . . . . 2.77 110.788 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.0 m -113.89 129.9 56.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.445 -0.576 . . . . 3.47 109.445 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -126.4 139.19 53.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.127 0.489 . . . . 3.35 109.734 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -94.97 116.84 29.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.588 -0.733 . . . . 5.34 109.417 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 76.4 mt -77.7 111.52 14.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.854 -0.612 . . . . 4.66 110.304 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . . . -97.43 109.04 21.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.585 -0.734 . . . . 4.85 110.658 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 88.6 m -85.43 120.86 27.36 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.455 0.472 . . . . 5.68 111.076 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -72.74 171.33 12.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.557 . . . . 6.25 110.698 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -57.92 -22.39 48.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.167 0.803 . . . . 8.58 113.167 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -111.08 -2.7 15.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.109 -0.636 . . . . 7.86 111.617 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 98.07 11.03 50.66 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.281 -0.961 . . . . 5.59 114.469 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -98.19 132.27 43.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.812 -0.81 . . . . 5.18 108.812 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.476 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -146.6 -178.24 6.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.212 0.53 . . . . 4.28 112.333 -174.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.16 -122.77 1.47 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.862 -1.063 . . . . 3.36 111.026 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.87 131.47 33.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.917 0.358 . . . . 2.84 110.389 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 74.5 m -142.65 159.53 42.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.128 -0.487 . . . . 4.34 109.738 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 57.72 54.96 5.84 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.762 0.664 . . . . 5.75 110.68 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.2 mp -82.84 114.22 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.803 -0.443 . . . . 3.55 109.803 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.45 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 34.3 ttt180 -120.14 128.76 53.72 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.99 -0.374 . . . . 5.96 109.99 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.2 tt -77.04 117.01 18.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.998 -0.546 . . . . 4.34 110.012 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -92.2 -54.82 3.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 4.97 111.015 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -122.1 106.46 36.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.068 -0.515 . . . . 5.37 110.653 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.58 -176.62 3.32 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.262 1.974 . . . . 5.44 112.069 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.994 -0.548 . . . . 6.1 110.186 178.868 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 109.814 -0.439 . . . . 12.4 109.814 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.428 ' CD ' ' HB2' ' A' ' 55' ' ' MET . 7.5 pt-20 -121.41 138.04 54.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.191 0.519 . . . . 11.63 111.056 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.0 p -109.11 160.89 15.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.031 -0.531 . . . . 9.15 111.562 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.73 174.28 42.11 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.001 -0.839 . . . . 6.81 111.001 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.9 mt -109.87 144.94 17.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.767 0.283 . . . . 10.17 110.393 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.402 HD11 HG11 ' A' ' 51' ' ' VAL . 45.9 mm -66.33 114.35 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.284 -0.265 . . . . 8.73 110.284 174.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.21 -55.17 5.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 10.86 111.49 -176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.595 ' HD3' ' N ' ' A' ' 15' ' ' LEU . 8.2 tmtt? -159.39 136.47 9.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.729 -0.471 . . . . 14.06 109.729 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.595 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 72.7 mt -93.62 117.17 29.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.311 0.577 . . . . 11.73 111.492 178.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.17 -178.57 3.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.876 -1.157 . . . . 11.36 107.876 172.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -88.26 130.61 35.05 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.082 -0.647 . . . . 15.94 109.696 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m 75.28 -44.24 0.53 Allowed 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.303 1.002 . . . . 13.01 112.016 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -121.87 148.85 44.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.131 0.491 . . . . 12.34 111.417 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -139.89 169.86 24.5 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.478 -0.649 . . . . 7.52 111.478 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -121.86 144.53 48.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.057 0.456 . . . . 9.24 111.608 -177.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -105.83 129.92 58.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.655 -0.702 . . . . 7.75 109.695 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.512 ' HG3' ' H ' ' A' ' 25' ' ' CYS . 13.8 tp60 -77.07 132.77 39.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.928 -0.578 . . . . 11.8 111.27 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.593 ' HB3' ' N ' ' A' ' 30' ' ' ARG . 6.5 p -84.94 0.62 50.6 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.348 0.87 . . . . 12.34 113.348 175.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.512 ' H ' ' HG3' ' A' ' 23' ' ' GLN . 68.4 m -60.74 -22.93 64.54 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.675 0.991 . . . . 13.33 113.675 -168.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -102.59 -29.47 11.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.347 0.594 . . . . 11.9 110.435 -178.765 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.535 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 12.6 ttp85 -105.61 -157.69 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.447 -0.797 . . . . 12.99 110.088 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.535 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 44.4 mt-30 -123.37 21.34 9.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 16.66 110.744 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.13 115.38 5.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.787 0.327 . . . . 12.09 111.847 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.593 ' N ' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -87.03 141.59 28.56 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.873 -0.788 . . . . 12.51 108.873 172.504 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.9 mt -138.37 162.39 34.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.662 0.267 . . . . 8.76 110.95 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -113.19 148.56 35.2 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.515 -0.55 . . . . 9.15 109.515 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -145.39 159.4 43.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.511 -0.551 . . . . 6.85 109.511 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -106.75 162.78 13.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.439 -0.578 . . . . 9.99 109.439 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.52 -19.12 65.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.938 0.399 . . . . 9.93 110.508 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.7 p -76.91 -15.32 59.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.031 -0.531 . . . . 12.28 110.729 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -102.06 20.69 16.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.389 -0.369 . . . . 10.62 110.789 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -123.02 108.11 12.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.222 0.534 . . . . 8.78 109.717 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' A' ' 68' ' ' GLN . 51.1 m -94.44 104.33 16.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.711 -0.677 . . . . 8.97 111.052 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.37 -165.84 35.07 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.48 -1.048 . . . . 9.98 110.48 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -94.21 119.34 32.87 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 117.347 0.573 . . . . 12.43 109.904 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.81 -20.66 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 11.58 111.067 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.65 -3.99 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 14.73 111.355 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -118.41 21.87 12.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.073 0.464 . . . . 13.3 109.89 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -125.88 112.34 15.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.205 -0.665 . . . . 10.07 109.205 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -120.05 178.58 4.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.255 0.55 . . . . 13.13 111.298 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.51 130.73 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.383 -0.826 . . . . 11.74 109.363 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.12 10.9 61.97 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.41 -0.9 . . . . 10.13 110.991 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -89.06 123.52 67.15 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.137 -0.531 . . . . 8.39 110.05 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.51 126.6 11.69 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.661 2.241 . . . . 7.28 112.539 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.422 HG12 ' CD ' ' A' ' 71' ' ' LYS . 28.0 m -125.51 151.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 4.74 111.389 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.33 129.8 56.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.222 -0.658 . . . . 7.09 109.222 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -144.61 175.56 10.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.249 0.547 . . . . 7.82 111.357 -175.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -123.48 138.44 54.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.604 -0.726 . . . . 11.59 109.969 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.428 ' HB2' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -92.1 111.38 22.91 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.56 -0.533 . . . . 12.41 109.56 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 p -134.43 133.77 40.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 13.17 112.037 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 64' ' ' PRO . 16.8 m-85 -89.13 109.6 20.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.158 -0.474 . . . . 16.21 110.103 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -77.28 97.38 4.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.723 -0.473 . . . . 16.64 109.723 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -72.38 -5.43 36.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.318 -0.401 . . . . 22.64 111.471 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -69.63 -30.6 68.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.356 -0.609 . . . . 21.43 109.356 174.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.9 p -113.11 -36.93 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.799 -0.637 . . . . 17.4 111.208 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.34 17.29 15.94 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.955 -0.566 . . . . 16.7 112.128 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -121.02 148.66 49.39 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.641 0.258 . . . . 14.73 111.277 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 78.7 Cg_endo -80.17 126.34 6.26 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.42 2.08 . . . . 12.6 112.144 175.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.0 pt -132.28 165.0 33.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.075 0.464 . . . . 11.73 110.555 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.52 157.24 16.3 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.979 -0.749 . . . . 8.91 108.979 171.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.9 t -70.68 -162.55 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.873 0.368 . . . . 9.83 110.038 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.449 ' HB2' ' OG ' ' A' ' 39' ' ' SER . 22.3 pt20 -74.05 8.16 2.25 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.66 0.615 . . . . 11.32 112.66 -172.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.2 t 53.33 99.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.705 0.764 . . . . 6.11 112.572 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -96.26 129.98 43.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.039 -0.528 . . . . 6.12 110.105 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.422 ' CD ' HG12 ' A' ' 51' ' ' VAL . 13.9 mmmm -76.72 132.34 39.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.242 -0.435 . . . . 6.3 110.411 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.6 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 115.759 -0.655 . . . . 5.77 110.573 -176.123 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.544 HG12 ' HB1' ' A' ' 144' ' ' ALA . 22.4 t . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.788 0.328 . . . . 6.19 111.242 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 64.0 t -77.27 102.86 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 6.26 111.402 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -98.32 16.23 22.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.822 0.82 . . . . 6.05 108.829 177.041 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -102.63 77.06 1.57 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.511 0.672 . . . . 7.02 110.137 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -149.17 106.8 3.65 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.974 -1.121 . . . . 7.07 107.974 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.47 ' OE1' ' HG2' ' A' ' 82' ' ' ARG . 7.8 tp10 -44.67 140.87 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.09 -0.959 . . . . 6.68 111.955 -175.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.47 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 8.5 ptp85 -60.14 106.73 0.55 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.99 -1.004 . . . . 6.43 110.973 -176.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.04 156.18 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.638 -0.71 . . . . 3.7 110.133 178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.7 p -115.77 140.0 49.63 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.827 -0.624 . . . . 3.49 110.695 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.6 166.9 26.04 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.649 -0.786 . . . . 2.58 112.052 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -97.02 127.97 43.52 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.173 -0.306 . . . . 3.34 110.173 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 91.2 t -64.0 124.51 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.479 -0.328 . . . . 3.14 110.242 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.7 p -112.02 -8.26 14.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.748 0.309 . . . . 3.61 111.159 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.476 ' HB ' ' N ' ' A' ' 108' ' ' ARG . 11.4 m -152.29 138.58 18.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.46 -0.336 . . . . 3.12 110.275 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.588 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 18.5 mt-10 -119.16 161.71 19.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 4.39 110.851 -174.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.427 HD22 ' HG3' ' A' ' 124' ' ' LYS . 5.2 mp . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 108.85 -0.796 . . . . 3.62 108.85 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 108.759 -0.83 . . . . 3.33 108.759 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 p -125.3 122.19 36.16 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.19 0.441 . . . . 2.57 112.19 -172.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -72.53 156.43 52.02 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 108.891 -1.683 . . . . 1.66 108.891 166.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.476 ' N ' ' HB ' ' A' ' 89' ' ' THR . 19.5 mtt180 -135.08 141.68 46.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.511 1.156 . . . . 3.03 111.723 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 72.4 mt -113.21 128.5 69.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.01 -0.995 . . . . 1.88 109.516 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 t -104.69 122.55 45.91 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.282 -0.636 . . . . 3.49 109.282 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -131.75 167.56 19.3 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.146 -0.316 . . . . 3.51 110.146 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -137.26 118.29 14.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.009 -0.738 . . . . 5.1 109.009 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -132.81 113.64 13.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.362 -0.381 . . . . 4.78 110.712 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 65.34 23.23 12.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.118 -0.492 . . . . 6.97 111.191 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.31 5.63 61.91 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.021 -0.609 . . . . 5.1 112.672 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -110.68 118.12 35.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.056 0.455 . . . . 5.38 110.157 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.5 p -119.97 125.09 47.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.954 -0.566 . . . . 4.72 110.584 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -134.81 172.36 13.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.706 0.289 . . . . 4.61 110.576 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -112.21 119.36 38.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.738 -0.665 . . . . 3.96 109.416 174.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 3.1 mm? -104.54 118.17 57.23 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.711 0.291 . . . . 2.75 110.344 -177.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 32.9 Cg_endo -80.2 131.67 8.87 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.19 1.927 . . . . 2.3 111.569 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -133.39 156.69 47.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.787 0.327 . . . . 2.13 110.273 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.64 169.01 9.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.99 -0.55 . . . . 3.07 110.156 175.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.427 ' HG3' HD22 ' A' ' 91' ' ' LEU . 52.8 mtmt -70.76 -18.95 62.76 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.08 0.4 . . . . 4.8 112.08 -174.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.59 -5.39 57.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.344 -0.389 . . . . 4.81 111.149 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -86.77 -13.84 44.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.652 -0.249 . . . . 3.84 111.031 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 156' ' ' ILE . 4.7 p -119.27 112.69 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.224 0.535 . . . . 4.39 110.688 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 155' ' ' HIS . 0.8 OUTLIER -95.05 175.17 6.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.167 -0.47 . . . . 6.43 110.415 178.002 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.76 -12.71 68.68 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.653 -0.784 . . . . 5.91 111.869 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.6 m120 59.31 41.41 19.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.062 0.458 . . . . 6.07 111.251 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.71 150.42 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.869 -0.605 . . . . 5.27 110.331 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -101.44 85.38 2.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.131 0.491 . . . . 5.78 110.037 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.724 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.1 pt? -75.37 128.6 35.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.694 -0.684 . . . . 3.62 110.325 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.588 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 18.0 tpt180 -105.65 143.71 33.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.673 . . . . 6.93 110.448 -173.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.603 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -63.82 113.64 3.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.997 0.427 . . . . 4.12 110.051 174.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 116.31 -11.52 16.79 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.268 -0.733 . . . . 4.07 111.268 -173.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.533 ' OD2' ' HA ' ' A' ' 161' ' ' PRO . 4.9 t70 -87.83 -179.13 6.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.211 -0.663 . . . . 4.06 109.211 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -122.87 114.62 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.123 0.487 . . . . 4.17 110.71 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.2 m -119.93 149.8 22.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.068 0.461 . . . . 2.77 111.316 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -100.88 135.07 42.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.602 -0.726 . . . . 3.47 109.554 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -144.95 149.71 35.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.41 -0.359 . . . . 3.35 110.536 -178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.7 139.36 38.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.191 -0.459 . . . . 5.34 109.893 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.2 mt -101.88 100.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.033 0.444 . . . . 4.66 110.627 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -97.3 110.92 23.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.3 -0.409 . . . . 4.85 110.964 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.7 m -79.89 110.79 15.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 5.68 111.311 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -83.53 165.68 18.89 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.059 -0.519 . . . . 6.25 110.466 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -48.98 -44.8 41.32 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.667 0.988 . . . . 8.58 113.667 -172.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -81.31 3.18 25.05 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.158 -0.617 . . . . 7.86 111.519 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.64 23.1 40.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.525 -0.845 . . . . 5.59 111.76 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -96.33 127.35 42.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.186 -0.302 . . . . 5.18 110.186 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.468 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.54 163.64 39.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.807 0.336 . . . . 4.28 110.401 175.575 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.86 -110.82 0.32 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.892 -0.883 . . . . 3.36 110.892 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.89 110.44 4.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.678 -0.49 . . . . 2.84 109.678 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -115.91 158.81 22.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.699 -0.482 . . . . 4.34 109.699 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.4 ' HA ' ' OE1' ' A' ' 128' ' ' GLU . 10.4 p80 38.46 65.35 0.63 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.352 1.033 . . . . 5.75 111.608 -174.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.43 ' HB ' ' HB ' ' A' ' 127' ' ' VAL . 77.7 mt -77.43 133.77 29.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.192 -1.367 . . . . 3.55 110.707 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -126.84 124.31 39.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.068 0.461 . . . . 5.96 110.825 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.5 tt -85.99 106.8 17.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.717 -0.846 . . . . 4.34 108.717 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.69 -42.37 5.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.078 -0.51 . . . . 4.97 111.934 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -121.22 93.84 48.8 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.789 -0.449 . . . . 5.37 109.789 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.533 ' HA ' ' OD2' ' A' ' 137' ' ' ASP . 74.2 Cg_endo -75.43 156.41 41.1 Favored 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 122.649 2.233 . . . . 5.44 112.603 -176.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.909 -0.587 . . . . 6.1 111.018 -177.548 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.977 0.418 . . . . 12.4 111.078 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.539 ' OE1' ' HD3' ' A' ' 27' ' ' ARG . 15.0 mm-40 -110.21 138.22 46.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.699 -0.682 . . . . 11.63 110.351 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -93.38 145.12 24.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.259 -0.428 . . . . 9.15 111.128 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.3 -175.48 23.18 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.553 -0.619 . . . . 6.81 111.553 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.1 mt -127.75 141.9 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.808 -0.442 . . . . 10.17 109.808 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.01 122.77 19.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.969 -0.292 . . . . 8.73 110.441 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -81.73 -53.78 5.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 10.86 111.197 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.409 ' HD3' HG12 ' A' ' 47' ' ' ILE . 53.4 mmtt -158.98 147.94 18.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.01 -0.541 . . . . 14.06 110.51 -177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.78 95.67 8.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 11.73 110.905 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 4.3 mm? -92.07 179.25 5.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.578 -0.737 . . . . 11.36 109.549 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -91.14 120.78 32.37 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.262 -0.273 . . . . 15.94 110.262 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.6 t 79.15 -40.97 0.25 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.961 0.905 . . . . 13.01 111.379 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 7.1 p90 -119.34 146.22 45.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.919 0.39 . . . . 12.34 111.051 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.77 163.02 22.89 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.599 -0.6 . . . . 7.52 111.599 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.97 143.59 47.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.892 0.377 . . . . 9.24 111.364 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.4 mt -110.44 129.28 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.65 -0.704 . . . . 7.75 110.232 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.79 140.53 42.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.81 0.814 . . . . 11.8 111.678 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.4 p -80.09 0.95 29.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.335 -1.302 . . . . 12.34 112.131 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.6 m -51.91 -39.6 59.36 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.471 0.545 . . . . 13.33 112.471 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -89.59 -13.31 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.251 0.548 . . . . 11.9 111.174 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.539 ' HD3' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -128.99 -158.46 0.89 Allowed 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.103 -0.373 . . . . 12.99 110.346 -175.362 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -124.03 19.22 9.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.076 0.465 . . . . 16.66 110.369 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.47 130.32 26.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.705 -0.679 . . . . 12.09 110.954 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -94.39 124.83 38.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.963 -0.754 . . . . 12.51 108.963 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.7 mt -123.72 162.4 23.22 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.069 0.462 . . . . 8.76 111.525 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -126.05 148.51 49.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.669 -0.696 . . . . 9.15 109.356 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -142.39 153.35 43.7 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.894 -0.41 . . . . 6.85 109.894 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -95.71 161.65 13.94 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.603 -0.517 . . . . 9.99 109.603 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -64.05 -13.61 48.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.059 0.457 . . . . 9.93 111.118 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.4 t -74.88 -20.64 59.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.13 -0.487 . . . . 12.28 110.155 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -100.25 23.37 10.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.415 -0.357 . . . . 10.62 111.332 -178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -124.02 111.69 16.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.027 0.442 . . . . 8.78 110.341 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.8 t -89.17 91.85 8.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.013 -0.54 . . . . 8.97 110.335 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.05 173.84 31.21 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.929 -0.653 . . . . 9.98 112.18 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -75.4 117.92 17.72 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.975 -0.38 . . . . 12.43 109.975 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.44 -18.86 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 11.58 111.93 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -54.97 -36.58 65.52 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.375 -0.375 . . . . 14.73 111.868 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -102.15 21.76 14.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.241 0.46 . . . . 13.3 112.241 -173.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -103.21 107.27 18.02 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.798 -0.361 . . . . 10.07 110.138 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -116.09 173.88 6.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.043 0.449 . . . . 13.13 110.904 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 47' ' ' ILE . 3.7 mp -80.56 125.84 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.911 -0.774 . . . . 11.74 108.911 177.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.19 -13.75 28.52 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.953 -0.641 . . . . 10.13 111.893 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.7 125.05 91.76 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-O 120.697 0.285 . . . . 8.39 110.553 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.98 132.07 15.04 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.469 2.113 . . . . 7.28 111.006 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 m -126.44 154.83 36.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.01 0.433 . . . . 4.74 111.296 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -109.51 126.57 53.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.414 -0.812 . . . . 7.09 109.468 176.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.3 161.08 38.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.901 0.381 . . . . 7.82 110.711 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -122.82 109.5 14.27 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.53 -0.544 . . . . 11.59 109.53 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.3 ttt -79.32 120.04 23.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.59 -0.732 . . . . 12.41 110.482 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.3 p -138.71 152.1 47.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.324 -0.398 . . . . 13.17 110.617 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -96.34 117.13 30.2 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.967 -0.383 . . . . 16.21 109.967 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -92.37 128.51 38.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.912 -0.585 . . . . 16.64 111.454 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -79.87 -13.28 59.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.535 -0.757 . . . . 22.64 111.473 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -79.53 -52.53 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 21.43 110.073 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.6 p -85.43 -37.8 19.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.024 -0.535 . . . . 17.4 110.75 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.03 14.06 50.42 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.491 -0.644 . . . . 16.7 111.491 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -116.6 151.42 47.09 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.542 0.211 . . . . 14.73 110.489 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.31 124.42 8.41 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.725 1.617 . . . . 12.6 110.044 168.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.47 169.69 17.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.15 0.5 . . . . 11.73 111.346 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.84 157.63 17.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.673 -0.862 . . . . 8.91 108.673 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.7 t -70.88 -162.23 0.06 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.481 -0.327 . . . . 9.83 110.56 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -74.57 7.85 2.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.301 0.482 . . . . 11.32 112.301 -172.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.9 t 49.84 91.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 124.026 0.829 . . . . 6.11 112.429 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.92 111.49 16.3 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.791 -0.64 . . . . 6.12 110.545 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 112.27 6.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.709 -0.678 . . . . 6.3 109.462 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.1 mt . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.696 -0.684 . . . . 5.77 111.093 -173.784 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 109.78 -0.452 . . . . 6.19 109.78 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 94.6 t -72.72 96.2 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 6.26 111.627 -176.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.596 HD23 ' HB2' ' A' ' 144' ' ' ALA . 54.3 mt -85.38 -27.81 25.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.811 -0.632 . . . . 6.05 111.152 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.0 m -110.86 81.2 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.197 0.523 . . . . 7.02 112.407 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -96.22 -66.72 0.89 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.682 -1.229 . . . . 7.07 107.682 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -147.02 142.76 27.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.936 -0.574 . . . . 6.68 109.786 173.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 82' ' ' ARG . 45.7 ttm180 -82.86 100.64 10.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.815 -0.629 . . . . 6.43 110.072 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.53 153.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.323 0.582 . . . . 3.7 111.554 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.485 HG22 ' OG ' ' A' ' 140' ' ' SER . 60.7 p -116.11 140.49 49.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.599 -0.728 . . . . 3.49 109.582 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.0 174.06 23.37 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.003 -1.094 . . . . 2.58 112.421 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.0 m -125.52 128.67 48.36 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.607 0.242 . . . . 3.34 110.467 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.616 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 51.9 t -71.97 132.79 32.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.053 -0.522 . . . . 3.14 110.326 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.4 p -116.16 -9.17 11.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.178 0.513 . . . . 3.61 111.31 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.2 m -152.57 125.38 8.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 3.12 109.847 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -107.1 174.73 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.361 . . . . 4.39 110.904 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 CA--C 1.516 -0.349 0 CA-C-O 120.945 0.403 . . . . 3.62 110.735 179.267 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 110.187 -0.301 . . . . 3.33 110.187 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.7 p -101.57 125.64 48.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.494 -0.321 . . . . 2.57 111.398 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -71.2 167.66 51.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.895 -0.882 . . . . 1.66 110.895 174.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -131.75 132.44 43.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.305 0.552 . . . . 3.03 111.289 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.1 mt -113.05 133.62 58.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.391 -0.822 . . . . 1.88 109.309 173.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.9 t -84.17 134.47 34.57 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.222 -0.659 . . . . 3.49 109.222 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.517 ' CD2' HD11 ' A' ' 120' ' ' LEU . 36.5 t80 -157.01 142.73 17.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.16 0.505 . . . . 3.51 111.27 -168.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -129.82 131.49 46.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 5.1 109.311 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -152.29 131.89 13.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.871 0.367 . . . . 4.78 110.639 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 63.48 21.87 12.96 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.017 -0.538 . . . . 6.97 111.616 171.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.26 70.22 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.966 -0.635 . . . . 5.1 112.344 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.97 132.87 43.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.049 0.452 . . . . 5.38 110.24 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 15.1 m -121.8 115.55 22.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.108 -0.496 . . . . 4.72 109.896 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -156.64 173.89 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.77 0.319 . . . . 4.61 111.168 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -107.38 141.85 38.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.971 -0.559 . . . . 3.96 110.167 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.517 HD11 ' CD2' ' A' ' 111' ' ' TYR . 1.7 mp -105.78 139.95 20.72 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.085 -0.709 . . . . 2.75 109.085 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 83.7 Cg_endo -86.93 132.17 3.3 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.951 2.434 . . . . 2.3 112.423 177.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -137.42 149.99 47.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.786 0.327 . . . . 2.13 110.559 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 31.8 p -113.56 177.99 4.44 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.781 -0.452 . . . . 3.07 109.781 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -70.85 -18.17 62.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.001 0.429 . . . . 4.8 110.635 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.98 -27.9 54.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.874 -0.603 . . . . 4.81 110.977 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -75.67 -25.79 57.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.069 0.461 . . . . 3.84 110.916 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 156' ' ' ILE . 2.0 p -90.73 107.78 18.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.619 0.724 . . . . 4.39 111.263 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.84 139.72 34.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.321 -0.854 . . . . 6.43 108.696 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 136.55 -12.81 4.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.517 -0.849 . . . . 5.91 112.252 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 68.09 19.17 9.31 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.913 0.485 . . . . 6.07 112.093 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.62 144.16 9.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.044 0.449 . . . . 5.27 110.855 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -105.28 97.38 7.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.029 -0.532 . . . . 5.78 110.392 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.686 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -89.71 149.86 22.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.075 -0.966 . . . . 3.62 110.741 -177.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -122.6 162.35 22.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.063 -0.517 . . . . 6.93 109.678 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.616 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.28 123.47 23.8 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.888 -0.508 . . . . 4.12 110.453 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.78 -14.07 11.57 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.606 -0.807 . . . . 4.07 113.405 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.61 176.42 6.02 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 117.763 0.782 . . . . 4.06 110.323 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -107.19 115.11 29.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.0 0.428 . . . . 4.17 110.951 -173.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.3 m -118.58 172.85 5.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.789 -0.641 . . . . 2.77 111.257 -178.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.485 ' OG ' HG22 ' A' ' 84' ' ' THR . 43.4 m -138.1 129.86 28.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.954 -0.758 . . . . 3.47 108.954 175.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -127.9 140.29 52.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.033 0.444 . . . . 3.35 110.982 -172.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -93.81 111.28 22.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.73 -0.668 . . . . 5.34 109.708 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.1 mt -79.07 100.36 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.086 -0.506 . . . . 4.66 110.128 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.725 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -80.7 110.08 15.86 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.226 -0.443 . . . . 4.85 110.195 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 m -103.09 126.05 50.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.792 -0.64 . . . . 5.68 109.885 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -93.97 -171.09 2.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.302 -0.408 . . . . 6.25 110.401 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -84.44 -8.79 58.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.999 0.428 . . . . 8.58 111.166 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 148' ' ' ARG . 7.3 tpt180 -89.25 -23.04 22.44 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.956 -0.566 . . . . 7.86 109.846 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.84 22.63 59.32 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.67 -0.695 . . . . 5.59 112.094 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -116.89 109.68 17.37 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.637 -0.505 . . . . 5.18 109.637 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.488 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.88 179.76 8.8 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.102 0.477 . . . . 4.28 111.491 -175.551 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -141.51 -94.46 0.23 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.505 -0.77 . . . . 3.36 111.267 174.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -143.58 156.09 44.49 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.386 -0.598 . . . . 2.84 109.386 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.9 t -162.55 161.84 27.04 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.842 -0.429 . . . . 4.34 109.842 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 53.5 m80 48.13 66.3 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.643 0.589 . . . . 5.75 111.69 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.546 ' O ' HG23 ' A' ' 127' ' ' VAL . 68.4 mt -93.94 117.72 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.335 -0.848 . . . . 3.55 110.365 -177.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.12 158.51 17.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 5.96 110.47 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.84 113.38 26.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.51 -0.552 . . . . 4.34 109.51 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -83.0 -58.59 2.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.013 0.435 . . . . 4.97 111.383 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -136.42 100.6 10.28 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.284 -0.416 . . . . 5.37 110.129 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.88 159.68 51.79 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.391 2.061 . . . . 5.44 111.478 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 121.029 0.442 . . . . 6.1 111.138 -177.073 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 83.3 mtt180 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.399 0.618 . . . . 12.4 111.478 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 6.8 mm-40 -102.76 143.74 32.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.839 -1.073 . . . . 11.63 110.441 -174.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.6 p -104.3 160.95 14.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.282 -0.636 . . . . 9.15 109.282 174.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.25 174.68 46.93 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.102 -1.047 . . . . 6.81 113.562 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.512 HG13 ' HB3' ' A' ' 23' ' ' GLN . 19.8 pt -120.57 148.81 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.924 -0.769 . . . . 10.17 108.924 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.543 HG21 HD22 ' A' ' 15' ' ' LEU . 1.9 mp -80.07 131.45 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.307 -0.557 . . . . 8.73 110.774 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.467 ' OE2' ' HB2' ' A' ' 14' ' ' LYS . 4.3 tm-20 -74.66 -46.74 36.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.687 -0.688 . . . . 10.86 111.026 -176.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 15' ' ' LEU . 6.8 tmtt? -157.09 133.17 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.002 -0.37 . . . . 14.06 110.002 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.543 HD22 HG21 ' A' ' 12' ' ' ILE . 3.6 mm? -78.06 110.88 13.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.943 -0.571 . . . . 11.73 110.901 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 72.2 mt -109.79 177.52 4.7 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.922 -1.14 . . . . 11.36 107.922 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -98.91 139.87 33.93 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.486 -0.485 . . . . 15.94 110.511 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t 76.89 -46.05 0.5 Allowed 'General case' 0 N--CA 1.468 0.425 0 O-C-N 124.366 1.041 . . . . 13.01 111.04 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.498 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 39.6 p90 -129.92 154.29 47.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.264 -0.425 . . . . 12.34 109.925 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -144.51 163.57 27.86 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.897 -0.668 . . . . 7.52 111.72 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -109.33 134.39 51.87 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.231 0.538 . . . . 9.24 111.262 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.6 mt -99.86 126.4 53.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 7.75 109.569 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.569 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 6.8 tp-100 -79.31 130.65 35.66 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.089 0.471 . . . . 11.8 110.319 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 p -67.86 3.63 1.43 Allowed 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 113.894 1.072 . . . . 12.34 113.894 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.569 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 74.4 m -51.75 -26.33 9.28 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.537 0.939 . . . . 13.33 113.537 -172.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -99.53 -6.35 27.62 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.131 0.419 . . . . 11.9 112.131 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.489 ' HG3' ' HB3' ' A' ' 8' ' ' GLU . 17.2 mmt180 -152.28 -159.89 1.07 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.801 0.334 . . . . 12.99 110.841 -173.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.418 ' H ' ' HB3' ' A' ' 27' ' ' ARG . 23.5 mp0 -116.3 17.23 15.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.092 0.472 . . . . 16.66 110.601 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.37 113.24 14.71 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.197 -0.456 . . . . 12.09 111.768 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -87.9 104.65 16.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.661 -0.866 . . . . 12.51 108.661 170.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.99 161.22 14.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.928 0.394 . . . . 8.76 111.232 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -110.95 129.36 55.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.308 -0.997 . . . . 9.15 108.308 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -110.64 141.56 43.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.084 0.469 . . . . 6.85 110.158 -175.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -87.16 137.61 32.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.031 -0.729 . . . . 9.99 109.031 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.46 -11.31 32.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.924 0.342 . . . . 9.93 111.924 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.6 t -72.21 -27.41 62.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.28 -0.418 . . . . 12.28 110.494 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.48 40.31 1.57 Allowed 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.154 -0.475 . . . . 10.62 111.321 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.432 ' CE1' ' HG ' ' A' ' 45' ' ' LEU . 22.8 t80 -113.7 129.16 56.61 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.057 -0.72 . . . . 8.78 109.057 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.0 t -108.79 115.25 29.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.907 -0.405 . . . . 8.97 109.907 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.3 -157.3 20.74 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.873 -0.679 . . . . 9.98 111.724 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -93.45 103.47 15.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.89 0.376 . . . . 12.43 110.626 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.3 tp -67.05 -21.82 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.917 -0.583 . . . . 11.58 110.757 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.64 -21.44 65.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 14.73 110.283 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -99.31 11.74 38.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.769 -0.651 . . . . 13.3 110.222 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.432 ' HG ' ' CE1' ' A' ' 38' ' ' PHE . 2.8 tm? -101.28 115.41 30.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.148 -0.686 . . . . 10.07 109.148 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -123.43 -177.6 3.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.382 -0.372 . . . . 13.13 111.153 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.9 mp -77.48 117.84 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.0 -0.371 . . . . 11.74 110.0 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.35 -1.3 64.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.86 -0.686 . . . . 10.13 111.776 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.98 125.28 90.34 Favored Pre-proline 0 C--O 1.234 0.276 0 N-CA-C 109.882 -0.414 . . . . 8.39 109.882 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.89 128.1 7.35 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.637 2.224 . . . . 7.28 113.66 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.48 161.66 38.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 4.74 110.358 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -122.41 127.35 49.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.399 0.618 . . . . 7.09 109.655 174.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 8' ' ' GLU . 45.3 p90 -131.71 -179.32 5.31 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.921 -0.582 . . . . 7.82 110.872 -174.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.439 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 37.6 tt0 -127.91 126.95 42.49 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.959 -0.756 . . . . 11.59 108.959 -176.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.5 ttt -100.53 112.45 24.83 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.289 -0.263 . . . . 12.41 110.289 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.2 p -131.9 170.67 14.55 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.339 -0.391 . . . . 13.17 111.351 -175.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -115.77 109.41 17.63 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.81 -0.441 . . . . 16.21 109.81 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.537 ' OD2' HG22 ' A' ' 61' ' ' THR . 31.2 t70 -76.59 122.88 25.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.139 -0.482 . . . . 16.64 111.063 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -79.51 -13.34 59.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 22.64 111.367 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.415 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 14.3 ttm180 -78.42 -62.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.377 . . . . 21.43 110.935 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.537 HG22 ' OD2' ' A' ' 58' ' ' ASP . 15.3 t -88.45 -22.49 23.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.308 -0.405 . . . . 17.4 110.594 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.02 17.63 57.43 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.747 -0.739 . . . . 16.7 113.288 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -104.5 141.72 23.12 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.589 0.195 . . . . 14.73 110.569 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.92 124.13 7.84 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.451 1.434 . . . . 12.6 109.317 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -141.27 171.56 11.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.133 -0.627 . . . . 11.73 112.397 -169.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.3 143.48 28.02 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.928 -1.033 . . . . 8.91 109.038 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.439 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 14.1 t -69.71 -155.68 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.357 -0.383 . . . . 9.83 110.46 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -75.27 29.1 0.1 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.397 0.888 . . . . 11.32 113.397 -172.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.0 t 19.92 103.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 125.14 1.376 . . . . 6.11 114.403 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -101.94 143.11 32.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.089 0.471 . . . . 6.12 111.572 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -69.72 138.85 53.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.569 -0.741 . . . . 6.3 110.791 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.0 mt . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 109.265 -0.642 . . . . 5.77 109.265 174.375 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.463 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 10.6 p . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.892 0.377 . . . . 6.19 110.728 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 47.3 t -80.75 95.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.312 0.577 . . . . 6.26 109.792 175.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tt -98.92 -24.68 14.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.112 -0.949 . . . . 6.05 110.741 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t -101.34 103.08 14.02 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.358 0.599 . . . . 7.02 112.088 -170.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -129.49 -63.59 0.93 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.166 -1.05 . . . . 7.07 108.166 169.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -168.64 147.09 4.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.723 -1.126 . . . . 6.68 108.392 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -77.11 98.56 5.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.61 -0.515 . . . . 6.43 109.61 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.6 m -81.8 157.24 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.44 0.638 . . . . 3.7 111.546 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.6 p -124.69 146.87 48.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.609 -0.723 . . . . 3.49 109.257 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.43 -173.33 13.71 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.272 -0.966 . . . . 2.58 112.063 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.7 m -130.92 131.15 44.29 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.015 -0.365 . . . . 3.34 110.015 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 88.0 t -64.18 129.95 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.519 -0.309 . . . . 3.14 110.33 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.3 p -113.98 -9.98 12.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.983 0.421 . . . . 3.61 110.722 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.7 m -152.26 128.76 10.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.429 . . . . 3.12 110.209 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -99.07 169.63 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 4.39 110.726 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.999 -0.546 . . . . 3.62 110.122 172.636 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.448 -0.556 0 CA-C-O 121.008 0.432 . . . . 3.33 109.872 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.19 116.2 32.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.109 0.481 . . . . 2.57 111.141 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -69.09 160.77 52.42 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.729 -0.748 . . . . 1.66 111.554 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -129.9 127.61 40.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.342 0.592 . . . . 3.03 110.868 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.5 mt -112.0 127.45 69.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.204 -0.907 . . . . 1.88 109.241 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.4 t -112.4 137.46 50.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.764 0.316 . . . . 3.49 110.441 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 2.7 p90 -143.37 155.42 44.42 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.115 -0.698 . . . . 3.51 109.115 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -111.56 125.24 53.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.864 0.364 . . . . 5.1 110.463 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.723 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 9.4 t30 -130.03 115.66 17.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.945 -0.571 . . . . 4.78 109.584 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 60.94 21.63 11.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.663 0.268 . . . . 6.97 111.581 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.87 -4.18 68.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.825 -0.702 . . . . 5.1 113.011 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.723 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 7.9 pt-20 -99.68 132.96 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.145 -0.687 . . . . 5.38 109.145 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 7.8 p -116.77 118.36 32.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.94 0.4 . . . . 4.72 110.427 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 116' ' ' GLU . 78.9 m-85 -108.4 155.01 21.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.142 -0.481 . . . . 4.61 110.494 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -110.26 123.34 49.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.952 -0.567 . . . . 3.96 109.715 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.77 120.2 52.14 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.384 -0.371 . . . . 2.75 110.408 -175.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -76.7 132.91 13.62 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.906 2.404 . . . . 2.3 111.722 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -145.3 155.0 42.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.804 0.335 . . . . 2.13 110.25 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 62.8 p -107.4 -174.71 2.6 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.124 -0.489 . . . . 3.07 110.084 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -71.39 -19.61 62.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.222 0.534 . . . . 4.8 110.514 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.85 -28.28 33.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.754 -0.657 . . . . 4.81 111.437 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.22 -19.61 60.46 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.387 -0.369 . . . . 3.84 111.364 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.9 p -107.43 107.91 23.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.588 0.709 . . . . 4.39 111.009 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -90.46 138.43 31.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 6.43 110.183 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.23 -20.65 4.98 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.777 -0.647 . . . . 5.91 111.51 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.8 t30 61.58 31.57 18.77 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.74 0.781 . . . . 6.07 110.001 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -89.92 138.51 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.692 -0.685 . . . . 5.27 110.151 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -82.5 103.38 12.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.735 0.302 . . . . 5.78 110.379 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.594 ' H ' HD12 ' A' ' 133' ' ' LEU . 2.2 mp -75.56 134.87 40.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.751 -0.659 . . . . 3.62 109.51 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -121.34 126.74 50.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.889 0.376 . . . . 6.93 110.159 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.597 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -57.46 112.91 1.56 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.359 0.599 . . . . 4.12 111.317 -175.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.36 -2.8 14.04 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.296 -0.865 . . . . 4.07 112.851 -174.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.6 p30 -95.01 178.27 5.61 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.442 0.621 . . . . 4.06 110.459 172.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -100.22 122.88 43.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.978 0.418 . . . . 4.17 111.036 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.09 151.82 24.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.668 -0.696 . . . . 2.77 110.584 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.3 t -124.93 129.33 50.16 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.704 -0.48 . . . . 3.47 109.704 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -136.67 154.6 50.58 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.557 -0.534 . . . . 3.35 109.557 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -113.0 114.76 27.36 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.37 -0.604 . . . . 5.34 109.37 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -78.43 108.16 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.594 . . . . 4.66 111.304 -174.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -100.62 110.5 22.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.128 -0.487 . . . . 4.85 109.81 172.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.2 m -85.85 108.95 18.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.198 -0.455 . . . . 5.68 111.126 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -64.53 146.1 55.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.937 -0.574 . . . . 6.25 109.661 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.17 -17.97 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.571 0.582 . . . . 8.58 112.571 -173.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -85.75 2.07 47.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 7.86 110.31 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.48 16.77 80.43 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.68 -0.691 . . . . 5.59 113.143 174.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -119.69 113.09 20.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.332 -0.618 . . . . 5.18 109.332 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.508 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -144.72 -179.17 6.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.214 -0.448 . . . . 4.28 111.067 -175.31 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.58 -153.3 5.84 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.057 -0.817 . . . . 3.36 111.057 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.26 118.01 34.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.213 0.507 . . . . 2.84 110.086 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 33.9 t -116.44 159.59 21.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.59 -0.277 . . . . 4.34 110.646 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 69.2 m80 60.47 33.58 20.57 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.95 -0.568 . . . . 5.75 111.174 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 55.0 mt -64.69 125.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.764 -0.653 . . . . 3.55 110.921 -176.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -140.44 159.92 41.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.724 -0.671 . . . . 5.96 110.056 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.1 tp -77.6 119.24 20.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.281 -0.637 . . . . 4.34 109.281 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -84.41 -47.67 10.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.031 -0.531 . . . . 4.97 109.628 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -162.5 113.94 1.12 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.864 -0.607 . . . . 5.37 109.492 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.12 152.08 80.46 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.126 1.884 . . . . 5.44 112.481 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.886 0 CA-C-N 115.897 -0.592 . . . . 6.1 110.774 -178.041 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 . . . . . 0 C--O 1.236 0.362 0 N-CA-C 110.128 -0.323 . . . . 12.4 110.128 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.505 ' CD ' ' HE ' ' A' ' 27' ' ' ARG . 14.1 pt-20 -142.38 162.12 36.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.924 -0.399 . . . . 11.63 109.924 174.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 52' ' ' GLU . 68.9 p -109.14 157.38 18.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.536 0.684 . . . . 9.15 112.133 -171.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.69 157.0 28.42 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.224 -1.15 . . . . 6.81 110.224 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.0 pt -105.01 141.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 117.097 0.448 . . . . 10.17 110.646 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.511 HG13 HD11 ' A' ' 45' ' ' LEU . 41.6 mm -74.37 123.45 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 110.067 -0.346 . . . . 8.73 110.067 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.68 -34.5 17.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.333 0.494 . . . . 10.86 112.333 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.5 ' HA ' HD12 ' A' ' 47' ' ' ILE . 1.9 tmtp? -160.74 130.4 4.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.947 0.404 . . . . 14.06 111.059 -175.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.488 ' H ' HD11 ' A' ' 47' ' ' ILE . 3.0 mm? -91.55 106.55 18.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.854 -0.612 . . . . 11.73 110.796 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 5.3 mp -96.93 179.77 4.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.763 -0.829 . . . . 11.36 108.763 174.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -89.81 116.11 27.66 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.268 -0.573 . . . . 15.94 110.434 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.4 t 78.54 -14.0 0.91 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.298 0.999 . . . . 13.01 111.635 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 10.1 p90 -145.45 162.97 36.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.187 -0.301 . . . . 12.34 110.187 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.67 177.22 33.72 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.67 -0.776 . . . . 7.52 112.125 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -126.68 148.49 49.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 9.24 110.914 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.7 mt -108.87 126.21 65.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.571 -0.741 . . . . 7.75 109.666 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.22 143.2 47.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.426 0.631 . . . . 11.8 110.766 -175.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.7 p -77.04 6.04 7.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.068 -0.969 . . . . 12.34 111.942 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -49.57 -39.97 36.85 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.077 0.399 . . . . 13.33 112.077 -173.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -116.91 6.38 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.835 -0.346 . . . . 11.9 111.4 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.622 ' HD3' ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -120.41 141.31 50.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.533 -0.543 . . . . 12.99 109.533 -173.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.622 ' N ' ' HD3' ' A' ' 27' ' ' ARG . 27.7 mm-40 -77.04 26.01 0.15 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.064 -0.397 . . . . 16.66 111.484 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB3' HH11 ' A' ' 27' ' ' ARG . . . 178.99 145.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.575 0.75 . . . . 12.09 109.333 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.523 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.9 OUTLIER -86.9 132.37 33.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.557 -0.534 . . . . 12.51 109.557 174.521 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.52 162.39 19.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.209 0.528 . . . . 8.76 111.636 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -116.16 147.98 40.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.486 -0.779 . . . . 9.15 109.882 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -150.22 172.92 14.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.77 -0.456 . . . . 6.85 109.77 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 16.9 p80 -135.06 165.79 24.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 9.99 111.172 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -66.29 -18.95 65.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.835 -0.621 . . . . 9.93 111.896 -173.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t -86.27 2.36 47.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.546 -0.297 . . . . 12.28 110.837 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 36.6 tp60 -110.74 -30.16 7.69 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.774 -0.454 . . . . 10.62 109.774 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -77.35 121.55 23.91 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.875 -0.602 . . . . 8.78 109.956 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.44 ' HB2' ' CG ' ' A' ' 68' ' ' GLN . 34.1 t -97.07 139.99 32.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.196 0.522 . . . . 8.97 110.528 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.41 -169.15 14.51 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.635 -0.793 . . . . 9.98 112.573 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -72.9 110.73 7.43 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.363 0.601 . . . . 12.43 111.068 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -77.75 -20.65 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.372 -0.831 . . . . 11.58 109.998 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.75 -31.63 72.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 14.73 110.401 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -97.02 24.53 6.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.815 -0.63 . . . . 13.3 110.768 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.511 HD11 HG13 ' A' ' 12' ' ' ILE . 3.2 tm? -113.19 120.79 42.44 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.007 -1.108 . . . . 10.07 108.007 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.29 176.49 8.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.628 0.252 . . . . 13.13 110.816 -170.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 14' ' ' LYS . 31.4 mm -70.63 128.25 33.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.562 -0.29 . . . . 11.74 110.26 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.13 11.09 67.82 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.322 -0.942 . . . . 10.13 112.611 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.45 121.35 71.21 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.972 -0.381 . . . . 8.39 109.972 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.48 125.3 9.51 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.564 2.176 . . . . 7.28 112.712 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 71' ' ' LYS . 34.0 m -124.61 152.96 31.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.78 -0.645 . . . . 4.74 109.65 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.551 ' HB3' HG22 ' A' ' 9' ' ' THR . 13.8 pt-20 -114.46 131.05 56.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.323 0.582 . . . . 7.09 109.752 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -137.67 172.73 12.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.371 0.605 . . . . 7.82 111.701 -172.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -118.4 133.69 55.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.189 -1.041 . . . . 11.59 108.189 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.9 ttt -100.7 122.53 43.49 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.283 -0.266 . . . . 12.41 110.283 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.3 p -135.09 144.25 47.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.413 0.625 . . . . 13.17 111.253 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -90.6 109.66 20.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.691 . . . . 16.21 109.16 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 60' ' ' ARG . 11.1 t70 -65.02 117.93 8.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.825 -0.625 . . . . 16.64 111.618 -174.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 -80.12 -12.25 59.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.175 -0.92 . . . . 22.64 111.712 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HB2' ' OD1' ' A' ' 58' ' ' ASP . 0.1 OUTLIER -73.82 -57.81 3.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.886 0.374 . . . . 21.43 110.397 -176.605 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.3 p -104.68 -39.43 6.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.074 -0.512 . . . . 17.4 111.117 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.87 16.85 7.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.511 -0.852 . . . . 16.7 112.825 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -101.34 148.31 35.0 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.156 -0.313 . . . . 14.73 110.156 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -79.63 125.22 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.675 1.583 . . . . 12.6 110.358 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.3 pt -128.87 162.91 35.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.483 0.659 . . . . 11.73 111.553 -175.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.46 161.97 13.25 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.977 -1.01 . . . . 8.91 108.635 170.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 69' ' ' VAL . 26.3 t -75.39 -153.29 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.222 -0.288 . . . . 9.83 110.222 177.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -67.82 -4.02 11.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.798 0.666 . . . . 11.32 112.798 -173.133 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 67' ' ' SER . 42.3 t 50.93 86.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.538 0.685 . . . . 6.11 111.56 176.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -97.23 129.86 44.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.836 -0.62 . . . . 6.12 110.649 -174.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.458 ' HA ' HG12 ' A' ' 51' ' ' VAL . 35.9 mtmm -67.61 141.21 56.84 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.157 -0.682 . . . . 6.3 109.157 175.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.9 mt . . . . . 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 5.77 111.318 -176.534 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.537 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 3.2 p . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 121.206 0.526 . . . . 6.19 111.016 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.642 HG12 ' H ' ' A' ' 79' ' ' SER . 46.7 t -85.37 118.97 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.915 -0.584 . . . . 6.26 111.856 -175.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HG ' ' CE1' ' A' ' 155' ' ' HIS . 10.7 mp -97.19 13.57 28.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.106 -0.497 . . . . 6.05 110.548 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.642 ' H ' HG12 ' A' ' 77' ' ' VAL . 21.1 m -116.48 -112.2 0.34 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.168 -0.469 . . . . 7.02 110.532 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 81' ' ' GLU . 6.3 tt0 57.82 33.05 22.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.098 0.559 . . . . 7.07 111.143 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 80' ' ' GLU . 10.3 tp10 76.0 117.51 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.222 -0.899 . . . . 6.68 111.126 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -77.71 90.88 4.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.662 0.744 . . . . 6.43 110.159 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.65 160.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.496 -0.775 . . . . 3.7 111.226 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 p -107.86 139.52 42.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.542 -0.754 . . . . 3.49 109.924 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.36 161.26 24.41 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.515 -0.85 . . . . 2.58 112.479 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -116.96 125.01 50.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.483 -0.562 . . . . 3.34 109.483 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 58.1 t -68.5 123.68 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 108.973 -0.751 . . . . 3.14 108.973 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.0 p -105.08 -20.3 13.56 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.623 -0.431 . . . . 3.61 111.066 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -151.83 126.18 9.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.273 -0.421 . . . . 3.12 110.258 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.27 -172.68 4.12 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.951 -0.388 . . . . 4.39 109.951 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.476 HD22 ' HG3' ' A' ' 124' ' ' LYS . 5.3 mp . . . . . 0 C--N 1.325 -0.457 0 N-CA-C 109.284 -0.636 . . . . 3.62 109.284 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.447 -0.585 0 CA-C-O 121.408 0.623 . . . . 3.33 109.341 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 t -122.09 148.76 44.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.71 -0.677 . . . . 2.57 110.631 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.03 163.41 39.74 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.671 -0.971 . . . . 1.66 110.671 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -125.27 128.42 48.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.965 0.412 . . . . 3.03 110.886 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 71.6 mt -112.88 125.46 70.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.909 -0.587 . . . . 1.88 109.506 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.8 t -100.17 137.89 37.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.838 -0.43 . . . . 3.49 109.838 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.526 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -148.8 167.48 25.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.527 0.203 . . . . 3.51 110.549 -178.703 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.38 127.93 56.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.366 -0.379 . . . . 5.1 110.446 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -152.85 130.12 11.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.604 -0.517 . . . . 4.78 109.604 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 64.74 20.85 12.25 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.427 0.455 . . . . 6.97 111.168 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.57 18.73 79.68 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.778 -0.725 . . . . 5.1 111.868 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -121.21 144.92 48.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.628 -0.508 . . . . 5.38 109.628 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 11.4 p -122.98 115.49 21.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.277 -0.42 . . . . 4.72 110.265 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -132.19 157.4 44.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.251 -0.431 . . . . 4.61 110.528 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -99.77 129.25 45.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 3.96 109.819 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 111' ' ' TYR . 4.2 mp -105.03 143.39 26.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 110.133 -0.321 . . . . 2.75 110.133 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 3.3 Cg_exo -80.11 148.56 19.34 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.511 2.141 . . . . 2.3 112.036 175.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -155.19 144.57 21.13 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.029 -0.73 . . . . 2.13 109.029 173.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.8 p -113.11 -175.59 2.7 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.67 0.272 . . . . 3.07 110.489 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.476 ' HG3' HD22 ' A' ' 91' ' ' LEU . 55.2 mttp -65.76 -27.97 68.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.24 0.543 . . . . 4.8 110.183 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -75.16 -22.92 57.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.211 -0.904 . . . . 4.81 111.598 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -83.13 -11.25 58.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 3.84 111.86 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 p -119.98 106.55 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.441 0.639 . . . . 4.39 111.37 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -108.26 150.25 27.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.779 -0.646 . . . . 6.43 110.102 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 125.39 16.93 2.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.913 -0.66 . . . . 5.91 112.943 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.9 t30 64.25 22.62 12.88 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.447 0.642 . . . . 6.07 110.454 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.2 130.54 35.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.946 -0.57 . . . . 5.27 110.929 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -111.61 111.56 22.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 5.78 110.148 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 133' ' ' LEU . 5.5 mp -98.97 149.83 22.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 3.62 110.939 -176.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -146.52 121.14 9.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.475 -0.565 . . . . 6.93 109.475 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -46.68 131.57 11.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.83 -0.623 . . . . 4.12 112.532 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.22 -12.69 14.15 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.126 -0.943 . . . . 4.07 111.192 -172.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -89.64 174.9 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 4.06 110.482 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -121.86 118.69 29.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.346 0.594 . . . . 4.17 110.147 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.7 m -121.19 159.07 23.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.314 -0.857 . . . . 2.77 111.264 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.9 m -109.73 137.82 46.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.622 -0.717 . . . . 3.47 109.22 173.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -139.79 139.21 36.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.024 0.44 . . . . 3.35 110.114 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -97.2 121.08 38.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.949 -0.569 . . . . 5.34 109.532 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.05 107.91 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 4.66 110.122 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.537 ' HB1' ' CG2' ' A' ' 76' ' ' VAL . . . -94.87 107.98 20.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.07 -0.514 . . . . 4.85 110.995 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.546 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 50.9 m -85.38 109.41 18.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.691 . . . . 5.68 111.075 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -74.76 159.29 32.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.316 -0.624 . . . . 6.25 109.316 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -57.77 -24.91 59.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 122.451 0.3 . . . . 8.58 111.693 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.615 ' HD2' ' OD1' ' A' ' 150' ' ' ASN . 1.3 tmt_? -69.81 -21.03 63.43 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.184 0.516 . . . . 7.86 110.116 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.41 2.76 61.69 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.882 -0.675 . . . . 5.59 112.107 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.615 ' OD1' ' HD2' ' A' ' 148' ' ' ARG . 15.1 m120 -99.73 135.92 40.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.632 -0.507 . . . . 5.18 109.632 177.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -145.34 174.44 11.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.062 0.458 . . . . 4.28 111.332 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.32 -160.83 10.7 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.995 -0.842 . . . . 3.36 110.995 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.6 109.79 22.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.123 0.487 . . . . 2.84 110.54 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 38.1 m -131.56 176.62 8.16 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.141 -0.688 . . . . 4.34 109.141 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.496 ' CE1' ' HG ' ' A' ' 78' ' ' LEU . 13.9 m80 58.47 38.6 25.54 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.317 -0.623 . . . . 5.75 109.317 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.3 mt -79.48 128.76 38.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.173 -0.921 . . . . 3.55 111.137 -169.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -134.73 140.86 46.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.281 0.562 . . . . 5.96 110.349 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.6 tp -103.97 105.76 16.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.828 -0.624 . . . . 4.34 109.906 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -109.74 -24.64 10.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.063 -0.517 . . . . 4.97 111.297 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -117.79 86.12 23.78 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.209 -0.45 . . . . 5.37 110.821 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.34 156.21 14.51 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.54 2.16 . . . . 5.44 111.772 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 116.288 -0.415 . . . . 6.1 110.685 -179.12 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HG2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 120.892 0.377 . . . . 12.4 111.061 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.76 153.56 21.6 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.098 -0.704 . . . . 11.63 109.098 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.515 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 20.3 p -86.52 161.36 18.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.066 0.46 . . . . 9.15 111.736 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.22 162.73 32.02 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.433 -0.667 . . . . 6.81 111.433 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 pt -113.9 148.57 16.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.724 0.262 . . . . 10.17 110.43 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.0 mm -75.28 123.4 31.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.513 -0.312 . . . . 8.73 110.687 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.53 ' OE2' ' HB3' ' A' ' 21' ' ' PHE . 29.1 mt-10 -72.53 -46.05 56.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.054 -0.521 . . . . 10.86 111.219 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.12 146.94 17.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.023 -0.535 . . . . 14.06 110.084 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.51 105.25 17.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.927 -0.579 . . . . 11.73 110.695 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 2.6 mm? -106.71 179.09 4.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.752 -0.833 . . . . 11.36 108.752 174.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -91.64 129.37 37.62 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.714 -0.394 . . . . 15.94 110.223 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.3 m 76.25 -37.79 0.31 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 124.152 0.907 . . . . 13.01 112.083 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 46.8 p90 -126.98 153.37 45.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.898 0.38 . . . . 12.34 111.081 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.4 165.95 26.24 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.03 -0.828 . . . . 7.52 111.03 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.53 ' HB3' ' OE2' ' A' ' 13' ' ' GLU . 91.5 m-85 -115.21 146.16 41.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.225 0.513 . . . . 9.24 111.459 -177.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.52 HG21 ' CE2' ' A' ' 53' ' ' PHE . 61.6 mt -117.71 127.15 75.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 7.75 110.338 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.419 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -78.22 133.14 37.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.588 0.708 . . . . 11.8 111.962 -172.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.5 p -81.22 -1.09 43.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.855 -1.066 . . . . 12.34 113.229 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -60.94 -43.18 99.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.085 0.469 . . . . 13.33 111.342 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' OE1' ' HB3' ' A' ' 128' ' ' GLU . 7.2 tp10 -90.28 -9.14 49.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.043 0.925 . . . . 11.9 109.747 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 9' ' ' THR . 1.1 mmt180 -112.29 -167.58 1.2 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.83 -1.077 . . . . 12.99 110.462 -174.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.61 21.62 6.0 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.147 -0.686 . . . . 16.66 109.147 171.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' H ' ' HB3' ' A' ' 27' ' ' ARG . . . -166.05 128.21 1.93 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.922 -1.035 . . . . 12.09 110.169 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -85.91 140.24 30.53 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.831 -0.803 . . . . 12.51 108.831 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.1 mt -145.59 161.32 40.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.106 0.479 . . . . 8.76 111.89 -175.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -120.96 130.15 53.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.363 -0.835 . . . . 9.15 108.767 172.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -119.21 157.37 28.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.922 -0.399 . . . . 6.85 109.922 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -108.19 151.99 25.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.324 -0.398 . . . . 9.99 110.051 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -57.76 -26.41 61.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.275 0.842 . . . . 9.93 113.275 -172.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.2 t -68.7 -13.54 62.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.181 0.515 . . . . 12.28 110.898 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -113.66 38.96 2.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.056 -0.52 . . . . 10.62 110.145 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -127.17 117.36 22.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.165 -0.47 . . . . 8.78 109.904 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 68' ' ' GLN . 22.5 t -79.71 91.85 5.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.544 -0.753 . . . . 8.97 110.225 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.91 -163.3 27.7 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.797 -0.716 . . . . 9.98 112.465 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -86.3 112.51 21.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.818 -0.438 . . . . 12.43 109.818 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -28.91 40.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.678 0.275 . . . . 11.58 111.556 -174.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -75.33 -13.36 60.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.426 0.631 . . . . 14.73 109.671 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -95.61 6.8 48.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.588 -0.733 . . . . 13.3 110.334 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.8 tp -94.43 125.81 39.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.738 -0.665 . . . . 10.07 110.026 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.524 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 2.6 mppt? -103.2 167.74 9.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.205 0.526 . . . . 13.13 110.841 -174.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.5 mt -84.5 114.68 25.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.814 -0.63 . . . . 11.74 109.688 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.74 9.4 43.36 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.259 -0.736 . . . . 10.13 111.259 -170.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -79.55 124.52 83.78 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 109.532 -0.544 . . . . 8.39 109.532 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.581 ' HB2' HD12 ' A' ' 72' ' ' ILE . 86.1 Cg_endo -82.39 129.22 5.77 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.847 2.364 . . . . 7.28 113.621 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.4 166.27 29.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 4.74 111.097 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.49 ' HB3' HG22 ' A' ' 9' ' ' THR . 7.7 pt-20 -122.58 124.89 44.54 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.578 -0.527 . . . . 7.09 109.578 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CE2' HG21 ' A' ' 22' ' ' ILE . 54.3 p90 -133.0 149.75 52.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.109 0.48 . . . . 7.82 111.349 -172.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HG3' ' HG2' ' A' ' 7' ' ' ARG . 2.6 mp0 -88.72 149.46 23.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.019 -0.992 . . . . 11.59 110.361 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.05 121.69 42.97 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.328 -0.619 . . . . 12.41 109.328 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.5 p -138.9 172.08 13.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.398 . . . . 13.17 111.265 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -125.75 125.33 42.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.333 -0.394 . . . . 16.21 110.573 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.59 124.96 34.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.066 0.46 . . . . 16.64 110.542 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -79.97 -25.26 40.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.791 -0.64 . . . . 22.64 111.404 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -70.85 -57.54 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.559 -0.292 . . . . 21.43 111.233 -172.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.0 p -91.46 -28.54 17.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.962 0.41 . . . . 17.4 110.559 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.98 11.01 57.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 16.7 112.741 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 131.32 31.35 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 122.815 -0.226 . . . . 14.73 110.442 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.02 126.43 15.82 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.257 1.971 . . . . 12.6 109.93 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 30.2 pt -126.52 147.67 31.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.411 0.624 . . . . 11.73 111.63 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.24 155.04 18.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.022 -0.99 . . . . 8.91 108.433 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.475 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 39.1 t -75.26 -151.29 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.338 0.399 . . . . 9.83 110.496 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 39' ' ' SER . 2.5 mp0 -67.9 -10.28 51.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.248 0.462 . . . . 11.32 112.248 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.3 t 56.56 96.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.489 0.661 . . . . 6.11 111.198 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 t -93.77 147.7 22.8 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.603 -0.518 . . . . 6.12 109.603 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -81.51 157.5 24.81 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.434 -0.58 . . . . 6.3 109.434 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' A' ' 50' ' ' PRO . 24.6 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-O 121.375 0.607 . . . . 5.77 109.905 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 108.831 -0.804 . . . . 6.19 108.831 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 47.5 t -68.49 103.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 6.26 111.531 -174.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -78.71 83.21 4.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.764 -0.653 . . . . 6.05 109.743 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 p 23.44 96.37 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.96 1.467 . . . . 7.02 114.96 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.73 -30.55 71.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.525 0.679 . . . . 7.07 109.533 171.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -108.68 117.71 34.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.081 -0.963 . . . . 6.68 109.947 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -81.4 144.71 31.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.354 -0.385 . . . . 6.43 109.968 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.91 152.95 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.342 0.591 . . . . 3.7 111.111 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.1 p -114.94 145.7 41.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.607 -0.724 . . . . 3.49 110.086 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.99 165.77 24.54 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.347 -0.93 . . . . 2.58 112.648 -177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 m -118.82 130.18 55.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.457 -0.571 . . . . 3.34 109.457 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.669 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 3.1 t -73.64 123.4 28.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.015 -0.365 . . . . 3.14 110.015 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.6 p -101.34 -22.48 14.58 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.143 0.497 . . . . 3.61 109.979 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.8 m -140.29 118.42 11.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.497 -0.774 . . . . 3.12 109.898 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -97.83 163.77 12.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.093 0.473 . . . . 4.39 110.895 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.751 -0.658 . . . . 3.62 110.498 179.709 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 109.366 -0.605 . . . . 3.33 109.366 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.4 t -146.89 149.11 32.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.679 -0.489 . . . . 2.57 109.679 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 122' ' ' TYR . . . -85.71 168.35 41.55 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.445 -0.883 . . . . 1.66 111.928 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -125.66 120.66 31.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.629 0.252 . . . . 3.03 110.657 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 82.8 mt -110.98 127.17 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.337 -0.616 . . . . 1.88 109.337 174.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.9 p -106.42 129.52 54.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.231 -0.441 . . . . 3.49 110.813 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.523 ' CE2' HD11 ' A' ' 120' ' ' LEU . 1.2 p90 -146.68 166.52 26.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.265 -0.643 . . . . 3.51 109.265 175.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.429 ' HG2' ' SG ' ' A' ' 117' ' ' CYS . 43.8 mt-10 -107.28 121.66 45.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.17 0.509 . . . . 5.1 111.18 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -116.36 114.1 23.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.454 -0.794 . . . . 4.78 109.069 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 64.84 21.01 12.28 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.978 0.511 . . . . 6.97 110.65 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.3 66.15 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.014 -0.539 . . . . 5.1 112.045 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -102.63 129.05 49.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.888 0.375 . . . . 5.38 110.887 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.429 ' SG ' ' HG2' ' A' ' 112' ' ' GLU . 62.9 m -81.78 124.95 30.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.202 -0.454 . . . . 4.72 110.332 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -121.38 147.13 46.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.225 -0.443 . . . . 4.61 110.491 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.85 123.22 49.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 3.96 109.845 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.523 HD11 ' CE2' ' A' ' 111' ' ' TYR . 4.9 mp -105.38 134.88 19.46 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.262 -0.273 . . . . 2.75 110.262 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.57 133.15 11.48 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.966 2.444 . . . . 2.3 111.381 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.402 ' CE1' ' HA3' ' A' ' 107' ' ' GLY . 12.7 p90 -144.81 147.76 33.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.789 -0.448 . . . . 2.13 109.789 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.2 p -112.95 -179.94 3.79 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.845 -0.428 . . . . 3.07 109.845 173.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -72.76 -20.22 61.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.24 0.543 . . . . 4.8 110.867 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.77 -4.8 58.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.79 -0.641 . . . . 4.81 111.23 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -89.45 -13.5 37.45 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.138 0.494 . . . . 3.84 110.58 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 156' ' ' ILE . 2.8 p -110.48 116.19 51.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.716 0.769 . . . . 4.39 111.124 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.43 ' HB3' ' OE1' ' A' ' 26' ' ' GLU . 1.1 mp0 -99.72 179.02 4.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.786 -1.097 . . . . 6.43 109.997 177.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.55 -10.78 64.93 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.569 -0.824 . . . . 5.91 112.315 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 66.46 25.46 10.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.88 0.472 . . . . 6.07 111.388 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -103.55 140.93 20.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.635 -0.257 . . . . 5.27 110.866 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -97.51 129.14 44.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.064 0.459 . . . . 5.78 110.239 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.633 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -115.33 149.56 37.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.859 -0.61 . . . . 3.62 110.075 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -124.23 174.44 7.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.16 0.505 . . . . 6.93 109.992 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.669 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.97 122.06 22.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.269 0.557 . . . . 4.12 111.442 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.04 -14.88 13.68 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.595 -0.812 . . . . 4.07 113.622 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -86.58 -177.55 6.18 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 117.901 0.85 . . . . 4.06 110.687 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -116.85 115.46 25.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.195 0.521 . . . . 4.17 111.815 -174.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.86 162.36 15.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.633 -0.712 . . . . 2.77 110.985 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 45.8 t -126.37 129.47 48.87 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.612 -0.885 . . . . 3.47 108.612 177.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.0 146.99 50.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.071 0.462 . . . . 3.35 110.488 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -106.18 112.81 26.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.736 -0.665 . . . . 5.34 109.919 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.72 100.63 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.496 -0.775 . . . . 4.66 111.539 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -83.01 111.05 18.5 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.731 -0.47 . . . . 4.85 109.731 173.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 21.1 m -86.72 116.12 24.61 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.802 -0.635 . . . . 5.68 111.309 -174.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -74.44 166.14 24.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 6.25 110.398 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.1 -32.58 73.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 8.58 111.856 -173.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 3.3 tmt_? -76.23 -22.9 54.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 7.86 110.382 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.68 11.78 42.92 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.575 -0.821 . . . . 5.59 112.766 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -114.49 127.34 55.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.794 -0.239 . . . . 5.18 110.384 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -147.63 -176.92 5.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.094 0.474 . . . . 4.28 111.672 -173.684 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -139.27 -143.56 4.43 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.92 -0.872 . . . . 3.36 110.92 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.76 110.52 14.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.143 0.472 . . . . 2.84 109.963 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 45.6 t -122.78 162.14 22.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.563 -0.532 . . . . 4.34 109.563 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 56.56 37.87 29.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.162 0.506 . . . . 5.75 110.748 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 127' ' ' VAL . 69.5 mt -61.53 115.69 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.32 -0.855 . . . . 3.55 110.382 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 140' ' ' SER . 0.7 OUTLIER -111.56 143.84 41.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.979 0.418 . . . . 5.96 110.58 -176.525 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.4 tp -103.48 93.36 4.9 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.194 -0.669 . . . . 4.34 109.194 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.1 -28.4 15.1 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.739 -0.385 . . . . 4.97 110.958 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -114.86 84.02 10.0 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.451 -0.574 . . . . 5.37 109.451 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.93 158.75 18.37 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.943 2.429 . . . . 5.44 113.185 -174.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.74 -0.664 . . . . 6.1 110.174 176.336 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 N-CA-C 112.038 -0.425 . . . . 21.66 112.038 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.477 ' HA ' ' HG2' ' A' ' 5' ' ' GLU . . . 65.24 31.57 10.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.945 0.498 . . . . 20.17 111.948 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -76.94 -34.47 57.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.989 0.424 . . . . 18.5 110.18 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -152.8 91.78 1.59 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.764 -0.653 . . . . 16.62 109.953 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 2' ' ' ALA . 5.1 pt-20 -165.38 130.09 2.45 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.485 -0.78 . . . . 18.35 109.767 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -128.34 96.13 4.35 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.485 -0.78 . . . . 16.2 109.715 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -86.95 106.06 17.54 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.542 0.687 . . . . 12.4 109.409 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.52 ' HB3' ' HG2' ' A' ' 27' ' ' ARG . 42.7 mt-10 -120.26 143.52 48.27 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.771 -0.649 . . . . 11.63 110.356 -174.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -110.87 144.36 40.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.439 . . . . 9.15 111.05 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.78 172.63 31.84 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.363 -0.922 . . . . 6.81 112.15 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.0 mt -120.8 133.99 65.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 110.083 -0.34 . . . . 10.17 110.083 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.04 112.79 11.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.536 -0.542 . . . . 8.73 109.536 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 11.8 tp10 -91.54 -29.95 16.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.799 -0.637 . . . . 10.86 110.988 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -159.77 128.33 5.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.039 -0.528 . . . . 14.06 109.62 -175.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 mt -99.45 126.8 45.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.178 0.513 . . . . 11.73 111.17 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.06 179.26 4.32 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.232 -1.025 . . . . 11.36 108.232 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -91.09 112.53 24.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.503 -0.554 . . . . 15.94 109.503 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 t 70.28 23.85 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.332 -0.849 . . . . 13.01 110.564 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -164.67 151.57 11.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.98 -0.555 . . . . 12.34 109.656 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -162.19 165.37 35.94 Favored Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.349 -0.929 . . . . 7.52 112.669 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -117.18 134.13 55.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.686 0.279 . . . . 9.24 111.486 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.407 HG21 ' CE2' ' A' ' 53' ' ' PHE . 75.6 mt -106.37 122.84 60.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 7.75 110.058 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.493 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 6.5 mm100 -83.8 147.98 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.533 0.938 . . . . 11.8 113.533 -175.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.2 p -77.94 6.59 7.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.811 -1.54 . . . . 12.34 113.302 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -49.87 -48.66 51.19 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.584 0.587 . . . . 13.33 112.584 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.4 -3.51 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.735 -0.386 . . . . 11.9 112.005 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 28.4 tpt180 -152.48 139.38 19.03 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.991 -0.374 . . . . 12.99 109.991 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -73.03 49.81 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.984 0.364 . . . . 16.66 111.984 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.22 127.86 12.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.933 0.397 . . . . 12.09 111.201 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -108.66 102.31 11.38 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.312 -0.625 . . . . 12.51 109.312 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.47 HD12 ' CE1' ' A' ' 53' ' ' PHE . 71.1 mt -109.91 135.7 50.37 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.876 0.369 . . . . 8.76 111.332 -176.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -91.57 125.36 36.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.139 -0.689 . . . . 9.15 109.139 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -118.13 147.89 42.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.885 0.374 . . . . 6.85 110.518 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -99.08 158.88 15.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.208 -0.451 . . . . 9.99 109.939 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -70.83 -12.42 61.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.058 0.392 . . . . 9.93 112.058 -174.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -81.09 -13.3 58.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.31 0.576 . . . . 12.28 109.895 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -103.94 29.33 5.95 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.652 -0.704 . . . . 10.62 110.771 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -126.31 128.45 47.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.016 0.436 . . . . 8.78 110.949 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 t -101.36 115.65 31.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.716 -0.675 . . . . 8.97 110.818 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.65 -156.19 21.53 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.787 -0.72 . . . . 9.98 112.278 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -89.73 113.62 25.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.854 0.359 . . . . 12.43 110.621 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -68.11 -24.28 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.29 0.567 . . . . 11.58 109.921 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -81.51 -2.61 50.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.768 -0.651 . . . . 14.73 110.369 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -112.94 15.7 19.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.454 0.645 . . . . 13.3 109.716 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.8 tp -103.49 134.0 47.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.51 -0.922 . . . . 10.07 108.51 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HG3' ' HB2' ' A' ' 49' ' ' ASP . 21.2 ptmt -133.75 170.13 16.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.9 0.381 . . . . 13.13 111.116 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.0 mp -81.15 119.24 30.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.971 -0.559 . . . . 11.74 109.565 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.48 36.65 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.322 -0.711 . . . . 10.13 111.322 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.422 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 14.7 t70 -92.93 127.26 48.27 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.442 -0.379 . . . . 8.39 110.143 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -89.31 128.91 1.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.062 2.508 . . . . 7.28 112.929 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.49 161.05 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.166 -0.47 . . . . 4.74 111.207 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.42 128.69 56.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.848 -0.614 . . . . 7.09 109.516 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.47 ' CE1' HD12 ' A' ' 31' ' ' LEU . 44.5 p90 -132.14 155.58 47.9 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.097 0.475 . . . . 7.82 111.204 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 38.1 tt0 -103.24 120.76 41.34 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.611 -0.722 . . . . 11.59 109.592 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.17 116.33 28.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.116 -0.493 . . . . 12.41 109.853 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 p -139.96 153.29 46.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.103 0.477 . . . . 13.17 111.73 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -92.86 108.95 20.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.964 -0.562 . . . . 16.21 109.944 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.508 ' OD2' HG22 ' A' ' 61' ' ' THR . 14.3 t70 -73.97 110.82 8.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.027 0.441 . . . . 16.64 109.835 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 59' ' ' ARG . 3.3 mmp_? -79.97 -7.2 58.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.059 -0.519 . . . . 22.64 111.2 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.455 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 54.3 ttt180 -70.86 -59.13 2.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 21.43 110.471 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.508 HG22 ' OD2' ' A' ' 58' ' ' ASP . 15.1 t -92.97 -19.26 21.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.25 -0.432 . . . . 17.4 110.44 178.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.57 31.54 15.71 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.856 -0.688 . . . . 16.7 112.492 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -132.63 149.28 72.58 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.036 -0.357 . . . . 14.73 110.036 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.52 126.79 8.51 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.079 1.853 . . . . 12.6 111.468 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.8 pt -130.65 168.75 22.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.321 0.581 . . . . 11.73 111.295 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.19 156.53 17.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.2 -0.909 . . . . 8.91 108.88 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 8.4 t -79.45 -150.9 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.399 -0.364 . . . . 9.83 110.101 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -8.87 51.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.649 0.611 . . . . 11.32 112.649 -172.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.2 t 55.88 99.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.471 0.653 . . . . 6.11 111.165 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 m -99.46 125.11 45.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.092 0.472 . . . . 6.12 111.12 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 71' ' ' LYS . 14.1 mmmt -60.16 135.77 57.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.788 -0.642 . . . . 6.3 109.744 172.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.72 113.3 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.775 0.321 . . . . 5.77 110.791 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 60.12 72.26 0.78 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 115.279 -0.873 . . . . 5.69 111.496 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -88.3 -61.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.802 2.335 . . . . 6.86 112.43 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -99.78 -7.39 25.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.312 0.577 . . . . 8.49 110.13 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.632 HG12 ' HB1' ' A' ' 144' ' ' ALA . 6.2 t -79.6 113.26 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.533 . . . . 6.19 110.41 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 79' ' ' SER . 43.4 t -97.5 134.12 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.306 -0.406 . . . . 6.26 110.548 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -75.15 16.41 0.32 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.685 0.279 . . . . 6.05 111.504 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.51 ' H ' HG12 ' A' ' 77' ' ' VAL . 8.3 t 66.53 -2.3 1.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.812 0.845 . . . . 7.02 111.842 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 62.58 13.76 6.53 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.274 0.63 . . . . 7.07 111.621 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -129.62 118.03 21.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.268 -0.424 . . . . 6.68 109.858 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -95.67 124.32 39.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.063 -0.517 . . . . 6.43 109.862 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.82 164.97 15.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.284 0.564 . . . . 3.7 111.452 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.8 p -125.88 148.28 49.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.292 -0.867 . . . . 3.49 109.774 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.09 161.09 25.54 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.224 -0.989 . . . . 2.58 112.37 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.7 m -102.24 125.61 49.0 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.408 -0.59 . . . . 3.34 109.408 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 51.0 t -68.11 126.23 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 110.189 -0.3 . . . . 3.14 110.189 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.3 p -113.7 -17.02 12.21 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.799 0.333 . . . . 3.61 111.844 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.2 m -150.95 135.03 16.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.282 -0.261 . . . . 3.12 110.597 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -100.0 171.22 7.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 4.39 110.508 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 91' ' ' LEU . 1.8 pt? -124.67 144.25 50.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.256 -0.646 . . . . 3.62 109.256 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.485 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 34.0 ptt85 -88.32 108.83 19.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.102 0.953 . . . . 7.2 112.006 -172.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.1 p -140.75 -154.07 0.5 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.466 -1.243 . . . . 5.1 107.739 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.24 43.25 14.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.183 0.516 . . . . 7.53 110.573 169.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.0 p -73.26 -163.91 0.17 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.818 -0.628 . . . . 7.47 110.486 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.35 6.29 34.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.944 -0.571 . . . . 7.58 111.125 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -155.15 -45.29 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.886 0.328 . . . . 8.32 111.886 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -109.43 156.38 20.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.023 0.439 . . . . 7.26 111.509 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.76 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 7.9 p -154.01 141.17 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.783 -0.644 . . . . 5.54 109.373 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' A' ' 99' ' ' VAL . 3.9 pp 59.65 2.16 0.33 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.483 1.113 . . . . 7.28 112.909 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.77 -39.46 87.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.349 0.595 . . . . 7.54 110.0 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.412 ' O ' HG22 ' A' ' 105' ' ' THR . 5.9 m -82.38 90.22 6.67 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.568 -0.742 . . . . 5.41 109.842 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.9 p -87.8 8.34 26.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.178 0.513 . . . . 4.58 110.795 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -96.68 14.62 24.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.896 -0.593 . . . . 5.09 110.463 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 102' ' ' SER . 9.0 t -122.94 139.88 53.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.615 -0.513 . . . . 3.33 109.615 176.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 t -146.87 143.31 28.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.402 -0.363 . . . . 2.57 110.748 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -97.61 -162.38 31.36 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.723 -0.751 . . . . 1.66 111.918 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 82.9 mmt-85 -140.15 135.15 32.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.99 0.424 . . . . 3.03 111.15 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.26 130.7 68.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.657 -0.701 . . . . 1.88 109.444 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.7 t -109.35 116.3 31.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.86 -0.422 . . . . 3.49 109.86 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -122.57 132.76 54.45 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.411 -0.589 . . . . 3.51 109.411 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -107.05 109.73 21.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.788 -0.642 . . . . 5.1 109.49 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -163.99 147.74 9.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.86 -0.609 . . . . 4.78 110.438 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 62.53 21.01 12.36 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.441 0.463 . . . . 6.97 111.714 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.52 -0.97 87.21 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.732 -0.746 . . . . 5.1 111.99 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -101.89 139.09 37.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.074 0.464 . . . . 5.38 110.589 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 13.8 p -139.47 106.18 5.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.501 -0.772 . . . . 4.72 109.997 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -155.69 162.16 40.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.376 -0.375 . . . . 4.61 110.537 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -95.22 133.75 38.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.646 -0.706 . . . . 3.96 110.584 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 5.6 mp -106.25 130.77 22.44 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.448 -0.342 . . . . 2.75 110.636 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 13.1 Cg_exo -69.74 131.79 22.01 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.632 2.222 . . . . 2.3 111.246 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -138.78 145.39 40.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.978 0.418 . . . . 2.13 110.3 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 p -112.94 164.22 13.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.616 -0.72 . . . . 3.07 109.335 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -77.16 -20.06 56.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.885 0.328 . . . . 4.8 111.885 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.82 -13.83 61.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.897 0.332 . . . . 4.81 111.897 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 154' ' ' CYS . 7.2 t70 -101.11 -0.44 36.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.511 0.672 . . . . 3.84 110.161 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.5 t -82.38 107.32 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.223 0.535 . . . . 4.39 110.374 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.4 145.84 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.992 -0.549 . . . . 6.43 110.774 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.5 -15.98 59.4 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.672 -0.775 . . . . 5.91 112.074 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 62.28 34.8 15.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.102 0.477 . . . . 6.07 110.911 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.3 m -79.98 174.71 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.038 -0.528 . . . . 5.27 110.663 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -127.84 81.35 2.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.295 0.569 . . . . 5.78 110.238 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.3 pt? -68.44 148.91 49.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.207 -0.906 . . . . 3.62 111.09 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -133.21 139.81 47.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.287 -0.415 . . . . 6.93 109.961 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.626 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -55.62 121.32 8.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.164 0.506 . . . . 4.12 111.675 -173.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.65 -13.2 11.9 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.301 -0.863 . . . . 4.07 112.572 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -91.19 177.41 6.26 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.292 0.546 . . . . 4.06 109.864 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -116.97 116.58 27.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.089 0.471 . . . . 4.17 110.711 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.11 159.98 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.076 -0.511 . . . . 2.77 110.714 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.1 t -114.83 139.51 49.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.974 -0.75 . . . . 3.47 108.974 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -144.73 143.62 30.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.016 0.436 . . . . 3.35 110.149 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -98.95 119.2 37.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.579 -0.737 . . . . 5.34 109.937 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.8 mt -78.67 96.86 2.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.085 -0.507 . . . . 4.66 109.709 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.632 ' HB1' HG12 ' A' ' 76' ' ' VAL . . . -90.16 111.2 22.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.796 -0.638 . . . . 4.85 110.758 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 28.4 m -84.25 112.9 20.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.509 -0.769 . . . . 5.68 110.335 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.42 158.52 31.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.936 -0.574 . . . . 6.25 109.549 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -60.92 -20.27 61.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.99 0.424 . . . . 8.58 111.379 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 148' ' ' ARG . 2.7 mmt180 -78.26 -8.2 58.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 7.86 111.717 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.71 -1.96 84.48 Favored Glycine 0 C--O 1.227 -0.292 0 C-N-CA 120.824 -0.703 . . . . 5.59 112.328 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -100.4 132.4 45.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.902 -0.406 . . . . 5.18 109.902 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.481 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -150.76 178.78 8.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.534 -0.303 . . . . 4.28 110.847 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -150.36 -125.17 1.28 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.805 -0.918 . . . . 3.36 110.805 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -121.28 126.1 48.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.841 -0.429 . . . . 2.84 109.841 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.514 ' HA ' ' OD2' ' A' ' 126' ' ' ASP . 17.7 t -136.59 159.22 42.46 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.114 -0.328 . . . . 4.34 110.114 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 63.08 36.26 12.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.319 0.581 . . . . 5.75 110.558 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.8 mt -75.77 115.99 18.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.637 -0.711 . . . . 3.55 110.816 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -135.94 160.04 39.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.806 0.336 . . . . 5.96 110.165 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.9 tp -92.35 110.93 22.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 4.34 110.353 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -98.84 -57.55 2.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.782 -0.645 . . . . 4.97 110.686 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -111.17 96.63 31.39 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.244 -0.434 . . . . 5.37 110.022 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.14 158.25 23.45 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.233 1.956 . . . . 5.44 113.114 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -120.4 91.6 3.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.578 -0.737 . . . . 6.1 109.775 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -100.02 125.16 40.97 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.902 -0.59 . . . . 9.49 110.771 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.06 99.33 0.98 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.474 2.116 . . . . 8.39 112.001 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 115.853 -0.612 . . . . 10.27 110.637 178.673 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 111.783 -0.527 . . . . 21.66 111.783 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.1 -75.33 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.555 0.216 . . . . 20.17 110.454 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.21 -38.23 27.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.408 0.623 . . . . 18.5 109.667 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.4 65.94 8.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.619 -0.719 . . . . 16.62 109.886 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -85.39 -19.28 31.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.497 0.665 . . . . 18.35 110.329 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -83.01 84.98 7.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.297 -0.865 . . . . 16.2 110.738 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -85.73 129.2 34.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.998 0.428 . . . . 12.4 109.969 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.464 ' CD ' ' HE ' ' A' ' 27' ' ' ARG . 6.3 mm-40 -98.13 136.77 37.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.106 -0.497 . . . . 11.63 109.886 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 67.2 p -109.33 138.69 45.3 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 121.102 -0.239 . . . . 9.15 110.593 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 26' ' ' GLU . . . -150.86 -176.03 23.38 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.147 -1.025 . . . . 6.81 112.45 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.0 mt -132.43 155.41 41.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.336 -0.987 . . . . 10.17 108.336 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.76 118.86 34.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.508 -0.477 . . . . 8.73 110.387 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.586 ' OE1' ' HD2' ' A' ' 30' ' ' ARG . 5.8 pt-20 -82.58 -32.59 28.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.376 -0.374 . . . . 10.86 111.089 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -159.19 158.15 32.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.28 -0.418 . . . . 14.06 109.899 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -125.44 118.16 25.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.107 -0.497 . . . . 11.73 110.984 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -105.57 178.95 4.41 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.488 -1.301 . . . . 11.36 107.488 172.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -92.1 138.46 31.52 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 119.917 -0.713 . . . . 15.94 109.986 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.3 p 74.62 -23.07 0.24 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.185 1.394 . . . . 13.01 112.032 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 49.5 p90 -151.8 158.59 43.5 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.872 0.368 . . . . 12.34 111.303 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.44 178.24 21.73 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.198 -0.761 . . . . 7.52 111.198 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -119.54 141.68 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.137 0.468 . . . . 9.24 111.542 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.443 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 67.4 mt -103.28 125.35 57.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.449 -0.796 . . . . 7.75 110.006 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.558 ' HG2' ' H ' ' A' ' 25' ' ' CYS . 34.8 tt0 -80.59 134.77 35.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.439 -0.8 . . . . 11.8 111.833 -172.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 p -78.96 2.33 20.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.718 -1.128 . . . . 12.34 112.231 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.558 ' H ' ' HG2' ' A' ' 23' ' ' GLN . 49.2 t -60.17 -29.96 69.02 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.059 -0.4 . . . . 13.33 110.949 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.428 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 19.8 tp10 -103.99 -43.41 5.29 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.446 -0.343 . . . . 11.9 110.914 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HG2' ' N ' ' A' ' 28' ' ' GLN . 28.5 ttt180 -95.09 155.48 16.71 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 110.16 -0.311 . . . . 12.99 110.16 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.5 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 87.2 mt-30 -77.62 20.06 0.34 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.282 0.475 . . . . 16.66 112.282 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.443 ' HB3' ' NH1' ' A' ' 27' ' ' ARG . . . -169.82 144.85 2.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.33 -0.395 . . . . 12.09 110.335 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.586 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 11.2 ttp180 -90.34 148.45 22.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 12.51 109.927 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -144.57 163.86 32.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.362 0.265 . . . . 8.76 110.676 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -121.1 149.3 42.96 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.953 -0.758 . . . . 9.15 108.953 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -138.98 153.38 48.16 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.852 -0.339 . . . . 6.85 110.237 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.512 ' HB2' ' OE1' ' A' ' 37' ' ' GLN . 96.8 m-70 -98.6 159.51 14.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.98 -0.748 . . . . 9.99 108.98 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -70.27 -9.65 56.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.134 0.492 . . . . 9.93 110.979 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.1 m -75.13 -15.37 60.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.02 0.438 . . . . 12.28 110.162 174.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.512 ' OE1' ' HB2' ' A' ' 34' ' ' HIS . 25.3 mp0 -113.28 36.95 3.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.002 -0.545 . . . . 10.62 110.938 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -125.32 116.31 21.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.852 0.358 . . . . 8.78 110.13 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 68' ' ' GLN . 22.3 t -87.04 95.36 9.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.017 -0.538 . . . . 8.97 110.856 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.1 175.57 14.48 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.73 -0.668 . . . . 9.98 111.613 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.04 122.25 16.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.679 0.276 . . . . 12.43 110.353 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.6 tp -66.08 -18.81 24.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.227 0.537 . . . . 11.58 110.335 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.7 -25.71 65.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.686 . . . . 14.73 110.637 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -83.88 0.25 48.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 13.3 110.459 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.9 tp -104.04 123.01 46.45 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.051 0.453 . . . . 10.07 110.472 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 12.9 mmmm -120.17 162.29 19.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.612 -0.722 . . . . 13.13 110.225 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.5 mt -71.8 114.81 11.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.993 -0.548 . . . . 11.74 109.793 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.07 -4.12 28.63 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.905 -0.664 . . . . 10.13 111.679 -173.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -80.01 133.75 57.46 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-O 120.621 0.248 . . . . 8.39 110.41 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.6 142.03 7.93 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.168 2.578 . . . . 7.28 113.102 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.81 161.14 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.65 -0.705 . . . . 4.74 110.588 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.72 135.06 53.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.065 0.46 . . . . 7.09 109.801 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -144.78 158.3 43.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 7.82 110.985 -170.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 2.5 mp0 -97.98 122.6 41.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.385 -0.37 . . . . 11.59 110.546 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.445 ' HG2' ' NH2' ' A' ' 27' ' ' ARG . 14.6 tpt -88.41 107.89 19.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.481 -0.563 . . . . 12.41 109.481 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.6 p -132.75 165.67 24.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.903 0.382 . . . . 13.17 111.149 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -118.64 122.28 42.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.1 -0.704 . . . . 16.21 109.1 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -90.65 134.58 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.133 0.492 . . . . 16.64 111.654 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -79.94 -13.8 59.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.474 -0.785 . . . . 22.64 112.757 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -92.24 -43.29 9.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 21.43 111.107 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -86.7 -32.9 20.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.356 -0.384 . . . . 17.4 111.483 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.49 19.34 68.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.024 -0.608 . . . . 16.7 112.122 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -122.38 158.26 56.49 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.263 -0.273 . . . . 14.73 110.263 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.28 126.53 8.53 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.33 2.02 . . . . 12.6 110.616 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.09 154.34 35.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.925 0.393 . . . . 11.73 111.338 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -99.83 158.81 15.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.865 -0.607 . . . . 8.91 109.997 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 p -73.75 -150.04 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.16 0.505 . . . . 9.83 111.592 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 39' ' ' SER . 30.1 pt20 -70.95 -5.35 30.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.817 -0.628 . . . . 11.32 112.277 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.9 t 50.95 89.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.714 0.769 . . . . 6.11 111.219 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.6 m -90.61 135.94 33.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.762 -0.654 . . . . 6.12 111.16 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -72.6 123.15 22.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.054 -0.721 . . . . 6.3 109.054 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.5 mt -52.94 113.01 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.237 0 O-C-N 123.805 0.69 . . . . 5.77 111.845 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.63 141.66 42.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 5.69 109.893 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.62 139.36 33.93 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.656 2.237 . . . . 6.86 113.304 -176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -91.64 179.56 5.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.464 -0.789 . . . . 8.49 109.867 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.531 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 9.9 p -80.96 156.38 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.691 -0.485 . . . . 6.19 109.691 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 39.6 t -76.93 108.07 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.035 0.445 . . . . 6.26 111.369 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.1 mt -104.24 -48.72 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 6.05 111.289 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.515 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 66.2 m -99.72 86.94 3.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.312 0.486 . . . . 7.02 112.312 -175.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 79' ' ' SER . 0.9 OUTLIER -177.55 116.04 0.09 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.095 0.958 . . . . 7.07 108.809 174.079 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 66.34 64.36 0.51 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.813 0.816 . . . . 6.68 109.885 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 6.4 ptm180 -78.32 107.39 10.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.351 -0.841 . . . . 6.43 110.322 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.4 m -93.7 160.49 2.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.986 -0.552 . . . . 3.7 111.76 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 p -119.51 139.39 52.18 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.285 -0.871 . . . . 3.49 109.426 171.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.92 163.69 25.27 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.277 -0.963 . . . . 2.58 112.081 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.8 m -107.76 125.16 51.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.493 -0.558 . . . . 3.34 109.493 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.551 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 1.6 t -66.47 131.2 32.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.05 -0.722 . . . . 3.14 109.05 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.8 p -109.45 -16.54 13.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.052 0.453 . . . . 3.61 110.756 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.8 m -154.44 122.7 6.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.291 -0.413 . . . . 3.12 110.859 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' A' ' 134' ' ' ARG . 4.7 mp0 -95.45 135.25 37.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.463 -0.335 . . . . 4.39 110.84 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 91' ' ' LEU . 1.7 pt? -82.99 76.4 9.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.706 1.241 . . . . 3.62 109.414 170.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -71.71 176.56 4.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.033 -1.439 . . . . 7.2 110.306 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.9 p -81.19 97.12 7.46 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.018 -0.734 . . . . 5.1 109.018 170.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -92.44 69.61 5.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.793 0.806 . . . . 7.53 110.458 -172.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 61.2 m -149.65 178.39 8.89 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.699 -1.137 . . . . 7.47 108.542 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.75 76.98 2.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.502 0.191 . . . . 7.58 110.547 177.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 t30 74.44 -20.45 0.32 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.596 0.758 . . . . 8.32 111.903 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 95' ' ' SER . 18.9 m120 -83.8 168.81 15.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.149 0.5 . . . . 7.26 111.146 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 p -114.24 132.14 64.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.83 -0.623 . . . . 5.54 109.495 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.0 tp -158.11 -75.47 0.08 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.418 0.628 . . . . 7.28 112.097 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -77.85 19.68 0.39 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.186 -0.916 . . . . 7.54 112.405 -171.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.18 -0.18 53.77 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 111.961 0.356 . . . . 5.41 111.961 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.9 p -106.67 -32.91 7.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.881 0.372 . . . . 4.58 111.235 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.11 -25.61 55.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 5.09 110.905 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 91' ' ' LEU . 4.8 t -95.85 160.47 14.46 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.977 -0.556 . . . . 3.33 109.641 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.4 m -134.28 134.51 41.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.542 -0.299 . . . . 2.57 110.373 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.86 168.9 54.91 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.896 -0.668 . . . . 1.66 112.257 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -128.81 122.6 30.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.808 0.337 . . . . 3.03 110.915 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 99.5 mt -112.17 127.67 69.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.773 -0.825 . . . . 1.88 108.773 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.7 t -111.53 125.8 54.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.8 0.333 . . . . 3.49 110.288 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 1.0 OUTLIER -129.41 145.81 51.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.171 -0.677 . . . . 3.51 109.171 178.177 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -118.2 112.37 20.05 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.255 -0.646 . . . . 5.1 109.255 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 23.0 t-20 -126.78 108.65 11.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 4.78 110.476 -175.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 62.4 30.44 17.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.028 -0.533 . . . . 6.97 111.994 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.03 -0.47 60.49 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.962 -0.637 . . . . 5.1 113.95 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 5.7 pt-20 -108.71 137.64 46.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.667 0.733 . . . . 5.38 109.718 172.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 3.8 p -141.03 92.54 2.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.053 -0.521 . . . . 4.72 110.776 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -98.02 163.52 12.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.964 -0.562 . . . . 4.61 110.345 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -98.44 121.17 40.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.29 -0.633 . . . . 3.96 109.29 176.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.0 mt -103.86 130.34 23.61 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.157 -0.474 . . . . 2.75 110.934 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.54 141.61 17.76 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.709 2.273 . . . . 2.3 111.997 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -146.78 144.26 29.24 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.417 -0.586 . . . . 2.13 109.417 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.426 ' HA ' HD11 ' A' ' 91' ' ' LEU . 37.9 p -105.89 173.25 6.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.677 -0.49 . . . . 3.07 109.677 175.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -71.04 -19.48 62.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.394 0.616 . . . . 4.8 109.95 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -81.03 -10.8 59.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.02 -0.991 . . . . 4.81 111.43 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -87.88 -10.25 51.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.93 0.395 . . . . 3.84 110.711 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.6 t -87.09 120.3 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.826 -0.624 . . . . 4.39 110.825 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -106.45 153.86 21.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.677 -0.692 . . . . 6.43 110.222 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.75 -1.57 85.46 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.96 -0.638 . . . . 5.91 112.31 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 63.61 17.11 10.17 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.103 0.561 . . . . 6.07 111.066 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.15 147.94 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.117 0.484 . . . . 5.27 110.892 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -106.83 108.6 20.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.2 -0.454 . . . . 5.78 110.564 -177.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.597 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -106.36 150.36 26.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.862 -0.608 . . . . 3.62 110.169 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.569 ' HA ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -149.96 175.31 11.79 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.786 -0.365 . . . . 6.93 110.511 171.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.551 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -69.81 119.5 14.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.677 0.275 . . . . 4.12 111.087 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.89 -7.54 11.94 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.859 -0.686 . . . . 4.07 113.567 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -111.6 173.57 6.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.898 0.849 . . . . 4.06 110.584 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -110.93 116.41 31.18 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.173 0.511 . . . . 4.17 111.519 -173.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.35 157.49 18.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.634 -0.712 . . . . 2.77 110.906 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.449 ' HB2' ' CG ' ' A' ' 159' ' ' GLU . 8.0 t -119.2 134.44 55.2 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.02 -0.733 . . . . 3.47 109.02 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -132.73 144.91 50.61 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.892 0.377 . . . . 3.35 110.237 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -95.42 112.26 24.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.779 -0.646 . . . . 5.34 109.699 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 57.8 mt -79.25 96.1 2.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.83 -0.623 . . . . 4.66 110.222 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.693 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -81.54 108.23 14.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.189 -0.46 . . . . 4.85 110.516 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 m -85.16 110.36 18.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.037 0.446 . . . . 5.68 110.862 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -75.14 155.37 37.08 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.108 -0.701 . . . . 6.25 109.108 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -61.22 -23.42 65.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.939 0.348 . . . . 8.58 111.939 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -72.21 -23.88 61.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.997 0.427 . . . . 7.86 110.414 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 96.3 10.76 55.57 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.048 -0.596 . . . . 5.59 112.701 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.01 132.95 46.18 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.827 -0.435 . . . . 5.18 109.827 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.48 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -155.44 -178.45 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.857 -0.611 . . . . 4.28 110.887 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.96 -139.79 2.78 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.854 -0.898 . . . . 3.36 110.854 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.42 110.05 21.92 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.861 -0.422 . . . . 2.84 109.861 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 59.0 m -117.87 151.14 37.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.417 -0.356 . . . . 4.34 110.704 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 56.74 51.58 10.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.856 -0.611 . . . . 5.75 110.958 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 133' ' ' LEU . 4.6 mp -66.54 115.72 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 3.55 110.364 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -114.21 157.91 22.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.165 -0.47 . . . . 5.96 109.98 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.2 tp -97.56 123.25 41.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.401 -0.363 . . . . 4.34 110.354 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 140' ' ' SER . 21.3 mm-40 -102.33 -53.37 2.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.986 0.422 . . . . 4.97 111.192 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -136.34 102.62 9.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.187 -0.461 . . . . 5.37 110.75 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.89 160.9 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.418 2.079 . . . . 5.44 111.778 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.99 92.96 2.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.222 -0.444 . . . . 6.1 110.031 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -99.05 124.71 44.39 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.96 -0.564 . . . . 9.49 109.947 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.04 129.48 19.59 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.42 2.08 . . . . 8.39 111.549 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 116.411 -0.359 . . . . 10.27 111.04 178.587 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.42 0 N-CA-C 111.886 -0.486 . . . . 21.66 111.886 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.68 -12.55 60.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.913 0.387 . . . . 20.17 111.124 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -81.83 -14.78 55.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.217 0.532 . . . . 18.5 109.901 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.48 19.88 4.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 16.62 111.545 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -152.81 128.77 10.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.727 0.775 . . . . 18.35 110.411 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -133.51 137.02 45.41 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.611 -1.177 . . . . 16.2 109.043 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -91.22 117.4 29.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.375 0.607 . . . . 12.4 111.013 -177.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -100.74 144.81 29.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.635 -0.711 . . . . 11.63 110.003 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p -113.68 136.11 53.19 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.711 0.291 . . . . 9.15 110.962 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.38 177.01 28.73 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.546 -0.835 . . . . 6.81 112.622 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -128.82 140.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.255 -0.646 . . . . 10.17 109.255 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.57 118.09 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.837 -0.345 . . . . 8.73 110.64 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 22.3 tt0 -83.04 -44.93 14.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 10.86 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -157.82 137.01 11.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.44 -0.8 . . . . 14.06 109.83 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.0 mt -99.55 121.14 40.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.445 0.64 . . . . 11.73 111.306 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.29 -178.45 3.65 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.834 -1.075 . . . . 11.36 108.421 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -88.78 111.11 21.62 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.562 -0.455 . . . . 15.94 110.33 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.0 t 79.03 3.43 2.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.595 -1.184 . . . . 13.01 111.429 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -158.92 153.19 23.89 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 110.276 -0.268 . . . . 12.34 110.276 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.95 162.79 27.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.423 -0.894 . . . . 7.52 112.407 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -104.44 136.45 43.97 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.058 0.456 . . . . 9.24 110.968 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -103.64 127.71 57.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.651 -0.704 . . . . 7.75 110.384 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -71.77 141.81 49.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.215 -0.902 . . . . 11.8 111.644 -178.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.8 p -78.14 2.78 16.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.626 -1.17 . . . . 12.34 111.408 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.4 t -50.3 -39.33 45.36 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.659 0.614 . . . . 13.33 112.659 -170.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -105.55 7.53 32.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.045 0.387 . . . . 11.9 112.045 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.404 ' HB3' ' H ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -151.2 -159.37 1.02 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.806 0.336 . . . . 12.99 111.143 -176.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.404 ' H ' ' HB3' ' A' ' 27' ' ' ARG . 41.5 mt-30 -120.66 22.41 11.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.689 0.28 . . . . 16.66 111.291 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.13 135.64 34.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.021 0.439 . . . . 12.09 111.458 -173.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -106.92 102.58 11.93 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.479 -0.934 . . . . 12.51 108.479 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -110.88 162.18 15.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.208 0.528 . . . . 8.76 111.379 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -126.25 139.41 53.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.381 -0.827 . . . . 9.15 109.333 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -132.59 152.37 51.65 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.053 -0.351 . . . . 6.85 110.053 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -91.98 161.4 14.82 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.204 -0.665 . . . . 9.99 109.204 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -71.71 -8.23 52.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 9.93 111.677 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -79.34 -12.21 59.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.368 0.604 . . . . 12.28 109.517 172.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -103.38 36.49 2.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.547 -0.751 . . . . 10.62 110.133 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -138.09 139.54 39.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.063 -0.347 . . . . 8.78 110.063 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t -121.69 119.48 31.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.25 -0.432 . . . . 8.97 110.552 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.57 -161.94 20.8 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.893 -0.67 . . . . 9.98 112.337 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -77.45 113.53 15.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.754 0.312 . . . . 12.43 110.836 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -72.35 -25.71 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.048 0.451 . . . . 11.58 110.911 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.71 -12.29 59.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.234 0.54 . . . . 14.73 110.332 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.17 -7.48 55.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 13.3 109.889 177.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.2 tp -93.17 124.79 37.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.593 -0.731 . . . . 10.07 109.944 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -132.12 178.26 6.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.028 0.442 . . . . 13.13 110.671 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.2 mp -73.8 129.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.946 -0.57 . . . . 11.74 109.745 177.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.65 -1.53 66.22 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.674 -0.774 . . . . 10.13 111.946 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -91.34 123.32 64.41 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.823 -0.436 . . . . 8.39 109.823 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.97 142.98 32.12 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.985 2.457 . . . . 7.28 113.808 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.408 HG12 ' HE3' ' A' ' 71' ' ' LYS . 18.7 m -134.85 156.79 40.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.63 -0.714 . . . . 4.74 110.91 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -116.6 138.6 51.3 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.483 -0.562 . . . . 7.09 109.483 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' HB3' HG22 ' A' ' 69' ' ' VAL . 33.3 p90 -150.16 176.6 10.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.52 -0.309 . . . . 7.82 110.688 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 26.7 mt-10 -118.88 132.86 56.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.22 -0.659 . . . . 11.59 109.22 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.5 tpt -93.59 113.85 26.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.001 -0.545 . . . . 12.41 109.64 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 p -135.8 138.45 42.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.587 0.588 . . . . 13.17 112.587 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -95.35 110.7 22.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.078 -0.51 . . . . 16.21 109.709 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.98 121.71 32.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.8 0.333 . . . . 16.64 111.076 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -79.23 -20.95 46.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 22.64 110.964 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HE ' ' C ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -67.09 -53.86 26.91 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.392 -0.596 . . . . 21.43 109.392 -177.061 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.8 p -86.36 -29.69 22.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.149 -0.478 . . . . 17.4 111.172 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.86 31.74 28.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.729 -0.748 . . . . 16.7 111.81 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -135.12 141.34 37.73 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.133 -0.321 . . . . 14.73 110.133 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.22 125.31 10.71 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.809 1.673 . . . . 12.6 110.642 172.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.13 162.6 27.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.245 0.545 . . . . 11.73 111.816 -174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.42 173.41 6.77 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.453 -0.794 . . . . 8.91 110.779 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 22.7 t -87.26 -160.97 0.64 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.983 -0.553 . . . . 9.83 110.114 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -83.49 25.35 0.76 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.693 -0.23 . . . . 11.32 111.491 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 53' ' ' PHE . 43.1 t 30.02 96.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.693 1.197 . . . . 6.11 113.713 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -91.83 141.93 28.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.231 0.539 . . . . 6.12 110.761 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HE3' HG12 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -76.16 110.03 10.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.802 -0.635 . . . . 6.3 111.44 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.92 -70.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.498 -0.774 . . . . 5.77 110.372 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -165.06 99.41 0.81 Allowed Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-N 116.245 -0.434 . . . . 5.69 111.164 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.16 153.98 18.99 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.585 1.523 . . . . 6.86 109.838 167.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 146' ' ' ASN . 19.0 pt-20 -104.72 175.82 5.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.134 -0.627 . . . . 8.49 111.306 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.606 HG13 ' HB1' ' A' ' 144' ' ' ALA . 45.0 t 53.26 59.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 122.688 1.232 . . . . 6.19 109.246 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 t -88.34 114.73 27.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 113.831 -1.532 . . . . 6.26 110.649 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.67 -18.14 58.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.005 0.431 . . . . 6.05 110.317 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 t -95.5 52.49 1.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 7.02 110.694 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.47 -68.2 0.92 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.953 -0.567 . . . . 7.07 110.343 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -152.52 106.13 3.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.899 -0.591 . . . . 6.68 109.627 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -95.04 133.38 38.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.606 -0.516 . . . . 6.43 109.606 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.98 169.07 20.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.204 0.526 . . . . 3.7 111.202 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.4 p -118.7 144.57 46.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.496 -0.775 . . . . 3.49 109.502 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.45 170.2 23.99 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.076 -1.059 . . . . 2.58 112.268 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.9 m -121.74 132.06 54.42 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.833 -0.432 . . . . 3.34 109.833 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.632 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 48.8 t -65.25 126.34 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.322 -0.399 . . . . 3.14 110.501 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.0 p -111.19 -16.63 13.39 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.857 0.361 . . . . 3.61 111.199 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.8 m -153.65 130.33 10.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.237 -0.438 . . . . 3.12 109.916 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -176.86 3.2 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.274 0.359 . . . . 4.39 111.093 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.0 mt -87.24 162.69 17.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.97 0.414 . . . . 3.62 111.072 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -109.02 4.53 23.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.315 0.579 . . . . 7.2 110.729 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.474 HG23 HG21 ' A' ' 105' ' ' THR . 38.8 p -94.21 175.43 6.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.419 -0.355 . . . . 5.1 111.183 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 71.16 3.31 4.6 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.507 -0.769 . . . . 7.53 111.811 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.8 m -87.65 106.67 18.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.472 -0.331 . . . . 7.47 110.285 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 55.89 64.67 1.66 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.233 -0.439 . . . . 7.58 111.329 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.45 0.9 0.07 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.97 1.308 . . . . 8.32 113.492 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -82.76 83.1 7.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.438 0.637 . . . . 7.26 110.711 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.4 m -107.3 163.18 5.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.49 -0.777 . . . . 5.54 110.544 176.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.6 tp -146.64 111.71 5.4 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.503 -0.555 . . . . 7.28 109.503 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -53.65 -39.82 65.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.212 -0.904 . . . . 7.54 110.944 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.5 m -65.8 97.08 0.32 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.036 -0.529 . . . . 5.41 109.947 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.0 m -77.33 61.15 2.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.067 -0.515 . . . . 4.58 111.294 -176.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -91.16 -7.91 50.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.131 0.491 . . . . 5.09 110.731 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.474 HG21 HG23 ' A' ' 93' ' ' THR . 6.1 t -90.58 118.34 29.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.074 -0.713 . . . . 3.33 109.074 172.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.11 125.51 44.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.429 -0.35 . . . . 2.57 110.721 -175.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -81.65 176.74 54.16 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.667 -0.778 . . . . 1.66 111.617 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -134.4 130.49 36.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 3.03 111.386 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.7 mt -112.57 129.11 68.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.458 -0.792 . . . . 1.88 108.961 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -107.28 132.74 52.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.616 0.246 . . . . 3.49 110.479 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.66 156.04 47.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.731 -0.84 . . . . 3.51 108.731 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.05 125.74 54.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.754 -0.462 . . . . 5.1 109.754 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 47.9 t30 -138.68 135.94 35.35 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.545 -0.909 . . . . 4.78 108.545 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 114' ' ' ARG . 9.2 mtp180 63.79 18.54 11.21 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.519 0.512 . . . . 6.97 111.8 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.33 3.73 78.2 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.668 -0.777 . . . . 5.1 112.171 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -123.11 141.29 52.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.111 0.482 . . . . 5.38 110.598 178.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 13.9 p -105.11 136.67 44.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.944 -0.571 . . . . 4.72 110.865 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -128.69 172.58 11.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.924 -0.58 . . . . 4.61 110.121 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.85 124.39 40.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.964 -0.562 . . . . 3.96 110.228 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 5.6 mp -104.36 131.45 21.88 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 110.18 -0.304 . . . . 2.75 110.18 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 3.6 Cg_exo -75.96 132.12 13.87 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.945 2.43 . . . . 2.3 111.55 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -138.5 153.42 48.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.067 0.46 . . . . 2.13 110.642 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.5 p -118.11 -175.16 2.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.878 -0.601 . . . . 3.07 110.121 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -17.65 61.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 4.8 110.651 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -82.82 -23.84 33.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.687 -0.688 . . . . 4.81 111.066 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -77.39 -26.09 51.46 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.281 -0.418 . . . . 3.84 111.364 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.83 116.22 47.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.646 0.736 . . . . 4.39 111.119 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.87 163.61 12.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.435 -0.802 . . . . 6.43 109.413 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.31 -9.52 30.99 Favored Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.69 -0.767 . . . . 5.91 112.521 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.1 t30 66.14 16.98 10.65 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.533 0.682 . . . . 6.07 110.655 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 t -78.12 120.35 28.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.808 -0.441 . . . . 5.27 109.808 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -81.57 119.56 23.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.934 0.397 . . . . 5.78 110.933 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 133' ' ' LEU . 1.8 pt? -115.56 149.24 38.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.424 -0.807 . . . . 3.62 110.679 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.606 ' HD2' ' OD1' ' A' ' 137' ' ' ASP . 0.0 OUTLIER -137.18 155.9 48.98 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.962 -0.755 . . . . 6.93 108.962 174.26 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.632 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -57.32 121.82 11.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.044 0.449 . . . . 4.12 110.835 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.26 -13.23 11.18 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.86 -0.686 . . . . 4.07 113.302 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.606 ' OD1' ' HD2' ' A' ' 134' ' ' ARG . 6.4 p30 -95.32 174.94 6.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.142 0.971 . . . . 4.06 110.216 172.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -110.17 122.27 47.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 4.17 111.381 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.28 150.68 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.018 -0.537 . . . . 2.77 110.929 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.6 t -120.92 133.83 55.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.113 -0.699 . . . . 3.47 109.113 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -137.37 143.26 41.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.021 0.438 . . . . 3.35 110.825 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -94.86 124.58 38.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.518 -0.764 . . . . 5.34 109.628 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.33 99.16 3.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.364 0.602 . . . . 4.66 110.582 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.606 ' HB1' HG13 ' A' ' 76' ' ' VAL . . . -89.79 109.32 20.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.196 -0.911 . . . . 4.85 110.867 -176.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.2 m -80.29 113.97 18.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.103 -0.498 . . . . 5.68 111.908 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 20.5 m-20 -66.24 159.05 27.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.402 -0.363 . . . . 6.25 110.068 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -31.06 67.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.955 0.407 . . . . 8.58 111.263 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -77.04 -13.33 59.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.084 -0.507 . . . . 7.86 111.17 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.59 5.65 78.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.571 -0.823 . . . . 5.59 111.434 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 5.1 m-20 -107.92 120.99 43.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.325 . . . . 5.18 110.279 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.506 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.1 178.35 9.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.299 -0.41 . . . . 4.28 110.623 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -131.36 -112.96 1.5 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.455 -0.658 . . . . 3.36 111.455 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -123.11 137.3 54.95 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.526 -0.546 . . . . 2.84 109.526 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 84.1 m -139.81 156.57 46.67 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.2 -0.2 . . . . 4.34 110.896 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 57.46 44.42 21.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.881 0.738 . . . . 5.75 111.045 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.73 114.89 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.68 -0.691 . . . . 3.55 110.729 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -119.48 131.12 55.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.208 -0.451 . . . . 5.96 110.554 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.19 116.13 22.78 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.96 -0.756 . . . . 4.34 108.96 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -95.42 -43.99 7.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.76 0.281 . . . . 4.97 111.76 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -126.29 96.26 36.9 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 5.37 110.001 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.35 155.12 14.29 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.759 2.306 . . . . 5.44 113.4 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.54 104.76 14.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.632 -0.713 . . . . 6.1 109.822 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -151.97 161.04 30.57 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.241 -0.436 . . . . 9.49 110.813 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.52 124.15 12.05 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.368 2.045 . . . . 8.39 111.626 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 116.366 -0.379 . . . . 10.27 110.304 178.855 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 111.993 -0.443 . . . . 21.66 111.993 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.56 97.86 4.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.022 0.439 . . . . 20.17 110.794 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -103.53 -38.15 7.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.675 -0.693 . . . . 18.5 109.608 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 46.86 35.68 3.39 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.866 1.432 . . . . 16.62 114.866 166.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -77.97 -22.01 50.07 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.798 -0.564 . . . . 18.35 110.367 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -80.69 89.12 5.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.567 -0.742 . . . . 16.2 111.454 -176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -119.87 105.81 11.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.478 -0.783 . . . . 12.4 109.374 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.524 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 3.5 pt-20 -121.73 166.73 13.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 11.63 110.729 -173.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 80.6 p -108.44 156.84 18.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.479 0.548 . . . . 9.15 112.479 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.82 -173.38 30.41 Favored Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 110.839 -0.904 . . . . 6.81 110.839 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 23' ' ' GLN . 12.6 pt -128.52 152.63 36.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 117.158 0.479 . . . . 10.17 110.327 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.07 127.33 28.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.76 0.314 . . . . 8.73 110.888 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.504 ' HA ' ' HG2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -68.95 -56.24 8.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.677 -0.692 . . . . 10.86 109.284 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -169.1 166.54 10.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.791 -1.095 . . . . 14.06 108.432 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -112.0 126.29 54.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.215 0.531 . . . . 11.73 111.521 -175.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 3.0 mm? -122.16 -179.02 4.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.946 -1.024 . . . . 11.36 108.598 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -88.71 124.57 34.24 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.007 -0.433 . . . . 15.94 110.114 -177.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m 78.39 -35.86 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.959 0.903 . . . . 13.01 112.169 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 17.5 p90 -131.79 151.57 51.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.45 . . . . 12.34 111.248 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.08 172.95 23.21 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.844 -0.903 . . . . 7.52 110.844 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 68.2 m-85 -119.49 155.22 32.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.049 0.425 . . . . 9.24 110.742 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.7 mt -111.69 128.77 68.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.97 -0.559 . . . . 7.75 110.141 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.504 ' HG2' ' HA ' ' A' ' 13' ' ' GLU . 2.5 mm-40 -74.79 132.03 41.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.309 0.576 . . . . 11.8 111.525 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.2 p -80.6 1.61 29.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.161 -0.927 . . . . 12.34 111.861 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 70.9 m -52.77 -42.21 64.77 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.604 0.24 . . . . 13.33 111.621 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.88 -42.84 14.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.234 0.54 . . . . 11.9 111.148 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HE ' ' CD ' ' A' ' 8' ' ' GLU . 31.5 tpt180 -132.34 142.29 49.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.077 -0.51 . . . . 12.99 109.779 -174.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.92 52.69 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.285 0.476 . . . . 16.66 112.285 -175.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.78 101.74 2.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.906 0.384 . . . . 12.09 110.428 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -85.91 100.91 12.42 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.293 -1.003 . . . . 12.51 108.293 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.8 mt -110.8 163.42 13.8 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.497 -0.774 . . . . 8.76 111.457 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -115.12 135.31 54.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.02 -0.733 . . . . 9.15 109.02 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -132.89 136.05 45.95 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.767 -0.457 . . . . 6.85 109.767 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 73.2 m80 -84.92 164.4 18.37 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.467 -0.568 . . . . 9.99 109.467 178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -70.07 -10.23 58.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.951 0.405 . . . . 9.93 110.71 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.6 p -84.12 -9.04 58.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.007 -0.542 . . . . 12.28 110.077 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -108.73 26.63 10.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.515 -0.766 . . . . 10.62 110.339 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -130.68 130.02 43.35 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.688 -0.405 . . . . 8.78 110.087 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 15.6 m -93.35 107.79 19.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.725 -0.671 . . . . 8.97 110.493 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.74 -156.34 22.06 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.429 -0.891 . . . . 9.98 113.15 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -93.55 117.85 30.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.17 0.509 . . . . 12.43 111.803 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.04 -22.63 10.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.492 -0.776 . . . . 11.58 110.319 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.95 -40.11 92.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.097 -0.501 . . . . 14.73 111.42 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.8 m80 -97.05 12.15 33.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.182 -0.463 . . . . 13.3 110.198 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.64 136.28 33.08 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.399 -0.593 . . . . 10.07 109.399 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.512 ' HE2' ' HB2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -130.41 157.49 42.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.241 0.544 . . . . 13.13 111.29 -174.167 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.6 mt -69.25 141.72 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.241 -0.89 . . . . 11.74 110.969 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.35 11.47 66.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.438 -0.886 . . . . 10.13 112.248 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.512 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 6.5 t70 -84.97 131.65 48.24 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.956 -0.143 . . . . 8.39 111.016 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.17 120.09 5.56 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.766 2.31 . . . . 7.28 112.864 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.564 HG12 ' HE3' ' A' ' 71' ' ' LYS . 27.8 m -128.45 162.45 35.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.893 -0.594 . . . . 4.74 110.451 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 1.2 pt-20 -113.22 139.57 48.68 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.369 -0.604 . . . . 7.09 109.369 173.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CE1' ' HG3' ' A' ' 8' ' ' GLU . 31.2 p90 -132.08 139.58 48.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.714 0.768 . . . . 7.82 111.784 -177.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 39.1 tt0 -88.9 104.87 17.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.847 -1.069 . . . . 11.59 108.7 174.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 13.7 tpt -88.45 114.85 25.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.197 -0.456 . . . . 12.41 110.473 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.6 p -142.85 167.12 22.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.057 0.456 . . . . 13.17 111.283 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 73.6 m-85 -112.47 109.41 18.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.901 -0.59 . . . . 16.21 109.508 175.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.22 125.53 31.05 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.839 -0.345 . . . . 16.64 110.212 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -78.35 -17.92 55.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.413 -0.358 . . . . 22.64 111.664 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 23.7 tpt180 -77.8 -42.55 33.46 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.6 -0.44 . . . . 21.43 110.007 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.4 p -84.35 -33.59 23.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.023 -0.535 . . . . 17.4 110.597 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.53 24.72 62.3 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.763 -0.653 . . . . 16.7 112.11 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -126.63 148.1 63.33 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.974 -0.38 . . . . 14.73 109.974 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HB3' ' CE1' ' A' ' 57' ' ' TYR . 43.1 Cg_endo -70.27 124.73 11.15 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 121.728 1.619 . . . . 12.6 109.807 169.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -139.77 151.17 22.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.88 0.848 . . . . 11.73 112.696 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.66 136.23 33.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.591 -1.186 . . . . 8.91 108.16 169.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 7.4 t -69.69 -150.16 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.984 0.421 . . . . 9.83 111.035 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.402 ' HB3' ' OG ' ' A' ' 39' ' ' SER . 15.1 mm100 -56.45 -18.89 12.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.322 0.86 . . . . 11.32 113.322 -175.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.1 t 55.13 96.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.635 0.731 . . . . 6.11 111.136 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m -79.5 152.0 30.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.703 -0.681 . . . . 6.12 110.197 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HE3' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -93.57 108.28 20.01 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.901 0.381 . . . . 6.3 110.52 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.532 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 65.5 mt -54.96 122.68 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 5.77 109.877 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -66.16 120.6 71.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 123.437 0.461 . . . . 5.69 110.051 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 25.4 Cg_exo -62.04 112.99 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.658 2.238 . . . . 6.86 112.605 -178.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -72.05 175.88 5.57 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.473 -0.936 . . . . 8.49 108.473 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.592 ' CG1' ' HB1' ' A' ' 144' ' ' ALA . 23.3 t -58.33 103.41 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.051 0.453 . . . . 6.19 110.08 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 67.5 t -72.77 97.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.557 -0.747 . . . . 6.26 111.34 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.01 -63.92 0.99 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.462 -0.57 . . . . 6.05 109.462 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.3 t -139.36 117.43 11.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.036 0.446 . . . . 7.02 110.615 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -159.39 -49.39 0.06 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.687 -0.688 . . . . 7.07 109.415 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -81.5 -172.98 4.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.641 -0.709 . . . . 6.68 109.947 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -166.83 71.41 0.12 Allowed 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.5 -0.555 . . . . 6.43 109.5 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.5 m -82.29 151.58 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.628 0.728 . . . . 3.7 111.027 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.5 p -117.65 139.74 50.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.313 -0.858 . . . . 3.49 109.976 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.51 154.02 25.24 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.209 -0.996 . . . . 2.58 112.642 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 137' ' ' ASP . 39.9 m -109.6 136.1 49.51 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.68 -0.489 . . . . 3.34 109.68 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.571 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 46.9 t -68.58 118.43 12.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.83 0.348 . . . . 3.14 110.086 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.5 p -95.35 -27.89 15.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.027 0.441 . . . . 3.61 110.84 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 m -153.16 127.88 9.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.864 -0.607 . . . . 3.12 110.112 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.08 -171.37 2.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.409 -0.36 . . . . 4.39 110.402 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.62 126.91 29.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.331 -0.395 . . . . 3.62 110.668 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -65.74 133.0 50.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.148 -0.478 . . . . 7.2 110.897 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 t -118.17 143.09 46.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.456 0.646 . . . . 5.1 110.307 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -116.73 15.72 15.39 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.135 -0.939 . . . . 7.53 109.536 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.3 t -113.57 -179.85 3.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.341 -0.845 . . . . 7.47 109.884 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.2 88.28 7.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.662 0.267 . . . . 7.58 111.047 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 75.23 -34.01 0.25 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.488 -0.778 . . . . 8.32 111.718 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -72.98 112.37 8.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.072 0.463 . . . . 7.26 110.425 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.4 m -79.96 95.48 2.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.216 0.531 . . . . 5.54 110.664 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.4 tp -137.33 90.09 2.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.883 0.849 . . . . 7.28 110.73 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -141.6 82.2 1.8 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.104 -1.407 . . . . 7.54 107.683 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.7 m -52.83 91.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.677 0.992 . . . . 5.41 113.677 -167.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.5 m 53.55 28.84 8.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.18 -0.918 . . . . 4.58 113.049 170.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -87.01 -20.28 27.46 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.596 -0.441 . . . . 5.09 110.488 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -135.45 156.4 48.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.06 -0.518 . . . . 3.33 110.345 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.6 t -112.92 153.92 27.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.849 -0.426 . . . . 2.57 109.849 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.66 -173.63 36.61 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.624 -0.59 . . . . 1.66 111.624 177.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -133.82 126.13 29.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.992 0.425 . . . . 3.03 111.381 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.501 HG13 ' CE1' ' A' ' 122' ' ' TYR . 83.7 mt -112.12 129.02 68.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.004 -0.739 . . . . 1.88 109.004 171.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 t -105.23 117.8 34.92 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.831 -0.433 . . . . 3.49 109.831 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 11.2 p90 -119.47 150.81 39.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.207 -0.452 . . . . 3.51 109.945 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -111.95 123.45 50.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.113 -0.494 . . . . 5.1 110.592 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.512 ' OD1' ' HG3' ' A' ' 114' ' ' ARG . 49.9 t-20 -131.59 119.07 20.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.148 -0.686 . . . . 4.78 109.148 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 71.2 mtp180 63.2 21.41 12.83 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.199 -0.455 . . . . 6.97 111.223 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.36 -9.67 71.75 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.04 -0.6 . . . . 5.1 112.163 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -92.16 122.74 34.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.764 0.316 . . . . 5.38 110.247 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.04 123.05 38.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.318 -0.401 . . . . 4.72 110.272 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.616 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . 64.4 m-85 -120.92 151.15 40.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.531 -0.304 . . . . 4.61 110.634 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.28 126.43 52.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 3.96 110.709 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 mt -112.94 135.25 21.66 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.053 -0.521 . . . . 2.75 110.848 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.74 137.64 11.4 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.713 2.275 . . . . 2.3 111.799 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.501 ' CE1' HG13 ' A' ' 109' ' ' ILE . 26.8 p90 -146.04 155.23 42.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.37 . . . . 2.13 110.14 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.0 p -115.42 -178.96 3.5 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.693 -0.484 . . . . 3.07 109.693 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -71.71 -21.1 61.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.44 0.638 . . . . 4.8 110.31 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.35 -23.56 50.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.398 -0.819 . . . . 4.81 111.289 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -86.99 3.95 43.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.992 0.425 . . . . 3.84 111.316 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 131' ' ' VAL . 52.7 t -87.52 137.65 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.234 -0.439 . . . . 4.39 110.921 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -87.17 135.55 33.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.986 -0.552 . . . . 6.43 110.105 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.76 2.03 68.85 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.177 -0.535 . . . . 5.91 112.671 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 56.42 38.08 29.39 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.159 0.504 . . . . 6.07 111.574 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.433 ' O ' HG11 ' A' ' 127' ' ' VAL . 43.7 t -78.63 145.82 9.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.884 -0.598 . . . . 5.27 109.749 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -91.39 137.82 32.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.332 -0.248 . . . . 5.78 110.332 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.7 mp -114.31 149.57 35.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.663 0.602 . . . . 3.62 111.018 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -141.7 123.67 15.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.636 -0.505 . . . . 6.93 109.636 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.571 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -50.14 129.14 20.57 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.515 0.674 . . . . 4.12 112.101 -170.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.83 -15.79 11.21 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 114.981 -1.009 . . . . 4.07 111.797 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 139' ' ' VAL . 2.4 p30 -85.4 169.25 13.86 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.397 -0.594 . . . . 4.06 109.397 173.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.463 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -123.1 116.8 24.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.071 0.462 . . . . 4.17 109.971 -177.273 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.513 HG13 ' OD1' ' A' ' 137' ' ' ASP . 30.2 m -116.0 179.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.516 0.674 . . . . 2.77 111.294 -173.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.9 m -143.12 145.76 33.14 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.367 -0.833 . . . . 3.47 109.086 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.38 172.53 12.65 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.127 -0.694 . . . . 3.35 109.127 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -112.76 136.89 51.85 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.399 0.437 . . . . 5.34 109.866 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.4 mt -106.72 101.66 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.98 0.419 . . . . 4.66 110.95 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -80.04 107.57 12.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.523 -0.547 . . . . 4.85 109.523 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.1 m -97.46 102.76 14.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.121 0.486 . . . . 5.68 110.747 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 148' ' ' ARG . 47.6 t30 -75.05 157.0 35.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.716 -0.846 . . . . 6.25 108.716 172.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.19 13.91 0.1 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.05 0.452 . . . . 8.58 112.049 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.479 ' NE ' ' HA ' ' A' ' 148' ' ' ARG . 5.0 mmp_? -110.05 -8.55 14.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.751 0.31 . . . . 7.86 110.207 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.73 20.98 77.82 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 116.009 -0.542 . . . . 5.59 112.374 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -112.29 111.49 22.4 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.905 -0.406 . . . . 5.18 109.905 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.481 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.3 179.94 8.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.128 0.49 . . . . 4.28 111.575 -177.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.85 -156.94 7.7 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.498 -1.041 . . . . 3.36 110.498 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.17 112.09 24.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.495 0.648 . . . . 2.84 109.491 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 24.2 m -103.87 140.03 38.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.123 -0.489 . . . . 4.34 111.242 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 52.43 61.39 3.22 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 123.848 0.718 . . . . 5.75 111.225 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.2 mt -78.78 125.65 38.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.643 -0.708 . . . . 3.55 110.225 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -126.93 145.54 50.64 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.748 -0.381 . . . . 5.96 110.588 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.512 ' HA ' HG12 ' A' ' 139' ' ' VAL . 55.4 tp -80.71 101.52 9.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 4.34 109.87 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.65 -53.96 5.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.566 . . . . 4.97 110.834 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -118.21 97.82 51.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 5.37 110.329 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.31 158.94 33.2 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.458 2.106 . . . . 5.44 112.164 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -110.23 126.18 53.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.198 -0.455 . . . . 6.1 110.206 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -132.8 104.47 12.94 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.801 -0.444 . . . . 9.49 109.801 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -86.21 161.56 9.95 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.949 2.433 . . . . 8.39 112.651 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.281 -0.418 . . . . 10.27 110.493 178.055 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 112.398 -0.281 . . . . 21.66 112.398 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.51 15.92 10.25 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.981 0.512 . . . . 20.17 111.64 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.07 -23.78 51.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.447 0.641 . . . . 18.5 109.622 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -87.77 29.08 0.94 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.265 -0.879 . . . . 16.62 110.859 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.18 -19.55 22.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.391 0.615 . . . . 18.35 110.632 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -79.28 106.76 11.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.612 -0.722 . . . . 16.2 110.648 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -100.84 121.62 42.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.609 -0.723 . . . . 12.4 110.422 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -93.34 136.88 33.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.515 -0.92 . . . . 11.63 108.515 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -118.39 140.6 49.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.48 -0.488 . . . . 9.15 111.463 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.72 -177.12 30.52 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.784 -0.722 . . . . 6.81 112.051 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 2.3 mt -124.97 143.36 38.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.809 -0.441 . . . . 10.17 109.809 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.53 116.15 11.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.414 -0.514 . . . . 8.73 109.675 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -88.47 -38.68 14.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 10.86 110.478 -176.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -153.79 140.62 19.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.619 -0.719 . . . . 14.06 109.591 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.4 mt -105.16 102.55 12.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.137 0.494 . . . . 11.73 110.591 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 mp -84.36 -178.34 6.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.053 -0.976 . . . . 11.36 109.307 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -89.69 108.73 19.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.864 0.364 . . . . 15.94 110.298 -173.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.5 m 67.57 22.31 9.2 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.251 -0.886 . . . . 13.01 110.983 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -160.52 141.21 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.628 -0.715 . . . . 12.34 109.429 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.14 157.33 21.62 Favored Glycine 0 C--N 1.322 -0.209 0 C-N-CA 120.471 -0.871 . . . . 7.52 113.094 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.0 129.19 55.01 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.108 0.163 . . . . 9.24 110.737 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.7 mt -112.59 126.92 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.846 0.355 . . . . 7.75 110.838 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 10.3 pt20 -85.38 145.73 27.34 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.145 0.498 . . . . 11.8 110.781 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 p -79.71 1.58 25.93 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.129 -0.942 . . . . 12.34 113.076 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.1 m -52.79 -24.87 9.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.932 1.086 . . . . 13.33 113.932 -170.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -99.37 10.59 41.11 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.123 0.416 . . . . 11.9 112.123 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -164.59 -158.97 0.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.438 -0.579 . . . . 12.99 109.438 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -123.37 24.37 8.71 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.162 0.506 . . . . 16.66 110.517 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.3 127.97 25.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.559 . . . . 12.09 111.125 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -96.2 119.42 34.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 12.51 110.147 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.66 162.46 18.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.407 0.622 . . . . 8.76 111.792 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -131.86 147.5 52.48 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.346 -0.983 . . . . 9.15 108.346 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -134.15 159.24 41.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.124 0.488 . . . . 6.85 111.204 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -98.84 154.77 17.77 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.994 -0.743 . . . . 9.99 108.994 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -68.86 -16.22 63.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.854 0.359 . . . . 9.93 110.786 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 t -78.36 -10.24 59.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.091 -0.504 . . . . 12.28 110.177 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -108.22 27.03 9.72 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.141 -0.482 . . . . 10.62 110.688 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -122.96 111.81 17.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.463 . . . . 8.78 110.376 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -89.15 111.66 22.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.089 0.471 . . . . 8.97 109.996 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.02 -151.01 23.04 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.988 -0.845 . . . . 9.98 110.988 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -107.22 120.71 42.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.808 0.304 . . . . 12.43 110.685 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -67.48 -19.63 25.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.601 0.715 . . . . 11.58 109.13 173.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.45 -32.44 70.23 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.803 -1.09 . . . . 14.73 110.688 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -109.65 21.24 17.21 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.584 -0.735 . . . . 13.3 111.092 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.8 tp -111.65 114.99 28.39 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.462 -0.57 . . . . 10.07 109.462 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -121.13 -179.27 3.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.008 0.433 . . . . 13.13 110.342 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.5 mp -76.24 120.51 26.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.648 -0.501 . . . . 11.74 109.648 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.59 0.1 30.76 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.74 -0.743 . . . . 10.13 112.471 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.54 122.99 88.31 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.559 0.219 . . . . 8.39 110.895 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -83.58 126.25 4.04 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.609 2.206 . . . . 7.28 111.979 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.05 156.08 39.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.068 0.461 . . . . 4.74 111.065 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -119.48 126.77 52.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.698 -0.683 . . . . 7.09 109.26 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -132.21 166.81 21.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.349 0.595 . . . . 7.82 111.036 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.503 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 31.8 tt0 -101.32 109.66 21.54 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.645 -0.707 . . . . 11.59 109.272 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.68 109.13 19.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.281 -0.637 . . . . 12.41 109.281 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.7 p -131.6 175.28 9.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.052 0.453 . . . . 13.17 111.352 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.23 121.48 42.18 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.492 -0.558 . . . . 16.21 109.492 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -75.22 124.9 27.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.409 0.623 . . . . 16.64 110.659 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -79.33 -7.33 58.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.002 -0.999 . . . . 22.64 111.506 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -92.43 -55.12 3.52 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.957 -0.297 . . . . 21.43 111.17 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.9 p -86.46 -22.69 26.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 111.772 0.286 . . . . 17.4 111.772 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.68 32.34 54.37 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.559 -0.829 . . . . 16.7 111.66 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -121.15 147.55 47.04 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.303 -0.258 . . . . 14.73 110.303 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.69 126.16 11.18 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 121.949 1.766 . . . . 12.6 110.753 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.54 162.1 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.222 0.534 . . . . 11.73 111.304 -174.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.27 139.06 40.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.551 -0.749 . . . . 8.91 109.146 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.503 ' OG ' ' HB3' ' A' ' 54' ' ' GLU . 17.6 m -70.0 -157.13 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.084 -0.507 . . . . 9.83 110.762 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -75.68 27.86 0.11 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.326 1.232 . . . . 11.32 114.326 -168.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.2 t 21.31 101.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 125.079 1.352 . . . . 6.11 114.582 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.4 m -107.67 143.3 36.35 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.106 -0.497 . . . . 6.12 110.096 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.56 142.33 51.77 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.165 -0.68 . . . . 6.3 109.165 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.6 mt -54.87 118.28 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.112 0.482 . . . . 5.77 111.137 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.75 162.42 21.21 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.451 -0.795 . . . . 5.69 110.749 -175.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -62.66 156.14 54.68 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.546 2.164 . . . . 6.86 112.599 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.505 ' HG2' ' H ' ' A' ' 76' ' ' VAL . 28.5 tt0 -85.42 -178.44 6.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.707 -0.679 . . . . 8.49 110.034 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.505 ' H ' ' HG2' ' A' ' 75' ' ' GLU . 30.9 t -59.12 149.21 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.018 0.437 . . . . 6.19 111.434 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.59 111.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 6.26 111.244 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -118.91 16.38 13.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 6.05 110.921 176.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 m -114.06 60.53 0.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.856 0.36 . . . . 7.02 111.516 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -117.11 -34.63 4.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.716 0.293 . . . . 7.07 110.834 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -168.1 147.85 4.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 6.68 110.191 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -105.23 115.49 30.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 6.43 110.413 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.04 159.44 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.2 -0.454 . . . . 3.7 110.452 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 p -110.46 139.66 45.46 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.127 -0.488 . . . . 3.49 110.13 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.48 163.43 23.19 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.231 -0.985 . . . . 2.58 112.443 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.2 m -122.44 129.04 51.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.771 -0.455 . . . . 3.34 109.771 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.589 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 90.4 t -69.27 126.16 28.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.416 -0.356 . . . . 3.14 110.665 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 p -105.82 -19.92 13.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.237 0.541 . . . . 3.61 110.63 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.5 m -149.9 129.42 13.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 3.12 110.198 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.13 -178.27 3.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.737 0.303 . . . . 4.39 110.71 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.435 HD12 HG23 ' A' ' 105' ' ' THR . 3.2 mm? -64.17 138.91 58.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.777 -0.647 . . . . 3.62 109.649 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -65.67 116.43 6.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.436 0.636 . . . . 7.2 111.465 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 p -135.92 104.81 5.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.246 -0.888 . . . . 5.1 110.042 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.49 -82.97 0.11 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.274 -0.421 . . . . 7.53 111.204 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.9 m -91.46 158.85 16.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.59 -0.277 . . . . 7.47 110.266 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.85 40.58 0.25 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.387 0.613 . . . . 7.58 110.869 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -145.39 -25.1 0.47 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.316 -0.857 . . . . 8.32 109.82 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -114.06 107.36 15.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 7.26 110.289 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.98 99.71 4.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.852 -0.613 . . . . 5.54 109.471 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.7 tp -110.29 92.94 4.25 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.706 0.765 . . . . 7.28 109.988 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.16 70.08 10.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.593 -1.185 . . . . 7.54 109.403 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.556 ' OG ' ' HG2' ' A' ' 104' ' ' GLU . 42.5 p -104.62 168.36 9.13 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.589 -1.187 . . . . 5.41 109.949 174.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.7 p -80.32 9.14 6.16 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.132 0.419 . . . . 4.58 112.132 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.556 ' HG2' ' OG ' ' A' ' 102' ' ' SER . 9.2 pt-20 -84.98 -22.21 29.23 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.047 0.451 . . . . 5.09 110.305 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.435 HG23 HD12 ' A' ' 91' ' ' LEU . 6.7 t -105.38 136.65 44.53 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.153 -0.684 . . . . 3.33 109.153 177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.5 m -145.28 130.2 18.27 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.993 -0.373 . . . . 2.57 109.993 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.64 169.71 49.3 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.656 -0.783 . . . . 1.66 112.183 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -129.61 133.64 47.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.918 0.39 . . . . 3.03 110.892 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 64.9 mt -111.8 126.48 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.6 -0.727 . . . . 1.88 109.89 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.8 p -98.07 119.18 36.26 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.9 -0.407 . . . . 3.49 109.9 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 2.5 p90 -127.4 153.69 45.93 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.639 -0.504 . . . . 3.51 109.639 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.95 120.61 38.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.246 -0.433 . . . . 5.1 110.35 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -146.72 137.81 24.14 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.058 -0.719 . . . . 4.78 109.058 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 64.08 20.89 12.39 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.867 0.365 . . . . 6.97 110.364 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.83 -8.15 63.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.202 -0.523 . . . . 5.1 112.366 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -100.68 138.84 37.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.893 -0.41 . . . . 5.38 109.893 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 1.3 p -108.2 121.58 45.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.046 0.451 . . . . 4.72 110.837 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -115.73 164.83 13.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.927 -0.579 . . . . 4.61 110.652 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 96.0 m-85 -119.39 119.3 33.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.01 -0.541 . . . . 3.96 110.397 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 153' ' ' ALA . 4.1 mm? -105.42 143.37 26.64 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.336 -0.393 . . . . 2.75 110.626 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.98 146.93 9.14 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.126 2.551 . . . . 2.3 112.066 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -153.75 151.78 29.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.102 0.477 . . . . 2.13 111.366 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.73 162.17 23.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.453 -0.794 . . . . 3.07 109.38 172.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.94 -30.57 71.66 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.005 0.431 . . . . 4.8 111.204 -175.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.43 -20.42 66.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.076 -0.511 . . . . 4.81 111.871 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -104.22 13.81 31.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.147 0.499 . . . . 3.84 110.638 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.06 128.45 41.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 4.39 110.792 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.426 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 1.4 tm-20 -94.93 145.62 24.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.939 -0.763 . . . . 6.43 108.939 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.01 -17.18 58.77 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.754 -0.736 . . . . 5.91 112.039 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 61.25 24.2 14.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.514 0.673 . . . . 6.07 110.671 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.6 t -90.81 137.71 21.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.065 -0.516 . . . . 5.27 110.284 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -79.08 102.53 8.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 5.78 110.314 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.709 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -88.6 148.85 23.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 3.62 110.605 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -133.13 171.5 13.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.11 -0.495 . . . . 6.93 109.809 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.589 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.96 118.9 17.47 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.095 -0.502 . . . . 4.12 110.581 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.93 -20.42 9.91 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.666 -0.697 . . . . 4.07 113.195 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.93 166.18 12.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.898 0.849 . . . . 4.06 110.634 175.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -98.58 122.96 42.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.732 0.777 . . . . 4.17 111.976 -170.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.33 157.94 24.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.678 -1.146 . . . . 2.77 110.125 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.4 m -126.23 141.07 52.07 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.913 -0.773 . . . . 3.47 108.913 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -135.37 149.59 49.72 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.953 0.406 . . . . 3.35 110.26 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -100.59 115.05 29.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.739 -0.664 . . . . 5.34 110.497 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 64.7 mt -78.05 110.31 13.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.603 -0.726 . . . . 4.66 110.375 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.537 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . . . -90.26 110.45 21.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.854 -0.612 . . . . 4.85 110.427 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 40.2 m -80.6 103.15 10.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.682 -0.69 . . . . 5.68 110.352 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -67.69 163.38 21.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.1 -0.5 . . . . 6.25 111.043 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.39 -18.32 65.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 8.58 111.663 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -100.03 6.85 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.118 0.485 . . . . 7.86 110.235 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.61 18.2 75.45 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.868 -0.605 . . . . 5.59 113.98 172.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -122.33 129.9 52.6 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.404 -0.591 . . . . 5.18 109.404 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.31 179.37 8.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.906 0.384 . . . . 4.28 111.685 -175.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -131.38 -112.43 1.45 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.839 -0.904 . . . . 3.36 110.839 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 120' ' ' LEU . . . -135.41 129.68 33.68 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.109 -0.33 . . . . 2.84 110.109 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 82.6 m -128.14 150.16 50.11 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.87 -0.419 . . . . 4.34 109.87 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 57.65 58.08 3.92 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.438 0.461 . . . . 5.75 111.333 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.447 HD12 ' H ' ' A' ' 156' ' ' ILE . 4.8 mp -74.57 113.61 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.346 -0.983 . . . . 3.55 108.346 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.426 ' HD2' ' OE2' ' A' ' 128' ' ' GLU . 26.4 ttt180 -129.2 131.14 47.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.977 0.418 . . . . 5.96 110.864 -173.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 133' ' ' LEU . 6.4 tt -83.42 115.82 22.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.338 -0.616 . . . . 4.34 109.338 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -105.89 -26.92 11.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.086 -0.506 . . . . 4.97 111.485 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.12 107.03 5.26 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.792 0.33 . . . . 5.37 110.7 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.42 161.66 17.22 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.843 2.362 . . . . 5.44 113.522 -175.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -126.55 138.58 53.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.411 -0.813 . . . . 6.1 109.314 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 61.35 81.27 0.24 Allowed Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 123.634 0.584 . . . . 9.49 111.389 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.58 95.79 1.08 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.572 2.181 . . . . 8.39 112.085 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 116.296 -0.411 . . . . 10.27 110.999 -177.191 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 111.864 -0.495 . . . . 21.66 111.864 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.46 112.21 23.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.746 0.308 . . . . 20.17 110.457 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.92 -51.78 2.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.246 0.546 . . . . 18.5 110.021 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.85 79.19 5.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.985 -1.007 . . . . 16.62 108.985 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -90.96 -71.57 0.62 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.063 -0.972 . . . . 18.35 113.185 -171.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 41.4 mt-10 -92.5 95.47 9.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.352 -0.84 . . . . 16.2 111.603 -169.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.521 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 19.2 ptt180 -85.76 138.74 31.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.231 -0.895 . . . . 12.4 111.563 -177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.412 ' CD ' HH22 ' A' ' 27' ' ' ARG . 4.9 mm-40 -109.63 137.04 48.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.298 -0.865 . . . . 11.63 110.249 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 p -105.48 141.7 36.5 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.458 -0.337 . . . . 9.15 111.383 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.29 178.85 39.44 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.583 -0.607 . . . . 6.81 111.583 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.3 pt -121.19 149.95 24.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.824 0.312 . . . . 10.17 110.617 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.7 mm -67.69 122.24 18.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.377 -0.374 . . . . 8.73 110.514 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.13 -51.16 10.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.749 0.309 . . . . 10.86 110.392 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -152.72 171.7 17.82 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.023 -0.535 . . . . 14.06 110.444 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.7 mt -127.59 99.53 5.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.6 -0.727 . . . . 11.73 110.628 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.2 mp -97.05 -179.9 4.7 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.286 -1.005 . . . . 11.36 108.286 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -91.19 131.9 36.43 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.506 -0.478 . . . . 15.94 110.293 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.3 t 76.24 -22.68 0.26 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.991 0.916 . . . . 13.01 112.196 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -152.27 162.89 40.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 12.34 111.26 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.99 -172.87 19.18 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.796 -0.521 . . . . 7.52 111.796 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.23 149.49 52.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.781 0.324 . . . . 9.24 110.931 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.1 mt -113.89 126.85 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.826 -0.625 . . . . 7.75 109.553 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.14 136.95 35.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.4 0.619 . . . . 11.8 111.561 -172.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 p -81.94 -0.59 44.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.999 -1.0 . . . . 12.34 112.887 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.4 m -53.6 -37.22 62.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.194 0.452 . . . . 13.33 112.035 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.53 20.32 13.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 11.9 111.476 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.476 HH21 ' HB3' ' A' ' 29' ' ' ALA . 7.1 ptm85 -163.16 -160.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.422 -0.174 . . . . 12.99 111.096 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -124.8 20.08 8.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.826 0.346 . . . . 16.66 111.223 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' HB3' HH21 ' A' ' 27' ' ' ARG . . . -146.13 122.46 10.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.392 -0.367 . . . . 12.09 111.692 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 30' ' ' ARG . 11.8 ptt180 -85.97 130.74 34.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.428 -0.953 . . . . 12.51 108.428 171.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.1 tp -141.64 158.6 43.62 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.689 -0.404 . . . . 8.76 110.777 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -113.99 149.92 34.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.141 -0.481 . . . . 9.15 109.831 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -136.49 155.39 50.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.006 -0.368 . . . . 6.85 110.006 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -110.73 150.25 29.33 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.691 -0.485 . . . . 9.99 109.691 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -63.93 -19.25 64.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.379 -0.373 . . . . 9.93 111.6 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -70.34 -24.07 62.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 12.28 111.129 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.88 40.1 1.72 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.026 -0.533 . . . . 10.62 110.525 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -120.5 129.8 53.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.336 -0.393 . . . . 8.78 110.393 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.3 m -97.7 104.78 16.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.263 -0.426 . . . . 8.97 110.349 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.89 -172.42 23.67 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.754 -0.736 . . . . 9.98 111.525 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -95.4 115.94 28.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.482 0.658 . . . . 12.43 110.3 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.63 -23.95 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.391 -0.822 . . . . 11.58 112.537 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -67.7 -21.19 65.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 14.73 111.329 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -99.62 9.07 43.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.766 0.317 . . . . 13.3 110.928 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.3 tp -94.17 130.75 40.27 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.242 -0.651 . . . . 10.07 109.242 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -122.92 172.98 8.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.96 0.409 . . . . 13.13 110.546 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.5 mp -81.79 128.44 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.756 -0.656 . . . . 11.74 109.397 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.47 0.58 67.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.687 -0.768 . . . . 10.13 112.119 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 31.9 t70 -80.4 129.97 67.1 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.192 . . . . 8.39 110.743 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 49' ' ' ASP . 8.2 Cg_exo -72.22 127.43 12.7 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.938 2.426 . . . . 7.28 113.032 -178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.79 154.47 34.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 4.74 110.88 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.521 ' OE1' ' HD2' ' A' ' 7' ' ' ARG . 37.3 tt0 -112.77 124.19 52.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.185 -0.461 . . . . 7.09 109.899 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -142.3 151.27 41.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.394 -0.366 . . . . 7.82 110.679 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 33.0 tt0 -104.4 130.49 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.313 -0.625 . . . . 11.59 109.313 174.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 14.7 tpt -83.19 114.68 21.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.25 -0.432 . . . . 12.41 109.853 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.5 p -133.2 170.96 14.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.371 0.605 . . . . 13.17 111.927 -173.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.411 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 84.4 m-85 -132.37 115.06 15.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.018 -0.734 . . . . 16.21 109.018 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -80.5 116.5 20.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.767 -0.457 . . . . 16.64 109.767 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -78.71 -7.05 57.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.57 . . . . 22.64 111.947 -173.339 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.07 -37.92 9.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.203 -0.453 . . . . 21.43 110.913 -175.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 p -87.69 -34.09 18.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.89 0.376 . . . . 17.4 110.924 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.54 8.58 63.88 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.503 -0.856 . . . . 16.7 112.178 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -106.45 145.51 31.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 122.893 -0.181 . . . . 14.73 110.804 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.48 125.02 5.48 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.8 1.667 . . . . 12.6 110.433 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.31 157.49 24.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.272 0.558 . . . . 11.73 111.21 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.0 157.79 16.6 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.742 -0.663 . . . . 8.91 109.556 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -65.3 -166.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.177 -0.465 . . . . 9.83 110.148 176.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -73.94 19.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.535 0.568 . . . . 11.32 112.535 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t 32.87 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.421 1.089 . . . . 6.11 113.193 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.8 m -88.4 136.45 32.98 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.113 0.482 . . . . 6.12 110.114 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.428 ' HE2' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -73.97 119.7 18.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.149 -0.478 . . . . 6.3 110.344 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.428 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 65.4 mt -57.17 108.56 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.951 -0.568 . . . . 5.77 109.77 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.15 165.11 55.62 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.357 -0.838 . . . . 5.69 110.21 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.74 107.66 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.373 2.049 . . . . 6.86 112.147 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -85.73 -163.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.375 -0.83 . . . . 8.49 110.584 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.09 139.09 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.763 -0.828 . . . . 6.19 108.763 172.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.74 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 39.0 t -68.13 89.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.419 . . . . 6.26 110.394 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 144' ' ' ALA . 1.5 tt -91.43 -8.7 47.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.153 -0.931 . . . . 6.05 110.782 -173.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.3 t -140.89 103.59 4.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.049 -0.523 . . . . 7.02 110.479 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.65 -59.77 1.96 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.553 -0.906 . . . . 7.07 108.553 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -135.97 119.73 17.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.912 -1.04 . . . . 6.68 108.51 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -79.77 107.85 12.87 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.695 -0.483 . . . . 6.43 109.695 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.49 179.3 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 3.7 111.571 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.573 ' HB ' ' HD2' ' A' ' 138' ' ' LYS . 37.4 p -121.55 165.16 16.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.445 -0.798 . . . . 3.49 108.853 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.18 145.1 15.47 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.136 -1.03 . . . . 2.58 113.002 -177.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 m -108.05 127.91 54.21 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.606 -0.516 . . . . 3.34 109.606 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.613 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -74.83 124.89 33.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.096 -0.335 . . . . 3.14 110.096 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 p -104.29 -22.41 13.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.119 0.485 . . . . 3.61 110.65 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.4 m -136.66 126.46 25.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.959 -0.564 . . . . 3.12 110.634 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -84.09 -176.73 6.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 4.39 110.709 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.8 mt -102.31 -178.6 3.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.876 -0.787 . . . . 3.62 108.876 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 92' ' ' ARG . 10.5 ptt180 -129.39 175.27 8.89 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.247 -0.649 . . . . 7.2 109.247 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 6.8 p -125.42 -13.41 6.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.054 0.454 . . . . 5.1 111.118 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 93' ' ' THR . 1.9 m-20 73.65 -56.66 0.65 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.307 -1.315 . . . . 7.53 110.209 -175.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 98' ' ' ASN . 47.6 t -100.56 155.64 17.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.421 -0.585 . . . . 7.47 109.421 174.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.55 -36.02 38.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.642 0.258 . . . . 7.58 111.392 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -110.59 -1.64 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.562 0.696 . . . . 8.32 110.94 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' A' ' 95' ' ' SER . 9.1 m120 -130.87 142.02 50.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.619 -0.511 . . . . 7.26 109.619 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.93 127.42 72.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.082 0.468 . . . . 5.54 110.525 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.5 tp -150.94 98.38 2.58 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.381 -0.6 . . . . 7.28 109.381 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.495 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 19.2 m120 -131.43 -62.8 0.86 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.794 -0.639 . . . . 7.54 112.141 -173.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 101' ' ' ASN . 71.6 m 66.05 24.38 11.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.255 0.55 . . . . 5.41 109.784 -171.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.0 m 59.49 52.82 5.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.084 -0.962 . . . . 4.58 111.051 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 101' ' ' ASN . 0.2 OUTLIER -79.63 -35.77 38.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.393 0.616 . . . . 5.09 109.586 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -98.96 167.42 10.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.296 -0.866 . . . . 3.33 109.414 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.3 m -137.39 135.44 36.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.051 0.453 . . . . 2.57 110.532 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.48 176.98 48.5 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.777 -0.725 . . . . 1.66 111.92 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -129.89 127.37 40.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.884 0.373 . . . . 3.03 111.256 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.4 HG13 ' CD1' ' A' ' 122' ' ' TYR . 78.4 mt -112.3 127.06 69.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.872 -0.604 . . . . 1.88 109.441 173.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.9 p -102.54 132.87 48.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.618 -0.264 . . . . 3.49 110.868 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.446 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -145.14 160.69 41.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.661 -0.496 . . . . 3.51 109.661 175.007 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -117.04 124.33 49.04 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.501 -0.555 . . . . 5.1 109.501 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -137.65 112.43 8.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 4.78 110.456 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 66.08 21.82 11.18 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.495 -0.32 . . . . 6.97 111.756 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.56 -1.22 68.77 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.675 -0.774 . . . . 5.1 111.7 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.489 ' HB3' ' CE2' ' A' ' 118' ' ' PHE . 69.8 mm-40 -96.85 128.75 44.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.9 -0.407 . . . . 5.38 109.9 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 84.9 m -118.16 101.44 8.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.124 -0.489 . . . . 4.72 110.293 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 116' ' ' GLU . 62.5 m-85 -116.79 155.0 29.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.168 0.508 . . . . 4.61 111.099 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -107.75 118.58 37.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.786 -0.82 . . . . 3.96 108.786 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.446 HD11 ' CE2' ' A' ' 111' ' ' TYR . 5.5 mp -102.42 137.89 19.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 120.875 -0.33 . . . . 2.75 110.66 -173.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.88 134.45 18.05 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.743 2.295 . . . . 2.3 112.115 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.4 ' CD1' HG13 ' A' ' 109' ' ' ILE . 23.0 p90 -137.09 151.22 48.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.175 -0.466 . . . . 2.13 109.797 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.3 p -116.72 178.77 4.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.419 -0.355 . . . . 3.07 110.137 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -69.91 -19.71 63.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.388 0.613 . . . . 4.8 110.167 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -78.98 -9.87 59.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.456 -0.793 . . . . 4.81 111.42 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -93.34 -14.55 26.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.411 -0.359 . . . . 3.84 111.873 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.449 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 7.6 p -103.98 137.68 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.183 0.516 . . . . 4.39 111.052 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -106.17 169.7 8.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.55 . . . . 6.43 111.196 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.73 -4.01 83.6 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.907 -0.588 . . . . 5.91 113.174 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 62.6 24.96 14.86 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.797 0.439 . . . . 6.07 110.65 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 t -84.34 122.18 37.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.958 -0.565 . . . . 5.27 110.41 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -83.86 95.31 8.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.308 0.575 . . . . 5.78 110.438 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.4 pt? -75.37 150.35 38.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.863 -1.062 . . . . 3.62 111.008 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.521 ' HG3' ' OD1' ' A' ' 137' ' ' ASP . 3.9 ppt_? -120.38 162.33 19.67 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.77 -0.456 . . . . 6.93 109.77 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.613 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -72.41 125.62 27.85 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.605 -0.438 . . . . 4.12 110.87 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.48 -25.73 7.59 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.934 -0.651 . . . . 4.07 113.613 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.521 ' OD1' ' HG3' ' A' ' 134' ' ' ARG . 2.8 p30 -86.53 178.66 7.02 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.258 1.029 . . . . 4.06 110.141 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.573 ' HD2' ' HB ' ' A' ' 84' ' ' THR . 2.3 tppp? -118.9 124.7 47.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.414 0.626 . . . . 4.17 111.795 -172.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.617 HG12 ' HG ' ' A' ' 158' ' ' LEU . 24.5 m -117.22 170.59 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 2.77 110.039 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -119.97 135.4 54.92 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.034 -0.728 . . . . 3.47 109.034 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -134.44 153.58 51.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.774 0.321 . . . . 3.35 110.536 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -113.83 131.23 56.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.864 -0.607 . . . . 5.34 109.801 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.4 mt -95.96 108.71 21.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.778 -0.647 . . . . 4.66 110.951 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.74 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -101.86 110.98 23.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.718 0.294 . . . . 4.85 111.285 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 66.8 m -99.0 122.7 42.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 5.68 111.814 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.52 174.92 8.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 6.25 110.533 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -59.58 -28.54 67.23 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.001 -0.545 . . . . 8.58 112.214 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 148' ' ' ARG . 21.8 mmt180 -88.48 8.66 26.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.877 0.325 . . . . 7.86 111.877 -174.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.07 14.51 73.67 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.909 -0.662 . . . . 5.59 113.22 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.9 130.51 53.84 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.254 -0.647 . . . . 5.18 109.254 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.491 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -152.94 -178.52 6.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.356 -0.384 . . . . 4.28 110.938 -177.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.14 -166.11 13.81 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.031 -0.828 . . . . 3.36 111.031 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.39 109.96 21.89 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.046 -0.353 . . . . 2.84 110.046 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 71.9 m -121.01 166.76 13.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.434 -0.348 . . . . 4.34 110.871 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 59.22 36.51 23.79 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.632 0.583 . . . . 5.75 110.144 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.449 ' HB ' ' HA ' ' A' ' 127' ' ' VAL . 77.1 mt -64.9 114.55 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.807 -0.633 . . . . 3.55 110.021 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -122.12 123.89 42.62 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.816 -0.809 . . . . 5.96 108.816 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.617 ' HG ' HG12 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -81.78 103.05 11.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.178 -0.464 . . . . 4.34 109.876 -176.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -97.08 -32.44 11.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.993 -0.549 . . . . 4.97 111.305 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -126.39 84.38 62.26 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 5.37 110.742 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.28 179.87 4.31 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.918 2.412 . . . . 5.44 112.975 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.408 ' HB2' ' HE ' ' A' ' 134' ' ' ARG . . . -97.77 141.91 30.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.73 -0.668 . . . . 6.1 110.49 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -105.79 120.26 49.76 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.35 -0.611 . . . . 9.49 109.35 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.06 135.26 67.44 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.696 2.264 . . . . 8.39 111.745 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.084 -0.507 . . . . 10.27 111.197 -176.123 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.157 -0.377 . . . . 21.66 112.157 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.39 103.04 13.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.881 0.372 . . . . 20.17 110.992 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -116.98 -19.78 9.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.047 0.451 . . . . 18.5 110.931 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -105.35 10.28 33.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.902 -0.59 . . . . 16.62 111.464 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -135.68 128.63 31.38 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 122.183 0.992 . . . . 18.35 110.433 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -146.13 88.44 1.8 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 113.668 -1.606 . . . . 16.2 108.157 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.429 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 17.3 ptt180 -82.73 136.03 34.83 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.108 0.48 . . . . 12.4 111.142 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.72 162.7 21.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.691 -0.686 . . . . 11.63 110.038 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 26' ' ' GLU . 36.8 p -100.79 162.12 13.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.399 -0.364 . . . . 9.15 110.233 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 26' ' ' GLU . . . -162.38 177.56 38.49 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.967 -0.635 . . . . 6.81 112.055 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.6 mt -129.45 141.9 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.557 -0.534 . . . . 10.17 109.557 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.6 mm -65.81 111.5 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.836 0.351 . . . . 8.73 110.086 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.15 -54.24 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.724 -0.671 . . . . 10.86 110.495 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HA ' HD12 ' A' ' 47' ' ' ILE . 41.0 mttm -146.47 163.9 34.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.434 -0.803 . . . . 14.06 110.253 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.5 mt -131.45 101.33 5.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.803 -0.635 . . . . 11.73 110.543 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.5 mt -92.41 -179.87 5.33 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.558 -1.275 . . . . 11.36 107.558 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -90.37 125.1 35.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.097 -0.641 . . . . 15.94 109.977 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.3 m 79.63 -16.6 0.65 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.136 0.974 . . . . 13.01 112.212 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -150.19 147.77 28.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.561 0.22 . . . . 12.34 110.949 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.48 -176.21 15.62 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.021 -0.609 . . . . 7.52 112.871 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -127.87 149.78 50.15 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.843 0.354 . . . . 9.24 111.312 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.8 mt -115.53 130.43 70.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 7.75 110.897 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.79 145.83 34.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.92 -0.582 . . . . 11.8 111.252 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 p -80.28 2.49 24.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.088 -0.96 . . . . 12.34 112.862 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -52.62 -35.44 54.6 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.006 0.372 . . . . 13.33 112.006 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.505 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 22.6 mm-40 -108.89 -25.39 10.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 11.9 111.409 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HD3' ' N ' ' A' ' 28' ' ' GLN . 1.6 tmt_? -113.38 135.3 54.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.475 -0.565 . . . . 12.99 109.475 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' N ' ' HD3' ' A' ' 27' ' ' ARG . 19.6 mp0 -74.62 43.7 0.19 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.797 0.332 . . . . 16.66 111.255 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.33 146.4 0.48 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.717 0.807 . . . . 12.09 109.541 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.585 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -100.96 111.81 24.1 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.57 -0.53 . . . . 12.51 109.57 177.767 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.1 mt -113.88 163.03 15.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.234 0.54 . . . . 8.76 111.923 -170.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -112.07 149.12 32.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.237 -0.892 . . . . 9.15 109.506 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -140.53 158.72 43.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.874 0.369 . . . . 6.85 110.195 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -103.76 158.19 16.56 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.703 -0.48 . . . . 9.99 109.703 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -67.91 -18.79 64.89 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.957 0.355 . . . . 9.93 111.957 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 t -82.56 -8.08 59.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.403 0.62 . . . . 12.28 109.773 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -107.48 37.89 2.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.618 -0.719 . . . . 10.62 110.03 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -129.67 125.39 35.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.964 0.412 . . . . 8.78 111.16 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 t -100.75 104.6 15.88 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.961 -0.563 . . . . 8.97 109.977 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.54 -148.85 20.67 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.114 -0.795 . . . . 9.98 111.114 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -107.13 104.03 13.58 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 110.022 -0.362 . . . . 12.43 110.022 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.0 tp -63.25 -25.48 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.155 0.502 . . . . 11.58 110.726 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.04 -25.42 61.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 14.73 110.383 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.17 -10.43 25.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.756 -0.656 . . . . 13.3 110.568 -176.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.0 tp -68.37 147.2 52.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 10.07 110.169 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 169.95 17.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.191 -0.458 . . . . 13.13 110.431 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 14' ' ' LYS . 31.8 mm -77.69 135.27 26.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.562 -0.533 . . . . 11.74 109.562 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.59 11.29 62.43 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.477 -0.868 . . . . 10.13 111.837 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -86.38 125.93 66.15 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.253 -0.277 . . . . 8.39 110.253 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.91 129.74 6.35 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.906 2.404 . . . . 7.28 112.985 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.98 165.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 4.74 110.584 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 9' ' ' THR . 10.2 pt-20 -126.52 146.63 50.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.969 0.414 . . . . 7.09 110.218 172.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -152.24 178.52 9.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.026 -0.534 . . . . 7.82 110.879 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.7 mp0 -124.08 114.17 19.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.882 -0.599 . . . . 11.59 110.575 177.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.9 ttt -78.28 109.65 12.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.599 -0.519 . . . . 12.41 109.599 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.5 p -131.67 167.74 18.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.937 0.399 . . . . 13.17 111.043 -176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -118.36 110.4 17.43 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 16.21 109.58 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.38 111.2 5.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.838 0.352 . . . . 16.64 110.143 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -6.63 46.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.0 -0.545 . . . . 22.64 111.608 -176.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.8 mmt-85 -78.25 -59.7 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 21.43 110.259 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.4 p -86.68 -30.36 21.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 17.4 111.896 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.17 31.55 16.73 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.937 -0.649 . . . . 16.7 111.893 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.28 141.5 33.26 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 122.935 -0.156 . . . . 14.73 110.827 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.91 125.53 7.4 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.298 1.999 . . . . 12.6 110.886 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.63 165.61 22.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.186 -0.461 . . . . 11.73 110.591 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -102.16 161.15 13.91 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.661 -0.496 . . . . 8.91 109.661 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 11.9 t -66.89 -166.91 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.721 -0.474 . . . . 9.83 109.721 172.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -78.46 26.27 0.23 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.355 0.502 . . . . 11.32 112.355 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.7 t 35.25 94.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.2 1.0 . . . . 6.11 113.447 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -93.21 132.26 37.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.285 -0.416 . . . . 6.12 110.435 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -67.46 140.36 57.09 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.444 -0.576 . . . . 6.3 109.444 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.2 mt -72.31 100.19 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 5.77 110.895 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -125.52 95.1 41.38 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.905 -0.589 . . . . 5.69 110.378 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -90.24 14.33 2.09 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.073 2.516 . . . . 6.86 112.722 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -110.64 131.78 54.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.601 -0.272 . . . . 8.49 110.762 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.622 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 1.7 p -63.29 117.01 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.773 -0.455 . . . . 6.19 109.773 172.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 4.8 p -79.97 107.21 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.575 0.703 . . . . 6.26 111.225 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.5 tp -89.87 -52.34 5.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.815 -1.084 . . . . 6.05 110.354 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.7 m -89.52 67.15 7.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.896 0.379 . . . . 7.02 111.718 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -88.64 -65.93 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.006 -0.738 . . . . 7.07 109.006 170.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -152.49 133.57 14.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.555 -0.906 . . . . 6.68 108.555 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -77.8 118.27 19.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.758 0.313 . . . . 6.43 110.278 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.13 166.9 7.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.215 0.531 . . . . 3.7 111.172 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 p -133.22 150.4 51.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.502 -0.772 . . . . 3.49 110.496 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -150.52 173.66 30.07 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.508 -0.853 . . . . 2.58 112.143 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.1 m -122.86 135.48 54.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.819 0.343 . . . . 3.34 110.256 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.549 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 39.8 t -64.9 132.02 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.269 -0.423 . . . . 3.14 110.728 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.5 p -115.15 -10.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.048 0.388 . . . . 3.61 112.048 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.5 m -145.05 131.99 20.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.711 0.291 . . . . 3.12 110.657 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.12 179.59 6.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 4.39 111.427 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.9 mt -107.95 167.8 9.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.57 -0.741 . . . . 3.62 109.339 175.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.501 ' HG2' HG21 ' A' ' 105' ' ' THR . 7.8 ptm180 -106.85 113.89 27.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.362 0.601 . . . . 7.2 111.529 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.6 p -135.58 139.14 43.63 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.522 -0.763 . . . . 5.1 109.604 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -107.69 -23.76 11.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.384 0.611 . . . . 7.53 110.288 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.8 t -157.78 166.7 32.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.785 -0.643 . . . . 7.47 109.441 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.67 -26.84 66.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.251 0.548 . . . . 7.58 109.927 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -93.66 -14.14 26.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.653 -0.703 . . . . 8.32 110.514 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -110.99 85.99 2.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.427 0.632 . . . . 7.26 110.19 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 m -113.69 143.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.027 -0.988 . . . . 5.54 110.103 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.7 mp -111.19 98.56 7.6 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.382 1.087 . . . . 7.28 110.821 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -93.64 13.34 22.41 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 113.165 -1.834 . . . . 7.54 109.992 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.1 m -59.07 123.9 18.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.369 -0.832 . . . . 5.41 109.825 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 27.5 t -70.63 -5.71 31.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.446 . . . . 4.58 111.966 -172.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.88 -26.41 64.18 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.652 -0.87 . . . . 5.09 108.652 172.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.501 HG21 ' HG2' ' A' ' 92' ' ' ARG . 94.7 m -103.02 113.03 26.17 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.828 -1.078 . . . . 3.33 110.511 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 t -136.25 141.27 43.9 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.073 -0.512 . . . . 2.57 109.981 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -81.2 177.58 54.23 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.468 -0.872 . . . . 1.66 111.541 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 8.0 mmt85 -132.82 127.65 34.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.989 0.423 . . . . 3.03 111.104 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.3 130.15 66.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 1.88 109.223 172.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.5 t -106.56 116.45 31.95 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.552 -0.536 . . . . 3.49 109.552 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -118.87 144.63 46.27 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.34 -0.615 . . . . 3.51 109.34 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -104.78 109.29 21.17 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.573 -0.74 . . . . 5.1 109.713 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.589 ' OD1' ' HD3' ' A' ' 114' ' ' ARG . 59.2 t30 -129.33 114.84 16.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.372 -0.376 . . . . 4.78 111.147 -174.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.589 ' HD3' ' OD1' ' A' ' 113' ' ' ASN . 6.0 mpt_? 61.55 26.13 15.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.978 0.418 . . . . 6.97 111.57 173.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.94 -2.77 69.67 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.872 -0.68 . . . . 5.1 112.617 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -110.19 135.23 51.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.828 0.347 . . . . 5.38 110.268 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 2.3 p -117.16 103.61 10.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.399 -0.364 . . . . 4.72 110.313 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -98.03 153.89 18.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.97 -0.559 . . . . 4.61 110.617 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -101.89 124.3 47.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.186 -0.461 . . . . 3.96 110.37 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 22.4 mt -105.66 130.01 23.73 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.839 -0.619 . . . . 2.75 110.685 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 76.2 Cg_endo -81.4 134.04 8.75 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.733 2.289 . . . . 2.3 111.544 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -140.24 157.76 45.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 2.13 111.363 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.5 p -120.73 177.2 5.17 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.612 -0.722 . . . . 3.07 109.582 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -76.65 -25.34 53.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.569 0.581 . . . . 4.8 112.569 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.01 -10.12 59.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.385 0.513 . . . . 4.81 112.385 -170.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -97.14 -12.63 22.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.037 0.446 . . . . 3.84 111.092 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.5 t -67.91 110.26 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.09 0.471 . . . . 4.39 111.041 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -68.25 127.51 33.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.571 -0.74 . . . . 6.43 110.719 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.89 -0.29 55.13 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.743 -0.741 . . . . 5.91 112.695 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 65.33 18.42 11.35 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.856 0.36 . . . . 6.07 110.771 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.63 135.08 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.803 -0.635 . . . . 5.27 112.238 -172.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -90.65 79.16 6.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.893 0.854 . . . . 5.78 109.135 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.566 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -77.34 149.95 35.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.86 -1.064 . . . . 3.62 112.129 -172.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -108.66 167.49 10.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.594 -0.73 . . . . 6.93 109.525 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.549 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.21 127.9 34.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.071 -0.652 . . . . 4.12 110.008 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.19 -24.24 9.4 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.847 -0.692 . . . . 4.07 111.605 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -64.99 137.94 58.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.855 0.36 . . . . 4.06 110.295 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -84.46 117.12 23.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.587 -0.523 . . . . 4.17 109.587 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -118.71 157.41 20.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.29 0.567 . . . . 2.77 111.998 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 m -118.8 129.94 55.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.534 -0.757 . . . . 3.47 109.336 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -138.24 152.52 48.67 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.77 -0.456 . . . . 3.35 109.77 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -107.94 132.4 53.53 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.837 -0.431 . . . . 5.34 109.837 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 75.6 mt -84.7 131.21 34.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.271 -0.422 . . . . 4.66 110.868 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -131.13 110.0 10.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.966 -0.561 . . . . 4.85 110.525 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 45.3 m -85.98 112.04 20.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 5.68 110.844 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -81.61 174.01 11.81 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.388 -0.597 . . . . 6.25 109.388 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -65.9 -7.29 15.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.168 0.803 . . . . 8.58 113.168 -172.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -90.54 -9.48 47.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.763 -0.375 . . . . 7.86 111.117 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.11 13.35 83.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.73 -0.748 . . . . 5.59 112.004 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -111.27 121.26 44.81 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.858 -0.423 . . . . 5.18 109.858 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.519 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -136.34 -178.25 5.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.275 -0.42 . . . . 4.28 110.308 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' HA2' HD22 ' A' ' 120' ' ' LEU . . . -160.78 -78.08 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.594 -1.003 . . . . 3.36 110.594 176.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -160.23 163.1 33.78 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.085 -0.709 . . . . 2.84 109.085 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -150.52 147.06 27.02 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.98 -0.378 . . . . 4.34 109.98 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.4 p80 40.74 51.2 3.06 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 124.638 1.211 . . . . 5.75 111.361 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.9 mt -59.52 114.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.827 -1.079 . . . . 3.55 110.063 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.27 148.0 31.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.454 -0.339 . . . . 5.96 110.363 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.5 tp -72.68 125.23 27.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.237 -0.653 . . . . 4.34 109.237 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.2 -62.17 1.3 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.334 -0.617 . . . . 4.97 109.334 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -135.6 109.18 10.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.812 -0.631 . . . . 5.37 109.484 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.08 154.95 65.97 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.789 2.326 . . . . 5.44 113.017 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -121.17 107.23 12.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.563 -0.744 . . . . 6.1 111.467 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 70.18 107.73 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 115.322 -0.854 . . . . 9.49 112.785 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.98 107.92 2.43 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.342 2.028 . . . . 8.39 111.4 172.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 97.5 t . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.027 -0.533 . . . . 10.27 110.851 -178.705 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.453 0 N-CA-C 111.854 -0.498 . . . . 21.66 111.854 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.64 138.55 32.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.94 0.4 . . . . 20.17 111.294 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -117.36 -50.51 2.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.578 0.704 . . . . 18.5 109.996 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.33 73.38 2.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.77 -1.104 . . . . 16.62 110.951 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -65.65 -76.97 0.07 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.741 -1.118 . . . . 18.35 110.068 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 38.87 72.8 0.12 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.397 1.06 . . . . 16.2 113.129 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 7' ' ' ARG . 43.6 mtt85 -121.7 150.3 41.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.217 -0.447 . . . . 12.4 110.176 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.523 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 17.5 mm-40 -103.24 137.8 40.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.911 -0.586 . . . . 11.63 110.3 -173.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -97.94 136.91 37.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.659 -0.701 . . . . 9.15 110.656 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.5 174.6 32.1 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.978 -1.106 . . . . 6.81 112.918 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.559 HG13 ' HB3' ' A' ' 23' ' ' GLN . 7.9 pt -124.88 146.13 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.92 -0.4 . . . . 10.17 109.92 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.7 mm -67.47 122.88 19.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.414 0.149 . . . . 8.73 110.664 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 23.6 tt0 -88.09 -45.61 10.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.023 0.44 . . . . 10.86 110.428 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -147.6 140.93 25.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.9 -0.591 . . . . 14.06 109.954 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 45' ' ' LEU . 37.3 mt -113.01 110.19 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.324 0.583 . . . . 11.73 111.282 176.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.12 178.41 4.52 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.32 -1.363 . . . . 11.36 107.32 171.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -90.79 130.76 36.73 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.575 -0.85 . . . . 15.94 110.172 -174.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.9 m 76.63 -25.51 0.2 Allowed 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.203 0.939 . . . . 13.01 112.17 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -141.79 142.28 33.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.647 0.26 . . . . 12.34 110.844 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.15 179.82 18.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.814 -0.708 . . . . 7.52 112.448 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.09 134.7 55.18 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.747 0.308 . . . . 9.24 111.383 -177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.416 HG21 ' CE1' ' A' ' 53' ' ' PHE . 74.8 mt -99.75 129.09 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.617 -0.512 . . . . 7.75 109.617 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.559 ' HB3' HG13 ' A' ' 11' ' ' ILE . 37.6 tt0 -85.79 133.7 33.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.465 0.65 . . . . 11.8 111.357 -173.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.6 p -79.21 1.41 24.76 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.231 -0.895 . . . . 12.34 112.444 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 t -57.11 -29.46 63.55 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.197 0.443 . . . . 13.33 112.197 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -97.3 -1.28 44.99 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.83 0.348 . . . . 11.9 111.512 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 12.8 tpt180 -148.59 -158.85 0.96 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.342 -0.614 . . . . 12.99 109.342 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.485 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 26.5 mm-40 -119.21 19.01 12.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.248 0.546 . . . . 16.66 109.703 170.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.3 131.5 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.669 -0.696 . . . . 12.09 111.352 -175.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -121.18 125.71 47.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.734 -0.839 . . . . 12.51 108.734 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.75 160.67 26.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.42 0.628 . . . . 8.76 112.624 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -95.49 110.89 22.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.871 -1.059 . . . . 9.15 108.307 172.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -103.06 138.02 40.47 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.726 -0.79 . . . . 6.85 110.417 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -95.85 151.41 19.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.629 -0.714 . . . . 9.99 109.571 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.4 -16.77 61.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.949 0.404 . . . . 9.93 110.981 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -70.18 -23.99 63.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 12.28 109.942 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -108.71 40.31 1.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.588 -0.733 . . . . 10.62 110.711 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -129.44 119.56 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.557 -0.534 . . . . 8.78 109.557 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 t -88.02 106.53 18.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.146 0.498 . . . . 8.97 110.409 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.66 -167.89 22.5 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.684 -0.769 . . . . 9.98 111.972 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -79.12 96.34 5.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.077 -0.342 . . . . 12.43 110.077 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.1 -27.28 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.504 0.669 . . . . 11.58 109.3 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.09 -21.77 65.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.465 -0.789 . . . . 14.73 110.952 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -99.72 13.95 31.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 13.3 110.646 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.466 HD23 HD21 ' A' ' 15' ' ' LEU . 39.1 tp -88.42 147.77 24.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 10.07 110.914 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -125.28 168.7 13.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.307 -0.406 . . . . 13.13 110.837 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.7 mp -80.55 122.8 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.915 -0.584 . . . . 11.74 109.889 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.36 -3.45 32.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.872 -0.68 . . . . 10.13 111.826 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -67.83 122.71 84.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.806 -0.197 . . . . 8.39 110.478 178.156 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 49' ' ' ASP . 13.4 Cg_exo -69.44 123.66 10.43 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.676 2.251 . . . . 7.28 112.052 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.62 153.0 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.048 0.452 . . . . 4.74 111.624 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.25 124.44 52.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.104 -0.702 . . . . 7.09 109.104 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 8' ' ' GLU . 53.5 p90 -132.69 144.56 50.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.375 0.607 . . . . 7.82 111.039 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 26.9 tt0 -97.28 102.72 14.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.441 -0.8 . . . . 11.59 109.199 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.9 ttt -82.05 132.86 35.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.933 -0.576 . . . . 12.41 110.784 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.52 164.45 8.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.162 -0.472 . . . . 13.17 110.505 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -99.69 133.27 44.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.458 -0.337 . . . . 16.21 110.713 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.554 ' OD1' ' HG2' ' A' ' 60' ' ' ARG . 8.4 t70 -95.39 134.34 38.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.955 -0.566 . . . . 16.64 110.295 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -81.26 -13.39 58.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.24 0.459 . . . . 22.64 112.24 -177.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.554 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 8.4 mmm-85 -74.38 -60.8 2.1 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.943 -0.391 . . . . 21.43 109.943 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.551 HG22 ' OD2' ' A' ' 58' ' ' ASP . 5.7 t -91.81 -26.2 18.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.976 -0.556 . . . . 17.4 111.075 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.46 -4.58 85.47 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.798 -0.715 . . . . 16.7 112.634 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.504 ' H ' HG23 ' A' ' 61' ' ' THR . 38.5 mtpt -93.89 142.52 25.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.517 -0.549 . . . . 14.73 109.517 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.08 128.56 23.22 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.58 2.186 . . . . 12.6 112.119 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.31 179.5 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.205 -0.452 . . . . 11.73 111.001 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -133.57 173.14 11.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.642 -0.708 . . . . 8.91 109.69 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.6 p -74.98 -160.53 0.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.231 0.332 . . . . 9.83 110.405 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.5 pm0 -76.61 24.29 0.15 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.406 0.521 . . . . 11.32 112.406 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.6 t 32.75 87.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.3 1.04 . . . . 6.11 112.724 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.4 m -90.16 135.73 33.48 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.246 -0.434 . . . . 6.12 110.876 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -62.73 134.86 56.92 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.082 -0.71 . . . . 6.3 109.082 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -69.73 100.61 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.247 0.546 . . . . 5.77 111.145 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -96.16 146.31 31.08 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.247 -0.888 . . . . 5.69 109.841 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.26 139.04 28.6 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.751 2.3 . . . . 6.86 112.644 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -79.42 88.1 5.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.002 -0.545 . . . . 8.49 110.389 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.417 ' CG1' ' HB1' ' A' ' 144' ' ' ALA . 2.9 t -95.95 155.07 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.006 -0.738 . . . . 6.19 109.006 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.2 100.16 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.88 0.371 . . . . 6.26 111.351 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 144' ' ' ALA . 68.9 mt -105.19 9.32 34.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.502 0.668 . . . . 6.05 109.791 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.9 m -83.73 26.53 0.69 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.982 -1.008 . . . . 7.02 112.137 -172.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -92.66 -93.74 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.113 0.483 . . . . 7.07 111.07 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -164.49 124.31 1.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.424 -0.584 . . . . 6.68 109.424 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -63.6 118.48 8.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 6.43 110.499 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.418 HG12 HD22 ' A' ' 113' ' ' ASN . 29.6 m -116.08 160.14 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.16 0.505 . . . . 3.7 111.629 -177.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.7 p -119.22 140.19 50.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.607 -0.724 . . . . 3.49 109.884 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.76 -179.11 16.94 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.346 -0.93 . . . . 2.58 112.464 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.1 m -129.39 130.62 46.24 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.765 -0.457 . . . . 3.34 109.765 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.602 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 33.7 t -71.62 129.41 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.402 -0.363 . . . . 3.14 110.031 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.5 p -106.2 -32.57 8.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.06 0.457 . . . . 3.61 110.562 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.8 m -146.38 122.98 11.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.938 -0.573 . . . . 3.12 110.218 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -85.24 -171.2 3.5 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.911 -0.403 . . . . 4.39 109.911 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.29 113.15 3.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.911 -0.774 . . . . 3.62 108.911 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.409 ' HG2' HG21 ' A' ' 105' ' ' THR . 13.2 ptp180 -61.71 145.67 51.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.43 . . . . 7.2 111.388 -174.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.6 p -115.95 147.17 41.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.927 -0.579 . . . . 5.1 110.33 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.77 -66.16 0.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.785 0.291 . . . . 7.53 111.785 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.6 m -75.94 -67.27 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.63 0.253 . . . . 7.47 111.11 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.6 -97.17 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.335 -0.393 . . . . 7.58 110.342 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -97.39 73.45 2.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.792 0.806 . . . . 8.32 109.773 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.552 ' O ' HG12 ' A' ' 99' ' ' VAL . 2.6 m-20 -106.41 -68.48 0.88 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.258 -0.883 . . . . 7.26 111.079 -175.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 98' ' ' ASN . 2.6 p 53.91 14.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 124.617 1.198 . . . . 5.54 111.503 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.8 tp -105.47 82.86 1.87 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.83 -1.174 . . . . 7.28 107.83 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.565 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 18.0 m120 -131.16 36.17 3.85 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.559 -1.2 . . . . 7.54 111.63 -171.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.4 m 53.65 25.08 4.67 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.234 0.457 . . . . 5.41 112.234 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.2 p 49.06 33.15 4.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.317 0.647 . . . . 4.58 112.106 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 101' ' ' ASN . 12.6 pt-20 -88.22 11.03 17.52 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.885 0.374 . . . . 5.09 111.117 -177.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.409 HG21 ' HG2' ' A' ' 92' ' ' ARG . 7.7 t -136.66 135.81 38.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.877 0.37 . . . . 3.33 110.572 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.4 p -100.55 151.79 21.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.123 -0.49 . . . . 2.57 110.444 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -90.77 175.7 40.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.724 -0.75 . . . . 1.66 111.536 175.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.482 ' HD2' ' HB3' ' A' ' 119' ' ' PHE . 24.2 mmt180 -130.51 122.18 27.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.024 0.44 . . . . 3.03 111.751 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.87 134.14 63.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.474 -0.785 . . . . 1.88 109.388 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.2 t -112.39 148.67 33.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.353 -0.24 . . . . 3.49 110.353 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -159.49 167.22 29.18 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 110.084 -0.339 . . . . 3.51 110.084 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -140.06 112.67 7.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.833 -0.432 . . . . 5.1 109.833 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.418 HD22 HG12 ' A' ' 83' ' ' VAL . 60.6 t30 -168.03 154.24 7.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.827 -0.434 . . . . 4.78 109.827 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 64.35 20.99 12.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.117 0.567 . . . . 6.97 110.474 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.77 89.84 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.165 -0.54 . . . . 5.1 112.47 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -111.71 140.84 46.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.227 0.537 . . . . 5.38 111.655 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 52.5 t -140.94 101.51 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.126 -0.943 . . . . 4.72 109.797 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -151.78 169.57 21.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.617 -0.265 . . . . 4.61 110.499 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.482 ' HB3' ' HD2' ' A' ' 108' ' ' ARG . 74.9 m-85 -98.34 130.85 45.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.067 -0.515 . . . . 3.96 110.742 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 120' ' ' LEU . 5.6 mp -105.64 134.5 19.68 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.29 -0.413 . . . . 2.75 110.244 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 93.3 Cg_endo -84.01 134.33 6.08 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.745 2.297 . . . . 2.3 112.029 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -135.77 159.44 41.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.41 -0.359 . . . . 2.13 110.224 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.31 175.09 5.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.24 -0.436 . . . . 3.07 110.689 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.82 -38.46 85.51 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.08 0.467 . . . . 4.8 111.694 -174.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -85.2 -3.1 58.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.793 -0.639 . . . . 4.81 112.363 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.83 -15.23 61.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.086 0.47 . . . . 3.84 110.94 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.422 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 38.5 t -81.99 114.57 23.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.199 -0.455 . . . . 4.39 110.171 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.61 110.05 3.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 6.43 110.606 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.5 -3.18 56.29 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.722 -0.672 . . . . 5.91 112.092 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.9 t30 59.12 71.01 0.61 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.071 0.462 . . . . 6.07 110.386 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.7 t -103.46 148.47 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.958 -0.565 . . . . 5.27 110.615 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -81.54 109.1 15.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.011 -0.54 . . . . 5.78 110.496 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.3 pt? -110.9 148.86 31.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.963 -0.562 . . . . 3.62 109.603 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -136.18 124.78 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.855 -0.424 . . . . 6.93 109.855 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.602 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -51.46 123.1 9.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.105 0.479 . . . . 4.12 112.207 -173.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.65 3.66 16.07 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.409 -0.814 . . . . 4.07 111.828 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -105.64 -174.21 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.115 0.484 . . . . 4.06 110.652 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 160' ' ' ASN . 2.7 mmmm -113.53 123.19 49.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.139 -0.482 . . . . 4.17 110.858 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.12 152.02 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.994 0.426 . . . . 2.77 110.665 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 m -113.57 128.8 56.57 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.386 -0.598 . . . . 3.47 109.386 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -130.87 159.5 37.2 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.094 -0.336 . . . . 3.35 110.094 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -111.01 125.14 53.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.326 -0.397 . . . . 5.34 110.218 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.0 mt -78.6 98.54 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.286 -0.635 . . . . 4.66 109.286 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.445 ' HB2' HD23 ' A' ' 78' ' ' LEU . . . -111.88 144.11 41.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.271 -0.877 . . . . 4.85 111.236 -171.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.2 m -117.96 116.99 28.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.364 -0.38 . . . . 5.68 110.784 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.716 ' H ' HD21 ' A' ' 151' ' ' LEU . 60.9 t30 -99.25 172.62 7.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.263 -0.643 . . . . 6.25 109.263 176.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -51.44 -43.91 62.18 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.187 0.81 . . . . 8.58 113.187 -171.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -23.05 62.55 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.416 0.524 . . . . 7.86 112.416 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.59 16.44 80.74 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.539 -0.838 . . . . 5.59 112.814 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.522 ' O ' HD13 ' A' ' 151' ' ' LEU . 18.7 m120 -105.66 77.46 1.27 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 110.051 -0.352 . . . . 5.18 110.051 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.716 HD21 ' H ' ' A' ' 146' ' ' ASN . 1.6 mm? -127.11 169.64 13.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.306 -0.406 . . . . 4.28 110.546 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.36 -102.91 0.4 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.631 -0.988 . . . . 3.36 110.631 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -125.49 110.26 13.68 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.307 -0.627 . . . . 2.84 109.307 175.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 3.7 t -125.48 168.67 13.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.499 -0.319 . . . . 4.34 110.509 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 57.79 41.44 25.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.23 0.538 . . . . 5.75 110.074 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 127' ' ' VAL . 56.6 mt -68.63 118.58 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.339 -0.846 . . . . 3.55 111.277 -176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -102.89 133.64 47.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.554 -0.748 . . . . 5.96 109.363 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 161' ' ' PRO . 36.4 tp -76.86 107.68 9.35 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.722 -0.844 . . . . 4.34 108.722 175.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -83.05 -62.7 1.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.89 -0.595 . . . . 4.97 110.626 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.533 ' HB2' ' HB2' ' A' ' 138' ' ' LYS . 16.1 m120 -129.08 103.19 18.55 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.995 -0.743 . . . . 5.37 108.995 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.486 ' HB3' HD21 ' A' ' 158' ' ' LEU . 65.1 Cg_endo -71.46 158.66 53.51 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.252 1.968 . . . . 5.44 112.264 -176.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.89 19.48 3.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.334 0.587 . . . . 6.1 109.993 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -94.17 139.35 22.49 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.421 -0.808 . . . . 9.49 109.968 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.41 104.31 1.07 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.533 2.155 . . . . 8.39 112.202 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.256 -0.429 . . . . 10.27 110.556 178.7 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.403 0 N-CA-C 112.096 -0.402 . . . . 21.66 112.096 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.42 143.85 20.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.67 0.271 . . . . 20.17 110.701 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.46 -31.38 18.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.886 0.85 . . . . 18.5 109.527 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.87 69.1 10.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.825 -1.079 . . . . 16.62 111.67 -169.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.538 ' HG3' ' H ' ' A' ' 6' ' ' GLU . 8.4 pt-20 -151.63 -64.62 0.18 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.01 0.374 . . . . 18.35 112.01 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.538 ' H ' ' HG3' ' A' ' 5' ' ' GLU . 6.4 mm-40 -88.58 93.74 9.65 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.413 0.625 . . . . 16.2 110.877 -177.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -137.43 116.35 12.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.682 -0.69 . . . . 12.4 110.219 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -141.18 170.28 16.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.282 -0.417 . . . . 11.63 110.684 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 27.2 p -97.26 173.52 7.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.113 0.482 . . . . 9.15 111.996 -174.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' HA2' ' HG3' ' A' ' 26' ' ' GLU . . . -169.06 152.07 19.21 Favored Glycine 0 C--O 1.225 -0.414 0 CA-C-N 115.405 -0.816 . . . . 6.81 111.176 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.451 HD11 ' SG ' ' A' ' 25' ' ' CYS . 18.1 pt -100.83 147.89 7.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 117.646 0.723 . . . . 10.17 110.407 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.79 121.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.486 -0.325 . . . . 8.73 111.043 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -72.03 -56.33 5.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.552 -0.749 . . . . 10.86 110.284 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -166.09 157.23 13.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.397 -0.819 . . . . 14.06 109.013 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -115.62 116.1 27.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.326 0.584 . . . . 11.73 111.33 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 2.8 mm? -98.3 -178.93 4.19 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.965 -1.124 . . . . 11.36 107.965 173.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 18' ' ' SER . 2.9 t60 -90.02 124.84 35.11 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.001 -0.74 . . . . 15.94 109.001 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 17' ' ' HIS . 68.7 m 81.35 -21.52 0.31 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.255 0.972 . . . . 13.01 112.399 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.442 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 50.4 p90 -150.01 156.68 42.13 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.104 -0.373 . . . . 12.34 111.062 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.36 178.27 21.66 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.667 -0.573 . . . . 7.52 111.667 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -119.34 146.36 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.03 0.415 . . . . 9.24 111.443 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.4 mt -108.33 134.71 49.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.631 -0.713 . . . . 7.75 109.798 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.411 ' HB2' HG13 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -85.1 144.77 28.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.651 0.739 . . . . 11.8 111.667 -175.64 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -80.68 2.83 24.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.573 -1.194 . . . . 12.34 113.065 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.451 ' SG ' HD11 ' A' ' 11' ' ' ILE . 69.1 m -52.85 -31.59 40.07 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.612 0.244 . . . . 13.33 111.3 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.424 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 17.0 mm-40 -84.37 -39.36 19.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.409 -0.36 . . . . 11.9 111.106 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.22 148.46 28.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.994 -0.373 . . . . 12.99 109.994 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.416 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 6.7 pt20 -70.8 68.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.936 0.717 . . . . 16.66 112.936 -174.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -169.75 139.24 1.94 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.9 -0.591 . . . . 12.09 110.132 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 5.5 ptp180 -107.33 118.37 36.54 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.488 -0.56 . . . . 12.51 109.488 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.46 150.08 29.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.842 0.353 . . . . 8.76 111.052 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -110.65 133.71 53.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.032 -0.729 . . . . 9.15 109.032 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -125.21 143.64 50.84 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.145 -0.317 . . . . 6.85 110.145 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -94.14 155.09 17.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.477 -0.564 . . . . 9.99 109.477 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -69.23 -9.22 52.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.899 0.38 . . . . 9.93 111.583 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -80.57 -13.33 59.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.055 0.455 . . . . 12.28 109.777 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -116.44 35.81 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.922 -0.581 . . . . 10.62 111.486 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -119.01 124.94 48.21 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.062 -0.347 . . . . 8.78 110.062 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 t -94.76 94.96 8.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.066 0.46 . . . . 8.97 110.25 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.86 -169.71 26.03 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.054 -0.593 . . . . 9.98 111.738 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -87.8 120.34 29.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.286 -0.264 . . . . 12.43 110.286 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -66.56 -20.77 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.236 0.541 . . . . 11.58 110.954 -176.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.04 -24.56 66.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.914 -0.584 . . . . 14.73 110.583 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -92.91 2.95 56.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.835 -0.621 . . . . 13.3 110.453 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -102.54 129.93 49.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.636 -0.711 . . . . 10.07 109.417 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.38 177.22 8.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.529 -0.305 . . . . 13.13 110.768 -175.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 47' ' ' ILE . 4.0 mp -80.05 141.03 15.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.537 -0.302 . . . . 11.74 110.187 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.53 10.57 85.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.091 -0.576 . . . . 10.13 111.767 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.9 134.47 21.48 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.583 -0.309 . . . . 8.39 110.194 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.507 ' HB2' HD12 ' A' ' 72' ' ' ILE . 90.4 Cg_endo -81.99 128.82 5.93 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.594 2.196 . . . . 7.28 113.653 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.0 m -120.65 167.99 13.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.448 -0.796 . . . . 4.74 109.779 175.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 4.7 pt-20 -120.17 124.48 45.85 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.258 -0.645 . . . . 7.09 109.258 174.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -131.27 147.8 52.62 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 122.165 0.983 . . . . 7.82 112.278 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 30.6 tt0 -100.29 122.13 42.59 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.003 -1.453 . . . . 11.59 108.448 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.93 118.08 36.26 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.243 -0.183 . . . . 12.41 110.726 -173.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.5 p -141.94 153.49 44.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.161 0.505 . . . . 13.17 111.459 -176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -96.8 108.52 21.2 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.13 -0.693 . . . . 16.21 109.13 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.57 111.13 18.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.062 0.458 . . . . 16.64 110.928 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -81.18 -7.08 59.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.966 -0.561 . . . . 22.64 111.706 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -67.99 -46.56 70.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.033 -0.729 . . . . 21.43 109.033 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.4 p -93.78 -31.33 14.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.179 -0.918 . . . . 17.4 110.9 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.33 28.46 17.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.679 -0.772 . . . . 16.7 111.905 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -133.41 152.91 80.1 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 110.132 -0.321 . . . . 14.73 110.132 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.06 125.88 6.77 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.322 2.015 . . . . 12.6 110.763 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -137.43 172.51 14.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.748 0.785 . . . . 11.73 112.749 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.69 149.76 24.12 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.753 -1.112 . . . . 8.91 108.028 170.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.499 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 8.6 t -69.39 -151.07 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.329 0.585 . . . . 9.83 110.547 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -75.79 26.7 0.11 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.524 0.564 . . . . 11.32 112.524 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.405 ' H ' ' C ' ' A' ' 67' ' ' SER . 38.5 t 21.58 96.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.959 1.304 . . . . 6.11 113.632 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.3 t -88.55 154.32 20.44 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.777 -0.647 . . . . 6.12 110.22 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -96.64 123.58 40.37 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.001 -0.545 . . . . 6.3 109.877 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.507 HD12 ' HB2' ' A' ' 50' ' ' PRO . 63.8 mt -47.25 111.09 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 124.0 0.812 . . . . 5.77 111.386 -175.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.95 146.78 49.69 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.26 -0.882 . . . . 5.69 110.113 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.19 109.41 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.45 2.1 . . . . 6.86 111.674 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -81.66 -154.21 0.11 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 8.49 110.819 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.436 HG12 ' HB1' ' A' ' 144' ' ' ALA . 3.9 t -59.56 135.04 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.642 -0.708 . . . . 6.19 110.624 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 38.9 t -77.64 103.56 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 6.26 109.749 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.19 41.57 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.624 -0.716 . . . . 6.05 110.493 -174.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 71.1 m -156.18 33.15 0.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.951 -0.568 . . . . 7.02 110.853 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 145' ' ' THR . 6.1 mm-40 -83.22 62.99 6.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.228 -0.442 . . . . 7.07 110.466 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 68.81 112.72 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.192 -1.367 . . . . 6.68 111.463 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -77.71 81.95 4.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.616 0.722 . . . . 6.43 109.927 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.3 m -77.42 168.95 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.715 -0.675 . . . . 3.7 110.974 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.44 ' HB ' ' HE3' ' A' ' 138' ' ' LYS . 46.8 p -116.45 150.26 38.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.819 -0.628 . . . . 3.49 109.83 175.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.29 153.88 20.78 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.425 -0.893 . . . . 2.58 111.713 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -107.03 126.4 52.28 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.289 -0.634 . . . . 3.34 109.289 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 21.4 t -70.56 110.87 3.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.4 -0.363 . . . . 3.14 110.784 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.3 p -98.24 -13.26 20.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.698 0.761 . . . . 3.61 110.172 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 26.7 m -155.34 115.93 3.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.118 -0.946 . . . . 3.12 109.381 -175.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 135' ' ' ALA . 0.3 OUTLIER -104.62 148.8 26.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 4.39 111.102 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -93.58 131.24 39.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.335 -0.987 . . . . 3.62 108.335 174.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -127.72 178.84 5.87 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.408 -0.59 . . . . 7.2 109.408 -173.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -66.97 98.08 0.54 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.293 0.568 . . . . 5.1 110.327 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -88.52 -17.81 29.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.426 -0.806 . . . . 7.53 109.364 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.89 -164.65 0.24 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.06 -0.973 . . . . 7.47 110.014 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.14 86.22 6.21 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.025 -0.422 . . . . 7.58 110.483 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 m120 73.94 -54.28 0.68 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.005 -0.998 . . . . 8.32 112.589 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -97.26 -178.9 4.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.644 -0.502 . . . . 7.26 109.644 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.91 141.46 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.522 -0.308 . . . . 5.54 110.746 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.2 tp -104.22 -80.59 0.53 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.193 0.521 . . . . 7.28 109.666 171.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 102' ' ' SER . 94.8 m-20 -110.96 -32.18 6.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.093 -0.958 . . . . 7.54 110.562 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 47.7 t 76.92 -34.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.538 -0.756 . . . . 5.41 111.125 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 p -70.09 -8.78 52.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.227 0.537 . . . . 4.58 110.611 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -61.82 -24.37 66.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.128 -0.942 . . . . 5.09 110.403 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 t -139.29 117.14 11.6 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.609 -0.723 . . . . 3.33 109.708 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t -97.34 135.98 38.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.27 -0.423 . . . . 2.57 110.193 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.445 ' HA3' ' CE1' ' A' ' 122' ' ' TYR . . . -75.41 -177.54 41.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.632 -0.794 . . . . 1.66 112.048 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.617 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -146.27 120.85 9.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.102 0.477 . . . . 3.03 110.164 -177.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -111.56 130.38 65.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.853 -0.612 . . . . 1.88 110.209 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.7 t -105.31 124.46 49.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.032 -0.531 . . . . 3.49 109.625 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -140.84 146.83 38.07 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.388 -0.597 . . . . 3.51 109.388 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.38 112.0 18.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.152 0.501 . . . . 5.1 110.802 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.71 121.89 46.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.568 -0.742 . . . . 4.78 109.936 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 60.57 23.82 13.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.502 -0.772 . . . . 6.97 111.06 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.25 -2.01 65.18 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.911 -0.661 . . . . 5.1 113.171 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.84 121.71 41.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.241 0.521 . . . . 5.38 110.559 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.4 p -102.47 113.15 26.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.117 -0.492 . . . . 4.72 110.754 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -118.51 147.03 44.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.291 -0.413 . . . . 4.61 110.377 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -101.63 126.84 48.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 3.96 109.648 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.9 118.54 55.95 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.586 -0.279 . . . . 2.75 110.93 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.82 132.68 14.6 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.691 2.261 . . . . 2.3 110.712 168.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CE1' ' HA3' ' A' ' 107' ' ' GLY . 35.0 p90 -140.95 159.78 41.48 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.932 -0.307 . . . . 2.13 110.54 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 64.7 p -121.02 -175.62 3.09 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.012 -0.54 . . . . 3.07 110.009 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -62.89 -30.13 71.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.351 . . . . 4.8 111.655 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.01 -9.38 59.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.07 -0.514 . . . . 4.81 111.202 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -91.17 -12.44 35.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.28 0.562 . . . . 3.84 110.309 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.2 t -85.81 126.82 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.002 -0.545 . . . . 4.39 110.152 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -80.92 127.93 33.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.229 -0.441 . . . . 6.43 109.973 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.24 -0.23 87.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.808 -0.711 . . . . 5.91 112.838 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 59.6 35.98 22.62 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.139 0.495 . . . . 6.07 111.087 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.87 137.19 23.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.145 -0.479 . . . . 5.27 111.249 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -80.74 112.62 18.29 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.694 -0.484 . . . . 5.78 109.694 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.68 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -102.9 150.9 23.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.055 -0.52 . . . . 3.62 111.536 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -115.46 135.57 53.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.689 -0.687 . . . . 6.93 110.044 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.597 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -60.91 114.39 3.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.258 0.551 . . . . 4.12 110.815 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.06 -3.92 14.11 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.517 -0.765 . . . . 4.07 112.874 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.497 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . 16.5 p30 -90.78 -177.35 4.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.442 0.621 . . . . 4.06 110.18 173.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HE3' ' HB ' ' A' ' 84' ' ' THR . 50.9 tptt -112.95 113.55 25.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.061 0.458 . . . . 4.17 110.874 -174.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.9 m -117.82 154.28 19.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.84 -0.618 . . . . 2.77 110.515 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.5 t -124.18 135.88 53.78 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.395 -0.594 . . . . 3.47 109.395 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.44 146.33 52.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.164 -0.471 . . . . 3.35 110.129 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -93.8 118.92 32.09 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.792 -0.64 . . . . 5.34 109.704 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 93.8 mt -78.4 133.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.646 -0.501 . . . . 4.66 109.646 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -125.81 110.7 14.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.992 -0.549 . . . . 4.85 110.322 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.468 ' H ' ' HG3' ' A' ' 80' ' ' GLU . 20.0 m -99.01 132.09 44.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.962 0.411 . . . . 5.68 110.895 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -107.27 -163.8 0.93 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.845 -0.616 . . . . 6.25 110.935 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -75.71 -37.94 59.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.969 -0.559 . . . . 8.58 110.651 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -74.94 -18.42 60.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.384 -0.371 . . . . 7.86 110.794 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.98 22.78 54.4 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.839 -0.696 . . . . 5.59 111.801 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -113.96 121.53 44.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.462 0.173 . . . . 5.18 110.585 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.504 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -148.9 -179.32 6.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.006 0.432 . . . . 4.28 111.659 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.23 -124.81 1.64 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.635 -0.986 . . . . 3.36 110.635 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -138.72 117.11 11.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.832 0.316 . . . . 2.84 110.378 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 4.7 t -128.59 158.48 38.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.446 -0.343 . . . . 4.34 110.08 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 57.43 42.95 23.85 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.741 0.65 . . . . 5.75 110.953 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 22.3 mt -74.6 116.29 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.329 -0.85 . . . . 3.55 110.666 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -114.2 142.02 46.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 5.96 110.901 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.1 tp -83.41 119.21 24.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.927 -0.578 . . . . 4.34 110.125 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -87.64 -53.74 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.744 0.307 . . . . 4.97 110.581 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -142.92 122.94 7.89 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.918 0.389 . . . . 5.37 110.9 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 137' ' ' ASP . 82.3 Cg_endo -79.78 157.36 24.42 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.787 2.325 . . . . 5.44 112.59 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -111.32 152.97 26.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.804 -0.634 . . . . 6.1 110.696 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -104.52 161.48 22.7 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.69 -0.485 . . . . 9.49 109.69 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.06 108.65 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.638 2.226 . . . . 8.39 112.652 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.236 0.349 0 CA-C-N 115.832 -0.622 . . . . 10.27 111.353 -179.23 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 112.087 -0.405 . . . . 21.66 112.087 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.28 149.47 33.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.853 0.359 . . . . 20.17 110.54 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.31 -52.61 4.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.139 -0.482 . . . . 18.5 112.007 -172.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -94.3 25.47 3.83 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.938 0.718 . . . . 16.62 112.938 -167.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -63.37 -77.4 0.05 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.208 0.528 . . . . 18.35 111.331 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -125.76 119.58 28.31 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.519 -0.764 . . . . 16.2 109.645 -176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.445 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 15.0 ptt180 -126.62 153.09 45.78 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.251 -0.431 . . . . 12.4 110.604 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.527 ' HB2' ' NH1' ' A' ' 27' ' ' ARG . 38.3 mt-10 -130.91 155.67 46.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.031 -0.531 . . . . 11.63 109.633 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -87.48 169.57 12.1 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.178 -0.465 . . . . 9.15 110.291 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.23 162.97 34.68 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.55 -0.833 . . . . 6.81 111.999 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -117.64 137.0 53.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.407 -0.59 . . . . 10.17 109.407 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.75 110.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.149 0.5 . . . . 8.73 110.471 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -72.09 -50.53 27.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.77 -0.65 . . . . 10.86 110.37 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.547 ' HA ' HD12 ' A' ' 47' ' ' ILE . 38.1 ttpt -161.04 155.17 22.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.899 -1.046 . . . . 14.06 109.098 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 mt -116.15 126.76 54.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.156 0.503 . . . . 11.73 111.183 -175.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.4 mp -114.57 -179.89 3.76 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.649 -1.241 . . . . 11.36 107.649 173.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -90.62 126.64 36.02 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.182 -0.607 . . . . 15.94 110.27 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 m 80.56 -14.58 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.605 1.191 . . . . 13.01 111.995 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 12.5 p90 -159.59 162.31 35.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.764 0.316 . . . . 12.34 111.389 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.24 -176.78 27.82 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.085 -0.579 . . . . 7.52 112.054 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -115.94 143.92 44.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.823 0.344 . . . . 9.24 111.475 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.9 mt -113.79 120.19 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.856 -0.611 . . . . 7.75 110.075 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -69.48 147.04 51.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.476 0.655 . . . . 11.8 111.809 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.404 ' HA ' ' HG3' ' A' ' 27' ' ' ARG . 3.2 p -79.89 0.57 30.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.842 -1.072 . . . . 12.34 112.299 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 m -53.24 -31.32 42.83 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.662 0.616 . . . . 13.33 112.662 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -105.53 11.27 32.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.712 0.291 . . . . 11.9 111.431 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.527 ' NH1' ' HB2' ' A' ' 8' ' ' GLU . 7.5 ptm85 -153.95 -170.24 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.524 0.202 . . . . 12.99 111.326 -173.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -112.14 17.81 19.22 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.15 0.426 . . . . 16.66 112.15 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.81 149.17 17.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.524 -0.307 . . . . 12.09 110.885 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -92.86 135.69 33.91 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.177 -0.675 . . . . 12.51 109.177 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.1 mt -135.82 163.23 30.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.355 0.597 . . . . 8.76 111.904 -174.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -124.08 149.2 46.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.447 -0.946 . . . . 9.15 108.447 172.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -135.36 152.15 51.17 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.941 -0.304 . . . . 6.85 110.248 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 10.9 p80 -109.71 152.4 25.67 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.689 -0.485 . . . . 9.99 109.689 175.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -70.2 4.52 2.15 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.252 0.834 . . . . 9.93 113.252 -168.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 t -77.78 -17.78 57.14 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.725 -0.472 . . . . 12.28 109.725 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -116.66 40.46 2.92 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.863 -0.608 . . . . 10.62 112.114 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -126.59 124.91 41.04 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.203 -0.599 . . . . 8.78 111.331 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 m -101.92 106.68 17.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.662 -0.699 . . . . 8.97 110.707 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.57 176.08 19.2 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.722 -0.751 . . . . 9.98 112.023 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -68.67 109.65 3.9 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.703 -0.481 . . . . 12.43 109.703 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -63.68 -25.05 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.166 0.508 . . . . 11.58 110.8 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.39 -23.19 62.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.126 -0.488 . . . . 14.73 110.745 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -93.42 2.96 56.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 13.3 110.949 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.441 HD12 ' OD1' ' A' ' 49' ' ' ASP . 26.3 tp -94.43 117.03 29.5 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.698 -0.853 . . . . 10.07 108.698 176.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -119.19 -173.9 2.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.523 -0.308 . . . . 13.13 110.849 -173.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 14' ' ' LYS . 24.6 mm -87.55 133.03 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.76 -0.459 . . . . 11.74 109.76 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.73 10.85 82.62 Favored Glycine 0 CA--C 1.51 -0.235 0 N-CA-C 110.922 -0.871 . . . . 10.13 110.922 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.441 ' OD1' HD12 ' A' ' 45' ' ' LEU . 43.4 t0 -92.97 121.73 65.16 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.838 -0.681 . . . . 8.39 109.906 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.62 143.21 18.79 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.102 2.535 . . . . 7.28 114.058 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.0 m -138.75 160.71 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.667 -0.697 . . . . 4.74 110.413 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -117.74 130.53 56.37 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.807 -0.442 . . . . 7.09 109.807 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -142.35 155.57 45.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.443 0.639 . . . . 7.82 111.245 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 21.1 mt-10 -104.53 131.53 51.82 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.46 -0.791 . . . . 11.59 109.075 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.7 ttt -103.87 123.11 46.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.557 -0.292 . . . . 12.41 110.944 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.0 p -141.97 169.76 16.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.923 0.392 . . . . 13.17 111.124 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 53.1 m-85 -116.9 120.7 39.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.564 -0.532 . . . . 16.21 109.564 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.53 ' OD2' HG22 ' A' ' 61' ' ' THR . 21.4 t70 -81.99 121.43 26.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.724 0.297 . . . . 16.64 110.38 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -79.86 -6.97 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 22.64 112.267 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -84.04 -57.66 3.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.601 0.238 . . . . 21.43 110.702 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.599 HG23 ' HG2' ' A' ' 63' ' ' LYS . 8.8 t -91.62 -19.26 22.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.116 0.484 . . . . 17.4 110.774 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.86 34.16 22.39 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.457 -0.878 . . . . 16.7 113.365 172.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.599 ' HG2' HG23 ' A' ' 61' ' ' THR . 19.2 ptpt -124.74 150.05 64.36 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 117.485 0.643 . . . . 14.73 110.963 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.495 ' HB3' ' CE1' ' A' ' 57' ' ' TYR . 58.4 Cg_endo -73.43 126.66 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.398 2.065 . . . . 12.6 110.913 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.29 -179.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.286 0.565 . . . . 11.73 111.252 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.0 162.96 19.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.445 -0.798 . . . . 8.91 109.842 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 30.4 t -72.87 -164.03 0.15 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.706 -0.679 . . . . 9.83 109.576 175.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -74.11 17.34 0.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.833 0.679 . . . . 11.32 112.833 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.2 t 37.88 93.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.149 0.98 . . . . 6.11 112.602 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.2 t -82.13 123.06 28.63 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.354 -0.609 . . . . 6.12 109.354 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -73.76 121.65 21.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.329 -0.619 . . . . 6.3 109.329 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.12 117.89 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.481 -0.781 . . . . 5.77 111.639 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.93 147.69 66.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.79 -0.641 . . . . 5.69 110.464 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.99 123.27 7.76 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.429 2.086 . . . . 6.86 112.297 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 75' ' ' GLU . 1.1 pm0 -86.6 110.95 20.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.48 0.657 . . . . 8.49 111.051 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.435 HG12 ' HB1' ' A' ' 144' ' ' ALA . 19.5 t -90.05 144.38 9.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.438 -0.801 . . . . 6.19 109.448 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 26.6 t -78.65 83.87 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.062 0.458 . . . . 6.26 110.541 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.584 HD12 ' HB2' ' A' ' 144' ' ' ALA . 3.6 tp -82.74 17.26 1.9 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.694 -0.684 . . . . 6.05 110.61 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 m -133.69 36.93 3.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.506 0.558 . . . . 7.02 112.506 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.14 -51.17 11.45 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.373 -0.531 . . . . 7.07 110.334 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -167.43 139.5 3.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 6.68 110.032 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.483 ' HD3' ' C ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -96.1 114.46 26.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.545 -0.539 . . . . 6.43 109.545 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.88 171.0 12.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.694 -0.684 . . . . 3.7 110.112 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.9 p -108.4 148.44 30.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.333 -0.618 . . . . 3.49 109.333 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -114.04 137.41 14.07 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.429 -0.891 . . . . 2.58 112.311 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -120.0 112.1 18.74 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.115 -0.698 . . . . 3.34 109.115 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.672 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 59.1 t -66.83 127.63 28.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.161 -0.472 . . . . 3.14 110.483 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.1 p -109.07 -20.0 13.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.135 0.493 . . . . 3.61 111.092 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.7 m -148.98 124.99 10.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.462 -0.57 . . . . 3.12 109.462 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.86 -179.1 7.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.033 0.444 . . . . 4.39 110.869 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.56 124.9 23.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.824 -0.626 . . . . 3.62 109.506 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -68.05 121.45 16.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.995 0.426 . . . . 7.2 111.078 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.463 HG22 ' CG2' ' A' ' 99' ' ' VAL . 40.5 p -76.72 97.25 4.42 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.068 0.461 . . . . 5.1 110.067 172.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -92.14 8.75 36.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.502 1.144 . . . . 7.53 108.317 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.5 t -124.85 142.56 51.36 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 113.476 -1.693 . . . . 7.47 107.788 172.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.49 85.57 0.43 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.68 0.276 . . . . 7.58 111.565 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.6 t30 74.94 -29.13 0.19 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.691 0.796 . . . . 8.32 112.33 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.439 ' ND2' HD22 ' A' ' 100' ' ' LEU . 63.7 t30 -66.64 -42.85 86.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.402 -0.222 . . . . 7.26 110.402 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.463 ' CG2' HG22 ' A' ' 93' ' ' THR . 5.0 p 50.5 26.56 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.025 0.93 . . . . 5.54 113.12 169.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.439 HD22 ' ND2' ' A' ' 98' ' ' ASN . 2.2 pt? -75.05 -2.81 29.09 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.16 0.8 . . . . 7.28 113.16 -172.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -125.35 32.38 5.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.098 0.475 . . . . 7.54 111.063 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 p -90.42 27.93 1.58 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.131 -0.486 . . . . 5.41 110.876 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.6 m -73.36 -34.99 65.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.145 -0.48 . . . . 4.58 111.36 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.32 -31.87 12.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 5.09 111.933 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -68.38 127.2 32.12 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.395 0.617 . . . . 3.33 110.055 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 56.9 p -98.56 137.2 37.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.435 -0.802 . . . . 2.57 111.537 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -86.39 -169.06 45.54 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.059 -0.816 . . . . 1.66 111.059 173.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -128.3 120.81 27.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.982 0.42 . . . . 3.03 111.226 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.437 HG12 HG22 ' A' ' 87' ' ' VAL . 80.0 mt -110.95 125.09 68.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.599 -0.728 . . . . 1.88 109.341 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.7 t -104.25 142.1 35.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.984 0.421 . . . . 3.49 110.681 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -147.44 165.58 29.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.456 -0.942 . . . . 3.51 108.456 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.96 125.21 27.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.386 -0.598 . . . . 5.1 109.386 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -135.27 107.75 7.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 4.78 110.938 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 62.64 28.66 16.71 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.749 -0.66 . . . . 6.97 111.906 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.34 -1.57 62.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.162 -0.542 . . . . 5.1 112.996 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 118' ' ' PHE . 42.3 mt-10 -104.65 110.81 23.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.1 0.476 . . . . 5.38 110.365 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 45.5 t -112.39 127.44 56.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.883 -0.599 . . . . 4.72 109.872 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 116' ' ' GLU . 73.3 m-85 -135.37 166.95 21.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 4.61 111.013 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -110.26 123.96 50.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.562 -0.744 . . . . 3.96 109.593 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 8.4 mp -104.48 132.88 20.54 Favored Pre-proline 0 C--N 1.322 -0.607 0 C-N-CA 121.069 -0.252 . . . . 2.75 110.492 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 2.8 Cg_exo -75.37 133.16 15.73 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.741 2.294 . . . . 2.3 111.664 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.436 ' CD1' HG13 ' A' ' 109' ' ' ILE . 17.6 p90 -135.16 144.81 47.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.679 -0.237 . . . . 2.13 110.483 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.4 p -109.18 -177.62 3.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.109 -0.33 . . . . 3.07 110.109 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -70.6 -22.4 62.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.236 0.541 . . . . 4.8 110.725 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.25 -25.93 52.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.488 -0.778 . . . . 4.81 110.975 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 153' ' ' ALA . 21.7 m-20 -74.26 -30.55 62.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.027 -0.533 . . . . 3.84 111.795 -175.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 156' ' ' ILE . 2.5 p -84.59 118.63 32.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.651 0.739 . . . . 4.39 111.052 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -89.92 136.22 33.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.347 -0.842 . . . . 6.43 109.769 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.34 -19.85 38.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.772 -0.728 . . . . 5.91 111.848 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 54.4 t30 60.09 71.01 0.59 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.383 0.611 . . . . 6.07 110.904 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 t -108.12 149.43 11.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.117 -0.492 . . . . 5.27 110.122 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -91.7 102.03 14.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.002 0.43 . . . . 5.78 110.155 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.609 HD23 ' H ' ' A' ' 133' ' ' LEU . 1.8 pt? -114.97 143.44 45.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.593 -0.731 . . . . 3.62 110.267 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -117.62 -179.99 3.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 6.93 109.913 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.672 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.81 132.46 42.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.314 -0.403 . . . . 4.12 110.47 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 104.95 -14.44 48.95 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.068 -0.587 . . . . 4.07 112.444 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.517 ' OD2' ' HB3' ' A' ' 162' ' ' ALA . 54.3 m-20 -84.77 146.45 27.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.466 -0.568 . . . . 4.06 109.466 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -93.5 116.47 29.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.588 0.709 . . . . 4.17 111.778 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.412 HG11 HD13 ' A' ' 133' ' ' LEU . 33.1 m -120.22 166.31 14.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.974 -1.012 . . . . 2.77 110.311 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.604 ' HB3' ' OE1' ' A' ' 159' ' ' GLU . 21.0 p -118.96 133.27 55.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.755 -0.461 . . . . 3.47 109.755 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -135.12 142.52 46.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.774 -0.454 . . . . 3.35 109.774 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' A' ' 142' ' ' GLN . 12.3 mm-40 -98.26 129.33 44.98 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.838 -0.619 . . . . 5.34 110.057 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.41 98.62 2.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.067 -0.716 . . . . 4.66 109.067 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.667 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -102.72 110.07 21.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.148 -0.933 . . . . 4.85 111.599 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.45 122.35 26.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.93 -0.577 . . . . 5.68 110.459 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.1 p30 -86.38 -172.42 4.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.057 0.456 . . . . 6.25 110.803 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -83.54 6.54 20.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.957 -0.565 . . . . 8.58 111.574 -172.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -115.28 1.66 13.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.353 -0.385 . . . . 7.86 110.935 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.79 20.75 70.2 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.768 -0.73 . . . . 5.59 113.294 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -123.99 154.97 39.05 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 5.18 109.127 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.484 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -156.07 176.43 12.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.225 0.536 . . . . 4.28 111.822 -178.135 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.59 -138.9 3.0 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.351 -1.1 . . . . 3.36 110.351 174.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 126' ' ' ASP . . . -121.97 109.0 14.06 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.582 -0.525 . . . . 2.84 109.582 175.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.17 162.7 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.505 -0.316 . . . . 4.34 110.535 -175.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 60.53 33.81 20.45 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.552 0.691 . . . . 5.75 110.043 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 127' ' ' VAL . 70.8 mt -59.84 123.33 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.7 -1.136 . . . . 3.55 110.95 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -124.13 127.55 47.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.9 0.381 . . . . 5.96 110.606 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.46 96.72 2.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 4.34 109.692 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.604 ' OE1' ' HB3' ' A' ' 140' ' ' SER . 6.6 pt-20 -76.86 -35.68 57.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 4.97 110.916 -176.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -137.56 102.26 8.76 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.499 -0.319 . . . . 5.37 110.699 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.23 151.71 49.31 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.523 2.149 . . . . 5.44 112.223 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.517 ' HB3' ' OD2' ' A' ' 137' ' ' ASP . . . -107.97 90.12 3.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.462 0.649 . . . . 6.1 110.549 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -102.12 146.52 32.45 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.42 -0.809 . . . . 9.49 109.903 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.84 107.57 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.472 2.115 . . . . 8.39 112.328 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.3 t . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.969 -0.56 . . . . 10.27 110.333 179.622 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.42 0 N-CA-C 112.21 -0.356 . . . . 21.66 112.21 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.57 11.74 12.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.169 0.509 . . . . 20.17 110.726 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.39 -39.18 85.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.766 . . . . 18.5 111.125 -178.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.39 63.53 3.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.519 . . . . 16.62 110.532 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -117.36 -59.58 1.92 Allowed 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 121.02 0.438 . . . . 18.35 110.705 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 3.8 mp0 -73.46 79.0 1.41 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.544 -0.753 . . . . 16.2 112.13 -178.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.404 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 10.6 ptp180 -106.99 115.86 30.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.344 0.592 . . . . 12.4 109.798 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.37 156.23 21.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.551 -0.75 . . . . 11.63 110.652 -173.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.1 p -110.52 136.75 49.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.414 -0.357 . . . . 9.15 111.007 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.96 178.21 25.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 6.81 111.909 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 25' ' ' CYS . 52.9 mt -124.56 143.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.842 0.321 . . . . 10.17 110.249 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.3 mm -73.58 106.59 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.438 -0.579 . . . . 8.73 109.438 174.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -73.41 -43.92 59.44 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.966 0.412 . . . . 10.86 110.504 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -155.75 162.59 40.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.005 -0.543 . . . . 14.06 109.563 -176.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 mt -119.82 118.63 31.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.171 0.51 . . . . 11.73 111.071 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -111.82 179.99 3.86 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.328 -0.99 . . . . 11.36 108.328 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -90.2 117.31 28.86 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.749 -0.781 . . . . 15.94 110.151 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.6 m 78.71 -7.55 1.77 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.06 -0.973 . . . . 13.01 112.442 178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.69 168.57 26.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.718 0.294 . . . . 12.34 110.886 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.68 -166.61 22.82 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.187 -0.53 . . . . 7.52 112.068 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -125.99 139.51 53.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 9.24 110.945 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.0 mt -101.77 120.36 51.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 7.75 109.574 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -75.92 143.02 41.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.559 -0.746 . . . . 11.8 110.993 -175.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -79.14 3.1 18.64 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.353 -0.839 . . . . 12.34 112.631 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.413 ' HB3' HD12 ' A' ' 11' ' ' ILE . 44.0 t -51.43 -51.26 56.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.506 0.558 . . . . 13.33 112.506 -173.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -90.46 16.94 7.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.289 0.566 . . . . 11.9 111.01 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.567 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 38.6 ttt180 -144.83 -158.63 0.91 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.041 -1.096 . . . . 12.99 108.041 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.567 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 13.4 mm-40 -136.22 23.58 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.189 0.518 . . . . 16.66 110.413 167.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' O ' ' HD3' ' A' ' 27' ' ' ARG . . . -151.8 119.53 6.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.664 -0.698 . . . . 12.09 110.633 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -86.63 151.71 23.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.147 -0.479 . . . . 12.51 110.112 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.507 HD11 ' SD ' ' A' ' 55' ' ' MET . 59.6 mt -141.77 162.17 36.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 8.76 111.423 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -103.6 143.41 32.79 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.664 -0.865 . . . . 9.15 108.664 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -137.93 147.62 44.51 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.269 -0.572 . . . . 6.85 110.179 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -103.41 155.11 18.73 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.368 -0.604 . . . . 9.99 109.368 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -67.25 -13.27 61.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.697 0.284 . . . . 9.93 111.37 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 p -70.78 -24.17 62.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.537 . . . . 12.28 110.148 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -94.1 20.53 7.83 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.642 -0.708 . . . . 10.62 110.995 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -125.03 123.17 39.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.932 0.396 . . . . 8.78 110.705 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 68' ' ' GLN . 13.3 t -111.51 100.8 9.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.72 -0.673 . . . . 8.97 110.218 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.77 -169.78 36.53 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.968 -0.634 . . . . 9.98 111.915 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -83.89 103.68 13.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 12.43 110.323 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.9 tp -67.62 -24.18 30.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.943 -0.571 . . . . 11.58 110.918 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.79 -12.78 61.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 14.73 111.023 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -104.25 4.5 33.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 13.3 110.202 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.9 tp -103.79 110.14 22.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.485 . . . . 10.07 110.701 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -114.11 -178.87 3.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.221 0.534 . . . . 13.13 110.935 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.3 mp -73.08 140.19 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.601 -0.727 . . . . 11.74 110.208 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.84 -2.19 66.37 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 121.013 -0.613 . . . . 10.13 112.378 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.71 127.98 48.03 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 120.58 0.229 . . . . 8.39 110.608 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.76 141.7 13.73 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.194 2.596 . . . . 7.28 113.632 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.412 HG12 ' HE3' ' A' ' 71' ' ' LYS . 23.7 m -128.57 157.93 40.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.799 -0.637 . . . . 4.74 111.186 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -113.17 124.06 51.67 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.997 -0.742 . . . . 7.09 108.997 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -136.87 142.13 42.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.286 0.565 . . . . 7.82 111.614 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.538 ' CD ' ' HB2' ' A' ' 67' ' ' SER . 0.2 OUTLIER -88.88 141.29 28.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.009 -0.737 . . . . 11.59 109.009 173.282 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' ' 31' ' ' LEU . 24.5 ttt -124.0 114.01 19.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.35 -0.241 . . . . 12.41 110.35 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.5 p -134.99 164.67 27.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.153 0.501 . . . . 13.17 111.425 -177.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -95.31 113.4 25.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.025 -0.534 . . . . 16.21 110.083 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.97 124.08 26.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.032 0.444 . . . . 16.64 110.469 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -79.72 -8.87 59.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.684 -0.689 . . . . 22.64 111.266 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -81.0 -56.87 3.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 21.43 110.357 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.5 p -86.65 -45.84 10.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.169 -0.469 . . . . 17.4 111.645 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.0 0.22 35.85 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.626 -0.797 . . . . 16.7 112.322 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -95.87 150.78 37.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.152 -0.314 . . . . 14.73 110.152 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.15 125.29 8.45 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.953 1.769 . . . . 12.6 109.502 171.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -126.94 162.4 31.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.04 0.447 . . . . 11.73 111.362 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.54 151.62 20.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.405 -0.816 . . . . 8.91 109.284 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.538 ' HB2' ' CD ' ' A' ' 54' ' ' GLU . 11.8 t -75.88 -157.22 0.07 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.041 -0.527 . . . . 9.83 109.79 177.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 39' ' ' SER . 23.6 mp0 -75.12 19.23 0.16 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.838 0.681 . . . . 11.32 112.838 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.0 t 33.83 94.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.537 1.135 . . . . 6.11 113.108 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.8 m -80.36 120.73 24.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.461 0.648 . . . . 6.12 110.358 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.686 ' HE2' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -68.1 113.48 5.8 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.664 -0.698 . . . . 6.3 110.537 -179.038 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.686 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 79.5 mt -56.63 106.22 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.175 -0.466 . . . . 5.77 110.328 173.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.91 163.79 4.44 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.067 -0.716 . . . . 5.69 109.067 -177.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -53.67 135.78 63.08 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.143 1.895 . . . . 6.86 111.866 173.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -75.29 -167.35 0.63 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.058 -0.519 . . . . 8.49 111.017 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.12 141.01 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.885 -0.598 . . . . 6.19 110.93 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 38.4 t -67.7 89.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 6.26 110.962 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 144' ' ' ALA . 4.1 tt -91.18 -27.95 18.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 6.05 110.781 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 t -116.37 99.86 7.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.071 -0.513 . . . . 7.02 110.68 -175.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -125.21 -68.15 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.514 -0.767 . . . . 7.07 109.017 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -130.69 127.88 39.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.181 -0.674 . . . . 6.68 109.181 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.457 ' H ' ' CD ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -82.98 126.39 32.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.964 0.411 . . . . 6.43 110.151 -177.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.39 167.4 13.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.093 -0.503 . . . . 3.7 111.117 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 p -120.75 146.23 46.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.809 -0.632 . . . . 3.49 110.327 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.39 162.61 26.5 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.6 -0.81 . . . . 2.58 112.382 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.5 m -106.61 135.24 48.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.826 -0.435 . . . . 3.34 109.826 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 1.1 t -68.98 121.56 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.863 -0.421 . . . . 3.14 109.863 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -27.82 16.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.146 0.498 . . . . 3.61 110.227 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.5 m -155.29 138.01 15.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.003 -0.544 . . . . 3.12 110.407 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -99.85 -171.8 2.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.339 0.59 . . . . 4.39 111.568 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 91' ' ' LEU . 2.5 mm? -83.79 136.89 33.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.95 -1.023 . . . . 3.62 109.22 174.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -73.69 141.44 46.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.155 0.502 . . . . 7.2 111.213 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.07 30.97 0.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.387 -0.824 . . . . 5.1 111.057 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.22 83.92 0.09 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.599 -0.728 . . . . 7.53 111.699 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.5 m -163.08 -173.08 3.27 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.053 -0.976 . . . . 7.47 109.173 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.33 -89.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.857 0.317 . . . . 7.58 111.857 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -99.12 -6.98 27.35 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.81 0.338 . . . . 8.32 111.474 -175.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -131.52 -167.68 1.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.28 -1.007 . . . . 7.26 108.28 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.85 166.94 3.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 110.022 -0.362 . . . . 5.54 110.022 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.6 tp -92.3 88.66 6.53 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.999 0.904 . . . . 7.28 108.633 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.417 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . 49.4 t30 -63.42 -25.54 68.33 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.901 -1.5 . . . . 7.54 111.409 -175.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.8 t -76.81 102.74 6.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.713 -0.847 . . . . 5.41 108.713 172.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m -75.77 86.27 2.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.158 -0.474 . . . . 4.58 111.819 -172.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 -20.59 28.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.339 0.59 . . . . 5.09 109.634 172.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.3 t -99.0 158.66 15.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.38 -0.827 . . . . 3.33 109.968 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 t -130.52 143.67 50.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.914 0.388 . . . . 2.57 110.3 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.74 -168.34 39.58 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.727 -0.749 . . . . 1.66 111.881 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.52 ' NH2' ' HB3' ' A' ' 121' ' ' PRO . 1.1 mmp_? -136.29 130.33 32.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.844 0.354 . . . . 3.03 110.746 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.6 mt -112.53 126.99 69.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.228 -0.656 . . . . 1.88 109.228 171.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 p -108.18 123.19 48.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.439 -0.346 . . . . 3.49 110.608 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.36 156.9 47.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.763 -0.458 . . . . 3.51 109.763 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 116' ' ' GLU . 3.5 tm-20 -132.35 120.86 22.64 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.339 -0.615 . . . . 5.1 109.339 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.773 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 8.6 t30 -130.74 106.48 8.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.199 -0.455 . . . . 4.78 110.724 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 57.94 38.19 26.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.024 -0.535 . . . . 6.97 111.64 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.59 -5.67 64.72 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.983 -0.627 . . . . 5.1 114.091 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.773 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 11.7 pt-20 -95.01 124.6 39.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 118.071 0.935 . . . . 5.38 109.733 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 44.1 t -124.24 104.46 8.83 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.518 -0.549 . . . . 4.72 109.518 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.23 152.71 32.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 4.61 110.979 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -102.65 117.55 34.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.776 -0.824 . . . . 3.96 108.776 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.19 127.64 29.31 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.817 0.341 . . . . 2.75 110.622 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.52 ' HB3' ' NH2' ' A' ' 108' ' ' ARG . 58.7 Cg_endo -76.18 135.88 17.46 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.547 2.165 . . . . 2.3 111.906 175.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -148.73 159.95 43.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.996 -0.742 . . . . 2.13 108.996 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.7 p -116.45 171.9 7.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.921 0.391 . . . . 3.07 110.294 175.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 101' ' ' ASN . 17.1 ttpp -63.93 -21.98 66.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.443 0.64 . . . . 4.8 110.484 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.4 -4.11 58.16 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.606 -0.724 . . . . 4.81 111.88 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -90.76 -9.54 46.24 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.712 0.291 . . . . 3.84 111.417 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 p -102.73 133.02 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.218 0.532 . . . . 4.39 111.335 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -94.45 144.86 25.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.948 -0.569 . . . . 6.43 110.24 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.33 -14.12 23.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.908 -0.663 . . . . 5.91 112.998 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 62.3 t30 53.89 50.86 15.92 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.653 0.74 . . . . 6.07 110.139 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.83 156.48 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.515 -0.766 . . . . 5.27 110.424 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -84.84 120.72 26.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.814 0.34 . . . . 5.78 111.632 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.42 136.72 44.45 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.69 -0.855 . . . . 3.62 108.69 173.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -142.62 157.5 44.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.741 -0.384 . . . . 6.93 110.561 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.543 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -58.66 120.28 8.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.869 0.366 . . . . 4.12 111.121 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.27 -17.4 10.51 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.668 -0.777 . . . . 4.07 113.487 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -92.45 175.47 6.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.017 0.908 . . . . 4.06 109.967 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -119.15 118.81 32.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.353 0.597 . . . . 4.17 111.17 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.2 m -117.18 160.79 16.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.586 -0.734 . . . . 2.77 111.339 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.3 t -117.14 131.74 56.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.051 -0.722 . . . . 3.47 109.051 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -134.31 155.42 50.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.823 0.344 . . . . 3.35 110.46 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -109.15 140.86 42.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.032 0.444 . . . . 5.34 110.292 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.6 mt -110.72 110.1 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.896 -0.593 . . . . 4.66 110.589 -174.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -87.39 107.17 18.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.033 0.444 . . . . 4.85 111.083 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 28.3 m -96.26 117.02 29.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.699 -0.682 . . . . 5.68 111.777 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -85.97 164.21 17.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.423 -0.584 . . . . 6.25 109.423 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.47 -27.95 62.93 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.698 0.399 . . . . 8.58 111.191 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -71.14 -13.53 61.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.08 -0.509 . . . . 7.86 111.704 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.65 22.3 62.27 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.689 -0.767 . . . . 5.59 111.967 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -105.47 124.06 48.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.832 -0.433 . . . . 5.18 109.832 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.477 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.43 168.87 23.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.963 0.411 . . . . 4.28 112.065 -177.652 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.78 -168.27 16.57 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.763 -0.935 . . . . 3.36 110.763 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.31 116.73 33.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.122 0.461 . . . . 2.84 110.852 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.3 t -140.46 158.5 43.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.519 -0.549 . . . . 4.34 109.519 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 58.2 65.72 1.23 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.294 0.569 . . . . 5.75 110.554 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 mp -89.16 138.5 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.432 -0.804 . . . . 3.55 110.53 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -126.09 129.36 48.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.872 -0.604 . . . . 5.96 110.278 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 161' ' ' PRO . 55.6 tp -82.69 110.98 18.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.982 -0.377 . . . . 4.34 109.982 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.07 -48.25 6.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 4.97 111.261 -176.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -128.19 100.13 23.83 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.806 0.336 . . . . 5.37 110.945 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.468 ' HB3' HD21 ' A' ' 158' ' ' LEU . 69.0 Cg_endo -87.2 151.28 8.08 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.013 2.475 . . . . 5.44 111.913 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -88.21 97.94 11.29 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.964 0.411 . . . . 6.1 110.474 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -129.52 143.56 49.42 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.883 -0.599 . . . . 9.49 111.221 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -87.94 155.18 7.22 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.791 2.327 . . . . 8.39 112.445 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 52.1 t . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.058 -0.519 . . . . 10.27 110.664 -178.687 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 112.27 -0.332 . . . . 21.66 112.27 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.96 83.35 1.27 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.823 -0.436 . . . . 20.17 109.823 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -113.0 -52.15 2.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.679 -0.691 . . . . 18.5 111.218 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -98.16 80.83 2.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.991 0.901 . . . . 16.62 110.938 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -121.2 -18.24 7.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.641 -1.163 . . . . 18.35 109.835 175.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -106.68 109.68 21.65 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.88 -1.054 . . . . 16.2 110.322 -174.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -103.73 148.75 25.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.278 -0.638 . . . . 12.4 109.278 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.644 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.9 pt-20 -156.82 148.93 22.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.667 0.746 . . . . 11.63 112.293 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 11.8 p -116.67 162.15 18.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.226 -0.897 . . . . 9.15 110.968 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.56 -176.21 36.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.155 -0.545 . . . . 6.81 111.992 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.2 mt -121.35 142.53 37.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.156 -0.683 . . . . 10.17 109.156 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.3 mm -65.87 117.99 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 117.843 0.292 . . . . 8.73 110.223 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -84.21 -49.73 8.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.76 -0.655 . . . . 10.86 110.427 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -151.47 145.9 25.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.376 -0.829 . . . . 14.06 110.324 -177.504 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.6 mt -117.58 110.51 18.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.218 0.532 . . . . 11.73 110.842 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.2 mt -108.35 -177.82 3.43 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.085 -0.961 . . . . 11.36 108.727 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -87.28 122.3 30.87 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.246 -0.582 . . . . 15.94 109.874 -174.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.2 m 83.1 -20.31 0.34 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.671 1.232 . . . . 13.01 112.102 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 32.3 p90 -147.19 143.51 28.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.028 0.442 . . . . 12.34 111.678 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.2 164.63 22.15 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.69 -0.686 . . . . 7.52 111.632 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -117.5 145.34 44.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.012 0.434 . . . . 9.24 111.369 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.3 mt -111.49 132.86 58.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.496 -0.775 . . . . 7.75 110.287 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.96 145.88 37.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.505 0.669 . . . . 11.8 111.401 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.0 p -79.51 3.97 17.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.894 -1.048 . . . . 12.34 112.639 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.4 m -51.14 -30.41 16.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.59 0.589 . . . . 13.33 112.59 -174.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 9' ' ' THR . 32.7 mm-40 -109.91 6.68 23.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.6 0.238 . . . . 11.9 111.523 -176.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 10.5 tpt180 -143.71 -176.75 5.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.8 0.333 . . . . 12.99 111.062 -171.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 81.9 mm-40 -104.09 12.97 33.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.435 0.636 . . . . 16.66 109.963 176.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.97 140.42 16.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.219 -0.901 . . . . 12.09 110.499 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -96.43 120.27 36.43 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.338 -0.616 . . . . 12.51 109.338 171.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.4 mt -102.5 162.96 12.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.379 0.609 . . . . 8.76 111.883 -173.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -125.22 145.31 50.04 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.064 -0.971 . . . . 9.15 109.346 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -142.7 149.48 38.88 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.555 -0.535 . . . . 6.85 109.555 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 8.8 p-80 -99.78 165.51 11.55 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.267 -0.573 . . . . 9.99 109.919 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -66.3 -2.41 4.39 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.845 0.683 . . . . 9.93 112.845 -169.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 m -79.28 -17.87 53.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.945 0.402 . . . . 12.28 110.531 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.449 ' HB3' ' O ' ' A' ' 67' ' ' SER . 26.0 mp0 -111.61 39.68 2.29 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.306 -0.407 . . . . 10.62 111.419 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -125.97 130.19 50.72 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.503 -0.479 . . . . 8.78 110.123 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 m -84.44 109.91 18.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 8.97 111.025 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.88 -157.63 15.07 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.636 -0.793 . . . . 9.98 112.607 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -90.07 133.2 34.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.788 0.328 . . . . 12.43 110.988 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -72.42 -11.25 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.416 0.627 . . . . 11.58 109.911 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.34 -29.42 68.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.164 -0.925 . . . . 14.73 111.79 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -106.11 14.08 28.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 13.3 111.817 -175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 tp -97.81 128.38 44.4 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.42 -0.512 . . . . 10.07 109.92 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -118.27 163.5 16.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.206 0.527 . . . . 13.13 110.455 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.28 122.9 24.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.269 -1.011 . . . . 11.74 108.269 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.82 -8.44 29.74 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.691 -0.766 . . . . 10.13 112.377 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.54 130.24 90.79 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.818 0.309 . . . . 8.39 110.167 176.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.39 122.62 5.68 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.697 2.264 . . . . 7.28 111.688 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.15 151.85 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.44 0.638 . . . . 4.74 111.746 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -111.17 125.73 54.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.921 -1.036 . . . . 7.09 109.045 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.644 ' CE2' ' HG3' ' A' ' 8' ' ' GLU . 33.2 p90 -131.75 179.35 6.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.405 0.621 . . . . 7.82 111.246 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 25.9 tt0 -148.51 104.29 3.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.432 -0.804 . . . . 11.59 109.074 -170.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.0 ttt -84.16 128.79 34.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.38 -0.373 . . . . 12.41 111.154 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -145.44 164.72 30.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.243 -0.435 . . . . 13.17 110.672 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -107.6 110.75 22.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.57 -0.286 . . . . 16.21 110.755 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.515 ' OD2' HG22 ' A' ' 61' ' ' THR . 16.6 t70 -79.15 109.81 13.81 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.825 -0.435 . . . . 16.64 109.825 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -69.61 -15.41 63.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.473 -0.785 . . . . 22.64 111.819 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.464 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 40.1 ttm105 -76.97 -54.01 7.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.713 0.292 . . . . 21.43 110.839 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.515 HG22 ' OD2' ' A' ' 58' ' ' ASP . 9.1 t -85.64 -35.03 21.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.18 -0.463 . . . . 17.4 111.059 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.07 30.77 9.78 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.878 -0.677 . . . . 16.7 113.762 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HG2' HG23 ' A' ' 61' ' ' THR . 16.8 ptpt -135.6 148.45 65.72 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 117.357 0.578 . . . . 14.73 110.022 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.82 126.89 11.06 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.088 1.859 . . . . 12.6 110.944 176.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.31 167.53 25.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.085 0.469 . . . . 11.73 111.303 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.23 159.91 15.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.058 -0.719 . . . . 8.91 109.058 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 9.1 t -70.91 -166.05 0.14 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.914 -0.402 . . . . 9.83 109.914 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -75.64 22.69 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.495 0.924 . . . . 11.32 113.495 -170.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t 34.24 98.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.141 1.164 . . . . 6.11 114.141 171.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.2 t -105.52 138.07 42.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.262 -0.644 . . . . 6.12 109.262 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -73.84 144.28 45.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.372 -0.603 . . . . 6.3 109.372 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.7 mt -76.41 116.71 19.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.887 0.375 . . . . 5.77 111.037 -175.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -83.47 148.88 56.49 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.71 -0.677 . . . . 5.69 110.767 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 17.7 Cg_exo -67.24 -50.21 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.414 2.076 . . . . 6.86 113.16 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 57.81 96.2 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.463 0.649 . . . . 8.49 111.967 -173.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.447 HG12 ' HB1' ' A' ' 144' ' ' ALA . 0.1 OUTLIER -78.53 113.58 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.671 -0.695 . . . . 6.19 110.318 -179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 43.8 t -70.35 105.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.923 0.392 . . . . 6.26 111.369 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 144' ' ' ALA . 36.5 mt -97.08 5.59 50.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.49 . . . . 6.05 111.705 -178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.7 t -149.16 100.73 3.07 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.528 -0.469 . . . . 7.02 111.434 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -132.69 -66.95 0.66 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.811 -0.811 . . . . 7.07 108.811 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -165.5 148.32 7.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.126 -0.943 . . . . 6.68 108.831 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -82.59 102.02 11.15 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.711 -0.478 . . . . 6.43 109.711 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 m -77.34 156.94 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.114 -0.493 . . . . 3.7 110.335 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.8 p -123.16 141.77 51.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.065 -0.516 . . . . 3.49 110.493 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.99 169.36 25.34 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.018 -0.611 . . . . 2.58 111.644 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.2 m -103.94 130.32 51.55 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.583 -0.525 . . . . 3.34 109.583 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 2.1 t -68.87 121.37 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 109.236 -0.653 . . . . 3.14 109.236 176.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.1 p -91.63 -24.71 19.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.34 0.59 . . . . 3.61 110.553 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.6 m -151.77 125.58 9.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.391 -0.822 . . . . 3.12 109.123 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.59 172.66 6.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.307 0.575 . . . . 4.39 112.079 -172.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.0 mt -75.78 141.17 42.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.054 -0.975 . . . . 3.62 110.354 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -111.0 112.07 23.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.106 0.479 . . . . 7.2 110.828 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 77.4 p -115.87 147.04 41.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.311 -0.858 . . . . 5.1 109.71 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.48 -37.02 57.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.724 0.297 . . . . 7.53 111.32 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 98' ' ' ASN . 34.5 t -151.36 -178.58 6.74 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.886 -0.413 . . . . 7.47 109.886 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.88 -36.11 56.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.272 -0.422 . . . . 7.58 110.257 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -99.04 -6.8 27.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 8.32 110.353 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 20.7 t-20 -109.42 93.9 4.75 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.515 0.674 . . . . 7.26 109.575 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 p -151.37 89.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 114.619 -1.173 . . . . 5.54 109.059 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.2 tp -138.99 96.84 3.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.406 -0.816 . . . . 7.28 110.632 -176.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 104' ' ' GLU . 8.7 p30 -133.47 -30.76 1.26 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.646 -1.161 . . . . 7.54 109.415 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t 58.86 71.29 0.59 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.265 -0.879 . . . . 5.41 111.481 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 p 53.65 23.05 3.38 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.053 1.131 . . . . 4.58 114.053 173.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.465 ' HG2' ' HB2' ' A' ' 101' ' ' ASN . 8.3 pt-20 -79.24 -43.98 22.68 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.227 -0.589 . . . . 5.09 110.272 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.441 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 8.3 t -106.96 123.87 48.8 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.219 0.533 . . . . 3.33 110.128 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.7 p -106.2 134.63 49.03 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.773 -0.649 . . . . 2.57 111.007 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -78.61 174.25 55.17 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.465 -0.874 . . . . 1.66 110.988 175.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -125.56 123.72 39.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.244 0.522 . . . . 3.03 111.502 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -111.3 129.1 67.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.971 -0.752 . . . . 1.88 108.971 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 118' ' ' PHE . 9.4 t -116.07 132.95 56.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.178 0.513 . . . . 3.49 110.931 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -143.81 155.95 44.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.946 -0.761 . . . . 3.51 108.946 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -109.02 137.12 47.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.793 0.33 . . . . 5.1 110.144 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -158.64 130.21 6.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.267 -0.424 . . . . 4.78 111.475 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 57.09 29.98 17.46 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.231 0.539 . . . . 6.97 112.121 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.33 -14.12 65.95 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.618 -0.719 . . . . 5.1 112.598 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -102.95 135.86 43.84 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.824 0.345 . . . . 5.38 110.811 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 12.1 p -107.6 111.73 24.11 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.114 -0.494 . . . . 4.72 109.69 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 110' ' ' SER . 88.5 m-85 -101.11 153.76 19.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.217 0.532 . . . . 4.61 111.961 -173.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -119.5 113.49 20.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.686 -0.857 . . . . 3.96 108.686 172.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.49 136.13 19.27 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.298 -0.41 . . . . 2.75 111.007 -172.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -77.32 132.9 12.81 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.733 2.289 . . . . 2.3 111.953 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -135.63 143.79 45.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.055 0.455 . . . . 2.13 110.035 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.8 p -114.25 -179.01 3.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.574 -0.528 . . . . 3.07 109.574 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -16.98 59.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.039 0.447 . . . . 4.8 110.769 178.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -84.03 -10.89 57.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.797 -0.638 . . . . 4.81 111.053 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -88.28 -21.05 24.67 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.758 0.313 . . . . 3.84 111.385 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -96.8 111.61 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.467 0.651 . . . . 4.39 110.918 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -89.87 129.37 36.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.561 -0.745 . . . . 6.43 110.115 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 128.22 -15.68 6.1 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.58 -0.737 . . . . 5.91 111.359 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.2 m120 57.95 46.6 16.33 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 122.978 0.511 . . . . 6.07 110.755 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.4 p -112.01 152.99 13.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.042 -0.527 . . . . 5.27 110.808 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -87.95 115.4 25.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 5.78 110.667 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.3 pt? -114.82 142.83 46.02 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.738 -0.467 . . . . 3.62 109.738 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.07 175.2 11.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.335 -0.546 . . . . 6.93 111.474 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.552 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -65.66 122.81 18.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.317 -0.401 . . . . 4.12 111.77 -177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 120.09 -29.69 5.9 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.836 -0.697 . . . . 4.07 113.265 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.61 166.96 11.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.576 0.688 . . . . 4.06 110.281 173.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -113.23 128.14 56.38 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.789 0.804 . . . . 4.17 111.245 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.32 152.6 19.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.593 -1.185 . . . . 2.77 110.796 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.3 m -106.35 137.48 44.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.813 -0.631 . . . . 3.47 109.675 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -142.6 149.57 39.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.809 0.338 . . . . 3.35 110.365 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.58 112.44 24.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.994 -0.373 . . . . 5.34 109.994 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 66.4 mt -79.06 111.69 16.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.974 -0.557 . . . . 4.66 110.141 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.674 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -89.71 107.31 19.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.143 -0.688 . . . . 4.85 109.143 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.64 117.61 24.64 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.203 0.525 . . . . 5.68 111.352 -174.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -82.63 154.4 24.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.451 -0.795 . . . . 6.25 108.9 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -62.36 -29.04 70.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.439 0.638 . . . . 8.58 109.63 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -69.92 -19.7 63.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.122 -0.945 . . . . 7.86 110.511 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.21 12.5 83.14 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.796 -0.638 . . . . 5.59 112.43 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -106.62 119.49 39.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.197 -0.668 . . . . 5.18 109.197 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.438 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -148.88 -177.81 6.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.645 -0.252 . . . . 4.28 111.537 -177.332 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.57 -173.73 16.18 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.393 -0.683 . . . . 3.36 111.393 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.44 111.43 23.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.864 0.332 . . . . 2.84 110.423 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 6.2 t -127.09 165.15 20.06 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 110.042 -0.355 . . . . 4.34 110.042 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 59.05 36.08 24.16 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.0 -0.545 . . . . 5.75 110.424 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.78 142.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.363 -0.835 . . . . 3.55 110.758 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -149.22 142.24 24.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.7 0.286 . . . . 5.96 110.904 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.2 tp -76.75 106.48 8.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 4.34 110.054 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -103.31 -35.19 8.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.122 -0.49 . . . . 4.97 111.805 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -132.13 90.4 35.03 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.965 -0.294 . . . . 5.37 110.852 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.55 156.55 28.4 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.559 2.173 . . . . 5.44 111.742 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -83.34 -5.81 59.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.245 0.545 . . . . 6.1 111.037 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -174.32 109.11 0.29 Allowed Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 114.457 -1.247 . . . . 9.49 109.78 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.26 123.19 11.16 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.332 2.021 . . . . 8.39 111.967 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.132 -0.485 . . . . 10.27 110.801 179.437 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 112.105 -0.398 . . . . 21.66 112.105 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.5 107.9 6.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.783 0.325 . . . . 20.17 110.623 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.12 -31.64 17.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.295 0.569 . . . . 18.5 110.591 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -87.13 69.23 10.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.809 -0.632 . . . . 16.62 111.751 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.55 ' HG3' ' H ' ' A' ' 6' ' ' GLU . 3.1 pt-20 -114.91 -92.02 0.51 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.756 0.312 . . . . 18.35 111.494 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.55 ' H ' ' HG3' ' A' ' 5' ' ' GLU . 1.6 tp10 -95.5 95.69 8.58 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.895 0.379 . . . . 16.2 111.075 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -125.63 138.5 53.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.831 -0.433 . . . . 12.4 109.831 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -119.45 148.78 42.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.648 -0.705 . . . . 11.63 111.164 -166.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.3 p -102.89 144.22 31.48 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.918 -0.583 . . . . 9.15 111.707 -174.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.19 176.57 29.62 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.371 -0.692 . . . . 6.81 111.371 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.0 mt -127.06 140.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.659 -0.497 . . . . 10.17 109.659 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.7 mm -66.15 126.04 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 121.206 -0.198 . . . . 8.73 110.491 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -87.0 -51.45 6.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.37 0.605 . . . . 10.86 111.258 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -157.92 131.77 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.086 -0.709 . . . . 14.06 109.086 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.11 105.56 17.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.546 0.689 . . . . 11.73 111.362 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.66 179.4 4.43 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.302 -0.999 . . . . 11.36 108.302 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -91.4 136.3 33.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.756 -0.378 . . . . 15.94 110.71 -177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t 76.75 -33.32 0.2 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.263 -0.881 . . . . 13.01 111.742 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -139.7 152.37 46.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.64 0.257 . . . . 12.34 111.24 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.8 168.76 23.49 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.636 -0.793 . . . . 7.52 112.418 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -116.89 140.8 49.03 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.914 0.388 . . . . 9.24 111.203 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.3 mt -111.59 130.51 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.905 -0.589 . . . . 7.75 110.462 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -72.98 138.46 46.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.445 0.64 . . . . 11.8 111.985 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.1 p -79.53 1.55 25.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.062 -0.972 . . . . 12.34 111.412 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -55.77 -30.06 60.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.298 -0.41 . . . . 13.33 111.776 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -113.89 -11.94 12.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.106 0.479 . . . . 11.9 111.259 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.745 HH11 ' HB3' ' A' ' 29' ' ' ALA . 3.9 tmt_? -137.52 137.56 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.692 -0.855 . . . . 12.99 108.692 -175.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -68.32 42.79 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.427 0.899 . . . . 16.66 113.427 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.745 ' HB3' HH11 ' A' ' 27' ' ' ARG . . . 177.2 133.98 0.06 Allowed 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 123.406 0.682 . . . . 12.09 110.12 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.511 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 6.6 ppt_? -86.27 141.31 29.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.147 -0.686 . . . . 12.51 109.147 171.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 47.1 mt -133.25 162.43 31.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.953 0.406 . . . . 8.76 111.486 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -114.9 141.87 47.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.128 -0.942 . . . . 9.15 108.506 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -136.21 145.3 45.53 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.455 -0.498 . . . . 6.85 110.733 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -84.53 141.44 30.73 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.919 -0.771 . . . . 9.99 108.919 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -63.87 -17.48 63.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.637 0.256 . . . . 9.93 111.481 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -70.6 -13.51 62.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.51 -0.314 . . . . 12.28 110.697 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -103.47 1.11 31.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.564 -0.289 . . . . 10.62 111.235 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -85.04 114.86 22.51 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.698 -0.401 . . . . 8.78 110.121 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.8 t -81.91 91.3 6.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.241 -0.436 . . . . 8.97 110.474 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.39 -175.02 26.06 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.637 -0.585 . . . . 9.98 111.637 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -79.14 123.85 27.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.698 -0.482 . . . . 12.43 109.698 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tp -65.24 -24.96 36.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.176 0.513 . . . . 11.58 111.094 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.22 -0.91 26.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.166 0.508 . . . . 14.73 111.168 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -103.39 10.1 37.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 13.3 109.672 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 tp -112.82 129.24 56.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.714 -0.676 . . . . 10.07 110.008 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -119.64 168.95 10.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.336 0.589 . . . . 13.13 111.099 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.6 mp -73.37 114.78 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.089 -0.505 . . . . 11.74 109.742 174.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.14 9.43 22.19 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.474 -0.87 . . . . 10.13 112.012 -175.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.29 133.08 71.99 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.245 -0.279 . . . . 8.39 110.245 175.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -85.58 109.88 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.941 2.428 . . . . 7.28 111.644 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.93 151.6 16.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.888 -0.596 . . . . 4.74 111.255 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -110.32 130.03 55.63 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.19 -0.67 . . . . 7.09 109.19 173.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.09 178.04 7.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.349 0.595 . . . . 7.82 111.014 -174.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 32.9 tt0 -142.65 105.08 4.47 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.468 -0.938 . . . . 11.59 108.468 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.3 ttt -83.15 124.29 30.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.767 0.318 . . . . 12.41 111.077 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.2 p -141.19 161.25 38.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.313 -0.403 . . . . 13.17 110.697 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -97.6 121.5 39.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.39 -0.368 . . . . 16.21 110.078 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' A' ' 60' ' ' ARG . 16.6 t70 -74.76 120.08 19.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.182 0.515 . . . . 16.64 110.312 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -79.85 -5.79 56.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.648 -0.705 . . . . 22.64 112.197 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.404 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . 2.4 mpt_? -79.77 -70.41 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.212 0.529 . . . . 21.43 110.641 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 t -101.71 -4.38 26.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 17.4 111.203 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.58 33.0 35.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.079 -0.582 . . . . 16.7 113.451 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -110.02 131.3 22.05 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.725 -0.279 . . . . 14.73 110.335 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.6 125.59 10.74 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.734 1.623 . . . . 12.6 110.028 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.69 179.54 2.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.455 0.645 . . . . 11.73 111.989 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.19 148.41 29.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.442 -0.799 . . . . 8.91 109.886 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 10.3 t -74.62 -150.38 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 9.83 111.48 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 2.1 mp0 -68.97 30.12 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.853 1.057 . . . . 11.32 113.853 -175.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.412 ' H ' ' C ' ' A' ' 67' ' ' SER . 39.8 t 0.0 101.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.228 1.411 . . . . 6.11 113.514 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -109.53 134.38 51.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.855 -0.338 . . . . 6.12 110.747 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -68.68 139.71 55.43 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.743 -0.465 . . . . 6.3 109.743 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.4 124.48 25.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.228 0.537 . . . . 5.77 111.84 -172.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -112.39 122.42 36.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.383 -0.826 . . . . 5.69 110.628 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 2.9 Cg_exo -73.49 144.4 36.08 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.801 2.334 . . . . 6.86 113.104 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.428 ' HB3' ' H ' ' A' ' 76' ' ' VAL . 0.4 OUTLIER -138.71 -80.3 0.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.419 -0.81 . . . . 8.49 108.937 176.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.614 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 0.7 OUTLIER -104.78 125.64 59.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.452 -0.795 . . . . 6.19 110.154 174.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 4.5 m -94.46 121.84 45.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.873 -0.603 . . . . 6.26 111.08 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.429 ' O ' HD23 ' A' ' 78' ' ' LEU . 2.2 tt -67.08 -27.54 67.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.586 -0.733 . . . . 6.05 109.859 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -131.29 103.56 6.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.188 -0.46 . . . . 7.02 111.238 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.96 -87.69 0.15 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.215 -0.661 . . . . 7.07 109.215 173.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.433 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 6.2 pt-20 -90.73 71.68 6.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.761 0.791 . . . . 6.68 110.353 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.468 ' HD3' ' H ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -68.53 137.64 54.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.442 -0.799 . . . . 6.43 109.935 177.773 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 m -140.39 170.42 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.037 0.446 . . . . 3.7 111.119 -174.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 p -115.7 139.88 49.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.768 -0.651 . . . . 3.49 109.689 175.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.7 155.18 20.0 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.032 -1.08 . . . . 2.58 112.878 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 m -111.04 127.0 55.4 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.388 -0.597 . . . . 3.34 109.388 175.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.573 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 57.3 t -69.21 120.63 17.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.217 -0.29 . . . . 3.14 110.217 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.5 p -107.47 -17.82 14.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.134 0.492 . . . . 3.61 111.113 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.7 m -150.78 131.29 13.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.38 -0.6 . . . . 3.12 109.38 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.77 -175.11 2.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.249 0.547 . . . . 4.39 111.296 -176.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.0 mt -87.86 135.63 33.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.729 . . . . 3.62 109.675 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -74.01 -11.09 60.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.474 0.654 . . . . 7.2 111.028 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -96.45 -51.9 4.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.95 0.881 . . . . 5.1 111.066 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.515 ' OD1' ' HD3' ' A' ' 124' ' ' LYS . 3.0 m-20 -84.09 25.18 0.85 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.094 -1.412 . . . . 7.53 111.459 -172.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 m -68.49 -31.97 71.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 7.47 110.429 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -167.72 -82.49 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.997 -0.547 . . . . 7.58 111.552 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -127.27 -1.11 6.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.01 0.374 . . . . 8.32 112.01 -174.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -86.65 36.71 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.043 0.449 . . . . 7.26 111.093 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 94' ' ' ASP . 22.8 t -86.72 105.9 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.097 -0.501 . . . . 5.54 110.53 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.6 mp -119.72 -142.83 0.35 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.388 -0.967 . . . . 7.28 108.388 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -109.53 62.64 0.6 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.346 0.593 . . . . 7.54 109.512 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.2 t -129.92 67.35 1.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.624 -0.716 . . . . 5.41 109.157 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.7 p -82.49 24.65 0.68 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.508 -0.769 . . . . 4.58 111.572 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.17 -9.4 59.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 5.09 109.961 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.2 t -82.1 127.78 33.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.247 -0.888 . . . . 3.33 109.87 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.75 118.91 25.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.943 0.402 . . . . 2.57 110.793 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.74 175.23 47.48 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.832 -0.699 . . . . 1.66 112.689 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 108' ' ' ARG . 48.5 mmt-85 -132.47 126.72 33.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.862 0.363 . . . . 3.03 110.442 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.3 mt -111.64 126.49 69.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.052 -0.522 . . . . 1.88 109.82 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 118' ' ' PHE . 12.0 t -103.62 125.46 50.15 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.603 -0.517 . . . . 3.49 109.603 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 4.1 p90 -134.06 155.58 49.78 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.323 -0.621 . . . . 3.51 109.323 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.16 119.56 37.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.983 0.42 . . . . 5.1 110.137 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -142.99 133.08 24.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.496 -0.775 . . . . 4.78 108.988 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 63.48 21.27 12.68 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.647 0.592 . . . . 6.97 111.042 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.05 21.15 59.57 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.96 -0.564 . . . . 5.1 112.446 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -132.83 135.47 45.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.675 0.274 . . . . 5.38 110.68 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 4.0 p -111.82 116.41 30.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.316 -0.402 . . . . 4.72 110.662 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 110' ' ' SER . 81.5 m-85 -114.59 172.77 6.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 4.61 110.898 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -114.75 120.01 38.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.831 -0.622 . . . . 3.96 110.058 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.8 mt -106.28 135.16 19.51 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.818 -0.628 . . . . 2.75 111.737 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.02 138.75 18.62 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.952 2.435 . . . . 2.3 111.872 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -150.35 160.29 43.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.997 0.427 . . . . 2.13 110.888 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.0 p -123.31 175.01 6.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.302 -0.863 . . . . 3.07 109.66 175.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.515 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 21.2 ttpp -66.02 -23.39 66.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.548 0.69 . . . . 4.8 109.99 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.5 -20.47 62.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.443 -0.799 . . . . 4.81 111.42 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -87.95 -2.63 58.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.09 -0.504 . . . . 3.84 110.671 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.16 137.61 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.258 -0.428 . . . . 4.39 111.516 -174.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -82.29 124.32 29.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.933 -0.576 . . . . 6.43 109.978 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.37 9.28 85.9 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.901 -0.666 . . . . 5.91 112.472 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.7 p30 47.08 29.27 1.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.14 0.976 . . . . 6.07 112.699 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.77 150.11 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.203 -0.453 . . . . 5.27 110.631 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -80.42 130.92 35.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.991 -0.55 . . . . 5.78 110.95 -175.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 mp -99.27 149.04 23.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.897 -0.592 . . . . 3.62 110.338 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -134.82 129.99 35.36 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.594 -0.521 . . . . 6.93 109.594 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.573 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -63.77 130.76 45.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.807 -0.633 . . . . 4.12 110.966 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.04 -23.09 10.13 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.519 -0.764 . . . . 4.07 112.307 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.09 177.42 5.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.101 0.477 . . . . 4.06 111.401 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -106.77 131.3 54.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.878 -0.601 . . . . 4.17 111.583 -170.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.25 165.95 18.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.213 -0.449 . . . . 2.77 110.326 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.1 m -129.71 127.93 41.46 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.816 -0.439 . . . . 3.47 109.816 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -128.99 150.21 50.5 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.963 -0.384 . . . . 3.35 109.963 -177.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -96.95 120.26 36.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.996 0.427 . . . . 5.34 110.113 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 59.2 mt -79.3 107.62 11.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.784 -0.644 . . . . 4.66 109.857 176.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -81.04 107.7 14.08 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.076 -0.713 . . . . 4.85 109.076 174.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 19.8 m -92.49 103.08 15.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.71 -0.677 . . . . 5.68 111.288 -173.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.522 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 15.5 m120 -67.91 153.63 43.31 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.566 -0.902 . . . . 6.25 108.566 170.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.402 ' HG2' ' OE2' ' A' ' 75' ' ' GLU . 18.9 pt20 -64.65 -20.03 66.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.891 0.377 . . . . 8.58 111.339 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -72.08 -23.34 61.33 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.079 0.466 . . . . 7.86 110.531 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.22 22.91 59.9 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.533 -0.841 . . . . 5.59 112.406 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -122.58 114.29 20.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.204 -0.295 . . . . 5.18 110.204 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.485 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -146.55 -178.15 6.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.286 -0.415 . . . . 4.28 111.168 -175.155 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -122.77 -132.07 3.96 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.993 -0.843 . . . . 3.36 110.993 174.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -132.0 126.82 34.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.814 0.34 . . . . 2.84 110.277 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 80.4 m -140.35 162.44 35.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.29 -0.413 . . . . 4.34 110.664 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 57.32 53.18 7.88 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.813 0.696 . . . . 5.75 110.676 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.3 mt -82.12 115.0 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.523 -0.762 . . . . 3.55 110.097 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.414 ' HD2' HH11 ' A' ' 157' ' ' ARG . 20.9 ttt180 -114.52 129.94 56.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.785 -0.643 . . . . 5.96 110.602 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.468 HD21 ' HA ' ' A' ' 161' ' ' PRO . 50.9 tp -82.59 98.33 8.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.67 -0.696 . . . . 4.34 110.057 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -82.68 -23.66 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.076 -0.511 . . . . 4.97 111.084 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -133.59 102.43 12.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 5.37 110.065 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.468 ' HA ' HD21 ' A' ' 158' ' ' LEU . 71.8 Cg_endo -79.03 154.32 25.56 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.562 2.175 . . . . 5.44 112.738 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -103.25 113.27 26.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.854 -0.612 . . . . 6.1 111.744 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 62.15 91.6 0.08 OUTLIER Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 123.985 0.803 . . . . 9.49 112.334 173.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.92 -171.37 1.18 Allowed 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 122.896 2.398 . . . . 8.39 111.769 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 32.2 m . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.297 -0.41 . . . . 10.27 111.036 -179.2 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 111.586 -0.606 . . . . 21.66 111.586 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.63 124.11 41.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.858 0.361 . . . . 20.17 110.688 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.25 -53.66 8.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.948 -0.569 . . . . 18.5 111.05 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.02 47.51 1.41 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.813 -0.63 . . . . 16.62 111.496 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -101.09 -38.68 8.05 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 112.024 0.379 . . . . 18.35 112.024 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -139.86 132.98 29.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.981 0.42 . . . . 16.2 111.444 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -134.86 140.24 45.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.079 -0.509 . . . . 12.4 111.021 177.515 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.65 172.68 12.44 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.79 -0.641 . . . . 11.63 109.88 -176.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.0 p -112.9 167.36 10.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.988 0.423 . . . . 9.15 111.534 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.6 172.65 37.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 116.19 -0.459 . . . . 6.81 112.189 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.0 mt -117.04 133.67 63.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.015 -0.365 . . . . 10.17 110.015 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.3 118.09 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.949 0.404 . . . . 8.73 110.585 176.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.52 -56.24 9.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.39 -0.823 . . . . 10.86 110.46 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -156.03 141.08 17.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.205 -0.907 . . . . 14.06 108.765 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.3 mt -98.2 103.16 15.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.268 0.556 . . . . 11.73 110.712 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 3.0 mm? -95.37 -179.77 4.89 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.034 -0.985 . . . . 11.36 108.412 173.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -90.68 123.11 34.03 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.518 -0.473 . . . . 15.94 110.022 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t 82.6 -27.86 0.11 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.453 1.095 . . . . 13.01 111.773 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 19.4 p90 -135.64 147.8 48.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.806 0.336 . . . . 12.34 111.304 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -139.89 162.85 26.3 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-N 116.055 -0.52 . . . . 7.52 111.87 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -118.38 146.89 44.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.821 0.31 . . . . 9.24 111.313 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.5 mt -121.34 128.16 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.301 -0.409 . . . . 7.75 110.535 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -76.85 146.0 38.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.202 0.525 . . . . 11.8 111.575 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.402 ' HB3' ' N ' ' A' ' 30' ' ' ARG . 6.5 p -79.82 -0.02 32.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.246 -0.888 . . . . 12.34 112.888 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.7 t -53.52 -31.32 45.73 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.85 0.685 . . . . 13.33 112.85 -173.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.97 -5.92 43.58 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.871 0.367 . . . . 11.9 111.889 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.517 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 12.0 ttt180 -131.66 -160.66 1.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.532 -0.303 . . . . 12.99 110.203 -173.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.517 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 78.0 mt-30 -118.66 14.93 13.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.379 0.609 . . . . 16.66 110.218 176.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.41 138.45 5.34 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.312 -0.858 . . . . 12.09 110.213 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.402 ' N ' ' HB3' ' A' ' 24' ' ' CYS . 6.6 ptp180 -85.62 151.02 24.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.424 -0.584 . . . . 12.51 109.424 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -138.86 162.52 34.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.026 0.441 . . . . 8.76 110.887 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.38 142.24 51.48 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.951 -0.759 . . . . 9.15 108.951 173.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -128.35 147.38 50.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.001 -0.37 . . . . 6.85 110.001 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.48 ' HB2' ' OE1' ' A' ' 37' ' ' GLN . 76.3 m-70 -95.64 160.81 14.32 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.525 -0.546 . . . . 9.99 109.525 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -70.71 -4.24 22.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.816 0.341 . . . . 9.93 111.675 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -85.75 -7.39 58.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.944 -0.391 . . . . 12.28 109.944 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.48 ' OE1' ' HB2' ' A' ' 34' ' ' HIS . 23.4 mp0 -117.44 40.48 3.05 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.936 -0.575 . . . . 10.62 111.199 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -122.63 139.48 53.88 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.42 -0.512 . . . . 8.78 111.142 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.3 t -116.27 114.49 24.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.549 . . . . 8.97 110.036 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.05 -161.35 23.51 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.736 . . . . 9.98 111.823 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -83.06 108.11 16.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.215 -0.291 . . . . 12.43 110.215 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 45' ' ' LEU . 10.6 tp -68.52 -25.16 30.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.344 0.592 . . . . 11.58 110.081 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -66.68 -22.7 66.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.489 -0.778 . . . . 14.73 110.908 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -105.45 20.25 19.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.854 -0.612 . . . . 13.3 111.303 -173.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 45' ' ' LEU . 1.5 mt -87.2 133.97 33.59 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.021 -0.363 . . . . 10.07 110.021 175.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -127.6 167.0 16.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.462 -0.57 . . . . 13.13 109.462 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.5 mp -81.99 132.82 30.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.563 -0.532 . . . . 11.74 109.563 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.65 11.24 58.27 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.647 -0.787 . . . . 10.13 111.987 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 32.3 t70 -86.15 133.35 41.03 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.655 -0.273 . . . . 8.39 110.75 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 49' ' ' ASP . 6.6 Cg_endo -86.18 127.42 2.95 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.241 2.627 . . . . 7.28 112.638 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.9 m -125.33 160.33 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.43 . . . . 4.74 111.092 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -112.54 128.03 56.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.913 -0.585 . . . . 7.09 110.029 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -131.94 150.19 52.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.345 0.593 . . . . 7.82 111.048 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 16.4 tt0 -101.58 119.65 39.1 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.735 -0.839 . . . . 11.59 108.735 177.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 14.3 tpt -90.93 133.42 35.28 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.909 -0.404 . . . . 12.41 109.909 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.402 HG23 HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -155.91 169.81 23.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.966 0.412 . . . . 13.17 110.531 -172.795 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -126.4 109.44 12.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.742 0.305 . . . . 16.21 110.426 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -83.12 113.42 20.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.223 -0.444 . . . . 16.64 110.108 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -79.21 -10.31 59.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.36 -0.382 . . . . 22.64 111.783 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -74.34 -41.54 60.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.405 -0.591 . . . . 21.43 109.405 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.8 p -88.55 -40.81 13.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.255 -0.43 . . . . 17.4 110.817 174.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.78 31.92 11.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.906 -0.664 . . . . 16.7 112.207 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -132.59 152.92 80.83 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.056 -0.35 . . . . 14.73 110.056 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.75 125.85 10.88 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.293 1.996 . . . . 12.6 110.641 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 56' ' ' THR . 2.0 pp -138.85 153.81 25.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.537 0.684 . . . . 11.73 112.251 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.42 157.29 16.52 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.576 -0.898 . . . . 8.91 108.576 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.8 t -70.66 -162.95 0.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.006 -0.368 . . . . 9.83 110.006 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -72.77 27.13 0.06 Allowed 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 113.368 0.877 . . . . 11.32 113.368 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.3 t 32.23 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.438 1.095 . . . . 6.11 113.664 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.5 t -88.61 151.29 22.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.429 -0.805 . . . . 6.12 111.378 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -87.55 137.96 31.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.376 -0.829 . . . . 6.3 110.993 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.8 mt -86.85 132.79 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.064 -0.516 . . . . 5.77 109.873 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.64 151.14 86.96 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 5.69 111.014 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.13 161.63 25.81 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.955 2.437 . . . . 6.86 112.842 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -96.28 169.28 10.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.668 -0.696 . . . . 8.49 110.663 -177.435 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.428 HG12 ' HB1' ' A' ' 144' ' ' ALA . 9.2 t -76.29 141.28 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.497 -0.557 . . . . 6.19 109.497 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 29.0 t -80.25 97.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.067 0.395 . . . . 6.26 112.067 -171.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.474 ' CD2' ' HB2' ' A' ' 144' ' ' ALA . 22.2 mt -88.96 -30.36 18.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.525 . . . . 6.05 110.948 175.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 p -98.95 96.95 8.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.334 0.588 . . . . 7.02 111.616 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.52 -69.14 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.434 -0.803 . . . . 7.07 109.31 174.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -131.57 147.67 52.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.899 -0.591 . . . . 6.68 109.987 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.4 ptt85 -107.77 125.88 51.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.845 0.355 . . . . 6.43 110.158 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.12 158.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.066 0.46 . . . . 3.7 111.9 -173.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.8 p -118.65 140.65 49.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.39 -0.823 . . . . 3.49 109.622 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.45 170.16 24.27 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.075 -1.06 . . . . 2.58 112.615 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.5 m -115.69 135.36 54.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.528 -0.545 . . . . 3.34 109.528 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 21.9 t -67.36 115.36 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.589 -0.522 . . . . 3.14 109.589 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.05 -34.1 15.24 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.326 0.584 . . . . 3.61 110.042 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.7 m -151.26 120.75 6.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.619 -0.719 . . . . 3.12 109.613 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.74 -176.82 5.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.799 0.333 . . . . 4.39 110.465 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.21 162.96 13.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.515 -0.311 . . . . 3.62 110.186 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -52.73 125.74 17.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.125 -0.489 . . . . 7.2 109.977 174.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.3 m -141.91 6.4 1.79 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.891 0.853 . . . . 5.1 110.426 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.55 132.71 33.84 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.389 -0.823 . . . . 7.53 110.616 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.5 t -161.83 159.68 27.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 7.47 109.874 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.67 -6.73 51.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.025 -0.534 . . . . 7.58 110.124 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -112.93 -65.62 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 8.32 110.608 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -163.54 170.1 17.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.473 -0.33 . . . . 7.26 110.249 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.7 m -75.61 51.08 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.349 0.595 . . . . 5.54 112.372 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.9 tp -99.57 88.08 3.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.688 0.756 . . . . 7.28 109.996 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.406 ' OD1' ' HE3' ' A' ' 124' ' ' LYS . 3.4 p-10 -111.01 1.32 17.34 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.549 -1.205 . . . . 7.54 110.03 176.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.4 p 49.96 -108.92 0.35 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.401 -0.818 . . . . 5.41 111.555 -174.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -146.6 35.46 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.213 0.53 . . . . 4.58 109.952 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 105' ' ' THR . 0.5 OUTLIER -62.71 -44.73 95.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 5.09 111.024 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.469 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -93.12 175.76 6.66 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.367 -0.833 . . . . 3.33 111.845 -171.299 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 m -142.55 127.84 18.76 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.198 -0.667 . . . . 2.57 109.198 173.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -94.7 176.02 34.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.582 -0.818 . . . . 1.66 112.581 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 20.3 mmt180 -133.43 132.31 40.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.643 0.259 . . . . 3.03 110.599 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.4 HG21 ' CE2' ' A' ' 141' ' ' PHE . 79.0 mt -113.94 130.66 67.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.028 -0.533 . . . . 1.88 109.584 174.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.5 p -105.86 123.0 47.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.316 -0.402 . . . . 3.49 110.389 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.686 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -140.47 152.36 45.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.817 0.341 . . . . 3.51 110.608 178.646 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.455 ' HG3' ' HB3' ' A' ' 117' ' ' CYS . 4.8 mp0 -107.31 122.48 46.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.053 0.454 . . . . 5.1 110.165 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -131.96 120.85 23.05 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.698 -0.683 . . . . 4.78 109.823 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 61.09 31.96 19.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.326 0.584 . . . . 6.97 110.861 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -20.15 50.82 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.413 -0.812 . . . . 5.1 113.395 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -99.47 136.32 39.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.672 0.273 . . . . 5.38 110.833 -175.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.455 ' HB3' ' HG3' ' A' ' 112' ' ' GLU . 7.8 p -102.51 128.3 49.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.178 -0.465 . . . . 4.72 110.572 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -128.59 164.2 23.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.323 -0.398 . . . . 4.61 110.875 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -122.85 114.37 20.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.696 -0.683 . . . . 3.96 109.595 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.686 HD11 ' CE2' ' A' ' 111' ' ' TYR . 2.5 mp -105.49 140.94 21.65 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.682 0.277 . . . . 2.75 110.878 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 94.1 Cg_endo -79.3 155.82 25.43 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.104 2.536 . . . . 2.3 112.068 175.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -163.99 163.68 23.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.9 -0.408 . . . . 2.13 109.9 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -118.76 -179.15 3.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.996 0.427 . . . . 3.07 111.154 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.406 ' HE3' ' OD1' ' A' ' 101' ' ' ASN . 16.2 tppt? -71.57 -21.26 61.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.08 -0.509 . . . . 4.8 110.54 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.49 -9.73 57.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 4.81 111.238 -173.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -85.41 -25.42 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 3.84 111.7 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 p -92.49 123.05 44.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.518 0.675 . . . . 4.39 110.69 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.61 159.63 16.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.6 -0.727 . . . . 6.43 110.844 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.92 -16.44 60.95 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.852 -0.689 . . . . 5.91 112.274 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 68.94 16.26 8.8 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.917 0.487 . . . . 6.07 110.783 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 t -72.45 116.29 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 5.27 110.088 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -85.98 84.86 7.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.749 0.785 . . . . 5.78 110.706 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.608 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.2 pt? -81.44 150.71 28.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.1 -1.409 . . . . 3.62 110.761 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.559 ' HD2' ' H ' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -110.49 -179.74 3.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.219 -0.659 . . . . 6.93 109.219 177.247 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.595 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.45 131.81 41.38 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.423 -0.511 . . . . 4.12 111.05 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.53 -14.55 13.14 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.135 -0.555 . . . . 4.07 112.072 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' A' ' 161' ' ' PRO . 4.9 m-20 -81.11 154.38 26.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.633 0.254 . . . . 4.06 110.544 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 160' ' ' ASN . 13.4 mmmm -104.6 127.83 52.45 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.162 0.506 . . . . 4.17 110.372 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.7 m -130.35 160.58 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.386 -0.825 . . . . 2.77 112.382 -171.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.6 p -122.53 140.96 52.19 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.993 -1.003 . . . . 3.47 109.534 172.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.503 ' HE1' HD11 ' A' ' 143' ' ' ILE . 19.9 p90 -151.24 167.9 26.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.568 -0.287 . . . . 3.35 110.654 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -104.24 133.42 49.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.15 0.5 . . . . 5.34 110.779 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.503 HD11 ' HE1' ' A' ' 141' ' ' PHE . 34.6 mm -95.49 102.27 13.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.428 -0.805 . . . . 4.66 110.368 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -87.59 108.78 19.23 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.622 -0.431 . . . . 4.85 110.406 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 15.6 m -90.04 125.7 35.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.046 -0.524 . . . . 5.68 111.345 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -98.72 164.98 12.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.204 -1.036 . . . . 6.25 108.204 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -59.98 -24.8 64.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.943 0.497 . . . . 8.58 111.883 -174.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -70.6 -17.75 62.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 7.86 110.868 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.93 5.39 86.24 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.856 -0.688 . . . . 5.59 111.891 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -99.39 119.64 38.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.164 -0.68 . . . . 5.18 109.164 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.504 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -132.87 163.33 29.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.171 0.51 . . . . 4.28 112.23 -177.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -136.14 -173.26 12.9 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.782 -0.927 . . . . 3.36 110.782 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.7 120.88 40.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.103 0.452 . . . . 2.84 110.91 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.6 t -128.12 154.37 45.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.749 -0.463 . . . . 4.34 109.749 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 55.75 65.29 1.5 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.794 0.807 . . . . 5.75 110.266 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.5 mt -92.44 135.29 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.566 -1.197 . . . . 3.55 109.794 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -132.14 152.84 51.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.909 -0.404 . . . . 5.96 109.909 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.9 tp -101.47 123.71 45.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.176 -0.465 . . . . 4.34 110.24 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -111.59 -40.56 4.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.515 -0.311 . . . . 4.97 111.067 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASN . . . . . 0.486 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 7.7 t30 -118.95 101.11 50.47 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 110.226 -0.287 . . . . 5.37 110.226 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.412 ' HA ' ' OD1' ' A' ' 137' ' ' ASP . 82.3 Cg_endo -83.15 155.56 14.75 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.127 2.551 . . . . 5.44 113.43 -176.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -83.68 154.48 23.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.78 -0.646 . . . . 6.1 110.86 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -74.72 124.97 89.99 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.463 -0.335 . . . . 9.49 110.658 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.36 113.88 2.11 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.71 2.273 . . . . 8.39 112.93 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.952 -0.567 . . . . 10.27 110.28 -178.641 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.454 0 N-CA-C 111.764 -0.535 . . . . 21.66 111.764 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 74.54 -13.07 0.84 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.589 0.756 . . . . 20.17 111.652 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.3 -17.96 47.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.882 0.849 . . . . 18.5 109.118 176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.32 5.35 3.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.375 -1.284 . . . . 16.62 111.317 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -84.51 -21.86 30.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.109 0.48 . . . . 18.35 111.537 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -82.97 89.22 6.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.231 0.539 . . . . 16.2 111.345 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -105.6 121.14 43.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.193 0.52 . . . . 12.4 110.033 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' CG ' ' HG3' ' A' ' 27' ' ' ARG . 35.5 tt0 -100.02 136.61 39.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.463 -0.789 . . . . 11.63 109.014 -177.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 52' ' ' GLU . 38.0 p -96.95 151.84 19.3 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.947 -0.301 . . . . 9.15 110.674 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.29 -177.5 37.75 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.913 -0.661 . . . . 6.81 111.893 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.509 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 1.2 mt -130.06 146.41 34.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.343 -0.614 . . . . 10.17 109.343 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.72 118.56 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.437 -0.579 . . . . 8.73 109.437 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -87.65 -44.72 10.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.536 -0.756 . . . . 10.86 109.37 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -149.16 154.59 39.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.217 -0.901 . . . . 14.06 110.806 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.8 mt -119.14 109.68 16.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.656 . . . . 11.73 110.169 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.401 HD13 ' CD2' ' A' ' 19' ' ' TYR . 4.6 mp -99.47 179.04 4.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.238 -1.023 . . . . 11.36 108.238 176.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -90.44 114.14 26.23 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.148 -0.621 . . . . 15.94 110.354 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 m 72.16 16.38 5.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.942 -1.026 . . . . 13.01 111.095 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.401 ' CD2' HD13 ' A' ' 16' ' ' LEU . 47.2 t80 -156.58 139.87 15.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.717 -0.674 . . . . 12.34 109.764 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' HA3' ' CE1' ' A' ' 33' ' ' PHE . . . -127.44 156.45 20.46 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.697 -0.763 . . . . 7.52 112.667 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.74 129.83 55.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.463 -0.199 . . . . 9.24 110.463 -176.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -114.22 127.55 71.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.153 -0.314 . . . . 7.75 110.153 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 9.8 pt20 -83.14 144.14 30.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.62 0.724 . . . . 11.8 111.877 -175.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 p -79.54 2.23 22.96 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 114.461 -1.245 . . . . 12.34 112.764 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.4 m -53.2 -24.46 11.03 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.803 0.668 . . . . 13.33 112.803 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -91.4 -6.95 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.977 0.362 . . . . 11.9 111.977 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HG3' ' CG ' ' A' ' 8' ' ' GLU . 9.7 mmt85 -151.33 -158.53 0.92 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.999 0.428 . . . . 12.99 110.529 -170.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.74 28.57 6.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.045 0.45 . . . . 16.66 109.996 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.48 135.22 19.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.844 -0.617 . . . . 12.09 110.699 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 16.7 ptp180 -89.39 121.76 31.95 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.658 -0.497 . . . . 12.51 109.658 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.37 155.13 23.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.172 0.51 . . . . 8.76 110.77 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -132.06 142.88 49.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.701 -0.681 . . . . 9.15 109.555 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.433 ' CE1' ' HA3' ' A' ' 20' ' ' GLY . 17.6 p90 -126.63 163.79 22.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.027 0.441 . . . . 6.85 110.416 -176.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -112.65 152.44 28.97 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.691 -0.485 . . . . 9.99 109.691 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -62.98 -21.55 66.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.316 -0.402 . . . . 9.93 111.772 -175.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.6 t -72.93 -19.82 61.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.526 -0.306 . . . . 12.28 111.09 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 1.9 mp0 -95.56 -26.24 15.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.603 -0.272 . . . . 10.62 111.41 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -68.48 112.81 5.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 8.78 110.553 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.2 t -91.56 97.22 10.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.977 -0.556 . . . . 8.97 110.195 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.6 -176.04 34.8 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.84 -0.904 . . . . 9.98 110.84 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -77.67 95.75 4.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.816 0.341 . . . . 12.43 110.176 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -60.75 -25.86 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.383 0.611 . . . . 11.58 110.514 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.38 -25.79 68.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.369 -0.832 . . . . 14.73 111.22 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -108.18 17.52 22.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.39 -0.368 . . . . 13.3 111.069 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.7 tp -97.71 125.95 42.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.009 -0.737 . . . . 10.07 109.009 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -123.4 173.88 7.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.998 -0.371 . . . . 13.13 109.998 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 47' ' ' ILE . 3.8 mp -70.97 131.78 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.968 -0.382 . . . . 11.74 109.968 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.79 2.24 58.51 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.504 -0.855 . . . . 10.13 112.276 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.0 124.61 89.58 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 110.559 -0.163 . . . . 8.39 110.559 175.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.55 132.05 7.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.788 2.326 . . . . 7.28 112.662 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.451 HG12 ' HG2' ' A' ' 71' ' ' LYS . 27.3 m -136.96 161.18 36.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.115 0.483 . . . . 4.74 111.311 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.424 ' HB3' HG22 ' A' ' 9' ' ' THR . 6.6 pt-20 -120.41 136.67 54.65 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.175 -0.676 . . . . 7.09 109.175 170.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -131.8 148.91 52.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.451 0.643 . . . . 7.82 111.214 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 35.8 tt0 -88.98 110.49 21.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.408 -0.815 . . . . 11.59 109.309 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.61 105.32 13.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.271 -0.64 . . . . 12.41 109.271 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.419 HG23 ' HG2' ' A' ' 54' ' ' GLU . 23.9 p -134.87 171.25 14.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.373 0.606 . . . . 13.17 111.987 -174.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -113.45 111.02 21.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.739 -0.664 . . . . 16.21 110.394 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -72.59 122.84 22.05 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.777 -0.453 . . . . 16.64 109.777 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -79.36 -6.74 57.46 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.666 0.617 . . . . 22.64 112.666 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -82.91 -44.54 15.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.49 . . . . 21.43 109.807 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.9 p -90.69 -28.23 18.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.832 -0.622 . . . . 17.4 111.391 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.9 29.13 61.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.113 -0.565 . . . . 16.7 111.871 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -127.37 153.73 77.17 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 110.224 -0.287 . . . . 14.73 110.224 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.77 125.47 9.47 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.051 1.834 . . . . 12.6 111.061 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -138.44 179.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.193 0.52 . . . . 11.73 111.078 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.7 139.32 50.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.724 -0.671 . . . . 8.91 109.302 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 14.7 m -70.16 -148.03 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.096 -0.502 . . . . 9.83 110.949 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 14.0 mm100 -66.74 29.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.841 1.423 . . . . 11.32 114.841 -170.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 68' ' ' GLN . 39.0 t 4.97 99.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 125.201 1.4 . . . . 6.11 113.677 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.8 m -112.15 138.02 49.41 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.981 0.419 . . . . 6.12 110.522 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.451 ' HG2' HG12 ' A' ' 51' ' ' VAL . 50.0 mtpt -70.51 142.2 51.87 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.494 -0.558 . . . . 6.3 109.494 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.3 mt -62.75 110.18 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.282 0.563 . . . . 5.77 110.739 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.48 163.6 21.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 5.69 111.236 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -58.08 146.98 85.52 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.439 2.093 . . . . 6.86 112.091 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.492 ' HG2' ' H ' ' A' ' 76' ' ' VAL . 14.1 tt0 -97.1 -147.11 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.072 -0.513 . . . . 8.49 110.304 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.492 ' H ' ' HG2' ' A' ' 75' ' ' GLU . 18.3 t -62.58 145.8 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 122.766 0.426 . . . . 6.19 111.09 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.07 111.6 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.493 -0.321 . . . . 6.26 110.908 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -112.16 -7.57 14.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.919 0.39 . . . . 6.05 111.507 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.8 m -85.45 28.6 0.74 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.34 0.496 . . . . 7.02 112.34 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.92 -36.78 13.26 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.585 -0.446 . . . . 7.07 111.372 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -169.13 144.65 3.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.291 0.567 . . . . 6.68 111.3 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -112.49 97.44 6.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.383 -0.826 . . . . 6.43 109.136 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.88 168.15 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.328 0.585 . . . . 3.7 111.137 -175.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -108.85 139.09 44.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.512 -0.767 . . . . 3.49 110.729 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -135.27 166.49 24.43 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.593 -0.813 . . . . 2.58 112.379 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 m -118.4 134.62 54.91 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.634 -0.506 . . . . 3.34 109.634 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 47.9 t -67.46 123.89 21.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.792 -0.447 . . . . 3.14 109.792 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.7 -24.13 12.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.196 -0.456 . . . . 3.61 111.131 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.6 m -153.09 132.44 12.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.084 -0.507 . . . . 3.12 110.11 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -92.52 -172.37 3.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.946 0.403 . . . . 4.39 110.169 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.62 126.85 30.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.711 -0.848 . . . . 3.62 108.711 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -65.14 111.91 3.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.308 0.575 . . . . 7.2 111.529 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 p -116.67 112.94 21.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.291 -0.868 . . . . 5.1 109.507 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -68.94 -60.03 2.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 7.53 110.983 -175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.0 m -105.78 154.09 20.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.021 -0.536 . . . . 7.47 110.107 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.46 -25.89 67.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 7.58 111.547 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -90.34 -20.59 22.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.882 -0.599 . . . . 8.32 110.437 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -102.87 102.59 12.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.17 0.509 . . . . 7.26 110.698 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.47 127.87 63.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.753 -0.658 . . . . 5.54 109.799 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -127.89 97.64 4.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.555 0.693 . . . . 7.28 110.503 -176.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -90.23 63.01 5.63 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.665 -1.152 . . . . 7.54 109.715 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.3 p -96.46 144.29 26.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.666 -0.697 . . . . 5.41 109.573 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.3 m -76.55 5.24 7.7 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.188 0.44 . . . . 4.58 112.188 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -86.39 -32.73 20.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.984 0.421 . . . . 5.09 110.287 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.3 t -98.8 87.15 3.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.153 0.978 . . . . 3.33 109.311 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.401 HG21 ' HB2' ' A' ' 121' ' ' PRO . 15.6 m -94.27 132.96 38.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.036 -0.984 . . . . 2.57 110.612 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.75 169.35 48.28 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.795 -0.717 . . . . 1.66 112.323 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -130.81 134.79 47.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.261 0.553 . . . . 3.03 111.551 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.495 HG13 ' CD1' ' A' ' 122' ' ' TYR . 97.7 mt -112.9 125.41 70.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.967 -1.015 . . . . 1.88 109.435 172.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 p -97.66 126.16 42.83 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.691 -0.485 . . . . 3.49 109.691 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -134.23 154.42 51.27 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.844 -0.428 . . . . 3.51 109.844 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -115.54 121.31 42.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.175 -0.466 . . . . 5.1 110.38 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.517 ' OD1' ' HG3' ' A' ' 114' ' ' ARG . 23.5 t-20 -160.69 143.27 12.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.464 . . . . 4.78 109.959 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.517 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 79.7 mtp180 64.48 20.77 12.27 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.464 0.478 . . . . 6.97 110.893 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.75 1.12 90.1 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.855 -0.611 . . . . 5.1 112.555 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -114.29 151.05 33.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.658 -0.497 . . . . 5.38 109.658 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.47 104.64 10.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.136 0.493 . . . . 4.72 110.435 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -104.2 169.24 8.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.757 -0.656 . . . . 4.61 111.054 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -120.27 123.15 42.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.708 -0.678 . . . . 3.96 110.173 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.51 138.19 19.44 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.536 -0.302 . . . . 2.75 110.372 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HB2' HG21 ' A' ' 106' ' ' THR . 73.3 Cg_endo -76.83 142.62 22.7 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.773 2.315 . . . . 2.3 111.827 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.495 ' CD1' HG13 ' A' ' 109' ' ' ILE . 34.5 p90 -146.35 152.27 38.85 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.086 0.469 . . . . 2.13 110.776 176.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.83 156.81 23.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.714 -0.676 . . . . 3.07 110.304 174.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -66.97 -28.15 68.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.084 0.469 . . . . 4.8 111.252 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.62 -16.18 63.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.811 -0.631 . . . . 4.81 111.38 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.05 23.93 12.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.078 -0.51 . . . . 3.84 111.242 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.08 114.71 39.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.352 0.596 . . . . 4.39 111.338 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 157' ' ' ARG . 0.6 OUTLIER -79.71 151.78 30.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.428 -0.805 . . . . 6.43 108.856 178.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.14 -16.55 42.58 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.714 -0.755 . . . . 5.91 111.47 -174.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 63.47 24.76 14.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.257 0.623 . . . . 6.07 111.445 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.61 138.17 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.362 -0.381 . . . . 5.27 109.985 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -83.01 91.84 7.25 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.737 -0.468 . . . . 5.78 109.737 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.1 pt? -71.69 144.2 49.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.633 -0.712 . . . . 3.62 110.943 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -140.69 148.96 41.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.833 -0.622 . . . . 6.93 110.33 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.645 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -49.98 124.34 9.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.124 -0.489 . . . . 4.12 112.181 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.0 -24.43 8.3 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.477 -0.783 . . . . 4.07 113.569 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -87.65 178.07 6.86 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 117.782 0.791 . . . . 4.06 110.625 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -117.18 122.77 44.96 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.461 0.648 . . . . 4.17 111.58 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.02 157.66 20.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.979 -1.01 . . . . 2.77 110.788 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.0 m -113.89 129.9 56.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.445 -0.576 . . . . 3.47 109.445 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -126.4 139.19 53.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.127 0.489 . . . . 3.35 109.734 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -94.97 116.84 29.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.588 -0.733 . . . . 5.34 109.417 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 76.4 mt -77.7 111.52 14.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.854 -0.612 . . . . 4.66 110.304 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . . . -97.43 109.04 21.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.585 -0.734 . . . . 4.85 110.658 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 88.6 m -85.43 120.86 27.36 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.455 0.472 . . . . 5.68 111.076 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -72.74 171.33 12.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.557 . . . . 6.25 110.698 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -57.92 -22.39 48.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.167 0.803 . . . . 8.58 113.167 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -111.08 -2.7 15.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.109 -0.636 . . . . 7.86 111.617 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 98.07 11.03 50.66 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.281 -0.961 . . . . 5.59 114.469 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -98.19 132.27 43.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.812 -0.81 . . . . 5.18 108.812 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.476 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -146.6 -178.24 6.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.212 0.53 . . . . 4.28 112.333 -174.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.16 -122.77 1.47 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.862 -1.063 . . . . 3.36 111.026 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.87 131.47 33.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.917 0.358 . . . . 2.84 110.389 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 74.5 m -142.65 159.53 42.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.128 -0.487 . . . . 4.34 109.738 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 57.72 54.96 5.84 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.762 0.664 . . . . 5.75 110.68 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.2 mp -82.84 114.22 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.803 -0.443 . . . . 3.55 109.803 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.45 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 34.3 ttt180 -120.14 128.76 53.72 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.99 -0.374 . . . . 5.96 109.99 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.2 tt -77.04 117.01 18.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.998 -0.546 . . . . 4.34 110.012 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -92.2 -54.82 3.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 4.97 111.015 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -122.1 106.46 36.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.068 -0.515 . . . . 5.37 110.653 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.58 -176.62 3.32 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.262 1.974 . . . . 5.44 112.069 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -139.75 121.04 14.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.994 -0.548 . . . . 6.1 110.186 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 66.79 90.47 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.257 0 O-C-N 123.829 0.706 . . . . 9.49 111.275 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.72 130.94 20.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.378 2.052 . . . . 8.39 112.659 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.549 . . . . 10.27 110.607 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.162 -0.375 . . . . 21.66 112.162 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.91 110.8 20.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.791 0.329 . . . . 20.17 110.232 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -116.01 -52.43 2.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.576 0.703 . . . . 18.5 110.252 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -85.25 43.27 1.0 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.095 -0.957 . . . . 16.62 111.378 -174.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -75.48 -75.78 0.17 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.831 -0.622 . . . . 18.35 110.816 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.93 133.41 28.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.285 -0.87 . . . . 16.2 110.144 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -104.12 121.97 44.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.959 -0.564 . . . . 12.4 109.814 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.428 ' CD ' ' HB2' ' A' ' 55' ' ' MET . 7.5 pt-20 -121.41 138.04 54.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.191 0.519 . . . . 11.63 111.056 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.0 p -109.11 160.89 15.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.031 -0.531 . . . . 9.15 111.562 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.73 174.28 42.11 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.001 -0.839 . . . . 6.81 111.001 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.9 mt -109.87 144.94 17.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.767 0.283 . . . . 10.17 110.393 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.402 HD11 HG11 ' A' ' 51' ' ' VAL . 45.9 mm -66.33 114.35 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.284 -0.265 . . . . 8.73 110.284 174.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.21 -55.17 5.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 10.86 111.49 -176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.595 ' HD3' ' N ' ' A' ' 15' ' ' LEU . 8.2 tmtt? -159.39 136.47 9.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.729 -0.471 . . . . 14.06 109.729 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.595 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 72.7 mt -93.62 117.17 29.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.311 0.577 . . . . 11.73 111.492 178.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.17 -178.57 3.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.876 -1.157 . . . . 11.36 107.876 172.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -88.26 130.61 35.05 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.082 -0.647 . . . . 15.94 109.696 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m 75.28 -44.24 0.53 Allowed 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.303 1.002 . . . . 13.01 112.016 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -121.87 148.85 44.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.131 0.491 . . . . 12.34 111.417 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -139.89 169.86 24.5 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.478 -0.649 . . . . 7.52 111.478 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -121.86 144.53 48.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.057 0.456 . . . . 9.24 111.608 -177.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -105.83 129.92 58.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.655 -0.702 . . . . 7.75 109.695 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.512 ' HG3' ' H ' ' A' ' 25' ' ' CYS . 13.8 tp60 -77.07 132.77 39.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.928 -0.578 . . . . 11.8 111.27 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.593 ' HB3' ' N ' ' A' ' 30' ' ' ARG . 6.5 p -84.94 0.62 50.6 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.348 0.87 . . . . 12.34 113.348 175.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.512 ' H ' ' HG3' ' A' ' 23' ' ' GLN . 68.4 m -60.74 -22.93 64.54 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.675 0.991 . . . . 13.33 113.675 -168.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -102.59 -29.47 11.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.347 0.594 . . . . 11.9 110.435 -178.765 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.535 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 12.6 ttp85 -105.61 -157.69 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.447 -0.797 . . . . 12.99 110.088 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.535 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 44.4 mt-30 -123.37 21.34 9.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 16.66 110.744 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.13 115.38 5.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.787 0.327 . . . . 12.09 111.847 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.593 ' N ' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -87.03 141.59 28.56 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.873 -0.788 . . . . 12.51 108.873 172.504 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.9 mt -138.37 162.39 34.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.662 0.267 . . . . 8.76 110.95 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -113.19 148.56 35.2 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.515 -0.55 . . . . 9.15 109.515 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -145.39 159.4 43.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.511 -0.551 . . . . 6.85 109.511 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -106.75 162.78 13.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.439 -0.578 . . . . 9.99 109.439 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.52 -19.12 65.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.938 0.399 . . . . 9.93 110.508 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.7 p -76.91 -15.32 59.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.031 -0.531 . . . . 12.28 110.729 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -102.06 20.69 16.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.389 -0.369 . . . . 10.62 110.789 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -123.02 108.11 12.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.222 0.534 . . . . 8.78 109.717 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' A' ' 68' ' ' GLN . 51.1 m -94.44 104.33 16.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.711 -0.677 . . . . 8.97 111.052 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.37 -165.84 35.07 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.48 -1.048 . . . . 9.98 110.48 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -94.21 119.34 32.87 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 117.347 0.573 . . . . 12.43 109.904 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.81 -20.66 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 11.58 111.067 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.65 -3.99 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 14.73 111.355 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -118.41 21.87 12.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.073 0.464 . . . . 13.3 109.89 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -125.88 112.34 15.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.205 -0.665 . . . . 10.07 109.205 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -120.05 178.58 4.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.255 0.55 . . . . 13.13 111.298 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.51 130.73 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.383 -0.826 . . . . 11.74 109.363 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.12 10.9 61.97 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.41 -0.9 . . . . 10.13 110.991 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -89.06 123.52 67.15 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.137 -0.531 . . . . 8.39 110.05 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.51 126.6 11.69 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.661 2.241 . . . . 7.28 112.539 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.422 HG12 ' CD ' ' A' ' 71' ' ' LYS . 28.0 m -125.51 151.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 4.74 111.389 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.33 129.8 56.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.222 -0.658 . . . . 7.09 109.222 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -144.61 175.56 10.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.249 0.547 . . . . 7.82 111.357 -175.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -123.48 138.44 54.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.604 -0.726 . . . . 11.59 109.969 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.428 ' HB2' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -92.1 111.38 22.91 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.56 -0.533 . . . . 12.41 109.56 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 p -134.43 133.77 40.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 13.17 112.037 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 64' ' ' PRO . 16.8 m-85 -89.13 109.6 20.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.158 -0.474 . . . . 16.21 110.103 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -77.28 97.38 4.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.723 -0.473 . . . . 16.64 109.723 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -72.38 -5.43 36.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.318 -0.401 . . . . 22.64 111.471 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -69.63 -30.6 68.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.356 -0.609 . . . . 21.43 109.356 174.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.9 p -113.11 -36.93 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.799 -0.637 . . . . 17.4 111.208 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.34 17.29 15.94 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.955 -0.566 . . . . 16.7 112.128 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -121.02 148.66 49.39 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.641 0.258 . . . . 14.73 111.277 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 78.7 Cg_endo -80.17 126.34 6.26 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.42 2.08 . . . . 12.6 112.144 175.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.0 pt -132.28 165.0 33.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.075 0.464 . . . . 11.73 110.555 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.52 157.24 16.3 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.979 -0.749 . . . . 8.91 108.979 171.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.9 t -70.68 -162.55 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.873 0.368 . . . . 9.83 110.038 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.449 ' HB2' ' OG ' ' A' ' 39' ' ' SER . 22.3 pt20 -74.05 8.16 2.25 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.66 0.615 . . . . 11.32 112.66 -172.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.2 t 53.33 99.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.705 0.764 . . . . 6.11 112.572 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -96.26 129.98 43.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.039 -0.528 . . . . 6.12 110.105 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.422 ' CD ' HG12 ' A' ' 51' ' ' VAL . 13.9 mmmm -76.72 132.34 39.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.242 -0.435 . . . . 6.3 110.411 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.6 mt -68.81 113.32 4.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.759 -0.655 . . . . 5.77 110.573 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.87 166.0 38.3 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.299 -0.864 . . . . 5.69 110.745 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.31 158.35 31.45 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.646 2.231 . . . . 6.86 112.042 174.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.17 167.83 19.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.883 -0.598 . . . . 8.49 110.589 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.544 HG12 ' HB1' ' A' ' 144' ' ' ALA . 22.4 t -54.4 142.06 8.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.169 -0.469 . . . . 6.19 111.242 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 64.0 t -77.27 102.86 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 6.26 111.402 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -98.32 16.23 22.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.822 0.82 . . . . 6.05 108.829 177.041 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -102.63 77.06 1.57 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.511 0.672 . . . . 7.02 110.137 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -149.17 106.8 3.65 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.974 -1.121 . . . . 7.07 107.974 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.47 ' OE1' ' HG2' ' A' ' 82' ' ' ARG . 7.8 tp10 -44.67 140.87 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.09 -0.959 . . . . 6.68 111.955 -175.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.47 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 8.5 ptp85 -60.14 106.73 0.55 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.99 -1.004 . . . . 6.43 110.973 -176.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.04 156.18 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.638 -0.71 . . . . 3.7 110.133 178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.7 p -115.77 140.0 49.63 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.827 -0.624 . . . . 3.49 110.695 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.6 166.9 26.04 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.649 -0.786 . . . . 2.58 112.052 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -97.02 127.97 43.52 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.173 -0.306 . . . . 3.34 110.173 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 91.2 t -64.0 124.51 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.479 -0.328 . . . . 3.14 110.242 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.7 p -112.02 -8.26 14.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.748 0.309 . . . . 3.61 111.159 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.476 ' HB ' ' N ' ' A' ' 108' ' ' ARG . 11.4 m -152.29 138.58 18.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.46 -0.336 . . . . 3.12 110.275 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.588 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 18.5 mt-10 -119.16 161.71 19.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 4.39 110.851 -174.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.427 HD22 ' HG3' ' A' ' 124' ' ' LYS . 5.2 mp -110.5 146.73 35.47 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.85 -0.796 . . . . 3.62 108.85 173.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -117.68 173.31 6.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.882 0.373 . . . . 7.2 111.202 -171.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 p -91.62 123.11 34.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.982 -0.554 . . . . 5.1 109.737 172.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.46 -171.2 1.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.888 -0.325 . . . . 7.53 110.7 -174.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.0 t 65.22 -82.31 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.649 0.78 . . . . 7.47 110.863 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -160.04 70.66 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.654 0.264 . . . . 7.58 110.952 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.7 m120 63.9 13.54 7.67 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.815 -0.63 . . . . 8.32 112.421 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -97.86 151.47 20.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.047 -0.353 . . . . 7.26 110.047 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.7 m -79.28 130.82 35.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.514 0.673 . . . . 5.54 110.859 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.5 tp -150.29 121.55 7.82 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.02 -1.474 . . . . 7.28 107.02 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -47.07 -50.81 19.09 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.008 0.818 . . . . 7.54 111.667 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 t 60.48 55.52 3.42 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.024 -0.732 . . . . 5.41 109.024 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.5 m -68.5 6.65 0.77 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.262 -0.881 . . . . 4.58 112.592 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -93.73 -10.77 33.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.946 0.403 . . . . 5.09 110.259 176.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t -119.66 145.25 46.65 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.759 -0.83 . . . . 3.33 108.759 174.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 p -125.3 122.19 36.16 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.19 0.441 . . . . 2.57 112.19 -172.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -72.53 156.43 52.02 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 108.891 -1.683 . . . . 1.66 108.891 166.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.476 ' N ' ' HB ' ' A' ' 89' ' ' THR . 19.5 mtt180 -135.08 141.68 46.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.511 1.156 . . . . 3.03 111.723 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 72.4 mt -113.21 128.5 69.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.01 -0.995 . . . . 1.88 109.516 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 t -104.69 122.55 45.91 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.282 -0.636 . . . . 3.49 109.282 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -131.75 167.56 19.3 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.146 -0.316 . . . . 3.51 110.146 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -137.26 118.29 14.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.009 -0.738 . . . . 5.1 109.009 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -132.81 113.64 13.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.362 -0.381 . . . . 4.78 110.712 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 65.34 23.23 12.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.118 -0.492 . . . . 6.97 111.191 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.31 5.63 61.91 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.021 -0.609 . . . . 5.1 112.672 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -110.68 118.12 35.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.056 0.455 . . . . 5.38 110.157 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.5 p -119.97 125.09 47.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.954 -0.566 . . . . 4.72 110.584 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -134.81 172.36 13.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.706 0.289 . . . . 4.61 110.576 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -112.21 119.36 38.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.738 -0.665 . . . . 3.96 109.416 174.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 3.1 mm? -104.54 118.17 57.23 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.711 0.291 . . . . 2.75 110.344 -177.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 32.9 Cg_endo -80.2 131.67 8.87 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.19 1.927 . . . . 2.3 111.569 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -133.39 156.69 47.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.787 0.327 . . . . 2.13 110.273 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.64 169.01 9.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.99 -0.55 . . . . 3.07 110.156 175.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.427 ' HG3' HD22 ' A' ' 91' ' ' LEU . 52.8 mtmt -70.76 -18.95 62.76 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.08 0.4 . . . . 4.8 112.08 -174.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.59 -5.39 57.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.344 -0.389 . . . . 4.81 111.149 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -86.77 -13.84 44.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.652 -0.249 . . . . 3.84 111.031 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 156' ' ' ILE . 4.7 p -119.27 112.69 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.224 0.535 . . . . 4.39 110.688 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 155' ' ' HIS . 0.8 OUTLIER -95.05 175.17 6.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.167 -0.47 . . . . 6.43 110.415 178.002 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.76 -12.71 68.68 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.653 -0.784 . . . . 5.91 111.869 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.6 m120 59.31 41.41 19.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.062 0.458 . . . . 6.07 111.251 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.71 150.42 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.869 -0.605 . . . . 5.27 110.331 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -101.44 85.38 2.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.131 0.491 . . . . 5.78 110.037 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.724 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.1 pt? -75.37 128.6 35.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.694 -0.684 . . . . 3.62 110.325 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.588 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 18.0 tpt180 -105.65 143.71 33.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.673 . . . . 6.93 110.448 -173.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.603 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -63.82 113.64 3.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.997 0.427 . . . . 4.12 110.051 174.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 116.31 -11.52 16.79 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.268 -0.733 . . . . 4.07 111.268 -173.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.533 ' OD2' ' HA ' ' A' ' 161' ' ' PRO . 4.9 t70 -87.83 -179.13 6.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.211 -0.663 . . . . 4.06 109.211 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -122.87 114.62 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.123 0.487 . . . . 4.17 110.71 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.2 m -119.93 149.8 22.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.068 0.461 . . . . 2.77 111.316 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -100.88 135.07 42.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.602 -0.726 . . . . 3.47 109.554 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -144.95 149.71 35.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.41 -0.359 . . . . 3.35 110.536 -178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.7 139.36 38.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.191 -0.459 . . . . 5.34 109.893 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.2 mt -101.88 100.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.033 0.444 . . . . 4.66 110.627 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -97.3 110.92 23.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.3 -0.409 . . . . 4.85 110.964 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.7 m -79.89 110.79 15.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 5.68 111.311 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -83.53 165.68 18.89 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.059 -0.519 . . . . 6.25 110.466 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -48.98 -44.8 41.32 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.667 0.988 . . . . 8.58 113.667 -172.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -81.31 3.18 25.05 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.158 -0.617 . . . . 7.86 111.519 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.64 23.1 40.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.525 -0.845 . . . . 5.59 111.76 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -96.33 127.35 42.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.186 -0.302 . . . . 5.18 110.186 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.468 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.54 163.64 39.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.807 0.336 . . . . 4.28 110.401 175.575 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.86 -110.82 0.32 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.892 -0.883 . . . . 3.36 110.892 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.89 110.44 4.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.678 -0.49 . . . . 2.84 109.678 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -115.91 158.81 22.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.699 -0.482 . . . . 4.34 109.699 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.4 ' HA ' ' OE1' ' A' ' 128' ' ' GLU . 10.4 p80 38.46 65.35 0.63 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.352 1.033 . . . . 5.75 111.608 -174.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.43 ' HB ' ' HB ' ' A' ' 127' ' ' VAL . 77.7 mt -77.43 133.77 29.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.192 -1.367 . . . . 3.55 110.707 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -126.84 124.31 39.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.068 0.461 . . . . 5.96 110.825 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.5 tt -85.99 106.8 17.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.717 -0.846 . . . . 4.34 108.717 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.69 -42.37 5.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.078 -0.51 . . . . 4.97 111.934 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -121.22 93.84 48.8 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.789 -0.449 . . . . 5.37 109.789 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.533 ' HA ' ' OD2' ' A' ' 137' ' ' ASP . 74.2 Cg_endo -75.43 156.41 41.1 Favored 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 122.649 2.233 . . . . 5.44 112.603 -176.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.56 157.83 44.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.909 -0.587 . . . . 6.1 111.018 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -111.77 114.07 52.32 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.931 -0.396 . . . . 9.49 109.931 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.79 139.9 13.47 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.733 2.956 . . . . 8.39 113.701 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--O 1.237 0.41 0 CA-C-N 115.57 -0.741 . . . . 10.27 112.064 -178.62 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 111.991 -0.443 . . . . 21.66 111.991 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.91 26.59 16.49 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.748 0.419 . . . . 20.17 111.346 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -99.48 6.14 46.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.483 0.659 . . . . 18.5 109.724 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -136.13 95.14 3.14 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.693 -0.854 . . . . 16.62 108.693 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -113.61 -84.62 0.6 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.228 -0.589 . . . . 18.35 112.558 -176.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -132.68 123.58 26.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.518 0.675 . . . . 16.2 111.43 -172.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -99.65 139.96 34.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.113 -0.949 . . . . 12.4 111.078 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.539 ' OE1' ' HD3' ' A' ' 27' ' ' ARG . 15.0 mm-40 -110.21 138.22 46.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.699 -0.682 . . . . 11.63 110.351 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -93.38 145.12 24.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.259 -0.428 . . . . 9.15 111.128 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.3 -175.48 23.18 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.553 -0.619 . . . . 6.81 111.553 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.1 mt -127.75 141.9 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.808 -0.442 . . . . 10.17 109.808 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.01 122.77 19.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.969 -0.292 . . . . 8.73 110.441 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -81.73 -53.78 5.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 10.86 111.197 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.409 ' HD3' HG12 ' A' ' 47' ' ' ILE . 53.4 mmtt -158.98 147.94 18.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.01 -0.541 . . . . 14.06 110.51 -177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.78 95.67 8.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 11.73 110.905 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 4.3 mm? -92.07 179.25 5.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.578 -0.737 . . . . 11.36 109.549 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -91.14 120.78 32.37 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.262 -0.273 . . . . 15.94 110.262 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.6 t 79.15 -40.97 0.25 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.961 0.905 . . . . 13.01 111.379 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 7.1 p90 -119.34 146.22 45.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.919 0.39 . . . . 12.34 111.051 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.77 163.02 22.89 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.599 -0.6 . . . . 7.52 111.599 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.97 143.59 47.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.892 0.377 . . . . 9.24 111.364 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.4 mt -110.44 129.28 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.65 -0.704 . . . . 7.75 110.232 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.79 140.53 42.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.81 0.814 . . . . 11.8 111.678 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.4 p -80.09 0.95 29.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.335 -1.302 . . . . 12.34 112.131 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.6 m -51.91 -39.6 59.36 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.471 0.545 . . . . 13.33 112.471 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -89.59 -13.31 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.251 0.548 . . . . 11.9 111.174 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.539 ' HD3' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -128.99 -158.46 0.89 Allowed 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.103 -0.373 . . . . 12.99 110.346 -175.362 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -124.03 19.22 9.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.076 0.465 . . . . 16.66 110.369 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.47 130.32 26.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.705 -0.679 . . . . 12.09 110.954 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -94.39 124.83 38.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.963 -0.754 . . . . 12.51 108.963 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.7 mt -123.72 162.4 23.22 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.069 0.462 . . . . 8.76 111.525 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -126.05 148.51 49.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.669 -0.696 . . . . 9.15 109.356 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -142.39 153.35 43.7 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.894 -0.41 . . . . 6.85 109.894 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -95.71 161.65 13.94 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.603 -0.517 . . . . 9.99 109.603 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -64.05 -13.61 48.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.059 0.457 . . . . 9.93 111.118 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.4 t -74.88 -20.64 59.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.13 -0.487 . . . . 12.28 110.155 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -100.25 23.37 10.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.415 -0.357 . . . . 10.62 111.332 -178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -124.02 111.69 16.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.027 0.442 . . . . 8.78 110.341 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.8 t -89.17 91.85 8.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.013 -0.54 . . . . 8.97 110.335 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.05 173.84 31.21 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.929 -0.653 . . . . 9.98 112.18 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -75.4 117.92 17.72 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.975 -0.38 . . . . 12.43 109.975 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.44 -18.86 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 11.58 111.93 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -54.97 -36.58 65.52 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.375 -0.375 . . . . 14.73 111.868 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -102.15 21.76 14.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.241 0.46 . . . . 13.3 112.241 -173.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -103.21 107.27 18.02 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.798 -0.361 . . . . 10.07 110.138 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -116.09 173.88 6.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.043 0.449 . . . . 13.13 110.904 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.7 mp -80.56 125.84 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.911 -0.774 . . . . 11.74 108.911 177.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.19 -13.75 28.52 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.953 -0.641 . . . . 10.13 111.893 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.7 125.05 91.76 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-O 120.697 0.285 . . . . 8.39 110.553 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.98 132.07 15.04 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.469 2.113 . . . . 7.28 111.006 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 m -126.44 154.83 36.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.01 0.433 . . . . 4.74 111.296 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -109.51 126.57 53.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.414 -0.812 . . . . 7.09 109.468 176.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.3 161.08 38.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.901 0.381 . . . . 7.82 110.711 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -122.82 109.5 14.27 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.53 -0.544 . . . . 11.59 109.53 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.3 ttt -79.32 120.04 23.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.59 -0.732 . . . . 12.41 110.482 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.3 p -138.71 152.1 47.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.324 -0.398 . . . . 13.17 110.617 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -96.34 117.13 30.2 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.967 -0.383 . . . . 16.21 109.967 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -92.37 128.51 38.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.912 -0.585 . . . . 16.64 111.454 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -79.87 -13.28 59.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.535 -0.757 . . . . 22.64 111.473 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -79.53 -52.53 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 21.43 110.073 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.6 p -85.43 -37.8 19.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.024 -0.535 . . . . 17.4 110.75 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.03 14.06 50.42 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.491 -0.644 . . . . 16.7 111.491 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -116.6 151.42 47.09 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.542 0.211 . . . . 14.73 110.489 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.31 124.42 8.41 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.725 1.617 . . . . 12.6 110.044 168.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.47 169.69 17.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.15 0.5 . . . . 11.73 111.346 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.84 157.63 17.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.673 -0.862 . . . . 8.91 108.673 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.7 t -70.88 -162.23 0.06 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.481 -0.327 . . . . 9.83 110.56 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -74.57 7.85 2.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.301 0.482 . . . . 11.32 112.301 -172.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.9 t 49.84 91.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 124.026 0.829 . . . . 6.11 112.429 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.92 111.49 16.3 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.791 -0.64 . . . . 6.12 110.545 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 112.27 6.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.709 -0.678 . . . . 6.3 109.462 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.1 mt -63.55 125.11 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.696 -0.684 . . . . 5.77 111.093 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.3 139.03 20.11 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 5.69 110.707 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -87.13 18.61 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.028 2.485 . . . . 6.86 113.653 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -86.63 174.79 8.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.025 0.44 . . . . 8.49 110.876 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.3 t -106.44 152.2 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.091 -0.504 . . . . 6.19 109.78 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 94.6 t -72.72 96.2 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 6.26 111.627 -176.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.596 HD23 ' HB2' ' A' ' 144' ' ' ALA . 54.3 mt -85.38 -27.81 25.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.811 -0.632 . . . . 6.05 111.152 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.0 m -110.86 81.2 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.197 0.523 . . . . 7.02 112.407 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -96.22 -66.72 0.89 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.682 -1.229 . . . . 7.07 107.682 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -147.02 142.76 27.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.936 -0.574 . . . . 6.68 109.786 173.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 82' ' ' ARG . 45.7 ttm180 -82.86 100.64 10.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.815 -0.629 . . . . 6.43 110.072 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.53 153.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.323 0.582 . . . . 3.7 111.554 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.485 HG22 ' OG ' ' A' ' 140' ' ' SER . 60.7 p -116.11 140.49 49.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.599 -0.728 . . . . 3.49 109.582 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.0 174.06 23.37 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.003 -1.094 . . . . 2.58 112.421 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.0 m -125.52 128.67 48.36 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.607 0.242 . . . . 3.34 110.467 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.616 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 51.9 t -71.97 132.79 32.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.053 -0.522 . . . . 3.14 110.326 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.4 p -116.16 -9.17 11.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.178 0.513 . . . . 3.61 111.31 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.2 m -152.57 125.38 8.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 3.12 109.847 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -107.1 174.73 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.361 . . . . 4.39 110.904 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.49 150.2 23.62 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.945 0.403 . . . . 3.62 110.735 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 92' ' ' ARG . 11.0 ptt180 -82.53 115.59 21.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.608 -0.724 . . . . 7.2 111.38 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 99' ' ' VAL . 1.4 p -156.08 143.84 19.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.237 -0.892 . . . . 5.1 109.496 177.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.9 -41.46 82.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.888 0.375 . . . . 7.53 111.231 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 t -163.94 -162.46 0.7 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.296 -0.411 . . . . 7.47 110.04 -175.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.44 ' HB2' HD21 ' A' ' 132' ' ' ASN . . . -67.6 -63.32 1.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 7.58 110.565 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -91.78 65.07 4.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.089 0.471 . . . . 8.32 110.485 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -172.46 92.43 0.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.208 -1.034 . . . . 7.26 108.208 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.453 ' HA ' HG22 ' A' ' 93' ' ' THR . 30.5 m -126.83 19.46 3.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.744 0.646 . . . . 5.54 112.744 -171.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.625 ' H ' HD23 ' A' ' 100' ' ' LEU . 1.8 pt? -86.13 15.23 5.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.388 0.613 . . . . 7.28 110.769 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -82.56 6.5 17.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.434 -0.803 . . . . 7.54 110.312 176.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m 66.49 84.85 0.15 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.196 -0.911 . . . . 5.41 111.277 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.6 m -82.09 53.03 2.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.959 -0.564 . . . . 4.58 110.429 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -82.44 -22.11 35.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.445 -0.798 . . . . 5.09 111.329 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.9 t -86.73 154.91 20.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.068 -0.515 . . . . 3.33 110.187 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.7 p -101.57 125.64 48.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.494 -0.321 . . . . 2.57 111.398 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -71.2 167.66 51.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.895 -0.882 . . . . 1.66 110.895 174.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -131.75 132.44 43.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.305 0.552 . . . . 3.03 111.289 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.1 mt -113.05 133.62 58.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.391 -0.822 . . . . 1.88 109.309 173.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.9 t -84.17 134.47 34.57 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.222 -0.659 . . . . 3.49 109.222 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.517 ' CD2' HD11 ' A' ' 120' ' ' LEU . 36.5 t80 -157.01 142.73 17.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.16 0.505 . . . . 3.51 111.27 -168.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -129.82 131.49 46.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 5.1 109.311 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -152.29 131.89 13.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.871 0.367 . . . . 4.78 110.639 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 63.48 21.87 12.96 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.017 -0.538 . . . . 6.97 111.616 171.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.26 70.22 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.966 -0.635 . . . . 5.1 112.344 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.97 132.87 43.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.049 0.452 . . . . 5.38 110.24 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 15.1 m -121.8 115.55 22.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.108 -0.496 . . . . 4.72 109.896 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -156.64 173.89 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.77 0.319 . . . . 4.61 111.168 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -107.38 141.85 38.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.971 -0.559 . . . . 3.96 110.167 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.517 HD11 ' CD2' ' A' ' 111' ' ' TYR . 1.7 mp -105.78 139.95 20.72 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.085 -0.709 . . . . 2.75 109.085 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 83.7 Cg_endo -86.93 132.17 3.3 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.951 2.434 . . . . 2.3 112.423 177.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -137.42 149.99 47.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.786 0.327 . . . . 2.13 110.559 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 31.8 p -113.56 177.99 4.44 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.781 -0.452 . . . . 3.07 109.781 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -70.85 -18.17 62.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.001 0.429 . . . . 4.8 110.635 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.98 -27.9 54.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.874 -0.603 . . . . 4.81 110.977 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -75.67 -25.79 57.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.069 0.461 . . . . 3.84 110.916 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 156' ' ' ILE . 2.0 p -90.73 107.78 18.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.619 0.724 . . . . 4.39 111.263 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.84 139.72 34.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.321 -0.854 . . . . 6.43 108.696 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 136.55 -12.81 4.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.517 -0.849 . . . . 5.91 112.252 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 68.09 19.17 9.31 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.913 0.485 . . . . 6.07 112.093 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.62 144.16 9.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.044 0.449 . . . . 5.27 110.855 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.44 HD21 ' HB2' ' A' ' 96' ' ' ALA . 46.3 m-80 -105.28 97.38 7.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.029 -0.532 . . . . 5.78 110.392 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.686 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -89.71 149.86 22.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.075 -0.966 . . . . 3.62 110.741 -177.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -122.6 162.35 22.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.063 -0.517 . . . . 6.93 109.678 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.616 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.28 123.47 23.8 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.888 -0.508 . . . . 4.12 110.453 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.78 -14.07 11.57 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.606 -0.807 . . . . 4.07 113.405 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.61 176.42 6.02 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 117.763 0.782 . . . . 4.06 110.323 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -107.19 115.11 29.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.0 0.428 . . . . 4.17 110.951 -173.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.3 m -118.58 172.85 5.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.789 -0.641 . . . . 2.77 111.257 -178.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.485 ' OG ' HG22 ' A' ' 84' ' ' THR . 43.4 m -138.1 129.86 28.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.954 -0.758 . . . . 3.47 108.954 175.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -127.9 140.29 52.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.033 0.444 . . . . 3.35 110.982 -172.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -93.81 111.28 22.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.73 -0.668 . . . . 5.34 109.708 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.1 mt -79.07 100.36 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.086 -0.506 . . . . 4.66 110.128 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.725 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -80.7 110.08 15.86 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.226 -0.443 . . . . 4.85 110.195 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 m -103.09 126.05 50.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.792 -0.64 . . . . 5.68 109.885 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -93.97 -171.09 2.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.302 -0.408 . . . . 6.25 110.401 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -84.44 -8.79 58.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.999 0.428 . . . . 8.58 111.166 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 148' ' ' ARG . 7.3 tpt180 -89.25 -23.04 22.44 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.956 -0.566 . . . . 7.86 109.846 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.84 22.63 59.32 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.67 -0.695 . . . . 5.59 112.094 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -116.89 109.68 17.37 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.637 -0.505 . . . . 5.18 109.637 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.488 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.88 179.76 8.8 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.102 0.477 . . . . 4.28 111.491 -175.551 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -141.51 -94.46 0.23 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.505 -0.77 . . . . 3.36 111.267 174.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -143.58 156.09 44.49 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.386 -0.598 . . . . 2.84 109.386 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.9 t -162.55 161.84 27.04 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.842 -0.429 . . . . 4.34 109.842 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 53.5 m80 48.13 66.3 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.643 0.589 . . . . 5.75 111.69 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.546 ' O ' HG23 ' A' ' 127' ' ' VAL . 68.4 mt -93.94 117.72 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.335 -0.848 . . . . 3.55 110.365 -177.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.12 158.51 17.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 5.96 110.47 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.84 113.38 26.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.51 -0.552 . . . . 4.34 109.51 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -83.0 -58.59 2.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.013 0.435 . . . . 4.97 111.383 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -136.42 100.6 10.28 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.284 -0.416 . . . . 5.37 110.129 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.88 159.68 51.79 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.391 2.061 . . . . 5.44 111.478 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -131.22 143.34 50.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.029 0.442 . . . . 6.1 111.138 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.01 161.17 50.59 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.698 -0.853 . . . . 9.49 108.698 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -43.07 110.25 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.847 2.365 . . . . 8.39 113.548 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.693 -0.685 . . . . 10.27 111.463 -178.472 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 111.8 -0.52 . . . . 21.66 111.8 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.28 66.75 1.79 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.209 0.528 . . . . 20.17 109.867 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.484 ' OD1' ' HB ' ' A' ' 56' ' ' THR . 9.2 t70 -78.54 -51.76 9.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.698 -0.683 . . . . 18.5 109.674 -177.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.05 63.79 5.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 16.62 110.684 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -141.62 -38.22 0.4 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.222 0.534 . . . . 18.35 110.879 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.405 ' HA ' ' OE2' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -77.67 104.93 8.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.632 -0.713 . . . . 16.2 109.709 -178.328 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 83.3 mtt180 -114.23 116.76 29.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.698 -0.683 . . . . 12.4 111.478 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 6.8 mm-40 -102.76 143.74 32.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.839 -1.073 . . . . 11.63 110.441 -174.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.6 p -104.3 160.95 14.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.282 -0.636 . . . . 9.15 109.282 174.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.25 174.68 46.93 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.102 -1.047 . . . . 6.81 113.562 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.512 HG13 ' HB3' ' A' ' 23' ' ' GLN . 19.8 pt -120.57 148.81 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.924 -0.769 . . . . 10.17 108.924 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.543 HG21 HD22 ' A' ' 15' ' ' LEU . 1.9 mp -80.07 131.45 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.307 -0.557 . . . . 8.73 110.774 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.467 ' OE2' ' HB2' ' A' ' 14' ' ' LYS . 4.3 tm-20 -74.66 -46.74 36.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.687 -0.688 . . . . 10.86 111.026 -176.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 15' ' ' LEU . 6.8 tmtt? -157.09 133.17 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.002 -0.37 . . . . 14.06 110.002 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.543 HD22 HG21 ' A' ' 12' ' ' ILE . 3.6 mm? -78.06 110.88 13.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.943 -0.571 . . . . 11.73 110.901 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 72.2 mt -109.79 177.52 4.7 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.922 -1.14 . . . . 11.36 107.922 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -98.91 139.87 33.93 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.486 -0.485 . . . . 15.94 110.511 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t 76.89 -46.05 0.5 Allowed 'General case' 0 N--CA 1.468 0.425 0 O-C-N 124.366 1.041 . . . . 13.01 111.04 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.498 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 39.6 p90 -129.92 154.29 47.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.264 -0.425 . . . . 12.34 109.925 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -144.51 163.57 27.86 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.897 -0.668 . . . . 7.52 111.72 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -109.33 134.39 51.87 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.231 0.538 . . . . 9.24 111.262 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.6 mt -99.86 126.4 53.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 7.75 109.569 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.569 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 6.8 tp-100 -79.31 130.65 35.66 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.089 0.471 . . . . 11.8 110.319 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 p -67.86 3.63 1.43 Allowed 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 113.894 1.072 . . . . 12.34 113.894 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.569 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 74.4 m -51.75 -26.33 9.28 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.537 0.939 . . . . 13.33 113.537 -172.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -99.53 -6.35 27.62 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.131 0.419 . . . . 11.9 112.131 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.489 ' HG3' ' HB3' ' A' ' 8' ' ' GLU . 17.2 mmt180 -152.28 -159.89 1.07 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.801 0.334 . . . . 12.99 110.841 -173.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.418 ' H ' ' HB3' ' A' ' 27' ' ' ARG . 23.5 mp0 -116.3 17.23 15.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.092 0.472 . . . . 16.66 110.601 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.37 113.24 14.71 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.197 -0.456 . . . . 12.09 111.768 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -87.9 104.65 16.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.661 -0.866 . . . . 12.51 108.661 170.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.99 161.22 14.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.928 0.394 . . . . 8.76 111.232 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -110.95 129.36 55.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.308 -0.997 . . . . 9.15 108.308 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -110.64 141.56 43.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.084 0.469 . . . . 6.85 110.158 -175.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -87.16 137.61 32.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.031 -0.729 . . . . 9.99 109.031 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.46 -11.31 32.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.924 0.342 . . . . 9.93 111.924 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.6 t -72.21 -27.41 62.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.28 -0.418 . . . . 12.28 110.494 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.48 40.31 1.57 Allowed 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.154 -0.475 . . . . 10.62 111.321 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.432 ' CE1' ' HG ' ' A' ' 45' ' ' LEU . 22.8 t80 -113.7 129.16 56.61 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.057 -0.72 . . . . 8.78 109.057 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.0 t -108.79 115.25 29.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.907 -0.405 . . . . 8.97 109.907 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.3 -157.3 20.74 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.873 -0.679 . . . . 9.98 111.724 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -93.45 103.47 15.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.89 0.376 . . . . 12.43 110.626 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.3 tp -67.05 -21.82 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.917 -0.583 . . . . 11.58 110.757 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.64 -21.44 65.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 14.73 110.283 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -99.31 11.74 38.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.769 -0.651 . . . . 13.3 110.222 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.432 ' HG ' ' CE1' ' A' ' 38' ' ' PHE . 2.8 tm? -101.28 115.41 30.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.148 -0.686 . . . . 10.07 109.148 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -123.43 -177.6 3.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.382 -0.372 . . . . 13.13 111.153 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.9 mp -77.48 117.84 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.0 -0.371 . . . . 11.74 110.0 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.35 -1.3 64.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.86 -0.686 . . . . 10.13 111.776 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.98 125.28 90.34 Favored Pre-proline 0 C--O 1.234 0.276 0 N-CA-C 109.882 -0.414 . . . . 8.39 109.882 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.89 128.1 7.35 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.637 2.224 . . . . 7.28 113.66 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.48 161.66 38.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 4.74 110.358 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -122.41 127.35 49.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.399 0.618 . . . . 7.09 109.655 174.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 8' ' ' GLU . 45.3 p90 -131.71 -179.32 5.31 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.921 -0.582 . . . . 7.82 110.872 -174.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.439 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 37.6 tt0 -127.91 126.95 42.49 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.959 -0.756 . . . . 11.59 108.959 -176.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.5 ttt -100.53 112.45 24.83 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.289 -0.263 . . . . 12.41 110.289 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.484 ' HB ' ' OD1' ' A' ' 3' ' ' ASP . 46.2 p -131.9 170.67 14.55 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.339 -0.391 . . . . 13.17 111.351 -175.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -115.77 109.41 17.63 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.81 -0.441 . . . . 16.21 109.81 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.537 ' OD2' HG22 ' A' ' 61' ' ' THR . 31.2 t70 -76.59 122.88 25.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.139 -0.482 . . . . 16.64 111.063 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -79.51 -13.34 59.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 22.64 111.367 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.415 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 14.3 ttm180 -78.42 -62.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.377 . . . . 21.43 110.935 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.537 HG22 ' OD2' ' A' ' 58' ' ' ASP . 15.3 t -88.45 -22.49 23.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.308 -0.405 . . . . 17.4 110.594 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.02 17.63 57.43 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.747 -0.739 . . . . 16.7 113.288 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -104.5 141.72 23.12 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.589 0.195 . . . . 14.73 110.569 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.92 124.13 7.84 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.451 1.434 . . . . 12.6 109.317 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -141.27 171.56 11.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.133 -0.627 . . . . 11.73 112.397 -169.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.3 143.48 28.02 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.928 -1.033 . . . . 8.91 109.038 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.439 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 14.1 t -69.71 -155.68 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.357 -0.383 . . . . 9.83 110.46 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -75.27 29.1 0.1 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.397 0.888 . . . . 11.32 113.397 -172.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.0 t 19.92 103.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 125.14 1.376 . . . . 6.11 114.403 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -101.94 143.11 32.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.089 0.471 . . . . 6.12 111.572 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -69.72 138.85 53.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.569 -0.741 . . . . 6.3 110.791 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.0 mt -81.42 100.6 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.265 -0.642 . . . . 5.77 109.265 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.0 153.45 95.39 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.346 -0.843 . . . . 5.69 111.344 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -49.45 139.95 28.51 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.462 2.775 . . . . 6.86 113.288 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.474 ' HG3' ' H ' ' A' ' 76' ' ' VAL . 3.2 pt-20 -93.02 -91.24 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.809 -0.632 . . . . 8.49 112.147 -175.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.474 ' H ' ' HG3' ' A' ' 75' ' ' GLU . 10.6 p -92.03 151.88 3.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.217 -0.447 . . . . 6.19 110.728 -176.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 47.3 t -80.75 95.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.312 0.577 . . . . 6.26 109.792 175.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tt -98.92 -24.68 14.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.112 -0.949 . . . . 6.05 110.741 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t -101.34 103.08 14.02 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.358 0.599 . . . . 7.02 112.088 -170.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -129.49 -63.59 0.93 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.166 -1.05 . . . . 7.07 108.166 169.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -168.64 147.09 4.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.723 -1.126 . . . . 6.68 108.392 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -77.11 98.56 5.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.61 -0.515 . . . . 6.43 109.61 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.6 m -81.8 157.24 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.44 0.638 . . . . 3.7 111.546 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.6 p -124.69 146.87 48.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.609 -0.723 . . . . 3.49 109.257 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.43 -173.33 13.71 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.272 -0.966 . . . . 2.58 112.063 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.7 m -130.92 131.15 44.29 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.015 -0.365 . . . . 3.34 110.015 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 88.0 t -64.18 129.95 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.519 -0.309 . . . . 3.14 110.33 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.3 p -113.98 -9.98 12.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.983 0.421 . . . . 3.61 110.722 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.7 m -152.26 128.76 10.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.429 . . . . 3.12 110.209 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -99.07 169.63 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 4.39 110.726 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.19 132.8 33.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.999 -0.546 . . . . 3.62 110.122 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -88.76 110.24 20.84 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.055 -0.521 . . . . 7.2 110.554 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m -146.97 155.29 42.15 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.696 -0.483 . . . . 5.1 109.696 173.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -88.7 -43.97 10.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.213 0.53 . . . . 7.53 110.673 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.5 t -140.3 -173.31 3.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.64 -0.709 . . . . 7.47 109.231 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.31 -55.94 23.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.735 0.303 . . . . 7.58 110.636 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -100.05 -12.8 19.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 8.32 112.06 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -81.69 84.77 6.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.343 0.592 . . . . 7.26 109.821 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.1 t -112.81 158.29 13.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.75 -1.114 . . . . 5.54 109.478 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.57 -77.47 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.415 0.626 . . . . 7.28 110.114 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.59 -46.05 2.03 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.379 -0.828 . . . . 7.54 111.177 173.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.0 p -167.75 -158.13 0.25 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.542 -0.299 . . . . 5.41 110.263 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 m -76.5 57.01 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.177 0.513 . . . . 4.58 110.203 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -78.9 -14.65 59.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.556 -0.747 . . . . 5.09 110.793 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -103.1 118.26 36.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.367 -0.833 . . . . 3.33 109.872 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.19 116.2 32.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.109 0.481 . . . . 2.57 111.141 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -69.09 160.77 52.42 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.729 -0.748 . . . . 1.66 111.554 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -129.9 127.61 40.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.342 0.592 . . . . 3.03 110.868 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.5 mt -112.0 127.45 69.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.204 -0.907 . . . . 1.88 109.241 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.4 t -112.4 137.46 50.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.764 0.316 . . . . 3.49 110.441 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 2.7 p90 -143.37 155.42 44.42 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.115 -0.698 . . . . 3.51 109.115 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -111.56 125.24 53.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.864 0.364 . . . . 5.1 110.463 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.723 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 9.4 t30 -130.03 115.66 17.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.945 -0.571 . . . . 4.78 109.584 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 60.94 21.63 11.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.663 0.268 . . . . 6.97 111.581 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.87 -4.18 68.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.825 -0.702 . . . . 5.1 113.011 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.723 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 7.9 pt-20 -99.68 132.96 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.145 -0.687 . . . . 5.38 109.145 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 7.8 p -116.77 118.36 32.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.94 0.4 . . . . 4.72 110.427 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 116' ' ' GLU . 78.9 m-85 -108.4 155.01 21.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.142 -0.481 . . . . 4.61 110.494 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -110.26 123.34 49.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.952 -0.567 . . . . 3.96 109.715 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.77 120.2 52.14 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.384 -0.371 . . . . 2.75 110.408 -175.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -76.7 132.91 13.62 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.906 2.404 . . . . 2.3 111.722 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -145.3 155.0 42.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.804 0.335 . . . . 2.13 110.25 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 62.8 p -107.4 -174.71 2.6 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.124 -0.489 . . . . 3.07 110.084 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -71.39 -19.61 62.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.222 0.534 . . . . 4.8 110.514 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.85 -28.28 33.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.754 -0.657 . . . . 4.81 111.437 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.22 -19.61 60.46 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.387 -0.369 . . . . 3.84 111.364 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.9 p -107.43 107.91 23.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.588 0.709 . . . . 4.39 111.009 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -90.46 138.43 31.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 6.43 110.183 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.23 -20.65 4.98 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.777 -0.647 . . . . 5.91 111.51 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.8 t30 61.58 31.57 18.77 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.74 0.781 . . . . 6.07 110.001 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -89.92 138.51 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.692 -0.685 . . . . 5.27 110.151 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -82.5 103.38 12.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.735 0.302 . . . . 5.78 110.379 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.594 ' H ' HD12 ' A' ' 133' ' ' LEU . 2.2 mp -75.56 134.87 40.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.751 -0.659 . . . . 3.62 109.51 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -121.34 126.74 50.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.889 0.376 . . . . 6.93 110.159 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.597 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -57.46 112.91 1.56 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.359 0.599 . . . . 4.12 111.317 -175.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.36 -2.8 14.04 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.296 -0.865 . . . . 4.07 112.851 -174.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.6 p30 -95.01 178.27 5.61 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.442 0.621 . . . . 4.06 110.459 172.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -100.22 122.88 43.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.978 0.418 . . . . 4.17 111.036 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.09 151.82 24.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.668 -0.696 . . . . 2.77 110.584 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.3 t -124.93 129.33 50.16 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.704 -0.48 . . . . 3.47 109.704 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -136.67 154.6 50.58 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.557 -0.534 . . . . 3.35 109.557 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -113.0 114.76 27.36 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.37 -0.604 . . . . 5.34 109.37 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -78.43 108.16 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.594 . . . . 4.66 111.304 -174.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -100.62 110.5 22.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.128 -0.487 . . . . 4.85 109.81 172.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.2 m -85.85 108.95 18.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.198 -0.455 . . . . 5.68 111.126 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -64.53 146.1 55.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.937 -0.574 . . . . 6.25 109.661 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.17 -17.97 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.571 0.582 . . . . 8.58 112.571 -173.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -85.75 2.07 47.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 7.86 110.31 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.48 16.77 80.43 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.68 -0.691 . . . . 5.59 113.143 174.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -119.69 113.09 20.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.332 -0.618 . . . . 5.18 109.332 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.508 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -144.72 -179.17 6.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.214 -0.448 . . . . 4.28 111.067 -175.31 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.58 -153.3 5.84 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.057 -0.817 . . . . 3.36 111.057 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.26 118.01 34.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.213 0.507 . . . . 2.84 110.086 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 33.9 t -116.44 159.59 21.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.59 -0.277 . . . . 4.34 110.646 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 69.2 m80 60.47 33.58 20.57 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.95 -0.568 . . . . 5.75 111.174 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 55.0 mt -64.69 125.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.764 -0.653 . . . . 3.55 110.921 -176.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -140.44 159.92 41.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.724 -0.671 . . . . 5.96 110.056 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.1 tp -77.6 119.24 20.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.281 -0.637 . . . . 4.34 109.281 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -84.41 -47.67 10.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.031 -0.531 . . . . 4.97 109.628 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -162.5 113.94 1.12 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.864 -0.607 . . . . 5.37 109.492 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.12 152.08 80.46 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.126 1.884 . . . . 5.44 112.481 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -121.64 143.52 49.28 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.897 -0.592 . . . . 6.1 110.774 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -99.03 139.57 21.11 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.0 -0.546 . . . . 9.49 109.662 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.33 107.18 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.152 1.901 . . . . 8.39 111.577 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 55.2 t . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.418 0.627 . . . . 10.27 111.503 -177.694 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 111.926 -0.47 . . . . 21.66 111.926 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.25 66.13 5.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.08 0.467 . . . . 20.17 111.226 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -117.11 6.54 12.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.878 0.847 . . . . 18.5 108.86 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -150.92 99.6 2.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.497 -1.229 . . . . 16.62 109.056 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -135.92 -82.65 0.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.514 0.561 . . . . 18.35 112.514 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -124.67 92.8 3.73 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.028 -0.533 . . . . 16.2 111.869 -169.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -69.64 138.43 53.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.928 -0.578 . . . . 12.4 110.128 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.505 ' CD ' ' HE ' ' A' ' 27' ' ' ARG . 14.1 pt-20 -142.38 162.12 36.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.924 -0.399 . . . . 11.63 109.924 174.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 52' ' ' GLU . 68.9 p -109.14 157.38 18.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.536 0.684 . . . . 9.15 112.133 -171.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.69 157.0 28.42 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.224 -1.15 . . . . 6.81 110.224 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.0 pt -105.01 141.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 117.097 0.448 . . . . 10.17 110.646 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.511 HG13 HD11 ' A' ' 45' ' ' LEU . 41.6 mm -74.37 123.45 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 110.067 -0.346 . . . . 8.73 110.067 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.68 -34.5 17.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.333 0.494 . . . . 10.86 112.333 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.5 ' HA ' HD12 ' A' ' 47' ' ' ILE . 1.9 tmtp? -160.74 130.4 4.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.947 0.404 . . . . 14.06 111.059 -175.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.488 ' H ' HD11 ' A' ' 47' ' ' ILE . 3.0 mm? -91.55 106.55 18.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.854 -0.612 . . . . 11.73 110.796 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 5.3 mp -96.93 179.77 4.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.763 -0.829 . . . . 11.36 108.763 174.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -89.81 116.11 27.66 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.268 -0.573 . . . . 15.94 110.434 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.4 t 78.54 -14.0 0.91 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.298 0.999 . . . . 13.01 111.635 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 10.1 p90 -145.45 162.97 36.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.187 -0.301 . . . . 12.34 110.187 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.67 177.22 33.72 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.67 -0.776 . . . . 7.52 112.125 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -126.68 148.49 49.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 9.24 110.914 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.7 mt -108.87 126.21 65.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.571 -0.741 . . . . 7.75 109.666 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.22 143.2 47.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.426 0.631 . . . . 11.8 110.766 -175.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.7 p -77.04 6.04 7.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.068 -0.969 . . . . 12.34 111.942 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -49.57 -39.97 36.85 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.077 0.399 . . . . 13.33 112.077 -173.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -116.91 6.38 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.835 -0.346 . . . . 11.9 111.4 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.622 ' HD3' ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -120.41 141.31 50.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.533 -0.543 . . . . 12.99 109.533 -173.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.622 ' N ' ' HD3' ' A' ' 27' ' ' ARG . 27.7 mm-40 -77.04 26.01 0.15 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.064 -0.397 . . . . 16.66 111.484 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB3' HH11 ' A' ' 27' ' ' ARG . . . 178.99 145.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.575 0.75 . . . . 12.09 109.333 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.523 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.9 OUTLIER -86.9 132.37 33.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.557 -0.534 . . . . 12.51 109.557 174.521 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.52 162.39 19.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.209 0.528 . . . . 8.76 111.636 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -116.16 147.98 40.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.486 -0.779 . . . . 9.15 109.882 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -150.22 172.92 14.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.77 -0.456 . . . . 6.85 109.77 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 16.9 p80 -135.06 165.79 24.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 9.99 111.172 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -66.29 -18.95 65.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.835 -0.621 . . . . 9.93 111.896 -173.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t -86.27 2.36 47.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.546 -0.297 . . . . 12.28 110.837 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 36.6 tp60 -110.74 -30.16 7.69 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.774 -0.454 . . . . 10.62 109.774 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -77.35 121.55 23.91 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.875 -0.602 . . . . 8.78 109.956 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.44 ' HB2' ' CG ' ' A' ' 68' ' ' GLN . 34.1 t -97.07 139.99 32.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.196 0.522 . . . . 8.97 110.528 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.41 -169.15 14.51 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.635 -0.793 . . . . 9.98 112.573 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -72.9 110.73 7.43 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.363 0.601 . . . . 12.43 111.068 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -77.75 -20.65 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.372 -0.831 . . . . 11.58 109.998 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.75 -31.63 72.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 14.73 110.401 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -97.02 24.53 6.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.815 -0.63 . . . . 13.3 110.768 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.511 HD11 HG13 ' A' ' 12' ' ' ILE . 3.2 tm? -113.19 120.79 42.44 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.007 -1.108 . . . . 10.07 108.007 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.29 176.49 8.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.628 0.252 . . . . 13.13 110.816 -170.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 14' ' ' LYS . 31.4 mm -70.63 128.25 33.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.562 -0.29 . . . . 11.74 110.26 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.13 11.09 67.82 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.322 -0.942 . . . . 10.13 112.611 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.45 121.35 71.21 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.972 -0.381 . . . . 8.39 109.972 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.48 125.3 9.51 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.564 2.176 . . . . 7.28 112.712 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 71' ' ' LYS . 34.0 m -124.61 152.96 31.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.78 -0.645 . . . . 4.74 109.65 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.551 ' HB3' HG22 ' A' ' 9' ' ' THR . 13.8 pt-20 -114.46 131.05 56.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.323 0.582 . . . . 7.09 109.752 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -137.67 172.73 12.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.371 0.605 . . . . 7.82 111.701 -172.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -118.4 133.69 55.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.189 -1.041 . . . . 11.59 108.189 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.9 ttt -100.7 122.53 43.49 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.283 -0.266 . . . . 12.41 110.283 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.3 p -135.09 144.25 47.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.413 0.625 . . . . 13.17 111.253 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -90.6 109.66 20.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.691 . . . . 16.21 109.16 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 60' ' ' ARG . 11.1 t70 -65.02 117.93 8.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.825 -0.625 . . . . 16.64 111.618 -174.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 -80.12 -12.25 59.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.175 -0.92 . . . . 22.64 111.712 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HB2' ' OD1' ' A' ' 58' ' ' ASP . 0.1 OUTLIER -73.82 -57.81 3.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.886 0.374 . . . . 21.43 110.397 -176.605 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.3 p -104.68 -39.43 6.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.074 -0.512 . . . . 17.4 111.117 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.87 16.85 7.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.511 -0.852 . . . . 16.7 112.825 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -101.34 148.31 35.0 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.156 -0.313 . . . . 14.73 110.156 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -79.63 125.22 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.675 1.583 . . . . 12.6 110.358 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.3 pt -128.87 162.91 35.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.483 0.659 . . . . 11.73 111.553 -175.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.46 161.97 13.25 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.977 -1.01 . . . . 8.91 108.635 170.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 69' ' ' VAL . 26.3 t -75.39 -153.29 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.222 -0.288 . . . . 9.83 110.222 177.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -67.82 -4.02 11.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.798 0.666 . . . . 11.32 112.798 -173.133 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 67' ' ' SER . 42.3 t 50.93 86.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.538 0.685 . . . . 6.11 111.56 176.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -97.23 129.86 44.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.836 -0.62 . . . . 6.12 110.649 -174.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.458 ' HA ' HG12 ' A' ' 51' ' ' VAL . 35.9 mtmm -67.61 141.21 56.84 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.157 -0.682 . . . . 6.3 109.157 175.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.12 95.62 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 5.77 111.318 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -163.56 136.59 4.21 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.309 -0.859 . . . . 5.69 109.395 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.39 135.32 22.17 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.524 2.149 . . . . 6.86 112.685 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.64 -141.39 0.36 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.34 -0.391 . . . . 8.49 110.239 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.537 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 3.2 p -64.92 164.16 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.206 0.526 . . . . 6.19 111.016 -177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.642 HG12 ' H ' ' A' ' 79' ' ' SER . 46.7 t -85.37 118.97 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.915 -0.584 . . . . 6.26 111.856 -175.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HG ' ' CE1' ' A' ' 155' ' ' HIS . 10.7 mp -97.19 13.57 28.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.106 -0.497 . . . . 6.05 110.548 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.642 ' H ' HG12 ' A' ' 77' ' ' VAL . 21.1 m -116.48 -112.2 0.34 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.168 -0.469 . . . . 7.02 110.532 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 81' ' ' GLU . 6.3 tt0 57.82 33.05 22.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.098 0.559 . . . . 7.07 111.143 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 80' ' ' GLU . 10.3 tp10 76.0 117.51 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.222 -0.899 . . . . 6.68 111.126 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -77.71 90.88 4.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.662 0.744 . . . . 6.43 110.159 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.65 160.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.496 -0.775 . . . . 3.7 111.226 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 p -107.86 139.52 42.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.542 -0.754 . . . . 3.49 109.924 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.36 161.26 24.41 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.515 -0.85 . . . . 2.58 112.479 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -116.96 125.01 50.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.483 -0.562 . . . . 3.34 109.483 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 58.1 t -68.5 123.68 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 108.973 -0.751 . . . . 3.14 108.973 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.0 p -105.08 -20.3 13.56 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.623 -0.431 . . . . 3.61 111.066 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -151.83 126.18 9.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.273 -0.421 . . . . 3.12 110.258 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.27 -172.68 4.12 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.951 -0.388 . . . . 4.39 109.951 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.476 HD22 ' HG3' ' A' ' 124' ' ' LYS . 5.3 mp -88.89 146.24 25.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.284 -0.636 . . . . 3.62 109.284 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -109.59 152.58 25.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.322 0.582 . . . . 7.2 111.438 -172.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 99' ' ' VAL . 1.3 p -84.16 138.43 33.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.194 -0.912 . . . . 5.1 111.309 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.47 -63.75 1.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.917 -0.583 . . . . 7.53 109.726 173.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.8 m -101.96 -177.5 3.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.598 -0.728 . . . . 7.47 109.993 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -94.74 -23.49 17.52 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.87 0.322 . . . . 7.58 111.87 -176.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -91.74 4.33 53.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.954 0.353 . . . . 8.32 111.954 -173.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -154.91 155.18 33.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.468 0.651 . . . . 7.26 111.719 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.479 ' HA ' HG22 ' A' ' 93' ' ' THR . 7.9 p -110.45 9.76 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 122.418 1.104 . . . . 5.54 109.534 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -148.41 105.3 3.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.595 -1.184 . . . . 7.28 110.065 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -133.81 -50.0 0.83 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.293 -0.867 . . . . 7.54 109.521 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.2 t -123.1 149.07 44.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 5.41 109.746 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.2 m -96.06 1.56 52.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.421 -0.354 . . . . 4.58 110.997 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.31 -14.04 61.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 5.09 111.083 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -82.27 112.08 18.94 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.408 0.623 . . . . 3.33 109.341 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 t -122.09 148.76 44.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.71 -0.677 . . . . 2.57 110.631 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.03 163.41 39.74 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.671 -0.971 . . . . 1.66 110.671 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -125.27 128.42 48.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.965 0.412 . . . . 3.03 110.886 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 71.6 mt -112.88 125.46 70.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.909 -0.587 . . . . 1.88 109.506 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.8 t -100.17 137.89 37.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.838 -0.43 . . . . 3.49 109.838 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.526 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -148.8 167.48 25.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.527 0.203 . . . . 3.51 110.549 -178.703 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.38 127.93 56.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.366 -0.379 . . . . 5.1 110.446 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -152.85 130.12 11.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.604 -0.517 . . . . 4.78 109.604 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 64.74 20.85 12.25 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.427 0.455 . . . . 6.97 111.168 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.57 18.73 79.68 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.778 -0.725 . . . . 5.1 111.868 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -121.21 144.92 48.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.628 -0.508 . . . . 5.38 109.628 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 11.4 p -122.98 115.49 21.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.277 -0.42 . . . . 4.72 110.265 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -132.19 157.4 44.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.251 -0.431 . . . . 4.61 110.528 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -99.77 129.25 45.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 3.96 109.819 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 111' ' ' TYR . 4.2 mp -105.03 143.39 26.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 110.133 -0.321 . . . . 2.75 110.133 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 3.3 Cg_exo -80.11 148.56 19.34 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.511 2.141 . . . . 2.3 112.036 175.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -155.19 144.57 21.13 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.029 -0.73 . . . . 2.13 109.029 173.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.8 p -113.11 -175.59 2.7 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.67 0.272 . . . . 3.07 110.489 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.476 ' HG3' HD22 ' A' ' 91' ' ' LEU . 55.2 mttp -65.76 -27.97 68.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.24 0.543 . . . . 4.8 110.183 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -75.16 -22.92 57.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.211 -0.904 . . . . 4.81 111.598 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -83.13 -11.25 58.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 3.84 111.86 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 p -119.98 106.55 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.441 0.639 . . . . 4.39 111.37 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -108.26 150.25 27.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.779 -0.646 . . . . 6.43 110.102 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 125.39 16.93 2.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.913 -0.66 . . . . 5.91 112.943 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.9 t30 64.25 22.62 12.88 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.447 0.642 . . . . 6.07 110.454 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.2 130.54 35.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.946 -0.57 . . . . 5.27 110.929 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -111.61 111.56 22.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 5.78 110.148 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 133' ' ' LEU . 5.5 mp -98.97 149.83 22.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 3.62 110.939 -176.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -146.52 121.14 9.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.475 -0.565 . . . . 6.93 109.475 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -46.68 131.57 11.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.83 -0.623 . . . . 4.12 112.532 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.22 -12.69 14.15 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.126 -0.943 . . . . 4.07 111.192 -172.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -89.64 174.9 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 4.06 110.482 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -121.86 118.69 29.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.346 0.594 . . . . 4.17 110.147 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.7 m -121.19 159.07 23.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.314 -0.857 . . . . 2.77 111.264 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.9 m -109.73 137.82 46.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.622 -0.717 . . . . 3.47 109.22 173.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -139.79 139.21 36.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.024 0.44 . . . . 3.35 110.114 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -97.2 121.08 38.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.949 -0.569 . . . . 5.34 109.532 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.05 107.91 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 4.66 110.122 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.537 ' HB1' ' CG2' ' A' ' 76' ' ' VAL . . . -94.87 107.98 20.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.07 -0.514 . . . . 4.85 110.995 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.546 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 50.9 m -85.38 109.41 18.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.691 . . . . 5.68 111.075 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -74.76 159.29 32.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.316 -0.624 . . . . 6.25 109.316 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -57.77 -24.91 59.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 122.451 0.3 . . . . 8.58 111.693 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.615 ' HD2' ' OD1' ' A' ' 150' ' ' ASN . 1.3 tmt_? -69.81 -21.03 63.43 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.184 0.516 . . . . 7.86 110.116 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.41 2.76 61.69 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.882 -0.675 . . . . 5.59 112.107 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.615 ' OD1' ' HD2' ' A' ' 148' ' ' ARG . 15.1 m120 -99.73 135.92 40.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.632 -0.507 . . . . 5.18 109.632 177.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -145.34 174.44 11.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.062 0.458 . . . . 4.28 111.332 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.32 -160.83 10.7 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.995 -0.842 . . . . 3.36 110.995 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.6 109.79 22.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.123 0.487 . . . . 2.84 110.54 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 38.1 m -131.56 176.62 8.16 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.141 -0.688 . . . . 4.34 109.141 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.496 ' CE1' ' HG ' ' A' ' 78' ' ' LEU . 13.9 m80 58.47 38.6 25.54 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.317 -0.623 . . . . 5.75 109.317 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.3 mt -79.48 128.76 38.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.173 -0.921 . . . . 3.55 111.137 -169.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -134.73 140.86 46.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.281 0.562 . . . . 5.96 110.349 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.6 tp -103.97 105.76 16.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.828 -0.624 . . . . 4.34 109.906 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -109.74 -24.64 10.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.063 -0.517 . . . . 4.97 111.297 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -117.79 86.12 23.78 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.209 -0.45 . . . . 5.37 110.821 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.34 156.21 14.51 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.54 2.16 . . . . 5.44 111.772 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.8 108.56 20.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.288 -0.415 . . . . 6.1 110.685 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -130.66 151.95 79.63 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.584 -0.28 . . . . 9.49 110.696 176.466 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 163' ' ' GLN . 13.4 Cg_exo -70.71 126.63 12.88 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.436 2.091 . . . . 8.39 111.959 177.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 10.27 111.028 -179.109 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 112.107 -0.397 . . . . 21.66 112.107 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 170.64 -49.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.493 0.717 . . . . 20.17 110.208 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -116.16 5.84 13.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.337 -0.847 . . . . 18.5 111.066 -172.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -133.53 35.5 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.501 -0.318 . . . . 16.62 110.748 -173.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -67.12 -90.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.738 0.644 . . . . 18.35 112.738 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.02 141.08 36.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.835 0.35 . . . . 16.2 110.301 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HG2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.36 99.89 5.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.731 -0.668 . . . . 12.4 111.061 178.21 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.76 153.56 21.6 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.098 -0.704 . . . . 11.63 109.098 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.515 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 20.3 p -86.52 161.36 18.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.066 0.46 . . . . 9.15 111.736 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.22 162.73 32.02 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.433 -0.667 . . . . 6.81 111.433 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 pt -113.9 148.57 16.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.724 0.262 . . . . 10.17 110.43 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.0 mm -75.28 123.4 31.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.513 -0.312 . . . . 8.73 110.687 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.53 ' OE2' ' HB3' ' A' ' 21' ' ' PHE . 29.1 mt-10 -72.53 -46.05 56.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.054 -0.521 . . . . 10.86 111.219 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.12 146.94 17.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.023 -0.535 . . . . 14.06 110.084 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.51 105.25 17.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.927 -0.579 . . . . 11.73 110.695 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 2.6 mm? -106.71 179.09 4.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.752 -0.833 . . . . 11.36 108.752 174.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -91.64 129.37 37.62 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.714 -0.394 . . . . 15.94 110.223 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.3 m 76.25 -37.79 0.31 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 124.152 0.907 . . . . 13.01 112.083 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 46.8 p90 -126.98 153.37 45.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.898 0.38 . . . . 12.34 111.081 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.4 165.95 26.24 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.03 -0.828 . . . . 7.52 111.03 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.53 ' HB3' ' OE2' ' A' ' 13' ' ' GLU . 91.5 m-85 -115.21 146.16 41.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.225 0.513 . . . . 9.24 111.459 -177.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.52 HG21 ' CE2' ' A' ' 53' ' ' PHE . 61.6 mt -117.71 127.15 75.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 7.75 110.338 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.419 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -78.22 133.14 37.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.588 0.708 . . . . 11.8 111.962 -172.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.5 p -81.22 -1.09 43.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.855 -1.066 . . . . 12.34 113.229 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -60.94 -43.18 99.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.085 0.469 . . . . 13.33 111.342 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' OE1' ' HB3' ' A' ' 128' ' ' GLU . 7.2 tp10 -90.28 -9.14 49.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.043 0.925 . . . . 11.9 109.747 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 9' ' ' THR . 1.1 mmt180 -112.29 -167.58 1.2 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.83 -1.077 . . . . 12.99 110.462 -174.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.61 21.62 6.0 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.147 -0.686 . . . . 16.66 109.147 171.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' H ' ' HB3' ' A' ' 27' ' ' ARG . . . -166.05 128.21 1.93 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.922 -1.035 . . . . 12.09 110.169 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -85.91 140.24 30.53 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.831 -0.803 . . . . 12.51 108.831 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.1 mt -145.59 161.32 40.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.106 0.479 . . . . 8.76 111.89 -175.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -120.96 130.15 53.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.363 -0.835 . . . . 9.15 108.767 172.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -119.21 157.37 28.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.922 -0.399 . . . . 6.85 109.922 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -108.19 151.99 25.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.324 -0.398 . . . . 9.99 110.051 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -57.76 -26.41 61.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.275 0.842 . . . . 9.93 113.275 -172.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.2 t -68.7 -13.54 62.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.181 0.515 . . . . 12.28 110.898 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -113.66 38.96 2.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.056 -0.52 . . . . 10.62 110.145 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -127.17 117.36 22.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.165 -0.47 . . . . 8.78 109.904 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 68' ' ' GLN . 22.5 t -79.71 91.85 5.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.544 -0.753 . . . . 8.97 110.225 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.91 -163.3 27.7 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.797 -0.716 . . . . 9.98 112.465 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -86.3 112.51 21.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.818 -0.438 . . . . 12.43 109.818 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -28.91 40.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.678 0.275 . . . . 11.58 111.556 -174.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -75.33 -13.36 60.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.426 0.631 . . . . 14.73 109.671 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -95.61 6.8 48.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.588 -0.733 . . . . 13.3 110.334 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.8 tp -94.43 125.81 39.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.738 -0.665 . . . . 10.07 110.026 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.524 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 2.6 mppt? -103.2 167.74 9.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.205 0.526 . . . . 13.13 110.841 -174.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.5 mt -84.5 114.68 25.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.814 -0.63 . . . . 11.74 109.688 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.74 9.4 43.36 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.259 -0.736 . . . . 10.13 111.259 -170.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -79.55 124.52 83.78 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 109.532 -0.544 . . . . 8.39 109.532 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.581 ' HB2' HD12 ' A' ' 72' ' ' ILE . 86.1 Cg_endo -82.39 129.22 5.77 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.847 2.364 . . . . 7.28 113.621 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.4 166.27 29.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 4.74 111.097 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.49 ' HB3' HG22 ' A' ' 9' ' ' THR . 7.7 pt-20 -122.58 124.89 44.54 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.578 -0.527 . . . . 7.09 109.578 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CE2' HG21 ' A' ' 22' ' ' ILE . 54.3 p90 -133.0 149.75 52.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.109 0.48 . . . . 7.82 111.349 -172.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HG3' ' HG2' ' A' ' 7' ' ' ARG . 2.6 mp0 -88.72 149.46 23.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.019 -0.992 . . . . 11.59 110.361 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.05 121.69 42.97 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.328 -0.619 . . . . 12.41 109.328 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.5 p -138.9 172.08 13.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.398 . . . . 13.17 111.265 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -125.75 125.33 42.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.333 -0.394 . . . . 16.21 110.573 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.59 124.96 34.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.066 0.46 . . . . 16.64 110.542 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -79.97 -25.26 40.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.791 -0.64 . . . . 22.64 111.404 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -70.85 -57.54 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.559 -0.292 . . . . 21.43 111.233 -172.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.0 p -91.46 -28.54 17.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.962 0.41 . . . . 17.4 110.559 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.98 11.01 57.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 16.7 112.741 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 131.32 31.35 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 122.815 -0.226 . . . . 14.73 110.442 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.02 126.43 15.82 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.257 1.971 . . . . 12.6 109.93 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 30.2 pt -126.52 147.67 31.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.411 0.624 . . . . 11.73 111.63 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.24 155.04 18.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.022 -0.99 . . . . 8.91 108.433 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.475 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 39.1 t -75.26 -151.29 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.338 0.399 . . . . 9.83 110.496 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 39' ' ' SER . 2.5 mp0 -67.9 -10.28 51.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.248 0.462 . . . . 11.32 112.248 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.3 t 56.56 96.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.489 0.661 . . . . 6.11 111.198 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 t -93.77 147.7 22.8 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.603 -0.518 . . . . 6.12 109.603 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -81.51 157.5 24.81 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.434 -0.58 . . . . 6.3 109.434 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' A' ' 50' ' ' PRO . 24.6 mt -73.97 85.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.375 0.607 . . . . 5.77 109.905 177.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.98 87.43 33.88 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.416 -0.811 . . . . 5.69 110.204 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.7 164.57 20.66 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.813 2.342 . . . . 6.86 111.781 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.42 -20.83 60.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.739 0.78 . . . . 8.49 109.588 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.2 t -83.5 135.59 24.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.945 -1.025 . . . . 6.19 108.831 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 47.5 t -68.49 103.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 6.26 111.531 -174.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -78.71 83.21 4.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.764 -0.653 . . . . 6.05 109.743 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 p 23.44 96.37 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.96 1.467 . . . . 7.02 114.96 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.73 -30.55 71.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.525 0.679 . . . . 7.07 109.533 171.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -108.68 117.71 34.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.081 -0.963 . . . . 6.68 109.947 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -81.4 144.71 31.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.354 -0.385 . . . . 6.43 109.968 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.91 152.95 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.342 0.591 . . . . 3.7 111.111 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.1 p -114.94 145.7 41.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.607 -0.724 . . . . 3.49 110.086 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.99 165.77 24.54 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.347 -0.93 . . . . 2.58 112.648 -177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 m -118.82 130.18 55.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.457 -0.571 . . . . 3.34 109.457 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.669 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 3.1 t -73.64 123.4 28.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.015 -0.365 . . . . 3.14 110.015 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.6 p -101.34 -22.48 14.58 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.143 0.497 . . . . 3.61 109.979 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.8 m -140.29 118.42 11.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.497 -0.774 . . . . 3.12 109.898 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 92' ' ' ARG . 7.2 pt-20 -97.83 163.77 12.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.093 0.473 . . . . 4.39 110.895 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.9 mt -83.84 108.23 16.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.751 -0.658 . . . . 3.62 110.498 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.575 ' HG2' ' H ' ' A' ' 93' ' ' THR . 21.0 ttm180 -134.65 -175.93 4.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.658 -0.497 . . . . 7.2 109.658 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.575 ' H ' ' HG2' ' A' ' 92' ' ' ARG . 17.8 p -90.2 156.76 18.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.864 0.364 . . . . 5.1 111.841 -175.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.09 -33.2 18.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 7.53 109.625 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.0 t -138.94 -70.06 0.42 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.329 -0.85 . . . . 7.47 109.599 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.08 -44.5 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.421 -0.354 . . . . 7.58 110.579 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 99' ' ' VAL . 83.1 m-20 -119.34 -136.38 0.34 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.584 -0.895 . . . . 8.32 108.584 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.9 t30 69.59 -23.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.787 0.835 . . . . 7.26 112.259 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.747 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 7.6 p -55.09 126.58 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.817 -0.174 . . . . 5.54 110.783 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 99' ' ' VAL . 4.4 pp 57.79 7.4 0.57 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.465 1.106 . . . . 7.28 113.066 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -74.97 -27.57 60.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.574 0.702 . . . . 7.54 109.627 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.1 t -150.53 159.37 44.53 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.371 -0.832 . . . . 5.41 109.008 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.2 t -82.96 44.77 0.95 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.488 0.661 . . . . 4.58 110.327 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -99.75 2.44 44.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.593 -0.731 . . . . 5.09 109.854 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -139.89 141.42 36.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.687 -0.688 . . . . 3.33 109.366 175.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.4 t -146.89 149.11 32.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.679 -0.489 . . . . 2.57 109.679 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 122' ' ' TYR . . . -85.71 168.35 41.55 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.445 -0.883 . . . . 1.66 111.928 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -125.66 120.66 31.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.629 0.252 . . . . 3.03 110.657 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 82.8 mt -110.98 127.17 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.337 -0.616 . . . . 1.88 109.337 174.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.9 p -106.42 129.52 54.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.231 -0.441 . . . . 3.49 110.813 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.523 ' CE2' HD11 ' A' ' 120' ' ' LEU . 1.2 p90 -146.68 166.52 26.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.265 -0.643 . . . . 3.51 109.265 175.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.429 ' HG2' ' SG ' ' A' ' 117' ' ' CYS . 43.8 mt-10 -107.28 121.66 45.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.17 0.509 . . . . 5.1 111.18 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -116.36 114.1 23.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.454 -0.794 . . . . 4.78 109.069 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 64.84 21.01 12.28 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.978 0.511 . . . . 6.97 110.65 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.3 66.15 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.014 -0.539 . . . . 5.1 112.045 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -102.63 129.05 49.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.888 0.375 . . . . 5.38 110.887 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.429 ' SG ' ' HG2' ' A' ' 112' ' ' GLU . 62.9 m -81.78 124.95 30.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.202 -0.454 . . . . 4.72 110.332 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -121.38 147.13 46.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.225 -0.443 . . . . 4.61 110.491 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.85 123.22 49.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 3.96 109.845 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.523 HD11 ' CE2' ' A' ' 111' ' ' TYR . 4.9 mp -105.38 134.88 19.46 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.262 -0.273 . . . . 2.75 110.262 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.57 133.15 11.48 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.966 2.444 . . . . 2.3 111.381 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.402 ' CE1' ' HA3' ' A' ' 107' ' ' GLY . 12.7 p90 -144.81 147.76 33.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.789 -0.448 . . . . 2.13 109.789 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.2 p -112.95 -179.94 3.79 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.845 -0.428 . . . . 3.07 109.845 173.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -72.76 -20.22 61.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.24 0.543 . . . . 4.8 110.867 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.77 -4.8 58.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.79 -0.641 . . . . 4.81 111.23 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -89.45 -13.5 37.45 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.138 0.494 . . . . 3.84 110.58 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 156' ' ' ILE . 2.8 p -110.48 116.19 51.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.716 0.769 . . . . 4.39 111.124 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.43 ' HB3' ' OE1' ' A' ' 26' ' ' GLU . 1.1 mp0 -99.72 179.02 4.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.786 -1.097 . . . . 6.43 109.997 177.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.55 -10.78 64.93 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.569 -0.824 . . . . 5.91 112.315 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 66.46 25.46 10.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.88 0.472 . . . . 6.07 111.388 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -103.55 140.93 20.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.635 -0.257 . . . . 5.27 110.866 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -97.51 129.14 44.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.064 0.459 . . . . 5.78 110.239 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.633 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -115.33 149.56 37.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.859 -0.61 . . . . 3.62 110.075 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -124.23 174.44 7.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.16 0.505 . . . . 6.93 109.992 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.669 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.97 122.06 22.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.269 0.557 . . . . 4.12 111.442 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.04 -14.88 13.68 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.595 -0.812 . . . . 4.07 113.622 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -86.58 -177.55 6.18 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 117.901 0.85 . . . . 4.06 110.687 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -116.85 115.46 25.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.195 0.521 . . . . 4.17 111.815 -174.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.86 162.36 15.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.633 -0.712 . . . . 2.77 110.985 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 45.8 t -126.37 129.47 48.87 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.612 -0.885 . . . . 3.47 108.612 177.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.0 146.99 50.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.071 0.462 . . . . 3.35 110.488 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -106.18 112.81 26.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.736 -0.665 . . . . 5.34 109.919 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.72 100.63 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.496 -0.775 . . . . 4.66 111.539 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -83.01 111.05 18.5 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.731 -0.47 . . . . 4.85 109.731 173.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 21.1 m -86.72 116.12 24.61 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.802 -0.635 . . . . 5.68 111.309 -174.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -74.44 166.14 24.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 6.25 110.398 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.1 -32.58 73.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 8.58 111.856 -173.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 3.3 tmt_? -76.23 -22.9 54.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 7.86 110.382 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.68 11.78 42.92 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.575 -0.821 . . . . 5.59 112.766 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -114.49 127.34 55.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.794 -0.239 . . . . 5.18 110.384 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -147.63 -176.92 5.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.094 0.474 . . . . 4.28 111.672 -173.684 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -139.27 -143.56 4.43 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.92 -0.872 . . . . 3.36 110.92 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.76 110.52 14.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.143 0.472 . . . . 2.84 109.963 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 45.6 t -122.78 162.14 22.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.563 -0.532 . . . . 4.34 109.563 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 56.56 37.87 29.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.162 0.506 . . . . 5.75 110.748 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 127' ' ' VAL . 69.5 mt -61.53 115.69 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.32 -0.855 . . . . 3.55 110.382 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 140' ' ' SER . 0.7 OUTLIER -111.56 143.84 41.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.979 0.418 . . . . 5.96 110.58 -176.525 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.4 tp -103.48 93.36 4.9 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.194 -0.669 . . . . 4.34 109.194 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.1 -28.4 15.1 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.739 -0.385 . . . . 4.97 110.958 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -114.86 84.02 10.0 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.451 -0.574 . . . . 5.37 109.451 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.93 158.75 18.37 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.943 2.429 . . . . 5.44 113.185 -174.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -91.26 103.64 16.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.74 -0.664 . . . . 6.1 110.174 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.419 ' H ' ' CD ' ' A' ' 163' ' ' GLN . 5.3 pm0 -69.3 155.06 94.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.125 -0.489 . . . . 9.49 110.411 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.57 114.1 1.32 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.056 2.504 . . . . 8.39 113.055 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.572 -0.74 . . . . 10.27 110.687 179.208 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.542 0.687 . . . . 12.4 109.409 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.52 ' HB3' ' HG2' ' A' ' 27' ' ' ARG . 42.7 mt-10 -120.26 143.52 48.27 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.771 -0.649 . . . . 11.63 110.356 -174.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -110.87 144.36 40.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.439 . . . . 9.15 111.05 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.78 172.63 31.84 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.363 -0.922 . . . . 6.81 112.15 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.0 mt -120.8 133.99 65.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 110.083 -0.34 . . . . 10.17 110.083 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.04 112.79 11.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.536 -0.542 . . . . 8.73 109.536 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 11.8 tp10 -91.54 -29.95 16.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.799 -0.637 . . . . 10.86 110.988 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -159.77 128.33 5.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.039 -0.528 . . . . 14.06 109.62 -175.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 mt -99.45 126.8 45.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.178 0.513 . . . . 11.73 111.17 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.06 179.26 4.32 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.232 -1.025 . . . . 11.36 108.232 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -91.09 112.53 24.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.503 -0.554 . . . . 15.94 109.503 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 t 70.28 23.85 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.332 -0.849 . . . . 13.01 110.564 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -164.67 151.57 11.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.98 -0.555 . . . . 12.34 109.656 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -162.19 165.37 35.94 Favored Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.349 -0.929 . . . . 7.52 112.669 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -117.18 134.13 55.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.686 0.279 . . . . 9.24 111.486 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.407 HG21 ' CE2' ' A' ' 53' ' ' PHE . 75.6 mt -106.37 122.84 60.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 7.75 110.058 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.493 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 6.5 mm100 -83.8 147.98 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.533 0.938 . . . . 11.8 113.533 -175.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.2 p -77.94 6.59 7.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.811 -1.54 . . . . 12.34 113.302 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -49.87 -48.66 51.19 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.584 0.587 . . . . 13.33 112.584 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.4 -3.51 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.735 -0.386 . . . . 11.9 112.005 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 28.4 tpt180 -152.48 139.38 19.03 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.991 -0.374 . . . . 12.99 109.991 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -73.03 49.81 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.984 0.364 . . . . 16.66 111.984 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.22 127.86 12.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.933 0.397 . . . . 12.09 111.201 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -108.66 102.31 11.38 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.312 -0.625 . . . . 12.51 109.312 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.47 HD12 ' CE1' ' A' ' 53' ' ' PHE . 71.1 mt -109.91 135.7 50.37 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.876 0.369 . . . . 8.76 111.332 -176.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -91.57 125.36 36.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.139 -0.689 . . . . 9.15 109.139 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -118.13 147.89 42.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.885 0.374 . . . . 6.85 110.518 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -99.08 158.88 15.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.208 -0.451 . . . . 9.99 109.939 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -70.83 -12.42 61.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.058 0.392 . . . . 9.93 112.058 -174.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -81.09 -13.3 58.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.31 0.576 . . . . 12.28 109.895 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -103.94 29.33 5.95 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.652 -0.704 . . . . 10.62 110.771 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -126.31 128.45 47.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.016 0.436 . . . . 8.78 110.949 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 t -101.36 115.65 31.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.716 -0.675 . . . . 8.97 110.818 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.65 -156.19 21.53 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.787 -0.72 . . . . 9.98 112.278 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -89.73 113.62 25.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.854 0.359 . . . . 12.43 110.621 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -68.11 -24.28 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.29 0.567 . . . . 11.58 109.921 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -81.51 -2.61 50.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.768 -0.651 . . . . 14.73 110.369 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -112.94 15.7 19.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.454 0.645 . . . . 13.3 109.716 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.8 tp -103.49 134.0 47.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.51 -0.922 . . . . 10.07 108.51 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HG3' ' HB2' ' A' ' 49' ' ' ASP . 21.2 ptmt -133.75 170.13 16.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.9 0.381 . . . . 13.13 111.116 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.0 mp -81.15 119.24 30.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.971 -0.559 . . . . 11.74 109.565 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.48 36.65 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.322 -0.711 . . . . 10.13 111.322 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.422 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 14.7 t70 -92.93 127.26 48.27 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.442 -0.379 . . . . 8.39 110.143 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -89.31 128.91 1.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.062 2.508 . . . . 7.28 112.929 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.49 161.05 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.166 -0.47 . . . . 4.74 111.207 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.42 128.69 56.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.848 -0.614 . . . . 7.09 109.516 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.47 ' CE1' HD12 ' A' ' 31' ' ' LEU . 44.5 p90 -132.14 155.58 47.9 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.097 0.475 . . . . 7.82 111.204 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 38.1 tt0 -103.24 120.76 41.34 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.611 -0.722 . . . . 11.59 109.592 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.17 116.33 28.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.116 -0.493 . . . . 12.41 109.853 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 p -139.96 153.29 46.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.103 0.477 . . . . 13.17 111.73 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -92.86 108.95 20.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.964 -0.562 . . . . 16.21 109.944 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.508 ' OD2' HG22 ' A' ' 61' ' ' THR . 14.3 t70 -73.97 110.82 8.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.027 0.441 . . . . 16.64 109.835 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 59' ' ' ARG . 3.3 mmp_? -79.97 -7.2 58.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.059 -0.519 . . . . 22.64 111.2 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.455 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 54.3 ttt180 -70.86 -59.13 2.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 21.43 110.471 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.508 HG22 ' OD2' ' A' ' 58' ' ' ASP . 15.1 t -92.97 -19.26 21.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.25 -0.432 . . . . 17.4 110.44 178.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.57 31.54 15.71 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.856 -0.688 . . . . 16.7 112.492 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -132.63 149.28 72.58 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.036 -0.357 . . . . 14.73 110.036 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.52 126.79 8.51 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.079 1.853 . . . . 12.6 111.468 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.8 pt -130.65 168.75 22.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.321 0.581 . . . . 11.73 111.295 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.19 156.53 17.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.2 -0.909 . . . . 8.91 108.88 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 8.4 t -79.45 -150.9 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.399 -0.364 . . . . 9.83 110.101 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -8.87 51.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.649 0.611 . . . . 11.32 112.649 -172.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.2 t 55.88 99.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.471 0.653 . . . . 6.11 111.165 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 m -99.46 125.11 45.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.092 0.472 . . . . 6.12 111.12 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 71' ' ' LYS . 14.1 mmmt -60.16 135.77 57.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.788 -0.642 . . . . 6.3 109.744 172.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.1 mt . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 120.775 0.321 . . . . 5.77 110.791 -176.773 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.632 HG12 ' HB1' ' A' ' 144' ' ' ALA . 6.2 t . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.726 0.298 . . . . 6.19 110.41 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 79' ' ' SER . 43.4 t -97.5 134.12 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.306 -0.406 . . . . 6.26 110.548 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -75.15 16.41 0.32 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.685 0.279 . . . . 6.05 111.504 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.51 ' H ' HG12 ' A' ' 77' ' ' VAL . 8.3 t 66.53 -2.3 1.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.812 0.845 . . . . 7.02 111.842 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 62.58 13.76 6.53 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.274 0.63 . . . . 7.07 111.621 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -129.62 118.03 21.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.268 -0.424 . . . . 6.68 109.858 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -95.67 124.32 39.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.063 -0.517 . . . . 6.43 109.862 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.82 164.97 15.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.284 0.564 . . . . 3.7 111.452 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.8 p -125.88 148.28 49.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.292 -0.867 . . . . 3.49 109.774 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.09 161.09 25.54 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.224 -0.989 . . . . 2.58 112.37 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.7 m -102.24 125.61 49.0 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.408 -0.59 . . . . 3.34 109.408 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 51.0 t -68.11 126.23 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 110.189 -0.3 . . . . 3.14 110.189 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.3 p -113.7 -17.02 12.21 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.799 0.333 . . . . 3.61 111.844 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.2 m -150.95 135.03 16.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.282 -0.261 . . . . 3.12 110.597 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -100.0 171.22 7.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 4.39 110.508 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 91' ' ' LEU . 1.8 pt? . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 109.256 -0.646 . . . . 3.62 109.256 175.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.615 -0.513 . . . . 3.33 109.615 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 t -146.87 143.31 28.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.402 -0.363 . . . . 2.57 110.748 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -97.61 -162.38 31.36 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.723 -0.751 . . . . 1.66 111.918 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 82.9 mmt-85 -140.15 135.15 32.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.99 0.424 . . . . 3.03 111.15 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.26 130.7 68.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.657 -0.701 . . . . 1.88 109.444 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.7 t -109.35 116.3 31.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.86 -0.422 . . . . 3.49 109.86 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -122.57 132.76 54.45 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.411 -0.589 . . . . 3.51 109.411 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -107.05 109.73 21.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.788 -0.642 . . . . 5.1 109.49 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -163.99 147.74 9.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.86 -0.609 . . . . 4.78 110.438 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 62.53 21.01 12.36 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.441 0.463 . . . . 6.97 111.714 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.52 -0.97 87.21 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.732 -0.746 . . . . 5.1 111.99 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -101.89 139.09 37.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.074 0.464 . . . . 5.38 110.589 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 13.8 p -139.47 106.18 5.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.501 -0.772 . . . . 4.72 109.997 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -155.69 162.16 40.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.376 -0.375 . . . . 4.61 110.537 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -95.22 133.75 38.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.646 -0.706 . . . . 3.96 110.584 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 5.6 mp -106.25 130.77 22.44 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.448 -0.342 . . . . 2.75 110.636 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 13.1 Cg_exo -69.74 131.79 22.01 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.632 2.222 . . . . 2.3 111.246 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -138.78 145.39 40.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.978 0.418 . . . . 2.13 110.3 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 p -112.94 164.22 13.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.616 -0.72 . . . . 3.07 109.335 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -77.16 -20.06 56.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.885 0.328 . . . . 4.8 111.885 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.82 -13.83 61.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.897 0.332 . . . . 4.81 111.897 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 154' ' ' CYS . 7.2 t70 -101.11 -0.44 36.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.511 0.672 . . . . 3.84 110.161 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.5 t -82.38 107.32 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.223 0.535 . . . . 4.39 110.374 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.4 145.84 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.992 -0.549 . . . . 6.43 110.774 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.5 -15.98 59.4 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.672 -0.775 . . . . 5.91 112.074 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 62.28 34.8 15.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.102 0.477 . . . . 6.07 110.911 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.3 m -79.98 174.71 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.038 -0.528 . . . . 5.27 110.663 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -127.84 81.35 2.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.295 0.569 . . . . 5.78 110.238 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.3 pt? -68.44 148.91 49.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.207 -0.906 . . . . 3.62 111.09 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -133.21 139.81 47.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.287 -0.415 . . . . 6.93 109.961 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.626 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -55.62 121.32 8.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.164 0.506 . . . . 4.12 111.675 -173.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.65 -13.2 11.9 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.301 -0.863 . . . . 4.07 112.572 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -91.19 177.41 6.26 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.292 0.546 . . . . 4.06 109.864 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -116.97 116.58 27.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.089 0.471 . . . . 4.17 110.711 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.11 159.98 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.076 -0.511 . . . . 2.77 110.714 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.1 t -114.83 139.51 49.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.974 -0.75 . . . . 3.47 108.974 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -144.73 143.62 30.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.016 0.436 . . . . 3.35 110.149 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -98.95 119.2 37.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.579 -0.737 . . . . 5.34 109.937 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.8 mt -78.67 96.86 2.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.085 -0.507 . . . . 4.66 109.709 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.632 ' HB1' HG12 ' A' ' 76' ' ' VAL . . . -90.16 111.2 22.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.796 -0.638 . . . . 4.85 110.758 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 28.4 m -84.25 112.9 20.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.509 -0.769 . . . . 5.68 110.335 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.42 158.52 31.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.936 -0.574 . . . . 6.25 109.549 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -60.92 -20.27 61.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.99 0.424 . . . . 8.58 111.379 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 148' ' ' ARG . 2.7 mmt180 -78.26 -8.2 58.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 7.86 111.717 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.71 -1.96 84.48 Favored Glycine 0 C--O 1.227 -0.292 0 C-N-CA 120.824 -0.703 . . . . 5.59 112.328 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -100.4 132.4 45.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.902 -0.406 . . . . 5.18 109.902 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.481 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -150.76 178.78 8.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.534 -0.303 . . . . 4.28 110.847 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -150.36 -125.17 1.28 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.805 -0.918 . . . . 3.36 110.805 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -121.28 126.1 48.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.841 -0.429 . . . . 2.84 109.841 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.514 ' HA ' ' OD2' ' A' ' 126' ' ' ASP . 17.7 t -136.59 159.22 42.46 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.114 -0.328 . . . . 4.34 110.114 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 63.08 36.26 12.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.319 0.581 . . . . 5.75 110.558 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.8 mt -75.77 115.99 18.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.637 -0.711 . . . . 3.55 110.816 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -135.94 160.04 39.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.806 0.336 . . . . 5.96 110.165 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.9 tp -92.35 110.93 22.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 4.34 110.353 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -98.84 -57.55 2.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.782 -0.645 . . . . 4.97 110.686 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -111.17 96.63 31.39 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.244 -0.434 . . . . 5.37 110.022 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.14 158.25 23.45 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.233 1.956 . . . . 5.44 113.114 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.578 -0.737 . . . . 6.1 109.775 175.555 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 120.998 0.428 . . . . 12.4 109.969 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.464 ' CD ' ' HE ' ' A' ' 27' ' ' ARG . 6.3 mm-40 -98.13 136.77 37.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.106 -0.497 . . . . 11.63 109.886 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 67.2 p -109.33 138.69 45.3 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 121.102 -0.239 . . . . 9.15 110.593 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 26' ' ' GLU . . . -150.86 -176.03 23.38 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.147 -1.025 . . . . 6.81 112.45 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.0 mt -132.43 155.41 41.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.336 -0.987 . . . . 10.17 108.336 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.76 118.86 34.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.508 -0.477 . . . . 8.73 110.387 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.586 ' OE1' ' HD2' ' A' ' 30' ' ' ARG . 5.8 pt-20 -82.58 -32.59 28.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.376 -0.374 . . . . 10.86 111.089 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -159.19 158.15 32.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.28 -0.418 . . . . 14.06 109.899 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -125.44 118.16 25.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.107 -0.497 . . . . 11.73 110.984 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -105.57 178.95 4.41 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.488 -1.301 . . . . 11.36 107.488 172.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -92.1 138.46 31.52 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 119.917 -0.713 . . . . 15.94 109.986 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.3 p 74.62 -23.07 0.24 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.185 1.394 . . . . 13.01 112.032 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 49.5 p90 -151.8 158.59 43.5 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.872 0.368 . . . . 12.34 111.303 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.44 178.24 21.73 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.198 -0.761 . . . . 7.52 111.198 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -119.54 141.68 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.137 0.468 . . . . 9.24 111.542 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.443 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 67.4 mt -103.28 125.35 57.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.449 -0.796 . . . . 7.75 110.006 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.558 ' HG2' ' H ' ' A' ' 25' ' ' CYS . 25.0 tt0 -80.59 134.77 35.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.439 -0.8 . . . . 11.8 111.833 -172.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 p -78.96 2.33 20.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.718 -1.128 . . . . 12.34 112.231 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.558 ' H ' ' HG2' ' A' ' 23' ' ' GLN . 49.2 t -60.17 -29.96 69.02 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.059 -0.4 . . . . 13.33 110.949 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.428 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 19.8 tp10 -103.99 -43.41 5.29 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.446 -0.343 . . . . 11.9 110.914 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HG2' ' N ' ' A' ' 28' ' ' GLN . 28.5 ttt180 -95.09 155.48 16.71 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 110.16 -0.311 . . . . 12.99 110.16 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.5 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 87.2 mt-30 -77.62 20.06 0.34 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.282 0.475 . . . . 16.66 112.282 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.443 ' HB3' ' NH1' ' A' ' 27' ' ' ARG . . . -169.82 144.85 2.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.33 -0.395 . . . . 12.09 110.335 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.586 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 11.2 ttp180 -90.34 148.45 22.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 12.51 109.927 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -144.57 163.86 32.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.362 0.265 . . . . 8.76 110.676 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -121.1 149.3 42.96 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.953 -0.758 . . . . 9.15 108.953 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -138.98 153.38 48.16 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.852 -0.339 . . . . 6.85 110.237 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.512 ' HB2' ' OE1' ' A' ' 37' ' ' GLN . 67.1 m80 -98.6 159.51 14.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.98 -0.748 . . . . 9.99 108.98 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -70.27 -9.65 56.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.134 0.492 . . . . 9.93 110.979 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.1 m -75.13 -15.37 60.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.02 0.438 . . . . 12.28 110.162 174.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.512 ' OE1' ' HB2' ' A' ' 34' ' ' HIS . 25.3 mp0 -113.28 36.95 3.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.002 -0.545 . . . . 10.62 110.938 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -125.32 116.31 21.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.852 0.358 . . . . 8.78 110.13 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 68' ' ' GLN . 22.3 t -87.04 95.36 9.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.017 -0.538 . . . . 8.97 110.856 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.1 175.57 14.48 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.73 -0.668 . . . . 9.98 111.613 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.04 122.25 16.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.679 0.276 . . . . 12.43 110.353 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.6 tp -66.08 -18.81 24.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.227 0.537 . . . . 11.58 110.335 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.7 -25.71 65.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.686 . . . . 14.73 110.637 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -83.88 0.25 48.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 13.3 110.459 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.9 tp -104.04 123.01 46.45 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.051 0.453 . . . . 10.07 110.472 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 12.9 mmmm -120.17 162.29 19.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.612 -0.722 . . . . 13.13 110.225 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.5 mt -71.8 114.81 11.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.993 -0.548 . . . . 11.74 109.793 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.07 -4.12 28.63 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.905 -0.664 . . . . 10.13 111.679 -173.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -80.01 133.75 57.46 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-O 120.621 0.248 . . . . 8.39 110.41 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.6 142.03 7.93 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.168 2.578 . . . . 7.28 113.102 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.81 161.14 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.65 -0.705 . . . . 4.74 110.588 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.72 135.06 53.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.065 0.46 . . . . 7.09 109.801 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -144.78 158.3 43.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 7.82 110.985 -170.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 2.5 mp0 -97.98 122.6 41.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.385 -0.37 . . . . 11.59 110.546 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.445 ' HG2' ' NH2' ' A' ' 27' ' ' ARG . 14.6 tpt -88.41 107.89 19.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.481 -0.563 . . . . 12.41 109.481 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.6 p -132.75 165.67 24.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.903 0.382 . . . . 13.17 111.149 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -118.64 122.28 42.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.1 -0.704 . . . . 16.21 109.1 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -90.65 134.58 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.133 0.492 . . . . 16.64 111.654 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -79.94 -13.8 59.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.474 -0.785 . . . . 22.64 112.757 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -92.24 -43.29 9.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 21.43 111.107 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -86.7 -32.9 20.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.356 -0.384 . . . . 17.4 111.483 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.49 19.34 68.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.024 -0.608 . . . . 16.7 112.122 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -122.38 158.26 56.49 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.263 -0.273 . . . . 14.73 110.263 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.28 126.53 8.53 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.33 2.02 . . . . 12.6 110.616 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.09 154.34 35.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.925 0.393 . . . . 11.73 111.338 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -99.83 158.81 15.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.865 -0.607 . . . . 8.91 109.997 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 p -73.75 -150.04 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.16 0.505 . . . . 9.83 111.592 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 39' ' ' SER . 30.1 pt20 -70.95 -5.35 30.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.817 -0.628 . . . . 11.32 112.277 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.9 t 50.95 89.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.714 0.769 . . . . 6.11 111.219 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.6 m -90.61 135.94 33.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.762 -0.654 . . . . 6.12 111.16 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -72.6 123.15 22.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.054 -0.721 . . . . 6.3 109.054 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.5 mt . . . . . 0 C--O 1.233 0.237 0 O-C-N 123.805 0.69 . . . . 5.77 111.845 -173.363 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.531 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 9.9 p . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 109.691 -0.485 . . . . 6.19 109.691 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 39.6 t -76.93 108.07 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.035 0.445 . . . . 6.26 111.369 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.1 mt -104.24 -48.72 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 6.05 111.289 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.515 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 66.2 m -99.72 86.94 3.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.312 0.486 . . . . 7.02 112.312 -175.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 79' ' ' SER . 0.9 OUTLIER -177.55 116.04 0.09 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.095 0.958 . . . . 7.07 108.809 174.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 66.34 64.36 0.51 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.813 0.816 . . . . 6.68 109.885 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 6.4 ptm180 -78.32 107.39 10.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.351 -0.841 . . . . 6.43 110.322 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.4 m -93.7 160.49 2.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.986 -0.552 . . . . 3.7 111.76 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 p -119.51 139.39 52.18 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.285 -0.871 . . . . 3.49 109.426 171.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.92 163.69 25.27 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.277 -0.963 . . . . 2.58 112.081 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.8 m -107.76 125.16 51.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.493 -0.558 . . . . 3.34 109.493 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.551 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 1.6 t -66.47 131.2 32.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.05 -0.722 . . . . 3.14 109.05 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.8 p -109.45 -16.54 13.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.052 0.453 . . . . 3.61 110.756 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.8 m -154.44 122.7 6.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.291 -0.413 . . . . 3.12 110.859 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' A' ' 134' ' ' ARG . 4.7 mp0 -95.45 135.25 37.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.463 -0.335 . . . . 4.39 110.84 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 91' ' ' LEU . 1.7 pt? . . . . . 0 C--N 1.324 -0.539 0 CA-C-O 122.706 1.241 . . . . 3.62 109.414 170.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 91' ' ' LEU . 4.8 t . . . . . 0 N--CA 1.447 -0.581 0 N-CA-C 109.641 -0.503 . . . . 3.33 109.641 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.4 m -134.28 134.51 41.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.542 -0.299 . . . . 2.57 110.373 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.86 168.9 54.91 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.896 -0.668 . . . . 1.66 112.257 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -128.81 122.6 30.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.808 0.337 . . . . 3.03 110.915 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 99.5 mt -112.17 127.67 69.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.773 -0.825 . . . . 1.88 108.773 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.7 t -111.53 125.8 54.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.8 0.333 . . . . 3.49 110.288 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 1.0 OUTLIER -129.41 145.81 51.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.171 -0.677 . . . . 3.51 109.171 178.177 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -118.2 112.37 20.05 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.255 -0.646 . . . . 5.1 109.255 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 23.0 t-20 -126.78 108.65 11.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 4.78 110.476 -175.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 62.4 30.44 17.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.028 -0.533 . . . . 6.97 111.994 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.03 -0.47 60.49 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.962 -0.637 . . . . 5.1 113.95 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 5.7 pt-20 -108.71 137.64 46.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.667 0.733 . . . . 5.38 109.718 172.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 3.8 p -141.03 92.54 2.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.053 -0.521 . . . . 4.72 110.776 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -98.02 163.52 12.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.964 -0.562 . . . . 4.61 110.345 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -98.44 121.17 40.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.29 -0.633 . . . . 3.96 109.29 176.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.0 mt -103.86 130.34 23.61 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.157 -0.474 . . . . 2.75 110.934 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.54 141.61 17.76 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.709 2.273 . . . . 2.3 111.997 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -146.78 144.26 29.24 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.417 -0.586 . . . . 2.13 109.417 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.426 ' HA ' HD11 ' A' ' 91' ' ' LEU . 37.9 p -105.89 173.25 6.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.677 -0.49 . . . . 3.07 109.677 175.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -71.04 -19.48 62.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.394 0.616 . . . . 4.8 109.95 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -81.03 -10.8 59.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.02 -0.991 . . . . 4.81 111.43 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -87.88 -10.25 51.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.93 0.395 . . . . 3.84 110.711 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.6 t -87.09 120.3 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.826 -0.624 . . . . 4.39 110.825 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -106.45 153.86 21.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.677 -0.692 . . . . 6.43 110.222 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.75 -1.57 85.46 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.96 -0.638 . . . . 5.91 112.31 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 63.61 17.11 10.17 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.103 0.561 . . . . 6.07 111.066 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.15 147.94 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.117 0.484 . . . . 5.27 110.892 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.83 108.6 20.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.2 -0.454 . . . . 5.78 110.564 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.597 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -106.36 150.36 26.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.862 -0.608 . . . . 3.62 110.169 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.569 ' HA ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -149.96 175.31 11.79 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.786 -0.365 . . . . 6.93 110.511 171.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.551 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -69.81 119.5 14.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.677 0.275 . . . . 4.12 111.087 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.89 -7.54 11.94 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.859 -0.686 . . . . 4.07 113.567 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -111.6 173.57 6.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.898 0.849 . . . . 4.06 110.584 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -110.93 116.41 31.18 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.173 0.511 . . . . 4.17 111.519 -173.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.35 157.49 18.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.634 -0.712 . . . . 2.77 110.906 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.449 ' HB2' ' CG ' ' A' ' 159' ' ' GLU . 8.0 t -119.2 134.44 55.2 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.02 -0.733 . . . . 3.47 109.02 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -132.73 144.91 50.61 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.892 0.377 . . . . 3.35 110.237 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -95.42 112.26 24.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.779 -0.646 . . . . 5.34 109.699 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 57.8 mt -79.25 96.1 2.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.83 -0.623 . . . . 4.66 110.222 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.693 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -81.54 108.23 14.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.189 -0.46 . . . . 4.85 110.516 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 m -85.16 110.36 18.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.037 0.446 . . . . 5.68 110.862 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -75.14 155.37 37.08 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.108 -0.701 . . . . 6.25 109.108 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -61.22 -23.42 65.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.939 0.348 . . . . 8.58 111.939 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -72.21 -23.88 61.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.997 0.427 . . . . 7.86 110.414 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 96.3 10.76 55.57 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.048 -0.596 . . . . 5.59 112.701 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.01 132.95 46.18 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.827 -0.435 . . . . 5.18 109.827 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.48 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -155.44 -178.45 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.857 -0.611 . . . . 4.28 110.887 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.96 -139.79 2.78 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.854 -0.898 . . . . 3.36 110.854 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.42 110.05 21.92 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.861 -0.422 . . . . 2.84 109.861 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 59.0 m -117.87 151.14 37.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.417 -0.356 . . . . 4.34 110.704 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 56.74 51.58 10.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.856 -0.611 . . . . 5.75 110.958 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 133' ' ' LEU . 4.6 mp -66.54 115.72 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 3.55 110.364 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -114.21 157.91 22.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.165 -0.47 . . . . 5.96 109.98 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.2 tp -97.56 123.25 41.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.401 -0.363 . . . . 4.34 110.354 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 140' ' ' SER . 21.3 mm-40 -102.33 -53.37 2.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.986 0.422 . . . . 4.97 111.192 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -136.34 102.62 9.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.187 -0.461 . . . . 5.37 110.75 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.89 160.9 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.418 2.079 . . . . 5.44 111.778 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 116.222 -0.444 . . . . 6.1 110.031 176.98 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 121.375 0.607 . . . . 12.4 111.013 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -100.74 144.81 29.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.635 -0.711 . . . . 11.63 110.003 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p -113.68 136.11 53.19 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.711 0.291 . . . . 9.15 110.962 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.38 177.01 28.73 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.546 -0.835 . . . . 6.81 112.622 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -128.82 140.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.255 -0.646 . . . . 10.17 109.255 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.57 118.09 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.837 -0.345 . . . . 8.73 110.64 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 22.3 tt0 -83.04 -44.93 14.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 10.86 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -157.82 137.01 11.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.44 -0.8 . . . . 14.06 109.83 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.0 mt -99.55 121.14 40.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.445 0.64 . . . . 11.73 111.306 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.29 -178.45 3.65 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.834 -1.075 . . . . 11.36 108.421 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -88.78 111.11 21.62 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.562 -0.455 . . . . 15.94 110.33 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.0 t 79.03 3.43 2.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.595 -1.184 . . . . 13.01 111.429 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -158.92 153.19 23.89 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 110.276 -0.268 . . . . 12.34 110.276 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.95 162.79 27.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.423 -0.894 . . . . 7.52 112.407 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -104.44 136.45 43.97 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.058 0.456 . . . . 9.24 110.968 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -103.64 127.71 57.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.651 -0.704 . . . . 7.75 110.384 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -71.77 141.81 49.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.215 -0.902 . . . . 11.8 111.644 -178.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.8 p -78.14 2.78 16.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.626 -1.17 . . . . 12.34 111.408 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.4 t -50.3 -39.33 45.36 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.659 0.614 . . . . 13.33 112.659 -170.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -105.55 7.53 32.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.045 0.387 . . . . 11.9 112.045 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.404 ' HB3' ' H ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -151.2 -159.37 1.02 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.806 0.336 . . . . 12.99 111.143 -176.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.404 ' H ' ' HB3' ' A' ' 27' ' ' ARG . 41.5 mt-30 -120.66 22.41 11.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.689 0.28 . . . . 16.66 111.291 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.13 135.64 34.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.021 0.439 . . . . 12.09 111.458 -173.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -106.92 102.58 11.93 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.479 -0.934 . . . . 12.51 108.479 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -110.88 162.18 15.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.208 0.528 . . . . 8.76 111.379 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -126.25 139.41 53.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.381 -0.827 . . . . 9.15 109.333 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -132.59 152.37 51.65 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.053 -0.351 . . . . 6.85 110.053 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -91.98 161.4 14.82 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.204 -0.665 . . . . 9.99 109.204 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -71.71 -8.23 52.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 9.93 111.677 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -79.34 -12.21 59.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.368 0.604 . . . . 12.28 109.517 172.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -103.38 36.49 2.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.547 -0.751 . . . . 10.62 110.133 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -138.09 139.54 39.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.063 -0.347 . . . . 8.78 110.063 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t -121.69 119.48 31.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.25 -0.432 . . . . 8.97 110.552 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.57 -161.94 20.8 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.893 -0.67 . . . . 9.98 112.337 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -77.45 113.53 15.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.754 0.312 . . . . 12.43 110.836 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -72.35 -25.71 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.048 0.451 . . . . 11.58 110.911 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.71 -12.29 59.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.234 0.54 . . . . 14.73 110.332 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -89.17 -7.48 55.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 13.3 109.889 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.2 tp -93.17 124.79 37.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.593 -0.731 . . . . 10.07 109.944 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -132.12 178.26 6.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.028 0.442 . . . . 13.13 110.671 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.2 mp -73.8 129.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.946 -0.57 . . . . 11.74 109.745 177.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.65 -1.53 66.22 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.674 -0.774 . . . . 10.13 111.946 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -91.34 123.32 64.41 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.823 -0.436 . . . . 8.39 109.823 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.97 142.98 32.12 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.985 2.457 . . . . 7.28 113.808 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.408 HG12 ' HE3' ' A' ' 71' ' ' LYS . 18.7 m -134.85 156.79 40.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.63 -0.714 . . . . 4.74 110.91 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -116.6 138.6 51.3 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.483 -0.562 . . . . 7.09 109.483 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' HB3' HG22 ' A' ' 69' ' ' VAL . 33.3 p90 -150.16 176.6 10.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.52 -0.309 . . . . 7.82 110.688 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 26.7 mt-10 -118.88 132.86 56.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.22 -0.659 . . . . 11.59 109.22 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.5 tpt -93.59 113.85 26.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.001 -0.545 . . . . 12.41 109.64 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 p -135.8 138.45 42.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.587 0.588 . . . . 13.17 112.587 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -95.35 110.7 22.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.078 -0.51 . . . . 16.21 109.709 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.98 121.71 32.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.8 0.333 . . . . 16.64 111.076 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -79.23 -20.95 46.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 22.64 110.964 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HE ' ' C ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -67.09 -53.86 26.91 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.392 -0.596 . . . . 21.43 109.392 -177.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.8 p -86.36 -29.69 22.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.149 -0.478 . . . . 17.4 111.172 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.86 31.74 28.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.729 -0.748 . . . . 16.7 111.81 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -135.12 141.34 37.73 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.133 -0.321 . . . . 14.73 110.133 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.22 125.31 10.71 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.809 1.673 . . . . 12.6 110.642 172.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.13 162.6 27.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.245 0.545 . . . . 11.73 111.816 -174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.42 173.41 6.77 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.453 -0.794 . . . . 8.91 110.779 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 22.7 t -87.26 -160.97 0.64 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.983 -0.553 . . . . 9.83 110.114 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -83.49 25.35 0.76 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.693 -0.23 . . . . 11.32 111.491 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 53' ' ' PHE . 43.1 t 30.02 96.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.693 1.197 . . . . 6.11 113.713 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -91.83 141.93 28.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.231 0.539 . . . . 6.12 110.761 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HE3' HG12 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -76.16 110.03 10.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.802 -0.635 . . . . 6.3 111.44 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 115.498 -0.774 . . . . 5.77 110.372 178.032 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.606 HG13 ' HB1' ' A' ' 144' ' ' ALA . 45.0 t . . . . . 0 N--CA 1.446 -0.652 0 CA-C-O 122.688 1.232 . . . . 6.19 109.246 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 t -88.34 114.73 27.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 113.831 -1.532 . . . . 6.26 110.649 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.67 -18.14 58.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.005 0.431 . . . . 6.05 110.317 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 t -95.5 52.49 1.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 7.02 110.694 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.47 -68.2 0.92 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.953 -0.567 . . . . 7.07 110.343 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -152.52 106.13 3.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.899 -0.591 . . . . 6.68 109.627 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -95.04 133.38 38.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.606 -0.516 . . . . 6.43 109.606 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.98 169.07 20.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.204 0.526 . . . . 3.7 111.202 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.4 p -118.7 144.57 46.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.496 -0.775 . . . . 3.49 109.502 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.45 170.2 23.99 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.076 -1.059 . . . . 2.58 112.268 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.9 m -121.74 132.06 54.42 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.833 -0.432 . . . . 3.34 109.833 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.632 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 48.8 t -65.25 126.34 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.322 -0.399 . . . . 3.14 110.501 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.0 p -111.19 -16.63 13.39 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.857 0.361 . . . . 3.61 111.199 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.8 m -153.65 130.33 10.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.237 -0.438 . . . . 3.12 109.916 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -176.86 3.2 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.274 0.359 . . . . 4.39 111.093 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.0 mt . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.97 0.414 . . . . 3.62 111.072 -176.705 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 109.074 -0.713 . . . . 3.33 109.074 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.11 125.51 44.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.429 -0.35 . . . . 2.57 110.721 -175.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -81.65 176.74 54.16 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.667 -0.778 . . . . 1.66 111.617 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -134.4 130.49 36.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 3.03 111.386 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.7 mt -112.57 129.11 68.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.458 -0.792 . . . . 1.88 108.961 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -107.28 132.74 52.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.616 0.246 . . . . 3.49 110.479 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.66 156.04 47.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.731 -0.84 . . . . 3.51 108.731 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.05 125.74 54.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.754 -0.462 . . . . 5.1 109.754 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 47.9 t30 -138.68 135.94 35.35 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.545 -0.909 . . . . 4.78 108.545 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 114' ' ' ARG . 9.2 mtp180 63.79 18.54 11.21 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.519 0.512 . . . . 6.97 111.8 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.33 3.73 78.2 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.668 -0.777 . . . . 5.1 112.171 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -123.11 141.29 52.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.111 0.482 . . . . 5.38 110.598 178.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 13.9 p -105.11 136.67 44.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.944 -0.571 . . . . 4.72 110.865 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -128.69 172.58 11.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.924 -0.58 . . . . 4.61 110.121 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.85 124.39 40.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.964 -0.562 . . . . 3.96 110.228 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 5.6 mp -104.36 131.45 21.88 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 110.18 -0.304 . . . . 2.75 110.18 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 3.6 Cg_exo -75.96 132.12 13.87 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.945 2.43 . . . . 2.3 111.55 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -138.5 153.42 48.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.067 0.46 . . . . 2.13 110.642 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.5 p -118.11 -175.16 2.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.878 -0.601 . . . . 3.07 110.121 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -17.65 61.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 4.8 110.651 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -82.82 -23.84 33.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.687 -0.688 . . . . 4.81 111.066 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -77.39 -26.09 51.46 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.281 -0.418 . . . . 3.84 111.364 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.83 116.22 47.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.646 0.736 . . . . 4.39 111.119 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.87 163.61 12.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.435 -0.802 . . . . 6.43 109.413 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.31 -9.52 30.99 Favored Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.69 -0.767 . . . . 5.91 112.521 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.1 t30 66.14 16.98 10.65 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.533 0.682 . . . . 6.07 110.655 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 t -78.12 120.35 28.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.808 -0.441 . . . . 5.27 109.808 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -81.57 119.56 23.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.934 0.397 . . . . 5.78 110.933 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 133' ' ' LEU . 1.8 pt? -115.56 149.24 38.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.424 -0.807 . . . . 3.62 110.679 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.606 ' HD2' ' OD1' ' A' ' 137' ' ' ASP . 0.0 OUTLIER -137.18 155.9 48.98 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.962 -0.755 . . . . 6.93 108.962 174.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.632 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -57.32 121.82 11.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.044 0.449 . . . . 4.12 110.835 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.26 -13.23 11.18 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.86 -0.686 . . . . 4.07 113.302 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.606 ' OD1' ' HD2' ' A' ' 134' ' ' ARG . 6.4 p30 -95.32 174.94 6.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.142 0.971 . . . . 4.06 110.216 172.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -110.17 122.27 47.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 4.17 111.381 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.28 150.68 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.018 -0.537 . . . . 2.77 110.929 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.6 t -120.92 133.83 55.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.113 -0.699 . . . . 3.47 109.113 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -137.37 143.26 41.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.021 0.438 . . . . 3.35 110.825 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -94.86 124.58 38.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.518 -0.764 . . . . 5.34 109.628 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.33 99.16 3.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.364 0.602 . . . . 4.66 110.582 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.606 ' HB1' HG13 ' A' ' 76' ' ' VAL . . . -89.79 109.32 20.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.196 -0.911 . . . . 4.85 110.867 -176.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.2 m -80.29 113.97 18.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.103 -0.498 . . . . 5.68 111.908 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 1.6 m120 -66.24 159.05 27.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.402 -0.363 . . . . 6.25 110.068 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -31.06 67.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.955 0.407 . . . . 8.58 111.263 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -77.04 -13.33 59.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.084 -0.507 . . . . 7.86 111.17 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.59 5.65 78.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.571 -0.823 . . . . 5.59 111.434 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 5.1 m-20 -107.92 120.99 43.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.325 . . . . 5.18 110.279 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.506 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.1 178.35 9.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.299 -0.41 . . . . 4.28 110.623 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -131.36 -112.96 1.5 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.455 -0.658 . . . . 3.36 111.455 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -123.11 137.3 54.95 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.526 -0.546 . . . . 2.84 109.526 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 84.1 m -139.81 156.57 46.67 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.2 -0.2 . . . . 4.34 110.896 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 57.46 44.42 21.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.881 0.738 . . . . 5.75 111.045 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.73 114.89 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.68 -0.691 . . . . 3.55 110.729 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -119.48 131.12 55.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.208 -0.451 . . . . 5.96 110.554 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.19 116.13 22.78 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.96 -0.756 . . . . 4.34 108.96 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -95.42 -43.99 7.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.76 0.281 . . . . 4.97 111.76 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -126.29 96.26 36.9 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 5.37 110.001 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.35 155.12 14.29 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.759 2.306 . . . . 5.44 113.4 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.632 -0.713 . . . . 6.1 109.822 175.909 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.374 -0.602 . . . . 12.4 109.374 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.524 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 3.5 pt-20 -121.73 166.73 13.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 11.63 110.729 -173.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 80.6 p -108.44 156.84 18.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.479 0.548 . . . . 9.15 112.479 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.82 -173.38 30.41 Favored Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 110.839 -0.904 . . . . 6.81 110.839 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 23' ' ' GLN . 12.6 pt -128.52 152.63 36.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 117.158 0.479 . . . . 10.17 110.327 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.07 127.33 28.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.76 0.314 . . . . 8.73 110.888 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.504 ' HA ' ' HG2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -68.95 -56.24 8.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.677 -0.692 . . . . 10.86 109.284 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -169.1 166.54 10.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.791 -1.095 . . . . 14.06 108.432 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -112.0 126.29 54.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.215 0.531 . . . . 11.73 111.521 -175.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 3.0 mm? -122.16 -179.02 4.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.946 -1.024 . . . . 11.36 108.598 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -88.71 124.57 34.24 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.007 -0.433 . . . . 15.94 110.114 -177.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m 78.39 -35.86 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.959 0.903 . . . . 13.01 112.169 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 17.5 p90 -131.79 151.57 51.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.45 . . . . 12.34 111.248 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.08 172.95 23.21 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.844 -0.903 . . . . 7.52 110.844 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 68.2 m-85 -119.49 155.22 32.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.049 0.425 . . . . 9.24 110.742 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.7 mt -111.69 128.77 68.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.97 -0.559 . . . . 7.75 110.141 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.504 ' HG2' ' HA ' ' A' ' 13' ' ' GLU . 2.5 mm-40 -74.79 132.03 41.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.309 0.576 . . . . 11.8 111.525 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.2 p -80.6 1.61 29.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.161 -0.927 . . . . 12.34 111.861 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 70.9 m -52.77 -42.21 64.77 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.604 0.24 . . . . 13.33 111.621 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.88 -42.84 14.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.234 0.54 . . . . 11.9 111.148 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HE ' ' CD ' ' A' ' 8' ' ' GLU . 31.5 tpt180 -132.34 142.29 49.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.077 -0.51 . . . . 12.99 109.779 -174.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.92 52.69 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.285 0.476 . . . . 16.66 112.285 -175.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.78 101.74 2.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.906 0.384 . . . . 12.09 110.428 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -85.91 100.91 12.42 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.293 -1.003 . . . . 12.51 108.293 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.8 mt -110.8 163.42 13.8 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.497 -0.774 . . . . 8.76 111.457 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -115.12 135.31 54.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.02 -0.733 . . . . 9.15 109.02 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -132.89 136.05 45.95 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.767 -0.457 . . . . 6.85 109.767 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 73.2 m80 -84.92 164.4 18.37 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.467 -0.568 . . . . 9.99 109.467 178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -70.07 -10.23 58.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.951 0.405 . . . . 9.93 110.71 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.6 p -84.12 -9.04 58.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.007 -0.542 . . . . 12.28 110.077 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -108.73 26.63 10.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.515 -0.766 . . . . 10.62 110.339 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -130.68 130.02 43.35 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.688 -0.405 . . . . 8.78 110.087 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 15.6 m -93.35 107.79 19.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.725 -0.671 . . . . 8.97 110.493 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.74 -156.34 22.06 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.429 -0.891 . . . . 9.98 113.15 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.476 ' ND2' ' HB2' ' A' ' 44' ' ' HIS . 1.0 OUTLIER -93.55 117.85 30.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.17 0.509 . . . . 12.43 111.803 -176.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.04 -22.63 10.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.492 -0.776 . . . . 11.58 110.319 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.95 -40.11 92.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.097 -0.501 . . . . 14.73 111.42 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.476 ' HB2' ' ND2' ' A' ' 41' ' ' ASN . 18.8 m80 -97.05 12.15 33.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.182 -0.463 . . . . 13.3 110.198 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.64 136.28 33.08 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.399 -0.593 . . . . 10.07 109.399 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.512 ' HE2' ' HB2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -130.41 157.49 42.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.241 0.544 . . . . 13.13 111.29 -174.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.6 mt -69.25 141.72 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.241 -0.89 . . . . 11.74 110.969 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.35 11.47 66.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.438 -0.886 . . . . 10.13 112.248 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.512 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 6.5 t70 -84.97 131.65 48.24 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.956 -0.143 . . . . 8.39 111.016 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.17 120.09 5.56 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.766 2.31 . . . . 7.28 112.864 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.564 HG12 ' HE3' ' A' ' 71' ' ' LYS . 27.8 m -128.45 162.45 35.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.893 -0.594 . . . . 4.74 110.451 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 1.2 pt-20 -113.22 139.57 48.68 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.369 -0.604 . . . . 7.09 109.369 173.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CE1' ' HG3' ' A' ' 8' ' ' GLU . 31.2 p90 -132.08 139.58 48.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.714 0.768 . . . . 7.82 111.784 -177.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 39.1 tt0 -88.9 104.87 17.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.847 -1.069 . . . . 11.59 108.7 174.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 13.7 tpt -88.45 114.85 25.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.197 -0.456 . . . . 12.41 110.473 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.6 p -142.85 167.12 22.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.057 0.456 . . . . 13.17 111.283 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 73.6 m-85 -112.47 109.41 18.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.901 -0.59 . . . . 16.21 109.508 175.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.22 125.53 31.05 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.839 -0.345 . . . . 16.64 110.212 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -78.35 -17.92 55.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.413 -0.358 . . . . 22.64 111.664 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 23.7 tpt180 -77.8 -42.55 33.46 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.6 -0.44 . . . . 21.43 110.007 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.4 p -84.35 -33.59 23.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.023 -0.535 . . . . 17.4 110.597 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.53 24.72 62.3 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.763 -0.653 . . . . 16.7 112.11 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -126.63 148.1 63.33 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.974 -0.38 . . . . 14.73 109.974 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HB3' ' CE1' ' A' ' 57' ' ' TYR . 43.1 Cg_endo -70.27 124.73 11.15 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 121.728 1.619 . . . . 12.6 109.807 169.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -139.77 151.17 22.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.88 0.848 . . . . 11.73 112.696 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.66 136.23 33.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.591 -1.186 . . . . 8.91 108.16 169.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 7.4 t -69.69 -150.16 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.984 0.421 . . . . 9.83 111.035 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.402 ' HB3' ' OG ' ' A' ' 39' ' ' SER . 15.1 mm100 -56.45 -18.89 12.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.322 0.86 . . . . 11.32 113.322 -175.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.1 t 55.13 96.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.635 0.731 . . . . 6.11 111.136 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m -79.5 152.0 30.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.703 -0.681 . . . . 6.12 110.197 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HE3' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -93.57 108.28 20.01 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.901 0.381 . . . . 6.3 110.52 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.532 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 65.5 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 5.77 109.877 175.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.592 ' CG1' ' HB1' ' A' ' 144' ' ' ALA . 23.3 t . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.051 0.453 . . . . 6.19 110.08 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 67.5 t -72.77 97.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.557 -0.747 . . . . 6.26 111.34 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.01 -63.92 0.99 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.462 -0.57 . . . . 6.05 109.462 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.3 t -139.36 117.43 11.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.036 0.446 . . . . 7.02 110.615 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -159.39 -49.39 0.06 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.687 -0.688 . . . . 7.07 109.415 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -81.5 -172.98 4.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.641 -0.709 . . . . 6.68 109.947 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -166.83 71.41 0.12 Allowed 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.5 -0.555 . . . . 6.43 109.5 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.5 m -82.29 151.58 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.628 0.728 . . . . 3.7 111.027 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.5 p -117.65 139.74 50.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.313 -0.858 . . . . 3.49 109.976 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.51 154.02 25.24 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.209 -0.996 . . . . 2.58 112.642 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 137' ' ' ASP . 39.9 m -109.6 136.1 49.51 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.68 -0.489 . . . . 3.34 109.68 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.571 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 46.9 t -68.58 118.43 12.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.83 0.348 . . . . 3.14 110.086 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.5 p -95.35 -27.89 15.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.027 0.441 . . . . 3.61 110.84 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 m -153.16 127.88 9.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.864 -0.607 . . . . 3.12 110.112 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.08 -171.37 2.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.409 -0.36 . . . . 4.39 110.402 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.331 -0.395 . . . . 3.62 110.668 -179.758 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 110.345 -0.243 . . . . 3.33 110.345 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.6 t -112.92 153.92 27.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.849 -0.426 . . . . 2.57 109.849 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.66 -173.63 36.61 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.624 -0.59 . . . . 1.66 111.624 177.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -133.82 126.13 29.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.992 0.425 . . . . 3.03 111.381 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.501 HG13 ' CE1' ' A' ' 122' ' ' TYR . 83.7 mt -112.12 129.02 68.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.004 -0.739 . . . . 1.88 109.004 171.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 t -105.23 117.8 34.92 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.831 -0.433 . . . . 3.49 109.831 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 11.2 p90 -119.47 150.81 39.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.207 -0.452 . . . . 3.51 109.945 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -111.95 123.45 50.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.113 -0.494 . . . . 5.1 110.592 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.512 ' OD1' ' HG3' ' A' ' 114' ' ' ARG . 49.9 t-20 -131.59 119.07 20.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.148 -0.686 . . . . 4.78 109.148 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 71.2 mtp180 63.2 21.41 12.83 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.199 -0.455 . . . . 6.97 111.223 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.36 -9.67 71.75 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.04 -0.6 . . . . 5.1 112.163 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -92.16 122.74 34.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.764 0.316 . . . . 5.38 110.247 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.04 123.05 38.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.318 -0.401 . . . . 4.72 110.272 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.616 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . 64.4 m-85 -120.92 151.15 40.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.531 -0.304 . . . . 4.61 110.634 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.28 126.43 52.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 3.96 110.709 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 mt -112.94 135.25 21.66 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.053 -0.521 . . . . 2.75 110.848 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.74 137.64 11.4 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.713 2.275 . . . . 2.3 111.799 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.501 ' CE1' HG13 ' A' ' 109' ' ' ILE . 26.8 p90 -146.04 155.23 42.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.37 . . . . 2.13 110.14 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.0 p -115.42 -178.96 3.5 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.693 -0.484 . . . . 3.07 109.693 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -71.71 -21.1 61.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.44 0.638 . . . . 4.8 110.31 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.35 -23.56 50.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.398 -0.819 . . . . 4.81 111.289 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -86.99 3.95 43.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.992 0.425 . . . . 3.84 111.316 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 131' ' ' VAL . 52.7 t -87.52 137.65 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.234 -0.439 . . . . 4.39 110.921 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -87.17 135.55 33.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.986 -0.552 . . . . 6.43 110.105 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.76 2.03 68.85 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.177 -0.535 . . . . 5.91 112.671 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 56.42 38.08 29.39 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.159 0.504 . . . . 6.07 111.574 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.433 ' O ' HG11 ' A' ' 127' ' ' VAL . 43.7 t -78.63 145.82 9.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.884 -0.598 . . . . 5.27 109.749 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -91.39 137.82 32.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.332 -0.248 . . . . 5.78 110.332 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.7 mp -114.31 149.57 35.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.663 0.602 . . . . 3.62 111.018 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -141.7 123.67 15.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.636 -0.505 . . . . 6.93 109.636 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.571 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -50.14 129.14 20.57 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.515 0.674 . . . . 4.12 112.101 -170.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.83 -15.79 11.21 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 114.981 -1.009 . . . . 4.07 111.797 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 139' ' ' VAL . 2.4 p30 -85.4 169.25 13.86 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.397 -0.594 . . . . 4.06 109.397 173.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.463 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -123.1 116.8 24.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.071 0.462 . . . . 4.17 109.971 -177.273 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.513 HG13 ' OD1' ' A' ' 137' ' ' ASP . 30.2 m -116.0 179.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.516 0.674 . . . . 2.77 111.294 -173.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.9 m -143.12 145.76 33.14 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.367 -0.833 . . . . 3.47 109.086 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.38 172.53 12.65 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.127 -0.694 . . . . 3.35 109.127 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -112.76 136.89 51.85 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.399 0.437 . . . . 5.34 109.866 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.4 mt -106.72 101.66 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.98 0.419 . . . . 4.66 110.95 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -80.04 107.57 12.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.523 -0.547 . . . . 4.85 109.523 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.1 m -97.46 102.76 14.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.121 0.486 . . . . 5.68 110.747 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 148' ' ' ARG . 47.6 t30 -75.05 157.0 35.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.716 -0.846 . . . . 6.25 108.716 172.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.19 13.91 0.1 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.05 0.452 . . . . 8.58 112.049 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.479 ' NE ' ' HA ' ' A' ' 148' ' ' ARG . 5.0 mmp_? -110.05 -8.55 14.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.751 0.31 . . . . 7.86 110.207 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.73 20.98 77.82 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 116.009 -0.542 . . . . 5.59 112.374 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -112.29 111.49 22.4 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.905 -0.406 . . . . 5.18 109.905 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.481 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.3 179.94 8.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.128 0.49 . . . . 4.28 111.575 -177.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.85 -156.94 7.7 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.498 -1.041 . . . . 3.36 110.498 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.17 112.09 24.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.495 0.648 . . . . 2.84 109.491 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 24.2 m -103.87 140.03 38.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.123 -0.489 . . . . 4.34 111.242 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 52.43 61.39 3.22 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 123.848 0.718 . . . . 5.75 111.225 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.2 mt -78.78 125.65 38.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.643 -0.708 . . . . 3.55 110.225 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -126.93 145.54 50.64 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.748 -0.381 . . . . 5.96 110.588 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.512 ' HA ' HG12 ' A' ' 139' ' ' VAL . 55.4 tp -80.71 101.52 9.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 4.34 109.87 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.65 -53.96 5.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.566 . . . . 4.97 110.834 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -118.21 97.82 51.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 5.37 110.329 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.31 158.94 33.2 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.458 2.106 . . . . 5.44 112.164 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 116.198 -0.455 . . . . 6.1 110.206 177.387 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 121.246 0.546 . . . . 12.4 110.422 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -93.34 136.88 33.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.515 -0.92 . . . . 11.63 108.515 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -118.39 140.6 49.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.48 -0.488 . . . . 9.15 111.463 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.72 -177.12 30.52 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.784 -0.722 . . . . 6.81 112.051 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 2.3 mt -124.97 143.36 38.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.809 -0.441 . . . . 10.17 109.809 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.53 116.15 11.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.414 -0.514 . . . . 8.73 109.675 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -88.47 -38.68 14.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 10.86 110.478 -176.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -153.79 140.62 19.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.619 -0.719 . . . . 14.06 109.591 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.4 mt -105.16 102.55 12.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.137 0.494 . . . . 11.73 110.591 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 mp -84.36 -178.34 6.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.053 -0.976 . . . . 11.36 109.307 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -89.69 108.73 19.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.864 0.364 . . . . 15.94 110.298 -173.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.5 m 67.57 22.31 9.2 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.251 -0.886 . . . . 13.01 110.983 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -160.52 141.21 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.628 -0.715 . . . . 12.34 109.429 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.14 157.33 21.62 Favored Glycine 0 C--N 1.322 -0.209 0 C-N-CA 120.471 -0.871 . . . . 7.52 113.094 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.0 129.19 55.01 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.108 0.163 . . . . 9.24 110.737 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.7 mt -112.59 126.92 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.846 0.355 . . . . 7.75 110.838 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 10.3 pt20 -85.38 145.73 27.34 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.145 0.498 . . . . 11.8 110.781 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 p -79.71 1.58 25.93 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.129 -0.942 . . . . 12.34 113.076 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.1 m -52.79 -24.87 9.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.932 1.086 . . . . 13.33 113.932 -170.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -99.37 10.59 41.11 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.123 0.416 . . . . 11.9 112.123 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -164.59 -158.97 0.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.438 -0.579 . . . . 12.99 109.438 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -123.37 24.37 8.71 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.162 0.506 . . . . 16.66 110.517 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.3 127.97 25.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.559 . . . . 12.09 111.125 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -96.2 119.42 34.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 12.51 110.147 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.66 162.46 18.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.407 0.622 . . . . 8.76 111.792 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -131.86 147.5 52.48 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.346 -0.983 . . . . 9.15 108.346 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -134.15 159.24 41.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.124 0.488 . . . . 6.85 111.204 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -98.84 154.77 17.77 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.994 -0.743 . . . . 9.99 108.994 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -68.86 -16.22 63.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.854 0.359 . . . . 9.93 110.786 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 t -78.36 -10.24 59.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.091 -0.504 . . . . 12.28 110.177 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -108.22 27.03 9.72 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.141 -0.482 . . . . 10.62 110.688 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -122.96 111.81 17.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.463 . . . . 8.78 110.376 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -89.15 111.66 22.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.089 0.471 . . . . 8.97 109.996 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.02 -151.01 23.04 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.988 -0.845 . . . . 9.98 110.988 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -107.22 120.71 42.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.808 0.304 . . . . 12.43 110.685 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -67.48 -19.63 25.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.601 0.715 . . . . 11.58 109.13 173.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.45 -32.44 70.23 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.803 -1.09 . . . . 14.73 110.688 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -109.65 21.24 17.21 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.584 -0.735 . . . . 13.3 111.092 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.8 tp -111.65 114.99 28.39 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.462 -0.57 . . . . 10.07 109.462 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -121.13 -179.27 3.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.008 0.433 . . . . 13.13 110.342 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 47' ' ' ILE . 3.5 mp -76.24 120.51 26.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.648 -0.501 . . . . 11.74 109.648 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.59 0.1 30.76 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.74 -0.743 . . . . 10.13 112.471 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.54 122.99 88.31 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.559 0.219 . . . . 8.39 110.895 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -83.58 126.25 4.04 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.609 2.206 . . . . 7.28 111.979 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.05 156.08 39.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.068 0.461 . . . . 4.74 111.065 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -119.48 126.77 52.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.698 -0.683 . . . . 7.09 109.26 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -132.21 166.81 21.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.349 0.595 . . . . 7.82 111.036 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.503 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 31.8 tt0 -101.32 109.66 21.54 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.645 -0.707 . . . . 11.59 109.272 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.68 109.13 19.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.281 -0.637 . . . . 12.41 109.281 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.7 p -131.6 175.28 9.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.052 0.453 . . . . 13.17 111.352 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.23 121.48 42.18 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.492 -0.558 . . . . 16.21 109.492 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -75.22 124.9 27.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.409 0.623 . . . . 16.64 110.659 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -79.33 -7.33 58.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.002 -0.999 . . . . 22.64 111.506 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -92.43 -55.12 3.52 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.957 -0.297 . . . . 21.43 111.17 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.9 p -86.46 -22.69 26.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 111.772 0.286 . . . . 17.4 111.772 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.68 32.34 54.37 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.559 -0.829 . . . . 16.7 111.66 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -121.15 147.55 47.04 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.303 -0.258 . . . . 14.73 110.303 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.69 126.16 11.18 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 121.949 1.766 . . . . 12.6 110.753 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.54 162.1 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.222 0.534 . . . . 11.73 111.304 -174.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.27 139.06 40.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.551 -0.749 . . . . 8.91 109.146 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.503 ' OG ' ' HB3' ' A' ' 54' ' ' GLU . 17.6 m -70.0 -157.13 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.084 -0.507 . . . . 9.83 110.762 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -75.68 27.86 0.11 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.326 1.232 . . . . 11.32 114.326 -168.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.2 t 21.31 101.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 125.079 1.352 . . . . 6.11 114.582 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.4 m -107.67 143.3 36.35 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.106 -0.497 . . . . 6.12 110.096 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.56 142.33 51.77 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.165 -0.68 . . . . 6.3 109.165 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.6 mt . . . . . 0 C--O 1.235 0.321 0 CA-C-O 121.112 0.482 . . . . 5.77 111.137 -177.466 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.41 ' CG1' ' HB1' ' A' ' 144' ' ' ALA . 30.9 t . . . . . 0 CA--C 1.536 0.417 0 CA-C-O 121.018 0.437 . . . . 6.19 111.434 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.59 111.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 6.26 111.244 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -118.91 16.38 13.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 6.05 110.921 176.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 m -114.06 60.53 0.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.856 0.36 . . . . 7.02 111.516 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -117.11 -34.63 4.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.716 0.293 . . . . 7.07 110.834 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -168.1 147.85 4.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 6.68 110.191 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -105.23 115.49 30.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 6.43 110.413 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.04 159.44 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.2 -0.454 . . . . 3.7 110.452 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 p -110.46 139.66 45.46 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.127 -0.488 . . . . 3.49 110.13 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.48 163.43 23.19 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.231 -0.985 . . . . 2.58 112.443 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.2 m -122.44 129.04 51.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.771 -0.455 . . . . 3.34 109.771 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.589 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 90.4 t -69.27 126.16 28.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.416 -0.356 . . . . 3.14 110.665 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 p -105.82 -19.92 13.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.237 0.541 . . . . 3.61 110.63 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.5 m -149.9 129.42 13.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 3.12 110.198 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.13 -178.27 3.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.737 0.303 . . . . 4.39 110.71 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.435 HD12 HG23 ' A' ' 105' ' ' THR . 3.2 mm? . . . . . 0 C--N 1.325 -0.499 0 CA-C-N 115.777 -0.647 . . . . 3.62 109.649 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.435 HG23 HD12 ' A' ' 91' ' ' LEU . 6.7 t . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.153 -0.684 . . . . 3.33 109.153 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.5 m -145.28 130.2 18.27 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.993 -0.373 . . . . 2.57 109.993 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.64 169.71 49.3 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.656 -0.783 . . . . 1.66 112.183 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -129.61 133.64 47.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.918 0.39 . . . . 3.03 110.892 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 64.9 mt -111.8 126.48 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.6 -0.727 . . . . 1.88 109.89 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.8 p -98.07 119.18 36.26 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.9 -0.407 . . . . 3.49 109.9 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 2.5 p90 -127.4 153.69 45.93 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.639 -0.504 . . . . 3.51 109.639 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.95 120.61 38.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.246 -0.433 . . . . 5.1 110.35 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -146.72 137.81 24.14 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.058 -0.719 . . . . 4.78 109.058 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 64.08 20.89 12.39 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.867 0.365 . . . . 6.97 110.364 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.83 -8.15 63.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.202 -0.523 . . . . 5.1 112.366 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -100.68 138.84 37.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.893 -0.41 . . . . 5.38 109.893 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 1.3 p -108.2 121.58 45.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.046 0.451 . . . . 4.72 110.837 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -115.73 164.83 13.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.927 -0.579 . . . . 4.61 110.652 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 96.0 m-85 -119.39 119.3 33.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.01 -0.541 . . . . 3.96 110.397 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 153' ' ' ALA . 4.1 mm? -105.42 143.37 26.64 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.336 -0.393 . . . . 2.75 110.626 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.98 146.93 9.14 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.126 2.551 . . . . 2.3 112.066 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -153.75 151.78 29.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.102 0.477 . . . . 2.13 111.366 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.73 162.17 23.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.453 -0.794 . . . . 3.07 109.38 172.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.94 -30.57 71.66 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.005 0.431 . . . . 4.8 111.204 -175.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.43 -20.42 66.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.076 -0.511 . . . . 4.81 111.871 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -104.22 13.81 31.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.147 0.499 . . . . 3.84 110.638 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.06 128.45 41.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 4.39 110.792 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.426 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 1.4 tm-20 -94.93 145.62 24.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.939 -0.763 . . . . 6.43 108.939 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.01 -17.18 58.77 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.754 -0.736 . . . . 5.91 112.039 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 61.25 24.2 14.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.514 0.673 . . . . 6.07 110.671 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.6 t -90.81 137.71 21.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.065 -0.516 . . . . 5.27 110.284 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -79.08 102.53 8.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 5.78 110.314 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.709 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -88.6 148.85 23.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 3.62 110.605 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -133.13 171.5 13.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.11 -0.495 . . . . 6.93 109.809 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.589 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.96 118.9 17.47 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.095 -0.502 . . . . 4.12 110.581 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.93 -20.42 9.91 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.666 -0.697 . . . . 4.07 113.195 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.93 166.18 12.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.898 0.849 . . . . 4.06 110.634 175.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -98.58 122.96 42.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.732 0.777 . . . . 4.17 111.976 -170.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.33 157.94 24.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.678 -1.146 . . . . 2.77 110.125 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.4 m -126.23 141.07 52.07 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.913 -0.773 . . . . 3.47 108.913 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -135.37 149.59 49.72 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.953 0.406 . . . . 3.35 110.26 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -100.59 115.05 29.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.739 -0.664 . . . . 5.34 110.497 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 64.7 mt -78.05 110.31 13.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.603 -0.726 . . . . 4.66 110.375 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.537 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . . . -90.26 110.45 21.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.854 -0.612 . . . . 4.85 110.427 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 40.2 m -80.6 103.15 10.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.682 -0.69 . . . . 5.68 110.352 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -67.69 163.38 21.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.1 -0.5 . . . . 6.25 111.043 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.39 -18.32 65.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 8.58 111.663 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -100.03 6.85 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.118 0.485 . . . . 7.86 110.235 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.61 18.2 75.45 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.868 -0.605 . . . . 5.59 113.98 172.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -122.33 129.9 52.6 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.404 -0.591 . . . . 5.18 109.404 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.31 179.37 8.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.906 0.384 . . . . 4.28 111.685 -175.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -131.38 -112.43 1.45 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.839 -0.904 . . . . 3.36 110.839 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 120' ' ' LEU . . . -135.41 129.68 33.68 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.109 -0.33 . . . . 2.84 110.109 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 82.6 m -128.14 150.16 50.11 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.87 -0.419 . . . . 4.34 109.87 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 57.65 58.08 3.92 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.438 0.461 . . . . 5.75 111.333 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 156' ' ' ILE . 4.8 mp -74.57 113.61 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.346 -0.983 . . . . 3.55 108.346 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.426 ' HD2' ' OE2' ' A' ' 128' ' ' GLU . 26.4 ttt180 -129.2 131.14 47.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.977 0.418 . . . . 5.96 110.864 -173.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 133' ' ' LEU . 6.4 tt -83.42 115.82 22.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.338 -0.616 . . . . 4.34 109.338 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -105.89 -26.92 11.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.086 -0.506 . . . . 4.97 111.485 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.12 107.03 5.26 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.792 0.33 . . . . 5.37 110.7 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.42 161.66 17.22 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.843 2.362 . . . . 5.44 113.522 -175.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.411 -0.813 . . . . 6.1 109.314 174.653 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.521 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 19.2 ptt180 . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.255 0.55 . . . . 12.4 111.563 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.412 ' CD ' HH22 ' A' ' 27' ' ' ARG . 4.9 mm-40 -109.63 137.04 48.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.298 -0.865 . . . . 11.63 110.249 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 p -105.48 141.7 36.5 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.458 -0.337 . . . . 9.15 111.383 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.29 178.85 39.44 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.583 -0.607 . . . . 6.81 111.583 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.3 pt -121.19 149.95 24.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.824 0.312 . . . . 10.17 110.617 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.7 mm -67.69 122.24 18.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.377 -0.374 . . . . 8.73 110.514 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.13 -51.16 10.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.749 0.309 . . . . 10.86 110.392 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -152.72 171.7 17.82 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.023 -0.535 . . . . 14.06 110.444 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.7 mt -127.59 99.53 5.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.6 -0.727 . . . . 11.73 110.628 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.2 mp -97.05 -179.9 4.7 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.286 -1.005 . . . . 11.36 108.286 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -91.19 131.9 36.43 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.506 -0.478 . . . . 15.94 110.293 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.3 t 76.24 -22.68 0.26 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.991 0.916 . . . . 13.01 112.196 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -152.27 162.89 40.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 12.34 111.26 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.99 -172.87 19.18 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.796 -0.521 . . . . 7.52 111.796 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.23 149.49 52.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.781 0.324 . . . . 9.24 110.931 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.1 mt -113.89 126.85 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.826 -0.625 . . . . 7.75 109.553 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.14 136.95 35.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.4 0.619 . . . . 11.8 111.561 -172.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 p -81.94 -0.59 44.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.999 -1.0 . . . . 12.34 112.887 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.4 m -53.6 -37.22 62.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.194 0.452 . . . . 13.33 112.035 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.53 20.32 13.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 11.9 111.476 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.476 HH21 ' HB3' ' A' ' 29' ' ' ALA . 7.1 ptm85 -163.16 -160.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.422 -0.174 . . . . 12.99 111.096 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -124.8 20.08 8.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.826 0.346 . . . . 16.66 111.223 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.476 ' HB3' HH21 ' A' ' 27' ' ' ARG . . . -146.13 122.46 10.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.392 -0.367 . . . . 12.09 111.692 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 30' ' ' ARG . 11.8 ptt180 -85.97 130.74 34.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.428 -0.953 . . . . 12.51 108.428 171.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.1 tp -141.64 158.6 43.62 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.689 -0.404 . . . . 8.76 110.777 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -113.99 149.92 34.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.141 -0.481 . . . . 9.15 109.831 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -136.49 155.39 50.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.006 -0.368 . . . . 6.85 110.006 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -110.73 150.25 29.33 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.691 -0.485 . . . . 9.99 109.691 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -63.93 -19.25 64.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.379 -0.373 . . . . 9.93 111.6 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -70.34 -24.07 62.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 12.28 111.129 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.88 40.1 1.72 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.026 -0.533 . . . . 10.62 110.525 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -120.5 129.8 53.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.336 -0.393 . . . . 8.78 110.393 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.3 m -97.7 104.78 16.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.263 -0.426 . . . . 8.97 110.349 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.89 -172.42 23.67 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.754 -0.736 . . . . 9.98 111.525 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -95.4 115.94 28.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.482 0.658 . . . . 12.43 110.3 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.63 -23.95 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.391 -0.822 . . . . 11.58 112.537 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -67.7 -21.19 65.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 14.73 111.329 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -99.62 9.07 43.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.766 0.317 . . . . 13.3 110.928 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.3 tp -94.17 130.75 40.27 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.242 -0.651 . . . . 10.07 109.242 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -122.92 172.98 8.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.96 0.409 . . . . 13.13 110.546 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.5 mp -81.79 128.44 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.756 -0.656 . . . . 11.74 109.397 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.47 0.58 67.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.687 -0.768 . . . . 10.13 112.119 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 31.9 t70 -80.4 129.97 67.1 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.192 . . . . 8.39 110.743 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 49' ' ' ASP . 8.2 Cg_exo -72.22 127.43 12.7 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.938 2.426 . . . . 7.28 113.032 -178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.79 154.47 34.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 4.74 110.88 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.521 ' OE1' ' HD2' ' A' ' 7' ' ' ARG . 37.3 tt0 -112.77 124.19 52.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.185 -0.461 . . . . 7.09 109.899 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -142.3 151.27 41.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.394 -0.366 . . . . 7.82 110.679 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -104.4 130.49 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.313 -0.625 . . . . 11.59 109.313 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 14.7 tpt -83.19 114.68 21.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.25 -0.432 . . . . 12.41 109.853 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.5 p -133.2 170.96 14.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.371 0.605 . . . . 13.17 111.927 -173.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.411 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 84.4 m-85 -132.37 115.06 15.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.018 -0.734 . . . . 16.21 109.018 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -80.5 116.5 20.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.767 -0.457 . . . . 16.64 109.767 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -78.71 -7.05 57.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.57 . . . . 22.64 111.947 -173.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.07 -37.92 9.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.203 -0.453 . . . . 21.43 110.913 -175.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 p -87.69 -34.09 18.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.89 0.376 . . . . 17.4 110.924 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.54 8.58 63.88 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.503 -0.856 . . . . 16.7 112.178 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -106.45 145.51 31.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 122.893 -0.181 . . . . 14.73 110.804 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.48 125.02 5.48 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.8 1.667 . . . . 12.6 110.433 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.31 157.49 24.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.272 0.558 . . . . 11.73 111.21 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.0 157.79 16.6 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.742 -0.663 . . . . 8.91 109.556 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -65.3 -166.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.177 -0.465 . . . . 9.83 110.148 176.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -73.94 19.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.535 0.568 . . . . 11.32 112.535 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t 32.87 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.421 1.089 . . . . 6.11 113.193 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.8 m -88.4 136.45 32.98 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.113 0.482 . . . . 6.12 110.114 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.428 ' HE2' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -73.97 119.7 18.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.149 -0.478 . . . . 6.3 110.344 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.428 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 65.4 mt . . . . . 0 N--CA 1.452 -0.341 0 CA-C-N 115.951 -0.568 . . . . 5.77 109.77 176.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 108.763 -0.828 . . . . 6.19 108.763 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.74 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 39.0 t -68.13 89.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.419 . . . . 6.26 110.394 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 144' ' ' ALA . 1.5 tt -91.43 -8.7 47.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.153 -0.931 . . . . 6.05 110.782 -173.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.3 t -140.89 103.59 4.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.049 -0.523 . . . . 7.02 110.479 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.65 -59.77 1.96 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.553 -0.906 . . . . 7.07 108.553 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -135.97 119.73 17.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.912 -1.04 . . . . 6.68 108.51 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -79.77 107.85 12.87 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.695 -0.483 . . . . 6.43 109.695 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.49 179.3 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 3.7 111.571 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.573 ' HB ' ' HD2' ' A' ' 138' ' ' LYS . 37.4 p -121.55 165.16 16.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.445 -0.798 . . . . 3.49 108.853 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.18 145.1 15.47 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.136 -1.03 . . . . 2.58 113.002 -177.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 m -108.05 127.91 54.21 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.606 -0.516 . . . . 3.34 109.606 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.613 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -74.83 124.89 33.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.096 -0.335 . . . . 3.14 110.096 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 p -104.29 -22.41 13.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.119 0.485 . . . . 3.61 110.65 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.4 m -136.66 126.46 25.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.959 -0.564 . . . . 3.12 110.634 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -84.09 -176.73 6.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 4.39 110.709 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.8 mt . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 108.876 -0.787 . . . . 3.62 108.876 171.434 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.444 -0.768 0 N-CA-C 109.414 -0.587 . . . . 3.33 109.414 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.3 m -137.39 135.44 36.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.051 0.453 . . . . 2.57 110.532 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.48 176.98 48.5 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.777 -0.725 . . . . 1.66 111.92 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -129.89 127.37 40.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.884 0.373 . . . . 3.03 111.256 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.4 HG13 ' CD1' ' A' ' 122' ' ' TYR . 78.4 mt -112.3 127.06 69.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.872 -0.604 . . . . 1.88 109.441 173.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.9 p -102.54 132.87 48.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.618 -0.264 . . . . 3.49 110.868 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.446 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -145.14 160.69 41.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.661 -0.496 . . . . 3.51 109.661 175.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -117.04 124.33 49.04 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.501 -0.555 . . . . 5.1 109.501 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -137.65 112.43 8.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 4.78 110.456 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 66.08 21.82 11.18 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.495 -0.32 . . . . 6.97 111.756 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.56 -1.22 68.77 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.675 -0.774 . . . . 5.1 111.7 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.489 ' HB3' ' CE2' ' A' ' 118' ' ' PHE . 69.8 mm-40 -96.85 128.75 44.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.9 -0.407 . . . . 5.38 109.9 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 84.9 m -118.16 101.44 8.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.124 -0.489 . . . . 4.72 110.293 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 116' ' ' GLU . 62.5 m-85 -116.79 155.0 29.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.168 0.508 . . . . 4.61 111.099 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -107.75 118.58 37.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.786 -0.82 . . . . 3.96 108.786 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.446 HD11 ' CE2' ' A' ' 111' ' ' TYR . 5.5 mp -102.42 137.89 19.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 120.875 -0.33 . . . . 2.75 110.66 -173.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.88 134.45 18.05 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.743 2.295 . . . . 2.3 112.115 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.4 ' CD1' HG13 ' A' ' 109' ' ' ILE . 23.0 p90 -137.09 151.22 48.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.175 -0.466 . . . . 2.13 109.797 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.3 p -116.72 178.77 4.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.419 -0.355 . . . . 3.07 110.137 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -69.91 -19.71 63.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.388 0.613 . . . . 4.8 110.167 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -78.98 -9.87 59.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.456 -0.793 . . . . 4.81 111.42 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -93.34 -14.55 26.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.411 -0.359 . . . . 3.84 111.873 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.449 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 7.6 p -103.98 137.68 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.183 0.516 . . . . 4.39 111.052 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -106.17 169.7 8.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.55 . . . . 6.43 111.196 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.73 -4.01 83.6 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.907 -0.588 . . . . 5.91 113.174 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 62.6 24.96 14.86 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.797 0.439 . . . . 6.07 110.65 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 t -84.34 122.18 37.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.958 -0.565 . . . . 5.27 110.41 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -83.86 95.31 8.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.308 0.575 . . . . 5.78 110.438 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.4 pt? -75.37 150.35 38.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.863 -1.062 . . . . 3.62 111.008 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.521 ' HG3' ' OD1' ' A' ' 137' ' ' ASP . 3.9 ppt_? -120.38 162.33 19.67 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.77 -0.456 . . . . 6.93 109.77 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.613 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -72.41 125.62 27.85 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.605 -0.438 . . . . 4.12 110.87 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.48 -25.73 7.59 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.934 -0.651 . . . . 4.07 113.613 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.521 ' OD1' ' HG3' ' A' ' 134' ' ' ARG . 2.8 p30 -86.53 178.66 7.02 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.258 1.029 . . . . 4.06 110.141 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.573 ' HD2' ' HB ' ' A' ' 84' ' ' THR . 2.3 tppp? -118.9 124.7 47.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.414 0.626 . . . . 4.17 111.795 -172.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.617 HG12 ' HG ' ' A' ' 158' ' ' LEU . 24.5 m -117.22 170.59 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 2.77 110.039 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -119.97 135.4 54.92 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.034 -0.728 . . . . 3.47 109.034 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -134.44 153.58 51.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.774 0.321 . . . . 3.35 110.536 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -113.83 131.23 56.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.864 -0.607 . . . . 5.34 109.801 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.4 mt -95.96 108.71 21.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.778 -0.647 . . . . 4.66 110.951 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.74 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -101.86 110.98 23.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.718 0.294 . . . . 4.85 111.285 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 66.8 m -99.0 122.7 42.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 5.68 111.814 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.52 174.92 8.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 6.25 110.533 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -59.58 -28.54 67.23 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.001 -0.545 . . . . 8.58 112.214 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 148' ' ' ARG . 21.8 mmt180 -88.48 8.66 26.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.877 0.325 . . . . 7.86 111.877 -174.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.07 14.51 73.67 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.909 -0.662 . . . . 5.59 113.22 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.9 130.51 53.84 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.254 -0.647 . . . . 5.18 109.254 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.491 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -152.94 -178.52 6.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.356 -0.384 . . . . 4.28 110.938 -177.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.14 -166.11 13.81 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.031 -0.828 . . . . 3.36 111.031 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.39 109.96 21.89 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.046 -0.353 . . . . 2.84 110.046 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 71.9 m -121.01 166.76 13.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.434 -0.348 . . . . 4.34 110.871 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 59.22 36.51 23.79 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.632 0.583 . . . . 5.75 110.144 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.449 ' HB ' ' HA ' ' A' ' 127' ' ' VAL . 77.1 mt -64.9 114.55 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.807 -0.633 . . . . 3.55 110.021 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -122.12 123.89 42.62 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.816 -0.809 . . . . 5.96 108.816 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.617 ' HG ' HG12 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -81.78 103.05 11.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.178 -0.464 . . . . 4.34 109.876 -176.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -97.08 -32.44 11.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.993 -0.549 . . . . 4.97 111.305 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -126.39 84.38 62.26 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 5.37 110.742 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.28 179.87 4.31 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.918 2.412 . . . . 5.44 112.975 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.408 ' HB2' ' HE ' ' A' ' 134' ' ' ARG . . . . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.73 -0.668 . . . . 6.1 110.49 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.429 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 17.3 ptt180 . . . . . 0 C--O 1.236 0.358 0 CA-C-O 121.108 0.48 . . . . 12.4 111.142 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.72 162.7 21.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.691 -0.686 . . . . 11.63 110.038 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 26' ' ' GLU . 36.8 p -100.79 162.12 13.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.399 -0.364 . . . . 9.15 110.233 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 26' ' ' GLU . . . -162.38 177.56 38.49 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.967 -0.635 . . . . 6.81 112.055 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.6 mt -129.45 141.9 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.557 -0.534 . . . . 10.17 109.557 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.6 mm -65.81 111.5 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.836 0.351 . . . . 8.73 110.086 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.15 -54.24 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.724 -0.671 . . . . 10.86 110.495 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HA ' HD12 ' A' ' 47' ' ' ILE . 41.0 mttm -146.47 163.9 34.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.434 -0.803 . . . . 14.06 110.253 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.5 mt -131.45 101.33 5.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.803 -0.635 . . . . 11.73 110.543 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.5 mt -92.41 -179.87 5.33 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.558 -1.275 . . . . 11.36 107.558 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -90.37 125.1 35.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.097 -0.641 . . . . 15.94 109.977 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.3 m 79.63 -16.6 0.65 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.136 0.974 . . . . 13.01 112.212 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -150.19 147.77 28.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.561 0.22 . . . . 12.34 110.949 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.48 -176.21 15.62 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.021 -0.609 . . . . 7.52 112.871 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -127.87 149.78 50.15 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.843 0.354 . . . . 9.24 111.312 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.8 mt -115.53 130.43 70.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 7.75 110.897 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.79 145.83 34.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.92 -0.582 . . . . 11.8 111.252 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 p -80.28 2.49 24.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.088 -0.96 . . . . 12.34 112.862 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -52.62 -35.44 54.6 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.006 0.372 . . . . 13.33 112.006 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.505 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 22.6 mm-40 -108.89 -25.39 10.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 11.9 111.409 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HD3' ' N ' ' A' ' 28' ' ' GLN . 1.6 tmt_? -113.38 135.3 54.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.475 -0.565 . . . . 12.99 109.475 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' N ' ' HD3' ' A' ' 27' ' ' ARG . 19.6 mp0 -74.62 43.7 0.19 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.797 0.332 . . . . 16.66 111.255 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.33 146.4 0.48 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.717 0.807 . . . . 12.09 109.541 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.585 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -100.96 111.81 24.1 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.57 -0.53 . . . . 12.51 109.57 177.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.1 mt -113.88 163.03 15.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.234 0.54 . . . . 8.76 111.923 -170.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -112.07 149.12 32.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.237 -0.892 . . . . 9.15 109.506 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -140.53 158.72 43.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.874 0.369 . . . . 6.85 110.195 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -103.76 158.19 16.56 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.703 -0.48 . . . . 9.99 109.703 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -67.91 -18.79 64.89 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.957 0.355 . . . . 9.93 111.957 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 t -82.56 -8.08 59.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.403 0.62 . . . . 12.28 109.773 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -107.48 37.89 2.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.618 -0.719 . . . . 10.62 110.03 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -129.67 125.39 35.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.964 0.412 . . . . 8.78 111.16 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 t -100.75 104.6 15.88 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.961 -0.563 . . . . 8.97 109.977 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.54 -148.85 20.67 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.114 -0.795 . . . . 9.98 111.114 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -107.13 104.03 13.58 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 110.022 -0.362 . . . . 12.43 110.022 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.0 tp -63.25 -25.48 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.155 0.502 . . . . 11.58 110.726 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.04 -25.42 61.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 14.73 110.383 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -97.17 -10.43 25.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.756 -0.656 . . . . 13.3 110.568 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.0 tp -68.37 147.2 52.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 10.07 110.169 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 169.95 17.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.191 -0.458 . . . . 13.13 110.431 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 14' ' ' LYS . 31.8 mm -77.69 135.27 26.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.562 -0.533 . . . . 11.74 109.562 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.59 11.29 62.43 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.477 -0.868 . . . . 10.13 111.837 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -86.38 125.93 66.15 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.253 -0.277 . . . . 8.39 110.253 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.91 129.74 6.35 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.906 2.404 . . . . 7.28 112.985 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.98 165.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 4.74 110.584 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 9' ' ' THR . 10.2 pt-20 -126.52 146.63 50.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.969 0.414 . . . . 7.09 110.218 172.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -152.24 178.52 9.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.026 -0.534 . . . . 7.82 110.879 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.7 mp0 -124.08 114.17 19.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.882 -0.599 . . . . 11.59 110.575 177.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.9 ttt -78.28 109.65 12.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.599 -0.519 . . . . 12.41 109.599 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.5 p -131.67 167.74 18.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.937 0.399 . . . . 13.17 111.043 -176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -118.36 110.4 17.43 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 16.21 109.58 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.38 111.2 5.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.838 0.352 . . . . 16.64 110.143 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -6.63 46.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.0 -0.545 . . . . 22.64 111.608 -176.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.8 mmt-85 -78.25 -59.7 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 21.43 110.259 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.4 p -86.68 -30.36 21.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 17.4 111.896 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.17 31.55 16.73 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.937 -0.649 . . . . 16.7 111.893 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.28 141.5 33.26 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 122.935 -0.156 . . . . 14.73 110.827 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.91 125.53 7.4 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.298 1.999 . . . . 12.6 110.886 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.63 165.61 22.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.186 -0.461 . . . . 11.73 110.591 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -102.16 161.15 13.91 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.661 -0.496 . . . . 8.91 109.661 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 11.9 t -66.89 -166.91 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.721 -0.474 . . . . 9.83 109.721 172.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -78.46 26.27 0.23 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.355 0.502 . . . . 11.32 112.355 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.7 t 35.25 94.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.2 1.0 . . . . 6.11 113.447 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -93.21 132.26 37.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.285 -0.416 . . . . 6.12 110.435 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -67.46 140.36 57.09 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.444 -0.576 . . . . 6.3 109.444 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.2 mt . . . . . 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 5.77 110.895 -176.303 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.622 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 1.7 p . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 109.773 -0.455 . . . . 6.19 109.773 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 4.8 p -79.97 107.21 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.575 0.703 . . . . 6.26 111.225 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.5 tp -89.87 -52.34 5.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.815 -1.084 . . . . 6.05 110.354 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.7 m -89.52 67.15 7.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.896 0.379 . . . . 7.02 111.718 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -88.64 -65.93 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.006 -0.738 . . . . 7.07 109.006 170.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -152.49 133.57 14.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.555 -0.906 . . . . 6.68 108.555 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -77.8 118.27 19.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.758 0.313 . . . . 6.43 110.278 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.13 166.9 7.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.215 0.531 . . . . 3.7 111.172 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 p -133.22 150.4 51.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.502 -0.772 . . . . 3.49 110.496 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -150.52 173.66 30.07 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.508 -0.853 . . . . 2.58 112.143 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.1 m -122.86 135.48 54.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.819 0.343 . . . . 3.34 110.256 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.549 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 39.8 t -64.9 132.02 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.269 -0.423 . . . . 3.14 110.728 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.5 p -115.15 -10.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.048 0.388 . . . . 3.61 112.048 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.5 m -145.05 131.99 20.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.711 0.291 . . . . 3.12 110.657 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.12 179.59 6.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 4.39 111.427 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.57 -0.741 . . . . 3.62 109.339 175.757 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 94.7 m . . . . . 0 N--CA 1.436 -1.138 0 CA-C-O 121.027 0.441 . . . . 3.33 110.511 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 t -136.25 141.27 43.9 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.073 -0.512 . . . . 2.57 109.981 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -81.2 177.58 54.23 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.468 -0.872 . . . . 1.66 111.541 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 8.0 mmt85 -132.82 127.65 34.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.989 0.423 . . . . 3.03 111.104 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.3 130.15 66.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 1.88 109.223 172.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.5 t -106.56 116.45 31.95 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.552 -0.536 . . . . 3.49 109.552 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -118.87 144.63 46.27 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.34 -0.615 . . . . 3.51 109.34 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -104.78 109.29 21.17 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.573 -0.74 . . . . 5.1 109.713 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.589 ' OD1' ' HD3' ' A' ' 114' ' ' ARG . 59.2 t30 -129.33 114.84 16.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.372 -0.376 . . . . 4.78 111.147 -174.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.589 ' HD3' ' OD1' ' A' ' 113' ' ' ASN . 6.0 mpt_? 61.55 26.13 15.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.978 0.418 . . . . 6.97 111.57 173.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.94 -2.77 69.67 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.872 -0.68 . . . . 5.1 112.617 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -110.19 135.23 51.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.828 0.347 . . . . 5.38 110.268 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 2.3 p -117.16 103.61 10.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.399 -0.364 . . . . 4.72 110.313 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -98.03 153.89 18.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.97 -0.559 . . . . 4.61 110.617 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -101.89 124.3 47.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.186 -0.461 . . . . 3.96 110.37 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 22.4 mt -105.66 130.01 23.73 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.839 -0.619 . . . . 2.75 110.685 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 76.2 Cg_endo -81.4 134.04 8.75 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.733 2.289 . . . . 2.3 111.544 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -140.24 157.76 45.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 2.13 111.363 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.5 p -120.73 177.2 5.17 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.612 -0.722 . . . . 3.07 109.582 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -76.65 -25.34 53.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.569 0.581 . . . . 4.8 112.569 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.01 -10.12 59.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.385 0.513 . . . . 4.81 112.385 -170.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -97.14 -12.63 22.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.037 0.446 . . . . 3.84 111.092 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.5 t -67.91 110.26 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.09 0.471 . . . . 4.39 111.041 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -68.25 127.51 33.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.571 -0.74 . . . . 6.43 110.719 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.89 -0.29 55.13 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.743 -0.741 . . . . 5.91 112.695 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 65.33 18.42 11.35 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.856 0.36 . . . . 6.07 110.771 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.63 135.08 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.803 -0.635 . . . . 5.27 112.238 -172.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -90.65 79.16 6.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.893 0.854 . . . . 5.78 109.135 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.566 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -77.34 149.95 35.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.86 -1.064 . . . . 3.62 112.129 -172.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -108.66 167.49 10.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.594 -0.73 . . . . 6.93 109.525 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.549 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.21 127.9 34.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.071 -0.652 . . . . 4.12 110.008 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.19 -24.24 9.4 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.847 -0.692 . . . . 4.07 111.605 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -64.99 137.94 58.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.855 0.36 . . . . 4.06 110.295 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -84.46 117.12 23.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.587 -0.523 . . . . 4.17 109.587 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -118.71 157.41 20.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.29 0.567 . . . . 2.77 111.998 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 m -118.8 129.94 55.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.534 -0.757 . . . . 3.47 109.336 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -138.24 152.52 48.67 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.77 -0.456 . . . . 3.35 109.77 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -107.94 132.4 53.53 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.837 -0.431 . . . . 5.34 109.837 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 75.6 mt -84.7 131.21 34.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.271 -0.422 . . . . 4.66 110.868 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -131.13 110.0 10.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.966 -0.561 . . . . 4.85 110.525 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 45.3 m -85.98 112.04 20.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 5.68 110.844 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -81.61 174.01 11.81 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.388 -0.597 . . . . 6.25 109.388 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -65.9 -7.29 15.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.168 0.803 . . . . 8.58 113.168 -172.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -90.54 -9.48 47.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.763 -0.375 . . . . 7.86 111.117 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.11 13.35 83.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.73 -0.748 . . . . 5.59 112.004 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -111.27 121.26 44.81 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.858 -0.423 . . . . 5.18 109.858 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.519 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -136.34 -178.25 5.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.275 -0.42 . . . . 4.28 110.308 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.422 ' HA2' HD22 ' A' ' 120' ' ' LEU . . . -160.78 -78.08 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.594 -1.003 . . . . 3.36 110.594 176.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -160.23 163.1 33.78 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.085 -0.709 . . . . 2.84 109.085 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -150.52 147.06 27.02 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.98 -0.378 . . . . 4.34 109.98 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.4 p80 40.74 51.2 3.06 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 124.638 1.211 . . . . 5.75 111.361 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.9 mt -59.52 114.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.827 -1.079 . . . . 3.55 110.063 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.27 148.0 31.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.454 -0.339 . . . . 5.96 110.363 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.5 tp -72.68 125.23 27.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.237 -0.653 . . . . 4.34 109.237 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.2 -62.17 1.3 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.334 -0.617 . . . . 4.97 109.334 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -135.6 109.18 10.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.812 -0.631 . . . . 5.37 109.484 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.08 154.95 65.97 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.789 2.326 . . . . 5.44 113.017 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.688 0 CA-C-N 115.563 -0.744 . . . . 6.1 111.467 -177.409 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 7' ' ' ARG . 43.6 mtt85 . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 120.834 0.349 . . . . 12.4 110.176 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.523 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 17.5 mm-40 -103.24 137.8 40.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.911 -0.586 . . . . 11.63 110.3 -173.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -97.94 136.91 37.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.659 -0.701 . . . . 9.15 110.656 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.5 174.6 32.1 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.978 -1.106 . . . . 6.81 112.918 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.559 HG13 ' HB3' ' A' ' 23' ' ' GLN . 7.9 pt -124.88 146.13 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.92 -0.4 . . . . 10.17 109.92 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.7 mm -67.47 122.88 19.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.414 0.149 . . . . 8.73 110.664 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 23.6 tt0 -88.09 -45.61 10.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.023 0.44 . . . . 10.86 110.428 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -147.6 140.93 25.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.9 -0.591 . . . . 14.06 109.954 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 45' ' ' LEU . 37.3 mt -113.01 110.19 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.324 0.583 . . . . 11.73 111.282 176.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.12 178.41 4.52 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.32 -1.363 . . . . 11.36 107.32 171.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -90.79 130.76 36.73 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.575 -0.85 . . . . 15.94 110.172 -174.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.9 m 76.63 -25.51 0.2 Allowed 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.203 0.939 . . . . 13.01 112.17 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -141.79 142.28 33.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.647 0.26 . . . . 12.34 110.844 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.15 179.82 18.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.814 -0.708 . . . . 7.52 112.448 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.09 134.7 55.18 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.747 0.308 . . . . 9.24 111.383 -177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.416 HG21 ' CE1' ' A' ' 53' ' ' PHE . 74.8 mt -99.75 129.09 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.617 -0.512 . . . . 7.75 109.617 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.559 ' HB3' HG13 ' A' ' 11' ' ' ILE . 37.6 tt0 -85.79 133.7 33.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.465 0.65 . . . . 11.8 111.357 -173.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.6 p -79.21 1.41 24.76 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.231 -0.895 . . . . 12.34 112.444 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 t -57.11 -29.46 63.55 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.197 0.443 . . . . 13.33 112.197 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -97.3 -1.28 44.99 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.83 0.348 . . . . 11.9 111.512 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 12.8 tpt180 -148.59 -158.85 0.96 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.342 -0.614 . . . . 12.99 109.342 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.485 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 26.5 mm-40 -119.21 19.01 12.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.248 0.546 . . . . 16.66 109.703 170.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.3 131.5 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.669 -0.696 . . . . 12.09 111.352 -175.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -121.18 125.71 47.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.734 -0.839 . . . . 12.51 108.734 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.75 160.67 26.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.42 0.628 . . . . 8.76 112.624 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -95.49 110.89 22.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.871 -1.059 . . . . 9.15 108.307 172.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -103.06 138.02 40.47 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.726 -0.79 . . . . 6.85 110.417 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -95.85 151.41 19.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.629 -0.714 . . . . 9.99 109.571 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.4 -16.77 61.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.949 0.404 . . . . 9.93 110.981 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -70.18 -23.99 63.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 12.28 109.942 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -108.71 40.31 1.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.588 -0.733 . . . . 10.62 110.711 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -129.44 119.56 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.557 -0.534 . . . . 8.78 109.557 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 t -88.02 106.53 18.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.146 0.498 . . . . 8.97 110.409 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.66 -167.89 22.5 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.684 -0.769 . . . . 9.98 111.972 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -79.12 96.34 5.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.077 -0.342 . . . . 12.43 110.077 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.1 -27.28 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.504 0.669 . . . . 11.58 109.3 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.09 -21.77 65.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.465 -0.789 . . . . 14.73 110.952 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -99.72 13.95 31.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 13.3 110.646 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.466 HD23 HD21 ' A' ' 15' ' ' LEU . 39.1 tp -88.42 147.77 24.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 10.07 110.914 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -125.28 168.7 13.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.307 -0.406 . . . . 13.13 110.837 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.7 mp -80.55 122.8 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.915 -0.584 . . . . 11.74 109.889 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.36 -3.45 32.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.872 -0.68 . . . . 10.13 111.826 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -67.83 122.71 84.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.806 -0.197 . . . . 8.39 110.478 178.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 49' ' ' ASP . 13.4 Cg_exo -69.44 123.66 10.43 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.676 2.251 . . . . 7.28 112.052 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.62 153.0 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.048 0.452 . . . . 4.74 111.624 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.25 124.44 52.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.104 -0.702 . . . . 7.09 109.104 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 8' ' ' GLU . 53.5 p90 -132.69 144.56 50.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.375 0.607 . . . . 7.82 111.039 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 26.9 tt0 -97.28 102.72 14.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.441 -0.8 . . . . 11.59 109.199 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.9 ttt -82.05 132.86 35.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.933 -0.576 . . . . 12.41 110.784 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.52 164.45 8.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.162 -0.472 . . . . 13.17 110.505 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -99.69 133.27 44.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.458 -0.337 . . . . 16.21 110.713 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.554 ' OD1' ' HG2' ' A' ' 60' ' ' ARG . 8.4 t70 -95.39 134.34 38.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.955 -0.566 . . . . 16.64 110.295 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -81.26 -13.39 58.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.24 0.459 . . . . 22.64 112.24 -177.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.554 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 8.4 mmm-85 -74.38 -60.8 2.1 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.943 -0.391 . . . . 21.43 109.943 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.551 HG22 ' OD2' ' A' ' 58' ' ' ASP . 5.7 t -91.81 -26.2 18.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.976 -0.556 . . . . 17.4 111.075 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.46 -4.58 85.47 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.798 -0.715 . . . . 16.7 112.634 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.504 ' H ' HG23 ' A' ' 61' ' ' THR . 38.5 mtpt -93.89 142.52 25.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.517 -0.549 . . . . 14.73 109.517 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.08 128.56 23.22 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.58 2.186 . . . . 12.6 112.119 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.31 179.5 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.205 -0.452 . . . . 11.73 111.001 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -133.57 173.14 11.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.642 -0.708 . . . . 8.91 109.69 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.6 p -74.98 -160.53 0.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.231 0.332 . . . . 9.83 110.405 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.5 pm0 -76.61 24.29 0.15 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.406 0.521 . . . . 11.32 112.406 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.6 t 32.75 87.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.3 1.04 . . . . 6.11 112.724 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.4 m -90.16 135.73 33.48 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.246 -0.434 . . . . 6.12 110.876 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -62.73 134.86 56.92 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.082 -0.71 . . . . 6.3 109.082 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt . . . . . 0 C--N 1.327 -0.407 0 CA-C-O 121.247 0.546 . . . . 5.77 111.145 -174.978 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.417 ' CG1' ' HB1' ' A' ' 144' ' ' ALA . 2.9 t . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.006 -0.738 . . . . 6.19 109.006 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.2 100.16 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.88 0.371 . . . . 6.26 111.351 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 144' ' ' ALA . 68.9 mt -105.19 9.32 34.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.502 0.668 . . . . 6.05 109.791 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.9 m -83.73 26.53 0.69 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.982 -1.008 . . . . 7.02 112.137 -172.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -92.66 -93.74 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.113 0.483 . . . . 7.07 111.07 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -164.49 124.31 1.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.424 -0.584 . . . . 6.68 109.424 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -63.6 118.48 8.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 6.43 110.499 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.418 HG12 HD22 ' A' ' 113' ' ' ASN . 29.6 m -116.08 160.14 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.16 0.505 . . . . 3.7 111.629 -177.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.7 p -119.22 140.19 50.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.607 -0.724 . . . . 3.49 109.884 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.76 -179.11 16.94 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.346 -0.93 . . . . 2.58 112.464 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.1 m -129.39 130.62 46.24 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.765 -0.457 . . . . 3.34 109.765 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.602 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 33.7 t -71.62 129.41 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.402 -0.363 . . . . 3.14 110.031 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.5 p -106.2 -32.57 8.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.06 0.457 . . . . 3.61 110.562 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.8 m -146.38 122.98 11.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.938 -0.573 . . . . 3.12 110.218 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -85.24 -171.2 3.5 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.911 -0.403 . . . . 4.39 109.911 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 108.911 -0.774 . . . . 3.62 108.911 172.49 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 120.877 0.37 . . . . 3.33 110.572 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.4 p -100.55 151.79 21.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.123 -0.49 . . . . 2.57 110.444 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -90.77 175.7 40.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.724 -0.75 . . . . 1.66 111.536 175.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.482 ' HD2' ' HB3' ' A' ' 119' ' ' PHE . 24.2 mmt180 -130.51 122.18 27.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.024 0.44 . . . . 3.03 111.751 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.87 134.14 63.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.474 -0.785 . . . . 1.88 109.388 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.2 t -112.39 148.67 33.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.353 -0.24 . . . . 3.49 110.353 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -159.49 167.22 29.18 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 110.084 -0.339 . . . . 3.51 110.084 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -140.06 112.67 7.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.833 -0.432 . . . . 5.1 109.833 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.418 HD22 HG12 ' A' ' 83' ' ' VAL . 60.6 t30 -168.03 154.24 7.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.827 -0.434 . . . . 4.78 109.827 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 64.35 20.99 12.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.117 0.567 . . . . 6.97 110.474 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.77 89.84 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.165 -0.54 . . . . 5.1 112.47 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -111.71 140.84 46.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.227 0.537 . . . . 5.38 111.655 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 52.5 t -140.94 101.51 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.126 -0.943 . . . . 4.72 109.797 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -151.78 169.57 21.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.617 -0.265 . . . . 4.61 110.499 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.482 ' HB3' ' HD2' ' A' ' 108' ' ' ARG . 74.9 m-85 -98.34 130.85 45.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.067 -0.515 . . . . 3.96 110.742 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 120' ' ' LEU . 5.6 mp -105.64 134.5 19.68 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.29 -0.413 . . . . 2.75 110.244 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 93.3 Cg_endo -84.01 134.33 6.08 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.745 2.297 . . . . 2.3 112.029 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -135.77 159.44 41.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.41 -0.359 . . . . 2.13 110.224 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.31 175.09 5.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.24 -0.436 . . . . 3.07 110.689 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.82 -38.46 85.51 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.08 0.467 . . . . 4.8 111.694 -174.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -85.2 -3.1 58.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.793 -0.639 . . . . 4.81 112.363 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.83 -15.23 61.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.086 0.47 . . . . 3.84 110.94 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.422 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 38.5 t -81.99 114.57 23.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.199 -0.455 . . . . 4.39 110.171 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.61 110.05 3.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 6.43 110.606 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.5 -3.18 56.29 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.722 -0.672 . . . . 5.91 112.092 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.9 t30 59.12 71.01 0.61 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.071 0.462 . . . . 6.07 110.386 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.7 t -103.46 148.47 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.958 -0.565 . . . . 5.27 110.615 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -81.54 109.1 15.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.011 -0.54 . . . . 5.78 110.496 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.3 pt? -110.9 148.86 31.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.963 -0.562 . . . . 3.62 109.603 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -136.18 124.78 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.855 -0.424 . . . . 6.93 109.855 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.602 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -51.46 123.1 9.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.105 0.479 . . . . 4.12 112.207 -173.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.65 3.66 16.07 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.409 -0.814 . . . . 4.07 111.828 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -105.64 -174.21 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.115 0.484 . . . . 4.06 110.652 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 160' ' ' ASN . 2.7 mmmm -113.53 123.19 49.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.139 -0.482 . . . . 4.17 110.858 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.12 152.02 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.994 0.426 . . . . 2.77 110.665 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 m -113.57 128.8 56.57 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.386 -0.598 . . . . 3.47 109.386 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -130.87 159.5 37.2 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.094 -0.336 . . . . 3.35 110.094 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -111.01 125.14 53.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.326 -0.397 . . . . 5.34 110.218 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.0 mt -78.6 98.54 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.286 -0.635 . . . . 4.66 109.286 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.445 ' HB2' HD23 ' A' ' 78' ' ' LEU . . . -111.88 144.11 41.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.271 -0.877 . . . . 4.85 111.236 -171.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.2 m -117.96 116.99 28.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.364 -0.38 . . . . 5.68 110.784 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.716 ' H ' HD21 ' A' ' 151' ' ' LEU . 60.9 t30 -99.25 172.62 7.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.263 -0.643 . . . . 6.25 109.263 176.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -51.44 -43.91 62.18 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.187 0.81 . . . . 8.58 113.187 -171.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -23.05 62.55 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.416 0.524 . . . . 7.86 112.416 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.59 16.44 80.74 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.539 -0.838 . . . . 5.59 112.814 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.522 ' O ' HD13 ' A' ' 151' ' ' LEU . 18.7 m120 -105.66 77.46 1.27 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 110.051 -0.352 . . . . 5.18 110.051 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.716 HD21 ' H ' ' A' ' 146' ' ' ASN . 1.6 mm? -127.11 169.64 13.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.306 -0.406 . . . . 4.28 110.546 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.36 -102.91 0.4 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.631 -0.988 . . . . 3.36 110.631 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -125.49 110.26 13.68 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.307 -0.627 . . . . 2.84 109.307 175.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 3.7 t -125.48 168.67 13.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.499 -0.319 . . . . 4.34 110.509 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 57.79 41.44 25.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.23 0.538 . . . . 5.75 110.074 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 127' ' ' VAL . 56.6 mt -68.63 118.58 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.339 -0.846 . . . . 3.55 111.277 -176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -102.89 133.64 47.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.554 -0.748 . . . . 5.96 109.363 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 161' ' ' PRO . 36.4 tp -76.86 107.68 9.35 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.722 -0.844 . . . . 4.34 108.722 175.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -83.05 -62.7 1.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.89 -0.595 . . . . 4.97 110.626 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.533 ' HB2' ' HB2' ' A' ' 138' ' ' LYS . 16.1 m120 -129.08 103.19 18.55 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.995 -0.743 . . . . 5.37 108.995 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.486 ' HB3' HD21 ' A' ' 158' ' ' LEU . 65.1 Cg_endo -71.46 158.66 53.51 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.252 1.968 . . . . 5.44 112.264 -176.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.68 0 CA-C-O 121.334 0.587 . . . . 6.1 109.993 175.163 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.813 0.339 . . . . 12.4 110.219 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -141.18 170.28 16.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.282 -0.417 . . . . 11.63 110.684 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 27.2 p -97.26 173.52 7.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.113 0.482 . . . . 9.15 111.996 -174.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' HA2' ' HG3' ' A' ' 26' ' ' GLU . . . -169.06 152.07 19.21 Favored Glycine 0 C--O 1.225 -0.414 0 CA-C-N 115.405 -0.816 . . . . 6.81 111.176 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.451 HD11 ' SG ' ' A' ' 25' ' ' CYS . 18.1 pt -100.83 147.89 7.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 117.646 0.723 . . . . 10.17 110.407 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.79 121.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.486 -0.325 . . . . 8.73 111.043 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -72.03 -56.33 5.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.552 -0.749 . . . . 10.86 110.284 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -166.09 157.23 13.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.397 -0.819 . . . . 14.06 109.013 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -115.62 116.1 27.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.326 0.584 . . . . 11.73 111.33 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 2.8 mm? -98.3 -178.93 4.19 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.965 -1.124 . . . . 11.36 107.965 173.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 18' ' ' SER . 2.9 t60 -90.02 124.84 35.11 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.001 -0.74 . . . . 15.94 109.001 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 17' ' ' HIS . 68.7 m 81.35 -21.52 0.31 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.255 0.972 . . . . 13.01 112.399 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.442 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 50.4 p90 -150.01 156.68 42.13 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.104 -0.373 . . . . 12.34 111.062 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.36 178.27 21.66 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.667 -0.573 . . . . 7.52 111.667 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -119.34 146.36 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.03 0.415 . . . . 9.24 111.443 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.4 mt -108.33 134.71 49.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.631 -0.713 . . . . 7.75 109.798 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.411 ' HB2' HG13 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -85.1 144.77 28.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.651 0.739 . . . . 11.8 111.667 -175.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -80.68 2.83 24.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.573 -1.194 . . . . 12.34 113.065 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.451 ' SG ' HD11 ' A' ' 11' ' ' ILE . 69.1 m -52.85 -31.59 40.07 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.612 0.244 . . . . 13.33 111.3 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.424 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 17.0 mm-40 -84.37 -39.36 19.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.409 -0.36 . . . . 11.9 111.106 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.22 148.46 28.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.994 -0.373 . . . . 12.99 109.994 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.416 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 6.7 pt20 -70.8 68.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.936 0.717 . . . . 16.66 112.936 -174.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -169.75 139.24 1.94 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.9 -0.591 . . . . 12.09 110.132 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 5.5 ptp180 -107.33 118.37 36.54 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.488 -0.56 . . . . 12.51 109.488 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.46 150.08 29.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.842 0.353 . . . . 8.76 111.052 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -110.65 133.71 53.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.032 -0.729 . . . . 9.15 109.032 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -125.21 143.64 50.84 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.145 -0.317 . . . . 6.85 110.145 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -94.14 155.09 17.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.477 -0.564 . . . . 9.99 109.477 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -69.23 -9.22 52.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.899 0.38 . . . . 9.93 111.583 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -80.57 -13.33 59.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.055 0.455 . . . . 12.28 109.777 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -116.44 35.81 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.922 -0.581 . . . . 10.62 111.486 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -119.01 124.94 48.21 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.062 -0.347 . . . . 8.78 110.062 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 t -94.76 94.96 8.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.066 0.46 . . . . 8.97 110.25 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.86 -169.71 26.03 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.054 -0.593 . . . . 9.98 111.738 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -87.8 120.34 29.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.286 -0.264 . . . . 12.43 110.286 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -66.56 -20.77 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.236 0.541 . . . . 11.58 110.954 -176.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.04 -24.56 66.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.914 -0.584 . . . . 14.73 110.583 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -92.91 2.95 56.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.835 -0.621 . . . . 13.3 110.453 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -102.54 129.93 49.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.636 -0.711 . . . . 10.07 109.417 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.38 177.22 8.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.529 -0.305 . . . . 13.13 110.768 -175.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 47' ' ' ILE . 4.0 mp -80.05 141.03 15.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.537 -0.302 . . . . 11.74 110.187 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.53 10.57 85.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.091 -0.576 . . . . 10.13 111.767 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.9 134.47 21.48 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.583 -0.309 . . . . 8.39 110.194 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.507 ' HB2' HD12 ' A' ' 72' ' ' ILE . 90.4 Cg_endo -81.99 128.82 5.93 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.594 2.196 . . . . 7.28 113.653 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.0 m -120.65 167.99 13.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.448 -0.796 . . . . 4.74 109.779 175.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 4.7 pt-20 -120.17 124.48 45.85 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.258 -0.645 . . . . 7.09 109.258 174.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -131.27 147.8 52.62 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 122.165 0.983 . . . . 7.82 112.278 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 30.6 tt0 -100.29 122.13 42.59 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.003 -1.453 . . . . 11.59 108.448 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.93 118.08 36.26 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.243 -0.183 . . . . 12.41 110.726 -173.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.5 p -141.94 153.49 44.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.161 0.505 . . . . 13.17 111.459 -176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -96.8 108.52 21.2 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.13 -0.693 . . . . 16.21 109.13 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.57 111.13 18.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.062 0.458 . . . . 16.64 110.928 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -81.18 -7.08 59.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.966 -0.561 . . . . 22.64 111.706 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -67.99 -46.56 70.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.033 -0.729 . . . . 21.43 109.033 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.4 p -93.78 -31.33 14.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.179 -0.918 . . . . 17.4 110.9 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.33 28.46 17.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.679 -0.772 . . . . 16.7 111.905 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -133.41 152.91 80.1 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 110.132 -0.321 . . . . 14.73 110.132 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.06 125.88 6.77 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.322 2.015 . . . . 12.6 110.763 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -137.43 172.51 14.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.748 0.785 . . . . 11.73 112.749 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.69 149.76 24.12 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.753 -1.112 . . . . 8.91 108.028 170.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.499 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 8.6 t -69.39 -151.07 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.329 0.585 . . . . 9.83 110.547 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -75.79 26.7 0.11 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.524 0.564 . . . . 11.32 112.524 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.405 ' H ' ' C ' ' A' ' 67' ' ' SER . 38.5 t 21.58 96.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.959 1.304 . . . . 6.11 113.632 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.3 t -88.55 154.32 20.44 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.777 -0.647 . . . . 6.12 110.22 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -96.64 123.58 40.37 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.001 -0.545 . . . . 6.3 109.877 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.507 HD12 ' HB2' ' A' ' 50' ' ' PRO . 63.8 mt . . . . . 0 C--O 1.236 0.371 0 O-C-N 124.0 0.812 . . . . 5.77 111.386 -175.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.436 HG12 ' HB1' ' A' ' 144' ' ' ALA . 3.9 t . . . . . 0 N--CA 1.451 -0.4 0 CA-C-O 120.547 0.213 . . . . 6.19 110.624 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 38.9 t -77.64 103.56 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 6.26 109.749 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.19 41.57 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.624 -0.716 . . . . 6.05 110.493 -174.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 71.1 m -156.18 33.15 0.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.951 -0.568 . . . . 7.02 110.853 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 145' ' ' THR . 6.1 mm-40 -83.22 62.99 6.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.228 -0.442 . . . . 7.07 110.466 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 68.81 112.72 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.192 -1.367 . . . . 6.68 111.463 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -77.71 81.95 4.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.616 0.722 . . . . 6.43 109.927 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.3 m -77.42 168.95 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.715 -0.675 . . . . 3.7 110.974 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.44 ' HB ' ' HE3' ' A' ' 138' ' ' LYS . 46.8 p -116.45 150.26 38.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.819 -0.628 . . . . 3.49 109.83 175.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.29 153.88 20.78 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.425 -0.893 . . . . 2.58 111.713 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -107.03 126.4 52.28 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.289 -0.634 . . . . 3.34 109.289 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 21.4 t -70.56 110.87 3.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.4 -0.363 . . . . 3.14 110.784 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.3 p -98.24 -13.26 20.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.698 0.761 . . . . 3.61 110.172 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 26.7 m -155.34 115.93 3.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.118 -0.946 . . . . 3.12 109.381 -175.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 135' ' ' ALA . 0.3 OUTLIER -104.62 148.8 26.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 4.39 111.102 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 108.335 -0.987 . . . . 3.62 108.335 174.636 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 121.366 0.603 . . . . 3.33 109.708 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t -97.34 135.98 38.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.27 -0.423 . . . . 2.57 110.193 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.445 ' HA3' ' CE1' ' A' ' 122' ' ' TYR . . . -75.41 -177.54 41.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.632 -0.794 . . . . 1.66 112.048 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.617 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -146.27 120.85 9.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.102 0.477 . . . . 3.03 110.164 -177.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -111.56 130.38 65.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.853 -0.612 . . . . 1.88 110.209 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.7 t -105.31 124.46 49.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.032 -0.531 . . . . 3.49 109.625 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -140.84 146.83 38.07 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.388 -0.597 . . . . 3.51 109.388 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.38 112.0 18.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.152 0.501 . . . . 5.1 110.802 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.71 121.89 46.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.568 -0.742 . . . . 4.78 109.936 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 60.57 23.82 13.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.502 -0.772 . . . . 6.97 111.06 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.25 -2.01 65.18 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.911 -0.661 . . . . 5.1 113.171 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.84 121.71 41.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.241 0.521 . . . . 5.38 110.559 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.4 p -102.47 113.15 26.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.117 -0.492 . . . . 4.72 110.754 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -118.51 147.03 44.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.291 -0.413 . . . . 4.61 110.377 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -101.63 126.84 48.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 3.96 109.648 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.9 118.54 55.95 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.586 -0.279 . . . . 2.75 110.93 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.82 132.68 14.6 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.691 2.261 . . . . 2.3 110.712 168.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CE1' ' HA3' ' A' ' 107' ' ' GLY . 35.0 p90 -140.95 159.78 41.48 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.932 -0.307 . . . . 2.13 110.54 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 64.7 p -121.02 -175.62 3.09 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.012 -0.54 . . . . 3.07 110.009 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -62.89 -30.13 71.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.351 . . . . 4.8 111.655 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.01 -9.38 59.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.07 -0.514 . . . . 4.81 111.202 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -91.17 -12.44 35.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.28 0.562 . . . . 3.84 110.309 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.2 t -85.81 126.82 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.002 -0.545 . . . . 4.39 110.152 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -80.92 127.93 33.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.229 -0.441 . . . . 6.43 109.973 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.24 -0.23 87.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.808 -0.711 . . . . 5.91 112.838 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.0 m120 59.6 35.98 22.62 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.139 0.495 . . . . 6.07 111.087 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.87 137.19 23.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.145 -0.479 . . . . 5.27 111.249 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -80.74 112.62 18.29 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.694 -0.484 . . . . 5.78 109.694 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.68 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -102.9 150.9 23.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.055 -0.52 . . . . 3.62 111.536 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -115.46 135.57 53.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.689 -0.687 . . . . 6.93 110.044 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.597 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -60.91 114.39 3.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.258 0.551 . . . . 4.12 110.815 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.06 -3.92 14.11 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.517 -0.765 . . . . 4.07 112.874 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.497 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . 16.5 p30 -90.78 -177.35 4.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.442 0.621 . . . . 4.06 110.18 173.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HE3' ' HB ' ' A' ' 84' ' ' THR . 50.9 tptt -112.95 113.55 25.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.061 0.458 . . . . 4.17 110.874 -174.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.9 m -117.82 154.28 19.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.84 -0.618 . . . . 2.77 110.515 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.5 t -124.18 135.88 53.78 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.395 -0.594 . . . . 3.47 109.395 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.44 146.33 52.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.164 -0.471 . . . . 3.35 110.129 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -93.8 118.92 32.09 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.792 -0.64 . . . . 5.34 109.704 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 93.8 mt -78.4 133.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.646 -0.501 . . . . 4.66 109.646 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -125.81 110.7 14.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.992 -0.549 . . . . 4.85 110.322 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.468 ' H ' ' HG3' ' A' ' 80' ' ' GLU . 20.0 m -99.01 132.09 44.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.962 0.411 . . . . 5.68 110.895 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -107.27 -163.8 0.93 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.845 -0.616 . . . . 6.25 110.935 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -75.71 -37.94 59.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.969 -0.559 . . . . 8.58 110.651 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -74.94 -18.42 60.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.384 -0.371 . . . . 7.86 110.794 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.98 22.78 54.4 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.839 -0.696 . . . . 5.59 111.801 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -113.96 121.53 44.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.462 0.173 . . . . 5.18 110.585 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.504 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -148.9 -179.32 6.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.006 0.432 . . . . 4.28 111.659 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.23 -124.81 1.64 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.635 -0.986 . . . . 3.36 110.635 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -138.72 117.11 11.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.832 0.316 . . . . 2.84 110.378 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 4.7 t -128.59 158.48 38.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.446 -0.343 . . . . 4.34 110.08 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 57.43 42.95 23.85 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.741 0.65 . . . . 5.75 110.953 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 22.3 mt -74.6 116.29 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.329 -0.85 . . . . 3.55 110.666 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -114.2 142.02 46.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 5.96 110.901 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.1 tp -83.41 119.21 24.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.927 -0.578 . . . . 4.34 110.125 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -87.64 -53.74 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.744 0.307 . . . . 4.97 110.581 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -142.92 122.94 7.89 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.918 0.389 . . . . 5.37 110.9 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 137' ' ' ASP . 82.3 Cg_endo -79.78 157.36 24.42 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.787 2.325 . . . . 5.44 112.59 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 115.804 -0.634 . . . . 6.1 110.696 178.931 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.445 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 15.0 ptt180 . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 120.935 0.398 . . . . 12.4 110.604 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.527 ' HB2' ' NH1' ' A' ' 27' ' ' ARG . 38.3 mt-10 -130.91 155.67 46.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.031 -0.531 . . . . 11.63 109.633 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -87.48 169.57 12.1 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.178 -0.465 . . . . 9.15 110.291 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.23 162.97 34.68 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.55 -0.833 . . . . 6.81 111.999 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -117.64 137.0 53.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.407 -0.59 . . . . 10.17 109.407 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.75 110.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.149 0.5 . . . . 8.73 110.471 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -72.09 -50.53 27.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.77 -0.65 . . . . 10.86 110.37 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.547 ' HA ' HD12 ' A' ' 47' ' ' ILE . 38.1 ttpt -161.04 155.17 22.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.899 -1.046 . . . . 14.06 109.098 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 mt -116.15 126.76 54.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.156 0.503 . . . . 11.73 111.183 -175.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.4 mp -114.57 -179.89 3.76 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.649 -1.241 . . . . 11.36 107.649 173.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -90.62 126.64 36.02 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.182 -0.607 . . . . 15.94 110.27 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 m 80.56 -14.58 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.605 1.191 . . . . 13.01 111.995 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 12.5 p90 -159.59 162.31 35.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.764 0.316 . . . . 12.34 111.389 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.24 -176.78 27.82 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.085 -0.579 . . . . 7.52 112.054 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -115.94 143.92 44.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.823 0.344 . . . . 9.24 111.475 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.9 mt -113.79 120.19 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.856 -0.611 . . . . 7.75 110.075 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -69.48 147.04 51.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.476 0.655 . . . . 11.8 111.809 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.404 ' HA ' ' HG3' ' A' ' 27' ' ' ARG . 3.2 p -79.89 0.57 30.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.842 -1.072 . . . . 12.34 112.299 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 m -53.24 -31.32 42.83 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.662 0.616 . . . . 13.33 112.662 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -105.53 11.27 32.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.712 0.291 . . . . 11.9 111.431 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.527 ' NH1' ' HB2' ' A' ' 8' ' ' GLU . 7.5 ptm85 -153.95 -170.24 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.524 0.202 . . . . 12.99 111.326 -173.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -112.14 17.81 19.22 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.15 0.426 . . . . 16.66 112.15 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.81 149.17 17.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.524 -0.307 . . . . 12.09 110.885 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -92.86 135.69 33.91 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.177 -0.675 . . . . 12.51 109.177 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.1 mt -135.82 163.23 30.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.355 0.597 . . . . 8.76 111.904 -174.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -124.08 149.2 46.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.447 -0.946 . . . . 9.15 108.447 172.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -135.36 152.15 51.17 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.941 -0.304 . . . . 6.85 110.248 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 32.4 p-80 -109.71 152.4 25.67 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.689 -0.485 . . . . 9.99 109.689 175.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -70.2 4.52 2.15 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.252 0.834 . . . . 9.93 113.252 -168.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 t -77.78 -17.78 57.14 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.725 -0.472 . . . . 12.28 109.725 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -116.66 40.46 2.92 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.863 -0.608 . . . . 10.62 112.114 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -126.59 124.91 41.04 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.203 -0.599 . . . . 8.78 111.331 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 m -101.92 106.68 17.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.662 -0.699 . . . . 8.97 110.707 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.57 176.08 19.2 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.722 -0.751 . . . . 9.98 112.023 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -68.67 109.65 3.9 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.703 -0.481 . . . . 12.43 109.703 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -63.68 -25.05 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.166 0.508 . . . . 11.58 110.8 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.39 -23.19 62.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.126 -0.488 . . . . 14.73 110.745 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -93.42 2.96 56.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 13.3 110.949 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.441 HD12 ' OD1' ' A' ' 49' ' ' ASP . 26.3 tp -94.43 117.03 29.5 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.698 -0.853 . . . . 10.07 108.698 176.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -119.19 -173.9 2.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.523 -0.308 . . . . 13.13 110.849 -173.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 14' ' ' LYS . 24.6 mm -87.55 133.03 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.76 -0.459 . . . . 11.74 109.76 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.73 10.85 82.62 Favored Glycine 0 CA--C 1.51 -0.235 0 N-CA-C 110.922 -0.871 . . . . 10.13 110.922 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.441 ' OD1' HD12 ' A' ' 45' ' ' LEU . 43.4 t0 -92.97 121.73 65.16 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.838 -0.681 . . . . 8.39 109.906 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.62 143.21 18.79 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.102 2.535 . . . . 7.28 114.058 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.0 m -138.75 160.71 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.667 -0.697 . . . . 4.74 110.413 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -117.74 130.53 56.37 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.807 -0.442 . . . . 7.09 109.807 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -142.35 155.57 45.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.443 0.639 . . . . 7.82 111.245 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 21.1 mt-10 -104.53 131.53 51.82 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.46 -0.791 . . . . 11.59 109.075 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.7 ttt -103.87 123.11 46.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.557 -0.292 . . . . 12.41 110.944 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.0 p -141.97 169.76 16.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.923 0.392 . . . . 13.17 111.124 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 53.1 m-85 -116.9 120.7 39.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.564 -0.532 . . . . 16.21 109.564 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.53 ' OD2' HG22 ' A' ' 61' ' ' THR . 21.4 t70 -81.99 121.43 26.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.724 0.297 . . . . 16.64 110.38 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -79.86 -6.97 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 22.64 112.267 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -84.04 -57.66 3.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.601 0.238 . . . . 21.43 110.702 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.599 HG23 ' HG2' ' A' ' 63' ' ' LYS . 8.8 t -91.62 -19.26 22.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.116 0.484 . . . . 17.4 110.774 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.86 34.16 22.39 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.457 -0.878 . . . . 16.7 113.365 172.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.599 ' HG2' HG23 ' A' ' 61' ' ' THR . 19.2 ptpt -124.74 150.05 64.36 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 117.485 0.643 . . . . 14.73 110.963 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.495 ' HB3' ' CE1' ' A' ' 57' ' ' TYR . 58.4 Cg_endo -73.43 126.66 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.398 2.065 . . . . 12.6 110.913 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.29 -179.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.286 0.565 . . . . 11.73 111.252 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.0 162.96 19.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.445 -0.798 . . . . 8.91 109.842 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 30.4 t -72.87 -164.03 0.15 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.706 -0.679 . . . . 9.83 109.576 175.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -74.11 17.34 0.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.833 0.679 . . . . 11.32 112.833 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.2 t 37.88 93.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.149 0.98 . . . . 6.11 112.602 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.2 t -82.13 123.06 28.63 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.354 -0.609 . . . . 6.12 109.354 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -73.76 121.65 21.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.329 -0.619 . . . . 6.3 109.329 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.4 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.481 -0.781 . . . . 5.77 111.639 -174.525 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.435 HG12 ' HB1' ' A' ' 144' ' ' ALA . 19.5 t . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.448 -0.575 . . . . 6.19 109.448 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 26.6 t -78.65 83.87 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.062 0.458 . . . . 6.26 110.541 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.584 HD12 ' HB2' ' A' ' 144' ' ' ALA . 3.6 tp -82.74 17.26 1.9 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.694 -0.684 . . . . 6.05 110.61 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 m -133.69 36.93 3.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.506 0.558 . . . . 7.02 112.506 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.14 -51.17 11.45 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.373 -0.531 . . . . 7.07 110.334 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -167.43 139.5 3.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 6.68 110.032 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.483 ' HD3' ' C ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -96.1 114.46 26.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.545 -0.539 . . . . 6.43 109.545 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.88 171.0 12.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.694 -0.684 . . . . 3.7 110.112 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.9 p -108.4 148.44 30.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.333 -0.618 . . . . 3.49 109.333 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -114.04 137.41 14.07 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.429 -0.891 . . . . 2.58 112.311 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -120.0 112.1 18.74 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.115 -0.698 . . . . 3.34 109.115 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.672 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 59.1 t -66.83 127.63 28.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.161 -0.472 . . . . 3.14 110.483 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.1 p -109.07 -20.0 13.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.135 0.493 . . . . 3.61 111.092 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.7 m -148.98 124.99 10.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.462 -0.57 . . . . 3.12 109.462 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.86 -179.1 7.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.033 0.444 . . . . 4.39 110.869 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.0 mt . . . . . 0 C--N 1.324 -0.516 0 CA-C-N 115.824 -0.626 . . . . 3.62 109.506 175.237 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 121.395 0.617 . . . . 3.33 110.055 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 56.9 p -98.56 137.2 37.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.435 -0.802 . . . . 2.57 111.537 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -86.39 -169.06 45.54 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.059 -0.816 . . . . 1.66 111.059 173.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -128.3 120.81 27.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.982 0.42 . . . . 3.03 111.226 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.437 HG12 HG22 ' A' ' 87' ' ' VAL . 80.0 mt -110.95 125.09 68.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.599 -0.728 . . . . 1.88 109.341 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.7 t -104.25 142.1 35.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.984 0.421 . . . . 3.49 110.681 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -147.44 165.58 29.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.456 -0.942 . . . . 3.51 108.456 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.96 125.21 27.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.386 -0.598 . . . . 5.1 109.386 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -135.27 107.75 7.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 4.78 110.938 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 62.64 28.66 16.71 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.749 -0.66 . . . . 6.97 111.906 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.34 -1.57 62.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.162 -0.542 . . . . 5.1 112.996 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 118' ' ' PHE . 42.3 mt-10 -104.65 110.81 23.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.1 0.476 . . . . 5.38 110.365 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 45.5 t -112.39 127.44 56.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.883 -0.599 . . . . 4.72 109.872 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 116' ' ' GLU . 73.3 m-85 -135.37 166.95 21.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 4.61 111.013 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -110.26 123.96 50.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.562 -0.744 . . . . 3.96 109.593 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 8.4 mp -104.48 132.88 20.54 Favored Pre-proline 0 C--N 1.322 -0.607 0 C-N-CA 121.069 -0.252 . . . . 2.75 110.492 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 2.8 Cg_exo -75.37 133.16 15.73 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.741 2.294 . . . . 2.3 111.664 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.436 ' CD1' HG13 ' A' ' 109' ' ' ILE . 17.6 p90 -135.16 144.81 47.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.679 -0.237 . . . . 2.13 110.483 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.4 p -109.18 -177.62 3.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.109 -0.33 . . . . 3.07 110.109 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -70.6 -22.4 62.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.236 0.541 . . . . 4.8 110.725 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.25 -25.93 52.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.488 -0.778 . . . . 4.81 110.975 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 153' ' ' ALA . 21.7 m-20 -74.26 -30.55 62.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.027 -0.533 . . . . 3.84 111.795 -175.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 156' ' ' ILE . 2.5 p -84.59 118.63 32.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.651 0.739 . . . . 4.39 111.052 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -89.92 136.22 33.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.347 -0.842 . . . . 6.43 109.769 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.34 -19.85 38.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.772 -0.728 . . . . 5.91 111.848 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 60.09 71.01 0.59 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.383 0.611 . . . . 6.07 110.904 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 t -108.12 149.43 11.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.117 -0.492 . . . . 5.27 110.122 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -91.7 102.03 14.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.002 0.43 . . . . 5.78 110.155 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.609 HD23 ' H ' ' A' ' 133' ' ' LEU . 1.8 pt? -114.97 143.44 45.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.593 -0.731 . . . . 3.62 110.267 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -117.62 -179.99 3.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 6.93 109.913 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.672 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.81 132.46 42.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.314 -0.403 . . . . 4.12 110.47 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 104.95 -14.44 48.95 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.068 -0.587 . . . . 4.07 112.444 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.517 ' OD2' ' HB3' ' A' ' 162' ' ' ALA . 54.3 m-20 -84.77 146.45 27.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.466 -0.568 . . . . 4.06 109.466 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -93.5 116.47 29.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.588 0.709 . . . . 4.17 111.778 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.412 HG11 HD13 ' A' ' 133' ' ' LEU . 33.1 m -120.22 166.31 14.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.974 -1.012 . . . . 2.77 110.311 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.604 ' HB3' ' OE1' ' A' ' 159' ' ' GLU . 21.0 p -118.96 133.27 55.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.755 -0.461 . . . . 3.47 109.755 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -135.12 142.52 46.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.774 -0.454 . . . . 3.35 109.774 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' A' ' 142' ' ' GLN . 12.3 mm-40 -98.26 129.33 44.98 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.838 -0.619 . . . . 5.34 110.057 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.41 98.62 2.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.067 -0.716 . . . . 4.66 109.067 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.667 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -102.72 110.07 21.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.148 -0.933 . . . . 4.85 111.599 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.45 122.35 26.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.93 -0.577 . . . . 5.68 110.459 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.1 p30 -86.38 -172.42 4.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.057 0.456 . . . . 6.25 110.803 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -83.54 6.54 20.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.957 -0.565 . . . . 8.58 111.574 -172.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -115.28 1.66 13.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.353 -0.385 . . . . 7.86 110.935 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.79 20.75 70.2 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.768 -0.73 . . . . 5.59 113.294 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -123.99 154.97 39.05 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 5.18 109.127 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.484 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -156.07 176.43 12.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.225 0.536 . . . . 4.28 111.822 -178.135 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.59 -138.9 3.0 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.351 -1.1 . . . . 3.36 110.351 174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 126' ' ' ASP . . . -121.97 109.0 14.06 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.582 -0.525 . . . . 2.84 109.582 175.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.17 162.7 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.505 -0.316 . . . . 4.34 110.535 -175.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 60.53 33.81 20.45 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.552 0.691 . . . . 5.75 110.043 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 127' ' ' VAL . 70.8 mt -59.84 123.33 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.7 -1.136 . . . . 3.55 110.95 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -124.13 127.55 47.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.9 0.381 . . . . 5.96 110.606 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.46 96.72 2.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 4.34 109.692 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.604 ' OE1' ' HB3' ' A' ' 140' ' ' SER . 6.6 pt-20 -76.86 -35.68 57.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 4.97 110.916 -176.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -137.56 102.26 8.76 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.499 -0.319 . . . . 5.37 110.699 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.23 151.71 49.31 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.523 2.149 . . . . 5.44 112.223 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.517 ' HB3' ' OD2' ' A' ' 137' ' ' ASP . . . . . . . . 0 C--N 1.317 -0.814 0 CA-C-O 121.462 0.649 . . . . 6.1 110.549 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.404 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 10.6 ptp180 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.344 0.592 . . . . 12.4 109.798 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.37 156.23 21.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.551 -0.75 . . . . 11.63 110.652 -173.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.1 p -110.52 136.75 49.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.414 -0.357 . . . . 9.15 111.007 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.96 178.21 25.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 6.81 111.909 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 25' ' ' CYS . 52.9 mt -124.56 143.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.842 0.321 . . . . 10.17 110.249 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.3 mm -73.58 106.59 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.438 -0.579 . . . . 8.73 109.438 174.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -73.41 -43.92 59.44 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.966 0.412 . . . . 10.86 110.504 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -155.75 162.59 40.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.005 -0.543 . . . . 14.06 109.563 -176.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 mt -119.82 118.63 31.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.171 0.51 . . . . 11.73 111.071 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -111.82 179.99 3.86 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.328 -0.99 . . . . 11.36 108.328 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -90.2 117.31 28.86 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.749 -0.781 . . . . 15.94 110.151 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.6 m 78.71 -7.55 1.77 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.06 -0.973 . . . . 13.01 112.442 178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.69 168.57 26.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.718 0.294 . . . . 12.34 110.886 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.68 -166.61 22.82 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.187 -0.53 . . . . 7.52 112.068 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -125.99 139.51 53.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 9.24 110.945 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.0 mt -101.77 120.36 51.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 7.75 109.574 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -75.92 143.02 41.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.559 -0.746 . . . . 11.8 110.993 -175.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -79.14 3.1 18.64 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.353 -0.839 . . . . 12.34 112.631 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.413 ' HB3' HD12 ' A' ' 11' ' ' ILE . 44.0 t -51.43 -51.26 56.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.506 0.558 . . . . 13.33 112.506 -173.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -90.46 16.94 7.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.289 0.566 . . . . 11.9 111.01 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.567 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 38.6 ttt180 -144.83 -158.63 0.91 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.041 -1.096 . . . . 12.99 108.041 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.567 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 13.4 mm-40 -136.22 23.58 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.189 0.518 . . . . 16.66 110.413 167.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' O ' ' HD3' ' A' ' 27' ' ' ARG . . . -151.8 119.53 6.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.664 -0.698 . . . . 12.09 110.633 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -86.63 151.71 23.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.147 -0.479 . . . . 12.51 110.112 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.507 HD11 ' SD ' ' A' ' 55' ' ' MET . 59.6 mt -141.77 162.17 36.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 8.76 111.423 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -103.6 143.41 32.79 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.664 -0.865 . . . . 9.15 108.664 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -137.93 147.62 44.51 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.269 -0.572 . . . . 6.85 110.179 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -103.41 155.11 18.73 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.368 -0.604 . . . . 9.99 109.368 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -67.25 -13.27 61.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.697 0.284 . . . . 9.93 111.37 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 p -70.78 -24.17 62.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.537 . . . . 12.28 110.148 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -94.1 20.53 7.83 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.642 -0.708 . . . . 10.62 110.995 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -125.03 123.17 39.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.932 0.396 . . . . 8.78 110.705 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 68' ' ' GLN . 13.3 t -111.51 100.8 9.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.72 -0.673 . . . . 8.97 110.218 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.77 -169.78 36.53 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.968 -0.634 . . . . 9.98 111.915 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -83.89 103.68 13.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 12.43 110.323 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.9 tp -67.62 -24.18 30.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.943 -0.571 . . . . 11.58 110.918 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.79 -12.78 61.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 14.73 111.023 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -104.25 4.5 33.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 13.3 110.202 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.9 tp -103.79 110.14 22.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.485 . . . . 10.07 110.701 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -114.11 -178.87 3.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.221 0.534 . . . . 13.13 110.935 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.3 mp -73.08 140.19 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.601 -0.727 . . . . 11.74 110.208 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.84 -2.19 66.37 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 121.013 -0.613 . . . . 10.13 112.378 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.71 127.98 48.03 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 120.58 0.229 . . . . 8.39 110.608 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.76 141.7 13.73 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.194 2.596 . . . . 7.28 113.632 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.412 HG12 ' HE3' ' A' ' 71' ' ' LYS . 23.7 m -128.57 157.93 40.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.799 -0.637 . . . . 4.74 111.186 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -113.17 124.06 51.67 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.997 -0.742 . . . . 7.09 108.997 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -136.87 142.13 42.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.286 0.565 . . . . 7.82 111.614 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.538 ' CD ' ' HB2' ' A' ' 67' ' ' SER . 0.2 OUTLIER -88.88 141.29 28.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.009 -0.737 . . . . 11.59 109.009 173.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' ' 31' ' ' LEU . 24.5 ttt -124.0 114.01 19.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.35 -0.241 . . . . 12.41 110.35 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.5 p -134.99 164.67 27.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.153 0.501 . . . . 13.17 111.425 -177.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -95.31 113.4 25.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.025 -0.534 . . . . 16.21 110.083 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.97 124.08 26.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.032 0.444 . . . . 16.64 110.469 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -79.72 -8.87 59.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.684 -0.689 . . . . 22.64 111.266 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -81.0 -56.87 3.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 21.43 110.357 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.5 p -86.65 -45.84 10.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.169 -0.469 . . . . 17.4 111.645 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.0 0.22 35.85 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.626 -0.797 . . . . 16.7 112.322 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -95.87 150.78 37.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.152 -0.314 . . . . 14.73 110.152 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.15 125.29 8.45 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.953 1.769 . . . . 12.6 109.502 171.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -126.94 162.4 31.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.04 0.447 . . . . 11.73 111.362 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.54 151.62 20.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.405 -0.816 . . . . 8.91 109.284 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.538 ' HB2' ' CD ' ' A' ' 54' ' ' GLU . 11.8 t -75.88 -157.22 0.07 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.041 -0.527 . . . . 9.83 109.79 177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 39' ' ' SER . 23.6 mp0 -75.12 19.23 0.16 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.838 0.681 . . . . 11.32 112.838 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.0 t 33.83 94.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.537 1.135 . . . . 6.11 113.108 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.8 m -80.36 120.73 24.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.461 0.648 . . . . 6.12 110.358 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.686 ' HE2' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -68.1 113.48 5.8 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.664 -0.698 . . . . 6.3 110.537 -179.038 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.686 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 79.5 mt . . . . . 0 C--O 1.236 0.376 0 CA-C-N 116.175 -0.466 . . . . 5.77 110.328 173.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.666 0.27 . . . . 6.19 110.93 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 38.4 t -67.7 89.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 6.26 110.962 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 144' ' ' ALA . 4.1 tt -91.18 -27.95 18.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 6.05 110.781 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 t -116.37 99.86 7.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.071 -0.513 . . . . 7.02 110.68 -175.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -125.21 -68.15 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.514 -0.767 . . . . 7.07 109.017 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -130.69 127.88 39.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.181 -0.674 . . . . 6.68 109.181 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.457 ' H ' ' CD ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -82.98 126.39 32.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.964 0.411 . . . . 6.43 110.151 -177.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.39 167.4 13.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.093 -0.503 . . . . 3.7 111.117 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 p -120.75 146.23 46.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.809 -0.632 . . . . 3.49 110.327 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.39 162.61 26.5 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.6 -0.81 . . . . 2.58 112.382 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.5 m -106.61 135.24 48.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.826 -0.435 . . . . 3.34 109.826 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 1.1 t -68.98 121.56 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.863 -0.421 . . . . 3.14 109.863 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -27.82 16.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.146 0.498 . . . . 3.61 110.227 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.5 m -155.29 138.01 15.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.003 -0.544 . . . . 3.12 110.407 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -99.85 -171.8 2.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.339 0.59 . . . . 4.39 111.568 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 91' ' ' LEU . 2.5 mm? . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 114.95 -1.023 . . . . 3.62 109.22 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 109.968 -0.382 . . . . 3.33 109.968 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 t -130.52 143.67 50.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.914 0.388 . . . . 2.57 110.3 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.74 -168.34 39.58 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.727 -0.749 . . . . 1.66 111.881 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.52 ' NH2' ' HB3' ' A' ' 121' ' ' PRO . 1.1 mmp_? -136.29 130.33 32.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.844 0.354 . . . . 3.03 110.746 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.6 mt -112.53 126.99 69.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.228 -0.656 . . . . 1.88 109.228 171.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 p -108.18 123.19 48.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.439 -0.346 . . . . 3.49 110.608 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.36 156.9 47.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.763 -0.458 . . . . 3.51 109.763 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 116' ' ' GLU . 3.5 tm-20 -132.35 120.86 22.64 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.339 -0.615 . . . . 5.1 109.339 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.773 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 8.6 t30 -130.74 106.48 8.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.199 -0.455 . . . . 4.78 110.724 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 57.94 38.19 26.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.024 -0.535 . . . . 6.97 111.64 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.59 -5.67 64.72 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.983 -0.627 . . . . 5.1 114.091 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.773 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 11.7 pt-20 -95.01 124.6 39.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 118.071 0.935 . . . . 5.38 109.733 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 44.1 t -124.24 104.46 8.83 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.518 -0.549 . . . . 4.72 109.518 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.23 152.71 32.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 4.61 110.979 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -102.65 117.55 34.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.776 -0.824 . . . . 3.96 108.776 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.19 127.64 29.31 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.817 0.341 . . . . 2.75 110.622 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.52 ' HB3' ' NH2' ' A' ' 108' ' ' ARG . 58.7 Cg_endo -76.18 135.88 17.46 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.547 2.165 . . . . 2.3 111.906 175.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -148.73 159.95 43.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.996 -0.742 . . . . 2.13 108.996 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.7 p -116.45 171.9 7.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.921 0.391 . . . . 3.07 110.294 175.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -63.93 -21.98 66.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.443 0.64 . . . . 4.8 110.484 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.4 -4.11 58.16 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.606 -0.724 . . . . 4.81 111.88 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -90.76 -9.54 46.24 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.712 0.291 . . . . 3.84 111.417 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 p -102.73 133.02 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.218 0.532 . . . . 4.39 111.335 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -94.45 144.86 25.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.948 -0.569 . . . . 6.43 110.24 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.33 -14.12 23.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.908 -0.663 . . . . 5.91 112.998 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 62.3 t30 53.89 50.86 15.92 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.653 0.74 . . . . 6.07 110.139 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.83 156.48 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.515 -0.766 . . . . 5.27 110.424 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -84.84 120.72 26.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.814 0.34 . . . . 5.78 111.632 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.42 136.72 44.45 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.69 -0.855 . . . . 3.62 108.69 173.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -142.62 157.5 44.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.741 -0.384 . . . . 6.93 110.561 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.543 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -58.66 120.28 8.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.869 0.366 . . . . 4.12 111.121 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.27 -17.4 10.51 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.668 -0.777 . . . . 4.07 113.487 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -92.45 175.47 6.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.017 0.908 . . . . 4.06 109.967 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -119.15 118.81 32.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.353 0.597 . . . . 4.17 111.17 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.2 m -117.18 160.79 16.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.586 -0.734 . . . . 2.77 111.339 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.3 t -117.14 131.74 56.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.051 -0.722 . . . . 3.47 109.051 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -134.31 155.42 50.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.823 0.344 . . . . 3.35 110.46 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -109.15 140.86 42.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.032 0.444 . . . . 5.34 110.292 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.6 mt -110.72 110.1 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.896 -0.593 . . . . 4.66 110.589 -174.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -87.39 107.17 18.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.033 0.444 . . . . 4.85 111.083 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 28.3 m -96.26 117.02 29.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.699 -0.682 . . . . 5.68 111.777 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -85.97 164.21 17.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.423 -0.584 . . . . 6.25 109.423 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.47 -27.95 62.93 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.698 0.399 . . . . 8.58 111.191 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -71.14 -13.53 61.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.08 -0.509 . . . . 7.86 111.704 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.65 22.3 62.27 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.689 -0.767 . . . . 5.59 111.967 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -105.47 124.06 48.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.832 -0.433 . . . . 5.18 109.832 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.477 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.43 168.87 23.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.963 0.411 . . . . 4.28 112.065 -177.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.78 -168.27 16.57 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.763 -0.935 . . . . 3.36 110.763 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.31 116.73 33.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.122 0.461 . . . . 2.84 110.852 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.3 t -140.46 158.5 43.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.519 -0.549 . . . . 4.34 109.519 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 58.2 65.72 1.23 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.294 0.569 . . . . 5.75 110.554 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 mp -89.16 138.5 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.432 -0.804 . . . . 3.55 110.53 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -126.09 129.36 48.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.872 -0.604 . . . . 5.96 110.278 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 161' ' ' PRO . 55.6 tp -82.69 110.98 18.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.982 -0.377 . . . . 4.34 109.982 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.07 -48.25 6.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 4.97 111.261 -176.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -128.19 100.13 23.83 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.806 0.336 . . . . 5.37 110.945 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.468 ' HB3' HD21 ' A' ' 158' ' ' LEU . 69.0 Cg_endo -87.2 151.28 8.08 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.013 2.475 . . . . 5.44 111.913 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.787 0 CA-C-O 120.964 0.411 . . . . 6.1 110.474 178.657 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 . . . . . 0 C--O 1.234 0.276 0 N-CA-C 109.278 -0.638 . . . . 12.4 109.278 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.644 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.9 pt-20 -156.82 148.93 22.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.667 0.746 . . . . 11.63 112.293 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 11.8 p -116.67 162.15 18.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.226 -0.897 . . . . 9.15 110.968 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.56 -176.21 36.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.155 -0.545 . . . . 6.81 111.992 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.2 mt -121.35 142.53 37.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.156 -0.683 . . . . 10.17 109.156 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.3 mm -65.87 117.99 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 117.843 0.292 . . . . 8.73 110.223 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -84.21 -49.73 8.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.76 -0.655 . . . . 10.86 110.427 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -151.47 145.9 25.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.376 -0.829 . . . . 14.06 110.324 -177.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.6 mt -117.58 110.51 18.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.218 0.532 . . . . 11.73 110.842 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.2 mt -108.35 -177.82 3.43 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.085 -0.961 . . . . 11.36 108.727 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -87.28 122.3 30.87 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.246 -0.582 . . . . 15.94 109.874 -174.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.2 m 83.1 -20.31 0.34 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.671 1.232 . . . . 13.01 112.102 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 32.3 p90 -147.19 143.51 28.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.028 0.442 . . . . 12.34 111.678 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.2 164.63 22.15 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.69 -0.686 . . . . 7.52 111.632 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -117.5 145.34 44.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.012 0.434 . . . . 9.24 111.369 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.3 mt -111.49 132.86 58.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.496 -0.775 . . . . 7.75 110.287 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.96 145.88 37.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.505 0.669 . . . . 11.8 111.401 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.0 p -79.51 3.97 17.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.894 -1.048 . . . . 12.34 112.639 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.4 m -51.14 -30.41 16.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.59 0.589 . . . . 13.33 112.59 -174.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 9' ' ' THR . 32.7 mm-40 -109.91 6.68 23.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.6 0.238 . . . . 11.9 111.523 -176.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 10.5 tpt180 -143.71 -176.75 5.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.8 0.333 . . . . 12.99 111.062 -171.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.453 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 14.6 mm100 -104.09 12.97 33.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.435 0.636 . . . . 16.66 109.963 176.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.97 140.42 16.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.219 -0.901 . . . . 12.09 110.499 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -96.43 120.27 36.43 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.338 -0.616 . . . . 12.51 109.338 171.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.4 mt -102.5 162.96 12.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.379 0.609 . . . . 8.76 111.883 -173.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -125.22 145.31 50.04 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.064 -0.971 . . . . 9.15 109.346 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -142.7 149.48 38.88 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.555 -0.535 . . . . 6.85 109.555 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 8.8 p-80 -99.78 165.51 11.55 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.267 -0.573 . . . . 9.99 109.919 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -66.3 -2.41 4.39 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.845 0.683 . . . . 9.93 112.845 -169.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 m -79.28 -17.87 53.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.945 0.402 . . . . 12.28 110.531 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.449 ' HB3' ' O ' ' A' ' 67' ' ' SER . 26.0 mp0 -111.61 39.68 2.29 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.306 -0.407 . . . . 10.62 111.419 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -125.97 130.19 50.72 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.503 -0.479 . . . . 8.78 110.123 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 m -84.44 109.91 18.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 8.97 111.025 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.88 -157.63 15.07 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.636 -0.793 . . . . 9.98 112.607 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -90.07 133.2 34.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.788 0.328 . . . . 12.43 110.988 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -72.42 -11.25 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.416 0.627 . . . . 11.58 109.911 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.34 -29.42 68.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.164 -0.925 . . . . 14.73 111.79 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -106.11 14.08 28.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 13.3 111.817 -175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 tp -97.81 128.38 44.4 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.42 -0.512 . . . . 10.07 109.92 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -118.27 163.5 16.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.206 0.527 . . . . 13.13 110.455 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.28 122.9 24.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.269 -1.011 . . . . 11.74 108.269 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.82 -8.44 29.74 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.691 -0.766 . . . . 10.13 112.377 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.54 130.24 90.79 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.818 0.309 . . . . 8.39 110.167 176.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.39 122.62 5.68 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.697 2.264 . . . . 7.28 111.688 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.15 151.85 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.44 0.638 . . . . 4.74 111.746 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -111.17 125.73 54.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.921 -1.036 . . . . 7.09 109.045 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.644 ' CE2' ' HG3' ' A' ' 8' ' ' GLU . 33.2 p90 -131.75 179.35 6.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.405 0.621 . . . . 7.82 111.246 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 25.9 tt0 -148.51 104.29 3.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.432 -0.804 . . . . 11.59 109.074 -170.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.0 ttt -84.16 128.79 34.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.38 -0.373 . . . . 12.41 111.154 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -145.44 164.72 30.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.243 -0.435 . . . . 13.17 110.672 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -107.6 110.75 22.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.57 -0.286 . . . . 16.21 110.755 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.515 ' OD2' HG22 ' A' ' 61' ' ' THR . 16.6 t70 -79.15 109.81 13.81 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.825 -0.435 . . . . 16.64 109.825 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -69.61 -15.41 63.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.473 -0.785 . . . . 22.64 111.819 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.464 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 40.1 ttm105 -76.97 -54.01 7.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.713 0.292 . . . . 21.43 110.839 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.515 HG22 ' OD2' ' A' ' 58' ' ' ASP . 9.1 t -85.64 -35.03 21.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.18 -0.463 . . . . 17.4 111.059 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.07 30.77 9.78 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.878 -0.677 . . . . 16.7 113.762 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HG2' HG23 ' A' ' 61' ' ' THR . 16.8 ptpt -135.6 148.45 65.72 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 117.357 0.578 . . . . 14.73 110.022 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.82 126.89 11.06 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.088 1.859 . . . . 12.6 110.944 176.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.31 167.53 25.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.085 0.469 . . . . 11.73 111.303 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.23 159.91 15.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.058 -0.719 . . . . 8.91 109.058 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 9.1 t -70.91 -166.05 0.14 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.914 -0.402 . . . . 9.83 109.914 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -75.64 22.69 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.495 0.924 . . . . 11.32 113.495 -170.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t 34.24 98.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.141 1.164 . . . . 6.11 114.141 171.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.2 t -105.52 138.07 42.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.262 -0.644 . . . . 6.12 109.262 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -73.84 144.28 45.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.372 -0.603 . . . . 6.3 109.372 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.7 mt . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 120.887 0.375 . . . . 5.77 111.037 -175.304 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.447 HG12 ' HB1' ' A' ' 144' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 110.318 -0.253 . . . . 6.19 110.318 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 43.8 t -70.35 105.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.923 0.392 . . . . 6.26 111.369 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 144' ' ' ALA . 36.5 mt -97.08 5.59 50.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.49 . . . . 6.05 111.705 -178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.7 t -149.16 100.73 3.07 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.528 -0.469 . . . . 7.02 111.434 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -132.69 -66.95 0.66 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.811 -0.811 . . . . 7.07 108.811 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -165.5 148.32 7.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.126 -0.943 . . . . 6.68 108.831 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -82.59 102.02 11.15 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.711 -0.478 . . . . 6.43 109.711 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 m -77.34 156.94 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.114 -0.493 . . . . 3.7 110.335 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.8 p -123.16 141.77 51.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.065 -0.516 . . . . 3.49 110.493 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.99 169.36 25.34 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.018 -0.611 . . . . 2.58 111.644 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.2 m -103.94 130.32 51.55 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.583 -0.525 . . . . 3.34 109.583 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 2.1 t -68.87 121.37 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 109.236 -0.653 . . . . 3.14 109.236 176.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.1 p -91.63 -24.71 19.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.34 0.59 . . . . 3.61 110.553 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.6 m -151.77 125.58 9.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.391 -0.822 . . . . 3.12 109.123 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.59 172.66 6.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.307 0.575 . . . . 4.39 112.079 -172.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.0 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.054 -0.975 . . . . 3.62 110.354 177.889 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.446 -0.656 0 CA-C-O 121.219 0.533 . . . . 3.33 110.128 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.7 p -106.2 134.63 49.03 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.773 -0.649 . . . . 2.57 111.007 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -78.61 174.25 55.17 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.465 -0.874 . . . . 1.66 110.988 175.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -125.56 123.72 39.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.244 0.522 . . . . 3.03 111.502 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -111.3 129.1 67.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.971 -0.752 . . . . 1.88 108.971 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 118' ' ' PHE . 9.4 t -116.07 132.95 56.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.178 0.513 . . . . 3.49 110.931 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -143.81 155.95 44.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.946 -0.761 . . . . 3.51 108.946 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -109.02 137.12 47.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.793 0.33 . . . . 5.1 110.144 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -158.64 130.21 6.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.267 -0.424 . . . . 4.78 111.475 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 57.09 29.98 17.46 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.231 0.539 . . . . 6.97 112.121 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.33 -14.12 65.95 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.618 -0.719 . . . . 5.1 112.598 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -102.95 135.86 43.84 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.824 0.345 . . . . 5.38 110.811 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 12.1 p -107.6 111.73 24.11 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.114 -0.494 . . . . 4.72 109.69 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 110' ' ' SER . 88.5 m-85 -101.11 153.76 19.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.217 0.532 . . . . 4.61 111.961 -173.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -119.5 113.49 20.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.686 -0.857 . . . . 3.96 108.686 172.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.49 136.13 19.27 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.298 -0.41 . . . . 2.75 111.007 -172.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -77.32 132.9 12.81 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.733 2.289 . . . . 2.3 111.953 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -135.63 143.79 45.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.055 0.455 . . . . 2.13 110.035 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.8 p -114.25 -179.01 3.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.574 -0.528 . . . . 3.07 109.574 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -16.98 59.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.039 0.447 . . . . 4.8 110.769 178.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -84.03 -10.89 57.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.797 -0.638 . . . . 4.81 111.053 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -88.28 -21.05 24.67 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.758 0.313 . . . . 3.84 111.385 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -96.8 111.61 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.467 0.651 . . . . 4.39 110.918 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -89.87 129.37 36.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.561 -0.745 . . . . 6.43 110.115 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 128.22 -15.68 6.1 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.58 -0.737 . . . . 5.91 111.359 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.2 m120 57.95 46.6 16.33 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 122.978 0.511 . . . . 6.07 110.755 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.4 p -112.01 152.99 13.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.042 -0.527 . . . . 5.27 110.808 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -87.95 115.4 25.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 5.78 110.667 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.3 pt? -114.82 142.83 46.02 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.738 -0.467 . . . . 3.62 109.738 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.07 175.2 11.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.335 -0.546 . . . . 6.93 111.474 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.552 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -65.66 122.81 18.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.317 -0.401 . . . . 4.12 111.77 -177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 120.09 -29.69 5.9 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.836 -0.697 . . . . 4.07 113.265 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.61 166.96 11.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.576 0.688 . . . . 4.06 110.281 173.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -113.23 128.14 56.38 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.789 0.804 . . . . 4.17 111.245 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.32 152.6 19.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.593 -1.185 . . . . 2.77 110.796 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.3 m -106.35 137.48 44.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.813 -0.631 . . . . 3.47 109.675 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -142.6 149.57 39.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.809 0.338 . . . . 3.35 110.365 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.58 112.44 24.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.994 -0.373 . . . . 5.34 109.994 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 66.4 mt -79.06 111.69 16.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.974 -0.557 . . . . 4.66 110.141 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.674 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -89.71 107.31 19.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.143 -0.688 . . . . 4.85 109.143 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.64 117.61 24.64 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.203 0.525 . . . . 5.68 111.352 -174.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -82.63 154.4 24.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.451 -0.795 . . . . 6.25 108.9 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -62.36 -29.04 70.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.439 0.638 . . . . 8.58 109.63 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -69.92 -19.7 63.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.122 -0.945 . . . . 7.86 110.511 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.21 12.5 83.14 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.796 -0.638 . . . . 5.59 112.43 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -106.62 119.49 39.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.197 -0.668 . . . . 5.18 109.197 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.438 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -148.88 -177.81 6.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.645 -0.252 . . . . 4.28 111.537 -177.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.57 -173.73 16.18 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.393 -0.683 . . . . 3.36 111.393 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.44 111.43 23.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.864 0.332 . . . . 2.84 110.423 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 6.2 t -127.09 165.15 20.06 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 110.042 -0.355 . . . . 4.34 110.042 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 59.05 36.08 24.16 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.0 -0.545 . . . . 5.75 110.424 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.78 142.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.363 -0.835 . . . . 3.55 110.758 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -149.22 142.24 24.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.7 0.286 . . . . 5.96 110.904 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.2 tp -76.75 106.48 8.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 4.34 110.054 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -103.31 -35.19 8.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.122 -0.49 . . . . 4.97 111.805 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -132.13 90.4 35.03 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.965 -0.294 . . . . 5.37 110.852 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.55 156.55 28.4 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.559 2.173 . . . . 5.44 111.742 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.245 0.545 . . . . 6.1 111.037 -179.811 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 109.831 -0.433 . . . . 12.4 109.831 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -119.45 148.78 42.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.648 -0.705 . . . . 11.63 111.164 -166.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.3 p -102.89 144.22 31.48 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.918 -0.583 . . . . 9.15 111.707 -174.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.19 176.57 29.62 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.371 -0.692 . . . . 6.81 111.371 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.0 mt -127.06 140.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.659 -0.497 . . . . 10.17 109.659 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.7 mm -66.15 126.04 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 121.206 -0.198 . . . . 8.73 110.491 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -87.0 -51.45 6.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.37 0.605 . . . . 10.86 111.258 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -157.92 131.77 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.086 -0.709 . . . . 14.06 109.086 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.11 105.56 17.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.546 0.689 . . . . 11.73 111.362 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.66 179.4 4.43 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.302 -0.999 . . . . 11.36 108.302 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -91.4 136.3 33.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.756 -0.378 . . . . 15.94 110.71 -177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t 76.75 -33.32 0.2 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.263 -0.881 . . . . 13.01 111.742 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -139.7 152.37 46.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.64 0.257 . . . . 12.34 111.24 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.8 168.76 23.49 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.636 -0.793 . . . . 7.52 112.418 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -116.89 140.8 49.03 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.914 0.388 . . . . 9.24 111.203 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.3 mt -111.59 130.51 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.905 -0.589 . . . . 7.75 110.462 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -72.98 138.46 46.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.445 0.64 . . . . 11.8 111.985 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.1 p -79.53 1.55 25.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.062 -0.972 . . . . 12.34 111.412 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -55.77 -30.06 60.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.298 -0.41 . . . . 13.33 111.776 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -113.89 -11.94 12.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.106 0.479 . . . . 11.9 111.259 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.745 HH11 ' HB3' ' A' ' 29' ' ' ALA . 3.9 tmt_? -137.52 137.56 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.692 -0.855 . . . . 12.99 108.692 -175.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -68.32 42.79 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.427 0.899 . . . . 16.66 113.427 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.745 ' HB3' HH11 ' A' ' 27' ' ' ARG . . . 177.2 133.98 0.06 Allowed 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 123.406 0.682 . . . . 12.09 110.12 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.511 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 6.6 ppt_? -86.27 141.31 29.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.147 -0.686 . . . . 12.51 109.147 171.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 47.1 mt -133.25 162.43 31.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.953 0.406 . . . . 8.76 111.486 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -114.9 141.87 47.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.128 -0.942 . . . . 9.15 108.506 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -136.21 145.3 45.53 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.455 -0.498 . . . . 6.85 110.733 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -84.53 141.44 30.73 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.919 -0.771 . . . . 9.99 108.919 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -63.87 -17.48 63.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.637 0.256 . . . . 9.93 111.481 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -70.6 -13.51 62.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.51 -0.314 . . . . 12.28 110.697 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -103.47 1.11 31.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.564 -0.289 . . . . 10.62 111.235 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -85.04 114.86 22.51 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.698 -0.401 . . . . 8.78 110.121 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.8 t -81.91 91.3 6.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.241 -0.436 . . . . 8.97 110.474 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.39 -175.02 26.06 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.637 -0.585 . . . . 9.98 111.637 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -79.14 123.85 27.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.698 -0.482 . . . . 12.43 109.698 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tp -65.24 -24.96 36.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.176 0.513 . . . . 11.58 111.094 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.22 -0.91 26.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.166 0.508 . . . . 14.73 111.168 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -103.39 10.1 37.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 13.3 109.672 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 tp -112.82 129.24 56.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.714 -0.676 . . . . 10.07 110.008 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -119.64 168.95 10.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.336 0.589 . . . . 13.13 111.099 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.6 mp -73.37 114.78 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.089 -0.505 . . . . 11.74 109.742 174.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.14 9.43 22.19 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.474 -0.87 . . . . 10.13 112.012 -175.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.29 133.08 71.99 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.245 -0.279 . . . . 8.39 110.245 175.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -85.58 109.88 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.941 2.428 . . . . 7.28 111.644 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.93 151.6 16.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.888 -0.596 . . . . 4.74 111.255 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -110.32 130.03 55.63 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.19 -0.67 . . . . 7.09 109.19 173.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.09 178.04 7.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.349 0.595 . . . . 7.82 111.014 -174.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 32.9 tt0 -142.65 105.08 4.47 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.468 -0.938 . . . . 11.59 108.468 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.3 ttt -83.15 124.29 30.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.767 0.318 . . . . 12.41 111.077 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.2 p -141.19 161.25 38.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.313 -0.403 . . . . 13.17 110.697 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -97.6 121.5 39.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.39 -0.368 . . . . 16.21 110.078 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' A' ' 60' ' ' ARG . 16.6 t70 -74.76 120.08 19.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.182 0.515 . . . . 16.64 110.312 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -79.85 -5.79 56.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.648 -0.705 . . . . 22.64 112.197 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.404 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . 2.4 mpt_? -79.77 -70.41 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.212 0.529 . . . . 21.43 110.641 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 t -101.71 -4.38 26.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 17.4 111.203 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.58 33.0 35.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.079 -0.582 . . . . 16.7 113.451 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -110.02 131.3 22.05 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.725 -0.279 . . . . 14.73 110.335 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.6 125.59 10.74 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.734 1.623 . . . . 12.6 110.028 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.69 179.54 2.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.455 0.645 . . . . 11.73 111.989 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.19 148.41 29.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.442 -0.799 . . . . 8.91 109.886 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 10.3 t -74.62 -150.38 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 9.83 111.48 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 2.1 mp0 -68.97 30.12 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.853 1.057 . . . . 11.32 113.853 -175.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.412 ' H ' ' C ' ' A' ' 67' ' ' SER . 39.8 t 0.0 101.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.228 1.411 . . . . 6.11 113.514 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -109.53 134.38 51.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.855 -0.338 . . . . 6.12 110.747 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -68.68 139.71 55.43 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.743 -0.465 . . . . 6.3 109.743 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.6 mt . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 121.228 0.537 . . . . 5.77 111.84 -172.914 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.614 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.906 0.384 . . . . 6.19 110.154 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 4.5 m -94.46 121.84 45.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.873 -0.603 . . . . 6.26 111.08 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.429 ' O ' HD23 ' A' ' 78' ' ' LEU . 2.2 tt -67.08 -27.54 67.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.586 -0.733 . . . . 6.05 109.859 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -131.29 103.56 6.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.188 -0.46 . . . . 7.02 111.238 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.96 -87.69 0.15 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.215 -0.661 . . . . 7.07 109.215 173.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.433 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 6.2 pt-20 -90.73 71.68 6.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.761 0.791 . . . . 6.68 110.353 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.468 ' HD3' ' H ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -68.53 137.64 54.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.442 -0.799 . . . . 6.43 109.935 177.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 m -140.39 170.42 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.037 0.446 . . . . 3.7 111.119 -174.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 p -115.7 139.88 49.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.768 -0.651 . . . . 3.49 109.689 175.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.7 155.18 20.0 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.032 -1.08 . . . . 2.58 112.878 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 m -111.04 127.0 55.4 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.388 -0.597 . . . . 3.34 109.388 175.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.573 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 57.3 t -69.21 120.63 17.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.217 -0.29 . . . . 3.14 110.217 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.5 p -107.47 -17.82 14.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.134 0.492 . . . . 3.61 111.113 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.7 m -150.78 131.29 13.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.38 -0.6 . . . . 3.12 109.38 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.77 -175.11 2.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.249 0.547 . . . . 4.39 111.296 -176.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.729 . . . . 3.62 109.675 179.915 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.45 -0.456 0 CA-C-O 120.988 0.423 . . . . 3.33 109.87 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.75 118.91 25.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.943 0.402 . . . . 2.57 110.793 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.74 175.23 47.48 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.832 -0.699 . . . . 1.66 112.689 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 108' ' ' ARG . 48.5 mmt-85 -132.47 126.72 33.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.862 0.363 . . . . 3.03 110.442 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.3 mt -111.64 126.49 69.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.052 -0.522 . . . . 1.88 109.82 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 118' ' ' PHE . 12.0 t -103.62 125.46 50.15 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.603 -0.517 . . . . 3.49 109.603 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 4.1 p90 -134.06 155.58 49.78 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.323 -0.621 . . . . 3.51 109.323 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.16 119.56 37.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.983 0.42 . . . . 5.1 110.137 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -142.99 133.08 24.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.496 -0.775 . . . . 4.78 108.988 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 63.48 21.27 12.68 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.647 0.592 . . . . 6.97 111.042 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.05 21.15 59.57 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.96 -0.564 . . . . 5.1 112.446 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -132.83 135.47 45.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.675 0.274 . . . . 5.38 110.68 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 4.0 p -111.82 116.41 30.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.316 -0.402 . . . . 4.72 110.662 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 110' ' ' SER . 81.5 m-85 -114.59 172.77 6.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 4.61 110.898 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -114.75 120.01 38.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.831 -0.622 . . . . 3.96 110.058 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.8 mt -106.28 135.16 19.51 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.818 -0.628 . . . . 2.75 111.737 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.02 138.75 18.62 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.952 2.435 . . . . 2.3 111.872 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -150.35 160.29 43.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.997 0.427 . . . . 2.13 110.888 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.0 p -123.31 175.01 6.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.302 -0.863 . . . . 3.07 109.66 175.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.2 ttpp -66.02 -23.39 66.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.548 0.69 . . . . 4.8 109.99 176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.5 -20.47 62.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.443 -0.799 . . . . 4.81 111.42 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -87.95 -2.63 58.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.09 -0.504 . . . . 3.84 110.671 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.16 137.61 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.258 -0.428 . . . . 4.39 111.516 -174.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -82.29 124.32 29.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.933 -0.576 . . . . 6.43 109.978 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.37 9.28 85.9 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.901 -0.666 . . . . 5.91 112.472 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.7 p30 47.08 29.27 1.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.14 0.976 . . . . 6.07 112.699 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.77 150.11 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.203 -0.453 . . . . 5.27 110.631 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -80.42 130.92 35.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.991 -0.55 . . . . 5.78 110.95 -175.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 mp -99.27 149.04 23.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.897 -0.592 . . . . 3.62 110.338 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -134.82 129.99 35.36 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.594 -0.521 . . . . 6.93 109.594 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.573 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -63.77 130.76 45.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.807 -0.633 . . . . 4.12 110.966 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.04 -23.09 10.13 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.519 -0.764 . . . . 4.07 112.307 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.09 177.42 5.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.101 0.477 . . . . 4.06 111.401 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -106.77 131.3 54.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.878 -0.601 . . . . 4.17 111.583 -170.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.25 165.95 18.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.213 -0.449 . . . . 2.77 110.326 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.1 m -129.71 127.93 41.46 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.816 -0.439 . . . . 3.47 109.816 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -128.99 150.21 50.5 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.963 -0.384 . . . . 3.35 109.963 -177.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -96.95 120.26 36.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.996 0.427 . . . . 5.34 110.113 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 59.2 mt -79.3 107.62 11.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.784 -0.644 . . . . 4.66 109.857 176.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -81.04 107.7 14.08 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.076 -0.713 . . . . 4.85 109.076 174.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 19.8 m -92.49 103.08 15.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.71 -0.677 . . . . 5.68 111.288 -173.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.522 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 15.5 m120 -67.91 153.63 43.31 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.566 -0.902 . . . . 6.25 108.566 170.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -64.65 -20.03 66.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.891 0.377 . . . . 8.58 111.339 -175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -72.08 -23.34 61.33 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.079 0.466 . . . . 7.86 110.531 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.22 22.91 59.9 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.533 -0.841 . . . . 5.59 112.406 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -122.58 114.29 20.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.204 -0.295 . . . . 5.18 110.204 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.485 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -146.55 -178.15 6.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.286 -0.415 . . . . 4.28 111.168 -175.155 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -122.77 -132.07 3.96 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.993 -0.843 . . . . 3.36 110.993 174.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -132.0 126.82 34.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.814 0.34 . . . . 2.84 110.277 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 80.4 m -140.35 162.44 35.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.29 -0.413 . . . . 4.34 110.664 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 57.32 53.18 7.88 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.813 0.696 . . . . 5.75 110.676 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.3 mt -82.12 115.0 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.523 -0.762 . . . . 3.55 110.097 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.414 ' HD2' HH11 ' A' ' 157' ' ' ARG . 20.9 ttt180 -114.52 129.94 56.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.785 -0.643 . . . . 5.96 110.602 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.468 HD21 ' HA ' ' A' ' 161' ' ' PRO . 50.9 tp -82.59 98.33 8.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.67 -0.696 . . . . 4.34 110.057 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -82.68 -23.66 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.076 -0.511 . . . . 4.97 111.084 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -133.59 102.43 12.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 5.37 110.065 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.468 ' HA ' HD21 ' A' ' 158' ' ' LEU . 71.8 Cg_endo -79.03 154.32 25.56 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.562 2.175 . . . . 5.44 112.738 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.854 -0.612 . . . . 6.1 111.744 -175.771 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.759 0.314 . . . . 12.4 111.021 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.65 172.68 12.44 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.79 -0.641 . . . . 11.63 109.88 -176.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.0 p -112.9 167.36 10.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.988 0.423 . . . . 9.15 111.534 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.6 172.65 37.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 116.19 -0.459 . . . . 6.81 112.189 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.0 mt -117.04 133.67 63.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.015 -0.365 . . . . 10.17 110.015 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.3 118.09 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.949 0.404 . . . . 8.73 110.585 176.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.52 -56.24 9.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.39 -0.823 . . . . 10.86 110.46 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -156.03 141.08 17.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.205 -0.907 . . . . 14.06 108.765 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.3 mt -98.2 103.16 15.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.268 0.556 . . . . 11.73 110.712 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 3.0 mm? -95.37 -179.77 4.89 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.034 -0.985 . . . . 11.36 108.412 173.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -90.68 123.11 34.03 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.518 -0.473 . . . . 15.94 110.022 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t 82.6 -27.86 0.11 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.453 1.095 . . . . 13.01 111.773 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 19.4 p90 -135.64 147.8 48.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.806 0.336 . . . . 12.34 111.304 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -139.89 162.85 26.3 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-N 116.055 -0.52 . . . . 7.52 111.87 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -118.38 146.89 44.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.821 0.31 . . . . 9.24 111.313 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.5 mt -121.34 128.16 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.301 -0.409 . . . . 7.75 110.535 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -76.85 146.0 38.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.202 0.525 . . . . 11.8 111.575 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.402 ' HB3' ' N ' ' A' ' 30' ' ' ARG . 6.5 p -79.82 -0.02 32.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.246 -0.888 . . . . 12.34 112.888 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.7 t -53.52 -31.32 45.73 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.85 0.685 . . . . 13.33 112.85 -173.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.97 -5.92 43.58 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.871 0.367 . . . . 11.9 111.889 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.517 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 12.0 ttt180 -131.66 -160.66 1.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.532 -0.303 . . . . 12.99 110.203 -173.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.517 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 78.0 mt-30 -118.66 14.93 13.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.379 0.609 . . . . 16.66 110.218 176.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.41 138.45 5.34 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.312 -0.858 . . . . 12.09 110.213 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.402 ' N ' ' HB3' ' A' ' 24' ' ' CYS . 6.6 ptp180 -85.62 151.02 24.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.424 -0.584 . . . . 12.51 109.424 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -138.86 162.52 34.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.026 0.441 . . . . 8.76 110.887 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.38 142.24 51.48 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.951 -0.759 . . . . 9.15 108.951 173.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -128.35 147.38 50.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.001 -0.37 . . . . 6.85 110.001 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.48 ' HB2' ' OE1' ' A' ' 37' ' ' GLN . 76.3 m-70 -95.64 160.81 14.32 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.525 -0.546 . . . . 9.99 109.525 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -70.71 -4.24 22.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.816 0.341 . . . . 9.93 111.675 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -85.75 -7.39 58.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.944 -0.391 . . . . 12.28 109.944 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.48 ' OE1' ' HB2' ' A' ' 34' ' ' HIS . 23.4 mp0 -117.44 40.48 3.05 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.936 -0.575 . . . . 10.62 111.199 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -122.63 139.48 53.88 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.42 -0.512 . . . . 8.78 111.142 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.3 t -116.27 114.49 24.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.549 . . . . 8.97 110.036 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.05 -161.35 23.51 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.736 . . . . 9.98 111.823 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -83.06 108.11 16.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.215 -0.291 . . . . 12.43 110.215 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 45' ' ' LEU . 10.6 tp -68.52 -25.16 30.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.344 0.592 . . . . 11.58 110.081 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -66.68 -22.7 66.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.489 -0.778 . . . . 14.73 110.908 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -105.45 20.25 19.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.854 -0.612 . . . . 13.3 111.303 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 45' ' ' LEU . 1.5 mt -87.2 133.97 33.59 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.021 -0.363 . . . . 10.07 110.021 175.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -127.6 167.0 16.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.462 -0.57 . . . . 13.13 109.462 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.5 mp -81.99 132.82 30.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.563 -0.532 . . . . 11.74 109.563 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.65 11.24 58.27 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.647 -0.787 . . . . 10.13 111.987 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 32.3 t70 -86.15 133.35 41.03 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.655 -0.273 . . . . 8.39 110.75 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 49' ' ' ASP . 6.6 Cg_endo -86.18 127.42 2.95 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.241 2.627 . . . . 7.28 112.638 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.9 m -125.33 160.33 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.43 . . . . 4.74 111.092 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -112.54 128.03 56.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.913 -0.585 . . . . 7.09 110.029 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -131.94 150.19 52.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.345 0.593 . . . . 7.82 111.048 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 16.4 tt0 -101.58 119.65 39.1 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.735 -0.839 . . . . 11.59 108.735 177.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 14.3 tpt -90.93 133.42 35.28 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.909 -0.404 . . . . 12.41 109.909 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.402 HG23 HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -155.91 169.81 23.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.966 0.412 . . . . 13.17 110.531 -172.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -126.4 109.44 12.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.742 0.305 . . . . 16.21 110.426 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -83.12 113.42 20.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.223 -0.444 . . . . 16.64 110.108 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -79.21 -10.31 59.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.36 -0.382 . . . . 22.64 111.783 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -74.34 -41.54 60.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.405 -0.591 . . . . 21.43 109.405 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.8 p -88.55 -40.81 13.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.255 -0.43 . . . . 17.4 110.817 174.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.78 31.92 11.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.906 -0.664 . . . . 16.7 112.207 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -132.59 152.92 80.83 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.056 -0.35 . . . . 14.73 110.056 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.75 125.85 10.88 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.293 1.996 . . . . 12.6 110.641 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 56' ' ' THR . 2.0 pp -138.85 153.81 25.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.537 0.684 . . . . 11.73 112.251 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.42 157.29 16.52 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.576 -0.898 . . . . 8.91 108.576 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.8 t -70.66 -162.95 0.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.006 -0.368 . . . . 9.83 110.006 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -72.77 27.13 0.06 Allowed 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 113.368 0.877 . . . . 11.32 113.368 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.3 t 32.23 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.438 1.095 . . . . 6.11 113.664 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.5 t -88.61 151.29 22.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.429 -0.805 . . . . 6.12 111.378 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -87.55 137.96 31.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.376 -0.829 . . . . 6.3 110.993 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.8 mt . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.064 -0.516 . . . . 5.77 109.873 177.864 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.428 HG12 ' HB1' ' A' ' 144' ' ' ALA . 9.2 t . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 109.497 -0.557 . . . . 6.19 109.497 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 29.0 t -80.25 97.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.067 0.395 . . . . 6.26 112.067 -171.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.474 ' CD2' ' HB2' ' A' ' 144' ' ' ALA . 22.2 mt -88.96 -30.36 18.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.525 . . . . 6.05 110.948 175.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 p -98.95 96.95 8.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.334 0.588 . . . . 7.02 111.616 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.52 -69.14 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.434 -0.803 . . . . 7.07 109.31 174.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -131.57 147.67 52.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.899 -0.591 . . . . 6.68 109.987 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.4 ptt85 -107.77 125.88 51.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.845 0.355 . . . . 6.43 110.158 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.12 158.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.066 0.46 . . . . 3.7 111.9 -173.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.8 p -118.65 140.65 49.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.39 -0.823 . . . . 3.49 109.622 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.45 170.16 24.27 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.075 -1.06 . . . . 2.58 112.615 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.5 m -115.69 135.36 54.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.528 -0.545 . . . . 3.34 109.528 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 21.9 t -67.36 115.36 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.589 -0.522 . . . . 3.14 109.589 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.05 -34.1 15.24 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.326 0.584 . . . . 3.61 110.042 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.7 m -151.26 120.75 6.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.619 -0.719 . . . . 3.12 109.613 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.74 -176.82 5.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.799 0.333 . . . . 4.39 110.465 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.515 -0.311 . . . . 3.62 110.186 178.675 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.578 0 CA-C-O 121.003 0.43 . . . . 3.33 111.845 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 m -142.55 127.84 18.76 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.198 -0.667 . . . . 2.57 109.198 173.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -94.7 176.02 34.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.582 -0.818 . . . . 1.66 112.581 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 20.3 mmt180 -133.43 132.31 40.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.643 0.259 . . . . 3.03 110.599 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.4 HG21 ' CE2' ' A' ' 141' ' ' PHE . 79.0 mt -113.94 130.66 67.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.028 -0.533 . . . . 1.88 109.584 174.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.5 p -105.86 123.0 47.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.316 -0.402 . . . . 3.49 110.389 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.686 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -140.47 152.36 45.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.817 0.341 . . . . 3.51 110.608 178.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.455 ' HG3' ' HB3' ' A' ' 117' ' ' CYS . 4.8 mp0 -107.31 122.48 46.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.053 0.454 . . . . 5.1 110.165 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -131.96 120.85 23.05 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.698 -0.683 . . . . 4.78 109.823 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 61.09 31.96 19.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.326 0.584 . . . . 6.97 110.861 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -20.15 50.82 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.413 -0.812 . . . . 5.1 113.395 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -99.47 136.32 39.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.672 0.273 . . . . 5.38 110.833 -175.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.455 ' HB3' ' HG3' ' A' ' 112' ' ' GLU . 7.8 p -102.51 128.3 49.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.178 -0.465 . . . . 4.72 110.572 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -128.59 164.2 23.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.323 -0.398 . . . . 4.61 110.875 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -122.85 114.37 20.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.696 -0.683 . . . . 3.96 109.595 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.686 HD11 ' CE2' ' A' ' 111' ' ' TYR . 2.5 mp -105.49 140.94 21.65 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.682 0.277 . . . . 2.75 110.878 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 94.1 Cg_endo -79.3 155.82 25.43 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.104 2.536 . . . . 2.3 112.068 175.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -163.99 163.68 23.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.9 -0.408 . . . . 2.13 109.9 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -118.76 -179.15 3.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.996 0.427 . . . . 3.07 111.154 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -71.57 -21.26 61.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.08 -0.509 . . . . 4.8 110.54 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.49 -9.73 57.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 4.81 111.238 -173.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -85.41 -25.42 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 3.84 111.7 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 p -92.49 123.05 44.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.518 0.675 . . . . 4.39 110.69 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.61 159.63 16.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.6 -0.727 . . . . 6.43 110.844 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.92 -16.44 60.95 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.852 -0.689 . . . . 5.91 112.274 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 68.94 16.26 8.8 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.917 0.487 . . . . 6.07 110.783 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 t -72.45 116.29 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 5.27 110.088 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -85.98 84.86 7.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.749 0.785 . . . . 5.78 110.706 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.608 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.2 pt? -81.44 150.71 28.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.1 -1.409 . . . . 3.62 110.761 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.559 ' HD2' ' H ' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -110.49 -179.74 3.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.219 -0.659 . . . . 6.93 109.219 177.247 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.595 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.45 131.81 41.38 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.423 -0.511 . . . . 4.12 111.05 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.53 -14.55 13.14 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.135 -0.555 . . . . 4.07 112.072 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' A' ' 161' ' ' PRO . 4.9 m-20 -81.11 154.38 26.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.633 0.254 . . . . 4.06 110.544 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 160' ' ' ASN . 13.4 mmmm -104.6 127.83 52.45 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.162 0.506 . . . . 4.17 110.372 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.7 m -130.35 160.58 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.386 -0.825 . . . . 2.77 112.382 -171.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.6 p -122.53 140.96 52.19 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.993 -1.003 . . . . 3.47 109.534 172.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.503 ' HE1' HD11 ' A' ' 143' ' ' ILE . 19.9 p90 -151.24 167.9 26.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.568 -0.287 . . . . 3.35 110.654 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -104.24 133.42 49.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.15 0.5 . . . . 5.34 110.779 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.503 HD11 ' HE1' ' A' ' 141' ' ' PHE . 34.6 mm -95.49 102.27 13.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.428 -0.805 . . . . 4.66 110.368 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -87.59 108.78 19.23 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.622 -0.431 . . . . 4.85 110.406 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 15.6 m -90.04 125.7 35.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.046 -0.524 . . . . 5.68 111.345 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -98.72 164.98 12.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.204 -1.036 . . . . 6.25 108.204 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -59.98 -24.8 64.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.943 0.497 . . . . 8.58 111.883 -174.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -70.6 -17.75 62.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 7.86 110.868 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.93 5.39 86.24 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.856 -0.688 . . . . 5.59 111.891 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -99.39 119.64 38.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.164 -0.68 . . . . 5.18 109.164 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.504 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -132.87 163.33 29.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.171 0.51 . . . . 4.28 112.23 -177.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -136.14 -173.26 12.9 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.782 -0.927 . . . . 3.36 110.782 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.7 120.88 40.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.103 0.452 . . . . 2.84 110.91 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.6 t -128.12 154.37 45.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.749 -0.463 . . . . 4.34 109.749 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 55.75 65.29 1.5 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.794 0.807 . . . . 5.75 110.266 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.5 mt -92.44 135.29 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.566 -1.197 . . . . 3.55 109.794 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -132.14 152.84 51.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.909 -0.404 . . . . 5.96 109.909 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.9 tp -101.47 123.71 45.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.176 -0.465 . . . . 4.34 110.24 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -111.59 -40.56 4.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.515 -0.311 . . . . 4.97 111.067 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . 0.486 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 7.7 t30 -118.95 101.11 50.47 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 110.226 -0.287 . . . . 5.37 110.226 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.412 ' HA ' ' OD1' ' A' ' 137' ' ' ASP . 82.3 Cg_endo -83.15 155.56 14.75 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.127 2.551 . . . . 5.44 113.43 -176.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.78 -0.646 . . . . 6.1 110.86 177.409 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.193 0.52 . . . . 12.4 110.033 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.487 ' CG ' ' HG3' ' A' ' 27' ' ' ARG . 35.5 tt0 -100.02 136.61 39.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.463 -0.789 . . . . 11.63 109.014 -177.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 52' ' ' GLU . 38.0 p -96.95 151.84 19.3 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.947 -0.301 . . . . 9.15 110.674 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.29 -177.5 37.75 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.913 -0.661 . . . . 6.81 111.893 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.509 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 1.2 mt -130.06 146.41 34.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.343 -0.614 . . . . 10.17 109.343 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.72 118.56 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.437 -0.579 . . . . 8.73 109.437 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -87.65 -44.72 10.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.536 -0.756 . . . . 10.86 109.37 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -149.16 154.59 39.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.217 -0.901 . . . . 14.06 110.806 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.8 mt -119.14 109.68 16.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.656 . . . . 11.73 110.169 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.401 HD13 ' CD2' ' A' ' 19' ' ' TYR . 4.6 mp -99.47 179.04 4.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.238 -1.023 . . . . 11.36 108.238 176.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -90.44 114.14 26.23 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.148 -0.621 . . . . 15.94 110.354 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 m 72.16 16.38 5.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.942 -1.026 . . . . 13.01 111.095 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.401 ' CD2' HD13 ' A' ' 16' ' ' LEU . 47.2 t80 -156.58 139.87 15.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.717 -0.674 . . . . 12.34 109.764 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.433 ' HA3' ' CE1' ' A' ' 33' ' ' PHE . . . -127.44 156.45 20.46 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.697 -0.763 . . . . 7.52 112.667 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.74 129.83 55.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.463 -0.199 . . . . 9.24 110.463 -176.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -114.22 127.55 71.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.153 -0.314 . . . . 7.75 110.153 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 9.8 pt20 -83.14 144.14 30.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.62 0.724 . . . . 11.8 111.877 -175.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 p -79.54 2.23 22.96 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 114.461 -1.245 . . . . 12.34 112.764 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.4 m -53.2 -24.46 11.03 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.803 0.668 . . . . 13.33 112.803 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -91.4 -6.95 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.977 0.362 . . . . 11.9 111.977 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HG3' ' CG ' ' A' ' 8' ' ' GLU . 9.7 mmt85 -151.33 -158.53 0.92 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.999 0.428 . . . . 12.99 110.529 -170.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.74 28.57 6.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.045 0.45 . . . . 16.66 109.996 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.48 135.22 19.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.844 -0.617 . . . . 12.09 110.699 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 16.7 ptp180 -89.39 121.76 31.95 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.658 -0.497 . . . . 12.51 109.658 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.37 155.13 23.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.172 0.51 . . . . 8.76 110.77 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -132.06 142.88 49.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.701 -0.681 . . . . 9.15 109.555 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.433 ' CE1' ' HA3' ' A' ' 20' ' ' GLY . 17.6 p90 -126.63 163.79 22.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.027 0.441 . . . . 6.85 110.416 -176.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -112.65 152.44 28.97 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.691 -0.485 . . . . 9.99 109.691 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -62.98 -21.55 66.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.316 -0.402 . . . . 9.93 111.772 -175.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.6 t -72.93 -19.82 61.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.526 -0.306 . . . . 12.28 111.09 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 1.9 mp0 -95.56 -26.24 15.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.603 -0.272 . . . . 10.62 111.41 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -68.48 112.81 5.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 8.78 110.553 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.2 t -91.56 97.22 10.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.977 -0.556 . . . . 8.97 110.195 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.6 -176.04 34.8 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.84 -0.904 . . . . 9.98 110.84 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -77.67 95.75 4.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.816 0.341 . . . . 12.43 110.176 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -60.75 -25.86 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.383 0.611 . . . . 11.58 110.514 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.38 -25.79 68.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.369 -0.832 . . . . 14.73 111.22 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -108.18 17.52 22.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.39 -0.368 . . . . 13.3 111.069 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.7 tp -97.71 125.95 42.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.009 -0.737 . . . . 10.07 109.009 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -123.4 173.88 7.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.998 -0.371 . . . . 13.13 109.998 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 47' ' ' ILE . 3.8 mp -70.97 131.78 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.968 -0.382 . . . . 11.74 109.968 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.79 2.24 58.51 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.504 -0.855 . . . . 10.13 112.276 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.0 124.61 89.58 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 110.559 -0.163 . . . . 8.39 110.559 175.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.55 132.05 7.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.788 2.326 . . . . 7.28 112.662 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.451 HG12 ' HG2' ' A' ' 71' ' ' LYS . 27.3 m -136.96 161.18 36.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.115 0.483 . . . . 4.74 111.311 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.424 ' HB3' HG22 ' A' ' 9' ' ' THR . 6.6 pt-20 -120.41 136.67 54.65 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.175 -0.676 . . . . 7.09 109.175 170.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -131.8 148.91 52.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.451 0.643 . . . . 7.82 111.214 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 35.8 tt0 -88.98 110.49 21.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.408 -0.815 . . . . 11.59 109.309 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.61 105.32 13.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.271 -0.64 . . . . 12.41 109.271 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.419 HG23 ' HG2' ' A' ' 54' ' ' GLU . 23.9 p -134.87 171.25 14.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.373 0.606 . . . . 13.17 111.987 -174.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -113.45 111.02 21.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.739 -0.664 . . . . 16.21 110.394 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -72.59 122.84 22.05 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.777 -0.453 . . . . 16.64 109.777 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -79.36 -6.74 57.46 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.666 0.617 . . . . 22.64 112.666 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -82.91 -44.54 15.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.49 . . . . 21.43 109.807 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.9 p -90.69 -28.23 18.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.832 -0.622 . . . . 17.4 111.391 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.9 29.13 61.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.113 -0.565 . . . . 16.7 111.871 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -127.37 153.73 77.17 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 110.224 -0.287 . . . . 14.73 110.224 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.77 125.47 9.47 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.051 1.834 . . . . 12.6 111.061 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -138.44 179.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.193 0.52 . . . . 11.73 111.078 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.7 139.32 50.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.724 -0.671 . . . . 8.91 109.302 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 14.7 m -70.16 -148.03 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.096 -0.502 . . . . 9.83 110.949 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 14.0 mm100 -66.74 29.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.841 1.423 . . . . 11.32 114.841 -170.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 68' ' ' GLN . 39.0 t 4.97 99.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 125.201 1.4 . . . . 6.11 113.677 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.8 m -112.15 138.02 49.41 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.981 0.419 . . . . 6.12 110.522 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.451 ' HG2' HG12 ' A' ' 51' ' ' VAL . 50.0 mtpt -70.51 142.2 51.87 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.494 -0.558 . . . . 6.3 109.494 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.3 mt . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 121.282 0.563 . . . . 5.77 110.739 -178.064 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.415 ' CG1' ' HB1' ' A' ' 144' ' ' ALA . 18.3 t . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.536 0.208 . . . . 6.19 111.09 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.07 111.6 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.493 -0.321 . . . . 6.26 110.908 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -112.16 -7.57 14.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.919 0.39 . . . . 6.05 111.507 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.8 m -85.45 28.6 0.74 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.34 0.496 . . . . 7.02 112.34 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.92 -36.78 13.26 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.585 -0.446 . . . . 7.07 111.372 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -169.13 144.65 3.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.291 0.567 . . . . 6.68 111.3 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -112.49 97.44 6.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.383 -0.826 . . . . 6.43 109.136 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.88 168.15 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.328 0.585 . . . . 3.7 111.137 -175.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -108.85 139.09 44.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.512 -0.767 . . . . 3.49 110.729 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -135.27 166.49 24.43 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.593 -0.813 . . . . 2.58 112.379 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 m -118.4 134.62 54.91 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.634 -0.506 . . . . 3.34 109.634 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 47.9 t -67.46 123.89 21.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.792 -0.447 . . . . 3.14 109.792 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.7 -24.13 12.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.196 -0.456 . . . . 3.61 111.131 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.6 m -153.09 132.44 12.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.084 -0.507 . . . . 3.12 110.11 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -92.52 -172.37 3.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.946 0.403 . . . . 4.39 110.169 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 108.711 -0.848 . . . . 3.62 108.711 172.074 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 122.153 0.978 . . . . 3.33 109.311 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.401 HG21 ' HB2' ' A' ' 121' ' ' PRO . 15.6 m -94.27 132.96 38.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.036 -0.984 . . . . 2.57 110.612 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.75 169.35 48.28 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.795 -0.717 . . . . 1.66 112.323 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -130.81 134.79 47.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.261 0.553 . . . . 3.03 111.551 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.495 HG13 ' CD1' ' A' ' 122' ' ' TYR . 97.7 mt -112.9 125.41 70.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.967 -1.015 . . . . 1.88 109.435 172.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 p -97.66 126.16 42.83 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.691 -0.485 . . . . 3.49 109.691 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -134.23 154.42 51.27 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.844 -0.428 . . . . 3.51 109.844 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -115.54 121.31 42.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.175 -0.466 . . . . 5.1 110.38 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.517 ' OD1' ' HG3' ' A' ' 114' ' ' ARG . 23.5 t-20 -160.69 143.27 12.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.464 . . . . 4.78 109.959 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.517 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 79.7 mtp180 64.48 20.77 12.27 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.464 0.478 . . . . 6.97 110.893 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.75 1.12 90.1 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.855 -0.611 . . . . 5.1 112.555 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -114.29 151.05 33.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.658 -0.497 . . . . 5.38 109.658 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.47 104.64 10.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.136 0.493 . . . . 4.72 110.435 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -104.2 169.24 8.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.757 -0.656 . . . . 4.61 111.054 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -120.27 123.15 42.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.708 -0.678 . . . . 3.96 110.173 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.51 138.19 19.44 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.536 -0.302 . . . . 2.75 110.372 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HB2' HG21 ' A' ' 106' ' ' THR . 73.3 Cg_endo -76.83 142.62 22.7 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.773 2.315 . . . . 2.3 111.827 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.495 ' CD1' HG13 ' A' ' 109' ' ' ILE . 34.5 p90 -146.35 152.27 38.85 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.086 0.469 . . . . 2.13 110.776 176.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.83 156.81 23.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.714 -0.676 . . . . 3.07 110.304 174.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -66.97 -28.15 68.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.084 0.469 . . . . 4.8 111.252 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.62 -16.18 63.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.811 -0.631 . . . . 4.81 111.38 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.05 23.93 12.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.078 -0.51 . . . . 3.84 111.242 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.08 114.71 39.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.352 0.596 . . . . 4.39 111.338 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 157' ' ' ARG . 0.6 OUTLIER -79.71 151.78 30.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.428 -0.805 . . . . 6.43 108.856 178.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.14 -16.55 42.58 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.714 -0.755 . . . . 5.91 111.47 -174.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m120 63.47 24.76 14.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.257 0.623 . . . . 6.07 111.445 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.61 138.17 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.362 -0.381 . . . . 5.27 109.985 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -83.01 91.84 7.25 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.737 -0.468 . . . . 5.78 109.737 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.1 pt? -71.69 144.2 49.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.633 -0.712 . . . . 3.62 110.943 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -140.69 148.96 41.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.833 -0.622 . . . . 6.93 110.33 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.645 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -49.98 124.34 9.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.124 -0.489 . . . . 4.12 112.181 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.0 -24.43 8.3 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.477 -0.783 . . . . 4.07 113.569 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -87.65 178.07 6.86 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 117.782 0.791 . . . . 4.06 110.625 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -117.18 122.77 44.96 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.461 0.648 . . . . 4.17 111.58 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.02 157.66 20.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.979 -1.01 . . . . 2.77 110.788 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.0 m -113.89 129.9 56.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.445 -0.576 . . . . 3.47 109.445 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -126.4 139.19 53.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.127 0.489 . . . . 3.35 109.734 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -94.97 116.84 29.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.588 -0.733 . . . . 5.34 109.417 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 76.4 mt -77.7 111.52 14.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.854 -0.612 . . . . 4.66 110.304 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . . . -97.43 109.04 21.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.585 -0.734 . . . . 4.85 110.658 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 88.6 m -85.43 120.86 27.36 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.455 0.472 . . . . 5.68 111.076 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -72.74 171.33 12.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.557 . . . . 6.25 110.698 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -57.92 -22.39 48.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.167 0.803 . . . . 8.58 113.167 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -111.08 -2.7 15.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.109 -0.636 . . . . 7.86 111.617 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 98.07 11.03 50.66 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.281 -0.961 . . . . 5.59 114.469 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -98.19 132.27 43.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.812 -0.81 . . . . 5.18 108.812 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.476 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -146.6 -178.24 6.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.212 0.53 . . . . 4.28 112.333 -174.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.16 -122.77 1.47 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.862 -1.063 . . . . 3.36 111.026 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.87 131.47 33.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.917 0.358 . . . . 2.84 110.389 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 74.5 m -142.65 159.53 42.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.128 -0.487 . . . . 4.34 109.738 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 57.72 54.96 5.84 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.762 0.664 . . . . 5.75 110.68 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.2 mp -82.84 114.22 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.803 -0.443 . . . . 3.55 109.803 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.45 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 34.3 ttt180 -120.14 128.76 53.72 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.99 -0.374 . . . . 5.96 109.99 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.2 tt -77.04 117.01 18.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.998 -0.546 . . . . 4.34 110.012 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -92.2 -54.82 3.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 4.97 111.015 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -122.1 106.46 36.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.068 -0.515 . . . . 5.37 110.653 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.58 -176.62 3.32 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.262 1.974 . . . . 5.44 112.069 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.994 -0.548 . . . . 6.1 110.186 178.868 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 . . . . . 0 CA--C 1.52 -0.192 0 N-CA-C 109.814 -0.439 . . . . 12.4 109.814 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.428 ' CD ' ' HB2' ' A' ' 55' ' ' MET . 7.5 pt-20 -121.41 138.04 54.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.191 0.519 . . . . 11.63 111.056 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.0 p -109.11 160.89 15.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.031 -0.531 . . . . 9.15 111.562 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.73 174.28 42.11 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.001 -0.839 . . . . 6.81 111.001 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.9 mt -109.87 144.94 17.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.767 0.283 . . . . 10.17 110.393 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.402 HD11 HG11 ' A' ' 51' ' ' VAL . 45.9 mm -66.33 114.35 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.284 -0.265 . . . . 8.73 110.284 174.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.21 -55.17 5.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 10.86 111.49 -176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.595 ' HD3' ' N ' ' A' ' 15' ' ' LEU . 8.2 tmtt? -159.39 136.47 9.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.729 -0.471 . . . . 14.06 109.729 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.595 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 72.7 mt -93.62 117.17 29.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.311 0.577 . . . . 11.73 111.492 178.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.17 -178.57 3.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.876 -1.157 . . . . 11.36 107.876 172.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -88.26 130.61 35.05 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.082 -0.647 . . . . 15.94 109.696 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m 75.28 -44.24 0.53 Allowed 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.303 1.002 . . . . 13.01 112.016 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -121.87 148.85 44.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.131 0.491 . . . . 12.34 111.417 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -139.89 169.86 24.5 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.478 -0.649 . . . . 7.52 111.478 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -121.86 144.53 48.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.057 0.456 . . . . 9.24 111.608 -177.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -105.83 129.92 58.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.655 -0.702 . . . . 7.75 109.695 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.512 ' HG3' ' H ' ' A' ' 25' ' ' CYS . 13.8 tp60 -77.07 132.77 39.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.928 -0.578 . . . . 11.8 111.27 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.593 ' HB3' ' N ' ' A' ' 30' ' ' ARG . 6.5 p -84.94 0.62 50.6 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.348 0.87 . . . . 12.34 113.348 175.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.512 ' H ' ' HG3' ' A' ' 23' ' ' GLN . 68.4 m -60.74 -22.93 64.54 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.675 0.991 . . . . 13.33 113.675 -168.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -102.59 -29.47 11.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.347 0.594 . . . . 11.9 110.435 -178.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.535 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 12.6 ttp85 -105.61 -157.69 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.447 -0.797 . . . . 12.99 110.088 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.535 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 44.4 mt-30 -123.37 21.34 9.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 16.66 110.744 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.13 115.38 5.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.787 0.327 . . . . 12.09 111.847 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.593 ' N ' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -87.03 141.59 28.56 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.873 -0.788 . . . . 12.51 108.873 172.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.9 mt -138.37 162.39 34.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.662 0.267 . . . . 8.76 110.95 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -113.19 148.56 35.2 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.515 -0.55 . . . . 9.15 109.515 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -145.39 159.4 43.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.511 -0.551 . . . . 6.85 109.511 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -106.75 162.78 13.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.439 -0.578 . . . . 9.99 109.439 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.52 -19.12 65.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.938 0.399 . . . . 9.93 110.508 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.7 p -76.91 -15.32 59.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.031 -0.531 . . . . 12.28 110.729 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -102.06 20.69 16.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.389 -0.369 . . . . 10.62 110.789 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -123.02 108.11 12.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.222 0.534 . . . . 8.78 109.717 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' A' ' 68' ' ' GLN . 51.1 m -94.44 104.33 16.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.711 -0.677 . . . . 8.97 111.052 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.37 -165.84 35.07 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.48 -1.048 . . . . 9.98 110.48 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -94.21 119.34 32.87 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 117.347 0.573 . . . . 12.43 109.904 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.81 -20.66 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 11.58 111.067 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.65 -3.99 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 14.73 111.355 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -118.41 21.87 12.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.073 0.464 . . . . 13.3 109.89 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -125.88 112.34 15.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.205 -0.665 . . . . 10.07 109.205 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -120.05 178.58 4.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.255 0.55 . . . . 13.13 111.298 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.51 130.73 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.383 -0.826 . . . . 11.74 109.363 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.12 10.9 61.97 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.41 -0.9 . . . . 10.13 110.991 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -89.06 123.52 67.15 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.137 -0.531 . . . . 8.39 110.05 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.51 126.6 11.69 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.661 2.241 . . . . 7.28 112.539 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.422 HG12 ' CD ' ' A' ' 71' ' ' LYS . 28.0 m -125.51 151.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 4.74 111.389 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.33 129.8 56.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.222 -0.658 . . . . 7.09 109.222 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -144.61 175.56 10.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.249 0.547 . . . . 7.82 111.357 -175.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -123.48 138.44 54.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.604 -0.726 . . . . 11.59 109.969 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.428 ' HB2' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -92.1 111.38 22.91 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.56 -0.533 . . . . 12.41 109.56 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 p -134.43 133.77 40.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 13.17 112.037 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 64' ' ' PRO . 16.8 m-85 -89.13 109.6 20.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.158 -0.474 . . . . 16.21 110.103 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -77.28 97.38 4.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.723 -0.473 . . . . 16.64 109.723 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -72.38 -5.43 36.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.318 -0.401 . . . . 22.64 111.471 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -69.63 -30.6 68.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.356 -0.609 . . . . 21.43 109.356 174.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.9 p -113.11 -36.93 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.799 -0.637 . . . . 17.4 111.208 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.34 17.29 15.94 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.955 -0.566 . . . . 16.7 112.128 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -121.02 148.66 49.39 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.641 0.258 . . . . 14.73 111.277 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 78.7 Cg_endo -80.17 126.34 6.26 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.42 2.08 . . . . 12.6 112.144 175.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.0 pt -132.28 165.0 33.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.075 0.464 . . . . 11.73 110.555 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.52 157.24 16.3 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.979 -0.749 . . . . 8.91 108.979 171.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.9 t -70.68 -162.55 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.873 0.368 . . . . 9.83 110.038 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.449 ' HB2' ' OG ' ' A' ' 39' ' ' SER . 22.3 pt20 -74.05 8.16 2.25 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.66 0.615 . . . . 11.32 112.66 -172.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.2 t 53.33 99.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.705 0.764 . . . . 6.11 112.572 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -96.26 129.98 43.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.039 -0.528 . . . . 6.12 110.105 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.422 ' CD ' HG12 ' A' ' 51' ' ' VAL . 13.9 mmmm -76.72 132.34 39.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.242 -0.435 . . . . 6.3 110.411 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.6 mt . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 115.759 -0.655 . . . . 5.77 110.573 -176.123 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.544 HG12 ' HB1' ' A' ' 144' ' ' ALA . 22.4 t . . . . . 0 C--O 1.234 0.246 0 CA-C-O 120.788 0.328 . . . . 6.19 111.242 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 64.0 t -77.27 102.86 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 6.26 111.402 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -98.32 16.23 22.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.822 0.82 . . . . 6.05 108.829 177.041 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -102.63 77.06 1.57 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.511 0.672 . . . . 7.02 110.137 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -149.17 106.8 3.65 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.974 -1.121 . . . . 7.07 107.974 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.47 ' OE1' ' HG2' ' A' ' 82' ' ' ARG . 7.8 tp10 -44.67 140.87 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.09 -0.959 . . . . 6.68 111.955 -175.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.47 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 8.5 ptp85 -60.14 106.73 0.55 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.99 -1.004 . . . . 6.43 110.973 -176.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.04 156.18 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.638 -0.71 . . . . 3.7 110.133 178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.7 p -115.77 140.0 49.63 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.827 -0.624 . . . . 3.49 110.695 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.6 166.9 26.04 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.649 -0.786 . . . . 2.58 112.052 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -97.02 127.97 43.52 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.173 -0.306 . . . . 3.34 110.173 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 91.2 t -64.0 124.51 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.479 -0.328 . . . . 3.14 110.242 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.7 p -112.02 -8.26 14.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.748 0.309 . . . . 3.61 111.159 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.476 ' HB ' ' N ' ' A' ' 108' ' ' ARG . 11.4 m -152.29 138.58 18.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.46 -0.336 . . . . 3.12 110.275 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.588 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 18.5 mt-10 -119.16 161.71 19.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 4.39 110.851 -174.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.427 HD22 ' HG3' ' A' ' 124' ' ' LYS . 5.2 mp . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 108.85 -0.796 . . . . 3.62 108.85 173.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 108.759 -0.83 . . . . 3.33 108.759 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 p -125.3 122.19 36.16 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.19 0.441 . . . . 2.57 112.19 -172.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -72.53 156.43 52.02 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 108.891 -1.683 . . . . 1.66 108.891 166.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.476 ' N ' ' HB ' ' A' ' 89' ' ' THR . 19.5 mtt180 -135.08 141.68 46.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.511 1.156 . . . . 3.03 111.723 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 72.4 mt -113.21 128.5 69.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.01 -0.995 . . . . 1.88 109.516 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 t -104.69 122.55 45.91 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.282 -0.636 . . . . 3.49 109.282 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -131.75 167.56 19.3 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.146 -0.316 . . . . 3.51 110.146 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -137.26 118.29 14.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.009 -0.738 . . . . 5.1 109.009 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -132.81 113.64 13.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.362 -0.381 . . . . 4.78 110.712 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 65.34 23.23 12.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.118 -0.492 . . . . 6.97 111.191 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.31 5.63 61.91 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.021 -0.609 . . . . 5.1 112.672 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -110.68 118.12 35.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.056 0.455 . . . . 5.38 110.157 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.5 p -119.97 125.09 47.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.954 -0.566 . . . . 4.72 110.584 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -134.81 172.36 13.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.706 0.289 . . . . 4.61 110.576 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -112.21 119.36 38.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.738 -0.665 . . . . 3.96 109.416 174.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 3.1 mm? -104.54 118.17 57.23 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.711 0.291 . . . . 2.75 110.344 -177.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 32.9 Cg_endo -80.2 131.67 8.87 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.19 1.927 . . . . 2.3 111.569 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -133.39 156.69 47.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.787 0.327 . . . . 2.13 110.273 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.64 169.01 9.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.99 -0.55 . . . . 3.07 110.156 175.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.427 ' HG3' HD22 ' A' ' 91' ' ' LEU . 52.8 mtmt -70.76 -18.95 62.76 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.08 0.4 . . . . 4.8 112.08 -174.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.59 -5.39 57.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.344 -0.389 . . . . 4.81 111.149 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -86.77 -13.84 44.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.652 -0.249 . . . . 3.84 111.031 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 156' ' ' ILE . 4.7 p -119.27 112.69 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.224 0.535 . . . . 4.39 110.688 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 155' ' ' HIS . 0.8 OUTLIER -95.05 175.17 6.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.167 -0.47 . . . . 6.43 110.415 178.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.76 -12.71 68.68 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.653 -0.784 . . . . 5.91 111.869 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.6 m120 59.31 41.41 19.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.062 0.458 . . . . 6.07 111.251 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.71 150.42 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.869 -0.605 . . . . 5.27 110.331 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -101.44 85.38 2.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.131 0.491 . . . . 5.78 110.037 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.724 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.1 pt? -75.37 128.6 35.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.694 -0.684 . . . . 3.62 110.325 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.588 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 18.0 tpt180 -105.65 143.71 33.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.673 . . . . 6.93 110.448 -173.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.603 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -63.82 113.64 3.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.997 0.427 . . . . 4.12 110.051 174.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 116.31 -11.52 16.79 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.268 -0.733 . . . . 4.07 111.268 -173.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.533 ' OD2' ' HA ' ' A' ' 161' ' ' PRO . 4.9 t70 -87.83 -179.13 6.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.211 -0.663 . . . . 4.06 109.211 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -122.87 114.62 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.123 0.487 . . . . 4.17 110.71 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.2 m -119.93 149.8 22.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.068 0.461 . . . . 2.77 111.316 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -100.88 135.07 42.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.602 -0.726 . . . . 3.47 109.554 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.444 ' C ' HE21 ' A' ' 142' ' ' GLN . 24.4 p90 -144.95 149.71 35.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.41 -0.359 . . . . 3.35 110.536 -178.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . 0.713 HE21 ' N ' ' A' ' 142' ' ' GLN . 0.0 OUTLIER -102.7 139.36 38.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.191 -0.459 . . . . 5.34 109.893 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.2 mt -101.88 100.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.033 0.444 . . . . 4.66 110.627 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -97.3 110.92 23.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.3 -0.409 . . . . 4.85 110.964 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.7 m -79.89 110.79 15.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 5.68 111.311 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -83.53 165.68 18.89 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.059 -0.519 . . . . 6.25 110.466 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -48.98 -44.8 41.32 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.667 0.988 . . . . 8.58 113.667 -172.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -81.31 3.18 25.05 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.158 -0.617 . . . . 7.86 111.519 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.64 23.1 40.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.525 -0.845 . . . . 5.59 111.76 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -96.33 127.35 42.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.186 -0.302 . . . . 5.18 110.186 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.468 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.54 163.64 39.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.807 0.336 . . . . 4.28 110.401 175.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.86 -110.82 0.32 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.892 -0.883 . . . . 3.36 110.892 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.89 110.44 4.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.678 -0.49 . . . . 2.84 109.678 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -115.91 158.81 22.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.699 -0.482 . . . . 4.34 109.699 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.4 ' HA ' ' OE1' ' A' ' 128' ' ' GLU . 10.4 p80 38.46 65.35 0.63 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.352 1.033 . . . . 5.75 111.608 -174.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.43 ' HB ' ' HB ' ' A' ' 127' ' ' VAL . 77.7 mt -77.43 133.77 29.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.192 -1.367 . . . . 3.55 110.707 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -126.84 124.31 39.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.068 0.461 . . . . 5.96 110.825 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.5 tt -85.99 106.8 17.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.717 -0.846 . . . . 4.34 108.717 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.69 -42.37 5.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.078 -0.51 . . . . 4.97 111.934 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -121.22 93.84 48.8 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.789 -0.449 . . . . 5.37 109.789 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.533 ' HA ' ' OD2' ' A' ' 137' ' ' ASP . 74.2 Cg_endo -75.43 156.41 41.1 Favored 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 122.649 2.233 . . . . 5.44 112.603 -176.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.691 0 CA-C-N 115.909 -0.587 . . . . 6.1 111.018 -177.548 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.977 0.418 . . . . 12.4 111.078 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.539 ' OE1' ' HD3' ' A' ' 27' ' ' ARG . 15.0 mm-40 -110.21 138.22 46.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.699 -0.682 . . . . 11.63 110.351 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -93.38 145.12 24.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.259 -0.428 . . . . 9.15 111.128 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.3 -175.48 23.18 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.553 -0.619 . . . . 6.81 111.553 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.1 mt -127.75 141.9 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.808 -0.442 . . . . 10.17 109.808 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.01 122.77 19.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.969 -0.292 . . . . 8.73 110.441 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -81.73 -53.78 5.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 10.86 111.197 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.409 ' HD3' HG12 ' A' ' 47' ' ' ILE . 53.4 mmtt -158.98 147.94 18.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.01 -0.541 . . . . 14.06 110.51 -177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.78 95.67 8.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 11.73 110.905 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 4.3 mm? -92.07 179.25 5.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.578 -0.737 . . . . 11.36 109.549 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -91.14 120.78 32.37 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.262 -0.273 . . . . 15.94 110.262 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.6 t 79.15 -40.97 0.25 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.961 0.905 . . . . 13.01 111.379 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 7.1 p90 -119.34 146.22 45.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.919 0.39 . . . . 12.34 111.051 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.77 163.02 22.89 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.599 -0.6 . . . . 7.52 111.599 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.97 143.59 47.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.892 0.377 . . . . 9.24 111.364 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.4 mt -110.44 129.28 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.65 -0.704 . . . . 7.75 110.232 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.79 140.53 42.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.81 0.814 . . . . 11.8 111.678 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.4 p -80.09 0.95 29.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.335 -1.302 . . . . 12.34 112.131 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.6 m -51.91 -39.6 59.36 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.471 0.545 . . . . 13.33 112.471 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -89.59 -13.31 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.251 0.548 . . . . 11.9 111.174 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.539 ' HD3' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -128.99 -158.46 0.89 Allowed 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.103 -0.373 . . . . 12.99 110.346 -175.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -124.03 19.22 9.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.076 0.465 . . . . 16.66 110.369 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.47 130.32 26.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.705 -0.679 . . . . 12.09 110.954 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -94.39 124.83 38.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.963 -0.754 . . . . 12.51 108.963 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.7 mt -123.72 162.4 23.22 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.069 0.462 . . . . 8.76 111.525 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -126.05 148.51 49.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.669 -0.696 . . . . 9.15 109.356 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -142.39 153.35 43.7 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.894 -0.41 . . . . 6.85 109.894 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -95.71 161.65 13.94 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.603 -0.517 . . . . 9.99 109.603 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -64.05 -13.61 48.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.059 0.457 . . . . 9.93 111.118 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.4 t -74.88 -20.64 59.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.13 -0.487 . . . . 12.28 110.155 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -100.25 23.37 10.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.415 -0.357 . . . . 10.62 111.332 -178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -124.02 111.69 16.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.027 0.442 . . . . 8.78 110.341 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.8 t -89.17 91.85 8.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.013 -0.54 . . . . 8.97 110.335 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.05 173.84 31.21 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.929 -0.653 . . . . 9.98 112.18 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -75.4 117.92 17.72 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.975 -0.38 . . . . 12.43 109.975 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.44 -18.86 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 11.58 111.93 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -54.97 -36.58 65.52 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.375 -0.375 . . . . 14.73 111.868 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -102.15 21.76 14.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.241 0.46 . . . . 13.3 112.241 -173.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -103.21 107.27 18.02 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.798 -0.361 . . . . 10.07 110.138 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -116.09 173.88 6.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.043 0.449 . . . . 13.13 110.904 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 47' ' ' ILE . 3.7 mp -80.56 125.84 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.911 -0.774 . . . . 11.74 108.911 177.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.19 -13.75 28.52 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.953 -0.641 . . . . 10.13 111.893 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.7 125.05 91.76 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-O 120.697 0.285 . . . . 8.39 110.553 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.98 132.07 15.04 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.469 2.113 . . . . 7.28 111.006 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 m -126.44 154.83 36.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.01 0.433 . . . . 4.74 111.296 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -109.51 126.57 53.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.414 -0.812 . . . . 7.09 109.468 176.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.3 161.08 38.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.901 0.381 . . . . 7.82 110.711 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -122.82 109.5 14.27 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.53 -0.544 . . . . 11.59 109.53 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.3 ttt -79.32 120.04 23.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.59 -0.732 . . . . 12.41 110.482 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.3 p -138.71 152.1 47.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.324 -0.398 . . . . 13.17 110.617 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -96.34 117.13 30.2 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.967 -0.383 . . . . 16.21 109.967 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -92.37 128.51 38.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.912 -0.585 . . . . 16.64 111.454 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -79.87 -13.28 59.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.535 -0.757 . . . . 22.64 111.473 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -79.53 -52.53 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 21.43 110.073 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.6 p -85.43 -37.8 19.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.024 -0.535 . . . . 17.4 110.75 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.03 14.06 50.42 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.491 -0.644 . . . . 16.7 111.491 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -116.6 151.42 47.09 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.542 0.211 . . . . 14.73 110.489 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.31 124.42 8.41 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.725 1.617 . . . . 12.6 110.044 168.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.47 169.69 17.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.15 0.5 . . . . 11.73 111.346 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.84 157.63 17.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.673 -0.862 . . . . 8.91 108.673 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.7 t -70.88 -162.23 0.06 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.481 -0.327 . . . . 9.83 110.56 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -74.57 7.85 2.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.301 0.482 . . . . 11.32 112.301 -172.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.9 t 49.84 91.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 124.026 0.829 . . . . 6.11 112.429 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.92 111.49 16.3 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.791 -0.64 . . . . 6.12 110.545 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 112.27 6.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.709 -0.678 . . . . 6.3 109.462 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.1 mt . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.696 -0.684 . . . . 5.77 111.093 -173.784 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 109.78 -0.452 . . . . 6.19 109.78 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 94.6 t -72.72 96.2 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 6.26 111.627 -176.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.596 HD23 ' HB2' ' A' ' 144' ' ' ALA . 54.3 mt -85.38 -27.81 25.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.811 -0.632 . . . . 6.05 111.152 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.0 m -110.86 81.2 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.197 0.523 . . . . 7.02 112.407 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -96.22 -66.72 0.89 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.682 -1.229 . . . . 7.07 107.682 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -147.02 142.76 27.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.936 -0.574 . . . . 6.68 109.786 173.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 82' ' ' ARG . 45.7 ttm180 -82.86 100.64 10.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.815 -0.629 . . . . 6.43 110.072 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.53 153.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.323 0.582 . . . . 3.7 111.554 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.485 HG22 ' OG ' ' A' ' 140' ' ' SER . 60.7 p -116.11 140.49 49.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.599 -0.728 . . . . 3.49 109.582 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.0 174.06 23.37 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.003 -1.094 . . . . 2.58 112.421 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.0 m -125.52 128.67 48.36 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.607 0.242 . . . . 3.34 110.467 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.616 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 51.9 t -71.97 132.79 32.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.053 -0.522 . . . . 3.14 110.326 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.4 p -116.16 -9.17 11.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.178 0.513 . . . . 3.61 111.31 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.2 m -152.57 125.38 8.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 3.12 109.847 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -107.1 174.73 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.361 . . . . 4.39 110.904 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 CA--C 1.516 -0.349 0 CA-C-O 120.945 0.403 . . . . 3.62 110.735 179.267 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.45 -0.447 0 N-CA-C 110.187 -0.301 . . . . 3.33 110.187 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.7 p -101.57 125.64 48.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.494 -0.321 . . . . 2.57 111.398 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -71.2 167.66 51.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.895 -0.882 . . . . 1.66 110.895 174.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -131.75 132.44 43.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.305 0.552 . . . . 3.03 111.289 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.1 mt -113.05 133.62 58.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.391 -0.822 . . . . 1.88 109.309 173.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.9 t -84.17 134.47 34.57 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.222 -0.659 . . . . 3.49 109.222 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.517 ' CD2' HD11 ' A' ' 120' ' ' LEU . 36.5 t80 -157.01 142.73 17.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.16 0.505 . . . . 3.51 111.27 -168.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -129.82 131.49 46.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 5.1 109.311 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -152.29 131.89 13.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.871 0.367 . . . . 4.78 110.639 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 63.48 21.87 12.96 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.017 -0.538 . . . . 6.97 111.616 171.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.26 70.22 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.966 -0.635 . . . . 5.1 112.344 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.97 132.87 43.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.049 0.452 . . . . 5.38 110.24 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 15.1 m -121.8 115.55 22.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.108 -0.496 . . . . 4.72 109.896 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -156.64 173.89 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.77 0.319 . . . . 4.61 111.168 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -107.38 141.85 38.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.971 -0.559 . . . . 3.96 110.167 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.517 HD11 ' CD2' ' A' ' 111' ' ' TYR . 1.7 mp -105.78 139.95 20.72 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.085 -0.709 . . . . 2.75 109.085 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 83.7 Cg_endo -86.93 132.17 3.3 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.951 2.434 . . . . 2.3 112.423 177.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -137.42 149.99 47.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.786 0.327 . . . . 2.13 110.559 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 31.8 p -113.56 177.99 4.44 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.781 -0.452 . . . . 3.07 109.781 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -70.85 -18.17 62.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.001 0.429 . . . . 4.8 110.635 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.98 -27.9 54.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.874 -0.603 . . . . 4.81 110.977 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -75.67 -25.79 57.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.069 0.461 . . . . 3.84 110.916 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 156' ' ' ILE . 2.0 p -90.73 107.78 18.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.619 0.724 . . . . 4.39 111.263 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.84 139.72 34.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.321 -0.854 . . . . 6.43 108.696 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 136.55 -12.81 4.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.517 -0.849 . . . . 5.91 112.252 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 68.09 19.17 9.31 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.913 0.485 . . . . 6.07 112.093 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.62 144.16 9.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.044 0.449 . . . . 5.27 110.855 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -105.28 97.38 7.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.029 -0.532 . . . . 5.78 110.392 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.686 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -89.71 149.86 22.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.075 -0.966 . . . . 3.62 110.741 -177.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -122.6 162.35 22.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.063 -0.517 . . . . 6.93 109.678 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.616 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.28 123.47 23.8 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.888 -0.508 . . . . 4.12 110.453 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.78 -14.07 11.57 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.606 -0.807 . . . . 4.07 113.405 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.61 176.42 6.02 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 117.763 0.782 . . . . 4.06 110.323 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -107.19 115.11 29.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.0 0.428 . . . . 4.17 110.951 -173.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.3 m -118.58 172.85 5.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.789 -0.641 . . . . 2.77 111.257 -178.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.485 ' OG ' HG22 ' A' ' 84' ' ' THR . 43.4 m -138.1 129.86 28.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.954 -0.758 . . . . 3.47 108.954 175.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -127.9 140.29 52.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.033 0.444 . . . . 3.35 110.982 -172.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -93.81 111.28 22.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.73 -0.668 . . . . 5.34 109.708 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.1 mt -79.07 100.36 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.086 -0.506 . . . . 4.66 110.128 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.725 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -80.7 110.08 15.86 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.226 -0.443 . . . . 4.85 110.195 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 m -103.09 126.05 50.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.792 -0.64 . . . . 5.68 109.885 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -93.97 -171.09 2.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.302 -0.408 . . . . 6.25 110.401 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -84.44 -8.79 58.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.999 0.428 . . . . 8.58 111.166 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 148' ' ' ARG . 7.3 tpt180 -89.25 -23.04 22.44 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.956 -0.566 . . . . 7.86 109.846 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.84 22.63 59.32 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.67 -0.695 . . . . 5.59 112.094 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -116.89 109.68 17.37 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.637 -0.505 . . . . 5.18 109.637 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.488 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.88 179.76 8.8 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.102 0.477 . . . . 4.28 111.491 -175.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -141.51 -94.46 0.23 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.505 -0.77 . . . . 3.36 111.267 174.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -143.58 156.09 44.49 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.386 -0.598 . . . . 2.84 109.386 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 155' ' ' HIS . 13.9 t -162.55 161.84 27.04 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.842 -0.429 . . . . 4.34 109.842 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.46 ' HD2' ' SG ' ' A' ' 154' ' ' CYS . 35.2 m-70 48.13 66.3 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.643 0.589 . . . . 5.75 111.69 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.546 ' O ' HG23 ' A' ' 127' ' ' VAL . 68.4 mt -93.94 117.72 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.335 -0.848 . . . . 3.55 110.365 -177.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.12 158.51 17.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 5.96 110.47 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.84 113.38 26.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.51 -0.552 . . . . 4.34 109.51 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -83.0 -58.59 2.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.013 0.435 . . . . 4.97 111.383 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -136.42 100.6 10.28 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.284 -0.416 . . . . 5.37 110.129 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.88 159.68 51.79 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.391 2.061 . . . . 5.44 111.478 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.692 0 CA-C-O 121.029 0.442 . . . . 6.1 111.138 -177.073 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 83.3 mtt180 . . . . . 0 N--CA 1.454 -0.268 0 CA-C-O 121.399 0.618 . . . . 12.4 111.478 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 6.8 mm-40 -102.76 143.74 32.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.839 -1.073 . . . . 11.63 110.441 -174.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.6 p -104.3 160.95 14.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.282 -0.636 . . . . 9.15 109.282 174.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.25 174.68 46.93 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.102 -1.047 . . . . 6.81 113.562 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.512 HG13 ' HB3' ' A' ' 23' ' ' GLN . 19.8 pt -120.57 148.81 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.924 -0.769 . . . . 10.17 108.924 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.543 HG21 HD22 ' A' ' 15' ' ' LEU . 1.9 mp -80.07 131.45 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.307 -0.557 . . . . 8.73 110.774 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.467 ' OE2' ' HB2' ' A' ' 14' ' ' LYS . 4.3 tm-20 -74.66 -46.74 36.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.687 -0.688 . . . . 10.86 111.026 -176.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 15' ' ' LEU . 6.8 tmtt? -157.09 133.17 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.002 -0.37 . . . . 14.06 110.002 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.543 HD22 HG21 ' A' ' 12' ' ' ILE . 3.6 mm? -78.06 110.88 13.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.943 -0.571 . . . . 11.73 110.901 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 72.2 mt -109.79 177.52 4.7 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.922 -1.14 . . . . 11.36 107.922 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -98.91 139.87 33.93 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.486 -0.485 . . . . 15.94 110.511 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t 76.89 -46.05 0.5 Allowed 'General case' 0 N--CA 1.468 0.425 0 O-C-N 124.366 1.041 . . . . 13.01 111.04 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.498 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 39.6 p90 -129.92 154.29 47.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.264 -0.425 . . . . 12.34 109.925 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -144.51 163.57 27.86 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.897 -0.668 . . . . 7.52 111.72 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -109.33 134.39 51.87 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.231 0.538 . . . . 9.24 111.262 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.6 mt -99.86 126.4 53.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 7.75 109.569 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.569 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 18.9 tp60 -79.31 130.65 35.66 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.089 0.471 . . . . 11.8 110.319 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 p -67.86 3.63 1.43 Allowed 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 113.894 1.072 . . . . 12.34 113.894 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.569 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 74.4 m -51.75 -26.33 9.28 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.537 0.939 . . . . 13.33 113.537 -172.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -99.53 -6.35 27.62 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.131 0.419 . . . . 11.9 112.131 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.489 ' HG3' ' HB3' ' A' ' 8' ' ' GLU . 17.2 mmt180 -152.28 -159.89 1.07 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.801 0.334 . . . . 12.99 110.841 -173.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.418 ' H ' ' HB3' ' A' ' 27' ' ' ARG . 23.5 mp0 -116.3 17.23 15.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.092 0.472 . . . . 16.66 110.601 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.37 113.24 14.71 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.197 -0.456 . . . . 12.09 111.768 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -87.9 104.65 16.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.661 -0.866 . . . . 12.51 108.661 170.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.99 161.22 14.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.928 0.394 . . . . 8.76 111.232 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -110.95 129.36 55.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.308 -0.997 . . . . 9.15 108.308 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -110.64 141.56 43.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.084 0.469 . . . . 6.85 110.158 -175.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -87.16 137.61 32.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.031 -0.729 . . . . 9.99 109.031 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.46 -11.31 32.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.924 0.342 . . . . 9.93 111.924 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.6 t -72.21 -27.41 62.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.28 -0.418 . . . . 12.28 110.494 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.48 40.31 1.57 Allowed 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.154 -0.475 . . . . 10.62 111.321 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.432 ' CE1' ' HG ' ' A' ' 45' ' ' LEU . 22.8 t80 -113.7 129.16 56.61 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.057 -0.72 . . . . 8.78 109.057 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.0 t -108.79 115.25 29.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.907 -0.405 . . . . 8.97 109.907 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.3 -157.3 20.74 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.873 -0.679 . . . . 9.98 111.724 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -93.45 103.47 15.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.89 0.376 . . . . 12.43 110.626 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.3 tp -67.05 -21.82 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.917 -0.583 . . . . 11.58 110.757 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.64 -21.44 65.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 14.73 110.283 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -99.31 11.74 38.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.769 -0.651 . . . . 13.3 110.222 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.432 ' HG ' ' CE1' ' A' ' 38' ' ' PHE . 2.8 tm? -101.28 115.41 30.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.148 -0.686 . . . . 10.07 109.148 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -123.43 -177.6 3.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.382 -0.372 . . . . 13.13 111.153 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.9 mp -77.48 117.84 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.0 -0.371 . . . . 11.74 110.0 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.35 -1.3 64.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.86 -0.686 . . . . 10.13 111.776 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.98 125.28 90.34 Favored Pre-proline 0 C--O 1.234 0.276 0 N-CA-C 109.882 -0.414 . . . . 8.39 109.882 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.89 128.1 7.35 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.637 2.224 . . . . 7.28 113.66 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.48 161.66 38.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 4.74 110.358 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -122.41 127.35 49.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.399 0.618 . . . . 7.09 109.655 174.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 8' ' ' GLU . 45.3 p90 -131.71 -179.32 5.31 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.921 -0.582 . . . . 7.82 110.872 -174.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.439 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 37.6 tt0 -127.91 126.95 42.49 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.959 -0.756 . . . . 11.59 108.959 -176.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.5 ttt -100.53 112.45 24.83 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.289 -0.263 . . . . 12.41 110.289 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.2 p -131.9 170.67 14.55 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.339 -0.391 . . . . 13.17 111.351 -175.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -115.77 109.41 17.63 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.81 -0.441 . . . . 16.21 109.81 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.537 ' OD2' HG22 ' A' ' 61' ' ' THR . 31.2 t70 -76.59 122.88 25.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.139 -0.482 . . . . 16.64 111.063 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -79.51 -13.34 59.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 22.64 111.367 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.415 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 14.3 ttm180 -78.42 -62.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.377 . . . . 21.43 110.935 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.537 HG22 ' OD2' ' A' ' 58' ' ' ASP . 15.3 t -88.45 -22.49 23.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.308 -0.405 . . . . 17.4 110.594 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.02 17.63 57.43 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.747 -0.739 . . . . 16.7 113.288 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -104.5 141.72 23.12 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.589 0.195 . . . . 14.73 110.569 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.92 124.13 7.84 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.451 1.434 . . . . 12.6 109.317 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -141.27 171.56 11.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.133 -0.627 . . . . 11.73 112.397 -169.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.3 143.48 28.02 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.928 -1.033 . . . . 8.91 109.038 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.439 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 14.1 t -69.71 -155.68 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.357 -0.383 . . . . 9.83 110.46 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -75.27 29.1 0.1 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.397 0.888 . . . . 11.32 113.397 -172.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.0 t 19.92 103.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 125.14 1.376 . . . . 6.11 114.403 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -101.94 143.11 32.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.089 0.471 . . . . 6.12 111.572 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -69.72 138.85 53.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.569 -0.741 . . . . 6.3 110.791 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.0 mt . . . . . 0 C--N 1.325 -0.471 0 N-CA-C 109.265 -0.642 . . . . 5.77 109.265 174.375 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.463 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 10.6 p . . . . . 0 C--O 1.234 0.254 0 CA-C-O 120.892 0.377 . . . . 6.19 110.728 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 47.3 t -80.75 95.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.312 0.577 . . . . 6.26 109.792 175.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tt -98.92 -24.68 14.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.112 -0.949 . . . . 6.05 110.741 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t -101.34 103.08 14.02 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.358 0.599 . . . . 7.02 112.088 -170.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -129.49 -63.59 0.93 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.166 -1.05 . . . . 7.07 108.166 169.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -168.64 147.09 4.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.723 -1.126 . . . . 6.68 108.392 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -77.11 98.56 5.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.61 -0.515 . . . . 6.43 109.61 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.6 m -81.8 157.24 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.44 0.638 . . . . 3.7 111.546 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.6 p -124.69 146.87 48.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.609 -0.723 . . . . 3.49 109.257 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.43 -173.33 13.71 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.272 -0.966 . . . . 2.58 112.063 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.7 m -130.92 131.15 44.29 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.015 -0.365 . . . . 3.34 110.015 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 88.0 t -64.18 129.95 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.519 -0.309 . . . . 3.14 110.33 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.3 p -113.98 -9.98 12.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.983 0.421 . . . . 3.61 110.722 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.7 m -152.26 128.76 10.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.429 . . . . 3.12 110.209 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -99.07 169.63 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 4.39 110.726 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.999 -0.546 . . . . 3.62 110.122 172.636 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.448 -0.556 0 CA-C-O 121.008 0.432 . . . . 3.33 109.872 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.19 116.2 32.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.109 0.481 . . . . 2.57 111.141 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -69.09 160.77 52.42 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.729 -0.748 . . . . 1.66 111.554 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -129.9 127.61 40.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.342 0.592 . . . . 3.03 110.868 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.5 mt -112.0 127.45 69.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.204 -0.907 . . . . 1.88 109.241 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.4 t -112.4 137.46 50.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.764 0.316 . . . . 3.49 110.441 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 2.7 p90 -143.37 155.42 44.42 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.115 -0.698 . . . . 3.51 109.115 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -111.56 125.24 53.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.864 0.364 . . . . 5.1 110.463 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.723 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 9.4 t30 -130.03 115.66 17.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.945 -0.571 . . . . 4.78 109.584 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 60.94 21.63 11.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.663 0.268 . . . . 6.97 111.581 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.87 -4.18 68.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.825 -0.702 . . . . 5.1 113.011 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.723 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 7.9 pt-20 -99.68 132.96 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.145 -0.687 . . . . 5.38 109.145 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 7.8 p -116.77 118.36 32.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.94 0.4 . . . . 4.72 110.427 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 116' ' ' GLU . 78.9 m-85 -108.4 155.01 21.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.142 -0.481 . . . . 4.61 110.494 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -110.26 123.34 49.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.952 -0.567 . . . . 3.96 109.715 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.77 120.2 52.14 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.384 -0.371 . . . . 2.75 110.408 -175.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -76.7 132.91 13.62 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.906 2.404 . . . . 2.3 111.722 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -145.3 155.0 42.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.804 0.335 . . . . 2.13 110.25 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 62.8 p -107.4 -174.71 2.6 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.124 -0.489 . . . . 3.07 110.084 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -71.39 -19.61 62.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.222 0.534 . . . . 4.8 110.514 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.85 -28.28 33.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.754 -0.657 . . . . 4.81 111.437 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.22 -19.61 60.46 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.387 -0.369 . . . . 3.84 111.364 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.9 p -107.43 107.91 23.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.588 0.709 . . . . 4.39 111.009 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -90.46 138.43 31.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 6.43 110.183 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.23 -20.65 4.98 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.777 -0.647 . . . . 5.91 111.51 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.8 t30 61.58 31.57 18.77 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.74 0.781 . . . . 6.07 110.001 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -89.92 138.51 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.692 -0.685 . . . . 5.27 110.151 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.436 ' N ' HD22 ' A' ' 132' ' ' ASN . 0.9 OUTLIER -82.5 103.38 12.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.735 0.302 . . . . 5.78 110.379 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.594 ' H ' HD12 ' A' ' 133' ' ' LEU . 2.2 mp -75.56 134.87 40.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.751 -0.659 . . . . 3.62 109.51 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -121.34 126.74 50.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.889 0.376 . . . . 6.93 110.159 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.597 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -57.46 112.91 1.56 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.359 0.599 . . . . 4.12 111.317 -175.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.36 -2.8 14.04 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.296 -0.865 . . . . 4.07 112.851 -174.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.6 p30 -95.01 178.27 5.61 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.442 0.621 . . . . 4.06 110.459 172.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -100.22 122.88 43.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.978 0.418 . . . . 4.17 111.036 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.09 151.82 24.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.668 -0.696 . . . . 2.77 110.584 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.3 t -124.93 129.33 50.16 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.704 -0.48 . . . . 3.47 109.704 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -136.67 154.6 50.58 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.557 -0.534 . . . . 3.35 109.557 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -113.0 114.76 27.36 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.37 -0.604 . . . . 5.34 109.37 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -78.43 108.16 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.594 . . . . 4.66 111.304 -174.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -100.62 110.5 22.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.128 -0.487 . . . . 4.85 109.81 172.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.2 m -85.85 108.95 18.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.198 -0.455 . . . . 5.68 111.126 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -64.53 146.1 55.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.937 -0.574 . . . . 6.25 109.661 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.17 -17.97 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.571 0.582 . . . . 8.58 112.571 -173.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -85.75 2.07 47.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 7.86 110.31 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.48 16.77 80.43 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.68 -0.691 . . . . 5.59 113.143 174.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -119.69 113.09 20.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.332 -0.618 . . . . 5.18 109.332 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.508 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -144.72 -179.17 6.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.214 -0.448 . . . . 4.28 111.067 -175.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.58 -153.3 5.84 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.057 -0.817 . . . . 3.36 111.057 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.26 118.01 34.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.213 0.507 . . . . 2.84 110.086 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 33.9 t -116.44 159.59 21.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.59 -0.277 . . . . 4.34 110.646 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 60.47 33.58 20.57 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.95 -0.568 . . . . 5.75 111.174 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 55.0 mt -64.69 125.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.764 -0.653 . . . . 3.55 110.921 -176.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -140.44 159.92 41.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.724 -0.671 . . . . 5.96 110.056 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.1 tp -77.6 119.24 20.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.281 -0.637 . . . . 4.34 109.281 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -84.41 -47.67 10.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.031 -0.531 . . . . 4.97 109.628 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -162.5 113.94 1.12 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.864 -0.607 . . . . 5.37 109.492 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.12 152.08 80.46 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.126 1.884 . . . . 5.44 112.481 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.886 0 CA-C-N 115.897 -0.592 . . . . 6.1 110.774 -178.041 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 . . . . . 0 C--O 1.236 0.362 0 N-CA-C 110.128 -0.323 . . . . 12.4 110.128 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.505 ' CD ' ' HE ' ' A' ' 27' ' ' ARG . 14.1 pt-20 -142.38 162.12 36.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.924 -0.399 . . . . 11.63 109.924 174.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 52' ' ' GLU . 68.9 p -109.14 157.38 18.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.536 0.684 . . . . 9.15 112.133 -171.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.69 157.0 28.42 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.224 -1.15 . . . . 6.81 110.224 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.0 pt -105.01 141.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 117.097 0.448 . . . . 10.17 110.646 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.511 HG13 HD11 ' A' ' 45' ' ' LEU . 41.6 mm -74.37 123.45 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 110.067 -0.346 . . . . 8.73 110.067 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.68 -34.5 17.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.333 0.494 . . . . 10.86 112.333 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.5 ' HA ' HD12 ' A' ' 47' ' ' ILE . 1.9 tmtp? -160.74 130.4 4.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.947 0.404 . . . . 14.06 111.059 -175.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.488 ' H ' HD11 ' A' ' 47' ' ' ILE . 3.0 mm? -91.55 106.55 18.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.854 -0.612 . . . . 11.73 110.796 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 5.3 mp -96.93 179.77 4.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.763 -0.829 . . . . 11.36 108.763 174.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -89.81 116.11 27.66 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.268 -0.573 . . . . 15.94 110.434 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.4 t 78.54 -14.0 0.91 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.298 0.999 . . . . 13.01 111.635 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 10.1 p90 -145.45 162.97 36.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.187 -0.301 . . . . 12.34 110.187 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.67 177.22 33.72 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.67 -0.776 . . . . 7.52 112.125 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -126.68 148.49 49.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 9.24 110.914 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.7 mt -108.87 126.21 65.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.571 -0.741 . . . . 7.75 109.666 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.22 143.2 47.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.426 0.631 . . . . 11.8 110.766 -175.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.7 p -77.04 6.04 7.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.068 -0.969 . . . . 12.34 111.942 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -49.57 -39.97 36.85 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.077 0.399 . . . . 13.33 112.077 -173.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -116.91 6.38 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.835 -0.346 . . . . 11.9 111.4 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.622 ' HD3' ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -120.41 141.31 50.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.533 -0.543 . . . . 12.99 109.533 -173.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.622 ' N ' ' HD3' ' A' ' 27' ' ' ARG . 27.7 mm-40 -77.04 26.01 0.15 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.064 -0.397 . . . . 16.66 111.484 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB3' HH11 ' A' ' 27' ' ' ARG . . . 178.99 145.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.575 0.75 . . . . 12.09 109.333 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.523 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.9 OUTLIER -86.9 132.37 33.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.557 -0.534 . . . . 12.51 109.557 174.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.52 162.39 19.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.209 0.528 . . . . 8.76 111.636 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -116.16 147.98 40.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.486 -0.779 . . . . 9.15 109.882 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -150.22 172.92 14.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.77 -0.456 . . . . 6.85 109.77 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 7.1 p-80 -135.06 165.79 24.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 9.99 111.172 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -66.29 -18.95 65.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.835 -0.621 . . . . 9.93 111.896 -173.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t -86.27 2.36 47.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.546 -0.297 . . . . 12.28 110.837 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 36.6 tp60 -110.74 -30.16 7.69 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.774 -0.454 . . . . 10.62 109.774 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -77.35 121.55 23.91 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.875 -0.602 . . . . 8.78 109.956 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.44 ' HB2' ' CG ' ' A' ' 68' ' ' GLN . 34.1 t -97.07 139.99 32.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.196 0.522 . . . . 8.97 110.528 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.41 -169.15 14.51 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.635 -0.793 . . . . 9.98 112.573 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -72.9 110.73 7.43 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.363 0.601 . . . . 12.43 111.068 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -77.75 -20.65 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.372 -0.831 . . . . 11.58 109.998 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.75 -31.63 72.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 14.73 110.401 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -97.02 24.53 6.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.815 -0.63 . . . . 13.3 110.768 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.511 HD11 HG13 ' A' ' 12' ' ' ILE . 3.2 tm? -113.19 120.79 42.44 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.007 -1.108 . . . . 10.07 108.007 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.29 176.49 8.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.628 0.252 . . . . 13.13 110.816 -170.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 14' ' ' LYS . 31.4 mm -70.63 128.25 33.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.562 -0.29 . . . . 11.74 110.26 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.13 11.09 67.82 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.322 -0.942 . . . . 10.13 112.611 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.45 121.35 71.21 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.972 -0.381 . . . . 8.39 109.972 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.48 125.3 9.51 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.564 2.176 . . . . 7.28 112.712 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 71' ' ' LYS . 34.0 m -124.61 152.96 31.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.78 -0.645 . . . . 4.74 109.65 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.551 ' HB3' HG22 ' A' ' 9' ' ' THR . 13.8 pt-20 -114.46 131.05 56.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.323 0.582 . . . . 7.09 109.752 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -137.67 172.73 12.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.371 0.605 . . . . 7.82 111.701 -172.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -118.4 133.69 55.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.189 -1.041 . . . . 11.59 108.189 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.9 ttt -100.7 122.53 43.49 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.283 -0.266 . . . . 12.41 110.283 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.3 p -135.09 144.25 47.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.413 0.625 . . . . 13.17 111.253 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -90.6 109.66 20.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.691 . . . . 16.21 109.16 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 60' ' ' ARG . 11.1 t70 -65.02 117.93 8.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.825 -0.625 . . . . 16.64 111.618 -174.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 -80.12 -12.25 59.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.175 -0.92 . . . . 22.64 111.712 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HB2' ' OD1' ' A' ' 58' ' ' ASP . 0.1 OUTLIER -73.82 -57.81 3.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.886 0.374 . . . . 21.43 110.397 -176.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.3 p -104.68 -39.43 6.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.074 -0.512 . . . . 17.4 111.117 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.87 16.85 7.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.511 -0.852 . . . . 16.7 112.825 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -101.34 148.31 35.0 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.156 -0.313 . . . . 14.73 110.156 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -79.63 125.22 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.675 1.583 . . . . 12.6 110.358 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.3 pt -128.87 162.91 35.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.483 0.659 . . . . 11.73 111.553 -175.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.46 161.97 13.25 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.977 -1.01 . . . . 8.91 108.635 170.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 69' ' ' VAL . 26.3 t -75.39 -153.29 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.222 -0.288 . . . . 9.83 110.222 177.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.621 HE21 ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -67.82 -4.02 11.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.798 0.666 . . . . 11.32 112.798 -173.133 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 67' ' ' SER . 42.3 t 50.93 86.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.538 0.685 . . . . 6.11 111.56 176.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -97.23 129.86 44.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.836 -0.62 . . . . 6.12 110.649 -174.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.458 ' HA ' HG12 ' A' ' 51' ' ' VAL . 35.9 mtmm -67.61 141.21 56.84 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.157 -0.682 . . . . 6.3 109.157 175.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.9 mt . . . . . 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 5.77 111.318 -176.534 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.537 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 3.2 p . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 121.206 0.526 . . . . 6.19 111.016 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.642 HG12 ' H ' ' A' ' 79' ' ' SER . 46.7 t -85.37 118.97 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.915 -0.584 . . . . 6.26 111.856 -175.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HG ' ' CE1' ' A' ' 155' ' ' HIS . 10.7 mp -97.19 13.57 28.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.106 -0.497 . . . . 6.05 110.548 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.642 ' H ' HG12 ' A' ' 77' ' ' VAL . 21.1 m -116.48 -112.2 0.34 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.168 -0.469 . . . . 7.02 110.532 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 81' ' ' GLU . 6.3 tt0 57.82 33.05 22.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.098 0.559 . . . . 7.07 111.143 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 80' ' ' GLU . 10.3 tp10 76.0 117.51 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.222 -0.899 . . . . 6.68 111.126 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -77.71 90.88 4.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.662 0.744 . . . . 6.43 110.159 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.65 160.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.496 -0.775 . . . . 3.7 111.226 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 p -107.86 139.52 42.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.542 -0.754 . . . . 3.49 109.924 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.36 161.26 24.41 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.515 -0.85 . . . . 2.58 112.479 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -116.96 125.01 50.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.483 -0.562 . . . . 3.34 109.483 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 58.1 t -68.5 123.68 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 108.973 -0.751 . . . . 3.14 108.973 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.0 p -105.08 -20.3 13.56 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.623 -0.431 . . . . 3.61 111.066 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -151.83 126.18 9.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.273 -0.421 . . . . 3.12 110.258 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.27 -172.68 4.12 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.951 -0.388 . . . . 4.39 109.951 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.476 HD22 ' HG3' ' A' ' 124' ' ' LYS . 5.3 mp . . . . . 0 C--N 1.325 -0.457 0 N-CA-C 109.284 -0.636 . . . . 3.62 109.284 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.447 -0.585 0 CA-C-O 121.408 0.623 . . . . 3.33 109.341 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 t -122.09 148.76 44.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.71 -0.677 . . . . 2.57 110.631 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.03 163.41 39.74 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.671 -0.971 . . . . 1.66 110.671 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -125.27 128.42 48.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.965 0.412 . . . . 3.03 110.886 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 71.6 mt -112.88 125.46 70.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.909 -0.587 . . . . 1.88 109.506 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.8 t -100.17 137.89 37.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.838 -0.43 . . . . 3.49 109.838 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.526 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -148.8 167.48 25.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.527 0.203 . . . . 3.51 110.549 -178.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.38 127.93 56.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.366 -0.379 . . . . 5.1 110.446 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -152.85 130.12 11.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.604 -0.517 . . . . 4.78 109.604 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 64.74 20.85 12.25 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.427 0.455 . . . . 6.97 111.168 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.57 18.73 79.68 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.778 -0.725 . . . . 5.1 111.868 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -121.21 144.92 48.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.628 -0.508 . . . . 5.38 109.628 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 11.4 p -122.98 115.49 21.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.277 -0.42 . . . . 4.72 110.265 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -132.19 157.4 44.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.251 -0.431 . . . . 4.61 110.528 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -99.77 129.25 45.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 3.96 109.819 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 111' ' ' TYR . 4.2 mp -105.03 143.39 26.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 110.133 -0.321 . . . . 2.75 110.133 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 3.3 Cg_exo -80.11 148.56 19.34 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.511 2.141 . . . . 2.3 112.036 175.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -155.19 144.57 21.13 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.029 -0.73 . . . . 2.13 109.029 173.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.8 p -113.11 -175.59 2.7 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.67 0.272 . . . . 3.07 110.489 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.476 ' HG3' HD22 ' A' ' 91' ' ' LEU . 55.2 mttp -65.76 -27.97 68.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.24 0.543 . . . . 4.8 110.183 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -75.16 -22.92 57.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.211 -0.904 . . . . 4.81 111.598 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -83.13 -11.25 58.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 3.84 111.86 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 p -119.98 106.55 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.441 0.639 . . . . 4.39 111.37 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -108.26 150.25 27.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.779 -0.646 . . . . 6.43 110.102 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 125.39 16.93 2.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.913 -0.66 . . . . 5.91 112.943 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.9 t30 64.25 22.62 12.88 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.447 0.642 . . . . 6.07 110.454 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.2 130.54 35.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.946 -0.57 . . . . 5.27 110.929 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -111.61 111.56 22.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 5.78 110.148 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 133' ' ' LEU . 5.5 mp -98.97 149.83 22.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 3.62 110.939 -176.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -146.52 121.14 9.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.475 -0.565 . . . . 6.93 109.475 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -46.68 131.57 11.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.83 -0.623 . . . . 4.12 112.532 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.22 -12.69 14.15 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.126 -0.943 . . . . 4.07 111.192 -172.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -89.64 174.9 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 4.06 110.482 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -121.86 118.69 29.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.346 0.594 . . . . 4.17 110.147 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.7 m -121.19 159.07 23.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.314 -0.857 . . . . 2.77 111.264 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.9 m -109.73 137.82 46.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.622 -0.717 . . . . 3.47 109.22 173.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -139.79 139.21 36.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.024 0.44 . . . . 3.35 110.114 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -97.2 121.08 38.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.949 -0.569 . . . . 5.34 109.532 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.05 107.91 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 4.66 110.122 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.537 ' HB1' ' CG2' ' A' ' 76' ' ' VAL . . . -94.87 107.98 20.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.07 -0.514 . . . . 4.85 110.995 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.546 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 50.9 m -85.38 109.41 18.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.691 . . . . 5.68 111.075 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -74.76 159.29 32.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.316 -0.624 . . . . 6.25 109.316 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -57.77 -24.91 59.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 122.451 0.3 . . . . 8.58 111.693 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.615 ' HD2' ' OD1' ' A' ' 150' ' ' ASN . 1.3 tmt_? -69.81 -21.03 63.43 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.184 0.516 . . . . 7.86 110.116 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.41 2.76 61.69 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.882 -0.675 . . . . 5.59 112.107 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.615 ' OD1' ' HD2' ' A' ' 148' ' ' ARG . 15.1 m120 -99.73 135.92 40.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.632 -0.507 . . . . 5.18 109.632 177.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -145.34 174.44 11.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.062 0.458 . . . . 4.28 111.332 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.32 -160.83 10.7 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.995 -0.842 . . . . 3.36 110.995 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.6 109.79 22.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.123 0.487 . . . . 2.84 110.54 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 38.1 m -131.56 176.62 8.16 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.141 -0.688 . . . . 4.34 109.141 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.496 ' CE1' ' HG ' ' A' ' 78' ' ' LEU . 13.9 m80 58.47 38.6 25.54 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.317 -0.623 . . . . 5.75 109.317 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.3 mt -79.48 128.76 38.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.173 -0.921 . . . . 3.55 111.137 -169.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -134.73 140.86 46.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.281 0.562 . . . . 5.96 110.349 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.6 tp -103.97 105.76 16.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.828 -0.624 . . . . 4.34 109.906 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -109.74 -24.64 10.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.063 -0.517 . . . . 4.97 111.297 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -117.79 86.12 23.78 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.209 -0.45 . . . . 5.37 110.821 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.34 156.21 14.51 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.54 2.16 . . . . 5.44 111.772 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 116.288 -0.415 . . . . 6.1 110.685 -179.12 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HG2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.202 0 CA-C-O 120.892 0.377 . . . . 12.4 111.061 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.76 153.56 21.6 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.098 -0.704 . . . . 11.63 109.098 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.515 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 20.3 p -86.52 161.36 18.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.066 0.46 . . . . 9.15 111.736 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.22 162.73 32.02 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.433 -0.667 . . . . 6.81 111.433 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 pt -113.9 148.57 16.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.724 0.262 . . . . 10.17 110.43 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.0 mm -75.28 123.4 31.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.513 -0.312 . . . . 8.73 110.687 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.53 ' OE2' ' HB3' ' A' ' 21' ' ' PHE . 29.1 mt-10 -72.53 -46.05 56.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.054 -0.521 . . . . 10.86 111.219 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.12 146.94 17.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.023 -0.535 . . . . 14.06 110.084 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.51 105.25 17.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.927 -0.579 . . . . 11.73 110.695 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 2.6 mm? -106.71 179.09 4.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.752 -0.833 . . . . 11.36 108.752 174.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -91.64 129.37 37.62 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.714 -0.394 . . . . 15.94 110.223 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.3 m 76.25 -37.79 0.31 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 124.152 0.907 . . . . 13.01 112.083 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 46.8 p90 -126.98 153.37 45.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.898 0.38 . . . . 12.34 111.081 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.4 165.95 26.24 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.03 -0.828 . . . . 7.52 111.03 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.53 ' HB3' ' OE2' ' A' ' 13' ' ' GLU . 91.5 m-85 -115.21 146.16 41.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.225 0.513 . . . . 9.24 111.459 -177.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.52 HG21 ' CE2' ' A' ' 53' ' ' PHE . 61.6 mt -117.71 127.15 75.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 7.75 110.338 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.419 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -78.22 133.14 37.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.588 0.708 . . . . 11.8 111.962 -172.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.5 p -81.22 -1.09 43.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.855 -1.066 . . . . 12.34 113.229 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -60.94 -43.18 99.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.085 0.469 . . . . 13.33 111.342 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' OE1' ' HB3' ' A' ' 128' ' ' GLU . 7.2 tp10 -90.28 -9.14 49.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.043 0.925 . . . . 11.9 109.747 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 9' ' ' THR . 1.1 mmt180 -112.29 -167.58 1.2 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.83 -1.077 . . . . 12.99 110.462 -174.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.61 21.62 6.0 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.147 -0.686 . . . . 16.66 109.147 171.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.426 ' H ' ' HB3' ' A' ' 27' ' ' ARG . . . -166.05 128.21 1.93 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.922 -1.035 . . . . 12.09 110.169 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -85.91 140.24 30.53 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.831 -0.803 . . . . 12.51 108.831 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.1 mt -145.59 161.32 40.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.106 0.479 . . . . 8.76 111.89 -175.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -120.96 130.15 53.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.363 -0.835 . . . . 9.15 108.767 172.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -119.21 157.37 28.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.922 -0.399 . . . . 6.85 109.922 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -108.19 151.99 25.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.324 -0.398 . . . . 9.99 110.051 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -57.76 -26.41 61.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.275 0.842 . . . . 9.93 113.275 -172.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.2 t -68.7 -13.54 62.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.181 0.515 . . . . 12.28 110.898 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.66 38.96 2.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.056 -0.52 . . . . 10.62 110.145 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -127.17 117.36 22.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.165 -0.47 . . . . 8.78 109.904 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 68' ' ' GLN . 22.5 t -79.71 91.85 5.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.544 -0.753 . . . . 8.97 110.225 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.91 -163.3 27.7 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.797 -0.716 . . . . 9.98 112.465 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -86.3 112.51 21.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.818 -0.438 . . . . 12.43 109.818 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -28.91 40.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.678 0.275 . . . . 11.58 111.556 -174.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -75.33 -13.36 60.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.426 0.631 . . . . 14.73 109.671 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -95.61 6.8 48.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.588 -0.733 . . . . 13.3 110.334 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.8 tp -94.43 125.81 39.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.738 -0.665 . . . . 10.07 110.026 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.524 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 2.6 mppt? -103.2 167.74 9.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.205 0.526 . . . . 13.13 110.841 -174.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.5 mt -84.5 114.68 25.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.814 -0.63 . . . . 11.74 109.688 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.74 9.4 43.36 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.259 -0.736 . . . . 10.13 111.259 -170.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -79.55 124.52 83.78 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 109.532 -0.544 . . . . 8.39 109.532 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.581 ' HB2' HD12 ' A' ' 72' ' ' ILE . 86.1 Cg_endo -82.39 129.22 5.77 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.847 2.364 . . . . 7.28 113.621 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.4 166.27 29.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 4.74 111.097 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.49 ' HB3' HG22 ' A' ' 9' ' ' THR . 7.7 pt-20 -122.58 124.89 44.54 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.578 -0.527 . . . . 7.09 109.578 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CE2' HG21 ' A' ' 22' ' ' ILE . 54.3 p90 -133.0 149.75 52.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.109 0.48 . . . . 7.82 111.349 -172.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HG3' ' HG2' ' A' ' 7' ' ' ARG . 2.6 mp0 -88.72 149.46 23.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.019 -0.992 . . . . 11.59 110.361 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.05 121.69 42.97 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.328 -0.619 . . . . 12.41 109.328 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.5 p -138.9 172.08 13.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.398 . . . . 13.17 111.265 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -125.75 125.33 42.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.333 -0.394 . . . . 16.21 110.573 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.59 124.96 34.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.066 0.46 . . . . 16.64 110.542 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -79.97 -25.26 40.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.791 -0.64 . . . . 22.64 111.404 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -70.85 -57.54 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.559 -0.292 . . . . 21.43 111.233 -172.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.0 p -91.46 -28.54 17.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.962 0.41 . . . . 17.4 110.559 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.98 11.01 57.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 16.7 112.741 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 131.32 31.35 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 122.815 -0.226 . . . . 14.73 110.442 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.02 126.43 15.82 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.257 1.971 . . . . 12.6 109.93 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 30.2 pt -126.52 147.67 31.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.411 0.624 . . . . 11.73 111.63 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.24 155.04 18.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.022 -0.99 . . . . 8.91 108.433 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.475 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 39.1 t -75.26 -151.29 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.338 0.399 . . . . 9.83 110.496 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 39' ' ' SER . 2.5 mp0 -67.9 -10.28 51.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.248 0.462 . . . . 11.32 112.248 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.3 t 56.56 96.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.489 0.661 . . . . 6.11 111.198 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 t -93.77 147.7 22.8 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.603 -0.518 . . . . 6.12 109.603 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -81.51 157.5 24.81 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.434 -0.58 . . . . 6.3 109.434 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' A' ' 50' ' ' PRO . 24.6 mt . . . . . 0 C--N 1.325 -0.472 0 CA-C-O 121.375 0.607 . . . . 5.77 109.905 177.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 108.831 -0.804 . . . . 6.19 108.831 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 47.5 t -68.49 103.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 6.26 111.531 -174.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -78.71 83.21 4.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.764 -0.653 . . . . 6.05 109.743 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 p 23.44 96.37 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.96 1.467 . . . . 7.02 114.96 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.73 -30.55 71.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.525 0.679 . . . . 7.07 109.533 171.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -108.68 117.71 34.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.081 -0.963 . . . . 6.68 109.947 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -81.4 144.71 31.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.354 -0.385 . . . . 6.43 109.968 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.91 152.95 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.342 0.591 . . . . 3.7 111.111 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.1 p -114.94 145.7 41.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.607 -0.724 . . . . 3.49 110.086 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.99 165.77 24.54 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.347 -0.93 . . . . 2.58 112.648 -177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 m -118.82 130.18 55.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.457 -0.571 . . . . 3.34 109.457 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.669 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 3.1 t -73.64 123.4 28.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.015 -0.365 . . . . 3.14 110.015 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.6 p -101.34 -22.48 14.58 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.143 0.497 . . . . 3.61 109.979 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.8 m -140.29 118.42 11.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.497 -0.774 . . . . 3.12 109.898 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -97.83 163.77 12.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.093 0.473 . . . . 4.39 110.895 -179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.9 mt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 115.751 -0.658 . . . . 3.62 110.498 179.709 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.446 -0.629 0 N-CA-C 109.366 -0.605 . . . . 3.33 109.366 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.4 t -146.89 149.11 32.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.679 -0.489 . . . . 2.57 109.679 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 122' ' ' TYR . . . -85.71 168.35 41.55 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.445 -0.883 . . . . 1.66 111.928 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -125.66 120.66 31.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.629 0.252 . . . . 3.03 110.657 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 82.8 mt -110.98 127.17 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.337 -0.616 . . . . 1.88 109.337 174.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.9 p -106.42 129.52 54.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.231 -0.441 . . . . 3.49 110.813 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.523 ' CE2' HD11 ' A' ' 120' ' ' LEU . 1.2 p90 -146.68 166.52 26.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.265 -0.643 . . . . 3.51 109.265 175.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.429 ' HG2' ' SG ' ' A' ' 117' ' ' CYS . 43.8 mt-10 -107.28 121.66 45.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.17 0.509 . . . . 5.1 111.18 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -116.36 114.1 23.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.454 -0.794 . . . . 4.78 109.069 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 64.84 21.01 12.28 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.978 0.511 . . . . 6.97 110.65 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.3 66.15 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.014 -0.539 . . . . 5.1 112.045 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -102.63 129.05 49.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.888 0.375 . . . . 5.38 110.887 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.429 ' SG ' ' HG2' ' A' ' 112' ' ' GLU . 62.9 m -81.78 124.95 30.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.202 -0.454 . . . . 4.72 110.332 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -121.38 147.13 46.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.225 -0.443 . . . . 4.61 110.491 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.85 123.22 49.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 3.96 109.845 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.523 HD11 ' CE2' ' A' ' 111' ' ' TYR . 4.9 mp -105.38 134.88 19.46 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.262 -0.273 . . . . 2.75 110.262 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.57 133.15 11.48 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.966 2.444 . . . . 2.3 111.381 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.402 ' CE1' ' HA3' ' A' ' 107' ' ' GLY . 12.7 p90 -144.81 147.76 33.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.789 -0.448 . . . . 2.13 109.789 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.2 p -112.95 -179.94 3.79 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.845 -0.428 . . . . 3.07 109.845 173.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -72.76 -20.22 61.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.24 0.543 . . . . 4.8 110.867 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.77 -4.8 58.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.79 -0.641 . . . . 4.81 111.23 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -89.45 -13.5 37.45 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.138 0.494 . . . . 3.84 110.58 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 156' ' ' ILE . 2.8 p -110.48 116.19 51.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.716 0.769 . . . . 4.39 111.124 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.43 ' HB3' ' OE1' ' A' ' 26' ' ' GLU . 1.1 mp0 -99.72 179.02 4.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.786 -1.097 . . . . 6.43 109.997 177.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.55 -10.78 64.93 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.569 -0.824 . . . . 5.91 112.315 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 66.46 25.46 10.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.88 0.472 . . . . 6.07 111.388 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -103.55 140.93 20.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.635 -0.257 . . . . 5.27 110.866 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -97.51 129.14 44.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.064 0.459 . . . . 5.78 110.239 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.633 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -115.33 149.56 37.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.859 -0.61 . . . . 3.62 110.075 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -124.23 174.44 7.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.16 0.505 . . . . 6.93 109.992 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.669 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.97 122.06 22.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.269 0.557 . . . . 4.12 111.442 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.04 -14.88 13.68 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.595 -0.812 . . . . 4.07 113.622 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -86.58 -177.55 6.18 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 117.901 0.85 . . . . 4.06 110.687 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -116.85 115.46 25.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.195 0.521 . . . . 4.17 111.815 -174.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.86 162.36 15.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.633 -0.712 . . . . 2.77 110.985 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 45.8 t -126.37 129.47 48.87 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.612 -0.885 . . . . 3.47 108.612 177.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.0 146.99 50.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.071 0.462 . . . . 3.35 110.488 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -106.18 112.81 26.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.736 -0.665 . . . . 5.34 109.919 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.72 100.63 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.496 -0.775 . . . . 4.66 111.539 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -83.01 111.05 18.5 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.731 -0.47 . . . . 4.85 109.731 173.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 21.1 m -86.72 116.12 24.61 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.802 -0.635 . . . . 5.68 111.309 -174.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -74.44 166.14 24.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 6.25 110.398 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.1 -32.58 73.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 8.58 111.856 -173.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 3.3 tmt_? -76.23 -22.9 54.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 7.86 110.382 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.68 11.78 42.92 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.575 -0.821 . . . . 5.59 112.766 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -114.49 127.34 55.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.794 -0.239 . . . . 5.18 110.384 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -147.63 -176.92 5.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.094 0.474 . . . . 4.28 111.672 -173.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -139.27 -143.56 4.43 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.92 -0.872 . . . . 3.36 110.92 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.76 110.52 14.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.143 0.472 . . . . 2.84 109.963 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 45.6 t -122.78 162.14 22.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.563 -0.532 . . . . 4.34 109.563 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 56.56 37.87 29.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.162 0.506 . . . . 5.75 110.748 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 127' ' ' VAL . 69.5 mt -61.53 115.69 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.32 -0.855 . . . . 3.55 110.382 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 140' ' ' SER . 0.7 OUTLIER -111.56 143.84 41.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.979 0.418 . . . . 5.96 110.58 -176.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.4 tp -103.48 93.36 4.9 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.194 -0.669 . . . . 4.34 109.194 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.1 -28.4 15.1 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.739 -0.385 . . . . 4.97 110.958 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -114.86 84.02 10.0 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.451 -0.574 . . . . 5.37 109.451 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.93 158.75 18.37 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.943 2.429 . . . . 5.44 113.185 -174.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.74 -0.664 . . . . 6.1 110.174 176.336 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 N-CA-C 112.038 -0.425 . . . . 21.66 112.038 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.477 ' HA ' ' HG2' ' A' ' 5' ' ' GLU . . . 65.24 31.57 10.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.945 0.498 . . . . 20.17 111.948 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -76.94 -34.47 57.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.989 0.424 . . . . 18.5 110.18 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -152.8 91.78 1.59 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.764 -0.653 . . . . 16.62 109.953 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 2' ' ' ALA . 5.1 pt-20 -165.38 130.09 2.45 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.485 -0.78 . . . . 18.35 109.767 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -128.34 96.13 4.35 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.485 -0.78 . . . . 16.2 109.715 175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -86.95 106.06 17.54 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.542 0.687 . . . . 12.4 109.409 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.52 ' HB3' ' HG2' ' A' ' 27' ' ' ARG . 42.7 mt-10 -120.26 143.52 48.27 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.771 -0.649 . . . . 11.63 110.356 -174.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.4 p -110.87 144.36 40.04 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.235 -0.439 . . . . 9.15 111.05 -176.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.78 172.63 31.84 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.363 -0.922 . . . . 6.81 112.15 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.0 mt -120.8 133.99 65.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 110.083 -0.34 . . . . 10.17 110.083 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.04 112.79 11.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.536 -0.542 . . . . 8.73 109.536 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 11.8 tp10 -91.54 -29.95 16.68 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.799 -0.637 . . . . 10.86 110.988 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -159.77 128.33 5.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.039 -0.528 . . . . 14.06 109.62 -175.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 mt -99.45 126.8 45.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.178 0.513 . . . . 11.73 111.17 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.06 179.26 4.32 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.232 -1.025 . . . . 11.36 108.232 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.7 m170 -91.09 112.53 24.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.503 -0.554 . . . . 15.94 109.503 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.5 t 70.28 23.85 4.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.332 -0.849 . . . . 13.01 110.564 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -164.67 151.57 11.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.98 -0.555 . . . . 12.34 109.656 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -162.19 165.37 35.94 Favored Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.349 -0.929 . . . . 7.52 112.669 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -117.18 134.13 55.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.686 0.279 . . . . 9.24 111.486 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.407 HG21 ' CE2' ' A' ' 53' ' ' PHE . 75.6 mt -106.37 122.84 60.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.931 -0.577 . . . . 7.75 110.058 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.493 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 6.5 mm100 -83.8 147.98 27.28 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.533 0.938 . . . . 11.8 113.533 -175.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.2 p -77.94 6.59 7.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 113.811 -1.54 . . . . 12.34 113.302 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -49.87 -48.66 51.19 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.584 0.587 . . . . 13.33 112.584 -171.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -104.4 -3.51 23.99 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.735 -0.386 . . . . 11.9 112.005 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' HG2' ' HB3' ' A' ' 8' ' ' GLU . 28.4 tpt180 -152.48 139.38 19.03 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.991 -0.374 . . . . 12.99 109.991 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -73.03 49.81 0.25 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.984 0.364 . . . . 16.66 111.984 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.22 127.86 12.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.933 0.397 . . . . 12.09 111.201 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -108.66 102.31 11.38 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.312 -0.625 . . . . 12.51 109.312 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.47 HD12 ' CE1' ' A' ' 53' ' ' PHE . 71.1 mt -109.91 135.7 50.37 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.876 0.369 . . . . 8.76 111.332 -176.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -91.57 125.36 36.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.139 -0.689 . . . . 9.15 109.139 172.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -118.13 147.89 42.86 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.885 0.374 . . . . 6.85 110.518 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -99.08 158.88 15.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.208 -0.451 . . . . 9.99 109.939 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -70.83 -12.42 61.54 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.058 0.392 . . . . 9.93 112.058 -174.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -81.09 -13.3 58.87 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.31 0.576 . . . . 12.28 109.895 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -103.94 29.33 5.95 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.652 -0.704 . . . . 10.62 110.771 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -126.31 128.45 47.14 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.016 0.436 . . . . 8.78 110.949 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 t -101.36 115.65 31.0 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.716 -0.675 . . . . 8.97 110.818 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 130.65 -156.19 21.53 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.787 -0.72 . . . . 9.98 112.278 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -89.73 113.62 25.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.854 0.359 . . . . 12.43 110.621 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -68.11 -24.28 29.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.29 0.567 . . . . 11.58 109.921 177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -81.51 -2.61 50.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.768 -0.651 . . . . 14.73 110.369 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -112.94 15.7 19.63 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.454 0.645 . . . . 13.3 109.716 175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.8 tp -103.49 134.0 47.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.51 -0.922 . . . . 10.07 108.51 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.422 ' HG3' ' HB2' ' A' ' 49' ' ' ASP . 21.2 ptmt -133.75 170.13 16.02 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 120.9 0.381 . . . . 13.13 111.116 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.0 mp -81.15 119.24 30.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.971 -0.559 . . . . 11.74 109.565 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.48 36.65 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.322 -0.711 . . . . 10.13 111.322 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.422 ' HB2' ' HG3' ' A' ' 46' ' ' LYS . 14.7 t70 -92.93 127.26 48.27 Favored Pre-proline 0 C--O 1.236 0.394 0 CA-C-N 115.442 -0.379 . . . . 8.39 110.143 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -89.31 128.91 1.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.062 2.508 . . . . 7.28 112.929 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.5 m -125.49 161.05 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.166 -0.47 . . . . 4.74 111.207 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.42 128.69 56.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.848 -0.614 . . . . 7.09 109.516 175.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.47 ' CE1' HD12 ' A' ' 31' ' ' LEU . 44.5 p90 -132.14 155.58 47.9 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.097 0.475 . . . . 7.82 111.204 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 38.1 tt0 -103.24 120.76 41.34 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.611 -0.722 . . . . 11.59 109.592 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.17 116.33 28.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.116 -0.493 . . . . 12.41 109.853 -176.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 p -139.96 153.29 46.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.103 0.477 . . . . 13.17 111.73 -176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -92.86 108.95 20.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.964 -0.562 . . . . 16.21 109.944 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.508 ' OD2' HG22 ' A' ' 61' ' ' THR . 14.3 t70 -73.97 110.82 8.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.027 0.441 . . . . 16.64 109.835 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.449 ' HA ' ' NE ' ' A' ' 59' ' ' ARG . 3.3 mmp_? -79.97 -7.2 58.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.059 -0.519 . . . . 22.64 111.2 -179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.455 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 54.3 ttt180 -70.86 -59.13 2.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.154 -0.475 . . . . 21.43 110.471 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.508 HG22 ' OD2' ' A' ' 58' ' ' ASP . 15.1 t -92.97 -19.26 21.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.25 -0.432 . . . . 17.4 110.44 178.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.57 31.54 15.71 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.856 -0.688 . . . . 16.7 112.492 178.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -132.63 149.28 72.58 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 110.036 -0.357 . . . . 14.73 110.036 -177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.52 126.79 8.51 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.079 1.853 . . . . 12.6 111.468 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.8 pt -130.65 168.75 22.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.321 0.581 . . . . 11.73 111.295 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.19 156.53 17.81 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.2 -0.909 . . . . 8.91 108.88 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.491 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 8.4 t -79.45 -150.9 0.06 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.399 -0.364 . . . . 9.83 110.101 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -8.87 51.48 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.649 0.611 . . . . 11.32 112.649 -172.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 86.2 t 55.88 99.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 121.471 0.653 . . . . 6.11 111.165 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 m -99.46 125.11 45.13 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.092 0.472 . . . . 6.12 111.12 -174.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.441 ' HE3' ' HB3' ' A' ' 71' ' ' LYS . 14.1 mmmt -60.16 135.77 57.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.788 -0.642 . . . . 6.3 109.744 172.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.72 113.3 13.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.775 0.321 . . . . 5.77 110.791 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 60.12 72.26 0.78 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-N 115.279 -0.873 . . . . 5.69 111.496 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -88.3 -61.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.802 2.335 . . . . 6.86 112.43 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -99.78 -7.39 25.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.312 0.577 . . . . 8.49 110.13 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.632 HG12 ' HB1' ' A' ' 144' ' ' ALA . 6.2 t -79.6 113.26 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.533 . . . . 6.19 110.41 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 79' ' ' SER . 43.4 t -97.5 134.12 36.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.306 -0.406 . . . . 6.26 110.548 -176.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.1 mp -75.15 16.41 0.32 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.685 0.279 . . . . 6.05 111.504 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.51 ' H ' HG12 ' A' ' 77' ' ' VAL . 8.3 t 66.53 -2.3 1.08 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.812 0.845 . . . . 7.02 111.842 177.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 62.58 13.76 6.53 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.274 0.63 . . . . 7.07 111.621 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -129.62 118.03 21.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.268 -0.424 . . . . 6.68 109.858 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -95.67 124.32 39.64 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.063 -0.517 . . . . 6.43 109.862 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.82 164.97 15.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.284 0.564 . . . . 3.7 111.452 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 6.8 p -125.88 148.28 49.23 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.292 -0.867 . . . . 3.49 109.774 176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.09 161.09 25.54 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.224 -0.989 . . . . 2.58 112.37 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.7 m -102.24 125.61 49.0 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.408 -0.59 . . . . 3.34 109.408 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.626 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 51.0 t -68.11 126.23 27.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 110.189 -0.3 . . . . 3.14 110.189 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.3 p -113.7 -17.02 12.21 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.799 0.333 . . . . 3.61 111.844 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.2 m -150.95 135.03 16.74 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.282 -0.261 . . . . 3.12 110.597 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -100.0 171.22 7.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 4.39 110.508 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.513 ' H ' HD23 ' A' ' 91' ' ' LEU . 1.8 pt? -124.67 144.25 50.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.256 -0.646 . . . . 3.62 109.256 175.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.485 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 34.0 ptt85 -88.32 108.83 19.53 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 122.102 0.953 . . . . 7.2 112.006 -172.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.1 p -140.75 -154.07 0.5 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.466 -1.243 . . . . 5.1 107.739 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.24 43.25 14.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.183 0.516 . . . . 7.53 110.573 169.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 60.0 p -73.26 -163.91 0.17 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.818 -0.628 . . . . 7.47 110.486 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -87.35 6.29 34.35 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.944 -0.571 . . . . 7.58 111.125 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -155.15 -45.29 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.886 0.328 . . . . 8.32 111.886 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -109.43 156.38 20.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.023 0.439 . . . . 7.26 111.509 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.76 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 7.9 p -154.01 141.17 12.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.783 -0.644 . . . . 5.54 109.373 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' A' ' 99' ' ' VAL . 3.9 pp 59.65 2.16 0.33 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.483 1.113 . . . . 7.28 112.909 178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -66.77 -39.46 87.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.349 0.595 . . . . 7.54 110.0 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.412 ' O ' HG22 ' A' ' 105' ' ' THR . 5.9 m -82.38 90.22 6.67 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.568 -0.742 . . . . 5.41 109.842 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.9 p -87.8 8.34 26.33 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.178 0.513 . . . . 4.58 110.795 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -96.68 14.62 24.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.896 -0.593 . . . . 5.09 110.463 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 102' ' ' SER . 9.0 t -122.94 139.88 53.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.615 -0.513 . . . . 3.33 109.615 176.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.8 t -146.87 143.31 28.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.402 -0.363 . . . . 2.57 110.748 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -97.61 -162.38 31.36 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.723 -0.751 . . . . 1.66 111.918 177.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 82.9 mmt-85 -140.15 135.15 32.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.99 0.424 . . . . 3.03 111.15 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.0 mt -114.26 130.7 68.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.657 -0.701 . . . . 1.88 109.444 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.7 t -109.35 116.3 31.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.86 -0.422 . . . . 3.49 109.86 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -122.57 132.76 54.45 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.411 -0.589 . . . . 3.51 109.411 176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -107.05 109.73 21.68 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.788 -0.642 . . . . 5.1 109.49 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -163.99 147.74 9.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.86 -0.609 . . . . 4.78 110.438 -172.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 62.53 21.01 12.36 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.441 0.463 . . . . 6.97 111.714 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.52 -0.97 87.21 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.732 -0.746 . . . . 5.1 111.99 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -101.89 139.09 37.99 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.074 0.464 . . . . 5.38 110.589 -177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 13.8 p -139.47 106.18 5.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.501 -0.772 . . . . 4.72 109.997 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -155.69 162.16 40.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.376 -0.375 . . . . 4.61 110.537 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -95.22 133.75 38.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.646 -0.706 . . . . 3.96 110.584 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 5.6 mp -106.25 130.77 22.44 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.448 -0.342 . . . . 2.75 110.636 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 13.1 Cg_exo -69.74 131.79 22.01 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.632 2.222 . . . . 2.3 111.246 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -138.78 145.39 40.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.978 0.418 . . . . 2.13 110.3 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.6 p -112.94 164.22 13.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.616 -0.72 . . . . 3.07 109.335 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -77.16 -20.06 56.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.885 0.328 . . . . 4.8 111.885 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -71.82 -13.83 61.8 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.897 0.332 . . . . 4.81 111.897 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.514 ' OD2' ' HA ' ' A' ' 154' ' ' CYS . 7.2 t70 -101.11 -0.44 36.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.511 0.672 . . . . 3.84 110.161 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 98.5 t -82.38 107.32 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.223 0.535 . . . . 4.39 110.374 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.4 145.84 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.992 -0.549 . . . . 6.43 110.774 -177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 99.5 -15.98 59.4 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.672 -0.775 . . . . 5.91 112.074 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 62.28 34.8 15.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.102 0.477 . . . . 6.07 110.911 179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.3 m -79.98 174.71 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 116.038 -0.528 . . . . 5.27 110.663 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -127.84 81.35 2.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.295 0.569 . . . . 5.78 110.238 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.516 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.3 pt? -68.44 148.91 49.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.207 -0.906 . . . . 3.62 111.09 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -133.21 139.81 47.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.287 -0.415 . . . . 6.93 109.961 -178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.626 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -55.62 121.32 8.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.164 0.506 . . . . 4.12 111.675 -173.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.65 -13.2 11.9 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.301 -0.863 . . . . 4.07 112.572 -176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -91.19 177.41 6.26 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 117.292 0.546 . . . . 4.06 109.864 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -116.97 116.58 27.65 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.089 0.471 . . . . 4.17 110.711 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -116.11 159.98 15.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.076 -0.511 . . . . 2.77 110.714 -176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.1 t -114.83 139.51 49.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.974 -0.75 . . . . 3.47 108.974 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -144.73 143.62 30.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.016 0.436 . . . . 3.35 110.149 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -98.95 119.2 37.33 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.579 -0.737 . . . . 5.34 109.937 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.8 mt -78.67 96.86 2.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.085 -0.507 . . . . 4.66 109.709 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.632 ' HB1' HG12 ' A' ' 76' ' ' VAL . . . -90.16 111.2 22.26 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.796 -0.638 . . . . 4.85 110.758 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 28.4 m -84.25 112.9 20.71 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.509 -0.769 . . . . 5.68 110.335 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -76.42 158.52 31.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.936 -0.574 . . . . 6.25 109.549 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -60.92 -20.27 61.84 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.99 0.424 . . . . 8.58 111.379 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 148' ' ' ARG . 2.7 mmt180 -78.26 -8.2 58.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.371 -0.377 . . . . 7.86 111.717 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.71 -1.96 84.48 Favored Glycine 0 C--O 1.227 -0.292 0 C-N-CA 120.824 -0.703 . . . . 5.59 112.328 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -100.4 132.4 45.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.902 -0.406 . . . . 5.18 109.902 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.481 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -150.76 178.78 8.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.534 -0.303 . . . . 4.28 110.847 -178.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -150.36 -125.17 1.28 Allowed Glycine 0 N--CA 1.45 -0.418 0 N-CA-C 110.805 -0.918 . . . . 3.36 110.805 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -121.28 126.1 48.71 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.841 -0.429 . . . . 2.84 109.841 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.514 ' HA ' ' OD2' ' A' ' 126' ' ' ASP . 17.7 t -136.59 159.22 42.46 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.114 -0.328 . . . . 4.34 110.114 -177.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 63.08 36.26 12.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.319 0.581 . . . . 5.75 110.558 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.8 mt -75.77 115.99 18.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.637 -0.711 . . . . 3.55 110.816 -177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -135.94 160.04 39.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.806 0.336 . . . . 5.96 110.165 176.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 59.9 tp -92.35 110.93 22.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.281 -0.418 . . . . 4.34 110.353 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -98.84 -57.55 2.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.782 -0.645 . . . . 4.97 110.686 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -111.17 96.63 31.39 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.244 -0.434 . . . . 5.37 110.022 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -80.14 158.25 23.45 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.233 1.956 . . . . 5.44 113.114 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -120.4 91.6 3.58 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.578 -0.737 . . . . 6.1 109.775 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -100.02 125.16 40.97 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.902 -0.59 . . . . 9.49 110.771 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.06 99.33 0.98 Allowed 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.474 2.116 . . . . 8.39 112.001 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 C--N 1.321 -0.673 0 CA-C-N 115.853 -0.612 . . . . 10.27 110.637 178.673 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 111.783 -0.527 . . . . 21.66 111.783 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.1 -75.33 0.59 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.555 0.216 . . . . 20.17 110.454 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -81.21 -38.23 27.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.408 0.623 . . . . 18.5 109.667 177.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.4 65.94 8.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.619 -0.719 . . . . 16.62 109.886 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -85.39 -19.28 31.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.497 0.665 . . . . 18.35 110.329 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -83.01 84.98 7.26 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.297 -0.865 . . . . 16.2 110.738 177.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -85.73 129.2 34.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.998 0.428 . . . . 12.4 109.969 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.464 ' CD ' ' HE ' ' A' ' 27' ' ' ARG . 6.3 mm-40 -98.13 136.77 37.88 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.106 -0.497 . . . . 11.63 109.886 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 67.2 p -109.33 138.69 45.3 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 121.102 -0.239 . . . . 9.15 110.593 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 26' ' ' GLU . . . -150.86 -176.03 23.38 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.147 -1.025 . . . . 6.81 112.45 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.0 mt -132.43 155.41 41.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.336 -0.987 . . . . 10.17 108.336 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.76 118.86 34.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 120.508 -0.477 . . . . 8.73 110.387 174.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.586 ' OE1' ' HD2' ' A' ' 30' ' ' ARG . 5.8 pt-20 -82.58 -32.59 28.4 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.376 -0.374 . . . . 10.86 111.089 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -159.19 158.15 32.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.28 -0.418 . . . . 14.06 109.899 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.0 mt -125.44 118.16 25.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.107 -0.497 . . . . 11.73 110.984 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -105.57 178.95 4.41 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 107.488 -1.301 . . . . 11.36 107.488 172.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 23.8 m80 -92.1 138.46 31.52 Favored 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 119.917 -0.713 . . . . 15.94 109.986 177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.3 p 74.62 -23.07 0.24 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.185 1.394 . . . . 13.01 112.032 -176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 49.5 p90 -151.8 158.59 43.5 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.872 0.368 . . . . 12.34 111.303 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.44 178.24 21.73 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.198 -0.761 . . . . 7.52 111.198 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -119.54 141.68 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.137 0.468 . . . . 9.24 111.542 -178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.443 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 67.4 mt -103.28 125.35 57.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.449 -0.796 . . . . 7.75 110.006 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.558 ' HG2' ' H ' ' A' ' 25' ' ' CYS . 25.0 tt0 -80.59 134.77 35.96 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.439 -0.8 . . . . 11.8 111.833 -172.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.0 p -78.96 2.33 20.7 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.718 -1.128 . . . . 12.34 112.231 -178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.558 ' H ' ' HG2' ' A' ' 23' ' ' GLN . 49.2 t -60.17 -29.96 69.02 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.059 -0.4 . . . . 13.33 110.949 177.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.428 ' HB3' ' HA2' ' A' ' 10' ' ' GLY . 19.8 tp10 -103.99 -43.41 5.29 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.446 -0.343 . . . . 11.9 110.914 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.5 ' HG2' ' N ' ' A' ' 28' ' ' GLN . 28.5 ttt180 -95.09 155.48 16.71 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 110.16 -0.311 . . . . 12.99 110.16 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.5 ' N ' ' HG2' ' A' ' 27' ' ' ARG . 87.2 mt-30 -77.62 20.06 0.34 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.282 0.475 . . . . 16.66 112.282 -177.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.443 ' HB3' ' NH1' ' A' ' 27' ' ' ARG . . . -169.82 144.85 2.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.33 -0.395 . . . . 12.09 110.335 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.586 ' HD2' ' OE1' ' A' ' 13' ' ' GLU . 11.2 ttp180 -90.34 148.45 22.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 12.51 109.927 -179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -144.57 163.86 32.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.362 0.265 . . . . 8.76 110.676 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -121.1 149.3 42.96 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.953 -0.758 . . . . 9.15 108.953 172.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -138.98 153.38 48.16 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.852 -0.339 . . . . 6.85 110.237 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.512 ' HB2' ' OE1' ' A' ' 37' ' ' GLN . 67.1 m80 -98.6 159.51 14.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.98 -0.748 . . . . 9.99 108.98 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -70.27 -9.65 56.62 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.134 0.492 . . . . 9.93 110.979 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.1 m -75.13 -15.37 60.59 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.02 0.438 . . . . 12.28 110.162 174.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.512 ' OE1' ' HB2' ' A' ' 34' ' ' HIS . 25.3 mp0 -113.28 36.95 3.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.002 -0.545 . . . . 10.62 110.938 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -125.32 116.31 21.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.852 0.358 . . . . 8.78 110.13 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.506 ' HB2' ' HB2' ' A' ' 68' ' ' GLN . 22.3 t -87.04 95.36 9.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.017 -0.538 . . . . 8.97 110.856 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.1 175.57 14.48 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.73 -0.668 . . . . 9.98 111.613 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -64.04 122.25 16.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.679 0.276 . . . . 12.43 110.353 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.6 tp -66.08 -18.81 24.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.227 0.537 . . . . 11.58 110.335 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.7 -25.71 65.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.69 -0.686 . . . . 14.73 110.637 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.0 m170 -83.88 0.25 48.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.06 -0.518 . . . . 13.3 110.459 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 53.9 tp -104.04 123.01 46.45 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.051 0.453 . . . . 10.07 110.472 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 49' ' ' ASP . 12.9 mmmm -120.17 162.29 19.6 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.612 -0.722 . . . . 13.13 110.225 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 61.5 mt -71.8 114.81 11.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.993 -0.548 . . . . 11.74 109.793 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.07 -4.12 28.63 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.905 -0.664 . . . . 10.13 111.679 -173.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -80.01 133.75 57.46 Favored Pre-proline 0 C--O 1.236 0.353 0 CA-C-O 120.621 0.248 . . . . 8.39 110.41 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -85.6 142.03 7.93 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 123.168 2.578 . . . . 7.28 113.102 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.81 161.14 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.65 -0.705 . . . . 4.74 110.588 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -123.72 135.06 53.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.065 0.46 . . . . 7.09 109.801 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -144.78 158.3 43.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.898 -0.592 . . . . 7.82 110.985 -170.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 2.5 mp0 -97.98 122.6 41.3 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.385 -0.37 . . . . 11.59 110.546 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.445 ' HG2' ' NH2' ' A' ' 27' ' ' ARG . 14.6 tpt -88.41 107.89 19.08 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.481 -0.563 . . . . 12.41 109.481 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 45.6 p -132.75 165.67 24.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.903 0.382 . . . . 13.17 111.149 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -118.64 122.28 42.18 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.1 -0.704 . . . . 16.21 109.1 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -90.65 134.58 34.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.133 0.492 . . . . 16.64 111.654 -174.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -79.94 -13.8 59.09 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.474 -0.785 . . . . 22.64 112.757 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 -92.24 -43.29 9.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.831 0.348 . . . . 21.43 111.107 -178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 22.5 p -86.7 -32.9 20.23 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.356 -0.384 . . . . 17.4 111.483 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.49 19.34 68.91 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.024 -0.608 . . . . 16.7 112.122 -178.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -122.38 158.26 56.49 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 110.263 -0.273 . . . . 14.73 110.263 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.28 126.53 8.53 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.33 2.02 . . . . 12.6 110.616 173.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -135.09 154.34 35.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 120.925 0.393 . . . . 11.73 111.338 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -99.83 158.81 15.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.865 -0.607 . . . . 8.91 109.997 177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 p -73.75 -150.04 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.16 0.505 . . . . 9.83 111.592 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 39' ' ' SER . 30.1 pt20 -70.95 -5.35 30.26 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.817 -0.628 . . . . 11.32 112.277 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.9 t 50.95 89.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-O 121.714 0.769 . . . . 6.11 111.219 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.6 m -90.61 135.94 33.38 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.762 -0.654 . . . . 6.12 111.16 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -72.6 123.15 22.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.054 -0.721 . . . . 6.3 109.054 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.5 mt -52.94 113.01 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.237 0 O-C-N 123.805 0.69 . . . . 5.77 111.845 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -130.63 141.66 42.74 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.711 -0.677 . . . . 5.69 109.893 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.62 139.36 33.93 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.656 2.237 . . . . 6.86 113.304 -176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -91.64 179.56 5.62 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.464 -0.789 . . . . 8.49 109.867 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.531 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 9.9 p -80.96 156.38 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.691 -0.485 . . . . 6.19 109.691 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 39.6 t -76.93 108.07 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.035 0.445 . . . . 6.26 111.369 -176.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 96.1 mt -104.24 -48.72 3.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.885 -0.598 . . . . 6.05 111.289 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.515 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 66.2 m -99.72 86.94 3.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.312 0.486 . . . . 7.02 112.312 -175.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 79' ' ' SER . 0.9 OUTLIER -177.55 116.04 0.09 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.095 0.958 . . . . 7.07 108.809 174.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 66.34 64.36 0.51 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.813 0.816 . . . . 6.68 109.885 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 82' ' ' ARG . 6.4 ptm180 -78.32 107.39 10.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.351 -0.841 . . . . 6.43 110.322 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.4 m -93.7 160.49 2.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.986 -0.552 . . . . 3.7 111.76 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 9.8 p -119.51 139.39 52.18 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.285 -0.871 . . . . 3.49 109.426 171.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -136.92 163.69 25.27 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.277 -0.963 . . . . 2.58 112.081 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 20.8 m -107.76 125.16 51.07 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.493 -0.558 . . . . 3.34 109.493 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.551 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 1.6 t -66.47 131.2 32.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.05 -0.722 . . . . 3.14 109.05 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.8 p -109.45 -16.54 13.98 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.052 0.453 . . . . 3.61 110.756 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.8 m -154.44 122.7 6.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.291 -0.413 . . . . 3.12 110.859 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' A' ' 134' ' ' ARG . 4.7 mp0 -95.45 135.25 37.33 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.463 -0.335 . . . . 4.39 110.84 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 91' ' ' LEU . 1.7 pt? -82.99 76.4 9.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.706 1.241 . . . . 3.62 109.414 170.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -71.71 176.56 4.76 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.033 -1.439 . . . . 7.2 110.306 179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.9 p -81.19 97.12 7.46 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 109.018 -0.734 . . . . 5.1 109.018 170.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -92.44 69.61 5.01 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.793 0.806 . . . . 7.53 110.458 -172.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 98' ' ' ASN . 61.2 m -149.65 178.39 8.89 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.699 -1.137 . . . . 7.47 108.542 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -75.75 76.98 2.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.502 0.191 . . . . 7.58 110.547 177.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.2 t30 74.44 -20.45 0.32 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.596 0.758 . . . . 8.32 111.903 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 95' ' ' SER . 18.9 m120 -83.8 168.81 15.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.149 0.5 . . . . 7.26 111.146 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.3 p -114.24 132.14 64.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.83 -0.623 . . . . 5.54 109.495 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 68.0 tp -158.11 -75.47 0.08 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.418 0.628 . . . . 7.28 112.097 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -77.85 19.68 0.39 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.186 -0.916 . . . . 7.54 112.405 -171.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.18 -0.18 53.77 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 111.961 0.356 . . . . 5.41 111.961 -176.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.9 p -106.67 -32.91 7.8 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.881 0.372 . . . . 4.58 111.235 178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -76.11 -25.61 55.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.012 -0.54 . . . . 5.09 110.905 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 91' ' ' LEU . 4.8 t -95.85 160.47 14.46 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.977 -0.556 . . . . 3.33 109.641 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.4 m -134.28 134.51 41.99 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.542 -0.299 . . . . 2.57 110.373 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -76.86 168.9 54.91 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.896 -0.668 . . . . 1.66 112.257 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 33.5 mmt180 -128.81 122.6 30.86 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.808 0.337 . . . . 3.03 110.915 -177.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 99.5 mt -112.17 127.67 69.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.773 -0.825 . . . . 1.88 108.773 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 22.7 t -111.53 125.8 54.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.8 0.333 . . . . 3.49 110.288 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 1.0 OUTLIER -129.41 145.81 51.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.171 -0.677 . . . . 3.51 109.171 178.177 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -118.2 112.37 20.05 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.255 -0.646 . . . . 5.1 109.255 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 23.0 t-20 -126.78 108.65 11.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.673 -0.694 . . . . 4.78 110.476 -175.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 62.4 30.44 17.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.028 -0.533 . . . . 6.97 111.994 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 97.03 -0.47 60.49 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.962 -0.637 . . . . 5.1 113.95 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 5.7 pt-20 -108.71 137.64 46.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.667 0.733 . . . . 5.38 109.718 172.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 3.8 p -141.03 92.54 2.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.053 -0.521 . . . . 4.72 110.776 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -98.02 163.52 12.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.964 -0.562 . . . . 4.61 110.345 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -98.44 121.17 40.04 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.29 -0.633 . . . . 3.96 109.29 176.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 26.0 mt -103.86 130.34 23.61 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.157 -0.474 . . . . 2.75 110.934 -175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.54 141.61 17.76 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.709 2.273 . . . . 2.3 111.997 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -146.78 144.26 29.24 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.417 -0.586 . . . . 2.13 109.417 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.426 ' HA ' HD11 ' A' ' 91' ' ' LEU . 37.9 p -105.89 173.25 6.39 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.677 -0.49 . . . . 3.07 109.677 175.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -71.04 -19.48 62.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.394 0.616 . . . . 4.8 109.95 -177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -81.03 -10.8 59.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.02 -0.991 . . . . 4.81 111.43 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -87.88 -10.25 51.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.93 0.395 . . . . 3.84 110.711 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 39.6 t -87.09 120.3 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.826 -0.624 . . . . 4.39 110.825 -175.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -106.45 153.86 21.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.677 -0.692 . . . . 6.43 110.222 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.75 -1.57 85.46 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.96 -0.638 . . . . 5.91 112.31 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 63.61 17.11 10.17 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.103 0.561 . . . . 6.07 111.066 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.3 m -69.15 147.94 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.117 0.484 . . . . 5.27 110.892 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.83 108.6 20.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.2 -0.454 . . . . 5.78 110.564 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.597 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -106.36 150.36 26.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.862 -0.608 . . . . 3.62 110.169 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.569 ' HA ' ' HG2' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -149.96 175.31 11.79 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.786 -0.365 . . . . 6.93 110.511 171.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.551 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -69.81 119.5 14.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.677 0.275 . . . . 4.12 111.087 -176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.89 -7.54 11.94 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.859 -0.686 . . . . 4.07 113.567 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -111.6 173.57 6.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.898 0.849 . . . . 4.06 110.584 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -110.93 116.41 31.18 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.173 0.511 . . . . 4.17 111.519 -173.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -117.35 157.49 18.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.634 -0.712 . . . . 2.77 110.906 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.449 ' HB2' ' CG ' ' A' ' 159' ' ' GLU . 8.0 t -119.2 134.44 55.2 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.02 -0.733 . . . . 3.47 109.02 177.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -132.73 144.91 50.61 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.892 0.377 . . . . 3.35 110.237 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -95.42 112.26 24.01 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.779 -0.646 . . . . 5.34 109.699 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 57.8 mt -79.25 96.1 2.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.83 -0.623 . . . . 4.66 110.222 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.693 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -81.54 108.23 14.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.189 -0.46 . . . . 4.85 110.516 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 8.9 m -85.16 110.36 18.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.037 0.446 . . . . 5.68 110.862 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -75.14 155.37 37.08 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.108 -0.701 . . . . 6.25 109.108 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -61.22 -23.42 65.61 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.939 0.348 . . . . 8.58 111.939 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -72.21 -23.88 61.32 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.997 0.427 . . . . 7.86 110.414 176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 96.3 10.76 55.57 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 121.048 -0.596 . . . . 5.59 112.701 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -101.01 132.95 46.18 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.827 -0.435 . . . . 5.18 109.827 175.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.48 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -155.44 -178.45 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.857 -0.611 . . . . 4.28 110.887 179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.96 -139.79 2.78 Favored Glycine 0 N--CA 1.441 -1.023 0 N-CA-C 110.854 -0.898 . . . . 3.36 110.854 175.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -107.42 110.05 21.92 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.861 -0.422 . . . . 2.84 109.861 175.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 59.0 m -117.87 151.14 37.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.417 -0.356 . . . . 4.34 110.704 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 56.74 51.58 10.76 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.856 -0.611 . . . . 5.75 110.958 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 133' ' ' LEU . 4.6 mp -66.54 115.72 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 3.55 110.364 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -114.21 157.91 22.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.165 -0.47 . . . . 5.96 109.98 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.2 tp -97.56 123.25 41.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.401 -0.363 . . . . 4.34 110.354 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 140' ' ' SER . 21.3 mm-40 -102.33 -53.37 2.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.986 0.422 . . . . 4.97 111.192 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -136.34 102.62 9.74 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.187 -0.461 . . . . 5.37 110.75 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.89 160.9 33.66 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.418 2.079 . . . . 5.44 111.778 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.99 92.96 2.39 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.222 -0.444 . . . . 6.1 110.031 176.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -99.05 124.71 44.39 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.96 -0.564 . . . . 9.49 109.947 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.04 129.48 19.59 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.42 2.08 . . . . 8.39 111.549 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 116.411 -0.359 . . . . 10.27 111.04 178.587 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.42 0 N-CA-C 111.886 -0.486 . . . . 21.66 111.886 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.68 -12.55 60.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.913 0.387 . . . . 20.17 111.124 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -81.83 -14.78 55.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.217 0.532 . . . . 18.5 109.901 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -90.48 19.88 4.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.621 -0.718 . . . . 16.62 111.545 -174.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -152.81 128.77 10.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.727 0.775 . . . . 18.35 110.411 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -133.51 137.02 45.41 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.611 -1.177 . . . . 16.2 109.043 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -91.22 117.4 29.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.375 0.607 . . . . 12.4 111.013 -177.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -100.74 144.81 29.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.635 -0.711 . . . . 11.63 110.003 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.5 p -113.68 136.11 53.19 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.711 0.291 . . . . 9.15 110.962 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.38 177.01 28.73 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.546 -0.835 . . . . 6.81 112.622 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -128.82 140.78 48.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 109.255 -0.646 . . . . 10.17 109.255 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.57 118.09 13.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 C-N-CA 120.837 -0.345 . . . . 8.73 110.64 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.444 ' HB2' ' HG2' ' A' ' 23' ' ' GLN . 22.3 tt0 -83.04 -44.93 14.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 10.86 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -157.82 137.01 11.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.44 -0.8 . . . . 14.06 109.83 -176.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.0 mt -99.55 121.14 40.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.445 0.64 . . . . 11.73 111.306 178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -106.29 -178.45 3.65 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.834 -1.075 . . . . 11.36 108.421 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -88.78 111.11 21.62 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.562 -0.455 . . . . 15.94 110.33 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.0 t 79.03 3.43 2.39 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.595 -1.184 . . . . 13.01 111.429 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -158.92 153.19 23.89 Favored 'General case' 0 C--O 1.226 -0.148 0 N-CA-C 110.276 -0.268 . . . . 12.34 110.276 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.95 162.79 27.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.423 -0.894 . . . . 7.52 112.407 -178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -104.44 136.45 43.97 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.058 0.456 . . . . 9.24 110.968 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -103.64 127.71 57.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.651 -0.704 . . . . 7.75 110.384 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -71.77 141.81 49.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.215 -0.902 . . . . 11.8 111.644 -178.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.8 p -78.14 2.78 16.97 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.626 -1.17 . . . . 12.34 111.408 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.4 t -50.3 -39.33 45.36 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.659 0.614 . . . . 13.33 112.659 -170.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -105.55 7.53 32.93 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.045 0.387 . . . . 11.9 112.045 -176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.404 ' HB3' ' H ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -151.2 -159.37 1.02 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.806 0.336 . . . . 12.99 111.143 -176.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.404 ' H ' ' HB3' ' A' ' 27' ' ' ARG . 41.5 mt-30 -120.66 22.41 11.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.689 0.28 . . . . 16.66 111.291 -178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.13 135.64 34.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.021 0.439 . . . . 12.09 111.458 -173.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.9 mtt85 -106.92 102.58 11.93 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.479 -0.934 . . . . 12.51 108.479 172.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.2 mt -110.88 162.18 15.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.208 0.528 . . . . 8.76 111.379 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -126.25 139.41 53.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.381 -0.827 . . . . 9.15 109.333 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -132.59 152.37 51.65 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 110.053 -0.351 . . . . 6.85 110.053 -177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -91.98 161.4 14.82 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.204 -0.665 . . . . 9.99 109.204 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -71.71 -8.23 52.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.885 0.374 . . . . 9.93 111.677 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 19.4 m -79.34 -12.21 59.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.368 0.604 . . . . 12.28 109.517 172.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -103.38 36.49 2.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.547 -0.751 . . . . 10.62 110.133 177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -138.09 139.54 39.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.063 -0.347 . . . . 8.78 110.063 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t -121.69 119.48 31.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.25 -0.432 . . . . 8.97 110.552 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.57 -161.94 20.8 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.893 -0.67 . . . . 9.98 112.337 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -77.45 113.53 15.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.754 0.312 . . . . 12.43 110.836 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.6 tp -72.35 -25.71 23.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.048 0.451 . . . . 11.58 110.911 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -79.71 -12.29 59.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.234 0.54 . . . . 14.73 110.332 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -89.17 -7.48 55.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 13.3 109.889 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 41.2 tp -93.17 124.79 37.4 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.593 -0.731 . . . . 10.07 109.944 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -132.12 178.26 6.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.028 0.442 . . . . 13.13 110.671 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.2 mp -73.8 129.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.946 -0.57 . . . . 11.74 109.745 177.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.65 -1.53 66.22 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.674 -0.774 . . . . 10.13 111.946 -177.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -91.34 123.32 64.41 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.823 -0.436 . . . . 8.39 109.823 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.97 142.98 32.12 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 122.985 2.457 . . . . 7.28 113.808 -174.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.408 HG12 ' HE3' ' A' ' 71' ' ' LYS . 18.7 m -134.85 156.79 40.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 115.63 -0.714 . . . . 4.74 110.91 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -116.6 138.6 51.3 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.483 -0.562 . . . . 7.09 109.483 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' HB3' HG22 ' A' ' 69' ' ' VAL . 33.3 p90 -150.16 176.6 10.68 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.52 -0.309 . . . . 7.82 110.688 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 26.7 mt-10 -118.88 132.86 56.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.22 -0.659 . . . . 11.59 109.22 175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.5 tpt -93.59 113.85 26.06 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.001 -0.545 . . . . 12.41 109.64 177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.8 p -135.8 138.45 42.6 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.587 0.588 . . . . 13.17 112.587 -173.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -95.35 110.7 22.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.078 -0.51 . . . . 16.21 109.709 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -89.98 121.71 32.33 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.8 0.333 . . . . 16.64 111.076 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -79.23 -20.95 46.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.082 -0.508 . . . . 22.64 110.964 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HE ' ' C ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -67.09 -53.86 26.91 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.392 -0.596 . . . . 21.43 109.392 -177.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.8 p -86.36 -29.69 22.75 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.149 -0.478 . . . . 17.4 111.172 178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.86 31.74 28.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.729 -0.748 . . . . 16.7 111.81 -178.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -135.12 141.34 37.73 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.133 -0.321 . . . . 14.73 110.133 -178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -72.22 125.31 10.71 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.809 1.673 . . . . 12.6 110.642 172.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -139.13 162.6 27.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.245 0.545 . . . . 11.73 111.816 -174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.42 173.41 6.77 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.453 -0.794 . . . . 8.91 110.779 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 22.7 t -87.26 -160.97 0.64 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.983 -0.553 . . . . 9.83 110.114 176.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -83.49 25.35 0.76 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.693 -0.23 . . . . 11.32 111.491 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.408 HG22 ' HB3' ' A' ' 53' ' ' PHE . 43.1 t 30.02 96.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.693 1.197 . . . . 6.11 113.713 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.3 m -91.83 141.93 28.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.231 0.539 . . . . 6.12 110.761 -177.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' HE3' HG12 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -76.16 110.03 10.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.802 -0.635 . . . . 6.3 111.44 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.0 mt -55.92 -70.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 115.498 -0.774 . . . . 5.77 110.372 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -165.06 99.41 0.81 Allowed Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-N 116.245 -0.434 . . . . 5.69 111.164 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.16 153.98 18.99 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.585 1.523 . . . . 6.86 109.838 167.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 146' ' ' ASN . 19.0 pt-20 -104.72 175.82 5.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.134 -0.627 . . . . 8.49 111.306 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.606 HG13 ' HB1' ' A' ' 144' ' ' ALA . 45.0 t 53.26 59.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 CA-C-O 122.688 1.232 . . . . 6.19 109.246 -174.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.9 t -88.34 114.73 27.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 113.831 -1.532 . . . . 6.26 110.649 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.7 mp -76.67 -18.14 58.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.005 0.431 . . . . 6.05 110.317 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 t -95.5 52.49 1.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 7.02 110.694 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -120.47 -68.2 0.92 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.953 -0.567 . . . . 7.07 110.343 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -152.52 106.13 3.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.899 -0.591 . . . . 6.68 109.627 -178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 7.6 ptp180 -95.04 133.38 38.89 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.606 -0.516 . . . . 6.43 109.606 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.98 169.07 20.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.204 0.526 . . . . 3.7 111.202 -176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 71.4 p -118.7 144.57 46.14 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.496 -0.775 . . . . 3.49 109.502 174.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.45 170.2 23.99 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.076 -1.059 . . . . 2.58 112.268 -177.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.9 m -121.74 132.06 54.42 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.833 -0.432 . . . . 3.34 109.833 177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.632 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 48.8 t -65.25 126.34 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.322 -0.399 . . . . 3.14 110.501 178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.0 p -111.19 -16.63 13.39 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 120.857 0.361 . . . . 3.61 111.199 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.8 m -153.65 130.33 10.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.237 -0.438 . . . . 3.12 109.916 176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.54 -176.86 3.2 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 123.274 0.359 . . . . 4.39 111.093 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.0 mt -87.24 162.69 17.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.97 0.414 . . . . 3.62 111.072 -176.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 53.6 ttt85 -109.02 4.53 23.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.315 0.579 . . . . 7.2 110.729 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.474 HG23 HG21 ' A' ' 105' ' ' THR . 38.8 p -94.21 175.43 6.7 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.419 -0.355 . . . . 5.1 111.183 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 71.16 3.31 4.6 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.507 -0.769 . . . . 7.53 111.811 171.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.8 m -87.65 106.67 18.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.472 -0.331 . . . . 7.47 110.285 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 55.89 64.67 1.66 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.233 -0.439 . . . . 7.58 111.329 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.45 0.9 0.07 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.97 1.308 . . . . 8.32 113.492 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -82.76 83.1 7.82 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.438 0.637 . . . . 7.26 110.711 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 26.4 m -107.3 163.18 5.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.49 -0.777 . . . . 5.54 110.544 176.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.6 tp -146.64 111.71 5.4 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 109.503 -0.555 . . . . 7.28 109.503 -178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -53.65 -39.82 65.34 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.212 -0.904 . . . . 7.54 110.944 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.5 m -65.8 97.08 0.32 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.036 -0.529 . . . . 5.41 109.947 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.0 m -77.33 61.15 2.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.067 -0.515 . . . . 4.58 111.294 -176.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -91.16 -7.91 50.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.131 0.491 . . . . 5.09 110.731 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.474 HG21 HG23 ' A' ' 93' ' ' THR . 6.1 t -90.58 118.34 29.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.074 -0.713 . . . . 3.33 109.074 172.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -124.11 125.51 44.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.429 -0.35 . . . . 2.57 110.721 -175.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -81.65 176.74 54.16 Favored Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.667 -0.778 . . . . 1.66 111.617 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -134.4 130.49 36.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.106 0.479 . . . . 3.03 111.386 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.7 mt -112.57 129.11 68.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.458 -0.792 . . . . 1.88 108.961 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -107.28 132.74 52.77 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.616 0.246 . . . . 3.49 110.479 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -138.66 156.04 47.76 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.731 -0.84 . . . . 3.51 108.731 176.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.05 125.74 54.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.754 -0.462 . . . . 5.1 109.754 178.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 47.9 t30 -138.68 135.94 35.35 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.545 -0.909 . . . . 4.78 108.545 177.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 114' ' ' ARG . 9.2 mtp180 63.79 18.54 11.21 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.519 0.512 . . . . 6.97 111.8 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 88.33 3.73 78.2 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.668 -0.777 . . . . 5.1 112.171 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.578 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -123.11 141.29 52.12 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.111 0.482 . . . . 5.38 110.598 178.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 13.9 p -105.11 136.67 44.17 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.944 -0.571 . . . . 4.72 110.865 -177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -128.69 172.58 11.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.924 -0.58 . . . . 4.61 110.121 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.85 124.39 40.81 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.964 -0.562 . . . . 3.96 110.228 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 5.6 mp -104.36 131.45 21.88 Favored Pre-proline 0 C--N 1.32 -0.687 0 N-CA-C 110.18 -0.304 . . . . 2.75 110.18 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 3.6 Cg_exo -75.96 132.12 13.87 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.945 2.43 . . . . 2.3 111.55 176.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -138.5 153.42 48.77 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.067 0.46 . . . . 2.13 110.642 177.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.5 p -118.11 -175.16 2.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.878 -0.601 . . . . 3.07 110.121 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.79 -17.65 61.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.089 0.471 . . . . 4.8 110.651 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -82.82 -23.84 33.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.687 -0.688 . . . . 4.81 111.066 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -77.39 -26.09 51.46 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.281 -0.418 . . . . 3.84 111.364 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.8 p -103.83 116.22 47.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.646 0.736 . . . . 4.39 111.119 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.87 163.61 12.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.435 -0.802 . . . . 6.43 109.413 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.31 -9.52 30.99 Favored Glycine 0 C--O 1.229 -0.168 0 C-N-CA 120.69 -0.767 . . . . 5.91 112.521 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 13.1 t30 66.14 16.98 10.65 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.533 0.682 . . . . 6.07 110.655 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.6 t -78.12 120.35 28.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 109.808 -0.441 . . . . 5.27 109.808 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -81.57 119.56 23.94 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.934 0.397 . . . . 5.78 110.933 -177.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 133' ' ' LEU . 1.8 pt? -115.56 149.24 38.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.424 -0.807 . . . . 3.62 110.679 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.606 ' HD2' ' OD1' ' A' ' 137' ' ' ASP . 0.0 OUTLIER -137.18 155.9 48.98 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.962 -0.755 . . . . 6.93 108.962 174.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.632 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -57.32 121.82 11.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.044 0.449 . . . . 4.12 110.835 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.26 -13.23 11.18 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.86 -0.686 . . . . 4.07 113.302 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.606 ' OD1' ' HD2' ' A' ' 134' ' ' ARG . 6.4 p30 -95.32 174.94 6.79 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.142 0.971 . . . . 4.06 110.216 172.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -110.17 122.27 47.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.051 0.453 . . . . 4.17 111.381 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.0 m -118.28 150.68 20.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.018 -0.537 . . . . 2.77 110.929 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 31.6 t -120.92 133.83 55.29 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.113 -0.699 . . . . 3.47 109.113 176.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -137.37 143.26 41.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.021 0.438 . . . . 3.35 110.825 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -94.86 124.58 38.98 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.518 -0.764 . . . . 5.34 109.628 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.33 99.16 3.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.364 0.602 . . . . 4.66 110.582 -177.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.606 ' HB1' HG13 ' A' ' 76' ' ' VAL . . . -89.79 109.32 20.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.196 -0.911 . . . . 4.85 110.867 -176.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 22.2 m -80.29 113.97 18.86 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.103 -0.498 . . . . 5.68 111.908 -175.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.527 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 1.6 m120 -66.24 159.05 27.36 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.402 -0.363 . . . . 6.25 110.068 172.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -31.06 67.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.955 0.407 . . . . 8.58 111.263 -177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 31.7 tpt180 -77.04 -13.33 59.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.084 -0.507 . . . . 7.86 111.17 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.59 5.65 78.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.571 -0.823 . . . . 5.59 111.434 -176.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 146' ' ' ASN . 5.1 m-20 -107.92 120.99 43.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.325 . . . . 5.18 110.279 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.506 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.1 178.35 9.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.299 -0.41 . . . . 4.28 110.623 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -131.36 -112.96 1.5 Allowed Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.455 -0.658 . . . . 3.36 111.455 174.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -123.11 137.3 54.95 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.526 -0.546 . . . . 2.84 109.526 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 84.1 m -139.81 156.57 46.67 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 121.2 -0.2 . . . . 4.34 110.896 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 57.46 44.42 21.36 Favored 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.881 0.738 . . . . 5.75 111.045 176.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.73 114.89 11.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.68 -0.691 . . . . 3.55 110.729 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -119.48 131.12 55.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.208 -0.451 . . . . 5.96 110.554 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.19 116.13 22.78 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.96 -0.756 . . . . 4.34 108.96 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -95.42 -43.99 7.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.76 0.281 . . . . 4.97 111.76 -178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 45.2 t-20 -126.29 96.26 36.9 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.932 0.396 . . . . 5.37 110.001 -178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -83.35 155.12 14.29 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 122.759 2.306 . . . . 5.44 113.4 -176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.54 104.76 14.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.632 -0.713 . . . . 6.1 109.822 175.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -151.97 161.04 30.57 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.241 -0.436 . . . . 9.49 110.813 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.52 124.15 12.05 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.368 2.045 . . . . 8.39 111.626 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 116.366 -0.379 . . . . 10.27 110.304 178.855 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 111.993 -0.443 . . . . 21.66 111.993 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.56 97.86 4.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.022 0.439 . . . . 20.17 110.794 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -103.53 -38.15 7.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.675 -0.693 . . . . 18.5 109.608 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 p30 46.86 35.68 3.39 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 114.866 1.432 . . . . 16.62 114.866 166.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.6 mp0 -77.97 -22.01 50.07 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 121.798 -0.564 . . . . 18.35 110.367 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -80.69 89.12 5.73 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.567 -0.742 . . . . 16.2 111.454 -176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -119.87 105.81 11.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.478 -0.783 . . . . 12.4 109.374 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.524 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 3.5 pt-20 -121.73 166.73 13.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.777 -0.647 . . . . 11.63 110.729 -173.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 80.6 p -108.44 156.84 18.99 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.479 0.548 . . . . 9.15 112.479 -171.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.82 -173.38 30.41 Favored Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 110.839 -0.904 . . . . 6.81 110.839 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.459 HG13 ' HB2' ' A' ' 23' ' ' GLN . 12.6 pt -128.52 152.63 36.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 117.158 0.479 . . . . 10.17 110.327 178.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.07 127.33 28.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.76 0.314 . . . . 8.73 110.888 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.504 ' HA ' ' HG2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -68.95 -56.24 8.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.677 -0.692 . . . . 10.86 109.284 179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -169.1 166.54 10.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.791 -1.095 . . . . 14.06 108.432 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.5 mt -112.0 126.29 54.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.215 0.531 . . . . 11.73 111.521 -175.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 3.0 mm? -122.16 -179.02 4.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.946 -1.024 . . . . 11.36 108.598 177.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -88.71 124.57 34.24 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 122.007 -0.433 . . . . 15.94 110.114 -177.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 m 78.39 -35.86 0.19 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.959 0.903 . . . . 13.01 112.169 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 17.5 p90 -131.79 151.57 51.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.45 . . . . 12.34 111.248 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.08 172.95 23.21 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.844 -0.903 . . . . 7.52 110.844 176.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 13' ' ' GLU . 68.2 m-85 -119.49 155.22 32.51 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 117.049 0.425 . . . . 9.24 110.742 -178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.7 mt -111.69 128.77 68.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.97 -0.559 . . . . 7.75 110.141 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.504 ' HG2' ' HA ' ' A' ' 13' ' ' GLU . 2.5 mm-40 -74.79 132.03 41.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.309 0.576 . . . . 11.8 111.525 -177.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.2 p -80.6 1.61 29.04 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.161 -0.927 . . . . 12.34 111.861 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 70.9 m -52.77 -42.21 64.77 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.604 0.24 . . . . 13.33 111.621 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -84.88 -42.84 14.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.234 0.54 . . . . 11.9 111.148 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HE ' ' CD ' ' A' ' 8' ' ' GLU . 31.5 tpt180 -132.34 142.29 49.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.077 -0.51 . . . . 12.99 109.779 -174.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -70.92 52.69 0.15 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.285 0.476 . . . . 16.66 112.285 -175.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.78 101.74 2.79 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.906 0.384 . . . . 12.09 110.428 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -85.91 100.91 12.42 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.293 -1.003 . . . . 12.51 108.293 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.8 mt -110.8 163.42 13.8 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.497 -0.774 . . . . 8.76 111.457 -170.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -115.12 135.31 54.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.02 -0.733 . . . . 9.15 109.02 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -132.89 136.05 45.95 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.767 -0.457 . . . . 6.85 109.767 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 73.2 m80 -84.92 164.4 18.37 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.467 -0.568 . . . . 9.99 109.467 178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -70.07 -10.23 58.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.951 0.405 . . . . 9.93 110.71 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 9.6 p -84.12 -9.04 58.91 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.007 -0.542 . . . . 12.28 110.077 173.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -108.73 26.63 10.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.515 -0.766 . . . . 10.62 110.339 -178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -130.68 130.02 43.35 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.688 -0.405 . . . . 8.78 110.087 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 68' ' ' GLN . 15.6 m -93.35 107.79 19.56 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.725 -0.671 . . . . 8.97 110.493 -179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.74 -156.34 22.06 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.429 -0.891 . . . . 9.98 113.15 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.476 ' ND2' ' HB2' ' A' ' 44' ' ' HIS . 1.0 OUTLIER -93.55 117.85 30.6 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.17 0.509 . . . . 12.43 111.803 -176.255 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.04 -22.63 10.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.492 -0.776 . . . . 11.58 110.319 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -60.95 -40.11 92.09 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.097 -0.501 . . . . 14.73 111.42 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.476 ' HB2' ' ND2' ' A' ' 41' ' ' ASN . 18.8 m80 -97.05 12.15 33.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.182 -0.463 . . . . 13.3 110.198 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.64 136.28 33.08 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.399 -0.593 . . . . 10.07 109.399 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.512 ' HE2' ' HB2' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -130.41 157.49 42.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.241 0.544 . . . . 13.13 111.29 -174.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 69.6 mt -69.25 141.72 16.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.241 -0.89 . . . . 11.74 110.969 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.35 11.47 66.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.438 -0.886 . . . . 10.13 112.248 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.512 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 6.5 t70 -84.97 131.65 48.24 Favored Pre-proline 0 C--N 1.324 -0.534 0 O-C-N 122.956 -0.143 . . . . 8.39 111.016 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.17 120.09 5.56 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.766 2.31 . . . . 7.28 112.864 178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.564 HG12 ' HE3' ' A' ' 71' ' ' LYS . 27.8 m -128.45 162.45 35.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.893 -0.594 . . . . 4.74 110.451 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 1.2 pt-20 -113.22 139.57 48.68 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.369 -0.604 . . . . 7.09 109.369 173.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.524 ' CE1' ' HG3' ' A' ' 8' ' ' GLU . 31.2 p90 -132.08 139.58 48.55 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.714 0.768 . . . . 7.82 111.784 -177.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 39.1 tt0 -88.9 104.87 17.35 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.847 -1.069 . . . . 11.59 108.7 174.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 13.7 tpt -88.45 114.85 25.49 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.197 -0.456 . . . . 12.41 110.473 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 16.6 p -142.85 167.12 22.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.057 0.456 . . . . 13.17 111.283 -177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 73.6 m-85 -112.47 109.41 18.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.901 -0.59 . . . . 16.21 109.508 175.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.22 125.53 31.05 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.839 -0.345 . . . . 16.64 110.212 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -78.35 -17.92 55.83 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.413 -0.358 . . . . 22.64 111.664 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 23.7 tpt180 -77.8 -42.55 33.46 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.6 -0.44 . . . . 21.43 110.007 -177.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 23.4 p -84.35 -33.59 23.82 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.023 -0.535 . . . . 17.4 110.597 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.53 24.72 62.3 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.763 -0.653 . . . . 16.7 112.11 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -126.63 148.1 63.33 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.974 -0.38 . . . . 14.73 109.974 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HB3' ' CE1' ' A' ' 57' ' ' TYR . 43.1 Cg_endo -70.27 124.73 11.15 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 121.728 1.619 . . . . 12.6 109.807 169.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -139.77 151.17 22.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.88 0.848 . . . . 11.73 112.696 -170.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.66 136.23 33.41 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.591 -1.186 . . . . 8.91 108.16 169.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 7.4 t -69.69 -150.16 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.984 0.421 . . . . 9.83 111.035 -178.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.402 ' HB3' ' OG ' ' A' ' 39' ' ' SER . 15.1 mm100 -56.45 -18.89 12.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.322 0.86 . . . . 11.32 113.322 -175.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.1 t 55.13 96.2 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 CA-C-O 121.635 0.731 . . . . 6.11 111.136 -178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m -79.5 152.0 30.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.703 -0.681 . . . . 6.12 110.197 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.564 ' HE3' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -93.57 108.28 20.01 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.901 0.381 . . . . 6.3 110.52 -178.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.532 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 65.5 mt -54.96 122.68 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 5.77 109.877 175.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -66.16 120.6 71.06 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 123.437 0.461 . . . . 5.69 110.051 177.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 25.4 Cg_exo -62.04 112.99 1.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.658 2.238 . . . . 6.86 112.605 -178.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -72.05 175.88 5.57 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.473 -0.936 . . . . 8.49 108.473 170.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.592 ' CG1' ' HB1' ' A' ' 144' ' ' ALA . 23.3 t -58.33 103.41 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.051 0.453 . . . . 6.19 110.08 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 67.5 t -72.77 97.21 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.557 -0.747 . . . . 6.26 111.34 -176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.01 -63.92 0.99 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.462 -0.57 . . . . 6.05 109.462 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.3 t -139.36 117.43 11.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.036 0.446 . . . . 7.02 110.615 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -159.39 -49.39 0.06 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.687 -0.688 . . . . 7.07 109.415 174.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -81.5 -172.98 4.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.641 -0.709 . . . . 6.68 109.947 177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -166.83 71.41 0.12 Allowed 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 109.5 -0.555 . . . . 6.43 109.5 -176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.5 m -82.29 151.58 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.628 0.728 . . . . 3.7 111.027 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.5 p -117.65 139.74 50.59 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.313 -0.858 . . . . 3.49 109.976 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -143.51 154.02 25.24 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.209 -0.996 . . . . 2.58 112.642 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 137' ' ' ASP . 39.9 m -109.6 136.1 49.51 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.68 -0.489 . . . . 3.34 109.68 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.571 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 46.9 t -68.58 118.43 12.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.83 0.348 . . . . 3.14 110.086 178.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.5 p -95.35 -27.89 15.23 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.027 0.441 . . . . 3.61 110.84 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 39.6 m -153.16 127.88 9.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.864 -0.607 . . . . 3.12 110.112 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.08 -171.37 2.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.409 -0.36 . . . . 4.39 110.402 177.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -64.62 126.91 29.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.331 -0.395 . . . . 3.62 110.668 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -65.74 133.0 50.1 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.148 -0.478 . . . . 7.2 110.897 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 t -118.17 143.09 46.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.456 0.646 . . . . 5.1 110.307 172.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -116.73 15.72 15.39 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.135 -0.939 . . . . 7.53 109.536 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.3 t -113.57 -179.85 3.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.341 -0.845 . . . . 7.47 109.884 -178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.2 88.28 7.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.662 0.267 . . . . 7.58 111.047 -176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 75.23 -34.01 0.25 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 115.488 -0.778 . . . . 8.32 111.718 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -72.98 112.37 8.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.072 0.463 . . . . 7.26 110.425 177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.4 m -79.96 95.48 2.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.216 0.531 . . . . 5.54 110.664 175.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 51.4 tp -137.33 90.09 2.49 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.883 0.849 . . . . 7.28 110.73 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -141.6 82.2 1.8 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.104 -1.407 . . . . 7.54 107.683 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.7 m -52.83 91.6 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.677 0.992 . . . . 5.41 113.677 -167.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.5 m 53.55 28.84 8.27 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.18 -0.918 . . . . 4.58 113.049 170.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -87.01 -20.28 27.46 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.596 -0.441 . . . . 5.09 110.488 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.7 t -135.45 156.4 48.97 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.06 -0.518 . . . . 3.33 110.345 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.6 t -112.92 153.92 27.21 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.849 -0.426 . . . . 2.57 109.849 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.66 -173.63 36.61 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.624 -0.59 . . . . 1.66 111.624 177.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -133.82 126.13 29.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.992 0.425 . . . . 3.03 111.381 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.501 HG13 ' CE1' ' A' ' 122' ' ' TYR . 83.7 mt -112.12 129.02 68.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.004 -0.739 . . . . 1.88 109.004 171.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 t -105.23 117.8 34.92 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.831 -0.433 . . . . 3.49 109.831 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.616 ' CE2' ' HB2' ' A' ' 118' ' ' PHE . 11.2 p90 -119.47 150.81 39.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.207 -0.452 . . . . 3.51 109.945 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -111.95 123.45 50.27 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.113 -0.494 . . . . 5.1 110.592 -178.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.512 ' OD1' ' HG3' ' A' ' 114' ' ' ARG . 49.9 t-20 -131.59 119.07 20.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.148 -0.686 . . . . 4.78 109.148 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 71.2 mtp180 63.2 21.41 12.83 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.199 -0.455 . . . . 6.97 111.223 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.36 -9.67 71.75 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 121.04 -0.6 . . . . 5.1 112.163 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -92.16 122.74 34.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.764 0.316 . . . . 5.38 110.247 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.04 123.05 38.31 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.318 -0.401 . . . . 4.72 110.272 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.616 ' HB2' ' CE2' ' A' ' 111' ' ' TYR . 64.4 m-85 -120.92 151.15 40.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.531 -0.304 . . . . 4.61 110.634 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -106.28 126.43 52.22 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.05 -0.523 . . . . 3.96 110.709 -178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.7 mt -112.94 135.25 21.66 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.053 -0.521 . . . . 2.75 110.848 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.74 137.64 11.4 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 122.713 2.275 . . . . 2.3 111.799 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.501 ' CE1' HG13 ' A' ' 109' ' ' ILE . 26.8 p90 -146.04 155.23 42.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.37 . . . . 2.13 110.14 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 81.0 p -115.42 -178.96 3.5 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.693 -0.484 . . . . 3.07 109.693 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -71.71 -21.1 61.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.44 0.638 . . . . 4.8 110.31 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.35 -23.56 50.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.398 -0.819 . . . . 4.81 111.289 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -86.99 3.95 43.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.992 0.425 . . . . 3.84 111.316 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 131' ' ' VAL . 52.7 t -87.52 137.65 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.234 -0.439 . . . . 4.39 110.921 -177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -87.17 135.55 33.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.986 -0.552 . . . . 6.43 110.105 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 75.76 2.03 68.85 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.177 -0.535 . . . . 5.91 112.671 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 56.42 38.08 29.39 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.159 0.504 . . . . 6.07 111.574 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.433 ' O ' HG11 ' A' ' 127' ' ' VAL . 43.7 t -78.63 145.82 9.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.884 -0.598 . . . . 5.27 109.749 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -91.39 137.82 32.06 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.332 -0.248 . . . . 5.78 110.332 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.7 mp -114.31 149.57 35.79 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 123.663 0.602 . . . . 3.62 111.018 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 9.6 mtm180 -141.7 123.67 15.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.636 -0.505 . . . . 6.93 109.636 174.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.571 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -50.14 129.14 20.57 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.515 0.674 . . . . 4.12 112.101 -170.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.83 -15.79 11.21 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 114.981 -1.009 . . . . 4.07 111.797 -173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 139' ' ' VAL . 2.4 p30 -85.4 169.25 13.86 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.397 -0.594 . . . . 4.06 109.397 173.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.463 ' HD2' ' C ' ' A' ' 138' ' ' LYS . 0.0 OUTLIER -123.1 116.8 24.08 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.071 0.462 . . . . 4.17 109.971 -177.273 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.513 HG13 ' OD1' ' A' ' 137' ' ' ASP . 30.2 m -116.0 179.91 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.516 0.674 . . . . 2.77 111.294 -173.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.9 m -143.12 145.76 33.14 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.367 -0.833 . . . . 3.47 109.086 173.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -143.38 172.53 12.65 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.127 -0.694 . . . . 3.35 109.127 -174.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -112.76 136.89 51.85 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.399 0.437 . . . . 5.34 109.866 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 68.4 mt -106.72 101.66 12.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.98 0.419 . . . . 4.66 110.95 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.712 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -80.04 107.57 12.93 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.523 -0.547 . . . . 4.85 109.523 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 19.1 m -97.46 102.76 14.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.121 0.486 . . . . 5.68 110.747 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 148' ' ' ARG . 47.6 t30 -75.05 157.0 35.54 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.716 -0.846 . . . . 6.25 108.716 172.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.19 13.91 0.1 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.05 0.452 . . . . 8.58 112.049 -175.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.479 ' NE ' ' HA ' ' A' ' 148' ' ' ARG . 5.0 mmp_? -110.05 -8.55 14.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.751 0.31 . . . . 7.86 110.207 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.73 20.98 77.82 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 116.009 -0.542 . . . . 5.59 112.374 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -112.29 111.49 22.4 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.905 -0.406 . . . . 5.18 109.905 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.481 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.3 179.94 8.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.128 0.49 . . . . 4.28 111.575 -177.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.85 -156.94 7.7 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.498 -1.041 . . . . 3.36 110.498 173.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.17 112.09 24.32 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.495 0.648 . . . . 2.84 109.491 178.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 24.2 m -103.87 140.03 38.24 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.123 -0.489 . . . . 4.34 111.242 -172.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 52.43 61.39 3.22 Favored 'General case' 0 C--O 1.233 0.194 0 O-C-N 123.848 0.718 . . . . 5.75 111.225 175.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.2 mt -78.78 125.65 38.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.643 -0.708 . . . . 3.55 110.225 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -126.93 145.54 50.64 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.748 -0.381 . . . . 5.96 110.588 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.512 ' HA ' HG12 ' A' ' 139' ' ' VAL . 55.4 tp -80.71 101.52 9.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.056 -0.52 . . . . 4.34 109.87 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.65 -53.96 5.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.566 . . . . 4.97 110.834 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -118.21 97.82 51.0 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.044 -0.526 . . . . 5.37 110.329 -177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.31 158.94 33.2 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.458 2.106 . . . . 5.44 112.164 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -110.23 126.18 53.87 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.198 -0.455 . . . . 6.1 110.206 177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -132.8 104.47 12.94 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.801 -0.444 . . . . 9.49 109.801 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -86.21 161.56 9.95 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.949 2.433 . . . . 8.39 112.651 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.281 -0.418 . . . . 10.27 110.493 178.055 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 112.398 -0.281 . . . . 21.66 112.398 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.51 15.92 10.25 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.981 0.512 . . . . 20.17 111.64 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.07 -23.78 51.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.447 0.641 . . . . 18.5 109.622 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -87.77 29.08 0.94 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.265 -0.879 . . . . 16.62 110.859 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -91.18 -19.55 22.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.391 0.615 . . . . 18.35 110.632 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -79.28 106.76 11.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.612 -0.722 . . . . 16.2 110.648 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -100.84 121.62 42.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.609 -0.723 . . . . 12.4 110.422 174.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -93.34 136.88 33.19 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.515 -0.92 . . . . 11.63 108.515 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.2 p -118.39 140.6 49.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 120.48 -0.488 . . . . 9.15 111.463 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.72 -177.12 30.52 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.784 -0.722 . . . . 6.81 112.051 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.489 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 2.3 mt -124.97 143.36 38.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.809 -0.441 . . . . 10.17 109.809 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -70.53 116.15 11.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.414 -0.514 . . . . 8.73 109.675 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -88.47 -38.68 14.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 10.86 110.478 -176.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -153.79 140.62 19.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.619 -0.719 . . . . 14.06 109.591 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.4 mt -105.16 102.55 12.04 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.137 0.494 . . . . 11.73 110.591 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 mp -84.36 -178.34 6.89 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.053 -0.976 . . . . 11.36 109.307 175.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -89.69 108.73 19.85 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.864 0.364 . . . . 15.94 110.298 -173.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.5 m 67.57 22.31 9.2 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.251 -0.886 . . . . 13.01 110.983 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -160.52 141.21 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.628 -0.715 . . . . 12.34 109.429 -176.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.14 157.33 21.62 Favored Glycine 0 C--N 1.322 -0.209 0 C-N-CA 120.471 -0.871 . . . . 7.52 113.094 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.0 129.19 55.01 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.108 0.163 . . . . 9.24 110.737 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.7 mt -112.59 126.92 70.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.846 0.355 . . . . 7.75 110.838 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 10.3 pt20 -85.38 145.73 27.34 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.145 0.498 . . . . 11.8 110.781 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 p -79.71 1.58 25.93 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.129 -0.942 . . . . 12.34 113.076 -172.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 69.1 m -52.79 -24.87 9.76 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.932 1.086 . . . . 13.33 113.932 -170.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -99.37 10.59 41.11 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 112.123 0.416 . . . . 11.9 112.123 -178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mmt85 -164.59 -158.97 0.44 Allowed 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.438 -0.579 . . . . 12.99 109.438 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -123.37 24.37 8.71 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.162 0.506 . . . . 16.66 110.517 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.3 127.97 25.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.971 -0.559 . . . . 12.09 111.125 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -96.2 119.42 34.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 12.51 110.147 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.66 162.46 18.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.407 0.622 . . . . 8.76 111.792 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -131.86 147.5 52.48 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.346 -0.983 . . . . 9.15 108.346 171.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -134.15 159.24 41.48 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.124 0.488 . . . . 6.85 111.204 -172.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -98.84 154.77 17.77 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.994 -0.743 . . . . 9.99 108.994 175.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-30 -68.86 -16.22 63.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.854 0.359 . . . . 9.93 110.786 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 t -78.36 -10.24 59.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.091 -0.504 . . . . 12.28 110.177 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -108.22 27.03 9.72 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.141 -0.482 . . . . 10.62 110.688 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -122.96 111.81 17.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.463 . . . . 8.78 110.376 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -89.15 111.66 22.48 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.089 0.471 . . . . 8.97 109.996 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.02 -151.01 23.04 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 110.988 -0.845 . . . . 9.98 110.988 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -107.22 120.71 42.85 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.808 0.304 . . . . 12.43 110.685 176.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -67.48 -19.63 25.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.601 0.715 . . . . 11.58 109.13 173.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.45 -32.44 70.23 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.803 -1.09 . . . . 14.73 110.688 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -109.65 21.24 17.21 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.584 -0.735 . . . . 13.3 111.092 -174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.8 tp -111.65 114.99 28.39 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.462 -0.57 . . . . 10.07 109.462 176.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -121.13 -179.27 3.99 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.008 0.433 . . . . 13.13 110.342 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.5 mp -76.24 120.51 26.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.648 -0.501 . . . . 11.74 109.648 177.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.59 0.1 30.76 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.74 -0.743 . . . . 10.13 112.471 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.54 122.99 88.31 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 120.559 0.219 . . . . 8.39 110.895 176.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -83.58 126.25 4.04 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 122.609 2.206 . . . . 7.28 111.979 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.05 156.08 39.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.068 0.461 . . . . 4.74 111.065 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -119.48 126.77 52.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.698 -0.683 . . . . 7.09 109.26 173.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -132.21 166.81 21.0 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.349 0.595 . . . . 7.82 111.036 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.503 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 31.8 tt0 -101.32 109.66 21.54 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.645 -0.707 . . . . 11.59 109.272 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -87.68 109.13 19.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.281 -0.637 . . . . 12.41 109.281 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.7 p -131.6 175.28 9.3 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.052 0.453 . . . . 13.17 111.352 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.23 121.48 42.18 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.492 -0.558 . . . . 16.21 109.492 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -75.22 124.9 27.88 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.409 0.623 . . . . 16.64 110.659 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.9 ptt-85 -79.33 -7.33 58.25 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.002 -0.999 . . . . 22.64 111.506 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -92.43 -55.12 3.52 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.957 -0.297 . . . . 21.43 111.17 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.9 p -86.46 -22.69 26.34 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 111.772 0.286 . . . . 17.4 111.772 -178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.68 32.34 54.37 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.559 -0.829 . . . . 16.7 111.66 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -121.15 147.55 47.04 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 110.303 -0.258 . . . . 14.73 110.303 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.69 126.16 11.18 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 121.949 1.766 . . . . 12.6 110.753 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.54 162.1 40.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.222 0.534 . . . . 11.73 111.304 -174.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.27 139.06 40.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.551 -0.749 . . . . 8.91 109.146 175.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.503 ' OG ' ' HB3' ' A' ' 54' ' ' GLU . 17.6 m -70.0 -157.13 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.084 -0.507 . . . . 9.83 110.762 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -75.68 27.86 0.11 Allowed 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 114.326 1.232 . . . . 11.32 114.326 -168.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.2 t 21.31 101.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 125.079 1.352 . . . . 6.11 114.582 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.4 m -107.67 143.3 36.35 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.106 -0.497 . . . . 6.12 110.096 177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.56 142.33 51.77 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.165 -0.68 . . . . 6.3 109.165 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.6 mt -54.87 118.28 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.112 0.482 . . . . 5.77 111.137 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.75 162.42 21.21 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.451 -0.795 . . . . 5.69 110.749 -175.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -62.66 156.14 54.68 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.546 2.164 . . . . 6.86 112.599 177.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.505 ' HG2' ' H ' ' A' ' 76' ' ' VAL . 28.5 tt0 -85.42 -178.44 6.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.707 -0.679 . . . . 8.49 110.034 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.505 ' H ' ' HG2' ' A' ' 75' ' ' GLU . 30.9 t -59.12 149.21 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.018 0.437 . . . . 6.19 111.434 -177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -94.59 111.58 25.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.243 -0.435 . . . . 6.26 111.244 -177.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -118.91 16.38 13.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.028 0.442 . . . . 6.05 110.921 176.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 19.7 m -114.06 60.53 0.67 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.856 0.36 . . . . 7.02 111.516 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -117.11 -34.63 4.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.716 0.293 . . . . 7.07 110.834 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -168.1 147.85 4.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 6.68 110.191 174.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 83.3 mtt180 -105.23 115.49 30.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 6.43 110.413 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -97.04 159.44 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.2 -0.454 . . . . 3.7 110.452 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 26.5 p -110.46 139.66 45.46 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.127 -0.488 . . . . 3.49 110.13 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -130.48 163.43 23.19 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.231 -0.985 . . . . 2.58 112.443 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 34.2 m -122.44 129.04 51.64 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.771 -0.455 . . . . 3.34 109.771 176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.589 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 90.4 t -69.27 126.16 28.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.416 -0.356 . . . . 3.14 110.665 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 p -105.82 -19.92 13.6 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.237 0.541 . . . . 3.61 110.63 175.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.5 m -149.9 129.42 13.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 3.12 110.198 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.13 -178.27 3.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.737 0.303 . . . . 4.39 110.71 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.435 HD12 HG23 ' A' ' 105' ' ' THR . 3.2 mm? -64.17 138.91 58.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.777 -0.647 . . . . 3.62 109.649 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -65.67 116.43 6.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.436 0.636 . . . . 7.2 111.465 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.3 p -135.92 104.81 5.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.246 -0.888 . . . . 5.1 110.042 175.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -80.49 -82.97 0.11 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.274 -0.421 . . . . 7.53 111.204 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 13.9 m -91.46 158.85 16.25 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.59 -0.277 . . . . 7.47 110.266 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.85 40.58 0.25 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.387 0.613 . . . . 7.58 110.869 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -145.39 -25.1 0.47 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.316 -0.857 . . . . 8.32 109.82 -175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -114.06 107.36 15.55 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.796 -0.638 . . . . 7.26 110.289 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 62.0 t -129.98 99.71 4.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.852 -0.613 . . . . 5.54 109.471 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 58.7 tp -110.29 92.94 4.25 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 121.706 0.765 . . . . 7.28 109.988 -176.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -83.16 70.08 10.02 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.593 -1.185 . . . . 7.54 109.403 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.556 ' OG ' ' HG2' ' A' ' 104' ' ' GLU . 42.5 p -104.62 168.36 9.13 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.589 -1.187 . . . . 5.41 109.949 174.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.7 p -80.32 9.14 6.16 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 112.132 0.419 . . . . 4.58 112.132 -177.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.556 ' HG2' ' OG ' ' A' ' 102' ' ' SER . 9.2 pt-20 -84.98 -22.21 29.23 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.047 0.451 . . . . 5.09 110.305 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.435 HG23 HD12 ' A' ' 91' ' ' LEU . 6.7 t -105.38 136.65 44.53 Favored 'General case' 0 C--N 1.323 -0.543 0 N-CA-C 109.153 -0.684 . . . . 3.33 109.153 177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.5 m -145.28 130.2 18.27 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.993 -0.373 . . . . 2.57 109.993 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.64 169.71 49.3 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.656 -0.783 . . . . 1.66 112.183 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -129.61 133.64 47.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.918 0.39 . . . . 3.03 110.892 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 119' ' ' PHE . 64.9 mt -111.8 126.48 69.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.6 -0.727 . . . . 1.88 109.89 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.8 p -98.07 119.18 36.26 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.9 -0.407 . . . . 3.49 109.9 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 2.5 p90 -127.4 153.69 45.93 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.639 -0.504 . . . . 3.51 109.639 177.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -116.95 120.61 38.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.246 -0.433 . . . . 5.1 110.35 -177.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -146.72 137.81 24.14 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.058 -0.719 . . . . 4.78 109.058 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 64.08 20.89 12.39 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.867 0.365 . . . . 6.97 110.364 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.83 -8.15 63.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.202 -0.523 . . . . 5.1 112.366 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -100.68 138.84 37.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.893 -0.41 . . . . 5.38 109.893 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 1.3 p -108.2 121.58 45.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.046 0.451 . . . . 4.72 110.837 178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -115.73 164.83 13.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.927 -0.579 . . . . 4.61 110.652 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.431 ' HA ' ' O ' ' A' ' 109' ' ' ILE . 96.0 m-85 -119.39 119.3 33.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.01 -0.541 . . . . 3.96 110.397 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 153' ' ' ALA . 4.1 mm? -105.42 143.37 26.64 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.336 -0.393 . . . . 2.75 110.626 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -85.98 146.93 9.14 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 123.126 2.551 . . . . 2.3 112.066 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -153.75 151.78 29.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.102 0.477 . . . . 2.13 111.366 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.73 162.17 23.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.453 -0.794 . . . . 3.07 109.38 172.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.94 -30.57 71.66 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.005 0.431 . . . . 4.8 111.204 -175.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -66.43 -20.42 66.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.076 -0.511 . . . . 4.81 111.871 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -104.22 13.81 31.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.147 0.499 . . . . 3.84 110.638 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.06 128.45 41.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.704 -0.68 . . . . 4.39 110.792 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.426 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 1.4 tm-20 -94.93 145.62 24.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.939 -0.763 . . . . 6.43 108.939 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 93.01 -17.18 58.77 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.754 -0.736 . . . . 5.91 112.039 -176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.3 t30 61.25 24.2 14.34 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.514 0.673 . . . . 6.07 110.671 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.6 t -90.81 137.71 21.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.065 -0.516 . . . . 5.27 110.284 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 -79.08 102.53 8.46 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.236 -0.438 . . . . 5.78 110.314 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.709 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -88.6 148.85 23.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.924 -0.58 . . . . 3.62 110.605 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -133.13 171.5 13.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.11 -0.495 . . . . 6.93 109.809 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.589 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.96 118.9 17.47 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.095 -0.502 . . . . 4.12 110.581 178.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.93 -20.42 9.91 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.666 -0.697 . . . . 4.07 113.195 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.93 166.18 12.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 117.898 0.849 . . . . 4.06 110.634 175.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -98.58 122.96 42.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.732 0.777 . . . . 4.17 111.976 -170.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.1 m -121.33 157.94 24.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 114.678 -1.146 . . . . 2.77 110.125 178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.4 m -126.23 141.07 52.07 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.913 -0.773 . . . . 3.47 108.913 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -135.37 149.59 49.72 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.953 0.406 . . . . 3.35 110.26 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -100.59 115.05 29.26 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.739 -0.664 . . . . 5.34 110.497 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 64.7 mt -78.05 110.31 13.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.603 -0.726 . . . . 4.66 110.375 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.537 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . . . -90.26 110.45 21.5 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.854 -0.612 . . . . 4.85 110.427 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 40.2 m -80.6 103.15 10.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.682 -0.69 . . . . 5.68 110.352 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -67.69 163.38 21.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.1 -0.5 . . . . 6.25 111.043 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -67.39 -18.32 65.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 8.58 111.663 -176.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -100.03 6.85 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.118 0.485 . . . . 7.86 110.235 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 70.61 18.2 75.45 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.868 -0.605 . . . . 5.59 113.98 172.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -122.33 129.9 52.6 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.404 -0.591 . . . . 5.18 109.404 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.479 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.31 179.37 8.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.906 0.384 . . . . 4.28 111.685 -175.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -131.38 -112.43 1.45 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.839 -0.904 . . . . 3.36 110.839 174.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 120' ' ' LEU . . . -135.41 129.68 33.68 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.109 -0.33 . . . . 2.84 110.109 176.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 82.6 m -128.14 150.16 50.11 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.87 -0.419 . . . . 4.34 109.87 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 57.65 58.08 3.92 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.438 0.461 . . . . 5.75 111.333 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.447 HD12 ' H ' ' A' ' 156' ' ' ILE . 4.8 mp -74.57 113.61 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.346 -0.983 . . . . 3.55 108.346 174.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.426 ' HD2' ' OE2' ' A' ' 128' ' ' GLU . 26.4 ttt180 -129.2 131.14 47.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.977 0.418 . . . . 5.96 110.864 -173.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.548 HD12 ' HA ' ' A' ' 133' ' ' LEU . 6.4 tt -83.42 115.82 22.22 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.338 -0.616 . . . . 4.34 109.338 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -105.89 -26.92 11.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.086 -0.506 . . . . 4.97 111.485 -175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -143.12 107.03 5.26 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.792 0.33 . . . . 5.37 110.7 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -82.42 161.66 17.22 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.843 2.362 . . . . 5.44 113.522 -175.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -126.55 138.58 53.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.411 -0.813 . . . . 6.1 109.314 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 61.35 81.27 0.24 Allowed Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 123.634 0.584 . . . . 9.49 111.389 -175.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.58 95.79 1.08 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.572 2.181 . . . . 8.39 112.085 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 116.296 -0.411 . . . . 10.27 110.999 -177.191 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.418 0 N-CA-C 111.864 -0.495 . . . . 21.66 111.864 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.46 112.21 23.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.746 0.308 . . . . 20.17 110.457 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -107.92 -51.78 2.85 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.246 0.546 . . . . 18.5 110.021 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.85 79.19 5.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.985 -1.007 . . . . 16.62 108.985 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -90.96 -71.57 0.62 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.063 -0.972 . . . . 18.35 113.185 -171.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 54' ' ' GLU . 41.4 mt-10 -92.5 95.47 9.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.352 -0.84 . . . . 16.2 111.603 -169.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.521 ' HD2' ' OE1' ' A' ' 52' ' ' GLU . 19.2 ptt180 -85.76 138.74 31.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.231 -0.895 . . . . 12.4 111.563 -177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.412 ' CD ' HH22 ' A' ' 27' ' ' ARG . 4.9 mm-40 -109.63 137.04 48.03 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.298 -0.865 . . . . 11.63 110.249 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.1 p -105.48 141.7 36.5 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.458 -0.337 . . . . 9.15 111.383 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.29 178.85 39.44 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.583 -0.607 . . . . 6.81 111.583 177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 37.3 pt -121.19 149.95 24.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 116.824 0.312 . . . . 10.17 110.617 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.7 mm -67.69 122.24 18.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.377 -0.374 . . . . 8.73 110.514 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -78.13 -51.16 10.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.749 0.309 . . . . 10.86 110.392 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -152.72 171.7 17.82 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.023 -0.535 . . . . 14.06 110.444 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.7 mt -127.59 99.53 5.63 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.6 -0.727 . . . . 11.73 110.628 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.2 mp -97.05 -179.9 4.7 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.286 -1.005 . . . . 11.36 108.286 174.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -91.19 131.9 36.43 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.506 -0.478 . . . . 15.94 110.293 -177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.3 t 76.24 -22.68 0.26 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.991 0.916 . . . . 13.01 112.196 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -152.27 162.89 40.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.838 0.352 . . . . 12.34 111.26 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -148.99 -172.87 19.18 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.796 -0.521 . . . . 7.52 111.796 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -131.23 149.49 52.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.781 0.324 . . . . 9.24 110.931 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.1 mt -113.89 126.85 71.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.826 -0.625 . . . . 7.75 109.553 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.14 136.95 35.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.4 0.619 . . . . 11.8 111.561 -172.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.9 p -81.94 -0.59 44.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.999 -1.0 . . . . 12.34 112.887 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.4 m -53.6 -37.22 62.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 118.194 0.452 . . . . 13.33 112.035 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -98.53 20.32 13.02 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.225 -0.443 . . . . 11.9 111.476 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.476 HH21 ' HB3' ' A' ' 29' ' ' ALA . 7.1 ptm85 -163.16 -160.82 0.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 O-C-N 122.422 -0.174 . . . . 12.99 111.096 -177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -124.8 20.08 8.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.826 0.346 . . . . 16.66 111.223 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' HB3' HH21 ' A' ' 27' ' ' ARG . . . -146.13 122.46 10.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.392 -0.367 . . . . 12.09 111.692 -179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 30' ' ' ARG . 11.8 ptt180 -85.97 130.74 34.45 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.428 -0.953 . . . . 12.51 108.428 171.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.1 tp -141.64 158.6 43.62 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 120.689 -0.404 . . . . 8.76 110.777 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -113.99 149.92 34.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.141 -0.481 . . . . 9.15 109.831 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -136.49 155.39 50.04 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.006 -0.368 . . . . 6.85 110.006 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -110.73 150.25 29.33 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.691 -0.485 . . . . 9.99 109.691 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -63.93 -19.25 64.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.379 -0.373 . . . . 9.93 111.6 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p -70.34 -24.07 62.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 12.28 111.129 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.88 40.1 1.72 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.026 -0.533 . . . . 10.62 110.525 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -120.5 129.8 53.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.336 -0.393 . . . . 8.78 110.393 176.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.3 m -97.7 104.78 16.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.263 -0.426 . . . . 8.97 110.349 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.89 -172.42 23.67 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.754 -0.736 . . . . 9.98 111.525 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -95.4 115.94 28.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.482 0.658 . . . . 12.43 110.3 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.2 tp -60.63 -23.95 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.391 -0.822 . . . . 11.58 112.537 -172.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -67.7 -21.19 65.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 14.73 111.329 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -99.62 9.07 43.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.766 0.317 . . . . 13.3 110.928 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.3 tp -94.17 130.75 40.27 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.242 -0.651 . . . . 10.07 109.242 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -122.92 172.98 8.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.96 0.409 . . . . 13.13 110.546 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.5 mp -81.79 128.44 38.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.756 -0.656 . . . . 11.74 109.397 178.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.47 0.58 67.11 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.687 -0.768 . . . . 10.13 112.119 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 31.9 t70 -80.4 129.97 67.1 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.192 . . . . 8.39 110.743 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 49' ' ' ASP . 8.2 Cg_exo -72.22 127.43 12.7 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.938 2.426 . . . . 7.28 113.032 -178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.79 154.47 34.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.97 -0.559 . . . . 4.74 110.88 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.521 ' OE1' ' HD2' ' A' ' 7' ' ' ARG . 37.3 tt0 -112.77 124.19 52.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.185 -0.461 . . . . 7.09 109.899 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -142.3 151.27 41.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.394 -0.366 . . . . 7.82 110.679 -174.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 33.0 tt0 -104.4 130.49 52.28 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.313 -0.625 . . . . 11.59 109.313 174.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 14.7 tpt -83.19 114.68 21.52 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.25 -0.432 . . . . 12.41 109.853 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 29.5 p -133.2 170.96 14.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.371 0.605 . . . . 13.17 111.927 -173.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.411 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 84.4 m-85 -132.37 115.06 15.11 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.018 -0.734 . . . . 16.21 109.018 178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -80.5 116.5 20.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.767 -0.457 . . . . 16.64 109.767 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -78.71 -7.05 57.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.947 -0.57 . . . . 22.64 111.947 -173.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -98.07 -37.92 9.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.203 -0.453 . . . . 21.43 110.913 -175.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 p -87.69 -34.09 18.53 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.89 0.376 . . . . 17.4 110.924 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.54 8.58 63.88 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.503 -0.856 . . . . 16.7 112.178 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -106.45 145.51 31.15 Favored Pre-proline 0 C--N 1.329 -0.297 0 O-C-N 122.893 -0.181 . . . . 14.73 110.804 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -80.48 125.02 5.48 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.8 1.667 . . . . 12.6 110.433 169.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.31 157.49 24.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.272 0.558 . . . . 11.73 111.21 -173.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.0 157.79 16.6 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.742 -0.663 . . . . 8.91 109.556 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.0 t -65.3 -166.3 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.177 -0.465 . . . . 9.83 110.148 176.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -73.94 19.77 0.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.535 0.568 . . . . 11.32 112.535 -172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.0 t 32.87 92.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 124.421 1.089 . . . . 6.11 113.193 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.8 m -88.4 136.45 32.98 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.113 0.482 . . . . 6.12 110.114 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.428 ' HE2' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -73.97 119.7 18.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.149 -0.478 . . . . 6.3 110.344 -179.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.428 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 65.4 mt -57.17 108.56 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-N 115.951 -0.568 . . . . 5.77 109.77 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.15 165.11 55.62 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 115.357 -0.838 . . . . 5.69 110.21 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -50.74 107.66 0.18 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.373 2.049 . . . . 6.86 112.147 176.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -85.73 -163.44 0.86 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.375 -0.83 . . . . 8.49 110.584 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 41.4 t -60.09 139.09 20.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.763 -0.828 . . . . 6.19 108.763 172.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.74 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 39.0 t -68.13 89.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.419 . . . . 6.26 110.394 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.493 ' HA ' ' HA ' ' A' ' 144' ' ' ALA . 1.5 tt -91.43 -8.7 47.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.153 -0.931 . . . . 6.05 110.782 -173.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.3 t -140.89 103.59 4.51 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.049 -0.523 . . . . 7.02 110.479 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.65 -59.77 1.96 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.553 -0.906 . . . . 7.07 108.553 175.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -135.97 119.73 17.27 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.912 -1.04 . . . . 6.68 108.51 174.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -79.77 107.85 12.87 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.695 -0.483 . . . . 6.43 109.695 -174.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -113.49 179.3 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.768 -0.651 . . . . 3.7 111.571 -174.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.573 ' HB ' ' HD2' ' A' ' 138' ' ' LYS . 37.4 p -121.55 165.16 16.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.445 -0.798 . . . . 3.49 108.853 171.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.18 145.1 15.47 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.136 -1.03 . . . . 2.58 113.002 -177.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.5 m -108.05 127.91 54.21 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.606 -0.516 . . . . 3.34 109.606 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.613 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -74.83 124.89 33.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 110.096 -0.335 . . . . 3.14 110.096 179.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 p -104.29 -22.41 13.36 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.119 0.485 . . . . 3.61 110.65 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.4 m -136.66 126.46 25.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.959 -0.564 . . . . 3.12 110.634 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -84.09 -176.73 6.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.04 -0.527 . . . . 4.39 110.709 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.8 mt -102.31 -178.6 3.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.876 -0.787 . . . . 3.62 108.876 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 92' ' ' ARG . 10.5 ptt180 -129.39 175.27 8.89 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.247 -0.649 . . . . 7.2 109.247 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 94' ' ' ASP . 6.8 p -125.42 -13.41 6.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.054 0.454 . . . . 5.1 111.118 177.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 93' ' ' THR . 1.9 m-20 73.65 -56.66 0.65 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.307 -1.315 . . . . 7.53 110.209 -175.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 98' ' ' ASN . 47.6 t -100.56 155.64 17.74 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.421 -0.585 . . . . 7.47 109.421 174.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -79.55 -36.02 38.99 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.642 0.258 . . . . 7.58 111.392 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -110.59 -1.64 16.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.562 0.696 . . . . 8.32 110.94 -176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' A' ' 95' ' ' SER . 9.1 m120 -130.87 142.02 50.35 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.619 -0.511 . . . . 7.26 109.619 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.93 127.42 72.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.082 0.468 . . . . 5.54 110.525 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.5 tp -150.94 98.38 2.58 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.381 -0.6 . . . . 7.28 109.381 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.495 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 19.2 m120 -131.43 -62.8 0.86 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.794 -0.639 . . . . 7.54 112.141 -173.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 101' ' ' ASN . 71.6 m 66.05 24.38 11.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.255 0.55 . . . . 5.41 109.784 -171.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 67.0 m 59.49 52.82 5.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.084 -0.962 . . . . 4.58 111.051 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.495 ' OE1' ' HA ' ' A' ' 101' ' ' ASN . 0.2 OUTLIER -79.63 -35.77 38.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.393 0.616 . . . . 5.09 109.586 179.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.4 t -98.96 167.42 10.75 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 115.296 -0.866 . . . . 3.33 109.414 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.3 m -137.39 135.44 36.96 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.051 0.453 . . . . 2.57 110.532 -177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -86.48 176.98 48.5 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.777 -0.725 . . . . 1.66 111.92 -179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -129.89 127.37 40.04 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.884 0.373 . . . . 3.03 111.256 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.4 HG13 ' CD1' ' A' ' 122' ' ' TYR . 78.4 mt -112.3 127.06 69.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.872 -0.604 . . . . 1.88 109.441 173.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.9 p -102.54 132.87 48.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.618 -0.264 . . . . 3.49 110.868 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.446 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -145.14 160.69 41.03 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.661 -0.496 . . . . 3.51 109.661 175.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -117.04 124.33 49.04 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.501 -0.555 . . . . 5.1 109.501 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -137.65 112.43 8.92 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.667 -0.697 . . . . 4.78 110.456 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 66.08 21.82 11.18 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.495 -0.32 . . . . 6.97 111.756 174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.56 -1.22 68.77 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.675 -0.774 . . . . 5.1 111.7 -178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.489 ' HB3' ' CE2' ' A' ' 118' ' ' PHE . 69.8 mm-40 -96.85 128.75 44.11 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.9 -0.407 . . . . 5.38 109.9 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 84.9 m -118.16 101.44 8.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.124 -0.489 . . . . 4.72 110.293 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' A' ' 116' ' ' GLU . 62.5 m-85 -116.79 155.0 29.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.168 0.508 . . . . 4.61 111.099 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -107.75 118.58 37.11 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.786 -0.82 . . . . 3.96 108.786 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.446 HD11 ' CE2' ' A' ' 111' ' ' TYR . 5.5 mp -102.42 137.89 19.52 Favored Pre-proline 0 C--N 1.323 -0.565 0 C-N-CA 120.875 -0.33 . . . . 2.75 110.66 -173.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.88 134.45 18.05 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.743 2.295 . . . . 2.3 112.115 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.4 ' CD1' HG13 ' A' ' 109' ' ' ILE . 23.0 p90 -137.09 151.22 48.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.175 -0.466 . . . . 2.13 109.797 175.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 72.3 p -116.72 178.77 4.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.419 -0.355 . . . . 3.07 110.137 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -69.91 -19.71 63.39 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.388 0.613 . . . . 4.8 110.167 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -78.98 -9.87 59.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.456 -0.793 . . . . 4.81 111.42 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -93.34 -14.55 26.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.411 -0.359 . . . . 3.84 111.873 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.449 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 7.6 p -103.98 137.68 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.183 0.516 . . . . 4.39 111.052 -177.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -106.17 169.7 8.35 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.991 -0.55 . . . . 6.43 111.196 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.73 -4.01 83.6 Favored Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.907 -0.588 . . . . 5.91 113.174 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 62.6 24.96 14.86 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 122.797 0.439 . . . . 6.07 110.65 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.8 t -84.34 122.18 37.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.958 -0.565 . . . . 5.27 110.41 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -83.86 95.31 8.44 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.308 0.575 . . . . 5.78 110.438 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.4 pt? -75.37 150.35 38.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.863 -1.062 . . . . 3.62 111.008 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.521 ' HG3' ' OD1' ' A' ' 137' ' ' ASP . 3.9 ppt_? -120.38 162.33 19.67 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.77 -0.456 . . . . 6.93 109.77 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.613 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -72.41 125.62 27.85 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.605 -0.438 . . . . 4.12 110.87 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.48 -25.73 7.59 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.934 -0.651 . . . . 4.07 113.613 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.521 ' OD1' ' HG3' ' A' ' 134' ' ' ARG . 2.8 p30 -86.53 178.66 7.02 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 118.258 1.029 . . . . 4.06 110.141 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.573 ' HD2' ' HB ' ' A' ' 84' ' ' THR . 2.3 tppp? -118.9 124.7 47.74 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.414 0.626 . . . . 4.17 111.795 -172.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.617 HG12 ' HG ' ' A' ' 158' ' ' LEU . 24.5 m -117.22 170.59 6.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.167 -0.924 . . . . 2.77 110.039 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -119.97 135.4 54.92 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.034 -0.728 . . . . 3.47 109.034 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -134.44 153.58 51.84 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.774 0.321 . . . . 3.35 110.536 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -113.83 131.23 56.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.864 -0.607 . . . . 5.34 109.801 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 45.4 mt -95.96 108.71 21.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.778 -0.647 . . . . 4.66 110.951 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.74 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -101.86 110.98 23.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.718 0.294 . . . . 4.85 111.285 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 66.8 m -99.0 122.7 42.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.782 -0.644 . . . . 5.68 111.814 -175.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -87.52 174.92 8.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 6.25 110.533 174.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -59.58 -28.54 67.23 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.001 -0.545 . . . . 8.58 112.214 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 148' ' ' ARG . 21.8 mmt180 -88.48 8.66 26.91 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.877 0.325 . . . . 7.86 111.877 -174.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.07 14.51 73.67 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.909 -0.662 . . . . 5.59 113.22 174.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.9 130.51 53.84 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.254 -0.647 . . . . 5.18 109.254 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.491 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -152.94 -178.52 6.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.356 -0.384 . . . . 4.28 110.938 -177.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.14 -166.11 13.81 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.031 -0.828 . . . . 3.36 111.031 177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.39 109.96 21.89 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.046 -0.353 . . . . 2.84 110.046 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 71.9 m -121.01 166.76 13.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.434 -0.348 . . . . 4.34 110.871 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 59.22 36.51 23.79 Favored 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.632 0.583 . . . . 5.75 110.144 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.449 ' HB ' ' HA ' ' A' ' 127' ' ' VAL . 77.1 mt -64.9 114.55 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.807 -0.633 . . . . 3.55 110.021 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 25.7 ttt85 -122.12 123.89 42.62 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.816 -0.809 . . . . 5.96 108.816 -178.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.617 ' HG ' HG12 ' A' ' 139' ' ' VAL . 0.4 OUTLIER -81.78 103.05 11.18 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.178 -0.464 . . . . 4.34 109.876 -176.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -97.08 -32.44 11.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.993 -0.549 . . . . 4.97 111.305 -176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -126.39 84.38 62.26 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 5.37 110.742 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.28 179.87 4.31 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.918 2.412 . . . . 5.44 112.975 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.408 ' HB2' ' HE ' ' A' ' 134' ' ' ARG . . . -97.77 141.91 30.2 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.73 -0.668 . . . . 6.1 110.49 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -105.79 120.26 49.76 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 109.35 -0.611 . . . . 9.49 109.35 175.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.06 135.26 67.44 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.696 2.264 . . . . 8.39 111.745 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.084 -0.507 . . . . 10.27 111.197 -176.123 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.157 -0.377 . . . . 21.66 112.157 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.39 103.04 13.96 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.881 0.372 . . . . 20.17 110.992 -178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -116.98 -19.78 9.64 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.047 0.451 . . . . 18.5 110.931 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -105.35 10.28 33.53 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.902 -0.59 . . . . 16.62 111.464 -174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -135.68 128.63 31.38 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 122.183 0.992 . . . . 18.35 110.433 178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -146.13 88.44 1.8 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 113.668 -1.606 . . . . 16.2 108.157 175.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.429 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 17.3 ptt180 -82.73 136.03 34.83 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.108 0.48 . . . . 12.4 111.142 -175.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.72 162.7 21.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.691 -0.686 . . . . 11.63 110.038 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.505 ' OG1' ' HB3' ' A' ' 26' ' ' GLU . 36.8 p -100.79 162.12 13.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.399 -0.364 . . . . 9.15 110.233 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 26' ' ' GLU . . . -162.38 177.56 38.49 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.967 -0.635 . . . . 6.81 112.055 178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.6 mt -129.45 141.9 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.557 -0.534 . . . . 10.17 109.557 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.6 mm -65.81 111.5 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 120.836 0.351 . . . . 8.73 110.086 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -79.15 -54.24 6.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.724 -0.671 . . . . 10.86 110.495 -177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HA ' HD12 ' A' ' 47' ' ' ILE . 41.0 mttm -146.47 163.9 34.22 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.434 -0.803 . . . . 14.06 110.253 178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.5 mt -131.45 101.33 5.48 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.803 -0.635 . . . . 11.73 110.543 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 80.5 mt -92.41 -179.87 5.33 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.558 -1.275 . . . . 11.36 107.558 169.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -90.37 125.1 35.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.097 -0.641 . . . . 15.94 109.977 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.3 m 79.63 -16.6 0.65 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.136 0.974 . . . . 13.01 112.212 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -150.19 147.77 28.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.561 0.22 . . . . 12.34 110.949 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.48 -176.21 15.62 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.021 -0.609 . . . . 7.52 112.871 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -127.87 149.78 50.15 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.843 0.354 . . . . 9.24 111.312 -176.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.8 mt -115.53 130.43 70.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.008 -0.542 . . . . 7.75 110.897 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.79 145.83 34.13 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.92 -0.582 . . . . 11.8 111.252 -178.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 7.0 p -80.28 2.49 24.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.088 -0.96 . . . . 12.34 112.862 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 63.6 m -52.62 -35.44 54.6 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.006 0.372 . . . . 13.33 112.006 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.505 ' HB3' ' OG1' ' A' ' 9' ' ' THR . 22.6 mm-40 -108.89 -25.39 10.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 11.9 111.409 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.461 ' HD3' ' N ' ' A' ' 28' ' ' GLN . 1.6 tmt_? -113.38 135.3 54.02 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.475 -0.565 . . . . 12.99 109.475 -175.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' N ' ' HD3' ' A' ' 27' ' ' ARG . 19.6 mp0 -74.62 43.7 0.19 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.797 0.332 . . . . 16.66 111.255 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.33 146.4 0.48 Allowed 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.717 0.807 . . . . 12.09 109.541 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.585 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -100.96 111.81 24.1 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.57 -0.53 . . . . 12.51 109.57 177.767 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.1 mt -113.88 163.03 15.63 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.234 0.54 . . . . 8.76 111.923 -170.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -112.07 149.12 32.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.237 -0.892 . . . . 9.15 109.506 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -140.53 158.72 43.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.874 0.369 . . . . 6.85 110.195 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.8 m80 -103.76 158.19 16.56 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.703 -0.48 . . . . 9.99 109.703 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.2 m-30 -67.91 -18.79 64.89 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 111.957 0.355 . . . . 9.93 111.957 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 t -82.56 -8.08 59.62 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.403 0.62 . . . . 12.28 109.773 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -107.48 37.89 2.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.618 -0.719 . . . . 10.62 110.03 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -129.67 125.39 35.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.964 0.412 . . . . 8.78 111.16 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.9 t -100.75 104.6 15.88 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.961 -0.563 . . . . 8.97 109.977 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 148.54 -148.85 20.67 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.114 -0.795 . . . . 9.98 111.114 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -107.13 104.03 13.58 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 110.022 -0.362 . . . . 12.43 110.022 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.0 tp -63.25 -25.48 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 121.155 0.502 . . . . 11.58 110.726 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -72.04 -25.42 61.79 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.165 -0.47 . . . . 14.73 110.383 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -97.17 -10.43 25.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.756 -0.656 . . . . 13.3 110.568 -176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.0 tp -68.37 147.2 52.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.008 -0.542 . . . . 10.07 110.169 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.44 169.95 17.32 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.191 -0.458 . . . . 13.13 110.431 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 14' ' ' LYS . 31.8 mm -77.69 135.27 26.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.562 -0.533 . . . . 11.74 109.562 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.59 11.29 62.43 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.477 -0.868 . . . . 10.13 111.837 -177.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -86.38 125.93 66.15 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.253 -0.277 . . . . 8.39 110.253 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.91 129.74 6.35 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.906 2.404 . . . . 7.28 112.985 -179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.5 m -136.98 165.01 28.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.501 -0.772 . . . . 4.74 110.584 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.488 ' HB3' HG22 ' A' ' 9' ' ' THR . 10.2 pt-20 -126.52 146.63 50.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.969 0.414 . . . . 7.09 110.218 172.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -152.24 178.52 9.42 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.026 -0.534 . . . . 7.82 110.879 -173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 1.7 mp0 -124.08 114.17 19.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.882 -0.599 . . . . 11.59 110.575 177.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.9 ttt -78.28 109.65 12.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.599 -0.519 . . . . 12.41 109.599 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.5 p -131.67 167.74 18.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.937 0.399 . . . . 13.17 111.043 -176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -118.36 110.4 17.43 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.58 -0.526 . . . . 16.21 109.58 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.38 111.2 5.11 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.838 0.352 . . . . 16.64 110.143 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -6.63 46.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.0 -0.545 . . . . 22.64 111.608 -176.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 46.8 mmt-85 -78.25 -59.7 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.948 0.404 . . . . 21.43 110.259 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.4 p -86.68 -30.36 21.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.032 -0.531 . . . . 17.4 111.896 -176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.17 31.55 16.73 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.937 -0.649 . . . . 16.7 111.893 -177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -121.28 141.5 33.26 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 122.935 -0.156 . . . . 14.73 110.827 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.91 125.53 7.4 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.298 1.999 . . . . 12.6 110.886 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.63 165.61 22.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 116.186 -0.461 . . . . 11.73 110.591 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -102.16 161.15 13.91 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.661 -0.496 . . . . 8.91 109.661 176.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 11.9 t -66.89 -166.91 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.721 -0.474 . . . . 9.83 109.721 172.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -78.46 26.27 0.23 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.355 0.502 . . . . 11.32 112.355 -177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.7 t 35.25 94.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.2 1.0 . . . . 6.11 113.447 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -93.21 132.26 37.53 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.285 -0.416 . . . . 6.12 110.435 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp -67.46 140.36 57.09 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.444 -0.576 . . . . 6.3 109.444 173.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 45.2 mt -72.31 100.19 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.038 0.447 . . . . 5.77 110.895 -176.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -125.52 95.1 41.38 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.905 -0.589 . . . . 5.69 110.378 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -90.24 14.33 2.09 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.073 2.516 . . . . 6.86 112.722 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -110.64 131.78 54.75 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.601 -0.272 . . . . 8.49 110.762 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.622 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 1.7 p -63.29 117.01 3.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.773 -0.455 . . . . 6.19 109.773 172.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 4.8 p -79.97 107.21 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 121.575 0.703 . . . . 6.26 111.225 -177.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 49.5 tp -89.87 -52.34 5.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.815 -1.084 . . . . 6.05 110.354 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.7 m -89.52 67.15 7.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.896 0.379 . . . . 7.02 111.718 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -88.64 -65.93 0.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.006 -0.738 . . . . 7.07 109.006 170.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -152.49 133.57 14.22 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.555 -0.906 . . . . 6.68 108.555 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -77.8 118.27 19.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.758 0.313 . . . . 6.43 110.278 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.1 m -114.13 166.9 7.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.215 0.531 . . . . 3.7 111.172 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.1 p -133.22 150.4 51.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.502 -0.772 . . . . 3.49 110.496 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -150.52 173.66 30.07 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.508 -0.853 . . . . 2.58 112.143 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 33.1 m -122.86 135.48 54.54 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.819 0.343 . . . . 3.34 110.256 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.549 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 39.8 t -64.9 132.02 30.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.269 -0.423 . . . . 3.14 110.728 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 13.5 p -115.15 -10.57 12.14 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 112.048 0.388 . . . . 3.61 112.048 177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.5 m -145.05 131.99 20.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.711 0.291 . . . . 3.12 110.657 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -86.12 179.59 6.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.726 -0.67 . . . . 4.39 111.427 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.9 mt -107.95 167.8 9.73 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.57 -0.741 . . . . 3.62 109.339 175.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.501 ' HG2' HG21 ' A' ' 105' ' ' THR . 7.8 ptm180 -106.85 113.89 27.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.362 0.601 . . . . 7.2 111.529 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.6 p -135.58 139.14 43.63 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.522 -0.763 . . . . 5.1 109.604 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -107.69 -23.76 11.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.384 0.611 . . . . 7.53 110.288 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.8 t -157.78 166.7 32.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.785 -0.643 . . . . 7.47 109.441 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.67 -26.84 66.39 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.251 0.548 . . . . 7.58 109.927 175.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -93.66 -14.14 26.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.653 -0.703 . . . . 8.32 110.514 177.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -110.99 85.99 2.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.427 0.632 . . . . 7.26 110.19 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.4 m -113.69 143.34 23.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 CA-C-N 115.027 -0.988 . . . . 5.54 110.103 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 6.7 mp -111.19 98.56 7.6 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.382 1.087 . . . . 7.28 110.821 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -93.64 13.34 22.41 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 113.165 -1.834 . . . . 7.54 109.992 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.1 m -59.07 123.9 18.15 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.369 -0.832 . . . . 5.41 109.825 176.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 27.5 t -70.63 -5.71 31.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.218 -0.446 . . . . 4.58 111.966 -172.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -69.88 -26.41 64.18 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.652 -0.87 . . . . 5.09 108.652 172.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.501 HG21 ' HG2' ' A' ' 92' ' ' ARG . 94.7 m -103.02 113.03 26.17 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.828 -1.078 . . . . 3.33 110.511 -177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.8 t -136.25 141.27 43.9 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.073 -0.512 . . . . 2.57 109.981 177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -81.2 177.58 54.23 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.468 -0.872 . . . . 1.66 111.541 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 8.0 mmt85 -132.82 127.65 34.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.989 0.423 . . . . 3.03 111.104 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 94.8 mt -112.3 130.15 66.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.464 -0.789 . . . . 1.88 109.223 172.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 30.5 t -106.56 116.45 31.95 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.552 -0.536 . . . . 3.49 109.552 178.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -118.87 144.63 46.27 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.34 -0.615 . . . . 3.51 109.34 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -104.78 109.29 21.17 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.573 -0.74 . . . . 5.1 109.713 -175.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.589 ' OD1' ' HD3' ' A' ' 114' ' ' ARG . 59.2 t30 -129.33 114.84 16.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.372 -0.376 . . . . 4.78 111.147 -174.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.589 ' HD3' ' OD1' ' A' ' 113' ' ' ASN . 6.0 mpt_? 61.55 26.13 15.91 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.978 0.418 . . . . 6.97 111.57 173.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.94 -2.77 69.67 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.872 -0.68 . . . . 5.1 112.617 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -110.19 135.23 51.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.828 0.347 . . . . 5.38 110.268 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 2.3 p -117.16 103.61 10.38 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 116.399 -0.364 . . . . 4.72 110.313 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -98.03 153.89 18.09 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.97 -0.559 . . . . 4.61 110.617 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -101.89 124.3 47.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.186 -0.461 . . . . 3.96 110.37 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 22.4 mt -105.66 130.01 23.73 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.839 -0.619 . . . . 2.75 110.685 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 76.2 Cg_endo -81.4 134.04 8.75 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.733 2.289 . . . . 2.3 111.544 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -140.24 157.76 45.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 2.13 111.363 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 7.5 p -120.73 177.2 5.17 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.612 -0.722 . . . . 3.07 109.582 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -76.65 -25.34 53.67 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.569 0.581 . . . . 4.8 112.569 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -76.01 -10.12 59.16 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.385 0.513 . . . . 4.81 112.385 -170.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -97.14 -12.63 22.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.037 0.446 . . . . 3.84 111.092 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 60.5 t -67.91 110.26 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.09 0.471 . . . . 4.39 111.041 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -68.25 127.51 33.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.571 -0.74 . . . . 6.43 110.719 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.89 -0.29 55.13 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.743 -0.741 . . . . 5.91 112.695 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 65.33 18.42 11.35 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.856 0.36 . . . . 6.07 110.771 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.63 135.08 27.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.803 -0.635 . . . . 5.27 112.238 -172.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -90.65 79.16 6.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.893 0.854 . . . . 5.78 109.135 171.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.566 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -77.34 149.95 35.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.86 -1.064 . . . . 3.62 112.129 -172.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -108.66 167.49 10.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.594 -0.73 . . . . 6.93 109.525 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.549 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.21 127.9 34.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.071 -0.652 . . . . 4.12 110.008 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.19 -24.24 9.4 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.847 -0.692 . . . . 4.07 111.605 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -64.99 137.94 58.04 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.855 0.36 . . . . 4.06 110.295 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -84.46 117.12 23.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.587 -0.523 . . . . 4.17 109.587 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.7 m -118.71 157.41 20.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.29 0.567 . . . . 2.77 111.998 -174.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.5 m -118.8 129.94 55.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.534 -0.757 . . . . 3.47 109.336 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -138.24 152.52 48.67 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.77 -0.456 . . . . 3.35 109.77 -178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -107.94 132.4 53.53 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.837 -0.431 . . . . 5.34 109.837 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 75.6 mt -84.7 131.21 34.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.271 -0.422 . . . . 4.66 110.868 -177.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.652 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -131.13 110.0 10.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.966 -0.561 . . . . 4.85 110.525 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 45.3 m -85.98 112.04 20.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.892 -0.595 . . . . 5.68 110.844 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -81.61 174.01 11.81 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.388 -0.597 . . . . 6.25 109.388 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -65.9 -7.29 15.74 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.168 0.803 . . . . 8.58 113.168 -172.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -90.54 -9.48 47.02 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.763 -0.375 . . . . 7.86 111.117 175.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.11 13.35 83.43 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.73 -0.748 . . . . 5.59 112.004 -177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -111.27 121.26 44.81 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.858 -0.423 . . . . 5.18 109.858 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.519 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -136.34 -178.25 5.08 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.275 -0.42 . . . . 4.28 110.308 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.422 ' HA2' HD22 ' A' ' 120' ' ' LEU . . . -160.78 -78.08 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 110.594 -1.003 . . . . 3.36 110.594 176.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -160.23 163.1 33.78 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.085 -0.709 . . . . 2.84 109.085 177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 13.0 t -150.52 147.06 27.02 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.98 -0.378 . . . . 4.34 109.98 176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 12.4 p80 40.74 51.2 3.06 Favored 'General case' 0 C--O 1.236 0.342 0 O-C-N 124.638 1.211 . . . . 5.75 111.361 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.9 mt -59.52 114.57 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 114.827 -1.079 . . . . 3.55 110.063 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.27 148.0 31.72 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.454 -0.339 . . . . 5.96 110.363 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 58.5 tp -72.68 125.23 27.0 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.237 -0.653 . . . . 4.34 109.237 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -102.2 -62.17 1.3 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.334 -0.617 . . . . 4.97 109.334 -177.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -135.6 109.18 10.17 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.812 -0.631 . . . . 5.37 109.484 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.08 154.95 65.97 Favored 'Trans proline' 0 C--O 1.237 0.463 0 C-N-CA 122.789 2.326 . . . . 5.44 113.017 -174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -121.17 107.23 12.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.563 -0.744 . . . . 6.1 111.467 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 70.18 107.73 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 115.322 -0.854 . . . . 9.49 112.785 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -77.98 107.92 2.43 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.342 2.028 . . . . 8.39 111.4 172.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 97.5 t . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.027 -0.533 . . . . 10.27 110.851 -178.705 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.453 0 N-CA-C 111.854 -0.498 . . . . 21.66 111.854 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.64 138.55 32.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.94 0.4 . . . . 20.17 111.294 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -117.36 -50.51 2.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.578 0.704 . . . . 18.5 109.996 176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.33 73.38 2.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.77 -1.104 . . . . 16.62 110.951 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -65.65 -76.97 0.07 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.741 -1.118 . . . . 18.35 110.068 174.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 38.87 72.8 0.12 Allowed 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.397 1.06 . . . . 16.2 113.129 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 7' ' ' ARG . 43.6 mtt85 -121.7 150.3 41.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.217 -0.447 . . . . 12.4 110.176 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.523 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . 17.5 mm-40 -103.24 137.8 40.9 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.911 -0.586 . . . . 11.63 110.3 -173.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -97.94 136.91 37.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.659 -0.701 . . . . 9.15 110.656 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -153.5 174.6 32.1 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.978 -1.106 . . . . 6.81 112.918 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.559 HG13 ' HB3' ' A' ' 23' ' ' GLN . 7.9 pt -124.88 146.13 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.92 -0.4 . . . . 10.17 109.92 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.7 mm -67.47 122.88 19.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 120.414 0.149 . . . . 8.73 110.664 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 23' ' ' GLN . 23.6 tt0 -88.09 -45.61 10.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.023 0.44 . . . . 10.86 110.428 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -147.6 140.93 25.26 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.9 -0.591 . . . . 14.06 109.954 -176.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.466 HD21 HD23 ' A' ' 45' ' ' LEU . 37.3 mt -113.01 110.19 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.324 0.583 . . . . 11.73 111.282 176.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.1 mp -108.12 178.41 4.52 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 107.32 -1.363 . . . . 11.36 107.32 171.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -90.79 130.76 36.73 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 119.575 -0.85 . . . . 15.94 110.172 -174.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 49.9 m 76.63 -25.51 0.2 Allowed 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.203 0.939 . . . . 13.01 112.17 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -141.79 142.28 33.2 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.647 0.26 . . . . 12.34 110.844 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -140.15 179.82 18.63 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.814 -0.708 . . . . 7.52 112.448 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -120.09 134.7 55.18 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.747 0.308 . . . . 9.24 111.383 -177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.416 HG21 ' CE1' ' A' ' 53' ' ' PHE . 74.8 mt -99.75 129.09 50.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.617 -0.512 . . . . 7.75 109.617 174.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.559 ' HB3' HG13 ' A' ' 11' ' ' ILE . 37.6 tt0 -85.79 133.7 33.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.465 0.65 . . . . 11.8 111.357 -173.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.6 p -79.21 1.41 24.76 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 115.231 -0.895 . . . . 12.34 112.444 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 t -57.11 -29.46 63.55 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.197 0.443 . . . . 13.33 112.197 -174.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -97.3 -1.28 44.99 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.83 0.348 . . . . 11.9 111.512 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 12.8 tpt180 -148.59 -158.85 0.96 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.342 -0.614 . . . . 12.99 109.342 -172.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.485 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 26.5 mm-40 -119.21 19.01 12.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.248 0.546 . . . . 16.66 109.703 170.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.3 131.5 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.669 -0.696 . . . . 12.09 111.352 -175.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -121.18 125.71 47.86 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.734 -0.839 . . . . 12.51 108.734 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.5 mp -123.75 160.67 26.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.42 0.628 . . . . 8.76 112.624 -172.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -95.49 110.89 22.89 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.871 -1.059 . . . . 9.15 108.307 172.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -103.06 138.02 40.47 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.726 -0.79 . . . . 6.85 110.417 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -95.85 151.41 19.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.629 -0.714 . . . . 9.99 109.571 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.4 -16.77 61.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.949 0.404 . . . . 9.93 110.981 -177.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.7 t -70.18 -23.99 63.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.968 -0.56 . . . . 12.28 109.942 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -108.71 40.31 1.82 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.588 -0.733 . . . . 10.62 110.711 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -129.44 119.56 23.98 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.557 -0.534 . . . . 8.78 109.557 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 8.0 t -88.02 106.53 18.2 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.146 0.498 . . . . 8.97 110.409 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.66 -167.89 22.5 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.684 -0.769 . . . . 9.98 111.972 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -79.12 96.34 5.81 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.077 -0.342 . . . . 12.43 110.077 179.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -70.1 -27.28 31.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.504 0.669 . . . . 11.58 109.3 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -67.09 -21.77 65.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.465 -0.789 . . . . 14.73 110.952 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -99.72 13.95 31.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 13.3 110.646 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.466 HD23 HD21 ' A' ' 15' ' ' LEU . 39.1 tp -88.42 147.77 24.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.175 -0.466 . . . . 10.07 110.914 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -125.28 168.7 13.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.307 -0.406 . . . . 13.13 110.837 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.7 mp -80.55 122.8 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.915 -0.584 . . . . 11.74 109.889 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.36 -3.45 32.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.872 -0.68 . . . . 10.13 111.826 -177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -67.83 122.71 84.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.806 -0.197 . . . . 8.39 110.478 178.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 49' ' ' ASP . 13.4 Cg_exo -69.44 123.66 10.43 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.676 2.251 . . . . 7.28 112.052 177.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -125.62 153.0 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.048 0.452 . . . . 4.74 111.624 -177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.25 124.44 52.22 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.104 -0.702 . . . . 7.09 109.104 175.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CE2' ' HB2' ' A' ' 8' ' ' GLU . 53.5 p90 -132.69 144.56 50.4 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.375 0.607 . . . . 7.82 111.039 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 66' ' ' ALA . 26.9 tt0 -97.28 102.72 14.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.441 -0.8 . . . . 11.59 109.199 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.9 ttt -82.05 132.86 35.26 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.933 -0.576 . . . . 12.41 110.784 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -170.52 164.45 8.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.162 -0.472 . . . . 13.17 110.505 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -99.69 133.27 44.28 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.458 -0.337 . . . . 16.21 110.713 -178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.554 ' OD1' ' HG2' ' A' ' 60' ' ' ARG . 8.4 t70 -95.39 134.34 38.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.955 -0.566 . . . . 16.64 110.295 176.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -81.26 -13.39 58.55 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.24 0.459 . . . . 22.64 112.24 -177.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.554 ' HG2' ' OD1' ' A' ' 58' ' ' ASP . 8.4 mmm-85 -74.38 -60.8 2.1 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.943 -0.391 . . . . 21.43 109.943 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.551 HG22 ' OD2' ' A' ' 58' ' ' ASP . 5.7 t -91.81 -26.2 18.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.976 -0.556 . . . . 17.4 111.075 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.46 -4.58 85.47 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.798 -0.715 . . . . 16.7 112.634 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.504 ' H ' HG23 ' A' ' 61' ' ' THR . 38.5 mtpt -93.89 142.52 25.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.517 -0.549 . . . . 14.73 109.517 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.08 128.56 23.22 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.58 2.186 . . . . 12.6 112.119 -177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -129.31 179.5 4.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.205 -0.452 . . . . 11.73 111.001 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 54' ' ' GLU . . . -133.57 173.14 11.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.642 -0.708 . . . . 8.91 109.69 177.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 52.6 p -74.98 -160.53 0.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.231 0.332 . . . . 9.83 110.405 175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.5 pm0 -76.61 24.29 0.15 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.406 0.521 . . . . 11.32 112.406 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.6 t 32.75 87.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.3 1.04 . . . . 6.11 112.724 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 46.4 m -90.16 135.73 33.48 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.246 -0.434 . . . . 6.12 110.876 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -62.73 134.86 56.92 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.082 -0.71 . . . . 6.3 109.082 173.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.9 mt -69.73 100.61 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.247 0.546 . . . . 5.77 111.145 -174.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -96.16 146.31 31.08 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.247 -0.888 . . . . 5.69 109.841 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.26 139.04 28.6 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.751 2.3 . . . . 6.86 112.644 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -79.42 88.1 5.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.002 -0.545 . . . . 8.49 110.389 174.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.417 ' CG1' ' HB1' ' A' ' 144' ' ' ALA . 2.9 t -95.95 155.07 3.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.006 -0.738 . . . . 6.19 109.006 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 60.9 t -66.2 100.16 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.88 0.371 . . . . 6.26 111.351 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 144' ' ' ALA . 68.9 mt -105.19 9.32 34.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.502 0.668 . . . . 6.05 109.791 178.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.9 m -83.73 26.53 0.69 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.982 -1.008 . . . . 7.02 112.137 -172.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -92.66 -93.74 0.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.113 0.483 . . . . 7.07 111.07 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -164.49 124.31 1.97 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.424 -0.584 . . . . 6.68 109.424 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -63.6 118.48 8.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.991 0.424 . . . . 6.43 110.499 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.418 HG12 HD22 ' A' ' 113' ' ' ASN . 29.6 m -116.08 160.14 15.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.16 0.505 . . . . 3.7 111.629 -177.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 81.7 p -119.22 140.19 50.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.607 -0.724 . . . . 3.49 109.884 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -138.76 -179.11 16.94 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.346 -0.93 . . . . 2.58 112.464 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 32.1 m -129.39 130.62 46.24 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.765 -0.457 . . . . 3.34 109.765 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.602 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 33.7 t -71.62 129.41 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.402 -0.363 . . . . 3.14 110.031 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 49.5 p -106.2 -32.57 8.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.06 0.457 . . . . 3.61 110.562 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.8 m -146.38 122.98 11.12 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.938 -0.573 . . . . 3.12 110.218 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -85.24 -171.2 3.5 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.911 -0.403 . . . . 4.39 109.911 174.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -63.29 113.15 3.04 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.911 -0.774 . . . . 3.62 108.911 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.409 ' HG2' HG21 ' A' ' 105' ' ' THR . 13.2 ptp180 -61.71 145.67 51.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.255 -0.43 . . . . 7.2 111.388 -174.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.6 p -115.95 147.17 41.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.927 -0.579 . . . . 5.1 110.33 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.77 -66.16 0.94 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.785 0.291 . . . . 7.53 111.785 -178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.6 m -75.94 -67.27 0.69 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.63 0.253 . . . . 7.47 111.11 -176.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -159.6 -97.17 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.335 -0.393 . . . . 7.58 110.342 178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -97.39 73.45 2.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.792 0.806 . . . . 8.32 109.773 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.552 ' O ' HG12 ' A' ' 99' ' ' VAL . 2.6 m-20 -106.41 -68.48 0.88 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.258 -0.883 . . . . 7.26 111.079 -175.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 98' ' ' ASN . 2.6 p 53.91 14.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 124.617 1.198 . . . . 5.54 111.503 -176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 21.8 tp -105.47 82.86 1.87 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 107.83 -1.174 . . . . 7.28 107.83 176.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.565 ' O ' ' HG2' ' A' ' 104' ' ' GLU . 18.0 m120 -131.16 36.17 3.85 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.559 -1.2 . . . . 7.54 111.63 -171.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.4 m 53.65 25.08 4.67 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.234 0.457 . . . . 5.41 112.234 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.2 p 49.06 33.15 4.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.317 0.647 . . . . 4.58 112.106 -176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 101' ' ' ASN . 12.6 pt-20 -88.22 11.03 17.52 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.885 0.374 . . . . 5.09 111.117 -177.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.409 HG21 ' HG2' ' A' ' 92' ' ' ARG . 7.7 t -136.66 135.81 38.57 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.877 0.37 . . . . 3.33 110.572 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.4 p -100.55 151.79 21.17 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.123 -0.49 . . . . 2.57 110.444 176.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.552 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -90.77 175.7 40.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.724 -0.75 . . . . 1.66 111.536 175.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.482 ' HD2' ' HB3' ' A' ' 119' ' ' PHE . 24.2 mmt180 -130.51 122.18 27.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.024 0.44 . . . . 3.03 111.751 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.87 134.14 63.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.474 -0.785 . . . . 1.88 109.388 172.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.2 t -112.39 148.67 33.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.353 -0.24 . . . . 3.49 110.353 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -159.49 167.22 29.18 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 110.084 -0.339 . . . . 3.51 110.084 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -140.06 112.67 7.94 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.833 -0.432 . . . . 5.1 109.833 176.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.418 HD22 HG12 ' A' ' 83' ' ' VAL . 60.6 t30 -168.03 154.24 7.44 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.827 -0.434 . . . . 4.78 109.827 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 64.35 20.99 12.37 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.117 0.567 . . . . 6.97 110.474 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.99 4.77 89.84 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.165 -0.54 . . . . 5.1 112.47 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -111.71 140.84 46.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.227 0.537 . . . . 5.38 111.655 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 52.5 t -140.94 101.51 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.126 -0.943 . . . . 4.72 109.797 177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -151.78 169.57 21.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.617 -0.265 . . . . 4.61 110.499 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.482 ' HB3' ' HD2' ' A' ' 108' ' ' ARG . 74.9 m-85 -98.34 130.85 45.0 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.067 -0.515 . . . . 3.96 110.742 -177.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 120' ' ' LEU . 5.6 mp -105.64 134.5 19.68 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.29 -0.413 . . . . 2.75 110.244 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 93.3 Cg_endo -84.01 134.33 6.08 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.745 2.297 . . . . 2.3 112.029 175.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -135.77 159.44 41.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.41 -0.359 . . . . 2.13 110.224 178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.31 175.09 5.59 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.24 -0.436 . . . . 3.07 110.689 175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -60.82 -38.46 85.51 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.08 0.467 . . . . 4.8 111.694 -174.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -85.2 -3.1 58.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.793 -0.639 . . . . 4.81 112.363 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.83 -15.23 61.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.086 0.47 . . . . 3.84 110.94 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.422 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 38.5 t -81.99 114.57 23.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.199 -0.455 . . . . 4.39 110.171 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -66.61 110.05 3.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 6.43 110.606 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 100.5 -3.18 56.29 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.722 -0.672 . . . . 5.91 112.092 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.9 t30 59.12 71.01 0.61 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.071 0.462 . . . . 6.07 110.386 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.7 t -103.46 148.47 8.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.958 -0.565 . . . . 5.27 110.615 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -81.54 109.1 15.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.011 -0.54 . . . . 5.78 110.496 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.751 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.3 pt? -110.9 148.86 31.54 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.963 -0.562 . . . . 3.62 109.603 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -136.18 124.78 23.66 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.855 -0.424 . . . . 6.93 109.855 -177.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.602 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -51.46 123.1 9.07 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.105 0.479 . . . . 4.12 112.207 -173.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.65 3.66 16.07 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.409 -0.814 . . . . 4.07 111.828 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.6 p30 -105.64 -174.21 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.115 0.484 . . . . 4.06 110.652 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.533 ' HB2' ' HB2' ' A' ' 160' ' ' ASN . 2.7 mmmm -113.53 123.19 49.4 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.139 -0.482 . . . . 4.17 110.858 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.9 m -125.12 152.02 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.994 0.426 . . . . 2.77 110.665 177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 m -113.57 128.8 56.57 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.386 -0.598 . . . . 3.47 109.386 175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -130.87 159.5 37.2 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.094 -0.336 . . . . 3.35 110.094 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -111.01 125.14 53.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.326 -0.397 . . . . 5.34 110.218 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.0 mt -78.6 98.54 2.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.286 -0.635 . . . . 4.66 109.286 176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.445 ' HB2' HD23 ' A' ' 78' ' ' LEU . . . -111.88 144.11 41.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.271 -0.877 . . . . 4.85 111.236 -171.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.2 m -117.96 116.99 28.04 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.364 -0.38 . . . . 5.68 110.784 177.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.716 ' H ' HD21 ' A' ' 151' ' ' LEU . 60.9 t30 -99.25 172.62 7.24 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.263 -0.643 . . . . 6.25 109.263 176.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -51.44 -43.91 62.18 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.187 0.81 . . . . 8.58 113.187 -171.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.54 -23.05 62.55 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.416 0.524 . . . . 7.86 112.416 -176.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.59 16.44 80.74 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.539 -0.838 . . . . 5.59 112.814 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.522 ' O ' HD13 ' A' ' 151' ' ' LEU . 18.7 m120 -105.66 77.46 1.27 Allowed 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 110.051 -0.352 . . . . 5.18 110.051 178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.716 HD21 ' H ' ' A' ' 146' ' ' ASN . 1.6 mm? -127.11 169.64 13.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.306 -0.406 . . . . 4.28 110.546 -175.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.36 -102.91 0.4 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.631 -0.988 . . . . 3.36 110.631 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -125.49 110.26 13.68 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.307 -0.627 . . . . 2.84 109.307 175.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 3.7 t -125.48 168.67 13.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.499 -0.319 . . . . 4.34 110.509 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 57.79 41.44 25.0 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.23 0.538 . . . . 5.75 110.074 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 127' ' ' VAL . 56.6 mt -68.63 118.58 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.339 -0.846 . . . . 3.55 111.277 -176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -102.89 133.64 47.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.554 -0.748 . . . . 5.96 109.363 177.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 161' ' ' PRO . 36.4 tp -76.86 107.68 9.35 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.722 -0.844 . . . . 4.34 108.722 175.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -83.05 -62.7 1.52 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.89 -0.595 . . . . 4.97 110.626 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.533 ' HB2' ' HB2' ' A' ' 138' ' ' LYS . 16.1 m120 -129.08 103.19 18.55 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.995 -0.743 . . . . 5.37 108.995 176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.486 ' HB3' HD21 ' A' ' 158' ' ' LEU . 65.1 Cg_endo -71.46 158.66 53.51 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.252 1.968 . . . . 5.44 112.264 -176.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -87.89 19.48 3.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.334 0.587 . . . . 6.1 109.993 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -94.17 139.35 22.49 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.421 -0.808 . . . . 9.49 109.968 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.41 104.31 1.07 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.533 2.155 . . . . 8.39 112.202 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.256 -0.429 . . . . 10.27 110.556 178.7 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.403 0 N-CA-C 112.096 -0.402 . . . . 21.66 112.096 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.42 143.85 20.31 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.67 0.271 . . . . 20.17 110.701 178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.46 -31.38 18.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.886 0.85 . . . . 18.5 109.527 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -84.87 69.1 10.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.825 -1.079 . . . . 16.62 111.67 -169.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.538 ' HG3' ' H ' ' A' ' 6' ' ' GLU . 8.4 pt-20 -151.63 -64.62 0.18 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.01 0.374 . . . . 18.35 112.01 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.538 ' H ' ' HG3' ' A' ' 5' ' ' GLU . 6.4 mm-40 -88.58 93.74 9.65 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.413 0.625 . . . . 16.2 110.877 -177.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -137.43 116.35 12.35 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.682 -0.69 . . . . 12.4 110.219 -178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -141.18 170.28 16.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.282 -0.417 . . . . 11.63 110.684 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 27.2 p -97.26 173.52 7.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.113 0.482 . . . . 9.15 111.996 -174.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' HA2' ' HG3' ' A' ' 26' ' ' GLU . . . -169.06 152.07 19.21 Favored Glycine 0 C--O 1.225 -0.414 0 CA-C-N 115.405 -0.816 . . . . 6.81 111.176 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.451 HD11 ' SG ' ' A' ' 25' ' ' CYS . 18.1 pt -100.83 147.89 7.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 117.646 0.723 . . . . 10.17 110.407 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.79 121.29 17.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.486 -0.325 . . . . 8.73 111.043 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -72.03 -56.33 5.83 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.552 -0.749 . . . . 10.86 110.284 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -166.09 157.23 13.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.397 -0.819 . . . . 14.06 109.013 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -115.62 116.1 27.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.326 0.584 . . . . 11.73 111.33 -176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 2.8 mm? -98.3 -178.93 4.19 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.965 -1.124 . . . . 11.36 107.965 173.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 18' ' ' SER . 2.9 t60 -90.02 124.84 35.11 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.001 -0.74 . . . . 15.94 109.001 -178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 17' ' ' HIS . 68.7 m 81.35 -21.52 0.31 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.255 0.972 . . . . 13.01 112.399 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.442 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 50.4 p90 -150.01 156.68 42.13 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.104 -0.373 . . . . 12.34 111.062 178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -143.36 178.27 21.66 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.667 -0.573 . . . . 7.52 111.667 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -119.34 146.36 45.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.03 0.415 . . . . 9.24 111.443 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.4 mt -108.33 134.71 49.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.631 -0.713 . . . . 7.75 109.798 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.411 ' HB2' HG13 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -85.1 144.77 28.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.651 0.739 . . . . 11.8 111.667 -175.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.3 p -80.68 2.83 24.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.573 -1.194 . . . . 12.34 113.065 -176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.451 ' SG ' HD11 ' A' ' 11' ' ' ILE . 69.1 m -52.85 -31.59 40.07 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 120.612 0.244 . . . . 13.33 111.3 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.424 ' HG3' ' HA2' ' A' ' 10' ' ' GLY . 17.0 mm-40 -84.37 -39.36 19.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.409 -0.36 . . . . 11.9 111.106 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.22 148.46 28.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.994 -0.373 . . . . 12.99 109.994 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.416 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 6.7 pt20 -70.8 68.8 0.43 Allowed 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.936 0.717 . . . . 16.66 112.936 -174.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -169.75 139.24 1.94 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.9 -0.591 . . . . 12.09 110.132 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 5.5 ptp180 -107.33 118.37 36.54 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.488 -0.56 . . . . 12.51 109.488 176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.46 150.08 29.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.842 0.353 . . . . 8.76 111.052 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -110.65 133.71 53.08 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.032 -0.729 . . . . 9.15 109.032 173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -125.21 143.64 50.84 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 110.145 -0.317 . . . . 6.85 110.145 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -94.14 155.09 17.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.477 -0.564 . . . . 9.99 109.477 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -69.23 -9.22 52.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.899 0.38 . . . . 9.93 111.583 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.7 t -80.57 -13.33 59.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.055 0.455 . . . . 12.28 109.777 175.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -116.44 35.81 4.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.922 -0.581 . . . . 10.62 111.486 -175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -119.01 124.94 48.21 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.062 -0.347 . . . . 8.78 110.062 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.6 t -94.76 94.96 8.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.066 0.46 . . . . 8.97 110.25 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.86 -169.71 26.03 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 121.054 -0.593 . . . . 9.98 111.738 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -87.8 120.34 29.04 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.286 -0.264 . . . . 12.43 110.286 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.1 tp -66.56 -20.77 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.236 0.541 . . . . 11.58 110.954 -176.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.04 -24.56 66.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.914 -0.584 . . . . 14.73 110.583 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -92.91 2.95 56.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.835 -0.621 . . . . 13.3 110.453 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -102.54 129.93 49.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.636 -0.711 . . . . 10.07 109.417 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.38 177.22 8.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.529 -0.305 . . . . 13.13 110.768 -175.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 47' ' ' ILE . 4.0 mp -80.05 141.03 15.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.537 -0.302 . . . . 11.74 110.187 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.53 10.57 85.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.091 -0.576 . . . . 10.13 111.767 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.9 134.47 21.48 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.583 -0.309 . . . . 8.39 110.194 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.507 ' HB2' HD12 ' A' ' 72' ' ' ILE . 90.4 Cg_endo -81.99 128.82 5.93 Favored 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.594 2.196 . . . . 7.28 113.653 -178.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 32.0 m -120.65 167.99 13.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.448 -0.796 . . . . 4.74 109.779 175.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 4.7 pt-20 -120.17 124.48 45.85 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.258 -0.645 . . . . 7.09 109.258 174.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -131.27 147.8 52.62 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 122.165 0.983 . . . . 7.82 112.278 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 30.6 tt0 -100.29 122.13 42.59 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.003 -1.453 . . . . 11.59 108.448 178.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 28.1 ttt -100.93 118.08 36.26 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 121.243 -0.183 . . . . 12.41 110.726 -173.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.5 p -141.94 153.49 44.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.161 0.505 . . . . 13.17 111.459 -176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -96.8 108.52 21.2 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.13 -0.693 . . . . 16.21 109.13 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.57 111.13 18.82 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.062 0.458 . . . . 16.64 110.928 -175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -81.18 -7.08 59.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.966 -0.561 . . . . 22.64 111.706 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -67.99 -46.56 70.97 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.033 -0.729 . . . . 21.43 109.033 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.4 p -93.78 -31.33 14.43 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.179 -0.918 . . . . 17.4 110.9 177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.33 28.46 17.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.679 -0.772 . . . . 16.7 111.905 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -133.41 152.91 80.1 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 110.132 -0.321 . . . . 14.73 110.132 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.06 125.88 6.77 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.322 2.015 . . . . 12.6 110.763 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.7 pp -137.43 172.51 14.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.748 0.785 . . . . 11.73 112.749 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.69 149.76 24.12 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.753 -1.112 . . . . 8.91 108.028 170.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.499 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 8.6 t -69.39 -151.07 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.329 0.585 . . . . 9.83 110.547 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -75.79 26.7 0.11 Allowed 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.524 0.564 . . . . 11.32 112.524 -174.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.405 ' H ' ' C ' ' A' ' 67' ' ' SER . 38.5 t 21.58 96.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.959 1.304 . . . . 6.11 113.632 178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.3 t -88.55 154.32 20.44 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.777 -0.647 . . . . 6.12 110.22 -177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.5 mmmt -96.64 123.58 40.37 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 116.001 -0.545 . . . . 6.3 109.877 176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.507 HD12 ' HB2' ' A' ' 50' ' ' PRO . 63.8 mt -47.25 111.09 0.1 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.371 0 O-C-N 124.0 0.812 . . . . 5.77 111.386 -175.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.95 146.78 49.69 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.26 -0.882 . . . . 5.69 110.113 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.19 109.41 0.54 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.45 2.1 . . . . 6.86 111.674 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -81.66 -154.21 0.11 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.171 0.51 . . . . 8.49 110.819 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.436 HG12 ' HB1' ' A' ' 144' ' ' ALA . 3.9 t -59.56 135.04 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.642 -0.708 . . . . 6.19 110.624 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 38.9 t -77.64 103.56 4.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.117 0.484 . . . . 6.26 109.749 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.19 41.57 1.06 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.624 -0.716 . . . . 6.05 110.493 -174.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 71.1 m -156.18 33.15 0.33 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.951 -0.568 . . . . 7.02 110.853 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.468 ' HG3' ' H ' ' A' ' 145' ' ' THR . 6.1 mm-40 -83.22 62.99 6.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.228 -0.442 . . . . 7.07 110.466 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 68.81 112.72 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.192 -1.367 . . . . 6.68 111.463 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -77.71 81.95 4.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.616 0.722 . . . . 6.43 109.927 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.3 m -77.42 168.95 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.715 -0.675 . . . . 3.7 110.974 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.44 ' HB ' ' HE3' ' A' ' 138' ' ' LYS . 46.8 p -116.45 150.26 38.14 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.819 -0.628 . . . . 3.49 109.83 175.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -132.29 153.88 20.78 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.425 -0.893 . . . . 2.58 111.713 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -107.03 126.4 52.28 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.289 -0.634 . . . . 3.34 109.289 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 21.4 t -70.56 110.87 3.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.4 -0.363 . . . . 3.14 110.784 -177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 36.3 p -98.24 -13.26 20.9 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.698 0.761 . . . . 3.61 110.172 176.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' A' ' 108' ' ' ARG . 26.7 m -155.34 115.93 3.85 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.118 -0.946 . . . . 3.12 109.381 -175.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 135' ' ' ALA . 0.3 OUTLIER -104.62 148.8 26.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.068 0.461 . . . . 4.39 111.102 179.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.3 pp -93.58 131.24 39.03 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.335 -0.987 . . . . 3.62 108.335 174.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -127.72 178.84 5.87 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.408 -0.59 . . . . 7.2 109.408 -173.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -66.97 98.08 0.54 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.293 0.568 . . . . 5.1 110.327 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -88.52 -17.81 29.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.426 -0.806 . . . . 7.53 109.364 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.89 -164.65 0.24 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.06 -0.973 . . . . 7.47 110.014 178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -81.14 86.22 6.21 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.025 -0.422 . . . . 7.58 110.483 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 m120 73.94 -54.28 0.68 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.005 -0.998 . . . . 8.32 112.589 175.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -97.26 -178.9 4.33 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.644 -0.502 . . . . 7.26 109.644 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.91 141.46 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 116.522 -0.308 . . . . 5.54 110.746 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 47.2 tp -104.22 -80.59 0.53 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.193 0.521 . . . . 7.28 109.666 171.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 102' ' ' SER . 94.8 m-20 -110.96 -32.18 6.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.093 -0.958 . . . . 7.54 110.562 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 47.7 t 76.92 -34.92 0.22 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.538 -0.756 . . . . 5.41 111.125 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 p -70.09 -8.78 52.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.227 0.537 . . . . 4.58 110.611 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -61.82 -24.37 66.84 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.128 -0.942 . . . . 5.09 110.403 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 t -139.29 117.14 11.6 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.609 -0.723 . . . . 3.33 109.708 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 10.0 t -97.34 135.98 38.46 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.27 -0.423 . . . . 2.57 110.193 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.445 ' HA3' ' CE1' ' A' ' 122' ' ' TYR . . . -75.41 -177.54 41.12 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.632 -0.794 . . . . 1.66 112.048 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.617 ' HB3' ' HB ' ' A' ' 89' ' ' THR . 0.2 OUTLIER -146.27 120.85 9.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.102 0.477 . . . . 3.03 110.164 -177.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -111.56 130.38 65.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.853 -0.612 . . . . 1.88 110.209 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.7 t -105.31 124.46 49.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.032 -0.531 . . . . 3.49 109.625 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -140.84 146.83 38.07 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.388 -0.597 . . . . 3.51 109.388 175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -119.38 112.0 18.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.152 0.501 . . . . 5.1 110.802 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.71 121.89 46.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.568 -0.742 . . . . 4.78 109.936 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 60.57 23.82 13.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.502 -0.772 . . . . 6.97 111.06 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.25 -2.01 65.18 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.911 -0.661 . . . . 5.1 113.171 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -99.84 121.71 41.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.241 0.521 . . . . 5.38 110.559 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 4.4 p -102.47 113.15 26.25 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.117 -0.492 . . . . 4.72 110.754 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -118.51 147.03 44.08 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.291 -0.413 . . . . 4.61 110.377 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -101.63 126.84 48.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.96 -0.564 . . . . 3.96 109.648 173.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.9 118.54 55.95 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.586 -0.279 . . . . 2.75 110.93 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.82 132.68 14.6 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.691 2.261 . . . . 2.3 110.712 168.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.445 ' CE1' ' HA3' ' A' ' 107' ' ' GLY . 35.0 p90 -140.95 159.78 41.48 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.932 -0.307 . . . . 2.13 110.54 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 64.7 p -121.02 -175.62 3.09 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.012 -0.54 . . . . 3.07 110.009 174.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -62.89 -30.13 71.29 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.838 0.351 . . . . 4.8 111.655 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -81.01 -9.38 59.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.07 -0.514 . . . . 4.81 111.202 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -91.17 -12.44 35.42 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.28 0.562 . . . . 3.84 110.309 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 48.2 t -85.81 126.82 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.002 -0.545 . . . . 4.39 110.152 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -80.92 127.93 33.1 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.229 -0.441 . . . . 6.43 109.973 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 81.24 -0.23 87.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.808 -0.711 . . . . 5.91 112.838 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 15.0 m120 59.6 35.98 22.62 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.139 0.495 . . . . 6.07 111.087 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -73.87 137.19 23.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.145 -0.479 . . . . 5.27 111.249 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -80.74 112.62 18.29 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.694 -0.484 . . . . 5.78 109.694 176.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.68 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -102.9 150.9 23.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.055 -0.52 . . . . 3.62 111.536 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 18.4 tpp180 -115.46 135.57 53.97 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.689 -0.687 . . . . 6.93 110.044 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.597 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -60.91 114.39 3.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.258 0.551 . . . . 4.12 110.815 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.06 -3.92 14.11 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.517 -0.765 . . . . 4.07 112.874 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.497 ' HB2' ' HA ' ' A' ' 161' ' ' PRO . 16.5 p30 -90.78 -177.35 4.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 117.442 0.621 . . . . 4.06 110.18 173.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.44 ' HE3' ' HB ' ' A' ' 84' ' ' THR . 50.9 tptt -112.95 113.55 25.66 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.061 0.458 . . . . 4.17 110.874 -174.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.9 m -117.82 154.28 19.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.84 -0.618 . . . . 2.77 110.515 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.5 t -124.18 135.88 53.78 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.395 -0.594 . . . . 3.47 109.395 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.44 146.33 52.2 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.164 -0.471 . . . . 3.35 110.129 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -93.8 118.92 32.09 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.792 -0.64 . . . . 5.34 109.704 -178.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 93.8 mt -78.4 133.54 30.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.646 -0.501 . . . . 4.66 109.646 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -125.81 110.7 14.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.992 -0.549 . . . . 4.85 110.322 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.468 ' H ' ' HG3' ' A' ' 80' ' ' GLU . 20.0 m -99.01 132.09 44.57 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.962 0.411 . . . . 5.68 110.895 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 29.2 p30 -107.27 -163.8 0.93 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.845 -0.616 . . . . 6.25 110.935 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -75.71 -37.94 59.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.969 -0.559 . . . . 8.58 110.651 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -74.94 -18.42 60.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.384 -0.371 . . . . 7.86 110.794 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.98 22.78 54.4 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.839 -0.696 . . . . 5.59 111.801 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -113.96 121.53 44.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.462 0.173 . . . . 5.18 110.585 -177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.504 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -148.9 -179.32 6.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.006 0.432 . . . . 4.28 111.659 -179.486 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.23 -124.81 1.64 Allowed Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.635 -0.986 . . . . 3.36 110.635 175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -138.72 117.11 11.98 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.832 0.316 . . . . 2.84 110.378 176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 4.7 t -128.59 158.48 38.36 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.446 -0.343 . . . . 4.34 110.08 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 57.43 42.95 23.85 Favored 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.741 0.65 . . . . 5.75 110.953 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 22.3 mt -74.6 116.29 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.329 -0.85 . . . . 3.55 110.666 -178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -114.2 142.02 46.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.995 0.426 . . . . 5.96 110.901 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.1 tp -83.41 119.21 24.37 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.927 -0.578 . . . . 4.34 110.125 176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -87.64 -53.74 4.63 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.744 0.307 . . . . 4.97 110.581 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -142.92 122.94 7.89 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-O 120.918 0.389 . . . . 5.37 110.9 -177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 137' ' ' ASP . 82.3 Cg_endo -79.78 157.36 24.42 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 122.787 2.325 . . . . 5.44 112.59 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -111.32 152.97 26.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.804 -0.634 . . . . 6.1 110.696 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -104.52 161.48 22.7 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.69 -0.485 . . . . 9.49 109.69 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -51.06 108.65 0.25 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.638 2.226 . . . . 8.39 112.652 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 34.8 m . . . . . 0 C--O 1.236 0.349 0 CA-C-N 115.832 -0.622 . . . . 10.27 111.353 -179.23 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 112.087 -0.405 . . . . 21.66 112.087 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.28 149.47 33.93 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.853 0.359 . . . . 20.17 110.54 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.31 -52.61 4.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.139 -0.482 . . . . 18.5 112.007 -172.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -94.3 25.47 3.83 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.938 0.718 . . . . 16.62 112.938 -167.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -63.37 -77.4 0.05 Allowed 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.208 0.528 . . . . 18.35 111.331 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -125.76 119.58 28.31 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.519 -0.764 . . . . 16.2 109.645 -176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.445 ' HB3' ' HG2' ' A' ' 54' ' ' GLU . 15.0 ptt180 -126.62 153.09 45.78 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.251 -0.431 . . . . 12.4 110.604 -177.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.527 ' HB2' ' NH1' ' A' ' 27' ' ' ARG . 38.3 mt-10 -130.91 155.67 46.37 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.031 -0.531 . . . . 11.63 109.633 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 p -87.48 169.57 12.1 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.178 -0.465 . . . . 9.15 110.291 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.23 162.97 34.68 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.55 -0.833 . . . . 6.81 111.999 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -117.64 137.0 53.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.407 -0.59 . . . . 10.17 109.407 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.75 110.46 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.149 0.5 . . . . 8.73 110.471 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 -72.09 -50.53 27.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.77 -0.65 . . . . 10.86 110.37 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.547 ' HA ' HD12 ' A' ' 47' ' ' ILE . 38.1 ttpt -161.04 155.17 22.79 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.899 -1.046 . . . . 14.06 109.098 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 mt -116.15 126.76 54.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.156 0.503 . . . . 11.73 111.183 -175.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.4 mp -114.57 -179.89 3.76 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.649 -1.241 . . . . 11.36 107.649 173.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -90.62 126.64 36.02 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.182 -0.607 . . . . 15.94 110.27 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 m 80.56 -14.58 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.605 1.191 . . . . 13.01 111.995 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 12.5 p90 -159.59 162.31 35.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.764 0.316 . . . . 12.34 111.389 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -155.24 -176.78 27.82 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.085 -0.579 . . . . 7.52 112.054 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -115.94 143.92 44.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.823 0.344 . . . . 9.24 111.475 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.9 mt -113.79 120.19 62.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.856 -0.611 . . . . 7.75 110.075 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -69.48 147.04 51.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.476 0.655 . . . . 11.8 111.809 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.404 ' HA ' ' HG3' ' A' ' 27' ' ' ARG . 3.2 p -79.89 0.57 30.67 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.842 -1.072 . . . . 12.34 112.299 -177.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.5 m -53.24 -31.32 42.83 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.662 0.616 . . . . 13.33 112.662 -175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -105.53 11.27 32.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.712 0.291 . . . . 11.9 111.431 -176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.527 ' NH1' ' HB2' ' A' ' 8' ' ' GLU . 7.5 ptm85 -153.95 -170.24 3.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.524 0.202 . . . . 12.99 111.326 -173.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -112.14 17.81 19.22 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.15 0.426 . . . . 16.66 112.15 -176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.81 149.17 17.96 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.524 -0.307 . . . . 12.09 110.885 -179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -92.86 135.69 33.91 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.177 -0.675 . . . . 12.51 109.177 177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.1 mt -135.82 163.23 30.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.355 0.597 . . . . 8.76 111.904 -174.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -124.08 149.2 46.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.447 -0.946 . . . . 9.15 108.447 172.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -135.36 152.15 51.17 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.941 -0.304 . . . . 6.85 110.248 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 32.4 p-80 -109.71 152.4 25.67 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.689 -0.485 . . . . 9.99 109.689 175.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.7 m-30 -70.2 4.52 2.15 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 113.252 0.834 . . . . 9.93 113.252 -168.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.4 t -77.78 -17.78 57.14 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.725 -0.472 . . . . 12.28 109.725 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -116.66 40.46 2.92 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.863 -0.608 . . . . 10.62 112.114 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -126.59 124.91 41.04 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.203 -0.599 . . . . 8.78 111.331 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.6 m -101.92 106.68 17.66 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.662 -0.699 . . . . 8.97 110.707 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.57 176.08 19.2 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.722 -0.751 . . . . 9.98 112.023 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -68.67 109.65 3.9 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.703 -0.481 . . . . 12.43 109.703 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.2 tp -63.68 -25.05 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.166 0.508 . . . . 11.58 110.8 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.39 -23.19 62.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.126 -0.488 . . . . 14.73 110.745 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -93.42 2.96 56.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.918 -0.583 . . . . 13.3 110.949 -178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.441 HD12 ' OD1' ' A' ' 49' ' ' ASP . 26.3 tp -94.43 117.03 29.5 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.698 -0.853 . . . . 10.07 108.698 176.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.7 mmtt -119.19 -173.9 2.6 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.523 -0.308 . . . . 13.13 110.849 -173.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 14' ' ' LYS . 24.6 mm -87.55 133.03 31.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.76 -0.459 . . . . 11.74 109.76 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.73 10.85 82.62 Favored Glycine 0 CA--C 1.51 -0.235 0 N-CA-C 110.922 -0.871 . . . . 10.13 110.922 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.441 ' OD1' HD12 ' A' ' 45' ' ' LEU . 43.4 t0 -92.97 121.73 65.16 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.838 -0.681 . . . . 8.39 109.906 -177.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -78.62 143.21 18.79 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 123.102 2.535 . . . . 7.28 114.058 -175.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.0 m -138.75 160.71 30.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.667 -0.697 . . . . 4.74 110.413 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -117.74 130.53 56.37 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.807 -0.442 . . . . 7.09 109.807 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -142.35 155.57 45.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.443 0.639 . . . . 7.82 111.245 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 67' ' ' SER . 21.1 mt-10 -104.53 131.53 51.82 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.46 -0.791 . . . . 11.59 109.075 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.7 ttt -103.87 123.11 46.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.557 -0.292 . . . . 12.41 110.944 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.0 p -141.97 169.76 16.99 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.923 0.392 . . . . 13.17 111.124 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.495 ' CE1' ' HB3' ' A' ' 64' ' ' PRO . 53.1 m-85 -116.9 120.7 39.26 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.564 -0.532 . . . . 16.21 109.564 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.53 ' OD2' HG22 ' A' ' 61' ' ' THR . 21.4 t70 -81.99 121.43 26.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.724 0.297 . . . . 16.64 110.38 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -79.86 -6.97 58.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 22.64 112.267 -176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.7 ttt-85 -84.04 -57.66 3.09 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.601 0.238 . . . . 21.43 110.702 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.599 HG23 ' HG2' ' A' ' 63' ' ' LYS . 8.8 t -91.62 -19.26 22.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.116 0.484 . . . . 17.4 110.774 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.86 34.16 22.39 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.457 -0.878 . . . . 16.7 113.365 172.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.599 ' HG2' HG23 ' A' ' 61' ' ' THR . 19.2 ptpt -124.74 150.05 64.36 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 117.485 0.643 . . . . 14.73 110.963 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.495 ' HB3' ' CE1' ' A' ' 57' ' ' TYR . 58.4 Cg_endo -73.43 126.66 11.14 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.398 2.065 . . . . 12.6 110.913 170.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.29 -179.83 2.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.286 0.565 . . . . 11.73 111.252 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.0 162.96 19.03 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.445 -0.798 . . . . 8.91 109.842 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.469 ' HB2' ' HB2' ' A' ' 54' ' ' GLU . 30.4 t -72.87 -164.03 0.15 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.706 -0.679 . . . . 9.83 109.576 175.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -74.11 17.34 0.18 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.833 0.679 . . . . 11.32 112.833 -173.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.2 t 37.88 93.14 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.149 0.98 . . . . 6.11 112.602 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.2 t -82.13 123.06 28.63 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 109.354 -0.609 . . . . 6.12 109.354 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -73.76 121.65 21.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.329 -0.619 . . . . 6.3 109.329 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.4 mt -58.12 117.89 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.481 -0.781 . . . . 5.77 111.639 -174.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.93 147.69 66.91 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.79 -0.641 . . . . 5.69 110.464 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.99 123.27 7.76 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.429 2.086 . . . . 6.86 112.297 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' CD ' ' H ' ' A' ' 75' ' ' GLU . 1.1 pm0 -86.6 110.95 20.17 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.48 0.657 . . . . 8.49 111.051 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.435 HG12 ' HB1' ' A' ' 144' ' ' ALA . 19.5 t -90.05 144.38 9.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.438 -0.801 . . . . 6.19 109.448 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.667 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 26.6 t -78.65 83.87 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.062 0.458 . . . . 6.26 110.541 -178.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.584 HD12 ' HB2' ' A' ' 144' ' ' ALA . 3.6 tp -82.74 17.26 1.9 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.694 -0.684 . . . . 6.05 110.61 -177.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 14.4 m -133.69 36.93 3.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.506 0.558 . . . . 7.02 112.506 -170.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.14 -51.17 11.45 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 120.373 -0.531 . . . . 7.07 110.334 177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -167.43 139.5 3.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 6.68 110.032 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.483 ' HD3' ' C ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -96.1 114.46 26.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.545 -0.539 . . . . 6.43 109.545 179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.88 171.0 12.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.694 -0.684 . . . . 3.7 110.112 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.9 p -108.4 148.44 30.13 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.333 -0.618 . . . . 3.49 109.333 174.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -114.04 137.41 14.07 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.429 -0.891 . . . . 2.58 112.311 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -120.0 112.1 18.74 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.115 -0.698 . . . . 3.34 109.115 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.672 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 59.1 t -66.83 127.63 28.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.161 -0.472 . . . . 3.14 110.483 -178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 23.1 p -109.07 -20.0 13.17 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.135 0.493 . . . . 3.61 111.092 178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 26.7 m -148.98 124.99 10.66 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.462 -0.57 . . . . 3.12 109.462 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.86 -179.1 7.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.033 0.444 . . . . 4.39 110.869 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 29.0 mt -65.56 124.9 23.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.824 -0.626 . . . . 3.62 109.506 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -68.05 121.45 16.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.995 0.426 . . . . 7.2 111.078 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.463 HG22 ' CG2' ' A' ' 99' ' ' VAL . 40.5 p -76.72 97.25 4.42 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.068 0.461 . . . . 5.1 110.067 172.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -92.14 8.75 36.49 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 122.502 1.144 . . . . 7.53 108.317 177.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 30.5 t -124.85 142.56 51.36 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 113.476 -1.693 . . . . 7.47 107.788 172.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.49 85.57 0.43 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.68 0.276 . . . . 7.58 111.565 -175.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.6 t30 74.94 -29.13 0.19 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.691 0.796 . . . . 8.32 112.33 172.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.439 ' ND2' HD22 ' A' ' 100' ' ' LEU . 63.7 t30 -66.64 -42.85 86.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.402 -0.222 . . . . 7.26 110.402 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.463 ' CG2' HG22 ' A' ' 93' ' ' THR . 5.0 p 50.5 26.56 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.025 0.93 . . . . 5.54 113.12 169.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.439 HD22 ' ND2' ' A' ' 98' ' ' ASN . 2.2 pt? -75.05 -2.81 29.09 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.16 0.8 . . . . 7.28 113.16 -172.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -125.35 32.38 5.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.098 0.475 . . . . 7.54 111.063 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.4 p -90.42 27.93 1.58 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.131 -0.486 . . . . 5.41 110.876 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.6 m -73.36 -34.99 65.88 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.145 -0.48 . . . . 4.58 111.36 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.32 -31.87 12.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 5.09 111.933 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -68.38 127.2 32.12 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.395 0.617 . . . . 3.33 110.055 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 56.9 p -98.56 137.2 37.56 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.435 -0.802 . . . . 2.57 111.537 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -86.39 -169.06 45.54 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.059 -0.816 . . . . 1.66 111.059 173.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -128.3 120.81 27.84 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.982 0.42 . . . . 3.03 111.226 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.437 HG12 HG22 ' A' ' 87' ' ' VAL . 80.0 mt -110.95 125.09 68.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.599 -0.728 . . . . 1.88 109.341 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.7 t -104.25 142.1 35.13 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 120.984 0.421 . . . . 3.49 110.681 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -147.44 165.58 29.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.456 -0.942 . . . . 3.51 108.456 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.96 125.21 27.74 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.386 -0.598 . . . . 5.1 109.386 -179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -135.27 107.75 7.36 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 4.78 110.938 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 62.64 28.66 16.71 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.749 -0.66 . . . . 6.97 111.906 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.34 -1.57 62.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.162 -0.542 . . . . 5.1 112.996 179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 118' ' ' PHE . 42.3 mt-10 -104.65 110.81 23.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.1 0.476 . . . . 5.38 110.365 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 45.5 t -112.39 127.44 56.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.883 -0.599 . . . . 4.72 109.872 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 116' ' ' GLU . 73.3 m-85 -135.37 166.95 21.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.87 0.367 . . . . 4.61 111.013 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -110.26 123.96 50.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.562 -0.744 . . . . 3.96 109.593 173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 8.4 mp -104.48 132.88 20.54 Favored Pre-proline 0 C--N 1.322 -0.607 0 C-N-CA 121.069 -0.252 . . . . 2.75 110.492 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 2.8 Cg_exo -75.37 133.16 15.73 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.741 2.294 . . . . 2.3 111.664 176.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.436 ' CD1' HG13 ' A' ' 109' ' ' ILE . 17.6 p90 -135.16 144.81 47.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.679 -0.237 . . . . 2.13 110.483 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.4 p -109.18 -177.62 3.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.109 -0.33 . . . . 3.07 110.109 174.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -70.6 -22.4 62.55 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.236 0.541 . . . . 4.8 110.725 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -77.25 -25.93 52.03 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.488 -0.778 . . . . 4.81 110.975 -177.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 153' ' ' ALA . 21.7 m-20 -74.26 -30.55 62.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.027 -0.533 . . . . 3.84 111.795 -175.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 156' ' ' ILE . 2.5 p -84.59 118.63 32.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.651 0.739 . . . . 4.39 111.052 -179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -89.92 136.22 33.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.347 -0.842 . . . . 6.43 109.769 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.34 -19.85 38.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.772 -0.728 . . . . 5.91 111.848 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 60.09 71.01 0.59 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.383 0.611 . . . . 6.07 110.904 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.0 t -108.12 149.43 11.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.117 -0.492 . . . . 5.27 110.122 -178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -91.7 102.03 14.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.002 0.43 . . . . 5.78 110.155 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.609 HD23 ' H ' ' A' ' 133' ' ' LEU . 1.8 pt? -114.97 143.44 45.16 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.593 -0.731 . . . . 3.62 110.267 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -117.62 -179.99 3.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.038 -0.528 . . . . 6.93 109.913 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.672 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.81 132.46 42.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.314 -0.403 . . . . 4.12 110.47 177.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 104.95 -14.44 48.95 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.068 -0.587 . . . . 4.07 112.444 -177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.517 ' OD2' ' HB3' ' A' ' 162' ' ' ALA . 54.3 m-20 -84.77 146.45 27.37 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.466 -0.568 . . . . 4.06 109.466 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -93.5 116.47 29.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.588 0.709 . . . . 4.17 111.778 -176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.412 HG11 HD13 ' A' ' 133' ' ' LEU . 33.1 m -120.22 166.31 14.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.974 -1.012 . . . . 2.77 110.311 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.604 ' HB3' ' OE1' ' A' ' 159' ' ' GLU . 21.0 p -118.96 133.27 55.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.755 -0.461 . . . . 3.47 109.755 174.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -135.12 142.52 46.23 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.774 -0.454 . . . . 3.35 109.774 177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' A' ' 142' ' ' GLN . 12.3 mm-40 -98.26 129.33 44.98 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.838 -0.619 . . . . 5.34 110.057 176.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 67.7 mt -78.41 98.62 2.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.067 -0.716 . . . . 4.66 109.067 177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.667 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -102.72 110.07 21.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.148 -0.933 . . . . 4.85 111.599 -174.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.45 122.35 26.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.93 -0.577 . . . . 5.68 110.459 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.1 p30 -86.38 -172.42 4.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.057 0.456 . . . . 6.25 110.803 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -83.54 6.54 20.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.957 -0.565 . . . . 8.58 111.574 -172.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.0 mmt180 -115.28 1.66 13.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.353 -0.385 . . . . 7.86 110.935 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.79 20.75 70.2 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.768 -0.73 . . . . 5.59 113.294 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -123.99 154.97 39.05 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.127 -0.694 . . . . 5.18 109.127 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.484 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -156.07 176.43 12.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.225 0.536 . . . . 4.28 111.822 -178.135 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -149.59 -138.9 3.0 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 110.351 -1.1 . . . . 3.36 110.351 174.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 126' ' ' ASP . . . -121.97 109.0 14.06 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.582 -0.525 . . . . 2.84 109.582 175.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 68.5 m -126.17 162.7 24.78 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.505 -0.316 . . . . 4.34 110.535 -175.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 60.53 33.81 20.45 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.552 0.691 . . . . 5.75 110.043 -176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.501 ' O ' HG23 ' A' ' 127' ' ' VAL . 70.8 mt -59.84 123.33 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 114.7 -1.136 . . . . 3.55 110.95 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -124.13 127.55 47.95 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.9 0.381 . . . . 5.96 110.606 177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.2 tp -73.46 96.72 2.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.779 -0.646 . . . . 4.34 109.692 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.604 ' OE1' ' HB3' ' A' ' 140' ' ' SER . 6.6 pt-20 -76.86 -35.68 57.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.06 -0.518 . . . . 4.97 110.916 -176.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -137.56 102.26 8.76 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.499 -0.319 . . . . 5.37 110.699 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -73.23 151.71 49.31 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.523 2.149 . . . . 5.44 112.223 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.517 ' HB3' ' OD2' ' A' ' 137' ' ' ASP . . . -107.97 90.12 3.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.462 0.649 . . . . 6.1 110.549 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -102.12 146.52 32.45 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.42 -0.809 . . . . 9.49 109.903 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.84 107.57 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.472 2.115 . . . . 8.39 112.328 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.3 t . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.969 -0.56 . . . . 10.27 110.333 179.622 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.42 0 N-CA-C 112.21 -0.356 . . . . 21.66 112.21 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.57 11.74 12.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.169 0.509 . . . . 20.17 110.726 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -67.39 -39.18 85.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.766 . . . . 18.5 111.125 -178.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -78.39 63.53 3.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.519 . . . . 16.62 110.532 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -117.36 -59.58 1.92 Allowed 'General case' 0 N--CA 1.441 -0.897 0 CA-C-O 121.02 0.438 . . . . 18.35 110.705 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 3.8 mp0 -73.46 79.0 1.41 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.544 -0.753 . . . . 16.2 112.13 -178.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.404 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 10.6 ptp180 -106.99 115.86 30.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.344 0.592 . . . . 12.4 109.798 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.37 156.23 21.9 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.551 -0.75 . . . . 11.63 110.652 -173.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.1 p -110.52 136.75 49.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.414 -0.357 . . . . 9.15 111.007 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -147.96 178.21 25.71 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.761 -0.733 . . . . 6.81 111.909 179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.413 HD12 ' HB3' ' A' ' 25' ' ' CYS . 52.9 mt -124.56 143.65 37.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.842 0.321 . . . . 10.17 110.249 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.3 mm -73.58 106.59 3.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.438 -0.579 . . . . 8.73 109.438 174.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -73.41 -43.92 59.44 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.966 0.412 . . . . 10.86 110.504 -177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -155.75 162.59 40.5 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.005 -0.543 . . . . 14.06 109.563 -176.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 mt -119.82 118.63 31.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.171 0.51 . . . . 11.73 111.071 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 83.1 mt -111.82 179.99 3.86 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.328 -0.99 . . . . 11.36 108.328 174.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -90.2 117.31 28.86 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.749 -0.781 . . . . 15.94 110.151 -174.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 68.6 m 78.71 -7.55 1.77 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.06 -0.973 . . . . 13.01 112.442 178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.69 168.57 26.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.718 0.294 . . . . 12.34 110.886 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.68 -166.61 22.82 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.187 -0.53 . . . . 7.52 112.068 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -125.99 139.51 53.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.7 0.286 . . . . 9.24 110.945 -178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.0 mt -101.77 120.36 51.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.961 -0.563 . . . . 7.75 109.574 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -75.92 143.02 41.9 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.559 -0.746 . . . . 11.8 110.993 -175.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 13.0 p -79.14 3.1 18.64 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 115.353 -0.839 . . . . 12.34 112.631 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.413 ' HB3' HD12 ' A' ' 11' ' ' ILE . 44.0 t -51.43 -51.26 56.33 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.506 0.558 . . . . 13.33 112.506 -173.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -90.46 16.94 7.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.289 0.566 . . . . 11.9 111.01 -177.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.567 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 38.6 ttt180 -144.83 -158.63 0.91 Allowed 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.041 -1.096 . . . . 12.99 108.041 -178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.567 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 13.4 mm-40 -136.22 23.58 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.189 0.518 . . . . 16.66 110.413 167.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' O ' ' HD3' ' A' ' 27' ' ' ARG . . . -151.8 119.53 6.12 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.664 -0.698 . . . . 12.09 110.633 178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -86.63 151.71 23.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.147 -0.479 . . . . 12.51 110.112 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.507 HD11 ' SD ' ' A' ' 55' ' ' MET . 59.6 mt -141.77 162.17 36.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 8.76 111.423 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -103.6 143.41 32.79 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.664 -0.865 . . . . 9.15 108.664 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -137.93 147.62 44.51 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.269 -0.572 . . . . 6.85 110.179 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -103.41 155.11 18.73 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.368 -0.604 . . . . 9.99 109.368 176.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -67.25 -13.27 61.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.697 0.284 . . . . 9.93 111.37 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.1 p -70.78 -24.17 62.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.227 0.537 . . . . 12.28 110.148 174.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -94.1 20.53 7.83 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.642 -0.708 . . . . 10.62 110.995 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -125.03 123.17 39.24 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.932 0.396 . . . . 8.78 110.705 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 68' ' ' GLN . 13.3 t -111.51 100.8 9.29 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.72 -0.673 . . . . 8.97 110.218 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.77 -169.78 36.53 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.968 -0.634 . . . . 9.98 111.915 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -83.89 103.68 13.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.808 0.337 . . . . 12.43 110.323 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.9 tp -67.62 -24.18 30.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.943 -0.571 . . . . 11.58 110.918 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -69.79 -12.78 61.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.955 -0.566 . . . . 14.73 111.023 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -104.25 4.5 33.86 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.186 -0.461 . . . . 13.3 110.202 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.9 tp -103.79 110.14 22.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.485 . . . . 10.07 110.701 -177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -114.11 -178.87 3.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.221 0.534 . . . . 13.13 110.935 174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.3 mp -73.08 140.19 18.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.601 -0.727 . . . . 11.74 110.208 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.84 -2.19 66.37 Favored Glycine 0 C--O 1.229 -0.194 0 C-N-CA 121.013 -0.613 . . . . 10.13 112.378 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -91.71 127.98 48.03 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 120.58 0.229 . . . . 8.39 110.608 -178.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.76 141.7 13.73 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.194 2.596 . . . . 7.28 113.632 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.412 HG12 ' HE3' ' A' ' 71' ' ' LYS . 23.7 m -128.57 157.93 40.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.799 -0.637 . . . . 4.74 111.186 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -113.17 124.06 51.67 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.997 -0.742 . . . . 7.09 108.997 176.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -136.87 142.13 42.78 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.286 0.565 . . . . 7.82 111.614 -174.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.538 ' CD ' ' HB2' ' A' ' 67' ' ' SER . 0.2 OUTLIER -88.88 141.29 28.62 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.009 -0.737 . . . . 11.59 109.009 173.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.507 ' SD ' HD11 ' A' ' 31' ' ' LEU . 24.5 ttt -124.0 114.01 19.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.35 -0.241 . . . . 12.41 110.35 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.5 p -134.99 164.67 27.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.153 0.501 . . . . 13.17 111.425 -177.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -95.31 113.4 25.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.025 -0.534 . . . . 16.21 110.083 178.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -75.97 124.08 26.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.032 0.444 . . . . 16.64 110.469 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -79.72 -8.87 59.51 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.684 -0.689 . . . . 22.64 111.266 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -81.0 -56.87 3.82 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 21.43 110.357 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.5 p -86.65 -45.84 10.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.169 -0.469 . . . . 17.4 111.645 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.0 0.22 35.85 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.626 -0.797 . . . . 16.7 112.322 -178.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -95.87 150.78 37.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.152 -0.314 . . . . 14.73 110.152 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.15 125.29 8.45 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 121.953 1.769 . . . . 12.6 109.502 171.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -126.94 162.4 31.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 121.04 0.447 . . . . 11.73 111.362 -173.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.54 151.62 20.44 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.405 -0.816 . . . . 8.91 109.284 174.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.538 ' HB2' ' CD ' ' A' ' 54' ' ' GLU . 11.8 t -75.88 -157.22 0.07 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.041 -0.527 . . . . 9.83 109.79 177.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.405 ' HB3' ' HB2' ' A' ' 39' ' ' SER . 23.6 mp0 -75.12 19.23 0.16 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.838 0.681 . . . . 11.32 112.838 -173.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.0 t 33.83 94.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.537 1.135 . . . . 6.11 113.108 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.8 m -80.36 120.73 24.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.461 0.648 . . . . 6.12 110.358 -178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.686 ' HE2' ' N ' ' A' ' 72' ' ' ILE . 0.0 OUTLIER -68.1 113.48 5.8 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.664 -0.698 . . . . 6.3 110.537 -179.038 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.686 ' N ' ' HE2' ' A' ' 71' ' ' LYS . 79.5 mt -56.63 106.22 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.175 -0.466 . . . . 5.77 110.328 173.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -171.91 163.79 4.44 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.067 -0.716 . . . . 5.69 109.067 -177.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -53.67 135.78 63.08 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.143 1.895 . . . . 6.86 111.866 173.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -75.29 -167.35 0.63 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.058 -0.519 . . . . 8.49 111.017 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.12 141.01 4.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.885 -0.598 . . . . 6.19 110.93 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 38.4 t -67.7 89.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 6.26 110.962 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.492 ' HA ' ' HA ' ' A' ' 144' ' ' ALA . 4.1 tt -91.18 -27.95 18.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 6.05 110.781 -178.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.9 t -116.37 99.86 7.49 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.071 -0.513 . . . . 7.02 110.68 -175.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -125.21 -68.15 0.86 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.514 -0.767 . . . . 7.07 109.017 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -130.69 127.88 39.75 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.181 -0.674 . . . . 6.68 109.181 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.457 ' H ' ' CD ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -82.98 126.39 32.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.964 0.411 . . . . 6.43 110.151 -177.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.39 167.4 13.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.093 -0.503 . . . . 3.7 111.117 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 17.7 p -120.75 146.23 46.71 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.809 -0.632 . . . . 3.49 110.327 175.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -140.39 162.61 26.5 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.6 -0.81 . . . . 2.58 112.382 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 27.5 m -106.61 135.24 48.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.826 -0.435 . . . . 3.34 109.826 178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 1.1 t -68.98 121.56 18.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.863 -0.421 . . . . 3.14 109.863 178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.33 -27.82 16.56 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.146 0.498 . . . . 3.61 110.227 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.5 m -155.29 138.01 15.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.003 -0.544 . . . . 3.12 110.407 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -99.85 -171.8 2.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.339 0.59 . . . . 4.39 111.568 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 91' ' ' LEU . 2.5 mm? -83.79 136.89 33.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.95 -1.023 . . . . 3.62 109.22 174.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -73.69 141.44 46.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.155 0.502 . . . . 7.2 111.213 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.07 30.97 0.56 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.387 -0.824 . . . . 5.1 111.057 178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.22 83.92 0.09 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.599 -0.728 . . . . 7.53 111.699 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.5 m -163.08 -173.08 3.27 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.053 -0.976 . . . . 7.47 109.173 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -90.33 -89.54 0.16 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.857 0.317 . . . . 7.58 111.857 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -99.12 -6.98 27.35 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.81 0.338 . . . . 8.32 111.474 -175.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -131.52 -167.68 1.9 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.28 -1.007 . . . . 7.26 108.28 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.85 166.94 3.97 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 110.022 -0.362 . . . . 5.54 110.022 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.6 tp -92.3 88.66 6.53 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 121.999 0.904 . . . . 7.28 108.633 176.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.417 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . 49.4 t30 -63.42 -25.54 68.33 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.901 -1.5 . . . . 7.54 111.409 -175.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.8 t -76.81 102.74 6.41 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.713 -0.847 . . . . 5.41 108.713 172.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m -75.77 86.27 2.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.158 -0.474 . . . . 4.58 111.819 -172.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 -20.59 28.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.339 0.59 . . . . 5.09 109.634 172.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.3 t -99.0 158.66 15.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.38 -0.827 . . . . 3.33 109.968 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.6 t -130.52 143.67 50.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.914 0.388 . . . . 2.57 110.3 -177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -92.74 -168.34 39.58 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.727 -0.749 . . . . 1.66 111.881 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.52 ' NH2' ' HB3' ' A' ' 121' ' ' PRO . 1.1 mmp_? -136.29 130.33 32.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.844 0.354 . . . . 3.03 110.746 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.6 mt -112.53 126.99 69.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.228 -0.656 . . . . 1.88 109.228 171.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.1 p -108.18 123.19 48.37 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.439 -0.346 . . . . 3.49 110.608 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -136.36 156.9 47.98 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.763 -0.458 . . . . 3.51 109.763 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.608 ' HA ' ' O ' ' A' ' 116' ' ' GLU . 3.5 tm-20 -132.35 120.86 22.64 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.339 -0.615 . . . . 5.1 109.339 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.773 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 8.6 t30 -130.74 106.48 8.49 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.199 -0.455 . . . . 4.78 110.724 -178.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 57.94 38.19 26.9 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.024 -0.535 . . . . 6.97 111.64 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.59 -5.67 64.72 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.983 -0.627 . . . . 5.1 114.091 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.773 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 11.7 pt-20 -95.01 124.6 39.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 118.071 0.935 . . . . 5.38 109.733 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 44.1 t -124.24 104.46 8.83 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.518 -0.549 . . . . 4.72 109.518 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.23 152.71 32.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.853 -0.612 . . . . 4.61 110.979 -177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -102.65 117.55 34.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.776 -0.824 . . . . 3.96 108.776 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.19 127.64 29.31 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.817 0.341 . . . . 2.75 110.622 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.52 ' HB3' ' NH2' ' A' ' 108' ' ' ARG . 58.7 Cg_endo -76.18 135.88 17.46 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.547 2.165 . . . . 2.3 111.906 175.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -148.73 159.95 43.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.996 -0.742 . . . . 2.13 108.996 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.7 p -116.45 171.9 7.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.921 0.391 . . . . 3.07 110.294 175.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 101' ' ' ASN . 17.1 ttpp -63.93 -21.98 66.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.443 0.64 . . . . 4.8 110.484 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.4 -4.11 58.16 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.606 -0.724 . . . . 4.81 111.88 -176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -90.76 -9.54 46.24 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.712 0.291 . . . . 3.84 111.417 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 p -102.73 133.02 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.218 0.532 . . . . 4.39 111.335 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -94.45 144.86 25.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.948 -0.569 . . . . 6.43 110.24 -178.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.33 -14.12 23.22 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.908 -0.663 . . . . 5.91 112.998 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 62.3 t30 53.89 50.86 15.92 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.653 0.74 . . . . 6.07 110.139 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.83 156.48 16.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.515 -0.766 . . . . 5.27 110.424 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -84.84 120.72 26.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.814 0.34 . . . . 5.78 111.632 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.42 136.72 44.45 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.69 -0.855 . . . . 3.62 108.69 173.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -142.62 157.5 44.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.741 -0.384 . . . . 6.93 110.561 177.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.543 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -58.66 120.28 8.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.869 0.366 . . . . 4.12 111.121 -177.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.27 -17.4 10.51 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.668 -0.777 . . . . 4.07 113.487 178.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -92.45 175.47 6.82 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.017 0.908 . . . . 4.06 109.967 174.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.6 tptm -119.15 118.81 32.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.353 0.597 . . . . 4.17 111.17 -171.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.2 m -117.18 160.79 16.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.586 -0.734 . . . . 2.77 111.339 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.3 t -117.14 131.74 56.82 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.051 -0.722 . . . . 3.47 109.051 175.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -134.31 155.42 50.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.823 0.344 . . . . 3.35 110.46 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -109.15 140.86 42.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.032 0.444 . . . . 5.34 110.292 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 36.6 mt -110.72 110.1 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.896 -0.593 . . . . 4.66 110.589 -174.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -87.39 107.17 18.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.033 0.444 . . . . 4.85 111.083 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 28.3 m -96.26 117.02 29.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.699 -0.682 . . . . 5.68 111.777 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -85.97 164.21 17.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.423 -0.584 . . . . 6.25 109.423 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -57.47 -27.95 62.93 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 122.698 0.399 . . . . 8.58 111.191 -178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -71.14 -13.53 61.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.08 -0.509 . . . . 7.86 111.704 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.65 22.3 62.27 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.689 -0.767 . . . . 5.59 111.967 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -105.47 124.06 48.93 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.832 -0.433 . . . . 5.18 109.832 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.477 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -151.43 168.87 23.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.963 0.411 . . . . 4.28 112.065 -177.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.78 -168.27 16.57 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.763 -0.935 . . . . 3.36 110.763 178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -102.31 116.73 33.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.122 0.461 . . . . 2.84 110.852 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 7.3 t -140.46 158.5 43.92 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.519 -0.549 . . . . 4.34 109.519 178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 58.2 65.72 1.23 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.294 0.569 . . . . 5.75 110.554 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.3 mp -89.16 138.5 19.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.432 -0.804 . . . . 3.55 110.53 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -126.09 129.36 48.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.872 -0.604 . . . . 5.96 110.278 176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 161' ' ' PRO . 55.6 tp -82.69 110.98 18.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.982 -0.377 . . . . 4.34 109.982 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -92.07 -48.25 6.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.04 -0.527 . . . . 4.97 111.261 -176.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -128.19 100.13 23.83 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-O 120.806 0.336 . . . . 5.37 110.945 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.468 ' HB3' HD21 ' A' ' 158' ' ' LEU . 69.0 Cg_endo -87.2 151.28 8.08 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.013 2.475 . . . . 5.44 111.913 176.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -88.21 97.94 11.29 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.964 0.411 . . . . 6.1 110.474 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -129.52 143.56 49.42 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.883 -0.599 . . . . 9.49 111.221 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -87.94 155.18 7.22 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.791 2.327 . . . . 8.39 112.445 174.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 52.1 t . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 116.058 -0.519 . . . . 10.27 110.664 -178.687 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 112.27 -0.332 . . . . 21.66 112.27 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.96 83.35 1.27 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.823 -0.436 . . . . 20.17 109.823 -178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -113.0 -52.15 2.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.679 -0.691 . . . . 18.5 111.218 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -98.16 80.83 2.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.991 0.901 . . . . 16.62 110.938 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -121.2 -18.24 7.47 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.641 -1.163 . . . . 18.35 109.835 175.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -106.68 109.68 21.65 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.88 -1.054 . . . . 16.2 110.322 -174.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -103.73 148.75 25.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.278 -0.638 . . . . 12.4 109.278 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.644 ' HG3' ' CE2' ' A' ' 53' ' ' PHE . 5.9 pt-20 -156.82 148.93 22.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.667 0.746 . . . . 11.63 112.293 -178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 26' ' ' GLU . 11.8 p -116.67 162.15 18.1 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.226 -0.897 . . . . 9.15 110.968 -178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.56 -176.21 36.1 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.155 -0.545 . . . . 6.81 111.992 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.2 mt -121.35 142.53 37.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.156 -0.683 . . . . 10.17 109.156 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.3 mm -65.87 117.99 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 117.843 0.292 . . . . 8.73 110.223 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -84.21 -49.73 8.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.76 -0.655 . . . . 10.86 110.427 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -151.47 145.9 25.54 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.376 -0.829 . . . . 14.06 110.324 -177.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.6 mt -117.58 110.51 18.01 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.218 0.532 . . . . 11.73 110.842 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.2 mt -108.35 -177.82 3.43 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.085 -0.961 . . . . 11.36 108.727 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.2 m80 -87.28 122.3 30.87 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 120.246 -0.582 . . . . 15.94 109.874 -174.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.2 m 83.1 -20.31 0.34 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 124.671 1.232 . . . . 13.01 112.102 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 32.3 p90 -147.19 143.51 28.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.028 0.442 . . . . 12.34 111.678 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.2 164.63 22.15 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.69 -0.686 . . . . 7.52 111.632 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -117.5 145.34 44.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.012 0.434 . . . . 9.24 111.369 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.3 mt -111.49 132.86 58.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.496 -0.775 . . . . 7.75 110.287 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.96 145.88 37.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.505 0.669 . . . . 11.8 111.401 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.0 p -79.51 3.97 17.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.894 -1.048 . . . . 12.34 112.639 -175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 60.4 m -51.14 -30.41 16.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.59 0.589 . . . . 13.33 112.59 -174.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' HB2' ' O ' ' A' ' 9' ' ' THR . 32.7 mm-40 -109.91 6.68 23.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.6 0.238 . . . . 11.9 111.523 -176.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' A' ' 28' ' ' GLN . 10.5 tpt180 -143.71 -176.75 5.1 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.8 0.333 . . . . 12.99 111.062 -171.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.453 ' H ' ' HG3' ' A' ' 27' ' ' ARG . 14.6 mm100 -104.09 12.97 33.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.435 0.636 . . . . 16.66 109.963 176.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.97 140.42 16.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.219 -0.901 . . . . 12.09 110.499 -176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.456 ' HD3' ' O ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -96.43 120.27 36.43 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.338 -0.616 . . . . 12.51 109.338 171.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 19.4 mt -102.5 162.96 12.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.379 0.609 . . . . 8.76 111.883 -173.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -125.22 145.31 50.04 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.064 -0.971 . . . . 9.15 109.346 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -142.7 149.48 38.88 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.555 -0.535 . . . . 6.85 109.555 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 8.8 p-80 -99.78 165.51 11.55 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.267 -0.573 . . . . 9.99 109.919 176.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -66.3 -2.41 4.39 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.845 0.683 . . . . 9.93 112.845 -169.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.6 m -79.28 -17.87 53.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.945 0.402 . . . . 12.28 110.531 177.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.449 ' HB3' ' O ' ' A' ' 67' ' ' SER . 26.0 mp0 -111.61 39.68 2.29 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.306 -0.407 . . . . 10.62 111.419 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -125.97 130.19 50.72 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.503 -0.479 . . . . 8.78 110.123 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.0 m -84.44 109.91 18.25 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.995 -0.548 . . . . 8.97 111.025 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 108.88 -157.63 15.07 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.636 -0.793 . . . . 9.98 112.607 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -90.07 133.2 34.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.788 0.328 . . . . 12.43 110.988 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -72.42 -11.25 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.416 0.627 . . . . 11.58 109.911 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.34 -29.42 68.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.164 -0.925 . . . . 14.73 111.79 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -106.11 14.08 28.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.321 -0.4 . . . . 13.3 111.817 -175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.5 tp -97.81 128.38 44.4 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.42 -0.512 . . . . 10.07 109.92 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -118.27 163.5 16.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.206 0.527 . . . . 13.13 110.455 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.28 122.9 24.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 108.269 -1.011 . . . . 11.74 108.269 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.82 -8.44 29.74 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.691 -0.766 . . . . 10.13 112.377 -175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.54 130.24 90.79 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.818 0.309 . . . . 8.39 110.167 176.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.39 122.62 5.68 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.697 2.264 . . . . 7.28 111.688 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.15 151.85 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.44 0.638 . . . . 4.74 111.746 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -111.17 125.73 54.1 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.921 -1.036 . . . . 7.09 109.045 176.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.644 ' CE2' ' HG3' ' A' ' 8' ' ' GLU . 33.2 p90 -131.75 179.35 6.11 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.405 0.621 . . . . 7.82 111.246 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 25.9 tt0 -148.51 104.29 3.49 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.432 -0.804 . . . . 11.59 109.074 -170.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.0 ttt -84.16 128.79 34.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.38 -0.373 . . . . 12.41 111.154 -173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.5 p -145.44 164.72 30.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.243 -0.435 . . . . 13.17 110.672 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -107.6 110.75 22.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.57 -0.286 . . . . 16.21 110.755 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.515 ' OD2' HG22 ' A' ' 61' ' ' THR . 16.6 t70 -79.15 109.81 13.81 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.825 -0.435 . . . . 16.64 109.825 177.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -69.61 -15.41 63.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.473 -0.785 . . . . 22.64 111.819 -175.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.464 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 40.1 ttm105 -76.97 -54.01 7.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.713 0.292 . . . . 21.43 110.839 -177.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.515 HG22 ' OD2' ' A' ' 58' ' ' ASP . 9.1 t -85.64 -35.03 21.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.18 -0.463 . . . . 17.4 111.059 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.07 30.77 9.78 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.878 -0.677 . . . . 16.7 113.762 175.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.489 ' HG2' HG23 ' A' ' 61' ' ' THR . 16.8 ptpt -135.6 148.45 65.72 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 117.357 0.578 . . . . 14.73 110.022 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.82 126.89 11.06 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.088 1.859 . . . . 12.6 110.944 176.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.31 167.53 25.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.085 0.469 . . . . 11.73 111.303 -176.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.23 159.91 15.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.058 -0.719 . . . . 8.91 109.058 174.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 9.1 t -70.91 -166.05 0.14 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.914 -0.402 . . . . 9.83 109.914 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -75.64 22.69 0.13 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.495 0.924 . . . . 11.32 113.495 -170.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.6 t 34.24 98.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.141 1.164 . . . . 6.11 114.141 171.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.2 t -105.52 138.07 42.31 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.262 -0.644 . . . . 6.12 109.262 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.1 mtmm -73.84 144.28 45.55 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.372 -0.603 . . . . 6.3 109.372 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.7 mt -76.41 116.71 19.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.887 0.375 . . . . 5.77 111.037 -175.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -83.47 148.88 56.49 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.71 -0.677 . . . . 5.69 110.767 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 17.7 Cg_exo -67.24 -50.21 1.08 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.414 2.076 . . . . 6.86 113.16 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 57.81 96.2 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.463 0.649 . . . . 8.49 111.967 -173.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.447 HG12 ' HB1' ' A' ' 144' ' ' ALA . 0.1 OUTLIER -78.53 113.58 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.671 -0.695 . . . . 6.19 110.318 -179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 43.8 t -70.35 105.33 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.923 0.392 . . . . 6.26 111.369 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 144' ' ' ALA . 36.5 mt -97.08 5.59 50.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.49 . . . . 6.05 111.705 -178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.7 t -149.16 100.73 3.07 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 120.528 -0.469 . . . . 7.02 111.434 -178.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -132.69 -66.95 0.66 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.811 -0.811 . . . . 7.07 108.811 169.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -165.5 148.32 7.82 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.126 -0.943 . . . . 6.68 108.831 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -82.59 102.02 11.15 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.711 -0.478 . . . . 6.43 109.711 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 m -77.34 156.94 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.114 -0.493 . . . . 3.7 110.335 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 18.8 p -123.16 141.77 51.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.065 -0.516 . . . . 3.49 110.493 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.99 169.36 25.34 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.018 -0.611 . . . . 2.58 111.644 179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.2 m -103.94 130.32 51.55 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.583 -0.525 . . . . 3.34 109.583 178.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.552 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 2.1 t -68.87 121.37 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 N-CA-C 109.236 -0.653 . . . . 3.14 109.236 176.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.1 p -91.63 -24.71 19.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.34 0.59 . . . . 3.61 110.553 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.6 m -151.77 125.58 9.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.391 -0.822 . . . . 3.12 109.123 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.59 172.66 6.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.307 0.575 . . . . 4.39 112.079 -172.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.0 mt -75.78 141.17 42.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.054 -0.975 . . . . 3.62 110.354 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.1 ttm180 -111.0 112.07 23.62 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.106 0.479 . . . . 7.2 110.828 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 77.4 p -115.87 147.04 41.49 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.311 -0.858 . . . . 5.1 109.71 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.48 -37.02 57.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.724 0.297 . . . . 7.53 111.32 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 98' ' ' ASN . 34.5 t -151.36 -178.58 6.74 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.886 -0.413 . . . . 7.47 109.886 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -76.88 -36.11 56.95 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.272 -0.422 . . . . 7.58 110.257 177.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -99.04 -6.8 27.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 8.32 110.353 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 95' ' ' SER . 20.7 t-20 -109.42 93.9 4.75 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.515 0.674 . . . . 7.26 109.575 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.5 p -151.37 89.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 114.619 -1.173 . . . . 5.54 109.059 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 62.2 tp -138.99 96.84 3.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.406 -0.816 . . . . 7.28 110.632 -176.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.465 ' HB2' ' HG2' ' A' ' 104' ' ' GLU . 8.7 p30 -133.47 -30.76 1.26 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.646 -1.161 . . . . 7.54 109.415 177.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.0 t 58.86 71.29 0.59 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.265 -0.879 . . . . 5.41 111.481 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 66.9 p 53.65 23.05 3.38 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 114.053 1.131 . . . . 4.58 114.053 173.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.465 ' HG2' ' HB2' ' A' ' 101' ' ' ASN . 8.3 pt-20 -79.24 -43.98 22.68 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.227 -0.589 . . . . 5.09 110.272 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.441 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 8.3 t -106.96 123.87 48.8 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.219 0.533 . . . . 3.33 110.128 -179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.7 p -106.2 134.63 49.03 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.773 -0.649 . . . . 2.57 111.007 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -78.61 174.25 55.17 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.465 -0.874 . . . . 1.66 110.988 175.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 -125.56 123.72 39.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.244 0.522 . . . . 3.03 111.502 -176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -111.3 129.1 67.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.971 -0.752 . . . . 1.88 108.971 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 118' ' ' PHE . 9.4 t -116.07 132.95 56.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.178 0.513 . . . . 3.49 110.931 -178.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -143.81 155.95 44.32 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.946 -0.761 . . . . 3.51 108.946 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -109.02 137.12 47.43 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.793 0.33 . . . . 5.1 110.144 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -158.64 130.21 6.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.267 -0.424 . . . . 4.78 111.475 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 57.09 29.98 17.46 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.231 0.539 . . . . 6.97 112.121 173.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.33 -14.12 65.95 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.618 -0.719 . . . . 5.1 112.598 177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -102.95 135.86 43.84 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.824 0.345 . . . . 5.38 110.811 -175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 12.1 p -107.6 111.73 24.11 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.114 -0.494 . . . . 4.72 109.69 174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 110' ' ' SER . 88.5 m-85 -101.11 153.76 19.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.217 0.532 . . . . 4.61 111.961 -173.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -119.5 113.49 20.82 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.686 -0.857 . . . . 3.96 108.686 172.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.49 136.13 19.27 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 116.298 -0.41 . . . . 2.75 111.007 -172.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -77.32 132.9 12.81 Favored 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.733 2.289 . . . . 2.3 111.953 173.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -135.63 143.79 45.74 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.055 0.455 . . . . 2.13 110.035 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.8 p -114.25 -179.01 3.51 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.574 -0.528 . . . . 3.07 109.574 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.59 -16.98 59.45 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.039 0.447 . . . . 4.8 110.769 178.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -84.03 -10.89 57.52 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.797 -0.638 . . . . 4.81 111.053 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -88.28 -21.05 24.67 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.758 0.313 . . . . 3.84 111.385 -177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.3 p -96.8 111.61 27.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.467 0.651 . . . . 4.39 110.918 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -89.87 129.37 36.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.561 -0.745 . . . . 6.43 110.115 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 128.22 -15.68 6.1 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.58 -0.737 . . . . 5.91 111.359 -173.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.2 m120 57.95 46.6 16.33 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 122.978 0.511 . . . . 6.07 110.755 178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.4 p -112.01 152.99 13.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.042 -0.527 . . . . 5.27 110.808 -177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -87.95 115.4 25.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.964 -0.562 . . . . 5.78 110.667 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.3 pt? -114.82 142.83 46.02 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.738 -0.467 . . . . 3.62 109.738 177.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -149.07 175.2 11.53 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.335 -0.546 . . . . 6.93 111.474 -176.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.552 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -65.66 122.81 18.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.317 -0.401 . . . . 4.12 111.77 -177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 120.09 -29.69 5.9 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.836 -0.697 . . . . 4.07 113.265 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.61 166.96 11.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 117.576 0.688 . . . . 4.06 110.281 173.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -113.23 128.14 56.38 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.789 0.804 . . . . 4.17 111.245 -172.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.32 152.6 19.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.593 -1.185 . . . . 2.77 110.796 -176.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 20.3 m -106.35 137.48 44.24 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.813 -0.631 . . . . 3.47 109.675 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -142.6 149.57 39.17 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.809 0.338 . . . . 3.35 110.365 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.58 112.44 24.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.994 -0.373 . . . . 5.34 109.994 -178.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 66.4 mt -79.06 111.69 16.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.974 -0.557 . . . . 4.66 110.141 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.674 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -89.71 107.31 19.02 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.143 -0.688 . . . . 4.85 109.143 174.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -85.64 117.61 24.64 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.203 0.525 . . . . 5.68 111.352 -174.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -82.63 154.4 24.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.451 -0.795 . . . . 6.25 108.9 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -62.36 -29.04 70.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.439 0.638 . . . . 8.58 109.63 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 -69.92 -19.7 63.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.122 -0.945 . . . . 7.86 110.511 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 80.21 12.5 83.14 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.796 -0.638 . . . . 5.59 112.43 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -106.62 119.49 39.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.197 -0.668 . . . . 5.18 109.197 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.438 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -148.88 -177.81 6.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.645 -0.252 . . . . 4.28 111.537 -177.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.57 -173.73 16.18 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.393 -0.683 . . . . 3.36 111.393 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.44 111.43 23.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.864 0.332 . . . . 2.84 110.423 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 6.2 t -127.09 165.15 20.06 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 110.042 -0.355 . . . . 4.34 110.042 -178.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 59.05 36.08 24.16 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.0 -0.545 . . . . 5.75 110.424 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 42.1 mt -70.78 142.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.363 -0.835 . . . . 3.55 110.758 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -149.22 142.24 24.85 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.7 0.286 . . . . 5.96 110.904 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 68.2 tp -76.75 106.48 8.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.357 -0.383 . . . . 4.34 110.054 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -103.31 -35.19 8.5 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.122 -0.49 . . . . 4.97 111.805 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -132.13 90.4 35.03 Favored Pre-proline 0 C--N 1.328 -0.345 0 C-N-CA 120.965 -0.294 . . . . 5.37 110.852 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -78.55 156.55 28.4 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.559 2.173 . . . . 5.44 111.742 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -83.34 -5.81 59.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.245 0.545 . . . . 6.1 111.037 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -174.32 109.11 0.29 Allowed Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 114.457 -1.247 . . . . 9.49 109.78 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.26 123.19 11.16 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.332 2.021 . . . . 8.39 111.967 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 116.132 -0.485 . . . . 10.27 110.801 179.437 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 112.105 -0.398 . . . . 21.66 112.105 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.5 107.9 6.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.783 0.325 . . . . 20.17 110.623 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.12 -31.64 17.9 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.295 0.569 . . . . 18.5 110.591 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -87.13 69.23 10.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.809 -0.632 . . . . 16.62 111.751 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.55 ' HG3' ' H ' ' A' ' 6' ' ' GLU . 3.1 pt-20 -114.91 -92.02 0.51 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.756 0.312 . . . . 18.35 111.494 175.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.55 ' H ' ' HG3' ' A' ' 5' ' ' GLU . 1.6 tp10 -95.5 95.69 8.58 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.895 0.379 . . . . 16.2 111.075 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -125.63 138.5 53.92 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.831 -0.433 . . . . 12.4 109.831 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -119.45 148.78 42.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.648 -0.705 . . . . 11.63 111.164 -166.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.3 p -102.89 144.22 31.48 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.918 -0.583 . . . . 9.15 111.707 -174.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.19 176.57 29.62 Favored Glycine 0 N--CA 1.449 -0.444 0 N-CA-C 111.371 -0.692 . . . . 6.81 111.371 177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.0 mt -127.06 140.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 109.659 -0.497 . . . . 10.17 109.659 -178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.7 mm -66.15 126.04 24.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 121.206 -0.198 . . . . 8.73 110.491 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -87.0 -51.45 6.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.37 0.605 . . . . 10.86 111.258 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -157.92 131.77 7.95 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.086 -0.709 . . . . 14.06 109.086 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.11 105.56 17.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.546 0.689 . . . . 11.73 111.362 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.66 179.4 4.43 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.302 -0.999 . . . . 11.36 108.302 172.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -91.4 136.3 33.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.756 -0.378 . . . . 15.94 110.71 -177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 t 76.75 -33.32 0.2 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.263 -0.881 . . . . 13.01 111.742 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -139.7 152.37 46.64 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.64 0.257 . . . . 12.34 111.24 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -134.8 168.76 23.49 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.636 -0.793 . . . . 7.52 112.418 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -116.89 140.8 49.03 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.914 0.388 . . . . 9.24 111.203 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.3 mt -111.59 130.51 65.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.905 -0.589 . . . . 7.75 110.462 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -72.98 138.46 46.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.445 0.64 . . . . 11.8 111.985 -177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.1 p -79.53 1.55 25.39 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.062 -0.972 . . . . 12.34 111.412 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -55.77 -30.06 60.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.298 -0.41 . . . . 13.33 111.776 -179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -113.89 -11.94 12.75 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.106 0.479 . . . . 11.9 111.259 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.745 HH11 ' HB3' ' A' ' 29' ' ' ALA . 3.9 tmt_? -137.52 137.56 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.692 -0.855 . . . . 12.99 108.692 -175.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -68.32 42.79 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.427 0.899 . . . . 16.66 113.427 -175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.745 ' HB3' HH11 ' A' ' 27' ' ' ARG . . . 177.2 133.98 0.06 Allowed 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 123.406 0.682 . . . . 12.09 110.12 176.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.511 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 6.6 ppt_? -86.27 141.31 29.36 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.147 -0.686 . . . . 12.51 109.147 171.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 47.1 mt -133.25 162.43 31.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.953 0.406 . . . . 8.76 111.486 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -114.9 141.87 47.35 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.128 -0.942 . . . . 9.15 108.506 173.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -136.21 145.3 45.53 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.455 -0.498 . . . . 6.85 110.733 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -84.53 141.44 30.73 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.919 -0.771 . . . . 9.99 108.919 176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -63.87 -17.48 63.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.637 0.256 . . . . 9.93 111.481 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.2 t -70.6 -13.51 62.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.51 -0.314 . . . . 12.28 110.697 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -103.47 1.11 31.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.564 -0.289 . . . . 10.62 111.235 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -85.04 114.86 22.51 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 120.698 -0.401 . . . . 8.78 110.121 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.8 t -81.91 91.3 6.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.241 -0.436 . . . . 8.97 110.474 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.39 -175.02 26.06 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.637 -0.585 . . . . 9.98 111.637 176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -79.14 123.85 27.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.698 -0.482 . . . . 12.43 109.698 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.7 tp -65.24 -24.96 36.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.176 0.513 . . . . 11.58 111.094 -178.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.22 -0.91 26.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.166 0.508 . . . . 14.73 111.168 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.9 m170 -103.39 10.1 37.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.953 -0.567 . . . . 13.3 109.672 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.9 tp -112.82 129.24 56.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.714 -0.676 . . . . 10.07 110.008 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -119.64 168.95 10.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.336 0.589 . . . . 13.13 111.099 176.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.6 mp -73.37 114.78 13.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.089 -0.505 . . . . 11.74 109.742 174.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.14 9.43 22.19 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.474 -0.87 . . . . 10.13 112.012 -175.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.29 133.08 71.99 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 110.245 -0.279 . . . . 8.39 110.245 175.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -85.58 109.88 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.941 2.428 . . . . 7.28 111.644 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.4 m -114.93 151.6 16.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.888 -0.596 . . . . 4.74 111.255 -175.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -110.32 130.03 55.63 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.19 -0.67 . . . . 7.09 109.19 173.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -131.09 178.04 7.0 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.349 0.595 . . . . 7.82 111.014 -174.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 67' ' ' SER . 32.9 tt0 -142.65 105.08 4.47 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.468 -0.938 . . . . 11.59 108.468 -175.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.3 ttt -83.15 124.29 30.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.767 0.318 . . . . 12.41 111.077 -175.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.2 p -141.19 161.25 38.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.313 -0.403 . . . . 13.17 110.697 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -97.6 121.5 39.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.39 -0.368 . . . . 16.21 110.078 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' A' ' 60' ' ' ARG . 16.6 t70 -74.76 120.08 19.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.182 0.515 . . . . 16.64 110.312 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -79.85 -5.79 56.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.648 -0.705 . . . . 22.64 112.197 -176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.404 ' HB2' ' OD2' ' A' ' 58' ' ' ASP . 2.4 mpt_? -79.77 -70.41 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.212 0.529 . . . . 21.43 110.641 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 2.6 t -101.71 -4.38 26.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.816 -0.629 . . . . 17.4 111.203 -174.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.58 33.0 35.82 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.079 -0.582 . . . . 16.7 113.451 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -110.02 131.3 22.05 Favored Pre-proline 0 C--N 1.324 -0.526 0 O-C-N 122.725 -0.279 . . . . 14.73 110.335 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.6 125.59 10.74 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.734 1.623 . . . . 12.6 110.028 171.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.69 179.54 2.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.455 0.645 . . . . 11.73 111.989 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.19 148.41 29.96 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.442 -0.799 . . . . 8.91 109.886 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.481 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 10.3 t -74.62 -150.38 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.882 -0.599 . . . . 9.83 111.48 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.487 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 2.1 mp0 -68.97 30.12 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.853 1.057 . . . . 11.32 113.853 -175.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.412 ' H ' ' C ' ' A' ' 67' ' ' SER . 39.8 t 0.0 101.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 125.228 1.411 . . . . 6.11 113.514 178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.5 m -109.53 134.38 51.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.855 -0.338 . . . . 6.12 110.747 -174.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.7 mtmt -68.68 139.71 55.43 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.743 -0.465 . . . . 6.3 109.743 177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.4 124.48 25.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.228 0.537 . . . . 5.77 111.84 -172.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -112.39 122.42 36.55 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.383 -0.826 . . . . 5.69 110.628 179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 2.9 Cg_exo -73.49 144.4 36.08 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.801 2.334 . . . . 6.86 113.104 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.448 ' HG2' HE21 ' A' ' 147' ' ' GLN . 0.4 OUTLIER -138.71 -80.3 0.33 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.419 -0.81 . . . . 8.49 108.937 176.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.614 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 0.7 OUTLIER -104.78 125.64 59.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.452 -0.795 . . . . 6.19 110.154 174.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 4.5 m -94.46 121.84 45.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.873 -0.603 . . . . 6.26 111.08 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.429 ' O ' HD23 ' A' ' 78' ' ' LEU . 2.2 tt -67.08 -27.54 67.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.586 -0.733 . . . . 6.05 109.859 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.1 m -131.29 103.56 6.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.188 -0.46 . . . . 7.02 111.238 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -141.96 -87.69 0.15 Allowed 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.215 -0.661 . . . . 7.07 109.215 173.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.433 ' H ' ' HG2' ' A' ' 81' ' ' GLU . 6.2 pt-20 -90.73 71.68 6.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.761 0.791 . . . . 6.68 110.353 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.468 ' HD3' ' H ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -68.53 137.64 54.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.442 -0.799 . . . . 6.43 109.935 177.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 m -140.39 170.42 14.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.037 0.446 . . . . 3.7 111.119 -174.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 31.6 p -115.7 139.88 49.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.768 -0.651 . . . . 3.49 109.689 175.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -127.7 155.18 20.0 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.032 -1.08 . . . . 2.58 112.878 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 m -111.04 127.0 55.4 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.388 -0.597 . . . . 3.34 109.388 175.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.573 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 57.3 t -69.21 120.63 17.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 110.217 -0.29 . . . . 3.14 110.217 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 17.5 p -107.47 -17.82 14.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.134 0.492 . . . . 3.61 111.113 179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 33.7 m -150.78 131.29 13.83 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.38 -0.6 . . . . 3.12 109.38 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.77 -175.11 2.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.249 0.547 . . . . 4.39 111.296 -176.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 51.0 mt -87.86 135.63 33.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.597 -0.729 . . . . 3.62 109.675 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -74.01 -11.09 60.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.474 0.654 . . . . 7.2 111.028 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 p -96.45 -51.9 4.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.95 0.881 . . . . 5.1 111.066 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.515 ' OD1' ' HD3' ' A' ' 124' ' ' LYS . 3.0 m-20 -84.09 25.18 0.85 Allowed 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.094 -1.412 . . . . 7.53 111.459 -172.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 m -68.49 -31.97 71.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.116 -0.493 . . . . 7.47 110.429 177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -167.72 -82.49 0.02 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.997 -0.547 . . . . 7.58 111.552 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -127.27 -1.11 6.36 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.01 0.374 . . . . 8.32 112.01 -174.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -86.65 36.71 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.043 0.449 . . . . 7.26 111.093 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.454 HG22 ' HA ' ' A' ' 94' ' ' ASP . 22.8 t -86.72 105.9 15.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.097 -0.501 . . . . 5.54 110.53 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.6 mp -119.72 -142.83 0.35 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.388 -0.967 . . . . 7.28 108.388 175.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -109.53 62.64 0.6 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.346 0.593 . . . . 7.54 109.512 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.2 t -129.92 67.35 1.46 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.624 -0.716 . . . . 5.41 109.157 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.7 p -82.49 24.65 0.68 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.508 -0.769 . . . . 4.58 111.572 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -83.17 -9.4 59.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 5.09 109.961 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.2 t -82.1 127.78 33.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.247 -0.888 . . . . 3.33 109.87 176.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.75 118.91 25.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.943 0.402 . . . . 2.57 110.793 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -73.74 175.23 47.48 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.832 -0.699 . . . . 1.66 112.689 -177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 108' ' ' ARG . 48.5 mmt-85 -132.47 126.72 33.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.862 0.363 . . . . 3.03 110.442 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 89.3 mt -111.64 126.49 69.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.052 -0.522 . . . . 1.88 109.82 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 118' ' ' PHE . 12.0 t -103.62 125.46 50.15 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.603 -0.517 . . . . 3.49 109.603 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 4.1 p90 -134.06 155.58 49.78 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.323 -0.621 . . . . 3.51 109.323 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -114.16 119.56 37.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.983 0.42 . . . . 5.1 110.137 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -142.99 133.08 24.35 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.496 -0.775 . . . . 4.78 108.988 177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 63.48 21.27 12.68 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.647 0.592 . . . . 6.97 111.042 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.05 21.15 59.57 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.96 -0.564 . . . . 5.1 112.446 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -132.83 135.47 45.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.675 0.274 . . . . 5.38 110.68 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.668 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 4.0 p -111.82 116.41 30.63 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.316 -0.402 . . . . 4.72 110.662 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 110' ' ' SER . 81.5 m-85 -114.59 172.77 6.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 4.61 110.898 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -114.75 120.01 38.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.831 -0.622 . . . . 3.96 110.058 -178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.8 mt -106.28 135.16 19.51 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.818 -0.628 . . . . 2.75 111.737 -177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -77.02 138.75 18.62 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.952 2.435 . . . . 2.3 111.872 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -150.35 160.29 43.84 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.997 0.427 . . . . 2.13 110.888 178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.0 p -123.31 175.01 6.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.302 -0.863 . . . . 3.07 109.66 175.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.515 ' HD3' ' OD1' ' A' ' 94' ' ' ASP . 21.2 ttpp -66.02 -23.39 66.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.548 0.69 . . . . 4.8 109.99 176.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.5 -20.47 62.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.443 -0.799 . . . . 4.81 111.42 -176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -87.95 -2.63 58.73 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.09 -0.504 . . . . 3.84 110.671 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.6 t -93.16 137.61 22.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.258 -0.428 . . . . 4.39 111.516 -174.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -82.29 124.32 29.86 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.933 -0.576 . . . . 6.43 109.978 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 76.37 9.28 85.9 Favored Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.901 -0.666 . . . . 5.91 112.472 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.7 p30 47.08 29.27 1.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.14 0.976 . . . . 6.07 112.699 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.4 m -63.77 150.11 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.203 -0.453 . . . . 5.27 110.631 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -80.42 130.92 35.47 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.991 -0.55 . . . . 5.78 110.95 -175.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 5.5 mp -99.27 149.04 23.52 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.897 -0.592 . . . . 3.62 110.338 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -134.82 129.99 35.36 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.594 -0.521 . . . . 6.93 109.594 175.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.573 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -63.77 130.76 45.53 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.807 -0.633 . . . . 4.12 110.966 -175.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.04 -23.09 10.13 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.519 -0.764 . . . . 4.07 112.307 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.09 177.42 5.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.101 0.477 . . . . 4.06 111.401 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -106.77 131.3 54.04 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.878 -0.601 . . . . 4.17 111.583 -170.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.6 m -123.25 165.95 18.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.213 -0.449 . . . . 2.77 110.326 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.1 m -129.71 127.93 41.46 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.816 -0.439 . . . . 3.47 109.816 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -128.99 150.21 50.5 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.963 -0.384 . . . . 3.35 109.963 -177.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -96.95 120.26 36.97 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.996 0.427 . . . . 5.34 110.113 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 59.2 mt -79.3 107.62 11.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.784 -0.644 . . . . 4.66 109.857 176.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -81.04 107.7 14.08 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 109.076 -0.713 . . . . 4.85 109.076 174.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' VAL . 19.8 m -92.49 103.08 15.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.71 -0.677 . . . . 5.68 111.288 -173.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.522 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 15.5 m120 -67.91 153.63 43.31 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.566 -0.902 . . . . 6.25 108.566 170.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.448 HE21 ' HG2' ' A' ' 75' ' ' GLU . 10.0 pt20 -64.65 -20.03 66.06 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.891 0.377 . . . . 8.58 111.339 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -72.08 -23.34 61.33 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.079 0.466 . . . . 7.86 110.531 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.22 22.91 59.9 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.533 -0.841 . . . . 5.59 112.406 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -122.58 114.29 20.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.204 -0.295 . . . . 5.18 110.204 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.485 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -146.55 -178.15 6.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.286 -0.415 . . . . 4.28 111.168 -175.155 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -122.77 -132.07 3.96 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 110.993 -0.843 . . . . 3.36 110.993 174.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -132.0 126.82 34.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.814 0.34 . . . . 2.84 110.277 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 80.4 m -140.35 162.44 35.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.29 -0.413 . . . . 4.34 110.664 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 57.32 53.18 7.88 Favored 'General case' 0 N--CA 1.462 0.127 0 O-C-N 123.813 0.696 . . . . 5.75 110.676 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 53.3 mt -82.12 115.0 23.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.523 -0.762 . . . . 3.55 110.097 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.414 ' HD2' HH11 ' A' ' 157' ' ' ARG . 20.9 ttt180 -114.52 129.94 56.71 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.785 -0.643 . . . . 5.96 110.602 -177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.468 HD21 ' HA ' ' A' ' 161' ' ' PRO . 50.9 tp -82.59 98.33 8.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.67 -0.696 . . . . 4.34 110.057 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -82.68 -23.66 34.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.076 -0.511 . . . . 4.97 111.084 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -133.59 102.43 12.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.371 -0.377 . . . . 5.37 110.065 176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.468 ' HA ' HD21 ' A' ' 158' ' ' LEU . 71.8 Cg_endo -79.03 154.32 25.56 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.562 2.175 . . . . 5.44 112.738 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -103.25 113.27 26.63 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.854 -0.612 . . . . 6.1 111.744 -175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 62.15 91.6 0.08 OUTLIER Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 123.985 0.803 . . . . 9.49 112.334 173.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -77.92 -171.37 1.18 Allowed 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 122.896 2.398 . . . . 8.39 111.769 176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 32.2 m . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.297 -0.41 . . . . 10.27 111.036 -179.2 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 111.586 -0.606 . . . . 21.66 111.586 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.63 124.11 41.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.858 0.361 . . . . 20.17 110.688 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -75.25 -53.66 8.42 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.948 -0.569 . . . . 18.5 111.05 -176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -91.02 47.51 1.41 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.813 -0.63 . . . . 16.62 111.496 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -101.09 -38.68 8.05 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 112.024 0.379 . . . . 18.35 112.024 -177.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -139.86 132.98 29.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.981 0.42 . . . . 16.2 111.444 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -134.86 140.24 45.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.079 -0.509 . . . . 12.4 111.021 177.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -139.65 172.68 12.44 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.79 -0.641 . . . . 11.63 109.88 -176.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 59.0 p -112.9 167.36 10.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.988 0.423 . . . . 9.15 111.534 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.6 172.65 37.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 116.19 -0.459 . . . . 6.81 112.189 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.0 mt -117.04 133.67 63.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 110.015 -0.365 . . . . 10.17 110.015 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.3 118.09 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.949 0.404 . . . . 8.73 110.585 176.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -68.52 -56.24 9.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.39 -0.823 . . . . 10.86 110.46 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -156.03 141.08 17.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.205 -0.907 . . . . 14.06 108.765 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.3 mt -98.2 103.16 15.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.268 0.556 . . . . 11.73 110.712 178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 3.0 mm? -95.37 -179.77 4.89 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.034 -0.985 . . . . 11.36 108.412 173.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -90.68 123.11 34.03 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.518 -0.473 . . . . 15.94 110.022 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.6 t 82.6 -27.86 0.11 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.453 1.095 . . . . 13.01 111.773 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 19.4 p90 -135.64 147.8 48.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.806 0.336 . . . . 12.34 111.304 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -139.89 162.85 26.3 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-N 116.055 -0.52 . . . . 7.52 111.87 178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -118.38 146.89 44.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.821 0.31 . . . . 9.24 111.313 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 70.5 mt -121.34 128.16 75.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 116.301 -0.409 . . . . 7.75 110.535 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -76.85 146.0 38.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.202 0.525 . . . . 11.8 111.575 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.402 ' HB3' ' N ' ' A' ' 30' ' ' ARG . 6.5 p -79.82 -0.02 32.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.246 -0.888 . . . . 12.34 112.888 -175.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.7 t -53.52 -31.32 45.73 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.85 0.685 . . . . 13.33 112.85 -173.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -94.97 -5.92 43.58 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.871 0.367 . . . . 11.9 111.889 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.517 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 12.0 ttt180 -131.66 -160.66 1.06 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.532 -0.303 . . . . 12.99 110.203 -173.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.517 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 78.0 mt-30 -118.66 14.93 13.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.379 0.609 . . . . 16.66 110.218 176.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -164.41 138.45 5.34 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.312 -0.858 . . . . 12.09 110.213 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.402 ' N ' ' HB3' ' A' ' 24' ' ' CYS . 6.6 ptp180 -85.62 151.02 24.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.424 -0.584 . . . . 12.51 109.424 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.0 mt -138.86 162.52 34.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.026 0.441 . . . . 8.76 110.887 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.38 142.24 51.48 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.951 -0.759 . . . . 9.15 108.951 173.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -128.35 147.38 50.62 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.001 -0.37 . . . . 6.85 110.001 -177.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.48 ' HB2' ' OE1' ' A' ' 37' ' ' GLN . 76.3 m-70 -95.64 160.81 14.32 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.525 -0.546 . . . . 9.99 109.525 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -70.71 -4.24 22.64 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.816 0.341 . . . . 9.93 111.675 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -85.75 -7.39 58.8 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.944 -0.391 . . . . 12.28 109.944 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.48 ' OE1' ' HB2' ' A' ' 34' ' ' HIS . 23.4 mp0 -117.44 40.48 3.05 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.936 -0.575 . . . . 10.62 111.199 -177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -122.63 139.48 53.88 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.42 -0.512 . . . . 8.78 111.142 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 31.3 t -116.27 114.49 24.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.993 -0.549 . . . . 8.97 110.036 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.05 -161.35 23.51 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.755 -0.736 . . . . 9.98 111.823 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -83.06 108.11 16.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.215 -0.291 . . . . 12.43 110.215 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.408 HD12 HD12 ' A' ' 45' ' ' LEU . 10.6 tp -68.52 -25.16 30.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.344 0.592 . . . . 11.58 110.081 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -66.68 -22.7 66.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.489 -0.778 . . . . 14.73 110.908 179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -105.45 20.25 19.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.854 -0.612 . . . . 13.3 111.303 -173.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' A' ' 45' ' ' LEU . 1.5 mt -87.2 133.97 33.59 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.021 -0.363 . . . . 10.07 110.021 175.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -127.6 167.0 16.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.462 -0.57 . . . . 13.13 109.462 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.5 mp -81.99 132.82 30.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 109.563 -0.532 . . . . 11.74 109.563 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 93.65 11.24 58.27 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.647 -0.787 . . . . 10.13 111.987 -177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' A' ' 50' ' ' PRO . 32.3 t70 -86.15 133.35 41.03 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-N 115.655 -0.273 . . . . 8.39 110.75 -178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 49' ' ' ASP . 6.6 Cg_endo -86.18 127.42 2.95 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.241 2.627 . . . . 7.28 112.638 176.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.9 m -125.33 160.33 31.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.253 -0.43 . . . . 4.74 111.092 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -112.54 128.03 56.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.913 -0.585 . . . . 7.09 110.029 176.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -131.94 150.19 52.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.345 0.593 . . . . 7.82 111.048 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . 16.4 tt0 -101.58 119.65 39.1 Favored 'General case' 0 C--N 1.314 -0.957 0 N-CA-C 108.735 -0.839 . . . . 11.59 108.735 177.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 14.3 tpt -90.93 133.42 35.28 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.909 -0.404 . . . . 12.41 109.909 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.402 HG23 HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -155.91 169.81 23.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.966 0.412 . . . . 13.17 110.531 -172.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -126.4 109.44 12.23 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.742 0.305 . . . . 16.21 110.426 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -83.12 113.42 20.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.223 -0.444 . . . . 16.64 110.108 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -79.21 -10.31 59.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.36 -0.382 . . . . 22.64 111.783 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -74.34 -41.54 60.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.405 -0.591 . . . . 21.43 109.405 178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 25.8 p -88.55 -40.81 13.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.255 -0.43 . . . . 17.4 110.817 174.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.78 31.92 11.97 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.906 -0.664 . . . . 16.7 112.207 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -132.59 152.92 80.83 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 110.056 -0.35 . . . . 14.73 110.056 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.75 125.85 10.88 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.293 1.996 . . . . 12.6 110.641 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 56' ' ' THR . 2.0 pp -138.85 153.81 25.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.537 0.684 . . . . 11.73 112.251 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.42 157.29 16.52 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.576 -0.898 . . . . 8.91 108.576 170.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.8 t -70.66 -162.95 0.07 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.006 -0.368 . . . . 9.83 110.006 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -72.77 27.13 0.06 Allowed 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 113.368 0.877 . . . . 11.32 113.368 -174.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.3 t 32.23 99.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.438 1.095 . . . . 6.11 113.664 172.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.5 t -88.61 151.29 22.57 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.429 -0.805 . . . . 6.12 111.378 -174.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -87.55 137.96 31.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.376 -0.829 . . . . 6.3 110.993 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.8 mt -86.85 132.79 31.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.064 -0.516 . . . . 5.77 109.873 177.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.64 151.14 86.96 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.129 -0.487 . . . . 5.69 111.014 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.13 161.63 25.81 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.955 2.437 . . . . 6.86 112.842 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 75' ' ' GLU . 0.1 OUTLIER -96.28 169.28 10.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.668 -0.696 . . . . 8.49 110.663 -177.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.428 HG12 ' HB1' ' A' ' 144' ' ' ALA . 9.2 t -76.29 141.28 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.497 -0.557 . . . . 6.19 109.497 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.672 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 29.0 t -80.25 97.99 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.067 0.395 . . . . 6.26 112.067 -171.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.474 ' CD2' ' HB2' ' A' ' 144' ' ' ALA . 22.2 mt -88.96 -30.36 18.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.525 . . . . 6.05 110.948 175.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 p -98.95 96.95 8.19 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.334 0.588 . . . . 7.02 111.616 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -148.52 -69.14 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.434 -0.803 . . . . 7.07 109.31 174.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -131.57 147.67 52.55 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.899 -0.591 . . . . 6.68 109.987 -178.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 19.4 ptt85 -107.77 125.88 51.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.845 0.355 . . . . 6.43 110.158 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.8 m -123.12 158.55 27.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.066 0.46 . . . . 3.7 111.9 -173.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.8 p -118.65 140.65 49.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.39 -0.823 . . . . 3.49 109.622 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -139.45 170.16 24.27 Favored Glycine 0 N--CA 1.44 -1.055 0 C-N-CA 120.075 -1.06 . . . . 2.58 112.615 -177.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.5 m -115.69 135.36 54.12 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.528 -0.545 . . . . 3.34 109.528 177.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.595 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 21.9 t -67.36 115.36 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.589 -0.522 . . . . 3.14 109.589 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.05 -34.1 15.24 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.326 0.584 . . . . 3.61 110.042 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 50.7 m -151.26 120.75 6.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.619 -0.719 . . . . 3.12 109.613 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.74 -176.82 5.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.799 0.333 . . . . 4.39 110.465 -178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.21 162.96 13.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.515 -0.311 . . . . 3.62 110.186 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -52.73 125.74 17.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.125 -0.489 . . . . 7.2 109.977 174.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.3 m -141.91 6.4 1.79 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.891 0.853 . . . . 5.1 110.426 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.55 132.71 33.84 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.389 -0.823 . . . . 7.53 110.616 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 31.5 t -161.83 159.68 27.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.008 -0.542 . . . . 7.47 109.874 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -91.67 -6.73 51.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.025 -0.534 . . . . 7.58 110.124 177.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -112.93 -65.62 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.874 -0.603 . . . . 8.32 110.608 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -163.54 170.1 17.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.473 -0.33 . . . . 7.26 110.249 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 35.7 m -75.61 51.08 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.349 0.595 . . . . 5.54 112.372 -175.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 36.9 tp -99.57 88.08 3.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.688 0.756 . . . . 7.28 109.996 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.406 ' OD1' ' HE3' ' A' ' 124' ' ' LYS . 3.4 p-10 -111.01 1.32 17.34 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 114.549 -1.205 . . . . 7.54 110.03 176.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 57.4 p 49.96 -108.92 0.35 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.401 -0.818 . . . . 5.41 111.555 -174.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.2 t -146.6 35.46 0.95 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.213 0.53 . . . . 4.58 109.952 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 105' ' ' THR . 0.5 OUTLIER -62.71 -44.73 95.47 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.862 -0.608 . . . . 5.09 111.024 179.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.469 ' N ' ' HG3' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -93.12 175.76 6.66 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.367 -0.833 . . . . 3.33 111.845 -171.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.3 m -142.55 127.84 18.76 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.198 -0.667 . . . . 2.57 109.198 173.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.543 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -94.7 176.02 34.63 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.582 -0.818 . . . . 1.66 112.581 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 120' ' ' LEU . 20.3 mmt180 -133.43 132.31 40.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.643 0.259 . . . . 3.03 110.599 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.4 HG21 ' CE2' ' A' ' 141' ' ' PHE . 79.0 mt -113.94 130.66 67.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.028 -0.533 . . . . 1.88 109.584 174.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.5 p -105.86 123.0 47.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.316 -0.402 . . . . 3.49 110.389 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.686 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.0 OUTLIER -140.47 152.36 45.57 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.817 0.341 . . . . 3.51 110.608 178.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.455 ' HG3' ' HB3' ' A' ' 117' ' ' CYS . 4.8 mp0 -107.31 122.48 46.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.053 0.454 . . . . 5.1 110.165 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -131.96 120.85 23.05 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.698 -0.683 . . . . 4.78 109.823 -178.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 61.09 31.96 19.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.326 0.584 . . . . 6.97 110.861 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -20.15 50.82 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.413 -0.812 . . . . 5.1 113.395 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -99.47 136.32 39.57 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.672 0.273 . . . . 5.38 110.833 -175.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.455 ' HB3' ' HG3' ' A' ' 112' ' ' GLU . 7.8 p -102.51 128.3 49.2 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.178 -0.465 . . . . 4.72 110.572 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -128.59 164.2 23.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.323 -0.398 . . . . 4.61 110.875 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -122.85 114.37 20.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.696 -0.683 . . . . 3.96 109.595 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.686 HD11 ' CE2' ' A' ' 111' ' ' TYR . 2.5 mp -105.49 140.94 21.65 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.682 0.277 . . . . 2.75 110.878 -175.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 94.1 Cg_endo -79.3 155.82 25.43 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.104 2.536 . . . . 2.3 112.068 175.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -163.99 163.68 23.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.9 -0.408 . . . . 2.13 109.9 177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 77.4 p -118.76 -179.15 3.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.996 0.427 . . . . 3.07 111.154 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.406 ' HE3' ' OD1' ' A' ' 101' ' ' ASN . 16.2 tppt? -71.57 -21.26 61.9 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.08 -0.509 . . . . 4.8 110.54 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.49 -9.73 57.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.16 -0.473 . . . . 4.81 111.238 -173.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -85.41 -25.42 27.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 3.84 111.7 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 2.7 p -92.49 123.05 44.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.518 0.675 . . . . 4.39 110.69 -179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.61 159.63 16.33 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.6 -0.727 . . . . 6.43 110.844 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.92 -16.44 60.95 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.852 -0.689 . . . . 5.91 112.274 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 68.94 16.26 8.8 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.917 0.487 . . . . 6.07 110.783 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 26.0 t -72.45 116.29 14.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.172 -0.467 . . . . 5.27 110.088 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 -85.98 84.86 7.42 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.749 0.785 . . . . 5.78 110.706 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.608 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.2 pt? -81.44 150.71 28.21 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.1 -1.409 . . . . 3.62 110.761 178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.559 ' HD2' ' H ' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -110.49 -179.74 3.85 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.219 -0.659 . . . . 6.93 109.219 177.247 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.595 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.45 131.81 41.38 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.423 -0.511 . . . . 4.12 111.05 176.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.53 -14.55 13.14 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 121.135 -0.555 . . . . 4.07 112.072 -175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' A' ' 161' ' ' PRO . 4.9 m-20 -81.11 154.38 26.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.633 0.254 . . . . 4.06 110.544 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.486 ' HB2' ' HB3' ' A' ' 160' ' ' ASN . 13.4 mmmm -104.6 127.83 52.45 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.162 0.506 . . . . 4.17 110.372 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.7 m -130.35 160.58 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.386 -0.825 . . . . 2.77 112.382 -171.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.6 p -122.53 140.96 52.19 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.993 -1.003 . . . . 3.47 109.534 172.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.503 ' HE1' HD11 ' A' ' 143' ' ' ILE . 19.9 p90 -151.24 167.9 26.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.568 -0.287 . . . . 3.35 110.654 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -104.24 133.42 49.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.15 0.5 . . . . 5.34 110.779 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.503 HD11 ' HE1' ' A' ' 141' ' ' PHE . 34.6 mm -95.49 102.27 13.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.428 -0.805 . . . . 4.66 110.368 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.672 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -87.59 108.78 19.23 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.622 -0.431 . . . . 4.85 110.406 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 15.6 m -90.04 125.7 35.5 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.046 -0.524 . . . . 5.68 111.345 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -98.72 164.98 12.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.204 -1.036 . . . . 6.25 108.204 174.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -59.98 -24.8 64.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.943 0.497 . . . . 8.58 111.883 -174.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.5 tpm_? -70.6 -17.75 62.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.799 0.333 . . . . 7.86 110.868 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 84.93 5.39 86.24 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.856 -0.688 . . . . 5.59 111.891 -178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -99.39 119.64 38.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.164 -0.68 . . . . 5.18 109.164 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.504 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -132.87 163.33 29.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.171 0.51 . . . . 4.28 112.23 -177.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -136.14 -173.26 12.9 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.782 -0.927 . . . . 3.36 110.782 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.7 120.88 40.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.103 0.452 . . . . 2.84 110.91 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 10.6 t -128.12 154.37 45.81 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.749 -0.463 . . . . 4.34 109.749 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 55.75 65.29 1.5 Allowed 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.794 0.807 . . . . 5.75 110.266 -175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 73.5 mt -92.44 135.29 27.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.566 -1.197 . . . . 3.55 109.794 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -132.14 152.84 51.04 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.909 -0.404 . . . . 5.96 109.909 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.9 tp -101.47 123.71 45.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.176 -0.465 . . . . 4.34 110.24 177.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -111.59 -40.56 4.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.515 -0.311 . . . . 4.97 111.067 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . 0.486 ' HB3' ' HB2' ' A' ' 138' ' ' LYS . 7.7 t30 -118.95 101.11 50.47 Favored Pre-proline 0 C--O 1.239 0.533 0 N-CA-C 110.226 -0.287 . . . . 5.37 110.226 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.412 ' HA ' ' OD1' ' A' ' 137' ' ' ASP . 82.3 Cg_endo -83.15 155.56 14.75 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 123.127 2.551 . . . . 5.44 113.43 -176.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -83.68 154.48 23.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.78 -0.646 . . . . 6.1 110.86 177.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.72 124.97 89.99 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.463 -0.335 . . . . 9.49 110.658 -175.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -62.36 113.88 2.11 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.71 2.273 . . . . 8.39 112.93 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.952 -0.567 . . . . 10.27 110.28 -178.641 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.454 0 N-CA-C 111.764 -0.535 . . . . 21.66 111.764 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 74.54 -13.07 0.84 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.589 0.756 . . . . 20.17 111.652 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -81.3 -17.96 47.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.882 0.849 . . . . 18.5 109.118 176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.32 5.35 3.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.375 -1.284 . . . . 16.62 111.317 -178.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -84.51 -21.86 30.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.109 0.48 . . . . 18.35 111.537 -174.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -82.97 89.22 6.85 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.231 0.539 . . . . 16.2 111.345 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -105.6 121.14 43.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.193 0.52 . . . . 12.4 110.033 173.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.487 ' CG ' ' HG3' ' A' ' 27' ' ' ARG . 35.5 tt0 -100.02 136.61 39.67 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.463 -0.789 . . . . 11.63 109.014 -177.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 52' ' ' GLU . 38.0 p -96.95 151.84 19.3 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.947 -0.301 . . . . 9.15 110.674 -177.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -165.29 -177.5 37.75 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.913 -0.661 . . . . 6.81 111.893 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.509 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 1.2 mt -130.06 146.41 34.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.343 -0.614 . . . . 10.17 109.343 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.72 118.56 13.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.437 -0.579 . . . . 8.73 109.437 174.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -87.65 -44.72 10.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.536 -0.756 . . . . 10.86 109.37 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt -149.16 154.59 39.4 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.217 -0.901 . . . . 14.06 110.806 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.8 mt -119.14 109.68 16.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.758 -0.656 . . . . 11.73 110.169 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.401 HD13 ' CD2' ' A' ' 19' ' ' TYR . 4.6 mp -99.47 179.04 4.69 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.238 -1.023 . . . . 11.36 108.238 176.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -90.44 114.14 26.23 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.148 -0.621 . . . . 15.94 110.354 -176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 m 72.16 16.38 5.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.942 -1.026 . . . . 13.01 111.095 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.401 ' CD2' HD13 ' A' ' 16' ' ' LEU . 47.2 t80 -156.58 139.87 15.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.717 -0.674 . . . . 12.34 109.764 -177.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.433 ' HA3' ' CE1' ' A' ' 33' ' ' PHE . . . -127.44 156.45 20.46 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.697 -0.763 . . . . 7.52 112.667 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -118.74 129.83 55.48 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.463 -0.199 . . . . 9.24 110.463 -176.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -114.22 127.55 71.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.153 -0.314 . . . . 7.75 110.153 178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 11' ' ' ILE . 9.8 pt20 -83.14 144.14 30.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.62 0.724 . . . . 11.8 111.877 -175.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.5 p -79.54 2.23 22.96 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 114.461 -1.245 . . . . 12.34 112.764 -175.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.4 m -53.2 -24.46 11.03 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 112.803 0.668 . . . . 13.33 112.803 -175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -91.4 -6.95 52.06 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.977 0.362 . . . . 11.9 111.977 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HG3' ' CG ' ' A' ' 8' ' ' GLU . 9.7 mmt85 -151.33 -158.53 0.92 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.999 0.428 . . . . 12.99 110.529 -170.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -123.74 28.57 6.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.045 0.45 . . . . 16.66 109.996 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.48 135.22 19.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.844 -0.617 . . . . 12.09 110.699 -177.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 16.7 ptp180 -89.39 121.76 31.95 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.658 -0.497 . . . . 12.51 109.658 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.37 155.13 23.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.172 0.51 . . . . 8.76 110.77 179.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -132.06 142.88 49.69 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.701 -0.681 . . . . 9.15 109.555 176.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.433 ' CE1' ' HA3' ' A' ' 20' ' ' GLY . 17.6 p90 -126.63 163.79 22.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.027 0.441 . . . . 6.85 110.416 -176.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -112.65 152.44 28.97 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.691 -0.485 . . . . 9.99 109.691 177.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-30 -62.98 -21.55 66.2 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.316 -0.402 . . . . 9.93 111.772 -175.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.6 t -72.93 -19.82 61.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.526 -0.306 . . . . 12.28 111.09 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 1.9 mp0 -95.56 -26.24 15.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.603 -0.272 . . . . 10.62 111.41 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -68.48 112.81 5.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 8.78 110.553 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 10.2 t -91.56 97.22 10.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.977 -0.556 . . . . 8.97 110.195 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.6 -176.04 34.8 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 110.84 -0.904 . . . . 9.98 110.84 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -77.67 95.75 4.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.816 0.341 . . . . 12.43 110.176 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tp -60.75 -25.86 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 121.383 0.611 . . . . 11.58 110.514 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.38 -25.79 68.12 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.369 -0.832 . . . . 14.73 111.22 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -108.18 17.52 22.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.39 -0.368 . . . . 13.3 111.069 -177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.7 tp -97.71 125.95 42.77 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.009 -0.737 . . . . 10.07 109.009 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -123.4 173.88 7.71 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.998 -0.371 . . . . 13.13 109.998 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 47' ' ' ILE . 3.8 mp -70.97 131.78 34.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.968 -0.382 . . . . 11.74 109.968 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 97.79 2.24 58.51 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.504 -0.855 . . . . 10.13 112.276 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.0 124.61 89.58 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 110.559 -0.163 . . . . 8.39 110.559 175.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.55 132.05 7.68 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.788 2.326 . . . . 7.28 112.662 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.451 HG12 ' HG2' ' A' ' 71' ' ' LYS . 27.3 m -136.96 161.18 36.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.115 0.483 . . . . 4.74 111.311 -177.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.424 ' HB3' HG22 ' A' ' 9' ' ' THR . 6.6 pt-20 -120.41 136.67 54.65 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.175 -0.676 . . . . 7.09 109.175 170.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -131.8 148.91 52.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.451 0.643 . . . . 7.82 111.214 -176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 67' ' ' SER . 35.8 tt0 -88.98 110.49 21.16 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.408 -0.815 . . . . 11.59 109.309 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.61 105.32 13.55 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.271 -0.64 . . . . 12.41 109.271 -176.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.419 HG23 ' HG2' ' A' ' 54' ' ' GLU . 23.9 p -134.87 171.25 14.67 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.373 0.606 . . . . 13.17 111.987 -174.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -113.45 111.02 21.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.739 -0.664 . . . . 16.21 110.394 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -72.59 122.84 22.05 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.777 -0.453 . . . . 16.64 109.777 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -79.36 -6.74 57.46 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.666 0.617 . . . . 22.64 112.666 -174.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -82.91 -44.54 15.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.13 0.49 . . . . 21.43 109.807 177.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 30.9 p -90.69 -28.23 18.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.832 -0.622 . . . . 17.4 111.391 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.9 29.13 61.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.113 -0.565 . . . . 16.7 111.871 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -127.37 153.73 77.17 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 110.224 -0.287 . . . . 14.73 110.224 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.77 125.47 9.47 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.051 1.834 . . . . 12.6 111.061 176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -138.44 179.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.193 0.52 . . . . 11.73 111.078 -175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.7 139.32 50.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.724 -0.671 . . . . 8.91 109.302 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.522 ' HB2' ' HB3' ' A' ' 54' ' ' GLU . 14.7 m -70.16 -148.03 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.096 -0.502 . . . . 9.83 110.949 177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.439 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 14.0 mm100 -66.74 29.09 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 114.841 1.423 . . . . 11.32 114.841 -170.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 68' ' ' GLN . 39.0 t 4.97 99.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 125.201 1.4 . . . . 6.11 113.677 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.8 m -112.15 138.02 49.41 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.981 0.419 . . . . 6.12 110.522 -174.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.451 ' HG2' HG12 ' A' ' 51' ' ' VAL . 50.0 mtpt -70.51 142.2 51.87 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.494 -0.558 . . . . 6.3 109.494 176.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.3 mt -62.75 110.18 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.282 0.563 . . . . 5.77 110.739 -178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.48 163.6 21.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.785 -0.643 . . . . 5.69 111.236 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -58.08 146.98 85.52 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.439 2.093 . . . . 6.86 112.091 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.492 ' HG2' ' H ' ' A' ' 76' ' ' VAL . 14.1 tt0 -97.1 -147.11 0.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.072 -0.513 . . . . 8.49 110.304 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.492 ' H ' ' HG2' ' A' ' 75' ' ' GLU . 18.3 t -62.58 145.8 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 122.766 0.426 . . . . 6.19 111.09 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.07 111.6 26.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.493 -0.321 . . . . 6.26 110.908 -177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.56 ' HB3' ' HB2' ' A' ' 144' ' ' ALA . 0.0 OUTLIER -112.16 -7.57 14.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.919 0.39 . . . . 6.05 111.507 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.8 m -85.45 28.6 0.74 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.34 0.496 . . . . 7.02 112.34 -174.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -91.92 -36.78 13.26 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.585 -0.446 . . . . 7.07 111.372 178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -169.13 144.65 3.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.291 0.567 . . . . 6.68 111.3 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -112.49 97.44 6.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.383 -0.826 . . . . 6.43 109.136 174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.7 m -90.88 168.15 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.328 0.585 . . . . 3.7 111.137 -175.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 23.3 p -108.85 139.09 44.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.512 -0.767 . . . . 3.49 110.729 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -135.27 166.49 24.43 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.593 -0.813 . . . . 2.58 112.379 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.4 m -118.4 134.62 54.91 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.634 -0.506 . . . . 3.34 109.634 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.645 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 47.9 t -67.46 123.89 21.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.792 -0.447 . . . . 3.14 109.792 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.7 -24.13 12.21 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.196 -0.456 . . . . 3.61 111.131 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.6 m -153.09 132.44 12.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.084 -0.507 . . . . 3.12 110.11 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -92.52 -172.37 3.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.946 0.403 . . . . 4.39 110.169 176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.62 126.85 30.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.711 -0.848 . . . . 3.62 108.711 172.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 ttt85 -65.14 111.91 3.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.308 0.575 . . . . 7.2 111.529 -175.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 p -116.67 112.94 21.94 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.291 -0.868 . . . . 5.1 109.507 176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -68.94 -60.03 2.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.146 -0.479 . . . . 7.53 110.983 -175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.0 m -105.78 154.09 20.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.021 -0.536 . . . . 7.47 110.107 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.46 -25.89 67.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 7.58 111.547 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -90.34 -20.59 22.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.882 -0.599 . . . . 8.32 110.437 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -102.87 102.59 12.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.17 0.509 . . . . 7.26 110.698 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 39.7 t -107.47 127.87 63.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.753 -0.658 . . . . 5.54 109.799 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 61.9 tp -127.89 97.64 4.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.555 0.693 . . . . 7.28 110.503 -176.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -90.23 63.01 5.63 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.665 -1.152 . . . . 7.54 109.715 177.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 53.3 p -96.46 144.29 26.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.666 -0.697 . . . . 5.41 109.573 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.3 m -76.55 5.24 7.7 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.188 0.44 . . . . 4.58 112.188 -173.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -86.39 -32.73 20.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.984 0.421 . . . . 5.09 110.287 175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.3 t -98.8 87.15 3.68 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.153 0.978 . . . . 3.33 109.311 175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.401 HG21 ' HB2' ' A' ' 121' ' ' PRO . 15.6 m -94.27 132.96 38.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.036 -0.984 . . . . 2.57 110.612 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.75 169.35 48.28 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.795 -0.717 . . . . 1.66 112.323 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -130.81 134.79 47.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.261 0.553 . . . . 3.03 111.551 -176.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.495 HG13 ' CD1' ' A' ' 122' ' ' TYR . 97.7 mt -112.9 125.41 70.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.967 -1.015 . . . . 1.88 109.435 172.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 p -97.66 126.16 42.83 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.691 -0.485 . . . . 3.49 109.691 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -134.23 154.42 51.27 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.844 -0.428 . . . . 3.51 109.844 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -115.54 121.31 42.25 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.175 -0.466 . . . . 5.1 110.38 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.517 ' OD1' ' HG3' ' A' ' 114' ' ' ARG . 23.5 t-20 -160.69 143.27 12.88 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.464 . . . . 4.78 109.959 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.517 ' HG3' ' OD1' ' A' ' 113' ' ' ASN . 79.7 mtp180 64.48 20.77 12.27 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.464 0.478 . . . . 6.97 110.893 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.75 1.12 90.1 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.855 -0.611 . . . . 5.1 112.555 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -114.29 151.05 33.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.658 -0.497 . . . . 5.38 109.658 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 1.6 p -120.47 104.64 10.14 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.136 0.493 . . . . 4.72 110.435 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -104.2 169.24 8.6 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.757 -0.656 . . . . 4.61 111.054 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -120.27 123.15 42.49 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.708 -0.678 . . . . 3.96 110.173 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.51 138.19 19.44 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 116.536 -0.302 . . . . 2.75 110.372 -178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HB2' HG21 ' A' ' 106' ' ' THR . 73.3 Cg_endo -76.83 142.62 22.7 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.773 2.315 . . . . 2.3 111.827 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.495 ' CD1' HG13 ' A' ' 109' ' ' ILE . 34.5 p90 -146.35 152.27 38.85 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.086 0.469 . . . . 2.13 110.776 176.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -113.83 156.81 23.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.714 -0.676 . . . . 3.07 110.304 174.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -66.97 -28.15 68.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.084 0.469 . . . . 4.8 111.252 -175.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -69.62 -16.18 63.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.811 -0.631 . . . . 4.81 111.38 -177.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -104.05 23.93 12.19 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.078 -0.51 . . . . 3.84 111.242 -173.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.9 t -100.08 114.71 39.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.352 0.596 . . . . 4.39 111.338 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 157' ' ' ARG . 0.6 OUTLIER -79.71 151.78 30.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.428 -0.805 . . . . 6.43 108.856 178.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.14 -16.55 42.58 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.714 -0.755 . . . . 5.91 111.47 -174.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.6 m120 63.47 24.76 14.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.257 0.623 . . . . 6.07 111.445 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.61 138.17 19.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.362 -0.381 . . . . 5.27 109.985 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -83.01 91.84 7.25 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.737 -0.468 . . . . 5.78 109.737 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.1 pt? -71.69 144.2 49.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.633 -0.712 . . . . 3.62 110.943 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -140.69 148.96 41.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.833 -0.622 . . . . 6.93 110.33 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.645 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -49.98 124.34 9.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.124 -0.489 . . . . 4.12 112.181 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.0 -24.43 8.3 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.477 -0.783 . . . . 4.07 113.569 -178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -87.65 178.07 6.86 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 117.782 0.791 . . . . 4.06 110.625 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -117.18 122.77 44.96 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-O 121.461 0.648 . . . . 4.17 111.58 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.02 157.66 20.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 114.979 -1.01 . . . . 2.77 110.788 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 69.0 m -113.89 129.9 56.55 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.445 -0.576 . . . . 3.47 109.445 173.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -126.4 139.19 53.45 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.127 0.489 . . . . 3.35 109.734 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -94.97 116.84 29.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.588 -0.733 . . . . 5.34 109.417 -175.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 76.4 mt -77.7 111.52 14.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.854 -0.612 . . . . 4.66 110.304 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.56 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . . . -97.43 109.04 21.88 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.585 -0.734 . . . . 4.85 110.658 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 88.6 m -85.43 120.86 27.36 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.455 0.472 . . . . 5.68 111.076 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -72.74 171.33 12.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.976 -0.557 . . . . 6.25 110.698 176.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -57.92 -22.39 48.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.167 0.803 . . . . 8.58 113.167 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -111.08 -2.7 15.77 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.109 -0.636 . . . . 7.86 111.617 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 98.07 11.03 50.66 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 120.281 -0.961 . . . . 5.59 114.469 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -98.19 132.27 43.85 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.812 -0.81 . . . . 5.18 108.812 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.476 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -146.6 -178.24 6.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.212 0.53 . . . . 4.28 112.333 -174.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -146.16 -122.77 1.47 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.862 -1.063 . . . . 3.36 111.026 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -136.87 131.47 33.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.917 0.358 . . . . 2.84 110.389 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 74.5 m -142.65 159.53 42.05 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.128 -0.487 . . . . 4.34 109.738 178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 57.72 54.96 5.84 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.762 0.664 . . . . 5.75 110.68 179.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.2 mp -82.84 114.22 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.803 -0.443 . . . . 3.55 109.803 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.45 ' HB2' ' HB3' ' A' ' 128' ' ' GLU . 34.3 ttt180 -120.14 128.76 53.72 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.99 -0.374 . . . . 5.96 109.99 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.2 tt -77.04 117.01 18.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.998 -0.546 . . . . 4.34 110.012 -178.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -92.2 -54.82 3.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.719 -0.673 . . . . 4.97 111.015 -177.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -122.1 106.46 36.15 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.068 -0.515 . . . . 5.37 110.653 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -77.58 -176.62 3.32 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.262 1.974 . . . . 5.44 112.069 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -139.75 121.04 14.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.994 -0.548 . . . . 6.1 110.186 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 66.79 90.47 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.257 0 O-C-N 123.829 0.706 . . . . 9.49 111.275 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.72 130.94 20.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.378 2.052 . . . . 8.39 112.659 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 59.9 t . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.993 -0.549 . . . . 10.27 110.607 179.933 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.357 0 N-CA-C 112.162 -0.375 . . . . 21.66 112.162 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.91 110.8 20.2 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.791 0.329 . . . . 20.17 110.232 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -116.01 -52.43 2.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.576 0.703 . . . . 18.5 110.252 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -85.25 43.27 1.0 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.095 -0.957 . . . . 16.62 111.378 -174.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -75.48 -75.78 0.17 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.831 -0.622 . . . . 18.35 110.816 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -140.93 133.41 28.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.285 -0.87 . . . . 16.2 110.144 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -104.12 121.97 44.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.959 -0.564 . . . . 12.4 109.814 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.428 ' CD ' ' HB2' ' A' ' 55' ' ' MET . 7.5 pt-20 -121.41 138.04 54.44 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.191 0.519 . . . . 11.63 111.056 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.0 p -109.11 160.89 15.7 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.031 -0.531 . . . . 9.15 111.562 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.73 174.28 42.11 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.001 -0.839 . . . . 6.81 111.001 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.9 mt -109.87 144.94 17.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.767 0.283 . . . . 10.17 110.393 178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.402 HD11 HG11 ' A' ' 51' ' ' VAL . 45.9 mm -66.33 114.35 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 110.284 -0.265 . . . . 8.73 110.284 174.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.21 -55.17 5.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.435 . . . . 10.86 111.49 -176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.595 ' HD3' ' N ' ' A' ' 15' ' ' LEU . 8.2 tmtt? -159.39 136.47 9.61 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.729 -0.471 . . . . 14.06 109.729 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.595 ' N ' ' HD3' ' A' ' 14' ' ' LYS . 72.7 mt -93.62 117.17 29.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.311 0.577 . . . . 11.73 111.492 178.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.5 mp -109.17 -178.57 3.6 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 107.876 -1.157 . . . . 11.36 107.876 172.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -88.26 130.61 35.05 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.082 -0.647 . . . . 15.94 109.696 -177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m 75.28 -44.24 0.53 Allowed 'General case' 0 N--CA 1.465 0.32 0 O-C-N 124.303 1.002 . . . . 13.01 112.016 -178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -121.87 148.85 44.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.131 0.491 . . . . 12.34 111.417 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -139.89 169.86 24.5 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 111.478 -0.649 . . . . 7.52 111.478 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -121.86 144.53 48.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.057 0.456 . . . . 9.24 111.608 -177.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.9 mt -105.83 129.92 58.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.655 -0.702 . . . . 7.75 109.695 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.512 ' HG3' ' H ' ' A' ' 25' ' ' CYS . 13.8 tp60 -77.07 132.77 39.08 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.928 -0.578 . . . . 11.8 111.27 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.593 ' HB3' ' N ' ' A' ' 30' ' ' ARG . 6.5 p -84.94 0.62 50.6 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.348 0.87 . . . . 12.34 113.348 175.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.512 ' H ' ' HG3' ' A' ' 23' ' ' GLN . 68.4 m -60.74 -22.93 64.54 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.675 0.991 . . . . 13.33 113.675 -168.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -102.59 -29.47 11.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.347 0.594 . . . . 11.9 110.435 -178.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.535 ' HG2' ' H ' ' A' ' 28' ' ' GLN . 12.6 ttp85 -105.61 -157.69 0.62 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.447 -0.797 . . . . 12.99 110.088 179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.535 ' H ' ' HG2' ' A' ' 27' ' ' ARG . 44.4 mt-30 -123.37 21.34 9.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 16.66 110.744 176.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.13 115.38 5.43 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.787 0.327 . . . . 12.09 111.847 -177.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.593 ' N ' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -87.03 141.59 28.56 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 108.873 -0.788 . . . . 12.51 108.873 172.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.9 mt -138.37 162.39 34.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.662 0.267 . . . . 8.76 110.95 -177.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -113.19 148.56 35.2 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.515 -0.55 . . . . 9.15 109.515 176.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -145.39 159.4 43.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.511 -0.551 . . . . 6.85 109.511 178.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -106.75 162.78 13.48 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.439 -0.578 . . . . 9.99 109.439 178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -66.52 -19.12 65.71 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.938 0.399 . . . . 9.93 110.508 179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.7 p -76.91 -15.32 59.71 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.031 -0.531 . . . . 12.28 110.729 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -102.06 20.69 16.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.389 -0.369 . . . . 10.62 110.789 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -123.02 108.11 12.55 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.222 0.534 . . . . 8.78 109.717 176.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' A' ' 68' ' ' GLN . 51.1 m -94.44 104.33 16.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.711 -0.677 . . . . 8.97 111.052 -178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 160.37 -165.84 35.07 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.48 -1.048 . . . . 9.98 110.48 -179.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -94.21 119.34 32.87 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 117.347 0.573 . . . . 12.43 109.904 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.8 tp -64.81 -20.66 27.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 11.58 111.067 -175.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -71.65 -3.99 24.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 14.73 111.355 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -118.41 21.87 12.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.073 0.464 . . . . 13.3 109.89 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -125.88 112.34 15.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.205 -0.665 . . . . 10.07 109.205 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -120.05 178.58 4.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.255 0.55 . . . . 13.13 111.298 -175.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.1 mt -86.51 130.73 36.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.383 -0.826 . . . . 11.74 109.363 176.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.12 10.9 61.97 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.41 -0.9 . . . . 10.13 110.991 -172.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -89.06 123.52 67.15 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.137 -0.531 . . . . 8.39 110.05 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.51 126.6 11.69 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 122.661 2.241 . . . . 7.28 112.539 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.422 HG12 ' CD ' ' A' ' 71' ' ' LYS . 28.0 m -125.51 151.57 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.211 -0.45 . . . . 4.74 111.389 -176.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.33 129.8 56.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.222 -0.658 . . . . 7.09 109.222 173.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.1 p90 -144.61 175.56 10.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.249 0.547 . . . . 7.82 111.357 -175.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -123.48 138.44 54.58 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.604 -0.726 . . . . 11.59 109.969 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.428 ' HB2' ' CD ' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -92.1 111.38 22.91 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.56 -0.533 . . . . 12.41 109.56 179.361 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.0 p -134.43 133.77 40.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.062 0.458 . . . . 13.17 112.037 -174.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 64' ' ' PRO . 16.8 m-85 -89.13 109.6 20.44 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.158 -0.474 . . . . 16.21 110.103 175.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -77.28 97.38 4.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.723 -0.473 . . . . 16.64 109.723 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -72.38 -5.43 36.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.318 -0.401 . . . . 22.64 111.471 -177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -69.63 -30.6 68.35 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.356 -0.609 . . . . 21.43 109.356 174.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.9 p -113.11 -36.93 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.799 -0.637 . . . . 17.4 111.208 176.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 104.34 17.29 15.94 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.955 -0.566 . . . . 16.7 112.128 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -121.02 148.66 49.39 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 120.641 0.258 . . . . 14.73 111.277 -176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 57' ' ' TYR . 78.7 Cg_endo -80.17 126.34 6.26 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.42 2.08 . . . . 12.6 112.144 175.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 45.0 pt -132.28 165.0 33.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.075 0.464 . . . . 11.73 110.555 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.52 157.24 16.3 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.979 -0.749 . . . . 8.91 108.979 171.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.9 t -70.68 -162.55 0.06 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.873 0.368 . . . . 9.83 110.038 176.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.449 ' HB2' ' OG ' ' A' ' 39' ' ' SER . 22.3 pt20 -74.05 8.16 2.25 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.66 0.615 . . . . 11.32 112.66 -172.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.2 t 53.33 99.29 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 121.705 0.764 . . . . 6.11 112.572 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -96.26 129.98 43.46 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.039 -0.528 . . . . 6.12 110.105 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.422 ' CD ' HG12 ' A' ' 51' ' ' VAL . 13.9 mmmm -76.72 132.34 39.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.242 -0.435 . . . . 6.3 110.411 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 29.6 mt -68.81 113.32 4.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.759 -0.655 . . . . 5.77 110.573 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.87 166.0 38.3 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.299 -0.864 . . . . 5.69 110.745 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -60.31 158.35 31.45 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.646 2.231 . . . . 6.86 112.042 174.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -81.17 167.83 19.21 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.883 -0.598 . . . . 8.49 110.589 -177.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.544 HG12 ' HB1' ' A' ' 144' ' ' ALA . 22.4 t -54.4 142.06 8.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.169 -0.469 . . . . 6.19 111.242 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 64.0 t -77.27 102.86 4.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.076 0.465 . . . . 6.26 111.402 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -98.32 16.23 22.18 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.822 0.82 . . . . 6.05 108.829 177.041 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.0 t -102.63 77.06 1.57 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.511 0.672 . . . . 7.02 110.137 178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -149.17 106.8 3.65 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.974 -1.121 . . . . 7.07 107.974 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.47 ' OE1' ' HG2' ' A' ' 82' ' ' ARG . 7.8 tp10 -44.67 140.87 2.26 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.09 -0.959 . . . . 6.68 111.955 -175.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.47 ' HG2' ' OE1' ' A' ' 81' ' ' GLU . 8.5 ptp85 -60.14 106.73 0.55 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.99 -1.004 . . . . 6.43 110.973 -176.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.8 m -95.04 156.18 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.638 -0.71 . . . . 3.7 110.133 178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 21.7 p -115.77 140.0 49.63 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.827 -0.624 . . . . 3.49 110.695 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.6 166.9 26.04 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.649 -0.786 . . . . 2.58 112.052 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.1 m -97.02 127.97 43.52 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 110.173 -0.306 . . . . 3.34 110.173 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 91.2 t -64.0 124.51 18.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.479 -0.328 . . . . 3.14 110.242 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 28.7 p -112.02 -8.26 14.06 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.748 0.309 . . . . 3.61 111.159 178.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.476 ' HB ' ' N ' ' A' ' 108' ' ' ARG . 11.4 m -152.29 138.58 18.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.46 -0.336 . . . . 3.12 110.275 178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.588 ' OE2' ' HD2' ' A' ' 134' ' ' ARG . 18.5 mt-10 -119.16 161.71 19.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.776 0.322 . . . . 4.39 110.851 -174.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.427 HD22 ' HG3' ' A' ' 124' ' ' LYS . 5.2 mp -110.5 146.73 35.47 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.85 -0.796 . . . . 3.62 108.85 173.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -117.68 173.31 6.81 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.882 0.373 . . . . 7.2 111.202 -171.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 p -91.62 123.11 34.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.982 -0.554 . . . . 5.1 109.737 172.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -113.46 -171.2 1.84 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.888 -0.325 . . . . 7.53 110.7 -174.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.0 t 65.22 -82.31 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.649 0.78 . . . . 7.47 110.863 -178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -160.04 70.66 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.654 0.264 . . . . 7.58 110.952 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.7 m120 63.9 13.54 7.67 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.815 -0.63 . . . . 8.32 112.421 174.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -97.86 151.47 20.19 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.047 -0.353 . . . . 7.26 110.047 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.7 m -79.28 130.82 35.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.514 0.673 . . . . 5.54 110.859 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 55.5 tp -150.29 121.55 7.82 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.02 -1.474 . . . . 7.28 107.02 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -47.07 -50.81 19.09 Favored 'General case' 0 C--N 1.314 -0.955 0 O-C-N 124.008 0.818 . . . . 7.54 111.667 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 6.3 t 60.48 55.52 3.42 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.024 -0.732 . . . . 5.41 109.024 -178.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 10.5 m -68.5 6.65 0.77 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.262 -0.881 . . . . 4.58 112.592 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -93.73 -10.77 33.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.946 0.403 . . . . 5.09 110.259 176.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 15.0 t -119.66 145.25 46.65 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.759 -0.83 . . . . 3.33 108.759 174.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 p -125.3 122.19 36.16 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.19 0.441 . . . . 2.57 112.19 -172.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -72.53 156.43 52.02 Favored Glycine 0 N--CA 1.439 -1.146 0 N-CA-C 108.891 -1.683 . . . . 1.66 108.891 166.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.476 ' N ' ' HB ' ' A' ' 89' ' ' THR . 19.5 mtt180 -135.08 141.68 46.13 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 118.511 1.156 . . . . 3.03 111.723 -174.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 72.4 mt -113.21 128.5 69.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.01 -0.995 . . . . 1.88 109.516 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 t -104.69 122.55 45.91 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.282 -0.636 . . . . 3.49 109.282 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -131.75 167.56 19.3 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 110.146 -0.316 . . . . 3.51 110.146 -178.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -137.26 118.29 14.34 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.009 -0.738 . . . . 5.1 109.009 175.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -132.81 113.64 13.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.362 -0.381 . . . . 4.78 110.712 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 65.34 23.23 12.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.118 -0.492 . . . . 6.97 111.191 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.31 5.63 61.91 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.021 -0.609 . . . . 5.1 112.672 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -110.68 118.12 35.31 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.056 0.455 . . . . 5.38 110.157 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 20.5 p -119.97 125.09 47.56 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.954 -0.566 . . . . 4.72 110.584 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -134.81 172.36 13.09 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.706 0.289 . . . . 4.61 110.576 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -112.21 119.36 38.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.738 -0.665 . . . . 3.96 109.416 174.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 108' ' ' ARG . 3.1 mm? -104.54 118.17 57.23 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 120.711 0.291 . . . . 2.75 110.344 -177.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 32.9 Cg_endo -80.2 131.67 8.87 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.19 1.927 . . . . 2.3 111.569 176.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -133.39 156.69 47.21 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.787 0.327 . . . . 2.13 110.273 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.64 169.01 9.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.99 -0.55 . . . . 3.07 110.156 175.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.427 ' HG3' HD22 ' A' ' 91' ' ' LEU . 52.8 mtmt -70.76 -18.95 62.76 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.08 0.4 . . . . 4.8 112.08 -174.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -81.59 -5.39 57.98 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.344 -0.389 . . . . 4.81 111.149 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -86.77 -13.84 44.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.652 -0.249 . . . . 3.84 111.031 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.43 ' HB ' ' HB ' ' A' ' 156' ' ' ILE . 4.7 p -119.27 112.69 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.224 0.535 . . . . 4.39 110.688 -178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.4 ' OE1' ' HA ' ' A' ' 155' ' ' HIS . 0.8 OUTLIER -95.05 175.17 6.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.167 -0.47 . . . . 6.43 110.415 178.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.76 -12.71 68.68 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.653 -0.784 . . . . 5.91 111.869 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 17.6 m120 59.31 41.41 19.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.062 0.458 . . . . 6.07 111.251 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.71 150.42 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.869 -0.605 . . . . 5.27 110.331 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -101.44 85.38 2.77 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.131 0.491 . . . . 5.78 110.037 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.724 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.1 pt? -75.37 128.6 35.73 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.694 -0.684 . . . . 3.62 110.325 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.588 ' HD2' ' OE2' ' A' ' 90' ' ' GLU . 18.0 tpt180 -105.65 143.71 33.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.718 -0.673 . . . . 6.93 110.448 -173.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.603 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -63.82 113.64 3.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.997 0.427 . . . . 4.12 110.051 174.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 116.31 -11.52 16.79 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 111.268 -0.733 . . . . 4.07 111.268 -173.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.533 ' OD2' ' HA ' ' A' ' 161' ' ' PRO . 4.9 t70 -87.83 -179.13 6.2 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 109.211 -0.663 . . . . 4.06 109.211 178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -122.87 114.62 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.123 0.487 . . . . 4.17 110.71 -176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.2 m -119.93 149.8 22.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.068 0.461 . . . . 2.77 111.316 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -100.88 135.07 42.9 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.602 -0.726 . . . . 3.47 109.554 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.444 ' C ' HE21 ' A' ' 142' ' ' GLN . 24.4 p90 -144.95 149.71 35.7 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.41 -0.359 . . . . 3.35 110.536 -178.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.713 HE21 ' N ' ' A' ' 142' ' ' GLN . 0.0 OUTLIER -102.7 139.36 38.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.191 -0.459 . . . . 5.34 109.893 178.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 56.2 mt -101.88 100.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.033 0.444 . . . . 4.66 110.627 -178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -97.3 110.92 23.38 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.3 -0.409 . . . . 4.85 110.964 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 26.7 m -79.89 110.79 15.6 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.976 -0.557 . . . . 5.68 111.311 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -83.53 165.68 18.89 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.059 -0.519 . . . . 6.25 110.466 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -48.98 -44.8 41.32 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.667 0.988 . . . . 8.58 113.667 -172.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.3 ptt85 -81.31 3.18 25.05 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.158 -0.617 . . . . 7.86 111.519 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 87.64 23.1 40.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.525 -0.845 . . . . 5.59 111.76 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -96.33 127.35 42.25 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.186 -0.302 . . . . 5.18 110.186 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.468 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.54 163.64 39.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.807 0.336 . . . . 4.28 110.401 175.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -156.86 -110.82 0.32 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.892 -0.883 . . . . 3.36 110.892 177.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -147.89 110.44 4.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.678 -0.49 . . . . 2.84 109.678 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 9.1 t -115.91 158.81 22.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.699 -0.482 . . . . 4.34 109.699 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.4 ' HA ' ' OE1' ' A' ' 128' ' ' GLU . 10.4 p80 38.46 65.35 0.63 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 124.352 1.033 . . . . 5.75 111.608 -174.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.43 ' HB ' ' HB ' ' A' ' 127' ' ' VAL . 77.7 mt -77.43 133.77 29.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 114.192 -1.367 . . . . 3.55 110.707 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -126.84 124.31 39.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.068 0.461 . . . . 5.96 110.825 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.5 tt -85.99 106.8 17.42 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.717 -0.846 . . . . 4.34 108.717 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.69 -42.37 5.2 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.078 -0.51 . . . . 4.97 111.934 -174.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -121.22 93.84 48.8 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.789 -0.449 . . . . 5.37 109.789 -176.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.533 ' HA ' ' OD2' ' A' ' 137' ' ' ASP . 74.2 Cg_endo -75.43 156.41 41.1 Favored 'Trans proline' 0 C--O 1.237 0.475 0 C-N-CA 122.649 2.233 . . . . 5.44 112.603 -176.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.56 157.83 44.12 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.909 -0.587 . . . . 6.1 111.018 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -111.77 114.07 52.32 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 109.931 -0.396 . . . . 9.49 109.931 174.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -46.79 139.9 13.47 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.733 2.956 . . . . 8.39 113.701 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 C--O 1.237 0.41 0 CA-C-N 115.57 -0.741 . . . . 10.27 112.064 -178.62 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 111.991 -0.443 . . . . 21.66 111.991 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.91 26.59 16.49 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 122.748 0.419 . . . . 20.17 111.346 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -99.48 6.14 46.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.483 0.659 . . . . 18.5 109.724 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -136.13 95.14 3.14 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.693 -0.854 . . . . 16.62 108.693 177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -113.61 -84.62 0.6 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.228 -0.589 . . . . 18.35 112.558 -176.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -132.68 123.58 26.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.518 0.675 . . . . 16.2 111.43 -172.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -99.65 139.96 34.54 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.113 -0.949 . . . . 12.4 111.078 -176.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.539 ' OE1' ' HD3' ' A' ' 27' ' ' ARG . 15.0 mm-40 -110.21 138.22 46.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.699 -0.682 . . . . 11.63 110.351 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -93.38 145.12 24.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.259 -0.428 . . . . 9.15 111.128 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.3 -175.48 23.18 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.553 -0.619 . . . . 6.81 111.553 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 40.1 mt -127.75 141.9 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.808 -0.442 . . . . 10.17 109.808 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.01 122.77 19.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.969 -0.292 . . . . 8.73 110.441 177.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -81.73 -53.78 5.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 10.86 111.197 -177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.409 ' HD3' HG12 ' A' ' 47' ' ' ILE . 53.4 mmtt -158.98 147.94 18.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.01 -0.541 . . . . 14.06 110.51 -177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -95.78 95.67 8.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.15 -0.477 . . . . 11.73 110.905 176.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 4.3 mm? -92.07 179.25 5.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.578 -0.737 . . . . 11.36 109.549 174.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -91.14 120.78 32.37 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.262 -0.273 . . . . 15.94 110.262 -175.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.6 t 79.15 -40.97 0.25 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.961 0.905 . . . . 13.01 111.379 179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 7.1 p90 -119.34 146.22 45.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.919 0.39 . . . . 12.34 111.051 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.77 163.02 22.89 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.599 -0.6 . . . . 7.52 111.599 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -119.97 143.59 47.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.892 0.377 . . . . 9.24 111.364 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.4 mt -110.44 129.28 65.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.65 -0.704 . . . . 7.75 110.232 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.79 140.53 42.39 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.81 0.814 . . . . 11.8 111.678 -177.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.4 p -80.09 0.95 29.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.335 -1.302 . . . . 12.34 112.131 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 59.6 m -51.91 -39.6 59.36 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 112.471 0.545 . . . . 13.33 112.471 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -89.59 -13.31 37.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.251 0.548 . . . . 11.9 111.174 -177.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.539 ' HD3' ' OE1' ' A' ' 8' ' ' GLU . 0.0 OUTLIER -128.99 -158.46 0.89 Allowed 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.103 -0.373 . . . . 12.99 110.346 -175.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -124.03 19.22 9.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.076 0.465 . . . . 16.66 110.369 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.47 130.32 26.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.705 -0.679 . . . . 12.09 110.954 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -94.39 124.83 38.65 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.963 -0.754 . . . . 12.51 108.963 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.7 mt -123.72 162.4 23.22 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.069 0.462 . . . . 8.76 111.525 -174.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -126.05 148.51 49.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.669 -0.696 . . . . 9.15 109.356 174.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -142.39 153.35 43.7 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.894 -0.41 . . . . 6.85 109.894 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -95.71 161.65 13.94 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.603 -0.517 . . . . 9.99 109.603 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -64.05 -13.61 48.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.059 0.457 . . . . 9.93 111.118 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.4 t -74.88 -20.64 59.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.13 -0.487 . . . . 12.28 110.155 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -100.25 23.37 10.17 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.415 -0.357 . . . . 10.62 111.332 -178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -124.02 111.69 16.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.027 0.442 . . . . 8.78 110.341 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.8 t -89.17 91.85 8.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.013 -0.54 . . . . 8.97 110.335 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.05 173.84 31.21 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.929 -0.653 . . . . 9.98 112.18 178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -75.4 117.92 17.72 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.975 -0.38 . . . . 12.43 109.975 177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 tp -64.44 -18.86 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.829 -0.623 . . . . 11.58 111.93 -174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -54.97 -36.58 65.52 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.375 -0.375 . . . . 14.73 111.868 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -102.15 21.76 14.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.241 0.46 . . . . 13.3 112.241 -173.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -103.21 107.27 18.02 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.798 -0.361 . . . . 10.07 110.138 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -116.09 173.88 6.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.043 0.449 . . . . 13.13 110.904 -177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.7 mp -80.56 125.84 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 108.911 -0.774 . . . . 11.74 108.911 177.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.19 -13.75 28.52 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.953 -0.641 . . . . 10.13 111.893 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.7 125.05 91.76 Favored Pre-proline 0 C--O 1.237 0.406 0 CA-C-O 120.697 0.285 . . . . 8.39 110.553 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -74.98 132.07 15.04 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.469 2.113 . . . . 7.28 111.006 174.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.8 m -126.44 154.83 36.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.01 0.433 . . . . 4.74 111.296 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -109.51 126.57 53.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.414 -0.812 . . . . 7.09 109.468 176.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -140.3 161.08 38.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.901 0.381 . . . . 7.82 110.711 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -122.82 109.5 14.27 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.53 -0.544 . . . . 11.59 109.53 177.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 26.3 ttt -79.32 120.04 23.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.59 -0.732 . . . . 12.41 110.482 -176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.3 p -138.71 152.1 47.72 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.324 -0.398 . . . . 13.17 110.617 -176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -96.34 117.13 30.2 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.967 -0.383 . . . . 16.21 109.967 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -92.37 128.51 38.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.912 -0.585 . . . . 16.64 111.454 -176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -79.87 -13.28 59.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.535 -0.757 . . . . 22.64 111.473 -178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -79.53 -52.53 7.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 21.43 110.073 -176.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.6 p -85.43 -37.8 19.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.024 -0.535 . . . . 17.4 110.75 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.03 14.06 50.42 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.491 -0.644 . . . . 16.7 111.491 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -116.6 151.42 47.09 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.542 0.211 . . . . 14.73 110.489 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.31 124.42 8.41 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.725 1.617 . . . . 12.6 110.044 168.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.9 pt -126.47 169.69 17.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.15 0.5 . . . . 11.73 111.346 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.84 157.63 17.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.673 -0.862 . . . . 8.91 108.673 172.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.7 t -70.88 -162.23 0.06 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.481 -0.327 . . . . 9.83 110.56 176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -74.57 7.85 2.71 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.301 0.482 . . . . 11.32 112.301 -172.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.9 t 49.84 91.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 124.026 0.829 . . . . 6.11 112.429 173.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.92 111.49 16.3 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.791 -0.64 . . . . 6.12 110.545 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 112.27 6.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.709 -0.678 . . . . 6.3 109.462 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.1 mt -63.55 125.11 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.696 -0.684 . . . . 5.77 111.093 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.3 139.03 20.11 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.543 -0.753 . . . . 5.69 110.707 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -87.13 18.61 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.028 2.485 . . . . 6.86 113.653 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -86.63 174.79 8.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.025 0.44 . . . . 8.49 110.876 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.3 t -106.44 152.2 8.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.091 -0.504 . . . . 6.19 109.78 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 94.6 t -72.72 96.2 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 6.26 111.627 -176.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.596 HD23 ' HB2' ' A' ' 144' ' ' ALA . 54.3 mt -85.38 -27.81 25.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.811 -0.632 . . . . 6.05 111.152 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.0 m -110.86 81.2 1.39 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.197 0.523 . . . . 7.02 112.407 -175.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -96.22 -66.72 0.89 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.682 -1.229 . . . . 7.07 107.682 166.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -147.02 142.76 27.82 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.936 -0.574 . . . . 6.68 109.786 173.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 82' ' ' ARG . 45.7 ttm180 -82.86 100.64 10.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.815 -0.629 . . . . 6.43 110.072 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.9 m -99.53 153.81 4.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.323 0.582 . . . . 3.7 111.554 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.485 HG22 ' OG ' ' A' ' 140' ' ' SER . 60.7 p -116.11 140.49 49.23 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.599 -0.728 . . . . 3.49 109.582 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -142.0 174.06 23.37 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.003 -1.094 . . . . 2.58 112.421 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.0 m -125.52 128.67 48.36 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.607 0.242 . . . . 3.34 110.467 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.616 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 51.9 t -71.97 132.79 32.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.053 -0.522 . . . . 3.14 110.326 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 33.4 p -116.16 -9.17 11.68 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.178 0.513 . . . . 3.61 111.31 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.2 m -152.57 125.38 8.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.97 -0.559 . . . . 3.12 109.847 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -107.1 174.73 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.361 . . . . 4.39 110.904 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.49 150.2 23.62 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.945 0.403 . . . . 3.62 110.735 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 92' ' ' ARG . 11.0 ptt180 -82.53 115.59 21.58 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.608 -0.724 . . . . 7.2 111.38 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 99' ' ' VAL . 1.4 p -156.08 143.84 19.53 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.237 -0.892 . . . . 5.1 109.496 177.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -67.9 -41.46 82.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.888 0.375 . . . . 7.53 111.231 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.0 t -163.94 -162.46 0.7 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.296 -0.411 . . . . 7.47 110.04 -175.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.44 ' HB2' HD21 ' A' ' 132' ' ' ASN . . . -67.6 -63.32 1.08 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 7.58 110.565 177.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -91.78 65.07 4.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.089 0.471 . . . . 8.32 110.485 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -172.46 92.43 0.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.208 -1.034 . . . . 7.26 108.208 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.453 ' HA ' HG22 ' A' ' 93' ' ' THR . 30.5 m -126.83 19.46 3.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.744 0.646 . . . . 5.54 112.744 -171.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.625 ' H ' HD23 ' A' ' 100' ' ' LEU . 1.8 pt? -86.13 15.23 5.31 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.388 0.613 . . . . 7.28 110.769 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -82.56 6.5 17.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.434 -0.803 . . . . 7.54 110.312 176.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m 66.49 84.85 0.15 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.196 -0.911 . . . . 5.41 111.277 178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 48.6 m -82.09 53.03 2.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.959 -0.564 . . . . 4.58 110.429 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -82.44 -22.11 35.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.445 -0.798 . . . . 5.09 111.329 -175.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 14.9 t -86.73 154.91 20.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.068 -0.515 . . . . 3.33 110.187 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 8.7 p -101.57 125.64 48.26 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.494 -0.321 . . . . 2.57 111.398 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -71.2 167.66 51.46 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 110.895 -0.882 . . . . 1.66 110.895 174.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -131.75 132.44 43.84 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 117.305 0.552 . . . . 3.03 111.289 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 74.1 mt -113.05 133.62 58.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.391 -0.822 . . . . 1.88 109.309 173.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.9 t -84.17 134.47 34.57 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.222 -0.659 . . . . 3.49 109.222 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.517 ' CD2' HD11 ' A' ' 120' ' ' LEU . 36.5 t80 -157.01 142.73 17.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.16 0.505 . . . . 3.51 111.27 -168.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -129.82 131.49 46.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.673 -0.694 . . . . 5.1 109.311 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -152.29 131.89 13.08 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.871 0.367 . . . . 4.78 110.639 177.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? 63.48 21.87 12.96 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.017 -0.538 . . . . 6.97 111.616 171.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.71 -6.26 70.22 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.966 -0.635 . . . . 5.1 112.344 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.97 132.87 43.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.049 0.452 . . . . 5.38 110.24 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 15.1 m -121.8 115.55 22.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.108 -0.496 . . . . 4.72 109.896 -178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -156.64 173.89 16.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.77 0.319 . . . . 4.61 111.168 -176.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -107.38 141.85 38.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.971 -0.559 . . . . 3.96 110.167 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.517 HD11 ' CD2' ' A' ' 111' ' ' TYR . 1.7 mp -105.78 139.95 20.72 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.085 -0.709 . . . . 2.75 109.085 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.619 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 83.7 Cg_endo -86.93 132.17 3.3 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.951 2.434 . . . . 2.3 112.423 177.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -137.42 149.99 47.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.786 0.327 . . . . 2.13 110.559 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 31.8 p -113.56 177.99 4.44 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.781 -0.452 . . . . 3.07 109.781 172.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -70.85 -18.17 62.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.001 0.429 . . . . 4.8 110.635 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -76.98 -27.9 54.91 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.874 -0.603 . . . . 4.81 110.977 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -75.67 -25.79 57.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.069 0.461 . . . . 3.84 110.916 -178.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 156' ' ' ILE . 2.0 p -90.73 107.78 18.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.619 0.724 . . . . 4.39 111.263 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -98.84 139.72 34.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.321 -0.854 . . . . 6.43 108.696 177.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 136.55 -12.81 4.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.517 -0.849 . . . . 5.91 112.252 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 68.09 19.17 9.31 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 122.913 0.485 . . . . 6.07 112.093 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.62 144.16 9.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.044 0.449 . . . . 5.27 110.855 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.44 HD21 ' HB2' ' A' ' 96' ' ' ALA . 46.3 m-80 -105.28 97.38 7.24 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.029 -0.532 . . . . 5.78 110.392 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.686 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.5 pt? -89.71 149.86 22.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.075 -0.966 . . . . 3.62 110.741 -177.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -122.6 162.35 22.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.063 -0.517 . . . . 6.93 109.678 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.616 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -73.28 123.47 23.8 Favored 'General case' 0 C--N 1.321 -0.65 0 O-C-N 121.888 -0.508 . . . . 4.12 110.453 176.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 118.78 -14.07 11.57 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.606 -0.807 . . . . 4.07 113.405 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.61 176.42 6.02 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 117.763 0.782 . . . . 4.06 110.323 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -107.19 115.11 29.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.0 0.428 . . . . 4.17 110.951 -173.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.3 m -118.58 172.85 5.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.789 -0.641 . . . . 2.77 111.257 -178.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.485 ' OG ' HG22 ' A' ' 84' ' ' THR . 43.4 m -138.1 129.86 28.23 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.954 -0.758 . . . . 3.47 108.954 175.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -127.9 140.29 52.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.033 0.444 . . . . 3.35 110.982 -172.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -93.81 111.28 22.95 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.73 -0.668 . . . . 5.34 109.708 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 43.1 mt -79.07 100.36 3.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.086 -0.506 . . . . 4.66 110.128 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.725 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -80.7 110.08 15.86 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.226 -0.443 . . . . 4.85 110.195 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.0 m -103.09 126.05 50.09 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.792 -0.64 . . . . 5.68 109.885 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -93.97 -171.09 2.47 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.302 -0.408 . . . . 6.25 110.401 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -84.44 -8.79 58.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.999 0.428 . . . . 8.58 111.166 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 148' ' ' ARG . 7.3 tpt180 -89.25 -23.04 22.44 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.956 -0.566 . . . . 7.86 109.846 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.84 22.63 59.32 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.67 -0.695 . . . . 5.59 112.094 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -116.89 109.68 17.37 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.637 -0.505 . . . . 5.18 109.637 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.488 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -154.88 179.76 8.8 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.102 0.477 . . . . 4.28 111.491 -175.551 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -141.51 -94.46 0.23 Allowed Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.505 -0.77 . . . . 3.36 111.267 174.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -143.58 156.09 44.49 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.386 -0.598 . . . . 2.84 109.386 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 155' ' ' HIS . 13.9 t -162.55 161.84 27.04 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.842 -0.429 . . . . 4.34 109.842 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.46 ' HD2' ' SG ' ' A' ' 154' ' ' CYS . 35.2 m-70 48.13 66.3 1.09 Allowed 'General case' 0 N--CA 1.469 0.507 0 O-C-N 123.643 0.589 . . . . 5.75 111.69 178.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.546 ' O ' HG23 ' A' ' 127' ' ' VAL . 68.4 mt -93.94 117.72 38.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.335 -0.848 . . . . 3.55 110.365 -177.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.12 158.51 17.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.953 0.406 . . . . 5.96 110.47 178.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.84 113.38 26.77 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.51 -0.552 . . . . 4.34 109.51 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -83.0 -58.59 2.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.013 0.435 . . . . 4.97 111.383 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -136.42 100.6 10.28 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.284 -0.416 . . . . 5.37 110.129 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -70.88 159.68 51.79 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 122.391 2.061 . . . . 5.44 111.478 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -131.22 143.34 50.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.029 0.442 . . . . 6.1 111.138 -177.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.01 161.17 50.59 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 108.698 -0.853 . . . . 9.49 108.698 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -43.07 110.25 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.847 2.365 . . . . 8.39 113.548 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 115.693 -0.685 . . . . 10.27 111.463 -178.472 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 111.8 -0.52 . . . . 21.66 111.8 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.28 66.75 1.79 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.209 0.528 . . . . 20.17 109.867 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.484 ' OD1' ' HB ' ' A' ' 56' ' ' THR . 9.2 t70 -78.54 -51.76 9.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.698 -0.683 . . . . 18.5 109.674 -177.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.05 63.79 5.55 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 16.62 110.684 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -141.62 -38.22 0.4 Allowed 'General case' 0 N--CA 1.445 -0.678 0 CA-C-O 121.222 0.534 . . . . 18.35 110.879 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.405 ' HA ' ' OE2' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -77.67 104.93 8.5 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.632 -0.713 . . . . 16.2 109.709 -178.328 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 83.3 mtt180 -114.23 116.76 29.55 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.698 -0.683 . . . . 12.4 111.478 -174.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.521 ' HB2' ' CE1' ' A' ' 53' ' ' PHE . 6.8 mm-40 -102.76 143.74 32.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.839 -1.073 . . . . 11.63 110.441 -174.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 42.6 p -104.3 160.95 14.47 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.282 -0.636 . . . . 9.15 109.282 174.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -178.25 174.68 46.93 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.102 -1.047 . . . . 6.81 113.562 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.512 HG13 ' HB3' ' A' ' 23' ' ' GLN . 19.8 pt -120.57 148.81 23.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 108.924 -0.769 . . . . 10.17 108.924 176.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.543 HG21 HD22 ' A' ' 15' ' ' LEU . 1.9 mp -80.07 131.45 34.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 120.307 -0.557 . . . . 8.73 110.774 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.467 ' OE2' ' HB2' ' A' ' 14' ' ' LYS . 4.3 tm-20 -74.66 -46.74 36.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.687 -0.688 . . . . 10.86 111.026 -176.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 15' ' ' LEU . 6.8 tmtt? -157.09 133.17 9.61 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.002 -0.37 . . . . 14.06 110.002 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.543 HD22 HG21 ' A' ' 12' ' ' ILE . 3.6 mm? -78.06 110.88 13.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.943 -0.571 . . . . 11.73 110.901 176.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 72.2 mt -109.79 177.52 4.7 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.922 -1.14 . . . . 11.36 107.922 171.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.4 m170 -98.91 139.87 33.93 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.486 -0.485 . . . . 15.94 110.511 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.4 t 76.89 -46.05 0.5 Allowed 'General case' 0 N--CA 1.468 0.425 0 O-C-N 124.366 1.041 . . . . 13.01 111.04 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.498 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 39.6 p90 -129.92 154.29 47.49 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.264 -0.425 . . . . 12.34 109.925 179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -144.51 163.57 27.86 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.897 -0.668 . . . . 7.52 111.72 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -109.33 134.39 51.87 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-O 121.231 0.538 . . . . 9.24 111.262 -177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.6 mt -99.86 126.4 53.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 7.75 109.569 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.569 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 18.9 tp60 -79.31 130.65 35.66 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.089 0.471 . . . . 11.8 110.319 -176.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 p -67.86 3.63 1.43 Allowed 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 113.894 1.072 . . . . 12.34 113.894 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.569 ' SG ' ' HG3' ' A' ' 23' ' ' GLN . 74.4 m -51.75 -26.33 9.28 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.537 0.939 . . . . 13.33 113.537 -172.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -99.53 -6.35 27.62 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.131 0.419 . . . . 11.9 112.131 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.489 ' HG3' ' HB3' ' A' ' 8' ' ' GLU . 17.2 mmt180 -152.28 -159.89 1.07 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.801 0.334 . . . . 12.99 110.841 -173.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.418 ' H ' ' HB3' ' A' ' 27' ' ' ARG . 23.5 mp0 -116.3 17.23 15.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.092 0.472 . . . . 16.66 110.601 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.37 113.24 14.71 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.197 -0.456 . . . . 12.09 111.768 -175.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -87.9 104.65 16.8 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.661 -0.866 . . . . 12.51 108.661 170.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.3 mt -105.99 161.22 14.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.928 0.394 . . . . 8.76 111.232 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -110.95 129.36 55.91 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.308 -0.997 . . . . 9.15 108.308 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -110.64 141.56 43.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.084 0.469 . . . . 6.85 110.158 -175.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -87.16 137.61 32.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.031 -0.729 . . . . 9.99 109.031 177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.46 -11.31 32.23 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.924 0.342 . . . . 9.93 111.924 -178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.6 t -72.21 -27.41 62.53 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.28 -0.418 . . . . 12.28 110.494 175.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.48 40.31 1.57 Allowed 'General case' 0 C--O 1.224 -0.271 0 CA-C-N 116.154 -0.475 . . . . 10.62 111.321 -176.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.432 ' CE1' ' HG ' ' A' ' 45' ' ' LEU . 22.8 t80 -113.7 129.16 56.61 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.057 -0.72 . . . . 8.78 109.057 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.0 t -108.79 115.25 29.74 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.907 -0.405 . . . . 8.97 109.907 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.3 -157.3 20.74 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.873 -0.679 . . . . 9.98 111.724 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -93.45 103.47 15.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.89 0.376 . . . . 12.43 110.626 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.3 tp -67.05 -21.82 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.917 -0.583 . . . . 11.58 110.757 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.64 -21.44 65.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 14.73 110.283 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -99.31 11.74 38.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.769 -0.651 . . . . 13.3 110.222 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.432 ' HG ' ' CE1' ' A' ' 38' ' ' PHE . 2.8 tm? -101.28 115.41 30.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.148 -0.686 . . . . 10.07 109.148 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -123.43 -177.6 3.76 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.382 -0.372 . . . . 13.13 111.153 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.9 mp -77.48 117.84 23.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.0 -0.371 . . . . 11.74 110.0 -178.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.35 -1.3 64.33 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.86 -0.686 . . . . 10.13 111.776 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -73.98 125.28 90.34 Favored Pre-proline 0 C--O 1.234 0.276 0 N-CA-C 109.882 -0.414 . . . . 8.39 109.882 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.89 128.1 7.35 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.637 2.224 . . . . 7.28 113.66 -174.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -129.48 161.66 38.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.568 -0.742 . . . . 4.74 110.358 177.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -122.41 127.35 49.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.399 0.618 . . . . 7.09 109.655 174.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.521 ' CE1' ' HB2' ' A' ' 8' ' ' GLU . 45.3 p90 -131.71 -179.32 5.31 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.921 -0.582 . . . . 7.82 110.872 -174.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.439 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 37.6 tt0 -127.91 126.95 42.49 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.959 -0.756 . . . . 11.59 108.959 -176.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 27.5 ttt -100.53 112.45 24.83 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.289 -0.263 . . . . 12.41 110.289 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.484 ' HB ' ' OD1' ' A' ' 3' ' ' ASP . 46.2 p -131.9 170.67 14.55 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.339 -0.391 . . . . 13.17 111.351 -175.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -115.77 109.41 17.63 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.81 -0.441 . . . . 16.21 109.81 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.537 ' OD2' HG22 ' A' ' 61' ' ' THR . 31.2 t70 -76.59 122.88 25.26 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.139 -0.482 . . . . 16.64 111.063 -175.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -79.51 -13.34 59.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 22.64 111.367 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.415 ' HB3' ' OD2' ' A' ' 58' ' ' ASP . 14.3 ttm180 -78.42 -62.37 1.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.372 -0.377 . . . . 21.43 110.935 -177.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.537 HG22 ' OD2' ' A' ' 58' ' ' ASP . 15.3 t -88.45 -22.49 23.66 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.308 -0.405 . . . . 17.4 110.594 -178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.02 17.63 57.43 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.747 -0.739 . . . . 16.7 113.288 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -104.5 141.72 23.12 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.589 0.195 . . . . 14.73 110.569 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.92 124.13 7.84 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 121.451 1.434 . . . . 12.6 109.317 166.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 pp -141.27 171.56 11.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.133 -0.627 . . . . 11.73 112.397 -169.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.3 143.48 28.02 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.928 -1.033 . . . . 8.91 109.038 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.439 ' CB ' ' HB3' ' A' ' 54' ' ' GLU . 14.1 t -69.71 -155.68 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.357 -0.383 . . . . 9.83 110.46 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -75.27 29.1 0.1 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.397 0.888 . . . . 11.32 113.397 -172.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 41.0 t 19.92 103.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 C-N-CA 125.14 1.376 . . . . 6.11 114.403 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.1 m -101.94 143.11 32.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.089 0.471 . . . . 6.12 111.572 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -69.72 138.85 53.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.569 -0.741 . . . . 6.3 110.791 175.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.0 mt -81.42 100.6 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.265 -0.642 . . . . 5.77 109.265 174.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.0 153.45 95.39 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.346 -0.843 . . . . 5.69 111.344 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -49.45 139.95 28.51 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.462 2.775 . . . . 6.86 113.288 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.474 ' HG3' ' H ' ' A' ' 76' ' ' VAL . 3.2 pt-20 -93.02 -91.24 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.809 -0.632 . . . . 8.49 112.147 -175.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.474 ' H ' ' HG3' ' A' ' 75' ' ' GLU . 10.6 p -92.03 151.88 3.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.217 -0.447 . . . . 6.19 110.728 -176.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 47.3 t -80.75 95.47 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.312 0.577 . . . . 6.26 109.792 175.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 tt -98.92 -24.68 14.86 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.112 -0.949 . . . . 6.05 110.741 -178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.4 t -101.34 103.08 14.02 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.358 0.599 . . . . 7.02 112.088 -170.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -129.49 -63.59 0.93 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.166 -1.05 . . . . 7.07 108.166 169.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -168.64 147.09 4.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.723 -1.126 . . . . 6.68 108.392 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -77.11 98.56 5.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.61 -0.515 . . . . 6.43 109.61 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.6 m -81.8 157.24 4.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.44 0.638 . . . . 3.7 111.546 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 55.6 p -124.69 146.87 48.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.609 -0.723 . . . . 3.49 109.257 176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -141.43 -173.33 13.71 Favored Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.272 -0.966 . . . . 2.58 112.063 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.7 m -130.92 131.15 44.29 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 110.015 -0.365 . . . . 3.34 110.015 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.597 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 88.0 t -64.18 129.95 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.519 -0.309 . . . . 3.14 110.33 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 21.3 p -113.98 -9.98 12.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.983 0.421 . . . . 3.61 110.722 176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.7 m -152.26 128.76 10.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.429 . . . . 3.12 110.209 176.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -99.07 169.63 9.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 4.39 110.726 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.19 132.8 33.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.999 -0.546 . . . . 3.62 110.122 172.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -88.76 110.24 20.84 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.055 -0.521 . . . . 7.2 110.554 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m -146.97 155.29 42.15 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.696 -0.483 . . . . 5.1 109.696 173.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -88.7 -43.97 10.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.213 0.53 . . . . 7.53 110.673 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.5 t -140.3 -173.31 3.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.64 -0.709 . . . . 7.47 109.231 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.31 -55.94 23.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.735 0.303 . . . . 7.58 110.636 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -100.05 -12.8 19.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 8.32 112.06 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -81.69 84.77 6.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.343 0.592 . . . . 7.26 109.821 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.1 t -112.81 158.29 13.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 114.75 -1.114 . . . . 5.54 109.478 -177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.57 -77.47 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.415 0.626 . . . . 7.28 110.114 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -123.59 -46.05 2.03 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.379 -0.828 . . . . 7.54 111.177 173.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 36.0 p -167.75 -158.13 0.25 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.542 -0.299 . . . . 5.41 110.263 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.8 m -76.5 57.01 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.177 0.513 . . . . 4.58 110.203 174.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -78.9 -14.65 59.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.556 -0.747 . . . . 5.09 110.793 -177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.5 t -103.1 118.26 36.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.367 -0.833 . . . . 3.33 109.872 178.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -102.19 116.2 32.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.109 0.481 . . . . 2.57 111.141 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 121' ' ' PRO . . . -69.09 160.77 52.42 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.729 -0.748 . . . . 1.66 111.554 178.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -129.9 127.61 40.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.342 0.592 . . . . 3.03 110.868 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.5 mt -112.0 127.45 69.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.204 -0.907 . . . . 1.88 109.241 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.4 t -112.4 137.46 50.54 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.764 0.316 . . . . 3.49 110.441 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 117' ' ' CYS . 2.7 p90 -143.37 155.42 44.42 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.115 -0.698 . . . . 3.51 109.115 176.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -111.56 125.24 53.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.864 0.364 . . . . 5.1 110.463 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.723 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 9.4 t30 -130.03 115.66 17.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.945 -0.571 . . . . 4.78 109.584 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.8 mtt-85 60.94 21.63 11.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.663 0.268 . . . . 6.97 111.581 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.87 -4.18 68.14 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.825 -0.702 . . . . 5.1 113.011 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.723 ' HG2' ' O ' ' A' ' 113' ' ' ASN . 7.9 pt-20 -99.68 132.96 44.68 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.145 -0.687 . . . . 5.38 109.145 177.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 111' ' ' TYR . 7.8 p -116.77 118.36 32.31 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.94 0.4 . . . . 4.72 110.427 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.429 ' CE1' ' HG3' ' A' ' 116' ' ' GLU . 78.9 m-85 -108.4 155.01 21.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.142 -0.481 . . . . 4.61 110.494 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -110.26 123.34 49.63 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.952 -0.567 . . . . 3.96 109.715 177.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -103.77 120.2 52.14 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.384 -0.371 . . . . 2.75 110.408 -175.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' GLY . 73.3 Cg_endo -76.7 132.91 13.62 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.906 2.404 . . . . 2.3 111.722 175.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -145.3 155.0 42.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.804 0.335 . . . . 2.13 110.25 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 62.8 p -107.4 -174.71 2.6 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.124 -0.489 . . . . 3.07 110.084 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -71.39 -19.61 62.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.222 0.534 . . . . 4.8 110.514 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.85 -28.28 33.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.754 -0.657 . . . . 4.81 111.437 -177.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -74.22 -19.61 60.46 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.387 -0.369 . . . . 3.84 111.364 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.9 p -107.43 107.91 23.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.588 0.709 . . . . 4.39 111.009 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -90.46 138.43 31.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.125 -0.489 . . . . 6.43 110.183 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.23 -20.65 4.98 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.777 -0.647 . . . . 5.91 111.51 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.8 t30 61.58 31.57 18.77 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.74 0.781 . . . . 6.07 110.001 178.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -89.92 138.51 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-N 115.692 -0.685 . . . . 5.27 110.151 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.436 ' N ' HD22 ' A' ' 132' ' ' ASN . 0.9 OUTLIER -82.5 103.38 12.0 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.735 0.302 . . . . 5.78 110.379 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.594 ' H ' HD12 ' A' ' 133' ' ' LEU . 2.2 mp -75.56 134.87 40.61 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.751 -0.659 . . . . 3.62 109.51 179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -121.34 126.74 50.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.889 0.376 . . . . 6.93 110.159 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.597 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -57.46 112.91 1.56 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.359 0.599 . . . . 4.12 111.317 -175.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 119.36 -2.8 14.04 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.296 -0.865 . . . . 4.07 112.851 -174.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 30.6 p30 -95.01 178.27 5.61 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.442 0.621 . . . . 4.06 110.459 172.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -100.22 122.88 43.73 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.978 0.418 . . . . 4.17 111.036 -179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.1 m -121.09 151.82 24.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.668 -0.696 . . . . 2.77 110.584 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.3 t -124.93 129.33 50.16 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.704 -0.48 . . . . 3.47 109.704 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -136.67 154.6 50.58 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.557 -0.534 . . . . 3.35 109.557 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 tp60 -113.0 114.76 27.36 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.37 -0.604 . . . . 5.34 109.37 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -78.43 108.16 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.892 -0.594 . . . . 4.66 111.304 -174.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.617 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -100.62 110.5 22.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.128 -0.487 . . . . 4.85 109.81 172.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.2 m -85.85 108.95 18.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.198 -0.455 . . . . 5.68 111.126 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -64.53 146.1 55.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.937 -0.574 . . . . 6.25 109.661 175.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.17 -17.97 64.92 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.571 0.582 . . . . 8.58 112.571 -173.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -85.75 2.07 47.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.02 0.438 . . . . 7.86 110.31 177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.48 16.77 80.43 Favored Glycine 0 C--N 1.33 0.248 0 CA-C-N 115.68 -0.691 . . . . 5.59 113.143 174.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -119.69 113.09 20.13 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.332 -0.618 . . . . 5.18 109.332 178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.508 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -144.72 -179.17 6.4 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.214 -0.448 . . . . 4.28 111.067 -175.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.58 -153.3 5.84 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.057 -0.817 . . . . 3.36 111.057 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.26 118.01 34.99 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.213 0.507 . . . . 2.84 110.086 177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 33.9 t -116.44 159.59 21.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.59 -0.277 . . . . 4.34 110.646 -176.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 60.47 33.58 20.57 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.95 -0.568 . . . . 5.75 111.174 179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 55.0 mt -64.69 125.47 21.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.764 -0.653 . . . . 3.55 110.921 -176.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -140.44 159.92 41.14 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.724 -0.671 . . . . 5.96 110.056 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.1 tp -77.6 119.24 20.88 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.281 -0.637 . . . . 4.34 109.281 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -84.41 -47.67 10.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.031 -0.531 . . . . 4.97 109.628 -175.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -162.5 113.94 1.12 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.864 -0.607 . . . . 5.37 109.492 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.12 152.08 80.46 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.126 1.884 . . . . 5.44 112.481 -177.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -121.64 143.52 49.28 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.897 -0.592 . . . . 6.1 110.774 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -99.03 139.57 21.11 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.0 -0.546 . . . . 9.49 109.662 178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.33 107.18 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.152 1.901 . . . . 8.39 111.577 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 55.2 t . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 121.418 0.627 . . . . 10.27 111.503 -177.694 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 111.926 -0.47 . . . . 21.66 111.926 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.25 66.13 5.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.08 0.467 . . . . 20.17 111.226 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -117.11 6.54 12.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.878 0.847 . . . . 18.5 108.86 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -150.92 99.6 2.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.497 -1.229 . . . . 16.62 109.056 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -135.92 -82.65 0.39 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.514 0.561 . . . . 18.35 112.514 -178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -124.67 92.8 3.73 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.028 -0.533 . . . . 16.2 111.869 -169.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -69.64 138.43 53.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.928 -0.578 . . . . 12.4 110.128 175.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.505 ' CD ' ' HE ' ' A' ' 27' ' ' ARG . 14.1 pt-20 -142.38 162.12 36.28 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.924 -0.399 . . . . 11.63 109.924 174.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 52' ' ' GLU . 68.9 p -109.14 157.38 18.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.536 0.684 . . . . 9.15 112.133 -171.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -160.69 157.0 28.42 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.224 -1.15 . . . . 6.81 110.224 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.0 pt -105.01 141.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 117.097 0.448 . . . . 10.17 110.646 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.511 HG13 HD11 ' A' ' 45' ' ' LEU . 41.6 mm -74.37 123.45 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 110.067 -0.346 . . . . 8.73 110.067 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.68 -34.5 17.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.333 0.494 . . . . 10.86 112.333 -173.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.5 ' HA ' HD12 ' A' ' 47' ' ' ILE . 1.9 tmtp? -160.74 130.4 4.99 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.947 0.404 . . . . 14.06 111.059 -175.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.488 ' H ' HD11 ' A' ' 47' ' ' ILE . 3.0 mm? -91.55 106.55 18.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.854 -0.612 . . . . 11.73 110.796 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 5.3 mp -96.93 179.77 4.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.763 -0.829 . . . . 11.36 108.763 174.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -89.81 116.11 27.66 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.268 -0.573 . . . . 15.94 110.434 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.4 t 78.54 -14.0 0.91 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.298 0.999 . . . . 13.01 111.635 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 34' ' ' HIS . 10.1 p90 -145.45 162.97 36.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.187 -0.301 . . . . 12.34 110.187 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -156.67 177.22 33.72 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.67 -0.776 . . . . 7.52 112.125 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -126.68 148.49 49.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 9.24 110.914 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.7 mt -108.87 126.21 65.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.571 -0.741 . . . . 7.75 109.666 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.22 143.2 47.23 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.426 0.631 . . . . 11.8 110.766 -175.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 20.7 p -77.04 6.04 7.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.068 -0.969 . . . . 12.34 111.942 -177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.2 t -49.57 -39.97 36.85 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.077 0.399 . . . . 13.33 112.077 -173.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -116.91 6.38 13.06 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.835 -0.346 . . . . 11.9 111.4 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.622 ' HD3' ' N ' ' A' ' 28' ' ' GLN . 0.0 OUTLIER -120.41 141.31 50.24 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.533 -0.543 . . . . 12.99 109.533 -173.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.622 ' N ' ' HD3' ' A' ' 27' ' ' ARG . 27.7 mm-40 -77.04 26.01 0.15 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.064 -0.397 . . . . 16.66 111.484 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.534 ' HB3' HH11 ' A' ' 27' ' ' ARG . . . 178.99 145.47 0.15 Allowed 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 123.575 0.75 . . . . 12.09 109.333 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.523 ' O ' ' HD2' ' A' ' 30' ' ' ARG . 0.9 OUTLIER -86.9 132.37 33.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.557 -0.534 . . . . 12.51 109.557 174.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.9 mt -120.52 162.39 19.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.209 0.528 . . . . 8.76 111.636 -172.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -116.16 147.98 40.83 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.486 -0.779 . . . . 9.15 109.882 179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -150.22 172.92 14.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.77 -0.456 . . . . 6.85 109.77 177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . 7.1 p-80 -135.06 165.79 24.55 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.804 0.335 . . . . 9.99 111.172 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -66.29 -18.95 65.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.835 -0.621 . . . . 9.93 111.896 -173.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.1 t -86.27 2.36 47.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.546 -0.297 . . . . 12.28 110.837 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' A' ' 68' ' ' GLN . 36.6 tp60 -110.74 -30.16 7.69 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 109.774 -0.454 . . . . 10.62 109.774 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -77.35 121.55 23.91 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.875 -0.602 . . . . 8.78 109.956 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.44 ' HB2' ' CG ' ' A' ' 68' ' ' GLN . 34.1 t -97.07 139.99 32.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.196 0.522 . . . . 8.97 110.528 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.41 -169.15 14.51 Favored Glycine 0 N--CA 1.435 -1.413 0 C-N-CA 120.635 -0.793 . . . . 9.98 112.573 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -72.9 110.73 7.43 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.363 0.601 . . . . 12.43 111.068 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.0 tp -77.75 -20.65 13.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.372 -0.831 . . . . 11.58 109.998 178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.75 -31.63 72.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.379 -0.828 . . . . 14.73 110.401 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -97.02 24.53 6.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.815 -0.63 . . . . 13.3 110.768 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.511 HD11 HG13 ' A' ' 12' ' ' ILE . 3.2 tm? -113.19 120.79 42.44 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.007 -1.108 . . . . 10.07 108.007 176.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.29 176.49 8.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.628 0.252 . . . . 13.13 110.816 -170.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 14' ' ' LYS . 31.4 mm -70.63 128.25 33.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.562 -0.29 . . . . 11.74 110.26 177.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.13 11.09 67.82 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.322 -0.942 . . . . 10.13 112.611 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -87.45 121.35 71.21 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.972 -0.381 . . . . 8.39 109.972 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.48 125.3 9.51 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.564 2.176 . . . . 7.28 112.712 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 71' ' ' LYS . 34.0 m -124.61 152.96 31.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.78 -0.645 . . . . 4.74 109.65 178.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.551 ' HB3' HG22 ' A' ' 9' ' ' THR . 13.8 pt-20 -114.46 131.05 56.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.323 0.582 . . . . 7.09 109.752 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -137.67 172.73 12.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.371 0.605 . . . . 7.82 111.701 -172.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -118.4 133.69 55.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.189 -1.041 . . . . 11.59 108.189 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 25.9 ttt -100.7 122.53 43.49 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.283 -0.266 . . . . 12.41 110.283 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.3 p -135.09 144.25 47.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.413 0.625 . . . . 13.17 111.253 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -90.6 109.66 20.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.681 -0.691 . . . . 16.21 109.16 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 60' ' ' ARG . 11.1 t70 -65.02 117.93 8.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.825 -0.625 . . . . 16.64 111.618 -174.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.7 mtp85 -80.12 -12.25 59.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.175 -0.92 . . . . 22.64 111.712 178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HB2' ' OD1' ' A' ' 58' ' ' ASP . 0.1 OUTLIER -73.82 -57.81 3.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.886 0.374 . . . . 21.43 110.397 -176.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.3 p -104.68 -39.43 6.36 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.074 -0.512 . . . . 17.4 111.117 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.87 16.85 7.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.511 -0.852 . . . . 16.7 112.825 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -101.34 148.31 35.0 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 110.156 -0.313 . . . . 14.73 110.156 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -79.63 125.22 6.07 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.675 1.583 . . . . 12.6 110.358 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.3 pt -128.87 162.91 35.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.483 0.659 . . . . 11.73 111.553 -175.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.46 161.97 13.25 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.977 -1.01 . . . . 8.91 108.635 170.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.462 ' O ' HG23 ' A' ' 69' ' ' VAL . 26.3 t -75.39 -153.29 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.222 -0.288 . . . . 9.83 110.222 177.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.621 HE21 ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -67.82 -4.02 11.34 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.798 0.666 . . . . 11.32 112.798 -173.133 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 67' ' ' SER . 42.3 t 50.93 86.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 121.538 0.685 . . . . 6.11 111.56 176.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -97.23 129.86 44.51 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.836 -0.62 . . . . 6.12 110.649 -174.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.458 ' HA ' HG12 ' A' ' 51' ' ' VAL . 35.9 mtmm -67.61 141.21 56.84 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.157 -0.682 . . . . 6.3 109.157 175.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 46.9 mt -67.12 95.62 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.14 0.495 . . . . 5.77 111.318 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -163.56 136.59 4.21 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.309 -0.859 . . . . 5.69 109.395 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.39 135.32 22.17 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 122.524 2.149 . . . . 6.86 112.685 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.64 -141.39 0.36 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.34 -0.391 . . . . 8.49 110.239 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.537 ' CG2' ' HB1' ' A' ' 144' ' ' ALA . 3.2 p -64.92 164.16 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.206 0.526 . . . . 6.19 111.016 -177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.642 HG12 ' H ' ' A' ' 79' ' ' SER . 46.7 t -85.37 118.97 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.915 -0.584 . . . . 6.26 111.856 -175.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' HG ' ' CE1' ' A' ' 155' ' ' HIS . 10.7 mp -97.19 13.57 28.89 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.106 -0.497 . . . . 6.05 110.548 176.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.642 ' H ' HG12 ' A' ' 77' ' ' VAL . 21.1 m -116.48 -112.2 0.34 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.168 -0.469 . . . . 7.02 110.532 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 81' ' ' GLU . 6.3 tt0 57.82 33.05 22.76 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.098 0.559 . . . . 7.07 111.143 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 80' ' ' GLU . 10.3 tp10 76.0 117.51 0.06 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.222 -0.899 . . . . 6.68 111.126 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -77.71 90.88 4.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.662 0.744 . . . . 6.43 110.159 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.0 m -77.65 160.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.496 -0.775 . . . . 3.7 111.226 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 25.9 p -107.86 139.52 42.34 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.542 -0.754 . . . . 3.49 109.924 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.36 161.26 24.41 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.515 -0.85 . . . . 2.58 112.479 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -116.96 125.01 50.77 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.483 -0.562 . . . . 3.34 109.483 177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.516 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 58.1 t -68.5 123.68 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 108.973 -0.751 . . . . 3.14 108.973 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 46.0 p -105.08 -20.3 13.56 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.623 -0.431 . . . . 3.61 111.066 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.2 m -151.83 126.18 9.36 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.273 -0.421 . . . . 3.12 110.258 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -82.27 -172.68 4.12 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 109.951 -0.388 . . . . 4.39 109.951 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.476 HD22 ' HG3' ' A' ' 124' ' ' LYS . 5.3 mp -88.89 146.24 25.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.284 -0.636 . . . . 3.62 109.284 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.5 ttp180 -109.59 152.58 25.33 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.322 0.582 . . . . 7.2 111.438 -172.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.479 HG22 ' HA ' ' A' ' 99' ' ' VAL . 1.3 p -84.16 138.43 33.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.194 -0.912 . . . . 5.1 111.309 179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.47 -63.75 1.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.917 -0.583 . . . . 7.53 109.726 173.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.8 m -101.96 -177.5 3.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.598 -0.728 . . . . 7.47 109.993 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -94.74 -23.49 17.52 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 111.87 0.322 . . . . 7.58 111.87 -176.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -91.74 4.33 53.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.954 0.353 . . . . 8.32 111.954 -173.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 26.7 p30 -154.91 155.18 33.84 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.468 0.651 . . . . 7.26 111.719 -178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.479 ' HA ' HG22 ' A' ' 93' ' ' THR . 7.9 p -110.45 9.76 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 122.418 1.104 . . . . 5.54 109.534 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 54.2 tp -148.41 105.3 3.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.595 -1.184 . . . . 7.28 110.065 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -133.81 -50.0 0.83 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.293 -0.867 . . . . 7.54 109.521 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 33.2 t -123.1 149.07 44.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 5.41 109.746 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.2 m -96.06 1.56 52.65 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.421 -0.354 . . . . 4.58 110.997 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.31 -14.04 61.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.896 0.379 . . . . 5.09 111.083 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -82.27 112.08 18.94 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.408 0.623 . . . . 3.33 109.341 174.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.1 t -122.09 148.76 44.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.71 -0.677 . . . . 2.57 110.631 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.03 163.41 39.74 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 110.671 -0.971 . . . . 1.66 110.671 174.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -125.27 128.42 48.24 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.965 0.412 . . . . 3.03 110.886 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 71.6 mt -112.88 125.46 70.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.909 -0.587 . . . . 1.88 109.506 174.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 24.8 t -100.17 137.89 37.98 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.838 -0.43 . . . . 3.49 109.838 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.526 ' CE2' HD11 ' A' ' 120' ' ' LEU . 0.3 OUTLIER -148.8 167.48 25.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.527 0.203 . . . . 3.51 110.549 -178.703 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.38 127.93 56.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.366 -0.379 . . . . 5.1 110.446 177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -152.85 130.12 11.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.604 -0.517 . . . . 4.78 109.604 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 64.74 20.85 12.25 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.427 0.455 . . . . 6.97 111.168 179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 75.57 18.73 79.68 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.778 -0.725 . . . . 5.1 111.868 -175.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -121.21 144.92 48.34 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.628 -0.508 . . . . 5.38 109.628 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 11.4 p -122.98 115.49 21.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.277 -0.42 . . . . 4.72 110.265 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -132.19 157.4 44.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.251 -0.431 . . . . 4.61 110.528 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -99.77 129.25 45.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 3.96 109.819 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 111' ' ' TYR . 4.2 mp -105.03 143.39 26.63 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 110.133 -0.321 . . . . 2.75 110.133 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 120' ' ' LEU . 3.3 Cg_exo -80.11 148.56 19.34 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.511 2.141 . . . . 2.3 112.036 175.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -155.19 144.57 21.13 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.029 -0.73 . . . . 2.13 109.029 173.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 60.8 p -113.11 -175.59 2.7 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.67 0.272 . . . . 3.07 110.489 178.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.476 ' HG3' HD22 ' A' ' 91' ' ' LEU . 55.2 mttp -65.76 -27.97 68.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.24 0.543 . . . . 4.8 110.183 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -75.16 -22.92 57.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.211 -0.904 . . . . 4.81 111.598 -173.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -83.13 -11.25 58.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.377 -0.374 . . . . 3.84 111.86 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.1 p -119.98 106.55 19.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.441 0.639 . . . . 4.39 111.37 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -108.26 150.25 27.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.779 -0.646 . . . . 6.43 110.102 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 125.39 16.93 2.75 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.913 -0.66 . . . . 5.91 112.943 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.9 t30 64.25 22.62 12.88 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.447 0.642 . . . . 6.07 110.454 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.7 t -81.2 130.54 35.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.946 -0.57 . . . . 5.27 110.929 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -111.61 111.56 22.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.184 -0.462 . . . . 5.78 110.148 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 133' ' ' LEU . 5.5 mp -98.97 149.83 22.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 3.62 110.939 -176.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -146.52 121.14 9.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.475 -0.565 . . . . 6.93 109.475 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.516 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -46.68 131.57 11.4 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.83 -0.623 . . . . 4.12 112.532 -171.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.22 -12.69 14.15 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.126 -0.943 . . . . 4.07 111.192 -172.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -89.64 174.9 7.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 4.06 110.482 177.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -121.86 118.69 29.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.346 0.594 . . . . 4.17 110.147 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.7 m -121.19 159.07 23.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 115.314 -0.857 . . . . 2.77 111.264 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 18.9 m -109.73 137.82 46.99 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.622 -0.717 . . . . 3.47 109.22 173.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -139.79 139.21 36.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.024 0.44 . . . . 3.35 110.114 177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -97.2 121.08 38.69 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.949 -0.569 . . . . 5.34 109.532 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 62.6 mt -78.05 107.91 10.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.019 -0.537 . . . . 4.66 110.122 -177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.537 ' HB1' ' CG2' ' A' ' 76' ' ' VAL . . . -94.87 107.98 20.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.07 -0.514 . . . . 4.85 110.995 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.546 ' HA ' ' HB3' ' A' ' 151' ' ' LEU . 50.9 m -85.38 109.41 18.4 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.681 -0.691 . . . . 5.68 111.075 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -74.76 159.29 32.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.316 -0.624 . . . . 6.25 109.316 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -57.77 -24.91 59.42 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 122.451 0.3 . . . . 8.58 111.693 -176.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.615 ' HD2' ' OD1' ' A' ' 150' ' ' ASN . 1.3 tmt_? -69.81 -21.03 63.43 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.184 0.516 . . . . 7.86 110.116 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 95.41 2.76 61.69 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.882 -0.675 . . . . 5.59 112.107 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.615 ' OD1' ' HD2' ' A' ' 148' ' ' ARG . 15.1 m120 -99.73 135.92 40.43 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.632 -0.507 . . . . 5.18 109.632 177.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -145.34 174.44 11.11 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.062 0.458 . . . . 4.28 111.332 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -159.32 -160.83 10.7 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 110.995 -0.842 . . . . 3.36 110.995 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -99.6 109.79 22.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.123 0.487 . . . . 2.84 110.54 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 38.1 m -131.56 176.62 8.16 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.141 -0.688 . . . . 4.34 109.141 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.496 ' CE1' ' HG ' ' A' ' 78' ' ' LEU . 13.9 m80 58.47 38.6 25.54 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 109.317 -0.623 . . . . 5.75 109.317 179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.3 mt -79.48 128.76 38.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.173 -0.921 . . . . 3.55 111.137 -169.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -134.73 140.86 46.27 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.281 0.562 . . . . 5.96 110.349 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.6 tp -103.97 105.76 16.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.828 -0.624 . . . . 4.34 109.906 -179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -109.74 -24.64 10.79 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.063 -0.517 . . . . 4.97 111.297 -177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -117.79 86.12 23.78 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.209 -0.45 . . . . 5.37 110.821 174.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.34 156.21 14.51 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.54 2.16 . . . . 5.44 111.772 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.8 108.56 20.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.288 -0.415 . . . . 6.1 110.685 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 0.0 OUTLIER -130.66 151.95 79.63 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 116.584 -0.28 . . . . 9.49 110.696 176.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 163' ' ' GLN . 13.4 Cg_exo -70.71 126.63 12.88 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.436 2.091 . . . . 8.39 111.959 177.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.014 -0.539 . . . . 10.27 111.028 -179.109 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.467 0 N-CA-C 112.107 -0.397 . . . . 21.66 112.107 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 170.64 -49.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.493 0.717 . . . . 20.17 110.208 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -116.16 5.84 13.82 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.337 -0.847 . . . . 18.5 111.066 -172.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -133.53 35.5 3.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.501 -0.318 . . . . 16.62 110.748 -173.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -67.12 -90.33 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.738 0.644 . . . . 18.35 112.738 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -140.02 141.08 36.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.835 0.35 . . . . 16.2 110.301 -178.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.524 ' HG2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -130.36 99.89 5.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.731 -0.668 . . . . 12.4 111.061 178.21 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.76 153.56 21.6 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.098 -0.704 . . . . 11.63 109.098 171.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.515 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 20.3 p -86.52 161.36 18.62 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.066 0.46 . . . . 9.15 111.736 -175.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.22 162.73 32.02 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.433 -0.667 . . . . 6.81 111.433 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 21.3 pt -113.9 148.57 16.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.724 0.262 . . . . 10.17 110.43 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 30.0 mm -75.28 123.4 31.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.513 -0.312 . . . . 8.73 110.687 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.53 ' OE2' ' HB3' ' A' ' 21' ' ' PHE . 29.1 mt-10 -72.53 -46.05 56.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.054 -0.521 . . . . 10.86 111.219 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -159.12 146.94 17.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.023 -0.535 . . . . 14.06 110.084 -175.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.51 105.25 17.31 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.927 -0.579 . . . . 11.73 110.695 177.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 19' ' ' TYR . 2.6 mm? -106.71 179.09 4.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.752 -0.833 . . . . 11.36 108.752 174.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -91.64 129.37 37.62 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.714 -0.394 . . . . 15.94 110.223 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 48.3 m 76.25 -37.79 0.31 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 124.152 0.907 . . . . 13.01 112.083 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 46.8 p90 -126.98 153.37 45.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.898 0.38 . . . . 12.34 111.081 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.4 165.95 26.24 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.03 -0.828 . . . . 7.52 111.03 176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.53 ' HB3' ' OE2' ' A' ' 13' ' ' GLU . 91.5 m-85 -115.21 146.16 41.7 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.225 0.513 . . . . 9.24 111.459 -177.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.52 HG21 ' CE2' ' A' ' 53' ' ' PHE . 61.6 mt -117.71 127.15 75.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 7.75 110.338 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.419 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -78.22 133.14 37.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.588 0.708 . . . . 11.8 111.962 -172.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.5 p -81.22 -1.09 43.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.855 -1.066 . . . . 12.34 113.229 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.2 t -60.94 -43.18 99.02 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.085 0.469 . . . . 13.33 111.342 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' OE1' ' HB3' ' A' ' 128' ' ' GLU . 7.2 tp10 -90.28 -9.14 49.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 122.043 0.925 . . . . 11.9 109.747 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 9' ' ' THR . 1.1 mmt180 -112.29 -167.58 1.2 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.83 -1.077 . . . . 12.99 110.462 -174.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -128.61 21.62 6.0 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.147 -0.686 . . . . 16.66 109.147 171.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.426 ' H ' ' HB3' ' A' ' 27' ' ' ARG . . . -166.05 128.21 1.93 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 114.922 -1.035 . . . . 12.09 110.169 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -85.91 140.24 30.53 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.831 -0.803 . . . . 12.51 108.831 175.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 32.1 mt -145.59 161.32 40.09 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.106 0.479 . . . . 8.76 111.89 -175.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -120.96 130.15 53.72 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.363 -0.835 . . . . 9.15 108.767 172.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -119.21 157.37 28.14 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.922 -0.399 . . . . 6.85 109.922 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -108.19 151.99 25.18 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.324 -0.398 . . . . 9.99 110.051 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -57.76 -26.41 61.83 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.275 0.842 . . . . 9.93 113.275 -172.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.2 t -68.7 -13.54 62.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.181 0.515 . . . . 12.28 110.898 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.66 38.96 2.78 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.056 -0.52 . . . . 10.62 110.145 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -127.17 117.36 22.21 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.165 -0.47 . . . . 8.78 109.904 174.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 68' ' ' GLN . 22.5 t -79.71 91.85 5.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.544 -0.753 . . . . 8.97 110.225 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.91 -163.3 27.7 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.797 -0.716 . . . . 9.98 112.465 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -86.3 112.51 21.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.818 -0.438 . . . . 12.43 109.818 178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -28.91 40.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.678 0.275 . . . . 11.58 111.556 -174.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -75.33 -13.36 60.41 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.426 0.631 . . . . 14.73 109.671 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -95.61 6.8 48.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.588 -0.733 . . . . 13.3 110.334 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.8 tp -94.43 125.81 39.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.738 -0.665 . . . . 10.07 110.026 177.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.524 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 2.6 mppt? -103.2 167.74 9.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.205 0.526 . . . . 13.13 110.841 -174.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.5 mt -84.5 114.68 25.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.814 -0.63 . . . . 11.74 109.688 178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.74 9.4 43.36 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.259 -0.736 . . . . 10.13 111.259 -170.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -79.55 124.52 83.78 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 109.532 -0.544 . . . . 8.39 109.532 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.581 ' HB2' HD12 ' A' ' 72' ' ' ILE . 86.1 Cg_endo -82.39 129.22 5.77 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.847 2.364 . . . . 7.28 113.621 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.4 166.27 29.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.75 -0.659 . . . . 4.74 111.097 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.49 ' HB3' HG22 ' A' ' 9' ' ' THR . 7.7 pt-20 -122.58 124.89 44.54 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.578 -0.527 . . . . 7.09 109.578 173.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CE2' HG21 ' A' ' 22' ' ' ILE . 54.3 p90 -133.0 149.75 52.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.109 0.48 . . . . 7.82 111.349 -172.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.524 ' HG3' ' HG2' ' A' ' 7' ' ' ARG . 2.6 mp0 -88.72 149.46 23.46 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.019 -0.992 . . . . 11.59 110.361 176.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.05 121.69 42.97 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.328 -0.619 . . . . 12.41 109.328 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.5 p -138.9 172.08 13.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.937 0.398 . . . . 13.17 111.265 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -125.75 125.33 42.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.333 -0.394 . . . . 16.21 110.573 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -87.59 124.96 34.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.066 0.46 . . . . 16.64 110.542 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 mmm180 -79.97 -25.26 40.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.791 -0.64 . . . . 22.64 111.404 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -70.85 -57.54 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.559 -0.292 . . . . 21.43 111.233 -172.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.0 p -91.46 -28.54 17.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.962 0.41 . . . . 17.4 110.559 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.98 11.01 57.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.729 -0.748 . . . . 16.7 112.741 177.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 131.32 31.35 Favored Pre-proline 0 C--N 1.324 -0.521 0 O-C-N 122.815 -0.226 . . . . 14.73 110.442 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -66.02 126.43 15.82 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.257 1.971 . . . . 12.6 109.93 171.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 30.2 pt -126.52 147.67 31.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.411 0.624 . . . . 11.73 111.63 -172.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.24 155.04 18.24 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.022 -0.99 . . . . 8.91 108.433 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.475 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 39.1 t -75.26 -151.29 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.716 0 O-C-N 123.338 0.399 . . . . 9.83 110.496 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 39' ' ' SER . 2.5 mp0 -67.9 -10.28 51.94 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.248 0.462 . . . . 11.32 112.248 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.3 t 56.56 96.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.489 0.661 . . . . 6.11 111.198 179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 t -93.77 147.7 22.8 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.603 -0.518 . . . . 6.12 109.603 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -81.51 157.5 24.81 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.434 -0.58 . . . . 6.3 109.434 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.581 HD12 ' HB2' ' A' ' 50' ' ' PRO . 24.6 mt -73.97 85.83 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.375 0.607 . . . . 5.77 109.905 177.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.98 87.43 33.88 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.416 -0.811 . . . . 5.69 110.204 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -80.7 164.57 20.66 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 122.813 2.342 . . . . 6.86 111.781 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -73.42 -20.83 60.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.739 0.78 . . . . 8.49 109.588 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.2 t -83.5 135.59 24.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 114.945 -1.025 . . . . 6.19 108.831 174.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.655 ' O ' ' HA ' ' A' ' 144' ' ' ALA . 47.5 t -68.49 103.41 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.848 0.356 . . . . 6.26 111.531 -174.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -78.71 83.21 4.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.764 -0.653 . . . . 6.05 109.743 179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.6 p 23.44 96.37 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.96 1.467 . . . . 7.02 114.96 173.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -63.73 -30.55 71.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.525 0.679 . . . . 7.07 109.533 171.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -108.68 117.71 34.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.081 -0.963 . . . . 6.68 109.947 175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -81.4 144.71 31.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.354 -0.385 . . . . 6.43 109.968 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.4 m -129.91 152.95 38.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.342 0.591 . . . . 3.7 111.111 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.1 p -114.94 145.7 41.94 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.607 -0.724 . . . . 3.49 110.086 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -134.99 165.77 24.54 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.347 -0.93 . . . . 2.58 112.648 -177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 m -118.82 130.18 55.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.457 -0.571 . . . . 3.34 109.457 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.669 ' HB ' ' HA ' ' A' ' 135' ' ' ALA . 3.1 t -73.64 123.4 28.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 110.015 -0.365 . . . . 3.14 110.015 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 44.6 p -101.34 -22.48 14.58 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.143 0.497 . . . . 3.61 109.979 175.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.8 m -140.29 118.42 11.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.497 -0.774 . . . . 3.12 109.898 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 92' ' ' ARG . 7.2 pt-20 -97.83 163.77 12.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.093 0.473 . . . . 4.39 110.895 -179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 50.9 mt -83.84 108.23 16.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.751 -0.658 . . . . 3.62 110.498 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.575 ' HG2' ' H ' ' A' ' 93' ' ' THR . 21.0 ttm180 -134.65 -175.93 4.05 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.658 -0.497 . . . . 7.2 109.658 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.575 ' H ' ' HG2' ' A' ' 92' ' ' ARG . 17.8 p -90.2 156.76 18.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.864 0.364 . . . . 5.1 111.841 -175.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -88.09 -33.2 18.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.935 -0.575 . . . . 7.53 109.625 175.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.0 t -138.94 -70.06 0.42 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.329 -0.85 . . . . 7.47 109.599 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -139.08 -44.5 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.421 -0.354 . . . . 7.58 110.579 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 99' ' ' VAL . 83.1 m-20 -119.34 -136.38 0.34 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.584 -0.895 . . . . 8.32 108.584 178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 66.9 t30 69.59 -23.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.787 0.835 . . . . 7.26 112.259 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.747 ' O ' ' HG ' ' A' ' 100' ' ' LEU . 7.6 p -55.09 126.58 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.817 -0.174 . . . . 5.54 110.783 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.747 ' HG ' ' O ' ' A' ' 99' ' ' VAL . 4.4 pp 57.79 7.4 0.57 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.465 1.106 . . . . 7.28 113.066 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -74.97 -27.57 60.22 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.574 0.702 . . . . 7.54 109.627 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.1 t -150.53 159.37 44.53 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.371 -0.832 . . . . 5.41 109.008 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.2 t -82.96 44.77 0.95 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.488 0.661 . . . . 4.58 110.327 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -99.75 2.44 44.19 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.593 -0.731 . . . . 5.09 109.854 177.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -139.89 141.42 36.56 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.687 -0.688 . . . . 3.33 109.366 175.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.4 t -146.89 149.11 32.6 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.679 -0.489 . . . . 2.57 109.679 -178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 122' ' ' TYR . . . -85.71 168.35 41.55 Favored Glycine 0 N--CA 1.439 -1.103 0 C-N-CA 120.445 -0.883 . . . . 1.66 111.928 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -125.66 120.66 31.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.629 0.252 . . . . 3.03 110.657 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 82.8 mt -110.98 127.17 68.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.337 -0.616 . . . . 1.88 109.337 174.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.9 p -106.42 129.52 54.39 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.231 -0.441 . . . . 3.49 110.813 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.523 ' CE2' HD11 ' A' ' 120' ' ' LEU . 1.2 p90 -146.68 166.52 26.33 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.265 -0.643 . . . . 3.51 109.265 175.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.429 ' HG2' ' SG ' ' A' ' 117' ' ' CYS . 43.8 mt-10 -107.28 121.66 45.0 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.17 0.509 . . . . 5.1 111.18 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -116.36 114.1 23.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.454 -0.794 . . . . 4.78 109.069 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 64.84 21.01 12.28 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.978 0.511 . . . . 6.97 110.65 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 95.33 -3.3 66.15 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 116.014 -0.539 . . . . 5.1 112.045 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -102.63 129.05 49.09 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.888 0.375 . . . . 5.38 110.887 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.429 ' SG ' ' HG2' ' A' ' 112' ' ' GLU . 62.9 m -81.78 124.95 30.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.202 -0.454 . . . . 4.72 110.332 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -121.38 147.13 46.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.225 -0.443 . . . . 4.61 110.491 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -109.85 123.22 49.19 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.149 -0.478 . . . . 3.96 109.845 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.523 HD11 ' CE2' ' A' ' 111' ' ' TYR . 4.9 mp -105.38 134.88 19.46 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 110.262 -0.273 . . . . 2.75 110.262 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.57 133.15 11.48 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.966 2.444 . . . . 2.3 111.381 173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.402 ' CE1' ' HA3' ' A' ' 107' ' ' GLY . 12.7 p90 -144.81 147.76 33.24 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.789 -0.448 . . . . 2.13 109.789 179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.2 p -112.95 -179.94 3.79 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.845 -0.428 . . . . 3.07 109.845 173.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -72.76 -20.22 61.22 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.24 0.543 . . . . 4.8 110.867 -173.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -82.77 -4.8 58.44 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.79 -0.641 . . . . 4.81 111.23 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -89.45 -13.5 37.45 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.138 0.494 . . . . 3.84 110.58 176.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 156' ' ' ILE . 2.8 p -110.48 116.19 51.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.716 0.769 . . . . 4.39 111.124 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.43 ' HB3' ' OE1' ' A' ' 26' ' ' GLU . 1.1 mp0 -99.72 179.02 4.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.786 -1.097 . . . . 6.43 109.997 177.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.55 -10.78 64.93 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.569 -0.824 . . . . 5.91 112.315 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 66.46 25.46 10.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.88 0.472 . . . . 6.07 111.388 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 41.4 t -103.55 140.93 20.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.635 -0.257 . . . . 5.27 110.866 -178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -97.51 129.14 44.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.064 0.459 . . . . 5.78 110.239 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.633 HD23 ' H ' ' A' ' 133' ' ' LEU . 2.6 pt? -115.33 149.56 37.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.859 -0.61 . . . . 3.62 110.075 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 -124.23 174.44 7.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.16 0.505 . . . . 6.93 109.992 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.669 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . . . -74.97 122.06 22.9 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.269 0.557 . . . . 4.12 111.442 178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 117.04 -14.88 13.68 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.595 -0.812 . . . . 4.07 113.622 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -86.58 -177.55 6.18 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 117.901 0.85 . . . . 4.06 110.687 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -116.85 115.46 25.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.195 0.521 . . . . 4.17 111.815 -174.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.86 162.36 15.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.633 -0.712 . . . . 2.77 110.985 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.483 ' O ' ' HG2' ' A' ' 157' ' ' ARG . 45.8 t -126.37 129.47 48.87 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.612 -0.885 . . . . 3.47 108.612 177.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.0 146.99 50.49 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.071 0.462 . . . . 3.35 110.488 -176.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -106.18 112.81 26.0 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.736 -0.665 . . . . 5.34 109.919 -175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 65.6 mt -82.72 100.63 6.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.496 -0.775 . . . . 4.66 111.539 -175.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' A' ' 77' ' ' VAL . . . -83.01 111.05 18.5 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.731 -0.47 . . . . 4.85 109.731 173.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 21.1 m -86.72 116.12 24.61 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.802 -0.635 . . . . 5.68 111.309 -174.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -74.44 166.14 24.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 6.25 110.398 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -63.1 -32.58 73.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 8.58 111.856 -173.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 3.3 tmt_? -76.23 -22.9 54.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 7.86 110.382 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.68 11.78 42.92 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.575 -0.821 . . . . 5.59 112.766 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -114.49 127.34 55.76 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.794 -0.239 . . . . 5.18 110.384 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.494 ' N ' HD13 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -147.63 -176.92 5.44 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.094 0.474 . . . . 4.28 111.672 -173.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -139.27 -143.56 4.43 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.92 -0.872 . . . . 3.36 110.92 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -124.76 110.52 14.43 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.143 0.472 . . . . 2.84 109.963 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 45.6 t -122.78 162.14 22.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.563 -0.532 . . . . 4.34 109.563 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 56.56 37.87 29.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.162 0.506 . . . . 5.75 110.748 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 127' ' ' VAL . 69.5 mt -61.53 115.69 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.32 -0.855 . . . . 3.55 110.382 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 140' ' ' SER . 0.7 OUTLIER -111.56 143.84 41.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.979 0.418 . . . . 5.96 110.58 -176.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.4 tp -103.48 93.36 4.9 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.194 -0.669 . . . . 4.34 109.194 174.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -95.1 -28.4 15.1 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.739 -0.385 . . . . 4.97 110.958 -177.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -114.86 84.02 10.0 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.451 -0.574 . . . . 5.37 109.451 172.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.93 158.75 18.37 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.943 2.429 . . . . 5.44 113.185 -174.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -91.26 103.64 16.28 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.74 -0.664 . . . . 6.1 110.174 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.419 ' H ' ' CD ' ' A' ' 163' ' ' GLN . 5.3 pm0 -69.3 155.06 94.27 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.125 -0.489 . . . . 9.49 110.411 177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.57 114.1 1.32 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.056 2.504 . . . . 8.39 113.055 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.572 -0.74 . . . . 10.27 110.687 179.208 . . . . . . . . 0 0 . 1 stop_ save_